Citrus Sinensis ID: 020826
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 321 | 2.2.26 [Sep-21-2011] | |||||||
| O64816 | 432 | Casein kinase II subunit | yes | no | 0.956 | 0.710 | 0.910 | 1e-159 | |
| Q08467 | 409 | Casein kinase II subunit | no | no | 0.943 | 0.740 | 0.881 | 1e-148 | |
| Q08466 | 403 | Casein kinase II subunit | no | no | 0.943 | 0.751 | 0.877 | 1e-147 | |
| P28523 | 332 | Casein kinase II subunit | N/A | no | 0.943 | 0.912 | 0.884 | 1e-147 | |
| O64817 | 333 | Probable casein kinase II | no | no | 0.940 | 0.906 | 0.837 | 1e-139 | |
| P40231 | 332 | Casein kinase II subunit | yes | no | 0.900 | 0.870 | 0.733 | 1e-126 | |
| Q8TG13 | 336 | Casein kinase II subunit | N/A | no | 0.931 | 0.889 | 0.766 | 1e-125 | |
| P28020 | 392 | Casein kinase II subunit | N/A | no | 0.925 | 0.757 | 0.764 | 1e-125 | |
| O76484 | 353 | Casein kinase II subunit | N/A | no | 0.909 | 0.827 | 0.777 | 1e-125 | |
| P21868 | 391 | Casein kinase II subunit | yes | no | 0.909 | 0.746 | 0.773 | 1e-125 |
| >sp|O64816|CSK2P_ARATH Casein kinase II subunit alpha, chloroplastic OS=Arabidopsis thaliana GN=At2g23070 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 561 bits (1445), Expect = e-159, Method: Compositional matrix adjust.
Identities = 285/313 (91%), Positives = 298/313 (95%), Gaps = 6/313 (1%)
Query: 7 MVIYWCVWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREI 66
+ + W V QDDYEVVRKVGRGKYSEVFEG+H TDNEKC+IKILKPVKKKKIKREI
Sbjct: 122 LAVQWGV------QDDYEVVRKVGRGKYSEVFEGIHATDNEKCVIKILKPVKKKKIKREI 175
Query: 67 KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLK 126
KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN DFKVLYPTLSDYDVRYYI+ELLK
Sbjct: 176 KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNKDFKVLYPTLSDYDVRYYIFELLK 235
Query: 127 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 186
ALD+CHS+GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL
Sbjct: 236 ALDFCHSRGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 295
Query: 187 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246
LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY
Sbjct: 296 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYR 355
Query: 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 306
IELDP+L +LVGRHSRKPW+KFI ENQHLAVPEAVDF+DKLLRYDHQERPTAKEAMAHP
Sbjct: 356 IELDPNLTSLVGRHSRKPWTKFINSENQHLAVPEAVDFVDKLLRYDHQERPTAKEAMAHP 415
Query: 307 YFFPIRNAESSRS 319
YF+PIRNAESSR+
Sbjct: 416 YFYPIRNAESSRT 428
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q08467|CSK21_ARATH Casein kinase II subunit alpha-1 OS=Arabidopsis thaliana GN=CKA1 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 523 bits (1348), Expect = e-148, Method: Compositional matrix adjust.
Identities = 267/303 (88%), Positives = 283/303 (93%)
Query: 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNI 78
EQDDYEVVRKVGRGKYSEVFEG++ EKCIIKILKPVKKKKI+REIKILQNLCGGPNI
Sbjct: 106 EQDDYEVVRKVGRGKYSEVFEGINVNSKEKCIIKILKPVKKKKIRREIKILQNLCGGPNI 165
Query: 79 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMH 138
VKLLD+VRDQ SKTPSLIFE+VN+TDFKVLYPTL+DYD+RYYIYELLKALD+CHSQGIMH
Sbjct: 166 VKLLDVVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDFCHSQGIMH 225
Query: 139 RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 198
RDVKPHNVMIDHE RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD
Sbjct: 226 RDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 285
Query: 199 LWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVG 258
+WSLGCMFAGMIFRKEPFFYGHDN DQLVKIAKVLGTDELNAYLNKY +ELDP L ALVG
Sbjct: 286 MWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIAKVLGTDELNAYLNKYQLELDPQLEALVG 345
Query: 259 RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSR 318
RHSRKPWSKFI +NQHL PEA+DFLDKLLRYDHQ+R TAKEAMAH YF +R AE+SR
Sbjct: 346 RHSRKPWSKFINADNQHLVSPEAIDFLDKLLRYDHQDRLTAKEAMAHAYFAQVRAAETSR 405
Query: 319 SRS 321
RS
Sbjct: 406 MRS 408
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q08466|CSK22_ARATH Casein kinase II subunit alpha-2 OS=Arabidopsis thaliana GN=CKA2 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 522 bits (1345), Expect = e-147, Method: Compositional matrix adjust.
Identities = 266/303 (87%), Positives = 285/303 (94%)
Query: 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNI 78
EQDDYEVVRKVGRGKYSEVFEG++ +NEKCIIKILKPVKKKKI+REIKILQNLCGGPNI
Sbjct: 100 EQDDYEVVRKVGRGKYSEVFEGINMNNNEKCIIKILKPVKKKKIRREIKILQNLCGGPNI 159
Query: 79 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMH 138
VKLLD+VRDQ SKTPSLIFE+VN+TDFKVLYPTL+DYD+RYYIYELLKALD+CHSQGIMH
Sbjct: 160 VKLLDVVRDQHSKTPSLIFEYVNSTDFKVLYPTLTDYDIRYYIYELLKALDFCHSQGIMH 219
Query: 139 RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 198
RDVKPHNVMIDHE RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD
Sbjct: 220 RDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 279
Query: 199 LWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVG 258
+WSLGCMFAGMIFRKEPFFYGHDN DQLVKIAKVLGTDELNAYLNKY +ELD L ALVG
Sbjct: 280 MWSLGCMFAGMIFRKEPFFYGHDNQDQLVKIAKVLGTDELNAYLNKYQLELDTQLEALVG 339
Query: 259 RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSR 318
RHSRKPWSKFI +N+HL PEA+D+LDKLLRYDHQ+R TAKEAMAHPYF +R AESSR
Sbjct: 340 RHSRKPWSKFINADNRHLVSPEAIDYLDKLLRYDHQDRLTAKEAMAHPYFAQVRAAESSR 399
Query: 319 SRS 321
R+
Sbjct: 400 MRT 402
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P28523|CSK2A_MAIZE Casein kinase II subunit alpha OS=Zea mays GN=ACK2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 520 bits (1339), Expect = e-147, Method: Compositional matrix adjust.
Identities = 268/303 (88%), Positives = 283/303 (93%)
Query: 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNI 78
EQDDYEVVRKVGRGKYSEVFEG++ +NEKCIIKILKPVKKKKIKREIKILQNLCGGPNI
Sbjct: 30 EQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNI 89
Query: 79 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMH 138
VKLLDIVRDQ SKTPSLIFE+VNNTDFKVLYPTL+DYD+RYYIYELLKALDYCHSQGIMH
Sbjct: 90 VKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMH 149
Query: 139 RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 198
RDVKPHNVMIDHE RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD
Sbjct: 150 RDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 209
Query: 199 LWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVG 258
+WSLGCMFAGMIFRKEPFFYGHDN+DQLVKIAKVLGTD LN YLNKY IELDP L ALVG
Sbjct: 210 MWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEALVG 269
Query: 259 RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSR 318
RHSRKPW KF+ +NQHL PEA+DFLDKLLRYDHQER TA EAM HPYF +R AE+SR
Sbjct: 270 RHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQQVRAAENSR 329
Query: 319 SRS 321
+R+
Sbjct: 330 TRA 332
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. Zea mays (taxid: 4577) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64817|CSK23_ARATH Probable casein kinase II subunit alpha OS=Arabidopsis thaliana GN=At2g23080 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 495 bits (1274), Expect = e-139, Method: Compositional matrix adjust.
Identities = 253/302 (83%), Positives = 277/302 (91%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIV 79
QDDYEVVRKVGRGKYSEVFEG + NE+C+IKILKPVKKKKIKREIKILQNLCGGPNIV
Sbjct: 31 QDDYEVVRKVGRGKYSEVFEGKNVNTNERCVIKILKPVKKKKIKREIKILQNLCGGPNIV 90
Query: 80 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHR 139
KL DIVRD+ SKTPSL+FE VN+ DFKVLYPTL+DYD+RYYIYELLKALD+CHSQGIMHR
Sbjct: 91 KLYDIVRDEHSKTPSLVFEFVNSVDFKVLYPTLTDYDIRYYIYELLKALDFCHSQGIMHR 150
Query: 140 DVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDL 199
DVKPHNVMIDH+ RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD+
Sbjct: 151 DVKPHNVMIDHQLRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDM 210
Query: 200 WSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR 259
WSLGCMFAGMIFRKEPFFYGHDN+DQLVKIAKVLGT+EL+ YLNKY ++LDP L ALVGR
Sbjct: 211 WSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTNELDHYLNKYQLDLDPQLEALVGR 270
Query: 260 HSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSRS 319
H KPWSKFI +NQHL PEA+DFLDKLL+YDHQ+R TA+EAM HPYF ++ AESSR
Sbjct: 271 HVPKPWSKFINADNQHLVSPEAIDFLDKLLQYDHQDRLTAREAMDHPYFAQVKAAESSRL 330
Query: 320 RS 321
R+
Sbjct: 331 RT 332
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May act as an ectokinase that phosphorylates several extracellular proteins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P40231|CSK2A_SCHPO Casein kinase II subunit alpha OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=cka1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 452 bits (1162), Expect = e-126, Method: Compositional matrix adjust.
Identities = 212/289 (73%), Positives = 248/289 (85%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIV 79
QD+YE++RKVGRGKYSEVFEG++ +N KCIIK+LKPVK KKIKREIKILQNL GGPNI+
Sbjct: 40 QDNYEIIRKVGRGKYSEVFEGLNVLNNSKCIIKVLKPVKYKKIKREIKILQNLAGGPNII 99
Query: 80 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHR 139
LLDIVRD +SKTPSLIFE V+N DF+ LYPTLSDYD+RYY YELLKALD+CHS+GIMHR
Sbjct: 100 SLLDIVRDPESKTPSLIFEFVDNIDFRTLYPTLSDYDIRYYSYELLKALDFCHSRGIMHR 159
Query: 140 DVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDL 199
DVKPHNVMIDH++RKLRLIDWGLAEFYH G EYNVRVASRYFKGPELLVD ++YDYSLD+
Sbjct: 160 DVKPHNVMIDHKKRKLRLIDWGLAEFYHAGMEYNVRVASRYFKGPELLVDFREYDYSLDI 219
Query: 200 WSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR 259
WS G MFA +IF+K+ FF G DNYDQLVKIAKVLGTDEL AY+ KY I LD ++G+
Sbjct: 220 WSFGVMFAALIFKKDTFFRGRDNYDQLVKIAKVLGTDELFAYVQKYQIVLDRQYDNILGQ 279
Query: 260 HSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
+ ++ W F+ +N+ LA EA+D L++LLRYDHQER T +EAMAHPYF
Sbjct: 280 YPKRDWYSFVNRDNRSLANDEAIDLLNRLLRYDHQERLTCQEAMAHPYF 328
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. Plays a role in the translation of cell polarity into polarized growth. The alpha and alpha' chains contain the catalytic site. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8TG13|CSK2A_NEUCR Casein kinase II subunit alpha OS=Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) GN=cka PE=2 SV=1 | Back alignment and function description |
|---|
Score = 448 bits (1152), Expect = e-125, Method: Compositional matrix adjust.
Identities = 230/300 (76%), Positives = 260/300 (86%), Gaps = 1/300 (0%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVK 80
++YEVVRK+GRGKYSEVFEG++ + +KC+IK+LKPVKKKKIKREIKILQNL GGPNIV
Sbjct: 30 ENYEVVRKIGRGKYSEVFEGINVVNYQKCVIKVLKPVKKKKIKREIKILQNLAGGPNIVA 89
Query: 81 LLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRD 140
LLD+VRD QSKTPSLIFE+VNNT+F+ LYP +D+DVRYYI+ELLKALD+CHS+GIMHRD
Sbjct: 90 LLDVVRDSQSKTPSLIFEYVNNTEFRTLYPRFNDFDVRYYIFELLKALDFCHSKGIMHRD 149
Query: 141 VKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLW 200
VKPHNVMIDHE RKLRLIDWGLAEFYHPG EYNVRVASRYFKGPELLVD Q+YDYSLD+W
Sbjct: 150 VKPHNVMIDHENRKLRLIDWGLAEFYHPGTEYNVRVASRYFKGPELLVDFQEYDYSLDMW 209
Query: 201 SLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRH 260
SLG MFA MIFRKEPFF+G N DQLVKIAKVLGTDEL YL+KY IELD ++GR
Sbjct: 210 SLGAMFASMIFRKEPFFHGQSNSDQLVKIAKVLGTDELFDYLDKYEIELDAQYDDILGRF 269
Query: 261 SRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSRSR 320
RKPW FI ENQ EA+DFLDKLLRYDH ER TAKEAMAHPYF P+R+ E++R+R
Sbjct: 270 QRKPWHSFINAENQRFVSNEAIDFLDKLLRYDHNERLTAKEAMAHPYFAPVRD-EATRAR 328
|
Phosphorylates the frq clock protein thus regulating the circadian clock. Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) (taxid: 367110) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P28020|CSK21_XENLA Casein kinase II subunit alpha OS=Xenopus laevis GN=csnk2a1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 448 bits (1152), Expect = e-125, Method: Compositional matrix adjust.
Identities = 227/297 (76%), Positives = 263/297 (88%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIV 79
QDDY++VRK+GRGKYSEVFE ++ T+NEK ++KILKPVKKKKIKREIKIL+NL GGPNI+
Sbjct: 36 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNII 95
Query: 80 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHR 139
L DIV+D S+TP+L+FEHVNNTDFK LY TL+DYD+R+Y+YE+LKALDYCHS GIMHR
Sbjct: 96 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHR 155
Query: 140 DVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDL 199
DVKPHNVMIDHE RKLRLIDWGLAEFYHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+
Sbjct: 156 DVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDM 215
Query: 200 WSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR 259
WSLGCM A MIFRKEPFF+GHDNYDQLV+IAKVLGT++L Y++KY+IELDP ++GR
Sbjct: 216 WSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGR 275
Query: 260 HSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAES 316
HSRK W +F+ ENQHL PEA+DFLDKLLRYDHQ R TA+EAM HPYF+PI +S
Sbjct: 276 HSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQTRLTAREAMDHPYFYPIVKDQS 332
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha and alpha' chains contain the catalytic site. Participates in Wnt signaling. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O76484|CSK2A_SPOFR Casein kinase II subunit alpha OS=Spodoptera frugiperda PE=2 SV=1 | Back alignment and function description |
|---|
Score = 447 bits (1150), Expect = e-125, Method: Compositional matrix adjust.
Identities = 227/292 (77%), Positives = 260/292 (89%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIV 79
Q+DY++VRK+GRGKYSEVFE ++ T+NEKC++KILKPVKKKKIKREIKIL+NL GG NI+
Sbjct: 36 QEDYQLVRKLGRGKYSEVFEAINITNNEKCVVKILKPVKKKKIKREIKILENLRGGTNII 95
Query: 80 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHR 139
L +V+D S+TP+LIFEHVNNTDFK LY TLSDYD+RYY+YELLKALDYCHS GIMHR
Sbjct: 96 TLQAVVKDPVSRTPALIFEHVNNTDFKQLYQTLSDYDIRYYLYELLKALDYCHSMGIMHR 155
Query: 140 DVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDL 199
DVKPHNVMIDH+ RKLRLIDWGLAEFYHPG++YNVRVASRYFKGPELLVD Q YDYSLD+
Sbjct: 156 DVKPHNVMIDHDHRKLRLIDWGLAEFYHPGQDYNVRVASRYFKGPELLVDYQMYDYSLDM 215
Query: 200 WSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR 259
WSLGCM A MIFRKEPFF+GHDNYDQLV+IAKVLGT+EL YL+KYHIELDP ++GR
Sbjct: 216 WSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEELFEYLDKYHIELDPRFNDILGR 275
Query: 260 HSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311
HSRK W +F+ ENQHL PEA+DFLD+LLRYDH ER TA+EAM HPYF+PI
Sbjct: 276 HSRKRWERFVHSENQHLVSPEALDFLDRLLRYDHYERYTAREAMDHPYFYPI 327
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha chain contains the catalytic site. May participate in Wnt signaling. Spodoptera frugiperda (taxid: 7108) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P21868|CSK21_CHICK Casein kinase II subunit alpha OS=Gallus gallus GN=CSNK2A1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 447 bits (1150), Expect = e-125, Method: Compositional matrix adjust.
Identities = 226/292 (77%), Positives = 261/292 (89%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIV 79
QDDY++VRK+GRGKYSEVFE ++ T+NEK ++KILKPVKKKKIKREIKIL+NL GGPNI+
Sbjct: 36 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNII 95
Query: 80 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHR 139
L DIV+D S+TP+L+FEHVNNTDFK LY TL+DYD+R+Y+YE+LKALDYCHS GIMHR
Sbjct: 96 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHR 155
Query: 140 DVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDL 199
DVKPHNVMIDHE RKLRLIDWGLAEFYHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+
Sbjct: 156 DVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDM 215
Query: 200 WSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR 259
WSLGCM A MIFRKEPFF+GHDNYDQLV+IAKVLGT++L Y++KY+IELDP ++GR
Sbjct: 216 WSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGR 275
Query: 260 HSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311
HSRK W +F+ ENQHL PEA+DFLDKLLRYDHQ R TA+EAM HPYF+PI
Sbjct: 276 HSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYPI 327
|
Casein kinases are operationally defined by their preferential utilization of acidic proteins such as caseins as substrates. The alpha and alpha' chains contain the catalytic site. Participates in Wnt signaling. Gallus gallus (taxid: 9031) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 321 | ||||||
| 255568569 | 489 | casein kinase II, alpha chain, putative | 0.943 | 0.619 | 0.953 | 1e-161 | |
| 225438980 | 424 | PREDICTED: casein kinase II subunit alph | 0.943 | 0.714 | 0.957 | 1e-160 | |
| 224071301 | 448 | predicted protein [Populus trichocarpa] | 0.943 | 0.676 | 0.960 | 1e-160 | |
| 147841853 | 392 | hypothetical protein VITISV_034030 [Viti | 0.943 | 0.772 | 0.957 | 1e-160 | |
| 15227778 | 432 | casein kinase 2, alpha polypeptide [Arab | 0.956 | 0.710 | 0.910 | 1e-157 | |
| 297825193 | 432 | hypothetical protein ARALYDRAFT_481178 [ | 0.956 | 0.710 | 0.910 | 1e-157 | |
| 356563529 | 347 | PREDICTED: casein kinase II subunit alph | 0.943 | 0.873 | 0.937 | 1e-157 | |
| 449519104 | 441 | PREDICTED: casein kinase II subunit alph | 0.943 | 0.687 | 0.940 | 1e-157 | |
| 449448236 | 423 | PREDICTED: casein kinase II subunit alph | 0.943 | 0.716 | 0.940 | 1e-157 | |
| 17977868 | 414 | casein kinase II alpha subunit [Sinapis | 0.934 | 0.724 | 0.943 | 1e-156 |
| >gi|255568569|ref|XP_002525258.1| casein kinase II, alpha chain, putative [Ricinus communis] gi|223535416|gb|EEF37086.1| casein kinase II, alpha chain, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 572 bits (1475), Expect = e-161, Method: Compositional matrix adjust.
Identities = 289/303 (95%), Positives = 299/303 (98%)
Query: 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNI 78
EQDDYEVVRKVGRGKYSEVFEGVHC DNEKC+IKILKPVKKKKIKREIKILQNLCGGPNI
Sbjct: 187 EQDDYEVVRKVGRGKYSEVFEGVHCADNEKCVIKILKPVKKKKIKREIKILQNLCGGPNI 246
Query: 79 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMH 138
VKLLDIVRDQQSKTPSLIFE+VNNTDFKVLYPTLSDYD+RYYIYELLKALDYCHSQGIMH
Sbjct: 247 VKLLDIVRDQQSKTPSLIFEYVNNTDFKVLYPTLSDYDIRYYIYELLKALDYCHSQGIMH 306
Query: 139 RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 198
RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD
Sbjct: 307 RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 366
Query: 199 LWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVG 258
LWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY IELDPHLAALVG
Sbjct: 367 LWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYRIELDPHLAALVG 426
Query: 259 RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSR 318
RH+RKPW+KFI ++NQHLAVPEAV+FLDKLLRYDHQERPTAKEAMAHPYF+PIRNAESSR
Sbjct: 427 RHNRKPWAKFINMDNQHLAVPEAVNFLDKLLRYDHQERPTAKEAMAHPYFYPIRNAESSR 486
Query: 319 SRS 321
R+
Sbjct: 487 VRT 489
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225438980|ref|XP_002284333.1| PREDICTED: casein kinase II subunit alpha isoform 1 [Vitis vinifera] gi|296087330|emb|CBI33704.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 572 bits (1473), Expect = e-160, Method: Compositional matrix adjust.
Identities = 290/303 (95%), Positives = 300/303 (99%)
Query: 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNI 78
EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNI
Sbjct: 121 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNI 180
Query: 79 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMH 138
VKLLDIVRDQQSKTPSLIFE+VNNTDFKVLYPTLSDYD+RYYIYELLKALDYCHSQGIMH
Sbjct: 181 VKLLDIVRDQQSKTPSLIFEYVNNTDFKVLYPTLSDYDIRYYIYELLKALDYCHSQGIMH 240
Query: 139 RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 198
RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD
Sbjct: 241 RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 300
Query: 199 LWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVG 258
LWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY +ELDPHLAALVG
Sbjct: 301 LWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYRLELDPHLAALVG 360
Query: 259 RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSR 318
RHSRKPW+KF+ +NQHLAVPE++DFLDKLLRYDHQERPTAKEAMAHPYF+PIRNAESSR
Sbjct: 361 RHSRKPWTKFVNADNQHLAVPESIDFLDKLLRYDHQERPTAKEAMAHPYFYPIRNAESSR 420
Query: 319 SRS 321
SR+
Sbjct: 421 SRA 423
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224071301|ref|XP_002303393.1| predicted protein [Populus trichocarpa] gi|222840825|gb|EEE78372.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 571 bits (1471), Expect = e-160, Method: Compositional matrix adjust.
Identities = 291/303 (96%), Positives = 300/303 (99%)
Query: 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNI 78
EQDDYEVV+KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNI
Sbjct: 146 EQDDYEVVKKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNI 205
Query: 79 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMH 138
VKLLDIVRDQQSKTPSLIFE+VNNTDFKVLYPTLSD+D+RYYIYELLKALDYCHSQGIMH
Sbjct: 206 VKLLDIVRDQQSKTPSLIFEYVNNTDFKVLYPTLSDFDIRYYIYELLKALDYCHSQGIMH 265
Query: 139 RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 198
RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD
Sbjct: 266 RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 325
Query: 199 LWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVG 258
LWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN+Y IELD HLAALVG
Sbjct: 326 LWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNRYRIELDLHLAALVG 385
Query: 259 RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSR 318
RHSRKPWSKFI V+NQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF+PIRNAESSR
Sbjct: 386 RHSRKPWSKFINVDNQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFYPIRNAESSR 445
Query: 319 SRS 321
+R+
Sbjct: 446 TRT 448
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147841853|emb|CAN71837.1| hypothetical protein VITISV_034030 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 570 bits (1468), Expect = e-160, Method: Compositional matrix adjust.
Identities = 290/303 (95%), Positives = 300/303 (99%)
Query: 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNI 78
EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNI
Sbjct: 89 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNI 148
Query: 79 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMH 138
VKLLDIVRDQQSKTPSLIFE+VNNTDFKVLYPTLSDYD+RYYIYELLKALDYCHSQGIMH
Sbjct: 149 VKLLDIVRDQQSKTPSLIFEYVNNTDFKVLYPTLSDYDIRYYIYELLKALDYCHSQGIMH 208
Query: 139 RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 198
RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD
Sbjct: 209 RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 268
Query: 199 LWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVG 258
LWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY +ELDPHLAALVG
Sbjct: 269 LWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYRLELDPHLAALVG 328
Query: 259 RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSR 318
RHSRKPW+KF+ +NQHLAVPE++DFLDKLLRYDHQERPTAKEAMAHPYF+PIRNAESSR
Sbjct: 329 RHSRKPWTKFVNADNQHLAVPESIDFLDKLLRYDHQERPTAKEAMAHPYFYPIRNAESSR 388
Query: 319 SRS 321
SR+
Sbjct: 389 SRA 391
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15227778|ref|NP_179889.1| casein kinase 2, alpha polypeptide [Arabidopsis thaliana] gi|75318502|sp|O64816.1|CSK2P_ARATH RecName: Full=Casein kinase II subunit alpha, chloroplastic; Flags: Precursor gi|3169180|gb|AAC17823.1| putative casein kinase II catalytic (alpha) subunit [Arabidopsis thaliana] gi|17065110|gb|AAL32709.1| putative casein kinase II catalytic (alpha) subunit [Arabidopsis thaliana] gi|20148299|gb|AAM10040.1| putative casein kinase II catalytic (alpha) subunit [Arabidopsis thaliana] gi|330252310|gb|AEC07404.1| casein kinase 2, alpha polypeptide [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 561 bits (1445), Expect = e-157, Method: Compositional matrix adjust.
Identities = 285/313 (91%), Positives = 298/313 (95%), Gaps = 6/313 (1%)
Query: 7 MVIYWCVWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREI 66
+ + W V QDDYEVVRKVGRGKYSEVFEG+H TDNEKC+IKILKPVKKKKIKREI
Sbjct: 122 LAVQWGV------QDDYEVVRKVGRGKYSEVFEGIHATDNEKCVIKILKPVKKKKIKREI 175
Query: 67 KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLK 126
KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN DFKVLYPTLSDYDVRYYI+ELLK
Sbjct: 176 KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNKDFKVLYPTLSDYDVRYYIFELLK 235
Query: 127 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 186
ALD+CHS+GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL
Sbjct: 236 ALDFCHSRGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 295
Query: 187 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246
LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY
Sbjct: 296 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYR 355
Query: 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 306
IELDP+L +LVGRHSRKPW+KFI ENQHLAVPEAVDF+DKLLRYDHQERPTAKEAMAHP
Sbjct: 356 IELDPNLTSLVGRHSRKPWTKFINSENQHLAVPEAVDFVDKLLRYDHQERPTAKEAMAHP 415
Query: 307 YFFPIRNAESSRS 319
YF+PIRNAESSR+
Sbjct: 416 YFYPIRNAESSRT 428
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297825193|ref|XP_002880479.1| hypothetical protein ARALYDRAFT_481178 [Arabidopsis lyrata subsp. lyrata] gi|297326318|gb|EFH56738.1| hypothetical protein ARALYDRAFT_481178 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 561 bits (1445), Expect = e-157, Method: Compositional matrix adjust.
Identities = 285/313 (91%), Positives = 298/313 (95%), Gaps = 6/313 (1%)
Query: 7 MVIYWCVWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREI 66
+ + W V QDDYEVVRKVGRGKYSEVFEG+H TDNEKC+IKILKPVKKKKIKREI
Sbjct: 122 LAVQWGV------QDDYEVVRKVGRGKYSEVFEGIHATDNEKCVIKILKPVKKKKIKREI 175
Query: 67 KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLK 126
KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN DFKVLYPTLSDYDVRYYI+ELLK
Sbjct: 176 KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNKDFKVLYPTLSDYDVRYYIFELLK 235
Query: 127 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 186
ALD+CHS+GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL
Sbjct: 236 ALDFCHSRGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 295
Query: 187 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246
LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY
Sbjct: 296 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYR 355
Query: 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 306
IELDP+L +LVGRHSRKPW+KFI ENQHLAVPEAVDF+DKLLRYDHQERPTAKEAMAHP
Sbjct: 356 IELDPNLTSLVGRHSRKPWTKFINSENQHLAVPEAVDFVDKLLRYDHQERPTAKEAMAHP 415
Query: 307 YFFPIRNAESSRS 319
YF+PIRNAESSR+
Sbjct: 416 YFYPIRNAESSRT 428
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356563529|ref|XP_003550014.1| PREDICTED: casein kinase II subunit alpha-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 560 bits (1444), Expect = e-157, Method: Compositional matrix adjust.
Identities = 284/303 (93%), Positives = 297/303 (98%)
Query: 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNI 78
EQDDYEVVRKVGRGKYSEVFEGVHCTD EKC+IKILKPVKKKKIKREIKILQNLCGGPN+
Sbjct: 44 EQDDYEVVRKVGRGKYSEVFEGVHCTDGEKCVIKILKPVKKKKIKREIKILQNLCGGPNV 103
Query: 79 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMH 138
VKLLDIVRDQQSKTPSLIFE+VNNTDFKVLYPTLSDYD+RYYI+ELLKALDYCHSQGIMH
Sbjct: 104 VKLLDIVRDQQSKTPSLIFEYVNNTDFKVLYPTLSDYDIRYYIFELLKALDYCHSQGIMH 163
Query: 139 RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 198
RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD
Sbjct: 164 RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 223
Query: 199 LWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVG 258
LWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL+ YL+KY IELDPHLAAL+G
Sbjct: 224 LWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELSVYLDKYRIELDPHLAALIG 283
Query: 259 RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSR 318
RHSRKPW+KFI VEN HLAVPEAVDF+DKLLRYDHQERPTAKEAMAHPYF P+RNAESSR
Sbjct: 284 RHSRKPWAKFINVENHHLAVPEAVDFVDKLLRYDHQERPTAKEAMAHPYFNPVRNAESSR 343
Query: 319 SRS 321
+R+
Sbjct: 344 TRA 346
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449519104|ref|XP_004166575.1| PREDICTED: casein kinase II subunit alpha, chloroplastic-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 560 bits (1442), Expect = e-157, Method: Compositional matrix adjust.
Identities = 285/303 (94%), Positives = 297/303 (98%)
Query: 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNI 78
+QD+YEVVRKVGRGKYSEVFEGVHCTDNEKC+IKILKPVKKKKIKREIKILQNLCGG NI
Sbjct: 138 DQDNYEVVRKVGRGKYSEVFEGVHCTDNEKCVIKILKPVKKKKIKREIKILQNLCGGINI 197
Query: 79 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMH 138
VKLLDIVRDQQSKTPSLIFEHVNN DFKVLYPTLSD+D+RYYIYELLKALDYCHSQGIMH
Sbjct: 198 VKLLDIVRDQQSKTPSLIFEHVNNIDFKVLYPTLSDFDIRYYIYELLKALDYCHSQGIMH 257
Query: 139 RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 198
RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD
Sbjct: 258 RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 317
Query: 199 LWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVG 258
LWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN YL+KY IELDPHL+ALVG
Sbjct: 318 LWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNTYLSKYRIELDPHLSALVG 377
Query: 259 RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSR 318
RHSRKPW+KFI V+NQHLAVPEAVDF+DKLLRYDHQER TAKEAMAHPYFFPIRNAESSR
Sbjct: 378 RHSRKPWTKFINVDNQHLAVPEAVDFVDKLLRYDHQERLTAKEAMAHPYFFPIRNAESSR 437
Query: 319 SRS 321
+R+
Sbjct: 438 TRN 440
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449448236|ref|XP_004141872.1| PREDICTED: casein kinase II subunit alpha, chloroplastic-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 560 bits (1442), Expect = e-157, Method: Compositional matrix adjust.
Identities = 285/303 (94%), Positives = 297/303 (98%)
Query: 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNI 78
+QD+YEVVRKVGRGKYSEVFEGVHCTDNEKC+IKILKPVKKKKIKREIKILQNLCGG NI
Sbjct: 120 DQDNYEVVRKVGRGKYSEVFEGVHCTDNEKCVIKILKPVKKKKIKREIKILQNLCGGINI 179
Query: 79 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMH 138
VKLLDIVRDQQSKTPSLIFEHVNN DFKVLYPTLSD+D+RYYIYELLKALDYCHSQGIMH
Sbjct: 180 VKLLDIVRDQQSKTPSLIFEHVNNIDFKVLYPTLSDFDIRYYIYELLKALDYCHSQGIMH 239
Query: 139 RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 198
RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD
Sbjct: 240 RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 299
Query: 199 LWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVG 258
LWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN YL+KY IELDPHL+ALVG
Sbjct: 300 LWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNTYLSKYRIELDPHLSALVG 359
Query: 259 RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSR 318
RHSRKPW+KFI V+NQHLAVPEAVDF+DKLLRYDHQER TAKEAMAHPYFFPIRNAESSR
Sbjct: 360 RHSRKPWTKFINVDNQHLAVPEAVDFVDKLLRYDHQERLTAKEAMAHPYFFPIRNAESSR 419
Query: 319 SRS 321
+R+
Sbjct: 420 TRN 422
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|17977868|emb|CAD12663.1| casein kinase II alpha subunit [Sinapis alba] | Back alignment and taxonomy information |
|---|
Score = 558 bits (1439), Expect = e-156, Method: Compositional matrix adjust.
Identities = 283/300 (94%), Positives = 292/300 (97%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIV 79
QDDYEVVRKVGRGKYSEVFEG+H TDNEKC+IKILKPVKKKKIKREIKILQNLCGGPNIV
Sbjct: 110 QDDYEVVRKVGRGKYSEVFEGIHATDNEKCVIKILKPVKKKKIKREIKILQNLCGGPNIV 169
Query: 80 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHR 139
KLLDIVRDQQSKTPSLIFEHVNN DFKVLYPTLSDYDVRYYIYELLKALD+CHS+GIMHR
Sbjct: 170 KLLDIVRDQQSKTPSLIFEHVNNKDFKVLYPTLSDYDVRYYIYELLKALDFCHSRGIMHR 229
Query: 140 DVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDL 199
DVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL DYDYSLDL
Sbjct: 230 DVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLMDYDYSLDL 289
Query: 200 WSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR 259
WSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN YLN+Y IELDP+LA+LVGR
Sbjct: 290 WSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNTYLNRYRIELDPNLASLVGR 349
Query: 260 HSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSRS 319
HSRKPWSKFI ENQHLAVPEAVDF+DKLL+YDHQERPTAKEAMAHPYF PIRNAESSRS
Sbjct: 350 HSRKPWSKFINSENQHLAVPEAVDFVDKLLKYDHQERPTAKEAMAHPYFNPIRNAESSRS 409
|
Source: Sinapis alba Species: Sinapis alba Genus: Sinapis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 321 | ||||||
| TAIR|locus:2045339 | 432 | AT2G23070 [Arabidopsis thalian | 0.934 | 0.694 | 0.876 | 2.2e-144 | |
| UNIPROTKB|Q9AR27 | 333 | OSCKA2 "Casein kinase II alpha | 0.940 | 0.906 | 0.831 | 1.3e-137 | |
| TAIR|locus:2045349 | 333 | CKA3 "casein kinase II, alpha | 0.940 | 0.906 | 0.774 | 2.8e-128 | |
| UNIPROTKB|P21868 | 391 | CSNK2A1 "Casein kinase II subu | 0.909 | 0.746 | 0.712 | 1e-116 | |
| ZFIN|ZDB-GENE-040625-181 | 393 | zgc:86598 "zgc:86598" [Danio r | 0.909 | 0.743 | 0.708 | 7.1e-116 | |
| UNIPROTKB|P68399 | 391 | CSNK2A1 "Casein kinase II subu | 0.909 | 0.746 | 0.705 | 9.1e-116 | |
| UNIPROTKB|E2RHZ1 | 391 | CSNK2A1 "Uncharacterized prote | 0.909 | 0.746 | 0.705 | 9.1e-116 | |
| UNIPROTKB|E7EU96 | 385 | CSNK2A1 "Casein kinase II subu | 0.909 | 0.758 | 0.705 | 9.1e-116 | |
| UNIPROTKB|P68400 | 391 | CSNK2A1 "Casein kinase II subu | 0.909 | 0.746 | 0.705 | 9.1e-116 | |
| UNIPROTKB|F2Z5I5 | 391 | CSNK2A1 "Uncharacterized prote | 0.909 | 0.746 | 0.705 | 9.1e-116 |
| TAIR|locus:2045339 AT2G23070 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1411 (501.8 bits), Expect = 2.2e-144, P = 2.2e-144
Identities = 263/300 (87%), Positives = 273/300 (91%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIV 79
QDDYEVVRKVGRGKYSEVFEG+H TDNE LQNLCGGPNIV
Sbjct: 129 QDDYEVVRKVGRGKYSEVFEGIHATDNEKCVIKILKPVKKKKIKREIKILQNLCGGPNIV 188
Query: 80 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHR 139
KLLDIVRDQQSKTPSLIFEHVNN DFKVLYPTLSDYDVRYYI+ELLKALD+CHS+GIMHR
Sbjct: 189 KLLDIVRDQQSKTPSLIFEHVNNKDFKVLYPTLSDYDVRYYIFELLKALDFCHSRGIMHR 248
Query: 140 DVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDL 199
DVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDL
Sbjct: 249 DVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDL 308
Query: 200 WSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR 259
WSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY IELDP+L +LVGR
Sbjct: 309 WSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYRIELDPNLTSLVGR 368
Query: 260 HSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSRS 319
HSRKPW+KFI ENQHLAVPEAVDF+DKLLRYDHQERPTAKEAMAHPYF+PIRNAESSR+
Sbjct: 369 HSRKPWTKFINSENQHLAVPEAVDFVDKLLRYDHQERPTAKEAMAHPYFYPIRNAESSRT 428
|
|
| UNIPROTKB|Q9AR27 OSCKA2 "Casein kinase II alpha subunit" [Oryza sativa Indica Group (taxid:39946)] | Back alignment and assigned GO terms |
|---|
Score = 1347 (479.2 bits), Expect = 1.3e-137, P = 1.3e-137
Identities = 251/302 (83%), Positives = 266/302 (88%)
Query: 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNI 78
EQDDYEVVRKVGRGKYSEVFEG++ +NE LQNLCGGPNI
Sbjct: 30 EQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGGPNI 89
Query: 79 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMH 138
VKLLDIVRDQ SKTPSLIFE+VNNTDFKVLYPTL+DYD+RYYIYELLKALDYCHSQGIMH
Sbjct: 90 VKLLDIVRDQHSKTPSLIFEYVNNTDFKVLYPTLTDYDIRYYIYELLKALDYCHSQGIMH 149
Query: 139 RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 198
RDVKPHNVMIDHE RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD
Sbjct: 150 RDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 209
Query: 199 LWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVG 258
+WSLGCMFAGMIFRKEPFFYGHDN+DQLVKIAKVLGT+ LNAYLNKYHIELDP L ALVG
Sbjct: 210 MWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTEALNAYLNKYHIELDPQLEALVG 269
Query: 259 RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSR 318
RHSRKPWSKFI +NQHL PEAVDFLDKLLRYDHQ+R TA+EAMAHPYF +R AE+SR
Sbjct: 270 RHSRKPWSKFINADNQHLVSPEAVDFLDKLLRYDHQDRLTAREAMAHPYFLQVRAAENSR 329
Query: 319 SR 320
+R
Sbjct: 330 AR 331
|
|
| TAIR|locus:2045349 CKA3 "casein kinase II, alpha chain 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1259 (448.2 bits), Expect = 2.8e-128, P = 2.8e-128
Identities = 234/302 (77%), Positives = 256/302 (84%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIV 79
QDDYEVVRKVGRGKYSEVFEG + NE LQNLCGGPNIV
Sbjct: 31 QDDYEVVRKVGRGKYSEVFEGKNVNTNERCVIKILKPVKKKKIKREIKILQNLCGGPNIV 90
Query: 80 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHR 139
KL DIVRD+ SKTPSL+FE VN+ DFKVLYPTL+DYD+RYYIYELLKALD+CHSQGIMHR
Sbjct: 91 KLYDIVRDEHSKTPSLVFEFVNSVDFKVLYPTLTDYDIRYYIYELLKALDFCHSQGIMHR 150
Query: 140 DVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDL 199
DVKPHNVMIDH+ RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD+
Sbjct: 151 DVKPHNVMIDHQLRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDM 210
Query: 200 WSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR 259
WSLGCMFAGMIFRKEPFFYGHDN+DQLVKIAKVLGT+EL+ YLNKY ++LDP L ALVGR
Sbjct: 211 WSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTNELDHYLNKYQLDLDPQLEALVGR 270
Query: 260 HSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSRS 319
H KPWSKFI +NQHL PEA+DFLDKLL+YDHQ+R TA+EAM HPYF ++ AESSR
Sbjct: 271 HVPKPWSKFINADNQHLVSPEAIDFLDKLLQYDHQDRLTAREAMDHPYFAQVKAAESSRL 330
Query: 320 RS 321
R+
Sbjct: 331 RT 332
|
|
| UNIPROTKB|P21868 CSNK2A1 "Casein kinase II subunit alpha" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 1150 (409.9 bits), Expect = 1.0e-116, P = 1.0e-116
Identities = 208/292 (71%), Positives = 241/292 (82%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIV 79
QDDY++VRK+GRGKYSEVFE ++ T+NE L+NL GGPNI+
Sbjct: 36 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNII 95
Query: 80 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHR 139
L DIV+D S+TP+L+FEHVNNTDFK LY TL+DYD+R+Y+YE+LKALDYCHS GIMHR
Sbjct: 96 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHR 155
Query: 140 DVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDL 199
DVKPHNVMIDHE RKLRLIDWGLAEFYHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+
Sbjct: 156 DVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDM 215
Query: 200 WSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR 259
WSLGCM A MIFRKEPFF+GHDNYDQLV+IAKVLGT++L Y++KY+IELDP ++GR
Sbjct: 216 WSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGR 275
Query: 260 HSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311
HSRK W +F+ ENQHL PEA+DFLDKLLRYDHQ R TA+EAM HPYF+PI
Sbjct: 276 HSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYPI 327
|
|
| ZFIN|ZDB-GENE-040625-181 zgc:86598 "zgc:86598" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 1142 (407.1 bits), Expect = 7.1e-116, P = 7.1e-116
Identities = 207/292 (70%), Positives = 240/292 (82%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIV 79
QDDY++VRK+GRGKYSEVFE ++ T+NE L+NL GGPNI+
Sbjct: 36 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNII 95
Query: 80 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHR 139
LLDI++D S+TP+L+FEHVNNTDFK LY TLSDYD+R+Y+YE+LKALDYCHS GIMHR
Sbjct: 96 TLLDIIKDPVSRTPALVFEHVNNTDFKQLYQTLSDYDIRFYMYEILKALDYCHSMGIMHR 155
Query: 140 DVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDL 199
DVKPHNVMIDHE RKLRLIDWGLAEFYHP +EYNVRVASRYFKGPELLVD Q YDYSLD+
Sbjct: 156 DVKPHNVMIDHEHRKLRLIDWGLAEFYHPSQEYNVRVASRYFKGPELLVDYQMYDYSLDM 215
Query: 200 WSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR 259
WSLGCM A MIFRKEPFF+GHDNYDQLV+IAKVLGT++L Y++KY+IELDP ++GR
Sbjct: 216 WSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGR 275
Query: 260 HSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311
HSRK W +F+ ENQHL EA+DFLDKLLRYDHQ R TA+EAM HPYF+PI
Sbjct: 276 HSRKRWERFVHSENQHLVSTEALDFLDKLLRYDHQARLTAREAMEHPYFYPI 327
|
|
| UNIPROTKB|P68399 CSNK2A1 "Casein kinase II subunit alpha" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 1141 (406.7 bits), Expect = 9.1e-116, P = 9.1e-116
Identities = 206/292 (70%), Positives = 240/292 (82%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIV 79
QDDY++VRK+GRGKYSEVFE ++ T+NE L+NL GGPNI+
Sbjct: 36 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNII 95
Query: 80 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHR 139
L DIV+D S+TP+L+FEHVNNTDFK LY TL+DYD+R+Y+YE+LKALDYCHS GIMHR
Sbjct: 96 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHR 155
Query: 140 DVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDL 199
DVKPHNVMIDHE RKLRLIDWGLAEFYHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+
Sbjct: 156 DVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDM 215
Query: 200 WSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR 259
WSLGCM A MIFRKEPFF+GHDNYDQLV+IAKVLGT++L Y++KY+IELDP ++GR
Sbjct: 216 WSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGR 275
Query: 260 HSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311
HSRK W +F+ ENQHL PEA+DFLDKLLRYDHQ R TA+EAM HPYF+ +
Sbjct: 276 HSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 327
|
|
| UNIPROTKB|E2RHZ1 CSNK2A1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 1141 (406.7 bits), Expect = 9.1e-116, P = 9.1e-116
Identities = 206/292 (70%), Positives = 240/292 (82%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIV 79
QDDY++VRK+GRGKYSEVFE ++ T+NE L+NL GGPNI+
Sbjct: 36 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNII 95
Query: 80 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHR 139
L DIV+D S+TP+L+FEHVNNTDFK LY TL+DYD+R+Y+YE+LKALDYCHS GIMHR
Sbjct: 96 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHR 155
Query: 140 DVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDL 199
DVKPHNVMIDHE RKLRLIDWGLAEFYHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+
Sbjct: 156 DVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDM 215
Query: 200 WSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR 259
WSLGCM A MIFRKEPFF+GHDNYDQLV+IAKVLGT++L Y++KY+IELDP ++GR
Sbjct: 216 WSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGR 275
Query: 260 HSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311
HSRK W +F+ ENQHL PEA+DFLDKLLRYDHQ R TA+EAM HPYF+ +
Sbjct: 276 HSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 327
|
|
| UNIPROTKB|E7EU96 CSNK2A1 "Casein kinase II subunit alpha" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1141 (406.7 bits), Expect = 9.1e-116, P = 9.1e-116
Identities = 206/292 (70%), Positives = 240/292 (82%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIV 79
QDDY++VRK+GRGKYSEVFE ++ T+NE L+NL GGPNI+
Sbjct: 36 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNII 95
Query: 80 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHR 139
L DIV+D S+TP+L+FEHVNNTDFK LY TL+DYD+R+Y+YE+LKALDYCHS GIMHR
Sbjct: 96 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHR 155
Query: 140 DVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDL 199
DVKPHNVMIDHE RKLRLIDWGLAEFYHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+
Sbjct: 156 DVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDM 215
Query: 200 WSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR 259
WSLGCM A MIFRKEPFF+GHDNYDQLV+IAKVLGT++L Y++KY+IELDP ++GR
Sbjct: 216 WSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGR 275
Query: 260 HSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311
HSRK W +F+ ENQHL PEA+DFLDKLLRYDHQ R TA+EAM HPYF+ +
Sbjct: 276 HSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 327
|
|
| UNIPROTKB|P68400 CSNK2A1 "Casein kinase II subunit alpha" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 1141 (406.7 bits), Expect = 9.1e-116, P = 9.1e-116
Identities = 206/292 (70%), Positives = 240/292 (82%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIV 79
QDDY++VRK+GRGKYSEVFE ++ T+NE L+NL GGPNI+
Sbjct: 36 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNII 95
Query: 80 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHR 139
L DIV+D S+TP+L+FEHVNNTDFK LY TL+DYD+R+Y+YE+LKALDYCHS GIMHR
Sbjct: 96 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHR 155
Query: 140 DVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDL 199
DVKPHNVMIDHE RKLRLIDWGLAEFYHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+
Sbjct: 156 DVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDM 215
Query: 200 WSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR 259
WSLGCM A MIFRKEPFF+GHDNYDQLV+IAKVLGT++L Y++KY+IELDP ++GR
Sbjct: 216 WSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGR 275
Query: 260 HSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311
HSRK W +F+ ENQHL PEA+DFLDKLLRYDHQ R TA+EAM HPYF+ +
Sbjct: 276 HSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 327
|
|
| UNIPROTKB|F2Z5I5 CSNK2A1 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 1141 (406.7 bits), Expect = 9.1e-116, P = 9.1e-116
Identities = 206/292 (70%), Positives = 240/292 (82%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEXXXXXXXXXXXXXXXXXXXXXLQNLCGGPNIV 79
QDDY++VRK+GRGKYSEVFE ++ T+NE L+NL GGPNI+
Sbjct: 36 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNII 95
Query: 80 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHR 139
L DIV+D S+TP+L+FEHVNNTDFK LY TL+DYD+R+Y+YE+LKALDYCHS GIMHR
Sbjct: 96 TLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHR 155
Query: 140 DVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDL 199
DVKPHNVMIDHE RKLRLIDWGLAEFYHPG+EYNVRVASRYFKGPELLVD Q YDYSLD+
Sbjct: 156 DVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDM 215
Query: 200 WSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR 259
WSLGCM A MIFRKEPFF+GHDNYDQLV+IAKVLGT++L Y++KY+IELDP ++GR
Sbjct: 216 WSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGR 275
Query: 260 HSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311
HSRK W +F+ ENQHL PEA+DFLDKLLRYDHQ R TA+EAM HPYF+ +
Sbjct: 276 HSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 327
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P19454 | CSK22_YEAST | 2, ., 7, ., 1, 1, ., 1 | 0.6515 | 0.8909 | 0.8436 | yes | no |
| O64817 | CSK23_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.8377 | 0.9408 | 0.9069 | no | no |
| P21869 | CSK22_CHICK | 2, ., 7, ., 1, 1, ., 1 | 0.7366 | 0.9345 | 0.8571 | no | no |
| P21868 | CSK21_CHICK | 2, ., 7, ., 1, 1, ., 1 | 0.7739 | 0.9096 | 0.7468 | yes | no |
| Q8TG13 | CSK2A_NEUCR | 2, ., 7, ., 1, 1, ., 1 | 0.7666 | 0.9314 | 0.8898 | N/A | no |
| P20427 | CSK22_BOVIN | 2, ., 7, ., 1, 1, ., 1 | 0.7441 | 0.9252 | 0.8485 | no | no |
| P68399 | CSK21_BOVIN | 2, ., 7, ., 1, 1, ., 1 | 0.7671 | 0.9096 | 0.7468 | yes | no |
| P28523 | CSK2A_MAIZE | 2, ., 7, ., 1, 1, ., 1 | 0.8844 | 0.9439 | 0.9126 | N/A | no |
| O64816 | CSK2P_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.9105 | 0.9563 | 0.7106 | yes | no |
| P18334 | CSK2A_CAEEL | 2, ., 7, ., 1, 1, ., 1 | 0.7533 | 0.9221 | 0.8222 | yes | no |
| P08181 | CSK2A_DROME | 2, ., 7, ., 1, 1, ., 1 | 0.7635 | 0.9221 | 0.8809 | yes | no |
| P19139 | CSK21_RAT | 2, ., 7, ., 1, 1, ., 1 | 0.7450 | 0.9408 | 0.7723 | yes | no |
| O76484 | CSK2A_SPOFR | 2, ., 7, ., 1, 1, ., 1 | 0.7773 | 0.9096 | 0.8271 | N/A | no |
| P28547 | CSK2A_THEPA | 2, ., 7, ., 1, 1, ., 1 | 0.7167 | 0.9127 | 0.8419 | yes | no |
| P68400 | CSK21_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.7671 | 0.9096 | 0.7468 | yes | no |
| Q8SRU0 | CSK2A_ENCCU | 2, ., 7, ., 1, 1, ., 1 | 0.5016 | 0.9127 | 0.9184 | yes | no |
| Q4U925 | CSK2A_THEAN | 2, ., 7, ., 1, 1, ., 1 | 0.7133 | 0.9127 | 0.8419 | no | no |
| P40231 | CSK2A_SCHPO | 2, ., 7, ., 1, 1, ., 1 | 0.7335 | 0.9003 | 0.8704 | yes | no |
| Q02720 | CSK2A_DICDI | 2, ., 7, ., 1, 1, ., 1 | 0.7278 | 0.9408 | 0.8961 | yes | no |
| P33674 | CSK21_RABIT | 2, ., 7, ., 1, 1, ., 1 | 0.7671 | 0.9096 | 0.7468 | yes | no |
| P19784 | CSK22_HUMAN | 2, ., 7, ., 1, 1, ., 1 | 0.7373 | 0.9252 | 0.8485 | no | no |
| O54833 | CSK22_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.7441 | 0.9252 | 0.8485 | no | no |
| P28020 | CSK21_XENLA | 2, ., 7, ., 1, 1, ., 1 | 0.7643 | 0.9252 | 0.7576 | N/A | no |
| Q60737 | CSK21_MOUSE | 2, ., 7, ., 1, 1, ., 1 | 0.7450 | 0.9408 | 0.7723 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.994 |
| 3rd Layer | 2.7.11 | 0.998 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 321 | |||
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-70 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-69 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 6e-64 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-60 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-57 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-55 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 3e-55 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 4e-54 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-52 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-48 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-48 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 7e-47 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-47 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-46 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-45 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-45 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-44 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-44 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-44 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-44 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-43 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-42 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-42 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 6e-42 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 6e-42 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-42 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-41 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-40 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-40 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-40 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-40 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 4e-40 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 8e-40 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-39 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-38 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-37 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-37 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 8e-36 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-35 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-35 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-34 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-34 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-34 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-34 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-32 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 3e-32 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-31 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 1e-31 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-31 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-31 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-31 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-30 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-30 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-29 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-29 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-29 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 7e-26 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-25 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-25 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 8e-25 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-24 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-24 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-24 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 5e-23 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 8e-23 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-22 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-22 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-21 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-21 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-20 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-19 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-18 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-18 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-17 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 2e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-17 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-17 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 9e-17 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-16 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 3e-16 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 5e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 8e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 8e-16 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-15 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-15 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-15 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-14 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-14 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-14 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-14 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 4e-14 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 5e-14 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-14 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-14 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-13 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-13 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-13 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-13 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-13 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-13 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-13 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-13 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-13 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-13 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-12 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-12 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-12 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-12 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 3e-12 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-12 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-12 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-12 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-12 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 6e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-12 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 7e-12 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 8e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 9e-12 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-11 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-11 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-11 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-11 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-11 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-11 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-11 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-11 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 4e-11 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 5e-11 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 6e-11 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 6e-11 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-11 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 8e-11 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 9e-11 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-10 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 2e-10 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-10 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-10 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-10 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-10 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-10 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 7e-10 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 8e-10 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-10 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-09 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-09 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-09 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 2e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-09 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-09 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-09 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-09 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-09 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 4e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-09 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 5e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-09 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-09 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-09 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-08 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-08 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-08 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-08 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-08 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-08 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-08 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 5e-08 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-08 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 9e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-07 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 3e-07 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 9e-07 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-06 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-06 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-06 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-06 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 3e-06 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-06 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-06 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 8e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-06 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 3e-05 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-05 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-05 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 3e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 4e-05 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-05 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 6e-05 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 8e-05 | |
| PRK09605 | 535 | PRK09605, PRK09605, bifunctional UGMP family prote | 1e-04 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-04 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-04 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-04 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 2e-04 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-04 | |
| pfam01636 | 238 | pfam01636, APH, Phosphotransferase enzyme family | 2e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-04 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-04 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-04 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 4e-04 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-04 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 5e-04 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-04 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-04 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 6e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 7e-04 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 8e-04 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 0.001 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 0.001 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.001 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 0.003 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 0.004 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 0.004 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 217 bits (556), Expect = 7e-70
Identities = 85/295 (28%), Positives = 137/295 (46%), Gaps = 44/295 (14%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-----REIKILQNLCGGPN 77
YE++RK+G G + V++ H + +KILK +K K REI+IL+ L PN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRL-SHPN 59
Query: 78 IVKLLDIVRDQQSKTPSLIFEHVNNTDFK---VLYPTLSDYDVRYYIYELLKALDYCHSQ 134
IV+L+D D L+ E+ D LS+ + + ++L+ L+Y HS
Sbjct: 60 IVRLIDAFED--KDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 135 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQDY 193
GI+HRD+KP N+++D +++ D+GLA+ V + ++ PE+L+ Y
Sbjct: 118 GIIHRDLKPENILLDENGV-VKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGY 176
Query: 194 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 253
+D+WSLG + ++ K P F G + DQL I ++LG
Sbjct: 177 GPKVDVWSLGVILYELLTGKPP-FSGENILDQLQLIRRILGPP----------------- 218
Query: 254 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
K+ + EA D + K L D +RPTA+E + HP+F
Sbjct: 219 -------LEFDEPKWSSGS------EEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 214 bits (548), Expect = 9e-69
Identities = 93/293 (31%), Positives = 148/293 (50%), Gaps = 46/293 (15%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGPNI 78
YE++ K+G G + +V+ + IK++K K KK I REIKIL+ L PNI
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKL-KHPNI 59
Query: 79 VKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL--YPTLSDYDVRYYIYELLKALDYCHSQG 135
V+L D+ D+ L+ E+ D F +L LS+ + R+Y+ ++L AL+Y HS+G
Sbjct: 60 VRLYDVFEDEDK--LYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG 117
Query: 136 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 195
I+HRD+KP N+++D E ++L D+GLA PG++ V + + PE+L+ + Y
Sbjct: 118 IVHRDLKPENILLD-EDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLG-KGYGK 175
Query: 196 SLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA 255
++D+WSLG + ++ K P F G D +L K
Sbjct: 176 AVDIWSLGVILYELLTGK-PPFPGDDQLLELFKK-------------------------- 208
Query: 256 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
+G+ + PEA D + KLL D ++R TA+EA+ HP+F
Sbjct: 209 -IGKPKPPFPPPEWDIS------PEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 203 bits (518), Expect = 6e-64
Identities = 100/298 (33%), Positives = 161/298 (54%), Gaps = 28/298 (9%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-IK----REIKILQNLCGGPN 77
YE + K+G G Y V++ E +K ++ +++ I REI +L+ L PN
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-KHPN 59
Query: 78 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYELLKALDYCHS 133
IVKLLD++ ++ L+FE+ + D K LS ++ +Y+LL+ L YCHS
Sbjct: 60 IVKLLDVIHTERKLY--LVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116
Query: 134 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQD 192
I+HRD+KP N++I+ + L+L D+GLA F P + Y V + +++ PE+L+ +
Sbjct: 117 HRILHRDLKPQNILINRDGV-LKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKH 175
Query: 193 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY--LNKYHIELD 250
Y ++D+WS+GC+FA MI +P F G DQL KI ++LGT ++ + K
Sbjct: 176 YSTAVDIWSVGCIFAEMI-TGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL----- 229
Query: 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
P + K K + + PE +D L K+L+Y+ +R +AKEA+ HPYF
Sbjct: 230 PDYKPTFPKFPPKDLEKVLPRLD-----PEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 196 bits (501), Expect = 1e-60
Identities = 107/320 (33%), Positives = 169/320 (52%), Gaps = 49/320 (15%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK----KKIKREIKILQNLCGGPN 77
YE+++ +G G Y V V K IK I K+I REIK+L++L N
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHEN 60
Query: 78 IVKLLDIVRDQQSKTPSLIFEHVN------NTDF-KVLY--PTLSDYDVRYYIYELLKAL 128
I+ LLDI+R + F V TD KV+ L+D ++Y++Y++L+ L
Sbjct: 61 IIGLLDILRPPSPED----FNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGL 116
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-----EFYHPGK--EYNVRVASRYF 181
Y HS ++HRD+KP N++++ L++ D+GLA + G EY V +R++
Sbjct: 117 KYLHSANVIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDEDEKGFLTEY---VVTRWY 172
Query: 182 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DEL 238
+ PELL+ Y ++D+WS+GC+FA ++ RK P F G D DQL I +VLGT ++L
Sbjct: 173 RAPELLLSSSRYTKAIDIWSVGCIFAELLTRK-PLFPGRDYIDQLNLIVEVLGTPSEEDL 231
Query: 239 NAYLN---KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE 295
+ + +++ P +KP SK + PEA+D L+K+L +D ++
Sbjct: 232 KFITSEKARNYLKSLPK-------KPKKPLSKLFPGAS-----PEAIDLLEKMLVFDPKK 279
Query: 296 RPTAKEAMAHPYFFPIRNAE 315
R TA EA+AHPY + + E
Sbjct: 280 RITADEALAHPYLAQLHDPE 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 185 bits (473), Expect = 4e-57
Identities = 90/301 (29%), Positives = 158/301 (52%), Gaps = 29/301 (9%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQNLCGGPN 77
YE + ++G G Y +V++ + E +K ++ +K+ REIK+LQ L PN
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRH-PN 59
Query: 78 IVKLLDIVRDQQSKTPSLIFEHV--------NNTDFKVLYPTLSDYDVRYYIYELLKALD 129
IV+L +IV + + ++FE++ ++ + K ++ ++ Y+ +LL+ L
Sbjct: 60 IVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK-----FTESQIKCYMKQLLEGLQ 114
Query: 130 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP--GKEYNVRVASRYFKGPELL 187
Y HS GI+HRD+K N++I+++ L+L D+GLA Y +Y RV + +++ PELL
Sbjct: 115 YLHSNGILHRDIKGSNILINNDGV-LKLADFGLARPYTKRNSADYTNRVITLWYRPPELL 173
Query: 188 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247
+ Y +D+WS+GC+ A + F +P F G +QL KI ++ G+ + +
Sbjct: 174 LGATRYGPEVDMWSVGCILAEL-FLGKPIFQGSTELEQLEKIFELCGSPTDENWPG---V 229
Query: 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 307
P L + + + +HL P A+D LDKLL D ++R +A +A+ H Y
Sbjct: 230 SKLPWFENL--KPKKPYKRRLREFF-KHLIDPSALDLLDKLLTLDPKKRISADQALQHEY 286
Query: 308 F 308
F
Sbjct: 287 F 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 181 bits (462), Expect = 2e-55
Identities = 95/300 (31%), Positives = 151/300 (50%), Gaps = 26/300 (8%)
Query: 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKKKKIK----REIKILQNLCGGP 76
Y+++ ++G G + VF+ E +K + + I REIK LQ C P
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQA-CQHP 59
Query: 77 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYELLKALDYCH 132
+VKLLD+ L+ E++ + +VL P L + V+ Y+ LLK + Y H
Sbjct: 60 YVVKLLDVFPHGSGF--VLVMEYMPSDLSEVLRDEERP-LPEAQVKSYMRMLLKGVAYMH 116
Query: 133 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDL 190
+ GIMHRD+KP N++I L++ D+GLA + + Y+ +VA+R+++ PELL
Sbjct: 117 ANGIMHRDLKPANLLIS-ADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGA 175
Query: 191 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250
+ YD +DLW++GC+FA ++ P F G ++ +QL + + LGT + +
Sbjct: 176 RKYDPGVDLWAVGCIFAELL-NGSPLFPGENDIEQLAIVFRTLGTPNEETWPG---LTSL 231
Query: 251 PHLAALVGRHS-RKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF 309
P + S P + A PEA+D L LL YD +R +A EA+ HPYF
Sbjct: 232 PDYNKITFPESKPIPLEEIFPD-----ASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 180 bits (460), Expect = 3e-55
Identities = 104/302 (34%), Positives = 162/302 (53%), Gaps = 35/302 (11%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPN 77
Y+ + K+G G Y V++ E IK +K K REIK+L+ L PN
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPN 59
Query: 78 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYELLKALDYCHS 133
I+KLLD+ R + L+FE ++ +K++ L + ++ Y+Y+LL+ L +CHS
Sbjct: 60 IIKLLDVFRHKGDL--YLVFEFMDTDLYKLIKDRQRG-LPESLIKSYLYQLLQGLAFCHS 116
Query: 134 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQD 192
GI+HRD+KP N++I+ + L+L D+GLA F P + Y V +R+++ PELL+ +
Sbjct: 117 HGILHRDLKPENLLIN-TEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG 175
Query: 193 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT------DELNAYLNKYH 246
Y +D+WS+GC+FA ++ R+ P F G DQL KI + LGT + + Y
Sbjct: 176 YSTPVDIWSVGCIFAELLSRR-PLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234
Query: 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 306
P A + P K A P+A+D L ++L YD +R TA++A+AHP
Sbjct: 235 FSF-PKKAGM-------PLPKLFPN-----ASPQALDLLSQMLHYDPHKRITAEQALAHP 281
Query: 307 YF 308
YF
Sbjct: 282 YF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 178 bits (454), Expect = 4e-54
Identities = 95/304 (31%), Positives = 156/304 (51%), Gaps = 36/304 (11%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--------REIKILQNLCG 74
YE +K+G G Y+ V++ IK +K ++K+ K REIK+LQ L
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-K 60
Query: 75 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDY 130
PNI+ LLD+ + + +L+FE + TD + + L+ D++ Y+ L+ L+Y
Sbjct: 61 HPNIIGLLDVFGHKSNI--NLVFEFME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEY 117
Query: 131 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVD 189
HS I+HRD+KP+N++I L+L D+GLA + P ++ +V +R+++ PELL
Sbjct: 118 LHSNWILHRDLKPNNLLIA-SDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFG 176
Query: 190 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN----AYLNKY 245
+ Y +D+WS+GC+FA ++ R PF G + DQL KI + LGT
Sbjct: 177 ARHYGVGVDMWSVGCIFAELLLRV-PFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD 235
Query: 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305
++E P P + + +A+D L +LL + +R TA++A+ H
Sbjct: 236 YVEFKP--------FPPTPLKQIFPAASD-----DALDLLQRLLTLNPNKRITARQALEH 282
Query: 306 PYFF 309
PYF
Sbjct: 283 PYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 174 bits (442), Expect = 2e-52
Identities = 105/301 (34%), Positives = 152/301 (50%), Gaps = 30/301 (9%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPN 77
YEV+ VG G Y V + + E IK K KK RE+K+L+ L N
Sbjct: 3 YEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHEN 61
Query: 78 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYD-VRYYIYELLKALDYCHSQ 134
IV L + R + L+FE+V T ++L P D VR YI++LL+A+ YCHS
Sbjct: 62 IVNLKEAFR--RKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSH 119
Query: 135 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH--PGKEYNVRVASRYFKGPELLVDLQD 192
I+HRD+KP N+++ E L+L D+G A P VA+R+++ PELLV +
Sbjct: 120 NIIHRDIKPENILVS-ESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178
Query: 193 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL--- 249
Y +D+W++GC+ A ++ EP F G + DQL I K LG L H EL
Sbjct: 179 YGKPVDVWAIGCIMAELL-DGEPLFPGDSDIDQLYLIQKCLGP------LPPSHQELFSS 231
Query: 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPE--AVDFLDKLLRYDHQERPTAKEAMAHPY 307
+P A + + S+ ++E ++ A+DFL LR D +ER T E + HPY
Sbjct: 232 NPRFAGV----AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287
Query: 308 F 308
F
Sbjct: 288 F 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 2e-48
Identities = 94/296 (31%), Positives = 160/296 (54%), Gaps = 24/296 (8%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKKKKIKREIKILQNLCGGPNI 78
Y+++ K+G G +SEV + + KC+ K K +++ REI+ L+ L PNI
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNI 60
Query: 79 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYELLKALDYCHSQ 134
++L++++ D+++ +L+FE ++ ++++ P L + V+ Y+Y+LLK+LD+ H
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRP-LPEKRVKSYMYQLLKSLDHMHRN 119
Query: 135 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 194
GI HRD+KP N++I L+L D+G + Y +++R+++ PE L+ Y
Sbjct: 120 GIFHRDIKPENILIK--DDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYG 177
Query: 195 YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT--DELNAYLNKYHIELDPH 252
+D+W++GC+F ++ P F G + DQ+ KI VLGT E+ K ++ +
Sbjct: 178 PKMDIWAVGCVFFEILSLF-PLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSR-HMNYN 235
Query: 253 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
+ G RK A E +D L KLL YD ER TAK+A+ HPYF
Sbjct: 236 FPSKKGTGLRK---------LLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 7e-48
Identities = 99/305 (32%), Positives = 158/305 (51%), Gaps = 41/305 (13%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIKIL 69
Y+ V K+G G Y V++ E V KKI+ REI +L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEI--------VALKKIRLETEDEGVPSTAIREISLL 52
Query: 70 QNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD-----VRYYIYEL 124
+ L PNIV+LLD+V ++K L+FE ++ D K + ++ Y+Y+L
Sbjct: 53 KEL-NHPNIVRLLDVVH-SENKL-YLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQL 108
Query: 125 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKG 183
L+ + YCHS ++HRD+KP N++ID E L+L D+GLA F P + Y V + +++
Sbjct: 109 LQGIAYCHSHRVLHRDLKPQNLLIDREG-ALKLADFGLARAFGVPVRTYTHEVVTLWYRA 167
Query: 184 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243
PE+L+ + Y +D+WS+GC+FA M+ R+ P F G DQL +I + LGT + + +
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRR-PLFPGDSEIDQLFRIFRTLGTPDEDVWPG 226
Query: 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 303
+ P + +R+ SK + + + +D L K+L YD +R +AK A+
Sbjct: 227 ---VTSLPDYKPTFPKWARQDLSKVVPNLD-----EDGLDLLSKMLVYDPAKRISAKAAL 278
Query: 304 AHPYF 308
HPYF
Sbjct: 279 QHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 7e-47
Identities = 100/317 (31%), Positives = 165/317 (52%), Gaps = 52/317 (16%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-----------REIKIL 69
D YE + K+G G Y +V++ + L +KK +++ REI +L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGK------LVALKKTRLEMDEEGIPPTALREISLL 54
Query: 70 QNLCGGPNIVKLLDIVR-DQQSKTPSL--IFEHVNNTDFKVLYPT--------LSDYDVR 118
Q L IV+LLD+ ++++ PSL +FE+++ +D K + L ++
Sbjct: 55 QMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLD-SDLKKFMDSNGRGPGRPLPAKTIK 113
Query: 119 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVA 177
++Y+LLK + +CH G+MHRD+KP N+++D ++ L++ D GL F P K Y +
Sbjct: 114 SFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV 173
Query: 178 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 237
+ +++ PE+L+ Y +D+WS+GC+FA M RK+P F G QL+ I K+LGT
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS-RKQPLFPGDSELQQLLHIFKLLGTPT 232
Query: 238 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAV------PEAVDFLDKLLRY 291
+ P ++ L + W +F + Q L+ PE +D L K+LRY
Sbjct: 233 EQVW---------PGVSKL------RDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRY 277
Query: 292 DHQERPTAKEAMAHPYF 308
D +R +AK A+ HPYF
Sbjct: 278 DPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (403), Expect = 8e-47
Identities = 91/304 (29%), Positives = 152/304 (50%), Gaps = 39/304 (12%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--------REIKILQNLCG 74
Y+V++++G G + V+ + E IK +K KK RE+K L+ L
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMK----KKFYSWEECMNLREVKSLRKLNE 56
Query: 75 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYELLKALDY 130
PNIVKL ++ R+ + +FE++ ++++ S+ +R IY++L+ L +
Sbjct: 57 HPNIVKLKEVFRE--NDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 131 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 190
H G HRD+KP N+++ +++ D+GLA Y V++R+++ PE+L+
Sbjct: 115 IHKHGFFHRDLKPENLLVS-GPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRS 173
Query: 191 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250
Y +D+W+LGC+ A + + P F G DQL KI VLGT + Y
Sbjct: 174 TSYSSPVDIWALGCIMAEL-YTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGY----- 227
Query: 251 PHLAALVGRHSRKPWSKFITVENQHL------AVPEAVDFLDKLLRYDHQERPTAKEAMA 304
LA+ +G +F L A PEA+D + +LR+D ++RPTA +A+
Sbjct: 228 -KLASKLGF-------RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279
Query: 305 HPYF 308
HPYF
Sbjct: 280 HPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 7e-46
Identities = 93/305 (30%), Positives = 162/305 (53%), Gaps = 29/305 (9%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-----KPVKKKKIKREIKILQNLCGG 75
Y+ + +G G Y V + +K IK + P K+ RE+KIL++
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KH 63
Query: 76 PNIVKLLDIVRDQQS--KTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYC 131
NI+ + DI+R + K ++ + + + +++ L++ +RY++Y+LL+ L Y
Sbjct: 64 DNIIAIRDILRPPGADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYI 123
Query: 132 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY------HPG--KEYNVRVASRYFKG 183
HS ++HRD+KP N++++ E +LR+ D+G+A H EY VA+R+++
Sbjct: 124 HSANVIHRDLKPSNLLVN-EDCELRIGDFGMARGLSSSPTEHKYFMTEY---VATRWYRA 179
Query: 184 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243
PELL+ L +Y ++D+WS+GC+FA M+ R++ F G + QL I VLG+ LN
Sbjct: 180 PELLLSLPEYTTAIDMWSVGCIFAEMLGRRQ-LFPGKNYVHQLKLILSVLGSPS-EEVLN 237
Query: 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 303
+ + + R PWSK A PEA+D L ++L++D +ER T ++A+
Sbjct: 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPK-----ASPEALDLLSQMLQFDPEERITVEQAL 292
Query: 304 AHPYF 308
HP+
Sbjct: 293 QHPFL 297
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 4e-45
Identities = 90/318 (28%), Positives = 153/318 (48%), Gaps = 63/318 (19%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIKIL 69
YE + ++G G Y V++ + V KK++ REI +L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTG--------RFVALKKVRVPLSEEGIPLSTLREIALL 52
Query: 70 QNL--CGGPNIVKLLDI---VRDQQSKTPSLIFEHVNN--TDF--KVLYPTLSDYDVRYY 120
+ L PNIV+LLD+ R + +L+FEHV+ + K P L ++
Sbjct: 53 KQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDL 112
Query: 121 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----V 176
+ +LL+ +D+ HS I+HRD+KP N+++ + + +++ D+GLA Y + + V
Sbjct: 113 MRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQ-VKIADFGLARIY----SFEMALTSVV 167
Query: 177 ASRYFKGPELLVDLQD-YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 235
+ +++ PE+L LQ Y +D+WS+GC+FA + FR+ P F G DQL KI V+G
Sbjct: 168 VTLWYRAPEVL--LQSSYATPVDMWSVGCIFAEL-FRRRPLFRGTSEADQLDKIFDVIGL 224
Query: 236 ---DE--LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLR 290
+E N L + ++ + + F+ E +D L K+L
Sbjct: 225 PSEEEWPRNVSLPRSSFP----------SYTPRSFKSFVPEIC-----EEGLDLLKKMLT 269
Query: 291 YDHQERPTAKEAMAHPYF 308
++ +R +A EA+ HPYF
Sbjct: 270 FNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 6e-45
Identities = 98/308 (31%), Positives = 167/308 (54%), Gaps = 39/308 (12%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK----KIKREIKILQNLCGGP 76
Y+ + +G G Y V H K IK + P + + + REIKIL+
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-KHE 63
Query: 77 NIVKLLDIVR--DQQSKTPSLIFEHVNNTD-FKVLYP-TLSDYDVRYYIYELLKALDYCH 132
NI+ +LDI+R +S I + + TD +K++ LS+ ++Y++Y++L+ L Y H
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIH 123
Query: 133 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-----EFYHPGK--EYNVRVASRYFKGPE 185
S ++HRD+KP N++++ L++ D+GLA E H G EY VA+R+++ PE
Sbjct: 124 SANVLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTGFLTEY---VATRWYRAPE 179
Query: 186 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYL 242
++++ + Y ++D+WS+GC+ A M+ + P F G D QL I VLGT ++LN +
Sbjct: 180 IMLNSKGYTKAIDIWSVGCILAEMLSNR-PLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238
Query: 243 N---KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA 299
+ + +I+ P + PW+K + P+A+D LDK+L ++ +R T
Sbjct: 239 SLRARNYIKSLPF-------KPKVPWNKLFPNAD-----PKALDLLDKMLTFNPHKRITV 286
Query: 300 KEAMAHPY 307
+EA+AHPY
Sbjct: 287 EEALAHPY 294
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 1e-44
Identities = 101/322 (31%), Positives = 161/322 (50%), Gaps = 52/322 (16%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI-------------KREIKIL 69
YE+++K+G+G Y V++ + E V KKI REI L
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEV--------VALKKIFDAFRNATDAQRTFREIMFL 60
Query: 70 QNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKA 127
Q L PNIVKLL++++ + K L+FE++ TD + L D RY +Y+LLKA
Sbjct: 61 QELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRANILEDVHKRYIMYQLLKA 119
Query: 128 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR------VASRYF 181
L Y HS ++HRD+KP N++++ + R ++L D+GLA +E VA+R++
Sbjct: 120 LKYIHSGNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATRWY 178
Query: 182 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---TDEL 238
+ PE+L+ Y +D+WS+GC+ M+ K P F G +QL KI +V+G +++
Sbjct: 179 RAPEILLGSTRYTKGVDMWSVGCILGEMLLGK-PLFPGTSTLNQLEKIIEVIGPPSAEDI 237
Query: 239 NAYLNKYHIELDPHLAALVGRHS----RKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQ 294
+ + AA + RKP + + A +A+D L KLL ++
Sbjct: 238 ES--------IKSPFAATMLDSLPSRPRKPLDELLPK-----ASDDALDLLKKLLVFNPN 284
Query: 295 ERPTAKEAMAHPYFFPIRNAES 316
+R TA+EA+ HPY N
Sbjct: 285 KRLTAEEALEHPYVAQFHNPSD 306
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 2e-44
Identities = 102/313 (32%), Positives = 162/313 (51%), Gaps = 40/313 (12%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLCG 74
D YE V K+G G Y V++ NE +K ++ V I REI +L+ +
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAI-REISLLKEMQH 60
Query: 75 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD-----VRYYIYELLKALD 129
G NIV+L D+V + K L+FE+++ D K + D+ ++ Y+Y++L+ +
Sbjct: 61 G-NIVRLQDVVHSE--KRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA 116
Query: 130 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 188
YCHS ++HRD+KP N++ID L+L D+GLA F P + + V + +++ PE+L+
Sbjct: 117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILL 176
Query: 189 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248
+ Y +D+WS+GC+FA M+ +K P F G D+L KI ++LGT +
Sbjct: 177 GSRHYSTPVDIWSVGCIFAEMVNQK-PLFPGDSEIDELFKIFRILGTPNEETW------- 228
Query: 249 LDPHLAALVGRHSRKP-WSKFITVENQHLAV------PEAVDFLDKLLRYDHQERPTAKE 301
P + +L S P W + LA P VD L K+LR D +R TA+
Sbjct: 229 --PGVTSLPDYKSAFPKW------PPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARA 280
Query: 302 AMAHPYFFPIRNA 314
A+ H YF + +A
Sbjct: 281 ALEHEYFKDLGDA 293
|
Length = 294 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 154 bits (390), Expect = 5e-44
Identities = 88/322 (27%), Positives = 141/322 (43%), Gaps = 55/322 (17%)
Query: 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK------IKREIKILQNLCGG 75
Y ++RK+G G + EV+ D + +K+L + K REI+IL +L
Sbjct: 1 SYRILRKLGEGSFGEVYLAR---DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 76 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALD 129
PNIVKL D +D+ S L+ E+V+ + L LS+ + + + ++L AL+
Sbjct: 58 PNIVKLYDFFQDEGSLY--LVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALE 115
Query: 130 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-------HPGKEYNVRVASRYFK 182
Y HS+GI+HRD+KP N+++D + R ++LID+GLA+ + V + +
Sbjct: 116 YLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 183 GPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPF--FYGHDNYDQLVKIAKVLGTDEL 238
PE+L+ L S D+WSLG ++ PF Q +KI L T L
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235
Query: 239 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT 298
+ L+ N L A D L KLL D + R +
Sbjct: 236 ASPLSPS---------------------------NPELISKAASDLLKKLLAKDPKNRLS 268
Query: 299 AKEAMAHPYFFPIRNAESSRSR 320
+ ++H ++ ES S
Sbjct: 269 SSSDLSHDLLAHLKLKESDLSD 290
|
Length = 384 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 149 bits (378), Expect = 7e-44
Identities = 56/190 (29%), Positives = 94/190 (49%), Gaps = 12/190 (6%)
Query: 29 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGPNIVKLLDI 84
+G G + V+ +K IKI+K + REI+IL+ L PNIVKL +
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGV 59
Query: 85 VRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRD 140
D+ L+ E+ K L LS+ ++ + ++L+ L+Y HS GI+HRD
Sbjct: 60 FEDENH--LYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 141 VKPHNVMIDHEQRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDL 199
+KP N+++D + K++L D+GL++ V + + PE+L+ Y D+
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDI 177
Query: 200 WSLGCMFAGM 209
WSLG + +
Sbjct: 178 WSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 3e-43
Identities = 92/320 (28%), Positives = 168/320 (52%), Gaps = 51/320 (15%)
Query: 21 DDYEVVRKVGRGKYSEVFEGV-HCTDNEKCIIKILKP----VKKKKIKREIKILQNLCGG 75
D Y+ + VG G Y +V T + I K+ +P + K+ RE+++L+++
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDH- 73
Query: 76 PNIVKLLDIVRDQQSKTPSLIFEHVNN-TDFKVLYP-------------TLSDYDVRYYI 121
N++ LLD+ TP+ + + D ++ LSD +++ +
Sbjct: 74 ENVIGLLDVF------TPA---SSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLV 124
Query: 122 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYF 181
Y++L+ L Y HS GI+HRD+KP N+ ++ E +L+++D+GLA H E VA+R++
Sbjct: 125 YQILRGLKYIHSAGIIHRDLKPSNIAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWY 181
Query: 182 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT--DELN 239
+ PE++++ Y+ ++D+WS+GC+ A ++ K F G D+ DQL +I ++GT +EL
Sbjct: 182 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK-TLFPGSDHIDQLKRIMNLVGTPDEELL 240
Query: 240 AYLN----KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE 295
++ + +I+ P + +K + + + N P A+D L+K+L D +
Sbjct: 241 QKISSESARNYIQSLP-------QMPKKDFKEVFSGAN-----PLAIDLLEKMLVLDPDK 288
Query: 296 RPTAKEAMAHPYFFPIRNAE 315
R TA EA+AHPY + E
Sbjct: 289 RITAAEALAHPYLAEYHDPE 308
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 1e-42
Identities = 93/302 (30%), Positives = 159/302 (52%), Gaps = 26/302 (8%)
Query: 23 YEVVRKVGRGKYSEVFEG--VHCTDNEKCIIKILKPVKKKKIK-----REIKILQNLCGG 75
YE+++++G+G Y V ++ E IK + V KKI RE+K+L++ G
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGH 61
Query: 76 PNIVKL--LDIVRDQQSKTPSLIFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDY 130
NI L +DIV L +E + D + + L+D + +IY++L L Y
Sbjct: 62 KNITCLYDMDIVFPGNFNELYL-YEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKY 120
Query: 131 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR-----VASRYFKGPE 185
HS ++HRD+KP N++++ + +L++ D+GLA + N VA+R+++ PE
Sbjct: 121 IHSANVLHRDLKPGNLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179
Query: 186 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245
+++ Q Y ++D+WS+GC+ A ++ RK P F G D DQL +I +VLGT + L++
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAELLGRK-PVFKGKDYVDQLNQILQVLGTPDEET-LSRI 237
Query: 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305
+ + +KP+ N P A+D L+KLL +D +R + +EA+ H
Sbjct: 238 GSPKAQNYIRSLPNIPKKPFESIFPNAN-----PLALDLLEKLLAFDPTKRISVEEALEH 292
Query: 306 PY 307
PY
Sbjct: 293 PY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 2e-42
Identities = 94/329 (28%), Positives = 153/329 (46%), Gaps = 64/329 (19%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKKKKIK----REIKILQNLCG 74
DYE++ K+G G + EV++ +K IL +K REIKIL+ L
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-K 65
Query: 75 GPNIVKLLDIV---RDQQSKTPSLIF------EH-----VNNTDFKVLYPTLSDYDVRYY 120
PN+V L+D+ D+ + ++ +H + N K L++ ++ Y
Sbjct: 66 HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK-----LTESQIKCY 120
Query: 121 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY--------HPG--- 169
+ +LL+ ++Y H I+HRD+K N++ID+ Q L++ D+GLA Y G
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDN-QGILKIADFGLARPYDGPPPNPKGGGGGG 179
Query: 170 -KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 228
++Y V +R+++ PELL+ + Y ++D+W +GC+FA M R+ P G + DQL
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR-PILQGKSDIDQLHL 238
Query: 229 IAKVLGT---------DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVP 279
I K+ GT L + + R +F + P
Sbjct: 239 IFKLCGTPTEETWPGWRSLPGCEGVH----------SFTNYPRTLEERFGKL------GP 282
Query: 280 EAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
E +D L KLL D +R TA +A+ HPYF
Sbjct: 283 EGLDLLSKLLSLDPYKRLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 6e-42
Identities = 90/297 (30%), Positives = 159/297 (53%), Gaps = 25/297 (8%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLCGGP 76
++ V K+G G Y V++ + E +K ++ V I REI +L+ L P
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKEL-NHP 59
Query: 77 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT----LSDYDVRYYIYELLKALDYCH 132
NIVKLLD++ + L+FE ++ K + + + ++ Y+++LL+ L +CH
Sbjct: 60 NIVKLLDVIHTE--NKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 133 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLVDLQ 191
S ++HRD+KP N++I+ + ++L D+GLA F P + Y V + +++ PE+L+ +
Sbjct: 118 SHRVLHRDLKPQNLLIN-TEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 176
Query: 192 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251
Y ++D+WSLGC+FA M+ R+ F G DQL +I + LGT + + + P
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRR-ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL---P 232
Query: 252 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
+ +R+ +SK + + + D L ++L YD +R +AK A+AHP+F
Sbjct: 233 DYKPSFPKWARQDFSKVVPPLD-----EDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 145 bits (368), Expect = 6e-42
Identities = 82/294 (27%), Positives = 135/294 (45%), Gaps = 49/294 (16%)
Query: 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK---IKREIKILQNLCGGPNI 78
+E++ K+G+G + EV++ H ++ IK++K K+K I EI+IL+ C PNI
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILK-KCKHPNI 59
Query: 79 VKLLDIVRDQQSKTPSLIFEHVNN---TD-FKVLYPTLSDYDVRYYIYELLKALDYCHSQ 134
VK + ++ E + D K TL++ + Y ELLK L+Y HS
Sbjct: 60 VKYYGSY--LKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 135 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 194
GI+HRD+K N+++ + +++LID+GL+ K N V + Y+ PE++ + YD
Sbjct: 118 GIIHRDIKAANILLTSDG-EVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-KPYD 175
Query: 195 YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLA 254
Y D+WSLG + K P+ EL P A
Sbjct: 176 YKADIWSLGITAIELAEGKPPYS------------------------------ELPPMKA 205
Query: 255 A-LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 307
+ + + N E DFL K L+ + ++RPTA++ + HP+
Sbjct: 206 LFKIATNG------PPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 9e-42
Identities = 88/300 (29%), Positives = 155/300 (51%), Gaps = 31/300 (10%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-------KKKIKREIKILQNLCGG 75
++ + K+G G Y+ V++G + T E I LK + REI +++ L
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGE---IVALKEIHLDAEEGTPSTAIREISLMKEL-KH 57
Query: 76 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT------LSDYDVRYYIYELLKALD 129
NIV+L D++ + L+FE+++ D K T L V+ + Y+LLK +
Sbjct: 58 ENIVRLHDVIHTENKLM--LVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIA 114
Query: 130 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYFKGPELLV 188
+CH ++HRD+KP N++I+ L+L D+GLA F P ++ V + +++ P++L+
Sbjct: 115 FCHENRVLHRDLKPQNLLINKRGE-LKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLL 173
Query: 189 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248
+ Y S+D+WS+GC+ A MI + P F G +N DQL+KI +++GT + + I
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMITGR-PLFPGTNNEDQLLKIFRIMGTPTESTWPG---IS 229
Query: 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
P R+ + + A P +D L +LL+ + + R +A +A+ HP+F
Sbjct: 230 QLPEYKPTFPRYPPQDLQQLFPH-----ADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 4e-41
Identities = 89/299 (29%), Positives = 151/299 (50%), Gaps = 29/299 (9%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--------KKKIKREIKILQNLCG 74
YE + K+G G Y VF+ + +E I LK V+ REI +L+ L
Sbjct: 2 YEKLEKIGEGTYGTVFKAKNRETHE---IVALKRVRLDDDDEGVPSSALREICLLKEL-K 57
Query: 75 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY----DVRYYIYELLKALDY 130
NIV+L D++ + T L+FE+ + D K + + + V+ ++++LLK L +
Sbjct: 58 HKNIVRLYDVLHSDKKLT--LVFEYCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAF 114
Query: 131 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVD 189
CHS ++HRD+KP N++I+ + +L+L D+GLA + P + Y+ V + +++ P++L
Sbjct: 115 CHSHNVLHRDLKPQNLLIN-KNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFG 173
Query: 190 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249
+ Y S+D+WS GC+FA + P F G+D DQL +I ++LGT ++ +
Sbjct: 174 AKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKL-- 231
Query: 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
P + + N D L LL + +R +A+EA+ HPYF
Sbjct: 232 -PDYKPYPMYPATTSLVNVVPKLN-----STGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 2e-40
Identities = 94/311 (30%), Positives = 155/311 (49%), Gaps = 48/311 (15%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--------PVKKKKIKREIKILQNL 72
+ YE + K+G G Y VF+ C + E I +K PV KK REI++L+ L
Sbjct: 1 EKYEKLSKIGEGSYGVVFK---CRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL 57
Query: 73 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPT-LSDYDVRYYIYELLKALD 129
PN+V L+++ R + + L+FE+ ++T L P + ++ ++ I++ L+A++
Sbjct: 58 -KHPNLVNLIEVFR--RKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVN 114
Query: 130 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLV 188
+CH +HRDVKP N++I + + ++L D+G A PG +Y VA+R+++ PELLV
Sbjct: 115 FCHKHNCIHRDVKPENILITKQGQ-IKLCDFGFARILTGPGDDYTDYVATRWYRAPELLV 173
Query: 189 -DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL--------- 238
D Q Y +D+W++GC+FA ++ +P + G + DQL I K LG +L
Sbjct: 174 GDTQ-YGPPVDVWAIGCVFAELL-TGQPLWPGKSDVDQLYLIRKTLG--DLIPRHQQIFS 229
Query: 239 -NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP 297
N + I L + A+ FL L+ D ER
Sbjct: 230 TNQFFKGLSIPEPETREPLESKFPNIS--------------SPALSFLKGCLQMDPTERL 275
Query: 298 TAKEAMAHPYF 308
+ +E + HPYF
Sbjct: 276 SCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 144 bits (364), Expect = 2e-40
Identities = 100/314 (31%), Positives = 165/314 (52%), Gaps = 44/314 (14%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-KPVKK----KKIKREIKILQNLCGGPN 77
Y +++VG G Y V + EK IK L +P + K+ RE+ +L+++ N
Sbjct: 17 YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM-QHEN 75
Query: 78 IVKLLDIVRDQQSKTPSLIFEHVNN---------TDF-KVLYPTLSDYDVRYYIYELLKA 127
++ LLD+ T ++ + + TD K++ LS+ V+Y +Y++L
Sbjct: 76 VIGLLDV------FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCG 129
Query: 128 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 187
L Y HS GI+HRD+KP N+ ++ E +L+++D+GLA H E V +R+++ PE++
Sbjct: 130 LKYIHSAGIIHRDLKPGNLAVN-EDCELKILDFGLAR--HADAEMTGYVVTRWYRAPEVI 186
Query: 188 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG------TDELNAY 241
++ Y+ ++D+WS+GC+ A M+ K F G D DQL +I KV G +L
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGKT-LFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245
Query: 242 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE 301
K +I+ P ++ RK +S A P+AVD L+K+L D +R TA E
Sbjct: 246 AAKSYIKSLP-------KYPRKDFSTLFPK-----ASPQAVDLLEKMLELDVDKRLTATE 293
Query: 302 AMAHPYFFPIRNAE 315
A+ HPYF R+A+
Sbjct: 294 ALEHPYFDSFRDAD 307
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 2e-40
Identities = 97/308 (31%), Positives = 159/308 (51%), Gaps = 44/308 (14%)
Query: 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIKI 68
DY + K+G G Y V++G + + V KKI+ REI +
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTG--------QIVAMKKIRLESEEEGVPSTAIREISL 52
Query: 69 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD------VRYYIY 122
L+ L PNIV L D++ Q+S+ LIFE ++ D K +L V+ Y+Y
Sbjct: 53 LKEL-QHPNIVCLQDVLM-QESRL-YLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLY 108
Query: 123 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE-FYHPGKEYNVRVASRYF 181
++L+ + +CHS+ ++HRD+KP N++ID + ++L D+GLA F P + Y V + ++
Sbjct: 109 QILQGILFCHSRRVLHRDLKPQNLLID-NKGVIKLADFGLARAFGIPVRVYTHEVVTLWY 167
Query: 182 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY 241
+ PE+L+ Y +D+WS+G +FA M +K P F+G DQL +I ++LGT + +
Sbjct: 168 RAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK-PLFHGDSEIDQLFRIFRILGTPTEDVW 226
Query: 242 LNKYHIELDPHLAALVGRHSRKP-WSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 300
P + +L + P W K + +D L+K+L YD +R +AK
Sbjct: 227 ---------PGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAK 277
Query: 301 EAMAHPYF 308
+A+ HPYF
Sbjct: 278 KALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 2e-40
Identities = 83/308 (26%), Positives = 161/308 (52%), Gaps = 34/308 (11%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQNLCGG 75
D ++++ ++G G Y +V++ E +K ++ +K+ REIKIL+ L
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL-NH 65
Query: 76 PNIVKLLDIVRDQQSKTP--------SLIFEHVNNTDFKVLYPTLSDYD---VRYYIYEL 124
NIV L +IV D+Q L+FE++++ +L L + ++ ++ +L
Sbjct: 66 RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQL 125
Query: 125 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG--KEYNVRVASRYFK 182
L+ L+YCH + +HRD+K N++++++ +++L D+GLA Y+ + Y +V + +++
Sbjct: 126 LEGLNYCHKKNFLHRDIKCSNILLNNKG-QIKLADFGLARLYNSEESRPYTNKVITLWYR 184
Query: 183 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242
PELL+ + Y ++D+WS GC+ G +F K+P F + QL I+++ G+ +
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCIL-GELFTKKPIFQANQELAQLELISRLCGSPCPAVW- 242
Query: 243 NKYHIELDPHLAALVGRHSRKP---WSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA 299
P + L ++ KP + + + E + A+D LD +L D +R TA
Sbjct: 243 --------PDVIKLPYFNTMKPKKQYRRRLREEFSFIP-TPALDLLDHMLTLDPSKRCTA 293
Query: 300 KEAMAHPY 307
+EA+ P+
Sbjct: 294 EEALNSPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (359), Expect = 4e-40
Identities = 95/307 (30%), Positives = 156/307 (50%), Gaps = 37/307 (12%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK------------REIK 67
+ Y+ + K+G G Y+ V++G + V K+I+ RE
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTG--------QLVALKEIRLEHEEGAPFTAIREAS 55
Query: 68 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPT-LSDYDVRYYIYE 123
+L++L NIV L DI+ + KT +L+FE+++ TD K LS ++VR ++++
Sbjct: 56 LLKDL-KHANIVTLHDIIHTK--KTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQ 111
Query: 124 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFK 182
LL+ L YCH + ++HRD+KP N++I E+ +L+L D+GLA P K Y+ V + +++
Sbjct: 112 LLRGLAYCHQRRVLHRDLKPQNLLIS-ERGELKLADFGLARAKSVPSKTYSNEVVTLWYR 170
Query: 183 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH-DNYDQLVKIAKVLGTDELNAY 241
P++L+ +Y SLD+W +GC+F M P F G D DQL KI +VLGT +
Sbjct: 171 PPDVLLGSTEYSTSLDMWGVGCIFYEMA-TGRPLFPGSTDVEDQLHKIFRVLGTPTEETW 229
Query: 242 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE 301
+ +P I + +P + K L+Y+ ++R +A E
Sbjct: 230 PG---VSSNPEFKPYSFPFYPP--RPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAE 284
Query: 302 AMAHPYF 308
AM HPYF
Sbjct: 285 AMKHPYF 291
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 8e-40
Identities = 96/301 (31%), Positives = 152/301 (50%), Gaps = 32/301 (10%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL------KPVKKKKIKREIKILQNLCGGP 76
YE + VG G Y V + H + IK K VKK + REI++L+ L
Sbjct: 3 YENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAM-REIRMLKQL-RHE 60
Query: 77 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYD-VRYYIYELLKALDYCHS 133
N+V L+++ R + K L+FE V++T L YP D VR Y++++L+ +++CHS
Sbjct: 61 NLVNLIEVFR--RKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHS 118
Query: 134 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQD 192
I+HRD+KP N+++ + ++L D+G A PG+ Y VA+R+++ PELLV
Sbjct: 119 HNIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTK 177
Query: 193 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL--- 249
Y ++D+W++GC+ M EP F G + DQL I K LG L H E+
Sbjct: 178 YGRAVDIWAVGCLVTEM-LTGEPLFPGDSDIDQLYHIIKCLGN------LIPRHQEIFQK 230
Query: 250 DPHLAALVGRHSRKPWSKFITVENQHLAV--PEAVDFLDKLLRYDHQERPTAKEAMAHPY 307
+P A + R P K I + +D + LR D +RP++ + + H +
Sbjct: 231 NPLFAGM-----RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
Query: 308 F 308
F
Sbjct: 286 F 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 2e-39
Identities = 98/314 (31%), Positives = 166/314 (52%), Gaps = 37/314 (11%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-KPVKK----KKIKREIKILQNLCG 74
D Y +++VG G Y V + K IK L +P + K+ RE+++L+++
Sbjct: 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-K 72
Query: 75 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP-------------TLSDYDVRYYI 121
N++ LLD+ TP L + + DF ++ P LS+ +++ +
Sbjct: 73 HENVIGLLDVF------TPDLSLDRFH--DFYLVMPFMGTDLGKLMKHEKLSEDRIQFLV 124
Query: 122 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYF 181
Y++LK L Y H+ GI+HRD+KP N+ ++ E +L+++D+GLA E V +R++
Sbjct: 125 YQMLKGLKYIHAAGIIHRDLKPGNLAVN-EDCELKILDFGLAR--QTDSEMTGYVVTRWY 181
Query: 182 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY 241
+ PE++++ Y ++D+WS+GC+ A M+ K P F GHD+ DQL++I KV GT +
Sbjct: 182 RAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK-PLFKGHDHLDQLMEIMKVTGTPS-KEF 239
Query: 242 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE 301
+ K E + + R +K + + N P AV+ L+K+L D + R TA E
Sbjct: 240 VQKLQSEDAKNYVKKLPRFRKKDFRSLLPNAN-----PLAVNVLEKMLVLDAESRITAAE 294
Query: 302 AMAHPYFFPIRNAE 315
A+AHPYF + E
Sbjct: 295 ALAHPYFEEFHDPE 308
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 138 bits (348), Expect = 2e-38
Identities = 99/299 (33%), Positives = 157/299 (52%), Gaps = 28/299 (9%)
Query: 23 YEVVRKVGRGKYSEVFEGV-HCTDNEKCIIKILKP----VKKKKIKREIKILQNLCGGPN 77
Y ++ VG G + V T I KI+KP V K+ RE+K+L++L N
Sbjct: 12 YVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHEN 70
Query: 78 IVKLLDIVRDQQSKTPSLIF-EHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYCHSQ 134
I+ L DI S + F + TD L + L ++Y++Y++L+ L Y HS
Sbjct: 71 IISLSDIF---ISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA 127
Query: 135 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYD 194
G++HRD+KP N++I+ E L++ D+GLA P + V++RY++ PE+++ Q YD
Sbjct: 128 GVVHRDLKPSNILIN-ENCDLKICDFGLARIQDP--QMTGYVSTRYYRAPEIMLTWQKYD 184
Query: 195 YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYLNKYHIELDP 251
+D+WS GC+FA M +P F G D+ +Q I +LGT D +N ++ +
Sbjct: 185 VEVDIWSAGCIFAEM-LEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF-- 241
Query: 252 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 310
+ +L R KF + P A+D L+K+L +D Q+R +A EA+AHPY P
Sbjct: 242 -VQSLPKREPVPFSEKFKNAD------PSAIDLLEKMLVFDPQKRISAAEALAHPYLAP 293
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-37
Identities = 96/308 (31%), Positives = 160/308 (51%), Gaps = 45/308 (14%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-KP----VKKKKIKREIKILQNLCGGPN 77
Y+ + VG G Y V +K +K L +P + ++ RE+++L+++ N
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM-KHEN 75
Query: 78 IVKLLDIVRDQQSKTPSLIFEHVN-----------NTDFKVLYPTLSDYDVRYYIYELLK 126
++ LLD+ TP+ E+ N + + V LSD V++ IY+LL+
Sbjct: 76 VIGLLDVF------TPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLR 129
Query: 127 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 186
L Y HS GI+HRD+KP NV ++ E +LR++D+GLA E VA+R+++ PE+
Sbjct: 130 GLKYIHSAGIIHRDLKPSNVAVN-EDCELRILDFGLAR--QADDEMTGYVATRWYRAPEI 186
Query: 187 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246
+++ Y+ ++D+WS+GC+ A ++ + + F G+D DQL +I +V+GT
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELL-KGKALFPGNDYIDQLKRIMEVVGTPSPEV------ 239
Query: 247 IELDPHLAALVGRHSRKPWSKFITVENQHL------AVPEAVDFLDKLLRYDHQERPTAK 300
L + H+RK + Q L A P A+D L+K+L D +R +A
Sbjct: 240 ------LKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISAS 293
Query: 301 EAMAHPYF 308
EA+AHPYF
Sbjct: 294 EALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 2e-37
Identities = 93/311 (29%), Positives = 155/311 (49%), Gaps = 39/311 (12%)
Query: 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK---IK--REIKILQNL 72
R D+YE + ++ G Y V+ E +K LK K+K+ I REI IL L
Sbjct: 2 RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL 61
Query: 73 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY----DVRYYIYELLKAL 128
PNIV + ++V ++ E+V + D K L T+ +V+ + +LL +
Sbjct: 62 -QHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGV 119
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELL 187
+ H I+HRD+K N+++++ L++ D+GLA E+ P K Y V + +++ PELL
Sbjct: 120 AHLHDNWILHRDLKTSNLLLNNRGI-LKICDFGLAREYGSPLKPYTQLVVTLWYRAPELL 178
Query: 188 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247
+ ++Y ++D+WS+GC+FA ++ K+P F G DQL KI K+LGT +
Sbjct: 179 LGAKEYSTAIDMWSVGCIFAELL-TKKPLFPGKSEIDQLNKIFKLLGTPTEKIW------ 231
Query: 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPE----------AVDFLDKLLRYDHQERP 297
P + L G K + + + + D L++LL YD +R
Sbjct: 232 ---PGFSELPG------AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRI 282
Query: 298 TAKEAMAHPYF 308
+A++A+ HPYF
Sbjct: 283 SAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 4e-37
Identities = 78/298 (26%), Positives = 133/298 (44%), Gaps = 49/298 (16%)
Query: 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK--ILKPVKKKK---IKREIKILQNLCGGP 76
++ +GRG + V+ + E +K L +++ ++REI+IL +L P
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHP 59
Query: 77 NIVKLLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHS 133
NIV+ RD++ T ++ E+V+ + + L + +R Y ++L+ L Y HS
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 134 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLA---EFYHPGKEYNVRVASRYFKGPELLVDL 190
GI+HRD+K N+++D + ++L D+G A G+ + Y+ PE++
Sbjct: 120 NGIVHRDIKGANILVDSDGV-VKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG- 177
Query: 191 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250
++Y + D+WSLGC M K P+ + L KI + E+
Sbjct: 178 EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS-----------SGEPPEIP 226
Query: 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
HL+ EA DFL K LR D ++RPTA E + HP+
Sbjct: 227 EHLS------------------------EEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 8e-36
Identities = 97/316 (30%), Positives = 163/316 (51%), Gaps = 52/316 (16%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-----KPVKKKKIKREIKILQNLCGGPN 77
Y ++ +GRG Y V + NEK IK + + K+ REIK+L++L N
Sbjct: 7 YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHEN 65
Query: 78 IVKLLDIVRDQQSKTPSLIFEHVN------NTDFKVLY---PTLSDYDVRYYIYELLKAL 128
++ + DI+ + F V +TD + TLSD +Y++Y+LL+ L
Sbjct: 66 VIAIKDIMPPPHREA----FNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGL 121
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-------EFYHPGKEYNVRVASRYF 181
Y HS ++HRD+KP N++++ L++ D+GLA +F EY V +R++
Sbjct: 122 KYIHSANVLHRDLKPSNLLLN-ANCDLKICDFGLARTTSEKGDFM---TEY---VVTRWY 174
Query: 182 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DEL 238
+ PELL++ +Y ++D+WS+GC+FA ++ RK P F G D QL I ++LG+ ++L
Sbjct: 175 RAPELLLNCSEYTTAIDVWSVGCIFAELLGRK-PLFPGKDYVHQLKLITELLGSPSEEDL 233
Query: 239 NAYLN---KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE 295
N + +I P R+ +++ N P A+D L+K+L +D +
Sbjct: 234 GFIRNEKARRYIRSLP-------YTPRQSFARLFPHAN-----PLAIDLLEKMLVFDPSK 281
Query: 296 RPTAKEAMAHPYFFPI 311
R T +EA+AHPY +
Sbjct: 282 RITVEEALAHPYLASL 297
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 3e-35
Identities = 89/304 (29%), Positives = 154/304 (50%), Gaps = 33/304 (10%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-KP----VKKKKIKREIKILQNLCGG 75
+ Y+ + VG G Y V + +K L +P + K+ RE+++L+++
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KH 75
Query: 76 PNIVKLLDIVRDQQSKTPSLIFEHVNN---------TDFK--VLYPTLSDYDVRYYIYEL 124
N++ LLD+ TP+ E N+ D V L+D V++ IY++
Sbjct: 76 ENVIGLLDVF------TPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 129
Query: 125 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 184
L+ L Y HS I+HRD+KP N+ ++ E +L+++D+GLA H E VA+R+++ P
Sbjct: 130 LRGLKYIHSADIIHRDLKPSNLAVN-EDCELKILDFGLAR--HTDDEMTGYVATRWYRAP 186
Query: 185 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244
E++++ Y+ ++D+WS+GC+ A ++ + F G D+ DQL I +++GT
Sbjct: 187 EIMLNWMHYNQTVDIWSVGCIMAELLTGRT-LFPGTDHIDQLKLILRLVGTPGAELLKKI 245
Query: 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304
++ +L + FI A P AVD L+K+L D +R TA +A+A
Sbjct: 246 SSESARNYIQSLTQMPKMNFANVFIG------ANPLAVDLLEKMLVLDSDKRITAAQALA 299
Query: 305 HPYF 308
H YF
Sbjct: 300 HAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 7e-35
Identities = 85/301 (28%), Positives = 153/301 (50%), Gaps = 31/301 (10%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK----REIKILQNLCGGPNI 78
Y + K+G G Y+ V++G+ + + +K++ ++ + RE +L+ L NI
Sbjct: 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL-KHANI 65
Query: 79 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT-LSDYDVRYYIYELLKALDYCHSQGIM 137
V L DI+ +++ T + H + + + +P L Y+VR ++++LL+ L Y H Q I+
Sbjct: 66 VLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHIL 125
Query: 138 HRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQDYDYS 196
HRD+KP N++I + +L+L D+GLA P + Y+ V + +++ P++L+ DY +
Sbjct: 126 HRDLKPQNLLISY-LGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSA 184
Query: 197 LDLWSLGCMFAGMIFRKEPFFYGHDN-YDQLVKIAKVLGTDELNAY-----LNKYHIELD 250
LD+W GC+F M + +P F G + ++QL KI VLG + + L Y E
Sbjct: 185 LDIWGAGCIFIEM-LQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEW- 242
Query: 251 PHLAALVGRHSRKPWSK---FITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 307
K V + P+A D ++L ++R +A++A+ HPY
Sbjct: 243 ------------FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290
Query: 308 F 308
F
Sbjct: 291 F 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 1e-34
Identities = 88/326 (26%), Positives = 137/326 (42%), Gaps = 84/326 (25%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKK---IKREIKILQNLCG 74
DD++ + +G G +S V N++ IKIL +K+KK +K E ++L L G
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 75 GPNIVKLLDIVRDQQSKTPSLIF--EHVNNTDFKVL---YPTLSDYDVRYYIYELLKALD 129
P I+KL +D+++ L F E+ N + Y +L + R+Y E+L AL+
Sbjct: 61 HPGIIKLYYTFQDEEN----LYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALE 116
Query: 130 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK---------------EYNV 174
Y HS+GI+HRD+KP N+++D + +++ D+G A+ P
Sbjct: 117 YLHSKGIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 175 RVASRYFKG------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV- 227
R F G PELL + + S DLW+LGC+ M+ K PF + + L
Sbjct: 176 RRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPF---RGSNEYLTF 231
Query: 228 -KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLD 286
KI K + P+A D ++
Sbjct: 232 QKILK-------------------------------------LEYSFPPNFPPDAKDLIE 254
Query: 287 KLLRYDHQERPTAKEA----MAHPYF 308
KLL D Q+R E AHP+F
Sbjct: 255 KLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 1e-34
Identities = 89/309 (28%), Positives = 152/309 (49%), Gaps = 35/309 (11%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK---REIKILQNLCGGPNIV 79
Y +R +G G VF V +++ +K + + +K REIKI++ L NIV
Sbjct: 7 YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-DHDNIV 65
Query: 80 KLLDIVRDQQSKTPSLIFE--HVN---------NTDFKVL--YPTLSDYDVRYYIYELLK 126
K+ +++ S + +N TD + LS+ R ++Y+LL+
Sbjct: 66 KVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR 125
Query: 127 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFK 182
L Y HS ++HRD+KP NV I+ E L++ D+GLA P + + + +++++
Sbjct: 126 GLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYR 185
Query: 183 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK---VLGTDELN 239
P LL+ +Y ++D+W+ GC+FA M+ K P F G +Q+ I + V+ ++ N
Sbjct: 186 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-PLFAGAHELEQMQLILESVPVVREEDRN 244
Query: 240 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA 299
LN P G R+P + N PEA+DFL+++L ++ +R TA
Sbjct: 245 ELLNV-----IPSFVRNDGGEPRRPLRDLLPGVN-----PEALDFLEQILTFNPMDRLTA 294
Query: 300 KEAMAHPYF 308
+EA+ HPY
Sbjct: 295 EEALMHPYM 303
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-34
Identities = 92/309 (29%), Positives = 155/309 (50%), Gaps = 44/309 (14%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--------REIKILQNLCG 74
YE V ++G G Y +VF+ + + + LK V+ + + RE+ +L++L
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVA--LKRVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 75 --GPNIVKLLDIV---RDQQSKTPSLIFEHVNN--TDF--KVLYPTLSDYDVRYYIYELL 125
PN+V+L D+ R + +L+FEHV+ T + KV P + ++ +++LL
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 126 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 185
+ LD+ HS ++HRD+KP N+++ +++L D+GLA Y V + +++ PE
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE 179
Query: 186 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245
+L+ Y +DLWS+GC+FA M FR++P F G + DQL KI V+G +
Sbjct: 180 VLLQ-SSYATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDVIGLPGEEDW---- 233
Query: 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLA--VPE----AVDFLDKLLRYDHQERPTA 299
P AL P F + Q + V + D L K L ++ +R +A
Sbjct: 234 -----PRDVAL-------PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISA 281
Query: 300 KEAMAHPYF 308
A++HPYF
Sbjct: 282 YSALSHPYF 290
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 4e-34
Identities = 100/322 (31%), Positives = 168/322 (52%), Gaps = 46/322 (14%)
Query: 16 INREQD-DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKKKKIKREIKILQNLC 73
INR + Y++ +G G + V+E + +EK IK +L+ + K RE+ I++NL
Sbjct: 60 INRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKN--RELLIMKNL- 116
Query: 74 GGPNIVKLLD------IVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYI 121
NI+ L D +++++ +++ E + T K + L + V+ Y
Sbjct: 117 NHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYS 176
Query: 122 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYF 181
Y+L +AL Y HS+ I HRD+KP N++ID L+L D+G A+ G+ + SR++
Sbjct: 177 YQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFY 236
Query: 182 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DEL 238
+ PEL++ +Y +DLWSLGC+ A MI P F G + DQLV+I +VLGT D+L
Sbjct: 237 RAPELMLGATNYTTHIDLWSLGCIIAEMIL-GYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295
Query: 239 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHL------AVP-EAVDFLDKLLRY 291
E++P+ A + KF V+ + L P +A++F+ + L+Y
Sbjct: 296 K--------EMNPNYADI----------KFPDVKPKDLKKVFPKGTPDDAINFISQFLKY 337
Query: 292 DHQERPTAKEAMAHPYFFPIRN 313
+ +R EA+A P+F +R+
Sbjct: 338 EPLKRLNPIEALADPFFDDLRD 359
|
Length = 440 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 1e-32
Identities = 93/303 (30%), Positives = 150/303 (49%), Gaps = 31/303 (10%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGG 75
+ +EV+ VG G Y V + H E IK K + K+ RE+K+L+ L
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQ 59
Query: 76 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYD-VRYYIYELLKALDYCH 132
NIV+L + R + L+FE+V ++L P + VR YIY+L+KA+ +CH
Sbjct: 60 ENIVELKEAFR--RRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCH 117
Query: 133 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDL 190
I+HRD+KP N++I H L+L D+G A G Y VA+R+++ PELL+
Sbjct: 118 KNDIVHRDIKPENLLISHND-VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG- 175
Query: 191 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---TDELNAYLNKYHI 247
Y ++D+WS+GC+ G + +P F G DQL I KVLG +++ + +
Sbjct: 176 APYGKAVDMWSVGCIL-GELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS---- 230
Query: 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAV--DFLDKLLRYDHQERPTAKEAMAH 305
+P L P ++E ++L + V D + LL+ + +R ++ + H
Sbjct: 231 --NPRFHGLRFPAVNHPQ----SLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH 284
Query: 306 PYF 308
P F
Sbjct: 285 PAF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 3e-32
Identities = 95/318 (29%), Positives = 165/318 (51%), Gaps = 64/318 (20%)
Query: 21 DDYEVVRKVGRGKYSEVFEG-VHCTDNEKCIIKILKPVKKKKIK-------REIKILQNL 72
+ Y + K+G G Y+ V++G TDN + LK ++ + + RE+ +L++L
Sbjct: 6 ETYIKLDKLGEGTYATVYKGRSKLTDN----LVALKEIRLEHEEGAPCTAIREVSLLKDL 61
Query: 73 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSD-------YDVRYYIYELL 125
NIV L DI+ ++S T L+FE+++ K L L D ++V+ ++++LL
Sbjct: 62 -KHANIVTLHDIIHTEKSLT--LVFEYLD----KDLKQYLDDCGNSINMHNVKLFLFQLL 114
Query: 126 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGP 184
+ L+YCH + ++HRD+KP N++I+ E+ +L+L D+GLA P K Y+ V + +++ P
Sbjct: 115 RGLNYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPP 173
Query: 185 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT--------- 235
++L+ DY +D+W +GC+F M + P F G +QL I ++LGT
Sbjct: 174 DILLGSTDYSTQIDMWGVGCIFYEMSTGR-PLFPGSTVEEQLHFIFRILGTPTEETWPGI 232
Query: 236 ---DELNAY-LNKYHIE-LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLR 290
+E +Y KY + L H L + + L KLL+
Sbjct: 233 LSNEEFKSYNYPKYRADCLHNHAPRLDS---------------------DGAELLSKLLQ 271
Query: 291 YDHQERPTAKEAMAHPYF 308
++ ++R +A+EAM HPYF
Sbjct: 272 FEGRKRISAEEAMKHPYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 91/308 (29%), Positives = 153/308 (49%), Gaps = 40/308 (12%)
Query: 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGP 76
D E R +G G + V+ D ++ +K + V K++ RE+K+L
Sbjct: 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKML-CFFKHD 59
Query: 77 NIVKLLDIVRDQQSKTPSL-IFEHVN------NTDF-KVLY--PTLSDYDVRYYIYELLK 126
N++ LDI+ + P + FE + +D K++ LS V+ ++Y++L+
Sbjct: 60 NVLSALDIL-----QPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILR 114
Query: 127 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP--GKEYNVRVASRYFKGP 184
L Y HS GI+HRD+KP N++++ L++ D+GLA P K V ++Y++ P
Sbjct: 115 GLKYLHSAGILHRDIKPGNLLVNSNCV-LKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173
Query: 185 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN- 243
E+L+ + Y ++D+WS+GC+FA ++ R+ F QL I +LGT L A +
Sbjct: 174 EILMGSRHYTSAVDIWSVGCIFAELLGRR-ILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232
Query: 244 ----KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA 299
+ HI L G H T+ +Q A EAV L ++L +D +R +A
Sbjct: 233 CEGARAHI--------LRGPHKPPSLPVLYTLSSQ--ATHEAVHLLCRMLVFDPDKRISA 282
Query: 300 KEAMAHPY 307
+A+AHPY
Sbjct: 283 ADALAHPY 290
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 1e-31
Identities = 84/322 (26%), Positives = 158/322 (49%), Gaps = 43/322 (13%)
Query: 23 YEVVRKVGRGKYSEVFEGV--HCTDNEKCIIKILKPVKKKKIK------REIKILQNLCG 74
YE+ +GRG Y V++ + D ++ IK K K++ REI +L+ L
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-K 60
Query: 75 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKA 127
N+V L+++ + K+ L+F++ + ++++ ++ V+ ++++L
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 128 LDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYH----PGKEYNVRVASRY 180
+ Y HS ++HRD+KP N+++ E+ +++ D GLA ++ P + + V + +
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIW 180
Query: 181 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD---------NYDQLVKIAK 231
++ PELL+ + Y ++D+W++GC+FA ++ EP F G + DQL +I +
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELL-TLEPIFKGREAKIKKSNPFQRDQLERIFE 239
Query: 232 VLG--TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAV---PEAVDFLD 286
VLG T++ + K P L+ K + + + D L
Sbjct: 240 VLGTPTEKDWPDIKKM-----PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLR 294
Query: 287 KLLRYDHQERPTAKEAMAHPYF 308
KLL YD +R TA+EA+ HPYF
Sbjct: 295 KLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 119 bits (298), Expect = 3e-31
Identities = 88/301 (29%), Positives = 158/301 (52%), Gaps = 27/301 (8%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK----REIKILQNLCGGP 76
D YE + K+G G Y+ V++G + + +K+++ +++ RE +L+ L
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KHA 63
Query: 77 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPT-LSDYDVRYYIYELLKALDYCHS 133
NIV L DI+ +++ T L+FE+V+ + + +P L +V+ ++++LL+ L Y H
Sbjct: 64 NIVLLHDIIHTKETLT--LVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121
Query: 134 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQD 192
+ I+HRD+KP N++I + +L+L D+GLA P Y+ V + +++ P++L+ +
Sbjct: 122 RYILHRDLKPQNLLIS-DTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTE 180
Query: 193 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 252
Y LD+W +GC+F MI F D DQL +I VLGT + + + + PH
Sbjct: 181 YSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL---PH 237
Query: 253 -----LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 307
++ R+ W+K V + A D KLL+ + R +A+ A++H Y
Sbjct: 238 FKPERFTLYSPKNLRQAWNKLSYVNH-------AEDLASKLLQCFPKNRLSAQAALSHEY 290
Query: 308 F 308
F
Sbjct: 291 F 291
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 7e-31
Identities = 88/312 (28%), Positives = 149/312 (47%), Gaps = 51/312 (16%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--------REIKILQNL-- 72
YE V ++G G Y V++ D LK V+ + + RE+ +L+ L
Sbjct: 2 YEPVAEIGVGAYGTVYKA---RDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEA 58
Query: 73 CGGPNIVKLLDIV----RDQQSKTPSLIFEHVNNTDF-----KVLYPTLSDYDVRYYIYE 123
PNIV+L+D+ D+++K +L+FEHV+ D KV P L ++ + +
Sbjct: 59 FDHPNIVRLMDVCATSRTDRETKV-TLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQ 116
Query: 124 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 183
L+ LD+ H+ I+HRD+KP N+++ +++L D+GLA Y V + +++
Sbjct: 117 FLRGLDFLHANCIVHRDLKPENILVT-SGGQVKLADFGLARIYSCQMALTPVVVTLWYRA 175
Query: 184 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG---TDELNA 240
PE+L+ Y +D+WS+GC+FA M FR++P F G+ DQL KI ++G D+
Sbjct: 176 PEVLLQ-STYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR 233
Query: 241 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPE----AVDFLDKLLRYDHQER 296
+ P +P VPE L ++L ++ +R
Sbjct: 234 DVTLPRGAFSP--------RGPRPVQSV---------VPEIEESGAQLLLEMLTFNPHKR 276
Query: 297 PTAKEAMAHPYF 308
+A A+ HP+F
Sbjct: 277 ISAFRALQHPFF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 8e-31
Identities = 81/300 (27%), Positives = 147/300 (49%), Gaps = 27/300 (9%)
Query: 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--------REIKILQNLC 73
++E + ++G G Y V+ T E I LK V+ + REI +L N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGE---IVALKKVRMDNERDGIPISSLREITLLLN-L 63
Query: 74 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDY 130
PNIV+L ++V + + L+ E+ +L S+ V+ + +LL+ L Y
Sbjct: 64 RHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQY 123
Query: 131 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVD 189
H I+HRD+K N+++ + L++ D+GLA Y P K +V + +++ PELL+
Sbjct: 124 LHENFIIHRDLKVSNLLLTD-KGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLG 182
Query: 190 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249
Y ++D+W++GC+ A + +P G +QL I ++LGT + + +
Sbjct: 183 CTTYTTAIDMWAVGCILAEL-LAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL-- 239
Query: 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEA-VDFLDKLLRYDHQERPTAKEAMAHPYF 308
P + +P++ ++++ + EA + L+ LL YD ++R TA+EA+ YF
Sbjct: 240 -PLVGKFTLPK--QPYN---NLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYF 293
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 2e-30
Identities = 95/318 (29%), Positives = 160/318 (50%), Gaps = 64/318 (20%)
Query: 21 DDYEVVRKVGRGKYSEVFEG-VHCTDNEKCIIKILKPVKKKKIK-------REIKILQNL 72
+ Y + K+G G Y+ VF+G T+N + LK ++ + + RE+ +L++L
Sbjct: 6 ETYIKLEKLGEGTYATVFKGRSKLTEN----LVALKEIRLEHEEGAPCTAIREVSLLKDL 61
Query: 73 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKAL 128
NIV L DIV +S T L+FE+++ D K +S ++V+ ++Y++L+ L
Sbjct: 62 -KHANIVTLHDIVHTDKSLT--LVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGL 117
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELL 187
YCH + ++HRD+KP N++I+ E+ +L+L D+GLA P K Y+ V + +++ P++L
Sbjct: 118 AYCHRRKVLHRDLKPQNLLIN-ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL 176
Query: 188 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT------------ 235
+ +Y +D+W +GC+F M + P F G D+L I ++LGT
Sbjct: 177 LGSSEYSTQIDMWGVGCIFFEMASGR-PLFPGSTVEDELHLIFRLLGTPTEETWPGISSN 235
Query: 236 DELNAY-LNKYH----IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLR 290
DE Y KY I P L E ++ L K L+
Sbjct: 236 DEFKNYNFPKYKPQPLINHAPRLDT------------------------EGIELLTKFLQ 271
Query: 291 YDHQERPTAKEAMAHPYF 308
Y+ ++R +A+EAM H YF
Sbjct: 272 YESKKRISAEEAMKHAYF 289
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 4e-30
Identities = 90/313 (28%), Positives = 159/313 (50%), Gaps = 24/313 (7%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPN 77
Y++ +G+G Y V + EK IK + V +I REIK+L+ L P+
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLR-LLRHPD 60
Query: 78 IVKLLDIV---RDQQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYCH 132
IV++ I+ ++ K ++FE + + +V+ L+ ++++Y+LL+AL Y H
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120
Query: 133 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV----RVASRYFKGPELLV 188
+ + HRD+KP N++ + + KL++ D+GLA + VA+R+++ PEL
Sbjct: 121 TANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCG 179
Query: 189 DL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247
Y ++D+WS+GC+FA ++ K P F G + QL I +LGT +
Sbjct: 180 SFFSKYTPAIDIWSIGCIFAEVLTGK-PLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238
Query: 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 307
+ +L+++ + KF + P A+ L++LL +D ++RPTA+EA+A PY
Sbjct: 239 KARRYLSSMRKKQPVPFSQKFPNAD------PLALRLLERLLAFDPKDRPTAEEALADPY 292
Query: 308 FFPIRNAESSRSR 320
F + E S
Sbjct: 293 FKGLAKVEREPSA 305
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-29
Identities = 72/292 (24%), Positives = 120/292 (41%), Gaps = 55/292 (18%)
Query: 29 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--------KKIKREIKILQNLCGGPNIVK 80
+G G + V+EG++ D + +K + K++++EI +L L PNIV+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQH-PNIVQ 66
Query: 81 LLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQGIM 137
L R+ + E V L Y + + +R Y ++L L+Y H + +
Sbjct: 67 YLGTERE--EDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTV 124
Query: 138 HRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 197
HRD+K N+++D ++L D+G+A+ S Y+ PE++ Y +
Sbjct: 125 HRDIKGANILVDTNG-VVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAA 183
Query: 198 DLWSLGCMFAGMIFRKEPF--FYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA 255
D+WSLGC M K P+ G + KI + +K + HL+
Sbjct: 184 DIWSLGCTVLEMATGKPPWSQLEG---VAAVFKIGR-----------SKELPPIPDHLS- 228
Query: 256 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 307
EA DF+ K L+ D RPTA E + HP+
Sbjct: 229 -----------------------DEAKDFILKCLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 3e-29
Identities = 89/311 (28%), Positives = 160/311 (51%), Gaps = 50/311 (16%)
Query: 21 DDYEVVRKVGRGKYSEVFEG-VHCTDNEKCIIKILKPVKKKKIK-------REIKILQNL 72
+ Y + K+G G Y+ VF+G T+N + LK ++ + + RE+ +L+NL
Sbjct: 5 ETYVKLDKLGEGTYATVFKGRSKLTEN----LVALKEIRLEHEEGAPCTAIREVSLLKNL 60
Query: 73 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT----LSDYDVRYYIYELLKAL 128
NIV L DI+ ++ T L+FE++++ D K +S ++V+ ++++LL+ L
Sbjct: 61 -KHANIVTLHDIIHTERCLT--LVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGL 116
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELL 187
YCH + I+HRD+KP N++I+ E+ +L+L D+GLA P K Y+ V + +++ P++L
Sbjct: 117 SYCHKRKILHRDLKPQNLLIN-EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVL 175
Query: 188 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247
+ +Y +D+W +GC+ M + P F G ++L I ++LGT
Sbjct: 176 LGSTEYSTPIDMWGVGCILYEMATGR-PMFPGSTVKEELHLIFRLLGT------------ 222
Query: 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVP----------EAVDFLDKLLRYDHQERP 297
P G S + + ++ Q+ A P + +D L LL Y+ + R
Sbjct: 223 ---PTEETWPGITSNEEFRSYLF--PQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRI 277
Query: 298 TAKEAMAHPYF 308
+A+ A+ H YF
Sbjct: 278 SAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-29
Identities = 94/318 (29%), Positives = 152/318 (47%), Gaps = 36/318 (11%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKKKKIK----REIKI 68
F + E YE + K+G+G + EVF+ H + +K +L +K+ REIKI
Sbjct: 6 PFCD-EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKI 64
Query: 69 LQNLCGGPNIVKLLDIVRDQQSK------TPSLIFEHVNNTDFKVLYPTLSDYDVRYYIY 122
LQ L N+V L++I R + + + L+FE + D L LS+ +V++ +
Sbjct: 65 LQLL-KHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGL---LSNKNVKFTLS 119
Query: 123 E-------LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---- 171
E LL L Y H I+HRD+K N++I + L+L D+GLA + K
Sbjct: 120 EIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG-ILKLADFGLARAFSLSKNSKPN 178
Query: 172 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 230
Y RV + +++ PELL+ +DY +D+W GC+ A M R P G+ QL I+
Sbjct: 179 RYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTR-SPIMQGNTEQHQLTLIS 237
Query: 231 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLR 290
++ G+ + +EL + G+ + V++ H A+D +DKLL
Sbjct: 238 QLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPH-----ALDLIDKLLV 292
Query: 291 YDHQERPTAKEAMAHPYF 308
D +R A A+ H +F
Sbjct: 293 LDPAKRIDADTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 7e-26
Identities = 71/263 (26%), Positives = 136/263 (51%), Gaps = 24/263 (9%)
Query: 60 KKIKREIKILQNLCGGPNIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDY 115
K+ RE+ +++ L NI+ LL++ Q+S + L+ E ++ +V+ L
Sbjct: 60 KRAYRELVLMK-LVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHE 118
Query: 116 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR 175
+ Y +Y++L + + HS GI+HRD+KP N+++ + L+++D+GLA
Sbjct: 119 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPY 177
Query: 176 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 235
V +RY++ PE+++ + Y ++D+WS+GC+ MI R F G D+ DQ KI + LGT
Sbjct: 178 VVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMI-RGTVLFPGTDHIDQWNKIIEQLGT 235
Query: 236 DELNAYLNKYHIELDPHLAALV---GRHSRKPWSKFI--------TVENQHLAVPEAVDF 284
+ ++++ L P + V +++ + + + + L +A D
Sbjct: 236 PS-DEFMSR----LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDL 290
Query: 285 LDKLLRYDHQERPTAKEAMAHPY 307
L K+L D ++R + +A+ HPY
Sbjct: 291 LSKMLVIDPEKRISVDDALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-25
Identities = 78/296 (26%), Positives = 131/296 (44%), Gaps = 62/296 (20%)
Query: 29 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR---------EIKILQNLCGGPNIV 79
+G+G + +V + +K+LK KKKI + E IL + P IV
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLK---KKKIIKRKEVEHTLTERNILSRINH-PFIV 56
Query: 80 KLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLKALDYCHSQGI 136
KL + ++ L+ E+ + F L S+ R+Y E++ AL+Y HS GI
Sbjct: 57 KLHYAFQTEEKL--YLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGI 114
Query: 137 MHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 195
++RD+KP N+++D ++L D+GLA E G N + + PE+L + Y
Sbjct: 115 IYRDLKPENILLD-ADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVL-LGKGYGK 172
Query: 196 SLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA 255
++D WSLG + M+ K PF+ ++ ++ + K+L D L
Sbjct: 173 AVDWWSLGVLLYEMLTGKPPFY--AEDRKEIYE--KIL-KDPLR---------------- 211
Query: 256 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA---MAHPYF 308
+ +F++ PEA D + LL+ D +R + A AHP+F
Sbjct: 212 ---------FPEFLS--------PEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 5e-25
Identities = 77/305 (25%), Positives = 149/305 (48%), Gaps = 30/305 (9%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEK------CIIKILKPVKK----KKIKREIKILQNL 72
Y+ ++ +G G +G+ C + + K+ +P + K+ RE+ +L+ +
Sbjct: 23 YQQLKPIGSGA-----QGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV 77
Query: 73 CGGPNIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 128
NI+ LL++ Q+S + L+ E ++ +V++ L + Y +Y++L +
Sbjct: 78 -NHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGI 136
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 188
+ HS GI+HRD+KP N+++ + L+++D+GLA V +RY++ PE+++
Sbjct: 137 KHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVIL 195
Query: 189 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN----- 243
+ Y ++D+WS+GC+ ++ + F G D+ DQ K+ + LGT ++N
Sbjct: 196 GMG-YKENVDIWSVGCIMGELV-KGSVIFQGTDHIDQWNKVIEQLGTPSAE-FMNRLQPT 252
Query: 244 -KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 302
+ ++E P + W E L +A D L K+L D +R + EA
Sbjct: 253 VRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEA 312
Query: 303 MAHPY 307
+ HPY
Sbjct: 313 LRHPY 317
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 7e-25
Identities = 77/304 (25%), Positives = 137/304 (45%), Gaps = 67/304 (22%)
Query: 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQNLCGGP 76
+Y++ +GRG + V++G++ + IK + K K+ I +EI +L+NL P
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHP 59
Query: 77 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD------VRYYIYELLKALDY 130
NIVK + + S +I E+ N L + + V Y+Y++L+ L Y
Sbjct: 60 NIVKYIGSIETSDSL--YIILEYAENGS---LRQIIKKFGPFPESLVAVYVYQVLQGLAY 114
Query: 131 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVD 189
H QG++HRD+K N++ + ++L D+G+A + K+ V + Y+ PE +++
Sbjct: 115 LHEQGVIHRDIKAANILTTKDG-VVKLADFGVATKLNDVSKDDASVVGTPYWMAPE-VIE 172
Query: 190 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249
+ + D+WSLGC ++ P++ +L
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGNPPYY------------------------------DL 202
Query: 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAV-----DFLDKLLRYDHQERPTAKEAMA 304
+P AAL F V++ H +PE + DFL + + D RPTAK+ +
Sbjct: 203 NPM-AAL-----------FRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250
Query: 305 HPYF 308
HP+
Sbjct: 251 HPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 8e-25
Identities = 81/322 (25%), Positives = 140/322 (43%), Gaps = 62/322 (19%)
Query: 29 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-----------------REIKILQN 71
+G G Y +V + + IK +K ++ RE+KI+
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 72 LCGGPNIVKLLD---------IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIY 122
+ NI+ L+D +V D + + D K+ L++ V+ +
Sbjct: 77 I-KHENIMGLVDVYVEGDFINLVMDIMASDLKKVV------DRKIR---LTESQVKCILL 126
Query: 123 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA---------------EFYH 167
++L L+ H MHRD+ P N+ I+ + ++ D+GLA E
Sbjct: 127 QILNGLNVLHKWYFMHRDLSPANIFIN-SKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 168 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 227
+E +V + +++ PELL+ + Y +++D+WS+GC+FA ++ K P F G + DQL
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK-PLFPGENEIDQLG 244
Query: 228 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDK 287
+I ++LGT + + + L RKP N A +A+D L
Sbjct: 245 RIFELLGTPNEDNWPQAKKLPLYTEFTP------RKPKDLKTIFPN---ASDDAIDLLQS 295
Query: 288 LLRYDHQERPTAKEAMAHPYFF 309
LL+ + ER +AKEA+ H YF
Sbjct: 296 LLKLNPLERISAKEALKHEYFK 317
|
Length = 335 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 80/312 (25%), Positives = 137/312 (43%), Gaps = 66/312 (21%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK--ILKPVKKKKIKREIKILQNLCGGPNIVK 80
Y+ + K+G G EV++ ++ IK L+ K+ I EI I+++ C PNIV
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKD-CKHPNIVD 79
Query: 81 LLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPT---LSDYDVRYYIYELLKALDYCHSQ 134
D ++ E+++ TD ++ +++ + Y E+L+ L+Y HSQ
Sbjct: 80 YYDSYLVG--DELWVVMEYMDGGSLTD--IITQNFVRMNEPQIAYVCREVLQGLEYLHSQ 135
Query: 135 GIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQDY 193
++HRD+K N+++ + ++L D+G A+ + N V + Y+ PE++ +DY
Sbjct: 136 NVIHRDIKSDNILLSKDGS-VKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR-KDY 193
Query: 194 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 253
+D+WSLG M M EP YL +P L
Sbjct: 194 GPKVDIWSLGIMCIEMA-EGEP------------------------PYLR------EPPL 222
Query: 254 AALVGRHSRKPWSKFIT------VENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 307
AL IT ++N PE DFL+K L D ++RP+A+E + HP+
Sbjct: 223 RAL----------FLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPF 272
Query: 308 FFPIRNAESSRS 319
++ A
Sbjct: 273 ---LKKACPKEE 281
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 2e-24
Identities = 57/223 (25%), Positives = 107/223 (47%), Gaps = 23/223 (10%)
Query: 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCGGP 76
YE+++++G+G + +V+ +D + ++K + +++ E+KIL+ L P
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHP 59
Query: 77 NIVKLLDIVRDQQSKTPSLIF-EHVNNTD-------FKVLYPTLSDYDVRYYIYELLKAL 128
NI+K + + K I E+ + D K + + + +L AL
Sbjct: 60 NIIKYYE---SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELL 187
Y HS+ I+HRD+KP N+ + ++L D+G+++ + V + Y+ PEL
Sbjct: 117 KYLHSRKILHRDIKPQNIFLTSNG-LVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELC 175
Query: 188 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV-KI 229
+ + Y+Y D+WSLGC+ + K PF +N +L KI
Sbjct: 176 QN-KPYNYKSDIWSLGCVLYELCTLKHPF--EGENLLELALKI 215
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 9e-24
Identities = 86/306 (28%), Positives = 149/306 (48%), Gaps = 32/306 (10%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCT------DNEKCIIKILKPVKK----KKIKREIKILQNL 72
Y+ ++ +G G +G+ C D I K+ +P + K+ RE+ +L
Sbjct: 19 YQNLKPIGSGA-----QGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL-VLMKC 72
Query: 73 CGGPNIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 128
NI+ LL++ Q+S + L+ E ++ +V+ L + Y +Y++L +
Sbjct: 73 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 132
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 188
+ HS GI+HRD+KP N+++ + L+++D+GLA V +RY++ PE+++
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 191
Query: 189 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT------DELNAYL 242
+ Y ++D+WS+GC+ M+ R + F G D DQ K+ + LGT +L +
Sbjct: 192 GM-GYKENVDIWSVGCIMGEMV-RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 243 NKYHIELDPHLAALVGRHSRKPWSKF-ITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE 301
Y +E P A L P S F E+ L +A D L K+L D +R + E
Sbjct: 250 RNY-VENRPKYAGLT-FPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDE 307
Query: 302 AMAHPY 307
A+ HPY
Sbjct: 308 ALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 5e-23
Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 18/205 (8%)
Query: 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGG 75
D++++ +VG+G Y +VF E +K +K + + + E IL
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKS 60
Query: 76 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCH 132
+VKLL +D + L E+V DF+ L LS+ R+Y+ E+ +A+D H
Sbjct: 61 EWLVKLLYAFQDDEYLY--LAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH 118
Query: 133 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVDLQ 191
G +HRD+KP N +ID ++L D+GL++ Y N V S + PE+L +
Sbjct: 119 ELGYIHRDLKPENFLIDASGH-IKLTDFGLSK---GIVTYANSVVGSPDYMAPEVLRG-K 173
Query: 192 DYDYSLDLWSLGCMFAGMIFRKEPF 216
YD+++D WSLGCM + PF
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPF 198
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.4 bits (238), Expect = 8e-23
Identities = 71/307 (23%), Positives = 124/307 (40%), Gaps = 58/307 (18%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNI 78
+E+V +G G Y +V++ H + IKI+ ++ +++IK E IL+ PNI
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNI 65
Query: 79 VKL--LDIVRDQQSKTPSLIF-----------EHVNNTDFKVLYPTLSDYDVRYYIYELL 125
I ++ L + V + L + + Y + E L
Sbjct: 66 ATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGL--RKKGKRLKEEWIAYILRETL 123
Query: 126 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGP 184
+ L Y H ++HRD+K N+++ ++L+D+G+ A+ N + + Y+ P
Sbjct: 124 RGLAYLHENKVIHRDIKGQNILLTKNAE-VKLVDFGVSAQLDSTLGRRNTFIGTPYWMAP 182
Query: 185 ELLV-DLQD---YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 240
E++ D Q YD D+WSLG + K P H L KI +
Sbjct: 183 EVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RALFKIPR--------- 232
Query: 241 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 300
N P L S + WSK + DF+ + L ++++RP +
Sbjct: 233 --NP-----PPTLK------SPENWSK------------KFNDFISECLIKNYEQRPFME 267
Query: 301 EAMAHPY 307
E + HP+
Sbjct: 268 ELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 96.7 bits (240), Expect = 1e-22
Identities = 79/309 (25%), Positives = 146/309 (47%), Gaps = 38/309 (12%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCT------DNEKCIIKILKPVKK----KKIKREIKILQNL 72
Y+ ++ +G G +G+ C + I K+ +P + K+ RE+ +L
Sbjct: 26 YQNLKPIGSGA-----QGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYREL-VLMKC 79
Query: 73 CGGPNIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 128
NI+ LL++ Q+S + ++ E ++ +V+ L + Y +Y++L +
Sbjct: 80 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 188
+ HS GI+HRD+KP N+++ + L+++D+GLA V +RY++ PE+++
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 198
Query: 189 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248
+ Y ++D+WS+GC+ MI F G D+ DQ K+ + LGT ++ +
Sbjct: 199 GM-GYKENVDIWSVGCIMGEMIKGG-VLFPGTDHIDQWNKVIEQLGTP-----CPEFMKK 251
Query: 249 LDPHLAALVGRHSRKPWSKFITV----------ENQHLAVPEAVDFLDKLLRYDHQERPT 298
L P + V + F + E+ L +A D L K+L D +R +
Sbjct: 252 LQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 311
Query: 299 AKEAMAHPY 307
EA+ HPY
Sbjct: 312 VDEALQHPY 320
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 1e-22
Identities = 70/297 (23%), Positives = 139/297 (46%), Gaps = 50/297 (16%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLCGGPN 77
++ ++++ K+G G Y V++ +H + IK++ PV++ ++I +EI IL+ C P
Sbjct: 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVV-PVEEDLQEIIKEISILKQ-CDSPY 59
Query: 78 IVKLLDIVRDQQSKTPSLIFEH-----VNNTDFKVLYPTLSDYDVRYYIYELLKALDYCH 132
IVK ++ ++ E+ V++ K+ TL++ ++ +Y+ LK L+Y H
Sbjct: 60 IVKYYGSY--FKNTDLWIVMEYCGAGSVSDI-MKITNKTLTEEEIAAILYQTLKGLEYLH 116
Query: 133 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 191
S +HRD+K N++++ E + +L D+G++ + + N + + ++ PE++ +
Sbjct: 117 SNKKIHRDIKAGNILLNEEG-QAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-I 174
Query: 192 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251
Y+ D+WSLG M K P+ ++ P
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPPYS------------------------------DIHP 204
Query: 252 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
A + + P T+ + PE DF+ K L D +ERP+A + + HP+
Sbjct: 205 MRAIFMIPNKPPP-----TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 93.3 bits (232), Expect = 4e-22
Identities = 60/227 (26%), Positives = 110/227 (48%), Gaps = 22/227 (9%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCI----IKILKPVKKK---KIKREIKILQNLC 73
++++ +K+G+G++S V++ + C + + + ++I + + K +EI +L+ L
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAI-CLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL- 59
Query: 74 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-------FKVLYPTLSDYDVRYYIYELLK 126
PN++K L + ++ E + D FK + + + Y +L
Sbjct: 60 DHPNVIKYLASFIENNELN--IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS 117
Query: 127 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPE 185
AL++ HS+ IMHRD+KP NV I ++L D GL F+ + V + Y+ PE
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176
Query: 186 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN-YDQLVKIAK 231
+ + Y++ D+WSLGC+ M + PF+ N Y KI K
Sbjct: 177 RIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 9e-22
Identities = 79/300 (26%), Positives = 131/300 (43%), Gaps = 57/300 (19%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKKKKIK---REIKILQNLCGG 75
+E++R +G+G + +V + K + K K V+K ++ E +ILQ L
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQ-KCVEKGSVRNVLNERRILQEL-NH 59
Query: 76 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDY 130
P +V L +D+++ L+ + + D + Y S+ V+++I E++ AL+Y
Sbjct: 60 PFLVNLWYSFQDEENMY--LVVDLLLGGDLR--YHLSQKVKFSEEQVKFWICEIVLALEY 115
Query: 131 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 190
HS+GI+HRD+KP N+++D EQ + + D+ +A P + + PE+L
Sbjct: 116 LHSKGIIHRDIKPDNILLD-EQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCR- 173
Query: 191 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250
Q Y ++D WSLG + K P + GH + AK D L
Sbjct: 174 QGYSVAVDWWSLGVTAYECLRGKRP-YRGHSRTIRDQIRAKQETADVL------------ 220
Query: 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER--PTAKEAMAHPYF 308
WS EA+D ++KLL D Q+R K+ HPYF
Sbjct: 221 ----------YPATWST------------EAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 1e-21
Identities = 78/303 (25%), Positives = 126/303 (41%), Gaps = 66/303 (21%)
Query: 29 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNLCGGPNIVK 80
+ +G Y VF + + IK++K K I++ E IL P +VK
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIK--KADMIRKNQVDQVLTERDILSQ-AQSPYVVK 57
Query: 81 LLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQGIM 137
L Q K L+ E++ D L +L + R YI E++ AL+Y HS GI+
Sbjct: 58 LYYSF--QGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGII 115
Query: 138 HRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR---------YFKGPELLV 188
HRD+KP N++ID L+L D+GL++ ++ N+ + + PE+++
Sbjct: 116 HRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVIL 174
Query: 189 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248
Q + ++D WSLGC+ + PF H + + +L K
Sbjct: 175 -GQGHSKTVDWWSLGCILYEFLVGIPPF---HGETPEEI-FQNILN--------GKI--- 218
Query: 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK---EAMAH 305
W + + V EA+D + KLL D ++R AK E H
Sbjct: 219 ---------------EWPEDVEVS------DEAIDLISKLLVPDPEKRLGAKSIEEIKNH 257
Query: 306 PYF 308
P+F
Sbjct: 258 PFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 5e-21
Identities = 80/316 (25%), Positives = 151/316 (47%), Gaps = 41/316 (12%)
Query: 28 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK----REIKILQNLCGGPNIVKLLD 83
KVGRG Y V++ D + LK ++ I REI +L+ L PN++ L
Sbjct: 8 KVGRGTYGHVYKAKR-KDGKDDRDYALKQIEGTGISMSACREIALLREL-KHPNVISLQK 65
Query: 84 IVRDQQSKTPSLIFEHVNNTDFKVLY-----------PTLSDYDVRYYIYELLKALDYCH 132
+ + L+F++ + + ++ L V+ +Y++L + Y H
Sbjct: 66 VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125
Query: 133 SQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYH----PGKEYNVRVASRYFKGPE 185
+ ++HRD+KP N+++ E+ ++++ D G A ++ P + + V + +++ PE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 186 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD---------NYDQLVKIAKVLGTD 236
LL+ + Y ++D+W++GC+FA ++ EP F+ ++DQL +I V+G
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG-- 242
Query: 237 ELNAYLNKYHIELDPHLAALVGRHSRKPWSK--FITVENQHLAVPEAVDF--LDKLLRYD 292
A + I+ P + L+ R ++ I +H P++ F L KLL D
Sbjct: 243 -FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMD 301
Query: 293 HQERPTAKEAMAHPYF 308
+R T+++AM PYF
Sbjct: 302 PIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-20
Identities = 80/316 (25%), Positives = 148/316 (46%), Gaps = 41/316 (12%)
Query: 28 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK----REIKILQNLCGGPNIVKLLD 83
KVGRG Y V++ D + LK ++ I REI +L+ L PN++ L
Sbjct: 8 KVGRGTYGHVYKAKR-KDGKDEKEYALKQIEGTGISMSACREIALLREL-KHPNVIALQK 65
Query: 84 IVRDQQSKTPSLIFEHVNNTDFKVLY-----------PTLSDYDVRYYIYELLKALDYCH 132
+ + L+F++ + + ++ L V+ +Y++L + Y H
Sbjct: 66 VFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125
Query: 133 SQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYH----PGKEYNVRVASRYFKGPE 185
+ ++HRD+KP N+++ E+ ++++ D G A ++ P + + V + +++ PE
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185
Query: 186 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD---------NYDQLVKIAKVLGTD 236
LL+ + Y ++D+W++GC+FA ++ EP F+ ++DQL +I V+G
Sbjct: 186 LLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG-- 242
Query: 237 ELNAYLNKYHIELDPHLAALVGRHSRKPW--SKFITVENQHLAVPEAVDF--LDKLLRYD 292
A + I P L R + S I +H P++ F L KLL D
Sbjct: 243 -FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMD 301
Query: 293 HQERPTAKEAMAHPYF 308
+R T+++A+ PYF
Sbjct: 302 PTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 2e-20
Identities = 76/296 (25%), Positives = 127/296 (42%), Gaps = 55/296 (18%)
Query: 26 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKI---KREIKILQNLCGGPNIV 79
++ + +G + V+ + + IK+LK + K ++ K E I+ P +
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 80 KLLDIVRDQQSKTP-SLIFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDYCHSQG 135
KL QSK L+ E++N D L T L + + YI E++ ++ H +G
Sbjct: 61 KLYYSF---QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG 117
Query: 136 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 195
I+HRD+KP N++ID + L+L D+GL+ K++ V + + PE ++ + D D
Sbjct: 118 IIHRDIKPENLLID-QTGHLKLTDFGLSRNGLENKKF---VGTPDYLAPETILGVGD-DK 172
Query: 196 SLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA 255
D WSLGC+ +F PF H V +L
Sbjct: 173 MSDWWSLGCVIFEFLFGYPPF---HAETPDAV-FDNIL---------------------- 206
Query: 256 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK---EAMAHPYF 308
R W + + + PEAVD +++LL D +R A E +HP+F
Sbjct: 207 ----SRRINWPEEV----KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF 254
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 3e-20
Identities = 74/301 (24%), Positives = 129/301 (42%), Gaps = 64/301 (21%)
Query: 29 VGRGKYSEVFEGVHCTDNEKCIIKIL-------KPVKKKK-----IKREIKILQNLCGGP 76
+G G + V+ G++ + E +K + +K+ + REI +L+ L
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHE 66
Query: 77 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHS 133
NIV+ L D + E+V L Y + VR ++ ++LK L+Y H+
Sbjct: 67 NIVQYLGSSLDADHLN--IFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 134 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR-------YFKGPEL 186
+GI+HRD+K N+++D++ +++ D+G+++ +R ++ PE
Sbjct: 125 RGIIHRDIKGANILVDNKG-GIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE- 182
Query: 187 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246
+V Y D+WSLGC+ M+ K PF + QL I K
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGKHPF----PDCTQLQAIFK--------------- 223
Query: 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 306
+G ++ I+ EA+DFL+K DH +RPTA E + HP
Sbjct: 224 ----------IGENASPEIPSNISS--------EAIDFLEKTFEIDHNKRPTAAELLKHP 265
Query: 307 Y 307
+
Sbjct: 266 F 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 9e-20
Identities = 70/301 (23%), Positives = 123/301 (40%), Gaps = 54/301 (17%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKKKKIKREIKILQNLCGGP 76
DD E + ++G G V + +H + K I + +K+I RE+ IL C P
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHK-CNSP 59
Query: 77 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYI----YELLKALDYCH 132
IV + S+ E+++ + + + +LK L Y H
Sbjct: 60 YIVGFYGAFYNNG--DISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLH 117
Query: 133 SQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN----VRVASRYFKGPELL 187
+ I+HRDVKP N++++ + +++L D+G++ G+ N V + + PE +
Sbjct: 118 EKHKIIHRDVKPSNILVNS-RGQIKLCDFGVS-----GQLVNSLAKTFVGTSSYMAPERI 171
Query: 188 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247
DY D+WSLG + + P+ +D D + + L +N
Sbjct: 172 QGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIF--------ELLQYIVN---- 218
Query: 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 307
E P L + +S P+ DF++ L D +ERP+ KE + HP+
Sbjct: 219 EPPPRLPS-------GKFS------------PDFQDFVNLCLIKDPRERPSYKELLEHPF 259
Query: 308 F 308
Sbjct: 260 I 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 85.9 bits (213), Expect = 1e-19
Identities = 82/303 (27%), Positives = 130/303 (42%), Gaps = 67/303 (22%)
Query: 27 RKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPNIVKL 81
K+G G + +V+ V+ E +K ++ P K+I E+K+L+ L PN+VK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVKY 64
Query: 82 --LDIVRDQ--------QSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYC 131
+++ R++ T + EH D V +R Y +LL+ L Y
Sbjct: 65 YGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV---------IRVYTLQLLEGLAYL 115
Query: 132 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-----GKEYNVRVASRYFKGPEL 186
HS GI+HRD+KP N+ +DH ++L D+G A G+E + + PE+
Sbjct: 116 HSHGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEV 174
Query: 187 LV--DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244
+ + + + D+WSLGC+ M K P+ D +I
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPW----SELDNEFQIM-------------- 216
Query: 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304
+H VG + P I Q PE DFLD+ L D ++RPTA E +
Sbjct: 217 FH----------VGAGHKPP----IPDSLQ--LSPEGKDFLDRCLESDPKKRPTASELLQ 260
Query: 305 HPY 307
HP+
Sbjct: 261 HPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 2e-18
Identities = 84/342 (24%), Positives = 134/342 (39%), Gaps = 102/342 (29%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI-----------KREIKIL 69
DD+EV++ +GRG + EV+ D + + +K ++K + +R+I
Sbjct: 1 DDFEVIKVIGRGAFGEVWL---VRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD 57
Query: 70 QNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV------RYYIYE 123
+ P IVKL +D++ L+ E++ D L L DV R+YI E
Sbjct: 58 AD---SPWIVKLYYSFQDEEHLY--LVMEYMPGGDLMNL---LIRKDVFPEETARFYIAE 109
Query: 124 LLKALDYCHSQGIMHRDVKPHNVMID---HEQRKLRLIDWGLA----------------- 163
L+ ALD H G +HRD+KP N++ID H ++L D+GL
Sbjct: 110 LVLALDSVHKLGFIHRDIKPDNILIDADGH----IKLADFGLCKKMNKAKDREYYLNDSH 165
Query: 164 ---------EFYHPGKEYNVR----VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI 210
K+ VR V + + PE+L Y D WSLG + M+
Sbjct: 166 NLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEML 224
Query: 211 FRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 270
+ PF+ +D L NK W + +
Sbjct: 225 YGFPPFY-----------------SDTLQETYNKII-----------------NWKESLR 250
Query: 271 VENQHLAVPEAVDFLDKLLRYDHQER-PTAKEAMAHPYFFPI 311
PEA+D + +LL D ++R + +E +HP+F I
Sbjct: 251 FPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-18
Identities = 57/211 (27%), Positives = 106/211 (50%), Gaps = 21/211 (9%)
Query: 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKC------IIKILKPVKKKKIKREIKILQNLCGG 75
++++ +K+GRG++SEV+ D + I +++ ++ +EI +L+ L
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NH 61
Query: 76 PNIVKLLD-IVRDQQSKTPSLIFEHVNNTD-------FKVLYPTLSDYDVRYYIYELLKA 127
PN++K LD + D + +++ E + D FK + + V Y +L A
Sbjct: 62 PNVIKYLDSFIEDNEL---NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA 118
Query: 128 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPEL 186
+++ HS+ +MHRD+KP NV I ++L D GL F+ + V + Y+ PE
Sbjct: 119 VEHMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 187 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 217
+ + Y++ D+WSLGC+ M + PF+
Sbjct: 178 IHE-NGYNFKSDIWSLGCLLYEMAALQSPFY 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-17
Identities = 67/256 (26%), Positives = 113/256 (44%), Gaps = 28/256 (10%)
Query: 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-----ILKPVKKKKIKREIKILQNLCGGP 76
DYEV+ +G+G + V + +D + + K + +K+++ E+ IL+ L P
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHP 59
Query: 77 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIY----ELLKALD 129
NIV+ D + D+ ++T ++ E+ D L Y +I+ +LL AL
Sbjct: 60 NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119
Query: 130 YCH-----SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKG 183
CH ++HRD+KP N+ +D ++L D+GLA+ + V + Y+
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMS 178
Query: 184 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF-YGHDNYDQLVKIAKVLG-----TDE 237
PE L YD D+WSLGC+ + PF +K K + E
Sbjct: 179 PEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSE 237
Query: 238 LNAYLNKYHIELDPHL 253
LN + K + +DP
Sbjct: 238 LNEVI-KSMLNVDPDK 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 2e-17
Identities = 74/300 (24%), Positives = 121/300 (40%), Gaps = 63/300 (21%)
Query: 29 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR---------EIKILQNLCGGPNIV 79
+G+G + EV K + K + KK++K+ E KIL+ IV
Sbjct: 1 LGKGGFGEVC-ACQVKATGK--MYACKKLDKKRLKKRKGEQMALNEKKILE-KVSSRFIV 56
Query: 80 KLLDIVRDQQSKTP-SLIFEHVNNTDFK-----VLYPTLSDYDVRYYIYELLKALDYCHS 133
L ++K L+ +N D K V P + +Y +++ L++ H
Sbjct: 57 SL---AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ 113
Query: 134 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 193
+ I++RD+KP NV++D + +R+ D GLA GK+ R + + PE+L + Y
Sbjct: 114 RRIVYRDLKPENVLLD-DHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQG-EVY 171
Query: 194 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 253
D+S+D ++LGC MI + PF K
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPF----------------------RQRKEK--------- 200
Query: 254 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER-----PTAKEAMAHPYF 308
V + K + + VE PEA D + LL+ D ++R +A E HP F
Sbjct: 201 ---VEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLF 257
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-17
Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 18/200 (9%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLCGGPNI 78
D +E++ +G+G Y +V++ + D +KIL P+ ++I+ E ILQ+L PN+
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNV 81
Query: 79 VKLLDIVRDQQSKTPS---LIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKAL 128
VK + L+ E N L L + + Y +Y L L
Sbjct: 82 VKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGL 141
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELL 187
+ H+ I+HRDVK +N+++ E ++L+D+G+ A+ N V + ++ PE++
Sbjct: 142 QHLHNNRIIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 200
Query: 188 VDLQDYDYSL----DLWSLG 203
Q YDYS D+WSLG
Sbjct: 201 ACEQQYDYSYDARCDVWSLG 220
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 4e-17
Identities = 66/305 (21%), Positives = 128/305 (41%), Gaps = 50/305 (16%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGP 76
D E V+ +G+G V++ H + +K + +K++ RE+K L++ C P
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRS-CESP 59
Query: 77 NIVKLLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHS 133
+VK + S++ E+++ D + + + Y ++LK LDY H+
Sbjct: 60 YVVKCYGAF--YKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117
Query: 134 Q-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVDLQ 191
+ I+HRD+KP N++I+ + ++++ D+G+++ + N V + + PE + +
Sbjct: 118 KRHIIHRDIKPSNLLINSKG-EVKIADFGISKVLENTLDQCNTFVGTVTYMSPERI-QGE 175
Query: 192 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251
Y Y+ D+WSLG K PF + + L
Sbjct: 176 SYSYAADIWSLGLTLLECALGKFPFLPP-GQPSFFELMQAICDGPP---------PSLPA 225
Query: 252 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311
+ PE DF+ L+ D ++RP+A E + HP+ I
Sbjct: 226 EEFS-----------------------PEFRDFISACLQKDPKKRPSAAELLQHPF---I 259
Query: 312 RNAES 316
+ A++
Sbjct: 260 KKADN 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (193), Expect = 9e-17
Identities = 73/303 (24%), Positives = 129/303 (42%), Gaps = 57/303 (18%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK---KKIKREIKILQNLCGGP 76
Q+DYE+++++G G Y +V++ E IK++K + I++EI +L+ C P
Sbjct: 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKE-CRHP 60
Query: 77 NIVKLL-DIVRDQQ-------SKTPSLIFEHVNNTD-FKVLYPTLSDYDVRYYIYELLKA 127
NIV +R + SL D ++V LS+ + Y E LK
Sbjct: 61 NIVAYFGSYLRRDKLWIVMEYCGGGSL-------QDIYQVTRGPLSELQIAYVCRETLKG 113
Query: 128 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPEL 186
L Y H G +HRD+K N+++ E ++L D+G+ A+ + + + Y+ PE+
Sbjct: 114 LAYLHETGKIHRDIKGANILLT-EDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEV 172
Query: 187 LVDLQ--DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244
+ YD D+W+LG + + P F H + L
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH--------PMRAL----------- 213
Query: 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304
L+ + + P ++++ P DF+ K L D ++RPTA + +
Sbjct: 214 ----------FLISKSNFPP----PKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259
Query: 305 HPY 307
HP+
Sbjct: 260 HPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-16
Identities = 75/309 (24%), Positives = 129/309 (41%), Gaps = 63/309 (20%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNI 78
D +E++ +G+G Y +VF+ ++ + K +KIL P+ ++I+ E IL+ L PN+
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNV 77
Query: 79 VKLLDIVRDQQSKTPS---LIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKAL 128
VK + + K L+ E N L + + + Y ++E L L
Sbjct: 78 VKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELL 187
+ H +HRDVK +N+++ E ++L+D+G+ A+ N V + ++ PE++
Sbjct: 138 QHLHVNKTIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI 196
Query: 188 VDLQD----YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243
Q YD D+WSLG
Sbjct: 197 ACEQQLDSTYDARCDVWSLGIT-------------------------------------- 218
Query: 244 KYHIEL---DPHLAALVGRHS--RKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT 298
IEL DP LA L + + P + T+ L E DF+ K L D+++RPT
Sbjct: 219 --AIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPT 276
Query: 299 AKEAMAHPY 307
+ + H +
Sbjct: 277 VSDLLQHVF 285
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 3e-16
Identities = 63/260 (24%), Positives = 107/260 (41%), Gaps = 55/260 (21%)
Query: 62 IKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD----- 116
+++EI+++ L P+I+++L + +L E + L LS Y
Sbjct: 50 LRKEIRLMARL-NHPHIIRMLGAT--CEDSHFNLFVEWMAGGSVSHL---LSKYGAFKEA 103
Query: 117 -VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-----EFYHPGK 170
+ Y +LL+ L Y H I+HRDVK N++ID ++LR+ D+G A + G+
Sbjct: 104 VIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE 163
Query: 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF-FYGHDNYDQLV-K 228
+ + F PE+L + Y S D+WS+GC+ M K P+ H N+ L+ K
Sbjct: 164 FQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFK 222
Query: 229 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKL 288
IA + +L+ P D +
Sbjct: 223 IASATTAPSIPEHLS-----------------------------------PGLRDVTLRC 247
Query: 289 LRYDHQERPTAKEAMAHPYF 308
L ++RP ++E + HP F
Sbjct: 248 LELQPEDRPPSRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 5e-16
Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 24/203 (11%)
Query: 29 VGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGG--PNIVK-- 80
+GRG Y V+ G H +KI+ I+RE+ +L L PNI K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 81 --LLDIVRDQQSKTPSL--IFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYCHSQ 134
L K P L I E+ + L +++ + I E+L AL Y H
Sbjct: 69 GSYL--------KGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKV 120
Query: 135 GIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQDY 193
G++HRD+K N+++ + ++L D+G+ A + + V + Y+ PE++ + + Y
Sbjct: 121 GVIHRDIKAANILVTNTGN-VKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYY 179
Query: 194 DYSLDLWSLGCMFAGMIFRKEPF 216
D D+WSLG M P+
Sbjct: 180 DTKADIWSLGITIYEMATGNPPY 202
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 76.3 bits (187), Expect = 8e-16
Identities = 73/301 (24%), Positives = 131/301 (43%), Gaps = 50/301 (16%)
Query: 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK---ILKPVKKKKIKREIKILQNL 72
I + Y K+G+G VF + ++ IK + K KK+ I EI +++ L
Sbjct: 14 IGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL 73
Query: 73 CGGPNIVKLLD--IVRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKAL 128
PNIV LD +V D+ ++ E++ V + + + E L+AL
Sbjct: 74 -KNPNIVNFLDSFLVGDELF----VVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQAL 128
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELL 187
++ H+ ++HRD+K NV++ + ++L D+G P + + + V + Y+ PE +
Sbjct: 129 EFLHANQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-V 186
Query: 188 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247
V + Y +D+WSLG M M+ + P+ ++N + + + GT EL
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPEL--------- 235
Query: 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 307
+N P DFL++ L D ++R +AKE + HP+
Sbjct: 236 ------------------------QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPF 271
Query: 308 F 308
Sbjct: 272 L 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 8e-16
Identities = 69/319 (21%), Positives = 121/319 (37%), Gaps = 83/319 (26%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGP 76
DDYE++ +G G + V+ + +NEK IK + ++++E++ + + C P
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAM-SQCNHP 59
Query: 77 NIVK----------------------LLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSD 114
N+VK LLDI++ S P +
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMK---SSYPRGGLDEAI------------- 103
Query: 115 YDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPG---- 169
+ + E+LK L+Y HS G +HRD+K N+++ E +++ D+G+ A G
Sbjct: 104 --IATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG-EDGSVKIADFGVSASLADGGDRTR 160
Query: 170 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 229
K V + + PE++ + YD+ D+WS G + P+ Y + +
Sbjct: 161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYS----KYPPMKVL 216
Query: 230 AKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLL 289
L D D K +SK + L
Sbjct: 217 MLTLQNDP-----PSLETGAD-----------YKKYSK------------SFRKMISLCL 248
Query: 290 RYDHQERPTAKEAMAHPYF 308
+ D +RPTA+E + H +F
Sbjct: 249 QKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-15
Identities = 72/305 (23%), Positives = 130/305 (42%), Gaps = 68/305 (22%)
Query: 29 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-------------KKIKREIKILQNLCGG 75
+G+G Y V+ ++ T E +K ++ K ++ EI+ L++L
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DH 67
Query: 76 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKALDYCH 132
NIV+ L + + S+ E+V T ++ VR++ ++L+ L Y H
Sbjct: 68 LNIVQYLGF--ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 133 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGL----AEFYHPGKEYNVRVASRYFKGPELLV 188
S+GI+HRD+K N+++D ++ D+G+ + Y + +++ S ++ PE ++
Sbjct: 126 SKGILHRDLKADNLLVDA-DGICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMAPE-VI 182
Query: 189 DLQDYDYS--LDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242
YS +D+WSLGC MFAG + P+ +E A +
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAG----RRPW-----------------SDEEAIAAM 221
Query: 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 302
K +G P I + P A+DFL+ + RPTA+E
Sbjct: 222 FK------------LGNKRSAP---PIPPDVSMNLSPVALDFLNACFTINPDNRPTAREL 266
Query: 303 MAHPY 307
+ HP+
Sbjct: 267 LQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 2e-15
Identities = 52/185 (28%), Positives = 104/185 (56%), Gaps = 12/185 (6%)
Query: 48 KCIIK--ILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD- 104
KC+ K I++ +++ I E +IL+ C P IVKL +D++ ++ E+ +
Sbjct: 24 KCVKKRHIVETGQQEHIFSEKEILEE-CNHPFIVKLYRTFKDKKYIY--MLMEYCLGGEL 80
Query: 105 FKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 162
+ +L +Y R+YI ++ A +Y H++GI++RD+KP N+++D ++L+D+G
Sbjct: 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGY-VKLVDFGF 139
Query: 163 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN 222
A+ G++ + + PE++++ + YD+S+D WSLG + ++ + PF G D+
Sbjct: 140 AKKLKSGQKTWTFCGTPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPF--GEDD 196
Query: 223 YDQLV 227
D +
Sbjct: 197 EDPME 201
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 2e-15
Identities = 59/222 (26%), Positives = 104/222 (46%), Gaps = 21/222 (9%)
Query: 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK------ILKPVKKKKIKREIKILQNLCGG 75
++ + +K+GRG++SEV+ D +K ++ + +EI +L+ L
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NH 61
Query: 76 PNIVKL-LDIVRDQQSKTPSLIFEHVNNTD-------FKVLYPTLSDYDVRYYIYELLKA 127
PN++K + D + +++ E + D FK + + V Y +L A
Sbjct: 62 PNVIKYYASFIEDNEL---NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA 118
Query: 128 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNVRVASRYFKGPEL 186
L++ HS+ +MHRD+KP NV I ++L D GL F+ + V + Y+ PE
Sbjct: 119 LEHMHSRRVMHRDIKPANVFIT-ATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 177
Query: 187 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 228
+ + Y++ D+WSLGC+ M + PF+ N L K
Sbjct: 178 IHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK 218
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 1e-14
Identities = 58/214 (27%), Positives = 102/214 (47%), Gaps = 32/214 (14%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKK---IKREIKILQNLCG 74
DD+E ++ +G G + V H + +KIL K VK K+ + E +ILQ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRH 60
Query: 75 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL--YPTLSDYDVRYYIYELLKALDYC 131
P +V L +D + L+ E+V + F L + R+Y +++ AL+Y
Sbjct: 61 -PFLVNLYGSFQDDSNL--YLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYL 117
Query: 132 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK--------G 183
HS I++RD+KP N+++D +++ D+G A RV R +
Sbjct: 118 HSLDIVYRDLKPENLLLDS-DGYIKITDFGFA----------KRVKGRTYTLCGTPEYLA 166
Query: 184 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 217
PE+++ + Y ++D W+LG + M+ PFF
Sbjct: 167 PEIIL-SKGYGKAVDWWALGILIYEMLAGYPPFF 199
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 2e-14
Identities = 54/196 (27%), Positives = 84/196 (42%), Gaps = 44/196 (22%)
Query: 125 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYF 181
LKAL + H+QG++HRD+K ++++ + R ++L D+G KE R V + Y+
Sbjct: 125 LKALSFLHAQGVIHRDIKSDSILLTSDGR-VKLSDFGFCA--QVSKEVPRRKSLVGTPYW 181
Query: 182 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY 241
PE++ L Y +D+WSLG M M+ + P+F
Sbjct: 182 MAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFN----------------------- 217
Query: 242 LNKYHIELDPHLAALVG-RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 300
+P L A+ R + P K N H P FLD++L D +R TA
Sbjct: 218 --------EPPLQAMKRIRDNLPPKLK-----NLHKVSPRLRSFLDRMLVRDPAQRATAA 264
Query: 301 EAMAHPYFFPIRNAES 316
E + HP+ S
Sbjct: 265 ELLNHPFLAKAGPPSS 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 2e-14
Identities = 60/243 (24%), Positives = 118/243 (48%), Gaps = 38/243 (15%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNE----KCI-IKILKPVKKKKIKREIKILQNLCGG 75
++YEV++K+G G++ EVF H E K I + LK +K ++ E+ +++ L
Sbjct: 13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-KH 71
Query: 76 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-------VLYPTLSDYDVRYYIYELLKAL 128
NIV+ +D ++ ++ ++ E + D ++ + ++ + +LL AL
Sbjct: 72 KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131
Query: 129 DYCHS-------QGIMHRDVKPHNVMIDHEQRKL----------------RLIDWGLAEF 165
YCH+ + ++HRD+KP N+ + R + ++ D+GL++
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191
Query: 166 YHPGKEYNVRVASRYFKGPELLV-DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD 224
+ V + Y+ PELL+ + + YD D+W+LGC+ + K P F+ +N+
Sbjct: 192 IGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP-FHKANNFS 250
Query: 225 QLV 227
QL+
Sbjct: 251 QLI 253
|
Length = 1021 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 71.8 bits (176), Expect = 3e-14
Identities = 59/218 (27%), Positives = 95/218 (43%), Gaps = 31/218 (14%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--------VKKKKIKREIKILQNL 72
D++V VGRG + EV + +K++K V + +R+I + N
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN- 59
Query: 73 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD-------VRYYIYELL 125
P I +L +D L+ E+ D L L+ Y+ ++Y+ EL+
Sbjct: 60 --SPWIPQLQYAFQD--KDNLYLVMEYQPGGD---LLSLLNRYEDQFDEDMAQFYLAELV 112
Query: 126 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR--VASRYFKG 183
A+ H G +HRD+KP NV+ID ++L D+G A K N + V + +
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLPVGTPDYIA 171
Query: 184 PELLVDLQD-----YDYSLDLWSLGCMFAGMIFRKEPF 216
PE+L + Y D WSLG + MI+ + PF
Sbjct: 172 PEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF 209
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 4e-14
Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 20/211 (9%)
Query: 27 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI---------KREIKILQNLCGGPN 77
R +GRG Y++V V N++ I +K VKK+ + + E + + P
Sbjct: 1 RVIGRGSYAKVLL-VRLKKNDQ--IYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPF 57
Query: 78 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQ 134
+V L Q + L+ E+VN D L + R+Y E+ AL++ H +
Sbjct: 58 LVGLHSCF--QTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHER 115
Query: 135 GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 193
GI++RD+K NV++D + ++L D+G+ E PG + + + PE+L ++Y
Sbjct: 116 GIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEY 173
Query: 194 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD 224
+S+D W+LG + M+ + PF DN D
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIITDNPD 204
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (174), Expect = 5e-14
Identities = 48/193 (24%), Positives = 95/193 (49%), Gaps = 16/193 (8%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGP 76
+ + ++ +G+G + EV++ + N+ IK++ + + I++EI+ L C P
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQ-CRSP 59
Query: 77 NIVKLLDIVRDQQSKTPSL--IFEHVNN-TDFKVLYP-TLSDYDVRYYIYELLKALDYCH 132
I K K L I E+ + +L P L + + + + E+L L+Y H
Sbjct: 60 YITKYYGSF----LKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLH 115
Query: 133 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 191
+G +HRD+K N+++ E+ ++L D+G++ + + N V + ++ PE++
Sbjct: 116 EEGKIHRDIKAANILLS-EEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQ-S 173
Query: 192 DYDYSLDLWSLGC 204
YD D+WSLG
Sbjct: 174 GYDEKADIWSLGI 186
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 5e-14
Identities = 57/218 (26%), Positives = 105/218 (48%), Gaps = 21/218 (9%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGPNI 78
YE+++K+G G + +++ +D+E C+IK + PVK+K+ ++ IL PNI
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61
Query: 79 VKLLDIVRDQQSKTPSLIFEHVNNTDFK--------VLYPTLSDYDVRYYIYELLKALDY 130
V Q++ ++ E+ + D VL+ S+ + + ++ L +
Sbjct: 62 VTFFASF--QENGRLFIVMEYCDGGDLMKRINRQRGVLF---SEDQILSWFVQISLGLKH 116
Query: 131 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVD 189
H + I+HRD+K N+ + +L D+G+A + E V + Y+ PE+ +
Sbjct: 117 IHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN 176
Query: 190 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 227
+ Y+ D+WSLGC+ + K PF +N QLV
Sbjct: 177 -RPYNNKTDIWSLGCVLYELCTLKHPF--EGNNLHQLV 211
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 6e-14
Identities = 53/187 (28%), Positives = 87/187 (46%), Gaps = 38/187 (20%)
Query: 124 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFK 182
+L+AL Y HSQG++HRD+K ++++ + R ++L D+G A+ + V + Y+
Sbjct: 126 VLQALCYLHSQGVIHRDIKSDSILLTLDGR-VKLSDFGFCAQISKDVPKRKSLVGTPYWM 184
Query: 183 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242
PE ++ Y +D+WSLG M M+ + P+F D V+ K L
Sbjct: 185 APE-VISRTPYGTEVDIWSLGIMVIEMVDGEPPYF-----SDSPVQAMKRL--------- 229
Query: 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 302
R S P ++N H P DFL+++L + QER TA+E
Sbjct: 230 ----------------RDSPPP-----KLKNAHKISPVLRDFLERMLTREPQERATAQEL 268
Query: 303 MAHPYFF 309
+ HP+
Sbjct: 269 LDHPFLL 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 7e-14
Identities = 71/304 (23%), Positives = 125/304 (41%), Gaps = 59/304 (19%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVK 80
+E+V VG G Y +V++G H + IK++ ++++IK+EI +L+ NI
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 67
Query: 81 LLDIVRDQQSKTPS-------LIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKAL 128
K P L+ E L TL + + Y E+L+ L
Sbjct: 68 YYGAF---IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELL 187
+ H ++HRD+K NV++ E +++L+D+G+ A+ N + + Y+ PE++
Sbjct: 125 SHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 183
Query: 188 VDLQD----YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243
++ YD+ DLWSLG M P +++
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC-------------------DMHPMRA 224
Query: 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 303
+ I +P R K WSK + F++ L +H +RPT ++ M
Sbjct: 225 LFLIPRNP-----APRLKSKKWSK------------KFQSFIESCLVKNHSQRPTTEQLM 267
Query: 304 AHPY 307
HP+
Sbjct: 268 KHPF 271
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 9e-14
Identities = 71/294 (24%), Positives = 128/294 (43%), Gaps = 50/294 (17%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK---ILKPVKKKKIKREIKILQNLCGGPNIV 79
Y K+G+G V+ + ++ IK + + KK+ I EI +++ PNIV
Sbjct: 21 YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE-NKNPNIV 79
Query: 80 KLLD--IVRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYCHSQG 135
LD +V D+ ++ E++ V + + + E L+ALD+ HS
Sbjct: 80 NYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQ 135
Query: 136 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYD 194
++HRD+K N+++ + ++L D+G P + + + V + Y+ PE +V + Y
Sbjct: 136 VIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTRKAYG 193
Query: 195 YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLA 254
+D+WSLG M M+ + P+ ++N + + + GT EL +P
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPPYL--NENPLRALYLIATNGTPELQ----------NPERL 241
Query: 255 ALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
+ V R DFL++ L D R +AKE + HP+
Sbjct: 242 SAVFR-----------------------DFLNRCLEMDVDRRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 1e-13
Identities = 75/300 (25%), Positives = 134/300 (44%), Gaps = 53/300 (17%)
Query: 26 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGPNIVKL 81
+ K+G+G + EVF+G+ + IKI+ + + I++EI +L C P + K
Sbjct: 9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDSPYVTKY 67
Query: 82 L-DIVRDQQSKTPSLIFEHVNN-TDFKVLYP-TLSDYDVRYYIYELLKALDYCHSQGIMH 138
++D + +I E++ + +L P L + + + E+LK LDY HS+ +H
Sbjct: 68 YGSYLKDTKL---WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIH 124
Query: 139 RDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 197
RD+K NV++ E +++L D+G+A + + N V + ++ PE ++ YD
Sbjct: 125 RDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDSKA 182
Query: 198 DLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALV 257
D+WSLG + A + + EP H EL P +
Sbjct: 183 DIWSLG-ITAIELAKGEP-----------------------------PHSELHPMKVLFL 212
Query: 258 GRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESS 317
+ P T+E + +F++ L + RPTAKE + H F +R A+ +
Sbjct: 213 IPKNNPP-----TLEGNY--SKPLKEFVEACLNKEPSFRPTAKELLKHK--FIVRFAKKT 263
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-13
Identities = 64/250 (25%), Positives = 108/250 (43%), Gaps = 47/250 (18%)
Query: 65 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK---VLYPTLSDYDVRYYI 121
EI++L+NL IV+ +RD+ KT ++ E++ K Y L++ R Y
Sbjct: 54 EIQLLKNL-QHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYT 112
Query: 122 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG----LAEFYHPGKEYNVRVA 177
++L+ + Y HS I+HRD+K N++ D ++L D+G L G
Sbjct: 113 RQILEGMSYLHSNMIVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICMSGTGIRSVTG 171
Query: 178 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 237
+ Y+ PE ++ + Y D+WSLGC M+ K P+ Y+ + I K+ T
Sbjct: 172 TPYWMSPE-VISGEGYGRKADVWSLGCTVVEMLTEKPPW----AEYEAMAAIFKI-ATQP 225
Query: 238 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP 297
N P L + + H+R DFL + + + RP
Sbjct: 226 TN-----------PQLPSHISEHAR--------------------DFLGCIF-VEARHRP 253
Query: 298 TAKEAMAHPY 307
+A+E + HP+
Sbjct: 254 SAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 1e-13
Identities = 73/287 (25%), Positives = 127/287 (44%), Gaps = 49/287 (17%)
Query: 28 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGPNIVKLLD 83
++G+G + EV++G+ E IKI+ + + I++EI +L C P I +
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDSPYITRYYG 69
Query: 84 IVRDQQSKTPSLIFEHVNN-TDFKVLYP-TLSDYDVRYYIYELLKALDYCHSQGIMHRDV 141
+ +I E++ + +L P L + + + E+LK LDY HS+ +HRD+
Sbjct: 70 SY--LKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDI 127
Query: 142 KPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLW 200
K NV++ EQ ++L D+G+A + + N V + ++ PE ++ YD+ D+W
Sbjct: 128 KAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIKQSAYDFKADIW 185
Query: 201 SLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRH 260
SLG + A + + EP L I K L G++
Sbjct: 186 SLG-ITAIELAKGEPPNSDLHPMRVLFLIPK-------------------NSPPTLEGQY 225
Query: 261 SRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 307
S KP+ +F++ L D + RPTAKE + H +
Sbjct: 226 S-KPFK----------------EFVEACLNKDPRFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 69.3 bits (169), Expect = 2e-13
Identities = 55/189 (29%), Positives = 86/189 (45%), Gaps = 44/189 (23%)
Query: 124 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRY 180
+LKAL H+QG++HRD+K ++++ H+ R ++L D+G KE R V + Y
Sbjct: 125 VLKALSVLHAQGVIHRDIKSDSILLTHDGR-VKLSDFGFCA--QVSKEVPRRKSLVGTPY 181
Query: 181 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 240
+ PEL+ L Y +D+WSLG M M+ + P+F
Sbjct: 182 WMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFN---------------------- 218
Query: 241 YLNKYHIELDPHLAAL-VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA 299
+P L A+ + R + P ++N H P FLD+LL D +R TA
Sbjct: 219 ---------EPPLKAMKMIRDNLPP-----KLKNLHKVSPSLKGFLDRLLVRDPAQRATA 264
Query: 300 KEAMAHPYF 308
E + HP+
Sbjct: 265 AELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 68.7 bits (169), Expect = 2e-13
Identities = 38/162 (23%), Positives = 77/162 (47%), Gaps = 18/162 (11%)
Query: 27 RKVGRGKYSEVFEGV----HCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNI 78
+K+G G + EV++G + +K LK ++ RE +I++ L PN+
Sbjct: 5 KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHPNV 63
Query: 79 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHS 133
VKLL + +++ ++ E++ D Y P LS D+ + ++ + ++Y S
Sbjct: 64 VKLLGVCTEEEP--LYIVMEYMEGGDLL-SYLRKNRPKLSLSDLLSFALQIARGMEYLES 120
Query: 134 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR 175
+ +HRD+ N ++ E +++ D+GL+ + Y R
Sbjct: 121 KNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDDYYRKR 161
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 66/216 (30%), Positives = 103/216 (47%), Gaps = 29/216 (13%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR-------EIKILQNLC 73
+DYEVV+ +GRG + EV H + + +K+L K + IKR E + +
Sbjct: 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLS--KFEMIKRSDSAFFWEERDIMAFA 100
Query: 74 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV-----RYYIYELLKAL 128
P +V+L +D + ++ E++ D L +S+YDV R+Y E++ AL
Sbjct: 101 NSPWVVQLFYAFQD--DRYLYMVMEYMPGGD---LVNLMSNYDVPEKWARFYTAEVVLAL 155
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGP 184
D HS G +HRDVKP N+++D + L+L D+G KE VR V + + P
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTC--MKMNKEGMVRCDTAVGTPDYISP 212
Query: 185 ELLVDLQD---YDYSLDLWSLGCMFAGMIFRKEPFF 217
E+L Y D WS+G M+ PF+
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-13
Identities = 63/250 (25%), Positives = 104/250 (41%), Gaps = 47/250 (18%)
Query: 65 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK---VLYPTLSDYDVRYYI 121
EI++L+NL IV+ +RD +T S+ EH+ K Y L++ R Y
Sbjct: 54 EIQLLKNLLH-ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYT 112
Query: 122 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG----LAEFYHPGKEYNVRVA 177
++L+ + Y HS I+HRD+K N++ D ++L D+G L G
Sbjct: 113 RQILEGVSYLHSNMIVHRDIKGANILRD-SVGNVKLGDFGASKRLQTICLSGTGMKSVTG 171
Query: 178 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 237
+ Y+ PE ++ + Y D+WS+GC M+ K P+ ++ + I K+ T
Sbjct: 172 TPYWMSPE-VISGEGYGRKADIWSVGCTVVEMLTEKPPW----AEFEAMAAIFKI-ATQP 225
Query: 238 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP 297
N P L V H R DFL ++ + + RP
Sbjct: 226 TN-----------PVLPPHVSDHCR--------------------DFLKRIF-VEAKLRP 253
Query: 298 TAKEAMAHPY 307
+A E + H +
Sbjct: 254 SADELLRHTF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 5e-13
Identities = 62/214 (28%), Positives = 100/214 (46%), Gaps = 22/214 (10%)
Query: 27 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI---------KREIKILQNLCGGPN 77
R +GRG Y++V V E+ I +K VKK+ + + E + + P
Sbjct: 1 RVIGRGSYAKVLL-VRLKKTER--IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPF 57
Query: 78 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQ 134
+V L Q + E+VN D L + R+Y E+ AL+Y H +
Sbjct: 58 LVGLHSCF--QTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 115
Query: 135 GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 193
GI++RD+K NV++D E ++L D+G+ E PG + + + PE+L +DY
Sbjct: 116 GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG-EDY 173
Query: 194 DYSLDLWSLGCMFAGMIFRKEPF--FYGHDNYDQ 225
+S+D W+LG + M+ + PF DN DQ
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ 207
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.6 bits (166), Expect = 5e-13
Identities = 47/205 (22%), Positives = 91/205 (44%), Gaps = 37/205 (18%)
Query: 27 RKVGRGKYSEVFEG-VHCTDNEKCI--IKILK----PVKKKKIKREIKILQNLCGGPNIV 79
+K+G G + EV++G + D + +K LK ++K +E ++++ L G PN+V
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVV 59
Query: 80 KLLDIVRDQQSKTPSLIFEHVNNTDFK------------VLYPTLSDYDVRYYIYELLKA 127
+LL + +++ L+ E++ D TLS D+ + ++ K
Sbjct: 60 RLLGVCTEEEP--LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKG 117
Query: 128 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 183
++Y S+ +HRD+ N ++ E +++ D+GL+ + Y + G
Sbjct: 118 MEYLASKKFVHRDLAARNCLVG-EDLVVKISDFGLSRDVYDDDYYRKKT-----GGKLPI 171
Query: 184 ----PELLVDLQDYDYSLDLWSLGC 204
PE L D + D+WS G
Sbjct: 172 RWMAPESLKD-GIFTSKSDVWSFGV 195
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 6e-13
Identities = 50/225 (22%), Positives = 97/225 (43%), Gaps = 25/225 (11%)
Query: 26 VRKVGRGKYSEVFEGVH--CTDN--EKCIIKILK----PVKKKKIKREIKILQNLCGGPN 77
++++G G + +V + DN E+ +K L + +REI+IL+ L N
Sbjct: 9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHEN 67
Query: 78 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVR----YYIYELLKALDYCHS 133
IVK + ++ LI E++ + + D + ++ K +DY S
Sbjct: 68 IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGS 127
Query: 134 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGPELLVD 189
Q +HRD+ N++++ E +++ D+GLA+ K+Y + ++ PE L
Sbjct: 128 QRYIHRDLAARNILVESEDL-VKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT 186
Query: 190 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 234
+ S D+WS G + F YG + + +++G
Sbjct: 187 SKFSSAS-DVWSFGVTLYEL------FTYGDPSQSPPAEFLRMIG 224
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 6e-13
Identities = 71/295 (24%), Positives = 127/295 (43%), Gaps = 58/295 (19%)
Query: 26 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK------IKREIKILQNLCGGPNIV 79
+R++G G + V+ NE IK + K+ I +E+K LQ + PN +
Sbjct: 30 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSI 88
Query: 80 KLLDIVRDQQSKTPSLIFEHV--NNTDF-KVLYPTLSDYDVRYYIYELLKALDYCHSQGI 136
+ + T L+ E+ + +D +V L + ++ + L+ L Y HS +
Sbjct: 89 EYKGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146
Query: 137 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD--YD 194
+HRD+K N+++ E +++L D+G A P + V + Y+ PE+++ + + YD
Sbjct: 147 IHRDIKAGNILLT-EPGQVKLADFGSASIASPANSF---VGTPYWMAPEVILAMDEGQYD 202
Query: 195 YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD--PH 252
+D+WSLG + RK P F +NA YHI + P
Sbjct: 203 GKVDVWSLGITCIELAERKPPLF-------------------NMNAMSALYHIAQNESPT 243
Query: 253 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 307
L + WS + +F+D L+ Q+RPT++E + H +
Sbjct: 244 LQS-------NEWSDYFR------------NFVDSCLQKIPQDRPTSEELLKHMF 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 1e-12
Identities = 62/214 (28%), Positives = 103/214 (48%), Gaps = 25/214 (11%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR-------EIKILQNLC 73
+DY+VV+ +GRG + EV H + + +K+L K + IKR E + +
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLS--KFEMIKRSDSAFFWEERDIMAFA 100
Query: 74 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV-----RYYIYELLKAL 128
P +V+L +D K ++ E++ D L +S+YDV ++Y E++ AL
Sbjct: 101 NSPWVVQLFCAFQDD--KYLYMVMEYMPGGD---LVNLMSNYDVPEKWAKFYTAEVVLAL 155
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEY-NVRVASRYFKGPEL 186
D HS G++HRDVKP N+++D + L+L D+G + G + V + + PE+
Sbjct: 156 DAIHSMGLIHRDVKPDNMLLD-KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEV 214
Query: 187 LVDLQD---YDYSLDLWSLGCMFAGMIFRKEPFF 217
L Y D WS+G M+ PF+
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFY 248
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 74/307 (24%), Positives = 136/307 (44%), Gaps = 57/307 (18%)
Query: 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI----------KREIKILQN 71
++E+++ +G G Y +VF T ++ + +K ++K + + E +L++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 72 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYP--TLSDYDVRYYIYELLKAL 128
+ P +V L Q LI ++V+ + F LY S+ +VR+Y E++ AL
Sbjct: 61 VRQSPFLVTLHYAF--QTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILAL 118
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVR-VASRYFKGPEL 186
++ H GI++RD+K N+++D E + L D+GL+ EF KE + + PE+
Sbjct: 119 EHLHKLGIVYRDIKLENILLDSEGH-VVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEI 177
Query: 187 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246
+ + ++D WSLG + ++ PF + G + +++
Sbjct: 178 IRGKGGHGKAVDWWSLGILIFELLTGASPF--------------TLEGERNTQSEVSRRI 223
Query: 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER-----PTAKE 301
++ DP + +G PEA D L KLLR D ++R A E
Sbjct: 224 LKCDPPFPSFIG--------------------PEAQDLLHKLLRKDPKKRLGAGPQGASE 263
Query: 302 AMAHPYF 308
HP+F
Sbjct: 264 IKEHPFF 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 20/203 (9%)
Query: 27 RKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKK----IKREIKILQNLCGGPNIVK 80
R +GRG Y++V +K++K V + ++ E + + P +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 81 LLDIVRDQQSKTPSLIF---EHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQ 134
L +T S +F E V+ D L + R+Y E+ AL++ H +
Sbjct: 61 LHSCF-----QTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHER 115
Query: 135 GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 193
GI++RD+K NV++D E ++L D+G+ E PG + + + PE+L +DY
Sbjct: 116 GIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRG-EDY 173
Query: 194 DYSLDLWSLGCMFAGMIFRKEPF 216
+S+D W+LG + M+ + PF
Sbjct: 174 GFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 74/300 (24%), Positives = 123/300 (41%), Gaps = 62/300 (20%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK------IKREIKILQNLCGGP 76
+ +R++G G + V+ NE IK + K+ I +E++ LQ P
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQ-LRHP 75
Query: 77 NIVKLLDI-VRDQQSKTPSLIFEHV--NNTD-FKVLYPTLSDYDVRYYIYELLKALDYCH 132
N ++ +R+ T L+ E+ + +D +V L + ++ + L+ L Y H
Sbjct: 76 NTIEYKGCYLREH---TAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLH 132
Query: 133 SQGIMHRDVKPHNVMI-DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE--LLVD 189
S +HRD+K N+++ + KL D+G A P N V + Y+ PE L +D
Sbjct: 133 SHERIHRDIKAGNILLTEPGTVKLA--DFGSASLVSPA---NSFVGTPYWMAPEVILAMD 187
Query: 190 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249
YD +D+WSLG + RK P F +NA YHI
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLF-------------------NMNAMSALYHIAQ 228
Query: 250 D--PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 307
+ P L S WS +F+D L+ Q+RP+++E + H +
Sbjct: 229 NDSPTL-------SSNDWSD------------YFRNFVDSCLQKIPQDRPSSEELLKHRF 269
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 65.6 bits (161), Expect = 2e-12
Identities = 39/162 (24%), Positives = 78/162 (48%), Gaps = 17/162 (10%)
Query: 27 RKVGRGKYSEVFEGV--HCTDN--EKCIIKILKPVK----KKKIKREIKILQNLCGGPNI 78
+K+G G + EV++G D + +K LK ++ RE +I++ L PNI
Sbjct: 5 KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKL-DHPNI 63
Query: 79 VKLLDIVRDQQSKTPSLIFEHVNNTDFK-VL----YPTLSDYDVRYYIYELLKALDYCHS 133
VKLL + +++ ++ E++ D L LS D+ + ++ + ++Y S
Sbjct: 64 VKLLGVCTEEEP--LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLES 121
Query: 134 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR 175
+ +HRD+ N ++ E +++ D+GL+ + Y V+
Sbjct: 122 KNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDDYYKVK 162
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-12
Identities = 60/214 (28%), Positives = 102/214 (47%), Gaps = 26/214 (12%)
Query: 29 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 88
+GRG + EV+ G D K + +K + KK+IK +K + L I +L +V
Sbjct: 2 IGRGGFGEVY-GCRKADTGK--MYAMKCLDKKRIK--MKQGETLALNERI--MLSLVSTG 54
Query: 89 QS----------KTP---SLIFEHVNNTDFKV---LYPTLSDYDVRYYIYELLKALDYCH 132
TP S I + +N D + S+ ++R+Y E++ L++ H
Sbjct: 55 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH 114
Query: 133 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 192
++ +++RD+KP N+++D E +R+ D GLA + K + V + + PE+L
Sbjct: 115 NRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPH-ASVGTHGYMAPEVLQKGVA 172
Query: 193 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL 226
YD S D +SLGCM ++ P F H D+
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSP-FRQHKTKDKH 205
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 3e-12
Identities = 74/297 (24%), Positives = 132/297 (44%), Gaps = 56/297 (18%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK---ILKPVKKKKIKREIKILQNLCGGPNIV 79
Y K+G+G V+ + ++ IK + + KK+ I EI +++ PNIV
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN-KHPNIV 79
Query: 80 KLLD--IVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 134
LD +V D+ ++ E++ TD V + + + E L+AL++ HS
Sbjct: 80 NYLDSYLVGDELW----VVMEYLAGGSLTDV-VTETCMDEGQIAAVCRECLQALEFLHSN 134
Query: 135 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVDLQ 191
++HRD+K N+++ + ++L D+G P E + R V + Y+ PE +V +
Sbjct: 135 QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPE-VVTRK 190
Query: 192 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251
Y +D+WSLG M M+ + P Y ++N + + + GT EL
Sbjct: 191 AYGPKVDIWSLGIMAIEMVEGEPP--YLNENPLRALYLIATNGTPEL------------- 235
Query: 252 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
++ K + F DFL++ L D ++R +AKE + HP+
Sbjct: 236 -------QNPEKLSAIF-------------RDFLNRCLEMDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 3e-12
Identities = 70/298 (23%), Positives = 130/298 (43%), Gaps = 47/298 (15%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR---EIKILQNLCGGPN 77
D +E++ ++G G + +V++ H KI++ +++++ EI IL C PN
Sbjct: 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSE-CKHPN 63
Query: 78 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKV--LYPTLSDYDVRYYIYELLKALDYCHSQG 135
IV L + + + F D + L L++ +RY ++L+AL++ HS
Sbjct: 64 IVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK 123
Query: 136 IMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV----DL 190
++HRD+K N+++ + ++L D+G+ A+ ++ + + + Y+ PE++
Sbjct: 124 VIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKD 182
Query: 191 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250
YDY D+WSLG + + P H + + + K+L ++
Sbjct: 183 NPYDYKADIWSLGITLIELAQMEPP----HHELNPMRVLLKILKSEP------------- 225
Query: 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
P L K WS DFL L D +RPTA E + HP+
Sbjct: 226 PTLDQ-----PSK-WSS------------SFNDFLKSCLVKDPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-12
Identities = 42/118 (35%), Positives = 67/118 (56%), Gaps = 6/118 (5%)
Query: 116 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE--FYHPGKEYN 173
DV++Y+ EL ALD+ HS GI++RD+KP N+++D E+ ++L D+GL++ H K Y+
Sbjct: 99 DVKFYLAELALALDHLHSLGIIYRDLKPENILLD-EEGHIKLTDFGLSKESIDHEKKAYS 157
Query: 174 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 231
Y PE +V+ + + S D WS G + M+ P F G D + + I K
Sbjct: 158 FCGTVEYM-APE-VVNRRGHTQSADWWSFGVLMFEMLTGSLP-FQGKDRKETMTMILK 212
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 24/205 (11%)
Query: 27 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR---------EIKILQNLCGGPN 77
R +G+G + EV C + K ++KK+IK+ E +IL+ + N
Sbjct: 6 RVLGKGGFGEV---CACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV----N 58
Query: 78 IVKLLDIVRDQQSKTP-SLIFEHVNNTDFKV-LY----PTLSDYDVRYYIYELLKALDYC 131
++++ ++K L+ +N D K +Y P + +Y E+L L+
Sbjct: 59 SQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDL 118
Query: 132 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 191
H + ++RD+KP N+++D + +R+ D GLA G+ RV + + PE+L + Q
Sbjct: 119 HRENTVYRDLKPENILLD-DYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNN-Q 176
Query: 192 DYDYSLDLWSLGCMFAGMIFRKEPF 216
Y S D W LGC+ MI + PF
Sbjct: 177 RYTLSPDYWGLGCLIYEMIEGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 3e-12
Identities = 55/210 (26%), Positives = 100/210 (47%), Gaps = 26/210 (12%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGP 76
YE +R VGRG + V D + IIK + PV ++ + E ++L+ L P
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQI-PVEQMTKDERLAAQNECQVLKLL-SHP 59
Query: 77 NIV---------KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKA 127
NI+ K L IV + + E++ K L + + ++ ++L A
Sbjct: 60 NIIEYYENFLEDKALMIV--MEYAPGGTLAEYIQ----KRCNSLLDEDTILHFFVQILLA 113
Query: 128 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPEL 186
L + H++ I+HRD+K N+++D + +++ D+G++ K Y V V + + PE
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTV-VGTPCYISPE- 171
Query: 187 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 216
L + + Y+ D+W+LGC+ + K F
Sbjct: 172 LCEGKPYNQKSDIWALGCVLYELASLKRAF 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 4e-12
Identities = 52/200 (26%), Positives = 94/200 (47%), Gaps = 23/200 (11%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVK 80
+E+V VG G Y +V++G H + IK++ + +++IK EI +L+ NI
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIAT 77
Query: 81 LLDIVRDQQSKTPS-------LIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKAL 128
K+P L+ E L L + + Y E+L+ L
Sbjct: 78 YYGAF---IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGL 134
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELL 187
+ H+ ++HRD+K NV++ E +++L+D+G+ A+ N + + Y+ PE++
Sbjct: 135 AHLHAHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 193
Query: 188 VDLQD----YDYSLDLWSLG 203
++ YDY D+WSLG
Sbjct: 194 ACDENPDATYDYRSDIWSLG 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 6e-12
Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 16/200 (8%)
Query: 29 VGRGKYSEVFEGVHCTDNEKCIIKIL--KPVKKKKIKREIK-----ILQNLCGGPNIVKL 81
+G+G + +V +D +K+L K + KKK + I +L+NL P +V L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGL 61
Query: 82 LDIVRDQQSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMH 138
Q ++ + ++VN + + R+Y E+ A+ Y HS I++
Sbjct: 62 H--YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIY 119
Query: 139 RDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 197
RD+KP N+++D Q + L D+GL E P + + + + PE+L + YD ++
Sbjct: 120 RDLKPENILLD-SQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRK-EPYDRTV 177
Query: 198 DLWSLGCMFAGMIFRKEPFF 217
D W LG + M++ PF+
Sbjct: 178 DWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 6e-12
Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 26/206 (12%)
Query: 27 RKVGRGKYSEVFEGVHCTDNEKCIIKI--LKPVKKKKIKR---------EIKILQNLCGG 75
R +G+G + EV C + K+ K ++KK+IK+ E +IL+ +
Sbjct: 6 RVLGKGGFGEV-----CACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NS 59
Query: 76 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKV-LY----PTLSDYDVRYYIYELLKALDY 130
+V L + + L+ +N D K +Y P + +Y E+ L+
Sbjct: 60 RFVVSLAYAYETKDALC--LVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLED 117
Query: 131 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 190
H + I++RD+KP N+++D + +R+ D GLA G+ RV + + PE +V
Sbjct: 118 LHRERIVYRDLKPENILLD-DYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPE-VVKN 175
Query: 191 QDYDYSLDLWSLGCMFAGMIFRKEPF 216
+ Y +S D W LGC+ MI K PF
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 6e-12
Identities = 76/312 (24%), Positives = 118/312 (37%), Gaps = 53/312 (16%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVKKKKIKREIKILQNLCGGPN 77
Y ++ + G EVF CT +K I+K + K REI IL+ +
Sbjct: 94 YNILSSLTPGSEGEVFV---CTKHGDEQRKKVIVKAV--TGGKTPGREIDILKTI-SHRA 147
Query: 78 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYDVRYYIYELLKALDYCHSQG 135
I+ L+ R + T ++ F + L LL+AL Y H +G
Sbjct: 148 IINLIHAYRWKS--TVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG 205
Query: 136 IMHRDVKPHNVMIDHEQRKLRLIDWGLA-----EFYHPGKEYNVRVASRYFKGPELLVDL 190
I+HRDVK N+ +D + + L D+G A P + Y + PELL L
Sbjct: 206 IIHRDVKTENIFLDEPENAV-LGDFGAACKLDAHPDTP-QCYG-WSGTLETNSPELLA-L 261
Query: 191 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD--QLVKIAKVLGTDELNAYLN----- 243
Y D+WS G + M + F QL I + + L N
Sbjct: 262 DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNL 321
Query: 244 -----KYHIELDPHLAALVGRHSRKPWS--KFITVENQHLAVPEAVDFLDKLLRYDHQER 296
+Y I L R P++ I H+ V + K+L +D + R
Sbjct: 322 CKHFKQYAIVL------------RPPYTIPPVIRKYGMHMDVEYLIA---KMLTFDQEFR 366
Query: 297 PTAKEAMAHPYF 308
P+A++ ++ P F
Sbjct: 367 PSAQDILSLPLF 378
|
Length = 392 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 7e-12
Identities = 72/287 (25%), Positives = 124/287 (43%), Gaps = 49/287 (17%)
Query: 28 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGPNIVKLLD 83
++G+G + EVF+G+ + IKI+ + + I++EI +L C P + K
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDSPYVTKYYG 69
Query: 84 IVRDQQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYCHSQGIMHRDV 141
+ +I E++ L ++ + + E+LK LDY HS+ +HRD+
Sbjct: 70 SY--LKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDI 127
Query: 142 KPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLW 200
K NV++ EQ ++L D+G+A + + N V + ++ PE ++ YD D+W
Sbjct: 128 KAANVLLS-EQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE-VIQQSAYDSKADIW 185
Query: 201 SLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRH 260
SLG + A + + EP N D + +VL + I + L G
Sbjct: 186 SLG-ITAIELAKGEP-----PNSD--MHPMRVL-----------FLIPKNNP-PTLTGEF 225
Query: 261 SRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 307
S+ +F+D L D RPTAKE + H +
Sbjct: 226 SKP-----------------FKEFIDACLNKDPSFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 7e-12
Identities = 52/227 (22%), Positives = 81/227 (35%), Gaps = 77/227 (33%)
Query: 123 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY-- 180
++L ALD HS GI+HRDVKP N++ ++ID G A ++RV Y
Sbjct: 263 QILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAA--------DLRVGINYIP 314
Query: 181 --------FKGPELLV------------------------DLQDYDYSLDLWSLGCMFAG 208
+ PE + +L D D++S G +F
Sbjct: 315 KEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPD---RFDIYSAGLIFLQ 371
Query: 209 MIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR-------HS 261
M F P N Q + K D L + ++P + + R
Sbjct: 372 MAF---PNLRSDSNLIQFNRQLKRNDYD-----LVAWRKLVEPRASPDLRRGFEVLDLDG 423
Query: 262 RKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
W + L ++R+ ++R +AK A+AHPYF
Sbjct: 424 GAGW-----------------ELLKSMMRFKGRQRISAKAALAHPYF 453
|
Length = 566 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 8e-12
Identities = 55/210 (26%), Positives = 97/210 (46%), Gaps = 24/210 (11%)
Query: 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNLC 73
D+E++ K+G+G + VF+ V D + +K + K+ R E ++L L
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKR---VYAMKQIDLSKMNRREREEAIDEARVLAKL- 56
Query: 74 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKA 127
I++ + D+ +++ E+ N D L P D R++I LL
Sbjct: 57 DSSYIIRYYESFLDKGKL--NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILL-G 113
Query: 128 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPEL 186
L + HS+ I+HRD+K N+ +D +++ D G+A+ + N V + Y+ PEL
Sbjct: 114 LAHLHSKKILHRDIKSLNLFLD-AYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPEL 172
Query: 187 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 216
D + Y+ D+W+LG + K PF
Sbjct: 173 CED-KPYNEKSDVWALGVVLYECCTGKHPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 9e-12
Identities = 71/294 (24%), Positives = 127/294 (43%), Gaps = 54/294 (18%)
Query: 26 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK------IKREIKILQNLCGGPNIV 79
+R++G G + V+ ++E IK + K+ I +E++ LQ L PN +
Sbjct: 20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTI 78
Query: 80 KLLDIVRDQQSKTPSLIFEHV--NNTDF-KVLYPTLSDYDVRYYIYELLKALDYCHSQGI 136
+ + T L+ E+ + +D +V L + ++ + L+ L Y HS +
Sbjct: 79 QYRGCYLREH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 137 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD--YD 194
+HRDVK N+++ E ++L D+G A P + V + Y+ PE+++ + + YD
Sbjct: 137 IHRDVKAGNILLS-EPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYD 192
Query: 195 YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLA 254
+D+WSLG + RK P F +NA YHI +
Sbjct: 193 GKVDVWSLGITCIELAERKPPLF-------------------NMNAMSALYHIAQNES-P 232
Query: 255 ALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
AL H WS++ +F+D L+ Q+RPT++ + H +
Sbjct: 233 ALQSGH----WSEYFR------------NFVDSCLQKIPQDRPTSEVLLKHRFV 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-11
Identities = 60/256 (23%), Positives = 111/256 (43%), Gaps = 48/256 (18%)
Query: 60 KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK---VLYPTLSDYD 116
++ EI++L+NL IV+ +RD + T S+ E++ K Y L++
Sbjct: 49 NALECEIQLLKNL-QHERIVQYYGCLRDDE--TLSIFMEYMPGGSVKDQLKAYGALTETV 105
Query: 117 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG----LAEFYHPGKEY 172
R Y ++L+ ++Y HS I+HRD+K N++ D ++L D+G L G
Sbjct: 106 TRKYTRQILEGVEYLHSNMIVHRDIKGANILRD-SAGNVKLGDFGASKRLQTICSSGTGM 164
Query: 173 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 232
+ Y+ PE ++ + Y D+WS+GC M+ K P+ ++ + I K+
Sbjct: 165 KSVTGTPYWMSPE-VISGEGYGRKADVWSVGCTVVEMLTEKPPW----AEFEAMAAIFKI 219
Query: 233 LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYD 292
T N +L H++ P+A +FL + +
Sbjct: 220 -ATQPTNP-------QLPSHVS------------------------PDARNFLRRTFVEN 247
Query: 293 HQERPTAKEAMAHPYF 308
++RP+A+E + H +
Sbjct: 248 AKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-11
Identities = 33/100 (33%), Positives = 55/100 (55%), Gaps = 2/100 (2%)
Query: 117 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 176
V +Y ++ + + HS I++RD+KP NV++D +Q RL D GLA GK R
Sbjct: 97 VIHYSAQITCGILHLHSMDIVYRDMKPENVLLD-DQGNCRLSDLGLAVELKDGKTITQRA 155
Query: 177 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 216
+ + PE+L + + Y Y +D +++GC M+ + PF
Sbjct: 156 GTNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 34/105 (32%), Positives = 61/105 (58%), Gaps = 2/105 (1%)
Query: 112 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 171
S+ ++R+Y E++ L++ H++ +++RD+KP N+++D E +R+ D GLA + K
Sbjct: 94 FSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKP 152
Query: 172 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 216
+ V + + PE+L YD S D +SLGCM ++ PF
Sbjct: 153 H-ASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 1e-11
Identities = 72/298 (24%), Positives = 127/298 (42%), Gaps = 53/298 (17%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR------EIKILQNLCGGP 76
+E++ ++G G + +V++ + E + K ++ K + EI+IL C P
Sbjct: 14 WEIIGELGDGAFGKVYKA---KNKETGALAAAKVIETKSEEELEDYMVEIEILAT-CNHP 69
Query: 77 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQ 134
IVKLL + F D +L L++ ++ ++L+AL Y HS
Sbjct: 70 YIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSM 129
Query: 135 GIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV--DLQ 191
I+HRD+K NV++ + ++L D+G+ A+ + + + + Y+ PE+++ ++
Sbjct: 130 KIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMK 188
Query: 192 D--YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249
D YDY D+WSLG M + EP + + L+KIAK
Sbjct: 189 DTPYDYKADIWSLGITLIEMA-QIEPPHHELNPMRVLLKIAKS----------------- 230
Query: 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 307
+P WS E DFL L + RP+A + + HP+
Sbjct: 231 EPP-----TLSQPSKWS------------MEFRDFLKTALDKHPETRPSAAQLLEHPF 271
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 2e-11
Identities = 68/294 (23%), Positives = 129/294 (43%), Gaps = 50/294 (17%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK---ILKPVKKKKIKREIKILQNLCGGPNIV 79
Y K+G+G V+ + ++ I+ + + KK+ I EI +++ PNIV
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE-NKNPNIV 80
Query: 80 KLLD--IVRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYELLKALDYCHSQG 135
LD +V D+ ++ E++ V + + + E L+AL++ HS
Sbjct: 81 NYLDSYLVGDELW----VVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 136 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYD 194
++HRD+K N+++ + ++L D+G P + + + V + Y+ PE +V + Y
Sbjct: 137 VIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VVTRKAYG 194
Query: 195 YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLA 254
+D+WSLG M MI + P+ ++N + + + GT EL +P
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYL--NENPLRALYLIATNGTPELQ----------NPEKL 242
Query: 255 ALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
+ + R DFL++ L D ++R +AKE + H +
Sbjct: 243 SAIFR-----------------------DFLNRCLDMDVEKRGSAKELLQHQFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 2e-11
Identities = 37/119 (31%), Positives = 65/119 (54%), Gaps = 5/119 (4%)
Query: 99 HVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI 158
H+ N D + P + +Y +++ L++ H + I++RD+KP NV++D++ +R+
Sbjct: 83 HIYNVDEE--NPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG-NVRIS 139
Query: 159 DWGLAEFYHPGKEYNVRVA-SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 216
D GLA G+ A + F PELL ++YD+S+D ++LG MI + PF
Sbjct: 140 DLGLAVELKDGQSKTKGYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 2e-11
Identities = 55/234 (23%), Positives = 103/234 (44%), Gaps = 37/234 (15%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILK----PVKKKKIKREIKILQNL 72
++D + R +G G++ +V++GV+ + + I +K K P ++K +E I++
Sbjct: 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF 64
Query: 73 CGGPNIVKLLDIVRDQQSKTPSLI------------FEHVNNTDFKVLYPTLSDYDVRYY 120
P+IVKL+ ++ + P I + VN + L Y
Sbjct: 65 -DHPHIVKLIGVITEN----PVWIVMELAPLGELRSYLQVNKYSLDLASLIL-------Y 112
Query: 121 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 180
Y+L AL Y S+ +HRD+ NV++ ++L D+GL+ + Y
Sbjct: 113 SYQLSTALAYLESKRFVHRDIAARNVLVSSPD-CVKLGDFGLSRYLEDESYYKASKGKLP 171
Query: 181 FK--GPELLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKIAK 231
K PE ++ + + + D+W G CM+ ++ +PF G N D + +I
Sbjct: 172 IKWMAPE-SINFRRFTSASDVWMFGVCMWEILMLGVKPFQ-GVKNNDVIGRIEN 223
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 2e-11
Identities = 51/211 (24%), Positives = 100/211 (47%), Gaps = 15/211 (7%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKKIKREIKILQNLCGGPN 77
Q+D+E+++++G G Y +V++ + E IK++K P + + ++ I+ C N
Sbjct: 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 78 IVKLLD--IVRDQQSKTPSLIFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDYCH 132
IV + RD+ + E + +Y LS+ + Y E L+ L Y H
Sbjct: 68 IVAYFGSYLRRDKLW----ICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLH 123
Query: 133 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQ 191
S+G MHRD+K N+++ + ++L D+G+ A+ + + + Y+ PE+ +
Sbjct: 124 SKGKMHRDIKGANILLT-DNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVER 182
Query: 192 D--YDYSLDLWSLGCMFAGMIFRKEPFFYGH 220
Y+ D+W++G + + P F H
Sbjct: 183 KGGYNQLCDIWAVGITAIELAELQPPMFDLH 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 69/295 (23%), Positives = 123/295 (41%), Gaps = 58/295 (19%)
Query: 26 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK------KIKREIKILQNLCGGPNIV 79
+ ++G G + V+ + NE +K + K+ I +E+K LQ L PN +
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTI 84
Query: 80 KLLDIVRDQQSKTPSLIFEHV--NNTD-FKVLYPTLSDYDVRYYIYELLKALDYCHSQGI 136
+ + T L+ E+ + +D +V L + ++ + L+ L Y HS +
Sbjct: 85 EYKGCYLKEH--TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 142
Query: 137 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD--YD 194
+HRD+K N+++ E +++L D+G A P + V + Y+ PE+++ + + YD
Sbjct: 143 IHRDIKAGNILLT-EPGQVKLADFGSASKSSPANSF---VGTPYWMAPEVILAMDEGQYD 198
Query: 195 YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD--PH 252
+D+WSLG + RK P F +NA YHI + P
Sbjct: 199 GKVDVWSLGITCIELAERKPPLF-------------------NMNAMSALYHIAQNDSPT 239
Query: 253 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 307
L + W+ F+D L+ QERP + E + H +
Sbjct: 240 LQS-------NEWTDSFR------------GFVDYCLQKIPQERPASAELLRHDF 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 3e-11
Identities = 79/310 (25%), Positives = 134/310 (43%), Gaps = 64/310 (20%)
Query: 22 DYEVVRKVGRGKYSEVF----EGVHCTDNEKCIIKILKP---VKKKKI----KREIKILQ 70
++E++R +G G Y +VF G H + +K+LK V+K K + E ++L+
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGH-DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLE 59
Query: 71 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPT--LSDYDVRYYIYELLKA 127
+ P +V L Q LI ++VN + F LY ++ +VR YI E++ A
Sbjct: 60 AVRRCPFLVTLHYAF--QTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLA 117
Query: 128 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGPE 185
LD+ H GI++RD+K N+++D E + L D+GL++ + +E + + PE
Sbjct: 118 LDHLHQLGIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPE 176
Query: 186 LLVDLQD-YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244
++ +D ++D WSLG + ++ PF V G
Sbjct: 177 VIRGGSGGHDKAVDWWSLGVLTFELLTGASPF--------------TVDG---------- 212
Query: 245 YHIELDPHLAALVGRHSRKPWSKFITVEN---QHLAVPEAVDFLDKLLRYDHQER---PT 298
++S+ S+ I EA DF+ KLL D ++R
Sbjct: 213 -------------EQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANG 259
Query: 299 AKEAMAHPYF 308
A E HP+F
Sbjct: 260 ADEIKNHPFF 269
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 4e-11
Identities = 75/321 (23%), Positives = 130/321 (40%), Gaps = 69/321 (21%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLL 82
Y V++ + G VF + ++KI +K E +LQN+ P+++++
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKI---GQKGTTLIEAMLLQNV-NHPSVIRMK 123
Query: 83 DIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYI-------YELLKALDYCHSQG 135
D + ++ H ++ LY L+ I ++L+ L Y H+Q
Sbjct: 124 DTL--VSGAITCMVLPHYSSD----LYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177
Query: 136 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---------PEL 186
I+HRDVK N+ I+ ++ + D G A+F V + F G PE+
Sbjct: 178 IIHRDVKTENIFINDVD-QVCIGDLGAAQF---------PVVAPAFLGLAGTVETNAPEV 227
Query: 187 LVDLQDYDYSLDLWSLGCMFAGM------IFRKEPFF---YGHDNYDQLVKIAKVLGTDE 237
L Y+ D+WS G + M IF P Y + L+KI L
Sbjct: 228 LAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLK--- 283
Query: 238 LNAYLNKYHIELDP---------HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFL-DK 287
++ DP A+L R+P++++ Q + +P +FL K
Sbjct: 284 ----VHPEEFPRDPGSRLVRGFIEYASLE----RQPYTRYPCF--QRVNLPIDGEFLVHK 333
Query: 288 LLRYDHQERPTAKEAMAHPYF 308
+L +D RP+A+E + +P F
Sbjct: 334 MLTFDAAMRPSAEEILNYPMF 354
|
Length = 357 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-11
Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 38/211 (18%)
Query: 29 VGRGKYSEVFEGVHCTDNEKCIIKIL--KPVKKKKIKREIKILQNLCGGPNIVKLLDIVR 86
+G+G + +V H + + +K+L K + KKK ++ I +N+ LL V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNV--------LLKNV- 53
Query: 87 DQQSKTPSLIFEHVNNTDFKVLYPTLSDY-------------------DVRYYIYELLKA 127
K P L+ H + LY L DY R+Y E+ A
Sbjct: 54 ----KHPFLVGLHFSFQTADKLYFVL-DYINGGELFYHLQRERCFLEPRARFYAAEIASA 108
Query: 128 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPEL 186
L Y HS I++RD+KP N+++D Q + L D+GL E + + + PE+
Sbjct: 109 LGYLHSLNIVYRDLKPENILLD-SQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEV 167
Query: 187 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 217
L Q YD ++D W LG + M++ PF+
Sbjct: 168 L-HKQPYDRTVDWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 4e-11
Identities = 74/301 (24%), Positives = 130/301 (43%), Gaps = 53/301 (17%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR------EIKILQNLC 73
++ +E++ ++G G + +V++ + E ++ K + K + EI IL + C
Sbjct: 4 EEFWEIIGELGDGAFGKVYKA---QNKETGVLAAAKVIDTKSEEELEDYMVEIDILAS-C 59
Query: 74 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYC 131
PNIVKLLD + + + F D +L L++ +R + L+AL+Y
Sbjct: 60 DHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYL 119
Query: 132 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV-- 188
H I+HRD+K N++ + ++L D+G+ A+ + + + + Y+ PE+++
Sbjct: 120 HENKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCE 178
Query: 189 --DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246
+ YDY D+WSLG M + EP + + L+KIAK
Sbjct: 179 TSKDRPYDYKADVWSLGITLIEMA-QIEPPHHELNPMRVLLKIAKS-------------- 223
Query: 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 306
+P A R WS E DFL K L + R T + + HP
Sbjct: 224 ---EPPTLAQPSR-----WS------------SEFKDFLKKCLEKNVDARWTTTQLLQHP 263
Query: 307 Y 307
+
Sbjct: 264 F 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 5e-11
Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 20/202 (9%)
Query: 29 VGRGKYSEVFEGVHCTDNEKCIIKIL--KPVKKKK----IKREIKILQNLCGGPNIVKLL 82
+G+G + +V H D + +K+L K + KKK I E +L P +V L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 83 DIVRDQQSKTPSLIFEHVNNTDFKVLYPTL------SDYDVRYYIYELLKALDYCHSQGI 136
Q + + ++VN + L+ L + R+Y E+ AL Y HS I
Sbjct: 63 --YSFQTADKLYFVLDYVNGGE---LFFHLQRERSFPEPRARFYAAEIASALGYLHSLNI 117
Query: 137 MHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 195
++RD+KP N+++D Q + L D+GL E K + + + PE+L Q YD
Sbjct: 118 IYRDLKPENILLDS-QGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK-QPYDR 175
Query: 196 SLDLWSLGCMFAGMIFRKEPFF 217
++D W LG + M++ PF+
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFY 197
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 6e-11
Identities = 79/339 (23%), Positives = 145/339 (42%), Gaps = 74/339 (21%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQN--LCGGPNI 78
++++ +G G + +V E E C +KI++ V K + K EI+ ++ +
Sbjct: 131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADR 190
Query: 79 VKLLDIVRDQQSKT-----------PSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKA 127
L+ I R Q++T P L+ D+ + + S + I++ A
Sbjct: 191 FPLMKIQRYFQNETGHMCIVMPKYGPCLL-------DWIMKHGPFSHRHLAQIIFQTGVA 243
Query: 128 LDYCHSQ-GIMHRDVKPHNVMIDHEQR---------------KLRLIDWGLAEFYHPGKE 171
LDY H++ +MH D+KP N++++ ++R+ D G E
Sbjct: 244 LDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC-----CDE 298
Query: 172 YNVR---VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 228
+ R V++R+++ PE+++ L + YS D+WS+GC+ + + + + HDN + L
Sbjct: 299 RHSRTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYEL-YTGKLLYDTHDNLEHLHL 356
Query: 229 IAKVL-----------GTDELNAYLN---KYHIELDPHLAALVGRHSRKPWSKFITVENQ 274
+ K L GT+E N + DP A + R +P + I
Sbjct: 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIAR--ARPVREVIR---- 410
Query: 275 HLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY---FFP 310
D + LL YD Q+R A++ HPY ++P
Sbjct: 411 ---DDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYP 446
|
Length = 467 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 61.4 bits (150), Expect = 6e-11
Identities = 36/162 (22%), Positives = 73/162 (45%), Gaps = 18/162 (11%)
Query: 27 RKVGRGKYSEVFEGV----HCTDNEKCIIKILKP----VKKKKIKREIKILQNLCGGPNI 78
+K+G G + EV++G K +K LK ++++ E I++ L PNI
Sbjct: 5 KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKL-SHPNI 63
Query: 79 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHS 133
V+LL + + ++ E++ D + L+ D+ ++ K ++Y S
Sbjct: 64 VRLLGVCTQGEP--LYIVTEYMPGGDLL-DFLRKHGEKLTLKDLLQMALQIAKGMEYLES 120
Query: 134 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR 175
+ +HRD+ N ++ E +++ D+GL+ + Y R
Sbjct: 121 KNFVHRDLAARNCLVT-ENLVVKISDFGLSRDIYEDDYYRKR 161
|
Length = 258 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 6e-11
Identities = 83/307 (27%), Positives = 131/307 (42%), Gaps = 72/307 (23%)
Query: 26 VRKVGRGKYSEVF--EGVHCTDNEKCIIKILKPVKKKKIKREIK----------ILQNLC 73
++ +G+G Y +VF V D K I +K +KK I R K IL+ +
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGK--IFAMKVLKKATIVRNQKDTAHTKAERNILEAV- 57
Query: 74 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV------RYYIYELLKA 127
P IV L I Q LI E+++ + L+ L + +Y+ E+ A
Sbjct: 58 KHPFIVDL--IYAFQTGGKLYLILEYLSGGE---LFMHLEREGIFMEDTACFYLSEISLA 112
Query: 128 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPEL 186
L++ H QGI++RD+KP N+++D Q ++L D+GL E H G + + + PE+
Sbjct: 113 LEHLHQQGIIYRDLKPENILLDA-QGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEI 171
Query: 187 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246
L+ + ++D WSLG + M+ PF +N + I K+L K
Sbjct: 172 LMR-SGHGKAVDWWSLGALMYDMLTGAPPF--TAENRKK--TIDKIL----------KGK 216
Query: 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER-----PTAKE 301
+ L P+L PEA D L KLL+ + R A E
Sbjct: 217 LNLPPYLT------------------------PEARDLLKKLLKRNPSSRLGAGPGDAAE 252
Query: 302 AMAHPYF 308
+HP+F
Sbjct: 253 VQSHPFF 259
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 7e-11
Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 29/216 (13%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR-------EIKILQNLC 73
+D++V++ +GRG + EV H + + +K+L K + IKR E + +
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLS--KFEMIKRSDSAFFWEERDIMAHA 100
Query: 74 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV-----RYYIYELLKAL 128
IV+L +D K ++ E++ D L +S+YD+ R+Y E++ AL
Sbjct: 101 NSEWIVQLHYAFQDD--KYLYMVMEYMPGGDLVNL---MSNYDIPEKWARFYTAEVVLAL 155
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGP 184
D HS G +HRDVKP N+++D + L+L D+G VR V + + P
Sbjct: 156 DAIHSMGFIHRDVKPDNMLLD-KSGHLKLADFGTC--MKMDANGMVRCDTAVGTPDYISP 212
Query: 185 ELLVDLQ---DYDYSLDLWSLGCMFAGMIFRKEPFF 217
E+L Y D WS+G M+ PF+
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 248
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 8e-11
Identities = 49/194 (25%), Positives = 88/194 (45%), Gaps = 40/194 (20%)
Query: 124 LLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 182
++KAL+Y HS+ ++HRDVKP NV+I+ +++L D+G++ + + + +
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVLINR-NGQVKLCDFGISGYLVDSVAKTIDAGCKPYM 170
Query: 183 GPELL---VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN 239
PE + ++ + YD D+WSLG + + P+ + QL ++ +
Sbjct: 171 APERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVE-------- 222
Query: 240 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA 299
E P L P KF PE DF++K L+ +++ERP
Sbjct: 223 --------EPSPQL----------PAEKF---------SPEFQDFVNKCLKKNYKERPNY 255
Query: 300 KEAMAHPYFFPIRN 313
E + HP+F +
Sbjct: 256 PELLQHPFFELHLS 269
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 9e-11
Identities = 52/209 (24%), Positives = 96/209 (45%), Gaps = 22/209 (10%)
Query: 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR-----EIKILQNLCGGP 76
D++V++K+G+G Y V++ +DN+ +K + + +R EI+IL ++ P
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV-NHP 59
Query: 77 NIVK----LLDIVR----DQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 128
NI+ LD + + + L + L P R +I +LL+ L
Sbjct: 60 NIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPE--QEIWRIFI-QLLRGL 116
Query: 129 DYCHSQGIMHRDVKPHNVMI-DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 187
H Q I+HRD+K N+++ ++ K+ D G+++ + + ++ PE+
Sbjct: 117 QALHEQKILHRDLKSANILLVANDLVKIG--DLGISKVLKKNMAKTQ-IGTPHYMAPEVW 173
Query: 188 VDLQDYDYSLDLWSLGCMFAGMIFRKEPF 216
+ Y Y D+WSLGC+ M PF
Sbjct: 174 KG-RPYSYKSDIWSLGCLLYEMATFAPPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 2/98 (2%)
Query: 119 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 178
+Y E+ L+ H + I++RD+KP N+++D + +R+ D GLA G+ RV +
Sbjct: 106 FYAAEICCGLEDLHQERIVYRDLKPENILLD-DHGHIRISDLGLAVHVPEGQTIKGRVGT 164
Query: 179 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 216
+ PE +V + Y +S D W+LGC+ MI + PF
Sbjct: 165 VGYMAPE-VVKNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 2e-10
Identities = 55/212 (25%), Positives = 101/212 (47%), Gaps = 37/212 (17%)
Query: 29 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 88
+G+G + +V++ V D + I +K + KK+I + ++ + G NI +VR
Sbjct: 1 IGKGTFGQVYQ-VRKKDTRR--IYAMKVLSKKEIVAKKEVAHTI-GERNI-----LVRTL 51
Query: 89 QSKTPSLI---FEHVNNTDFKVLYPTLSDY-------------------DVRYYIYELLK 126
++P ++ F ++D LY ++DY ++YI EL+
Sbjct: 52 LDESPFIVGLKFSFQTDSD---LY-LVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVL 107
Query: 127 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF-YHPGKEYNVRVASRYFKGPE 185
AL++ H I++RD+KP N+++D + L D+GL++ K N + + PE
Sbjct: 108 ALEHLHKYDIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFCGTTEYLAPE 166
Query: 186 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 217
+L+D + Y +D WSLG + M PF+
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFY 198
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 2e-10
Identities = 65/300 (21%), Positives = 123/300 (41%), Gaps = 63/300 (21%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-----ILKPVKKKKIKREIKILQNLCGGPN 77
Y +R +G+G + E D+ + K L +++ EI IL L PN
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPN 60
Query: 78 IVKLLDIVRDQQSKTPSL-------IFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDY 130
I+ + D + + +++ + ++ + V +Y+++++ A+ Y
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLF----EEEMVLWYLFQIVSAVSY 116
Query: 131 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELL 187
H GI+HRD+K N+ + + ++L D+G+++ G EY++ V + Y+ PE L
Sbjct: 117 IHKAGILHRDIKTLNIFLT-KAGLIKLGDFGISKIL--GSEYSMAETVVGTPYYMSPE-L 172
Query: 188 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV-KIAKVLGTDELNAYLNKYH 246
Y++ D+W+LGC+ ++ K F N LV KI + T ++ Y
Sbjct: 173 CQGVKYNFKSDIWALGCVLYELLTLKRTF--DATNPLNLVVKIVQGNYTPVVSVY----- 225
Query: 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 306
E + + LL+ D ++RPTA E + P
Sbjct: 226 -------------------------------SSELISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 52/210 (24%), Positives = 100/210 (47%), Gaps = 13/210 (6%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK---IKREIKILQNLCGGP 76
Q DYE++++VG G Y +V++ + E +KI+K I++EI +++ C
Sbjct: 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKE-CKHC 66
Query: 77 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDYCHS 133
NIV ++ + E+ + +Y LS+ + Y E L+ L Y HS
Sbjct: 67 NIVAYFGSYLSREKLW--ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHS 124
Query: 134 QGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDLQD 192
+G MHRD+K N+++ + ++L D+G+ A+ + + + Y+ PE+ ++
Sbjct: 125 KGKMHRDIKGANILLT-DNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKN 183
Query: 193 --YDYSLDLWSLGCMFAGMIFRKEPFFYGH 220
Y+ D+W++G + + P F H
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDLH 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-10
Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 38/216 (17%)
Query: 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR------EIKILQNLCGG 75
D+E+ +G G + V H E IK LK + K+K+ E IL L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSH- 77
Query: 76 PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL-----YPTLSDYDV-RYYIYELLKAL 128
P IV ++ +D+ + E V + F L +P DV ++Y EL+ A
Sbjct: 78 PFIVNMMCSFQDE--NRVYFLLEFVVGGELFTHLRKAGRFPN----DVAKFYHAELVLAF 131
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK---GPE 185
+Y HS+ I++RD+KP N+++D + +++ D+G A+ +V R F PE
Sbjct: 132 EYLHSKDIIYRDLKPENLLLD-NKGHVKVTDFGFAK----------KVPDRTFTLCGTPE 180
Query: 186 LL----VDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 217
L + + + ++D W++G + I PFF
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFF 216
|
Length = 329 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 77/295 (26%), Positives = 128/295 (43%), Gaps = 49/295 (16%)
Query: 43 CTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 102
C DN+ C ++K ++ E IL+ + P+I++L +K LI
Sbjct: 111 CIDNKTCEHVVIKAGQRGGTATEAHILRAI-NHPSIIQLKGTF--TYNKFTCLILPRYK- 166
Query: 103 TDFKVLYPTLSDY------DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLR 156
TD LY L+ D+ +L+A+ Y H I+HRD+K N+ I+H +
Sbjct: 167 TD---LYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPG-DVC 222
Query: 157 LIDWGLAEFYHPGKEYNVRV-ASRYF--------KGPELLVDLQDYDYSLDLWSLGCMFA 207
L D+G A + V + A++Y+ PELL Y ++D+WS G +
Sbjct: 223 LGDFGAA-------CFPVDINANKYYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLF 274
Query: 208 GM------IFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE----LDPHLAALV 257
M +F K+ D+ Q+ I + GT + N++ I+ LD L
Sbjct: 275 EMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGT-----HPNEFPIDAQANLDEIYIGLA 329
Query: 258 GRHSRKPWSKFITVENQHLAVPEAVDFLD-KLLRYDHQERPTAKEAMAHPYFFPI 311
+ SRKP S+ + L P +++L K+L +D RP+A+ + F I
Sbjct: 330 KKSSRKPGSRPLWTNLYEL--PIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI 382
|
Length = 391 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 4e-10
Identities = 51/198 (25%), Positives = 98/198 (49%), Gaps = 28/198 (14%)
Query: 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL----KPVKKKKIKREIKILQNLCGGPN 77
+ E V ++G G V++ +H +K++ + +++I REI+IL+++ PN
Sbjct: 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-NHPN 133
Query: 78 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHS 133
+VK D+ + ++ E ++ + + L+D ++L + Y H
Sbjct: 134 VVKCHDMF--DHNGEIQVLLEFMDGGSLEGTHIADEQFLADVA-----RQILSGIAYLHR 186
Query: 134 QGIMHRDVKPHNVMIDHEQRKLRLIDWG----LAEFYHPGKEYNVRVASRYFKGPELL-V 188
+ I+HRD+KP N++I+ + +++ D+G LA+ P N V + + PE +
Sbjct: 187 RHIVHRDIKPSNLLIN-SAKNVKIADFGVSRILAQTMDP---CNSSVGTIAYMSPERINT 242
Query: 189 DLQD--YD-YSLDLWSLG 203
DL YD Y+ D+WSLG
Sbjct: 243 DLNHGAYDGYAGDIWSLG 260
|
Length = 353 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 4e-10
Identities = 51/206 (24%), Positives = 101/206 (49%), Gaps = 16/206 (7%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK---PVKKKK---IKREIKILQNLCG 74
DD E ++ VG G + V +K++ ++ K+ + E ++L+ +
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-S 59
Query: 75 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYP--TLSDYDVRYYIYELLKALDYC 131
P I++L DQ+ ++ E+V + F L S+ +Y E++ AL+Y
Sbjct: 60 HPFIIRLFWTEHDQRFLY--MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYL 117
Query: 132 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 191
HS+ I++RD+KP N+++D E ++L D+G A+ + + + Y PE++ +
Sbjct: 118 HSKEIVYRDLKPENILLDKEGH-IKLTDFGFAKKLR-DRTWTLCGTPEYL-APEVIQS-K 173
Query: 192 DYDYSLDLWSLGCMFAGMIFRKEPFF 217
++ ++D W+LG + M+ PFF
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPPFF 199
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 5e-10
Identities = 77/337 (22%), Positives = 123/337 (36%), Gaps = 79/337 (23%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPVKKKKIKREIKILQNLCGGP 76
DD+E + ++G G V + +H K I +KP + +I RE+K+L C P
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHE-CNSP 59
Query: 77 NIVKL---------------------LDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY 115
IV LD V + + P I ++
Sbjct: 60 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKIS-------------- 105
Query: 116 DVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV 174
+L+ L Y + IMHRDVKP N++++ + +++L D+G++ N
Sbjct: 106 ------IAVLRGLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA-NS 157
Query: 175 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 234
V +R + PE L Y D+WSLG M + P D ++ + G
Sbjct: 158 FVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPI----PPPDAK-ELEAMFG 211
Query: 235 TDELNAYLNKYHIELDPH-------------LAALVGRHSRKPWSKFITVENQHLAVPEA 281
+ H + H L +V K S + E
Sbjct: 212 RPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFS--------DEF 263
Query: 282 VDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSR 318
DF+DK L+ + +ER KE HP+ I+ AE
Sbjct: 264 QDFVDKCLKKNPKERADLKELTKHPF---IKRAELEE 297
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 6e-10
Identities = 49/187 (26%), Positives = 84/187 (44%), Gaps = 40/187 (21%)
Query: 124 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFK 182
+L+AL Y H+QG++HRD+K ++++ + R ++L D+G A+ + V + Y+
Sbjct: 127 VLRALSYLHNQGVIHRDIKSDSILLTSDGR-IKLSDFGFCAQVSKEVPKRKSLVGTPYWM 185
Query: 183 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242
PE++ L Y +D+WSLG M MI + P+F
Sbjct: 186 APEVISRLP-YGTEVDIWSLGIMVIEMIDGEPPYFN------------------------ 220
Query: 243 NKYHIELDPHLAALVG-RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE 301
+P L A+ R + P V++ H FLD +L + +R TA+E
Sbjct: 221 -------EPPLQAMRRIRDNLPP-----RVKDSHKVSSVLRGFLDLMLVREPSQRATAQE 268
Query: 302 AMAHPYF 308
+ HP+
Sbjct: 269 LLQHPFL 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 7e-10
Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 2/98 (2%)
Query: 119 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 178
+Y EL L+ + I++RD+KP N+++D ++ +R+ D GLA G+ RV +
Sbjct: 106 FYAAELCCGLEDLQRERIVYRDLKPENILLD-DRGHIRISDLGLAVQIPEGETVRGRVGT 164
Query: 179 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 216
+ PE++ + + Y +S D W LGC+ MI + PF
Sbjct: 165 VGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 8e-10
Identities = 62/260 (23%), Positives = 109/260 (41%), Gaps = 39/260 (15%)
Query: 56 PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY 115
P +K+I RE++I ++ C P IVK D+ S + + E+ +Y +
Sbjct: 40 PDLQKQILRELEINKS-CKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKR 98
Query: 116 DVRYYIYEL-------LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYH 167
R L LK L Y HS+ I+HRD+KP N+++ + +++L D+G++ E +
Sbjct: 99 GGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLT-RKGQVKLCDFGVSGELVN 157
Query: 168 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 227
+ ++ PE + + Y + D+WSLG + + PF + L
Sbjct: 158 SLA--GTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPF--PPEGEPPLG 212
Query: 228 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDK 287
I + L+ +N + EL + WS+ E DF+ +
Sbjct: 213 PI------ELLSYIVNMPNPELKDEPGNGIK------WSE------------EFKDFIKQ 248
Query: 288 LLRYDHQERPTAKEAMAHPY 307
L D RPT + + HP+
Sbjct: 249 CLEKDPTRRPTPWDMLEHPW 268
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 9e-10
Identities = 35/131 (26%), Positives = 70/131 (53%), Gaps = 7/131 (5%)
Query: 95 LIFEHVNNTDFKVLYPTLSDYDV---RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 151
+ E++N D + +D+ +Y E++ L + HS+GI++RD+K N+++D +
Sbjct: 73 FVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD 132
Query: 152 QRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI 210
+++ D+G+ + G + + + PE+L+ Q Y+ S+D WS G + M+
Sbjct: 133 GH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEML 190
Query: 211 FRKEPFFYGHD 221
+ P F+GHD
Sbjct: 191 IGQSP-FHGHD 200
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 60/250 (24%), Positives = 103/250 (41%), Gaps = 47/250 (18%)
Query: 65 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK---VLYPTLSDYDVRYYI 121
EI++L+NL IV+ +RD + K S+ E++ K Y L++ R Y
Sbjct: 54 EIQLLKNL-RHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYT 112
Query: 122 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE----FYHPGKEYNVRVA 177
++L+ + Y HS I+HRD+K N++ D ++L D+G ++ G
Sbjct: 113 RQILQGVSYLHSNMIVHRDIKGANILRD-SAGNVKLGDFGASKRIQTICMSGTGIKSVTG 171
Query: 178 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 237
+ Y+ PE ++ + Y D+WS+ C M+ K P+ Y+ + I K+ T
Sbjct: 172 TPYWMSPE-VISGEGYGRKADVWSVACTVVEMLTEKPPW----AEYEAMAAIFKI-ATQP 225
Query: 238 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP 297
P L V R DFL ++ + + RP
Sbjct: 226 TK-----------PMLPDGVSDACR--------------------DFLKQIFVEEKR-RP 253
Query: 298 TAKEAMAHPY 307
TA+ + HP+
Sbjct: 254 TAEFLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 58/215 (26%), Positives = 96/215 (44%), Gaps = 24/215 (11%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCII-------KILKPVKKKKIKREIKILQNLC 73
DD+E+++ +GRG + EV V E+ ++LK + + E +L N
Sbjct: 1 DDFEIIKVIGRGAFGEV-AVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVN-- 57
Query: 74 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY----DVRYYIYELLKALD 129
G + L Q L+ ++ D L D R+YI E++ A+
Sbjct: 58 GDCQWITTLHYAF-QDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIH 116
Query: 130 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG--LAEFYHPGKEYNVRVASRYFKGPELL 187
H +HRD+KP NV++D +RL D+G L + +V V + + PE+L
Sbjct: 117 SIHQLHYVHRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEIL 175
Query: 188 VDLQD----YDYSLDLWSLG-CMFAGMIFRKEPFF 217
++D Y D WSLG CM+ M++ + PF+
Sbjct: 176 QAMEDGMGKYGPECDWWSLGVCMYE-MLYGETPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 1e-09
Identities = 54/214 (25%), Positives = 95/214 (44%), Gaps = 22/214 (10%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCII-------KILKPVKKKKIKREIKILQNLC 73
+D+E+++ +GRG + EV V + +K ++LK + + E +L N
Sbjct: 1 EDFEILKVIGRGAFGEV-AVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVN-- 57
Query: 74 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY----DVRYYIYELLKALD 129
G + L Q L+ ++ D L D R+Y+ E++ A+D
Sbjct: 58 GDNQWITTLHYAF-QDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAID 116
Query: 130 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG--LAEFYHPGKEYNVRVASRYFKGPELL 187
H +HRD+KP N+++D +RL D+G L + +V V + + PE+L
Sbjct: 117 SVHQLHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 175
Query: 188 VDLQD----YDYSLDLWSLGCMFAGMIFRKEPFF 217
++D Y D WSLG M++ + PF+
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFY 209
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 1e-09
Identities = 38/107 (35%), Positives = 61/107 (57%), Gaps = 9/107 (8%)
Query: 118 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG--LAEFYHPGKEYNVR 175
R+Y+ E++ A+D H G +HRD+KP NV++D + +RL D+G L + NV
Sbjct: 105 RFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLD-KNGHIRLADFGSCLRLLADGTVQSNVA 163
Query: 176 VASRYFKGPELLVDLQD----YDYSLDLWSLG-CMFAGMIFRKEPFF 217
V + + PE+L ++D Y D WSLG CM+ M++ + PF+
Sbjct: 164 VGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYE-MLYGETPFY 209
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 49/205 (23%), Positives = 88/205 (42%), Gaps = 26/205 (12%)
Query: 29 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGPNIVKLLDI 84
+G+G Y V+ + + IK + P + + + EI + L NIV+ L
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEI-PERDSRYVQPLHEEIALHSYLKHR-NIVQYLG- 72
Query: 85 VRDQQSKTPSLIFEHVNNTDFKVLYPT----LSDYD--VRYYIYELLKALDYCHSQGIMH 138
D ++ + E V L + L D + + +Y ++L+ L Y H I+H
Sbjct: 73 -SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131
Query: 139 RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PELL-VDLQ 191
RD+K NV+++ +++ D+G ++ + + + F G PE++ +
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSK-----RLAGINPCTETFTGTLQYMAPEVIDKGPR 186
Query: 192 DYDYSLDLWSLGCMFAGMIFRKEPF 216
Y D+WSLGC M K PF
Sbjct: 187 GYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 71/301 (23%), Positives = 124/301 (41%), Gaps = 49/301 (16%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPVKKKKIKREIKILQNLCGGP 76
+D E + +G G V + H +K + K +K+I RE++I+ C P
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHE-CRSP 63
Query: 77 NIVKLLDIVRDQQSKTPSLIFEHVNNTD--FKVLYPTLSDYDVRYYIYELLKALDYCHS- 133
IV ++ + + F + D +K P + + +++ L Y ++
Sbjct: 64 YIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEI-LGKIAVAVVEGLTYLYNV 122
Query: 134 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN----VRVASRYFKGPELLVD 189
IMHRD+KP N++++ + +++L D+G++ G+ N V + + PE
Sbjct: 123 HRIMHRDIKPSNILVN-SRGQIKLCDFGVS-----GELINSIADTFVGTSTYMSPE---R 173
Query: 190 LQDYDYSL--DLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247
+Q Y++ D+WSLG + K PF + + + D +L D L +
Sbjct: 174 IQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGIL--DLLQQIVQ---- 227
Query: 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 307
E P L P S F + DF+D L D ERPT ++ A P
Sbjct: 228 EPPPRL----------PSSDF---------PEDLRDFVDACLLKDPTERPTPQQLCAMPP 268
Query: 308 F 308
F
Sbjct: 269 F 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-09
Identities = 52/194 (26%), Positives = 90/194 (46%), Gaps = 19/194 (9%)
Query: 26 VRKVGRGKYSEV----FEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGPN 77
+R +G G + +V ++ E+ +K LKP +K+EI+IL+NL N
Sbjct: 9 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYH-EN 67
Query: 78 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHS 133
IVK I + LI E + + K P ++ Y ++ K +DY S
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS 127
Query: 134 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV----RVASRYFKGPELLVD 189
+ +HRD+ NV+++ E + +++ D+GL + KEY + ++ PE L+
Sbjct: 128 RQYVHRDLAARNVLVESEHQ-VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186
Query: 190 LQDYDYSLDLWSLG 203
+ Y S D+WS G
Sbjct: 187 SKFYIAS-DVWSFG 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 35/113 (30%), Positives = 58/113 (51%), Gaps = 5/113 (4%)
Query: 118 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRV 176
R+Y E+ AL Y HS I++RD+KP N+++D Q + L D+GL E
Sbjct: 99 RFYAAEIASALGYLHSINIVYRDLKPENILLD-SQGHVVLTDFGLCKEGIAQSDTTTTFC 157
Query: 177 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY--GHDNYDQLV 227
+ + PE++ Q YD ++D W LG + M++ PF+ + YD ++
Sbjct: 158 GTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL 209
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 2e-09
Identities = 48/202 (23%), Positives = 79/202 (39%), Gaps = 44/202 (21%)
Query: 122 YELLKALDYC-HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 180
++KAL Y G++HRDVKP N+++D ++L D+G++ K
Sbjct: 121 VAIVKALHYLKEKHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAA 179
Query: 181 FKGPELLVDLQD----YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD 236
+ PE + D D YD D+WSLG + + P+ ++ L KI
Sbjct: 180 YMAPERI-DPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL------ 232
Query: 237 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER 296
+ +P S P+ F+D L DH++R
Sbjct: 233 -----------QEEPPSLPPNEGFS-----------------PDFCSFVDLCLTKDHRKR 264
Query: 297 PTAKEAMAHPYFFPIRNAESSR 318
P +E + HP+ IR E++
Sbjct: 265 PKYRELLQHPF---IRRYETAE 283
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-09
Identities = 41/133 (30%), Positives = 67/133 (50%), Gaps = 9/133 (6%)
Query: 91 KTPSLIF---EHVNNTDFKVLYPTLSDYD---VRYYIYELLKALDYCHSQGIMHRDVKPH 144
+TP +F E VN D +D R+Y E+ AL + H +GI++RD+K
Sbjct: 66 QTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLD 125
Query: 145 NVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG 203
NV++DHE +L D+G+ E GK + + + PE+L ++ Y S+D W++G
Sbjct: 126 NVLLDHEGH-CKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEML-YGPSVDWWAMG 183
Query: 204 CMFAGMIFRKEPF 216
+ M+ PF
Sbjct: 184 VLLYEMLCGHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 32/101 (31%), Positives = 57/101 (56%), Gaps = 3/101 (2%)
Query: 118 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRV 176
R+Y E++ AL+Y HS+ +++RD+K N+M+D + +++ D+GL E G
Sbjct: 98 RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFC 156
Query: 177 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 217
+ + PE+L D DY ++D W LG + M+ + PF+
Sbjct: 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 42/157 (26%), Positives = 77/157 (49%), Gaps = 15/157 (9%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKRE----IKILQNLCG-- 74
DD+E ++ +GRG + EV +K L+ K + +++E ++ +++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLR--KSEMLEKEQVAHVRAERDILAEA 58
Query: 75 -GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDY 130
P +VKL +D LI E++ D L T ++ + R+YI E + A+D
Sbjct: 59 DNPWVVKLYYSFQD--ENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDS 116
Query: 131 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167
H G +HRD+KP N+++D + ++L D+GL
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGH-IKLSDFGLCTGLK 152
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 3e-09
Identities = 56/227 (24%), Positives = 101/227 (44%), Gaps = 23/227 (10%)
Query: 26 VRKVGRGKYSEVFEGVHCTD------NEKCIIKILK----PVKKKKIKREIKILQNLCGG 75
+R +G G + +V ++C D E +K LK K+EI IL+ L
Sbjct: 9 IRVLGEGHFGKV--SLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YH 65
Query: 76 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHS 133
NIVK +Q K LI E+V + P L+ + + ++ + + Y HS
Sbjct: 66 ENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHS 125
Query: 134 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR-----YFKGPELLV 188
Q +HRD+ NV++D++ R +++ D+GLA+ G EY RV ++ E L
Sbjct: 126 QHYIHRDLAARNVLLDND-RLVKIGDFGLAKAVPEGHEY-YRVREDGDSPVFWYAVECLK 183
Query: 189 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 235
+ + Y+ D+WS G ++ + +++++ + T
Sbjct: 184 ENKFS-YASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMT 229
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-09
Identities = 39/135 (28%), Positives = 65/135 (48%), Gaps = 8/135 (5%)
Query: 96 IFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ 152
+ E+VN D +D R+Y E+ AL + H G+++RD+K N+++D E
Sbjct: 74 VMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG 133
Query: 153 RKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF 211
+L D+G+ E G + + PE+L + +Y S+D W+LG + M+
Sbjct: 134 H-CKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMA 191
Query: 212 RKEPFFYGHDNYDQL 226
+ PF DN D L
Sbjct: 192 GQPPF--EADNEDDL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 5e-09
Identities = 32/104 (30%), Positives = 55/104 (52%), Gaps = 3/104 (2%)
Query: 115 YDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YN 173
R+Y ELL AL+ H +++RD+KP N+++D+ Q + L D+GL + + N
Sbjct: 93 SRARFYTAELLCALENLHKFNVIYRDLKPENILLDY-QGHIALCDFGLCKLNMKDDDKTN 151
Query: 174 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 217
+ + PELL+ Y ++D W+LG + M+ PF+
Sbjct: 152 TFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFY 194
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-09
Identities = 57/208 (27%), Positives = 94/208 (45%), Gaps = 21/208 (10%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPN 77
Y VR VG+G Y EV H TD ++ +IK L ++K ++E ++L L PN
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPN 60
Query: 78 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY--------DVRYYIYELLKALD 129
IV R+ L++ + + LY L + V + ++ AL
Sbjct: 61 IV----AYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ 116
Query: 130 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLV 188
Y H + I+HRD+K NV + +++ D G+A + + + + Y+ PEL
Sbjct: 117 YLHEKHILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFS 175
Query: 189 DLQDYDYSLDLWSLGCMFAGMIFRKEPF 216
+ + Y+Y D+W+LGC M K F
Sbjct: 176 N-KPYNYKSDVWALGCCVYEMATLKHAF 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 6e-09
Identities = 36/119 (30%), Positives = 66/119 (55%), Gaps = 5/119 (4%)
Query: 115 YDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYN 173
Y +Y E++ L + HS+GI++RD+K NVM+D + +++ D+G+ E +
Sbjct: 96 YRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRAS 154
Query: 174 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 232
+ + PE+L L+ Y +S+D WS G + M+ + P F+G D+ D+L + +V
Sbjct: 155 TFCGTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSP-FHG-DDEDELFESIRV 210
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 7e-09
Identities = 51/213 (23%), Positives = 102/213 (47%), Gaps = 24/213 (11%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-----ILKPVKKKKIKREIKILQNLCGGPN 77
Y V+K+G G + + D ++ +IK + P ++++ ++E+ +L N+ PN
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPN 60
Query: 78 IVKL---------LDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 128
IV+ L IV D +++ +N VL+P + + + ++ AL
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGD--LYKKINAQR-GVLFP---EDQILDWFVQICLAL 114
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELL 187
+ H + I+HRD+K N+ + + ++L D+G+A + E + + Y+ PE +
Sbjct: 115 KHVHDRKILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVELARTCIGTPYYLSPE-I 172
Query: 188 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH 220
+ + Y+ D+W+LGC+ M K F G+
Sbjct: 173 CENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 8e-09
Identities = 33/108 (30%), Positives = 57/108 (52%), Gaps = 3/108 (2%)
Query: 111 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPG 169
S+ R+Y E++ AL Y HS +++RD+K N+M+D + +++ D+GL E G
Sbjct: 91 VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDG 149
Query: 170 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 217
+ + PE+L D DY ++D W LG + M+ + PF+
Sbjct: 150 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 1e-08
Identities = 34/107 (31%), Positives = 57/107 (53%), Gaps = 3/107 (2%)
Query: 112 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK 170
S+ R+Y E++ ALDY HS I++RD+K N+M+D + +++ D+GL E
Sbjct: 92 FSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGH-IKITDFGLCKEGITDAA 150
Query: 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 217
+ + PE+L D DY ++D W LG + M+ + PF+
Sbjct: 151 TMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 30/100 (30%), Positives = 55/100 (55%), Gaps = 3/100 (3%)
Query: 118 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRV 176
R+Y E++ L + H +GI++RD+K NV++D E +++ D+G+ E G +
Sbjct: 99 RFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFC 157
Query: 177 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 216
+ + PE+L Q Y ++D W+LG + M+ + PF
Sbjct: 158 GTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 34/116 (29%), Positives = 62/116 (53%), Gaps = 7/116 (6%)
Query: 113 SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA--EFYHPGK 170
+ R+Y E++ L + H +GI++RD+K NV++D + +++ D+G+ GK
Sbjct: 94 DEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGK 152
Query: 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL 226
+ + + PE+L Q Y+ S+D WS G + M+ + P F+G D D+L
Sbjct: 153 A-STFCGTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSP-FHGEDE-DEL 204
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 1e-08
Identities = 50/193 (25%), Positives = 85/193 (44%), Gaps = 22/193 (11%)
Query: 28 KVGRGKYSEVFEGVHCTDNEKCIIK----ILKPVKKKKIKREIKILQNLCGGPNIVKLLD 83
++GRG + EVF G DN +K L P K K +E +IL+ PNIV+L+
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIG 60
Query: 84 IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLK-------ALDYCHSQGI 136
+ Q + ++ E V DF L R + EL++ ++Y S+
Sbjct: 61 VC--TQKQPIYIVMELVQGGDFLTF---LRTEGPRLKVKELIQMVENAAAGMEYLESKHC 115
Query: 137 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG---KEYNVRVASRYFKGPELLVDLQDY 193
+HRD+ N ++ E+ L++ D+G++ G ++ + PE L + Y
Sbjct: 116 IHRDLAARNCLVT-EKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEAL-NYGRY 173
Query: 194 DYSLDLWSLGCMF 206
D+WS G +
Sbjct: 174 SSESDVWSFGILL 186
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 1e-08
Identities = 45/167 (26%), Positives = 78/167 (46%), Gaps = 16/167 (9%)
Query: 61 KIKREIKILQNLCGGPNIVKL---------LDIVRDQQSKTPSLIFEHVNNTDFKVLYPT 111
I E+ I++ PNIV+ L IV D P + EH N+ K
Sbjct: 54 DIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAP--LGEHFNS--LKEKKQR 109
Query: 112 LSDYDVRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170
++ + +++ AL Y H + I+HRD+ P+N+M+ E K+ + D+GLA+ P
Sbjct: 110 FTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQPES 168
Query: 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 217
+ V + + PE++ + Y D+W+ GC+ M + PF+
Sbjct: 169 KLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFY 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.6 bits (132), Expect = 2e-08
Identities = 42/155 (27%), Positives = 73/155 (47%), Gaps = 17/155 (10%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTD-NEKCIIKILKP---VKKKKIKR---EIKILQNLC 73
++ ++ +G+G VF V + +K+L +K+ K+KR E +IL L
Sbjct: 1 KHFKKIKLLGKGDVGRVFL-VRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL- 58
Query: 74 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT-----LSDYDVRYYIYELLKAL 128
P + L Q L+ ++ + L LS+ R+Y E+L AL
Sbjct: 59 DHPFLPTLY--ASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLAL 116
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163
+Y H GI++RD+KP N+++ HE + L D+ L+
Sbjct: 117 EYLHLLGIVYRDLKPENILL-HESGHIMLSDFDLS 150
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 2e-08
Identities = 42/151 (27%), Positives = 79/151 (52%), Gaps = 11/151 (7%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQN---LCGG 75
+++ +V+ + RG + +V+ G +++ +K++K K + +++ ++ L
Sbjct: 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63
Query: 76 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD---VRYYIYELLKALDYCH 132
P IV L + Q + L+ E++ D K L +D YI E+ ALDY H
Sbjct: 64 PFIVHLYYSL--QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLH 121
Query: 133 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163
GI+HRD+KP N++I +E ++L D+GL+
Sbjct: 122 RHGIIHRDLKPDNMLISNEGH-IKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 62/241 (25%), Positives = 107/241 (44%), Gaps = 50/241 (20%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKK---IKREIKILQNLCG 74
DD+E ++ +GRG + EV +KIL+ ++K++ I+ E IL
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE-AD 59
Query: 75 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYC 131
G +VK+ +D+++ LI E + D L TLS+ ++YI E + A+D
Sbjct: 60 GAWVVKMFYSFQDKRNLY--LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAI 117
Query: 132 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL---------AEFY-----HPGKEYNVR-- 175
H G +HRD+KP N+++D + ++L D+GL EFY +P +++ +
Sbjct: 118 HQLGFIHRDIKPDNLLLD-AKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176
Query: 176 --------------------VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEP 215
V + + PE+ + Y+ D WSLG + M+ P
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP 235
Query: 216 F 216
F
Sbjct: 236 F 236
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 34/108 (31%), Positives = 59/108 (54%), Gaps = 4/108 (3%)
Query: 112 LSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPG 169
S+ R+Y E++ ALDY HS+ +++RD+K N+M+D + +++ D+GL E G
Sbjct: 92 FSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDG 150
Query: 170 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 217
+ + PE+L D DY ++D W LG + M+ + PF+
Sbjct: 151 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY 197
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 4e-08
Identities = 49/207 (23%), Positives = 96/207 (46%), Gaps = 19/207 (9%)
Query: 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-PVKKKKIK--REIKILQNLCGGPNI 78
Y V+R VG G + H ++K +K ++ P ++ R+ +L PNI
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNI 60
Query: 79 VKLLDIVRDQQSKTPSLIFEHVNNTDF--KV------LYPTLSDYDVRYYIYELLKALDY 130
V + + ++ E+ + D K+ L+P D +++++ ++ + +
Sbjct: 61 VAFKESF--EADGHLYIVMEYCDGGDLMQKIKLQRGKLFP--EDTILQWFV-QMCLGVQH 115
Query: 131 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPGKEYNVRVASRYFKGPELLVD 189
H + ++HRD+K N+ + + K++L D+G A PG V + Y+ PE+ +
Sbjct: 116 IHEKRVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWEN 174
Query: 190 LQDYDYSLDLWSLGCMFAGMIFRKEPF 216
+ Y+ D+WSLGC+ + K PF
Sbjct: 175 MP-YNNKSDIWSLGCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-08
Identities = 48/159 (30%), Positives = 77/159 (48%), Gaps = 19/159 (11%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KK-----IKREIKILQN 71
+D+ V+ +G+G + EV V D K I +K + K KK +K E +L
Sbjct: 1 EDFHTVKVIGKGAFGEV-RLVQKKDTGK--IYAMKTLLKSEMFKKDQLAHVKAERDVLAE 57
Query: 72 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKAL 128
P +V L +D Q LI E + D + Y T S+ R+Y+ E + A+
Sbjct: 58 -SDSPWVVSLYYSFQDAQYLY--LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAI 114
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167
+ H G +HRD+KP N++ID ++L D+GL+ +H
Sbjct: 115 EAVHKLGFIHRDIKPDNILIDRGGH-IKLSDFGLSTGFH 152
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 5e-08
Identities = 31/112 (27%), Positives = 54/112 (48%), Gaps = 15/112 (13%)
Query: 60 KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS----LIFEHVNNTDFKVLYPT---L 112
+ +RE + L PNIV LLD + P +FE+V + + L
Sbjct: 23 ARFRRETALCARL-YHPNIVALLD-----SGEAPPGLLFAVFEYVPGRTLREVLAADGAL 76
Query: 113 SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGL 162
+ + ++L AL H+QGI+HRD+KP N+M+ + +++D+G+
Sbjct: 77 PAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGI 128
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 5e-08
Identities = 47/212 (22%), Positives = 101/212 (47%), Gaps = 21/212 (9%)
Query: 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI----------KREIKILQN 71
++E+++ +G G Y +VF + ++ + +K +KK I + E ++L++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 72 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF---KVLYPTLSDYDVRYYIYELLKAL 128
+ P +V L Q LI +++N + + +V+ Y E++ AL
Sbjct: 61 IRQSPFLVTLHYAF--QTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLAL 118
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG---KEYNVRVASRYFKGPE 185
++ H GI++RD+K N+++D + L D+GL++ +H + Y+ Y P+
Sbjct: 119 EHLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFHEDEVERAYSFCGTIEYM-APD 176
Query: 186 LLVDLQD-YDYSLDLWSLGCMFAGMIFRKEPF 216
++ +D ++D WS+G + ++ PF
Sbjct: 177 IVRGGDGGHDKAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 9e-08
Identities = 54/212 (25%), Positives = 92/212 (43%), Gaps = 28/212 (13%)
Query: 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPVKKKKIKREIKILQNLCG 74
+ DD+E + ++G G VF+ H K I +KP + +I RE+++L C
Sbjct: 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHE-CN 61
Query: 75 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF--------KVLYPTLSDYDVRYYIYELLK 126
P IV S+ EH++ ++ L + ++K
Sbjct: 62 SPYIVGFYGAFYSDGEI--SICMEHMDGGSLDQVLKKAGRIPEQILGKVSI-----AVIK 114
Query: 127 ALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 185
L Y + IMHRDVKP N++++ + +++L D+G++ N V +R + PE
Sbjct: 115 GLTYLREKHKIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSPE 172
Query: 186 LLVDLQDYDYSL--DLWSLGCMFAGMIFRKEP 215
LQ YS+ D+WS+G M + P
Sbjct: 173 ---RLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 3/99 (3%)
Query: 119 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVA 177
+Y E+ L + HS+GI++RD+K NVM+D E +++ D+G+ E GK
Sbjct: 105 FYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCG 163
Query: 178 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 216
+ + PE ++ Q Y S+D W+ G + M+ + PF
Sbjct: 164 TPDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 3e-07
Identities = 78/308 (25%), Positives = 119/308 (38%), Gaps = 68/308 (22%)
Query: 48 KCIIKILKPVKKK-----KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 102
KC I K VK +++ EI L L NI+K+ +I+R + + +
Sbjct: 191 KCERLIAKRVKAGSRAAIQLENEILALGRL-NHENILKIEEILR-----SEANTYMITQK 244
Query: 103 TDFKVLYPTLSDYDV-----------RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 151
DF LY + D R + +LL A++Y H + ++HRD+K N+ ++ +
Sbjct: 245 YDFD-LYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303
Query: 152 QRKLRLIDWGLAEFYHPGKEYNVRVASRY-------FKGPELLVDLQDYDYSLDLWSLGC 204
K+ L D+G A + R A Y PE+L Y D+WS G
Sbjct: 304 G-KIVLGDFGTAMPFE-----KEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGL 356
Query: 205 MFAGMIFRKE-PFFYGHDN-YDQLVKIAKVLGT-DE--------LNAYLNKYHIELDPHL 253
+ M+ P G QL+KI L DE L Y++ I+ H
Sbjct: 357 ILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHS 416
Query: 254 AALVGRHSRKPWSKFITVENQHLAVPEAVDF-LDKLLRYDHQERPTAKEAMAHPYFFPIR 312
+ R N L P ++ L K+L +D RP A E +A P F
Sbjct: 417 VPPLIR-------------NLGL--PADFEYPLVKMLTFDWHLRPGAAELLALPLF---- 457
Query: 313 NAESSRSR 320
+AE
Sbjct: 458 SAEEEEEI 465
|
Length = 501 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 6e-07
Identities = 49/237 (20%), Positives = 81/237 (34%), Gaps = 82/237 (34%)
Query: 118 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL---------AEFYHP 168
R+YI EL A++ H G +HRD+KP N++ID + ++L D+GL +++Y
Sbjct: 104 RFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGH-IKLTDFGLCTGFRWTHDSKYYQK 162
Query: 169 G-------------------------KEYNVR----------VASRYFKGPELLVDLQDY 193
G + R V + + PE+L+ Y
Sbjct: 163 GDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGY 221
Query: 194 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 253
D WS+G + M+ + PF + T
Sbjct: 222 TQLCDWWSVGVILYEMLVGQPPF---LAD--------TPAET------------------ 252
Query: 254 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLR--YDHQERPTAKEAMAHPYF 308
+ W + + +Q EA D + +L D + A E AHP+F
Sbjct: 253 -----QLKVINWETTLHIPSQAKLSREASDLILRLCCGAEDRLGKNGADEIKAHPFF 304
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 9e-07
Identities = 47/201 (23%), Positives = 89/201 (44%), Gaps = 18/201 (8%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--------REIKILQNLCG 74
Y + +++G+G + V+ + +K+LK + ++ +E ++L L
Sbjct: 2 YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-D 60
Query: 75 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALD 129
P IVK ++ + + + D K+ TLS+ V + +LL +
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 130 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLV 188
Y H + I+HRD+K N+ + + L++ D+G++ + + Y+ PE L
Sbjct: 121 YMHQRRILHRDLKAKNIFL--KNNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALK 178
Query: 189 DLQDYDYSLDLWSLGCMFAGM 209
Q YD D+WSLGC+ M
Sbjct: 179 H-QGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 1e-06
Identities = 56/234 (23%), Positives = 110/234 (47%), Gaps = 31/234 (13%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQN 71
W I RE ++V+K+G G++ EV+ G + ++ K +K LKP + + E +++
Sbjct: 1 WEIPRES--IKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMSVQAFLEEANLMKT 57
Query: 72 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN---TDF-------KVLYPTLSDYDVRYYI 121
L +V+L +V + + +I E++ DF KVL P L D+
Sbjct: 58 L-QHDKLVRLYAVV--TKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA---- 110
Query: 122 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY- 180
++ + + Y + +HRD++ NV++ E ++ D+GLA EY R +++
Sbjct: 111 -QIAEGMAYIERKNYIHRDLRAANVLVS-ESLMCKIADFGLARVIE-DNEYTAREGAKFP 167
Query: 181 --FKGPELLVDLQDYDYSLDLWSLGCMFAGMI-FRKEPFFYGHDNYDQLVKIAK 231
+ PE ++ + D+WS G + ++ + K P + G N D + + +
Sbjct: 168 IKWTAPE-AINFGSFTIKSDVWSFGILLYEIVTYGKIP-YPGMSNSDVMSALQR 219
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 1e-06
Identities = 63/294 (21%), Positives = 112/294 (38%), Gaps = 52/294 (17%)
Query: 29 VGRGKYSEVFEGVHCTDNEKCIIKI-LKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRD 87
+G+G Y V+ G+ + ++ L ++E + LQ +K ++IV+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 88 ----QQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQGIMHRD 140
T S+ E V + + L + Y ++L + Y H+ ++HRD
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRD 127
Query: 141 VKPHNVMIDHEQRKLRLIDWG----LAEFYHPGKEYNVRVASR---YFKGPELLVDLQDY 193
+K +NVM+ ++LID+G LA G N+ + Y+ PE++ + Y
Sbjct: 128 IKGNNVML-MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE-SGY 185
Query: 194 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 253
D+WS+GC M K P + D+L + + L L
Sbjct: 186 GRKSDIWSIGCTVFEMATGKPPL----ASMDRLAAMFYIGAHRGLMP-------RLPDSF 234
Query: 254 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 307
+A A+DF+ L D ERP+A + + H +
Sbjct: 235 SA------------------------AAIDFVTSCLTRDQHERPSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 1e-06
Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 33/207 (15%)
Query: 123 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF--------YHPGKEYNV 174
+LL A+DY H +GI+HRD+K NV+++ + + L D+G A F +H G V
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWSTPFHYGIAGTV 326
Query: 175 RVASRYFKGPELLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDN----YD-QLVK 228
PE+L Y S+D+WS G +F + F + YD Q+++
Sbjct: 327 DT-----NAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILR 380
Query: 229 I---AKVLGTDELNAYLNKYHIELDPHLAALVGR--HSRKPWSKFITVENQHLAVPEAVD 283
I A+V DE + + H AA R ++R W+++ + L V V
Sbjct: 381 IIRQAQV-HVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKL---DLDVEYLV- 435
Query: 284 FLDKLLRYDHQERPTAKEAMAHPYFFP 310
+ L +D RP+A E + P F
Sbjct: 436 --CRALTFDGARRPSAAELLRLPLFQS 460
|
Length = 461 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 44/197 (22%), Positives = 79/197 (40%), Gaps = 46/197 (23%)
Query: 118 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRV 176
+Y ++ L Y H I++RD+K N+++D E +++ D+GL E G +
Sbjct: 104 VFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFC 162
Query: 177 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD 236
+ F PE+L + Y ++D W LG + M+ + PF G D
Sbjct: 163 GTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPF----------------PGDD 205
Query: 237 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER 296
E + ++V R P + L+ EA+ + +LLR + + R
Sbjct: 206 E------------EEVFDSIVNDEVRYP---------RFLSR-EAISIMRRLLRRNPERR 243
Query: 297 -----PTAKEAMAHPYF 308
A++ P+F
Sbjct: 244 LGSGEKDAEDVKKQPFF 260
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 3e-06
Identities = 54/232 (23%), Positives = 93/232 (40%), Gaps = 46/232 (19%)
Query: 112 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNV------------------MIDHEQR 153
+S+ + Y + +LKALDY H G +HR VK ++ MI+H QR
Sbjct: 98 MSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157
Query: 154 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL-VDLQDYDYSLDLWSLGCMFAGMIFR 212
LR++ H +Y+V+V + PE+L +LQ YD D++S+G +
Sbjct: 158 -LRVV--------HDFPKYSVKVLP--WLSPEVLQQNLQGYDAKSDIYSVGITACELANG 206
Query: 213 KEPFFYGHDNYDQLVKIAKVLGT------------DELNAYLNKYHIELDPHLAALVGRH 260
PF D + + K+ GT +EL ++ + V
Sbjct: 207 HVPF---KDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTP 263
Query: 261 SRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312
N+ + P F+++ L+ + RP+A + H +F I+
Sbjct: 264 RPSNGESSSHPYNRTFS-PHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 3e-06
Identities = 34/121 (28%), Positives = 57/121 (47%), Gaps = 26/121 (21%)
Query: 117 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE---------FYH 167
R Y E + AL+Y H+ GI+HRD+KP N++I ++L D+GL++ Y
Sbjct: 103 ARMYFAETVLALEYLHNYGIVHRDLKPDNLLIT-SMGHIKLTDFGLSKIGLMSLTTNLY- 160
Query: 168 PGKEYNVRVASRYFK-----------GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 216
E ++ +R F PE+++ Q Y +D W++G + + PF
Sbjct: 161 ---EGHIEKDTREFLDKQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPF 216
Query: 217 F 217
F
Sbjct: 217 F 217
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 3e-06
Identities = 34/105 (32%), Positives = 56/105 (53%), Gaps = 15/105 (14%)
Query: 119 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR-VA 177
+Y E+ L + H +GI++RD+K NVM+D E +++ D+G+ KE+ V V
Sbjct: 105 FYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH-IKIADFGMC------KEHMVDGVT 157
Query: 178 SRYFKG------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 216
+R F G PE++ Q Y S+D W+ G + M+ + PF
Sbjct: 158 TRTFCGTPDYIAPEIIA-YQPYGKSVDWWAYGVLLYEMLAGQPPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 31/106 (29%), Positives = 56/106 (52%), Gaps = 5/106 (4%)
Query: 114 DYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 173
+Y+V Y+++ ALD HS+ +MHRD+K N+ + ++L D+G ++ Y +
Sbjct: 168 EYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL-MPTGIIKLGDFGFSKQYSDSVSLD 226
Query: 174 VRVA---SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 216
V + + Y+ PEL + + Y D+WSLG + ++ PF
Sbjct: 227 VASSFCGTPYYLAPELW-ERKRYSKKADMWSLGVILYELLTLHRPF 271
|
Length = 478 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 6e-06
Identities = 43/151 (28%), Positives = 78/151 (51%), Gaps = 13/151 (8%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKK---IKREIKILQNLCG 74
+D+E ++ +GRG + EV +KIL+ ++K++ I+ E IL
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE-AD 59
Query: 75 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYC 131
+VK+ +D+ + LI E + D L TL++ + ++YI E + A+D
Sbjct: 60 SLWVVKMFYSFQDKLNLY--LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSI 117
Query: 132 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 162
H G +HRD+KP N+++D + ++L D+GL
Sbjct: 118 HQLGFIHRDIKPDNLLLD-SKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 8e-06
Identities = 45/186 (24%), Positives = 77/186 (41%), Gaps = 36/186 (19%)
Query: 124 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE--FYHPGKEYNVRVASRYF 181
++K L Y S I+HRDVKP N++++ + +++L D+G++ K Y V + +
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVN-TRGQVKLCDFGVSTQLVNSIAKTY---VGTNAY 159
Query: 182 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY 241
PE + Q Y D+WSLG F + + P+ N L+ + +L
Sbjct: 160 MAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL-------QL--- 208
Query: 242 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE 301
L +V P V + V F+ + +R +ERP +
Sbjct: 209 -----------LQCIV--DEDPP------VLPVGQFSEKFVHFITQCMRKQPKERPAPEN 249
Query: 302 AMAHPY 307
M HP+
Sbjct: 250 LMDHPF 255
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (110), Expect = 8e-06
Identities = 51/198 (25%), Positives = 87/198 (43%), Gaps = 39/198 (19%)
Query: 112 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 171
LS+ +V+ I +L++AL+ H I+H D+K NV+ D + ++ L D+GL +
Sbjct: 106 LSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSC 165
Query: 172 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 231
Y+ + YF PE + +YD S D W++G + ++ K PF D
Sbjct: 166 YDGTLD--YFS-PEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDE--------- 212
Query: 232 VLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRY 291
ELD +L+ R +K FI +++ A DF+ +L+Y
Sbjct: 213 ----------------ELDL--ESLLKRQQKKL--PFIKNVSKN-----ANDFVQSMLKY 247
Query: 292 DHQER-PTAKEAMAHPYF 308
+ R E + HP+
Sbjct: 248 NINYRLTNYNEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 9e-06
Identities = 55/241 (22%), Positives = 84/241 (34%), Gaps = 86/241 (35%)
Query: 118 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL---------AEFYHP 168
R+YI EL A++ H G +HRD+KP N++ID + ++L D+GL +++Y
Sbjct: 104 RFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGH-IKLTDFGLCTGFRWTHNSKYYQK 162
Query: 169 GKEY---------------NVRVASRY------------------------FKGPELLVD 189
G N R R + PE+L+
Sbjct: 163 GSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR 222
Query: 190 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249
+ Y D WS+G + M+ + PF QL KV+
Sbjct: 223 -KGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQL----KVIN--------------- 262
Query: 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLL--RYDHQERPTAKEAMAHPY 307
W + + Q PEAVD + KL + R A + AHP+
Sbjct: 263 ---------------WENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPF 307
Query: 308 F 308
F
Sbjct: 308 F 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 30/99 (30%), Positives = 52/99 (52%), Gaps = 3/99 (3%)
Query: 119 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVA 177
+Y E+ L + HS+GI++RD+K NVM+D E +++ D+G+ E G
Sbjct: 105 FYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCG 163
Query: 178 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 216
+ + PE++ Q Y S+D W+ G + M+ + PF
Sbjct: 164 TPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQAPF 201
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 2e-05
Identities = 39/170 (22%), Positives = 70/170 (41%), Gaps = 38/170 (22%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLCGGP 76
Y+++R +G+G EV+ + + +K ++ P+ KK+ RE KI +L P
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH-P 62
Query: 77 NIVKLLDIVRDQQS---------------------KTPSLIFEHVNNTDFKVLYPTLSDY 115
IV + I D + SL E T
Sbjct: 63 GIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF--- 119
Query: 116 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165
+++ ++Y HS+G++HRD+KP N+++ + ++DWG A F
Sbjct: 120 ------HKICATIEYVHSKGVLHRDLKPDNILLGLFGEVV-ILDWGAAIF 162
|
Length = 932 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 53/207 (25%), Positives = 93/207 (44%), Gaps = 18/207 (8%)
Query: 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPVKKKKIKREIKILQNLCG 74
+ DD+E + ++G G V + H K I +KP + +I RE+++L C
Sbjct: 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHE-CN 61
Query: 75 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF-KVLYPT--LSDYDVRYYIYELLKALDYC 131
P IV S+ EH++ +VL + + + +L+ L Y
Sbjct: 62 SPYIVGFYGAFYSDGEI--SICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYL 119
Query: 132 HSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 190
+ IMHRDVKP N++++ + +++L D+G++ N V +R + PE L
Sbjct: 120 REKHQIMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSPE---RL 174
Query: 191 QDYDYSL--DLWSLGCMFAGMIFRKEP 215
Q YS+ D+WS+G + + P
Sbjct: 175 QGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 2e-05
Identities = 23/58 (39%), Positives = 35/58 (60%), Gaps = 4/58 (6%)
Query: 118 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA---EFYHPGKEY 172
R+YI EL A++ H G +HRD+KP N++ID + ++L D+GL + H K Y
Sbjct: 104 RFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH-IKLTDFGLCTGFRWTHDSKYY 160
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 51/234 (21%), Positives = 89/234 (38%), Gaps = 62/234 (26%)
Query: 117 VRYYIYELLKALDYCHSQGIMHRDVKPHNV------------------MIDHEQRKLRLI 158
+ + + ++L ALDY HS+G +HR VK ++ MI H +R+ +
Sbjct: 103 IAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVH 162
Query: 159 DWGLAEFYHPGKEYNVRVASRYFKGPELL-VDLQDYDYSLDLWSLG---CMFAGMIFRKE 214
D+ N+ S PE+L +LQ Y+ D++S+G C A
Sbjct: 163 DFPK------SSVKNLPWLS-----PEVLQQNLQGYNEKSDIYSVGITACELANGH---V 208
Query: 215 PFFYGHDNYDQLVKIAKVLGT-----------DELNAYLNKYHIELDPHLAALVGRHSRK 263
PF D + + KV GT ++ P+ V +
Sbjct: 209 PFK---DMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTR 265
Query: 264 PWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESS 317
+S E+ H F++ L+ D + RP+A + + H +F + +S
Sbjct: 266 TFS-----EHFH-------QFVELCLQRDPESRPSASQLLNHSFFKQCKRRNTS 307
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 3e-05
Identities = 50/227 (22%), Positives = 95/227 (41%), Gaps = 35/227 (15%)
Query: 29 VGRGKYSEVFEGV------HCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGPNI 78
+G G + EV+EG + + +K L+ +KK+ +E ++ N PNI
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNI 61
Query: 79 VKLLDIVRDQQSKTPSLIFEHVNNTDF----------KVLYPTLSDYDVRYYIYELLKAL 128
VKLL + + + +I E + D + P L+ ++ ++ K
Sbjct: 62 VKLLGVCLLNEPQ--YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGC 119
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQ----RKLRLIDWGLAEFYHPGKEYNVR----VASRY 180
Y +HRD+ N ++ + R +++ D+GLA + Y + R+
Sbjct: 120 VYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179
Query: 181 FKGPELLVDLQDYDYSLDLWSLGC-MFAGMIFRKEPFFYGHDNYDQL 226
PE L+D + S D+WS G M+ + ++P + +N + L
Sbjct: 180 M-APESLLDGKFTTQS-DVWSFGVLMWEILTLGQQP-YPALNNQEVL 223
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 45/212 (21%), Positives = 83/212 (39%), Gaps = 35/212 (16%)
Query: 28 KVGRGKYSEVFEGVHCTDNEKCI---IKILKPVKKKKIK----REIKILQNLCGGPNIVK 80
K+G G + V G T K I +K LK K I +E I+ +L N+++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLIR 60
Query: 81 LLDIVRDQQSKTPSLIFE-----------HVNNTDFKVLYPTLSDYDVRYYIYELLKALD 129
L +V ++ E + L TL DY V ++ +
Sbjct: 61 LYGVVLTHPLM---MVTELAPLGSLLDRLRKDALGH-FLISTLCDYAV-----QIANGMR 111
Query: 130 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK----GPE 185
Y S+ +HRD+ N+++ K+++ D+GL +++ V PE
Sbjct: 112 YLESKRFIHRDLAARNILL-ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE 170
Query: 186 LLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPF 216
L + ++ D+W G ++ + +EP+
Sbjct: 171 SLRTRT-FSHASDVWMFGVTLWEMFTYGEEPW 201
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 3e-05
Identities = 48/226 (21%), Positives = 103/226 (45%), Gaps = 30/226 (13%)
Query: 27 RKVGRGKYSEVFEGVHCTDNEK---CIIKILKPVKK----KKIKREIKILQNLCGGPNIV 79
R +G+G + V+ G + + C +K L + ++ +E I+++ PN++
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-SHPNVL 59
Query: 80 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCHS 133
LL I + +P ++ ++ + D + PT+ D + + ++ K ++Y S
Sbjct: 60 SLLGICLPSEG-SPLVVLPYMKHGDLRNFIRSETHNPTVKD--LIGFGLQVAKGMEYLAS 116
Query: 134 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPGKEYNVRVASRYFKGPELL 187
+ +HRD+ N M+D E +++ D+GLA E+Y ++ ++ L
Sbjct: 117 KKFVHRDLAARNCMLD-ESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMA----L 171
Query: 188 VDLQDYDYSL--DLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 231
LQ ++ D+WS G + ++ R P + D++D V + +
Sbjct: 172 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ 217
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-05
Identities = 18/44 (40%), Positives = 28/44 (63%), Gaps = 1/44 (2%)
Query: 123 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 166
++L L+Y H GI H D+KP N+M+D R +ID+G+A +
Sbjct: 134 DMLTTLEYIHEHGISHGDIKPENIMVDGNNRGY-IIDYGIASHF 176
|
Length = 294 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.6 bits (103), Expect = 5e-05
Identities = 50/192 (26%), Positives = 84/192 (43%), Gaps = 25/192 (13%)
Query: 27 RKVGRGKYSEVFEGVHCTDNE---KCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLD 83
K+G+G + +V++GV + E K L P K+K +E +IL+ PNIVKL+
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLIG 59
Query: 84 IVRDQQSKTPSLI-FEHVNNTDFKVLYPTLSDYDVRYYIYELLK-------ALDYCHSQG 135
+ +Q P I E V + R + +LL+ ++Y S+
Sbjct: 60 VCVQKQ---PIYIVMELVPGGSLLTFLRKKKN---RLTVKKLLQMSLDAAAGMEYLESKN 113
Query: 136 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY----FKGPELLVDLQ 191
+HRD+ N ++ E L++ D+G++ G Y V + + PE L +
Sbjct: 114 CIHRDLAARNCLVG-ENNVLKISDFGMSREEEGG-IYTVSDGLKQIPIKWTAPEAL-NYG 170
Query: 192 DYDYSLDLWSLG 203
Y D+WS G
Sbjct: 171 RYTSESDVWSYG 182
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (104), Expect = 5e-05
Identities = 51/216 (23%), Positives = 101/216 (46%), Gaps = 36/216 (16%)
Query: 24 EVVRKVGRGKYSEVFEGVHCTDNEK-CI---IKILK----PVKKKKIKREIKILQNLCGG 75
E ++ +G G + V++GV + EK I IK+L+ P K+I E ++ +
Sbjct: 10 EKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMAS-VDH 68
Query: 76 PNIVKLLDIVRDQQSKTPSLI---------FEHV-NNTDFKVLYPTLSDYDVRYYIYELL 125
P++V+LL I S LI ++V N+ D + + + ++
Sbjct: 69 PHVVRLLGIC---LSSQVQLITQLMPLGCLLDYVRNHKD------NIGSQYLLNWCVQIA 119
Query: 126 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNV---RVASRYF 181
K + Y + ++HRD+ NV++ + +++ D+GLA+ KEY+ +V ++
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLV-KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178
Query: 182 KGPELLVDLQDYDYSLDLWSLGC-MFAGMIFRKEPF 216
E ++ + Y + D+WS G ++ M F +P+
Sbjct: 179 -ALESIL-HRIYTHKSDVWSYGVTVWELMTFGAKPY 212
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 6e-05
Identities = 49/209 (23%), Positives = 94/209 (44%), Gaps = 21/209 (10%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDN---------EKCIIKILKPVKKKKIKREIKILQN 71
+D+ +R +G G + V + ++ EK KI+K + + E KIL N
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKS--KIIKQKQVDHVFSERKIL-N 86
Query: 72 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY--DVR-YYIYELLKAL 128
P V L +D+ L+ E V +F + DV +Y +++
Sbjct: 87 YINHPFCVNLYGSFKDESYLY--LVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIF 144
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 188
+Y S I++RD+KP N+++D + +++ D+G A+ + Y + Y PE+L+
Sbjct: 145 EYLQSLNIVYRDLKPENLLLDKDGF-IKMTDFGFAKVVDT-RTYTLCGTPEYI-APEILL 201
Query: 189 DLQDYDYSLDLWSLGCMFAGMIFRKEPFF 217
++ + + D W+LG ++ PF+
Sbjct: 202 NV-GHGKAADWWTLGIFIYEILVGCPPFY 229
|
Length = 340 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 8e-05
Identities = 42/220 (19%), Positives = 87/220 (39%), Gaps = 42/220 (19%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGV--HCTDNE---KCIIKILKPV----KKKKIKR 64
W + R + ++R++G+G + V+EG+ E + IK + ++ +
Sbjct: 1 WELPR--EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLN 58
Query: 65 EIKILQNL-CGGPNIVKLLDIVRDQQSKTPSLIF--------------EHVNNTDFKVLY 109
E +++ C ++V+LL +V Q P+L+ +
Sbjct: 59 EASVMKEFNC--HHVVRLLGVVSTGQ---PTLVVMELMAKGDLKSYLRSRRPEAENNPGL 113
Query: 110 PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------ 163
+ E+ + Y ++ +HRD+ N M+ E +++ D+G+
Sbjct: 114 GPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV-AEDLTVKIGDFGMTRDIYET 172
Query: 164 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLG 203
++Y G + + V R+ PE L D + D+WS G
Sbjct: 173 DYYRKGGKGLLPV--RWM-APESLKD-GVFTTKSDVWSFG 208
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 1e-04
Identities = 18/83 (21%), Positives = 40/83 (48%), Gaps = 9/83 (10%)
Query: 84 IVRDQQSKTPSLIFEHVNNTDFK-VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVK 142
++ D + +++ E++ D K VL + ++ + + H GI+H D+
Sbjct: 402 VIYDVDPEEKTIVMEYIGGKDLKDVLEGNPE------LVRKVGEIVAKLHKAGIVHGDLT 455
Query: 143 PHNVMIDHEQRKLRLIDWGLAEF 165
N ++ + +L LID+GL ++
Sbjct: 456 TSNFIVRDD--RLYLIDFGLGKY 476
|
Length = 535 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 29/99 (29%), Positives = 51/99 (51%), Gaps = 7/99 (7%)
Query: 112 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP--- 168
LS D+ Y++ + ++Y S+ +HRD+ NV++ E +++ D+GLA H
Sbjct: 137 LSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLARDIHHIDY 195
Query: 169 -GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMF 206
K N R+ ++ PE L D + Y + D+WS G +
Sbjct: 196 YKKTTNGRLPVKWM-APEALFD-RIYTHQSDVWSFGVLL 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 26/88 (29%), Positives = 47/88 (53%), Gaps = 7/88 (7%)
Query: 122 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP----GKEYNVRVA 177
Y++ + ++Y SQ +HRD+ NV++ E +++ D+GLA + K N R+
Sbjct: 144 YQVARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLARDVNNIDYYKKTTNGRLP 202
Query: 178 SRYFKGPELLVDLQDYDYSLDLWSLGCM 205
++ PE L D + Y + D+WS G +
Sbjct: 203 VKWM-APEALFD-RVYTHQSDVWSFGVL 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 29/100 (29%), Positives = 51/100 (51%), Gaps = 7/100 (7%)
Query: 111 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-- 168
L+ D+ Y++ + ++Y SQ +HRD+ NV++ E +++ D+GLA H
Sbjct: 130 QLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVT-EDNVMKIADFGLARDVHNID 188
Query: 169 --GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMF 206
K N R+ ++ PE L D + Y + D+WS G +
Sbjct: 189 YYKKTTNGRLPVKWM-APEALFD-RVYTHQSDVWSFGVLL 226
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 2e-04
Identities = 43/194 (22%), Positives = 83/194 (42%), Gaps = 26/194 (13%)
Query: 27 RKVGRGKYSEVFEGVHCTDNEK---CIIKILKPVK----KKKIKREIKILQNLCGGPNIV 79
+++G G + V +GV+ + K +K LK KK+ RE ++ L P IV
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIV 59
Query: 80 KLLDIVRDQQSKTPS--LIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 134
+L+ + K L+ E + + D++ +++ + Y S+
Sbjct: 60 RLIGV-----CKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESK 114
Query: 135 GIMHRDVKPHNVMI-DHEQRKLRLIDWGLAEFYHPGKE-YNVRVASRY---FKGPELLVD 189
+HRD+ NV++ + Q K+ D+G++ G + Y A R+ + PE ++
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKIS--DFGMSRALGAGSDYYRATTAGRWPLKWYAPE-CIN 171
Query: 190 LQDYDYSLDLWSLG 203
+ D+WS G
Sbjct: 172 YGKFSSKSDVWSYG 185
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 2e-04
Identities = 29/129 (22%), Positives = 53/129 (41%), Gaps = 10/129 (7%)
Query: 44 TDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 102
T +E ++KI K +RE+ ILQ L V + + + L+ E +
Sbjct: 19 TKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKV-LASGESDGWSYLLMEWIEG 77
Query: 103 TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHEQRKLRLID 159
+S+ + +L + L H + H D+ P N+++D + + L +ID
Sbjct: 78 ET----LDEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVD-DGKILGIID 132
Query: 160 WGLAEFYHP 168
W A + P
Sbjct: 133 WEYAGYGPP 141
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 48/222 (21%), Positives = 96/222 (43%), Gaps = 37/222 (16%)
Query: 13 VWFINREQDDYEVVRKVGRGKYSEVFE----GVHCTDNE-KCIIKILKPVKKKK----IK 63
W + R++ + + +G G + +V + G+ + +K+LK +K +
Sbjct: 6 EWELPRDR--LTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLV 63
Query: 64 REIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE---HVNNTDF--------------- 105
E+++++ + NI+ LL + Q ++ E H N DF
Sbjct: 64 SEMEMMKMIGKHKNIINLLGVC--TQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDD 121
Query: 106 -KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 164
+ TL+ D+ + Y++ + +++ S+ +HRD+ NV++ E +++ D+GLA
Sbjct: 122 PRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT-EDHVMKIADFGLAR 180
Query: 165 FYHPGKEYNVRVASRY---FKGPELLVDLQDYDYSLDLWSLG 203
H Y R + PE L D + Y + D+WS G
Sbjct: 181 DIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFG 221
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|216618 pfam01636, APH, Phosphotransferase enzyme family | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 2e-04
Identities = 13/48 (27%), Positives = 22/48 (45%)
Query: 121 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168
+ L AL ++H D+ P N+++D R +ID+ A P
Sbjct: 152 LLAALLALLPALPLVLVHGDLHPGNLLVDPGGRVTGVIDFEDAGLGDP 199
|
This family consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include: aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation. This family also includes homoserine kinase. This family is related to fructosamine kinase pfam03881. Length = 238 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 3e-04
Identities = 69/313 (22%), Positives = 118/313 (37%), Gaps = 59/313 (18%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK----ILKPVKKKKIKREIKILQNLCGGP 76
D+ EV+ ++G+G Y V++ +H +K L K +I E+ IL P
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHK-AVSP 59
Query: 77 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD------VRYYIYELLKALDY 130
IV + E+++ LY + +R Y ++K L +
Sbjct: 60 YIVDFYGAF--FIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 131 CHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELL- 187
+ I+HRDVKP NV+++ +++L D+G++ + N+ S + PE +
Sbjct: 118 LKEEHNIIHRDVKPTNVLVN-GNGQVKLCDFGVSGNLVASLAKTNIGCQS--YMAPERIK 174
Query: 188 ----VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243
Y D+WSLG M + P Y + Y +
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGRYP--YPPETYANIFA--------------- 217
Query: 244 KYHIELDPHLAALV-GRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 302
L+A+V G P S + +A DF+ K L RPT +
Sbjct: 218 --------QLSAIVDGDPPTLP-SGY---------SDDAQDFVAKCLNKIPNRRPTYAQL 259
Query: 303 MAHPYFFPIRNAE 315
+ HP+ +NA+
Sbjct: 260 LEHPWLVKYKNAD 272
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 3e-04
Identities = 51/232 (21%), Positives = 104/232 (44%), Gaps = 28/232 (12%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQN 71
W I RE ++++K+G G++ EV+ G N K +K LKP + + E +I++
Sbjct: 1 WEIPRES--LQLIKKLGNGQFGEVWMGT-WNGNTKVAVKTLKPGTMSPESFLEEAQIMKK 57
Query: 72 LCGGPNIVKLLDIVRDQ--------QSKTPSLIFEHVNNTDFKVL-YPTLSDYDVRYYIY 122
L +V+L +V ++ SK L F + + + + L P L D
Sbjct: 58 L-RHDKLVQLYAVVSEEPIYIVTEYMSKGSLLDF--LKDGEGRALKLPNLVDMAA----- 109
Query: 123 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY-- 180
++ + Y +HRD++ N+++ + ++ D+GLA EY R +++
Sbjct: 110 QVAAGMAYIERMNYIHRDLRSANILVG-DGLVCKIADFGLARLIE-DNEYTARQGAKFPI 167
Query: 181 -FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 231
+ PE + + D+WS G + ++ + + G +N + L ++ +
Sbjct: 168 KWTAPEAAL-YGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVER 218
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 3e-04
Identities = 52/225 (23%), Positives = 99/225 (44%), Gaps = 27/225 (12%)
Query: 27 RKVGRGKYSEVFEGVHCTDNE--KCIIKILKPVKKKKIKREIKILQNLC----GGPNIVK 80
+ +G G++ V EG D+ K +K +K + + E + + +C PN+++
Sbjct: 5 KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64
Query: 81 LLDI----VRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRY-------YIYELLKA 127
L+ + V + +P +I + + D +LY L D ++ ++
Sbjct: 65 LIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASG 124
Query: 128 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV-RVASRYFK--GP 184
++Y S+ +HRD+ N M++ E + + D+GL++ + G Y R+A K
Sbjct: 125 MEYLSSKSFIHRDLAARNCMLN-ENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 185 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN---YDQL 226
E L D + Y D+WS G + R + + G +N YD L
Sbjct: 184 ESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYL 227
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 4e-04
Identities = 48/228 (21%), Positives = 90/228 (39%), Gaps = 46/228 (20%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--REIKILQN 71
W IN + + ++ +G+G++ +V G + +K +K LK E ++
Sbjct: 1 WAINSK--ELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTT 56
Query: 72 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY------------DVRY 119
L PN+V+LL +V ++ E++ +L DY
Sbjct: 57 L-RHPNLVQLLGVVLQGNPLY--IVTEYMAKG-------SLVDYLRSRGRAVITLAQQLG 106
Query: 120 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR 179
+ ++ + ++Y + +HRD+ NV++ E ++ D+GLA KE + S
Sbjct: 107 FALDVCEGMEYLEEKNFVHRDLAARNVLVS-EDLVAKVSDFGLA------KEASQGQDSG 159
Query: 180 YF----KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY 223
PE L + + D+WS G I E + +G Y
Sbjct: 160 KLPVKWTAPEAL-REKKFSTKSDVWSFG------ILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 5e-04
Identities = 40/158 (25%), Positives = 79/158 (50%), Gaps = 21/158 (13%)
Query: 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCG 74
R ++++ + RK+G G + EV+EG+ + + IKILK +K++ ++E++ L+ L
Sbjct: 3 RPREEFTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQDFQKEVQALKRL-R 60
Query: 75 GPNIVKLLD---------IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELL 125
+++ L I+ + K L F + + + +VL P S D+ + E
Sbjct: 61 HKHLISLFAVCSVGEPVYIITELMEKGSLLAF--LRSPEGQVL-PVASLIDMACQVAE-- 115
Query: 126 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163
+ Y Q +HRD+ N+++ E ++ D+GLA
Sbjct: 116 -GMAYLEEQNSIHRDLAARNILVG-EDLVCKVADFGLA 151
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 5e-04
Identities = 44/180 (24%), Positives = 83/180 (46%), Gaps = 27/180 (15%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQN 71
W I RE ++ RK+G G++ EV+ G K +K LKP + + +E +I++
Sbjct: 1 WEIPRES--LKLERKLGAGQFGEVWMGTW-NGTTKVAVKTLKPGTMSPEAFLQEAQIMKK 57
Query: 72 LCGGPNIVKLLDIVRDQQSKTPSLIF-EHVNN---TDF-------KVLYPTLSDYDVRYY 120
L +V+L + +++ P I E+++ DF K+ P L D
Sbjct: 58 L-RHDKLVQLYAVCSEEE---PIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAA--- 110
Query: 121 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 180
++ + + Y S+ +HRD+ N+++ E ++ D+GLA EY R +++
Sbjct: 111 --QIAEGMAYLESRNYIHRDLAARNILVG-ENLVCKIADFGLARLIED-DEYTAREGAKF 166
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 40.6 bits (95), Expect = 5e-04
Identities = 47/213 (22%), Positives = 96/213 (45%), Gaps = 32/213 (15%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQN 71
W + RE ++V+K+G G++ EV+ G + + K IK LK + + E +++
Sbjct: 1 WEVPRE--TLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQ 57
Query: 72 LCGGPNIVKLLDIVRDQQSKTPSLIF-EHVNN---TDF-------KVLYPTLSDYDVRYY 120
L P +V+L +V ++ P I E++ N DF K+ L D
Sbjct: 58 L-QHPRLVRLYAVV----TQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAA--- 109
Query: 121 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY 180
++ + + + + +HRD++ N+++ ++ D+GLA EY R +++
Sbjct: 110 --QIAEGMAFIERKNYIHRDLRAANILVSETL-CCKIADFGLARLIED-NEYTAREGAKF 165
Query: 181 ---FKGPELLVDLQDYDYSLDLWSLGCMFAGMI 210
+ PE ++ + D+WS G + ++
Sbjct: 166 PIKWTAPE-AINYGTFTIKSDVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 6e-04
Identities = 31/129 (24%), Positives = 62/129 (48%), Gaps = 12/129 (9%)
Query: 81 LLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRD 140
L + +R ++ P F+ + ++ + D+ Y++ + ++Y S+ +HRD
Sbjct: 105 LREFLRARRPPGPDYTFDITKVPEEQLSFK-----DLVSCAYQVARGMEYLESRRCIHRD 159
Query: 141 VKPHNVMIDHEQRKLRLIDWGLAEFYHP----GKEYNVRVASRYFKGPELLVDLQDYDYS 196
+ NV++ E +++ D+GLA H K N R+ ++ PE L D + Y +
Sbjct: 160 LAARNVLVT-EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWM-APEALFD-RVYTHQ 216
Query: 197 LDLWSLGCM 205
D+WS G +
Sbjct: 217 SDVWSFGIL 225
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 6e-04
Identities = 21/81 (25%), Positives = 42/81 (51%), Gaps = 11/81 (13%)
Query: 76 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY------DVRYYIYELLKALD 129
PN+V L + + S +F + + + L+ +S + V+ + E++ ALD
Sbjct: 45 PNMVCLHKYIVSEDS-----VFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALD 99
Query: 130 YCHSQGIMHRDVKPHNVMIDH 150
H +GI+ RD+ P+N+++D
Sbjct: 100 ALHREGIVCRDLNPNNILLDD 120
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 7e-04
Identities = 46/201 (22%), Positives = 89/201 (44%), Gaps = 21/201 (10%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGV-----HCTDNEKCIIKILKPV----KKKKIKREIKILQ 70
+++ + +G G + +V E K +K+LKP +++ + E+KI+
Sbjct: 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMS 93
Query: 71 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF-----KVLYPTLSDYDVRYYIYELL 125
+L NIV LL +I E+ D + L+ D+ + Y++
Sbjct: 94 HLGNHENIVNLLGAC--TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151
Query: 126 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FK 182
K + + S+ +HRD+ NV++ H + +++ D+GLA Y V+ +R +
Sbjct: 152 KGMAFLASKNCIHRDLAARNVLLTH-GKIVKICDFGLARDIMNDSNYVVKGNARLPVKWM 210
Query: 183 GPELLVDLQDYDYSLDLWSLG 203
PE + + Y + D+WS G
Sbjct: 211 APESIFNCV-YTFESDVWSYG 230
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 8e-04
Identities = 49/204 (24%), Positives = 91/204 (44%), Gaps = 27/204 (13%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQN 71
W I+R +++RK+G G++ EV+EG+ + +K LKP + K E +I++
Sbjct: 1 WEIDRTS--IQLLRKLGAGQFGEVWEGL-WNNTTPVAVKTLKPGTMDPKDFLAEAQIMKK 57
Query: 72 LCGGPNIVKLLDIVRDQQS--------KTPSLIFEHVNNTDFKVL-YPTLSDYDVRYYIY 122
L P +++L + ++ K SL+ E++ + L P L D
Sbjct: 58 L-RHPKLIQLYAVCTLEEPIYIVTELMKYGSLL-EYLQGGAGRALKLPQLIDMAA----- 110
Query: 123 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY-- 180
++ + Y +Q +HRD+ NV++ E ++ D+GLA Y R +++
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVG-ENNICKVADFGLARVIKE-DIYEAREGAKFPI 168
Query: 181 -FKGPELLVDLQDYDYSLDLWSLG 203
+ PE + D+WS G
Sbjct: 169 KWTAPE-AALYNRFSIKSDVWSFG 191
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 43/171 (25%), Positives = 81/171 (47%), Gaps = 28/171 (16%)
Query: 51 IKILKPVKKKKI---KREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKV 107
+K L+ + + +REI+IL++L NIVK + + L+ E++
Sbjct: 38 VKKLQHSTAEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRRNLRLVMEYLP------ 90
Query: 108 LYPTLSDYDVRY-----------YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLR 156
Y +L DY ++ Y ++ K ++Y S+ +HRD+ N++++ E R ++
Sbjct: 91 -YGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR-VK 148
Query: 157 LIDWGLAEFYHPGKE-YNVRVASR---YFKGPELLVDLQDYDYSLDLWSLG 203
+ D+GL + KE Y VR ++ PE L + + + D+WS G
Sbjct: 149 IGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFG 198
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.001
Identities = 40/199 (20%), Positives = 92/199 (46%), Gaps = 20/199 (10%)
Query: 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGP 76
E+ D + K+G G+Y EV+EGV + +K LK ++ ++ +E +++ + P
Sbjct: 4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHP 62
Query: 77 NIVKLLDIVRDQ-------QSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALD 129
N+V+LL + + + T + +++ + + + + + Y ++ A++
Sbjct: 63 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV----LLYMATQISSAME 118
Query: 130 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FKGPEL 186
Y + +HRD+ N ++ E +++ D+GL+ G Y +++ + PE
Sbjct: 119 YLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWTAPES 176
Query: 187 LVDLQDYDYSLDLWSLGCM 205
L + D+W+ G +
Sbjct: 177 LA-YNKFSIKSDVWAFGVL 194
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.001
Identities = 48/233 (20%), Positives = 92/233 (39%), Gaps = 32/233 (13%)
Query: 105 FKVLYPT-LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW-GL 162
K +P +S+ + ++ L+ L+Y H G +HR++K +++I + L+ GL
Sbjct: 90 LKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG----LVSLSGL 145
Query: 163 AEFY---HPGKEYNVRVASRYFK-------GPELL-VDLQDYDYSLDLWSLGCMFAGMIF 211
+ Y G++ V F PELL DL Y+ D++S+G +
Sbjct: 146 SHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELAT 205
Query: 212 RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVG-----RHSRKPWS 266
+ PF D + + K+ G + + E + G S
Sbjct: 206 GRVPF---QDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAG 262
Query: 267 KFITVENQHLAVPEAVDFLDKL-------LRYDHQERPTAKEAMAHPYFFPIR 312
T+ ++ L P + F L+ D ++RP+A ++H +F ++
Sbjct: 263 MTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVK 315
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.003
Identities = 40/175 (22%), Positives = 77/175 (44%), Gaps = 32/175 (18%)
Query: 28 KVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGPNIVKLLD 83
KV +G+ + E + T IK LK P +++ ++E +++ +L PNIV LL
Sbjct: 20 KVYKGELTGPNERLSAT---SVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPNIVCLLG 75
Query: 84 IVRDQQSKTPSLIFEHVNNTD---FKVLYPTLSDY----------------DVRYYIYEL 124
+ + + ++FE++ + D F V SD D + ++
Sbjct: 76 VC--TKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQI 133
Query: 125 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR 179
++Y S +HRD+ N ++ E +++ D+GL+ + Y RV S+
Sbjct: 134 AAGMEYLSSHHFVHRDLAARNCLV-GEGLTVKISDFGLSRDIYSADYY--RVQSK 185
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.004
Identities = 43/209 (20%), Positives = 89/209 (42%), Gaps = 24/209 (11%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQN 71
W I RE E +K+G G++ EV+ + + K +K +KP + + E +++
Sbjct: 1 WEIPRESLKLE--KKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSVEAFLAEANVMKT 57
Query: 72 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF-------KVLYPTLSDYDVRYYIYEL 124
L +VKL +V + + + DF K P L D+ ++
Sbjct: 58 L-QHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA-----QI 111
Query: 125 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---F 181
+ + + + +HRD++ N+++ ++ D+GLA EY R +++ +
Sbjct: 112 AEGMAFIEQRNYIHRDLRAANILVS-ASLVCKIADFGLARVIE-DNEYTAREGAKFPIKW 169
Query: 182 KGPELLVDLQDYDYSLDLWSLGCMFAGMI 210
PE ++ + D+WS G + ++
Sbjct: 170 TAPE-AINFGSFTIKSDVWSFGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 38.1 bits (89), Expect = 0.004
Identities = 27/87 (31%), Positives = 42/87 (48%), Gaps = 8/87 (9%)
Query: 122 YELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRK--LRLIDWGLAEFYHPGKEYNVRVAS 178
+KAL+Y + I+HRDVKP N+++D R ++L D+G++
Sbjct: 114 VATVKALNYLKEELKIIHRDVKPSNILLD---RNGNIKLCDFGISGQLVDSIAKTRDAGC 170
Query: 179 RYFKGPELLV--DLQDYDYSLDLWSLG 203
R + PE + YD D+WSLG
Sbjct: 171 RPYMAPERIDPSARDGYDVRSDVWSLG 197
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 321 | |||
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.98 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.98 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.89 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.86 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.86 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.84 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.82 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.81 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.79 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.76 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.71 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.7 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.69 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.66 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.61 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.51 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.51 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.49 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.48 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.46 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.41 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.34 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.33 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.32 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.31 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.29 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.29 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.27 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.19 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.19 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.06 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.03 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.96 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.83 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.81 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.75 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.59 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.54 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.53 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.49 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.45 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.4 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.35 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.33 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.28 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.26 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.25 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.19 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.92 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.88 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.87 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.8 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.75 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.64 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.6 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.58 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.53 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.5 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.5 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.32 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.22 | |
| PLN02236 | 344 | choline kinase | 97.2 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.16 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.1 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 96.98 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 96.96 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.94 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.7 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.53 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.39 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.3 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.24 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 95.98 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.91 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.81 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.72 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.54 | |
| PF03109 | 119 | ABC1: ABC1 family; InterPro: IPR004147 This entry | 94.97 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 94.85 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 94.59 |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-59 Score=362.87 Aligned_cols=303 Identities=85% Similarity=1.372 Sum_probs=293.4
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEE
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 98 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 98 (321)
.+++|++.+++|+|.++.||.|....+.++++||++++...+.+.+|+.+|+.|.++|||++++++..++....+.+++|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE 115 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE 115 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence 57899999999999999999999999999999999999999999999999999988999999999999999999999999
Q ss_pred eecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCccccccCC
Q 020826 99 HVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 178 (321)
Q Consensus 99 ~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~~~~~~~ 178 (321)
+.+..++..+.+.++...++.++.+++.||.|+|++||.|||+||.|++++.....++|+|||++..+.++..++.++.+
T Consensus 116 ~v~n~Dfk~ly~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVAS 195 (338)
T KOG0668|consen 116 YVNNTDFKQLYPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVAS 195 (338)
T ss_pred hhccccHHHHhhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeeh
Confidence 99999999999999999999999999999999999999999999999999988879999999999999999999999999
Q ss_pred ccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhc
Q 020826 179 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVG 258 (321)
Q Consensus 179 ~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (321)
..|-.||.+.....++.+.|+|||||++..|+..+.||+.+.++.+++..+.+.+|...+..+........++.+..+.+
T Consensus 196 RyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~ 275 (338)
T KOG0668|consen 196 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILG 275 (338)
T ss_pred hhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhh
Confidence 99999999998888999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCccccccCC
Q 020826 259 RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSRSRS 321 (321)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~~~~~~~ 321 (321)
...+++|..+...++....+++..+|+.++|.+|.++|+||.|++.||||..+.++..+.+||
T Consensus 276 ~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~~~~~~~ 338 (338)
T KOG0668|consen 276 RHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAESSRMRS 338 (338)
T ss_pred ccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHhhcccCC
Confidence 999999999999999999999999999999999999999999999999999998888777765
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-58 Score=381.59 Aligned_cols=265 Identities=27% Similarity=0.433 Sum_probs=216.0
Q ss_pred eeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----------hHHHHHHHHHHHhhcCCCCeeeeeee
Q 020826 15 FINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----------KKKIKREIKILQNLCGGPNIVKLLDI 84 (321)
Q Consensus 15 ~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----------~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (321)
......+.|.+.+.||+|+||.|-+|..+++++.||||++++.. .....+|+++|++| +||+||+++++
T Consensus 166 ~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL-~HP~IV~~~d~ 244 (475)
T KOG0615|consen 166 PPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKL-SHPNIVRIKDF 244 (475)
T ss_pred ccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhc-CCCCEEEEeee
Confidence 34457889999999999999999999999999999999997432 12357999999999 99999999999
Q ss_pred eeccCCCCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCC--CCeEEEee
Q 020826 85 VRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLID 159 (321)
Q Consensus 85 ~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~--~~~v~l~d 159 (321)
++. ..+.|+|+||+.||.|.+.+ ..+.+...+.++.|++.|+.|||++||+||||||+|||++.+ .-.+||+|
T Consensus 245 f~~--~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItD 322 (475)
T KOG0615|consen 245 FEV--PDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITD 322 (475)
T ss_pred eec--CCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecc
Confidence 965 44557999999999998777 458999999999999999999999999999999999999865 22789999
Q ss_pred ccceeecCCCCccccccCCccccccccccCCC--CCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChh
Q 020826 160 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ--DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 237 (321)
Q Consensus 160 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (321)
||+++......-..+.+||+.|.|||++.+.+ .+..+.|+|||||++|-+++|..||.....+...-+++.+.
T Consensus 323 FGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G----- 397 (475)
T KOG0615|consen 323 FGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKG----- 397 (475)
T ss_pred cchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcC-----
Confidence 99999988777778899999999999997632 23347899999999999999999995433332222222110
Q ss_pred hhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 238 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
.+...+ ..-..+|++.++||.+||..||++|||++|+|+||||+.....+
T Consensus 398 --------~y~f~p--------------------~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~s 447 (475)
T KOG0615|consen 398 --------RYAFGP--------------------LQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCLS 447 (475)
T ss_pred --------cccccC--------------------hhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccccc
Confidence 000000 00113678999999999999999999999999999999876544
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-57 Score=379.81 Aligned_cols=283 Identities=30% Similarity=0.561 Sum_probs=236.4
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
..++|.++++||.|+||.||+|+.+.+++.||||.++... .-.-.+|+..|++|..||||+++.+++.+.+. .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~-~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDR-ILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCc-eEe
Confidence 4679999999999999999999999999999999886432 22356899999999559999999999987654 788
Q ss_pred EEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc
Q 020826 95 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 171 (321)
Q Consensus 95 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~ 171 (321)
+|||+|..+...... +.|++..++.|+.||+.||+|+|++|+.|||+||+|||+.... .+||+|||+|+.......
T Consensus 87 fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~-~iKiaDFGLARev~SkpP 165 (538)
T KOG0661|consen 87 FVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGND-VIKIADFGLAREVRSKPP 165 (538)
T ss_pred eeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccc-eeEecccccccccccCCC
Confidence 999999977543333 4599999999999999999999999999999999999999666 899999999998888888
Q ss_pred cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCCh
Q 020826 172 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (321)
++..+.|.+|+|||+++....|+.+.|+|++||+++|+.+-+ |.|++.++.+++..|++.+|.+....+......
T Consensus 166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLr-PLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~L---- 240 (538)
T KOG0661|consen 166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLR-PLFPGASEIDQIYKICEVLGTPDKDSWPEGYNL---- 240 (538)
T ss_pred cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhc-ccCCCCcHHHHHHHHHHHhCCCccccchhHHHH----
Confidence 899999999999999988789999999999999999999988 566999999999999999999987766554222
Q ss_pred hhHhhhccc-CCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 252 HLAALVGRH-SRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 252 ~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
...+.-. ....... +....+ ..++++.++|.+||.+||.+||||.|+|+||||+--.
T Consensus 241 --a~~mnf~~P~~~~~~-l~~L~p-~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 241 --ASAMNFRFPQVKPSP-LKDLLP-NASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred --HHHhccCCCcCCCCC-hHHhCc-ccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 1111111 1111111 111122 2778999999999999999999999999999999643
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-56 Score=368.54 Aligned_cols=253 Identities=23% Similarity=0.408 Sum_probs=216.6
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEec----ccchHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~----~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
++.+.++.||+|..|+||+++++.+++.+|+|++. ....+++.+|+++++.. +||+||.+|+.|.++.. .+.|+
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~-~spyIV~~ygaF~~~~~-~isI~ 156 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSC-QSPYIVGFYGAFYSNGE-EISIC 156 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhC-CCCCeeeEeEEEEeCCc-eEEee
Confidence 37888999999999999999999999999999994 34467889999999999 99999999999987665 56799
Q ss_pred EEeecCchhhhhcCC---CCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCcc
Q 020826 97 FEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 172 (321)
Q Consensus 97 ~e~~~~~~l~~~~~~---~~~~~~~~i~~qi~~~l~~lh~-~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~ 172 (321)
||||.+|+|+.++.. +++....+++.+|++||.|||. .+|+||||||.|+|++..| .|||+|||.+...... ..
T Consensus 157 mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG-eVKicDFGVS~~lvnS-~a 234 (364)
T KOG0581|consen 157 MEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG-EVKICDFGVSGILVNS-IA 234 (364)
T ss_pred hhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC-CEEeccccccHHhhhh-hc
Confidence 999999999998864 9999999999999999999995 8999999999999999988 8999999999877544 55
Q ss_pred ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCC----hHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 173 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN----YDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
.+..||..|||||.+.+ ..|+.++||||||++++|+.+|+.||.+.... .+.+..|+....+.
T Consensus 235 ~tfvGT~~YMsPERi~g-~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~------------ 301 (364)
T KOG0581|consen 235 NTFVGTSAYMSPERISG-ESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPR------------ 301 (364)
T ss_pred ccccccccccChhhhcC-CcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCC------------
Confidence 78899999999999998 79999999999999999999999999654221 22222222211100
Q ss_pred CChhhHhhhcccCCCCCcccccccccc-CCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQH-LAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
.+. .+|+++++|+..||+.||.+|||++|+++|||+++....
T Consensus 302 ------------------------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~ 344 (364)
T KOG0581|consen 302 ------------------------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDP 344 (364)
T ss_pred ------------------------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccc
Confidence 111 378999999999999999999999999999999976543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-56 Score=354.96 Aligned_cols=279 Identities=30% Similarity=0.542 Sum_probs=229.4
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
+.|+.+.++|+|+||+||+++++.||+.||||.+...+ ++-..+|+.+|++| +|+|+|.++++|... .-+.+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqL-kH~NLVnLiEVFrrk--rklhL 78 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQL-KHENLVNLIEVFRRK--RKLHL 78 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhc-ccchHHHHHHHHHhc--ceeEE
Confidence 57999999999999999999999999999999986432 35678999999999 999999999999654 44569
Q ss_pred EEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC-CCCc
Q 020826 96 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKE 171 (321)
Q Consensus 96 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~-~~~~ 171 (321)
|+|||...-|.++- ..++...++.++.|++.|+.|+|+++++||||||+||+++.+| .+||||||+|+... ++..
T Consensus 79 VFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~g-vvKLCDFGFAR~L~~pgd~ 157 (396)
T KOG0593|consen 79 VFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNG-VVKLCDFGFARTLSAPGDN 157 (396)
T ss_pred EeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCC-cEEeccchhhHhhcCCcch
Confidence 99999998776655 5699999999999999999999999999999999999999999 89999999998887 6777
Q ss_pred cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCCh
Q 020826 172 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (321)
++..+.|.+|+|||.+.+...|....|||++||++.||++|. |++++.++.+++..|.+.+|.-...-..-.. .++
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~-pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~---~N~ 233 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGE-PLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS---SNP 233 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCC-cCCCCcchHHHHHHHHHHHcccCHHHHHHhc---cCC
Confidence 888899999999999999889999999999999999999998 6669999999999999998864322111110 011
Q ss_pred hhHhhhcccCCCCCcccccc-ccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 252 HLAALVGRHSRKPWSKFITV-ENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
.+....-... ...+.+ ..-..++..+.+|+++||+.||.+|+|.+++|.||||.+.
T Consensus 234 ~F~Gv~lP~~----~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~ 290 (396)
T KOG0593|consen 234 FFHGVRLPEP----EHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF 290 (396)
T ss_pred ceeeeecCCC----CCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence 1111111111 111111 1112466789999999999999999999999999999764
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-54 Score=372.55 Aligned_cols=257 Identities=25% Similarity=0.472 Sum_probs=220.5
Q ss_pred EeeeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecc------cchHHHHHHHHHHHhhcCCCCeeeeeee
Q 020826 11 WCVWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDI 84 (321)
Q Consensus 11 ~~~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~------~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (321)
.+....+....+|...+.||+|||+++|.+++..+|+.||+|++.+ ..+..+.+|+++.+.| +|||||+++++
T Consensus 8 ip~~i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L-~HpnIV~f~~~ 86 (592)
T KOG0575|consen 8 IPEVIEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSL-KHPNIVQFYHF 86 (592)
T ss_pred CCCeeecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhc-CCCcEEeeeeE
Confidence 3455666666889999999999999999999999999999999864 3456789999999999 99999999999
Q ss_pred eeccCCCCcEEEEEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecc
Q 020826 85 VRDQQSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 161 (321)
Q Consensus 85 ~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg 161 (321)
|+|. .+.|+|.|.|..++|..+.+ .++|.++++++.||+.||.|||+.+|+|||||..|++++.+. +|||+|||
T Consensus 87 FEDs--~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~-~VKIgDFG 163 (592)
T KOG0575|consen 87 FEDS--NNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENM-NVKIGDFG 163 (592)
T ss_pred eecC--CceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcC-cEEecccc
Confidence 9665 55669999999999877774 599999999999999999999999999999999999999887 89999999
Q ss_pred ceeecCCC-CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhH
Q 020826 162 LAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 240 (321)
Q Consensus 162 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (321)
+|+..... ....+.+||+.|.|||++.. ...+..+||||+||++|-|+.|+.|| .+....+....+..
T Consensus 164 LAt~le~~~Erk~TlCGTPNYIAPEVl~k-~gHsfEvDiWSlGcvmYtLL~G~PPF-etk~vkety~~Ik~--------- 232 (592)
T KOG0575|consen 164 LATQLEYDGERKKTLCGTPNYIAPEVLNK-SGHSFEVDIWSLGCVMYTLLVGRPPF-ETKTVKETYNKIKL--------- 232 (592)
T ss_pred eeeeecCcccccceecCCCcccChhHhcc-CCCCCchhhhhhhhHHHhhhhCCCCc-ccchHHHHHHHHHh---------
Confidence 99988744 56678899999999999986 78899999999999999999999998 23333333333211
Q ss_pred HhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCccc
Q 020826 241 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 310 (321)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~ 310 (321)
.....+..+|.+..+||.++|+.||++|||++++|.|+||+.
T Consensus 233 ----------------------------~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 233 ----------------------------NEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred ----------------------------cCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence 011223357889999999999999999999999999999954
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-54 Score=339.15 Aligned_cols=280 Identities=34% Similarity=0.632 Sum_probs=232.2
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccch-----HHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-----KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
++|...+++|+|.||.||+|++..+|+.||||.++..+. ....+|+..|+.+ +|+||+.++++|.+ ...+.+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel-~h~nIi~LiD~F~~--~~~l~l 78 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQEL-KHPNIIELIDVFPH--KSNLSL 78 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHc-cCcchhhhhhhccC--CCceEE
Confidence 578999999999999999999999999999999975433 4578999999999 89999999999954 455669
Q ss_pred EEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC-C
Q 020826 96 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K 170 (321)
Q Consensus 96 v~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~-~ 170 (321)
|+|++..+ |...+ ..++...++.++.+++.|++|||++.|.||||||.|++++.+| .+||+|||+++.+.+. .
T Consensus 79 VfEfm~td-Le~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g-~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 79 VFEFMPTD-LEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDG-QLKIADFGLARFFGSPNR 156 (318)
T ss_pred EEEecccc-HHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCC-cEEeecccchhccCCCCc
Confidence 99999854 44444 3489999999999999999999999999999999999999999 8999999999887644 3
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
.....+.|.+|+|||.+.|...|+...|+||.||++.||+.|. ||+++.++.+|+..+...+|.+....|-.-......
T Consensus 157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~-P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY 235 (318)
T KOG0659|consen 157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRV-PFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY 235 (318)
T ss_pred ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccC-CCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence 4455689999999999999899999999999999999999776 888999999999999999999988777554332222
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
.... ..|...... .-...+++..+|+.+||.+||.+|+|+.|+|+|+||+....++
T Consensus 236 ---~~~~----~~P~~~~~~--lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt 291 (318)
T KOG0659|consen 236 ---VKIQ----QFPKPPLNN--LFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPT 291 (318)
T ss_pred ---HHHh----cCCCCcccc--ccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCC
Confidence 2221 111111111 1223567889999999999999999999999999999765543
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-54 Score=365.64 Aligned_cols=286 Identities=31% Similarity=0.590 Sum_probs=240.0
Q ss_pred eeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccC
Q 020826 15 FINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 89 (321)
Q Consensus 15 ~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (321)
+..+..+.|+.+++||+|+||.||+|++..+|+.||+|.++.+. .....+|+.+|++| +||||+++.++..+..
T Consensus 111 w~~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l-~HpNIikL~eivt~~~ 189 (560)
T KOG0600|consen 111 WGPRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRL-DHPNIIKLEEIVTSKL 189 (560)
T ss_pred ccccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhc-CCCcccceeeEEEecC
Confidence 34667789999999999999999999999999999999987543 35678999999999 9999999999998776
Q ss_pred CCCcEEEEEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeec
Q 020826 90 SKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 166 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~ 166 (321)
...+|+|+|||..+....... .|++.+++.++.|++.||+|+|.+|+.|||||..|||+|.+| .+||+|||+++.+
T Consensus 190 ~~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G-~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 190 SGSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNG-VLKIADFGLARFY 268 (560)
T ss_pred CceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCC-CEEeccccceeec
Confidence 678899999999776544443 599999999999999999999999999999999999999888 8999999999977
Q ss_pred CCCC--ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhh
Q 020826 167 HPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244 (321)
Q Consensus 167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (321)
.... .++..+-|.+|+|||+++|...|+++.|+||.||++.||++|+ |++++..+.+|+..|.+..|.+....|. .
T Consensus 269 ~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gk-PI~~G~tEveQl~kIfklcGSP~e~~W~-~ 346 (560)
T KOG0600|consen 269 TPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGK-PILQGRTEVEQLHKIFKLCGSPTEDYWP-V 346 (560)
T ss_pred cCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCC-CCcCCccHHHHHHHHHHHhCCCChhccc-c
Confidence 5443 4677889999999999999889999999999999999999998 5568999999999999999998877654 2
Q ss_pred hcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
..+.....+ ....+........ -..+++...+|+..||..||.+|.||.++|+|+||...
T Consensus 347 ~kLP~~~~~------kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~ 406 (560)
T KOG0600|consen 347 SKLPHATIF------KPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTE 406 (560)
T ss_pred ccCCccccc------CCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcCcccccC
Confidence 111111111 1112222222211 44688899999999999999999999999999999543
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-53 Score=345.33 Aligned_cols=295 Identities=28% Similarity=0.461 Sum_probs=243.8
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccch-----HHHHHHHHHHHhhcCCCCeeeeeeeeec
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-----KKIKREIKILQNLCGGPNIVKLLDIVRD 87 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (321)
....-+..++|+.+..|++|+||.||+|+++.+++.||+|.++.+.. -...+|+.+|.++ +|||||.+.++...
T Consensus 68 ~l~gCrsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~-~H~NIV~vkEVVvG 146 (419)
T KOG0663|consen 68 LLGGCRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKA-RHPNIVEVKEVVVG 146 (419)
T ss_pred cccCcccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhc-CCCCeeeeEEEEec
Confidence 35556678899999999999999999999999999999999986543 2367999999999 89999999999988
Q ss_pred cCCCCcEEEEEeecCc--hhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecccee
Q 020826 88 QQSKTPSLIFEHVNNT--DFKVLY-PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 164 (321)
Q Consensus 88 ~~~~~~~lv~e~~~~~--~l~~~~-~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~ 164 (321)
.+...+++|||||..+ ++.+.+ .++...+++-++.|++.|++|||.+.|+||||||+|++++..| .+||+|||+|+
T Consensus 147 ~~~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G-~lKiaDFGLAR 225 (419)
T KOG0663|consen 147 SNMDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKG-ILKIADFGLAR 225 (419)
T ss_pred cccceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCC-cEEecccchhh
Confidence 8877889999999865 333333 5799999999999999999999999999999999999999888 89999999998
Q ss_pred ecCCC-CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 165 FYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 165 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
.+... ...+..+-|.+|+|||++++...|+++.|+||+||++.|+++++ |.+++.+..+++..|.+.+|.+....|.+
T Consensus 226 ~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~k-Plf~G~sE~dQl~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 226 EYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQK-PLFPGKSEIDQLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred hhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcC-CCCCCCchHHHHHHHHHHhCCCccccCCC
Confidence 77543 44677788999999999999899999999999999999999998 56699999999999999999987766654
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
......-. .......+...+........+|+...+|+..+|.+||.+|.||++.|+|+||.....+.
T Consensus 305 ~~~lp~~k-----~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~ 371 (419)
T KOG0663|consen 305 YSELPAVK-----KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPI 371 (419)
T ss_pred ccccchhh-----ccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCC
Confidence 43222110 01112222222222222222678999999999999999999999999999999865554
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-53 Score=346.71 Aligned_cols=285 Identities=33% Similarity=0.596 Sum_probs=234.5
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC---CCcEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---KTPSLI 96 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~---~~~~lv 96 (321)
.-.|+-.+.+|.|+||.||+|....+++.+|||..-.+. +--.+|+++|+.+ .||||+++.-+|..... .+..+|
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~-r~knrEl~im~~l-~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK-RYKNRELQIMRKL-DHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC-CcCcHHHHHHHhc-CCcCeeeEEEEEEecCCCchhHHHHH
Confidence 346899999999999999999999999999999864332 2446899999988 99999999998864433 377799
Q ss_pred EEeecCchhhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 97 FEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 97 ~e~~~~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
|||++........ ..++...++-+..||.+||+|||..||+||||||+|+|+|.+...+||+|||.|+....+.
T Consensus 101 leymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e 180 (364)
T KOG0658|consen 101 LEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE 180 (364)
T ss_pred HHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence 9999977654443 5689999999999999999999999999999999999999986699999999999998888
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
...+..-|..|+|||.+.+...|+.+.||||.||++.||+.|+ |++++.+...++.++.+.+|.+.......-......
T Consensus 181 pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~-plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~ 259 (364)
T KOG0658|consen 181 PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQ-PLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTE 259 (364)
T ss_pred CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCC-cccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccccc
Confidence 7778888999999999999899999999999999999999998 555899999999999999999876544322111111
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
..+. .....++.. ......+++..+|+.++|+++|++|.++.|++.||||+.+..+.
T Consensus 260 ~~~p----~ik~~~~~~----~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~ 316 (364)
T KOG0658|consen 260 FKFP----QIKAHPWHK----VFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPN 316 (364)
T ss_pred ccCc----cccccccee----ecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcC
Confidence 1111 111222222 23345778999999999999999999999999999999987764
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-52 Score=358.89 Aligned_cols=256 Identities=31% Similarity=0.528 Sum_probs=220.3
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
.....+|.+.+.||+|+|++|++|+++.+++.||||++.+. ..+-+..|-++|.+|.+||.|++++-.|+|+
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~-- 146 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDE-- 146 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecc--
Confidence 44567999999999999999999999999999999998642 2355778999999999999999999999665
Q ss_pred CCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 91 KTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
..+|+|+||+++|.|..++ +.|++..++.++.||+.||+|||++||+||||||+|||++.++ .++|+|||.++.+.
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dm-hikITDFGsAK~l~ 225 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDG-HIKITDFGSAKILS 225 (604)
T ss_pred cceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCC-cEEEeeccccccCC
Confidence 5567999999999988888 4599999999999999999999999999999999999999999 89999999998764
Q ss_pred CCCcc--------------ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHh
Q 020826 168 PGKEY--------------NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL 233 (321)
Q Consensus 168 ~~~~~--------------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 233 (321)
+.... ...+||..|.+||++.. ...++.+|+|+|||++|+|+.|..|| .+.++...++.|.+.
T Consensus 226 ~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~-~~~~~~sDiWAlGCilyQmlaG~PPF-ra~NeyliFqkI~~l- 302 (604)
T KOG0592|consen 226 PSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND-SPAGPSSDLWALGCILYQMLAGQPPF-RAANEYLIFQKIQAL- 302 (604)
T ss_pred hhhccccCccCcccccCcccceeeeecccCHHHhcC-CCCCcccchHHHHHHHHHHhcCCCCC-ccccHHHHHHHHHHh-
Confidence 32111 34689999999999988 89999999999999999999999888 566666666665441
Q ss_pred CChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCC
Q 020826 234 GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~ 313 (321)
....+..+++.+++|++++|..||.+|+|+++|-+||||..++-
T Consensus 303 ------------------------------------~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw 346 (604)
T KOG0592|consen 303 ------------------------------------DYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDW 346 (604)
T ss_pred ------------------------------------cccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCCh
Confidence 12223356789999999999999999999999999999998864
Q ss_pred c
Q 020826 314 A 314 (321)
Q Consensus 314 ~ 314 (321)
.
T Consensus 347 ~ 347 (604)
T KOG0592|consen 347 E 347 (604)
T ss_pred h
Confidence 3
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-52 Score=340.80 Aligned_cols=253 Identities=30% Similarity=0.509 Sum_probs=216.4
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
...++|++++.||+|+||+||.++.+.+++.+|+|++++. +.+....|..+|..+ +||.|++++..|++ ..
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v-~hPFiv~l~ysFQt--~~ 98 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKI-KHPFIVKLIYSFQT--EE 98 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhC-CCCcEeeeEEeccc--CC
Confidence 4478999999999999999999999999999999998753 346688999999998 99999999999955 45
Q ss_pred CcEEEEEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC-
Q 020826 92 TPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH- 167 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~- 167 (321)
.+++|+||+.||.|...+. .+++..++-++++|+.||.|||++||+||||||+||+++.+| .++|+|||+++...
T Consensus 99 kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~G-Hi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 99 KLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQG-HIKLTDFGLCKEDLK 177 (357)
T ss_pred eEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCC-cEEEeccccchhccc
Confidence 6679999999999988875 699999999999999999999999999999999999999999 89999999998543
Q ss_pred CCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 168 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
.+....+.+||+.|+|||++.+ ..++.++|.||||+++|+|++|..||. +.+..+....+.+.-
T Consensus 178 ~~~~t~tfcGT~eYmAPEil~~-~gy~~~vDWWsLGillYeML~G~pPF~-~~~~~~~~~~I~~~k-------------- 241 (357)
T KOG0598|consen 178 DGDATRTFCGTPEYMAPEILLG-KGYDKAVDWWSLGILLYEMLTGKPPFY-AEDVKKMYDKILKGK-------------- 241 (357)
T ss_pred CCCccccccCCccccChHHHhc-CCCCcccchHhHHHHHHHHhhCCCCCc-CccHHHHHHHHhcCc--------------
Confidence 4455667799999999999998 799999999999999999999999983 444444444332211
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc----CHHHHhcCCCcccCC
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP----TAKEAMAHPYFFPIR 312 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp----s~~ell~hp~~~~~~ 312 (321)
....+..+|++.+++++++|+.||++|. .++++-+||||..++
T Consensus 242 ----------------------~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in 288 (357)
T KOG0598|consen 242 ----------------------LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN 288 (357)
T ss_pred ----------------------CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence 0111223678999999999999999995 789999999999874
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-52 Score=339.82 Aligned_cols=286 Identities=33% Similarity=0.604 Sum_probs=231.0
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecc-----cchHHHHHHHHHHHhhcCCCCeeeeeeeeec---cCCC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRD---QQSK 91 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~-----~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~---~~~~ 91 (321)
...|..++.||.|+||.|..+.++.+|+.||+|.+.. ...++..+|+..++.+ +|+||+.+.+++.- ....
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~-~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHL-RHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHh-cCCCcceEEeecccccccccc
Confidence 3456668999999999999999999999999998863 2356788999999999 79999999998864 2234
Q ss_pred CcEEEEEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 92 TPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
-.++|+|.| +.+|...++ .++...+..++.|++.||+|+|+.|++||||||.|++++.+. .+||+|||+++...+
T Consensus 100 DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c-~lKI~DFGLAR~~~~ 177 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADC-DLKICDFGLARYLDK 177 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCC-CEEeccccceeeccc
Confidence 467999999 456666663 389999999999999999999999999999999999999888 789999999988754
Q ss_pred ---CCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhh
Q 020826 169 ---GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245 (321)
Q Consensus 169 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (321)
....+..+.|.+|+|||++.....|+.+.||||+||++.||++|+. .|++.+...++..+...+|.+.......-
T Consensus 178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkp-lFpG~d~v~Ql~lI~~~lGtP~~e~l~~i- 255 (359)
T KOG0660|consen 178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKP-LFPGKDYVHQLQLILELLGTPSEEDLQKI- 255 (359)
T ss_pred cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCC-CCCCCchHHHHHHHHHhcCCCCHHHHHHh-
Confidence 2333566889999999999888899999999999999999999995 55899999999999999999855443322
Q ss_pred cccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
. .......+..-...+...+.... ...++...+|+++||.+||.+|+|++|+|+||||.....++
T Consensus 256 ~---s~~ar~yi~slp~~p~~~f~~~f--p~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~ 320 (359)
T KOG0660|consen 256 R---SEKARPYIKSLPQIPKQPFSSIF--PNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPE 320 (359)
T ss_pred c---cHHHHHHHHhCCCCCCCCHHHHc--CCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCc
Confidence 1 12222222222222222222221 25778999999999999999999999999999999876554
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=337.11 Aligned_cols=258 Identities=29% Similarity=0.505 Sum_probs=216.6
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
+.....+|.+.+.||+|+|++||+|+++.++..||||.+... ..+.+..|+.+|+.+ +|||||.+++++.+.
T Consensus 5 ~~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel-~H~nIV~l~d~~~~~-- 81 (429)
T KOG0595|consen 5 SMRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKEL-KHPNIVRLLDCIEDD-- 81 (429)
T ss_pred cccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhc-CCcceeeEEEEEecC--
Confidence 345678999999999999999999999999999999998755 245578999999999 899999999999654
Q ss_pred CCcEEEEEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCC--C---CeEEEeeccc
Q 020826 91 KTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--Q---RKLRLIDWGL 162 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~--~---~~v~l~dfg~ 162 (321)
.++++|||||.||+|..++. .+++..++.++.|++.||++||+++|+||||||+|||++.. . ..+||+|||+
T Consensus 82 ~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGf 161 (429)
T KOG0595|consen 82 DFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGF 161 (429)
T ss_pred CeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccch
Confidence 47789999999999999884 59999999999999999999999999999999999999864 2 3689999999
Q ss_pred eeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHh
Q 020826 163 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242 (321)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (321)
++...++....+.+|++.|||||++.. ..|+-++|+||+|+++|+|++|+.||. .....+-+..+.+ +..
T Consensus 162 AR~L~~~~~a~tlcGSplYMAPEV~~~-~~YdAKADLWSiG~Ilyq~l~g~~Pf~-a~t~~eL~~~~~k--~~~------ 231 (429)
T KOG0595|consen 162 ARFLQPGSMAETLCGSPLYMAPEVIMS-QQYDAKADLWSIGTILYQCLTGKPPFD-AETPKELLLYIKK--GNE------ 231 (429)
T ss_pred hhhCCchhHHHHhhCCccccCHHHHHh-ccccchhhHHHHHHHHHHHHhCCCCcc-ccCHHHHHHHHhc--ccc------
Confidence 999998888889999999999999987 789999999999999999999999983 2222222222111 000
Q ss_pred hhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
.....+..+++++.+++...|+.||..|.+..+-+.|+++....
T Consensus 232 --------------------------~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 232 --------------------------IVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred --------------------------ccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 00111123567888999999999999999999999999988654
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-51 Score=355.60 Aligned_cols=254 Identities=26% Similarity=0.441 Sum_probs=222.6
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
-|++.+.||.|+-|.|-+|++..||+.+|||++.+. ....+++|+-+|+.+ .|||++++++++ ++..++++
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi-~HpnVl~LydVw--e~~~~lyl 89 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLI-EHPNVLRLYDVW--ENKQHLYL 89 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHh-cCCCeeeeeeee--ccCceEEE
Confidence 467778899999999999999999999999998754 246689999999998 999999999999 55677889
Q ss_pred EEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCcc
Q 020826 96 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 172 (321)
Q Consensus 96 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~ 172 (321)
|.||+.+|-|.+++ +++++.++.+++.||+.|+.|+|..+|+|+|+||+|.+++..+ ++||+|||+|..-.++.-.
T Consensus 90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~-nIKIADFGMAsLe~~gklL 168 (786)
T KOG0588|consen 90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKN-NIKIADFGMASLEVPGKLL 168 (786)
T ss_pred EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhccc-CEeeeccceeecccCCccc
Confidence 99999999887777 5699999999999999999999999999999999999999888 6999999999988888888
Q ss_pred ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChh
Q 020826 173 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 252 (321)
Q Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (321)
.+.+|++.|+|||++.+..+...++||||+|++||.|++|++|| +.++.+.+...++...
T Consensus 169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPF--dDdNir~LLlKV~~G~------------------ 228 (786)
T KOG0588|consen 169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPF--DDDNIRVLLLKVQRGV------------------ 228 (786)
T ss_pred cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCC--CCccHHHHHHHHHcCc------------------
Confidence 99999999999999999777789999999999999999999999 4555555444332111
Q ss_pred hHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcccc
Q 020826 253 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESS 317 (321)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~~~ 317 (321)
.+.+..+|+++++||++||.+||++|.|.+|+++|||+++-.....+
T Consensus 229 ------------------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~ 275 (786)
T KOG0588|consen 229 ------------------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSS 275 (786)
T ss_pred ------------------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChh
Confidence 12345688999999999999999999999999999999998776654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-50 Score=347.54 Aligned_cols=252 Identities=30% Similarity=0.478 Sum_probs=212.2
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc--------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 89 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (321)
....+|++.+.||+|+||+|+.|.+..++..||+|++... ....+.+|+.+++.+..||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4567999999999999999999999999999999987653 23456789999999955999999999996554
Q ss_pred CCCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCC-CCeEEEeeccceee
Q 020826 90 SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEF 165 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~-~~~v~l~dfg~~~~ 165 (321)
. +++||||+.+|.|.+++ .++.+.+++.++.|++.|++|||++||+||||||+|++++.+ + ++||+|||++..
T Consensus 94 ~--~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~-~~Kl~DFG~s~~ 170 (370)
T KOG0583|consen 94 K--IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEG-NLKLSDFGLSAI 170 (370)
T ss_pred e--EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCC-CEEEeccccccc
Confidence 4 78999999999887777 469999999999999999999999999999999999999988 6 899999999998
Q ss_pred c-CCCCccccccCCccccccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 166 Y-HPGKEYNVRVASRYFKGPELLVDLQ-DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 166 ~-~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
. .........+||+.|+|||++.+.. +...++||||+|++||.|++|+.||.. .+...+..... .
T Consensus 171 ~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d--~~~~~l~~ki~---~-------- 237 (370)
T KOG0583|consen 171 SPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD--SNVPNLYRKIR---K-------- 237 (370)
T ss_pred cCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC--ccHHHHHHHHh---c--------
Confidence 7 4566778899999999999999855 445899999999999999999999942 22111111100 0
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCC-cchHHHHHHHhhccCCCCCcCHHHHhcCCCccc
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLA-VPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 310 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~ 310 (321)
.....+..+ |+++.+|+++||..||.+|+|+.++++||||+.
T Consensus 238 -------------------------~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 238 -------------------------GEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred -------------------------CCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 011122345 789999999999999999999999999999997
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-50 Score=342.49 Aligned_cols=257 Identities=29% Similarity=0.470 Sum_probs=211.2
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
..++|+++..||+|+||.||+|+.+.||+.+|+|++++.. ...+..|..+|... .+|+||+++..|++ ..+
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD--~~~ 215 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQD--KEY 215 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecC--CCe
Confidence 4689999999999999999999999999999999998643 45678899999996 99999999999955 667
Q ss_pred cEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC-
Q 020826 93 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP- 168 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~- 168 (321)
+||||||++||++..++ ..+++..++-++.+++.|++.+|+.|++||||||+|+|+|..| .+||+|||+++....
T Consensus 216 LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~G-HiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 216 LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKG-HIKLSDFGLSTGLDKK 294 (550)
T ss_pred eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCC-CEeeccccccchhhhh
Confidence 88999999999988877 4599999999999999999999999999999999999999999 899999999843210
Q ss_pred ---------------------C--C-----cc-------------------ccccCCccccccccccCCCCCCCcchHHH
Q 020826 169 ---------------------G--K-----EY-------------------NVRVASRYFKGPELLVDLQDYDYSLDLWS 201 (321)
Q Consensus 169 ---------------------~--~-----~~-------------------~~~~~~~~y~aPE~~~~~~~~~~~~Dvws 201 (321)
. . .. ...+|||.|+|||++.+ ..++..+|.||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~-kgY~~~cDwWS 373 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG-KGYGKECDWWS 373 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc-CCCCccccHHH
Confidence 0 0 00 11469999999999999 77999999999
Q ss_pred HHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchH
Q 020826 202 LGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEA 281 (321)
Q Consensus 202 lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 281 (321)
||||+|||+.|..||. +.+..+....+...- ..........+|++.
T Consensus 374 LG~ImyEmLvGyPPF~-s~tp~~T~rkI~nwr---------------------------------~~l~fP~~~~~s~eA 419 (550)
T KOG0605|consen 374 LGCIMYEMLVGYPPFC-SETPQETYRKIVNWR---------------------------------ETLKFPEEVDLSDEA 419 (550)
T ss_pred HHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHh---------------------------------hhccCCCcCcccHHH
Confidence 9999999999999995 333333333332211 111111222466899
Q ss_pred HHHHHHhhccCCCCCc---CHHHHhcCCCcccCCCcc
Q 020826 282 VDFLDKLLRYDHQERP---TAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 282 ~~ll~~~l~~dp~~Rp---s~~ell~hp~~~~~~~~~ 315 (321)
++||.+||+ ||++|. +++||-+||||++++=..
T Consensus 420 ~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~ 455 (550)
T KOG0605|consen 420 KDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDH 455 (550)
T ss_pred HHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcch
Confidence 999999999 999996 699999999999986443
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-50 Score=328.28 Aligned_cols=285 Identities=31% Similarity=0.552 Sum_probs=229.3
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCC-eeeeeeeeeccC----
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPN-IVKLLDIVRDQQ---- 89 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~-i~~~~~~~~~~~---- 89 (321)
...|+.+++||+|+||+||+|+.+.+|+.||+|.++... .....+|+.+++.| +|+| |+.+++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L-~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRL-SHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHh-CCCcceEEEEeeeeecccccc
Confidence 456888899999999999999999999999999997543 35578999999999 8888 999999986544
Q ss_pred CCCcEEEEEeecCchhhhhc---C----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccc
Q 020826 90 SKTPSLIFEHVNNTDFKVLY---P----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 162 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~---~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~ 162 (321)
...+++|+|++.... ..++ . .++...++.++.||+.||+|||+++|+||||||+|++++.+| .+||+|||+
T Consensus 89 ~~~l~lvfe~~d~DL-~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G-~lKlaDFGl 166 (323)
T KOG0594|consen 89 IGKLYLVFEFLDRDL-KKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSG-VLKLADFGL 166 (323)
T ss_pred cceEEEEEEeecccH-HHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCC-cEeeeccch
Confidence 235679999987543 2222 2 467788999999999999999999999999999999999988 899999999
Q ss_pred eeecC-CCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHH
Q 020826 163 AEFYH-PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY 241 (321)
Q Consensus 163 ~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (321)
+.... +...++....|.+|+|||++.+...|++..||||+||+++||++++ |.+++.++.+++..+-+.+|.+....|
T Consensus 167 Ara~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~-~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 167 ARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRR-PLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCC-CCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 98665 4455778889999999999999778999999999999999999977 555899999999999999999987666
Q ss_pred hhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 242 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
..-........ .. ......... ...-...+++..+++.+||+++|.+|.|++.+|.||||.......
T Consensus 246 p~v~~~~~~k~---~f--~~~~~~~~l--~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~ 312 (323)
T KOG0594|consen 246 PGVSSLPDYKA---PF--PKWPGPKDL--SSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKS 312 (323)
T ss_pred CCccccccccc---cC--cCCCCccch--HHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccch
Confidence 44322221110 00 000001111 111123447899999999999999999999999999999986654
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-49 Score=348.47 Aligned_cols=284 Identities=29% Similarity=0.492 Sum_probs=219.0
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc--hHHHHHHHHHHHhhcCC-----CCeeeeeeeeeccCCCCcE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGG-----PNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~E~~~l~~l~~h-----~~i~~~~~~~~~~~~~~~~ 94 (321)
+|++.+.||+|+||.|.+|.+.+|++.||||+++... ..+...|+.+|..|.+| -|+|+++++|.. ..++|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f--r~Hlc 264 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF--RNHLC 264 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc--cccee
Confidence 9999999999999999999999999999999998654 35677899999999533 489999999954 56778
Q ss_pred EEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcC-CCCeEEEeeccceeecCCC
Q 020826 95 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-EQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 95 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~-~~~~v~l~dfg~~~~~~~~ 169 (321)
||+|.+..+..+.+. .+++...++.++.||+.||.+||+.||+|+||||+||++.. +...|||+|||.++...
T Consensus 265 iVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~-- 342 (586)
T KOG0667|consen 265 IVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES-- 342 (586)
T ss_pred eeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccC--
Confidence 999999865443333 35999999999999999999999999999999999999963 33379999999998654
Q ss_pred CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 170 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
........+..|+|||++++ ..|+.+.|||||||+++||++|. |++++.+..+++..|.+.+|.+.............
T Consensus 343 q~vytYiQSRfYRAPEVILG-lpY~~~IDmWSLGCIlAEL~tG~-PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~k 420 (586)
T KOG0667|consen 343 QRVYTYIQSRFYRAPEVILG-LPYDTAIDMWSLGCILAELFTGE-PLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHK 420 (586)
T ss_pred Ccceeeeeccccccchhhcc-CCCCCccceeehhhhHHhHhcCc-cccCCCCHHHHHHHHHHHhCCCCHHHHHhccccce
Confidence 22337788999999999999 89999999999999999999995 77899999999999999999765433222111110
Q ss_pred Chhh-------Hhhh------------------cccCCCC-CccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHh
Q 020826 250 DPHL-------AALV------------------GRHSRKP-WSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 303 (321)
Q Consensus 250 ~~~~-------~~~~------------------~~~~~~~-~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell 303 (321)
.... .... ....+.+ ............-...+.+||++||.+||.+|+|+.++|
T Consensus 421 ff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal 500 (586)
T KOG0667|consen 421 FFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQAL 500 (586)
T ss_pred ehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHh
Confidence 0000 0000 0111111 111111111111224689999999999999999999999
Q ss_pred cCCCcccC
Q 020826 304 AHPYFFPI 311 (321)
Q Consensus 304 ~hp~~~~~ 311 (321)
+||||...
T Consensus 501 ~Hpfl~~~ 508 (586)
T KOG0667|consen 501 NHPFLTGT 508 (586)
T ss_pred cCcccccc
Confidence 99999954
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=316.45 Aligned_cols=249 Identities=24% Similarity=0.454 Sum_probs=214.3
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
.-++|+++..||.|+||.|-+++.+.+|..+|+|++++.. .....+|..+|+.+ .||+++++++.+.+ ..+
T Consensus 42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v-~~PFlv~l~~t~~d--~~~ 118 (355)
T KOG0616|consen 42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAV-SHPFLVKLYGTFKD--NSN 118 (355)
T ss_pred chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhc-cCceeEEEEEeecc--CCe
Confidence 3479999999999999999999999999999999997654 24467899999999 89999999998855 556
Q ss_pred cEEEEEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 93 PSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
+++||||.+||.+..+++ ++++..++-++.||+.||+|||+++|++|||||+||++|++| .+||+|||+++....
T Consensus 119 lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G-~iKitDFGFAK~v~~- 196 (355)
T KOG0616|consen 119 LYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNG-HIKITDFGFAKRVSG- 196 (355)
T ss_pred EEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCC-cEEEEeccceEEecC-
Confidence 779999999998877774 699999999999999999999999999999999999999999 899999999998753
Q ss_pred CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 170 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
.+.+.+||+.|+|||++.. .+++.++|-||||+++|||+.|..||+.... ..+.+.|+. +
T Consensus 197 -rT~TlCGTPeYLAPEii~s-k~ynkavDWWalGVLIYEMlaG~pPF~~~~~-~~iY~KI~~--~--------------- 256 (355)
T KOG0616|consen 197 -RTWTLCGTPEYLAPEIIQS-KGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-IQIYEKILE--G--------------- 256 (355)
T ss_pred -cEEEecCCccccChHHhhc-CCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-HHHHHHHHh--C---------------
Confidence 3677899999999999998 8999999999999999999999999964433 334333332 0
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCC-----cCHHHHhcCCCcccCC
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER-----PTAKEAMAHPYFFPIR 312 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~R-----ps~~ell~hp~~~~~~ 312 (321)
...-+..+|+++++||+++|+.|-++| ....++.+||||+.++
T Consensus 257 --------------------~v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~ 304 (355)
T KOG0616|consen 257 --------------------KVKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVD 304 (355)
T ss_pred --------------------cccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccccc
Confidence 112234577899999999999999999 3567999999999874
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-50 Score=334.45 Aligned_cols=257 Identities=26% Similarity=0.439 Sum_probs=207.4
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc---hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
..++...+.||+|+||+||++.+.++|...|||...... .+.+.+|+.+|.+| +|||||++++.........+++.
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l-~~p~IV~~~G~~~~~~~~~~~i~ 94 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRL-NHPNIVQYYGSSSSRENDEYNIF 94 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhC-CCCCEEeeCCccccccCeeeEee
Confidence 456888999999999999999999889999999987654 45589999999999 69999999997433322457899
Q ss_pred EEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcC-CCCeEEEeeccceeecCC---
Q 020826 97 FEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-EQRKLRLIDWGLAEFYHP--- 168 (321)
Q Consensus 97 ~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~-~~~~v~l~dfg~~~~~~~--- 168 (321)
|||+.+|+|..++. ++++..++.+..||++||+|||++|++|+||||+||+++. ++ .+||+|||++.....
T Consensus 95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~-~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNG-DVKLADFGLAKKLESKGT 173 (313)
T ss_pred eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCC-eEEeccCccccccccccc
Confidence 99999999988884 5899999999999999999999999999999999999998 46 899999999876552
Q ss_pred -CCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 169 -GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 169 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
........||+.|+|||++.......+++|||||||++.||+||+.||... ......+.........
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~---~~~~~~~~~ig~~~~~--------- 241 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF---FEEAEALLLIGREDSL--------- 241 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh---cchHHHHHHHhccCCC---------
Confidence 122345689999999999985234446999999999999999999998421 1111111111111000
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCC
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~ 313 (321)
-..+..+|++.++||.+||..||++||||+++|+|||.++...
T Consensus 242 -----------------------P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 242 -----------------------PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred -----------------------CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 0233458889999999999999999999999999999987654
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=334.03 Aligned_cols=285 Identities=29% Similarity=0.490 Sum_probs=214.1
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
..++|++.+.||+|+||+||+|++..+++.+|+|+++... .....+|+.+++.+ +||||+++++++.+ ....+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~~ 79 (303)
T cd07869 3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGL-KHANIVLLHDIIHT--KETLT 79 (303)
T ss_pred ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhC-CCCCcCeEEEEEec--CCeEE
Confidence 3578999999999999999999998899999999987432 23567899999999 99999999999865 45678
Q ss_pred EEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC-CC
Q 020826 95 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GK 170 (321)
Q Consensus 95 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~-~~ 170 (321)
+|+||+.++.+.... ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++..... ..
T Consensus 80 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~ 158 (303)
T cd07869 80 LVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTG-ELKLADFGLARAKSVPSH 158 (303)
T ss_pred EEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECCCCcceeccCCCc
Confidence 999999866544433 3488999999999999999999999999999999999999887 899999999865432 22
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
......++..|+|||++.+...++.++|||||||++|+|++|..||....+....+..+...++.+....+........
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 237 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH- 237 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccc-
Confidence 2344567889999999876566889999999999999999999999654454555666555555443222211100000
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
+.. ....................++++.+|+++||+.||++|||+.|+++||||+++.
T Consensus 238 --~~~--~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~ 295 (303)
T cd07869 238 --FKP--ERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP 295 (303)
T ss_pred --ccc--ccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence 000 0000000000011111123457899999999999999999999999999999874
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-49 Score=341.17 Aligned_cols=257 Identities=25% Similarity=0.460 Sum_probs=217.4
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc---chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
.......|....+||+|+.|.||.|....+++.||+|.+... .+..+.+|+.+|+.+ +|+|||.+++.+... ..
T Consensus 268 ~~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~-~H~NiVnfl~Sylv~--de 344 (550)
T KOG0578|consen 268 QGDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDL-HHPNIVNFLDSYLVG--DE 344 (550)
T ss_pred CCChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhc-cchHHHHHHHHhccc--ce
Confidence 344557888999999999999999999999999999998643 356689999999999 999999999977433 56
Q ss_pred cEEEEEeecCchhhhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 93 PSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~~~--~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
++.||||+.|++|.+.... +++.++..++.+++.||+|||.+||+|+|||.+||++..+| .+||+|||++.......
T Consensus 345 LWVVMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g-~vKltDFGFcaqi~~~~ 423 (550)
T KOG0578|consen 345 LWVVMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDG-SVKLTDFGFCAQISEEQ 423 (550)
T ss_pred eEEEEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCC-cEEEeeeeeeecccccc
Confidence 7899999999999888854 89999999999999999999999999999999999999998 79999999997765443
Q ss_pred -ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 171 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
.-.+.+||++|+|||+... ..|.++.||||||++++||+.|..||+.. +....+.. ...-|.+.
T Consensus 424 ~KR~TmVGTPYWMAPEVvtr-k~YG~KVDIWSLGIMaIEMveGEPPYlnE-~PlrAlyL-Ia~ng~P~------------ 488 (550)
T KOG0578|consen 424 SKRSTMVGTPYWMAPEVVTR-KPYGPKVDIWSLGIMAIEMVEGEPPYLNE-NPLRALYL-IATNGTPK------------ 488 (550)
T ss_pred CccccccCCCCccchhhhhh-cccCccccchhhhhHHHHHhcCCCCccCC-ChHHHHHH-HhhcCCCC------------
Confidence 4566789999999999987 88999999999999999999999999642 22222222 22222222
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
+..+..+|+++++||.+||+.|+++|+||.|||+||||+...
T Consensus 489 ---------------------lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~ 530 (550)
T KOG0578|consen 489 ---------------------LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAK 530 (550)
T ss_pred ---------------------cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcC
Confidence 233456889999999999999999999999999999997653
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-51 Score=323.18 Aligned_cols=249 Identities=26% Similarity=0.491 Sum_probs=204.8
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecc-----cchHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~-----~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
-.+|+++++||.|.||+||++.+..+|..+|.|.++- ..+.....|+.+|++| +||||+++++.-.+.++..+.
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL-~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQL-NHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhc-CCchHHHHHHHhhhccchhhH
Confidence 4579999999999999999999999999999998762 2346688999999999 999999999955455566678
Q ss_pred EEEEeecCchhhhhc-------CCCCHHHHHHHHHHHHHHHHHHHH--CC--CeeecCCCCCeEEcCCCCeEEEeeccce
Q 020826 95 LIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHS--QG--IMHRDVKPHNVMIDHEQRKLRLIDWGLA 163 (321)
Q Consensus 95 lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lh~--~~--i~H~dlkp~nili~~~~~~v~l~dfg~~ 163 (321)
||||+|..|+|...+ +.+++..+|+++.|++.||..+|. .+ +.||||||-||+++.+| .|||+|||++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g-vvKLGDfGL~ 175 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG-VVKLGDFGLG 175 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC-ceeeccchhH
Confidence 999999999998887 349999999999999999999999 45 99999999999999998 9999999999
Q ss_pred eecCCCCc-cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHh
Q 020826 164 EFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242 (321)
Q Consensus 164 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (321)
+.+..... ..+.+|||+||+||.+.+ ..|+.+|||||+||++|||+.-..||+.+ +...+...+.....+..+
T Consensus 176 r~l~s~~tfA~S~VGTPyYMSPE~i~~-~~Y~~kSDiWslGCllyEMcaL~~PF~g~--n~~~L~~KI~qgd~~~~p--- 249 (375)
T KOG0591|consen 176 RFLSSKTTFAHSLVGTPYYMSPERIHE-SGYNFKSDIWSLGCLLYEMCALQSPFYGD--NLLSLCKKIEQGDYPPLP--- 249 (375)
T ss_pred hHhcchhHHHHhhcCCCcccCHHHHhc-CCCCcchhHHHHHHHHHHHHhcCCCcccc--cHHHHHHHHHcCCCCCCc---
Confidence 88765443 345689999999999998 89999999999999999999999999533 333333222211111111
Q ss_pred hhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
+...|.++..++..|+..||+.||+. +|+++++.
T Consensus 250 -------------------------------~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~ 283 (375)
T KOG0591|consen 250 -------------------------------DEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQ 283 (375)
T ss_pred -------------------------------HHHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHH
Confidence 01356789999999999999999986 55555543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-48 Score=324.37 Aligned_cols=268 Identities=23% Similarity=0.368 Sum_probs=216.9
Q ss_pred eeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccC
Q 020826 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 89 (321)
Q Consensus 14 ~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (321)
...+...+.|++...||.|..++||+|+...+++.||||++..+. .+.+.+|+..|..+ +||||++.+..|..
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~-~HPNIv~~~~sFvv-- 95 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLI-DHPNIVTYHCSFVV-- 95 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhc-CCCCcceEEEEEEe--
Confidence 344556789999999999999999999999999999999997543 36789999999998 99999999999954
Q ss_pred CCCcEEEEEeecCchhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecccee
Q 020826 90 SKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 164 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~ 164 (321)
...+|+||.+|.+|++.+++ ..+++..+..++++++.||.|||++|.+|||||+.|||++.+| .|||+|||.+.
T Consensus 96 ~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG-~VkLadFgvsa 174 (516)
T KOG0582|consen 96 DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDG-TVKLADFGVSA 174 (516)
T ss_pred cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCC-cEEEcCceeee
Confidence 45688999999999987777 3599999999999999999999999999999999999999999 89999999876
Q ss_pred ecCCCC-cc----ccccCCcccccccc-ccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhh
Q 020826 165 FYHPGK-EY----NVRVASRYFKGPEL-LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 238 (321)
Q Consensus 165 ~~~~~~-~~----~~~~~~~~y~aPE~-~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (321)
....+. .. ....+|++|+|||+ ......|+.++||||||++..|+.+|..|| ...+....+... +.....
T Consensus 175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf-~k~pPmkvLl~t---Lqn~pp 250 (516)
T KOG0582|consen 175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPF-SKYPPMKVLLLT---LQNDPP 250 (516)
T ss_pred eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCc-ccCChHHHHHHH---hcCCCC
Confidence 554332 21 44589999999999 444467999999999999999999999998 344443333322 211110
Q ss_pred hHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCC
Q 020826 239 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~ 313 (321)
. ........+..+.++..+++++..||+.||++||||+++|+|+||++...
T Consensus 251 ~------------------------~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~ 301 (516)
T KOG0582|consen 251 T------------------------LLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS 301 (516)
T ss_pred C------------------------cccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence 0 00111122223346679999999999999999999999999999998643
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=327.74 Aligned_cols=275 Identities=28% Similarity=0.545 Sum_probs=212.0
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
.++|++.+.||.|+||+||+|.+..++..||+|+++... ...+.+|+.+++.+ +||||+++++++.+ ....++
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~~l 80 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNL-KHANIVTLHDIIHT--ERCLTL 80 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhC-CCCCEeeEEEEEcC--CCeEEE
Confidence 568999999999999999999999999999999986432 34577899999999 99999999999854 446789
Q ss_pred EEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-
Q 020826 96 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 170 (321)
Q Consensus 96 v~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~- 170 (321)
++|++.+ +|..++ ..+++..+..++.||+.||+|||++|++|+||||+||+++.++ .++|+|||++.......
T Consensus 81 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 81 VFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKG-ELKLADFGLARAKSVPTK 158 (288)
T ss_pred EEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEECcCcceeeccCCCc
Confidence 9999987 555444 2378899999999999999999999999999999999999888 89999999987643222
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
......++..|+|||.+.+...++.++||||+||++|+|++|+.|| .+.+..+.+..+....+.+....+.... ..
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 234 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF-PGSTVKEELHLIFRLLGTPTEETWPGIT---SN 234 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCChHHhhccc---cc
Confidence 2334567889999999876567899999999999999999999888 4555566666666666654433322110 00
Q ss_pred hhhHhhhcc-cCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 251 PHLAALVGR-HSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 251 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
..+...... ....+ .......+++++++||++||++||.+|||++|+++||||
T Consensus 235 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 235 EEFRSYLFPQYRAQP-----LINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred hhhhccccCccCCCc-----hHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 001000000 00000 011223567899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-48 Score=346.16 Aligned_cols=285 Identities=31% Similarity=0.512 Sum_probs=218.5
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeeeecc------CCCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ------QSKT 92 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~------~~~~ 92 (321)
...+|++.+.||+|+||+||+|.+..+++.||+|.+... .....+|+.+++.+ +||||+++++++... ...+
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~-~~~~~~Ei~il~~l-~h~niv~l~~~~~~~~~~~~~~~~~ 141 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD-PQYKNRELLIMKNL-NHINIIFLKDYYYTECFKKNEKNIF 141 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecC-cchHHHHHHHHHhc-CCCCCcceeeeEeecccccCCCceE
Confidence 456899999999999999999999889999999987543 23456799999999 899999998876322 2235
Q ss_pred cEEEEEeecCchhhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeec
Q 020826 93 PSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 166 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~ 166 (321)
++++|||++++...... ..+++..++.++.||+.||+|||++||+||||||+||+++.++..+||+|||+++..
T Consensus 142 l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~ 221 (440)
T PTZ00036 142 LNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221 (440)
T ss_pred EEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhc
Confidence 67999999976433221 358999999999999999999999999999999999999876657999999999876
Q ss_pred CCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhc
Q 020826 167 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246 (321)
Q Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (321)
..........+|+.|+|||++.+...++.++|||||||++|+|++|..|| .+....+.+..+.+.++.+........
T Consensus 222 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf-~~~~~~~~~~~i~~~~~~p~~~~~~~~-- 298 (440)
T PTZ00036 222 LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIF-SGQSSVDQLVRIIQVLGTPTEDQLKEM-- 298 (440)
T ss_pred cCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHHHh--
Confidence 54444455678899999999877567899999999999999999999887 566666777777777776544332211
Q ss_pred ccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
.+.+....-. . ..........+...|+++.+||.+||+.||++|||+.|+++||||+.+..+
T Consensus 299 ---~~~~~~~~~~-~--~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~~ 360 (440)
T PTZ00036 299 ---NPNYADIKFP-D--VKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDP 360 (440)
T ss_pred ---chhhhcccCC-c--cCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhcc
Confidence 0111100000 0 000001111233467899999999999999999999999999999887543
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=315.23 Aligned_cols=255 Identities=29% Similarity=0.491 Sum_probs=212.2
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEec-----ccchHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~-----~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
+.+.|++.+.||+|.|+.|+++.+..+|+.+++|.+. ......+.+|+.+.+.| +||||+++.+.+ +...+.
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~L-qHP~IvrL~~ti--~~~~~~ 85 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSI--QEESFH 85 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhc-CCCcEeehhhhh--ccccee
Confidence 5688999999999999999999999999999888764 33457789999999999 999999999988 445667
Q ss_pred EEEEEeecCchhhhhc-CC--CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcC--CCCeEEEeeccceeecCC
Q 020826 94 SLIFEHVNNTDFKVLY-PT--LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~-~~--~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~--~~~~v~l~dfg~~~~~~~ 168 (321)
++|+|.+.|+.|..-+ .. +++..+...+.||+++|.|+|.+||+|||+||+|+++.+ .+.-+||+|||++.....
T Consensus 86 ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 86 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred EEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 8999999999875544 32 788999999999999999999999999999999999953 344799999999998886
Q ss_pred CCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 169 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
+.......||+.|+|||++.. .+++..+|||+.|++||-++.|+.||+ +.+..+..+.|.+ ...+ .+
T Consensus 166 g~~~~G~~GtP~fmaPEvvrk-dpy~kpvDiW~cGViLfiLL~G~~PF~-~~~~~rlye~I~~-g~yd-~~--------- 232 (355)
T KOG0033|consen 166 GEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFW-DEDQHRLYEQIKA-GAYD-YP--------- 232 (355)
T ss_pred ccccccccCCCcccCHHHhhc-CCCCCcchhhhhhHHHHHHHhCCCCCC-CccHHHHHHHHhc-cccC-CC---------
Confidence 667788899999999999988 789999999999999999999999995 3333333333322 1110 00
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
.. .-+.++++.++|+++||..||++|.|+.|+|+|||+.+-
T Consensus 233 ----------------~~------~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 233 ----------------SP------EWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred ----------------Cc------ccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 00 012477899999999999999999999999999999874
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=335.25 Aligned_cols=285 Identities=26% Similarity=0.455 Sum_probs=216.9
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC---
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS--- 90 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~--- 90 (321)
..++|++.+.||+|+||.||++.+..++..+|+|.+... ....+.+|+.+++.+ +||||+++++++.....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCV-NHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhC-CCCCEeeeeeeeccCCCccc
Confidence 468999999999999999999999999999999998642 235577899999999 89999999998854332
Q ss_pred -CCcEEEEEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 91 -KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 91 -~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
...+++|||+.++.+......+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++......
T Consensus 98 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~-~~kl~Dfg~a~~~~~~ 176 (359)
T cd07876 98 FQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTN 176 (359)
T ss_pred cceeEEEEeCCCcCHHHHHhccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEecCCCccccccC
Confidence 34689999999876666666789999999999999999999999999999999999999888 8999999998765444
Q ss_pred CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 170 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
.......+|..|+|||.+.+ ..++.++|||||||++|+|++|..||. +.+.......+.+.++.+........ .
T Consensus 177 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~tg~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~-~--- 250 (359)
T cd07876 177 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQ-GTDHIDQWNKVIEQLGTPSAEFMNRL-Q--- 250 (359)
T ss_pred ccCCCCcccCCCCCchhccC-CCCCcchhhHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhcCCCcHHHHHHH-H---
Confidence 44455678899999999987 788999999999999999999999984 44445555555555554332111100 0
Q ss_pred ChhhHhhhcccCCCCCcc----------ccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 250 DPHLAALVGRHSRKPWSK----------FITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
.............+... ..........++++.+||.+||+.||++|||+.|+++||||+.+.
T Consensus 251 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 322 (359)
T cd07876 251 -PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY 322 (359)
T ss_pred -HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhc
Confidence 00000000000000000 000111223567899999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-48 Score=338.37 Aligned_cols=255 Identities=26% Similarity=0.444 Sum_probs=221.9
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccC
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 89 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (321)
.....++|.++.+||+|.||+|+++..+.+++.+|||+++++ +......|..++....+||.++.++..| +.
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f--QT 440 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF--QT 440 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc--cc
Confidence 344568999999999999999999999999999999999854 4566788999988887899999999999 55
Q ss_pred CCCcEEEEEeecCchhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 90 SKTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
..++++||||+.||++..++ ..+++..++-++..|+.||.|||++||+|||||.+|||+|.+| .+||+|||+++...
T Consensus 441 ~~~l~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eG-h~kiADFGlcKe~m 519 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEG-HVKIADFGLCKEGM 519 (694)
T ss_pred CCeEEEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccC-cEEecccccccccC
Confidence 67788999999999965555 4699999999999999999999999999999999999999999 89999999998765
Q ss_pred -CCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhc
Q 020826 168 -PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246 (321)
Q Consensus 168 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (321)
.+..+.+.+||+.|+|||++.+ ..|+.+.|-||||+++|+|+.|..|| ++.+..+....|..
T Consensus 520 ~~g~~TsTfCGTpey~aPEil~e-~~Yt~aVDWW~lGVLlyeML~Gq~PF-~gddEee~FdsI~~--------------- 582 (694)
T KOG0694|consen 520 GQGDRTSTFCGTPEFLAPEVLTE-QSYTRAVDWWGLGVLLYEMLVGESPF-PGDDEEEVFDSIVN--------------- 582 (694)
T ss_pred CCCCccccccCChhhcChhhhcc-CcccchhhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHhc---------------
Confidence 5567788999999999999998 89999999999999999999999998 56776666666533
Q ss_pred ccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC-----HHHHhcCCCcccCC
Q 020826 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPIR 312 (321)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps-----~~ell~hp~~~~~~ 312 (321)
.....+..+|.+..++|+++|..||++|.. ++++.+||||+.++
T Consensus 583 ----------------------d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~ 631 (694)
T KOG0694|consen 583 ----------------------DEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID 631 (694)
T ss_pred ----------------------CCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence 111223357789999999999999999964 68999999999864
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=328.07 Aligned_cols=254 Identities=28% Similarity=0.518 Sum_probs=209.5
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----------------hHHHHHHHHHHHhhcCCCCeeeee
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------------KKKIKREIKILQNLCGGPNIVKLL 82 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----------------~~~~~~E~~~l~~l~~h~~i~~~~ 82 (321)
-++|++...||+|.||.|-+|++..+++.||+|++.+.. .....+|+.+|+++ .|||||+++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl-~H~nVV~Li 174 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKL-HHPNVVKLI 174 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhc-CCcCeeEEE
Confidence 468999999999999999999999999999999986432 14578999999999 999999999
Q ss_pred eeeeccCCCCcEEEEEeecCchhhhhc--CC-CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEee
Q 020826 83 DIVRDQQSKTPSLIFEHVNNTDFKVLY--PT-LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLID 159 (321)
Q Consensus 83 ~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~-~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~d 159 (321)
++..++....+|+|+|||..|.+.+-- .. +++.+++.++.+++.||+|||.+||+||||||.|+|++.+| .|||+|
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g-~VKIsD 253 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG-TVKISD 253 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC-cEEeec
Confidence 999999999999999999988776554 23 88999999999999999999999999999999999999998 899999
Q ss_pred ccceeecCCCC------ccccccCCccccccccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHH
Q 020826 160 WGLAEFYHPGK------EYNVRVASRYFKGPELLVDL---QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 230 (321)
Q Consensus 160 fg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 230 (321)
||.+.....+. ......||+.|+|||...+. ...+.+.||||+|++||.++.|+.||+.+. ..+....|+
T Consensus 254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~-~~~l~~KIv 332 (576)
T KOG0585|consen 254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDF-ELELFDKIV 332 (576)
T ss_pred cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccch-HHHHHHHHh
Confidence 99998763332 23457899999999998762 346788999999999999999999995322 222222221
Q ss_pred HHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCccc
Q 020826 231 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 310 (321)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~ 310 (321)
. .+ +.......+.+.+++||.+||+.||++|.++.++..|||..+
T Consensus 333 n---~p--------------------------------L~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~ 377 (576)
T KOG0585|consen 333 N---DP--------------------------------LEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR 377 (576)
T ss_pred c---Cc--------------------------------ccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence 1 00 001111134578999999999999999999999999999986
Q ss_pred C
Q 020826 311 I 311 (321)
Q Consensus 311 ~ 311 (321)
-
T Consensus 378 ~ 378 (576)
T KOG0585|consen 378 D 378 (576)
T ss_pred C
Confidence 4
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-49 Score=310.42 Aligned_cols=255 Identities=25% Similarity=0.476 Sum_probs=212.4
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----------hHHHHHHHHHHHhhcCCCCeeeeeeeeecc
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 88 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (321)
-..|...+.+|.|..++|.++.++.++..+++|++.... .....+|+.+|+++.+||+|+++.+++ +
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y--e 93 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY--E 93 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec--c
Confidence 356788889999999999999999999999999985321 234568999999999999999999999 4
Q ss_pred CCCCcEEEEEeecCchhhhhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 89 QSKTPSLIFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 89 ~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
.+.+.++|+|.|+.|.|.+++.. +++.+.++++.|+.+|++|||.++|||+||||+||+++.+. +++|+|||+++.
T Consensus 94 s~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~-~i~isDFGFa~~ 172 (411)
T KOG0599|consen 94 SDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNM-NIKISDFGFACQ 172 (411)
T ss_pred CcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeecccc-ceEEeccceeec
Confidence 46677899999999999998854 89999999999999999999999999999999999999877 899999999999
Q ss_pred cCCCCccccccCCccccccccccCC-----CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhH
Q 020826 166 YHPGKEYNVRVASRYFKGPELLVDL-----QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 240 (321)
Q Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (321)
..++......+||++|+|||.+... ..|+...|+|++|+++|-++.|..||+. ..++..+...... ...
T Consensus 173 l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH----RkQmlMLR~ImeG-kyq- 246 (411)
T KOG0599|consen 173 LEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH----RKQMLMLRMIMEG-KYQ- 246 (411)
T ss_pred cCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH----HHHHHHHHHHHhc-ccc-
Confidence 9999999999999999999998542 4578899999999999999999999952 2233322111111 000
Q ss_pred HhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 241 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
...+ .=.++|.+..+||.+||+.||++|.|++|+|+||||++.
T Consensus 247 -------F~sp---------------------eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 247 -------FRSP---------------------EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred -------cCCc---------------------chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 0000 001366799999999999999999999999999999764
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-47 Score=330.88 Aligned_cols=284 Identities=31% Similarity=0.584 Sum_probs=211.3
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC---CCc
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---KTP 93 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~---~~~ 93 (321)
+|++.+.||+|+||.||+|++..++..||+|.++.. ....+.+|+.+++.+ +||||+++++++..... ...
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLL-RHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhC-CCCCEeeecceEeccCCCCCceE
Confidence 699999999999999999999999999999998642 234578899999999 89999999998754322 346
Q ss_pred EEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 94 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
+++|||+++ +|...+ ..+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++.......
T Consensus 80 ~lv~e~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~ 157 (338)
T cd07859 80 YVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDT 157 (338)
T ss_pred EEEEecCCC-CHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-cEEEccCcccccccccc
Confidence 899999975 555444 3589999999999999999999999999999999999999888 89999999987542211
Q ss_pred ----ccccccCCccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhh
Q 020826 171 ----EYNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245 (321)
Q Consensus 171 ----~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (321)
......++..|+|||++.+. ..++.++|||||||++|+|++|+.|| .+.+....+..+....+.+.......-.
T Consensus 158 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (338)
T cd07859 158 PTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLF-PGKNVVHQLDLITDLLGTPSPETISRVR 236 (338)
T ss_pred CccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCC-CCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence 12335688999999998642 46889999999999999999999887 4455555555555555544332211110
Q ss_pred cccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
........... .. ..+ ..+ ......+++++.++|.+||+.||++|||++|+++||||+++....
T Consensus 237 ~~~~~~~~~~~-~~--~~~-~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~~~ 300 (338)
T cd07859 237 NEKARRYLSSM-RK--KQP-VPF--SQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAKVE 300 (338)
T ss_pred hhhHHHHHHhh-cc--cCC-Cch--HHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCccc
Confidence 00000000000 00 000 000 001123567899999999999999999999999999999876654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-47 Score=322.88 Aligned_cols=254 Identities=24% Similarity=0.375 Sum_probs=205.6
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
.|++.+.||+|+||+||+|.+..+++.||+|.+.... ...+.+|+.+++.+ +|++++++++.+.+ ....++
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~iv~~~~~~~~--~~~~~l 77 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKV-NSRFVVSLAYAYET--KDALCL 77 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhc-CCCcEEEEEEEEcc--CCeEEE
Confidence 4788999999999999999999999999999986432 23467899999999 99999999998854 346789
Q ss_pred EEEeecCchhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 96 IFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 96 v~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
++||+.+++|...+ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++.......
T Consensus 78 v~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~-~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 78 VLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRG-HIRISDLGLAVQIPEGE 156 (285)
T ss_pred EEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC-CEEEeeCCCcEEcCCCC
Confidence 99999999987654 2488999999999999999999999999999999999999877 79999999998765444
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
......++..|+|||++.+ ..++.++|||||||++|+|++|+.||...... .....+.......
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-~~~~~~~~~~~~~-------------- 220 (285)
T cd05631 157 TVRGRVGTVGYMAPEVINN-EKYTFSPDWWGLGCLIYEMIQGQSPFRKRKER-VKREEVDRRVKED-------------- 220 (285)
T ss_pred eecCCCCCCCccCHhhhcC-CCCCcccCchhHHHHHHHHHhCCCCCCCCCcc-hhHHHHHHHhhcc--------------
Confidence 4455678999999999987 78899999999999999999999999533221 1111111100000
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC-----HHHHhcCCCcccCCCc
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPIRNA 314 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps-----~~ell~hp~~~~~~~~ 314 (321)
....+..+++++.+|+++||+.||++||| ++++++||||++++..
T Consensus 221 -------------------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~ 270 (285)
T cd05631 221 -------------------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFK 270 (285)
T ss_pred -------------------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHH
Confidence 00112246789999999999999999997 8999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=324.75 Aligned_cols=277 Identities=31% Similarity=0.554 Sum_probs=209.5
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
++|++.+.||+|+||+||+|+++.+++.+++|+++.. ....+.+|+.+++.+ +||||+++++++.. ....++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 77 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTL-KQENIVELKEAFRR--RGKLYL 77 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhC-CCccccchhhhEec--CCEEEE
Confidence 4799999999999999999999999999999998643 235578899999999 89999999999854 456789
Q ss_pred EEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC--
Q 020826 96 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-- 170 (321)
Q Consensus 96 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~-- 170 (321)
||||+.++++..+. ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~ 156 (287)
T cd07848 78 VFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND-VLKLCDFGFARNLSEGSNA 156 (287)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEEeeccCcccccccccc
Confidence 99999998876654 3589999999999999999999999999999999999999887 89999999987654322
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
......++..|+|||++.+ ..++.++|+|||||++|+|++|+.|| ++.+....+..+....+......... .. ..
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~-~~--~~ 231 (287)
T cd07848 157 NYTEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLF-PGESEIDQLFTIQKVLGPLPAEQMKL-FY--SN 231 (287)
T ss_pred cccccccccccCCcHHHcC-CCCCCchhHHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhhCCCCHHHHHh-hh--cc
Confidence 2233468889999999987 67899999999999999999999887 44444455554444443322111110 00 00
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
+............+ ..........+|+++.+||++||+.||++|||++++++||||
T Consensus 232 ~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 232 PRFHGLRFPAVNHP--QSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred chhcccccCcccCc--ccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 11000000000000 000011122467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-47 Score=326.53 Aligned_cols=249 Identities=24% Similarity=0.401 Sum_probs=204.4
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
++|++.+.||+|+||+||+|.+..+++.+|+|++.... ...+.+|+.+++.+ +||||+++++++.+ ....+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~ 77 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV-SHPFIIRLFWTEHD--QRFLY 77 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhC-CCCcHhhhHhhhcc--CCeEE
Confidence 47999999999999999999998899999999986432 34577899999999 89999999998854 45678
Q ss_pred EEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc
Q 020826 95 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 171 (321)
Q Consensus 95 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~ 171 (321)
++|||+.+++|.+++ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++..... .
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~-~~kl~Dfg~~~~~~~--~ 154 (291)
T cd05612 78 MLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG-HIKLTDFGFAKKLRD--R 154 (291)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEEEecCcchhccC--C
Confidence 999999999987776 3589999999999999999999999999999999999999887 899999999875532 2
Q ss_pred cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCCh
Q 020826 172 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (321)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|..||.. .+.......+...
T Consensus 155 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~~l~~g~~pf~~-~~~~~~~~~i~~~------------------- 213 (291)
T cd05612 155 TWTLCGTPEYLAPEVIQS-KGHNKAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILAG------------------- 213 (291)
T ss_pred cccccCChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhC-------------------
Confidence 234568899999999987 6789999999999999999999999843 2222222221110
Q ss_pred hhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC-----HHHHhcCCCcccCCCc
Q 020826 252 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPIRNA 314 (321)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps-----~~ell~hp~~~~~~~~ 314 (321)
....+..+++.+.++|++||+.||++|++ ++++++||||+.++..
T Consensus 214 ------------------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 263 (291)
T cd05612 214 ------------------KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD 263 (291)
T ss_pred ------------------CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence 00112235678999999999999999995 9999999999876433
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-47 Score=334.64 Aligned_cols=289 Identities=24% Similarity=0.325 Sum_probs=212.6
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
....+|++.+.||+|+||.||+|.+..+++.||+|... ...+.+|+.+++.+ +||||+++++++.. ....++++
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~~~~~lv~ 162 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---RGGTATEAHILRAI-NHPSIIQLKGTFTY--NKFTCLIL 162 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---hhhhHHHHHHHHhC-CCCCCCCEeEEEEE--CCeeEEEE
Confidence 34568999999999999999999999999999999754 45678999999999 99999999999854 45667999
Q ss_pred EeecCchhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC--Cccc
Q 020826 98 EHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG--KEYN 173 (321)
Q Consensus 98 e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~--~~~~ 173 (321)
|++.+..+.... ..+++..++.++.|++.||+|||++||+|+||||+||+++.++ .++|+|||++...... ....
T Consensus 163 e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~-~vkL~DFG~a~~~~~~~~~~~~ 241 (391)
T PHA03212 163 PRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPG-DVCLGDFGAACFPVDINANKYY 241 (391)
T ss_pred ecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCC-CEEEEeCCcccccccccccccc
Confidence 998754333322 4588999999999999999999999999999999999999887 7999999998643221 2223
Q ss_pred cccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCC------CChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 174 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH------DNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
...||+.|+|||++.+ ..++.++|||||||++|+|++|..||+... +...++..+....+........ ....
T Consensus 242 ~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~-~~~~ 319 (391)
T PHA03212 242 GWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPI-DAQA 319 (391)
T ss_pred cccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCc-chhH
Confidence 4578999999999987 678999999999999999999999886533 2234555555555442211000 0000
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCccc
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAES 316 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~~ 316 (321)
.....+..........+... ........++.++.+||.+||+.||++|||++|+|+||||+.+..+-.
T Consensus 320 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~~~ 387 (391)
T PHA03212 320 NLDEIYIGLAKKSSRKPGSR-PLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDPYP 387 (391)
T ss_pred HHHHHHHHHHhccCCCCCCC-CCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCCCC
Confidence 00000001111111111111 011111235678999999999999999999999999999999866543
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-47 Score=329.15 Aligned_cols=247 Identities=25% Similarity=0.420 Sum_probs=204.3
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
.++|++.+.||+|+||+||+|++..+++.+|+|+++... ...+.+|+.+++.+ +||||+++++.+.+ ....
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~ 93 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL-SHPFIVNMMCSFQD--ENRV 93 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEc--CCEE
Confidence 478999999999999999999999999999999987432 24578899999999 99999999999865 4467
Q ss_pred EEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 94 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
+++|||+.+++|...+ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++......
T Consensus 94 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~- 171 (329)
T PTZ00263 94 YFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKG-HVKVTDFGFAKKVPDR- 171 (329)
T ss_pred EEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCC-CEEEeeccCceEcCCC-
Confidence 8999999999987766 3588999999999999999999999999999999999999888 8999999999765432
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|..||.. .+.......+.. +.
T Consensus 172 -~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~-~~~~~~~~~i~~--~~--------------- 231 (329)
T PTZ00263 172 -TFTLCGTPEYLAPEVIQS-KGHGKAVDWWTMGVLLYEFIAGYPPFFD-DTPFRIYEKILA--GR--------------- 231 (329)
T ss_pred -cceecCChhhcCHHHHcC-CCCCCcceeechHHHHHHHHcCCCCCCC-CCHHHHHHHHhc--CC---------------
Confidence 234578899999999987 6789999999999999999999999842 222222211110 00
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC-----HHHHhcCCCcccC
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPI 311 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps-----~~ell~hp~~~~~ 311 (321)
...+..+++.+.+||++||+.||++|++ ++++++||||++.
T Consensus 232 --------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 232 --------------------LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred --------------------cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 0111235678999999999999999986 7999999999874
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=331.05 Aligned_cols=287 Identities=26% Similarity=0.475 Sum_probs=217.3
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccC----
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---- 89 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~---- 89 (321)
..++|++.+.||+|+||.||++.+..+++.+|+|++... ....+.+|+.+++.+ +||||+++++++....
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhc-CCCCccccceeecccccccc
Confidence 467999999999999999999999989999999998642 235577899999999 8999999999875432
Q ss_pred CCCcEEEEEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 90 SKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
....++||||+.++........++...+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++......
T Consensus 101 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 101 FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTS 179 (364)
T ss_pred cCeEEEEEeCCCCCHHHHHHhcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCC-cEEEEeCCCccccCCC
Confidence 234689999999876666656789999999999999999999999999999999999999888 8999999999765544
Q ss_pred CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 170 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
.......++..|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+.......+...++.+... +.....
T Consensus 180 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--- 253 (364)
T cd07875 180 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLF-PGTDHIDQWNKVIEQLGTPCPE-FMKKLQ--- 253 (364)
T ss_pred CcccCCcccCCcCCHHHHhC-CCCCchhhHHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCCHH-HHHhhh---
Confidence 44455678899999999987 78899999999999999999999998 4555556666665555543221 111110
Q ss_pred ChhhHhhhcccCCCCCccc----------cccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 250 DPHLAALVGRHSRKPWSKF----------ITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
+................+ .........++++++||.+||+.||++|||+.++|+||||+.+..+
T Consensus 254 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~ 327 (364)
T cd07875 254 -PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDP 327 (364)
T ss_pred -HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCc
Confidence 111111111000000000 0001111234679999999999999999999999999999865433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-48 Score=334.67 Aligned_cols=246 Identities=30% Similarity=0.532 Sum_probs=209.6
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchH-----HHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK-----KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~-----~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
++|-+.+.||+|.||.||+|+.+.+.+.||+|.+.+..+. .+.+|+++++.| +||||+.+++.| +.....++
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~l-kHpniv~m~esf--Et~~~~~v 78 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSL-KHPNIVEMLESF--ETSAHLWV 78 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhc-CCcchhhHHHhh--cccceEEE
Confidence 5788999999999999999999999999999999765543 489999999999 999999999999 55677889
Q ss_pred EEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc-
Q 020826 96 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE- 171 (321)
Q Consensus 96 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~- 171 (321)
|+||+.| +|..++ ..++++.+..++.++..||.|||+.+|.|+|+||.||++..++ .+|++|||+++....+..
T Consensus 79 Vte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~-~~KlcdFg~Ar~m~~~t~v 156 (808)
T KOG0597|consen 79 VTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGG-TLKLCDFGLARAMSTNTSV 156 (808)
T ss_pred Eehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCC-ceeechhhhhhhcccCcee
Confidence 9999998 766666 5799999999999999999999999999999999999999888 899999999987665443
Q ss_pred cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCCh
Q 020826 172 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (321)
.+...||+.|+|||++.+ .+++..+|+|||||++||+++|+.||+... .......|.. ++
T Consensus 157 ltsikGtPlYmAPElv~e-~pyd~~sDlWslGcilYE~~~G~PPF~a~s-i~~Lv~~I~~----d~-------------- 216 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEE-QPYDHTSDLWSLGCILYELYVGQPPFYARS-ITQLVKSILK----DP-------------- 216 (808)
T ss_pred eeeccCcccccCHHHHcC-CCccchhhHHHHHHHHHHHhcCCCCchHHH-HHHHHHHHhc----CC--------------
Confidence 455689999999999997 899999999999999999999999995222 1111111111 10
Q ss_pred hhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCccc
Q 020826 252 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 310 (321)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~ 310 (321)
...+...|..+.+||+.+|..||.+|.|=.+++.|||.++
T Consensus 217 -------------------v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 217 -------------------VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKG 256 (808)
T ss_pred -------------------CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhh
Confidence 1112246789999999999999999999999999999986
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=330.13 Aligned_cols=285 Identities=27% Similarity=0.458 Sum_probs=215.6
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccC----
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---- 89 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~---- 89 (321)
..++|++.+.||+|+||.||++.+..+++.+|+|.+... ....+.+|+.+++.+ +||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHh-CCCchhceeeeeeccccccc
Confidence 468999999999999999999999889999999998642 234567899999999 8999999999885432
Q ss_pred CCCcEEEEEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 90 SKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
....+++||++.++........++...+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++......
T Consensus 94 ~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~-~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 94 FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTS 172 (355)
T ss_pred cceeEEEhhhhcccHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCC-CEEEeeCcccccCCCc
Confidence 234689999999876666666789999999999999999999999999999999999999888 8999999999765544
Q ss_pred CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 170 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
.......++..|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+.......+...++.+.... ....
T Consensus 173 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~-~~~~---- 245 (355)
T cd07874 173 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFP-GRDYIDQWNKVIEQLGTPCPEF-MKKL---- 245 (355)
T ss_pred cccCCccccCCccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHhCCCCHHH-HHhh----
Confidence 44455678899999999987 678999999999999999999999984 4444455555555544432111 1100
Q ss_pred ChhhHhhhcccCCCC---------Cc-cccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 250 DPHLAALVGRHSRKP---------WS-KFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~---------~~-~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
.+............. .. ...........+.++.+||.+||+.||++|||+.|+++||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~ 318 (355)
T cd07874 246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY 318 (355)
T ss_pred cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence 011111111000000 00 0001111223456789999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=325.99 Aligned_cols=255 Identities=23% Similarity=0.435 Sum_probs=221.9
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
..-|.+.+.||+|.|+.|-+|++..+|++||||++.+.. ...+.+|+.-|+.+ +|||||++|++...+ .-+|
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLV-QHpNiVRLYEViDTQ--TKly 93 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLV-QHPNIVRLYEVIDTQ--TKLY 93 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHh-cCcCeeeeeehhccc--ceEE
Confidence 345889999999999999999999999999999997543 45688999999998 999999999998443 4467
Q ss_pred EEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 95 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 95 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
+|.|.-.+|+|.+++ ..+++..++++++||+.|+.|+|+.++|||||||+||++...-+.|||+|||++..+.++.
T Consensus 94 LiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 94 LILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred EEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 999999999998888 4599999999999999999999999999999999999886554489999999999999999
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
...+.+|+..|.|||++++..+..++.||||||++||.++.|+.|| ...++.+.+..|...
T Consensus 174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PF-qeANDSETLTmImDC------------------ 234 (864)
T KOG4717|consen 174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPF-QEANDSETLTMIMDC------------------ 234 (864)
T ss_pred hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCcc-ccccchhhhhhhhcc------------------
Confidence 9999999999999999999777789999999999999999999998 455555555544321
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
....+..+|.++++||..||..||.+|.|.+|+..|+|++.++..-
T Consensus 235 -------------------KYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~ 280 (864)
T KOG4717|consen 235 -------------------KYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGL 280 (864)
T ss_pred -------------------cccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCc
Confidence 1222345778999999999999999999999999999999987653
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-46 Score=318.82 Aligned_cols=274 Identities=29% Similarity=0.547 Sum_probs=206.4
Q ss_pred CceEEeeeeeeecceEEEEEEEec-CCceEEEEEecccc-----hHHHHHHHHHHHhhc--CCCCeeeeeeeeec---cC
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCT-DNEKCIIKILKPVK-----KKKIKREIKILQNLC--GGPNIVKLLDIVRD---QQ 89 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~-~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~--~h~~i~~~~~~~~~---~~ 89 (321)
++|++.+.||+|+||+||+|++.. ++..+|+|.++... .....+|+.+++.+. .||||+++++++.. ..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 479999999999999999999854 46889999886432 234667888877763 69999999998752 23
Q ss_pred CCCcEEEEEeecCchhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecccee
Q 020826 90 SKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 164 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~ 164 (321)
...+++++|++.+ +|..++ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++.
T Consensus 81 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~-~~kl~Dfg~~~ 158 (290)
T cd07862 81 ETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLAR 158 (290)
T ss_pred CCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCC-CEEEccccceE
Confidence 4567899999986 454444 2378999999999999999999999999999999999999888 89999999998
Q ss_pred ecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhh
Q 020826 165 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244 (321)
Q Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (321)
............++..|+|||.+.+ ..++.++|||||||++|+|++|..|| .+....+.+..+....+.+....+...
T Consensus 159 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~~f-~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (290)
T cd07862 159 IYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLF-RGSSDVDQLGKILDVIGLPGEEDWPRD 236 (290)
T ss_pred eccCCcccccccccccccChHHHhC-CCCCCccchHHHHHHHHHHHcCCCCc-CCCCHHHHHHHHHHHhCCCChhhchhh
Confidence 7654444455678899999999977 67899999999999999999999887 455556666666665554332221111
Q ss_pred hcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
.... .... ...+..... .....+++.+.+++.+||+.||++|||+.|+++||||
T Consensus 237 ~~~~-----~~~~---~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 237 VALP-----RQAF---HSKSAQPIE--KFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hccc-----chhc---cCCCCCCHH--HHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0000 0000 000111111 1112467789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=327.35 Aligned_cols=242 Identities=26% Similarity=0.422 Sum_probs=197.9
Q ss_pred eeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEee
Q 020826 27 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 100 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 100 (321)
+.||+|+||+||+|++..+++.+|+|+++... ...+.+|+.+++.+ +||||+++++.+.. ....++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~--~~~~~lv~e~~ 77 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNT-RHPFLTALKYSFQT--HDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEc--CCEEEEEEeCC
Confidence 36899999999999999999999999987432 24567899999999 89999999999854 45678999999
Q ss_pred cCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC-CCcccccc
Q 020826 101 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV 176 (321)
Q Consensus 101 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~-~~~~~~~~ 176 (321)
.+++|..++ ..+++..+..++.||+.||+|||++|++|+||||+||+++.++ .++|+|||++..... ........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DfG~a~~~~~~~~~~~~~~ 156 (323)
T cd05571 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-CEEEeeCCCCcccccCCCccccee
Confidence 999987766 3589999999999999999999999999999999999999888 799999999875322 22334457
Q ss_pred CCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhh
Q 020826 177 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAAL 256 (321)
Q Consensus 177 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (321)
|++.|+|||++.+ ..++.++|||||||++|+|++|..||... +.......+.. +
T Consensus 157 gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~-~~~~~~~~~~~--~---------------------- 210 (323)
T cd05571 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHEKLFELILM--E---------------------- 210 (323)
T ss_pred cCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCC-CHHHHHHHHHc--C----------------------
Confidence 8999999999987 77899999999999999999999999432 21111111100 0
Q ss_pred hcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc-----CHHHHhcCCCcccC
Q 020826 257 VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPI 311 (321)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp-----s~~ell~hp~~~~~ 311 (321)
....+..+++++.++|++||+.||++|| ++.++++||||..+
T Consensus 211 -------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 211 -------------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred -------------CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 0011224678999999999999999999 89999999999875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-46 Score=328.68 Aligned_cols=282 Identities=30% Similarity=0.515 Sum_probs=216.6
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC---CCc
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---KTP 93 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~---~~~ 93 (321)
+|++.+.||+|+||+||++.+..+++.||+|.+... ....+.+|+.+++.+ +||||+++++++..... ...
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFF-KHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhC-CCCCcCCHhheecCCCccccceE
Confidence 478899999999999999999889999999988642 235678899999999 89999999999865431 256
Q ss_pred EEEEEeecCchhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-
Q 020826 94 SLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 170 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~- 170 (321)
++++||+.++.+.... ..+++..+..++.||+.||+|||++|++|+||||+||+++.++ .++|+|||++.......
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 80 YVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNC-VLKICDFGLARVEEPDES 158 (372)
T ss_pred EEEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCC-CEEeccccceeecccCcc
Confidence 8999999865443333 3589999999999999999999999999999999999999888 89999999987653322
Q ss_pred -ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 171 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
......++..|+|||.+.+...++.++||||+||++|+|++|+.|| .+.+...++..+...++.+..........
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~g~~~~~~~~~~~~--- 234 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILF-QAQSPIQQLDLITDLLGTPSLEAMRSACE--- 234 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCC-CCCCHHHHHHHHHHHcCCCCHHHHHHhhH---
Confidence 1233457888999999987556889999999999999999999888 45666677777777777765543322210
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
............+.............++++.+||.+||+.||++|||++|+++||||+..
T Consensus 235 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 235 --GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG 294 (372)
T ss_pred --HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence 111111111111111111112223457899999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-46 Score=325.28 Aligned_cols=255 Identities=29% Similarity=0.478 Sum_probs=206.4
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
++|++.+.||+|+||.||+|++..+++.||+|+++.. ....+..|+.++..+ +||||+++++++.+ ....+
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~--~~~~~ 77 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTT-KSEWLVKLLYAFQD--DEYLY 77 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhC-CCCCCccEEEEEEc--CCEEE
Confidence 4799999999999999999999889999999998743 234577899999999 79999999999854 45678
Q ss_pred EEEEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc
Q 020826 95 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 171 (321)
Q Consensus 95 lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~ 171 (321)
+||||+.+++|..++. .+++..++.++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++..... .
T Consensus 78 lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kL~Dfg~a~~~~~--~ 154 (333)
T cd05600 78 LAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASG-HIKLTDFGLSKGIVT--Y 154 (333)
T ss_pred EEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-CEEEEeCcCCccccc--c
Confidence 9999999999988873 589999999999999999999999999999999999999888 899999999876543 2
Q ss_pred cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCCh
Q 020826 172 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (321)
.....+++.|+|||++.+ ..++.++|||||||++|+|++|..||. ..+..+....+.......
T Consensus 155 ~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~-~~~~~~~~~~i~~~~~~~--------------- 217 (333)
T cd05600 155 ANSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFPPFS-GSTPNETWENLKYWKETL--------------- 217 (333)
T ss_pred cCCcccCccccChhHhcC-CCCCCccceecchHHHhhhhhCCCCCC-CCCHHHHHHHHHhccccc---------------
Confidence 345578999999999987 688999999999999999999999984 222222222221100000
Q ss_pred hhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 252 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
..+. .......+++++.++|.+||+.+|++|||++++++||||+++.
T Consensus 218 ----------~~~~----~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~ 264 (333)
T cd05600 218 ----------QRPV----YDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD 264 (333)
T ss_pred ----------cCCC----CCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCC
Confidence 0000 0000124678999999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=319.25 Aligned_cols=283 Identities=28% Similarity=0.526 Sum_probs=215.0
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
.++|++.+.||+|+||+||+|++..+++.+|+|.++... ...+.+|+.+++++ +||||+++++++... ...++
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~l 81 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIVHTD--KSLTL 81 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhC-CCCCcceEEEEEeeC--CeEEE
Confidence 478999999999999999999998899999999986432 24567899999999 899999999998653 45679
Q ss_pred EEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-c
Q 020826 96 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 171 (321)
Q Consensus 96 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~-~ 171 (321)
++||+.+..+.... ..++...+..++.|++.||+|||++|++||||||+||+++.++ .++|+|||++....... .
T Consensus 82 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~ 160 (309)
T cd07872 82 VFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERG-ELKLADFGLARAKSVPTKT 160 (309)
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECccccceecCCCccc
Confidence 99999874443332 2378899999999999999999999999999999999999887 89999999987543222 2
Q ss_pred cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCCh
Q 020826 172 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (321)
.....++..|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+..+.+..+...++.+....+...... .
T Consensus 161 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 236 (309)
T cd07872 161 YSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF-PGSTVEDELHLIFRLLGTPTEETWPGISSN---D 236 (309)
T ss_pred cccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHhhhcch---h
Confidence 234467889999999876567899999999999999999999888 455555666666666665544333211000 0
Q ss_pred hhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 252 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
.+.. .......+ . ........+++++.++|++||+.||.+|||++|+++||||+.+...
T Consensus 237 ~~~~-~~~~~~~~-~--~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~ 295 (309)
T cd07872 237 EFKN-YNFPKYKP-Q--PLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTR 295 (309)
T ss_pred hhhh-hhcCccCC-C--chhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcccc
Confidence 0000 00000000 0 0111223477899999999999999999999999999999987533
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=320.48 Aligned_cols=280 Identities=25% Similarity=0.492 Sum_probs=202.7
Q ss_pred eeeeeeecceEEEEEEEe--cCCceEEEEEecccc-hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeecC
Q 020826 26 VRKVGRGKYSEVFEGVHC--TDNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 102 (321)
Q Consensus 26 ~~~lg~g~~g~v~~~~~~--~~~~~~~vK~~~~~~-~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 102 (321)
..+||+|+||+||+|+++ .++..+|+|.+.... ...+.+|+.+++.+ +||||+++++++........++++|++.+
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLREL-KHPNVISLQKVFLSHADRKVWLLFDYAEH 84 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhc-CCCCCcceeeeEecCCCcEEEEEEeccCC
Confidence 357999999999999975 366899999987543 34678899999999 99999999999876666778899999886
Q ss_pred chhhhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEc----CCCCeEEEeeccceeecC
Q 020826 103 TDFKVLY-----------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID----HEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 103 ~~l~~~~-----------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~----~~~~~v~l~dfg~~~~~~ 167 (321)
....... ..+++..++.++.|++.||.|||++|++|+||||+||++. .++ .+||+|||++....
T Consensus 85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~-~~kl~DfG~a~~~~ 163 (317)
T cd07868 85 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG-RVKIADMGFARLFN 163 (317)
T ss_pred CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcC-cEEEeecCceeccC
Confidence 5332211 1488899999999999999999999999999999999994 334 79999999997654
Q ss_pred CCC----ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCC--------hHHHHHHHHHhCC
Q 020826 168 PGK----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN--------YDQLVKIAKVLGT 235 (321)
Q Consensus 168 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~ 235 (321)
... ......+|..|+|||++.+...++.++||||+||++|+|++|..||...... ..++..+...++.
T Consensus 164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (317)
T cd07868 164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF 243 (317)
T ss_pred CCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCC
Confidence 321 2234567889999999987567899999999999999999999998533321 3455556666665
Q ss_pred hhhhHHhhhhcccCChhhHhhhcccCCC--CCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 236 DELNAYLNKYHIELDPHLAALVGRHSRK--PWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
+....+...................... ...... .......++++.+||++||++||++|||++|+|+||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 244 PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYM-EKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred CChHHhHHHhhccchhhhhhhhhccccCcccccchH-HhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 4443333222111111111100000000 000000 01112234678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-46 Score=328.40 Aligned_cols=252 Identities=25% Similarity=0.410 Sum_probs=200.2
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
++|++.+.||+|+||+||+|.+..+++.||+|+++... ...+..|+.++..+ +||+|+++++.+.+ ....+
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~-~~~~iv~~~~~~~~--~~~~~ 77 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA-DSLWVVKMFYSFQD--KLNLY 77 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhC-CCCCcceEEEEEec--CCeEE
Confidence 57999999999999999999999999999999987432 24577899999999 89999999999855 45678
Q ss_pred EEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-
Q 020826 95 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 170 (321)
Q Consensus 95 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~- 170 (321)
+||||+.+++|..++ ..+++..++.++.|++.||+|||++||+||||||+||+++.++ .++|+|||+++......
T Consensus 78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~-~vkL~DFGla~~~~~~~~ 156 (363)
T cd05628 78 LIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG-HVKLSDFGLCTGLKKAHR 156 (363)
T ss_pred EEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC-CEEEeeccCccccccccc
Confidence 999999999988776 4589999999999999999999999999999999999999888 89999999986432110
Q ss_pred -----------------------------------ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCC
Q 020826 171 -----------------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEP 215 (321)
Q Consensus 171 -----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p 215 (321)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred ccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC-CCCCCchhhhhhHHHHHHHHhCCCC
Confidence 0123468999999999987 6789999999999999999999999
Q ss_pred CccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCC
Q 020826 216 FFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE 295 (321)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~ 295 (321)
|. +....+....+....... .......+++++.++|.+|+. +|.+
T Consensus 236 f~-~~~~~~~~~~i~~~~~~~---------------------------------~~p~~~~~s~~~~~li~~l~~-~~~~ 280 (363)
T cd05628 236 FC-SETPQETYKKVMNWKETL---------------------------------IFPPEVPISEKAKDLILRFCC-EWEH 280 (363)
T ss_pred CC-CCCHHHHHHHHHcCcCcc---------------------------------cCCCcCCCCHHHHHHHHHHcC-Chhh
Confidence 94 222222222221100000 000111366799999999875 4544
Q ss_pred ---CcCHHHHhcCCCcccCC
Q 020826 296 ---RPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 296 ---Rps~~ell~hp~~~~~~ 312 (321)
||+++|+++||||++++
T Consensus 281 r~~r~~~~ei~~hp~f~~~~ 300 (363)
T cd05628 281 RIGAPGVEEIKTNPFFEGVD 300 (363)
T ss_pred cCCCCCHHHHhCCCCCCCCC
Confidence 58999999999999764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=324.65 Aligned_cols=252 Identities=21% Similarity=0.369 Sum_probs=205.3
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEecCC-ceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeecc
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDN-EKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 88 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~-~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (321)
.....++|++.+.||+|+||.||+|.+..++ ..+|+|.+... ....+.+|+.++..+ +||||+++++++.+.
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~~ 103 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYI-NHPFCVNLYGSFKDE 103 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCCcceEEEEEeC
Confidence 3345678999999999999999999976654 68999998642 234577899999999 899999999999554
Q ss_pred CCCCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 89 QSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 89 ~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
...+++|||+.+++|..++ ..+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++..
T Consensus 104 --~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~-~ikL~DFG~a~~ 180 (340)
T PTZ00426 104 --SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG-FIKMTDFGFAKV 180 (340)
T ss_pred --CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC-CEEEecCCCCee
Confidence 5678999999999988776 3589999999999999999999999999999999999999887 899999999976
Q ss_pred cCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhh
Q 020826 166 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245 (321)
Q Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (321)
... ......||+.|+|||++.+ ..++.++|+|||||++|+|++|..||... +.......+...
T Consensus 181 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~-~~~~~~~~i~~~------------- 243 (340)
T PTZ00426 181 VDT--RTYTLCGTPEYIAPEILLN-VGHGKAADWWTLGIFIYEILVGCPPFYAN-EPLLIYQKILEG------------- 243 (340)
T ss_pred cCC--CcceecCChhhcCHHHHhC-CCCCccccccchhhHHHHHhcCCCCCCCC-CHHHHHHHHhcC-------------
Confidence 532 2234578999999999987 67899999999999999999999999532 222222211110
Q ss_pred cccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc-----CHHHHhcCCCcccCC
Q 020826 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIR 312 (321)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp-----s~~ell~hp~~~~~~ 312 (321)
....+..+++++.++|++||+.||++|+ |++++++||||++++
T Consensus 244 ------------------------~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~ 291 (340)
T PTZ00426 244 ------------------------IIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNID 291 (340)
T ss_pred ------------------------CCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 0011234567899999999999999995 899999999999764
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=322.57 Aligned_cols=262 Identities=30% Similarity=0.542 Sum_probs=218.2
Q ss_pred eeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeecc
Q 020826 15 FINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 88 (321)
Q Consensus 15 ~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (321)
.-......|++.+.||.|.||.||+++.+.+|+.+|+|.+.+.. ...+.+|+.+|+++..||||+.+++.+++.
T Consensus 29 ~~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~ 108 (382)
T KOG0032|consen 29 FSEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP 108 (382)
T ss_pred ccccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC
Confidence 34556678999999999999999999999999999999997543 257899999999996699999999999665
Q ss_pred CCCCcEEEEEeecCchhhhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCC---CeEEEeeccce
Q 020826 89 QSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ---RKLRLIDWGLA 163 (321)
Q Consensus 89 ~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~---~~v~l~dfg~~ 163 (321)
. ..++|||++.|+.|.+.+.. +++..+..++.|++.+++|||+.|++|+||||+|+++.... ..++++|||++
T Consensus 109 ~--~~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla 186 (382)
T KOG0032|consen 109 D--SVYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLA 186 (382)
T ss_pred C--eEEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCc
Confidence 4 56799999999998777744 99999999999999999999999999999999999997542 27999999999
Q ss_pred eecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 164 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
............+||+.|+|||++.. ..++..+||||+|+++|.|++|..||+..... .....+... ..
T Consensus 187 ~~~~~~~~~~~~~Gtp~y~APEvl~~-~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~-~~~~~i~~~--~~------- 255 (382)
T KOG0032|consen 187 KFIKPGERLHTIVGTPEYVAPEVLGG-RPYGDEVDVWSIGVILYILLSGVPPFWGETEF-EIFLAILRG--DF------- 255 (382)
T ss_pred eEccCCceEeeecCCccccCchhhcC-CCCCcccchhHHHHHHHHHhhCCCCCcCCChh-HHHHHHHcC--CC-------
Confidence 98877667788899999999999987 78999999999999999999999999543332 222222110 00
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCC
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~ 313 (321)
.+ ....-..+|..+.+++++||..||.+|+|+.++|+|||++....
T Consensus 256 -----------------------~f-~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~ 301 (382)
T KOG0032|consen 256 -----------------------DF-TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGE 301 (382)
T ss_pred -----------------------CC-CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcc
Confidence 00 00111246789999999999999999999999999999998633
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=315.30 Aligned_cols=273 Identities=28% Similarity=0.535 Sum_probs=206.3
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhc--CCCCeeeeeeeeecc---CCC
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLC--GGPNIVKLLDIVRDQ---QSK 91 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~--~h~~i~~~~~~~~~~---~~~ 91 (321)
+|++.+.||+|+||+||+|.+..+++.+|+|.++... .....+|+.+++.+. +||||+++++++... ...
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 5899999999999999999999999999999986432 234667888887763 699999999987543 234
Q ss_pred CcEEEEEeecCchhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeec
Q 020826 92 TPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 166 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~ 166 (321)
..++++|++.+ ++..++ ..+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++...
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~-~~kl~dfg~~~~~ 158 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-QVKLADFGLARIY 158 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECccCccccc
Confidence 57899999986 444333 2389999999999999999999999999999999999999888 8999999999766
Q ss_pred CCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhc
Q 020826 167 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246 (321)
Q Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (321)
..........++..|+|||++.+ ..++.++|||||||++|+|++|..|| .+......+..+....+.+....+.....
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~~f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T cd07863 159 SCQMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLF-CGNSEADQLGKIFDLIGLPPEDDWPRDVT 236 (288)
T ss_pred cCcccCCCccccccccCchHhhC-CCCCCcchhhhHHHHHHHHHhCCcCc-CCCCHHHHHHHHHHHhCCCChhhCccccc
Confidence 54444445667889999999987 67899999999999999999998776 45555555666555554443222211100
Q ss_pred ccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
.. .....+............+++++.++|.+||+.||++|||+.|++.||||
T Consensus 237 ~~----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 237 LP----------RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cc----------ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 00000000000011112466789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=329.50 Aligned_cols=254 Identities=30% Similarity=0.515 Sum_probs=206.1
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
++|++.+.||+|+||+||+|++..+++.||+|+++.. ....+..|+.++..+ +||||+++++++.+ ..+.+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~ 77 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-DSPWIVKLYYSFQD--EEHLY 77 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhc-CCCCccchhhheec--CCeEE
Confidence 4799999999999999999999889999999998743 234578899999999 89999999999854 45678
Q ss_pred EEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-
Q 020826 95 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 170 (321)
Q Consensus 95 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~- 170 (321)
+||||+.+++|..++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 78 LVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADG-HIKLADFGLCKKMNKAKD 156 (350)
T ss_pred EEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEeecCCCCccCcccCc
Confidence 999999999987776 3589999999999999999999999999999999999999888 89999999987654332
Q ss_pred -----------------------------ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCC
Q 020826 171 -----------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 221 (321)
Q Consensus 171 -----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~ 221 (321)
......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~Pf~~~~- 234 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSDT- 234 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCceeeEecchhhhhhccCCCCCCCCC-
Confidence 2234568899999999987 688999999999999999999999995332
Q ss_pred ChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC-HH
Q 020826 222 NYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-AK 300 (321)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps-~~ 300 (321)
.......+...... ........+++++.++|.+||+ ||.+|++ ++
T Consensus 235 ~~~~~~~i~~~~~~---------------------------------~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~ 280 (350)
T cd05573 235 LQETYNKIINWKES---------------------------------LRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFE 280 (350)
T ss_pred HHHHHHHHhccCCc---------------------------------ccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHH
Confidence 22222211110000 0011111257899999999998 9999999 99
Q ss_pred HHhcCCCcccCCCc
Q 020826 301 EAMAHPYFFPIRNA 314 (321)
Q Consensus 301 ell~hp~~~~~~~~ 314 (321)
++++||||++++..
T Consensus 281 ~ll~hp~~~~~~~~ 294 (350)
T cd05573 281 EIKSHPFFKGIDWE 294 (350)
T ss_pred HHhcCCCcCCCCHH
Confidence 99999999986443
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-46 Score=327.45 Aligned_cols=252 Identities=27% Similarity=0.460 Sum_probs=202.4
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
++|++.+.||+|+||+||+|++..+++.||+|+++... ...+.+|+.++..+ +||||+++++.+.+ ..+.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~--~~~~~ 77 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEA-DNPWVVKLYYSFQD--ENYLY 77 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEc--CCeEE
Confidence 47999999999999999999999999999999987432 24467899999999 89999999999865 45678
Q ss_pred EEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc
Q 020826 95 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 171 (321)
Q Consensus 95 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~ 171 (321)
+||||+.+++|..++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++........
T Consensus 78 lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 78 LIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKG-HIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred EEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEeecccceecccccc
Confidence 999999999998776 3589999999999999999999999999999999999999888 899999999865421110
Q ss_pred ---------------------------------------cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhC
Q 020826 172 ---------------------------------------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFR 212 (321)
Q Consensus 172 ---------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g 212 (321)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~G 235 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ-TGYNKECDWWSLGVIMYEMLVG 235 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC-CCCCCeeeeecchhHHHHhhcC
Confidence 012358999999999977 6789999999999999999999
Q ss_pred CCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccC
Q 020826 213 KEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYD 292 (321)
Q Consensus 213 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~d 292 (321)
..||... +..+....+.... ..........+++++.++|++||. +
T Consensus 236 ~~Pf~~~-~~~~~~~~i~~~~---------------------------------~~~~~~~~~~~s~~~~~li~~ll~-~ 280 (364)
T cd05599 236 YPPFCSD-NPQETYRKIINWK---------------------------------ETLQFPDEVPLSPEAKDLIKRLCC-E 280 (364)
T ss_pred CCCCCCC-CHHHHHHHHHcCC---------------------------------CccCCCCCCCCCHHHHHHHHHHcc-C
Confidence 9998422 2222221111000 000011112467899999999997 9
Q ss_pred CCCCcC---HHHHhcCCCcccCC
Q 020826 293 HQERPT---AKEAMAHPYFFPIR 312 (321)
Q Consensus 293 p~~Rps---~~ell~hp~~~~~~ 312 (321)
|.+|++ ++++++||||++.+
T Consensus 281 p~~R~~~~~~~~ll~h~~~~~~~ 303 (364)
T cd05599 281 AERRLGNNGVNEIKSHPFFKGVD 303 (364)
T ss_pred HhhcCCCCCHHHHhcCCCcCCCC
Confidence 999997 99999999998764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=318.52 Aligned_cols=250 Identities=20% Similarity=0.332 Sum_probs=201.6
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEecCCce-EEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeee
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEK-CIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVR 86 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~-~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (321)
.|.|. .++..+...+|+|+||+||+|.+ .|.. ||+|.+.... ...+.+|+.+|.++ +||||+++++++.
T Consensus 35 ~~~i~--~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~f~G~~~ 109 (362)
T KOG0192|consen 35 EEEID--PDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRL-RHPNIVQFYGACT 109 (362)
T ss_pred ceecC--hHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEc
Confidence 35554 45666777799999999999998 4444 9999998654 45899999999999 9999999999996
Q ss_pred ccCCCCcEEEEEeecCchhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-CeeecCCCCCeEEcCCCCeEEEeec
Q 020826 87 DQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHEQRKLRLIDW 160 (321)
Q Consensus 87 ~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~~-i~H~dlkp~nili~~~~~~v~l~df 160 (321)
++.. ..++||||+.+|+|..++ ..++...+..++.||+.||+|||+++ |+|+||||+|+|++.++..+||+||
T Consensus 110 ~~~~-~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DF 188 (362)
T KOG0192|consen 110 SPPG-SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADF 188 (362)
T ss_pred CCCC-ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCC
Confidence 6543 568999999999998887 35899999999999999999999999 9999999999999987658999999
Q ss_pred cceeecCCC-CccccccCCccccccccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhh
Q 020826 161 GLAEFYHPG-KEYNVRVASRYFKGPELLVD-LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 238 (321)
Q Consensus 161 g~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (321)
|+++..... .......||..|+|||++.+ ...++.++||||||+++|||+||+.||. +.........+......+.
T Consensus 189 Glsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~-~~~~~~~~~~v~~~~~Rp~- 266 (362)
T KOG0192|consen 189 GLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFE-DLAPVQVASAVVVGGLRPP- 266 (362)
T ss_pred ccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhcCCCCC-
Confidence 999876543 33344689999999999984 2689999999999999999999999993 3222222222222111111
Q ss_pred hHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 239 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
.+..+++.+..++..||+.||++||+..+++.
T Consensus 267 ----------------------------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 267 ----------------------------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred ----------------------------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 12235678999999999999999999987764
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-46 Score=309.50 Aligned_cols=255 Identities=25% Similarity=0.395 Sum_probs=211.3
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
-.-++|++++.||.|.-|+||++...+++..+|+|++.+.. ..+.+.|.++|..+ +||.++.+|..+ +...
T Consensus 74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~l-DHPFlPTLYa~f--et~~ 150 (459)
T KOG0610|consen 74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLL-DHPFLPTLYASF--ETDK 150 (459)
T ss_pred cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhc-CCCccchhhhee--eccc
Confidence 34568899999999999999999999999999999997543 35678899999999 999999999999 5567
Q ss_pred CcEEEEEeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeec
Q 020826 92 TPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 166 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~ 166 (321)
+.|++||||+||+|..+++ .+++..++-++.+|+.||+|||-.|||+|||||+||++..+| .|-|+||.++...
T Consensus 151 ~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredG-HIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 151 YSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDG-HIMLSDFDLSLRC 229 (459)
T ss_pred eeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCC-cEEeeeccccccC
Confidence 8899999999999987773 399999999999999999999999999999999999999998 8999999987322
Q ss_pred CC---------------------------------C-C-----------------------ccccccCCccccccccccC
Q 020826 167 HP---------------------------------G-K-----------------------EYNVRVASRYFKGPELLVD 189 (321)
Q Consensus 167 ~~---------------------------------~-~-----------------------~~~~~~~~~~y~aPE~~~~ 189 (321)
.- . . .....+||-.|.|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 00 0 0 0112367888999999998
Q ss_pred CCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCcccc
Q 020826 190 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFI 269 (321)
Q Consensus 190 ~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 269 (321)
..-+.+.|-|+||+++|||+.|..|| .+.++.+.+..++.. + .
T Consensus 310 -~GHgsAVDWWtfGIflYEmLyG~TPF-KG~~~~~Tl~NIv~~---~------------------------l-------- 352 (459)
T KOG0610|consen 310 -EGHGSAVDWWTFGIFLYEMLYGTTPF-KGSNNKETLRNIVGQ---P------------------------L-------- 352 (459)
T ss_pred -CCCCchhhHHHHHHHHHHHHhCCCCc-CCCCchhhHHHHhcC---C------------------------C--------
Confidence 67788999999999999999999999 566666666654330 0 0
Q ss_pred ccccccCCcchHHHHHHHhhccCCCCCcC----HHHHhcCCCcccCCC
Q 020826 270 TVENQHLAVPEAVDFLDKLLRYDHQERPT----AKEAMAHPYFFPIRN 313 (321)
Q Consensus 270 ~~~~~~~~s~~~~~ll~~~l~~dp~~Rps----~~ell~hp~~~~~~~ 313 (321)
.......+|.++++||+++|..||++|.. |+||-+||||++++=
T Consensus 353 ~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnW 400 (459)
T KOG0610|consen 353 KFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNW 400 (459)
T ss_pred cCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCCh
Confidence 00111145678999999999999999998 999999999998753
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=320.12 Aligned_cols=243 Identities=25% Similarity=0.437 Sum_probs=197.6
Q ss_pred eeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEee
Q 020826 27 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 100 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 100 (321)
+.||+|+||.||++++..++..||+|+++.. ....+.+|+.+++.+ +||||+++++.+.. ....++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~--~~~~~lv~E~~ 77 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQT--HDRLCFVMEYA 77 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCcceeeEEec--CCEEEEEEeCC
Confidence 3689999999999999999999999998743 223466899999999 99999999999854 44678999999
Q ss_pred cCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC-CCcccccc
Q 020826 101 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV 176 (321)
Q Consensus 101 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~-~~~~~~~~ 176 (321)
.+++|..++ ..+++..++.++.||+.||+|||++|++|+||||+||+++.++ .++|+|||++..... ........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~ 156 (323)
T cd05595 78 NGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDGATMKTFC 156 (323)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCC-CEEecccHHhccccCCCCcccccc
Confidence 999987665 3489999999999999999999999999999999999999887 899999999865322 22233456
Q ss_pred CCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhh
Q 020826 177 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAAL 256 (321)
Q Consensus 177 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (321)
++..|+|||.+.+ ..++.++|||||||++|+|++|..||.... .......+..
T Consensus 157 gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~g~~Pf~~~~-~~~~~~~~~~------------------------- 209 (323)
T cd05595 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELILM------------------------- 209 (323)
T ss_pred CCcCcCCcccccC-CCCCchhchhhhHHHHHHHHhCCCCCCCCC-HHHHHHHHhc-------------------------
Confidence 8899999999987 678999999999999999999999984322 2111111110
Q ss_pred hcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc-----CHHHHhcCCCcccCC
Q 020826 257 VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIR 312 (321)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp-----s~~ell~hp~~~~~~ 312 (321)
. ....+..+++++.++|++||+.||++|+ ++.++++||||....
T Consensus 210 --~----------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~ 258 (323)
T cd05595 210 --E----------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 258 (323)
T ss_pred --C----------CCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 0 0011224678999999999999999998 899999999998754
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=332.44 Aligned_cols=288 Identities=22% Similarity=0.402 Sum_probs=205.8
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc--hHHHHHHHHHHHhhc-----CCCCeeeeeeeeeccCCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLC-----GGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~E~~~l~~l~-----~h~~i~~~~~~~~~~~~~ 91 (321)
..++|++.+.||+|+||+||+|.+..+++.||||+++... ......|+.++..+. +|.+++++++++... ..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~-~~ 205 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE-TG 205 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC-Cc
Confidence 4578999999999999999999998899999999986432 344567888887762 345688899888644 34
Q ss_pred CcEEEEEeecCchhhhhc--CCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCeEEcCCCC---------------
Q 020826 92 TPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQR--------------- 153 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lh~-~~i~H~dlkp~nili~~~~~--------------- 153 (321)
+.++|++++++..+..+. ..+++..+..++.||+.||+|||+ .||+|+||||+||+++.++.
T Consensus 206 ~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~ 285 (467)
T PTZ00284 206 HMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC 285 (467)
T ss_pred eEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence 678999988665554443 358999999999999999999998 59999999999999986552
Q ss_pred eEEEeeccceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHh
Q 020826 154 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL 233 (321)
Q Consensus 154 ~v~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 233 (321)
.+||+|||.+.... .......+|..|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+.+..+.+.+
T Consensus 286 ~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvil~elltG~~pf-~~~~~~~~~~~i~~~~ 361 (467)
T PTZ00284 286 RVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGCIIYELYTGKLLY-DTHDNLEHLHLMEKTL 361 (467)
T ss_pred eEEECCCCccccCc--cccccccCCccccCcHHhhc-CCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHc
Confidence 48999999875432 22345678999999999987 78999999999999999999999888 4555666666666666
Q ss_pred CChhhhHHhhhhcccCChhhHhhhcc-cCCCCCccccccc-----cccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCC
Q 020826 234 GTDELNAYLNKYHIELDPHLAALVGR-HSRKPWSKFITVE-----NQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 307 (321)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-----~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~ 307 (321)
+..... +...........+...... ............. ....-++.+.+||.+||++||++|||++|+|+|||
T Consensus 362 g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~ 440 (467)
T PTZ00284 362 GRLPSE-WAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440 (467)
T ss_pred CCCCHH-HHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcc
Confidence 643221 1111000000000000000 0000000000000 00011357889999999999999999999999999
Q ss_pred cccCC
Q 020826 308 FFPIR 312 (321)
Q Consensus 308 ~~~~~ 312 (321)
|++..
T Consensus 441 ~~~~~ 445 (467)
T PTZ00284 441 VLKYY 445 (467)
T ss_pred ccccC
Confidence 99853
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-45 Score=318.26 Aligned_cols=249 Identities=24% Similarity=0.377 Sum_probs=201.2
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
+|++.+.||+|+||.||+|++..+++.||+|+++.. ....+..|..++..+.+|++|+++++++.+. ...++
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l 78 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM--DRLYF 78 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC--CEEEE
Confidence 589999999999999999999999999999998743 2345677888888885566789999888543 46789
Q ss_pred EEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC-CCCc
Q 020826 96 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKE 171 (321)
Q Consensus 96 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~-~~~~ 171 (321)
||||+.+++|..++ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++.... ....
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05587 79 VMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG-HIKIADFGMCKENIFGGKT 157 (324)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCC-CEEEeecCcceecCCCCCc
Confidence 99999999987776 3589999999999999999999999999999999999999888 89999999986532 2223
Q ss_pred cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCCh
Q 020826 172 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (321)
.....|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||. +.+..+....+...
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~-~~~~~~~~~~i~~~------------------- 216 (324)
T cd05587 158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPFD-GEDEDELFQSIMEH------------------- 216 (324)
T ss_pred eeeecCCccccChhhhcC-CCCCcccchhhhHHHHHHHHhCCCCCC-CCCHHHHHHHHHcC-------------------
Confidence 344568999999999987 678999999999999999999999984 22222222221110
Q ss_pred hhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCH-----HHHhcCCCcccCC
Q 020826 252 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA-----KEAMAHPYFFPIR 312 (321)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~-----~ell~hp~~~~~~ 312 (321)
....+..+++++.+++++||+.||++|++. +++++||||+.++
T Consensus 217 ------------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~ 264 (324)
T cd05587 217 ------------------NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRID 264 (324)
T ss_pred ------------------CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 001122466789999999999999999976 8999999998754
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=319.34 Aligned_cols=244 Identities=24% Similarity=0.393 Sum_probs=197.8
Q ss_pred eeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEee
Q 020826 27 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 100 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 100 (321)
+.||+|+||+||+|+++.+++.||+|+++.. ....+..|..++..+.+||||+++++++.+ ....++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~--~~~~~iv~Ey~ 78 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT--PDRLFFVMEFV 78 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc--CCEEEEEEcCC
Confidence 3689999999999999999999999998743 224466788888877689999999999854 45678999999
Q ss_pred cCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC-CCcccccc
Q 020826 101 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV 176 (321)
Q Consensus 101 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~-~~~~~~~~ 176 (321)
.+++|..++ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++..... ........
T Consensus 79 ~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~-~~kL~DfG~~~~~~~~~~~~~~~~ 157 (320)
T cd05590 79 NGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGIFNGKTTSTFC 157 (320)
T ss_pred CCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-cEEEeeCCCCeecCcCCCcccccc
Confidence 999987666 4589999999999999999999999999999999999999888 899999999875422 22334456
Q ss_pred CCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhh
Q 020826 177 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAAL 256 (321)
Q Consensus 177 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (321)
|++.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+.......+.. .
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~-~~~~~~~~~~i~~---~--------------------- 211 (320)
T cd05590 158 GTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFE-AENEDDLFEAILN---D--------------------- 211 (320)
T ss_pred cCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCC-CCCHHHHHHHHhc---C---------------------
Confidence 8999999999987 678999999999999999999999984 2222222222110 0
Q ss_pred hcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCH------HHHhcCCCcccCC
Q 020826 257 VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA------KEAMAHPYFFPIR 312 (321)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~------~ell~hp~~~~~~ 312 (321)
....+..+++++.++|++||+.||++|+++ +++++||||+.+.
T Consensus 212 -------------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~ 260 (320)
T cd05590 212 -------------EVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELD 260 (320)
T ss_pred -------------CCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCC
Confidence 001122356799999999999999999998 9999999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=325.44 Aligned_cols=252 Identities=25% Similarity=0.439 Sum_probs=199.0
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
.|++++.||+|+||+||+|++..+++.+|+|+++... ...+.+|+.+++.+ +||||+++++.+.+ ....++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~l~~~~~~--~~~~~l 78 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEA-DNEWVVKLYYSFQD--KDNLYF 78 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhc-CCCCeeeeEEEEec--CCEEEE
Confidence 6899999999999999999999999999999986432 24577899999999 99999999999965 456789
Q ss_pred EEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC--
Q 020826 96 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-- 170 (321)
Q Consensus 96 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~-- 170 (321)
||||+.+++|..++ ..+++..++.++.||+.||+|||+.||+||||||+||+++.++ .++|+|||++.......
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~-~~kL~DFGl~~~~~~~~~~ 157 (381)
T cd05626 79 VMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG-HIKLTDFGLCTGFRWTHNS 157 (381)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC-CEEEeeCcCCccccccccc
Confidence 99999999988776 3588999999999999999999999999999999999999887 89999999875321000
Q ss_pred ----------------------------------------------ccccccCCccccccccccCCCCCCCcchHHHHHH
Q 020826 171 ----------------------------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGC 204 (321)
Q Consensus 171 ----------------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~ 204 (321)
......||..|+|||++.+ ..++.++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlG~ 236 (381)
T cd05626 158 KYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR-KGYTQLCDWWSVGV 236 (381)
T ss_pred ccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC-CCCCCccceeehhh
Confidence 0012468899999999987 67899999999999
Q ss_pred HHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHH
Q 020826 205 MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDF 284 (321)
Q Consensus 205 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 284 (321)
++|+|++|..||...... .....+...... ........+++++.+|
T Consensus 237 il~elltG~~Pf~~~~~~-~~~~~i~~~~~~---------------------------------~~~~~~~~~s~~~~dl 282 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPT-ETQLKVINWENT---------------------------------LHIPPQVKLSPEAVDL 282 (381)
T ss_pred HHHHHHhCCCCCcCCCHH-HHHHHHHccccc---------------------------------cCCCCCCCCCHHHHHH
Confidence 999999999999533321 111111110000 0011112467899999
Q ss_pred HHHhhcc--CCCCCcCHHHHhcCCCcccCC
Q 020826 285 LDKLLRY--DHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 285 l~~~l~~--dp~~Rps~~ell~hp~~~~~~ 312 (321)
|.+|+.. +|..|+|++++++||||.+++
T Consensus 283 i~~ll~~~~~~~~R~~~~~~l~hp~f~~~~ 312 (381)
T cd05626 283 ITKLCCSAEERLGRNGADDIKAHPFFSEVD 312 (381)
T ss_pred HHHHccCcccccCCCCHHHHhcCcccCCCC
Confidence 9996654 455599999999999998754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-46 Score=327.99 Aligned_cols=252 Identities=26% Similarity=0.450 Sum_probs=200.0
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
++|++++.||+|+||+||++.+..+++.||+|++.... ...+.+|+.+++.+ +||||+++++++.+ ..+.+
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~--~~~~~ 77 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAES-DSPWVVSLYYSFQD--AQYLY 77 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhC-CCCCcceEEEEEEc--CCeeE
Confidence 47999999999999999999999999999999986432 24577899999998 99999999999965 45678
Q ss_pred EEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc
Q 020826 95 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 171 (321)
Q Consensus 95 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~ 171 (321)
+||||+.+++|..++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||+++.......
T Consensus 78 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~-~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 78 LIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGG-HIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC-CEEEeecccccccccccc
Confidence 999999999988776 3588999999999999999999999999999999999999888 899999999853211000
Q ss_pred ------------------------------------------------cccccCCccccccccccCCCCCCCcchHHHHH
Q 020826 172 ------------------------------------------------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLG 203 (321)
Q Consensus 172 ------------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG 203 (321)
.....||+.|+|||++.+ ..++.++||||||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG 235 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLG 235 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc-CCCCCceeeEecc
Confidence 012358899999999987 6789999999999
Q ss_pred HHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHH
Q 020826 204 CMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVD 283 (321)
Q Consensus 204 ~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 283 (321)
|++|+|++|..||... +..+....+...... ........+++++.+
T Consensus 236 vil~elltG~~Pf~~~-~~~~~~~~i~~~~~~---------------------------------~~~p~~~~~s~~~~d 281 (377)
T cd05629 236 AIMFECLIGWPPFCSE-NSHETYRKIINWRET---------------------------------LYFPDDIHLSVEAED 281 (377)
T ss_pred hhhhhhhcCCCCCCCC-CHHHHHHHHHccCCc---------------------------------cCCCCCCCCCHHHHH
Confidence 9999999999998432 222222222110000 001111235679999
Q ss_pred HHHHhhccCCCCC---cCHHHHhcCCCcccCC
Q 020826 284 FLDKLLRYDHQER---PTAKEAMAHPYFFPIR 312 (321)
Q Consensus 284 ll~~~l~~dp~~R---ps~~ell~hp~~~~~~ 312 (321)
||.+||+ +|.+| +|+.++++||||++++
T Consensus 282 li~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~ 312 (377)
T cd05629 282 LIRRLIT-NAENRLGRGGAHEIKSHPFFRGVD 312 (377)
T ss_pred HHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCC
Confidence 9999998 77775 5999999999999764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=318.65 Aligned_cols=240 Identities=24% Similarity=0.393 Sum_probs=195.7
Q ss_pred eeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeecC
Q 020826 29 VGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 102 (321)
Q Consensus 29 lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 102 (321)
||+|+||+||+|++..+++.+|+|+++.. ....+..|+.++..+ +||||+++++.+.+ ....++|+||+.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~e~~~~ 77 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQV-NCPFIVPLKFSFQS--PEKLYLVLAFING 77 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCcEeceeeEEec--CCeEEEEEcCCCC
Confidence 69999999999999989999999998642 224567899999999 99999999998854 4567899999999
Q ss_pred chhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC-CccccccCC
Q 020826 103 TDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNVRVAS 178 (321)
Q Consensus 103 ~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~-~~~~~~~~~ 178 (321)
++|..++ ..+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++...... .......||
T Consensus 78 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt 156 (312)
T cd05585 78 GELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQG-HIALCDFGLCKLNMKDDDKTNTFCGT 156 (312)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCC-cEEEEECcccccCccCCCccccccCC
Confidence 9997776 3589999999999999999999999999999999999999888 8999999998754322 223345689
Q ss_pred ccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhc
Q 020826 179 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVG 258 (321)
Q Consensus 179 ~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (321)
+.|+|||++.+ ..++.++|||||||++|+|++|..||... +..+....+.. .
T Consensus 157 ~~y~aPE~~~~-~~~~~~~DvwslGvil~el~tg~~pf~~~-~~~~~~~~~~~---~----------------------- 208 (312)
T cd05585 157 PEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLPPFYDE-NVNEMYRKILQ---E----------------------- 208 (312)
T ss_pred cccCCHHHHcC-CCCCCccceechhHHHHHHHhCCCCcCCC-CHHHHHHHHHc---C-----------------------
Confidence 99999999987 77899999999999999999999998422 21111111100 0
Q ss_pred ccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc---CHHHHhcCCCcccC
Q 020826 259 RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP---TAKEAMAHPYFFPI 311 (321)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp---s~~ell~hp~~~~~ 311 (321)
....+..+++++.++|.+||+.||++|| ++.|+++||||.+.
T Consensus 209 -----------~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 209 -----------PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred -----------CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 0011234668999999999999999997 58999999999986
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=319.58 Aligned_cols=254 Identities=24% Similarity=0.404 Sum_probs=200.8
Q ss_pred ceEEeeeeeeecceEEEEEEEe---cCCceEEEEEecccc-------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPVK-------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~---~~~~~~~vK~~~~~~-------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
+|++.+.||+|+||+||++++. .+++.+|+|+++... ...+..|+.++..+.+||+|+++++++.. ..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT--EA 78 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec--CC
Confidence 5899999999999999999874 468899999986422 23467899999999779999999998854 44
Q ss_pred CcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 92 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
..+++|||+.+++|..++ ..+++..+..++.||+.||+|||++|++||||||+||+++.++ .++|+|||++.....
T Consensus 79 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~-~~kl~DfG~~~~~~~ 157 (332)
T cd05614 79 KLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG-HVVLTDFGLSKEFLS 157 (332)
T ss_pred EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCC-CEEEeeCcCCccccc
Confidence 567999999999987766 4589999999999999999999999999999999999999888 899999999875432
Q ss_pred CC--ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhc
Q 020826 169 GK--EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246 (321)
Q Consensus 169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (321)
.. ......||..|+|||++.+...++.++|||||||++|+|++|..||....... ....+.....
T Consensus 158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-~~~~~~~~~~------------ 224 (332)
T cd05614 158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERN-TQSEVSRRIL------------ 224 (332)
T ss_pred cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCC-CHHHHHHHHh------------
Confidence 22 22345689999999999874568899999999999999999999984221110 0111100000
Q ss_pred ccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc-----CHHHHhcCCCcccCC
Q 020826 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIR 312 (321)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp-----s~~ell~hp~~~~~~ 312 (321)
.. ....+..+++.+.++|.+||+.||++|| +++++++||||++..
T Consensus 225 -----------~~----------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~ 274 (332)
T cd05614 225 -----------KC----------DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274 (332)
T ss_pred -----------cC----------CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence 00 0011224667899999999999999999 889999999999753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=319.40 Aligned_cols=280 Identities=22% Similarity=0.350 Sum_probs=207.9
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
..++|++.+.||+|+||.||++++..++..+++|.++... ...+.+|+++++.+ +||||+++++++.+. ...+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~ 79 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSD--GEIS 79 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEEC--CEEE
Confidence 3689999999999999999999999999999999987532 35688999999999 899999999998654 4567
Q ss_pred EEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 95 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 95 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~-~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
++|||+.+++|..++ ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .++|+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS- 157 (331)
T ss_pred EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC-cEEEccCccccccccc-
Confidence 999999999998877 3489999999999999999999986 599999999999999888 8999999998755322
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHH------hhh
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY------LNK 244 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~ 244 (321)
......++..|+|||++.+ ..++.++|||||||++|+|++|+.||... + ...+..+ ++....... ...
T Consensus 158 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~~~-~-~~~~~~~---~~~~~~~~~~~~~~~~~~ 231 (331)
T cd06649 158 MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVELAIGRYPIPPP-D-AKELEAI---FGRPVVDGEEGEPHSISP 231 (331)
T ss_pred ccccCCCCcCcCCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCCC-C-HHHHHHH---hcccccccccCCccccCc
Confidence 2234568899999999987 67899999999999999999999998422 2 2222211 111100000 000
Q ss_pred hccc-----------CCh--hhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 245 YHIE-----------LDP--HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 245 ~~~~-----------~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
.... ..+ ............. ........+++++.+||.+||+.||++|||+.++++||||+..
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~ 307 (331)
T cd06649 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEP----PPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS 307 (331)
T ss_pred ccccccccccccccccccchhHHHHHHHHHhCC----CcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence 0000 000 0000000000000 0000112366789999999999999999999999999999876
Q ss_pred CC
Q 020826 312 RN 313 (321)
Q Consensus 312 ~~ 313 (321)
..
T Consensus 308 ~~ 309 (331)
T cd06649 308 EV 309 (331)
T ss_pred cc
Confidence 43
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=310.97 Aligned_cols=254 Identities=25% Similarity=0.373 Sum_probs=204.9
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
.|++.+.||+|+||+||++.+..+++.||+|.+.... ...+.+|+.+++.+ +||||+++++.+.. ....++
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 77 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYET--KDALCL 77 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhc-CCCCEeeeeeeecC--CCeEEE
Confidence 4889999999999999999998899999999986432 23456799999999 89999999998854 346789
Q ss_pred EEEeecCchhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 96 IFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 96 v~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
+|||+.+++|..++ ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 78 VLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG-HIRISDLGLAVEIPEGE 156 (285)
T ss_pred EEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCC-CEEEeeCCCceecCCCC
Confidence 99999999987654 2488999999999999999999999999999999999999877 89999999988765444
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
......++..|+|||++.+ ..++.++||||+||++|++++|..||... ........+........
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~-~~~~~~~~~~~~~~~~~------------- 221 (285)
T cd05605 157 TIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQR-KEKVKREEVERRVKEDQ------------- 221 (285)
T ss_pred ccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCC-chhhHHHHHHHHhhhcc-------------
Confidence 4445578899999999987 67899999999999999999999998432 22222222111110000
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc-----CHHHHhcCCCcccCCCc
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp-----s~~ell~hp~~~~~~~~ 314 (321)
...+..+++.+.+++.+||+.||++|| +++++++||||...+-.
T Consensus 222 --------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05605 222 --------------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK 270 (285)
T ss_pred --------------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence 001123567899999999999999999 99999999999985433
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-45 Score=313.18 Aligned_cols=275 Identities=30% Similarity=0.519 Sum_probs=212.6
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
+|++.+.||+|++|.||+|++..+|+.+++|.++... ...+.+|+.+++.+ +|||++++++++.+ ....+++
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 77 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLYDVLHS--DKKLTLV 77 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhc-CCCCeeeHHHHhcc--CCceEEE
Confidence 5899999999999999999999999999999986432 24577899999999 89999999999855 4467899
Q ss_pred EEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-cc
Q 020826 97 FEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EY 172 (321)
Q Consensus 97 ~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~-~~ 172 (321)
+||+.++.+..+. ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||++....... ..
T Consensus 78 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~ 156 (284)
T cd07839 78 FEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG-ELKLADFGLARAFGIPVRCY 156 (284)
T ss_pred EecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCC-cEEECccchhhccCCCCCCc
Confidence 9999875544333 3589999999999999999999999999999999999999887 89999999987553322 22
Q ss_pred ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChh
Q 020826 173 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 252 (321)
Q Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (321)
....++..|+|||.+.+...++.++|||||||++|+|++|+.|++.+.+..+.+..+.+.++......+..........
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 235 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK- 235 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccccc-
Confidence 3345678899999987755678999999999999999999999888777777777776666554433322111000000
Q ss_pred hHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 253 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
. ... .............+++++.++|++||+.||++|||++++++||||
T Consensus 236 --~----~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 236 --P----YPM-YPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred --c----cCC-CCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 000 000000011223477899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=324.18 Aligned_cols=256 Identities=25% Similarity=0.400 Sum_probs=205.3
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
...++|++.+.||+|+||+||++++..+++.+|+|+++.. ....+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~-~h~~iv~~~~~~~~--~~ 116 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHA-NSEWIVQLHYAFQD--DK 116 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEec--CC
Confidence 3467999999999999999999999999999999998642 223467899999998 99999999998854 45
Q ss_pred CcEEEEEeecCchhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 92 TPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
+.++||||+.+++|..++. .+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++......
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~-~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCC-CEEEEeccceeeccCC
Confidence 6789999999999988774 488899999999999999999999999999999999999888 8999999998765432
Q ss_pred C--ccccccCCccccccccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhh
Q 020826 170 K--EYNVRVASRYFKGPELLVDL---QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244 (321)
Q Consensus 170 ~--~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (321)
. ......||+.|+|||++.+. ..++.++|+|||||++|+|++|..||.... .......+......
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~-~~~~~~~i~~~~~~--------- 265 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS-LVGTYSKIMDHKNS--------- 265 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC-HHHHHHHHHcCCCc---------
Confidence 2 22345789999999998652 247889999999999999999999994322 22222221110000
Q ss_pred hcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCC--CcCHHHHhcCCCcccC
Q 020826 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE--RPTAKEAMAHPYFFPI 311 (321)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~--Rps~~ell~hp~~~~~ 311 (321)
........+|+++.++|++||+.+|.+ |+|++++++||||++.
T Consensus 266 ------------------------~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 266 ------------------------LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred ------------------------CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 001111246789999999999999988 9999999999999874
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=313.23 Aligned_cols=247 Identities=23% Similarity=0.479 Sum_probs=211.7
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
..+|++.+.||+|.||+|-+|.....|..||||.++++. .-.+.+|+++|..| +||||++++++|+ +..-+
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsL-NHPhII~IyEVFE--NkdKI 128 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSL-NHPHIIQIYEVFE--NKDKI 128 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhc-CCCceeehhhhhc--CCceE
Confidence 468999999999999999999998999999999998653 23578999999999 9999999999994 45567
Q ss_pred EEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 94 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
+|||||..+|.|.+++ +.+++.+++.++.||..|+.|+|+++++|+|||.+||++|.++ ++||+|||++..+....
T Consensus 129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~-NiKIADFGLSNly~~~k 207 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNN-NIKIADFGLSNLYADKK 207 (668)
T ss_pred EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCC-Ceeeeccchhhhhcccc
Confidence 7999999999999998 4699999999999999999999999999999999999999998 89999999999887777
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
-..+.+|++.|.+||++.+..+-.+..|-||||++||-++.|..||. +.+....+.+|.. .
T Consensus 208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFD-G~Dhk~lvrQIs~----G-------------- 268 (668)
T KOG0611|consen 208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFD-GRDHKRLVRQISR----G-------------- 268 (668)
T ss_pred HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccC-CchHHHHHHHhhc----c--------------
Confidence 78899999999999999986666789999999999999999999992 3333222222211 0
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcc
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF 309 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~ 309 (321)
..+.+ .-+.+..-||+.||.+||++|.|++++.+|=|.+
T Consensus 269 ---------aYrEP-----------~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 269 ---------AYREP-----------ETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred ---------cccCC-----------CCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 00111 1224788999999999999999999999998887
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=319.33 Aligned_cols=242 Identities=26% Similarity=0.414 Sum_probs=196.7
Q ss_pred eeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEee
Q 020826 27 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 100 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 100 (321)
+.||+|+||.||++.+..+++.+|+|+++.. ....+.+|+.+++.+ +||||+++++.+.+ ....++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~lv~Ey~ 77 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT-RHPFLTSLKYSFQT--KDRLCFVMEYV 77 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceEEEEEc--CCEEEEEEeCC
Confidence 3689999999999999999999999998743 234567899999999 89999999998854 45678999999
Q ss_pred cCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC-CCcccccc
Q 020826 101 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV 176 (321)
Q Consensus 101 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~-~~~~~~~~ 176 (321)
.+++|...+ ..+++..+..++.||+.||+|||++|++|+||||+||+++.++ .++|+|||++..... ........
T Consensus 78 ~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kL~DfG~~~~~~~~~~~~~~~~ 156 (328)
T cd05593 78 NGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG-HIKITDFGLCKEGITDAATMKTFC 156 (328)
T ss_pred CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCC-cEEEecCcCCccCCCccccccccc
Confidence 999987666 3589999999999999999999999999999999999999888 899999999875322 22223456
Q ss_pred CCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhh
Q 020826 177 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAAL 256 (321)
Q Consensus 177 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (321)
+++.|+|||++.+ ..++.++|||||||++|+|++|..||... +.......+.. .
T Consensus 157 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~Pf~~~-~~~~~~~~~~~----~-------------------- 210 (328)
T cd05593 157 GTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHEKLFELILM----E-------------------- 210 (328)
T ss_pred CCcCccChhhhcC-CCCCccCCccccchHHHHHhhCCCCCCCC-CHHHHHHHhcc----C--------------------
Confidence 8999999999987 67899999999999999999999998432 21111111100 0
Q ss_pred hcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc-----CHHHHhcCCCcccC
Q 020826 257 VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPI 311 (321)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp-----s~~ell~hp~~~~~ 311 (321)
....+..+++++.++|++||+.||++|+ ++.++++||||...
T Consensus 211 -------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 257 (328)
T cd05593 211 -------------DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGV 257 (328)
T ss_pred -------------CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 0011224678999999999999999997 89999999999874
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=326.56 Aligned_cols=252 Identities=25% Similarity=0.417 Sum_probs=200.5
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
+|++++.||+|+||+||+|++..+++.+|+|++.... ...+.+|+.+++.+ +||||+++++.+.+ ....++
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~-~h~~iv~~~~~~~~--~~~~~l 78 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEA-DNEWVVRLYYSFQD--KDNLYF 78 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhC-CCCcCCeEEEEEEe--CCEEEE
Confidence 6899999999999999999999999999999987432 24577899999999 99999999999965 456789
Q ss_pred EEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC---
Q 020826 96 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG--- 169 (321)
Q Consensus 96 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~--- 169 (321)
||||+.+++|..++ ..+++..++.++.||+.||+|||++||+|+||||+||+++.++ .++|+|||++......
T Consensus 79 v~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g-~~kL~DFGla~~~~~~~~~ 157 (382)
T cd05625 79 VMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWTHDS 157 (382)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEEeECCCCccccccccc
Confidence 99999999987776 3488999999999999999999999999999999999999888 8999999987432100
Q ss_pred ---------------------------------------------CccccccCCccccccccccCCCCCCCcchHHHHHH
Q 020826 170 ---------------------------------------------KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGC 204 (321)
Q Consensus 170 ---------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~ 204 (321)
.......||+.|+|||++.+ ..++.++|||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGv 236 (382)
T cd05625 158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGV 236 (382)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC-CCCCCeeeEEechH
Confidence 00112368899999999987 67899999999999
Q ss_pred HHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHH
Q 020826 205 MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDF 284 (321)
Q Consensus 205 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 284 (321)
++|+|++|..||... +..+....+...... ........+++++.++
T Consensus 237 il~elltG~~Pf~~~-~~~~~~~~i~~~~~~---------------------------------~~~p~~~~~s~~~~~l 282 (382)
T cd05625 237 ILYEMLVGQPPFLAQ-TPLETQMKVINWQTS---------------------------------LHIPPQAKLSPEASDL 282 (382)
T ss_pred HHHHHHhCCCCCCCC-CHHHHHHHHHccCCC---------------------------------cCCCCcccCCHHHHHH
Confidence 999999999999432 222222211110000 0011122467899999
Q ss_pred HHHhhccCCCCCcC---HHHHhcCCCcccCCC
Q 020826 285 LDKLLRYDHQERPT---AKEAMAHPYFFPIRN 313 (321)
Q Consensus 285 l~~~l~~dp~~Rps---~~ell~hp~~~~~~~ 313 (321)
|.+|+ .+|++|++ ++++++||||+.++.
T Consensus 283 i~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~ 313 (382)
T cd05625 283 IIKLC-RGPEDRLGKNGADEIKAHPFFKTIDF 313 (382)
T ss_pred HHHHc-cCHhHcCCCCCHHHHhcCCCcCCcCh
Confidence 99986 59999987 999999999998643
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=321.36 Aligned_cols=284 Identities=31% Similarity=0.553 Sum_probs=212.3
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccC----
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---- 89 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~---- 89 (321)
..++|++.+.||+|+||+||+|.+..+++.||+|.+.... ...+.+|+.+++.+ +||||+++++++....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM-KHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhc-CCCchhhhhhhhcccccccc
Confidence 3578999999999999999999999999999999986432 24567899999999 8999999999875322
Q ss_pred CCCcEEEEEeecCchhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 90 SKTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
....+++++++ +++|..++ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++....
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~ 169 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC-ELRILDFGLARQAD 169 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCC-CEEEcCCccceecC
Confidence 13457888887 45666555 3599999999999999999999999999999999999999888 89999999987654
Q ss_pred CCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 168 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
. ......++..|+|||++.+...++.++|||||||++|+|++|+.|| .+.+....+..+....+.......... ..
T Consensus 170 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 245 (343)
T cd07878 170 D--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALF-PGNDYIDQLKRIMEVVGTPSPEVLKKI-SS 245 (343)
T ss_pred C--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHhc-ch
Confidence 2 2334568899999999977567889999999999999999999888 444555555555555544332221110 00
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
.............+..... ......++.+.+||.+||+.||++|||+.|+++||||.+...+
T Consensus 246 ---~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~ 307 (343)
T cd07878 246 ---EHARKYIQSLPHMPQQDLK--KIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP 307 (343)
T ss_pred ---hhHHHHhhccccccchhHH--HhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCC
Confidence 0000000000001111000 0111345678999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=311.88 Aligned_cols=283 Identities=28% Similarity=0.536 Sum_probs=212.0
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
..++|++.+.||+|+||.||+|++..+++.|++|.++... ...+.+|+.+++.+ +||||+++++++.. ....+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~nI~~~~~~~~~--~~~~~ 80 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHT--EKSLT 80 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhc-CCCCcceEEEEEec--CCeEE
Confidence 3578999999999999999999998899999999986432 34577899999999 89999999999864 44678
Q ss_pred EEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC-
Q 020826 95 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG- 169 (321)
Q Consensus 95 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~- 169 (321)
+++||+.+ +|..++ ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||++......
T Consensus 81 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 81 LVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERG-ELKLADFGLARAKSIPT 158 (301)
T ss_pred EEEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCC-cEEECcCcchhccCCCC
Confidence 99999986 444433 3488999999999999999999999999999999999999887 8999999998654322
Q ss_pred CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 170 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
.......++..|+|||.+.+...++.++||||||+++|+|++|+.||. +.+..+....+...++.+....+.......
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 236 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFP-GSTVEEQLHFIFRILGTPTEETWPGILSNE- 236 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHcCCCChhhchhhhccc-
Confidence 222334567889999998765668899999999999999999998884 444445555555554443322211100000
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
.....................+++.+.+||.+||+.||.+|||++|+++||||+.+.+.
T Consensus 237 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~ 295 (301)
T cd07873 237 ------EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGER 295 (301)
T ss_pred ------cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccch
Confidence 00000000000000011223567889999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=316.82 Aligned_cols=248 Identities=23% Similarity=0.413 Sum_probs=199.2
Q ss_pred eEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhc--CCCCeeeeeeeeeccCCCCcE
Q 020826 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLC--GGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 23 y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~--~h~~i~~~~~~~~~~~~~~~~ 94 (321)
|++.+.||+|+||.||+|.+..+++.||+|+++... ...+..|..++..+. +||||+++++++.+ ....+
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~--~~~~~ 78 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT--EDHVC 78 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc--CCEEE
Confidence 688999999999999999999999999999987432 244666766654332 79999999999854 45678
Q ss_pred EEEEeecCchhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC-CCc
Q 020826 95 LIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKE 171 (321)
Q Consensus 95 lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~-~~~ 171 (321)
+||||+.+++|...+. .+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++..... ...
T Consensus 79 lv~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~ 157 (324)
T cd05589 79 FVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEG-FVKIADFGLCKEGMGFGDR 157 (324)
T ss_pred EEEcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC-cEEeCcccCCccCCCCCCc
Confidence 9999999999877763 589999999999999999999999999999999999999888 899999999864322 222
Q ss_pred cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCCh
Q 020826 172 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (321)
.....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||. +.+..+....+..
T Consensus 158 ~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~G~~pf~-~~~~~~~~~~i~~-------------------- 215 (324)
T cd05589 158 TSTFCGTPEFLAPEVLTE-TSYTRAVDWWGLGVLIYEMLVGESPFP-GDDEEEVFDSIVN-------------------- 215 (324)
T ss_pred ccccccCccccCHhHhcC-CCCCcccchhhHHHHHHHHHhCCCCCC-CCCHHHHHHHHHh--------------------
Confidence 344568899999999987 678999999999999999999999983 2222222222111
Q ss_pred hhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc-----CHHHHhcCCCcccCC
Q 020826 252 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIR 312 (321)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp-----s~~ell~hp~~~~~~ 312 (321)
.. ...+..+++++.++|++||+.||++|| ++.++++||||+++.
T Consensus 216 -------~~----------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~ 264 (324)
T cd05589 216 -------DE----------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDIN 264 (324)
T ss_pred -------CC----------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCC
Confidence 00 001223567899999999999999999 799999999998753
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=327.12 Aligned_cols=252 Identities=25% Similarity=0.413 Sum_probs=200.5
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
.+|++++.||+|+||+||+|++..+++.+|+|++... ....+.+|+.+++.+ +||||+++++.+.+ ...++
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~h~~iv~~~~~~~~--~~~~~ 77 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEA-DNEWVVKLYYSFQD--KDNLY 77 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhC-CCCCcceEEEEEEc--CCEEE
Confidence 4799999999999999999999999999999998643 234577899999999 99999999999865 45678
Q ss_pred EEEEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC--
Q 020826 95 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-- 169 (321)
Q Consensus 95 lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~-- 169 (321)
+||||+.+++|.+++. .+++..++.++.||+.||+|||++||+||||||+||+++.++ .++|+|||++......
T Consensus 78 lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~-~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 78 FVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCC-CEEEEeCCCCcccccccc
Confidence 9999999999988763 478899999999999999999999999999999999999888 8999999987422100
Q ss_pred ------------------------------------------CccccccCCccccccccccCCCCCCCcchHHHHHHHHH
Q 020826 170 ------------------------------------------KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFA 207 (321)
Q Consensus 170 ------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~ 207 (321)
.......||+.|+|||++.+ ..++.++|||||||++|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvily 235 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR-TGYTQLCDWWSVGVILY 235 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC-CCCCcceeeeeccceee
Confidence 00012368899999999987 77899999999999999
Q ss_pred HHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHH
Q 020826 208 GMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDK 287 (321)
Q Consensus 208 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~ 287 (321)
+|++|+.||... +..+....+.... ..........+++++.++|.+
T Consensus 236 ell~G~~Pf~~~-~~~~~~~~i~~~~---------------------------------~~~~~~~~~~~s~~~~~li~~ 281 (376)
T cd05598 236 EMLVGQPPFLAD-TPAETQLKVINWE---------------------------------TTLHIPSQAKLSREASDLILR 281 (376)
T ss_pred ehhhCCCCCCCC-CHHHHHHHHhccC---------------------------------ccccCCCCCCCCHHHHHHHHH
Confidence 999999999432 2222211111000 000011112467899999999
Q ss_pred hhccCCCCCc---CHHHHhcCCCcccCC
Q 020826 288 LLRYDHQERP---TAKEAMAHPYFFPIR 312 (321)
Q Consensus 288 ~l~~dp~~Rp---s~~ell~hp~~~~~~ 312 (321)
|+ .+|++|+ |+.++++||||++++
T Consensus 282 l~-~~p~~R~~~~t~~ell~h~~~~~~~ 308 (376)
T cd05598 282 LC-CGAEDRLGKNGADEIKAHPFFKGID 308 (376)
T ss_pred Hh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence 76 5999999 999999999999764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=321.04 Aligned_cols=253 Identities=26% Similarity=0.436 Sum_probs=203.6
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
++|++.+.||+|+||+||+|++..+++.+|+|+++... ...+.+|+.+++.+ +||||+++++++.+ ....+
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~~~~i~~~~~~~~~--~~~~~ 77 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS-NSPWIPQLQYAFQD--KDNLY 77 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCcceeeEEec--CCeEE
Confidence 47999999999999999999999999999999987532 24577889998888 99999999998855 45678
Q ss_pred EEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 95 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 95 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
+||||+.+++|..++ ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||++.......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~~~~ 156 (330)
T cd05601 78 LVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTG-HIKLADFGSAARLTANK 156 (330)
T ss_pred EEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCC-CEEeccCCCCeECCCCC
Confidence 999999999988776 3589999999999999999999999999999999999999888 89999999997664333
Q ss_pred c--cccccCCccccccccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 171 E--YNVRVASRYFKGPELLVD-----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 171 ~--~~~~~~~~~y~aPE~~~~-----~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
. .....+|..|+|||++.. ...++.++|||||||++|+|++|..||.... .......+...
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~-~~~~~~~i~~~----------- 224 (330)
T cd05601 157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT-SAKTYNNIMNF----------- 224 (330)
T ss_pred ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC-HHHHHHHHHcC-----------
Confidence 2 223468899999999863 2567889999999999999999999984322 22222211110
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
...........+++++.+||++||+ ||.+|||++++++||||..++
T Consensus 225 ----------------------~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~ 270 (330)
T cd05601 225 ----------------------QRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKID 270 (330)
T ss_pred ----------------------CCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence 0000011122466899999999998 999999999999999999754
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=318.26 Aligned_cols=252 Identities=24% Similarity=0.414 Sum_probs=197.4
Q ss_pred eeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEee
Q 020826 27 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 100 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 100 (321)
+.||+|+||+||+|.+..+++.||+|+++... ...+..|..++..+.+||||+++++++.+ ....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~--~~~~~lv~e~~ 78 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT--ESRLFFVIEFV 78 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc--CCEEEEEEeCC
Confidence 36899999999999999999999999997531 24467899999988789999999999854 45678999999
Q ss_pred cCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC-CCCcccccc
Q 020826 101 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRV 176 (321)
Q Consensus 101 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~-~~~~~~~~~ 176 (321)
.+++|..++ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++.... .........
T Consensus 79 ~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (329)
T cd05588 79 SGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGIRPGDTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEECcCccccccccCCCcccccc
Confidence 999987665 4699999999999999999999999999999999999999887 89999999986432 223334567
Q ss_pred CCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhh
Q 020826 177 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAAL 256 (321)
Q Consensus 177 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (321)
||..|+|||++.+ ..++.++|+|||||++|+|++|+.||........... ..... .....
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~---------~~~~~----------~~~~~ 217 (329)
T cd05588 158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQ---------NTEDY----------LFQVI 217 (329)
T ss_pred CCccccCHHHHcC-CCCCCccceechHHHHHHHHHCCCCcccccccccccc---------cchHH----------HHHHH
Confidence 8999999999987 7789999999999999999999999842110000000 00000 00000
Q ss_pred hcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC------HHHHhcCCCcccC
Q 020826 257 VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT------AKEAMAHPYFFPI 311 (321)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps------~~ell~hp~~~~~ 311 (321)
... ....+..+++++.++|++||+.||++|+| ++++++||||+.+
T Consensus 218 ~~~----------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~ 268 (329)
T cd05588 218 LEK----------QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI 268 (329)
T ss_pred HcC----------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 000 01122346788999999999999999987 7899999999875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=309.29 Aligned_cols=287 Identities=24% Similarity=0.460 Sum_probs=219.9
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc--hHHHHHHHHHHHhhcCC-C----CeeeeeeeeeccCC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGG-P----NIVKLLDIVRDQQS 90 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~E~~~l~~l~~h-~----~i~~~~~~~~~~~~ 90 (321)
....+|+++..+|+|+||.|-.+.+..++..+|||+++... +....-|+++++++..+ | .++++.++|. -.
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd--yr 163 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD--YR 163 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh--cc
Confidence 34789999999999999999999999999999999998654 35678899999999432 2 4788888884 45
Q ss_pred CCcEEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCC---------------
Q 020826 91 KTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--------------- 151 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~--------------- 151 (321)
.+.|||+|.++..+...+.. +++...++.|+.|+++++++||+.+++|-||||+||++..+
T Consensus 164 ghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~ 243 (415)
T KOG0671|consen 164 GHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI 243 (415)
T ss_pred CceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCcccee
Confidence 67789999998666555543 49999999999999999999999999999999999999321
Q ss_pred ----CCeEEEeeccceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHH
Q 020826 152 ----QRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 227 (321)
Q Consensus 152 ----~~~v~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~ 227 (321)
...|+++|||.++... ......+.|..|+|||++++ -.|+..+||||+||+|+|+.+|...| ++.++.+.++
T Consensus 244 r~~ks~~I~vIDFGsAtf~~--e~hs~iVsTRHYRAPEViLg-LGwS~pCDvWSiGCIL~ElytG~~LF-qtHen~EHLa 319 (415)
T KOG0671|consen 244 RPLKSTAIKVIDFGSATFDH--EHHSTIVSTRHYRAPEVILG-LGWSQPCDVWSIGCILVELYTGETLF-QTHENLEHLA 319 (415)
T ss_pred ccCCCcceEEEecCCcceec--cCcceeeeccccCCchheec-cCcCCccCceeeeeEEEEeeccceec-ccCCcHHHHH
Confidence 1258999999998643 33466789999999999999 89999999999999999999999887 7888999999
Q ss_pred HHHHHhCChhhhHHhhhh-cccCChhhHhhhc-------c---cCCCCCccccccccccCCcchHHHHHHHhhccCCCCC
Q 020826 228 KIAKVLGTDELNAYLNKY-HIELDPHLAALVG-------R---HSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER 296 (321)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-------~---~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~R 296 (321)
.+...+|+.......... ..........+.. . ..-++....+.. .+.--.++.+||++||.+||.+|
T Consensus 320 MMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~--~d~e~~~LfDLl~~mL~fDP~~R 397 (415)
T KOG0671|consen 320 MMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQ--DDLEHVQLFDLLRRMLEFDPARR 397 (415)
T ss_pred HHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhcc--CcHHHhHHHHHHHHHHccCcccc
Confidence 999999954443333321 1111101000000 0 011122222111 11112369999999999999999
Q ss_pred cCHHHHhcCCCcccCC
Q 020826 297 PTAKEAMAHPYFFPIR 312 (321)
Q Consensus 297 ps~~ell~hp~~~~~~ 312 (321)
+|+.|+|.||||+...
T Consensus 398 iTl~EAL~HpFF~~~~ 413 (415)
T KOG0671|consen 398 ITLREALSHPFFARLT 413 (415)
T ss_pred ccHHHHhcCHHhhcCC
Confidence 9999999999999864
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=319.62 Aligned_cols=279 Identities=21% Similarity=0.344 Sum_probs=203.7
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEe
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 99 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 99 (321)
..+|++++.||+|+||.||+|++..++..|++|+... .....|+.+++++ +||||+++++++... ...++++|+
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~---~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e~ 138 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK---GTTLIEAMLLQNV-NHPSVIRMKDTLVSG--AITCMVLPH 138 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc---cccHHHHHHHHhC-CCCCCcChhheEEeC--CeeEEEEEc
Confidence 4579999999999999999999988999999997543 3446799999999 899999999998654 456799999
Q ss_pred ecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCcccccc
Q 020826 100 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 176 (321)
Q Consensus 100 ~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~~~~~ 176 (321)
+.+..+..+. ..+++..+..++.||+.||.|||++||+||||||+||+++.++ .++|+|||++.............
T Consensus 139 ~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~~~~~ 217 (357)
T PHA03209 139 YSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPAFLGLA 217 (357)
T ss_pred cCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEecCccccccccCccccccc
Confidence 9765544333 3589999999999999999999999999999999999999888 79999999987543333334456
Q ss_pred CCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCCh---------HHHHHHHHHhCChhhhHHhhhhcc
Q 020826 177 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY---------DQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 177 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
+|..|+|||++.+ ..++.++|||||||++|+|+++..+++...... ..+..+...++.... .+....
T Consensus 218 gt~~y~aPE~~~~-~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~-~~~~~~-- 293 (357)
T PHA03209 218 GTVETNAPEVLAR-DKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE-EFPRDP-- 293 (357)
T ss_pred ccccccCCeecCC-CCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh-hcCCCC--
Confidence 8899999999987 678999999999999999999877775443221 122222222222110 000000
Q ss_pred cCChhhHhhh--cccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 248 ELDPHLAALV--GRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 248 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
......... ....+.+..... ......++.++.+||.+||+.||++|||+.|+|+||||+++
T Consensus 294 -~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 294 -GSRLVRGFIEYASLERQPYTRYP-CFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred -ccHHHHHHHhhcccCCCcccccH-HHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 000000000 001111111111 11122466788999999999999999999999999999874
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=315.65 Aligned_cols=249 Identities=24% Similarity=0.361 Sum_probs=201.9
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
+|++.+.||+|+||+||+|++..+++.+|+|+++... ......|..++..+.+|++|+++++++.+ ....++
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~l 78 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT--MDRLYF 78 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec--CCEEEE
Confidence 5889999999999999999999899999999987532 23356677778777678999999999855 346789
Q ss_pred EEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC-CCc
Q 020826 96 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKE 171 (321)
Q Consensus 96 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~-~~~ 171 (321)
||||+.+++|...+ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++..... ...
T Consensus 79 v~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-~~kL~DfG~~~~~~~~~~~ 157 (323)
T cd05616 79 VMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENMWDGVT 157 (323)
T ss_pred EEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCC-cEEEccCCCceecCCCCCc
Confidence 99999999987766 4589999999999999999999999999999999999999888 899999999875432 223
Q ss_pred cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCCh
Q 020826 172 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (321)
.....||+.|+|||++.+ ..++.++|+|||||++|+|++|..||. +.+.......+...
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~-~~~~~~~~~~i~~~------------------- 216 (323)
T cd05616 158 TKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFE-GEDEDELFQSIMEH------------------- 216 (323)
T ss_pred cccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCC-CCCHHHHHHHHHhC-------------------
Confidence 344568999999999987 788999999999999999999999984 22222222222110
Q ss_pred hhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCH-----HHHhcCCCcccCC
Q 020826 252 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA-----KEAMAHPYFFPIR 312 (321)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~-----~ell~hp~~~~~~ 312 (321)
....+..+++++.+++.+||+.||++|++. .++++||||+.++
T Consensus 217 ------------------~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~ 264 (323)
T cd05616 217 ------------------NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 264 (323)
T ss_pred ------------------CCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence 001122466799999999999999999984 8999999998764
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=311.72 Aligned_cols=280 Identities=24% Similarity=0.474 Sum_probs=200.3
Q ss_pred eeeeeecceEEEEEEEec--CCceEEEEEecccc-hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeecCc
Q 020826 27 RKVGRGKYSEVFEGVHCT--DNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT 103 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~--~~~~~~vK~~~~~~-~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~ 103 (321)
.+||+|+||+||+|++.. ++..+++|.++... ...+.+|+.+++.+ +||||+++++++........++++||++++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~lv~e~~~~~ 85 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLREL-KHPNVIALQKVFLSHSDRKVWLLFDYAEHD 85 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhC-CCCCeeeEEEEEeccCCCeEEEEEeeeCCc
Confidence 579999999999999754 56789999987543 34678899999999 899999999998766667788999999875
Q ss_pred hhhhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEc----CCCCeEEEeeccceeecCC
Q 020826 104 DFKVLY-----------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID----HEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 104 ~l~~~~-----------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~----~~~~~v~l~dfg~~~~~~~ 168 (321)
.+.... ..+++..++.++.|++.||.|||+.|++|+||||+||++. .++ .++|+|||++.....
T Consensus 86 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~-~~kl~DfG~a~~~~~ 164 (317)
T cd07867 86 LWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG-RVKIADMGFARLFNS 164 (317)
T ss_pred HHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCC-cEEEeeccceeccCC
Confidence 433221 1378888999999999999999999999999999999993 334 799999999976543
Q ss_pred CC----ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCC--------hHHHHHHHHHhCCh
Q 020826 169 GK----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN--------YDQLVKIAKVLGTD 236 (321)
Q Consensus 169 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~~~~~~~ 236 (321)
.. ......+|..|+|||.+.+...++.++|||||||++|+|+||..||.....+ ..++..+...++.+
T Consensus 165 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (317)
T cd07867 165 PLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFP 244 (317)
T ss_pred CcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCC
Confidence 22 1233467889999999977556899999999999999999999998533221 23344445555544
Q ss_pred hhhHHhhhhcccCChhhHhhhcccCCCCCccccc-cccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 237 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT-VENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
....+.........+................... .......+..+.+||.+||+.||++|||++|+|+||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 245 ADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred ChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 3333322211111111111111100000000000 11112244679999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=317.11 Aligned_cols=243 Identities=24% Similarity=0.365 Sum_probs=197.1
Q ss_pred eeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEee
Q 020826 27 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 100 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 100 (321)
+.||+|+||+||+|++..+++.+|+|+++... ...+..|..++..+.+||+|+++++++.+. ...++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~--~~~~lv~E~~ 78 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK--DRLFFVMEYV 78 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC--CeEEEEEeCC
Confidence 36899999999999998899999999987532 234667888888776899999999999654 4578999999
Q ss_pred cCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC-CCcccccc
Q 020826 101 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV 176 (321)
Q Consensus 101 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~-~~~~~~~~ 176 (321)
.+++|...+ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++..... ........
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~ 157 (321)
T cd05591 79 NGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG-HCKLADFGMCKEGILNGVTTTTFC 157 (321)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEeecccceecccCCccccccc
Confidence 999987665 4588999999999999999999999999999999999999888 899999999875432 22234456
Q ss_pred CCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhh
Q 020826 177 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAAL 256 (321)
Q Consensus 177 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (321)
++..|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+.......+.. .
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~-~~~~~~~~~~i~~---~--------------------- 211 (321)
T cd05591 158 GTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFE-ADNEDDLFESILH---D--------------------- 211 (321)
T ss_pred cCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCC-CCCHHHHHHHHHc---C---------------------
Confidence 8899999999987 678999999999999999999999984 2222222222111 0
Q ss_pred hcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc-------CHHHHhcCCCcccC
Q 020826 257 VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-------TAKEAMAHPYFFPI 311 (321)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp-------s~~ell~hp~~~~~ 311 (321)
....+..+++++.++|++||+.||++|+ +++++++||||..+
T Consensus 212 -------------~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~ 260 (321)
T cd05591 212 -------------DVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI 260 (321)
T ss_pred -------------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence 0001123567999999999999999999 99999999999875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=290.26 Aligned_cols=249 Identities=26% Similarity=0.441 Sum_probs=211.2
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
.-++|++.+.||+|.||.||.|+.++++..||+|++.+.. ..++.+|+++-..| +||||+++|++|.|. .-
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L-~hpnilrlY~~fhd~--~r 96 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHL-RHPNILRLYGYFHDS--KR 96 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeeccc-CCccHHhhhhheecc--ce
Confidence 3568999999999999999999999999999999986543 36688999999999 999999999999665 45
Q ss_pred cEEEEEeecCchhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 93 PSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
.|+++||...+.+...+ ..+++..++.++.|++.||.|+|.++++||||||+|++++..+ .+|++|||.+...+
T Consensus 97 iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~-~lkiAdfGwsV~~p 175 (281)
T KOG0580|consen 97 IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAP 175 (281)
T ss_pred eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCC-CeeccCCCceeecC
Confidence 56999999988765444 3599999999999999999999999999999999999999888 89999999987655
Q ss_pred CCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 168 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
...-.+.+||..|.+||...+ ...+...|+|++|++.||++.|..||.... ..+...++.+
T Consensus 176 -~~kR~tlcgt~dyl~pEmv~~-~~hd~~Vd~w~lgvl~yeflvg~ppFes~~-~~etYkrI~k---------------- 236 (281)
T KOG0580|consen 176 -SNKRKTLCGTLDYLPPEMVEG-RGHDKFVDLWSLGVLCYEFLVGLPPFESQS-HSETYKRIRK---------------- 236 (281)
T ss_pred -CCCceeeecccccCCHhhcCC-CCccchhhHHHHHHHHHHHHhcCCchhhhh-hHHHHHHHHH----------------
Confidence 444567789999999999988 788999999999999999999999994333 3333333322
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
.....+..+|.++.++|.+||..+|.+|.+..|++.|||+.+.
T Consensus 237 ---------------------~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 237 ---------------------VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred ---------------------ccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 1112234577899999999999999999999999999999875
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=321.69 Aligned_cols=257 Identities=25% Similarity=0.385 Sum_probs=203.9
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
....++|++.+.||+|+||.||++++..+++.+|+|++... ....+.+|+.+++.+ +||||+++++.+.+ .
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~--~ 115 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFCAFQD--D 115 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEc--C
Confidence 34567999999999999999999999999999999998642 224467899999988 99999999999854 4
Q ss_pred CCcEEEEEeecCchhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 91 KTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
.+.++||||+.+++|..++. .+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||++.....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~-~~kL~DFG~a~~~~~ 194 (370)
T cd05621 116 KYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG-HLKLADFGTCMKMDE 194 (370)
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC-CEEEEecccceeccc
Confidence 56789999999999988774 478899999999999999999999999999999999999888 899999999976543
Q ss_pred CCc--cccccCCccccccccccCCC---CCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 169 GKE--YNVRVASRYFKGPELLVDLQ---DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 169 ~~~--~~~~~~~~~y~aPE~~~~~~---~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
... .....||+.|+|||++.+.. .++.++|+|||||++|+|++|..||... +.......+.......
T Consensus 195 ~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~-~~~~~~~~i~~~~~~~------- 266 (370)
T cd05621 195 TGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD-SLVGTYSKIMDHKNSL------- 266 (370)
T ss_pred CCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC-CHHHHHHHHHhCCccc-------
Confidence 222 23557899999999986532 3788999999999999999999999432 2222222221100000
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCC--CcCHHHHhcCCCcccC
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE--RPTAKEAMAHPYFFPI 311 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~--Rps~~ell~hp~~~~~ 311 (321)
.......+++.+.+++.+||+.++.+ |+|++|+++||||+..
T Consensus 267 --------------------------~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 267 --------------------------NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred --------------------------CCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 01111235678999999999865543 8899999999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=308.58 Aligned_cols=245 Identities=24% Similarity=0.388 Sum_probs=195.6
Q ss_pred eeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeecC
Q 020826 29 VGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 102 (321)
Q Consensus 29 lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 102 (321)
||+|+||+||++.+..+++.+|+|.+.... ...+..|+.+++.+ +||||+++.+++.. ....+++|||+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKV-HSRFIVSLAYAFQT--KTDLCLVMTIMNG 77 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhC-CCCcEeeeeEEEcC--CCeEEEEEeCCCC
Confidence 689999999999999999999999986432 13456799999999 99999999998854 4457899999999
Q ss_pred chhhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc-ccc
Q 020826 103 TDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YNV 174 (321)
Q Consensus 103 ~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~-~~~ 174 (321)
++|...+ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++........ ...
T Consensus 78 g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~ 156 (280)
T cd05608 78 GDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG-NVRISDLGLAVELKDGQSKTKG 156 (280)
T ss_pred CCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCccceecCCCCccccc
Confidence 9987554 2488999999999999999999999999999999999999877 799999999876543322 233
Q ss_pred ccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhH
Q 020826 175 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLA 254 (321)
Q Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (321)
..++..|+|||++.+ ..++.++|+|||||++|+|++|+.||......... ..+......
T Consensus 157 ~~g~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~------------------- 215 (280)
T cd05608 157 YAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-KELKQRILN------------------- 215 (280)
T ss_pred cCCCcCccCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH-HHHHHhhcc-------------------
Confidence 468889999999987 68899999999999999999999998433221111 110000000
Q ss_pred hhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc-----CHHHHhcCCCcccCC
Q 020826 255 ALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIR 312 (321)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp-----s~~ell~hp~~~~~~ 312 (321)
. ....+..+++++.+++.+||+.||++|| |++++++||||+++.
T Consensus 216 --------~------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~ 264 (280)
T cd05608 216 --------D------SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLN 264 (280)
T ss_pred --------c------CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCC
Confidence 0 0111234678999999999999999999 889999999999863
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-45 Score=314.33 Aligned_cols=244 Identities=23% Similarity=0.399 Sum_probs=196.0
Q ss_pred eeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEee
Q 020826 27 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 100 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 100 (321)
+.||+|+||.||+|.++.+++.||+|+++.. .......|..++..+.+||+|+++++.+.+ ..+.++||||+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~--~~~~~lv~E~~ 78 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT--KEHLFFVMEFL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe--CCEEEEEECCC
Confidence 3699999999999999999999999998753 234456777777766589999999999855 45678999999
Q ss_pred cCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC-CCcccccc
Q 020826 101 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV 176 (321)
Q Consensus 101 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~-~~~~~~~~ 176 (321)
.+++|..++ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++..... ........
T Consensus 79 ~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05620 79 NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG-HIKIADFGMCKENVFGDNRASTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEeCccCCCeecccCCCceeccC
Confidence 999987666 3589999999999999999999999999999999999999888 899999999864322 12234456
Q ss_pred CCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhh
Q 020826 177 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAAL 256 (321)
Q Consensus 177 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (321)
|+..|+|||++.+ ..++.++|||||||++|+|++|..||.. .+.......+.. ..
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~el~~g~~Pf~~-~~~~~~~~~~~~--~~--------------------- 212 (316)
T cd05620 158 GTPDYIAPEILQG-LKYTFSVDWWSFGVLLYEMLIGQSPFHG-DDEDELFESIRV--DT--------------------- 212 (316)
T ss_pred CCcCccCHHHHcC-CCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHh--CC---------------------
Confidence 8999999999987 6889999999999999999999999942 222222211110 00
Q ss_pred hcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCH-HHHhcCCCcccCC
Q 020826 257 VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA-KEAMAHPYFFPIR 312 (321)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~-~ell~hp~~~~~~ 312 (321)
...+..+++++.++|++||+.||++|+++ +++++||||+.++
T Consensus 213 --------------~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~ 255 (316)
T cd05620 213 --------------PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTIN 255 (316)
T ss_pred --------------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCC
Confidence 00112356789999999999999999998 5899999998864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=316.87 Aligned_cols=248 Identities=21% Similarity=0.365 Sum_probs=206.1
Q ss_pred EeeeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc--chHHHHHHHHHHHhhcCCCCeeeeeeeeecc
Q 020826 11 WCVWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 88 (321)
Q Consensus 11 ~~~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (321)
...|.|++. .+++++.||+|.||.||.|.+ .....|++|.++.. ....+.+|+++|++| +|++||++++++..+
T Consensus 198 ~d~wei~r~--~l~l~~~LG~G~FG~V~~g~~-~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L-~H~~lV~l~gV~~~~ 273 (468)
T KOG0197|consen 198 RDPWEIPRE--ELKLIRELGSGQFGEVWLGKW-NGSTKVAVKTIKEGSMSPEAFLREAQIMKKL-RHEKLVKLYGVCTKQ 273 (468)
T ss_pred cCCeeecHH--HHHHHHHhcCCccceEEEEEE-cCCCcccceEEeccccChhHHHHHHHHHHhC-cccCeEEEEEEEecC
Confidence 557888855 788889999999999999999 45568999998753 457788999999999 999999999999654
Q ss_pred CCCCcEEEEEeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccce
Q 020826 89 QSKTPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163 (321)
Q Consensus 89 ~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~ 163 (321)
. -++|||||+..|+|.++++ .+...+...++.||++||+||+++++|||||.+.||||+.+. .+||+|||++
T Consensus 274 ~--piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~-~vKIsDFGLA 350 (468)
T KOG0197|consen 274 E--PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDL-VVKISDFGLA 350 (468)
T ss_pred C--ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCc-eEEEcccccc
Confidence 4 5679999999999988885 388889999999999999999999999999999999999888 8999999999
Q ss_pred eecCCCCccccccC---CccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhH
Q 020826 164 EFYHPGKEYNVRVA---SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 240 (321)
Q Consensus 164 ~~~~~~~~~~~~~~---~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (321)
+... ...+....+ ..-|.|||++.. ..++.+|||||||++|+|++|.....+++.++.+.+..+.+.
T Consensus 351 r~~~-d~~Y~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G-------- 420 (468)
T KOG0197|consen 351 RLIG-DDEYTASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG-------- 420 (468)
T ss_pred cccC-CCceeecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc--------
Confidence 9432 333333333 335999999987 789999999999999999998555555777777776665332
Q ss_pred HhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHh
Q 020826 241 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 303 (321)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell 303 (321)
..+..+..+|+++.+++..||+.+|++|||++.+.
T Consensus 421 ----------------------------yRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 421 ----------------------------YRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred ----------------------------CcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 22334557889999999999999999999998654
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-45 Score=314.42 Aligned_cols=244 Identities=23% Similarity=0.385 Sum_probs=197.8
Q ss_pred eeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEee
Q 020826 27 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 100 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 100 (321)
+.||+|+||+||+|.+..++..+|+|+++.. ....+..|..++..+.+||||+++++++.+ ....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~--~~~~~lv~e~~ 78 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT--KDRLFFVMEYV 78 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 3699999999999999989999999998753 234566788888887689999999999855 44678999999
Q ss_pred cCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC-CCcccccc
Q 020826 101 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV 176 (321)
Q Consensus 101 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~-~~~~~~~~ 176 (321)
.+++|...+ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++..... ........
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (318)
T cd05570 79 NGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG-HIKIADFGMCKEGILGGVTTSTFC 157 (318)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCC-cEEecccCCCeecCcCCCccccee
Confidence 999987666 3589999999999999999999999999999999999999888 899999999865322 22233456
Q ss_pred CCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhh
Q 020826 177 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAAL 256 (321)
Q Consensus 177 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (321)
++..|+|||++.+ ..++.++|+|||||++|+|++|..||.. .+.......+..
T Consensus 158 g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~-~~~~~~~~~i~~------------------------- 210 (318)
T cd05570 158 GTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEG-DDEDELFQSILE------------------------- 210 (318)
T ss_pred cCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCC-CCHHHHHHHHHc-------------------------
Confidence 8899999999987 7889999999999999999999999842 222111111100
Q ss_pred hcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCH-----HHHhcCCCcccCC
Q 020826 257 VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA-----KEAMAHPYFFPIR 312 (321)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~-----~ell~hp~~~~~~ 312 (321)
.. ...+..+++++.++|++||+.||++|||+ .++++||||+.++
T Consensus 211 --~~----------~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~ 259 (318)
T cd05570 211 --DE----------VRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREID 259 (318)
T ss_pred --CC----------CCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence 00 00122356799999999999999999999 9999999998864
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=314.65 Aligned_cols=287 Identities=25% Similarity=0.475 Sum_probs=214.8
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccC----
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---- 89 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~---- 89 (321)
..++|++.+.||+|+||.||+|.+..+++.+++|.+... ....+.+|+.+++.+ +|||++++++++....
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLV-NHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhc-CCCCCcceeeeeccCCCccc
Confidence 468899999999999999999999999999999998632 234567899999999 9999999999885432
Q ss_pred CCCcEEEEEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 90 SKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
....++|+|++.+.........++...+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++......
T Consensus 93 ~~~~~lv~e~~~~~l~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~ 171 (353)
T cd07850 93 FQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTS 171 (353)
T ss_pred cCcEEEEEeccCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEccCccceeCCCC
Confidence 235689999998754444445589999999999999999999999999999999999999888 8999999999876544
Q ss_pred CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 170 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
.......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||. ..+.......+...++.+.. .+.......
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~- 247 (353)
T cd07850 172 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFP-GTDHIDQWNKIIEQLGTPSD-EFMSRLQPT- 247 (353)
T ss_pred CCCCCCcccccccCHHHHhC-CCCCCchhhHhHHHHHHHHHHCCCCCC-CCCHHHHHHHHHHhcCCCCH-HHHHHhhhh-
Confidence 33344567888999999987 788999999999999999999999984 44445555556555555432 111111100
Q ss_pred ChhhHhhhcccCC---CCCcccc--------ccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 250 DPHLAALVGRHSR---KPWSKFI--------TVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 250 ~~~~~~~~~~~~~---~~~~~~~--------~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
.......... .+..... ........+++++++|.+||+.||++|||+.|+|+||||+.+-.+
T Consensus 248 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~ 320 (353)
T cd07850 248 ---VRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP 320 (353)
T ss_pred ---hhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence 0000000000 0000000 000012345678999999999999999999999999999875443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=313.47 Aligned_cols=244 Identities=25% Similarity=0.409 Sum_probs=195.5
Q ss_pred eeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEee
Q 020826 27 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 100 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 100 (321)
+.||+|+||+||+|.+..+++.||+|+++... ......|..++..+.+||||+++++++.. ....++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~--~~~~~lv~e~~ 78 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT--KEHLFFVMEYL 78 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc--CCEEEEEEcCC
Confidence 36899999999999999999999999987432 23345677777665589999999999854 45678999999
Q ss_pred cCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC-Ccccccc
Q 020826 101 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNVRV 176 (321)
Q Consensus 101 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~-~~~~~~~ 176 (321)
.+++|..++ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++...... .......
T Consensus 79 ~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~~~~~~~~~ 157 (316)
T cd05592 79 NGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG-HIKIADFGMCKENMNGEGKASTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCC-CEEEccCcCCeECCCCCCcccccc
Confidence 999987766 4589999999999999999999999999999999999999888 8999999998754322 2234457
Q ss_pred CCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhh
Q 020826 177 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAAL 256 (321)
Q Consensus 177 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (321)
||..|+|||.+.+ ..++.++|||||||++|+|++|..||. +.+.......+.. ..
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~G~~Pf~-~~~~~~~~~~i~~--~~--------------------- 212 (316)
T cd05592 158 GTPDYIAPEILKG-QKYNESVDWWSFGVLLYEMLIGQSPFH-GEDEDELFDSILN--DR--------------------- 212 (316)
T ss_pred CCccccCHHHHcC-CCCCCcccchhHHHHHHHHHhCCCCCC-CCCHHHHHHHHHc--CC---------------------
Confidence 8999999999987 678999999999999999999999984 2222222222110 00
Q ss_pred hcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCH-HHHhcCCCcccCC
Q 020826 257 VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA-KEAMAHPYFFPIR 312 (321)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~-~ell~hp~~~~~~ 312 (321)
...+..+++++.++|.+||+.||++||++ .++++||||+.++
T Consensus 213 --------------~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05592 213 --------------PHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGID 255 (316)
T ss_pred --------------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCC
Confidence 00112356789999999999999999986 5899999998764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=321.33 Aligned_cols=252 Identities=27% Similarity=0.439 Sum_probs=200.6
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
++|++.+.||+|+||+||++.+..+++.+|+|+++... ...+..|+.++..+ +||+|+++++.+.+ ....+
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~--~~~~~ 77 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA-DGAWVVKMFYSFQD--KRNLY 77 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCEeeEEEEEEc--CCEEE
Confidence 47999999999999999999999999999999986432 34577899999999 89999999999854 45678
Q ss_pred EEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-
Q 020826 95 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 170 (321)
Q Consensus 95 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~- 170 (321)
+||||+.+++|..++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++.......
T Consensus 78 lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~-~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 78 LIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG-HVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred EEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC-CEEEeeccCCcccccccc
Confidence 999999999988776 3589999999999999999999999999999999999999888 89999999976432110
Q ss_pred -----------------------------------ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCC
Q 020826 171 -----------------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEP 215 (321)
Q Consensus 171 -----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p 215 (321)
......||+.|+|||++.+ ..++.++|+|||||++|+|++|+.|
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyel~tG~~P 235 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ-TGYNKLCDWWSLGVIMYEMLIGYPP 235 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC-CCCCCcceeccccceeeecccCCCC
Confidence 0113468899999999987 7889999999999999999999999
Q ss_pred CccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCC
Q 020826 216 FFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE 295 (321)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~ 295 (321)
|... +.......+...... ........+++++.++|.+|+ .||++
T Consensus 236 f~~~-~~~~~~~~i~~~~~~---------------------------------~~~p~~~~~s~~~~~li~~l~-~~p~~ 280 (360)
T cd05627 236 FCSE-TPQETYRKVMNWKET---------------------------------LVFPPEVPISEKAKDLILRFC-TDSEN 280 (360)
T ss_pred CCCC-CHHHHHHHHHcCCCc---------------------------------eecCCCCCCCHHHHHHHHHhc-cChhh
Confidence 8432 222222221110000 000011135679999999977 49999
Q ss_pred Cc---CHHHHhcCCCcccCC
Q 020826 296 RP---TAKEAMAHPYFFPIR 312 (321)
Q Consensus 296 Rp---s~~ell~hp~~~~~~ 312 (321)
|+ +++++++||||++++
T Consensus 281 R~~~~~~~ei~~hp~f~~~~ 300 (360)
T cd05627 281 RIGSNGVEEIKSHPFFEGVD 300 (360)
T ss_pred cCCCCCHHHHhcCCCCCCCC
Confidence 98 589999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=318.52 Aligned_cols=252 Identities=22% Similarity=0.396 Sum_probs=199.9
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
.++|+..+.||+|+||+||+|++..+++.|++|++.... ...+.+|+.+++.+ +|+||+++++++.+ ....++
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 149 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDV-NHPNVVKCHDMFDH--NGEIQV 149 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhC-CCCCcceeeeEecc--CCeEEE
Confidence 467999999999999999999998899999999986432 35678999999999 89999999999854 445679
Q ss_pred EEEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-cccc
Q 020826 96 IFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNV 174 (321)
Q Consensus 96 v~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~-~~~~ 174 (321)
++||+.+++|... ...++..+..++.||+.||+|||++|++|+||||+||+++.++ .++|+|||++....... ....
T Consensus 150 v~e~~~~~~L~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kL~DfG~~~~~~~~~~~~~~ 227 (353)
T PLN00034 150 LLEFMDGGSLEGT-HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK-NVKIADFGVSRILAQTMDPCNS 227 (353)
T ss_pred EEecCCCCccccc-ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CEEEcccccceecccccccccc
Confidence 9999999988654 2356778889999999999999999999999999999999887 89999999987654322 2244
Q ss_pred ccCCccccccccccCC----CCCCCcchHHHHHHHHHHHHhCCCCCccCCC-ChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 175 RVASRYFKGPELLVDL----QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD-NYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 175 ~~~~~~y~aPE~~~~~----~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
..|+..|+|||.+... ...+.++|||||||++|+|++|+.||..... +...+.. . ....
T Consensus 228 ~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~--~-~~~~------------- 291 (353)
T PLN00034 228 SVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC--A-ICMS------------- 291 (353)
T ss_pred cccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHH--H-Hhcc-------------
Confidence 5789999999987431 3345789999999999999999999952211 1111100 0 0000
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
........+++++.+||.+||+.||++|||+.|+++||||.+.
T Consensus 292 -------------------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 292 -------------------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred -------------------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 0001122456789999999999999999999999999999986
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=317.55 Aligned_cols=243 Identities=27% Similarity=0.429 Sum_probs=196.5
Q ss_pred eeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEee
Q 020826 27 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 100 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 100 (321)
+.||+|+||+||++.+..++..+|+|+++... ...+..|+.+++.+ +||||+++++.+.. ....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~-~hp~i~~~~~~~~~--~~~~~lv~E~~ 77 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQT--HDRLCFVMEYA 77 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCCCceEEEEEc--CCEEEEEEeCC
Confidence 36899999999999999999999999987532 24456788889988 89999999998854 45678999999
Q ss_pred cCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC-CCccccc
Q 020826 101 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVR 175 (321)
Q Consensus 101 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~-~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~-~~~~~~~ 175 (321)
.+++|..++ ..+++..+..++.||+.||+|||+ .|++|+||||+||+++.++ .++|+|||++..... .......
T Consensus 78 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~ 156 (325)
T cd05594 78 NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKDGATMKTF 156 (325)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC-CEEEecCCCCeecCCCCcccccc
Confidence 999987766 358999999999999999999997 7999999999999999888 899999999875432 2223345
Q ss_pred cCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHh
Q 020826 176 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA 255 (321)
Q Consensus 176 ~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (321)
.++..|+|||++.+ ..++.++|||||||++|+|++|..||... +.......+.. .
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~-~~~~~~~~i~~----~------------------- 211 (325)
T cd05594 157 CGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ-DHEKLFELILM----E------------------- 211 (325)
T ss_pred cCCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCC-CHHHHHHHHhc----C-------------------
Confidence 68999999999987 67899999999999999999999998432 22111111100 0
Q ss_pred hhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc-----CHHHHhcCCCcccCC
Q 020826 256 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIR 312 (321)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp-----s~~ell~hp~~~~~~ 312 (321)
....+..+++++.++|++||+.||++|+ ++.++++||||.++.
T Consensus 212 --------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~ 259 (325)
T cd05594 212 --------------EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIV 259 (325)
T ss_pred --------------CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCC
Confidence 0011224668999999999999999997 999999999999753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=315.29 Aligned_cols=248 Identities=24% Similarity=0.421 Sum_probs=196.6
Q ss_pred eeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEee
Q 020826 27 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 100 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 100 (321)
+.||+|+||+||+|++..+++.+|+|+++... ...+..|+.++..+.+||||+++++++.. ....++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~E~~ 78 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESRLFFVIEYV 78 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe--CCEEEEEEeCC
Confidence 36999999999999999999999999987532 23467888888887689999999999865 34678999999
Q ss_pred cCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC-CCCcccccc
Q 020826 101 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRV 176 (321)
Q Consensus 101 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~-~~~~~~~~~ 176 (321)
.+++|..++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++.... .........
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~-~~kL~DfG~~~~~~~~~~~~~~~~ 157 (329)
T cd05618 79 NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPGDTTSTFC 157 (329)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC-CEEEeeCCccccccCCCCcccccc
Confidence 999987665 4589999999999999999999999999999999999999888 89999999987532 222334457
Q ss_pred CCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCC----ChHHHHHHHHHhCChhhhHHhhhhcccCChh
Q 020826 177 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD----NYDQLVKIAKVLGTDELNAYLNKYHIELDPH 252 (321)
Q Consensus 177 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (321)
||..|+|||++.+ ..++.++|+|||||++|+|++|..||..... .......+.+
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~--------------------- 215 (329)
T cd05618 158 GTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ--------------------- 215 (329)
T ss_pred CCccccCHHHHcC-CCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHH---------------------
Confidence 8999999999987 7889999999999999999999999842110 0000000000
Q ss_pred hHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC------HHHHhcCCCcccC
Q 020826 253 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT------AKEAMAHPYFFPI 311 (321)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps------~~ell~hp~~~~~ 311 (321)
..... ....+..+++++.++|++||+.||++||| ++++++||||+.+
T Consensus 216 --~i~~~----------~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 216 --VILEK----------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred --HHhcC----------CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 00000 01122346678999999999999999998 5799999999875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=311.72 Aligned_cols=244 Identities=24% Similarity=0.389 Sum_probs=196.2
Q ss_pred eeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEee
Q 020826 27 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 100 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 100 (321)
+.||+|+||+||+|.+..+++.||+|+++.. .......|..++..+.+||||+++++++.+. ...++||||+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~--~~~~lv~ey~ 78 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK--ENLFFVMEYL 78 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC--CEEEEEEeCC
Confidence 3689999999999999999999999998753 2234566777777655899999999998653 4678999999
Q ss_pred cCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC-CCcccccc
Q 020826 101 NNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRV 176 (321)
Q Consensus 101 ~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~-~~~~~~~~ 176 (321)
.+++|..++. .+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++..... ........
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (316)
T cd05619 79 NGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDG-HIKIADFGMCKENMLGDAKTCTFC 157 (316)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-CEEEccCCcceECCCCCCceeeec
Confidence 9999987763 588999999999999999999999999999999999999888 899999999875422 22334456
Q ss_pred CCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhh
Q 020826 177 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAAL 256 (321)
Q Consensus 177 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (321)
+|..|+|||++.+ ..++.++|||||||++|+|++|..||.. .+..+....+.. ..
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~i~~--~~--------------------- 212 (316)
T cd05619 158 GTPDYIAPEILLG-QKYNTSVDWWSFGVLLYEMLIGQSPFHG-HDEEELFQSIRM--DN--------------------- 212 (316)
T ss_pred CCccccCHHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCC-CCHHHHHHHHHh--CC---------------------
Confidence 8999999999987 6789999999999999999999999842 222222211110 00
Q ss_pred hcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHH-HHhcCCCcccCC
Q 020826 257 VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK-EAMAHPYFFPIR 312 (321)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~-ell~hp~~~~~~ 312 (321)
...+..++.++.++|.+||+.||++||++. ++++||||+.++
T Consensus 213 --------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~ 255 (316)
T cd05619 213 --------------PCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID 255 (316)
T ss_pred --------------CCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence 001123557899999999999999999996 999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=306.25 Aligned_cols=251 Identities=25% Similarity=0.411 Sum_probs=203.3
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
+|++.+.||+|+||+||++.+..+++.+++|.+.... ...+..|+.+++++ +|++++++++.+.+ ....++
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~--~~~~~l 77 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKV-NSRFVVSLAYAYET--KDALCL 77 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhC-CCCCeeeeeEEEec--CCEEEE
Confidence 4788899999999999999999999999999886432 23466899999999 89999999998854 346789
Q ss_pred EEEeecCchhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 96 IFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 96 v~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
++||+.+++|..++ ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++.......
T Consensus 78 v~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05630 78 VLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHG-HIRISDLGLAVHVPEGQ 156 (285)
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC-CEEEeeccceeecCCCc
Confidence 99999999987765 2488999999999999999999999999999999999999887 79999999987655444
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCCh--HHHHHHHHHhCChhhhHHhhhhccc
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY--DQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
......++..|+|||++.+ ..++.++|+||+|+++|+|++|..||....... +....+.....
T Consensus 157 ~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~-------------- 221 (285)
T cd05630 157 TIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ-------------- 221 (285)
T ss_pred cccCCCCCccccChHHHcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh--------------
Confidence 4344578899999999987 678999999999999999999999995332211 11111100000
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC-----HHHHhcCCCcccCCC
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPIRN 313 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps-----~~ell~hp~~~~~~~ 313 (321)
......+++++.+|+++||+.||++||| ++|+++||||++++.
T Consensus 222 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~ 269 (285)
T cd05630 222 ----------------------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINF 269 (285)
T ss_pred ----------------------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCH
Confidence 0011235678999999999999999999 999999999998643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=304.73 Aligned_cols=247 Identities=24% Similarity=0.337 Sum_probs=196.0
Q ss_pred eeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeecC
Q 020826 29 VGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 102 (321)
Q Consensus 29 lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 102 (321)
||+|+||+||++.++.+++.+++|.+.... ......|+++++.+ +||||+++++.+.+ ..+.+++|||+.+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~i~~~~~~~~~--~~~~~lv~e~~~g 77 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKV-NSPFIVNLAYAFES--KTHLCLVMSLMNG 77 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhc-CCCcEEEEEEEEec--CCeEEEEEecCCC
Confidence 689999999999999999999999986422 23456799999999 99999999998854 4567899999999
Q ss_pred chhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCccccccC
Q 020826 103 TDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA 177 (321)
Q Consensus 103 ~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~~~~~~ 177 (321)
++|..++ ..+++..+..++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||++.............+
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05607 78 GDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAG 156 (277)
T ss_pred CCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCC-CEEEeeceeeeecCCCceeeccCC
Confidence 9987665 2478888899999999999999999999999999999999887 899999999877654444445678
Q ss_pred CccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhh
Q 020826 178 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALV 257 (321)
Q Consensus 178 ~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (321)
+..|+|||++.+ ..++.++|+|||||++|+|++|..||........ ...+.......
T Consensus 157 ~~~y~aPE~~~~-~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~--------------------- 213 (277)
T cd05607 157 TNGYMAPEILKE-EPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-KEELKRRTLED--------------------- 213 (277)
T ss_pred CCCccCHHHHcc-CCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-HHHHHHHhhcc---------------------
Confidence 889999999987 5699999999999999999999999843221111 11110000000
Q ss_pred cccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCH----HHHhcCCCcccCCC
Q 020826 258 GRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA----KEAMAHPYFFPIRN 313 (321)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~----~ell~hp~~~~~~~ 313 (321)
.. . .....+++++.+++++||+.||++||++ ++++.||||+.++-
T Consensus 214 --~~--------~-~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~ 262 (277)
T cd05607 214 --EV--------K-FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINF 262 (277)
T ss_pred --cc--------c-cccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCH
Confidence 00 0 0011356789999999999999999999 67889999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-44 Score=301.86 Aligned_cols=251 Identities=31% Similarity=0.555 Sum_probs=202.7
Q ss_pred eEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHH-----HHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 23 y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~-----~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
|++.+.||+|+||+||++++..+++.+|+|.+....... ..+|+.+++.+ +||||+++++++.+ ....++++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~~v~ 77 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRL-RHPNIVQILDVFQD--DNYLYIVM 77 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHH-TBTTBCHEEEEEEE--SSEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccc-cccccccccccccc--cccccccc
Confidence 889999999999999999999999999999998654322 34589999999 99999999999966 45667999
Q ss_pred EeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeec-CCCCccc
Q 020826 98 EHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPGKEYN 173 (321)
Q Consensus 98 e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~-~~~~~~~ 173 (321)
|++.+++|..++ ..++...+..++.|++.||++||++|++|+||||+||+++.++ .++|+|||.+... .......
T Consensus 78 ~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~-~~~l~Dfg~~~~~~~~~~~~~ 156 (260)
T PF00069_consen 78 EYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENG-EVKLIDFGSSVKLSENNENFN 156 (260)
T ss_dssp EEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTS-EEEESSGTTTEESTSTTSEBS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccc
Confidence 999998887665 5689999999999999999999999999999999999999777 8999999998763 3334445
Q ss_pred cccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhh
Q 020826 174 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 253 (321)
Q Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (321)
...++..|+|||+.......+.++|+||||+++++|++|..||... ........+.+............
T Consensus 157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~---------- 225 (260)
T PF00069_consen 157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES-NSDDQLEIIEKILKRPLPSSSQQ---------- 225 (260)
T ss_dssp SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS-SHHHHHHHHHHHHHTHHHHHTTS----------
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccc-cchhhhhhhhhcccccccccccc----------
Confidence 6678889999999883378999999999999999999999998432 22233333333222221111000
Q ss_pred HhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 254 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
....++++.++|++||+.||++|||+.++++||||
T Consensus 226 --------------------~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 226 --------------------SREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp --------------------HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred --------------------cchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 00112589999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=312.00 Aligned_cols=242 Identities=27% Similarity=0.440 Sum_probs=194.9
Q ss_pred eeeeeecceEEEEEEEe---cCCceEEEEEecccc-------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 27 RKVGRGKYSEVFEGVHC---TDNEKCIIKILKPVK-------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~---~~~~~~~vK~~~~~~-------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
+.||+|+||.||++++. .+++.+|+|+++... ...+..|+.+++.+ +||||+++++.+... ...+++
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~iv~~~~~~~~~--~~~~lv 78 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV-KHPFIVDLIYAFQTG--GKLYLI 78 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhC-CCCchhceeeEEecC--CeEEEE
Confidence 57999999999999874 467899999987432 23467899999999 899999999998653 467899
Q ss_pred EEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC-Ccc
Q 020826 97 FEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEY 172 (321)
Q Consensus 97 ~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~-~~~ 172 (321)
|||+.+++|...+ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++...... ...
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~ 157 (323)
T cd05584 79 LEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG-HVKLTDFGLCKESIHEGTVT 157 (323)
T ss_pred EeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEeeCcCCeecccCCCcc
Confidence 9999999987776 3478889999999999999999999999999999999999888 8999999998754322 223
Q ss_pred ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChh
Q 020826 173 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 252 (321)
Q Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (321)
....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.. .+.......+..
T Consensus 158 ~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~pf~~-~~~~~~~~~~~~--------------------- 214 (323)
T cd05584 158 HTFCGTIEYMAPEILMR-SGHGKAVDWWSLGALMYDMLTGAPPFTA-ENRKKTIDKILK--------------------- 214 (323)
T ss_pred cccCCCccccChhhccC-CCCCCcceecccHHHHHHHhcCCCCCCC-CCHHHHHHHHHc---------------------
Confidence 34568999999999987 6788999999999999999999999842 222222221111
Q ss_pred hHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc-----CHHHHhcCCCcccC
Q 020826 253 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPI 311 (321)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp-----s~~ell~hp~~~~~ 311 (321)
. ....+..+++++.++|++||+.||++|| +++++++||||+..
T Consensus 215 ------~----------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 215 ------G----------KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred ------C----------CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 0 0011234668999999999999999999 89999999999864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=294.75 Aligned_cols=261 Identities=25% Similarity=0.426 Sum_probs=209.6
Q ss_pred ccCceEEee-eeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeeeeccC--CCCcEE
Q 020826 19 EQDDYEVVR-KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ--SKTPSL 95 (321)
Q Consensus 19 ~~~~y~~~~-~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~--~~~~~l 95 (321)
..++|.+.. +||-|-.|.|..+.++.+++++|+|++.+. ....+|++..-....|||||.+++++.+.- -.++.+
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLi 136 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLI 136 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEe
Confidence 356777754 599999999999999999999999998754 445777777666678999999999996543 356779
Q ss_pred EEEeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCC--CeEEEeeccceeecCC
Q 020826 96 IFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEFYHP 168 (321)
Q Consensus 96 v~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~--~~v~l~dfg~~~~~~~ 168 (321)
|||.+.||.|...+. .+++.++..|+.||..|+.|||+.+|+||||||+|+|....+ ..+||+|||+++....
T Consensus 137 VmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~ 216 (400)
T KOG0604|consen 137 VMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE 216 (400)
T ss_pred eeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCC
Confidence 999999999877772 499999999999999999999999999999999999997443 3689999999998776
Q ss_pred CCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 169 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
.....+.+.|++|.|||++.. ..++..+|+||+|+++|-|+.|..||+......
T Consensus 217 ~~~L~TPc~TPyYvaPevlg~-eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a------------------------- 270 (400)
T KOG0604|consen 217 PGDLMTPCFTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA------------------------- 270 (400)
T ss_pred CccccCCcccccccCHHHhCc-hhcCCCCCccchhHHHHHhhcCCCcccccCCcc-------------------------
Confidence 777788899999999999876 779999999999999999999999997554310
Q ss_pred CChhhHhhhcccC-CCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCC
Q 020826 249 LDPHLAALVGRHS-RKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 249 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~ 313 (321)
+.+.....+...+ ..|..+ =+.+|++.+++|+++|..+|++|.|+.+++.|||+++-..
T Consensus 271 ispgMk~rI~~gqy~FP~pE------Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~ 330 (400)
T KOG0604|consen 271 ISPGMKRRIRTGQYEFPEPE------WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA 330 (400)
T ss_pred CChhHHhHhhccCccCCChh------HhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence 1111111000000 001111 1247789999999999999999999999999999997543
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=307.35 Aligned_cols=285 Identities=27% Similarity=0.490 Sum_probs=209.5
Q ss_pred ceEEeeeeeeecceEEEEEEEec--CCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCT--DNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~--~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
+|++.+.||+|++|.||+|.+.. ++..+|+|.+.... ...+.+|+.++..+ +||||+++++++.+......
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLREL-KHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhc-CCCCccceEEEEeCCCCceE
Confidence 58899999999999999999988 78999999987622 35678899999999 89999999999987655778
Q ss_pred EEEEEeecCchhhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcC----CCCeEEEeeccc
Q 020826 94 SLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH----EQRKLRLIDWGL 162 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~----~~~~v~l~dfg~ 162 (321)
++|+|+++++.+.... ..+++..++.++.|++.||.|||+.+++|+||+|+||+++. ++ .++|+|||+
T Consensus 80 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~-~~kl~Dfg~ 158 (316)
T cd07842 80 YLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERG-VVKIGDLGL 158 (316)
T ss_pred EEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccc-eEEECCCcc
Confidence 9999999875543221 25789999999999999999999999999999999999998 66 899999999
Q ss_pred eeecCCCCc----cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCC--------hHHHHHHH
Q 020826 163 AEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN--------YDQLVKIA 230 (321)
Q Consensus 163 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~--------~~~~~~~~ 230 (321)
+........ .....++..|+|||.+.+...++.++|+|||||++++|++|..||...... ...+..+.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (316)
T cd07842 159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF 238 (316)
T ss_pred ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence 876532221 233456788999999877556889999999999999999999988533222 12344445
Q ss_pred HHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 231 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
..++.+....+....................................++++.+++.+||+.||++|||+.|+++||||
T Consensus 239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 555544333322211111111111111100000011111111112466789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=309.86 Aligned_cols=249 Identities=23% Similarity=0.351 Sum_probs=200.9
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
+|++.+.||+|+||+||+|.++.+++.||+|+++... ...+..|..++..+.+|++|+++++++.+. ...++
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--~~~~l 78 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV--DRLYF 78 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC--CEEEE
Confidence 4788999999999999999999999999999987432 234667888888886678899999988554 45779
Q ss_pred EEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC-Cc
Q 020826 96 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KE 171 (321)
Q Consensus 96 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~-~~ 171 (321)
||||+.+++|..++ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++...... ..
T Consensus 79 v~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~-~ikL~Dfg~~~~~~~~~~~ 157 (323)
T cd05615 79 VMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG-HIKIADFGMCKEHMVDGVT 157 (323)
T ss_pred EEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEeccccccccCCCCcc
Confidence 99999999988776 4589999999999999999999999999999999999999888 8999999998754322 22
Q ss_pred cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCCh
Q 020826 172 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (321)
.....||..|+|||++.+ ..++.++|+|||||++|+|++|..||. +.........+...
T Consensus 158 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~-~~~~~~~~~~i~~~------------------- 216 (323)
T cd05615 158 TRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFD-GEDEDELFQSIMEH------------------- 216 (323)
T ss_pred ccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCC-CCCHHHHHHHHHhC-------------------
Confidence 334568899999999987 678999999999999999999999984 22222222221110
Q ss_pred hhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC-----HHHHhcCCCcccCC
Q 020826 252 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPIR 312 (321)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps-----~~ell~hp~~~~~~ 312 (321)
. ...+..+++++.+++.+||+.||++|++ .+++++||||+.++
T Consensus 217 --------~----------~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~ 264 (323)
T cd05615 217 --------N----------VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRID 264 (323)
T ss_pred --------C----------CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCC
Confidence 0 0111235678999999999999999997 47999999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=311.78 Aligned_cols=285 Identities=21% Similarity=0.310 Sum_probs=206.6
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
..++|++.+.||+|+||.||++.+..++..+++|.++.. ....+.+|+.+++.+ +||||+++++++.+ ....+
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~ 79 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYS--DGEIS 79 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHC-CCCcccceeEEEEE--CCEEE
Confidence 368999999999999999999999989999999987643 235688999999999 89999999999965 34678
Q ss_pred EEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 95 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 95 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~-~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
++|||+.+++|.+++ ..+++..+..++.|++.||.|||+. +++|+||||+||+++.++ .++|+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 80 ICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS- 157 (333)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC-CEEEeeCCcchhhhhh-
Confidence 999999999998876 3488899999999999999999985 799999999999999887 7999999998654322
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHh-hhhcccC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL-NKYHIEL 249 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 249 (321)
......++..|+|||.+.+ ..++.++|+|||||++|++++|+.||..... ..+................ .......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (333)
T cd06650 158 MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAIGRYPIPPPDA--KELELMFGCPVEGDPAESETSPRPRPP 234 (333)
T ss_pred ccccCCCCccccCHHHhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcch--hHHHHHhcCcccCCccccccCcccCCc
Confidence 2234468889999999987 6789999999999999999999999843221 1111111100000000000 0000000
Q ss_pred ChhhHhhhcccCCCCCcc-----------ccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCC
Q 020826 250 DPHLAALVGRHSRKPWSK-----------FITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~ 313 (321)
....... . ....+... .........+++++.+||.+||+.||++|||+.|++.||||+....
T Consensus 235 ~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~ 307 (333)
T cd06650 235 GRPLSSY-G-PDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSEA 307 (333)
T ss_pred cchhhhh-c-ccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCcc
Confidence 0000000 0 00000000 0000011135678999999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=307.04 Aligned_cols=285 Identities=26% Similarity=0.475 Sum_probs=215.4
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
..++|++.+.||+|+||.||+|.+..+++.|++|.++... .....+|+.+++.+ +|+|++++++++.+......
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL-RHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhC-CCCCCcceEEEEecCCCCeE
Confidence 4678999999999999999999999999999999986432 12456899999999 89999999999876655667
Q ss_pred EEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 94 SLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
++|+||+.+. |..++ ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||.+......
T Consensus 84 ~lv~e~~~~~-l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 84 FLVMEYCEQD-LASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG-CLKIADFGLARTYGLP 161 (309)
T ss_pred EEEEecCCCC-HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECccceeeecCCc
Confidence 8999999864 43332 4589999999999999999999999999999999999999887 8999999998766433
Q ss_pred C-ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 170 K-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
. ......++..|+|||.+.+...++.++|+|||||++|+|++|..|| ...+....+..+...++.+....+.......
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLL-PGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred cCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 2 2233345778999999876566889999999999999999999887 4555666666666666554332211100000
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
....+ .....+..... ......++++.++|++||++||++|||++++++||||++...+
T Consensus 241 ~~~~~-----~~~~~~~~~~~--~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~ 299 (309)
T cd07845 241 LVGKF-----TLPKQPYNNLK--HKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP 299 (309)
T ss_pred ccccc-----cccCCCCCchH--HhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence 00000 00001111000 0112357889999999999999999999999999999987655
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=311.22 Aligned_cols=255 Identities=26% Similarity=0.397 Sum_probs=199.8
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
++|++.+.||+|+||+||++++..+++.||+|++++. ....+.+|+.++..+ +|+||+++++.+.+ ..+.+
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~ 77 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNG-DRRWITNLHYAFQD--ENNLY 77 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhC-CCCCCCceEEEEec--CCeEE
Confidence 5799999999999999999999999999999998642 224477899999888 99999999999854 45678
Q ss_pred EEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 95 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 95 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
+||||+.+++|..++ ..+++..+..++.||+.||+|||++|++|+||||+||+++.++ .++|+|||++.......
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNG-HIRLADFGSCLRLLADG 156 (331)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCC-CEEEEECCceeecCCCC
Confidence 999999999988776 3488999999999999999999999999999999999999888 89999999987654332
Q ss_pred c--cccccCCccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhh
Q 020826 171 E--YNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244 (321)
Q Consensus 171 ~--~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (321)
. .....+|+.|+|||++.. ...++.++|||||||++|+|++|+.||.. .+..+....+.....
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~-~~~~~~~~~i~~~~~---------- 225 (331)
T cd05597 157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNHKE---------- 225 (331)
T ss_pred CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCC-CCHHHHHHHHHcCCC----------
Confidence 2 223468999999999863 24577899999999999999999999842 222222211110000
Q ss_pred hcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCC--CcCHHHHhcCCCcccCC
Q 020826 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE--RPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~--Rps~~ell~hp~~~~~~ 312 (321)
... .......+|++++++|++||+.++++ |++++++++||||.+.+
T Consensus 226 -----------------~~~-----~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~ 273 (331)
T cd05597 226 -----------------HFQ-----FPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGID 273 (331)
T ss_pred -----------------ccc-----CCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence 000 00011236789999999999765544 78999999999998753
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=310.53 Aligned_cols=246 Identities=25% Similarity=0.442 Sum_probs=198.6
Q ss_pred eeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEee
Q 020826 27 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 100 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 100 (321)
+.||+|+||+||+|.+..+++.+|+|+++... ...+..|..++.++.+||+|+++++++.+. ...++||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~~ 78 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT--SRLFLVIEYV 78 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC--CEEEEEEeCC
Confidence 36999999999999999999999999997532 244678999998887899999999998554 4578999999
Q ss_pred cCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC-CCCcccccc
Q 020826 101 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRV 176 (321)
Q Consensus 101 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~-~~~~~~~~~ 176 (321)
.+++|..++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++.... .........
T Consensus 79 ~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~ 157 (327)
T cd05617 79 NGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADG-HIKLTDYGMCKEGLGPGDTTSTFC 157 (327)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCC-CEEEeccccceeccCCCCceeccc
Confidence 999987665 4699999999999999999999999999999999999999888 79999999987532 223334567
Q ss_pred CCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCC-----hHHHHHHHHHhCChhhhHHhhhhcccCCh
Q 020826 177 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN-----YDQLVKIAKVLGTDELNAYLNKYHIELDP 251 (321)
Q Consensus 177 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (321)
|+..|+|||++.+ ..++.++|+|||||++|+|++|..||...... .........
T Consensus 158 gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------- 216 (327)
T cd05617 158 GTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL-------------------- 216 (327)
T ss_pred CCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH--------------------
Confidence 8999999999987 78899999999999999999999999432211 111111000
Q ss_pred hhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC------HHHHhcCCCcccCC
Q 020826 252 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT------AKEAMAHPYFFPIR 312 (321)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps------~~ell~hp~~~~~~ 312 (321)
.. ....+..+++.+.++|++||+.||++|++ ++++++||||+.++
T Consensus 217 ------~~----------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~ 267 (327)
T cd05617 217 ------EK----------PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSID 267 (327)
T ss_pred ------hC----------CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence 00 01112346678999999999999999998 56999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-44 Score=320.35 Aligned_cols=282 Identities=22% Similarity=0.295 Sum_probs=203.9
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEE
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 98 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 98 (321)
....|.+.+.||+|+||.||+|.+..++..|++|... .....+|+.+++++ +|+||+++++++.. ....+++++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---~~~~~~E~~iL~~L-~HpnIv~l~~~~~~--~~~~~lv~e 240 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---YASSVHEARLLRRL-SHPAVLALLDVRVV--GGLTCLVLP 240 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---ccCHHHHHHHHHHC-CCCCCCcEEEEEEE--CCEEEEEEE
Confidence 3568999999999999999999999999999999643 34567899999999 99999999998854 345679999
Q ss_pred eecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc---c
Q 020826 99 HVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---Y 172 (321)
Q Consensus 99 ~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~---~ 172 (321)
++.+..+..+. ..+++..+..++.|++.||.|||++||+|+||||+||+++.++ .++|+|||+++....... .
T Consensus 241 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~~~~~~~ 319 (461)
T PHA03211 241 KYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWSTPFH 319 (461)
T ss_pred ccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCC-CEEEcccCCceecccccccccc
Confidence 99765444332 3589999999999999999999999999999999999999877 799999999876543221 1
Q ss_pred ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCC------hHHHHHHHHHhCChhhhHHhhhhc
Q 020826 173 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN------YDQLVKIAKVLGTDELNAYLNKYH 246 (321)
Q Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~ 246 (321)
....||..|+|||++.+ ..++.++|||||||++|+|++|..+++..... ..++..+....+.... .+.....
T Consensus 320 ~~~~GT~~Y~APE~~~~-~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~-~~~~~~~ 397 (461)
T PHA03211 320 YGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD-EFPQHAG 397 (461)
T ss_pred cccCCCcCCcCHHHHcC-CCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc-cCCCCcc
Confidence 23468999999999987 67899999999999999999998877654321 2334443333222100 0000000
Q ss_pred ccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCccc
Q 020826 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 310 (321)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~ 310 (321)
......+...... ...+......+.....+++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 398 ~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 398 SRLVSQYRHRAAR-NRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred hHHHHHHHhhhhc-ccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0000000000000 00111111111111245678999999999999999999999999999975
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=302.80 Aligned_cols=273 Identities=32% Similarity=0.583 Sum_probs=203.4
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
+|++.+.||+|++|.||+|++..++..|++|.++... ...+.+|+.+++.+ +|||++++++++.+ ....++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v 77 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL-QHPNIVCLQDVLMQ--ESRLYLI 77 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhc-CCCCEeeeEEEEee--CCeEEEE
Confidence 5899999999999999999998899999999986432 35678899999999 89999999999865 4466899
Q ss_pred EEeecCchhhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 97 FEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 97 ~e~~~~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
+||+.+ ++..++ ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 78 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~ 155 (285)
T cd07861 78 FEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKG-VIKLADFGLARAFGIPV 155 (285)
T ss_pred EecCCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCC-cEEECcccceeecCCCc
Confidence 999985 444433 3488999999999999999999999999999999999999888 89999999987553221
Q ss_pred -ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 171 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
......++..|+|||.+.+...++.++|+|||||++++|++|+.||. +.........+....+......+... ..
T Consensus 156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 231 (285)
T cd07861 156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFH-GDSEIDQLFRIFRILGTPTEDVWPGV---TS 231 (285)
T ss_pred ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHHHhCCCChhhhhcc---hh
Confidence 22334567889999998764567899999999999999999998884 33333444444333332221111000 00
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
...+..... .............+++++.++|++||+.||++|||+.++++||||
T Consensus 232 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 232 LPDYKNTFP-----KWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hHHHHhhcc-----ccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 000110000 000000111123477899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-44 Score=315.44 Aligned_cols=257 Identities=25% Similarity=0.397 Sum_probs=202.9
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
....++|++.+.||+|+||.||+|++..+++.+|+|++.... ...+.+|+.+++.+ +||||+++++.+.+ .
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~-~hp~iv~~~~~~~~--~ 115 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQD--D 115 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEc--C
Confidence 344689999999999999999999999999999999986421 23467889999988 99999999999854 4
Q ss_pred CCcEEEEEeecCchhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 91 KTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
.+.++||||+.+++|..++. .+++..+..++.||+.||+|||++|++|+||||+||+++.++ .++|+|||++.....
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~-~ikL~DfG~a~~~~~ 194 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMNK 194 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCC-CEEEEeCCceeEcCc
Confidence 56789999999999987774 478889999999999999999999999999999999999888 899999999976543
Q ss_pred CC--ccccccCCccccccccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 169 GK--EYNVRVASRYFKGPELLVDL---QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 169 ~~--~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
.. ......||+.|+|||++.+. ..++.++|||||||++|+|++|..||... +.......+......
T Consensus 195 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~-~~~~~~~~i~~~~~~-------- 265 (371)
T cd05622 195 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD-SLVGTYSKIMNHKNS-------- 265 (371)
T ss_pred CCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC-CHHHHHHHHHcCCCc--------
Confidence 22 22345789999999998652 23788999999999999999999999422 221122211110000
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCC--CcCHHHHhcCCCcccC
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE--RPTAKEAMAHPYFFPI 311 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~--Rps~~ell~hp~~~~~ 311 (321)
........+++++.++|.+||..++.+ |++++++++||||++.
T Consensus 266 -------------------------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 266 -------------------------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred -------------------------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 001112246789999999999844433 7899999999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=303.67 Aligned_cols=279 Identities=33% Similarity=0.569 Sum_probs=212.3
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEecccch--------HHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--------KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~--------~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
+|++.+.||+|++|.||+|.+..+++.|++|.++.... ..+..|+++++.+ +|+|++++++++.+ ....
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~ 77 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL-KHPNIIGLLDVFGH--KSNI 77 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhc-CCCCChhhhheeec--CCEE
Confidence 58899999999999999999988999999999875432 3456799999999 89999999999965 4567
Q ss_pred EEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 94 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
++|+||+ +++|..++. .+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||++......
T Consensus 78 ~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 78 NLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDG-VLKLADFGLARSFGSP 155 (298)
T ss_pred EEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCC-CEEEccceeeeeccCC
Confidence 8999999 778877762 488999999999999999999999999999999999999887 8999999999766433
Q ss_pred C-ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 170 K-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
. ......++..|+|||.+.+...++.++|+|||||+++++++|. |++.+.+..+.+..+....+.+....+.......
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (298)
T cd07841 156 NRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV-PFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLP 234 (298)
T ss_pred CccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCC-ccccCCccHHHHHHHHHHcCCCchhhhhhccccc
Confidence 2 2233456778999999866567889999999999999999995 4445655555555555444443322221110000
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
.. ... ...+.. .........+.++.++|.+||+.||++|||+.|++.||||++...+.
T Consensus 235 ---~~---~~~-~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~ 292 (298)
T cd07841 235 ---DY---VEF-KPFPPT--PLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPT 292 (298)
T ss_pred ---cc---ccc-cccCCc--chhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCC
Confidence 00 000 000000 00111124567899999999999999999999999999999987765
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=310.92 Aligned_cols=243 Identities=26% Similarity=0.439 Sum_probs=192.4
Q ss_pred eeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHH-HHhhcCCCCeeeeeeeeeccCCCCcEEEEEe
Q 020826 27 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKI-LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 99 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~-l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 99 (321)
+.||+|+||+||+|++..+++.||+|++.... ...+..|... ++.+ +||||+++++.+.+ ....++||||
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l-~hp~iv~~~~~~~~--~~~~~lv~e~ 77 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQT--ADKLYFVLDY 77 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhC-CCCCCCCeeEEEEe--CCEEEEEEcC
Confidence 36899999999999999999999999986432 1234445444 4556 89999999998854 4567899999
Q ss_pred ecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC-CCccccc
Q 020826 100 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVR 175 (321)
Q Consensus 100 ~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~-~~~~~~~ 175 (321)
+.+++|..++ ..+++..+..++.||+.||+|||++|++|+||||+||+++.++ .++|+|||++..... .......
T Consensus 78 ~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~ 156 (323)
T cd05575 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGIEHSKTTSTF 156 (323)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-cEEEeccCCCcccccCCCccccc
Confidence 9999987666 3589999999999999999999999999999999999999888 899999999865322 2223345
Q ss_pred cCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHh
Q 020826 176 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA 255 (321)
Q Consensus 176 ~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (321)
.|+..|+|||++.+ ..++.++|||||||++|+|++|..||.. .+..+....+.. .
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~-~~~~~~~~~i~~---~-------------------- 211 (323)
T cd05575 157 CGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYS-RDTAEMYDNILN---K-------------------- 211 (323)
T ss_pred cCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCC-CCHHHHHHHHHc---C--------------------
Confidence 68999999999987 7789999999999999999999999842 222222111110 0
Q ss_pred hhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCH----HHHhcCCCcccCC
Q 020826 256 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA----KEAMAHPYFFPIR 312 (321)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~----~ell~hp~~~~~~ 312 (321)
.......+++++.++|++||+.||++||++ .++++||||..+.
T Consensus 212 --------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~ 258 (323)
T cd05575 212 --------------PLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSIN 258 (323)
T ss_pred --------------CCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCC
Confidence 001112356799999999999999999998 6999999998653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-44 Score=335.59 Aligned_cols=261 Identities=25% Similarity=0.438 Sum_probs=209.1
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
.+...++|++++.||+|+||+||+|.+..++..+++|++... ....+..|+.++..| +||||+++++++.+...
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L-~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMREL-KHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEecCC
Confidence 345567999999999999999999999999999999998642 235678899999999 89999999999876666
Q ss_pred CCcEEEEEeecCchhhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHC-------CCeeecCCCCCeEEcCC-----
Q 020826 91 KTPSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQ-------GIMHRDVKPHNVMIDHE----- 151 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lh~~-------~i~H~dlkp~nili~~~----- 151 (321)
..+++||||+.+++|..++ ..+++..++.++.||+.||.|||+. +|+|+||||+|||++.+
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg 166 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG 166 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence 7788999999999987766 3589999999999999999999984 49999999999999642
Q ss_pred -----------CCeEEEeeccceeecCCCCccccccCCccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCccC
Q 020826 152 -----------QRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYG 219 (321)
Q Consensus 152 -----------~~~v~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~ 219 (321)
...++|+|||++.............+|+.|+|||++.+. ..++.++|||||||++|+|++|..||...
T Consensus 167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 167 KITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred cccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 124899999999765444344456789999999998642 45789999999999999999999998433
Q ss_pred CCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCH
Q 020826 220 HDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA 299 (321)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~ 299 (321)
. ....+...... .+.+ .....++++.+||..||+.+|.+|||+
T Consensus 247 ~-~~~qli~~lk~--~p~l----------------------------------pi~~~S~eL~dLI~~~L~~dPeeRPSa 289 (1021)
T PTZ00266 247 N-NFSQLISELKR--GPDL----------------------------------PIKGKSKELNILIKNLLNLSAKERPSA 289 (1021)
T ss_pred C-cHHHHHHHHhc--CCCC----------------------------------CcCCCCHHHHHHHHHHhcCChhHCcCH
Confidence 2 22222211110 0000 001245789999999999999999999
Q ss_pred HHHhcCCCcccCCCc
Q 020826 300 KEAMAHPYFFPIRNA 314 (321)
Q Consensus 300 ~ell~hp~~~~~~~~ 314 (321)
.++|.|||++.+..+
T Consensus 290 ~QlL~h~~ik~i~~p 304 (1021)
T PTZ00266 290 LQCLGYQIIKNVGPP 304 (1021)
T ss_pred HHHhccHHHhhcCCC
Confidence 999999999876543
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=312.94 Aligned_cols=250 Identities=26% Similarity=0.488 Sum_probs=213.7
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
.++|..++.+|.|+||.++.++++..+..+++|.+... .+.....|..++.++ .||||+.+.+.|... +.+.+
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~-~hP~iv~y~ds~~~~-~~~l~ 80 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKL-LHPNIVEYKDSFEED-GQLLC 80 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhc-cCCCeeeeccchhcC-CceEE
Confidence 57899999999999999999999999999999998643 245688999999998 999999999999654 34478
Q ss_pred EEEEeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 95 LIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 95 lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
|+|+||.||++.+.+. .+++..+..++.|++.|+.|||+++|+|||||+.|||+..++ .|+|+|||+++...+.
T Consensus 81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~-~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDK-KVKLGDFGLAKILNPE 159 (426)
T ss_pred EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccC-ceeecchhhhhhcCCc
Confidence 9999999999988873 389999999999999999999999999999999999999998 6899999999988776
Q ss_pred C-ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 170 K-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
. ...+..||+.|++||++.+ .+|+.++|||||||++|||++-+.+|. ..+-......+......+
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d-~pYn~KSDiWsLGC~~yEm~~lk~aF~-a~~m~~Li~ki~~~~~~P------------ 225 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSD-IPYNEKSDIWSLGCCLYEMCTLKPAFK-ASNMSELILKINRGLYSP------------ 225 (426)
T ss_pred hhhhheecCCCcccCHHHhCC-CCCCccCcchhhcchHHHHHhcccccC-ccchHHHHHHHhhccCCC------------
Confidence 6 5677899999999999998 899999999999999999999998883 333223333333322111
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCccc
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 310 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~ 310 (321)
.+...|.+++.+++.||+.+|+.||++.++|.+|.++.
T Consensus 226 ------------------------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~ 263 (426)
T KOG0589|consen 226 ------------------------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLR 263 (426)
T ss_pred ------------------------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhh
Confidence 22346679999999999999999999999999998874
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=293.75 Aligned_cols=291 Identities=29% Similarity=0.505 Sum_probs=226.2
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCc----eEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~----~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
..|+.++.||+|+||.||+|..+++.. .+|+|.++... ....-+|+..++.+ +|||++.+..++... ..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl-~h~nvi~Lv~Vfl~~-d~ 101 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLREL-KHPNVISLVKVFLSH-DK 101 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHh-cCCcchhHHHHHhcc-Cc
Confidence 479999999999999999997765543 68999987552 34577999999999 999999999988654 56
Q ss_pred CcEEEEEeecCchhhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCC----CCeEEEeec
Q 020826 92 TPSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----QRKLRLIDW 160 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~----~~~v~l~df 160 (321)
..++++||++...+.-.. +.++...++.++.||+.|+.|||++-+.||||||.||++..+ | .|||+|+
T Consensus 102 ~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG-~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERG-RVKIADL 180 (438)
T ss_pred eEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccC-eeEeecc
Confidence 778999999987654322 348999999999999999999999999999999999999877 5 8999999
Q ss_pred cceeecCCC----CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCC--------ChHHHHH
Q 020826 161 GLAEFYHPG----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--------NYDQLVK 228 (321)
Q Consensus 161 g~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~--------~~~~~~~ 228 (321)
|+++.+.+. ...+..+-|.+|+|||.+++...|+++.|||+.||++.||+|-...|..... ..+++..
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 999876543 2345567889999999999989999999999999999999998866643211 2467889
Q ss_pred HHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 229 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
|.+.+|.+....|..-.........-.........+.+...-......-++...+|+.+||++||-+|.|++++|+|+||
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF 340 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYF 340 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccc
Confidence 99999998887776655544442222111111111111111112222234568999999999999999999999999999
Q ss_pred ccCCCc
Q 020826 309 FPIRNA 314 (321)
Q Consensus 309 ~~~~~~ 314 (321)
..-..+
T Consensus 341 ~~d~lp 346 (438)
T KOG0666|consen 341 TEDPLP 346 (438)
T ss_pred ccCCCC
Confidence 987555
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=299.50 Aligned_cols=277 Identities=30% Similarity=0.541 Sum_probs=208.3
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
++|++...||+|++|.||+|++..+++.+++|.+.... .+.+.+|+.+++.+ +|||++++++++.. ....++
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~~ 77 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQL-KHPNLVNLIEVFRR--KRKLHL 77 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhC-CCCCEeeeeeEEee--CCEEEE
Confidence 57999999999999999999998899999999886432 24567899999999 89999999999854 456679
Q ss_pred EEEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-c
Q 020826 96 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 171 (321)
Q Consensus 96 v~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~-~ 171 (321)
++||++++++..+.. .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||++....... .
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07847 78 VFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG-QIKLCDFGFARILTGPGDD 156 (286)
T ss_pred EEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC-cEEECccccceecCCCccc
Confidence 999999998887763 489999999999999999999999999999999999999888 89999999997664333 2
Q ss_pred cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCCh
Q 020826 172 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (321)
.....++..|+|||.+.+...++.++|+||||+++++|++|+.||. +....+.+..+.+..+....... .... ...
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~ 232 (286)
T cd07847 157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWP-GKSDVDQLYLIRKTLGDLIPRHQ-QIFS--TNQ 232 (286)
T ss_pred ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCChHHh-hhcc--ccc
Confidence 2334567889999998765567889999999999999999998884 44445555555444433211100 0000 000
Q ss_pred hhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 252 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
...... ...+............+++.+.+|+.+||+.||++|||+.|++.||||
T Consensus 233 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 233 FFKGLS---IPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cccccc---CCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000000 000000000000112357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-44 Score=316.33 Aligned_cols=285 Identities=24% Similarity=0.309 Sum_probs=209.0
Q ss_pred cCceEEeeeeeeecceEEEEEEEec--CCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCT--DNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~--~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
..+|++++.||+|+||.||++.... ++..+++|.+... ....+|+.+++.+ +||||+++++.+.. ....+++|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--~~~~~E~~il~~l-~h~~iv~~~~~~~~--~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--KTPGREIDILKTI-SHRAIINLIHAYRW--KSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--ccHHHHHHHHHhc-CCCCccceeeeEee--CCEEEEEe
Confidence 4579999999999999999997643 4578999987643 4457899999999 89999999998854 44677999
Q ss_pred EeecCchhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc---c
Q 020826 98 EHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---Y 172 (321)
Q Consensus 98 e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~---~ 172 (321)
|++.+..+.... ..+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++........ .
T Consensus 166 e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~-~~~l~DfG~a~~~~~~~~~~~~ 244 (392)
T PHA03207 166 PKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE-NAVLGDFGAACKLDAHPDTPQC 244 (392)
T ss_pred hhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC-CEEEccCccccccCcccccccc
Confidence 999865444332 4589999999999999999999999999999999999999888 899999999876543222 2
Q ss_pred ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCC--ChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 173 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--NYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
....+|..|+|||++.+ ..++.++|||||||++|+|++|+.||+.... ....+..+.+.++........ .......
T Consensus 245 ~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~-~~~~~~~ 322 (392)
T PHA03207 245 YGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQ-NGSTNLC 322 (392)
T ss_pred cccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCC-ccchhHH
Confidence 23568999999999987 6789999999999999999999999965432 344555555555433221100 0000000
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
..+... ....+.+.. .........++.++.++|++||+.||++|||+.|+|+||||++....
T Consensus 323 ~~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~ 384 (392)
T PHA03207 323 KHFKQY-AIVLRPPYT-IPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPIN 384 (392)
T ss_pred HHHHhh-cccccCCcc-ccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchh
Confidence 001110 001111111 11111122456789999999999999999999999999999986544
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=297.04 Aligned_cols=247 Identities=23% Similarity=0.412 Sum_probs=199.8
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc--------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~--------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
+.|++.+.||+|++|.||.|.+..++..+++|.++... ...+.+|+.+++++ +||||+++++++.+. ..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~ 78 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL-QHERIVQYYGCLRDD--ET 78 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEccC--Ce
Confidence 57899999999999999999998899999999986431 24577899999999 999999999999654 47
Q ss_pred cEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 93 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
.++++|++++++|.+.+ ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 79 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~-~~~l~dfg~~~~~~~~ 157 (263)
T cd06625 79 LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRLQTI 157 (263)
T ss_pred EEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeecccceecccc
Confidence 78999999999987776 3578899999999999999999999999999999999999877 8999999998765332
Q ss_pred Ccc----ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhh
Q 020826 170 KEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245 (321)
Q Consensus 170 ~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (321)
... ....++..|+|||.+.+ ..++.++||||||+++|++++|+.||... +.......... ..
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~-~~~~~~~~~~~---~~--------- 223 (263)
T cd06625 158 CSSGTGMKSVTGTPYWMSPEVISG-EGYGRKADVWSVGCTVVEMLTEKPPWAEF-EAMAAIFKIAT---QP--------- 223 (263)
T ss_pred ccccccccCCCcCccccCcceecc-CCCCchhhhHHHHHHHHHHHhCCCCcccc-chHHHHHHHhc---cC---------
Confidence 211 23456778999999987 67889999999999999999999998422 22111111100 00
Q ss_pred cccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
.....+..+++++.++|++||..+|++|||+.++++||||
T Consensus 224 -----------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 224 -----------------------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred -----------------------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 0011122456789999999999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=269.61 Aligned_cols=279 Identities=30% Similarity=0.552 Sum_probs=227.2
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
.+|...++||+|.||+||+|++..+++.||+|.++.++ .+...+|+-+++.+ +|.||++++++... ...+.+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkel-khknivrl~dvlhs--dkkltl 78 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHS--DKKLTL 78 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHh-hhcceeehhhhhcc--CceeEE
Confidence 35777889999999999999999999999999987543 36789999999999 99999999998844 445679
Q ss_pred EEEeecCch---hhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-c
Q 020826 96 IFEHVNNTD---FKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 171 (321)
Q Consensus 96 v~e~~~~~~---l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~-~ 171 (321)
|+|+|.... +....+.++.+.++.++.|++.||.++|++++.|+|+||+|.+++.+| .+|++|||+++.+.-.- -
T Consensus 79 vfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ng-elkladfglarafgipvrc 157 (292)
T KOG0662|consen 79 VFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNG-ELKLADFGLARAFGIPVRC 157 (292)
T ss_pred eHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCC-cEEecccchhhhcCCceEe
Confidence 999998653 233335689999999999999999999999999999999999999999 89999999997664332 3
Q ss_pred cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCCh
Q 020826 172 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (321)
++..+-|.+|++|.++.+..-+++..|+||-||++.|+....-|.+++.+..+++..+...+|.+....|..-.......
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 45667889999999999988899999999999999999988889999999999999999999998776664432222111
Q ss_pred hhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 252 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
.+. .-.....+. .....++...+++++++|.-+|.+|.+++++++||||.+.
T Consensus 238 ~yp---~ypattsws-----qivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 238 PYP---IYPATTSWS-----QIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred ccC---CccccchHH-----HHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 100 000001111 1123455678999999999999999999999999999875
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=312.20 Aligned_cols=242 Identities=28% Similarity=0.457 Sum_probs=195.6
Q ss_pred eeeeeecceEEEEEEEe---cCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEE
Q 020826 27 RKVGRGKYSEVFEGVHC---TDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 98 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~---~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 98 (321)
+.||+|+||.||++++. .+++.+|+|+++... ...+..|+.++.++ +||||+++++++.+ ....++|+|
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~~lv~e 78 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPFIVKLHYAFQT--EGKLYLILD 78 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhC-CCCCcccEEEEEEc--CCEEEEEEc
Confidence 57999999999999874 468899999987532 24467899999999 89999999999865 456779999
Q ss_pred eecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC-Ccccc
Q 020826 99 HVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNV 174 (321)
Q Consensus 99 ~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~-~~~~~ 174 (321)
|+.+++|..++. .+++..++.++.||+.||+|||++|++|+||||+||+++.++ .++|+|||++...... .....
T Consensus 79 ~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~~~~~~ 157 (318)
T cd05582 79 FLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESIDHEKKAYS 157 (318)
T ss_pred CCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCC-cEEEeeccCCcccCCCCCceec
Confidence 999999877763 489999999999999999999999999999999999999888 8999999998755433 22334
Q ss_pred ccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhH
Q 020826 175 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLA 254 (321)
Q Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (321)
..++..|+|||.+.+ ..++.++|||||||++|+|++|+.||. +.+.......+...
T Consensus 158 ~~g~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tg~~p~~-~~~~~~~~~~i~~~---------------------- 213 (318)
T cd05582 158 FCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGSLPFQ-GKDRKETMTMILKA---------------------- 213 (318)
T ss_pred ccCChhhcCHHHHcC-CCCCCccceeccceEeeeeccCCCCCC-CCCHHHHHHHHHcC----------------------
Confidence 568899999999987 678899999999999999999999984 22222222211100
Q ss_pred hhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC-----HHHHhcCCCcccC
Q 020826 255 ALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPI 311 (321)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps-----~~ell~hp~~~~~ 311 (321)
....+..+++++.++|++||+.||++||| ++++++||||+.+
T Consensus 214 ---------------~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 214 ---------------KLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred ---------------CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence 00112246678999999999999999999 7889999999875
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=300.72 Aligned_cols=275 Identities=32% Similarity=0.560 Sum_probs=211.1
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
+|++.+.||+|++|.||+|.+..+++.+++|.+.... ...+.+|+.+++++ +|||++++++++.+ ....++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~~v 77 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC-QHPYVVKLLDVFPH--GSGFVLV 77 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhC-CCCCCcceeeEEec--CCeeEEE
Confidence 5899999999999999999998899999999987433 35688999999999 79999999999865 4566899
Q ss_pred EEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC--
Q 020826 97 FEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-- 170 (321)
Q Consensus 97 ~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~-- 170 (321)
+|++ +++|..++ ..+++..++.++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||.+.......
T Consensus 78 ~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~-~~~l~dfg~~~~~~~~~~~ 155 (286)
T cd07832 78 MEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG-VLKIADFGLARLFSEEEPR 155 (286)
T ss_pred eccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCC-cEEEeeeeecccccCCCCC
Confidence 9999 88887665 3489999999999999999999999999999999999999877 89999999987654332
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
......++..|+|||.+.+...++.++||||+||+++++++|..+ +.+..+......+...++.+....+..... .
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 231 (286)
T cd07832 156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPL-FPGENDIEQLAIVFRTLGTPNEETWPGLTS---L 231 (286)
T ss_pred ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcC-cCCCCHHHHHHHHHHHcCCCChHHHhhccC---c
Confidence 234456888999999987655678999999999999999999644 466666666666666555543322211100 0
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcc
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF 309 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~ 309 (321)
........ ........ .......++++.++|++||+.||++|||++++++||||.
T Consensus 232 ~~~~~~~~--~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 232 PDYNKITF--PESKPIPL--EEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred chhhcccC--CCCCcchH--HHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 00000000 00000000 011123557899999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=301.39 Aligned_cols=280 Identities=30% Similarity=0.533 Sum_probs=209.6
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
..++|++.+.||+|++|.||+|.+..+++.+++|.++... ...+.+|+.++.++ +||||+++++++.+.+....
T Consensus 3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL-QHPNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhc-CCCCEEEEEEEEEecCCCcE
Confidence 3468999999999999999999998899999999986432 23467899999999 79999999999876655788
Q ss_pred EEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 94 SLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
++++||+.+ +|..++ ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||++......
T Consensus 82 ~lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~ 159 (293)
T cd07843 82 YMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRG-ILKICDFGLAREYGSP 159 (293)
T ss_pred EEEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC-cEEEeecCceeeccCC
Confidence 899999986 554443 2489999999999999999999999999999999999999887 8999999998766433
Q ss_pred -CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 170 -KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 170 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
.......++..|+|||.+.+...++.++|+||||+++++|++|..||. ..+.......+....+.+....+.......
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T cd07843 160 LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFP-GKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238 (293)
T ss_pred ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence 233345577889999998764567899999999999999999998874 444444455554544443322222111100
Q ss_pred CChhhHhhhcccCCCCCcccccccccc-CCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQH-LAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
.... ........... ....+. .+++.+.++|++||+.||++|||+.|+++||||
T Consensus 239 ~~~~-----~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 239 GAKK-----KTFTKYPYNQL-RKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hhcc-----cccccccchhh-hccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0000 00000000000 000111 156789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=300.93 Aligned_cols=258 Identities=21% Similarity=0.372 Sum_probs=204.5
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
++|++.+.||+|++|.||+|.+..++..+++|.+.... ...+.+|+.++.++ +|||++++++.+... ...+++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv 77 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKC-DSPYIIGFYGAFFVE--NRISIC 77 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEEC--CEEEEE
Confidence 47889999999999999999999999999999986432 34577899999999 899999999998654 455699
Q ss_pred EEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCcccccc
Q 020826 97 FEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 176 (321)
Q Consensus 97 ~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~~~~~ 176 (321)
+||+.++++..+ ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++...... ......
T Consensus 78 ~e~~~~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~-~~~l~dfg~~~~~~~~-~~~~~~ 154 (279)
T cd06619 78 TEFMDGGSLDVY-RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVNS-IAKTYV 154 (279)
T ss_pred EecCCCCChHHh-hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCC-CEEEeeCCcceecccc-cccCCC
Confidence 999999988654 4678899999999999999999999999999999999999888 8999999998765432 223457
Q ss_pred CCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHH--HHHHHhCChhhhHHhhhhcccCChhhH
Q 020826 177 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV--KIAKVLGTDELNAYLNKYHIELDPHLA 254 (321)
Q Consensus 177 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (321)
++..|+|||.+.+ ..++.++|+|||||++|+|++|..||........... ...+..
T Consensus 155 ~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------------------- 212 (279)
T cd06619 155 GTNAYMAPERISG-EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI--------------------- 212 (279)
T ss_pred CChhhcCceeecC-CCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHH---------------------
Confidence 8889999999987 6789999999999999999999999853221111000 000000
Q ss_pred hhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCccc
Q 020826 255 ALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAES 316 (321)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~~ 316 (321)
... .... ......++++.+++.+||+.||++||+++++++||||+.......
T Consensus 213 --~~~-~~~~-------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~~~~ 264 (279)
T cd06619 213 --VDE-DPPV-------LPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYNDGNA 264 (279)
T ss_pred --hcc-CCCC-------CCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccCccH
Confidence 000 0000 001235578999999999999999999999999999998765543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=322.15 Aligned_cols=257 Identities=20% Similarity=0.314 Sum_probs=205.8
Q ss_pred eeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccC
Q 020826 15 FINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 89 (321)
Q Consensus 15 ~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (321)
.+....++|++.+.||+|+||+||+|++..+++.||+|++... ....+.+|+..+..+ +|+|+++++..+....
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~-~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNC-DFFSIVKCHEDFAKKD 104 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcC-CCCcEEEeecceeccc
Confidence 3445678999999999999999999999999999999998643 234577899999988 8999999988764322
Q ss_pred C------CCcEEEEEeecCchhhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEE
Q 020826 90 S------KTPSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLR 156 (321)
Q Consensus 90 ~------~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~ 156 (321)
. ...++|+||+.+++|.+++ ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~-~vk 183 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG-LVK 183 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC-CEE
Confidence 1 2367999999999987766 2488999999999999999999999999999999999999888 899
Q ss_pred EeeccceeecCCC---CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHh
Q 020826 157 LIDWGLAEFYHPG---KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL 233 (321)
Q Consensus 157 l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 233 (321)
|+|||+++..... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.. .+..+.+..+..
T Consensus 184 L~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~~-~~~~~~~~~~~~-- 259 (496)
T PTZ00283 184 LGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFDG-ENMEEVMHKTLA-- 259 (496)
T ss_pred EEecccCeeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHhc--
Confidence 9999998765422 12234568999999999987 7789999999999999999999999832 221111111100
Q ss_pred CChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 234 GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
. .. ...+..+++++.+++.+||+.||++|||+.++++|||++..
T Consensus 260 -~-------------------------~~--------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 260 -G-------------------------RY--------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred -C-------------------------CC--------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 0 00 00123467899999999999999999999999999998764
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-46 Score=311.67 Aligned_cols=251 Identities=24% Similarity=0.418 Sum_probs=207.9
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
....|...+.||+|.||.||+|.+..+++.||+|++..+ +-..+++|+.++.++ +++||.++|+.+.. ...++
T Consensus 11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~-~~~~it~yygsyl~--g~~Lw 87 (467)
T KOG0201|consen 11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQC-DSPNITEYYGSYLK--GTKLW 87 (467)
T ss_pred cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhc-CcchHHhhhhheee--cccHH
Confidence 355788889999999999999999999999999999754 346789999999999 88999999998854 45677
Q ss_pred EEEEeecCchhhhhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-
Q 020826 95 LIFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 170 (321)
Q Consensus 95 lv~e~~~~~~l~~~~~~---~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~- 170 (321)
++||||.||++...+.. +.+..+..++.+++.||.|||.++.+|+|||+.||++..+| .||++|||.+-......
T Consensus 88 iiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g-~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 88 IIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESG-DVKLADFGVAGQLTNTVK 166 (467)
T ss_pred HHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccC-cEEEEecceeeeeechhh
Confidence 99999999998887743 48888999999999999999999999999999999999887 89999999986554332
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
...+.+||+.|||||++.+ ..|+.++||||||++.+||.+|..|+. +......+..|-+
T Consensus 167 rr~tfvGTPfwMAPEVI~~-~~Y~~KADIWSLGITaiEla~GePP~s-~~hPmrvlflIpk------------------- 225 (467)
T KOG0201|consen 167 RRKTFVGTPFWMAPEVIKQ-SGYDTKADIWSLGITAIELAKGEPPHS-KLHPMRVLFLIPK------------------- 225 (467)
T ss_pred ccccccccccccchhhhcc-ccccchhhhhhhhHHHHHHhcCCCCCc-ccCcceEEEeccC-------------------
Confidence 2367799999999999996 789999999999999999999998873 2222111111100
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
..| .. ....+|+.+++|+..||+.||+.||||.++|+|+|++..
T Consensus 226 -----------~~P-P~-----L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 226 -----------SAP-PR-----LDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred -----------CCC-Cc-----cccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence 000 00 111577899999999999999999999999999999983
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=297.47 Aligned_cols=280 Identities=28% Similarity=0.493 Sum_probs=207.0
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
..+|++.+.||+|+||.||+|.+..++..+++|.++... ...+.+|+.+++.+ +|+||+++++++.+ ....++
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~--~~~~~l 80 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGL-KHANIVLLHDIIHT--KETLTF 80 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhc-CCCCEeEEEEEEec--CCeEEE
Confidence 478999999999999999999998899999999986432 23567899999999 89999999999854 456789
Q ss_pred EEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC-Cc
Q 020826 96 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KE 171 (321)
Q Consensus 96 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~-~~ 171 (321)
++|++.++.+.... ..++...+..++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||++...... ..
T Consensus 81 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~~ 159 (291)
T cd07870 81 VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG-ELKLADFGLARAKSIPSQT 159 (291)
T ss_pred EEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCC-cEEEeccccccccCCCCCC
Confidence 99999865554443 2477888999999999999999999999999999999999888 8999999988654322 12
Q ss_pred cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCCh
Q 020826 172 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (321)
.....++..|+|||.+.+...++.++|+||||++++++++|..||....+..+.+..+....+.+....+.......
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 236 (291)
T cd07870 160 YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLP--- 236 (291)
T ss_pred CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcc---
Confidence 23345688899999987645678899999999999999999999865555555666655555543222111110000
Q ss_pred hhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 252 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
......... ...............++++.+++.+||+.||++|||+++++.||||
T Consensus 237 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 237 NYKPEWFLP--CKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cccchhccc--cCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 000000000 0000011111111224689999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=299.11 Aligned_cols=254 Identities=25% Similarity=0.363 Sum_probs=204.3
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
.|+..+.||+|+||+||++.+..+++.+|+|.+.... ...+.+|+++++.+ +|++++++.+.+.. ....++
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l-~~~~i~~~~~~~~~--~~~~~l 77 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKV-NSQFVVNLAYAYET--KDALCL 77 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHc-CCcCceeEEEEEec--CCEEEE
Confidence 4788899999999999999999999999999986432 23467899999999 99999999998854 456789
Q ss_pred EEEeecCchhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 96 IFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 96 v~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
++||+.+++|...+ ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05632 78 VLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG-HIRISDLGLAVKIPEGE 156 (285)
T ss_pred EEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC-CEEEecCCcceecCCCC
Confidence 99999999887655 2489999999999999999999999999999999999999887 89999999987654443
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
......++..|+|||.+.+ ..++.++|+||||+++|++++|..||... ........+........
T Consensus 157 ~~~~~~g~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~P~~~~-~~~~~~~~~~~~~~~~~------------- 221 (285)
T cd05632 157 SIRGRVGTVGYMAPEVLNN-QRYTLSPDYWGLGCLIYEMIEGQSPFRGR-KEKVKREEVDRRVLETE------------- 221 (285)
T ss_pred cccCCCCCcCccChHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHHhhhccc-------------
Confidence 3445578899999999977 67899999999999999999999998432 22212222111110000
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC-----HHHHhcCCCcccCCCc
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPIRNA 314 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps-----~~ell~hp~~~~~~~~ 314 (321)
......+++++.+|+.+||+.||++||| +.++++||||+.....
T Consensus 222 --------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05632 222 --------------------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK 270 (285)
T ss_pred --------------------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence 0011235678999999999999999999 8899999999987544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=307.74 Aligned_cols=255 Identities=24% Similarity=0.392 Sum_probs=199.9
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
++|++.+.||+|+||+||+++++.+++.+|+|++.... ...+..|+.++..+ +|++|+++++.+.+. ...+
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~--~~~~ 77 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DNQWITTLHYAFQDE--NNLY 77 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhC-CCCCEeeEEEEEecC--CEEE
Confidence 47999999999999999999999999999999986421 23467788888888 999999999998554 5678
Q ss_pred EEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 95 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 95 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
+||||+.+++|..++ ..+++..++.++.|++.||+|||++|++||||||+||+++.++ .++|+|||++.......
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~-~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG-HIRLADFGSCLKLMEDG 156 (332)
T ss_pred EEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC-CEEEeecchheecccCC
Confidence 999999999988777 3488999999999999999999999999999999999999887 89999999987543222
Q ss_pred c--cccccCCccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhh
Q 020826 171 E--YNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244 (321)
Q Consensus 171 ~--~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (321)
. .....||..|+|||++.+ ...++.++|||||||++|+|++|+.||.. .+..+....+.. ..
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~---~~-------- 224 (332)
T cd05623 157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMN---HK-------- 224 (332)
T ss_pred cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCC-CCHHHHHHHHhC---CC--------
Confidence 2 233568999999999863 24678899999999999999999999942 222222222111 00
Q ss_pred hcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCC--CcCHHHHhcCCCcccCC
Q 020826 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE--RPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~--Rps~~ell~hp~~~~~~ 312 (321)
...+ .......+++++.+||++||+.++.+ |++++++++||||++++
T Consensus 225 ----------------~~~~-----~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~ 273 (332)
T cd05623 225 ----------------ERFQ-----FPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGID 273 (332)
T ss_pred ----------------cccc-----CCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCC
Confidence 0000 00011246789999999999776555 68999999999999764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-43 Score=298.43 Aligned_cols=277 Identities=32% Similarity=0.542 Sum_probs=205.9
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
-++|++.+.||+|++|+||+|.+..+++.|++|.+.... ...+.+|+.+++.+ +||||+++++++.+ ..+.++
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 80 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDL-KHANIVTLHDIIHT--KKTLTL 80 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhC-CCcceeeEEEEEec--CCeEEE
Confidence 478999999999999999999998899999999986432 24467899999999 99999999999854 456789
Q ss_pred EEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC-C
Q 020826 96 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K 170 (321)
Q Consensus 96 v~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~-~ 170 (321)
|+||+.+ +|..++ ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++...... .
T Consensus 81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERG-ELKLADFGLARAKSVPSK 158 (291)
T ss_pred EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCC-CEEECccccccccCCCCc
Confidence 9999986 555544 3478999999999999999999999999999999999999888 8999999998654221 1
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
......++..|+|||.+.+...++.++||||+|+++|+|++|..||.......+.+..+...++.+....+.........
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 12233467789999998765568899999999999999999999985444345555555555554332222111100000
Q ss_pred hhhHhhhcccCCCCCccccccccccCCc--chHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAV--PEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s--~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
.. . ............ ....++ .++.+++.+||+.||++|||+.|+++||||
T Consensus 239 ~~---~--~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 239 KP---Y--SFPFYPPRPLIN--HAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cc---c--cccccCChhHHH--hCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00 0 000000000000 011233 688999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=296.53 Aligned_cols=275 Identities=32% Similarity=0.575 Sum_probs=206.3
Q ss_pred eEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEE
Q 020826 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 98 (321)
Q Consensus 23 y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 98 (321)
|++.+.||+|++|.||+|.+..++..+++|.++... .....+|+..+.++.+|||++++++++.+.....+++++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 678999999999999999998899999999986532 1234578888999867999999999997765567899999
Q ss_pred eecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCccccc
Q 020826 99 HVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR 175 (321)
Q Consensus 99 ~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~~~~ 175 (321)
|+.++.+.... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++. + .++|+|||++............
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~-~~kl~dfg~~~~~~~~~~~~~~ 158 (282)
T cd07831 81 LMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-D-ILKLADFGSCRGIYSKPPYTEY 158 (282)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-C-CeEEEecccccccccCCCcCCC
Confidence 99876555444 24899999999999999999999999999999999999998 6 8999999998766544443445
Q ss_pred cCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHh
Q 020826 176 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA 255 (321)
Q Consensus 176 ~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (321)
.++..|+|||.+.....++.++|+|||||++|+|++|..|| .+.+..+....+....+...... ...........+
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~-- 234 (282)
T cd07831 159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLF-PGTNELDQIAKIHDVLGTPDAEV-LKKFRKSRHMNY-- 234 (282)
T ss_pred CCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCC-CCCCHHHHHHHHHHHcCCCCHHH-HHhhcccccccc--
Confidence 67889999998765456789999999999999999998887 44554555555555444433211 100000000000
Q ss_pred hhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 256 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
.......... ......+++++.++|.+||+.||++|||++++++||||
T Consensus 235 ---~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 235 ---NFPSKKGTGL--RKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ---cCcccccccH--HHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0000000000 01112467899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=308.77 Aligned_cols=242 Identities=26% Similarity=0.437 Sum_probs=191.6
Q ss_pred eeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHH-HHhhcCCCCeeeeeeeeeccCCCCcEEEEEe
Q 020826 27 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKI-LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 99 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~-l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 99 (321)
+.||+|+||+||+|++..+++.+|+|++.... ...+..|... ++.+ +||||+++++.+.. ....+++|||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~hp~iv~~~~~~~~--~~~~~lv~e~ 77 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNV-KHPFLVGLHYSFQT--TEKLYFVLDF 77 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhC-CCCCCccEEEEEec--CCEEEEEEcC
Confidence 36899999999999999999999999986431 2334555554 4556 89999999998855 4466799999
Q ss_pred ecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC-CCccccc
Q 020826 100 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVR 175 (321)
Q Consensus 100 ~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~-~~~~~~~ 175 (321)
+.+++|...+ ..+++..+..++.||+.||+|||++|++|+||||+||+++.++ .++|+|||++..... .......
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~-~~kL~DfG~~~~~~~~~~~~~~~ 156 (325)
T cd05604 78 VNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQG-HVVLTDFGLCKEGIAQSDTTTTF 156 (325)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEEeecCCcccCCCCCCCcccc
Confidence 9999987665 4589999999999999999999999999999999999999888 899999999865322 2223445
Q ss_pred cCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHh
Q 020826 176 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA 255 (321)
Q Consensus 176 ~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (321)
.++..|+|||++.+ ..++.++|||||||++|+|++|..||.. .+..+....+.. .
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~-~~~~~~~~~~~~---~-------------------- 211 (325)
T cd05604 157 CGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYC-RDVAEMYDNILH---K-------------------- 211 (325)
T ss_pred cCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCC-CCHHHHHHHHHc---C--------------------
Confidence 68999999999987 6788999999999999999999999843 222222211110 0
Q ss_pred hhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCH----HHHhcCCCcccC
Q 020826 256 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA----KEAMAHPYFFPI 311 (321)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~----~ell~hp~~~~~ 311 (321)
........+.++.++|++||+.||++||++ .++++||||+..
T Consensus 212 --------------~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 212 --------------PLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred --------------CccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 001112356789999999999999999976 599999999875
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=319.40 Aligned_cols=250 Identities=23% Similarity=0.376 Sum_probs=201.7
Q ss_pred cCceEEeeeeeeecceEEEEEEEecC-CceEEEEEecccc---hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTD-NEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~-~~~~~vK~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
...|.+.+.||+|++|.||+|.+..+ +..+++|.+.... ...+..|+.++..+ +||||+++++++... ...++
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l-~Hpniv~~~~~~~~~--~~~~l 142 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAAC-DHFGIVKHFDDFKSD--DKLLL 142 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEEEC--CEEEE
Confidence 34599999999999999999998777 7889999765433 24567899999999 999999999999654 56789
Q ss_pred EEEeecCchhhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 96 IFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 96 v~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
||||+.+++|...+ ..+++.++..++.|++.||+|||++||+||||||+||+++.++ .++|+|||++.....
T Consensus 143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~-~~kL~DFgla~~~~~ 221 (478)
T PTZ00267 143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG-IIKLGDFGFSKQYSD 221 (478)
T ss_pred EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCC-cEEEEeCcCceecCC
Confidence 99999999987654 2488999999999999999999999999999999999999888 899999999986543
Q ss_pred CCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhh
Q 020826 169 GKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245 (321)
Q Consensus 169 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (321)
... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+.. +..
T Consensus 222 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~-~~~~~~~~~~~~~--~~~--------- 288 (478)
T PTZ00267 222 SVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFK-GPSQREIMQQVLY--GKY--------- 288 (478)
T ss_pred ccccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHh--CCC---------
Confidence 322 234568999999999987 678999999999999999999999984 2222222221111 000
Q ss_pred cccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
. ..+..+++++.++|.+||+.||++|||+++++.|||++.+
T Consensus 289 -----------------~--------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~ 329 (478)
T PTZ00267 289 -----------------D--------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYV 329 (478)
T ss_pred -----------------C--------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHH
Confidence 0 0112356789999999999999999999999999999754
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=297.07 Aligned_cols=260 Identities=26% Similarity=0.450 Sum_probs=205.4
Q ss_pred eeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc--chHHHHHHHHHHHhhcCCCCeeeeeeeeeccC--
Q 020826 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ-- 89 (321)
Q Consensus 14 ~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-- 89 (321)
-.+....++|++.+.||+|+||.||++.+..+++.+++|++... ....+.+|+.+++++.+|||++++++++...+
T Consensus 15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 45566789999999999999999999999999999999998653 23567889999999878999999999886433
Q ss_pred -CCCcEEEEEeecCchhhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecc
Q 020826 90 -SKTPSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 161 (321)
Q Consensus 90 -~~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg 161 (321)
....++++||+.+++|.+++ ..+++..++.++.|++.||++||+.|++|+||+|+||+++.++ .++|+|||
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~-~~kl~dfg 173 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG-GVKLVDFG 173 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC-CEEEeecc
Confidence 24578999999999987765 3488999999999999999999999999999999999999887 79999999
Q ss_pred ceeecCCCC-ccccccCCccccccccccCCC----CCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCCh
Q 020826 162 LAEFYHPGK-EYNVRVASRYFKGPELLVDLQ----DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD 236 (321)
Q Consensus 162 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~----~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (321)
++....... ......++..|+|||.+.... .++.++|+|||||++|++++|+.||... .....+..+.. ..
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~-~~~~~~~~~~~---~~ 249 (291)
T cd06639 174 VSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM-HPVKTLFKIPR---NP 249 (291)
T ss_pred cchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC-cHHHHHHHHhc---CC
Confidence 987544322 223446788899999975422 3678999999999999999999998432 11111111100 00
Q ss_pred hhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcc
Q 020826 237 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF 309 (321)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~ 309 (321)
. .....+...+..+.++|.+||+.||++|||+.|+++||||+
T Consensus 250 ~-------------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 250 P-------------------------------PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred C-------------------------------CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 0 00011123446899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=306.78 Aligned_cols=270 Identities=26% Similarity=0.384 Sum_probs=223.0
Q ss_pred CccEEEEEEeeeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCC
Q 020826 3 RGHVMVIYWCVWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGP 76 (321)
Q Consensus 3 ~~~~~~~~~~~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~ 76 (321)
+..+++|.|-.+ ++-..+.|..-++||+|+||.|+-++-..||+.||.|.+.+. .......|..++.++ +.+
T Consensus 168 f~rFlQWK~lE~-qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV-~s~ 245 (591)
T KOG0986|consen 168 FTRFLQWKWLEL-QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKV-SSP 245 (591)
T ss_pred HHHHHHHHHHHh-hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHh-ccC
Confidence 344566777666 677788999999999999999999999999999999987532 224467899999999 899
Q ss_pred CeeeeeeeeeccCCCCcEEEEEeecCchhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCC
Q 020826 77 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 151 (321)
Q Consensus 77 ~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~ 151 (321)
.||.+--.+ +....+|+|+..|+||+|..++ +.+++..+.-++.+|+.||++||..+||+||+||+||++|..
T Consensus 246 FiVslaYAf--eTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~ 323 (591)
T KOG0986|consen 246 FIVSLAYAF--ETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDH 323 (591)
T ss_pred cEEEEeeee--cCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccC
Confidence 999998877 4456678999999999998777 359999999999999999999999999999999999999988
Q ss_pred CCeEEEeeccceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHH
Q 020826 152 QRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 231 (321)
Q Consensus 152 ~~~v~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 231 (321)
| .|+|+|+|++...+.+......+||..|||||++.+ ..|+...|-|||||++|+|+.|+.||.... ...--+++-+
T Consensus 324 G-hvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~n-e~Y~~s~Dwf~lGCllYemi~G~sPFr~~K-eKvk~eEvdr 400 (591)
T KOG0986|consen 324 G-HVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQN-EVYDFSPDWFSLGCLLYEMIAGHSPFRQRK-EKVKREEVDR 400 (591)
T ss_pred C-CeEeeccceEEecCCCCccccccCcccccCHHHHcC-CcccCCccHHHHHhHHHHHHcccCchhhhh-hhhhHHHHHH
Confidence 8 899999999999888888788899999999999998 569999999999999999999999994211 1111111100
Q ss_pred HhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc-----CHHHHhcCC
Q 020826 232 VLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHP 306 (321)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp-----s~~ell~hp 306 (321)
.. .....+.+..+|++++++++.+|+.||++|. .++++-+||
T Consensus 401 r~---------------------------------~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~Hp 447 (591)
T KOG0986|consen 401 RT---------------------------------LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHP 447 (591)
T ss_pred HH---------------------------------hcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCc
Confidence 00 0011223346889999999999999999996 578999999
Q ss_pred CcccCC
Q 020826 307 YFFPIR 312 (321)
Q Consensus 307 ~~~~~~ 312 (321)
||+.++
T Consensus 448 fFk~ln 453 (591)
T KOG0986|consen 448 FFKDLN 453 (591)
T ss_pred ccccCC
Confidence 999874
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=305.08 Aligned_cols=287 Identities=30% Similarity=0.550 Sum_probs=212.3
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccC---CC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---SK 91 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~---~~ 91 (321)
..++|++.+.||+|++|.||+|.+..+++.|++|.++... ...+.+|+.+++.+ +||||+++++++.... ..
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRF-KHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhC-CCCCcCchhheeecccccccc
Confidence 3578999999999999999999999999999999986432 24567899999999 8999999999875432 23
Q ss_pred CcEEEEEeecCchhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 92 TPSLIFEHVNNTDFKVLY-PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
..++++|++.+....... ..+++..++.++.|++.||++||++|++|+||||+||+++.++ .++|+|||++.......
T Consensus 82 ~~~lv~e~~~~~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~ 160 (336)
T cd07849 82 DVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNC-DLKICDFGLARIADPEH 160 (336)
T ss_pred eEEEEehhcccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC-CEEECcccceeeccccc
Confidence 468999999864433333 3589999999999999999999999999999999999999887 89999999987653222
Q ss_pred c----cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhc
Q 020826 171 E----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246 (321)
Q Consensus 171 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (321)
. .....++..|+|||.+.+...++.++||||||+++|+|++|+.|| .+.+.......+...++.+.........
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f-~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 238 (336)
T cd07849 161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLF-PGKDYLHQLNLILGVLGTPSQEDLNCII- 238 (336)
T ss_pred cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCCHHHHHHhh-
Confidence 1 123457888999998766467889999999999999999999888 4455455555555555544332221110
Q ss_pred ccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
..............+..... ......++++.+++++||+.||++|||+.|+++||||++...+
T Consensus 239 ---~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~ 301 (336)
T cd07849 239 ---SLRARNYIKSLPFKPKVPWN--KLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP 301 (336)
T ss_pred ---chhhhhHHhhcCcCCcccHH--HHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence 00000000000000100000 0112356889999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=307.52 Aligned_cols=284 Identities=19% Similarity=0.224 Sum_probs=197.1
Q ss_pred Eeeeeeee--cceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 25 VVRKVGRG--KYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 25 ~~~~lg~g--~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
++++||+| +|++||++.++.+++.||+|.++... ...+.+|+.+++.+ +||||+++++++... ...++|+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~hpniv~~~~~~~~~--~~~~lv~ 78 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLF-NHPNIVPYRATFIAD--NELWVVT 78 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEEC--CEEEEEE
Confidence 56789999 78899999999999999999987432 24577899999999 999999999999654 4567999
Q ss_pred EeecCchhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC--
Q 020826 98 EHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-- 170 (321)
Q Consensus 98 e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~-- 170 (321)
||+.++++.+++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++++||+.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~-~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG-KVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred eccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCC-cEEEcccchhhcccccccc
Confidence 999999988776 2488999999999999999999999999999999999999888 89999998653321110
Q ss_pred ------ccccccCCccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCCh----hh-
Q 020826 171 ------EYNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD----EL- 238 (321)
Q Consensus 171 ------~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~- 238 (321)
......++..|+|||++.+. ..++.++|||||||++|++++|+.||............+....... ..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP 237 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence 01223456679999998753 3588999999999999999999999853322221111111000000 00
Q ss_pred hHH--hhhhcccCChhhHhhhccc-CCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 239 NAY--LNKYHIELDPHLAALVGRH-SRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 239 ~~~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
... +.......+.......... ................+++++.+|+++||+.||++|||++|+++||||+++.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~ 314 (327)
T cd08227 238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK 314 (327)
T ss_pred hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcc
Confidence 000 0000000000000000000 0000000000112224567899999999999999999999999999999864
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=308.16 Aligned_cols=250 Identities=20% Similarity=0.357 Sum_probs=191.9
Q ss_pred eeeecccCceEEeeeeeeecceEEEEEEEe-----cCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeee
Q 020826 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDI 84 (321)
Q Consensus 14 ~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (321)
|.++ .++|++.+.||+|+||.||+|.+. .++..||+|.++... ...+.+|+.++..+.+||||++++++
T Consensus 2 ~~~~--~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~ 79 (338)
T cd05102 2 WEFP--RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGA 79 (338)
T ss_pred cccc--hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence 4444 579999999999999999999853 345689999986432 34678899999999789999999998
Q ss_pred eeccCCCCcEEEEEeecCchhhhhcC------------------------------------------------------
Q 020826 85 VRDQQSKTPSLIFEHVNNTDFKVLYP------------------------------------------------------ 110 (321)
Q Consensus 85 ~~~~~~~~~~lv~e~~~~~~l~~~~~------------------------------------------------------ 110 (321)
+...+ ...+++|||+++++|.+++.
T Consensus 80 ~~~~~-~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (338)
T cd05102 80 CTKPN-GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTN 158 (338)
T ss_pred ecCCC-CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccc
Confidence 75433 35689999999999876652
Q ss_pred -----------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc---ccccc
Q 020826 111 -----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRV 176 (321)
Q Consensus 111 -----------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~---~~~~~ 176 (321)
.+++..+..++.||+.||+|||++|++|+||||+||+++.++ .++|+|||++........ .....
T Consensus 159 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~ 237 (338)
T cd05102 159 PPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSAR 237 (338)
T ss_pred cchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCC-cEEEeecccccccccCcchhcccCCC
Confidence 256677888999999999999999999999999999999877 899999999875432221 12233
Q ss_pred CCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHh
Q 020826 177 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA 255 (321)
Q Consensus 177 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (321)
++..|+|||++.+ ..++.++|||||||++|+|++ |..||...... +....... ..
T Consensus 238 ~~~~y~aPE~~~~-~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~-~~~~~~~~---~~------------------- 293 (338)
T cd05102 238 LPLKWMAPESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN-EEFCQRLK---DG------------------- 293 (338)
T ss_pred CCccccCcHHhhc-CCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc-HHHHHHHh---cC-------------------
Confidence 4567999999977 678999999999999999997 88887422222 11111100 00
Q ss_pred hhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 256 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
. ....+..+++++.+++.+||+.||++|||+.++++
T Consensus 294 -----~--------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 294 -----T--------RMRAPENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred -----C--------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0 00012245678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=298.12 Aligned_cols=261 Identities=26% Similarity=0.465 Sum_probs=210.1
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc---chHHHHHHHHHHHhhcCCCCeeeeeeeeeccC
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 89 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (321)
.+..+....+|++.+.||.|++|+||+|.+..+++.+++|.+... ....+.+|+..++.+ +|||++++++.+.+
T Consensus 11 ~~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~-- 87 (296)
T cd06655 11 IVSIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL-KNPNIVNFLDSFLV-- 87 (296)
T ss_pred HHhcCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhc-CCCceeeeeeeEec--
Confidence 344556677899999999999999999999899999999988643 245678899999999 89999999999854
Q ss_pred CCCcEEEEEeecCchhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 90 SKTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
....++++||+.+++|..++. .+++..+..++.|++.||++||+.|++|+||+|+||+++.++ .++|+|||++....
T Consensus 88 ~~~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~-~~kl~dfg~~~~~~ 166 (296)
T cd06655 88 GDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQIT 166 (296)
T ss_pred CceEEEEEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEccCccchhcc
Confidence 456789999999999988774 489999999999999999999999999999999999999877 89999999887544
Q ss_pred CCCc-cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhc
Q 020826 168 PGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246 (321)
Q Consensus 168 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (321)
.... .....++..|+|||.+.+ ..++.++|+|||||++|++++|+.||.... .......+.. ....
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~-~~~~~~~~~~-~~~~---------- 233 (296)
T cd06655 167 PEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNEN-PLRALYLIAT-NGTP---------- 233 (296)
T ss_pred cccccCCCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHh-cCCc----------
Confidence 3322 233467788999999876 678899999999999999999999984322 2121111100 0000
Q ss_pred ccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCC
Q 020826 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~ 313 (321)
....+..+++.+.++|++||..||++|||+.+++.||||+....
T Consensus 234 -----------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~ 277 (296)
T cd06655 234 -----------------------ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKP 277 (296)
T ss_pred -----------------------ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhccc
Confidence 01112246678999999999999999999999999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=296.61 Aligned_cols=273 Identities=32% Similarity=0.602 Sum_probs=205.5
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
+|++.+.||.|++|.||+|++..+++.+++|.++... ...+.+|+++++++ +||||+++++++.+ ....+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v 77 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHT--ENKLYLV 77 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhc-CCCCCcchhhhccc--CCcEEEE
Confidence 4889999999999999999998899999999886432 24688999999999 89999999999854 4567899
Q ss_pred EEeecCchhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-
Q 020826 97 FEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 170 (321)
Q Consensus 97 ~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~- 170 (321)
+||+.+ ++..++ ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 78 ~e~~~~-~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~-~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 78 FEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVR 155 (284)
T ss_pred eecccc-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEeeccchhhcccCcc
Confidence 999975 555443 3478999999999999999999999999999999999999888 89999999986543221
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
......++..|+|||.+.+...++.++|+||||+++|+++||+.||. +.+.......+....+.+....+....
T Consensus 156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 229 (284)
T cd07860 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFP-GDSEIDQLFRIFRTLGTPDEVVWPGVT----- 229 (284)
T ss_pred ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHHHhCCCChhhhhhhh-----
Confidence 22334567789999998765557889999999999999999999984 444445555555555544322111000
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
................... ....+++++.++|.+||+.||++|||++++++||||
T Consensus 230 -~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 230 -SLPDYKPSFPKWARQDFSK--VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred -HHHHHHhhcccccccCHHH--HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0000000000011111111 122467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=297.66 Aligned_cols=278 Identities=31% Similarity=0.578 Sum_probs=204.5
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC---CC
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---KT 92 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~---~~ 92 (321)
++|++.+.||+|+||.||+|.+..+++.|++|.++... ...+.+|+.++..+.+|||++++++++..... ..
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 47999999999999999999998899999999976432 24578899999999778999999998754322 23
Q ss_pred cEEEEEeecCchhhhhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecccee
Q 020826 93 PSLIFEHVNNTDFKVLY--------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 164 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~ 164 (321)
.++++||+.++ +..++ ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++..++|+|||++.
T Consensus 81 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDSD-LKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCcC-HHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 68999999974 54433 2378999999999999999999999999999999999999834489999999987
Q ss_pred ecCCC-CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 165 FYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 165 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
..... .......++..|+|||.+.+...++.++|+||||+++|+|++|..||. +.+....+..+...++.+....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFP-GDSELQQLLHIFKLLGTPTEQVWPG 238 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHHHHhCCCChhhCcc
Confidence 55322 222334567789999998764567899999999999999999998884 4444444444444433322111100
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcc
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF 309 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~ 309 (321)
.. ......................+++++.++|.+||+.||++|||+.|++.||||+
T Consensus 239 ~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 239 VS---------KLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hh---------hccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00 0000000000000000111124678899999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=305.28 Aligned_cols=254 Identities=25% Similarity=0.392 Sum_probs=198.9
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
++|++.+.||+|+||+||++++..+++.+|+|++.... ...+.+|..++..+ +|++|+++++++.+ ..+.+
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~l~~~~~~--~~~~~ 77 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNG-DCQWITTLHYAFQD--ENYLY 77 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEc--CCEEE
Confidence 58999999999999999999999999999999986421 23467788888888 89999999999854 45678
Q ss_pred EEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 95 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 95 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
+||||+.+++|..++ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++.......
T Consensus 78 lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 78 LVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG-HIRLADFGSCLKMNQDG 156 (331)
T ss_pred EEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCC-CEEEEeccceeeccCCC
Confidence 999999999998776 3478999999999999999999999999999999999999888 89999999987654332
Q ss_pred c--cccccCCccccccccccCC----CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhh
Q 020826 171 E--YNVRVASRYFKGPELLVDL----QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244 (321)
Q Consensus 171 ~--~~~~~~~~~y~aPE~~~~~----~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (321)
. .....|+..|+|||++.+. ..++.++|+|||||++|+|++|+.||.. .+..+....+... .
T Consensus 157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~-~~~~~~~~~i~~~---~-------- 224 (331)
T cd05624 157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYA-ESLVETYGKIMNH---E-------- 224 (331)
T ss_pred ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccC-CCHHHHHHHHHcC---C--------
Confidence 2 1234689999999998642 3577899999999999999999999942 2222222211110 0
Q ss_pred hcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCC--CcCHHHHhcCCCcccC
Q 020826 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE--RPTAKEAMAHPYFFPI 311 (321)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~--Rps~~ell~hp~~~~~ 311 (321)
...+. ......+++++.++|.+||+.++.+ |++++++++||||+..
T Consensus 225 ----------------~~~~~-----p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~ 272 (331)
T cd05624 225 ----------------ERFQF-----PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272 (331)
T ss_pred ----------------CcccC-----CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCC
Confidence 00000 0001235689999999999976654 4699999999999875
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=297.20 Aligned_cols=247 Identities=26% Similarity=0.471 Sum_probs=203.7
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
++|++.+.||+|++|.||++.+..+++.+++|+++.. ....+.+|+++++++ +||||+++++++.+ ....+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~ 77 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSI-RHPFLVNLYGSFQD--DSNLY 77 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhC-CCCCccceeeEEEc--CCeEE
Confidence 4799999999999999999999889999999998643 235578899999999 79999999999855 45678
Q ss_pred EEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc
Q 020826 95 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 171 (321)
Q Consensus 95 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~ 171 (321)
+++||+.+++|..++ ..+++..+..++.|++.||++||++|++|+||+|.||+++.++ .++|+|||++......
T Consensus 78 ~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~-~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 78 LVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG-YIKITDFGFAKRVKGR-- 154 (290)
T ss_pred EEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC-CEEEeeCCCccccCCC--
Confidence 999999999987776 4589999999999999999999999999999999999999888 8999999998765433
Q ss_pred cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCCh
Q 020826 172 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (321)
.....++..|+|||.+.+ ...+.++|+||||+++|+|++|..||.... .......+.. +.
T Consensus 155 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~--~~---------------- 214 (290)
T cd05580 155 TYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDN-PIQIYEKILE--GK---------------- 214 (290)
T ss_pred CCCCCCCccccChhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhc--CC----------------
Confidence 334467888999999877 678899999999999999999999984322 1111111110 00
Q ss_pred hhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc-----CHHHHhcCCCcccCC
Q 020826 252 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIR 312 (321)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp-----s~~ell~hp~~~~~~ 312 (321)
...+..+++.+.++|++||+.||++|+ +++|+++||||+.+.
T Consensus 215 -------------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 215 -------------------VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred -------------------ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 001123457899999999999999999 999999999999875
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=309.97 Aligned_cols=244 Identities=26% Similarity=0.403 Sum_probs=191.6
Q ss_pred eeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhc--CCCCeeeeeeeeeccCCCCcEEEEEee
Q 020826 29 VGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLC--GGPNIVKLLDIVRDQQSKTPSLIFEHV 100 (321)
Q Consensus 29 lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~--~h~~i~~~~~~~~~~~~~~~~lv~e~~ 100 (321)
||+|+||+||+|++..+++.||+|++.... ......|..++..+. +||+|+++++.+.+ ....++||||+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~--~~~~~lv~e~~ 78 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT--DSDLYLVTDYM 78 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec--CCeEEEEEcCC
Confidence 699999999999999999999999986422 122345666666554 79999999999854 45677999999
Q ss_pred cCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC-Ccccccc
Q 020826 101 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNVRV 176 (321)
Q Consensus 101 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~-~~~~~~~ 176 (321)
.+++|...+ ..+++..+..++.||+.||+|||++|++|+||||+||+++.++ .++|+|||++...... .......
T Consensus 79 ~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~ 157 (330)
T cd05586 79 SGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG-HIALCDFGLSKANLTDNKTTNTFC 157 (330)
T ss_pred CCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEecCCcCcCCCCCCCCccCcc
Confidence 999887665 3589999999999999999999999999999999999999888 8999999998654322 2234457
Q ss_pred CCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhh
Q 020826 177 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAAL 256 (321)
Q Consensus 177 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (321)
||..|+|||++.+...++.++|||||||++|+|++|..||... +..+....+.. +.
T Consensus 158 gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~-~~~~~~~~i~~--~~--------------------- 213 (330)
T cd05586 158 GTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE-DTQQMYRNIAF--GK--------------------- 213 (330)
T ss_pred CCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC-CHHHHHHHHHc--CC---------------------
Confidence 8999999999876456889999999999999999999998432 21111111100 00
Q ss_pred hcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc----CHHHHhcCCCcccCC
Q 020826 257 VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP----TAKEAMAHPYFFPIR 312 (321)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp----s~~ell~hp~~~~~~ 312 (321)
... ....+++++.++|++||+.||.+|| +++++++||||+...
T Consensus 214 ----~~~---------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~ 260 (330)
T cd05586 214 ----VRF---------PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADID 260 (330)
T ss_pred ----CCC---------CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCC
Confidence 000 0113567899999999999999998 799999999998754
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=297.22 Aligned_cols=282 Identities=32% Similarity=0.572 Sum_probs=207.7
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
++|++.+.||+|++|+||+|.++.+++.+++|.++... ...+.+|+.+++.+ +|||++++++++.+ ....++
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 78 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEM-QHGNIVRLQDVVHS--EKRLYL 78 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhc-cCCCEeeEEEEEec--CCeEEE
Confidence 57999999999999999999998899999999886432 24678899999999 89999999999964 456789
Q ss_pred EEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC-C
Q 020826 96 IFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K 170 (321)
Q Consensus 96 v~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~-~ 170 (321)
|+||+++..+..... .+++..++.++.||+.||+|||++|++|+||+|+||+++.++..++|+|||++...... .
T Consensus 79 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~ 158 (294)
T PLN00009 79 VFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR 158 (294)
T ss_pred EEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc
Confidence 999997644333322 25778888999999999999999999999999999999865557999999998754322 1
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
......++..|+|||.+.+...++.++|+||||+++|++++|..||. +.+.......+....+.+....+.....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 233 (294)
T PLN00009 159 TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFP-GDSEIDELFKIFRILGTPNEETWPGVTS---- 233 (294)
T ss_pred ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHhCCCChhhcccccc----
Confidence 22334567889999998765568899999999999999999998884 3333334444433333332221110000
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
...........+ ..........+++++.+++.+||+.||++||++.++++||||.++...
T Consensus 234 --~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~~~ 293 (294)
T PLN00009 234 --LPDYKSAFPKWP--PKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLGDA 293 (294)
T ss_pred --chhhhhhcccCC--CCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHhcC
Confidence 000000000000 001111123467889999999999999999999999999999988654
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=303.05 Aligned_cols=286 Identities=31% Similarity=0.572 Sum_probs=212.7
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC---C
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---K 91 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~---~ 91 (321)
..+|++.+.||+|+||+||+|++..++..|++|.++.. ....+.+|+.+++.+ +||||+++++++..... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHL-DHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhc-CCCCccchHHheecccccccC
Confidence 45899999999999999999999999999999998642 234567899999999 89999999998754322 3
Q ss_pred CcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 92 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
..++++||+.+ +|..++ ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++ .++|+|||++.....
T Consensus 83 ~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 83 DVYIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARTTSE 160 (337)
T ss_pred cEEEEEeCCCC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEECcCccccccCC
Confidence 57899999975 454444 4589999999999999999999999999999999999999887 899999999876543
Q ss_pred C-CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 169 G-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 169 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
. .......++..|+|||.+.....++.++|+|||||++|+|++|+.|| .+.+.......+....+........ .
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~----~ 235 (337)
T cd07858 161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLF-PGKDYVHQLKLITELLGSPSEEDLG----F 235 (337)
T ss_pred CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCC-CCCChHHHHHHHHHHhCCCChHHhh----h
Confidence 3 22233457788999999875456889999999999999999999887 4444444444454544443322210 0
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
................+..... .....+++++.++|++||+.||++|||++++++||||+.+..++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~~ 301 (337)
T cd07858 236 IRNEKARRYIRSLPYTPRQSFA--RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDPS 301 (337)
T ss_pred cCchhhhHHHHhcCcccccCHH--HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCcc
Confidence 0111111111111111111111 11224778999999999999999999999999999999875554
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=296.80 Aligned_cols=254 Identities=25% Similarity=0.435 Sum_probs=201.3
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc--chHHHHHHHHHHHhhcCCCCeeeeeeeeeccC----CC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----SK 91 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~----~~ 91 (321)
...+.|++.+.||+|+||.||+|.+..+++.+++|.+... ....+..|+.++.++.+|||++++++++.... ..
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 3467899999999999999999999999999999998643 34568899999999877999999999886533 23
Q ss_pred CcEEEEEeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeec
Q 020826 92 TPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 166 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~ 166 (321)
..++++||+++++|..++. .+++..+..++.|++.||+|||+++++|+||+|+||+++.++ .++|+|||++...
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~-~~~l~Dfg~~~~~ 161 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQL 161 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCC-CEEEccCCCceec
Confidence 5789999999998877653 478999999999999999999999999999999999999887 8999999998765
Q ss_pred CCC-CccccccCCccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHH
Q 020826 167 HPG-KEYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY 241 (321)
Q Consensus 167 ~~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (321)
... .......++..|+|||++.+ ...++.++|+||+||++|+|++|..||.... ..........
T Consensus 162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~-~~~~~~~~~~---------- 230 (272)
T cd06637 162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPR---------- 230 (272)
T ss_pred ccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC-HHHHHHHHhc----------
Confidence 322 22234567888999999853 1357889999999999999999999984221 1111100000
Q ss_pred hhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 242 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
. .........++.++.+|+.+||+.||++|||+.+++.||||
T Consensus 231 ------------------~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 231 ------------------N-------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred ------------------C-------CCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 0 00001112356789999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=297.16 Aligned_cols=257 Identities=24% Similarity=0.421 Sum_probs=204.2
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccch---HHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK---KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~---~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
++.|++++.||.|+||.||+|.+..++..+++|.+..... ..+.+|+.+++.+ +|||++++++.+.. ....+++
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATC-NHPYIVKLLGAFYW--DGKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCcEeeeEEEEEe--CCeEEEE
Confidence 5789999999999999999999988999999999875443 4577899999999 89999999998854 3467899
Q ss_pred EEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC-Cc
Q 020826 97 FEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KE 171 (321)
Q Consensus 97 ~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~-~~ 171 (321)
|||+.++++..++ ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++ .++|+|||++...... ..
T Consensus 88 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~~~~~~ 166 (292)
T cd06644 88 IEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNVKTLQR 166 (292)
T ss_pred EecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCC-CEEEccCccceeccccccc
Confidence 9999999987654 3589999999999999999999999999999999999999777 8999999987653222 22
Q ss_pred cccccCCccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 172 YNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
.....++..|+|||++.+ ...++.++|+|||||++|+|++|..||.... .......+. ....
T Consensus 167 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~-~~~~~~~~~---~~~~---------- 232 (292)
T cd06644 167 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN-PMRVLLKIA---KSEP---------- 232 (292)
T ss_pred cceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc-HHHHHHHHh---cCCC----------
Confidence 234567788999999853 2456889999999999999999998884222 111111110 0000
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
+ ....+..++.++.++|++||+.||++||+++++++||||..+....
T Consensus 233 ----------------~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~ 279 (292)
T cd06644 233 ----------------P-----TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNR 279 (292)
T ss_pred ----------------c-----cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccch
Confidence 0 0111224567899999999999999999999999999999876554
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=304.77 Aligned_cols=242 Identities=25% Similarity=0.445 Sum_probs=191.6
Q ss_pred eeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHH-HHHhhcCCCCeeeeeeeeeccCCCCcEEEEEe
Q 020826 27 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIK-ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 99 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~-~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 99 (321)
+.||+|+||+||+|++..+++.+|+|++.... ...+..|.. +++.+ +||||+++++.+.. ....+++|||
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~Iv~~~~~~~~--~~~~~lv~e~ 77 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQT--ADKLYFVLDY 77 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhC-CCCCCCceeEEEEc--CCeEEEEEeC
Confidence 36899999999999999899999999986432 123344444 34556 89999999999855 3456799999
Q ss_pred ecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC-CCccccc
Q 020826 100 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVR 175 (321)
Q Consensus 100 ~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~-~~~~~~~ 175 (321)
+.+++|...+ ..+++..+..++.||+.||+|||++|++|+||||+||+++.++ .++|+|||++..... .......
T Consensus 78 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~-~~kl~DfG~a~~~~~~~~~~~~~ 156 (325)
T cd05602 78 INGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEHNGTTSTF 156 (325)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEEccCCCCcccccCCCCcccc
Confidence 9999987776 3488899999999999999999999999999999999999888 899999999865322 2233445
Q ss_pred cCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHh
Q 020826 176 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA 255 (321)
Q Consensus 176 ~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (321)
.|++.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+....+.. .
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~-~~~~~~~~~~i~~---~-------------------- 211 (325)
T cd05602 157 CGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFY-SRNTAEMYDNILN---K-------------------- 211 (325)
T ss_pred cCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCC-CCCHHHHHHHHHh---C--------------------
Confidence 68999999999987 788999999999999999999999984 2222222222111 0
Q ss_pred hhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHH----HHhcCCCcccC
Q 020826 256 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK----EAMAHPYFFPI 311 (321)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~----ell~hp~~~~~ 311 (321)
.......+++.+.++|++||+.||.+|+++. ++++|+||...
T Consensus 212 --------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~ 257 (325)
T cd05602 212 --------------PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPI 257 (325)
T ss_pred --------------CcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCC
Confidence 0011124668999999999999999999876 89999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=296.32 Aligned_cols=306 Identities=25% Similarity=0.396 Sum_probs=239.8
Q ss_pred EEEEEEeeeeeeccc-CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc--hHHHHHHHHHHHhhcC-------C
Q 020826 6 VMVIYWCVWFINREQ-DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCG-------G 75 (321)
Q Consensus 6 ~~~~~~~~~~i~~~~-~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~E~~~l~~l~~-------h 75 (321)
+...|++|..+..+. .+|-+.++||.|.|+|||+|.|..+.+.||+|+.+... ......|+.+|+++.. .
T Consensus 62 ~kGGYHpV~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~ 141 (590)
T KOG1290|consen 62 RKGGYHPVRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGK 141 (590)
T ss_pred hcCCCceeeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCC
Confidence 346789999999999 99999999999999999999999999999999998543 4667889999998853 2
Q ss_pred CCeeeeeeeee--ccCCCCcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCeEE
Q 020826 76 PNIVKLLDIVR--DQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMI 148 (321)
Q Consensus 76 ~~i~~~~~~~~--~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~-~~i~H~dlkp~nili 148 (321)
.+||++++.|. ..+..+.|+|+|+++...|...+ +.++...++.|+.||+.||.|||. .||+|.||||+|||+
T Consensus 142 ~~VV~LlD~FkhsGpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 142 KCVVQLLDHFKHSGPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred ceeeeeeccceecCCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 47999999986 45678899999999999887666 569999999999999999999996 599999999999999
Q ss_pred cCC-----------------------------------------------------------------------------
Q 020826 149 DHE----------------------------------------------------------------------------- 151 (321)
Q Consensus 149 ~~~----------------------------------------------------------------------------- 151 (321)
..+
T Consensus 222 ~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~ 301 (590)
T KOG1290|consen 222 CSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQE 301 (590)
T ss_pred eccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhccccccccccccc
Confidence 000
Q ss_pred -----------------------------------------------------------------C--------------
Q 020826 152 -----------------------------------------------------------------Q-------------- 152 (321)
Q Consensus 152 -----------------------------------------------------------------~-------------- 152 (321)
.
T Consensus 302 s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~ 381 (590)
T KOG1290|consen 302 SYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVN 381 (590)
T ss_pred ccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccC
Confidence 0
Q ss_pred ---------CeEEEeeccceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCC---
Q 020826 153 ---------RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH--- 220 (321)
Q Consensus 153 ---------~~v~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~--- 220 (321)
-+|||+|||.++... ...+....|..|+|||++++ ..|++.+||||++|++|||.||-..|.+..
T Consensus 382 p~~~~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllG-sgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~ 458 (590)
T KOG1290|consen 382 PDIPLPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLG-SGYSTSADIWSTACMAFELATGDYLFEPHSGEN 458 (590)
T ss_pred CCCCCCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeec-CCCCCchhHHHHHHHHHHhhcCceeecCCCCCC
Confidence 026677777776543 33445667889999999999 899999999999999999999999996532
Q ss_pred --CChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcc-cCCCCCccccccccccCCc----chHHHHHHHhhccCC
Q 020826 221 --DNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR-HSRKPWSKFITVENQHLAV----PEAVDFLDKLLRYDH 293 (321)
Q Consensus 221 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s----~~~~~ll~~~l~~dp 293 (321)
-+.+.++.|.+.+|.-...-...........+....... ..-++|....-+...-.+| .++.+||.-||+++|
T Consensus 459 Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~P 538 (590)
T KOG1290|consen 459 YSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDP 538 (590)
T ss_pred CCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCc
Confidence 245678888888887554444443333322333322222 2345555555444444444 369999999999999
Q ss_pred CCCcCHHHHhcCCCcccCCCc
Q 020826 294 QERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 294 ~~Rps~~ell~hp~~~~~~~~ 314 (321)
++||||.++|+|||++.+..+
T Consensus 539 eKR~tA~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 539 EKRPTAAQCLKHPWLNPVAGP 559 (590)
T ss_pred cccccHHHHhcCccccCCCCC
Confidence 999999999999999987664
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-43 Score=301.55 Aligned_cols=282 Identities=22% Similarity=0.314 Sum_probs=205.7
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
++|++.+.||+|+||.||++.+..++..+++|.++... ...+.+|+++++++ +||||+++++.+.+ ....+++
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHEC-NSPYIVGFYGAFYS--DGEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEee--CCEEEEE
Confidence 47999999999999999999998899999999986432 34578899999999 89999999999865 4567899
Q ss_pred EEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCcc
Q 020826 97 FEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 172 (321)
Q Consensus 97 ~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~-~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~ 172 (321)
+||+.+++|..++ ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++ .++|+|||++...... ..
T Consensus 78 ~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~-~~ 155 (308)
T cd06615 78 MEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS-MA 155 (308)
T ss_pred eeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC-cEEEccCCCccccccc-cc
Confidence 9999999998887 358899999999999999999997 5899999999999999887 7999999988654322 22
Q ss_pred ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhh----HHhhhhccc
Q 020826 173 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN----AYLNKYHIE 248 (321)
Q Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ 248 (321)
....++..|+|||.+.+ ..++.++|+||||++++++++|..||.... ................. .........
T Consensus 156 ~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (308)
T cd06615 156 NSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPD--AKELEAMFGRPVSEGEAKESHRPVSGHPPD 232 (308)
T ss_pred ccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcc--hhhHHHhhcCccccccccCCcccccCCCCC
Confidence 34567889999999876 678899999999999999999999984322 11111111100000000 000000000
Q ss_pred C--ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 249 L--DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 249 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
. ................ .......+++++.+++.+||..||++|||+.++++||||.+...+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 296 (308)
T cd06615 233 SPRPMAIFELLDYIVNEPP----PKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRAELE 296 (308)
T ss_pred ccchhhHHHHHHHHhcCCC----ccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhcccc
Confidence 0 0000000000000000 000111256789999999999999999999999999999987555
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=304.59 Aligned_cols=243 Identities=26% Similarity=0.431 Sum_probs=190.9
Q ss_pred eeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHH-HHHhhcCCCCeeeeeeeeeccCCCCcEEEEEe
Q 020826 27 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIK-ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 99 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~-~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 99 (321)
+.||+|+||+||+|++..+++.+|+|++.... ...+..|.. +++.+ +||||+++++.+.+ ....++||||
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~-~h~~iv~~~~~~~~--~~~~~lv~e~ 77 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNL-KHPFLVGLHYSFQT--AEKLYFVLDY 77 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhC-CCCCccceeeEEEc--CCEEEEEEcC
Confidence 36899999999999999999999999986432 223445554 45666 89999999998854 4467899999
Q ss_pred ecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC-CCCccccc
Q 020826 100 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVR 175 (321)
Q Consensus 100 ~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~-~~~~~~~~ 175 (321)
+.+++|...+ ..+++..+..++.||+.||.|||++|++|+||||+||+++.++ .++|+|||++.... ........
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~ 156 (321)
T cd05603 78 VNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGVEPEETTSTF 156 (321)
T ss_pred CCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEccCCCCccCCCCCCccccc
Confidence 9999887665 3588999999999999999999999999999999999999888 89999999986532 22223445
Q ss_pred cCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHh
Q 020826 176 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA 255 (321)
Q Consensus 176 ~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (321)
.+++.|+|||.+.+ ..++.++|||||||++|+|++|..||... +.......+.. .
T Consensus 157 ~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~~i~~---~-------------------- 211 (321)
T cd05603 157 CGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSR-DVSQMYDNILH---K-------------------- 211 (321)
T ss_pred cCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCC-CHHHHHHHHhc---C--------------------
Confidence 68899999999977 67899999999999999999999998432 21111111100 0
Q ss_pred hhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCH----HHHhcCCCcccCC
Q 020826 256 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA----KEAMAHPYFFPIR 312 (321)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~----~ell~hp~~~~~~ 312 (321)
....+...+.++.++|.+||+.||.+|+++ .++++||||..++
T Consensus 212 --------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~ 258 (321)
T cd05603 212 --------------PLQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPIN 258 (321)
T ss_pred --------------CCCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCC
Confidence 001112345789999999999999999875 4999999998653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=294.94 Aligned_cols=253 Identities=24% Similarity=0.418 Sum_probs=205.7
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
++|++.+.||.|++|.||+|++..+++.+++|.+.... ...+.+|+.+++.+ +|||++++++.+.+. ...+++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQC-RSPYITKYYGSFLKG--SKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHc-CCCCeeeeeEEEEEC--CeEEEE
Confidence 47899999999999999999998899999999986432 34578899999999 799999999988654 567899
Q ss_pred EEeecCchhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC-Cccc
Q 020826 97 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYN 173 (321)
Q Consensus 97 ~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~-~~~~ 173 (321)
+|++.+++|.+++. .+++..+..++.|++.||.+||+++++|+||+|+||+++.++ .++|+|||.+...... ....
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~~~~~ 156 (274)
T cd06609 78 MEYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEG-DVKLADFGVSGQLTSTMSKRN 156 (274)
T ss_pred EEeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEcccccceeecccccccc
Confidence 99999999988875 489999999999999999999999999999999999999888 8999999998766533 2233
Q ss_pred cccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhh
Q 020826 174 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 253 (321)
Q Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (321)
...++..|+|||.+.+ ..++.++|+||||+++|++++|..||.... .......+.... .+
T Consensus 157 ~~~~~~~y~~PE~~~~-~~~~~~sDv~slG~il~~l~tg~~p~~~~~-~~~~~~~~~~~~-~~----------------- 216 (274)
T cd06609 157 TFVGTPFWMAPEVIKQ-SGYDEKADIWSLGITAIELAKGEPPLSDLH-PMRVLFLIPKNN-PP----------------- 216 (274)
T ss_pred cccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCcccCc-hHHHHHHhhhcC-CC-----------------
Confidence 4567788999999987 569999999999999999999999984222 111111111000 00
Q ss_pred HhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 254 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
... ...+++++.+++.+||..||++|||++++++||||++....
T Consensus 217 ----------------~~~-~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 217 ----------------SLE-GNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred ----------------CCc-ccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence 000 01156789999999999999999999999999999987544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=301.57 Aligned_cols=253 Identities=25% Similarity=0.402 Sum_probs=203.0
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
++|++.+.||+|++|+||+|.+..+++.+++|.+.... ...+..|++.++.+ +||+|+++++.+.+ ....+
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~ 77 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATL-DHPFLPTLYASFQT--ETYLC 77 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhC-CCCCchhheeeeec--CCEEE
Confidence 47999999999999999999998889999999986532 24578899999999 89999999999854 45678
Q ss_pred EEEEeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 95 LIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 95 lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
+++|++.+++|..++. .+++..+..++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||++......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 78 LVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESG-HIMLSDFDLSKQSDVE 156 (316)
T ss_pred EEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCC-CEEEeecchhhccccc
Confidence 9999999999887763 488999999999999999999999999999999999999887 8999999987654221
Q ss_pred Cc------------------------------cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccC
Q 020826 170 KE------------------------------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYG 219 (321)
Q Consensus 170 ~~------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~ 219 (321)
.. .....++..|+|||.+.+ ..++.++||||||+++|++++|..||. +
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~-~ 234 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG-DGHGSAVDWWTLGILLYEMLYGTTPFK-G 234 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC-CCCCchHHHHHHHHHHHHHhhCCCCCC-C
Confidence 11 112356788999999987 678999999999999999999999984 2
Q ss_pred CCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC-
Q 020826 220 HDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT- 298 (321)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps- 298 (321)
.+.......+.. .... ......+++++.++|++||+.||++|||
T Consensus 235 ~~~~~~~~~~~~---------------------------~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~R~s~ 279 (316)
T cd05574 235 SNRDETFSNILK---------------------------KEVT--------FPGSPPVSSSARDLIRKLLVKDPSKRLGS 279 (316)
T ss_pred CchHHHHHHHhc---------------------------CCcc--------CCCccccCHHHHHHHHHHccCCHhHCCCc
Confidence 222222221110 0000 0001125679999999999999999999
Q ss_pred ---HHHHhcCCCcccCCCc
Q 020826 299 ---AKEAMAHPYFFPIRNA 314 (321)
Q Consensus 299 ---~~ell~hp~~~~~~~~ 314 (321)
++++++||||++..-+
T Consensus 280 ~~~~~~ll~~~~~~~~~~~ 298 (316)
T cd05574 280 KRGAAEIKQHPFFRGVNWA 298 (316)
T ss_pred hhhHHHHHcCchhhcCChh
Confidence 9999999999987543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=292.54 Aligned_cols=249 Identities=24% Similarity=0.396 Sum_probs=197.4
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc--------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
.+|+..+.||+|+||.||+|.+..++..+++|.+... ....+.+|+.+++.+ +||||+++++.+.+.....
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL-QHERIVQYYGCLRDRAEKT 80 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHc-CCCCeeeEEEEEEcCCCCE
Confidence 4688999999999999999999889999999987532 124578899999999 8999999999887655567
Q ss_pred cEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 93 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
.++++|++.+++|...+ ..++...++.++.|++.||++||+++++|+||+|+||+++.++ .++|+|||++......
T Consensus 81 ~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~-~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 81 LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEccCCCccccccc
Confidence 78999999999988776 3478899999999999999999999999999999999999877 7999999998654321
Q ss_pred C----ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhh
Q 020826 170 K----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245 (321)
Q Consensus 170 ~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (321)
. ......++..|+|||.+.+ ..++.++|+||+||++|++++|+.||... ......... .....
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~-~~~~~~~~~---~~~~~-------- 226 (266)
T cd06651 160 CMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEY-EAMAAIFKI---ATQPT-------- 226 (266)
T ss_pred cccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCcccc-chHHHHHHH---hcCCC--------
Confidence 1 1123457788999999977 67899999999999999999999998422 111111111 00000
Q ss_pred cccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcc
Q 020826 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF 309 (321)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~ 309 (321)
....+..+++.+.+++ +||..+|++|||++|+++||||+
T Consensus 227 ------------------------~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 227 ------------------------NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred ------------------------CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 0001123456788888 67778999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=293.60 Aligned_cols=256 Identities=24% Similarity=0.422 Sum_probs=203.8
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc--hHHHHHHHHHHHhhcCCCCeeeeeeeeeccC----C
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----S 90 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~----~ 90 (321)
+...++|++.+.||+|++|+||+|.+..+++.+++|++.... ...+.+|+.+++++.+|+||+++++++.... .
T Consensus 2 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CCchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 456799999999999999999999998889999999987543 3568899999999977999999999986543 4
Q ss_pred CCcEEEEEeecCchhhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccce
Q 020826 91 KTPSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~ 163 (321)
...++++||+.+++|.+++ ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||.+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~-~~~l~d~~~~ 160 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA-EVKLVDFGVS 160 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCC-eEEECCCccc
Confidence 5578999999999887664 3578999999999999999999999999999999999999887 8999999998
Q ss_pred eecCCCC-ccccccCCccccccccccCC----CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhh
Q 020826 164 EFYHPGK-EYNVRVASRYFKGPELLVDL----QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 238 (321)
Q Consensus 164 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~----~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (321)
....... ......++..|+|||++... ..++.++||||||++++++++|..||... ........+.. ..
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~---~~-- 234 (275)
T cd06608 161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDM-HPMRALFKIPR---NP-- 234 (275)
T ss_pred eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcccc-chHHHHHHhhc---cC--
Confidence 7543222 22345678889999987542 34678999999999999999999998422 22111111110 00
Q ss_pred hHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 239 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
..........++++.++|++||..||++|||++++++|||+
T Consensus 235 -----------------------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 235 -----------------------------PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred -----------------------------CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 00011112355789999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=293.94 Aligned_cols=257 Identities=26% Similarity=0.459 Sum_probs=203.0
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc--hHHHHHHHHHHHhhcCCCCeeeeeeeeec---cCC
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRD---QQS 90 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~---~~~ 90 (321)
++...++|++.+.||+|+||.||+|.+..+++.+++|+++... ...+..|+.+++.+.+|||++++++++.. ...
T Consensus 13 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 13 FPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred CCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence 4556789999999999999999999999999999999986532 35678899999998779999999998743 234
Q ss_pred CCcEEEEEeecCchhhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccce
Q 020826 91 KTPSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~ 163 (321)
..++++|||+++++|..++ ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++ .++|+|||++
T Consensus 93 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~-~~kl~dfg~~ 171 (286)
T cd06638 93 DQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG-GVKLVDFGVS 171 (286)
T ss_pred CeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCC-CEEEccCCce
Confidence 5678999999999987654 3478888999999999999999999999999999999999888 7999999998
Q ss_pred eecCCCC-ccccccCCccccccccccCC----CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhh
Q 020826 164 EFYHPGK-EYNVRVASRYFKGPELLVDL----QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 238 (321)
Q Consensus 164 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~----~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (321)
....... ......++..|+|||++... ..++.++|+|||||++|+|++|..||.... ....+.....
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~-~~~~~~~~~~------- 243 (286)
T cd06638 172 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLH-PMRALFKIPR------- 243 (286)
T ss_pred eecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCc-hhHHHhhccc-------
Confidence 7654322 22345688899999998531 347889999999999999999999984322 1111110000
Q ss_pred hHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 239 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
.. ......+...+.++.+++.+||+.||++|||+.|+++|+||
T Consensus 244 -----------------------~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 244 -----------------------NP----PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred -----------------------cC----CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 00 00011122345689999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=275.22 Aligned_cols=256 Identities=21% Similarity=0.302 Sum_probs=200.0
Q ss_pred eeeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc---chHHHHHHHHHHHhhcCCCCeeeeeeeeecc
Q 020826 12 CVWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 88 (321)
Q Consensus 12 ~~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (321)
.+..|+ +.+|++.+.||+|||+-||+++...++..||+|.+.-. +.+...+|++..+++ +|||+++++++....
T Consensus 14 ~tv~In--~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf-~s~~vl~l~dh~l~~ 90 (302)
T KOG2345|consen 14 GTVIIN--NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKF-NSPNVLRLVDHQLRE 90 (302)
T ss_pred CcEEEc--CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhh-CCcchHHHHHHHHHh
Confidence 455566 78999999999999999999999999999999988643 346678999999999 899999999976433
Q ss_pred ---CCCCcEEEEEeecCchhhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC--CeeecCCCCCeEEcCCCCeEE
Q 020826 89 ---QSKTPSLIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLR 156 (321)
Q Consensus 89 ---~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lh~~~--i~H~dlkp~nili~~~~~~v~ 156 (321)
.....+++++|...|+|.+.+. .+++.++..++.+|+.||++||+.. ++|+||||.||+++.++ .++
T Consensus 91 ~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~-~~v 169 (302)
T KOG2345|consen 91 EKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG-LPV 169 (302)
T ss_pred hccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC-ceE
Confidence 2345789999999998877762 4899999999999999999999998 99999999999999877 899
Q ss_pred EeeccceeecCCCCc----------cccccCCccccccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChH
Q 020826 157 LIDWGLAEFYHPGKE----------YNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD 224 (321)
Q Consensus 157 l~dfg~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~ 224 (321)
+.|||.++...-... ......|..|+|||.+.-. ...+.++|||||||++|.|+.|..||..-..
T Consensus 170 l~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~--- 246 (302)
T KOG2345|consen 170 LMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ--- 246 (302)
T ss_pred EEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh---
Confidence 999999865432111 1223467789999998532 4578999999999999999999999931110
Q ss_pred HHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 225 QLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
.|..- .. ........+.+....|+.+.++|+.||+.||.+||++.+++.
T Consensus 247 --------~GgSl----------aL-------------Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~ 295 (302)
T KOG2345|consen 247 --------QGGSL----------AL-------------AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLS 295 (302)
T ss_pred --------cCCeE----------EE-------------eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 00000 00 000001112223347789999999999999999999999986
Q ss_pred C
Q 020826 305 H 305 (321)
Q Consensus 305 h 305 (321)
+
T Consensus 296 ~ 296 (302)
T KOG2345|consen 296 K 296 (302)
T ss_pred H
Confidence 4
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=297.95 Aligned_cols=261 Identities=24% Similarity=0.419 Sum_probs=208.8
Q ss_pred eeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc---hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 14 ~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
+-+.....+|++.+.||+|++|.||+|.+..++..+++|.+.... ...+.+|+.+++.+ .|||++++++.+.. .
T Consensus 13 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~v~~~~~~~~~--~ 89 (296)
T cd06654 13 VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLV--G 89 (296)
T ss_pred cccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhC-CCCCEeeEEEEEEe--C
Confidence 344556689999999999999999999998899999999886432 35678899999998 99999999998864 4
Q ss_pred CCcEEEEEeecCchhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 91 KTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
...++|+||+.+++|..++. .++..++..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~-~~kl~dfg~~~~~~~ 168 (296)
T cd06654 90 DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITP 168 (296)
T ss_pred CEEEEeecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CEEECccccchhccc
Confidence 46789999999999988774 478999999999999999999999999999999999999887 899999998875433
Q ss_pred CCc-cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 169 GKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 169 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||..... ......... .+.+
T Consensus 169 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~-~~~~~~~~~-~~~~----------- 234 (296)
T cd06654 169 EQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENP-LRALYLIAT-NGTP----------- 234 (296)
T ss_pred cccccCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCH-HHhHHHHhc-CCCC-----------
Confidence 221 233467889999999877 6788999999999999999999999843221 111111100 0000
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
....+..+++.+.+++.+||..||++|||+.++++||||......
T Consensus 235 ----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~ 279 (296)
T cd06654 235 ----------------------ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKPL 279 (296)
T ss_pred ----------------------CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccCCc
Confidence 001122355789999999999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=298.56 Aligned_cols=261 Identities=25% Similarity=0.441 Sum_probs=209.3
Q ss_pred eeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc---chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 15 FINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 15 ~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
-......+|++.+.||+|++|.||++.+..+++.+++|.+... ....+.+|+.+++.+ +|||++++++.+.. ..
T Consensus 13 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~ 89 (297)
T cd06656 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLV--GD 89 (297)
T ss_pred ccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhC-CCCCEeeEEEEEec--CC
Confidence 3455668999999999999999999999889999999998643 235577899999998 99999999999854 45
Q ss_pred CcEEEEEeecCchhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 92 TPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
..++++||+++++|..++. .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~-~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 90 ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPE 168 (297)
T ss_pred EEEEeecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEECcCccceEccCC
Confidence 6789999999999988773 488899999999999999999999999999999999999887 8999999998765433
Q ss_pred Cc-cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 170 KE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
.. .....++..|+|||.+.+ ..++.++|+||||+++|++++|..||...... .....+.. .+
T Consensus 169 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~-~~~~~~~~-~~-------------- 231 (297)
T cd06656 169 QSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL-RALYLIAT-NG-------------- 231 (297)
T ss_pred ccCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc-hheeeecc-CC--------------
Confidence 22 233467888999999987 77889999999999999999999998432211 11100000 00
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
.+ ....+..+++.+.+++.+||+.||++|||++++++||||+.....+
T Consensus 232 --------------~~-----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 279 (297)
T cd06656 232 --------------TP-----ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPLS 279 (297)
T ss_pred --------------CC-----CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccccc
Confidence 00 0111224567899999999999999999999999999999775544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=297.01 Aligned_cols=285 Identities=29% Similarity=0.472 Sum_probs=203.9
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
.....++|++.+.||+|++|.||+|.+..+++.+++|.+.... .....+|+.+++.+ +||||+++++++.....
T Consensus 7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~ 85 (310)
T cd07865 7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKAT 85 (310)
T ss_pred ccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhC-CCCCccceEEEEecccc
Confidence 3445678999999999999999999999999999999885432 23456899999999 99999999998754332
Q ss_pred ------CCcEEEEEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecc
Q 020826 91 ------KTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 161 (321)
Q Consensus 91 ------~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg 161 (321)
...++++||+.+.....+.. .+++..++.++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||
T Consensus 86 ~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg 164 (310)
T cd07865 86 PYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG-ILKLADFG 164 (310)
T ss_pred cccCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC-cEEECcCC
Confidence 34589999998754333332 589999999999999999999999999999999999999887 89999999
Q ss_pred ceeecCCCCc-----cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCCh
Q 020826 162 LAEFYHPGKE-----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD 236 (321)
Q Consensus 162 ~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (321)
++........ .....++..|+|||.+.+...++.++|+||||+++|+|++|..|| .+.+....+..+.+..+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~-~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIM-QGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCC
Confidence 9876532221 123356778999999876455788999999999999999999887 3444444444444433322
Q ss_pred hhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 237 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
....+....... .... .. ..............+...++.+.++|.+||+.||++|||++++++||||
T Consensus 244 ~~~~~~~~~~~~---~~~~-~~-~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 244 TPEVWPGVDKLE---LFKK-ME-LPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred Chhhcccccchh---hhhh-cc-CCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 111100000000 0000 00 0000000000111111234678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=289.85 Aligned_cols=246 Identities=23% Similarity=0.387 Sum_probs=201.5
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
+|++.+.||+|++|.||++.+..++..+++|.+... ....+.+|+.+++.+ +|||++++++.+.. ....+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLL-SHPNIIEYYENFLE--DKALMIV 77 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhC-CCCchhheeeeEec--CCEEEEE
Confidence 589999999999999999999999999999998643 235688899999999 89999999998854 4567899
Q ss_pred EEeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc
Q 020826 97 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 171 (321)
Q Consensus 97 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~ 171 (321)
+|++++++|.+++. .+++..+..++.|++.+|++||++|++|+||+|+||+++.++..++|+|||.+........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (256)
T cd08220 78 MEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK 157 (256)
T ss_pred EecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence 99999999887763 3788999999999999999999999999999999999987665789999999987654444
Q ss_pred cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCCh
Q 020826 172 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (321)
.....++..|+|||.+.+ ..++.++|+||||++++++++|+.||.. .+.......+....
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~-~~~~~~~~~~~~~~------------------ 217 (256)
T cd08220 158 AYTVVGTPCYISPELCEG-KPYNQKSDIWALGCVLYELASLKRAFEA-ANLPALVLKIMSGT------------------ 217 (256)
T ss_pred ccccccCCcccCchhccC-CCCCcccchHHHHHHHHHHHhCCCCccc-CchHHHHHHHHhcC------------------
Confidence 444567889999999987 6788999999999999999999999832 22222221111000
Q ss_pred hhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 252 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
....+..+++++.+++.+||+.||++|||+.|+++||||
T Consensus 218 ------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 218 ------------------FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred ------------------CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 000112356789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=293.38 Aligned_cols=264 Identities=20% Similarity=0.297 Sum_probs=204.6
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
++|+..+.||.|++|.||++.+..+++.+++|.+... ....+.+|++++.++ +||||+++++++.+......+++
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSC-KSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhC-CCCCeeeeeeEEEccCCCeEEEE
Confidence 4789999999999999999999889999999998743 235688999999999 89999999999876666677899
Q ss_pred EEeecCchhhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 97 FEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 97 ~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
|||+++++|.+++ ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKG-QVKLCDFGVSGELVNS 158 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCC-eEEEeecccccccccc
Confidence 9999999887654 2378889999999999999999999999999999999999877 8999999998654322
Q ss_pred CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 170 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
. .....++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...........+.........
T Consensus 159 ~-~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~------------ 224 (287)
T cd06621 159 L-AGTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP------------ 224 (287)
T ss_pred c-cccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC------------
Confidence 2 123456778999999877 67899999999999999999999998543221000001101000000
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
..............++++.++|.+||+.||++|||+.|++.||||++....
T Consensus 225 --------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~ 275 (287)
T cd06621 225 --------------NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK 275 (287)
T ss_pred --------------chhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence 000000001111245689999999999999999999999999999766443
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=294.52 Aligned_cols=277 Identities=29% Similarity=0.519 Sum_probs=206.8
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
++|++.+.||+|++|.||+|.+..+++.+++|.+.... ...+.+|+++++.+ +||||+++++++.+ ....++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 77 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQL-RHENLVNLIEVFRR--KKRLYL 77 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhc-CCcchhhHHHhccc--CCeEEE
Confidence 47999999999999999999998889999999875422 34577899999999 89999999999854 556789
Q ss_pred EEEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-c
Q 020826 96 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 171 (321)
Q Consensus 96 v~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~-~ 171 (321)
++||+.++++..+.. .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||++....... .
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~-~~~l~dfg~~~~~~~~~~~ 156 (286)
T cd07846 78 VFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSG-VVKLCDFGFARTLAAPGEV 156 (286)
T ss_pred EEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-cEEEEeeeeeeeccCCccc
Confidence 999999998877653 488999999999999999999999999999999999999887 89999999987654322 2
Q ss_pred cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCCh
Q 020826 172 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (321)
.....++..|+|||.+.+...++.++||||||+++++|++|..|| ......+....+....+....... . .....+
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~ 232 (286)
T cd07846 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLF-PGDSDIDQLYHIIKCLGNLIPRHQ-E--IFQKNP 232 (286)
T ss_pred cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCC-CCCchHHHHHHHHHHhCCCchhhH-H--Hhccch
Confidence 233457788999999876456788999999999999999998777 344444444444443332111000 0 000000
Q ss_pred hhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 252 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
......... .... .........++..+.+++++||+.||++|||+.++++||||
T Consensus 233 ~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 233 LFAGMRLPE--VKEI-EPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred Hhhcccccc--ccCc-chHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 000000000 0000 00011123567899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=295.22 Aligned_cols=256 Identities=24% Similarity=0.437 Sum_probs=201.8
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc--chHHHHHHHHHHHhhcCCCCeeeeeeeeecc----C
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----Q 89 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~----~ 89 (321)
+....+.|++.+.||.|+||.||+|.+..+++.+++|++... ....+..|+.+++++.+|||++++++++... .
T Consensus 11 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 11 LRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 334567999999999999999999999999999999998654 3356788999999987899999999988532 2
Q ss_pred CCCcEEEEEeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecccee
Q 020826 90 SKTPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 164 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~ 164 (321)
....+++|||+++++|..++. .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~-~~~l~dfg~~~ 169 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENA-EVKLVDFGVSA 169 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCcchh
Confidence 456789999999998877662 378888999999999999999999999999999999999887 79999999986
Q ss_pred ecCCC-CccccccCCccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhh
Q 020826 165 FYHPG-KEYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN 239 (321)
Q Consensus 165 ~~~~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (321)
..... .......++..|+|||.+.. ...++.++|+|||||++|+|++|..||.... .......+.. ..
T Consensus 170 ~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~-~~~~~~~~~~---~~--- 242 (282)
T cd06636 170 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH-PMRALFLIPR---NP--- 242 (282)
T ss_pred hhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC-HHhhhhhHhh---CC---
Confidence 54321 22334567888999998753 2457789999999999999999999984222 1111111000 00
Q ss_pred HHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 240 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
. .......+++++.++|++||+.||.+|||+.|+++||||
T Consensus 243 ------------------------~-----~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 243 ------------------------P-----PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred ------------------------C-----CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 0 000112356799999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=294.42 Aligned_cols=254 Identities=24% Similarity=0.423 Sum_probs=196.7
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
++|++.+.||+|+||.||+|.+..+++.||+|.++... ...+..|+..+.+..+|||++++++++... ...+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~--~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFRE--GDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecC--CcEEEE
Confidence 47999999999999999999999999999999987532 234556666655555899999999998543 456799
Q ss_pred EEeecCchhhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 97 FEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 97 ~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lh~~-~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
+||+++. |..++ ..+++..++.++.|++.||+|||++ +++|+||||+||+++.++ .++|+|||.+.....
T Consensus 79 ~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~-~~kl~dfg~~~~~~~ 156 (283)
T cd06617 79 MEVMDTS-LDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYLVD 156 (283)
T ss_pred hhhhccc-HHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeeccccccccc
Confidence 9999854 32222 2489999999999999999999997 999999999999999887 899999999876543
Q ss_pred CCccccccCCccccccccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhh
Q 020826 169 GKEYNVRVASRYFKGPELLVDL---QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245 (321)
Q Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (321)
........++..|+|||.+.+. ..++.++|+|||||++|+|++|..||.......+.+..........
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--------- 227 (283)
T cd06617 157 SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQ--------- 227 (283)
T ss_pred ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCC---------
Confidence 3333345678889999988642 3467899999999999999999999843333322222211100000
Q ss_pred cccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCC
Q 020826 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~ 313 (321)
. ....+|+++.++|.+||..+|++|||+.++++||||+....
T Consensus 228 -----------------~---------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 269 (283)
T cd06617 228 -----------------L---------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLS 269 (283)
T ss_pred -----------------C---------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhccc
Confidence 0 01125678999999999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=296.17 Aligned_cols=255 Identities=25% Similarity=0.445 Sum_probs=203.8
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccch---HHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK---KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~---~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
.++|++.+.||.|++|+||++.+..++..+++|.++.... ..+..|+.+++++ +|||++++++.+.. ....+++
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSEC-KHPNIVGLYEAYFY--ENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEec--CCeEEEE
Confidence 4689999999999999999999988899999999875433 4577899999999 79999999999864 4466899
Q ss_pred EEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC-Cc
Q 020826 97 FEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KE 171 (321)
Q Consensus 97 ~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~-~~ 171 (321)
|||+++++|..++ ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||.+...... ..
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~ 159 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQK 159 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCC-CEEEccCccchhhcccccc
Confidence 9999999998776 3489999999999999999999999999999999999999888 8999999987654322 22
Q ss_pred cccccCCccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 172 YNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
.....++..|+|||.+.. ...++.++|+||||+++|+|++|..||. ..+.......+.. ..
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~---~~----------- 224 (280)
T cd06611 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHH-ELNPMRVLLKILK---SE----------- 224 (280)
T ss_pred cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcc-cCCHHHHHHHHhc---CC-----------
Confidence 234467888999999752 2457789999999999999999999983 2222111111100 00
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCC
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~ 313 (321)
......+..++.++.++|.+||+.||.+|||+.++++||||.....
T Consensus 225 --------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (280)
T cd06611 225 --------------------PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSD 270 (280)
T ss_pred --------------------CCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccch
Confidence 0001112245678999999999999999999999999999998743
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=293.37 Aligned_cols=278 Identities=34% Similarity=0.542 Sum_probs=208.6
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
++|++.+.||+|++|.||+|.+..+++.|++|.++.. ....+.+|+++++.+ .|+||+++++++.+ ....++
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~i 77 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQL-RHENIVNLKEAFRR--KGRLYL 77 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhc-CCCCeeehhheEEE--CCEEEE
Confidence 4799999999999999999999889999999988643 235688999999999 79999999999965 456789
Q ss_pred EEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC--
Q 020826 96 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-- 170 (321)
Q Consensus 96 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~-- 170 (321)
++||++++.+..+. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 78 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~-~~kl~d~g~~~~~~~~~~~ 156 (288)
T cd07833 78 VFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESG-VLKLCDFGFARALRARPAS 156 (288)
T ss_pred EEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEEeeecccccCCCccc
Confidence 99999998876655 3488999999999999999999999999999999999999877 89999999987654333
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
......++..|+|||++.+...++.++|+||||+++|++++|..||. +.+....+..+....+........... ..
T Consensus 157 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 232 (288)
T cd07833 157 PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFP-GDSDIDQLYLIQKCLGPLPPSHQELFS---SN 232 (288)
T ss_pred cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHhCCCCHHHhhhcc---cC
Confidence 22345677889999999874478899999999999999999998773 444444444444433322211110000 00
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
...... ...............+..+++++.++|++||..||++|||++++++||||
T Consensus 233 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 233 PRFAGV--AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred cccccc--ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 000000 00000000000111223457899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=290.23 Aligned_cols=249 Identities=26% Similarity=0.469 Sum_probs=203.0
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 98 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 98 (321)
.++|++.+.||+|++|.||+|.+..++..+++|.++... ...+.+|+.+++.+ +|||++++++.+.+. ...++++|
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~--~~~~l~~e 78 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQC-DSPYIVKYYGSYFKN--TDLWIVME 78 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhC-CCCcEeeeeeeeecC--CcEEEEEe
Confidence 578999999999999999999998889999999987543 56788999999999 999999999998654 56789999
Q ss_pred eecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-ccc
Q 020826 99 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN 173 (321)
Q Consensus 99 ~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~-~~~ 173 (321)
++.+++|.+++ ..+++..+..++.|++.||.+||+.+++|+||+|+||+++.++ .++|+|||++....... ...
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~-~~~l~dfg~~~~~~~~~~~~~ 157 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEG-QAKLADFGVSGQLTDTMAKRN 157 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCC-cEEEcccccchhcccCccccc
Confidence 99999998776 3489999999999999999999999999999999999999887 89999999987654332 223
Q ss_pred cccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhh
Q 020826 174 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 253 (321)
Q Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (321)
...++..|+|||.+.+ ..++.++||||||+++++|++|+.||..... ......+..
T Consensus 158 ~~~~~~~y~~PE~~~~-~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~-~~~~~~~~~---------------------- 213 (256)
T cd06612 158 TVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKPPYSDIHP-MRAIFMIPN---------------------- 213 (256)
T ss_pred cccCCccccCHHHHhc-CCCCchhhHHHHHHHHHHHHhCCCCCCCcch-hhhhhhhcc----------------------
Confidence 4457788999999877 6788999999999999999999999842211 111100000
Q ss_pred HhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 254 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
........+..+++++.++|.+||+.||++|||+.+++.||||
T Consensus 214 ------------~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 214 ------------KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred ------------CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 0000111122356789999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=301.71 Aligned_cols=286 Identities=29% Similarity=0.567 Sum_probs=215.2
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeecc--CCCC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSKT 92 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~~~ 92 (321)
.++|++.+.||+|++|.||+|.++.+++.|++|.+... ....+.+|+.+++.+ +||||+++++++... ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF-KHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhc-CCCCccCHHHhccccCCCCce
Confidence 47899999999999999999999999999999998653 234567899999999 899999999987533 3356
Q ss_pred cEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 93 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
.++++||+.+ +|..++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++......
T Consensus 83 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 83 VYVVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEEEehhhh-hHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEecccccceeeccc
Confidence 7899999975 565555 3489999999999999999999999999999999999999888 8999999998765322
Q ss_pred Cc-----cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhh
Q 020826 170 KE-----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244 (321)
Q Consensus 170 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (321)
.. .....++..|+|||.+.+...++.++|+|||||++|+|++|+.|| .+.+....+..+...++.+........
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf-~~~~~~~~~~~~~~~~g~~~~~~~~~~ 239 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLF-PGKNYVHQLKLILSVLGSPSEEVLNRI 239 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCcc-CCCChHHHHHHHHHHhCCChhHhhhhh
Confidence 11 123467888999999866456889999999999999999999988 455555566666666665433221110
Q ss_pred hcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
. ................... .......++++.++|++||+.||++|||+++++.||||++...+.
T Consensus 240 ~----~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~ 304 (334)
T cd07855 240 G----SDRVRKYIQNLPRKQPVPW--SKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPD 304 (334)
T ss_pred c----hhhHHHHHhhcccCCCCCH--HHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCc
Confidence 0 0000000000000000000 001123578999999999999999999999999999999876654
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=287.07 Aligned_cols=246 Identities=26% Similarity=0.425 Sum_probs=198.1
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
.|++.+.||.|++|.||++.+..+++.+++|.+... ..+.+.+|+.+++.+ +|+|++++++.+... ...++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~~~~~lv 78 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQL-KHPNIVAYRESWEGE-DGLLYIV 78 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeecCC-CCEEEEE
Confidence 589999999999999999999888999999998643 234578899999999 899999999877432 3456899
Q ss_pred EEeecCchhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-
Q 020826 97 FEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 170 (321)
Q Consensus 97 ~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~- 170 (321)
+|+++++++..++ ..+++.++..++.|++.|+++||++|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 79 ~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~-~~~l~df~~~~~~~~~~~ 157 (257)
T cd08223 79 MGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN-IIKVGDLGIARVLENQCD 157 (257)
T ss_pred ecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCC-cEEEecccceEEecccCC
Confidence 9999999887665 2489999999999999999999999999999999999999877 89999999987654322
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
......++..|+|||+..+ ..++.++|+||||++++++++|..||... +.......+.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~-~~~~~~~~~~~~~~---------------- 219 (257)
T cd08223 158 MASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAK-DMNSLVYRIIEGKL---------------- 219 (257)
T ss_pred ccccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHHhcCC----------------
Confidence 2233457888999999987 67889999999999999999999998422 21111111111000
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
...+..+++++.+++.+||+.||++|||+.++++||||
T Consensus 220 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 220 --------------------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred --------------------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00112356789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=299.48 Aligned_cols=285 Identities=29% Similarity=0.511 Sum_probs=207.6
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc---hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC------
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS------ 90 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~------ 90 (321)
..+|++.+.||.|+||.||+|.+..++..|++|.+.... .+.+.+|+++++.+ +||||+++++.+.....
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhc-CCCcchhhHhhhccccccccccc
Confidence 579999999999999999999999999999999886432 35678899999999 99999999987654322
Q ss_pred ------CCcEEEEEeecCchhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccc
Q 020826 91 ------KTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 162 (321)
Q Consensus 91 ------~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~ 162 (321)
...++++||+++ +|...+ ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++..++|+|||.
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~ 161 (342)
T cd07854 83 GSLTELNSVYIVQEYMET-DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGL 161 (342)
T ss_pred ccccccceEEEEeecccc-cHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCccc
Confidence 246899999985 565555 35899999999999999999999999999999999999986665789999999
Q ss_pred eeecCCCCc----cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhh
Q 020826 163 AEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 238 (321)
Q Consensus 163 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (321)
+........ .....++..|+|||.+.+...++.++|||||||++|+|++|+.||. +.........+.+.......
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~-~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07854 162 ARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFA-GAHELEQMQLILESVPVVRE 240 (342)
T ss_pred ceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhcCCCCh
Confidence 876532211 1233567789999987664678899999999999999999999984 33333333333332222111
Q ss_pred hHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 239 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
...... .... +............+.. .....++.++.+|+++||+.||++|||+.++++||||+....+
T Consensus 241 ~~~~~~-~~~~-~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~~~~ 309 (342)
T cd07854 241 EDRNEL-LNVI-PSFVRNDGGEPRRPLR-----DLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCYSCP 309 (342)
T ss_pred HHhhhh-hhhh-hhhhhhcccccCCCHH-----HHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccccCC
Confidence 110000 0000 0000000000011100 0112466789999999999999999999999999999976554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=304.63 Aligned_cols=258 Identities=25% Similarity=0.450 Sum_probs=194.6
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecc-----cchHHHHHHHHHHHhhcCCCCeeeeeeeeec
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRD 87 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~-----~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (321)
.-.|...+..|++++.||+||.+.||++.. .+...|++|.+.. .....+..|+..|.+|++|.+|+++++|-.
T Consensus 353 ~~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv- 430 (677)
T KOG0596|consen 353 NEIIKVKGREYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEV- 430 (677)
T ss_pred CeeEEECcchhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeec-
Confidence 356777789999999999999999999987 4455566655432 123568999999999999999999999874
Q ss_pred cCCCCcEEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccce
Q 020826 88 QQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163 (321)
Q Consensus 88 ~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~ 163 (321)
.+.++++|||+-.- +|..+++ ..+...++.++.||++++.++|++||||.||||-|+++- .| .+||+|||++
T Consensus 431 -~d~~lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG-~LKLIDFGIA 506 (677)
T KOG0596|consen 431 -TDGYLYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KG-RLKLIDFGIA 506 (677)
T ss_pred -cCceEEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-ee-eEEeeeechh
Confidence 36778899997654 4544442 245458899999999999999999999999999999997 44 7999999999
Q ss_pred eecCCCCc---cccccCCccccccccccCCC----------CCCCcchHHHHHHHHHHHHhCCCCCccCCCChH-HHHHH
Q 020826 164 EFYHPGKE---YNVRVASRYFKGPELLVDLQ----------DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD-QLVKI 229 (321)
Q Consensus 164 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~----------~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~ 229 (321)
....+... ....+||..|++||++.... .+++++|||||||+||+|+.|+.||. ... ....+
T Consensus 507 ~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~----~~~n~~aKl 582 (677)
T KOG0596|consen 507 NAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFG----QIINQIAKL 582 (677)
T ss_pred cccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchH----HHHHHHHHH
Confidence 87654433 25578999999999985421 26789999999999999999999992 111 11111
Q ss_pred HHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcc
Q 020826 230 AKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF 309 (321)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~ 309 (321)
.. +..+ +. ..++-.+.. ..++.++++.||+.||.+|||+.|+|+|||++
T Consensus 583 ~a-I~~P---------------~~-----------~Iefp~~~~----~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~ 631 (677)
T KOG0596|consen 583 HA-ITDP---------------NH-----------EIEFPDIPE----NDELIDVMKCCLARDPKKRWSIPELLQHPFLQ 631 (677)
T ss_pred Hh-hcCC---------------Cc-----------cccccCCCC----chHHHHHHHHHHhcCcccCCCcHHHhcCcccc
Confidence 11 0000 00 001111110 02499999999999999999999999999998
Q ss_pred cC
Q 020826 310 PI 311 (321)
Q Consensus 310 ~~ 311 (321)
..
T Consensus 632 ~~ 633 (677)
T KOG0596|consen 632 IQ 633 (677)
T ss_pred cc
Confidence 73
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=290.54 Aligned_cols=245 Identities=28% Similarity=0.521 Sum_probs=196.3
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccC
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 89 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (321)
+|.+...||+|++|.||+|.+..++..+++|.+.... ...+.+|+.+++.+ +||||+++++++.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-- 77 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL-QHENIVQYLGSSLD-- 77 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEEe--
Confidence 4677889999999999999998889999999885321 13577899999999 99999999999855
Q ss_pred CCCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeec
Q 020826 90 SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 166 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~ 166 (321)
..+.++++||+++++|..++ ..+++..+..++.|++.||++||++|++|+||+|+||+++.++ .++|+|||.+...
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~-~~~l~dfg~~~~~ 156 (267)
T cd06628 78 ADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKG-GIKISDFGISKKL 156 (267)
T ss_pred CCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCC-CEEecccCCCccc
Confidence 45677999999999988777 3488899999999999999999999999999999999999877 8999999998765
Q ss_pred CCCCc-------cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhh
Q 020826 167 HPGKE-------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN 239 (321)
Q Consensus 167 ~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (321)
..... .....++..|+|||.+.+ ..++.++|+|||||++|++++|..||.... .......+.. .
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~---~---- 227 (267)
T cd06628 157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQ-TSYTRKADIWSLGCLVVEMLTGKHPFPDCT-QLQAIFKIGE---N---- 227 (267)
T ss_pred ccccccCCccccccccCCCcCccChhHhcc-CCCCchhhhHHHHHHHHHHhhCCCCCCCcc-HHHHHHHHhc---c----
Confidence 42111 112346778999999877 678899999999999999999999984221 1111111100 0
Q ss_pred HHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 240 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
.....+..++.++.++|++||+.||++||++.++++||||
T Consensus 228 -----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 228 -----------------------------ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred -----------------------------CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 0001112356789999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=288.60 Aligned_cols=249 Identities=23% Similarity=0.420 Sum_probs=198.8
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc--------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
.+|++.+.||+|+||.||++.+..++..|++|.+... ....+.+|+.+++.+ .||||+++++++.+.....
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNL-LHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhc-CCCCeeeEEeEeccCCCce
Confidence 5799999999999999999999999999999987532 124577899999999 8999999999887655566
Q ss_pred cEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 93 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
+++++||+++++|..++ ..+++..+..++.|++.||++||++|++|+||+|+||+++.++ .++|+|||.+......
T Consensus 81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVG-NVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCC-CEEECcCccccccccc
Confidence 78999999999998776 4578889999999999999999999999999999999999877 8999999988754321
Q ss_pred ----CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhh
Q 020826 170 ----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245 (321)
Q Consensus 170 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (321)
.......++..|+|||.+.+ ..++.++|+|||||++|++++|+.||.. .+........ .....
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~-~~~~~~~~~~---~~~~~-------- 226 (265)
T cd06652 160 CLSGTGMKSVTGTPYWMSPEVISG-EGYGRKADIWSVGCTVVEMLTEKPPWAE-FEAMAAIFKI---ATQPT-------- 226 (265)
T ss_pred cccccccccCCCCccccChhhhcC-CCCCcchhHHHHHHHHHHHhhCCCCCCc-cchHHHHHHH---hcCCC--------
Confidence 11223457788999999877 6789999999999999999999999832 1111111111 10000
Q ss_pred cccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcc
Q 020826 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF 309 (321)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~ 309 (321)
....+..++..+.++|++|+. +|++|||++++++|||+.
T Consensus 227 ------------------------~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 227 ------------------------NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred ------------------------CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 000112345689999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=291.26 Aligned_cols=276 Identities=32% Similarity=0.602 Sum_probs=206.2
Q ss_pred eEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 23 y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
|++.+.||+|++|.||+|.+..+++.+++|.++... ...+.+|+.+++.+ +|||++++++++.+......++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL-RHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCeeeheeeEecCCCCcEEEEe
Confidence 678999999999999999998889999999997542 34577899999999 899999999998655346778999
Q ss_pred EeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC--c
Q 020826 98 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--E 171 (321)
Q Consensus 98 e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~--~ 171 (321)
||+++ ++..++ ..+++..++.++.|++.||++||+.|++|+||+|+||+++.++ .++|+|||.+....... .
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~-~~~l~d~g~~~~~~~~~~~~ 157 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDG-VLKLADFGLARPYTKRNSAD 157 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCC-CEEEccccceeeccCCCccc
Confidence 99986 555444 2589999999999999999999999999999999999999888 89999999987665432 2
Q ss_pred cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCCh
Q 020826 172 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (321)
.....++..|+|||.+.+...++.++||||||++++++++|..||. .......+..+.+..+......+......
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 232 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ-GSTELEQLEKIFELCGSPTDENWPGVSKL---- 232 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCchhhccccccc----
Confidence 3344567789999988765568899999999999999999998884 34444445554444443322221110000
Q ss_pred hhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 252 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
.......................+++++.+++++||+.||++|||+.++++||||
T Consensus 233 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 233 --PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred --hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0000000000000000011111247899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=291.02 Aligned_cols=251 Identities=24% Similarity=0.432 Sum_probs=199.4
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc---------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~---------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
+|+..+.||+|++|.||++.+..+++.+++|+++... ...+..|+..++++ +|+|++++++++.+ ...
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~ 77 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL-NHPHIIRMLGATCE--DSH 77 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHc-CCCceehhhceecc--CCe
Confidence 4788899999999999999999999999999986432 35678899999999 99999999999854 456
Q ss_pred cEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 93 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
.++++||+.+++|.+++ .++++..+..++.|++.||++||++|++|+||+|+||+++.++..++|+|||.+......
T Consensus 78 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~ 157 (268)
T cd06630 78 FNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK 157 (268)
T ss_pred EEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence 67999999999998776 458899999999999999999999999999999999999877657999999998665432
Q ss_pred Cc-----cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhh
Q 020826 170 KE-----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244 (321)
Q Consensus 170 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (321)
.. .....++..|+|||.+.+ ..++.++|+||||++++++++|..||.... .......+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~~~~~~--------- 226 (268)
T cd06630 158 GTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEK-HSNHLALIFKIASA--------- 226 (268)
T ss_pred cccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCC-CcchHHHHHHHhcc---------
Confidence 11 122356778999999876 678899999999999999999999984221 11111111000000
Q ss_pred hcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcc
Q 020826 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF 309 (321)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~ 309 (321)
......+..+++++.+++.+||+.||++|||+.++++||||+
T Consensus 227 -----------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 227 -----------------------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred -----------------------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 000011223567899999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=295.27 Aligned_cols=280 Identities=30% Similarity=0.532 Sum_probs=205.7
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccC----
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---- 89 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~---- 89 (321)
..++|++.+.||+|++|.||+|.+..+++.+++|.+.... .....+|+++++.+ +||||+++++++.+..
T Consensus 6 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL-KHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred ccccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhc-CCCCccchhhheeccccccc
Confidence 3689999999999999999999998899999999885432 23567899999999 8999999999875433
Q ss_pred --CCCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecccee
Q 020826 90 --SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 164 (321)
Q Consensus 90 --~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~ 164 (321)
....+++++|+.+..+..+. ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||++.
T Consensus 85 ~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~ 163 (311)
T cd07866 85 RKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQG-ILKIADFGLAR 163 (311)
T ss_pred ccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECcCccch
Confidence 23568999999876554443 3589999999999999999999999999999999999999888 89999999986
Q ss_pred ecCCCCc------------cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHH
Q 020826 165 FYHPGKE------------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 232 (321)
Q Consensus 165 ~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 232 (321)
....... .....++..|+|||.+.+...++.++||||||+++|+|++|+.|| .+.+.......+...
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~-~~~~~~~~~~~~~~~ 242 (311)
T cd07866 164 PYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL-QGKSDIDQLHLIFKL 242 (311)
T ss_pred hccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHH
Confidence 5432211 112245778999999876556889999999999999999999877 455555555555444
Q ss_pred hCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 233 LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
.+......+........... ......... ........+++++.++|++||+.||++|||+.|++.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 243 CGTPTEETWPGWRSLPGCEG------VHSFTNYPR-TLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred hCCCChhhchhhhhcccccc------cccCCCCCc-cHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 44332222111100000000 000000000 0000112345789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=288.03 Aligned_cols=247 Identities=27% Similarity=0.464 Sum_probs=201.6
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
+|++.+.||.|++|.||++.+..++..+++|.++.. ....+..|+++++.+ +|||++++++.+........+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILREL-KHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhc-CCCccceeeeeeecCCCCEEEEE
Confidence 588999999999999999999999999999988632 234577899999999 89999999998876666677899
Q ss_pred EEeecCchhhhhc-------CCCCHHHHHHHHHHHHHHHHHHH-----HCCCeeecCCCCCeEEcCCCCeEEEeecccee
Q 020826 97 FEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCH-----SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 164 (321)
Q Consensus 97 ~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lh-----~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~ 164 (321)
+||+++++|..++ ..+++..++.++.|++.||++|| +.+++|+||+|+||+++.++ .++|+|||++.
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~-~~kl~d~g~~~ 158 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN-NVKLGDFGLAK 158 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC-CEEEecccccc
Confidence 9999999887665 35788999999999999999999 89999999999999999877 89999999988
Q ss_pred ecCCCCc-cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 165 FYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 165 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
....... .....++..|+|||.+.+ ..++.++|+||||++++++++|..||... + ...+..... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~-~~~~~~~~~---~~~~----- 227 (265)
T cd08217 159 ILGHDSSFAKTYVGTPYYMSPEQLNH-MSYDEKSDIWSLGCLIYELCALSPPFTAR-N-QLQLASKIK---EGKF----- 227 (265)
T ss_pred cccCCcccccccccCCCccChhhhcC-CCCCchhHHHHHHHHHHHHHHCCCcccCc-C-HHHHHHHHh---cCCC-----
Confidence 7654333 334567889999999987 67889999999999999999999998422 2 222111110 0000
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
...+...++++.+++.+||+.+|++|||+.++++|||+
T Consensus 228 ---------------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 228 ---------------------------RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred ---------------------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 00112355789999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=298.44 Aligned_cols=285 Identities=34% Similarity=0.600 Sum_probs=216.9
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccC---CCCc
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---SKTP 93 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~---~~~~ 93 (321)
+|++.+.||.|++|.||+|++..+++.+++|.+.... .+.+.+|+.+++.+ +||||+++.+++.... ....
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhc-CCcchhhhhhhhcccCcccccce
Confidence 6899999999999999999998889999999886532 35688899999999 8999999999886543 2356
Q ss_pred EEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 94 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
+++++|+++ ++...+ ..+++..+..++.|++.||++||++|++|+||||+||+++.++ .++|+|||++.......
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~-~~~L~dfg~~~~~~~~~ 157 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNC-DLKICDFGLARGVDPDE 157 (330)
T ss_pred EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEcccCceEeecccc
Confidence 899999985 555444 2589999999999999999999999999999999999999887 89999999998765432
Q ss_pred ----ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhc
Q 020826 171 ----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246 (321)
Q Consensus 171 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (321)
......++..|+|||.+.+...++.++|+||||+++++|++|..|| .+.+..+....+....+.+........
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~-- 234 (330)
T cd07834 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLF-PGRDYIDQLNLIVEVLGTPSEEDLKFI-- 234 (330)
T ss_pred cccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCc-CCCCHHHHHHHHHHhcCCCChhHhhhc--
Confidence 2334567888999999987448899999999999999999999887 455555556666665555443332210
Q ss_pred ccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCccc
Q 020826 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAES 316 (321)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~~ 316 (321)
.................... ......+++++.++|++||+.||++|||++++++||||+++..++.
T Consensus 235 --~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~~~ 300 (330)
T cd07834 235 --TSEKARNYLKSLPKKPKKPL--SKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDPED 300 (330)
T ss_pred --cccchhhHHhhcccCCcchh--HHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccccc
Confidence 00111111110000000000 1111236789999999999999999999999999999998876654
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=291.38 Aligned_cols=254 Identities=25% Similarity=0.406 Sum_probs=201.2
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc---hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
+-|++.+.||+|+||.||++.+..++..+++|.+.... ...+.+|+.+++.+ +|||++++++.+.. ....++++
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~--~~~~~~v~ 81 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYY--ENNLWILI 81 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHC-CCCCeeeEEEEEee--CCEEEEEE
Confidence 44788899999999999999998899999999986533 34577899999999 89999999998855 34678999
Q ss_pred EeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC-Ccc
Q 020826 98 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEY 172 (321)
Q Consensus 98 e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~-~~~ 172 (321)
||+.++++...+ ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++...... ...
T Consensus 82 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~~~~~~ 160 (282)
T cd06643 82 EFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRR 160 (282)
T ss_pred EecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCC-CEEEcccccccccccccccc
Confidence 999999987654 3589999999999999999999999999999999999999888 8999999998654322 122
Q ss_pred ccccCCccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 173 NVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 173 ~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
....++..|+|||++.. ...++.++|+|||||++|+|++|+.||. ..+..+....+.....
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~-~~~~~~~~~~~~~~~~-------------- 225 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHH-ELNPMRVLLKIAKSEP-------------- 225 (282)
T ss_pred ccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcc-ccCHHHHHHHHhhcCC--------------
Confidence 34467888999999742 2457889999999999999999998873 2222222222111000
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCC
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~ 313 (321)
.....+..++.++.++|++||+.||++|||++++++||||+....
T Consensus 226 --------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 270 (282)
T cd06643 226 --------------------PTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSN 270 (282)
T ss_pred --------------------CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence 001112235678999999999999999999999999999997643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=290.05 Aligned_cols=252 Identities=23% Similarity=0.409 Sum_probs=201.2
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
++|++.+.||.|++|+||+|....++..+++|++... ....+.+|+..++.+ +|+|++++++.+.+ ....+++
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQC-NHPNVVKYYTSFVV--GDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhc-CCCCEEEEEEEEee--CCEEEEE
Confidence 4799999999999999999999889999999998643 235688999999998 89999999998854 4567799
Q ss_pred EEeecCchhhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 97 FEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 97 ~e~~~~~~l~~~~~------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
+|++.+++|..++. .+++..+..++.|++.||++||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~-~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 78 MPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDG-SVKIADFGVSASLADGG 156 (267)
T ss_pred EeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC-CEEEcccchHHHhccCc
Confidence 99999999887762 378899999999999999999999999999999999999877 79999999986654332
Q ss_pred cc-----ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhh
Q 020826 171 EY-----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245 (321)
Q Consensus 171 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (321)
.. ....++..|+|||.+.....++.++|+||||+++++|++|..||... +.......... ..
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~-~~~~~~~~~~~---~~--------- 223 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY-PPMKVLMLTLQ---ND--------- 223 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcccc-ChhhhHHHHhc---CC---------
Confidence 21 23457888999999877447899999999999999999999998422 22111111111 00
Q ss_pred cccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
............+++++.+++.+||+.||++|||+.++++||||
T Consensus 224 -------------------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 224 -------------------PPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred -------------------CCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 00000001112466789999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=288.14 Aligned_cols=250 Identities=27% Similarity=0.483 Sum_probs=200.9
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc---hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
.++|++.+.||+|++|.||+|.+..+++.+++|++.... ...+.+|+++++.+ +|||++++++.+.+ ....+++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKEC-RHPNIVAYFGSYLR--RDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhC-CCCChhceEEEEEe--CCEEEEE
Confidence 578999999999999999999998889999999987543 45688999999999 99999999998855 4467899
Q ss_pred EEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-c
Q 020826 97 FEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 171 (321)
Q Consensus 97 ~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~-~ 171 (321)
|||++++++..++ ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||.+....... .
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~~~ 157 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG-DVKLADFGVSAQLTATIAK 157 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCC-CEEECccccchhhhhhhhc
Confidence 9999999988766 4589999999999999999999999999999999999999887 79999999987554322 2
Q ss_pred cccccCCccccccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHH-hCChhhhHHhhhhccc
Q 020826 172 YNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV-LGTDELNAYLNKYHIE 248 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 248 (321)
.....++..|+|||.+... ..++.++|+||||+++++|++|..||.... .......+... +...
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~-~~~~~~~~~~~~~~~~------------ 224 (262)
T cd06613 158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH-PMRALFLISKSNFPPP------------ 224 (262)
T ss_pred cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHhccCCCc------------
Confidence 2334677889999998762 268889999999999999999999984322 22222111110 0000
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCC
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 307 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~ 307 (321)
........+.++.+++++||..||.+|||+.+++.|||
T Consensus 225 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 225 ---------------------KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred ---------------------cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 00011234568999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=293.18 Aligned_cols=251 Identities=23% Similarity=0.436 Sum_probs=199.2
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc---hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
.++|++.+.||+|+||.||+|.+..+++.+++|+++... ...+.+|+.+++.+ +|||++++++.+.+ ....+++
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l-~h~~ii~~~~~~~~--~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDC-KHSNIVAYFGSYLR--RDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCeeeEEEEEEe--CCEEEEE
Confidence 468999999999999999999999999999999987543 23567899999999 99999999998854 4566799
Q ss_pred EEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-cc
Q 020826 97 FEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EY 172 (321)
Q Consensus 97 ~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~-~~ 172 (321)
+||+++++|.+++ ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++ .++|+|||++....... ..
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNG-HVKLADFGVSAQITATIAKR 163 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECcceeeeEccCccccc
Confidence 9999999998776 3589999999999999999999999999999999999999887 79999999987553222 22
Q ss_pred ccccCCcccccccccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 173 NVRVASRYFKGPELLV--DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 173 ~~~~~~~~y~aPE~~~--~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
....++..|+|||.+. ....++.++|+|||||++|+|++|..||+..... ........ ..
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~-~~~~~~~~--~~--------------- 225 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-RALFLMTK--SN--------------- 225 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccch-hhHHhhhc--cC---------------
Confidence 3446888999999874 2245788999999999999999999998533321 11111000 00
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCC
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 307 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~ 307 (321)
..+ . .......++..+.+++++||+.||++|||++++++|||
T Consensus 226 -----------~~~-~---~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 226 -----------FQP-P---KLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred -----------CCC-C---cccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 000 0 00011135578999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=290.23 Aligned_cols=247 Identities=27% Similarity=0.455 Sum_probs=203.1
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
+|++.+.||.|+||.||+|.+..+++.+++|.+... ..+.+.+|+++++++ +||||+++++.+.+ ....++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 77 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQEL-NHPFLVNLWYSFQD--EENMYL 77 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhC-CCCChHHHHHhhcC--CCeEEE
Confidence 589999999999999999999889999999998642 235688899999999 99999999998844 456789
Q ss_pred EEEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCcc
Q 020826 96 IFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 172 (321)
Q Consensus 96 v~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~ 172 (321)
++||+.+++|..++. .+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||.+.........
T Consensus 78 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~ 156 (258)
T cd05578 78 VVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQG-HVHITDFNIATKVTPDTLT 156 (258)
T ss_pred EEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCC-CEEEeecccccccCCCccc
Confidence 999999999987773 689999999999999999999999999999999999999888 8999999998776554444
Q ss_pred ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChh
Q 020826 173 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 252 (321)
Q Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (321)
....++..|+|||.+.. ..++.++|+||||+++|++++|..||...... ....+.+.....
T Consensus 157 ~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~---------------- 217 (258)
T cd05578 157 TSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQETA---------------- 217 (258)
T ss_pred cccCCChhhcCHHHHcc-cCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHhccc----------------
Confidence 55667888999999977 66899999999999999999999998533321 111111100000
Q ss_pred hHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCH--HHHhcCCCc
Q 020826 253 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA--KEAMAHPYF 308 (321)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~--~ell~hp~~ 308 (321)
....+..+++++.++|++||+.||.+||++ +|+++||||
T Consensus 218 -----------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 218 -----------------DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred -----------------cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 001112355799999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=294.54 Aligned_cols=253 Identities=24% Similarity=0.409 Sum_probs=202.5
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
++|++.+.||+|++|.||++.+..+++.+++|.+.... ...+.+|+++++++ .||||+++++.+... ...+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~--~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC-NSPYIVGFYGAFYNN--GDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHC-CCCchhhhheeeecC--CEEEEE
Confidence 46888999999999999999998899999999986542 35678899999999 799999999988554 567899
Q ss_pred EEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc
Q 020826 97 FEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 171 (321)
Q Consensus 97 ~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~-~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~ 171 (321)
+|++.+++|..++ ..+++..+..++.|++.||++||+ .|++|+||+|+||+++.++ .++|+|||.+........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~-~~~l~d~g~~~~~~~~~~ 156 (265)
T cd06605 78 MEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQLVNSLA 156 (265)
T ss_pred EEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC-CEEEeecccchhhHHHHh
Confidence 9999999988777 457899999999999999999999 9999999999999999877 899999998865432222
Q ss_pred cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHH-HhCChhhhHHhhhhcccCC
Q 020826 172 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK-VLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 250 (321)
....++..|+|||.+.+ ..++.++|+||||++++++++|..||..............+ .....
T Consensus 157 -~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-------------- 220 (265)
T cd06605 157 -KTFVGTSSYMAPERIQG-NDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP-------------- 220 (265)
T ss_pred -hcccCChhccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC--------------
Confidence 12667788999999977 68899999999999999999999998544221111111111 00000
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
... .....+++++.++|.+||..||++|||+.+++.||||++.
T Consensus 221 -------------~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 221 -------------PPR-----LPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred -------------CCC-----CChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 000 0000156789999999999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=309.16 Aligned_cols=252 Identities=22% Similarity=0.386 Sum_probs=208.6
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecc-------cchHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~-------~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
..=.+....||+|+|.+||+|.|..+|..||.-.++. ....++..|+.+|+.| +||||+++++.|.+....+
T Consensus 39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL-~H~NIirfy~SW~d~~n~~ 117 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSL-KHPNIIRFYDSWVDTDNKT 117 (632)
T ss_pred CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccC-CCCceeeeeeheecCCCce
Confidence 3334556679999999999999999999888654432 2347799999999999 9999999999999988888
Q ss_pred cEEEEEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--CeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 93 PSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~--i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
+.+|+|.+..|+|+.+++ .++...++.+++||+.||.|||++. |+|||||.+||||+.+.+.|||+|+|+|+...
T Consensus 118 in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 118 INFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred eeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 999999999999999984 5889999999999999999999986 99999999999999887799999999998765
Q ss_pred CCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 168 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
.... ....|||.|||||... ..|+...||||||+++.||+|+..||..-.+...+...+.....+..+..
T Consensus 198 ~s~a-ksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~k------- 267 (632)
T KOG0584|consen 198 KSHA-KSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSK------- 267 (632)
T ss_pred cccc-ceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhc-------
Confidence 4333 3478999999999986 58999999999999999999999999544444333333322222221111
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
.=.|++++||.+||.. .++|+|+.|||.||||..-
T Consensus 268 ----------------------------V~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 268 ----------------------------VKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred ----------------------------cCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 1127999999999999 9999999999999999975
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=285.01 Aligned_cols=245 Identities=24% Similarity=0.436 Sum_probs=199.1
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
+|++.+.||+|++|.||+|.+..+++.+++|.+... ....+.+|+.+++.+ +|||++++++.+.+ ....+++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKL-DSSYIIRYYESFLD--KGKLNIV 77 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhc-CCCCeehheeeecc--CCEEEEE
Confidence 588999999999999999999999999999997632 345678899999999 89999999999854 4567899
Q ss_pred EEeecCchhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc
Q 020826 97 FEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 171 (321)
Q Consensus 97 ~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~ 171 (321)
+||+.+++|..++ ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++........
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~-~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 78 MEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred EEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCC-CEEEcccccceeccCccc
Confidence 9999999988776 3478889999999999999999999999999999999999877 899999999876543322
Q ss_pred -cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 172 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
.....++..|+|||+..+ ..++.++|+||||+++++|++|..||.... .......+.. .
T Consensus 157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~----~-------------- 216 (256)
T cd08529 157 FANTIVGTPYYLSPELCED-KPYNEKSDVWALGVVLYECCTGKHPFDANN-QGALILKIIR----G-------------- 216 (256)
T ss_pred hhhccccCccccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHc----C--------------
Confidence 233457788999999987 678899999999999999999999984322 1111111100 0
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
.. ......+++++.+++++||+.+|++||++.++++|||+
T Consensus 217 ----------~~--------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 217 ----------VF--------PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ----------CC--------CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 00 00111355789999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=297.44 Aligned_cols=283 Identities=33% Similarity=0.589 Sum_probs=208.3
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC----
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---- 90 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~---- 90 (321)
.++|.+...||+|++|.||+|++..+++.+|+|.++.. ....+.+|+.+++.+ .||||+++++++.....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHM-QHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhc-CCCCccchhheecccccCCCC
Confidence 46899999999999999999999889999999998642 124577899999999 99999999998854322
Q ss_pred CCcEEEEEeecCchhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 91 KTPSLIFEHVNNTDFKVLYP-TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
...++++|++.. ++..... .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~-~~kL~dfg~~~~~~~- 169 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC-ELKILDFGLARHADA- 169 (342)
T ss_pred ceEEEEeccccc-CHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCCCCcCCCC-
Confidence 235799999875 4554443 689999999999999999999999999999999999999888 899999999865422
Q ss_pred CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 170 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
......++..|+|||.+.+...++.++|+|||||++|+|++|+.||. +.+....+..+....+.+... +........
T Consensus 170 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 246 (342)
T cd07879 170 -EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFK-GKDYLDQLTQILKVTGVPGPE-FVQKLEDKA 246 (342)
T ss_pred -CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhcCCCCHH-HHHHhcccc
Confidence 22334567789999998764568899999999999999999999984 333344444444444432211 111110000
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
..... ......+..... ......++++.++|++||+.||++|||+++++.||||+.+...
T Consensus 247 ~~~~~---~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 247 AKSYI---KSLPKYPRKDFS--TLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306 (342)
T ss_pred hHHHH---hhcCCcccchHH--HHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence 00000 000000000000 0011356789999999999999999999999999999988654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-42 Score=299.60 Aligned_cols=285 Identities=31% Similarity=0.575 Sum_probs=213.4
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC---
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS--- 90 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~--- 90 (321)
..++|++.+.||+|++|.||+|++..++..+++|++... ....+.+|+.+++.+ .|||++++.+++.....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHM-DHENVIGLLDVFTPASSLED 91 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhc-cCCCHHHHHHHhhccccccc
Confidence 467899999999999999999999889999999998642 224567899999999 99999999987754322
Q ss_pred -CCcEEEEEeecCchhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 91 -KTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 91 -~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
...++++|+++ ++|.+++ ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++....
T Consensus 92 ~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~-~~kL~dfg~~~~~~ 169 (343)
T cd07851 92 FQDVYLVTHLMG-ADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC-ELKILDFGLARHTD 169 (343)
T ss_pred cccEEEEEecCC-CCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEcccccccccc
Confidence 34689999985 4666665 3589999999999999999999999999999999999999887 89999999987653
Q ss_pred CCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 168 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
.. .....++..|+|||.+.+...++.++||||||+++|++++|+.||. +......+..+....+.... .+......
T Consensus 170 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~-~~~~~~~~~~i~~~~~~~~~-~~~~~~~~ 245 (343)
T cd07851 170 DE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFP-GSDHIDQLKRIMNLVGTPDE-ELLQKISS 245 (343)
T ss_pred cc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHhcCCCCH-HHHhhccc
Confidence 22 2334577889999998764567899999999999999999999884 44445555555555443322 11111111
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
.............+...+.. ....+++++.++|++||+.||++|||+.++++||||++...++
T Consensus 246 ---~~~~~~~~~~~~~~~~~~~~--~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~~ 308 (343)
T cd07851 246 ---ESARNYIQSLPQMPKKDFKE--VFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDPE 308 (343)
T ss_pred ---hhHHHHHHhccccCCCCHHH--HhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCCc
Confidence 11111111111111111111 1123568999999999999999999999999999999876654
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=288.44 Aligned_cols=246 Identities=24% Similarity=0.414 Sum_probs=195.8
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc---------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~---------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
+|++.+.||+|+||+||+|.+ .+++.+++|.++... ...+.+|+++++.+ +|+||+++++++.+. ..
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~ 76 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSL-KHVNIVQYLGTCLDD--NT 76 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhc-CCCCEeeEeeEeecC--Ce
Confidence 578889999999999999987 578899999876321 24578899999999 899999999998654 56
Q ss_pred cEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 93 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
.++++||+.+++|..++ ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 77 ISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG-IIKLIDFGCARRLAWV 155 (265)
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCC-eEEeccchhhHhhhhc
Confidence 78999999999998876 3488999999999999999999999999999999999999887 8999999988653211
Q ss_pred -------CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHh
Q 020826 170 -------KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242 (321)
Q Consensus 170 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (321)
.......++..|+|||.+.+ ..++.++|+||||++++++++|..||.... .......+....+.
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-~~~~~~~~~~~~~~------- 226 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINE-SGYGRKSDIWSIGCTVFEMATGKPPLASMD-RLAAMFYIGAHRGL------- 226 (265)
T ss_pred cccccccccccccCCCccccChhhhcC-CCCcchhhHHHHHHHHHHHHhCCCccccCC-hHHHHHHhhhccCC-------
Confidence 11223457888999999987 678899999999999999999999984222 11111111000000
Q ss_pred hhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
....+..+++++.++|++||+.+|++|||+.++++||||
T Consensus 227 ---------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 227 ---------------------------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred ---------------------------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 000122356789999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=291.69 Aligned_cols=252 Identities=24% Similarity=0.414 Sum_probs=198.9
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc---chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
..++|++.+.||+|+||.||+|++..+++.+++|+++.. ....+.+|+.+++.+ +||||+++++.+.. ....++
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~-~h~~ii~~~~~~~~--~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKEC-KHCNIVAYFGSYLS--REKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhc-CCCCeeeeeEEEEe--CCEEEE
Confidence 356899999999999999999999889999999998643 234577899999998 99999999999854 356689
Q ss_pred EEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-c
Q 020826 96 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 171 (321)
Q Consensus 96 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~-~ 171 (321)
++||+++++|.+++ ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++....... .
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNG-DVKLADFGVAAKITATIAK 162 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-CEEECcCccceeecccccc
Confidence 99999999998765 3589999999999999999999999999999999999999887 79999999987653222 2
Q ss_pred cccccCCccccccccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 172 YNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
.....++..|+|||.+.. ...++.++|+||+||++|+|++|+.||...... .....+..
T Consensus 163 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~-~~~~~~~~------------------ 223 (267)
T cd06646 163 RKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM-RALFLMSK------------------ 223 (267)
T ss_pred cCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh-hhheeeec------------------
Confidence 233467788999998742 245778999999999999999999998422211 00000000
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCC
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 307 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~ 307 (321)
....+ ........++..+.+++++||+.||++|||++++++|+|
T Consensus 224 ----------~~~~~----~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 224 ----------SNFQP----PKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ----------CCCCC----CCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 00000 000111235678999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=299.42 Aligned_cols=288 Identities=32% Similarity=0.571 Sum_probs=215.2
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
...++|++.+.||+|+||.||+|.+..+++.+++|.+... ....+.+|+.++.++.+||||+++++++...+...
T Consensus 4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 3467899999999999999999999888999999987532 23456789999999978999999999987666667
Q ss_pred cEEEEEeecCchhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 93 PSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
.++|+|++.+ +|..++. .+++..+..++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||.+.......
T Consensus 84 ~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~-~~kl~d~g~~~~~~~~~ 161 (337)
T cd07852 84 IYLVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDC-RVKLADFGLARSLSELE 161 (337)
T ss_pred EEEEeccccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEEeeccchhcccccc
Confidence 7899999985 6665553 478888899999999999999999999999999999999888 89999999987553322
Q ss_pred ------ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhh
Q 020826 171 ------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244 (321)
Q Consensus 171 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (321)
......++..|+|||.+.+...++.++|+||||+++|+|++|+.|| .+.........+....+........ .
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~-~ 239 (337)
T cd07852 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLF-PGTSTLNQLEKIIEVIGPPSAEDIE-S 239 (337)
T ss_pred ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHH-H
Confidence 1223457888999998876567889999999999999999999888 4555555555555544433221111 0
Q ss_pred hcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
..... ................. . ....+++++.++|.+||+.||++|||+.++++||||++...+
T Consensus 240 ~~~~~---~~~~~~~~~~~~~~~~~-~-~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~~ 304 (337)
T cd07852 240 IKSPF---AATMLDSLPSRPRKPLD-E-LLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP 304 (337)
T ss_pred HHhhh---HHHhhhhcccccccchh-h-hccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhccC
Confidence 00000 00011111111111111 1 112267899999999999999999999999999999987554
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=296.79 Aligned_cols=280 Identities=27% Similarity=0.472 Sum_probs=208.1
Q ss_pred cCceEE-eeeeeeecceEEEEEEEecCCceEEEEEecccch-----------------HHHHHHHHHHHhhcCCCCeeee
Q 020826 20 QDDYEV-VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-----------------KKIKREIKILQNLCGGPNIVKL 81 (321)
Q Consensus 20 ~~~y~~-~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~-----------------~~~~~E~~~l~~l~~h~~i~~~ 81 (321)
.++|.. .+.||.|+||+||+|.+..+++.+++|.++.... ..+.+|+.+++.+ +||||+++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~ 85 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEI-KHENIMGL 85 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhC-CCcceeee
Confidence 467765 4669999999999999988999999999864322 1367899999999 89999999
Q ss_pred eeeeeccCCCCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEe
Q 020826 82 LDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI 158 (321)
Q Consensus 82 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~ 158 (321)
++++.. ..+.++++|++.+ ++..++ ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++ .++|+
T Consensus 86 ~~~~~~--~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~-~~kl~ 161 (335)
T PTZ00024 86 VDVYVE--GDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKG-ICKIA 161 (335)
T ss_pred eEEEec--CCcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCC-CEEEC
Confidence 999854 4567899999985 555444 3489999999999999999999999999999999999999887 89999
Q ss_pred eccceeecCCC---------------CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCCh
Q 020826 159 DWGLAEFYHPG---------------KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY 223 (321)
Q Consensus 159 dfg~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~ 223 (321)
|||.+...... .......++..|+|||.+.+...++.++|+|||||++++|++|..|| .+.+..
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~-~~~~~~ 240 (335)
T PTZ00024 162 DFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF-PGENEI 240 (335)
T ss_pred CccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHH
Confidence 99998755311 11122345778999999876556789999999999999999999887 455555
Q ss_pred HHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHh
Q 020826 224 DQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 303 (321)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell 303 (321)
+.+..+....+.+....+......... . .......... .......++++.++|++||+.+|++|||+++++
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~---~----~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 311 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLY---T----EFTPRKPKDL--KTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccc---c----ccCcCCcccH--HHhCcCCChHHHHHHHHHcCCCchhccCHHHHh
Confidence 566666665554433221111000000 0 0000000000 111224567899999999999999999999999
Q ss_pred cCCCcccCCCc
Q 020826 304 AHPYFFPIRNA 314 (321)
Q Consensus 304 ~hp~~~~~~~~ 314 (321)
.||||+...-.
T Consensus 312 ~~~~~~~~~~~ 322 (335)
T PTZ00024 312 KHEYFKSDPLP 322 (335)
T ss_pred cCcccCCCCCC
Confidence 99999976443
|
|
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=292.14 Aligned_cols=255 Identities=23% Similarity=0.405 Sum_probs=201.9
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
++|++++.||+|+||.||++.+..++..+++|.++... ...+.+|+.+++++ +||||+++++.+.. ....+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKA-VSPYIVDFYGAFFI--EGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhc-CCCcHHhhhhheec--CCeEEEE
Confidence 57899999999999999999998899999999886431 34678899999999 99999999998854 4567799
Q ss_pred EEeecCchhhhhcC------CCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 97 FEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 97 ~e~~~~~~l~~~~~------~~~~~~~~~i~~qi~~~l~~lh~-~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
+||+.+++|..++. .+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++ .++|+|||++......
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~ 156 (286)
T cd06622 78 MEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVAS 156 (286)
T ss_pred EeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC-CEEEeecCCcccccCC
Confidence 99999999877662 58899999999999999999997 5999999999999999877 8999999998755322
Q ss_pred CccccccCCccccccccccCCC-----CCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhh
Q 020826 170 KEYNVRVASRYFKGPELLVDLQ-----DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244 (321)
Q Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (321)
......++..|+|||.+.+.. .++.++|+|||||++|++++|..||.... .......+.......
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~-~~~~~~~~~~~~~~~-------- 226 (286)
T cd06622 157 -LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET-YANIFAQLSAIVDGD-------- 226 (286)
T ss_pred -ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc-hhhHHHHHHHHhhcC--------
Confidence 223345777899999985422 35789999999999999999999984321 111111111100000
Q ss_pred hcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
+ ...+..+++++.++|.+||+.+|++||+++++++||||......
T Consensus 227 -------------------~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~ 271 (286)
T cd06622 227 -------------------P------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA 271 (286)
T ss_pred -------------------C------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence 0 00112356789999999999999999999999999999887655
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=287.75 Aligned_cols=273 Identities=30% Similarity=0.584 Sum_probs=203.5
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
+|++.+.||.|++|+||+|++..++..+++|.++... ...+.+|+.+++.+ +|||++++++.+.+. ...++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKEL-KHENIVRLHDVIHTE--NKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhh-cCCCEeeeeeeEeeC--CcEEEEE
Confidence 5899999999999999999998899999999987432 35677899999999 899999999999654 4567999
Q ss_pred EeecCchhhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-
Q 020826 98 EHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 170 (321)
Q Consensus 98 e~~~~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~- 170 (321)
||+.+ ++..++ ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~-~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 78 EYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRG-ELKLADFGLARAFGIPVN 155 (284)
T ss_pred ecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC-cEEEeecchhhhhcCCcc
Confidence 99997 444433 2479999999999999999999999999999999999999887 89999999986543221
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
......++..|++||.+.+...++.++|+||||++++++++|..||. +.+..+....+......+....+..-.
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~----- 229 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFP-GTNNEDQLLKIFRIMGTPTESTWPGIS----- 229 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCcHHHHHHHHHHhCCCChhhHHHHh-----
Confidence 22334567889999998765567899999999999999999998884 444444444444443333222111100
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
................ .......+++.+.+++.+||+.||.+|||+.++++||||
T Consensus 230 -~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 230 -QLPEYKPTFPRYPPQD--LQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred -cCchhcccccCCChHH--HHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0000000000000000 011112356889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=285.62 Aligned_cols=251 Identities=25% Similarity=0.451 Sum_probs=205.9
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
++|++.+.||+|++|.||+|.+..+++.+++|.+.... ...+..|+..+..+ +|+|++++++++... ...+++
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~lv 77 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSC-ESPYVVKCYGAFYKE--GEISIV 77 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEccC--CeEEEE
Confidence 47899999999999999999998899999999987543 46788999999999 799999999998544 567899
Q ss_pred EEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCcc
Q 020826 97 FEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 172 (321)
Q Consensus 97 ~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~-~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~ 172 (321)
+||+.+++|.+++ ..+++..+..++.|++.|+++||+ .|++|+||+|+||+++.++ .++|+|||.+.........
T Consensus 78 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~-~~~l~df~~~~~~~~~~~~ 156 (264)
T cd06623 78 LEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKG-EVKIADFGISKVLENTLDQ 156 (264)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCC-CEEEccCccceecccCCCc
Confidence 9999999998887 458999999999999999999999 9999999999999999888 8999999998766433332
Q ss_pred -ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCC-ChHH-HHHHHHHhCChhhhHHhhhhcccC
Q 020826 173 -NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD-NYDQ-LVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 173 -~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
....++..|+|||.+.. ..++.++|+||||+++|++++|..||..... .... ...+.. ..
T Consensus 157 ~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~----~~------------ 219 (264)
T cd06623 157 CNTFVGTVTYMSPERIQG-ESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD----GP------------ 219 (264)
T ss_pred ccceeecccccCHhhhCC-CCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc----CC------------
Confidence 24567788999999877 6888999999999999999999999843321 1111 111100 00
Q ss_pred ChhhHhhhcccCCCCCccccccccccC-CcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHL-AVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
. ...+.. ++..+.++|++||..+|++|||+.++++||||+..+
T Consensus 220 ------------~--------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~~ 263 (264)
T cd06623 220 ------------P--------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKAD 263 (264)
T ss_pred ------------C--------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhcc
Confidence 0 001112 567899999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=285.57 Aligned_cols=243 Identities=26% Similarity=0.453 Sum_probs=197.0
Q ss_pred eeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeecC
Q 020826 29 VGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 102 (321)
Q Consensus 29 lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 102 (321)
||.|++|.||+|++..+++.+++|++... ..+.+.+|+.+++.+ +||||+++++.+.+ ....++++||+.+
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEEC-NHPFIVKLYRTFKD--KKYIYMLMEYCLG 77 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhC-CCCCEeeeeeeEEc--CCccEEEEecCCC
Confidence 68999999999999888999999998642 235688899999999 89999999998854 4567799999999
Q ss_pred chhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCccccccCCc
Q 020826 103 TDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR 179 (321)
Q Consensus 103 ~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~ 179 (321)
++|.+++. .+++..+..++.|++.||++||++|++|+||+|+||+++.++ .++|+|||++.............++.
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~ 156 (262)
T cd05572 78 GELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG-YVKLVDFGFAKKLKSGQKTWTFCGTP 156 (262)
T ss_pred CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCC-CEEEeeCCcccccCcccccccccCCc
Confidence 99988763 478999999999999999999999999999999999999887 89999999987665443334456788
Q ss_pred cccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChH-HHHHHHHHhCChhhhHHhhhhcccCChhhHhhhc
Q 020826 180 YFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD-QLVKIAKVLGTDELNAYLNKYHIELDPHLAALVG 258 (321)
Q Consensus 180 ~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (321)
.|++||.+.+ ..++.++|+||+|+++|++++|..||.....+.. ....+.....
T Consensus 157 ~~~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------------------------ 211 (262)
T cd05572 157 EYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNG------------------------ 211 (262)
T ss_pred CccChhHhcC-CCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCC------------------------
Confidence 8999999876 6789999999999999999999999853332111 1111100000
Q ss_pred ccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC-----HHHHhcCCCcccC
Q 020826 259 RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPI 311 (321)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps-----~~ell~hp~~~~~ 311 (321)
....+...++++.++|.+||+.||++||| ++|+++||||+..
T Consensus 212 -----------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 212 -----------KLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred -----------CCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence 00111123578999999999999999999 9999999999975
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=312.23 Aligned_cols=283 Identities=21% Similarity=0.280 Sum_probs=196.3
Q ss_pred cCceEEeeeeeeecceEEEEEEEecC-CceEEEE------------------Eecc--cchHHHHHHHHHHHhhcCCCCe
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTD-NEKCIIK------------------ILKP--VKKKKIKREIKILQNLCGGPNI 78 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~-~~~~~vK------------------~~~~--~~~~~~~~E~~~l~~l~~h~~i 78 (321)
.++|++++.||+|+||+||++..+.. +...+.| .+.. .....+.+|+.+++.+ +||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l-~HpnI 225 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL-NHENI 225 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhC-CCCCc
Confidence 46899999999999999999876432 2222222 1111 1124578899999999 99999
Q ss_pred eeeeeeeeccCCCCcEEEEEeecCchhhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCC
Q 020826 79 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 151 (321)
Q Consensus 79 ~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~ 151 (321)
+++++++.+.. ..+++++++.+..+..... ......+..++.|++.||+|||++||+|+||||+||+++.+
T Consensus 226 v~l~~~~~~~~--~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~ 303 (501)
T PHA03210 226 LKIEEILRSEA--NTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD 303 (501)
T ss_pred CcEeEEEEECC--eeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence 99999996544 4569999987665543332 23456778899999999999999999999999999999988
Q ss_pred CCeEEEeeccceeecCCCCc--cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCC--CChHHHH
Q 020826 152 QRKLRLIDWGLAEFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH--DNYDQLV 227 (321)
Q Consensus 152 ~~~v~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~--~~~~~~~ 227 (321)
+ .+||+|||++........ .....|+..|+|||++.+ ..++.++|||||||++|+|++|..+++... ....++.
T Consensus 304 ~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~ 381 (501)
T PHA03210 304 G-KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG-DGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL 381 (501)
T ss_pred C-CEEEEeCCCceecCcccccccccccCCcCCCCchhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence 8 899999999976643322 223578999999999987 678999999999999999999987654332 2334444
Q ss_pred HHHHHhCChhhhHHhhhhcccCChhhHhhhc-ccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCC
Q 020826 228 KIAKVLGTDELNAYLNKYHIELDPHLAALVG-RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 306 (321)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp 306 (321)
.+...++..... +.. ........+. ..................+++++.++|.+||++||++|||+.|+|+||
T Consensus 382 ~~~~~~~~~~~~-~p~-----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 382 KIIDSLSVCDEE-FPD-----PPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHHhcccChhh-cCC-----cHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 444433321110 000 0000000000 000001111111112223567899999999999999999999999999
Q ss_pred CcccCCC
Q 020826 307 YFFPIRN 313 (321)
Q Consensus 307 ~~~~~~~ 313 (321)
||.....
T Consensus 456 ~f~~~~~ 462 (501)
T PHA03210 456 LFSAEEE 462 (501)
T ss_pred hhhcCCc
Confidence 9987543
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=289.82 Aligned_cols=255 Identities=24% Similarity=0.388 Sum_probs=201.1
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
++|++.+.||+|+||.||++.+..+++.|++|.+.... ...+.+|+.+++.+ +||||+++++.+.. ....+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~ 77 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-ENPFVVSMFCSFET--KRHLC 77 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhC-CCCCeeeeEEEEec--CCEEE
Confidence 47999999999999999999999999999999986532 24567899999998 89999999998854 45678
Q ss_pred EEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-
Q 020826 95 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 170 (321)
Q Consensus 95 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~- 170 (321)
+++|++.+++|..++ ..+++..+..++.|++.||+|||++|++|+||+|.||+++.++ .++|+|||++.......
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~-~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 78 MVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMG-HIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCC-CEEEeeCCCccccCcCcc
Confidence 999999999998777 3488999999999999999999999999999999999999877 89999999876321100
Q ss_pred ---------------ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCC
Q 020826 171 ---------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 235 (321)
Q Consensus 171 ---------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (321)
......++..|+|||.+.+ ..++.++|+|||||++|++++|..||.. ....+...........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~vl~el~~g~~pf~~-~~~~~~~~~~~~~~~~ 234 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFG-DTPEELFGQVISDDIE 234 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccC-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcccC
Confidence 0012346778999999877 6789999999999999999999999842 2222222211110000
Q ss_pred hhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC---HHHHhcCCCcccCC
Q 020826 236 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT---AKEAMAHPYFFPIR 312 (321)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps---~~ell~hp~~~~~~ 312 (321)
.+ .....+++++.++|++||+.||++||| +.++++||||...+
T Consensus 235 ---------------------------~~-------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~ 280 (305)
T cd05609 235 ---------------------------WP-------EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD 280 (305)
T ss_pred ---------------------------CC-------CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence 00 001135678999999999999999997 79999999997765
Q ss_pred Ccc
Q 020826 313 NAE 315 (321)
Q Consensus 313 ~~~ 315 (321)
-..
T Consensus 281 ~~~ 283 (305)
T cd05609 281 WNG 283 (305)
T ss_pred HHH
Confidence 443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=294.20 Aligned_cols=285 Identities=29% Similarity=0.546 Sum_probs=208.8
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccC----
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---- 89 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~---- 89 (321)
..++|++.+.||+|+||.||+|.+..+++.||+|.+.... ...+.+|+.++..+ +||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHc-CCCcccceeeeeeecccccc
Confidence 4588999999999999999999998899999999986432 24567899999999 8999999999875332
Q ss_pred CCCcEEEEEeecCchhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 90 SKTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
....+++++++ +++|..++ ..+++..++.++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||++....
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kl~dfg~~~~~~ 171 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTD 171 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCC-CEEEeccccccccc
Confidence 13356777776 55666555 3589999999999999999999999999999999999999888 89999999987543
Q ss_pred CCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 168 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
.......++..|+|||.+.+...++.++|||||||++++|++|+.|| ...+....+..+....+...... ......
T Consensus 172 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 247 (345)
T cd07877 172 --DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAEL-LKKISS 247 (345)
T ss_pred --ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHH-Hhhccc
Confidence 22234467888999999876456888999999999999999999888 34444444455544444322211 111100
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
.....+ .......+...+.. .....++++.++|.+||+.||++|||+.++++||||++...+.
T Consensus 248 ~~~~~~---~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~~ 310 (345)
T cd07877 248 ESARNY---IQSLTQMPKMNFAN--VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 310 (345)
T ss_pred HhHHHH---HHHhcccCCcchhh--hcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCCC
Confidence 000000 00000000000000 0113567899999999999999999999999999999865544
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=284.77 Aligned_cols=245 Identities=20% Similarity=0.434 Sum_probs=198.8
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
+|++.+.||+|+||++|.+.+..+++.+++|.+... ....+.+|+.+++.+ +||||+++.+.+.+ ....+++
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~lv 77 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNM-KHPNIVQYQESFEE--NGNLYIV 77 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhC-CCCCeeeeEeeecC--CCeEEEE
Confidence 589999999999999999999889999999988632 234688899999999 89999999999854 4567899
Q ss_pred EEeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc
Q 020826 97 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 171 (321)
Q Consensus 97 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~ 171 (321)
+|++.+++|...+. .+++..+..++.|++.||.+||++|++|+||+|+||+++.++ .++++|||.+........
T Consensus 78 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~-~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 78 MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVE 156 (256)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEEeeccceeecCcchh
Confidence 99999988876652 378889999999999999999999999999999999999877 799999999876543322
Q ss_pred -cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 172 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
.....++..|+|||++.+ ..++.++|+|||||+++++++|..||.... ..+....+.. +.
T Consensus 157 ~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~-~~~~~~~~~~--~~--------------- 217 (256)
T cd08218 157 LARTCIGTPYYLSPEICEN-RPYNNKSDIWALGCVLYEMCTLKHAFEAGN-MKNLVLKIIR--GS--------------- 217 (256)
T ss_pred hhhhccCCccccCHHHhCC-CCCCCccchhHHHHHHHHHHcCCCCccCCC-HHHHHHHHhc--CC---------------
Confidence 223457778999999877 678899999999999999999999984322 1121111110 00
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
. ...+..++.++.++|.+||+.+|++||++.++++||||
T Consensus 218 -----------~--------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 218 -----------Y--------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred -----------C--------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 0 00112356789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=292.10 Aligned_cols=282 Identities=27% Similarity=0.540 Sum_probs=208.7
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccC--
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ-- 89 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-- 89 (321)
....++|++.+.||+|++|+||+|.++.+++.+++|.++... ...+.+|+++++.+ +|||++++++++.+..
T Consensus 3 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~~i~~~~~~~~~~~~~ 81 (302)
T cd07864 3 KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL-NHRNIVNLKEIVTDKQDA 81 (302)
T ss_pred hhhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhC-CCCCeeeeeheecCcchh
Confidence 455689999999999999999999998899999999986432 24567899999999 8999999999886543
Q ss_pred ------CCCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeec
Q 020826 90 ------SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW 160 (321)
Q Consensus 90 ------~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~df 160 (321)
....++++||++++.+.... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+||
T Consensus 82 ~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~-~~kl~df 160 (302)
T cd07864 82 LDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG-QIKLADF 160 (302)
T ss_pred hhccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-cEEeCcc
Confidence 23678999999985544433 3589999999999999999999999999999999999999887 8999999
Q ss_pred cceeecCCCC--ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhh
Q 020826 161 GLAEFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 238 (321)
Q Consensus 161 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (321)
|.+....... ......++..|+|||.+.+....+.++|||||||+++++++|+.||. ..+....+..+.+..+.+..
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~-~~~~~~~~~~~~~~~~~~~~ 239 (302)
T cd07864 161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQ-ANQELAQLELISRLCGSPCP 239 (302)
T ss_pred cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHHHHhCCCCh
Confidence 9987654332 12223456789999988764567899999999999999999998874 44445555555554443332
Q ss_pred hHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 239 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
..+..-.... .+.. ......... ........+++.+.+++.+||+.||++|||+.+++.||||
T Consensus 240 ~~~~~~~~~~---~~~~---~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 240 AVWPDVIKLP---YFNT---MKPKKQYRR-RLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hhcccccccc---cccc---ccccccccc-chhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 2111000000 0000 000000000 0001112356899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=285.58 Aligned_cols=250 Identities=26% Similarity=0.383 Sum_probs=194.1
Q ss_pred ccCceEEeeee--eeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 19 EQDDYEVVRKV--GRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 19 ~~~~y~~~~~l--g~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
..++|++.+.+ |+|+||.||++.++.++..+++|.+........ |+.....+.+|||++++++.+... ...++|
T Consensus 12 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--e~~~~~~~~~h~~iv~~~~~~~~~--~~~~iv 87 (267)
T PHA03390 12 FLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI--EPMVHQLMKDNPNFIKLYYSVTTL--KGHVLI 87 (267)
T ss_pred HHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh--hHHHHHHhhcCCCEEEEEEEEecC--CeeEEE
Confidence 34567777776 999999999999999999999999875432222 333333344799999999998654 367899
Q ss_pred EEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCccc
Q 020826 97 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 173 (321)
Q Consensus 97 ~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~~ 173 (321)
|||+++++|..++. .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++..++|+|||.+...... .
T Consensus 88 ~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---~ 164 (267)
T PHA03390 88 MDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---S 164 (267)
T ss_pred EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---c
Confidence 99999999987762 58999999999999999999999999999999999999977657999999998765322 2
Q ss_pred cccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhh
Q 020826 174 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 253 (321)
Q Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (321)
...++..|+|||++.+ ..++.++|+||+|+++|+|++|..||..................
T Consensus 165 ~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------- 224 (267)
T PHA03390 165 CYDGTLDYFSPEKIKG-HNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQ------------------- 224 (267)
T ss_pred cCCCCCcccChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhc-------------------
Confidence 3457888999999987 67899999999999999999999998532221111111111000
Q ss_pred HhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC-HHHHhcCCCccc
Q 020826 254 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-AKEAMAHPYFFP 310 (321)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps-~~ell~hp~~~~ 310 (321)
........+|+.+.++|.+||+.||++||+ ++++++||||+.
T Consensus 225 ---------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 225 ---------------KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred ---------------ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 000111246789999999999999999996 699999999973
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=283.12 Aligned_cols=249 Identities=30% Similarity=0.505 Sum_probs=204.4
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
+|++.+.||+|++|.||+|.+..+++.+++|++.... .+.+.+|+.+++++ +||||+++++.+.+......+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSL-QHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHc-CCCCEeeEEEEEecCCCCeEEEE
Confidence 5788999999999999999998899999999987554 56788999999999 89999999999866533567899
Q ss_pred EEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc--
Q 020826 97 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-- 171 (321)
Q Consensus 97 ~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~-- 171 (321)
+|++.+++|.+++. .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||.+........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~ 158 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG-VVKLADFGCAKRLGDIETGE 158 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC-CEEEcccccEEecccccccc
Confidence 99999999887773 589999999999999999999999999999999999999877 899999999987655443
Q ss_pred -cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 172 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
.....++..|+|||...+ ...+.++|+||||++++++++|..||....+.......+.. ..
T Consensus 159 ~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~-------------- 220 (260)
T cd06606 159 GTGSVRGTPYWMAPEVIRG-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS---SG-------------- 220 (260)
T ss_pred cccCCCCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc---cC--------------
Confidence 345567888999999877 56899999999999999999999998433311111111100 00
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
.....+..+++.+.+++.+||+.||++|||+.++++||||
T Consensus 221 ------------------~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 221 ------------------EPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred ------------------CCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 0001122346789999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=284.22 Aligned_cols=247 Identities=27% Similarity=0.454 Sum_probs=199.2
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc--------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~--------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
+|+..+.||+|++|+||+|.+..++..+++|.+.... ...+.+|+.+++.+ +|||++++++++.+ ....
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~ 77 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKL-QHPNIVQYLGTERE--EDNL 77 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhc-CCCCchheeeeEec--CCeE
Confidence 4778889999999999999998889999999986432 24678899999999 89999999998854 4566
Q ss_pred EEEEEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 94 SLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
++++||+++++|..++. .+++..+..++.|++.||++||+.|++|+||+|+||+++.++ .++|+|||.+.......
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~-~~kl~d~~~~~~~~~~~ 156 (258)
T cd06632 78 YIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNG-VVKLADFGMAKQVVEFS 156 (258)
T ss_pred EEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEccCccceeccccc
Confidence 79999999999987773 378899999999999999999999999999999999999887 89999999987654443
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
......++..|++||.+.....++.++|+||||+++|++++|..||.... .......+......
T Consensus 157 ~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~-~~~~~~~~~~~~~~--------------- 220 (258)
T cd06632 157 FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE-GVAAVFKIGRSKEL--------------- 220 (258)
T ss_pred cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc-HHHHHHHHHhcccC---------------
Confidence 33455678889999998763338899999999999999999999984322 11111111000000
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
...+..+++++.+++++||+.+|++|||+.+++.|||+
T Consensus 221 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 221 --------------------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred --------------------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 00112356789999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=294.70 Aligned_cols=284 Identities=33% Similarity=0.576 Sum_probs=209.6
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC---
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS--- 90 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~--- 90 (321)
..++|++.+.||+|++|.||++.+..++..||+|.+... ....+.+|+.+++.+ +||||+++++++.....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-KHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCccceeeeecCCccccc
Confidence 467899999999999999999999889999999998532 124577899999999 99999999998864332
Q ss_pred -CCcEEEEEeecCchhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 91 -KTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 91 -~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
...+++++++ ++++..++ ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||++....
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~-~~kl~dfg~~~~~~ 169 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQTD 169 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeecccccccc
Confidence 2357999998 55666665 4689999999999999999999999999999999999999887 79999999987543
Q ss_pred CCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 168 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
. ......++..|+|||.+.+...++.++|+||||++++++++|..||. +.+.......+.+...... ..+......
T Consensus 170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 245 (343)
T cd07880 170 S--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFK-GHDHLDQLMEIMKVTGTPS-KEFVQKLQS 245 (343)
T ss_pred c--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhcCCCC-HHHHHhhcc
Confidence 2 22334567889999998764568899999999999999999999984 3333334444333322221 111111110
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
.....+. ..........+ ......+++++.++|.+||+.||++|||+.+++.||||+.....
T Consensus 246 ~~~~~~~---~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~ 307 (343)
T cd07880 246 EDAKNYV---KKLPRFRKKDF--RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307 (343)
T ss_pred hhHHHHH---HhccccCcchH--HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence 0000000 00000000011 11123567889999999999999999999999999999987554
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=289.24 Aligned_cols=253 Identities=18% Similarity=0.198 Sum_probs=197.4
Q ss_pred EEeeeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeee
Q 020826 10 YWCVWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLD 83 (321)
Q Consensus 10 ~~~~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (321)
....+.|+...=+..-...+|+|+++.||+|.+ +++.||+|+++... .+.+.+|+.++.++ +||||+++++
T Consensus 9 ~~~~~~i~~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g 85 (283)
T PHA02988 9 INDIKCIESDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRI-DSNNILKIYG 85 (283)
T ss_pred cCcceecCHHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhc-CCCCEEEEee
Confidence 344566665544444347899999999999987 78899999987532 24567999999999 8999999999
Q ss_pred eeec--cCCCCcEEEEEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCCeEEcCCCCeEEE
Q 020826 84 IVRD--QQSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRL 157 (321)
Q Consensus 84 ~~~~--~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~-~i~H~dlkp~nili~~~~~~v~l 157 (321)
++.+ ......++++||+.+++|..++. .++......++.|++.||.+||+. +++|+||||+||+++.++ .+||
T Consensus 86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~-~~kl 164 (283)
T PHA02988 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY-KLKI 164 (283)
T ss_pred eEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC-cEEE
Confidence 9876 44456789999999999988873 488889999999999999999984 999999999999999888 8999
Q ss_pred eeccceeecCCCCccccccCCccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCCh
Q 020826 158 IDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD 236 (321)
Q Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (321)
+|||++...... .....++..|+|||++.+. ..++.++|||||||++|+|++|..||. +.+..+....+......
T Consensus 165 ~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~-~~~~~~~~~~i~~~~~~- 240 (283)
T PHA02988 165 ICHGLEKILSSP--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE-NLTTKEIYDLIINKNNS- 240 (283)
T ss_pred cccchHhhhccc--cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhcCCC-
Confidence 999998754322 2235678889999998652 468999999999999999999999994 22222222221110000
Q ss_pred hhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 237 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
...+..+++++.+++.+||+.||++|||++|+++
T Consensus 241 ----------------------------------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 241 ----------------------------------LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred ----------------------------------CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 0011235678999999999999999999999985
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=287.86 Aligned_cols=245 Identities=25% Similarity=0.401 Sum_probs=190.1
Q ss_pred eeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhh--cCCCCeeeeeeeeeccCCCCcEEEEEe
Q 020826 28 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNL--CGGPNIVKLLDIVRDQQSKTPSLIFEH 99 (321)
Q Consensus 28 ~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l--~~h~~i~~~~~~~~~~~~~~~~lv~e~ 99 (321)
.||+|+||.||++.+..++..+++|.+.... .....+|..+++.+ ..||+++.+++.+... ...++||||
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~lv~e~ 78 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP--DKLCFILDL 78 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC--CeEEEEEec
Confidence 3899999999999998899999999886432 12234444444433 2689999999988543 456799999
Q ss_pred ecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCcccccc
Q 020826 100 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 176 (321)
Q Consensus 100 ~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~~~~~ 176 (321)
+.+++|..++ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++...... ......
T Consensus 79 ~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~-~~~l~dfg~~~~~~~~-~~~~~~ 156 (279)
T cd05633 79 MNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKK-KPHASV 156 (279)
T ss_pred CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCC-CEEEccCCcceecccc-CccCcC
Confidence 9999997776 4589999999999999999999999999999999999999887 8999999998654322 223456
Q ss_pred CCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCC-hHHHHHHHHHhCChhhhHHhhhhcccCChhhHh
Q 020826 177 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN-YDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA 255 (321)
Q Consensus 177 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (321)
++..|+|||.......++.++|+||+||++|++++|..||...... ...+..... .
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~---~-------------------- 213 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL---T-------------------- 213 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh---c--------------------
Confidence 8889999999865356889999999999999999999998532221 111111000 0
Q ss_pred hhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc-----CHHHHhcCCCcccCC
Q 020826 256 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIR 312 (321)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp-----s~~ell~hp~~~~~~ 312 (321)
.....+..+++++.++|++||+.||++|+ |++|+++||||++..
T Consensus 214 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~ 262 (279)
T cd05633 214 -------------VNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262 (279)
T ss_pred -------------CCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCC
Confidence 00011224667999999999999999999 699999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=309.04 Aligned_cols=256 Identities=26% Similarity=0.442 Sum_probs=209.0
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc---chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
.+.++|++.||.|+||.||+|..+.++-..|.|++... ....+.-|+++|... +||+|+++++.+...+ .++++
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~C-dHP~ivkLl~ayy~en--kLwil 107 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAEC-DHPVIVKLLSAYYFEN--KLWIL 107 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcC-CChHHHHHHHHHhccC--ceEEE
Confidence 45678899999999999999999888888899988643 345678899999998 8999999999775443 46799
Q ss_pred EEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC-CCCc
Q 020826 97 FEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKE 171 (321)
Q Consensus 97 ~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~-~~~~ 171 (321)
.|+|+||.....+ +.+.+.++..++.|++.||.|||+++|+|||||+.||++..+| .++|+|||.+.... ....
T Consensus 108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldG-dirLADFGVSAKn~~t~qk 186 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDG-DIRLADFGVSAKNKSTRQK 186 (1187)
T ss_pred EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecC-cEeeecccccccchhHHhh
Confidence 9999999876665 6799999999999999999999999999999999999999999 79999999975432 2233
Q ss_pred cccccCCccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 172 YNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
-....||++|+|||+... ..+|++++||||||++|.+|..+..|- ..-+....+..+.+
T Consensus 187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPH-helnpMRVllKiaK---------------- 249 (1187)
T KOG0579|consen 187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPH-HELNPMRVLLKIAK---------------- 249 (1187)
T ss_pred hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCc-cccchHHHHHHHhh----------------
Confidence 466789999999999853 257999999999999999999988664 23333333333322
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
+..-++..+...|..+.+||++||..||..||+++++++||||+.+++.
T Consensus 250 ------------------SePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn 298 (1187)
T KOG0579|consen 250 ------------------SEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN 298 (1187)
T ss_pred ------------------cCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence 1112333455667799999999999999999999999999999987554
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=288.62 Aligned_cols=246 Identities=26% Similarity=0.412 Sum_probs=195.5
Q ss_pred eeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeecC
Q 020826 29 VGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 102 (321)
Q Consensus 29 lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 102 (321)
||+|+||+||+|.+..+++.+++|.+.... ...+..|+.+++.+ +|||++++++.+.. ....++++||+++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKV-SSRFIVSLAYAFET--KDDLCLVMTLMNG 77 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhC-CCCCEeeeeeEEec--CCeEEEEEecCCC
Confidence 689999999999998899999999986422 23456899999999 89999999999854 3467899999999
Q ss_pred chhhhhc---C--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCccccccC
Q 020826 103 TDFKVLY---P--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA 177 (321)
Q Consensus 103 ~~l~~~~---~--~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~~~~~~ 177 (321)
++|..++ . .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||.+.............+
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~ 156 (277)
T cd05577 78 GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHG-NVRISDLGLAVELKGGKKIKGRAG 156 (277)
T ss_pred CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEccCcchhhhccCCccccccC
Confidence 9988765 2 588999999999999999999999999999999999999887 899999998876543333344567
Q ss_pred CccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhh
Q 020826 178 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALV 257 (321)
Q Consensus 178 ~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (321)
+..|+|||.+.+ ..++.++|+||||+++++|++|+.||....... ....+....
T Consensus 157 ~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~------------------------ 210 (277)
T cd05577 157 TPGYMAPEVLQG-EVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKV-EKEELKRRT------------------------ 210 (277)
T ss_pred CCCcCCHHHhcC-CCCCchhhhHHHHHHHHHHhhCCCCCCCCcccc-cHHHHHhcc------------------------
Confidence 778999999877 568999999999999999999999984322210 011110000
Q ss_pred cccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc-----CHHHHhcCCCcccCCC
Q 020826 258 GRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIRN 313 (321)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp-----s~~ell~hp~~~~~~~ 313 (321)
.. .....+..+++.+.++|++||+.||++|| ++.++++||||++++-
T Consensus 211 ---~~------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~ 262 (277)
T cd05577 211 ---LE------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNW 262 (277)
T ss_pred ---cc------ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCCh
Confidence 00 00111223568999999999999999999 8999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=288.80 Aligned_cols=274 Identities=36% Similarity=0.643 Sum_probs=206.4
Q ss_pred eEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 23 y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
|++.+.||+|++|.||+|.+..+++.+++|.++... ...+.+|+.+++.+ +||+++++++++.+. ...++++
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~~v~ 77 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL-NHPNIIKLLDVFRHK--GDLYLVF 77 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHh-cCCCcchHHHhhccC--CCEEEEE
Confidence 567889999999999999998899999999986532 34678899999999 799999999998554 5677999
Q ss_pred EeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-ccc
Q 020826 98 EHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN 173 (321)
Q Consensus 98 e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~-~~~ 173 (321)
||+.+.....+. ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+....... ...
T Consensus 78 e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~df~~~~~~~~~~~~~~ 156 (283)
T cd05118 78 EFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG-VLKLADFGLARSFGSPVRPYT 156 (283)
T ss_pred eccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCC-cEEEeeeeeeEecCCCccccc
Confidence 999875443333 2589999999999999999999999999999999999999877 89999999997765443 233
Q ss_pred cccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhh
Q 020826 174 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 253 (321)
Q Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (321)
...++..|+|||.+.+...++.++|+||||+++|++++|+.|| ++.+..+....+...++......+...........
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 234 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLF-PGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK- 234 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh-
Confidence 3457778999999987447899999999999999999999887 45555555555555544432211111100000000
Q ss_pred HhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 254 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
........... ......+++++.++|.+||+.||.+||++.++++||||
T Consensus 235 ----~~~~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 235 ----FSFPKKAGMPL--PKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred ----hhhccccccCH--HHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 00000000000 11122467899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=284.24 Aligned_cols=251 Identities=22% Similarity=0.377 Sum_probs=194.8
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc---hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
.+.......||+|+||.||+|.+..++..+++|.+.... ...+.+|+.+++.+ +|+||+++++++.. ....+++
T Consensus 7 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv 83 (268)
T cd06624 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYL-KHRNIVQYLGSDSE--NGFFKIF 83 (268)
T ss_pred cccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhc-CCCCeeeeeeeecc--CCEEEEE
Confidence 334444567999999999999998889999999887543 34678999999999 89999999999854 4567899
Q ss_pred EEeecCchhhhhcC----CC--CHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 97 FEHVNNTDFKVLYP----TL--SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 97 ~e~~~~~~l~~~~~----~~--~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
+|++.+++|..++. .+ ++..+..++.|++.||+|||++|++|+||+|+||+++.+...++|+|||.+.......
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 84 MEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred EecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 99999999987763 34 7788889999999999999999999999999999998744489999999987553222
Q ss_pred c-cccccCCccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 171 E-YNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 171 ~-~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
. .....++..|+|||.+... ..++.++|+||||++++++++|..||...............
T Consensus 164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~----------------- 226 (268)
T cd06624 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGM----------------- 226 (268)
T ss_pred CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhh-----------------
Confidence 2 2234577889999998652 34788999999999999999999998432211111110000
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
.. .....+..+++++.+++++||+.+|++|||+.+++.||||
T Consensus 227 -----------~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 227 -----------FK-------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred -----------hc-------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 00 0001122356789999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=299.46 Aligned_cols=245 Identities=21% Similarity=0.325 Sum_probs=188.4
Q ss_pred CceEEeeeeeeecceEEEEEEEe-----cCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
++|++.+.||+|+||+||+|++. .++..||+|+++... ...+.+|+.++..+.+||||+++++++.+. .
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~--~ 112 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG--G 112 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC--C
Confidence 48999999999999999999752 356689999987432 346788999999997899999999998554 4
Q ss_pred CcEEEEEeecCchhhhhcC-------------------------------------------------------------
Q 020826 92 TPSLIFEHVNNTDFKVLYP------------------------------------------------------------- 110 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~~------------------------------------------------------------- 110 (321)
..++||||+.+++|..++.
T Consensus 113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (375)
T cd05104 113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG 192 (375)
T ss_pred cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence 5679999999998865552
Q ss_pred -----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCcc-
Q 020826 111 -----------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY- 172 (321)
Q Consensus 111 -----------------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~- 172 (321)
.+++..+..++.||+.||+|||++|++|+||||+||+++.++ .++|+|||++.........
T Consensus 193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR-ITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC-cEEEecCccceeccCccccc
Confidence 256777889999999999999999999999999999999776 8999999998765432221
Q ss_pred --ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 173 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 173 --~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||............+...
T Consensus 272 ~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~----------------- 333 (375)
T cd05104 272 VKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG----------------- 333 (375)
T ss_pred ccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhC-----------------
Confidence 11233456999999987 788999999999999999998 777773222211111111000
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
. ....+...++++.+++.+||+.||++|||+.++++.
T Consensus 334 -----------~--------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 334 -----------Y--------RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred -----------c--------cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 0 000112345689999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=300.08 Aligned_cols=245 Identities=23% Similarity=0.326 Sum_probs=189.9
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCC-----ceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDN-----EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~-----~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
.++|++.+.||+|+||.||+|++...+ ..||+|.++... ...+.+|+.+++.+.+||||+++++.+...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~-- 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG-- 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC--
Confidence 568999999999999999999875443 479999986432 345788999999987899999999998554
Q ss_pred CCcEEEEEeecCchhhhhcC------------------------------------------------------------
Q 020826 91 KTPSLIFEHVNNTDFKVLYP------------------------------------------------------------ 110 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------ 110 (321)
...+++|||+.+++|.+++.
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 45679999999998876541
Q ss_pred -------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCcc---cc
Q 020826 111 -------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NV 174 (321)
Q Consensus 111 -------------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~---~~ 174 (321)
++++..+.+++.||+.||+|||++|++|+||||+||+++.++ .++|+|||++......... ..
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~-~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGR-VAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCC-eEEEeeceeeeeccCCcceeeccC
Confidence 256778899999999999999999999999999999999777 8999999998765332221 11
Q ss_pred ccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhh
Q 020826 175 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 253 (321)
Q Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (321)
..++..|+|||++.+ ..++.++|||||||++|+|++ |..||....... ..........
T Consensus 274 ~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~~------------------- 332 (374)
T cd05106 274 ARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRGY------------------- 332 (374)
T ss_pred CCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHccc-------------------
Confidence 234457999999876 678999999999999999997 998884322211 1111111000
Q ss_pred HhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 254 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
....+..+++++.+++.+||+.||++|||+.++++
T Consensus 333 ----------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 333 ----------------QMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred ----------------CccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00011235679999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=293.17 Aligned_cols=255 Identities=21% Similarity=0.398 Sum_probs=203.6
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc---hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
+.|.....||+|+||.||++.+..++..+++|.+.... ...+.+|+..++.+ +|||++++++.+.. ....++++
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~ii~~~~~~~~--~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDY-HHENVVDMYNSYLV--GDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhC-CCCcHHHHHHheec--CCeEEEEE
Confidence 45666778999999999999998899999999986432 34577899999999 89999999998854 45678999
Q ss_pred EeecCchhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-cccc
Q 020826 98 EHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNV 174 (321)
Q Consensus 98 e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~-~~~~ 174 (321)
||+++++|..++ ..+++..+..++.||+.||+|||++|++|+||+|+||+++.++ .++|+|||++....... ....
T Consensus 99 e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kL~dfg~~~~~~~~~~~~~~ 177 (292)
T cd06658 99 EFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKS 177 (292)
T ss_pred eCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CEEEccCcchhhcccccccCce
Confidence 999999998776 4588999999999999999999999999999999999999887 89999999886543221 2233
Q ss_pred ccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhH
Q 020826 175 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLA 254 (321)
Q Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (321)
..++..|+|||.+.+ ..++.++|+||||++++++++|+.||.. .+.......+.......
T Consensus 178 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~-~~~~~~~~~~~~~~~~~------------------ 237 (292)
T cd06658 178 LVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFN-EPPLQAMRRIRDNLPPR------------------ 237 (292)
T ss_pred eecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhcCCCc------------------
Confidence 467888999999876 6788999999999999999999999842 22222221111100000
Q ss_pred hhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 255 ALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
.......++.+.+++.+||+.||++|||++++++||||+....++
T Consensus 238 ----------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~~ 282 (292)
T cd06658 238 ----------------VKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPPS 282 (292)
T ss_pred ----------------cccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCcc
Confidence 000113557899999999999999999999999999999886665
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=287.38 Aligned_cols=272 Identities=33% Similarity=0.627 Sum_probs=202.4
Q ss_pred eEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 23 y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
|++.+.||.|++|+||+|.+..++..+++|++.... ...+.+|++.++.+ +|||++++++++.+ ....++++
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~iv~~~~~~~~--~~~~~iv~ 77 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKEL-NHPNIVRLLDVVHS--ENKLYLVF 77 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhc-CCCCccCHhheecc--CCeEEEEE
Confidence 678899999999999999998899999999986432 24577899999999 89999999999854 45678999
Q ss_pred EeecCchhhhhc---C--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC-Cc
Q 020826 98 EHVNNTDFKVLY---P--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KE 171 (321)
Q Consensus 98 e~~~~~~l~~~~---~--~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~-~~ 171 (321)
||+++ ++..++ . .+++..+..++.|++.||+|||+++++|+||+|+||+++.++ .++|+|||.+...... ..
T Consensus 78 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 78 EFLDL-DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG-ALKLADFGLARAFGVPVRT 155 (283)
T ss_pred eccCc-CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC-cEEEeecccccccCCCccc
Confidence 99964 565554 2 478999999999999999999999999999999999999877 8999999998654322 12
Q ss_pred cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCCh
Q 020826 172 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (321)
.....++..|+|||++.+...++.++|+||||+++|+|++|..||. ..+....+..+.+..+.+....+.... ..+
T Consensus 156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~ 231 (283)
T cd07835 156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFP-GDSEIDQLFRIFRTLGTPDEDVWPGVT---SLP 231 (283)
T ss_pred cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHhCCCChHHhhhhh---hch
Confidence 2334567789999988764567899999999999999999998884 334444444444444333221110000 000
Q ss_pred hhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 252 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
.+... .... ...........+++++.++|.+||+.||++|||++|++.||||
T Consensus 232 ~~~~~---~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 232 DYKPT---FPKW--ARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred hhhhh---cccc--cccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 00000 0000 0000011123466789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=293.31 Aligned_cols=257 Identities=22% Similarity=0.384 Sum_probs=198.2
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
++|+..+.||+|+||.||++.+..++..+++|.+... ....+.+|+..+.++.+||||+++++++... ...+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~--~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE--GDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC--CcEEEE
Confidence 5677888999999999999999999999999998643 2346788999999985699999999988653 455699
Q ss_pred EEeecCc--hhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 97 FEHVNNT--DFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 97 ~e~~~~~--~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~-~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
+|++... ++...+ ..+++..+..++.|++.||+|||+. +++|+||||+||+++.++ .++|+|||++.....
T Consensus 82 ~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG-NIKLCDFGISGQLVD 160 (288)
T ss_pred EecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC-cEEEeecchhHHhcc
Confidence 9998753 222221 4589999999999999999999975 999999999999999877 899999999865543
Q ss_pred CCccccccCCccccccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhc
Q 020826 169 GKEYNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246 (321)
Q Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (321)
........++..|+|||.+.+. ..++.++||||||+++|++++|+.||..... ....+.+......
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~---~~~~~~~~~~~~~--------- 228 (288)
T cd06616 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS---VFDQLTQVVKGDP--------- 228 (288)
T ss_pred CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch---HHHHHhhhcCCCC---------
Confidence 3333445678889999998763 3688999999999999999999999842221 1111111110000
Q ss_pred ccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
+ . ........+++++.+|+++||+.||++|||++++++||||++..
T Consensus 229 -----------------~-~--~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 229 -----------------P-I--LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred -----------------C-c--CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 0 0 00001123667899999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=281.45 Aligned_cols=245 Identities=25% Similarity=0.459 Sum_probs=200.3
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
+|++.+.||.|+||.||.+++..++..+++|.+... ....+.+|+++++++ +|+||+++++++.+ ...++++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~~~ 77 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLL-QHPNIIAYYNHFMD--DNTLLIE 77 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhC-CCCCeeEEEeEEec--CCeEEEE
Confidence 589999999999999999999999999999987532 234578999999999 99999999999965 4567899
Q ss_pred EEeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-
Q 020826 97 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 170 (321)
Q Consensus 97 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~- 170 (321)
+||+.+++|.+++. .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~-~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 78 MEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAG-LIKLGDFGISKILGSEYS 156 (256)
T ss_pred EEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCC-CEEECcCcceEEcccccc
Confidence 99999999887773 378899999999999999999999999999999999999887 89999999987654333
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
......++..|.|||...+ ..++.++|+||||+++++|++|..||.. ....+....+.. +.
T Consensus 157 ~~~~~~~~~~y~ape~~~~-~~~~~~~Dv~slG~i~~~l~~g~~~~~~-~~~~~~~~~~~~--~~--------------- 217 (256)
T cd08221 157 MAETVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLTLKRTFDA-TNPLNLVVKIVQ--GN--------------- 217 (256)
T ss_pred cccccCCCccccCHhhcCC-CCCCCcchhHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHc--CC---------------
Confidence 2334567889999999887 5688999999999999999999998832 222222222111 00
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
. ......++.++.+++.+||+.||.+|||+.++++|||+
T Consensus 218 -----------~--------~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 218 -----------Y--------TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred -----------C--------CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 0 00012356789999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=300.53 Aligned_cols=258 Identities=22% Similarity=0.399 Sum_probs=219.0
Q ss_pred eeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccC
Q 020826 15 FINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 89 (321)
Q Consensus 15 ~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (321)
-.......|.+...||+|.|++|.++++..++..||+|.+.+.. ...+.+|+++|+.| +||||++++.+...
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l-~HPnIvkl~~v~~t-- 126 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSL-NHPNIVKLFSVIET-- 126 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhc-CCcceeeeeeeeee--
Confidence 44566778999999999999999999999999999999987543 34478999999999 99999999999844
Q ss_pred CCCcEEEEEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeec
Q 020826 90 SKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 166 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~ 166 (321)
...+++||||+.++.+.+++. .+.+..+..++.|+..|++|||+++|+|+|||++|++++.+. ++||+|||++..+
T Consensus 127 ~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~m-nikIaDfgfS~~~ 205 (596)
T KOG0586|consen 127 EATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENM-NIKIADFGFSTFF 205 (596)
T ss_pred cceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccccccc-ceeeeccccceee
Confidence 456779999999999988883 477899999999999999999999999999999999999887 8999999999999
Q ss_pred CCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhc
Q 020826 167 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246 (321)
Q Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (321)
..+....+.+|++.|.|||++.+..+..+++|+||+|+++|-++.|.+||.... .. .+..
T Consensus 206 ~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~-lk-~Lr~------------------ 265 (596)
T KOG0586|consen 206 DYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN-LK-ELRP------------------ 265 (596)
T ss_pred cccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc-cc-cccc------------------
Confidence 888888999999999999999997888899999999999999999999993211 10 0000
Q ss_pred ccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
....-....+-.+|.++.++|+++|-.+|.+|++.++++.|+|.+...+.
T Consensus 266 ------------------rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 266 ------------------RVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred ------------------hheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 00001111222466799999999999999999999999999999976554
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=302.64 Aligned_cols=250 Identities=16% Similarity=0.325 Sum_probs=198.9
Q ss_pred eeeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeee
Q 020826 12 CVWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVR 86 (321)
Q Consensus 12 ~~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (321)
..|+|+ .+++.+...||+|.||+||+|++. -.||||+++.+. .+.|++|+..+++. .|-||+-+.+++.
T Consensus 385 ~~WeIp--~~ev~l~~rIGsGsFGtV~Rg~wh---GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkT-RH~NIlLFMG~~~ 458 (678)
T KOG0193|consen 385 EEWEIP--PEEVLLGERIGSGSFGTVYRGRWH---GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKT-RHENILLFMGACM 458 (678)
T ss_pred cccccC--HHHhhccceeccccccceeecccc---cceEEEEEecCCCCHHHHHHHHHHHHHHhhc-chhhheeeehhhc
Confidence 578887 558899999999999999999983 469999987543 46789999999999 9999999999995
Q ss_pred ccCCCCcEEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccc
Q 020826 87 DQQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 162 (321)
Q Consensus 87 ~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~ 162 (321)
.+ .+ .||+.+|+|.+|..++. +|.+...+.|+.||++||.|||.++|+|+|||..|||+..++ +|||+|||+
T Consensus 459 ~p--~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~-kVkIgDFGL 534 (678)
T KOG0193|consen 459 NP--PL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDL-KVKIGDFGL 534 (678)
T ss_pred CC--ce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCC-cEEEecccc
Confidence 43 33 89999999999988883 589999999999999999999999999999999999999777 899999999
Q ss_pred eeec---CCCCccccccCCccccccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChh
Q 020826 163 AEFY---HPGKEYNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 237 (321)
Q Consensus 163 ~~~~---~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (321)
+..- .-........+...|+|||++... .++++.+||||||+++|||++|..||. ......++..+......++
T Consensus 535 atvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dqIifmVGrG~l~pd 613 (678)
T KOG0193|consen 535 ATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQIIFMVGRGYLMPD 613 (678)
T ss_pred eeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhheEEEecccccCcc
Confidence 8542 212223444567789999998642 468999999999999999999999994 3332222332221111111
Q ss_pred hhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 238 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
.......++.++++|+..||.+++++||++.+||.
T Consensus 614 --------------------------------~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 614 --------------------------------LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred --------------------------------chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 11122345569999999999999999999988876
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=309.81 Aligned_cols=248 Identities=20% Similarity=0.308 Sum_probs=194.7
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc---hHHHHHHHHHHHhhcCCCCeeeeee-eeec---cC
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLD-IVRD---QQ 89 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~-~~~~---~~ 89 (321)
.....++++.+.|.+|||+.||.|.+.+.+..||+|.+-..+ ...+.+|+++|+.|.+|+|||.+++ .... .+
T Consensus 33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 334679999999999999999999998888999999864333 3567899999999988999999999 3321 22
Q ss_pred -CCCcEEEEEeecCchhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC--CeeecCCCCCeEEcCCCCeEEEeecc
Q 020826 90 -SKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWG 161 (321)
Q Consensus 90 -~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~~--i~H~dlkp~nili~~~~~~v~l~dfg 161 (321)
.....|+||||.|+.|-+++ ..|++.++.+|+.++++|+++||... |+|||||.+|||++.++ ..||||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g-~~KLCDFG 191 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG-NYKLCDFG 191 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC-CEEeCccc
Confidence 24467999999988877766 35999999999999999999999998 99999999999999888 89999999
Q ss_pred ceeecCCCC-c---------cccccCCcccccccccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHH
Q 020826 162 LAEFYHPGK-E---------YNVRVASRYFKGPELLV--DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 229 (321)
Q Consensus 162 ~~~~~~~~~-~---------~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 229 (321)
.++-..... . ......|+.|+|||.+. .+..+++++|||+|||+||.|+....||..+... .++.
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l-aIln-- 268 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL-AILN-- 268 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce-eEEe--
Confidence 985432221 1 12245788999999972 2267899999999999999999999999322110 0000
Q ss_pred HHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 230 AKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
. . -.+......|+.+.+||+.||+.||.+||++.+++.+
T Consensus 269 -g---~---------------------------------Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 269 -G---N---------------------------------YSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred -c---c---------------------------------ccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 0 0 0011112456789999999999999999999988865
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=284.41 Aligned_cols=251 Identities=25% Similarity=0.481 Sum_probs=196.1
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-------------hHHHHHHHHHHHhhcCCCCeeeeeeeeecc
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-------------KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 88 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-------------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (321)
+|.+.+.||+|++|.||+|.+..+++.+++|.++... .+.+..|+.+++.+ +|||++++++++..
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~- 79 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL-DHLNIVQYLGFETT- 79 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhc-CCCCcceEEEEecc-
Confidence 6888999999999999999998899999999875311 13467899999999 89999999998854
Q ss_pred CCCCcEEEEEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 89 QSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 89 ~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
....++|+||+.+++|..++. .++...+..++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||++..
T Consensus 80 -~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~-~~~l~d~~~~~~ 157 (272)
T cd06629 80 -EEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADG-ICKISDFGISKK 157 (272)
T ss_pred -CCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCC-eEEEeecccccc
Confidence 456679999999999987763 488899999999999999999999999999999999999887 899999999875
Q ss_pred cCCCC---ccccccCCccccccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHH
Q 020826 166 YHPGK---EYNVRVASRYFKGPELLVDLQ-DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY 241 (321)
Q Consensus 166 ~~~~~---~~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (321)
..... ......++..|+|||.+.... .++.++|+||||++++++++|..||. ..........+.. .
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~-~~~~~~~~~~~~~---~------ 227 (272)
T cd06629 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWS-DEEAIAAMFKLGN---K------ 227 (272)
T ss_pred ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCc-CcchHHHHHHhhc---c------
Confidence 43221 122345778899999987633 47899999999999999999999983 2211111111000 0
Q ss_pred hhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 242 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
..... ........++.++.+++.+||+.+|++|||++++++||||
T Consensus 228 ------------------~~~~~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 228 ------------------RSAPP----IPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred ------------------ccCCc----CCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 00000 0001112356799999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=285.18 Aligned_cols=274 Identities=31% Similarity=0.552 Sum_probs=206.9
Q ss_pred eEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEE
Q 020826 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 98 (321)
Q Consensus 23 y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 98 (321)
|++.+.||+|++|+||+|++..+++.+++|.+.... .....+|+..+.++.+|||++++++++.+ ....++++|
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~--~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE--NDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc--CCcEEEEEe
Confidence 678899999999999999998889999999986432 23456789999999449999999999865 456789999
Q ss_pred eecCchhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCccc
Q 020826 99 HVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 173 (321)
Q Consensus 99 ~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~~ 173 (321)
++. +++...+ ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.++ .++|+|||.+..........
T Consensus 79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~ 156 (283)
T cd07830 79 YME-GNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYT 156 (283)
T ss_pred cCC-CCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC-CEEEeecccceeccCCCCcC
Confidence 994 5554433 2478999999999999999999999999999999999999877 89999999998765544445
Q ss_pred cccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhh
Q 020826 174 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 253 (321)
Q Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (321)
...++..|+|||.+.+...++.++|+||||++++++++|+.|| +.....+....+...++......+...........
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 234 (283)
T cd07830 157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLF-PGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG- 234 (283)
T ss_pred CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCcc-CCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc-
Confidence 5667888999999866567889999999999999999999777 55555666666666666554333222111110000
Q ss_pred HhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 254 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
............. .....++.+.++|++||+.||++|||+.|++.||||
T Consensus 235 -----~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 -----FRFPQFAPTSLHQ-LIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred -----ccccccccccHHH-HcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 0000000000000 011225789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=287.13 Aligned_cols=255 Identities=24% Similarity=0.415 Sum_probs=203.1
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc----chHHHHHHHHHHHhhc--CCCCeeeeeeeeeccCCCCcEE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLC--GGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~----~~~~~~~E~~~l~~l~--~h~~i~~~~~~~~~~~~~~~~l 95 (321)
.|++.+.||+|+||.||+|.+..+++.+++|.++.. ....+.+|+.+++.+. .|||++++++++.+ ....++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~--~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK--GPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee--CCEEEE
Confidence 478889999999999999999889999999998643 2356788999999984 49999999998854 456789
Q ss_pred EEEeecCchhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc-c
Q 020826 96 IFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-Y 172 (321)
Q Consensus 96 v~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~-~ 172 (321)
++||+.+++|..++. .+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+........ .
T Consensus 80 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06917 80 IMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG-NVKLCDFGVAALLNQNSSKR 158 (277)
T ss_pred EEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC-CEEEccCCceeecCCCcccc
Confidence 999999999887763 578899999999999999999999999999999999999877 899999999877654332 2
Q ss_pred ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChh
Q 020826 173 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 252 (321)
Q Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (321)
....++..|+|||.+.+...++.++|+||||+++|+|++|..||.... ....... ...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~-~~~~~~~----~~~----------------- 216 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD-AFRAMML----IPK----------------- 216 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC-hhhhhhc----ccc-----------------
Confidence 334678889999998765667899999999999999999999983211 1000000 000
Q ss_pred hHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 253 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
..+.. . .....++++.+++.+||+.||++|||+.++++||||++....+
T Consensus 217 ---------~~~~~----~-~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~~~ 265 (277)
T cd06917 217 ---------SKPPR----L-EDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSKTP 265 (277)
T ss_pred ---------CCCCC----C-CcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccccCc
Confidence 00000 0 0012557899999999999999999999999999999876544
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=286.73 Aligned_cols=251 Identities=25% Similarity=0.404 Sum_probs=202.3
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
..|+..+.||.|+||.||+|.+..++..+++|.++... ...+.+|+.+++.+ .|||++++++.+.+ ....++|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 80 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLK--GTKLWII 80 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEE--CCEEEEE
Confidence 46888899999999999999998889999999986432 34578899999999 89999999999865 4567899
Q ss_pred EEeecCchhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc-cc
Q 020826 97 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YN 173 (321)
Q Consensus 97 ~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~-~~ 173 (321)
+||+.+++|.+++. ++++..+..++.|++.||++||+.+++|+||+|+||+++.++ .++++|||++........ ..
T Consensus 81 ~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06640 81 MEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred EecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCC-CEEEcccccceeccCCccccc
Confidence 99999999887774 488889999999999999999999999999999999999887 899999999876543322 22
Q ss_pred cccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhh
Q 020826 174 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 253 (321)
Q Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (321)
...++..|+|||++.+ ..++.++|+|||||++|+|++|..||... ........+ ....
T Consensus 160 ~~~~~~~y~apE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~-~~~~~~~~~-~~~~------------------- 217 (277)
T cd06640 160 TFVGTPFWMAPEVIQQ-SAYDSKADIWSLGITAIELAKGEPPNSDM-HPMRVLFLI-PKNN------------------- 217 (277)
T ss_pred cccCcccccCHhHhcc-CCCccHHHHHHHHHHHHHHHHCCCCCCCc-ChHhHhhhh-hcCC-------------------
Confidence 3456778999999877 67899999999999999999999998422 111111110 0000
Q ss_pred HhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCC
Q 020826 254 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~ 313 (321)
+ ......++.++.+++.+||+.+|++||++.++++||||.+...
T Consensus 218 ----------~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 218 ----------P------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred ----------C------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcch
Confidence 0 0011124568999999999999999999999999999988754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=290.12 Aligned_cols=260 Identities=25% Similarity=0.442 Sum_probs=207.5
Q ss_pred eeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc---chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 15 FINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 15 ~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
-++...++|++.+.||+|+||.||++.+..++..+++|.+... ....+.+|+.+++.+ +|||++++++.+.+. .
T Consensus 13 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~~--~ 89 (293)
T cd06647 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN-KHPNIVNYLDSYLVG--D 89 (293)
T ss_pred eccCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhc-CCCCeeehhheeeeC--C
Confidence 3455678999999999999999999999888999999998643 235678899999999 899999999998654 4
Q ss_pred CcEEEEEeecCchhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 92 TPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
..++|+||+.+++|..++. .++...+..++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||++......
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~-~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 90 ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPE 168 (293)
T ss_pred cEEEEEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCC-CEEEccCcceeccccc
Confidence 5679999999999988874 478999999999999999999999999999999999999877 8999999988655433
Q ss_pred Cc-cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 170 KE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
.. .....++..|+|||.+.. ..++.++|+||||+++|++++|..||.... ....+..+.. .+
T Consensus 169 ~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~-~~~~~~~~~~-~~-------------- 231 (293)
T cd06647 169 QSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNEN-PLRALYLIAT-NG-------------- 231 (293)
T ss_pred ccccccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hhhheeehhc-CC--------------
Confidence 22 233457788999999876 678899999999999999999999984222 1111110000 00
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
.+ .......+++.+.+++++||+.+|++||++.+++.||||+.....
T Consensus 232 --------------~~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~ 278 (293)
T cd06647 232 --------------TP-----ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPL 278 (293)
T ss_pred --------------CC-----CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCccc
Confidence 00 001122355789999999999999999999999999999976533
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=287.94 Aligned_cols=284 Identities=32% Similarity=0.573 Sum_probs=210.3
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
..++|++.+.||.|+||.||+|.+..+++.+++|.+... ....+..|+.+++.+ +|||++++.+++.... ...
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~-~~~ 85 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHL-RHENIISLSDIFISPL-EDI 85 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhc-CCCCeeeEeeeEecCC-CcE
Confidence 467899999999999999999999999999999987532 235678899999999 8999999999885432 356
Q ss_pred EEEEEeecCchhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc
Q 020826 94 SLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 171 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~ 171 (321)
++++|++++ +|..++ ..+++..+..++.|++.||++||+.|++|+||+|.||+++.++ .++|+|||.+..... .
T Consensus 86 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~-~~~l~dfg~~~~~~~--~ 161 (328)
T cd07856 86 YFVTELLGT-DLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC-DLKICDFGLARIQDP--Q 161 (328)
T ss_pred EEEeehhcc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCC-CEEeCccccccccCC--C
Confidence 799999864 566665 3578888999999999999999999999999999999999877 899999999875432 2
Q ss_pred cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCCh
Q 020826 172 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (321)
.....++..|+|||.+.+...++.++|+||||+++|++++|..||. ..+.......+.+.++.+... +..........
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~-~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 239 (328)
T cd07856 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFP-GKDHVNQFSIITDLLGTPPDD-VINTICSENTL 239 (328)
T ss_pred cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHHhCCCCHH-HHHhccchhhH
Confidence 2334567789999988664578999999999999999999998883 433334444444444443211 11110000000
Q ss_pred hhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 252 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
.+..........+. ......+++++.++|++||+.+|++|||+++++.||||.+...+.
T Consensus 240 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~ 298 (328)
T cd07856 240 RFVQSLPKREPVPF-----SEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPT 298 (328)
T ss_pred HHHhhccccCCCcH-----HHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCc
Confidence 00000000000000 011124567899999999999999999999999999998876654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=281.65 Aligned_cols=249 Identities=28% Similarity=0.505 Sum_probs=199.3
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
+|++.+.||+|++|.||+|.+..++..+++|.++... ...+..|+++++.+ +|+||+++++...+ ....+++
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~lv 77 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELL-KHPNLVKYYGVEVH--REKVYIF 77 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhC-CCCChhheeeeEec--CCEEEEE
Confidence 6899999999999999999998889999999987542 35688999999999 99999999998744 4566799
Q ss_pred EEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCcc-
Q 020826 97 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY- 172 (321)
Q Consensus 97 ~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~- 172 (321)
+||+.+++|.+++. .+++..+..++.|++.||++||+.|++|+||+|+||+++.++ .++|+|||.+.........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~-~~kl~d~g~~~~~~~~~~~~ 156 (264)
T cd06626 78 MEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKLKNNTTTM 156 (264)
T ss_pred EecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEcccccccccCCCCCcc
Confidence 99999999988873 378899999999999999999999999999999999999877 8999999998765432221
Q ss_pred ----ccccCCccccccccccCCC--CCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhc
Q 020826 173 ----NVRVASRYFKGPELLVDLQ--DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246 (321)
Q Consensus 173 ----~~~~~~~~y~aPE~~~~~~--~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (321)
....++..|+|||.+.+.. ..+.++||||||++++++++|..||............+.. +..
T Consensus 157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~--~~~---------- 224 (264)
T cd06626 157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA--GHK---------- 224 (264)
T ss_pred cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc--CCC----------
Confidence 1245677899999987632 2789999999999999999999998433222222211111 000
Q ss_pred ccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
........+++.+.+++++||+.+|++|||+.+++.|||+
T Consensus 225 ----------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 225 ----------------------PPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred ----------------------CCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0000111246789999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=281.77 Aligned_cols=250 Identities=26% Similarity=0.444 Sum_probs=211.0
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
-++|+.++.||+|.||+|.+++.+.+++.||+|++++. +......|-.+|++. .||.+..+.-.| +....+
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~-~HPFLt~LKYsF--Qt~drl 243 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNC-RHPFLTSLKYSF--QTQDRL 243 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhc-cCcHHHHhhhhh--ccCceE
Confidence 46889999999999999999999999999999998753 345567788899987 899999888777 445678
Q ss_pred EEEEEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC-CC
Q 020826 94 SLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PG 169 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~-~~ 169 (321)
|+||||++||.|..++. -+++..++-+...|+.||.|||+++||+||+|.+|.++|.+| .+||+|||+++... .+
T Consensus 244 CFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDG-HIKitDFGLCKE~I~~g 322 (516)
T KOG0690|consen 244 CFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDG-HIKITDFGLCKEEIKYG 322 (516)
T ss_pred EEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCC-ceEeeecccchhccccc
Confidence 89999999999877664 499999999999999999999999999999999999999999 89999999997543 34
Q ss_pred CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 170 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
....+.+||+.|+|||++.. .+|..+.|-|.+|+++|||++|+.||+....+ .+.+++-.
T Consensus 323 ~t~kTFCGTPEYLAPEVleD-nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~--kLFeLIl~----------------- 382 (516)
T KOG0690|consen 323 DTTKTFCGTPEYLAPEVLED-NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE--KLFELILM----------------- 382 (516)
T ss_pred ceeccccCChhhcCchhhcc-ccccceeehhhhhHHHHHHHhccCcccccchh--HHHHHHHh-----------------
Confidence 55677899999999999987 89999999999999999999999999643332 22222110
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc-----CHHHHhcCCCcccCC
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIR 312 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp-----s~~ell~hp~~~~~~ 312 (321)
+.+.-+..+|++...|+..+|..||.+|. .+.|+.+|+||..++
T Consensus 383 -------------------ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~ 431 (516)
T KOG0690|consen 383 -------------------EDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVD 431 (516)
T ss_pred -------------------hhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence 11223346889999999999999999996 488999999999764
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=288.22 Aligned_cols=249 Identities=18% Similarity=0.321 Sum_probs=188.6
Q ss_pred cCceEEeeeeeeecceEEEEEEEec----------------CCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCee
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCT----------------DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIV 79 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~----------------~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~ 79 (321)
.++|++.+.||+|+||.||+|.+.. ++..||+|+++... ...+.+|+.++..+ +||||+
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv 82 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRL-KDPNII 82 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhc-CCCCee
Confidence 5689999999999999999998632 33479999987532 34688999999999 999999
Q ss_pred eeeeeeeccCCCCcEEEEEeecCchhhhhcC----------------------CCCHHHHHHHHHHHHHHHHHHHHCCCe
Q 020826 80 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----------------------TLSDYDVRYYIYELLKALDYCHSQGIM 137 (321)
Q Consensus 80 ~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----------------------~~~~~~~~~i~~qi~~~l~~lh~~~i~ 137 (321)
++++++.+. ...++++||+.+++|..++. .++...+..++.|++.||.|||+.|++
T Consensus 83 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 83 RLLGVCVDE--DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred EEEEEEecC--CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 999998654 45689999999999877652 256678899999999999999999999
Q ss_pred eecCCCCCeEEcCCCCeEEEeeccceeecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh--C
Q 020826 138 HRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF--R 212 (321)
Q Consensus 138 H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~--g 212 (321)
|+||||+||+++.++ .++|+|||++........ .....++..|+|||++.+ ..++.++||||||+++|+|++ +
T Consensus 161 H~dlkp~Nill~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~ 238 (304)
T cd05096 161 HRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVTLWEILMLCK 238 (304)
T ss_pred ccCcchhheEEcCCc-cEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHHHHHHHHccC
Confidence 999999999999887 899999999876543322 122334678999999877 678999999999999999987 4
Q ss_pred CCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccC
Q 020826 213 KEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYD 292 (321)
Q Consensus 213 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~d 292 (321)
..||. ..+................. ......+..+++.+.+++.+||+.|
T Consensus 239 ~~p~~-~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~li~~cl~~~ 288 (304)
T cd05096 239 EQPYG-ELTDEQVIENAGEFFRDQGR-----------------------------QVYLFRPPPCPQGLYELMLQCWSRD 288 (304)
T ss_pred CCCCC-cCCHHHHHHHHHHHhhhccc-----------------------------cccccCCCCCCHHHHHHHHHHccCC
Confidence 45653 22222222221111100000 0000112245678999999999999
Q ss_pred CCCCcCHHHHh
Q 020826 293 HQERPTAKEAM 303 (321)
Q Consensus 293 p~~Rps~~ell 303 (321)
|++|||+.++.
T Consensus 289 p~~RPs~~~i~ 299 (304)
T cd05096 289 CRERPSFSDIH 299 (304)
T ss_pred chhCcCHHHHH
Confidence 99999999984
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=289.18 Aligned_cols=284 Identities=31% Similarity=0.536 Sum_probs=210.2
Q ss_pred ceEEeeeeeeecceEEEEEEEecC--CceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeec--cCCCC
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTD--NEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRD--QQSKT 92 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~--~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~ 92 (321)
+|++.+.||+|+||.||++.+..+ +..+|+|.+... ....+.+|+.+++++.+||||+++++.... .....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 588999999999999999999877 889999998642 134577899999999779999999986532 22345
Q ss_pred cEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 93 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
.+++++++++ +|...+ ..+++..++.++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||.+......
T Consensus 81 ~~~~~e~~~~-~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~-~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 81 LYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADC-ELKICDFGLARGFSEN 158 (332)
T ss_pred EEEEEecccC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCC-CEEeCcCCCceecccc
Confidence 6788888875 454444 4589999999999999999999999999999999999999887 7999999998765432
Q ss_pred Cc-----cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhh
Q 020826 170 KE-----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244 (321)
Q Consensus 170 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (321)
.. .....++..|+|||...+...++.++|+||+|+++|++++|..|| .+.+....+..+...++.+.......-
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVF-KGKDYVDQLNQILQVLGTPDEETLSRI 237 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCC-CCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence 21 123467888999998876457889999999999999999999877 455555667777776665443221111
Q ss_pred hcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
. .+............+...+.. .....++++.+++.+||+.||++|||+.+++.||||+.+..+
T Consensus 238 ~----~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~ 301 (332)
T cd07857 238 G----SPKAQNYIRSLPNIPKKPFES--IFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDP 301 (332)
T ss_pred h----hhhHHHHHHhccccCCcchHh--hCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCc
Confidence 0 000011111101111111111 112346789999999999999999999999999999877544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=282.29 Aligned_cols=246 Identities=22% Similarity=0.450 Sum_probs=198.9
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
+|++.+.||+|+||.||++.+..++..+++|.+... ....+.+|+.+++.+ +|+|++++++.+.+ ....+++
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~-~h~~i~~~~~~~~~--~~~~~lv 77 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKM-KHPNIVTFFASFQE--NGRLFIV 77 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhC-CCCChhhhhheecc--CCeEEEE
Confidence 588999999999999999999999999999998643 345678999999999 89999999998854 4567899
Q ss_pred EEeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc
Q 020826 97 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 171 (321)
Q Consensus 97 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~ 171 (321)
+||+.+++|..++. .+++..+..++.|++.||.|||+.+++|+||+|+||+++.++..++++|||.+........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~ 157 (257)
T cd08225 78 MEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME 157 (257)
T ss_pred EecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence 99999999877763 3688899999999999999999999999999999999998765689999999876543322
Q ss_pred -cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 172 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
.....++..|+|||.+.+ ..++.++|+||||++++++++|..||... +..+....+.. ..
T Consensus 158 ~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~---~~-------------- 218 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQN-RPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLHQLVLKICQ---GY-------------- 218 (257)
T ss_pred cccccCCCccccCHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHhc---cc--------------
Confidence 223457888999999876 67889999999999999999999998422 21111111100 00
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
. ......++.++.+++.+||+.+|++|||+.++++||||
T Consensus 219 -----------~--------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 219 -----------F--------APISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred -----------C--------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 0 00112355789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=284.33 Aligned_cols=252 Identities=25% Similarity=0.406 Sum_probs=201.9
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
+-|++.+.||+|+||.||+|.+..++..+++|.+.... ...+.+|+..+.++ +|||++++++.+.+ ....++|
T Consensus 4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv 80 (277)
T cd06641 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLK--DTKLWII 80 (277)
T ss_pred HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhc-CCCCEeEEEEEEEe--CCeEEEE
Confidence 35788899999999999999998889999999876432 24577899999999 89999999999855 4466799
Q ss_pred EEeecCchhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-ccc
Q 020826 97 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN 173 (321)
Q Consensus 97 ~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~-~~~ 173 (321)
+||+.+++|..++. .++...+..++.|++.++.+||+.|++|+||+|+||+++.++ .++|+|||++....... ...
T Consensus 81 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~-~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06641 81 MEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred EEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCC-CEEEeecccceecccchhhhc
Confidence 99999999888774 488999999999999999999999999999999999999887 79999999987654322 123
Q ss_pred cccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhh
Q 020826 174 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 253 (321)
Q Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (321)
...++..|+|||.+.+ ..++.++|+|||||+++++++|..||.. .........+.. ...
T Consensus 160 ~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~-~~~------------------ 218 (277)
T cd06641 160 TFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSE-LHPMKVLFLIPK-NNP------------------ 218 (277)
T ss_pred cccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCc-cchHHHHHHHhc-CCC------------------
Confidence 3457788999999876 6788999999999999999999999832 211111111100 000
Q ss_pred HhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 254 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
......++.++.+++.+||+.+|++||++.++++||||++....
T Consensus 219 -----------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~~~ 262 (277)
T cd06641 219 -----------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKK 262 (277)
T ss_pred -----------------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhhhc
Confidence 00112355789999999999999999999999999999986543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=282.85 Aligned_cols=272 Identities=29% Similarity=0.553 Sum_probs=201.9
Q ss_pred eEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhc--CCCCeeeeeeeeeccCC---CC
Q 020826 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLC--GGPNIVKLLDIVRDQQS---KT 92 (321)
Q Consensus 23 y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~--~h~~i~~~~~~~~~~~~---~~ 92 (321)
|++.+.||+|++|.||+|++..++..+++|.++... ...+.+|+.+++++. .|||++++++++.+... ..
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678999999999999999998889999999986321 234667888887774 59999999999865432 34
Q ss_pred cEEEEEeecCchhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 93 PSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
.++++|++.+ ++..++ ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++....
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~-~~~l~dfg~~~~~~ 158 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDG-QVKIADFGLARIYS 158 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCC-CEEEeccCcceecc
Confidence 7899999986 454433 2489999999999999999999999999999999999999887 89999999987765
Q ss_pred CCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 168 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
.........++..|+|||.+.+ ..++.++|+|||||++|+|++|..|| .+....+....+.+.........+.....
T Consensus 159 ~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~s~G~~l~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 235 (287)
T cd07838 159 FEMALTSVVVTLWYRAPEVLLQ-SSYATPVDMWSVGCIFAELFRRRPLF-RGTSEADQLDKIFDVIGLPSEEEWPRNVS- 235 (287)
T ss_pred CCcccccccccccccChHHhcc-CCCCCcchhhhHHHHHHHHHhCCCcc-cCCChHHHHHHHHHHcCCCChHhcCCCcc-
Confidence 4444344557788999999987 67889999999999999999998776 45555555555544433322111110000
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
.............. ......+++.+.++|++||+.||++||+++++++||||
T Consensus 236 -------~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 236 -------LPRSSFPSYTPRSF--KSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred -------cchhhcccccccch--hhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 00000000000000 11112356789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=287.22 Aligned_cols=266 Identities=22% Similarity=0.349 Sum_probs=204.3
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
..++|++.+.||+|++|+||++.+..++..+++|++.... ...+.+|+++++.+ +||||+++++.+... ...+
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~~~~ 79 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHEC-RSPYIVSFYGAFLNE--NNIC 79 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHc-CCCCcceEeeeEecC--CEEE
Confidence 3578999999999999999999998889999999876432 35688999999999 899999999998654 5678
Q ss_pred EEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 95 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 95 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~-~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
+++||+++++|..++ ..+++..+..++.+++.+|.|||+ .+++|+||+|+||+++.++ .++|+|||++......
T Consensus 80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~d~gl~~~~~~~- 157 (284)
T cd06620 80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGELINS- 157 (284)
T ss_pred EEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC-cEEEccCCcccchhhh-
Confidence 999999999998776 348899999999999999999997 6899999999999999877 8999999988654322
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
......++..|+|||++.+ ..++.++|+|||||++|++++|..||............. ......
T Consensus 158 ~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~------~~~~~~--------- 221 (284)
T cd06620 158 IADTFVGTSTYMSPERIQG-GKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDP------MGILDL--------- 221 (284)
T ss_pred ccCccccCcccCCHHHHcc-CCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhh------hHHHHH---------
Confidence 2234567889999999877 688899999999999999999999985332211000000 000000
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
......... ... ....++.++.+|+.+||+.||++|||+.|+++||||.+...+.
T Consensus 222 --~~~~~~~~~----~~~----~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~~ 276 (284)
T cd06620 222 --LQQIVQEPP----PRL----PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRAS 276 (284)
T ss_pred --HHHHhhccC----CCC----CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccccc
Confidence 000000000 000 0012456899999999999999999999999999998765443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=291.36 Aligned_cols=252 Identities=25% Similarity=0.421 Sum_probs=201.4
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
+.|+..+.||+|+||.||+|.+..++..+++|.++... ...+.+|+.++..+ +||||+++++.+.. ....++|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 80 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYITRYYGSYLK--GTKLWII 80 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcC-CCCccHhhhccccc--CCceEEE
Confidence 45777888999999999999998889999999987432 34678999999999 89999999999854 4467899
Q ss_pred EEeecCchhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc-cc
Q 020826 97 FEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YN 173 (321)
Q Consensus 97 ~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~-~~ 173 (321)
+||+++++|..++. .+++..+..++.|++.|+.|||++|++|+||+|+||+++.++ .++++|||++........ ..
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06642 81 MEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRN 159 (277)
T ss_pred EEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCC-CEEEccccccccccCcchhhh
Confidence 99999999887774 488999999999999999999999999999999999999877 899999999876543221 22
Q ss_pred cccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhh
Q 020826 174 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 253 (321)
Q Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (321)
...++..|+|||.+.+ ..++.++|+||||++++++++|..|+.... .......+.. .
T Consensus 160 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~tg~~p~~~~~-~~~~~~~~~~----~----------------- 216 (277)
T cd06642 160 TFVGTPFWMAPEVIKQ-SAYDFKADIWSLGITAIELAKGEPPNSDLH-PMRVLFLIPK----N----------------- 216 (277)
T ss_pred cccCcccccCHHHhCc-CCCchhhhHHHHHHHHHHHHhCCCCCcccc-hhhHHhhhhc----C-----------------
Confidence 3457788999999987 678899999999999999999999873221 1111110000 0
Q ss_pred HhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 254 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
.+ ......++.++.+++.+||+.+|++|||+.++++||||......
T Consensus 217 ---------~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 262 (277)
T cd06642 217 ---------SP------PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKK 262 (277)
T ss_pred ---------CC------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhhh
Confidence 00 00111345689999999999999999999999999999876544
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=282.12 Aligned_cols=244 Identities=14% Similarity=0.267 Sum_probs=191.3
Q ss_pred ccCceEEeeeeeeecceEEEEEEEe---cCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~---~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
...+|++.+.||+|+||.||+|.++ ..+..+++|.++... ...+.+|+..+..+ +||||+++++++.. ..
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~ 79 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQF-DHSNIVRLEGVITR--GN 79 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEec--CC
Confidence 4678999999999999999999875 345689999987542 24577899999998 89999999999854 45
Q ss_pred CcEEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 92 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
..++||||+++++|..++. .+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++++|||.+....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~-~~~l~dfg~~~~~~ 158 (266)
T cd05064 80 TMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL-VCKISGFRRLQEDK 158 (266)
T ss_pred CcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCC-cEEECCCccccccc
Confidence 6789999999999987762 478999999999999999999999999999999999999887 89999999875432
Q ss_pred CCCccc--cccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhh
Q 020826 168 PGKEYN--VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244 (321)
Q Consensus 168 ~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (321)
...... ...++..|+|||.+.+ ..++.++|||||||++|++++ |..||. ..........+....
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~-~~~~~~~~~~~~~~~----------- 225 (266)
T cd05064 159 SEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYW-DMSGQDVIKAVEDGF----------- 225 (266)
T ss_pred ccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcC-cCCHHHHHHHHHCCC-----------
Confidence 221111 1234567999999877 788999999999999999775 888884 222222222211100
Q ss_pred hcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
....+..++..+.+++.+||+.+|++|||++++++
T Consensus 226 -------------------------~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 226 -------------------------RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred -------------------------CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 00112245678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=271.02 Aligned_cols=256 Identities=20% Similarity=0.359 Sum_probs=210.7
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
.++.++++.||+|+.|+|++++...++...|||..+.. +.+++...+.++..-..+|+||+++++|....... +
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~--I 168 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVF--I 168 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHH--H
Confidence 44567788999999999999999999999999998753 34567777777766546899999999996544443 6
Q ss_pred EEEee---cCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc
Q 020826 96 IFEHV---NNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 171 (321)
Q Consensus 96 v~e~~---~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~-~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~ 171 (321)
.||.| ....|.....++++..+-++...++.||.||-++ |++|||+||.||++|..| ++|++|||++-.......
T Consensus 169 cMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G-niKlCDFGIsGrlvdSkA 247 (391)
T KOG0983|consen 169 CMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-NIKLCDFGISGRLVDSKA 247 (391)
T ss_pred HHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC-CEEeecccccceeecccc
Confidence 66654 4456666778899999999999999999999975 799999999999999888 899999999988777777
Q ss_pred cccccCCccccccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 172 YNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
.+...|.+.|+|||.+... ..|+.++||||||++++|+.||..||.....+++.+..+..... +.+
T Consensus 248 htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP-P~L----------- 315 (391)
T KOG0983|consen 248 HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP-PLL----------- 315 (391)
T ss_pred cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC-CCC-----------
Confidence 7888899999999998542 45888999999999999999999999766777777776655211 111
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
.....+|+.+++|+..||+.|+.+||.-.++|+|||++.-+
T Consensus 316 ----------------------~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 316 ----------------------PGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred ----------------------CcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 11223789999999999999999999999999999988643
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=282.78 Aligned_cols=255 Identities=22% Similarity=0.411 Sum_probs=203.0
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc---hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
...|.....||+|++|.||++.+..++..+++|.++... .+.+.+|+.+++.+ +|||++++++++.. ....+++
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~-~h~~vv~~~~~~~~--~~~~~~v 94 (285)
T cd06648 18 RSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDY-QHPNIVEMYSSYLV--GDELWVV 94 (285)
T ss_pred hHhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHc-CCCChheEEEEEEc--CCeEEEE
Confidence 346777789999999999999998899999999886432 34578899999999 89999999998854 4556899
Q ss_pred EEeecCchhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-ccc
Q 020826 97 FEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYN 173 (321)
Q Consensus 97 ~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~-~~~ 173 (321)
+|++.+++|.+++ .+++...+..++.|++.||++||++|++|+||+|+||+++.++ .++|+|||.+....... ...
T Consensus 95 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~d~g~~~~~~~~~~~~~ 173 (285)
T cd06648 95 MEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG-RVKLSDFGFCAQVSKEVPRRK 173 (285)
T ss_pred EeccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCC-cEEEcccccchhhccCCcccc
Confidence 9999999998776 3588899999999999999999999999999999999999887 89999999876543222 123
Q ss_pred cccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhh
Q 020826 174 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 253 (321)
Q Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (321)
...++..|+|||...+ ..++.++|+||||++++++++|..||.... .......+... ...
T Consensus 174 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~~-~~~~~~~~~~~-~~~----------------- 233 (285)
T cd06648 174 SLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEP-PLQAMKRIRDN-LPP----------------- 233 (285)
T ss_pred cccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCCC-HHHHHHHHHhc-CCC-----------------
Confidence 3457888999999877 678899999999999999999999985322 11111111110 000
Q ss_pred HhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 254 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
.......+++.+.+++++||+.+|++|||+.++++||||+....+
T Consensus 234 ----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 278 (285)
T cd06648 234 ----------------KLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPP 278 (285)
T ss_pred ----------------CCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCCc
Confidence 000112356789999999999999999999999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=281.66 Aligned_cols=246 Identities=24% Similarity=0.465 Sum_probs=195.9
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
++|++.+.||+|+||.||+|++..+++.+++|.++.. ....+.+|+.+++.+ +|||++++++++.+. ...+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~ 78 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQL-NHPNVIKYLDSFIED--NELN 78 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhC-CCcceeeeeeeEEEC--CeEE
Confidence 5899999999999999999999999999999987532 124578899999999 899999999998654 4567
Q ss_pred EEEEeecCchhhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 95 LIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 95 lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
+++||+++++|..++ ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||++....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~-~~~l~d~g~~~~~~ 157 (267)
T cd08228 79 IVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFS 157 (267)
T ss_pred EEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCC-CEEECccccceecc
Confidence 999999999887665 2378889999999999999999999999999999999999887 79999999987654
Q ss_pred CCCc-cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhc
Q 020826 168 PGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246 (321)
Q Consensus 168 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (321)
.... .....++..|+|||.+.+ ..++.++|+||+|+++|++++|+.||+....+.............+..
T Consensus 158 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-------- 228 (267)
T cd08228 158 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL-------- 228 (267)
T ss_pred chhHHHhcCCCCccccChhhhcc-CCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCC--------
Confidence 3222 223457788999999877 678899999999999999999999986443332222211111010000
Q ss_pred ccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
.....+..+.+++.+||+.+|++|||+.++++.
T Consensus 229 --------------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 229 --------------------------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred --------------------------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 011245689999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=288.38 Aligned_cols=253 Identities=22% Similarity=0.413 Sum_probs=202.0
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc---chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
..|+....||+|+||.||++.+..++..+++|.+... ....+.+|+.++..+ +|||++++++.+.. ....++++
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~hp~i~~~~~~~~~--~~~~~iv~ 97 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHQNVVEMYKSYLV--GEELWVLM 97 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhC-CCCchhhhhhheee--CCeEEEEE
Confidence 3455566899999999999999889999999998642 235678899999999 89999999998855 35667999
Q ss_pred EeecCchhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-cccc
Q 020826 98 EHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNV 174 (321)
Q Consensus 98 e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~-~~~~ 174 (321)
||+.+++|..+.. .+++..+..++.|++.||++||++|++|+||+|+||+++.++ .++|+|||++....... ....
T Consensus 98 e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~-~~kL~dfg~~~~~~~~~~~~~~ 176 (297)
T cd06659 98 EFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKS 176 (297)
T ss_pred ecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCC-cEEEeechhHhhcccccccccc
Confidence 9999999987763 488999999999999999999999999999999999999888 89999999986543222 2234
Q ss_pred ccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhH
Q 020826 175 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLA 254 (321)
Q Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (321)
..++..|+|||.+.+ ..++.++|+|||||++++|++|+.||... +....+..+.. ..
T Consensus 177 ~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~p~~~~-~~~~~~~~~~~---~~------------------ 233 (297)
T cd06659 177 LVGTPYWMAPEVISR-TPYGTEVDIWSLGIMVIEMVDGEPPYFSD-SPVQAMKRLRD---SP------------------ 233 (297)
T ss_pred eecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHhc---cC------------------
Confidence 567889999999977 67899999999999999999999998532 22222221110 00
Q ss_pred hhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCC
Q 020826 255 ALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~ 313 (321)
.........+++.+.++|++||+.+|++|||++++++||||.+...
T Consensus 234 -------------~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 234 -------------PPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred -------------CCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence 0000111235678999999999999999999999999999998753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=293.52 Aligned_cols=247 Identities=19% Similarity=0.330 Sum_probs=191.3
Q ss_pred cCceEEeeeeeeecceEEEEEEEec-----CCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
.++|++.+.||+|+||.||+|.+.. +++.|++|+++... ...+..|+.++.++.+||||+++++++... .
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~-~ 84 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP-G 84 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC-C
Confidence 5699999999999999999997543 34789999986432 245678999999997899999999987543 3
Q ss_pred CCcEEEEEeecCchhhhhcC------------------------------------------------------------
Q 020826 91 KTPSLIFEHVNNTDFKVLYP------------------------------------------------------------ 110 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------ 110 (321)
...++++||+.+++|..++.
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 46679999999998876652
Q ss_pred ----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc---cccccCCccccc
Q 020826 111 ----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKG 183 (321)
Q Consensus 111 ----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~---~~~~~~~~~y~a 183 (321)
.+++..+..++.||+.||+|||++||+|+||||+||+++.++ .++|+|||++........ .....++..|+|
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~-~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCC-cEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 467888999999999999999999999999999999999877 899999999876532221 122344567999
Q ss_pred cccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCC
Q 020826 184 PELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSR 262 (321)
Q Consensus 184 PE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (321)
||++.+ ..++.++|||||||++++|++ |..||.. ....+.+..... ...
T Consensus 244 PE~~~~-~~~~~~~Di~SlGv~l~el~t~g~~p~~~-~~~~~~~~~~~~---------------------------~~~- 293 (337)
T cd05054 244 PESIFD-KVYTTQSDVWSFGVLLWEIFSLGASPYPG-VQIDEEFCRRLK---------------------------EGT- 293 (337)
T ss_pred cHHhcC-CCCCccccHHHHHHHHHHHHHcCCCCCCC-CCccHHHHHHHh---------------------------ccC-
Confidence 999987 789999999999999999998 8888742 222111111100 000
Q ss_pred CCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 263 KPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 263 ~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
....+...++++.+++.+||+.+|++|||+.|+++|
T Consensus 294 -------~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 294 -------RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred -------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 000112355789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=284.85 Aligned_cols=244 Identities=18% Similarity=0.335 Sum_probs=193.1
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCC-----ceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDN-----EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~-----~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
-++|++.+.||+|+||.||+|.+...+ ..+++|.++... ...+.+|+..+..+ +||||+++++++.+ .
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~--~ 80 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL-QHPNIVCLLGVCTK--E 80 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhc-CCcccceEEEEEcC--C
Confidence 358999999999999999999986655 679999986432 34578899999999 89999999999854 3
Q ss_pred CCcEEEEEeecCchhhhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCC
Q 020826 91 KTPSLIFEHVNNTDFKVLY-------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 151 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~ 151 (321)
...++++||+.+++|.+++ ..++...+..++.|++.||+|||++|++|+||||+||+++.+
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 4567999999999987766 236778899999999999999999999999999999999987
Q ss_pred CCeEEEeeccceeecCCCC---ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHH
Q 020826 152 QRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLV 227 (321)
Q Consensus 152 ~~~v~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~ 227 (321)
+ .++|+|||++....... ......++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.. ....+...
T Consensus 161 ~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDv~slG~il~el~~~g~~p~~~-~~~~~~~~ 237 (283)
T cd05048 161 L-TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPYYG-FSNQEVIE 237 (283)
T ss_pred C-cEEECCCcceeeccccccccccCCCcccccccCHHHhcc-CcCchhhhHHHHHHHHHHHHcCCCCCCCC-CCHHHHHH
Confidence 7 89999999987643222 1233455678999999877 678999999999999999998 8888842 22222211
Q ss_pred HHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 228 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
.+.. . . ....+..+++++.+|+.+||+.||.+|||+.+++++
T Consensus 238 ~i~~----~------------------------~--------~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 238 MIRS----R------------------------Q--------LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred HHHc----C------------------------C--------cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 1110 0 0 001123467899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=278.94 Aligned_cols=242 Identities=19% Similarity=0.337 Sum_probs=191.7
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc--chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
.++|++.++||+|++|.||+|.+ .++..+++|.+... ....+.+|+.+++.+ +|+||+++++.+.+ ....++++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~ 80 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMSVQAFLEEANLMKTL-QHDKLVRLYAVVTK--EEPIYIIT 80 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCchhHHHHHHHHHHHHhC-CCCCeeeEEEEEcC--CCCcEEEE
Confidence 57999999999999999999987 46678999987643 345788999999999 89999999998854 45568999
Q ss_pred EeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCcc
Q 020826 98 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 172 (321)
Q Consensus 98 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~ 172 (321)
|++.+++|..++. .++...+..++.|++.||+|||+.+++|+||+|+||+++.++ .++|+|||++.........
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 81 EYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESL-MCKIADFGLARVIEDNEYT 159 (261)
T ss_pred ecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCC-cEEECCCccceecCCCcee
Confidence 9999999887762 378888899999999999999999999999999999999887 8999999999765432211
Q ss_pred --ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 173 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 173 --~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
....++..|+|||...+ ..++.++|+|||||++|+|++ |..||. ..........+....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~-~~~~~~~~~~~~~~~---------------- 221 (261)
T cd05072 160 AREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYP-GMSNSDVMSALQRGY---------------- 221 (261)
T ss_pred ccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCC-CCCHHHHHHHHHcCC----------------
Confidence 22234567999999876 678899999999999999998 888873 222222222211100
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
+ ......++.++.+++.+||..+|++|||++++++
T Consensus 222 --------------~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 222 --------------R------MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred --------------C------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0 0111235678999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=287.10 Aligned_cols=245 Identities=19% Similarity=0.305 Sum_probs=189.7
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCc--eEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNE--KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~--~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
.++|++.+.||+|+||.||+|.+..++. .+++|.++.. ....+.+|+.++.++.+||||+++++++.. ...+
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~--~~~~ 83 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYL 83 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC--CCCc
Confidence 4689999999999999999999877765 4577766532 234577899999999789999999999854 4567
Q ss_pred EEEEEeecCchhhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCe
Q 020826 94 SLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK 154 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~ 154 (321)
++++||+.+++|..++. .+++..+..++.|++.||+|||++|++|+||||+||+++.++ .
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~-~ 162 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-V 162 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC-c
Confidence 89999999998877662 367889999999999999999999999999999999999887 8
Q ss_pred EEEeeccceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHh
Q 020826 155 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL 233 (321)
Q Consensus 155 v~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 233 (321)
++|+|||++..............+..|+|||...+ ..++.++|||||||++++++| |..||. +.+..+....+..
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~-~~~~~~~~~~~~~-- 238 (303)
T cd05088 163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYC-GMTCAELYEKLPQ-- 238 (303)
T ss_pred EEeCccccCcccchhhhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhcCCCCcc-cCChHHHHHHHhc--
Confidence 99999999864321111222233557999998876 678899999999999999998 888883 2222111111100
Q ss_pred CChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 234 GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
. .....+..+++++.+++.+||+.+|++|||+++++++
T Consensus 239 --~--------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 239 --G--------------------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred --C--------------------------------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 0000112356789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=301.77 Aligned_cols=246 Identities=22% Similarity=0.390 Sum_probs=202.1
Q ss_pred eeeeecceEEEEEEEecCCceEEEEEecccc---hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeecCch
Q 020826 28 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD 104 (321)
Q Consensus 28 ~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~ 104 (321)
+||+|.||+||-|+|..+...+|||-+...+ ..-+..|+...++| .|.|||++++.+ ..+.++-|.||..+||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~L-rHkNIVrYLGs~--senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTL-RHKNIVRYLGSV--SENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHH-hhHhHHHHhhcc--CCCCeEEEEeecCCCCc
Confidence 5999999999999999999999999986433 34477899999999 999999999998 55567789999999999
Q ss_pred hhhhcC----CC--CHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC-CCCccccccC
Q 020826 105 FKVLYP----TL--SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVA 177 (321)
Q Consensus 105 l~~~~~----~~--~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~-~~~~~~~~~~ 177 (321)
|..+++ ++ ++..+..+..||++||.|||++.|||||||-+||+++.-.+.+||+|||-++... -+.-+.+..|
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTG 738 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTG 738 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCcccccccc
Confidence 998884 45 7888889999999999999999999999999999998766699999999987663 2334466789
Q ss_pred CccccccccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhh
Q 020826 178 SRYFKGPELLVD-LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAAL 256 (321)
Q Consensus 178 ~~~y~aPE~~~~-~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (321)
|..|||||++.. ...|..++|||||||++.||.||+.||..-.+....+..+..-
T Consensus 739 TLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmy------------------------ 794 (1226)
T KOG4279|consen 739 TLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMY------------------------ 794 (1226)
T ss_pred chhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcce------------------------
Confidence 999999999954 3578999999999999999999999995433332222221100
Q ss_pred hcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 257 VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
... ..++..+|.++++||.+|+.+||.+||+|.++|..||++..
T Consensus 795 ----KvH-------P~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 795 ----KVH-------PPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred ----ecC-------CCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 000 11233466799999999999999999999999999999976
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=277.97 Aligned_cols=248 Identities=23% Similarity=0.404 Sum_probs=199.1
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc--------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
.+|++.+.||+|++|.||+|.+..++..+++|.+... ....+.+|+.+++++ +||||+++++.+.+.....
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL-RHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHc-CCCCcceEEEEEEcCCCCE
Confidence 5799999999999999999999999999999987421 124678899999999 8999999999987665566
Q ss_pred cEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 93 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
.++++|++.+++|...+ ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEECccccccccccc
Confidence 78999999999987776 3478899999999999999999999999999999999999877 7999999998754321
Q ss_pred ----CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhh
Q 020826 170 ----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245 (321)
Q Consensus 170 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (321)
.......++..|+|||.+.+ ..++.++|+|||||+++++++|..||... ... ..+.+....+.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~-~~~---~~~~~~~~~~~-------- 226 (264)
T cd06653 160 CMSGTGIKSVTGTPYWMSPEVISG-EGYGRKADVWSVACTVVEMLTEKPPWAEY-EAM---AAIFKIATQPT-------- 226 (264)
T ss_pred cccCccccccCCcccccCHhhhcC-CCCCccccHHHHHHHHHHHHhCCCCCCcc-CHH---HHHHHHHcCCC--------
Confidence 11223457788999999987 67889999999999999999999998321 111 11111111100
Q ss_pred cccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
....+..+++++.+++++||+ +|..|||+.++++|||.
T Consensus 227 ------------------------~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 227 ------------------------KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred ------------------------CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 001123466789999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=278.74 Aligned_cols=243 Identities=19% Similarity=0.354 Sum_probs=193.7
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc--hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
..+|++.+.||+|++|.||+|.+..++..+++|.+.... ...+.+|+..++.+ +||||+++++++.. ....++++
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~ 81 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTR--EPPFYIIT 81 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhC-CCCChhheEEEEcC--CCCcEEEE
Confidence 557999999999999999999998899999999987543 35678899999999 89999999999854 44567999
Q ss_pred EeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCcc
Q 020826 98 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 172 (321)
Q Consensus 98 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~ 172 (321)
||+++++|.+++. .++...+..++.|++.||++||++|++|+||||+||+++.++ .++|+|||.+.........
T Consensus 82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC-cEEeCCCccccccccceee
Confidence 9999999887763 378888999999999999999999999999999999999877 8999999998765432211
Q ss_pred --ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 173 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 173 --~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
.....+..|+|||.+.+ ..++.++|||||||++|+|++ |..||. +.+..+....+....
T Consensus 161 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~-~~~~~~~~~~~~~~~---------------- 222 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYP-GIDLSQVYELLEKGY---------------- 222 (263)
T ss_pred ccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCC-CCCHHHHHHHHHCCC----------------
Confidence 11223457999999876 678899999999999999998 777773 322221111110000
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
....+..+++++.+++.+||+.||++|||+.++++
T Consensus 223 --------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 223 --------------------RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred --------------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 00112246689999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=292.96 Aligned_cols=284 Identities=17% Similarity=0.242 Sum_probs=194.4
Q ss_pred eeeeee--cceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEe
Q 020826 27 RKVGRG--KYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 99 (321)
Q Consensus 27 ~~lg~g--~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 99 (321)
..||.| +||+||++.+..+++.||+|++.... .+.+.+|+.+++.+ +||||+++++++.. ....++++|+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~--~~~~~~v~e~ 80 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFF-RHPNIMTSWTVFTT--GSWLWVISPF 80 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcceEeeeEec--CCceEEEEec
Confidence 356666 99999999998999999999986432 25678899888888 89999999999965 4456899999
Q ss_pred ecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc---
Q 020826 100 VNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--- 171 (321)
Q Consensus 100 ~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~--- 171 (321)
+.++++..++. .+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++++||+.+........
T Consensus 81 ~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~-~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 81 MAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDG-LVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred ccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCC-cEEEechHHHhhhhccCcccc
Confidence 99988877663 378899999999999999999999999999999999999887 899999986532211110
Q ss_pred -----cccccCCccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhh-HHhhh
Q 020826 172 -----YNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN-AYLNK 244 (321)
Q Consensus 172 -----~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~ 244 (321)
.....++..|+|||++.+. ..++.++|||||||+++++++|..||... ................... .....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM-LRTQMLLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc-ChHHHHHHHhcCCCCCCccccccch
Confidence 0112345569999998763 34789999999999999999999998432 2222222111110000000 00000
Q ss_pred hc-ccC--ChhhH-----hhhc-ccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 245 YH-IEL--DPHLA-----ALVG-RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 245 ~~-~~~--~~~~~-----~~~~-~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
.. ... ..... .... ..................+++.+.+|+++||+.||++|||++|+++||||+++....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~~ 318 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQT 318 (328)
T ss_pred hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHhc
Confidence 00 000 00000 0000 000000001111122234667899999999999999999999999999999876544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=284.93 Aligned_cols=258 Identities=22% Similarity=0.393 Sum_probs=198.5
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
..++|++.+.||+|++|.||+|.+..+++.+++|.++... ...+..|+.++.....||||+++++++.+ ....+
T Consensus 13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~ 90 (296)
T cd06618 13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT--DSDVF 90 (296)
T ss_pred CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec--CCeEE
Confidence 4578999999999999999999998889999999987432 23456677777777579999999999855 44577
Q ss_pred EEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 95 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 95 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~-~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
+++|++++. +..+. ..+++..+..++.|++.||+|||+ .|++|+||+|+||+++.++ .++|+|||++......
T Consensus 91 ~v~e~~~~~-l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~-~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 91 ICMELMSTC-LDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG-NVKLCDFGISGRLVDS 168 (296)
T ss_pred EEeeccCcC-HHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC-CEEECccccchhccCC
Confidence 999998763 33322 358899999999999999999997 5999999999999999777 8999999998755433
Q ss_pred CccccccCCccccccccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhc
Q 020826 170 KEYNVRVASRYFKGPELLVDL---QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246 (321)
Q Consensus 170 ~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (321)
.......++..|+|||.+.+. ..++.++|+||||+++|+|++|+.||.......+.+..+.. ...
T Consensus 169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~--------- 236 (296)
T cd06618 169 KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQ---EEP--------- 236 (296)
T ss_pred CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhc---CCC---------
Confidence 333344567789999998653 24788999999999999999999998432222222221111 000
Q ss_pred ccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
. .......+++++.+++.+||+.||++|||+++++.||||+.....
T Consensus 237 --------------~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 282 (296)
T cd06618 237 --------------P--------SLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETA 282 (296)
T ss_pred --------------C--------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchh
Confidence 0 000111356789999999999999999999999999999986544
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=278.90 Aligned_cols=245 Identities=28% Similarity=0.446 Sum_probs=190.7
Q ss_pred eeeeeecceEEEEEEEecCCceEEEEEecccch------HHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEee
Q 020826 27 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK------KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 100 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~------~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 100 (321)
+.||+|++|.||+|.+..+++.+++|.++.... .....|..++....+|||++++++.+.. ...+++++||+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~--~~~~~lv~e~~ 79 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS--KDYLYLVMEYL 79 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc--CCeEEEEEecc
Confidence 468999999999999988999999999864321 2234455555544489999999999854 45678999999
Q ss_pred cCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCccccccC
Q 020826 101 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA 177 (321)
Q Consensus 101 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~~~~~~ 177 (321)
++++|..++ ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++..... .....+
T Consensus 80 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~---~~~~~~ 155 (260)
T cd05611 80 NGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTG-HLKLTDFGLSRNGLE---NKKFVG 155 (260)
T ss_pred CCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-cEEEeecccceeccc---cccCCC
Confidence 999998877 4589999999999999999999999999999999999999877 899999998875432 233457
Q ss_pred CccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhh
Q 020826 178 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALV 257 (321)
Q Consensus 178 ~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (321)
+..|+|||.+.+ ..++.++|+||||+++|++++|..||... +.......+..
T Consensus 156 ~~~y~~pe~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~-~~~~~~~~~~~-------------------------- 207 (260)
T cd05611 156 TPDYLAPETILG-VGDDKMSDWWSLGCVIFEFLFGYPPFHAE-TPDAVFDNILS-------------------------- 207 (260)
T ss_pred CcCccChhhhcC-CCCcchhhhHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHHh--------------------------
Confidence 788999999887 56889999999999999999999998422 22211111100
Q ss_pred cccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC---HHHHhcCCCcccCC
Q 020826 258 GRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT---AKEAMAHPYFFPIR 312 (321)
Q Consensus 258 ~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps---~~ell~hp~~~~~~ 312 (321)
.....+ ......+++++.+++.+||+.||++||| ++|+++||||++..
T Consensus 208 -~~~~~~------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 208 -RRINWP------EEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred -cccCCC------CcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence 000000 0011135689999999999999999995 57999999998764
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=284.64 Aligned_cols=252 Identities=25% Similarity=0.410 Sum_probs=198.2
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
....|++.+.||+|+||+||+|.+..+++.|++|.+.... ...+.+|+.+++.+ +|||++++.+++.+. ..
T Consensus 13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~niv~~~~~~~~~--~~ 89 (307)
T cd06607 13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQL-RHPNTIEYKGCYLRE--HT 89 (307)
T ss_pred cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEEeC--Ce
Confidence 3467999999999999999999998899999999886321 24578899999999 899999999998654 45
Q ss_pred cEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 93 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
.++|+||+.+..+.... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 90 ~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~-~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 90 AWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPG-TVKLADFGSASLVSPA 168 (307)
T ss_pred EEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCC-CEEEeecCcceecCCC
Confidence 67999999865443332 4589999999999999999999999999999999999999887 8999999998754322
Q ss_pred CccccccCCccccccccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 170 KEYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 170 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
....++..|+|||.+.+ ...++.++||||||+++|++++|..||... +.......+.. ....
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~-~~~~~~~~~~~-~~~~----------- 232 (307)
T cd06607 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQ-NDSP----------- 232 (307)
T ss_pred ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCc-cHHHHHHHHhc-CCCC-----------
Confidence 23457788999998752 256888999999999999999999998422 21111111100 0000
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCC
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~ 313 (321)
. ......+.++.++|.+||+.||++|||+.+++.||||.....
T Consensus 233 ------------------~-----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 275 (307)
T cd06607 233 ------------------T-----LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRERP 275 (307)
T ss_pred ------------------C-----CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccCC
Confidence 0 001124568999999999999999999999999999987654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=294.62 Aligned_cols=245 Identities=26% Similarity=0.495 Sum_probs=206.8
Q ss_pred eeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEee
Q 020826 26 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 100 (321)
Q Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 100 (321)
.+.||+|.||+||-|++.++|+.||||++.+. ..+.+..|+.+|+++ .||.||.+...++ .....+.|||.+
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l-~HPGiV~le~M~E--T~ervFVVMEKl 645 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNL-HHPGIVNLECMFE--TPERVFVVMEKL 645 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhc-CCCCeeEEEEeec--CCceEEEEehhh
Confidence 36799999999999999999999999998642 347799999999999 9999999999984 455567999999
Q ss_pred cCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCC--CeEEEeeccceeecCCCCcccc
Q 020826 101 NNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEFYHPGKEYNV 174 (321)
Q Consensus 101 ~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~--~~v~l~dfg~~~~~~~~~~~~~ 174 (321)
.|.-|.-.+ .++++...+-++.||+.||.|||-+||+|+||||+||++.... ..+||+|||+++......--..
T Consensus 646 ~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrs 725 (888)
T KOG4236|consen 646 HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRS 725 (888)
T ss_pred cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhh
Confidence 999876555 5699999999999999999999999999999999999997543 4799999999998876666677
Q ss_pred ccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhH
Q 020826 175 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLA 254 (321)
Q Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (321)
.+||+.|+|||++.. +.|+..-|+||.|+++|--++|..||..+.+..++++.-.= .
T Consensus 726 VVGTPAYLaPEVLrn-kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaF--M-------------------- 782 (888)
T KOG4236|consen 726 VVGTPAYLAPEVLRN-KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAF--M-------------------- 782 (888)
T ss_pred hcCCccccCHHHHhh-ccccccccceeeeEEEEEEecccccCCCccchhHHhhcccc--c--------------------
Confidence 899999999999998 88999999999999999999999999544443333332100 0
Q ss_pred hhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCccc
Q 020826 255 ALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 310 (321)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~ 310 (321)
....||+ .+|++..+||..+|+..-.+|-|++..+.|||+++
T Consensus 783 -----yPp~PW~---------eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~ 824 (888)
T KOG4236|consen 783 -----YPPNPWS---------EISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQD 824 (888)
T ss_pred -----cCCCchh---------hcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhc
Confidence 1112222 36689999999999999999999999999999996
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=281.84 Aligned_cols=251 Identities=18% Similarity=0.356 Sum_probs=193.4
Q ss_pred cCceEEeeeeeeecceEEEEEEEec-----CCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
.++|++.+.||+|+||.||+|.++. .+..+++|.++... ...+.+|+..++.+ +|||++++++++.+.
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-- 81 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGF-TCHHVVRLLGVVSKG-- 81 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcCC--
Confidence 5799999999999999999997642 24579999876432 23467899999999 899999999998544
Q ss_pred CCcEEEEEeecCchhhhhcCC-------------CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEE
Q 020826 91 KTPSLIFEHVNNTDFKVLYPT-------------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRL 157 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~~~-------------~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l 157 (321)
...+++|||+.+++|..++.. .+...+..++.|++.||.|||++|++|+||||+||+++.++ .++|
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~-~~~L 160 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF-TVKI 160 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCC-cEEE
Confidence 456899999999999877732 34567888999999999999999999999999999999877 8999
Q ss_pred eeccceeecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHh
Q 020826 158 IDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL 233 (321)
Q Consensus 158 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 233 (321)
+|||++........ .....++..|+|||.+.+ ..++.++|+|||||++|++++ |..||. +....+....+..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~DvwslG~~l~el~~~~~~p~~-~~~~~~~~~~~~~-- 236 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQ-GLSNEQVLKFVMD-- 236 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhcc-CCCChHhHHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHc--
Confidence 99999875432211 112234567999999877 678999999999999999998 676763 2222221111110
Q ss_pred CChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc------CCC
Q 020826 234 GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA------HPY 307 (321)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~------hp~ 307 (321)
.. ....+...++.+.+++.+||+.||++|||+.++++ |||
T Consensus 237 -~~---------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~ 282 (288)
T cd05061 237 -GG---------------------------------YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPS 282 (288)
T ss_pred -CC---------------------------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCC
Confidence 00 00011234578999999999999999999999987 999
Q ss_pred cccCC
Q 020826 308 FFPIR 312 (321)
Q Consensus 308 ~~~~~ 312 (321)
|++++
T Consensus 283 ~~~~~ 287 (288)
T cd05061 283 FPEVS 287 (288)
T ss_pred CCCCC
Confidence 99874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=275.92 Aligned_cols=246 Identities=33% Similarity=0.561 Sum_probs=200.4
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc---hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 98 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 98 (321)
+|++.+.||+|++|.||++.+..+++.+++|.++... ...+.+|+..++.+ +||+++++++.+... ...++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKC-KHPNIVKYYGSYLKK--DELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEEecC--CeEEEEEe
Confidence 5888999999999999999998889999999987643 46788999999999 799999999998654 55679999
Q ss_pred eecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCcccc
Q 020826 99 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV 174 (321)
Q Consensus 99 ~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~~~ 174 (321)
|+++++|.+++ ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||.+...........
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~~ 156 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG-EVKLIDFGLSAQLSDTKARNT 156 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCC-eEEEeeccccccccccccccc
Confidence 99999998776 3579999999999999999999999999999999999999877 899999999876654432345
Q ss_pred ccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhH
Q 020826 175 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLA 254 (321)
Q Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (321)
..++..|+|||.+.+ ..++.++|+||||++++++++|..||.... .......... ....
T Consensus 157 ~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~-~~~~------------------ 215 (253)
T cd05122 157 MVGTPYWMAPEVING-KPYDYKADIWSLGITAIELAEGKPPYSELP-PMKALFKIAT-NGPP------------------ 215 (253)
T ss_pred eecCCcccCHHHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCc-hHHHHHHHHh-cCCC------------------
Confidence 567888999999987 568899999999999999999999984322 1111111111 0000
Q ss_pred hhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCC
Q 020826 255 ALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 307 (321)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~ 307 (321)
.......++..+.++|.+||+.||++|||+.++++|||
T Consensus 216 ---------------~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 216 ---------------GLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred ---------------CcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 00011123578999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=284.29 Aligned_cols=244 Identities=18% Similarity=0.302 Sum_probs=189.1
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCc--eEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNE--KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~--~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
++|++.+.||+|+||.||+|.+..++. .+++|.++.. ....+.+|+.++.++.+||||+++++++.. ....+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN--RGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc--CCcce
Confidence 689999999999999999999876664 4688887642 224578899999998779999999999854 34578
Q ss_pred EEEEeecCchhhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeE
Q 020826 95 LIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL 155 (321)
Q Consensus 95 lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v 155 (321)
+++||+++++|.+++. .+++..+..++.|++.||+|||++|++|+||||+||+++.++ .+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~ 158 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL-AS 158 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC-eE
Confidence 9999999999877662 377888999999999999999999999999999999999877 89
Q ss_pred EEeeccceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhC
Q 020826 156 RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLG 234 (321)
Q Consensus 156 ~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~ 234 (321)
+|+|||++..............+..|+|||...+ ..++.++|||||||++|+|++ |..||. +.........+...
T Consensus 159 kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~g~~pf~-~~~~~~~~~~~~~~-- 234 (297)
T cd05089 159 KIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSLGGTPYC-GMTCAELYEKLPQG-- 234 (297)
T ss_pred EECCcCCCccccceeccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCC-CCCHHHHHHHHhcC--
Confidence 9999999864322111122223456999999876 678999999999999999997 888883 22221211111000
Q ss_pred ChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 235 TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
.....+..+++++.+++.+||+.||.+|||++++++.
T Consensus 235 ----------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 235 ----------------------------------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred ----------------------------------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0001122466799999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=288.82 Aligned_cols=275 Identities=19% Similarity=0.242 Sum_probs=192.1
Q ss_pred cceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeecCchhhh
Q 020826 33 KYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKV 107 (321)
Q Consensus 33 ~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~ 107 (321)
+.+.||.+++..+++.+|+|+++.. ....+.+|+.+++.+ +||||+++++++.+. ...++++||++++++..
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l-~h~~i~~~~~~~~~~--~~~~~~~e~~~~~~l~~ 88 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQL-QHPNILPYVTSFIVD--SELYVVSPLMAYGSCED 88 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhc-CCcchhhhhheeecC--CeEEEEEeccCCCCHHH
Confidence 4566677777779999999998643 235688999999999 899999999998654 45679999999999877
Q ss_pred hcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc--------ccc
Q 020826 108 LYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--------YNV 174 (321)
Q Consensus 108 ~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~--------~~~ 174 (321)
++. .+++..+..++.|++.||+|||+++++|+||+|+||+++.++ .++|+|||.+........ ...
T Consensus 89 ~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~-~~kl~d~~~~~~~~~~~~~~~~~~~~~~~ 167 (314)
T cd08216 89 LLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDG-KVVLSGLRYSVSMIKHGKRQRVVHDFPKS 167 (314)
T ss_pred HHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCC-ceEEecCccceeecccccccccccccccc
Confidence 763 478899999999999999999999999999999999999877 899999998865432111 123
Q ss_pred ccCCccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC-hh
Q 020826 175 RVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD-PH 252 (321)
Q Consensus 175 ~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 252 (321)
..++..|+|||++.+. ..++.++|+||+||++++|++|..||............+. +.. ............ ..
T Consensus 168 ~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~---~~~--~~~~~~~~~~~~~~~ 242 (314)
T cd08216 168 SVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVR---GTV--PCLLDKSTYPLYEDS 242 (314)
T ss_pred ccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh---ccC--ccccccCchhhhcCC
Confidence 3466789999998653 3578899999999999999999999954332222222111 100 000000000000 00
Q ss_pred hHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCccc
Q 020826 253 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAES 316 (321)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~~ 316 (321)
........................+++++.+++++||+.||++|||++++++||||+++.+.+.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~~~~~ 306 (314)
T cd08216 243 MSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCKRRNT 306 (314)
T ss_pred cCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhcccch
Confidence 0000000000000000111112234568999999999999999999999999999999876554
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=275.95 Aligned_cols=245 Identities=25% Similarity=0.496 Sum_probs=199.6
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
+|++.+.||.|++|.||++.+..++..+++|.+... ....+..|+++++.+ +|||++++.+.+.+. ...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~~~~~~~~~~~~--~~~~lv 77 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKL-NHPNIIKYYESFEEK--GKLCIV 77 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhc-CCCChhheEEEEecC--CEEEEE
Confidence 588999999999999999999888999999998643 345688899999999 799999999988654 667899
Q ss_pred EEeecCchhhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 97 FEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 97 ~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
+|++++++|...+ ..+++..+..++.+++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+......
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 78 MEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNG-LVKLGDFGISKVLSST 156 (258)
T ss_pred EEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCC-cEEECCccceeecccC
Confidence 9999999887665 3488999999999999999999999999999999999999877 8999999998765433
Q ss_pred C-ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 170 K-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
. ......++..|+|||...+ ..++.++|+||+|++++++++|..||.... .......... ..
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-~~~~~~~~~~----~~----------- 219 (258)
T cd08215 157 VDLAKTVVGTPYYLSPELCQN-KPYNYKSDIWSLGCVLYELCTLKHPFEGEN-LLELALKILK----GQ----------- 219 (258)
T ss_pred cceecceeeeecccChhHhcc-CCCCccccHHHHHHHHHHHHcCCCCCCCCc-HHHHHHHHhc----CC-----------
Confidence 2 2233467788999999877 678899999999999999999999983222 1111111100 00
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
. ...+..++.++.+++++||..+|++|||+.++++||||
T Consensus 220 -------------~--------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 220 -------------Y--------PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred -------------C--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 0 00111456789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=276.12 Aligned_cols=242 Identities=20% Similarity=0.396 Sum_probs=194.2
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
+|++.+.||+|+||.||++.+..++..+++|.++.. ....+..|+.+++.+ +|||++++++.+.+ ...+++++
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKM-KHPNIVAFKESFEA--DGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhC-CCCCcceEEEEEEE--CCEEEEEE
Confidence 589999999999999999999999999999998532 235677899999999 89999999999854 45678999
Q ss_pred EeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc-
Q 020826 98 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE- 171 (321)
Q Consensus 98 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~- 171 (321)
||++++++..++. .+++..+..++.|++.||.+||++|++|+||+|+||+++.++ .++++|||.+........
T Consensus 78 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~~~~~ 156 (255)
T cd08219 78 EYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLTSPGAY 156 (255)
T ss_pred eeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCC-cEEEcccCcceeecccccc
Confidence 9999998866552 378999999999999999999999999999999999999887 899999999876543222
Q ss_pred cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCCh
Q 020826 172 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (321)
.....++..|+|||++.+ ..++.++|+||||+++|+|++|..||.. .+.......+.. .
T Consensus 157 ~~~~~~~~~~~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~-~~~~~~~~~~~~----~--------------- 215 (255)
T cd08219 157 ACTYVGTPYYVPPEIWEN-MPYNNKSDIWSLGCILYELCTLKHPFQA-NSWKNLILKVCQ----G--------------- 215 (255)
T ss_pred cccccCCccccCHHHHcc-CCcCchhhhhhhchhheehhhccCCCCC-CCHHHHHHHHhc----C---------------
Confidence 233567888999999877 6789999999999999999999999842 211111111100 0
Q ss_pred hhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 252 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
... ..+..++..+.+++.+||+.||++|||+.++++-
T Consensus 216 ---------~~~--------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 216 ---------SYK--------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ---------CCC--------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 000 0112355689999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=281.76 Aligned_cols=246 Identities=33% Similarity=0.565 Sum_probs=199.0
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
++|++.+.||+|++|.||+|.+..++..+++|++... ....+..|..+++++.+||||+++++++.+ ....+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~ 78 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD--EENLY 78 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC--CceEE
Confidence 4799999999999999999999889999999998642 235578899999999449999999998854 45677
Q ss_pred EEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc
Q 020826 95 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 171 (321)
Q Consensus 95 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~ 171 (321)
++||++.+++|..++ ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++ .++++|||++........
T Consensus 79 lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~-~~~l~df~~~~~~~~~~~ 157 (280)
T cd05581 79 FVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDM-HIKITDFGTAKVLDPNSS 157 (280)
T ss_pred EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEecCCccccccCCccc
Confidence 999999999987777 3589999999999999999999999999999999999999888 899999999876533221
Q ss_pred ---------------------cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHH
Q 020826 172 ---------------------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 230 (321)
Q Consensus 172 ---------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 230 (321)
.....++..|+|||.... ..++.++|+||||++++++++|..||.... .......+.
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~-~~~~~~~~~ 235 (280)
T cd05581 158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRGSN-EYLTFQKIL 235 (280)
T ss_pred cccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHH
Confidence 122346778999999877 678899999999999999999999984222 111111111
Q ss_pred HHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCH----HHHhcCC
Q 020826 231 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA----KEAMAHP 306 (321)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~----~ell~hp 306 (321)
. .....+..+++.+.++|++||+.||++|||+ +++++||
T Consensus 236 ~-------------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~ 278 (280)
T cd05581 236 K-------------------------------------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHP 278 (280)
T ss_pred h-------------------------------------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCC
Confidence 0 0001112346789999999999999999999 9999999
Q ss_pred Cc
Q 020826 307 YF 308 (321)
Q Consensus 307 ~~ 308 (321)
||
T Consensus 279 ~~ 280 (280)
T cd05581 279 FF 280 (280)
T ss_pred CC
Confidence 98
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=281.68 Aligned_cols=259 Identities=22% Similarity=0.334 Sum_probs=194.3
Q ss_pred Cce-EEeeeeeeecceEEEEEEE----ecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 21 DDY-EVVRKVGRGKYSEVFEGVH----CTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 21 ~~y-~~~~~lg~g~~g~v~~~~~----~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
++| ++.+.||+|+||+||++.. ..++..+++|.++... ...+.+|+++++.+ +||||+++++++......
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTL-YHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCCc
Confidence 455 9999999999999988653 3467789999987532 35678899999999 899999999988766566
Q ss_pred CcEEEEEeecCchhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 92 TPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
..+++||++.+++|..++. .+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR-LVKIGDFGLAKAVPEG 160 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC-cEEEeecccccccCCc
Confidence 7789999999999988774 589999999999999999999999999999999999999887 8999999998765432
Q ss_pred Cc----cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhh
Q 020826 170 KE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245 (321)
Q Consensus 170 ~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (321)
.. .....++..|+|||...+ ..++.++||||||+++++|++|..|+............ ...+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~--~~~~~~--------- 228 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIG--PKQGQM--------- 228 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhc--cccccc---------
Confidence 21 112234556999999876 67899999999999999999999997432221110000 000000
Q ss_pred cccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
............. ....+..+++++.+++.+||+.||++|||++++++
T Consensus 229 ---~~~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 229 ---TVVRLIELLERGM--------RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred ---chhhhhhhhhcCC--------CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 0000000000000 11122346689999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=276.62 Aligned_cols=264 Identities=22% Similarity=0.347 Sum_probs=198.7
Q ss_pred eeeeeecceEEEEEEEecCCceEEEEEeccc---chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeecCc
Q 020826 27 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT 103 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~ 103 (321)
+.||+|+++.|-.++...++..||||++.+. .++++.+|++++.+.++|+||++++++|+++. ..|+|||.+.||
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~--~FYLVfEKm~GG 161 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDT--RFYLVFEKMRGG 161 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccc--eEEEEEecccCc
Confidence 4699999999999999999999999999754 56889999999999999999999999997654 456999999999
Q ss_pred hhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCC--eEEEeeccceeecCC--------CC
Q 020826 104 DFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHP--------GK 170 (321)
Q Consensus 104 ~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~--~v~l~dfg~~~~~~~--------~~ 170 (321)
.+...+ ..+++.++.++..+|+.||.+||.+||+|||+||+||+-...+. -|||+||.+..-... ..
T Consensus 162 plLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP 241 (463)
T KOG0607|consen 162 PLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTP 241 (463)
T ss_pred hHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCc
Confidence 987776 34999999999999999999999999999999999999964432 489999998643211 12
Q ss_pred ccccccCCccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCccCCCC--hHHHHHHHHHhCChhhhHHhhh
Q 020826 171 EYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN--YDQLVKIAKVLGTDELNAYLNK 244 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 244 (321)
...+.+|+..|||||+..- ...|+.++|.||||+++|-|+.|+.||...-.. -....+.+.
T Consensus 242 ~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr------------- 308 (463)
T KOG0607|consen 242 ELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCR------------- 308 (463)
T ss_pred cccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccH-------------
Confidence 2344577788999999732 146889999999999999999999999432110 000000000
Q ss_pred hcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCC
Q 020826 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~ 313 (321)
..+.......+...-+|-..+. ..+|.+..++++.+|..|+.+|.++.++++|||++....
T Consensus 309 -------~CQ~~LFesIQEGkYeFPdkdW-ahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 309 -------VCQNKLFESIQEGKYEFPDKDW-AHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAP 369 (463)
T ss_pred -------HHHHHHHHHHhccCCcCChhhh-HHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccch
Confidence 0000000000111111111000 136789999999999999999999999999999998644
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=295.91 Aligned_cols=244 Identities=27% Similarity=0.400 Sum_probs=203.5
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEE
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 98 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 98 (321)
..++|++...+|.|+|+.|-.+.+..+++..++|++... .....+|+.++....+|||+++..+.+. .....++|||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~-~~~~~~e~~~~~~~~~h~niv~~~~v~~--~~~~~~~v~e 396 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKR-ADDNQDEIPISLLVRDHPNIVKSHDVYE--DGKEIYLVME 396 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccc-ccccccccchhhhhcCCCcceeecceec--CCceeeeeeh
Confidence 578899999999999999999999999999999999765 4556788888888779999999999994 4667789999
Q ss_pred eecCchhhhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEc-CCCCeEEEeeccceeecCCCCccccc
Q 020826 99 HVNNTDFKVLYPT--LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID-HEQRKLRLIDWGLAEFYHPGKEYNVR 175 (321)
Q Consensus 99 ~~~~~~l~~~~~~--~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~-~~~~~v~l~dfg~~~~~~~~~~~~~~ 175 (321)
.+.|+.+...+.. ....++..++++|+.|+.|||.+|++||||||+||+++ ..+ .++|+|||.++..... ....
T Consensus 397 ~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g-~lrltyFG~a~~~~~~--~~tp 473 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAG-HLRLTYFGFWSELERS--CDTP 473 (612)
T ss_pred hccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCC-cEEEEEechhhhCchh--hccc
Confidence 9999987666643 33367778999999999999999999999999999994 555 8999999998765543 5566
Q ss_pred cCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHh
Q 020826 176 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA 255 (321)
Q Consensus 176 ~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (321)
+.|..|.|||+... ..++.++|+||||++||+|++|+.||.......+.... ++.+...
T Consensus 474 ~~t~~y~APEvl~~-~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~----i~~~~~s---------------- 532 (612)
T KOG0603|consen 474 ALTLQYVAPEVLAI-QEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTR----IQMPKFS---------------- 532 (612)
T ss_pred chhhcccChhhhcc-CCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHh----hcCCccc----------------
Confidence 78889999999986 89999999999999999999999999544433222222 2222111
Q ss_pred hhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 256 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
..+|++.++||++||++||.+|++++++..||||
T Consensus 533 -------------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 533 -------------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred -------------------cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 3578899999999999999999999999999999
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=282.61 Aligned_cols=253 Identities=23% Similarity=0.403 Sum_probs=201.6
Q ss_pred eEEeeeeeeecceEEEEEEEecCCceEEEEEeccc---chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEe
Q 020826 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 99 (321)
Q Consensus 23 y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 99 (321)
|+....||+|+||.||++....++..+++|.+... ....+.+|+.+++.+ +|+|++++++.+.. ....++++||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLV--GDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhc-CCcchhheeeEEEe--CCEEEEEEec
Confidence 34445799999999999999889999999987532 234578899999999 89999999999855 4567899999
Q ss_pred ecCchhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-cccccc
Q 020826 100 VNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRV 176 (321)
Q Consensus 100 ~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~-~~~~~~ 176 (321)
+++++|.++. ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++ .++|+|||++....... ......
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~-~~~l~dfg~~~~~~~~~~~~~~~~ 177 (292)
T cd06657 99 LEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKSLV 177 (292)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEcccccceecccccccccccc
Confidence 9999998776 3588999999999999999999999999999999999999887 79999999886543222 123345
Q ss_pred CCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhh
Q 020826 177 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAAL 256 (321)
Q Consensus 177 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (321)
++..|+|||.+.+ ..++.++|+||+|+++|++++|..||.. .........+.....
T Consensus 178 ~~~~y~~pE~~~~-~~~~~~~Dv~slGvil~el~tg~~p~~~-~~~~~~~~~~~~~~~---------------------- 233 (292)
T cd06657 178 GTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFN-EPPLKAMKMIRDNLP---------------------- 233 (292)
T ss_pred cCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhhCC----------------------
Confidence 7788999998876 6788999999999999999999999842 222222221111000
Q ss_pred hcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 257 VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
........+++.+.+++.+||+.||.+||++.++++||||..+..++
T Consensus 234 ------------~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~~~ 280 (292)
T cd06657 234 ------------PKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPPS 280 (292)
T ss_pred ------------cccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCCCc
Confidence 00001123567899999999999999999999999999999988655
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=275.32 Aligned_cols=243 Identities=18% Similarity=0.320 Sum_probs=190.7
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc--hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
.++|++.+.||+|++|+||.+.+. ++..+++|.++... ...+.+|+.++..+ +||||+++++++... ...+++|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~ 78 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMKL-SHEKLVQLYGVCTKQ--RPIYIVT 78 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcccHHHHHHHHHHHhcC-CCCCeeeEEEEEccC--CCcEEEE
Confidence 568999999999999999999874 44569999887533 45688999999999 899999999998543 4568999
Q ss_pred EeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCcc-
Q 020826 98 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY- 172 (321)
Q Consensus 98 e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~- 172 (321)
||+.+++|..++. .+++..+..++.|++.||+|||+.|++|+||+|.||+++.++ .++|+|||.+.........
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~-~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-CEEECCCccceecCCCceee
Confidence 9999998887762 478999999999999999999999999999999999999877 8999999998765432211
Q ss_pred -ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 173 -NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 173 -~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
....++..|+|||...+ ..++.++|+||||+++|+|++ |..||.. .........+.....
T Consensus 158 ~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~~---------------- 219 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLY-SKFSSKSDVWAFGVLMWEVYSLGKMPYER-FNNSETVEKVSQGLR---------------- 219 (256)
T ss_pred cCCCccChhhCCHHHHhc-CcccchhHHHHHHHHHHHHhcCCCCCcCc-CCHHHHHHHHhcCCC----------------
Confidence 12234567999999976 678899999999999999998 8888732 222111111111000
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
...+...++.+.+++.+||+.||++|||+.+++.+
T Consensus 220 --------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 220 --------------------LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred --------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 00011245789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=278.84 Aligned_cols=247 Identities=25% Similarity=0.396 Sum_probs=190.3
Q ss_pred eeeeecceEEEEEEEecCCceEEEEEecccch------HHHHHHHHHHHhh--cCCCCeeeeeeeeeccCCCCcEEEEEe
Q 020826 28 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK------KKIKREIKILQNL--CGGPNIVKLLDIVRDQQSKTPSLIFEH 99 (321)
Q Consensus 28 ~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~------~~~~~E~~~l~~l--~~h~~i~~~~~~~~~~~~~~~~lv~e~ 99 (321)
.||+|+||.||+|.+..+++.||+|.+..... .....|...++.+ ..||+++++++.+.+. ...++|+||
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--~~~~~v~e~ 78 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP--DKLSFILDL 78 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC--CEEEEEEec
Confidence 37999999999999988999999998864321 1233343333322 2799999999988653 466799999
Q ss_pred ecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCcccccc
Q 020826 100 VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRV 176 (321)
Q Consensus 100 ~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~~~~~ 176 (321)
+.+++|..++ ..+++..+..++.|++.||+|||+.+++|+||+|+||+++.++ .++|+|||++...... ......
T Consensus 79 ~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~-~~kl~dfg~~~~~~~~-~~~~~~ 156 (278)
T cd05606 79 MNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKK-KPHASV 156 (278)
T ss_pred CCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCC-CEEEccCcCccccCcc-CCcCcC
Confidence 9999987766 3489999999999999999999999999999999999999887 8999999998654322 223456
Q ss_pred CCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCC-hHHHHHHHHHhCChhhhHHhhhhcccCChhhHh
Q 020826 177 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN-YDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA 255 (321)
Q Consensus 177 ~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (321)
++..|+|||.+.+...++.++|+||+|+++|+|++|..||...... ..........
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----------------------- 213 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT----------------------- 213 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc-----------------------
Confidence 8889999999876456889999999999999999999998432211 1111100000
Q ss_pred hhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc-----CHHHHhcCCCcccCCCc
Q 020826 256 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp-----s~~ell~hp~~~~~~~~ 314 (321)
.....+..+|+++.+++.+||..||++|| ++.++++||||+.....
T Consensus 214 -------------~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~ 264 (278)
T cd05606 214 -------------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQ 264 (278)
T ss_pred -------------cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCch
Confidence 00111223567999999999999999999 99999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=280.14 Aligned_cols=272 Identities=35% Similarity=0.625 Sum_probs=205.7
Q ss_pred eEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 23 y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
|++.+.||+|++|.||+|++..+++.+++|.+.... ...+..|+.+++.+ +|++++++++++.+. ...++++
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~--~~~~~v~ 77 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKEL-KHPNIVKLLDVIHTE--RKLYLVF 77 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhc-CCCCHHHHHhhhhcC--CceEEEe
Confidence 677889999999999999998899999999987532 24567899999999 899999999998544 5678999
Q ss_pred EeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-cc
Q 020826 98 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EY 172 (321)
Q Consensus 98 e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~-~~ 172 (321)
|++++ +|..++ ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++ .++|+|||.+....... ..
T Consensus 78 e~~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~-~~~l~d~g~~~~~~~~~~~~ 155 (282)
T cd07829 78 EYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDG-VLKLADFGLARAFGIPLRTY 155 (282)
T ss_pred cCcCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCC-CEEEecCCcccccCCCcccc
Confidence 99985 666665 2589999999999999999999999999999999999999877 89999999987654322 23
Q ss_pred ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChh
Q 020826 173 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 252 (321)
Q Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (321)
.....+..|+|||.+.+...++.++|+||||++++++++|..|| .+......+..+.+..+......+..-.... .
T Consensus 156 ~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~ 231 (282)
T cd07829 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLF-PGDSEIDQLFKIFQILGTPTEESWPGVTKLP---D 231 (282)
T ss_pred CccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCC-CCccHHHHHHHHHHHhCCCcHHHHHhhcccc---c
Confidence 33455678999999877447899999999999999999998777 4454555555555555544333222111110 0
Q ss_pred hHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 253 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
............. ......+++++.++|++||+.||++||++.+++.||||
T Consensus 232 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 232 YKPTFPKFPPKDL-----EKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred ccccccccCccch-----HHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0000000000000 01111236789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-43 Score=273.23 Aligned_cols=290 Identities=29% Similarity=0.465 Sum_probs=221.1
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeecc-----
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----- 88 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~----- 88 (321)
....|+-..++|+|.||.||+|+.+++++.|++|..--+ ..-...+|+.+++.| +|+|++.+++++...
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~l-kHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKATPTN 93 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHh-cchhHHHHHHHHhhccCCcc
Confidence 356788889999999999999999999999998864321 234578999999999 999999999877421
Q ss_pred -CCCCcEEEEEeecCch---hhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecccee
Q 020826 89 -QSKTPSLIFEHVNNTD---FKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 164 (321)
Q Consensus 89 -~~~~~~lv~e~~~~~~---l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~ 164 (321)
....+++|+..|.... |.+...+++..++.+++.+++.||.|+|.+.|.|||+||.|++++.++ .++|+|||+++
T Consensus 94 r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dg-ilklADFGlar 172 (376)
T KOG0669|consen 94 RDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDG-ILKLADFGLAR 172 (376)
T ss_pred cccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCc-eEEeecccccc
Confidence 1234789999998654 444446799999999999999999999999999999999999999988 89999999996
Q ss_pred ecCCCC-----ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhh
Q 020826 165 FYHPGK-----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN 239 (321)
Q Consensus 165 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (321)
.+.... .++.++-|.+|++||.+++...++++.|+|+-||++.+|+++. |.++++.+..++..|....|.-...
T Consensus 173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrs-pimqgnteqqql~~Is~LcGs~tke 251 (376)
T KOG0669|consen 173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRS-PIMQGNTEQQQLHLISQLCGSITKE 251 (376)
T ss_pred ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccC-ccccCChHHHHHHHHHHHhccCCcc
Confidence 654322 2455677899999999999999999999999999999999987 5668888889999888888875444
Q ss_pred HHhhhhcccCChhhHhhhcc-cCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 240 AYLNKYHIELDPHLAALVGR-HSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
.|.+--.... ++.+... -.............+-.-+++..+|+.++|..||.+|++++++++|.||..-..+
T Consensus 252 vWP~~d~lpL---~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 252 VWPNVDNLPL---YQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred cCCCcccchH---HHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 3322211111 1111000 0000011111111111224689999999999999999999999999999876554
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=274.24 Aligned_cols=242 Identities=18% Similarity=0.316 Sum_probs=190.8
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc--chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
.++|++.+.||+|+||.||++..+ .+..+++|.+... ....+.+|+.+++.+ +||||+++++++.+ ....+++|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~iv~ 78 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKL-SHPKLVQLYGVCTQ--QKPLYIVT 78 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHC-CCCCceeEEEEEcc--CCCEEEEE
Confidence 467999999999999999999874 5568999987643 245788999999999 89999999999854 44578999
Q ss_pred EeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCcc-
Q 020826 98 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY- 172 (321)
Q Consensus 98 e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~- 172 (321)
||+.+++|.+++. .+++..+..++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||.+.........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG-VVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCC-eEEECCCCCccccCCCceec
Confidence 9999999887763 378899999999999999999999999999999999999877 8999999988754322221
Q ss_pred -ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 173 -NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 173 -~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
....++..|+|||.+.+ ..++.++|+||||+++|++++ |+.||. ..+..+....+.....
T Consensus 158 ~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~-~~~~~~~~~~i~~~~~---------------- 219 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFE-KKSNYEVVEMISRGFR---------------- 219 (256)
T ss_pred cCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCC-CCCHHHHHHHHHCCCC----------------
Confidence 12234457999999876 678999999999999999999 787873 3322222222211000
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
...+...++++.+++.+||+.||++|||++++++
T Consensus 220 --------------------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 220 --------------------LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred --------------------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0011124468999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=275.54 Aligned_cols=241 Identities=18% Similarity=0.312 Sum_probs=189.1
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc--chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
.++|++.++||+|++|+||+|.+..+ ..+++|.++.. ....+.+|+++++.+ +||||+++++.+.. ...++++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~---~~~~lv~ 79 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE---EPIYIVT 79 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhC-CCCCcceEEEEECC---CCcEEEE
Confidence 56799999999999999999988554 46999998753 245688999999999 89999999998632 3468999
Q ss_pred EeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCcc
Q 020826 98 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 172 (321)
Q Consensus 98 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~ 172 (321)
|++.+++|.+++. .+++..+..++.|++.||++||+++++|+||+|+||+++.++ .++|+|||.+.........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~-~~~L~dfg~~~~~~~~~~~ 158 (262)
T cd05071 80 EYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYT 158 (262)
T ss_pred EcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCC-cEEeccCCceeeccccccc
Confidence 9999999887774 378889999999999999999999999999999999999877 8999999998765432221
Q ss_pred --ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 173 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 173 --~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
....++..|+|||...+ ..++.++|+|||||++|++++ |..||. +.........+....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~-~~~~~~~~~~~~~~~---------------- 220 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYP-GMVNREVLDQVERGY---------------- 220 (262)
T ss_pred cccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCC-CCChHHHHHHHhcCC----------------
Confidence 12334567999999876 678999999999999999999 666663 332222222111000
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
.......+++.+.+++.+||+.||++|||+.++++
T Consensus 221 --------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 221 --------------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred --------------------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 00011235678999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=294.95 Aligned_cols=244 Identities=19% Similarity=0.312 Sum_probs=202.3
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
.|+|+. +....++-||+|+-|.||+|+. .++.||||.++ ..-+.++.-|++| +||||+++.++|. ...+
T Consensus 118 ~WeiPF--e~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~----elkETdIKHLRkL-kH~NII~FkGVCt--qsPc 186 (904)
T KOG4721|consen 118 LWEIPF--EEISELEWLGSGAQGAVFLGRL--HNETVAVKKVR----ELKETDIKHLRKL-KHPNIITFKGVCT--QSPC 186 (904)
T ss_pred hccCCH--HHhhhhhhhccCcccceeeeec--cCceehhHHHh----hhhhhhHHHHHhc-cCcceeeEeeeec--CCce
Confidence 466663 3566778899999999999996 67889999765 3446678889999 9999999999994 4567
Q ss_pred cEEEEEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 93 PSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
+|||||||..|.|.+.++ .+.......+..+|+.|+.|||.+.|+|||||.-||||+.++ .|||+|||-++.....
T Consensus 187 yCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d-~VKIsDFGTS~e~~~~ 265 (904)
T KOG4721|consen 187 YCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDD-VVKISDFGTSKELSDK 265 (904)
T ss_pred eEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccc-eEEeccccchHhhhhh
Confidence 789999999999988884 588888899999999999999999999999999999999888 8999999999877666
Q ss_pred CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 170 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
...-...||..|||||++.. .+++.+.||||||++||||+||..||-.-. ..+.| +
T Consensus 266 STkMSFaGTVaWMAPEvIrn-ePcsEKVDIwSfGVVLWEmLT~EiPYkdVd----ssAII---------------w---- 321 (904)
T KOG4721|consen 266 STKMSFAGTVAWMAPEVIRN-EPCSEKVDIWSFGVVLWEMLTGEIPYKDVD----SSAII---------------W---- 321 (904)
T ss_pred hhhhhhhhhHhhhCHHHhhc-CCcccccceehhHHHHHHHHhcCCCccccc----hheeE---------------E----
Confidence 55566789999999999998 899999999999999999999999982111 11100 0
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
..-...+.+.-+..+++-+.-||+.||+-.|..|||+.+++.|
T Consensus 322 -------------GVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 322 -------------GVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred -------------eccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHH
Confidence 0011122344455677889999999999999999999999998
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=283.54 Aligned_cols=254 Identities=23% Similarity=0.363 Sum_probs=208.3
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
..+-|.++++||+|+||.||+|.++.+|..+|+|.+..+ +...+.+|+.++++. ++|++|++|+.+-. ..-+++||
T Consensus 31 PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC-~S~yVVKYYGSYFK--~sDLWIVM 107 (502)
T KOG0574|consen 31 PEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQC-KSKYVVKYYGSYFK--HSDLWIVM 107 (502)
T ss_pred hHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHc-CCchhhhhhhhhcc--CCceEeeh
Confidence 345688999999999999999999999999999998754 457889999999998 99999999996632 34478999
Q ss_pred EeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC-CCCcc
Q 020826 98 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEY 172 (321)
Q Consensus 98 e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~-~~~~~ 172 (321)
|||+.|+..+.+ +++++.++..++..-+.||+|||...=+|||||+.||+++.+| ..||+|||.+-.+. ....-
T Consensus 108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G-~AKLADFGVAGQLTDTMAKR 186 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDG-IAKLADFGVAGQLTDTMAKR 186 (502)
T ss_pred hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccc-hhhhhhccccchhhhhHHhh
Confidence 999999987776 4699999999999999999999999999999999999999999 89999999985432 12234
Q ss_pred ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChh
Q 020826 173 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 252 (321)
Q Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (321)
++..||+.|+|||++.. -.|+..+||||||++..||..|+.||. +-...+....+
T Consensus 187 NTVIGTPFWMAPEVI~E-IGY~~~ADIWSLGITaIEMAEG~PPYs-DIHPMRAIFMI----------------------- 241 (502)
T KOG0574|consen 187 NTVIGTPFWMAPEVIEE-IGYDTKADIWSLGITAIEMAEGRPPYS-DIHPMRAIFMI----------------------- 241 (502)
T ss_pred CccccCcccccHHHHHH-hccchhhhHhhhcchhhhhhcCCCCcc-cccccceeEec-----------------------
Confidence 66789999999999987 678999999999999999999998873 22221111110
Q ss_pred hHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 253 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
...|.. +...+...|+++.+|+++||-.+|++|.||.++++|||.+...
T Consensus 242 --------PT~PPP---TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 242 --------PTKPPP---TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred --------cCCCCC---CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 111111 1222345678999999999999999999999999999999754
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=278.84 Aligned_cols=254 Identities=22% Similarity=0.402 Sum_probs=199.0
Q ss_pred ceEEeeeeeeecceEEEEEEEe---cCCceEEEEEecccc-------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPVK-------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~---~~~~~~~vK~~~~~~-------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
+|++.+.||+|+||.||+|.+. .++..+++|+++... ...+..|+.++..+.+|++|+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~--~~ 78 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--DT 78 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec--CC
Confidence 4889999999999999999875 378899999986422 24577899999999779999999998854 34
Q ss_pred CcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 92 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
..++++||+.+++|.+++ ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~ 157 (290)
T cd05613 79 KLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEFHE 157 (290)
T ss_pred eEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC-CEEEeeCccceeccc
Confidence 667999999999988776 3488999999999999999999999999999999999999887 899999999876533
Q ss_pred CC--ccccccCCccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhh
Q 020826 169 GK--EYNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245 (321)
Q Consensus 169 ~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (321)
.. ......++..|+|||.+.+. ...+.++||||||+++|++++|..||...... .....+.+.....
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~-~~~~~~~~~~~~~--------- 227 (290)
T cd05613 158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEK-NSQAEISRRILKS--------- 227 (290)
T ss_pred ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcc-ccHHHHHHHhhcc---------
Confidence 22 12234578889999998652 24678999999999999999999998422111 1111111100000
Q ss_pred cccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc-----CHHHHhcCCCcccCC
Q 020826 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIR 312 (321)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp-----s~~ell~hp~~~~~~ 312 (321)
. ...+..+++.+.+++++||+.||++|| ++++++.||||+.+.
T Consensus 228 ----------------~--------~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 228 ----------------E--------PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred ----------------C--------CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 0 001123567899999999999999997 899999999999886
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=280.33 Aligned_cols=244 Identities=19% Similarity=0.324 Sum_probs=191.5
Q ss_pred ccCceEEeeeeeeecceEEEEEEEe-----cCCceEEEEEecccc---hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~~~vK~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
..++|.+.+.||+|+||+||++.+. .++..+++|.+.... ...+.+|+++++++ +|||++++++++.. .
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~ 79 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVE--G 79 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec--C
Confidence 4678999999999999999999853 245578999886533 35688999999999 89999999999854 4
Q ss_pred CCcEEEEEeecCchhhhhcC----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCe
Q 020826 91 KTPSLIFEHVNNTDFKVLYP----------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK 154 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~~----------------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~ 154 (321)
...++++||+.+++|..++. .+++..+..++.|++.||+|||++|++|+||||+||+++.++ .
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~-~ 158 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL-L 158 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC-c
Confidence 56789999999999877762 378999999999999999999999999999999999999887 8
Q ss_pred EEEeeccceeecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHH
Q 020826 155 LRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIA 230 (321)
Q Consensus 155 v~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~ 230 (321)
++|+|||++........ .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||. ..........+.
T Consensus 159 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t~g~~p~~-~~~~~~~~~~i~ 236 (288)
T cd05093 159 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWY-QLSNNEVIECIT 236 (288)
T ss_pred EEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHH
Confidence 99999999875432221 122334567999999987 678999999999999999998 777773 222222222211
Q ss_pred HHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 231 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
... . ...+..+++++.+++.+||+.||.+|||+.++++
T Consensus 237 ~~~----------------------------~--------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 237 QGR----------------------------V--------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cCC----------------------------c--------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 100 0 0011235678999999999999999999999854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=290.74 Aligned_cols=250 Identities=23% Similarity=0.328 Sum_probs=191.5
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEecC-----CceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeee
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCTD-----NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLD 83 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~-----~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (321)
.|.++ .++|++.+.||+|+||.||+|.+... +..||+|+++... ...+.+|+.++.++..||||+++++
T Consensus 31 ~~~~~--~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 31 RWEFP--RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred ceecc--ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 55555 56999999999999999999987433 3479999987532 3567889999999955999999999
Q ss_pred eeeccCCCCcEEEEEeecCchhhhhcC-----------------------------------------------------
Q 020826 84 IVRDQQSKTPSLIFEHVNNTDFKVLYP----------------------------------------------------- 110 (321)
Q Consensus 84 ~~~~~~~~~~~lv~e~~~~~~l~~~~~----------------------------------------------------- 110 (321)
++.+ ....++||||+.+++|.+++.
T Consensus 109 ~~~~--~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (400)
T cd05105 109 ACTK--SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTT 186 (400)
T ss_pred EEcc--CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccc
Confidence 9954 456789999999998865531
Q ss_pred ----------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCC
Q 020826 111 ----------------------------------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPH 144 (321)
Q Consensus 111 ----------------------------------------------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~ 144 (321)
.+++..+..++.|++.||+|||+.+++|+||||+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~ 266 (400)
T cd05105 187 QYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAAR 266 (400)
T ss_pred ccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChH
Confidence 2566778889999999999999999999999999
Q ss_pred CeEEcCCCCeEEEeeccceeecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCC
Q 020826 145 NVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGH 220 (321)
Q Consensus 145 nili~~~~~~v~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~ 220 (321)
||+++.++ .++|+|||++........ .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||....
T Consensus 267 Nill~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~ 344 (400)
T cd05105 267 NVLLAQGK-IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFD-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMI 344 (400)
T ss_pred hEEEeCCC-EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence 99999877 899999999876533222 122345667999999877 678999999999999999997 888874222
Q ss_pred CChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHH
Q 020826 221 DNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 300 (321)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ 300 (321)
........+.. .. ....+..+++++.+++.+||+.||++|||+.
T Consensus 345 ~~~~~~~~~~~----------------------------~~--------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ 388 (400)
T cd05105 345 VDSTFYNKIKS----------------------------GY--------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFL 388 (400)
T ss_pred hhHHHHHHHhc----------------------------CC--------CCCCCccCCHHHHHHHHHHCccCHhHCcCHH
Confidence 11111111100 00 0001124567899999999999999999998
Q ss_pred HHhc
Q 020826 301 EAMA 304 (321)
Q Consensus 301 ell~ 304 (321)
++.+
T Consensus 389 ~l~~ 392 (400)
T cd05105 389 HLSD 392 (400)
T ss_pred HHHH
Confidence 8764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=283.50 Aligned_cols=243 Identities=18% Similarity=0.350 Sum_probs=190.3
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCc----eEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~----~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
..+|++.+.||+|+||+||+|++..+++ .+++|.++... ...+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~g~~~~~--- 81 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS--- 81 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEcCC---
Confidence 4679999999999999999999866655 38999986432 35677899999999 999999999988543
Q ss_pred CcEEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 92 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
..+++++++.+++|.+++. .++...+..++.||+.||+|||++|++|+||||+||+++.++ .++|+|||++....
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~-~~kl~DfG~a~~~~ 160 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG 160 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCC-cEEEcccccccccc
Confidence 3569999999998877663 378888999999999999999999999999999999999877 89999999998654
Q ss_pred CCCcc---ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 168 PGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 168 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
..... .....+..|+|||.+.+ ..++.++||||||+++|++++ |..||. +.. ......+... .
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~-~~~-~~~~~~~~~~---~------- 227 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYD-GIP-ASEISSILEK---G------- 227 (316)
T ss_pred CCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCC-CCC-HHHHHHHHhC---C-------
Confidence 33221 11223557999999987 788999999999999999997 888873 222 1111111110 0
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
. ....+..++.++.+++.+||+.||++|||+.+++.+
T Consensus 228 -----------------~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 228 -----------------E--------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred -----------------C--------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0 001112345689999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=280.14 Aligned_cols=258 Identities=28% Similarity=0.479 Sum_probs=207.5
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc--hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
.+...+.|++...||+|++|.||+|.+..++..+++|++.... ...+..|++.++.+ +|+|++++++.+... ...
T Consensus 14 ~~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~ 90 (286)
T cd06614 14 EGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDC-KHPNIVDYYDSYLVG--DEL 90 (286)
T ss_pred CCCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHC-CCCCeeEEEEEEEEC--CEE
Confidence 4556778999999999999999999998889999999997654 46688999999999 899999999998654 567
Q ss_pred EEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 94 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
++++||+.+++|.+++. .++...+..++.|++.||++||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDG-SVKLADFGFAAQLTKE 169 (286)
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCC-CEEECccchhhhhccc
Confidence 79999999999988773 689999999999999999999999999999999999999887 8999999987654322
Q ss_pred C-ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 170 K-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
. ......++..|+|||.+.+ ..++.++|+||||+++|++++|..||. ..+.......+.. ....
T Consensus 170 ~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~-~~~~~~~~~~~~~-~~~~------------ 234 (286)
T cd06614 170 KSKRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYL-REPPLRALFLITT-KGIP------------ 234 (286)
T ss_pred hhhhccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHh-cCCC------------
Confidence 1 1223356778999999876 678999999999999999999999983 2222221111110 0000
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCC
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~ 313 (321)
.......++.++.++|++||+.+|.+|||+.++++||||++...
T Consensus 235 ---------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 278 (286)
T cd06614 235 ---------------------PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKACP 278 (286)
T ss_pred ---------------------CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccCc
Confidence 00111125578999999999999999999999999999998543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=280.80 Aligned_cols=243 Identities=21% Similarity=0.366 Sum_probs=192.9
Q ss_pred cCceEEeeeeeeecceEEEEEEEec-----CCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
.++|.+.+.||+|+||.||+|.+.. ++..+++|.++... ...+.+|+++++.+ +|||++++++++...
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-- 80 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNF-QHENIVKFYGVCTEG-- 80 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhc-CCCCchheeeEEecC--
Confidence 5679999999999999999998743 35789999987542 35688999999999 899999999998654
Q ss_pred CCcEEEEEeecCchhhhhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCC
Q 020826 91 KTPSLIFEHVNNTDFKVLYP-----------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 153 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~~-----------------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~ 153 (321)
...+++|||+.+++|..++. .+++..+..++.|++.||.+||++|++|+||||+||+++.++
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~- 159 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL- 159 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC-
Confidence 56789999999999887762 267888999999999999999999999999999999999887
Q ss_pred eEEEeeccceeecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHH
Q 020826 154 KLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKI 229 (321)
Q Consensus 154 ~v~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~ 229 (321)
.++|+|||++........ .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||+.. +..+....+
T Consensus 160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~e~~~~g~~p~~~~-~~~~~~~~~ 237 (280)
T cd05049 160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPWYGL-SNEEVIECI 237 (280)
T ss_pred eEEECCcccceecccCcceecCCCCcccceecChhhhcc-CCcchhhhHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHH
Confidence 899999999875432221 123344677999999987 778999999999999999998 99888432 222222211
Q ss_pred HHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 230 AKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
.. +. ....+..++.++.+++++||+.||++|||+.|+++
T Consensus 238 ~~--~~----------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 238 TQ--GR----------------------------------LLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred Hc--CC----------------------------------cCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 10 00 00011235678999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=295.91 Aligned_cols=248 Identities=25% Similarity=0.419 Sum_probs=204.1
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
..|.-++.||.|+||.||-|++..+.+.||||...-. .-.++.+|+.+|+++ .|||++.+.+++..+ ...|
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l-~HPntieYkgCyLre--~TaW 102 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQL-RHPNTIEYKGCYLRE--HTAW 102 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhc-cCCCcccccceeecc--chHH
Confidence 3466778899999999999999999999999987532 235688999999999 999999999998553 4567
Q ss_pred EEEEeecCch---hhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc
Q 020826 95 LIFEHVNNTD---FKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 171 (321)
Q Consensus 95 lv~e~~~~~~---l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~ 171 (321)
+|||||-|.. +.-+.+++.+.++..|+.+.+.||+|||+.+.+|+|||+.||+++..| .|||+|||.+.... .
T Consensus 103 LVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g-~VKLaDFGSAsi~~---P 178 (948)
T KOG0577|consen 103 LVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPG-LVKLADFGSASIMA---P 178 (948)
T ss_pred HHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCC-eeeeccccchhhcC---c
Confidence 9999997763 455557899999999999999999999999999999999999999888 89999999987643 3
Q ss_pred cccccCCccccccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 172 YNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
.+..+|||+|+|||+++.. +.|+-+.||||||++..++...+.|+| +.+....+.-|.+.-.+. +
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF-nMNAMSALYHIAQNesPt-L----------- 245 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-NMNAMSALYHIAQNESPT-L----------- 245 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc-CchHHHHHHHHHhcCCCC-C-----------
Confidence 4678999999999998643 579999999999999999999998886 333333344333211111 0
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
.....|+.+++|+..||+.-|.+|||.+++|.|+|...-
T Consensus 246 -----------------------qs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 246 -----------------------QSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred -----------------------CCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 112356789999999999999999999999999998764
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=279.45 Aligned_cols=243 Identities=30% Similarity=0.513 Sum_probs=193.9
Q ss_pred eeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeecC
Q 020826 29 VGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 102 (321)
Q Consensus 29 lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 102 (321)
||.|+||.||++.+..+++.+++|.+.... ...+.+|+++++++ +|||++++++.+.. ....++++|++.+
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQA-QSPYVVKLYYSFQG--KKNLYLVMEYLPG 77 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhC-CCcchhHHHHheec--CcEEEEEEecCCC
Confidence 589999999999998889999999986432 34678899999999 79999999998854 4567899999999
Q ss_pred chhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC---------
Q 020826 103 TDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--------- 170 (321)
Q Consensus 103 ~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~--------- 170 (321)
++|..++ ..+++..+..++.|++.||++||+.|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 78 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~ 156 (265)
T cd05579 78 GDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQINLNDDEK 156 (265)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCC-CEEEEecccchhcccCcccccccccc
Confidence 9987776 3589999999999999999999999999999999999999888 89999999986543221
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
......++..|+|||.... ...+.++|+||||++++++++|..||.... .......+.. +..
T Consensus 157 ~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~-~~~~~~~~~~--~~~-------------- 218 (265)
T cd05579 157 EDKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGET-PEEIFQNILN--GKI-------------- 218 (265)
T ss_pred cccCcccCccccCHHHhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHhc--CCc--------------
Confidence 1223456778999999877 568899999999999999999999984222 1111111100 000
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCH---HHHhcCCCcccCC
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA---KEAMAHPYFFPIR 312 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~---~ell~hp~~~~~~ 312 (321)
... ....+++.+.+++++||+.+|++|||+ .++++||||++++
T Consensus 219 -------------~~~------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~ 264 (265)
T cd05579 219 -------------EWP------EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264 (265)
T ss_pred -------------CCC------ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCC
Confidence 000 001146789999999999999999999 9999999998763
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=278.90 Aligned_cols=245 Identities=18% Similarity=0.350 Sum_probs=189.0
Q ss_pred ccCceEEeeeeeeecceEEEEEEEec-----CCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 89 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (321)
..++|++.+.||+|++|+||+|.+.. ++..+++|.++... ...+.+|+.+++.+ +||||+++++++.+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~iv~~~~~~~~-- 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ-- 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEcC--
Confidence 46789999999999999999998753 34679999886432 34577899999998 89999999999844
Q ss_pred CCCcEEEEEeecCchhhhhcCC-------------CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEE
Q 020826 90 SKTPSLIFEHVNNTDFKVLYPT-------------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLR 156 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~~~-------------~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~ 156 (321)
....++++||+.+++|..++.. ++...+..++.|++.||+|||+.|++|+||||+||+++.++ .++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~-~~~ 159 (277)
T cd05062 81 GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-TVK 159 (277)
T ss_pred CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCC-CEE
Confidence 4567899999999999877632 35667888999999999999999999999999999999887 899
Q ss_pred EeeccceeecCCCCcc---ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHH
Q 020826 157 LIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKV 232 (321)
Q Consensus 157 l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 232 (321)
|+|||++......... ....++..|+|||++.+ ..++.++|+|||||++|++++ |..||. +.........+..
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~p~~-~~~~~~~~~~~~~- 236 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQ-GMSNEQVLRFVME- 236 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCCCCCC-CCCHHHHHHHHHc-
Confidence 9999998654322211 12234667999999877 678999999999999999999 566763 3322222211111
Q ss_pred hCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 233 LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
... ...+..+++.+.+++.+||+.||++|||+.|++++
T Consensus 237 ~~~-----------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 237 GGL-----------------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCc-----------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000 00112355789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=274.39 Aligned_cols=241 Identities=18% Similarity=0.340 Sum_probs=191.8
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc--hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
.++|++.++||+|+||.||+|.. .+++.+++|.+.... ...+.+|+.+++.+ +|||++++++++.+ ...++++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~~~~v~ 79 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQL-QHPRLVRLYAVVTQ---EPIYIIT 79 (260)
T ss_pred hHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhc-CCcCeeeEEEEEcc---CCcEEEE
Confidence 67999999999999999999986 467789999987533 46788999999999 89999999998743 3468999
Q ss_pred EeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc-
Q 020826 98 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE- 171 (321)
Q Consensus 98 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~- 171 (321)
|++.+++|.+++. .++...+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||.+........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 80 EYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETL-CCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCC-CEEEccCcceeecCCCCcc
Confidence 9999999877652 478889999999999999999999999999999999999887 899999999876542221
Q ss_pred -cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 172 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
.....++..|+|||.+.. ..++.++|+||||+++|++++ |+.||. +.+..+....+.....
T Consensus 159 ~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~-~~~~~~~~~~~~~~~~--------------- 221 (260)
T cd05067 159 AREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYP-GMTNPEVIQNLERGYR--------------- 221 (260)
T ss_pred cccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCC-CCChHHHHHHHHcCCC---------------
Confidence 122234567999999876 678899999999999999998 888883 3332222222111000
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
...+...+.++.+++.+||+.+|++|||++++++
T Consensus 222 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 222 ---------------------MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred ---------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0111235578999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=276.79 Aligned_cols=243 Identities=18% Similarity=0.335 Sum_probs=191.0
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCC-----ceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDN-----EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~-----~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
.++|++.+.||+|+||.||+|.++..+ ..+++|.+.... ...+.+|+.++..+ +|||++++++++.+ .
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~ 81 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEF-NCHHVVRLLGVVST--G 81 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhC-CCCceeEEEEEEcC--C
Confidence 569999999999999999999986543 789999986432 24577899999998 89999999999855 4
Q ss_pred CCcEEEEEeecCchhhhhcC-------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEE
Q 020826 91 KTPSLIFEHVNNTDFKVLYP-------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRL 157 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~~-------------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l 157 (321)
...++++||+.+++|..++. .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++ .++|
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~-~~kl 160 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL-TVKI 160 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCC-CEEE
Confidence 56789999999999887763 256778899999999999999999999999999999999888 8999
Q ss_pred eeccceeecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHh
Q 020826 158 IDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL 233 (321)
Q Consensus 158 ~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 233 (321)
+|||++........ .....++..|+|||.+.+ ..++.++|||||||++|++++ |..||. +.+.......+.. .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~-~~~~~~~~~~~~~-~ 237 (277)
T cd05032 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPYQ-GLSNEEVLKFVID-G 237 (277)
T ss_pred CCcccchhhccCcccccCCCCCccccccCHHHHhc-CCCCcccchHHHHHHHHHhhccCCCCCc-cCCHHHHHHHHhc-C
Confidence 99999865432221 123345678999999876 678999999999999999998 777773 3222222221110 0
Q ss_pred CChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 234 GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
.. ...+..+++++.+++.+||+.+|++|||+.++++
T Consensus 238 ~~-----------------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 238 GH-----------------------------------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred CC-----------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00 0011234678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-40 Score=277.88 Aligned_cols=246 Identities=18% Similarity=0.336 Sum_probs=191.6
Q ss_pred ccCceEEeeeeeeecceEEEEEEEec-----CCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 89 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (321)
..++|++.+.||+|++|.||+|.+.. ++..+++|.++... ...+..|+.+++.+ +|+||+++++++.+.
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~- 81 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF-NHQNIVRLIGVSFER- 81 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEccC-
Confidence 35789999999999999999999976 67889999876432 24578899999999 899999999988543
Q ss_pred CCCcEEEEEeecCchhhhhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCC--CeEEE
Q 020826 90 SKTPSLIFEHVNNTDFKVLYP----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRL 157 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~~----------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~--~~v~l 157 (321)
...++++|++.+++|..++. .+++..+..++.||+.||+|||+++++|+||+|+||+++.++ ..++|
T Consensus 82 -~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 82 -LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred -CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEe
Confidence 45679999999999887762 378889999999999999999999999999999999998653 25899
Q ss_pred eeccceeecCCCCcc---ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHh
Q 020826 158 IDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL 233 (321)
Q Consensus 158 ~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 233 (321)
+|||++......... .....+..|+|||++.+ ..++.++|||||||++|+|++ |..||. +.........+.. .
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~~g~~pf~-~~~~~~~~~~~~~-~ 237 (277)
T cd05036 161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYP-GRTNQEVMEFVTG-G 237 (277)
T ss_pred ccCccccccCCccceecCCCCCccHhhCCHHHHhc-CCcCchhHHHHHHHHHHHHHcCCCCCCC-CCCHHHHHHHHHc-C
Confidence 999998765322111 12223457999999977 679999999999999999997 888873 3222222111110 0
Q ss_pred CChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 234 GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
. ....+..+++++.+++++||+.||++|||+.++++|
T Consensus 238 ~-----------------------------------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 238 G-----------------------------------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred C-----------------------------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 000122456789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=277.31 Aligned_cols=262 Identities=20% Similarity=0.367 Sum_probs=194.7
Q ss_pred ccCceEEeeeeeeecceEEEEEEE----ecCCceEEEEEecccch---HHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVH----CTDNEKCIIKILKPVKK---KKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~----~~~~~~~~vK~~~~~~~---~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
...+|++.+.||+|+||+||++.. ..++..+++|.++.... ..+.+|++++..+ +|||++++++++......
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEccCCCC
Confidence 356899999999999999999973 45688999999875443 4678899999999 899999999987655556
Q ss_pred CcEEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 92 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
..++++||+.+++|..++. .+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~ 159 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESEN-RVKIGDFGLTKVLP 159 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCC-eEEECCCccccccc
Confidence 7789999999999987762 378899999999999999999999999999999999999887 89999999987654
Q ss_pred CCCcc----ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 168 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 168 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
..... ....++..|+|||...+ ..++.++|+||||+++++|++|..++.... .... +..+......
T Consensus 160 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~--~~~~----~~~~~~~~~~--- 229 (284)
T cd05081 160 QDKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPP--AEFM----RMMGNDKQGQ--- 229 (284)
T ss_pred CCCcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcc--hhhh----hhcccccccc---
Confidence 32221 11123345999999876 678999999999999999999887652211 1111 1111100000
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
.............. .......+++++.+++.+||+.+|++|||+.|+++
T Consensus 230 ----~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 230 ----MIVYHLIELLKNNG--------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred ----cchHHHHHHHhcCC--------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 00000001111100 01122346678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=279.36 Aligned_cols=248 Identities=19% Similarity=0.345 Sum_probs=192.5
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCC-----ceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeec
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDN-----EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRD 87 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~-----~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (321)
....++|++.+.||+|+||.||++.+...+ ..+++|.++... ...+.+|+++++.+.+||||+++++++..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 344679999999999999999999886443 689999887532 23577899999998779999999999854
Q ss_pred cCCCCcEEEEEeecCchhhhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEE
Q 020826 88 QQSKTPSLIFEHVNNTDFKVLY-------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 148 (321)
Q Consensus 88 ~~~~~~~lv~e~~~~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili 148 (321)
....++++||+.+++|..++ ..+++..+..++.|++.||+|||++|++|+||||+||++
T Consensus 88 --~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~ 165 (293)
T cd05053 88 --EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV 165 (293)
T ss_pred --CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEE
Confidence 44578999999999987765 237888899999999999999999999999999999999
Q ss_pred cCCCCeEEEeeccceeecCCCCcc---ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChH
Q 020826 149 DHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYD 224 (321)
Q Consensus 149 ~~~~~~v~l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~ 224 (321)
+.++ .++|+|||.+......... ....++..|+|||++.+ ..++.++|||||||++|++++ |..||. +....+
T Consensus 166 ~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~-~~~~~~ 242 (293)
T cd05053 166 TEDH-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYP-GIPVEE 242 (293)
T ss_pred cCCC-eEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHHhcCCCCCCC-CCCHHH
Confidence 9887 8999999998765432211 11223456999999876 678999999999999999997 888873 222222
Q ss_pred HHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 225 QLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
....+.. . . ....+...++++.+|+.+||..||++|||+.++++
T Consensus 243 ~~~~~~~---------------------------~-~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~ 286 (293)
T cd05053 243 LFKLLKE---------------------------G-Y--------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVE 286 (293)
T ss_pred HHHHHHc---------------------------C-C--------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 1111100 0 0 00111234578999999999999999999999986
Q ss_pred C
Q 020826 305 H 305 (321)
Q Consensus 305 h 305 (321)
+
T Consensus 287 ~ 287 (293)
T cd05053 287 D 287 (293)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=272.79 Aligned_cols=245 Identities=25% Similarity=0.488 Sum_probs=195.0
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
++|++.+.||+|++|.||+|.+..+++.+++|.++.. ....+.+|+.+++++ +|++++++++.+.+. ...+
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~-~~~~i~~~~~~~~~~--~~~~ 78 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQL-DHPNVIKYLASFIEN--NELN 78 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhC-CCCCeeeeeeeeecC--CeEE
Confidence 5899999999999999999999889999999988631 245688999999999 999999999998654 4567
Q ss_pred EEEEeecCchhhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 95 LIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 95 lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
+++||+++++|..++ ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||++....
T Consensus 79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~-~~~l~d~~~~~~~~ 157 (267)
T cd08224 79 IVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATG-VVKLGDLGLGRFFS 157 (267)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCC-cEEEeccceeeecc
Confidence 999999999987665 2378899999999999999999999999999999999999888 79999999987654
Q ss_pred CCC-ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhc
Q 020826 168 PGK-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246 (321)
Q Consensus 168 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (321)
... ......++..|+|||.+.+ ..++.++|+||||+++|++++|..||............. ....
T Consensus 158 ~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~~---------- 223 (267)
T cd08224 158 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK---IEKC---------- 223 (267)
T ss_pred CCCcccceecCCccccCHHHhcc-CCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhh---hhcC----------
Confidence 322 2233467888999999876 678999999999999999999999985433221111110 0000
Q ss_pred ccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
...+ .....++.++.++|.+||..+|++|||+.++++
T Consensus 224 --------------~~~~-------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 224 --------------DYPP-------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred --------------CCCC-------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 0000 001134568999999999999999999998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=271.08 Aligned_cols=245 Identities=28% Similarity=0.515 Sum_probs=200.2
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
+|++.+.||+|++|.||++++..+++.+++|.+.... ...+.+|++++.++ .||+++++++++.+. ...+++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~~v 77 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNL-KHPNIVKYIGSIETS--DSLYII 77 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhC-CCCCccEEEEEEEeC--CEEEEE
Confidence 5889999999999999999998889999999987543 35678999999999 899999999988553 567799
Q ss_pred EEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc-c
Q 020826 97 FEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-Y 172 (321)
Q Consensus 97 ~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~-~ 172 (321)
+|++.+++|.+++ ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+........ .
T Consensus 78 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~ 156 (254)
T cd06627 78 LEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG-VVKLADFGVATKLNDVSKDD 156 (254)
T ss_pred EecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC-CEEEeccccceecCCCcccc
Confidence 9999999998777 3589999999999999999999999999999999999999877 899999999876654332 2
Q ss_pred ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChh
Q 020826 173 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 252 (321)
Q Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (321)
....++..|+|||...+ ..++.++|+||+|++++++++|..||.... .......... .
T Consensus 157 ~~~~~~~~y~~pe~~~~-~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~-~~~~~~~~~~---~----------------- 214 (254)
T cd06627 157 ASVVGTPYWMAPEVIEM-SGASTASDIWSLGCTVIELLTGNPPYYDLN-PMAALFRIVQ---D----------------- 214 (254)
T ss_pred cccccchhhcCHhhhcC-CCCCcchhHHHHHHHHHHHHhCCCCCCCcc-HHHHHHHHhc---c-----------------
Confidence 33467788999999877 558899999999999999999999984222 1111111100 0
Q ss_pred hHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 253 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
. ....+..+++++.+++.+||..+|++|||+.++++||||
T Consensus 215 --------~--------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 215 --------D--------HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred --------C--------CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 0 001122456789999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=275.91 Aligned_cols=243 Identities=19% Similarity=0.353 Sum_probs=188.9
Q ss_pred eEEeeeeeeecceEEEEEEEecC---CceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccC----C
Q 020826 23 YEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----S 90 (321)
Q Consensus 23 y~~~~~lg~g~~g~v~~~~~~~~---~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~----~ 90 (321)
|++.+.||+|+||.||+|....+ +..+|+|.++... ...+..|+..++.+ +|||++++++++.... .
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDF-DHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhC-CCCCeeeEEeeeccCCccccC
Confidence 56788999999999999987653 4789999987432 24578899999999 8999999999875432 2
Q ss_pred CCcEEEEEeecCchhhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecc
Q 020826 91 KTPSLIFEHVNNTDFKVLY---------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 161 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg 161 (321)
...++++||+.+++|..++ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~dfg 158 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM-TVCVADFG 158 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCC-eEEECCcc
Confidence 3578999999999987665 2478899999999999999999999999999999999999887 89999999
Q ss_pred ceeecCCCCcc---ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChh
Q 020826 162 LAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDE 237 (321)
Q Consensus 162 ~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (321)
++......... .....+..|+|||.+.+ ..++.++|||||||++|++++ |..|| .+....+....+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~SlG~il~el~~~g~~p~-~~~~~~~~~~~~~~~~---- 232 (273)
T cd05035 159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGQTPY-PGVENHEIYDYLRHGN---- 232 (273)
T ss_pred ceeeccccccccccccccCCccccCHhhccc-CCCCcccchHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCC----
Confidence 98765433221 12234567999999876 778999999999999999999 66666 3333322222211100
Q ss_pred hhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 238 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
....+..+++++.+++.+||+.||++|||+.|++++
T Consensus 233 --------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 233 --------------------------------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred --------------------------------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000112456789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=301.08 Aligned_cols=247 Identities=23% Similarity=0.400 Sum_probs=201.4
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEec-----CCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeee
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLD 83 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (321)
+..|++. +.+..+.||+|.||+||+|+..+ ....||||.++... ..+|++|++.+..| +|||||++++
T Consensus 480 ~~~i~r~--~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l-~H~nIVrLlG 556 (774)
T KOG1026|consen 480 VLEIPRS--DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAEL-QHPNIVRLLG 556 (774)
T ss_pred eeEechh--heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhc-cCCCeEEEEE
Confidence 4455544 66777899999999999998643 34589999998653 45799999999999 9999999999
Q ss_pred eeeccCCCCcEEEEEeecCchhhhhcC-------------C----CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCe
Q 020826 84 IVRDQQSKTPSLIFEHVNNTDFKVLYP-------------T----LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNV 146 (321)
Q Consensus 84 ~~~~~~~~~~~lv~e~~~~~~l~~~~~-------------~----~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~ni 146 (321)
++... .-.++|+|||..|+|.++++ . ++..+...|+.||+.||+||-++.+|||||.+.|+
T Consensus 557 VC~~~--~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNC 634 (774)
T KOG1026|consen 557 VCREG--DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNC 634 (774)
T ss_pred EEccC--CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhc
Confidence 99654 44569999999999998882 1 77888999999999999999999999999999999
Q ss_pred EEcCCCCeEEEeeccceeecCCCCcccc---ccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCC
Q 020826 147 MIDHEQRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDN 222 (321)
Q Consensus 147 li~~~~~~v~l~dfg~~~~~~~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~ 222 (321)
||..+- .|||+|||+++.....+-+.. ..-..+|||||.+.. +.++++|||||+|++|||+++ |..|+ .+..+
T Consensus 635 LVge~l-~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly-~kFTteSDVWs~GVvLWEIFsyG~QPy-~glSn 711 (774)
T KOG1026|consen 635 LVGENL-VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILY-GKFTTESDVWSFGVVLWEIFSYGKQPY-YGLSN 711 (774)
T ss_pred eeccce-EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhc-CcccchhhhhhhhhhhhhhhccccCcc-cccch
Confidence 999776 999999999976543332222 223457999999998 899999999999999999996 67776 56666
Q ss_pred hHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHH
Q 020826 223 YDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 302 (321)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~el 302 (321)
.+.++.+.+. . .+..+..+|+++.+|+..||+.+|++|||++||
T Consensus 712 ~EVIe~i~~g----------------------------------~--lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 712 QEVIECIRAG----------------------------------Q--LLSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred HHHHHHHHcC----------------------------------C--cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 6666654330 0 134455788999999999999999999999987
Q ss_pred h
Q 020826 303 M 303 (321)
Q Consensus 303 l 303 (321)
=
T Consensus 756 ~ 756 (774)
T KOG1026|consen 756 H 756 (774)
T ss_pred H
Confidence 3
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=277.63 Aligned_cols=244 Identities=18% Similarity=0.349 Sum_probs=190.8
Q ss_pred cCceEEeeeeeeecceEEEEEEEe----cCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHC----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~----~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
-++|++.+.||+|+||+||+|... .++..+++|.++... ...+.+|+.+++.+ +||||+++++++... .
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~ 80 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAEL-HHPNIVCLLGVVTQE--Q 80 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCCeeeEEEEEecC--C
Confidence 368999999999999999999853 345789999987432 24578899999999 899999999998553 4
Q ss_pred CcEEEEEeecCchhhhhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCC
Q 020826 92 TPSLIFEHVNNTDFKVLYP--------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 151 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~~--------------------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~ 151 (321)
..+++|||+.+++|..++. .+++..+..++.|++.||+|||++|++|+||||+||+++.+
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 5679999999999877651 36778889999999999999999999999999999999987
Q ss_pred CCeEEEeeccceeecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHH
Q 020826 152 QRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLV 227 (321)
Q Consensus 152 ~~~v~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~ 227 (321)
+ .++|+|||++........ .....++..|+|||.+.+ ..++.++|+||||+++|+|++ |..||. +........
T Consensus 161 ~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~g~~p~~-~~~~~~~~~ 237 (283)
T cd05090 161 L-HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMY-GKFSSDSDIWSFGVVLWEIFSFGLQPYY-GFSNQEVIE 237 (283)
T ss_pred C-cEEeccccccccccCCcceecccCCCccceecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCC-CCCHHHHHH
Confidence 7 799999999876532221 122334567999999976 678999999999999999998 877773 222222222
Q ss_pred HHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 228 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
.+.. ... ...+..+++.+.+++.+||+.||++||++.+++++
T Consensus 238 ~~~~-~~~-----------------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 238 MVRK-RQL-----------------------------------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred HHHc-CCc-----------------------------------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 2111 000 00122356789999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=273.54 Aligned_cols=244 Identities=22% Similarity=0.431 Sum_probs=198.1
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
+|++.+.||+|++|.||++++..+++.+++|.+... ....+.+|+.+++.+ +||||+++.+.+.+. ...+++
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~~v 77 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV-NHPNIISYKEAFLDG--NKLCIV 77 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhC-CCCCchhhhhhhccC--CEEEEE
Confidence 589999999999999999999889999999998643 234567899999999 799999999988554 567899
Q ss_pred EEeecCchhhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 97 FEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 97 ~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
+|++++++|..++ ..+++..++.++.|++.||++||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~-~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 78 MEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND-LVKIGDLGISKVLKKN 156 (256)
T ss_pred ehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCC-cEEEeeccchhhhccC
Confidence 9999999987766 3488899999999999999999999999999999999999877 8999999998766544
Q ss_pred CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 170 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
......++..|+|||.+.+ ..++.++|+||||++++++++|+.||. ..+..+....+.. .
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~-~~~~~~~~~~~~~----~------------- 216 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFE-ARSMQDLRYKVQR----G------------- 216 (256)
T ss_pred -CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHhc----C-------------
Confidence 3334567888999999977 678899999999999999999999983 2222111111100 0
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
... ......+.++.+++.+||+.+|++|||+.++++||++
T Consensus 217 -----------~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 217 -----------KYP--------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred -----------CCC--------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 000 0011345789999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=284.05 Aligned_cols=266 Identities=21% Similarity=0.327 Sum_probs=201.2
Q ss_pred eeeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc---hHHHHHHHHHHHhhcCCCCeeeeeeeeecc
Q 020826 12 CVWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 88 (321)
Q Consensus 12 ~~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (321)
+--.|....++|.-...||+|+||.||+|.. .++..||||.+.... ...+.+|+.++.++ +|||+++++++|.+.
T Consensus 66 s~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l-~H~Nlv~LlGyC~e~ 143 (361)
T KOG1187|consen 66 SYDELRKATNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRL-RHPNLVKLLGYCLEG 143 (361)
T ss_pred eHHHHHHHHhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcC-CCcCcccEEEEEecC
Confidence 3345566678899889999999999999998 455899999887644 45699999999999 799999999999765
Q ss_pred CCCCcEEEEEeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeeecCCCCCeEEcCCCCeEEEeec
Q 020826 89 QSKTPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQG---IMHRDVKPHNVMIDHEQRKLRLIDW 160 (321)
Q Consensus 89 ~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~---i~H~dlkp~nili~~~~~~v~l~df 160 (321)
+. ..+||+||+..|+|.+++. .+++....+|+.+++.||+|||... |+|||||+.|||+|.+. +.||+||
T Consensus 144 ~~-~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~-~aKlsDF 221 (361)
T KOG1187|consen 144 GE-HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF-NAKLSDF 221 (361)
T ss_pred Cc-eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC-CEEccCc
Confidence 43 5789999999999988872 5789999999999999999999854 99999999999999887 8999999
Q ss_pred cceeecCC-CCccccc-cCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCC-hHHHHH-HHHHhCCh
Q 020826 161 GLAEFYHP-GKEYNVR-VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN-YDQLVK-IAKVLGTD 236 (321)
Q Consensus 161 g~~~~~~~-~~~~~~~-~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~-~~~~~~-~~~~~~~~ 236 (321)
|++...+. ....... .||..|++||+... +..+.++||||||+++.|++||+.+....... ...+.. ....+...
T Consensus 222 GLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~ 300 (361)
T KOG1187|consen 222 GLAKLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG 300 (361)
T ss_pred cCcccCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence 99976554 3333333 89999999999987 78999999999999999999999887543211 111111 11111111
Q ss_pred hhhHHhhhhcccCChhhHhhhcccCC-CCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 237 ELNAYLNKYHIELDPHLAALVGRHSR-KPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
.. ..+++.... ....... .-..+..+..+|++.+|.+||++.|+++
T Consensus 301 ~~---------------~eiiD~~l~~~~~~~~~-------~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 301 KL---------------REIVDPRLKEGEYPDEK-------EVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred ch---------------hheeCCCccCCCCChHH-------HHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 11 112221111 0000000 0125888999999999999999998753
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=279.32 Aligned_cols=251 Identities=25% Similarity=0.386 Sum_probs=196.4
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
..+.|...+.||+|++|+||+|++..+++.+++|.+.... ...+..|+.+++.+ +|||++++++++.+. ..
T Consensus 19 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~ 95 (313)
T cd06633 19 PEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQL-KHPNTIEYKGCYLKE--HT 95 (313)
T ss_pred HHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEeC--CE
Confidence 3455777888999999999999998899999999986321 24577899999999 899999999998654 45
Q ss_pred cEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 93 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
.++++||+.+..+..+. ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.++ .++|+|||++....
T Consensus 96 ~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~-~~kL~dfg~~~~~~-- 172 (313)
T cd06633 96 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG-QVKLADFGSASKSS-- 172 (313)
T ss_pred EEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCC-CEEEeecCCCcccC--
Confidence 67999999875544332 3588999999999999999999999999999999999999887 79999999886432
Q ss_pred CccccccCCccccccccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 170 KEYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 170 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
......++..|+|||.+.. ...++.++|+||||+++|+|++|..||.... .......+... ..+
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~-~~~~~~~~~~~-~~~----------- 238 (313)
T cd06633 173 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQN-DSP----------- 238 (313)
T ss_pred -CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHhc-CCC-----------
Confidence 2234567888999999842 2568889999999999999999999985332 22222211110 000
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
......++..+.+++.+||+.+|++||++.++++||||+...
T Consensus 239 -----------------------~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 239 -----------------------TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred -----------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 000112446799999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=304.40 Aligned_cols=244 Identities=23% Similarity=0.341 Sum_probs=190.0
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
++|++.+.||+|+||.||+|.+..+++.||+|+++... .+.+.+|+.++..+ +||||+++++++.+ ....+
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L-~HPNIVkl~~v~~d--~~~ly 78 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADL-IHPGIVPVYSICSD--GDPVY 78 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhC-CCcCcCeEEEEEee--CCEEE
Confidence 58999999999999999999999999999999986431 34678899999999 89999999999855 44667
Q ss_pred EEEEeecCchhhhhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeec
Q 020826 95 LIFEHVNNTDFKVLYP--------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW 160 (321)
Q Consensus 95 lv~e~~~~~~l~~~~~--------------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~df 160 (321)
++|||+++++|..++. ..+...+..++.||+.||+|||++|++||||||+||+++.++ .++|+||
T Consensus 79 LVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg-~vKLiDF 157 (932)
T PRK13184 79 YTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFG-EVVILDW 157 (932)
T ss_pred EEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCC-CEEEEec
Confidence 9999999999877652 234566788999999999999999999999999999999888 7999999
Q ss_pred cceeecCCCC-------------------ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCC
Q 020826 161 GLAEFYHPGK-------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 221 (321)
Q Consensus 161 g~~~~~~~~~-------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~ 221 (321)
|++....... ......||+.|+|||.+.+ ..++.++|||||||++|+|++|..||....
T Consensus 158 GLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g-~~~S~kSDIWSLGVILyELLTG~~PF~~~~- 235 (932)
T PRK13184 158 GAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG-VPASESTDIYALGVILYQMLTLSFPYRRKK- 235 (932)
T ss_pred CcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcC-CCCCcHhHHHHHHHHHHHHHHCCCCCCCcc-
Confidence 9987652110 0112358999999999987 678999999999999999999999984311
Q ss_pred ChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHH
Q 020826 222 NYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE 301 (321)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~e 301 (321)
....... .....+ ........+++.+.+++.+||+.||++|++..+
T Consensus 236 ~~ki~~~--~~i~~P--------------------------------~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~e 281 (932)
T PRK13184 236 GRKISYR--DVILSP--------------------------------IEVAPYREIPPFLSQIAMKALAVDPAERYSSVQ 281 (932)
T ss_pred hhhhhhh--hhccCh--------------------------------hhccccccCCHHHHHHHHHHccCChhhCcCHHH
Confidence 1111000 000000 000011246678999999999999999987655
Q ss_pred Hhc
Q 020826 302 AMA 304 (321)
Q Consensus 302 ll~ 304 (321)
.+.
T Consensus 282 eLl 284 (932)
T PRK13184 282 ELK 284 (932)
T ss_pred HHH
Confidence 443
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=276.96 Aligned_cols=245 Identities=25% Similarity=0.465 Sum_probs=193.7
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
++|++.+.||+|++|.||++.+..++..+++|.+... ....+.+|+.+++.+ +||||+++++.+.+. ...+
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~~--~~~~ 78 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIED--NELN 78 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHc-cCCchhhhhheeEeC--CeEE
Confidence 5788999999999999999999889999999987532 234677899999999 899999999998653 4567
Q ss_pred EEEEeecCchhhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 95 LIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 95 lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
+++|++.+++|..++. .+++..++.++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||++....
T Consensus 79 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~ 157 (267)
T cd08229 79 IVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFS 157 (267)
T ss_pred EEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEECcchhhhccc
Confidence 9999999998877652 378899999999999999999999999999999999999887 89999999887654
Q ss_pred CCCc-cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhc
Q 020826 168 PGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246 (321)
Q Consensus 168 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (321)
.... .....++..|+|||.+.+ ...+.++|+||||+++|+|++|..||...................
T Consensus 158 ~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----------- 225 (267)
T cd08229 158 SKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY----------- 225 (267)
T ss_pred cCCcccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCC-----------
Confidence 3222 233467888999999977 678899999999999999999999985332221111110000000
Q ss_pred ccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
+ ......+++++.+++.+||+.||++|||+.++++
T Consensus 226 -----------------~------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 226 -----------------P------PLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred -----------------C------CCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 0 0001235678999999999999999999997763
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=271.23 Aligned_cols=242 Identities=19% Similarity=0.335 Sum_probs=190.8
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc--hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
.++|++.+.||+|++|.||+|.+. ++..+++|.++... ...+.+|+.+++++ +|||++++++++... ...++++
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~ 80 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKL-RHPKLIQLYAVCTLE--EPIYIVT 80 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHC-CCCCccceeEEEecC--CCeeeee
Confidence 467999999999999999999974 55789999987543 45688999999999 899999999988544 4567999
Q ss_pred EeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCcc
Q 020826 98 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 172 (321)
Q Consensus 98 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~ 172 (321)
|++.+++|.+++. .++...+..++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||++.........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 81 ELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENN-ICKVADFGLARVIKEDIYE 159 (261)
T ss_pred ecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCC-CEEECCcceEEEccCCccc
Confidence 9999999987763 478999999999999999999999999999999999999888 7999999999876422211
Q ss_pred --ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 173 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 173 --~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
.....+..|+|||+..+ ..++.++|+||||++++++++ |..||. +.........+....
T Consensus 160 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~-~~~~~~~~~~~~~~~---------------- 221 (261)
T cd05068 160 AREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYP-GMTNAEVLQQVDQGY---------------- 221 (261)
T ss_pred ccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCC-CCCHHHHHHHHHcCC----------------
Confidence 11122346999999877 678999999999999999999 887773 322222222111100
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
+ ......+++++.+++.+||+.+|++||+++++++
T Consensus 222 --------------~------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 222 --------------R------MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred --------------C------CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 0 0011235578999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=279.78 Aligned_cols=251 Identities=20% Similarity=0.318 Sum_probs=193.2
Q ss_pred eeeeeecccCceEEeeeeeeecceEEEEEEEecC-------CceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeee
Q 020826 12 CVWFINREQDDYEVVRKVGRGKYSEVFEGVHCTD-------NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVK 80 (321)
Q Consensus 12 ~~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~-------~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~ 80 (321)
+.|.++ .++|.+.+.||+|+||.||++++... ...+++|.++... ...+..|+.+++.+.+||||++
T Consensus 11 ~~~~~~--~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~ 88 (307)
T cd05098 11 PRWEVP--RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIIN 88 (307)
T ss_pred Ccceee--hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEee
Confidence 456666 46999999999999999999987532 2469999987532 2457789999999878999999
Q ss_pred eeeeeeccCCCCcEEEEEeecCchhhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecC
Q 020826 81 LLDIVRDQQSKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDV 141 (321)
Q Consensus 81 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dl 141 (321)
+++++... ...++++||+.+++|..++. .++...+..++.|++.||+|||++|++|+||
T Consensus 89 ~~~~~~~~--~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dl 166 (307)
T cd05098 89 LLGACTQD--GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDL 166 (307)
T ss_pred EEEEEecC--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccc
Confidence 99998554 45679999999999877763 2677889999999999999999999999999
Q ss_pred CCCCeEEcCCCCeEEEeeccceeecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCc
Q 020826 142 KPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFF 217 (321)
Q Consensus 142 kp~nili~~~~~~v~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~ 217 (321)
||+||+++.++ .++|+|||.+........ .....++..|+|||.+.+ ..++.++|+|||||++|+|++ |..||.
T Consensus 167 kp~Nill~~~~-~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~~~g~~p~~ 244 (307)
T cd05098 167 AARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYP 244 (307)
T ss_pred cHHheEEcCCC-cEEECCCcccccccccchhhccccCCCccceeChHHhcc-CCCCcHHHHHHHHHHHHHHHcCCCCCCC
Confidence 99999999887 899999999875532211 111223457999999877 678999999999999999998 777762
Q ss_pred cCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc
Q 020826 218 YGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP 297 (321)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp 297 (321)
+.+ .+.+........ ....+..++.++.+++.+||..+|++||
T Consensus 245 -~~~-~~~~~~~~~~~~-----------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp 287 (307)
T cd05098 245 -GVP-VEELFKLLKEGH-----------------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRP 287 (307)
T ss_pred -cCC-HHHHHHHHHcCC-----------------------------------CCCCCCcCCHHHHHHHHHHcccChhhCc
Confidence 222 222111111000 0011223567999999999999999999
Q ss_pred CHHHHhcC
Q 020826 298 TAKEAMAH 305 (321)
Q Consensus 298 s~~ell~h 305 (321)
|+.+++++
T Consensus 288 s~~evl~~ 295 (307)
T cd05098 288 TFKQLVED 295 (307)
T ss_pred CHHHHHHH
Confidence 99999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=273.81 Aligned_cols=244 Identities=18% Similarity=0.317 Sum_probs=191.7
Q ss_pred cCceEEeeeeeeecceEEEEEEEecC---CceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~---~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
.++|++.+.||+|+||+||+|.+..+ ...+++|.++... ...+.+|+..++.+ +||||+++++.+.. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~ 79 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQF-DHPNIIRLEGVVTK--SRP 79 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCcceEeEEEec--CCc
Confidence 46899999999999999999998644 4579999886432 34577899999999 89999999998854 455
Q ss_pred cEEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 93 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
.++++|++.+++|..++. .++...+..++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~-~~~l~dfg~~~~~~~ 158 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRRLED 158 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-CEEECccchhhcccc
Confidence 689999999999988762 488999999999999999999999999999999999999887 899999999976642
Q ss_pred CCc-cc--cccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhh
Q 020826 169 GKE-YN--VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244 (321)
Q Consensus 169 ~~~-~~--~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (321)
... .. ...++..|+|||.+.+ ..++.++||||||+++|++++ |..||.. .........+.+..
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~-~~~~~~~~~~~~~~----------- 225 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWD-MSNQDVIKAVEDGY----------- 225 (266)
T ss_pred cccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCC-CCHHHHHHHHHcCC-----------
Confidence 111 11 1233467999999876 678999999999999999997 8888732 22221111111100
Q ss_pred hcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
. ...+...++.+.+++.+||+.+|++||++.+++++
T Consensus 226 -----------------~--------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 226 -----------------R--------LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred -----------------C--------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 00112356789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=275.91 Aligned_cols=244 Identities=19% Similarity=0.348 Sum_probs=194.8
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc---hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
+...+|++.+.||.|++|.||+|.+.. +..+++|.++... ...+..|+.+++.+ +|||++++++++.+ ....+
T Consensus 3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~ 78 (261)
T cd05148 3 RPREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRL-RHKHLISLFAVCSV--GEPVY 78 (261)
T ss_pred CcHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcC-CCcchhheeeeEec--CCCeE
Confidence 456789999999999999999999966 8899999987543 35688999999999 89999999998854 44678
Q ss_pred EEEEeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 95 LIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 95 lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
+++||+.+++|.+++. .++...+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||.+......
T Consensus 79 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~-~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 79 IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDL-VCKVADFGLARLIKED 157 (261)
T ss_pred EEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCc-eEEEccccchhhcCCc
Confidence 9999999999988874 378889999999999999999999999999999999999887 8999999998655322
Q ss_pred Cc-cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 170 KE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 170 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
.. .....++..|+|||.... ..++.++|+||||++++++++ |..||. ..+..+....+.....
T Consensus 158 ~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~-~~~~~~~~~~~~~~~~------------- 222 (261)
T cd05148 158 VYLSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYP-GMNNHEVYDQITAGYR------------- 222 (261)
T ss_pred cccccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCC-cCCHHHHHHHHHhCCc-------------
Confidence 11 122234567999999876 678899999999999999998 787873 3322222222111000
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
......+++++.+++.+||+.||++|||+.++++
T Consensus 223 -----------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 223 -----------------------MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred -----------------------CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0111245678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=272.14 Aligned_cols=241 Identities=18% Similarity=0.347 Sum_probs=190.2
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc--chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
.++|++.+.||+|++|.||+|.+. ++..+++|.++.. ....+.+|+.+++++ +||+++++++++.. ...+++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~---~~~~lv~ 79 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKL-RHDKLVQLYAVVSE---EPIYIVT 79 (260)
T ss_pred hHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhc-CCCceEEEEeEECC---CCcEEEE
Confidence 568999999999999999999874 5667999998753 346788999999999 89999999998743 3467999
Q ss_pred EeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCcc
Q 020826 98 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 172 (321)
Q Consensus 98 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~ 172 (321)
||+.+++|.+++. .+++..+..++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||.+.........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~-~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05070 80 EYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL-VCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCc-eEEeCCceeeeeccCcccc
Confidence 9999999887762 378899999999999999999999999999999999999877 8999999999765432211
Q ss_pred --ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 173 --NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 173 --~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
....++..|+|||...+ ..++.++|+||||+++|++++ |..||. +.+..+....+....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~-~~~~~~~~~~~~~~~---------------- 220 (260)
T cd05070 159 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYP-GMNNREVLEQVERGY---------------- 220 (260)
T ss_pred cccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCC-CCCHHHHHHHHHcCC----------------
Confidence 11234456999999876 678899999999999999999 777773 333322222211100
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
....+...+.++.+++.+||+.||++|||++++.+
T Consensus 221 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 221 --------------------RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred --------------------CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 00111235678999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=271.20 Aligned_cols=241 Identities=18% Similarity=0.315 Sum_probs=188.4
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc--hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
.++|++.+.||+|++|+||+|.+..+ ..+++|.+.... ...+.+|+.+++.+ +||+++++++++.. ...+++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~---~~~~~v~ 79 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKL-RHDKLVPLYAVVSE---EPIYIVT 79 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhC-CCCCeeeEEEEEcC---CCcEEEE
Confidence 45799999999999999999988544 468999876532 35688899999999 89999999998742 3467999
Q ss_pred EeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc-
Q 020826 98 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE- 171 (321)
Q Consensus 98 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~- 171 (321)
||+.+++|.+++. .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||.+........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~-~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNL-VCKIADFGLARLIEDNEYT 158 (260)
T ss_pred EcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC-eEEECCCccceEccCCccc
Confidence 9999998877763 268888999999999999999999999999999999999887 899999999876533221
Q ss_pred -cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 172 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
.....++..|+|||...+ ...+.++|+||||+++|++++ |..||. +....+....+.....
T Consensus 159 ~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~-~~~~~~~~~~~~~~~~--------------- 221 (260)
T cd05069 159 ARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYP-GMVNREVLEQVERGYR--------------- 221 (260)
T ss_pred ccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHcCCC---------------
Confidence 112234567999998876 678999999999999999999 787773 3222222221111000
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
...+...+..+.+++++||+.||++|||++++++
T Consensus 222 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 222 ---------------------MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred ---------------------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 0011235578999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=278.44 Aligned_cols=246 Identities=22% Similarity=0.333 Sum_probs=191.3
Q ss_pred ccCceEEeeeeeeecceEEEEEEEe-----cCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 89 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (321)
..++|++.+.||+|+||.||++.+. .++..+++|.++... ...+.+|+.+++++.+||||+++++.+...
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 111 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG- 111 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC-
Confidence 3568999999999999999999863 234579999886432 245788999999997799999999998554
Q ss_pred CCCcEEEEEeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecccee
Q 020826 90 SKTPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 164 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~ 164 (321)
...++++||+.+++|..++. .+++..+..++.|++.||+|||+++++|+||||+||+++.++ .++++|||++.
T Consensus 112 -~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~~l~dfg~~~ 189 (302)
T cd05055 112 -GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK-IVKICDFGLAR 189 (302)
T ss_pred -CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC-eEEECCCcccc
Confidence 45689999999999887763 278999999999999999999999999999999999999777 89999999987
Q ss_pred ecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhH
Q 020826 165 FYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNA 240 (321)
Q Consensus 165 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (321)
....... .....++..|+|||.+.+ ..++.++||||+||++|++++ |..||..... .........
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslGvil~el~t~g~~p~~~~~~-~~~~~~~~~--------- 258 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSNPYPGMPV-DSKFYKLIK--------- 258 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhcc-CCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc-hHHHHHHHH---------
Confidence 5543221 112234567999999877 678999999999999999998 8888742222 111111110
Q ss_pred HhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 241 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
... ....+...++++.+++.+||..+|++|||+.++++
T Consensus 259 ------------------~~~--------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 259 ------------------EGY--------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred ------------------cCC--------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 000 00011234578999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=310.43 Aligned_cols=256 Identities=26% Similarity=0.431 Sum_probs=208.7
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecc------cchHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~------~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
-..++|+++..||+|+||.|..++.+.+++.||+|++++ ....-|..|.++|-.- +.+.|+.++-.|+| ..
T Consensus 72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~-ns~Wiv~LhyAFQD--~~ 148 (1317)
T KOG0612|consen 72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFG-NSEWIVQLHYAFQD--ER 148 (1317)
T ss_pred CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcC-CcHHHHHHHHHhcC--cc
Confidence 346799999999999999999999999999999999875 2345688899999876 89999999999955 56
Q ss_pred CcEEEEEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 92 TPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
++|+||||++||+|-.++. .+++..++-++..|..||..+|+.|+|||||||+|||+|..| .+||+|||.+-....
T Consensus 149 ~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~G-HikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 149 YLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSG-HIKLADFGSCLKMDA 227 (1317)
T ss_pred ceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccC-cEeeccchhHHhcCC
Confidence 7889999999999877774 488999999999999999999999999999999999999999 899999999876654
Q ss_pred CCc--cccccCCccccccccccCC----CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHh
Q 020826 169 GKE--YNVRVASRYFKGPELLVDL----QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242 (321)
Q Consensus 169 ~~~--~~~~~~~~~y~aPE~~~~~----~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (321)
... ....+|||.|.+||++... +.|++.+|-||+|+++|||+.|..||+.+.-.... ...+
T Consensus 228 dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY-------------~KIm 294 (1317)
T KOG0612|consen 228 DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETY-------------GKIM 294 (1317)
T ss_pred CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHH-------------HHHh
Confidence 433 4567899999999998542 45789999999999999999999999643321111 1111
Q ss_pred hhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC---HHHHhcCCCcccCC
Q 020826 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT---AKEAMAHPYFFPIR 312 (321)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps---~~ell~hp~~~~~~ 312 (321)
++.. .+..+....+|++.++||++++ .+|+.|.. ++++-+||||.+++
T Consensus 295 ~hk~---------------------~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~ 345 (1317)
T KOG0612|consen 295 NHKE---------------------SLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGID 345 (1317)
T ss_pred chhh---------------------hcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCC
Confidence 1100 0111112248899999999988 57889988 99999999999864
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=278.70 Aligned_cols=244 Identities=19% Similarity=0.310 Sum_probs=190.1
Q ss_pred cCceEEeeeeeeecceEEEEEEEecC-----CceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTD-----NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~-----~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
..+|++.+.||+|+||+||+|.+..+ +..+++|.++... ...+..|+.++..+ +||||+++++++...
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~~-- 80 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRL-QHPNIVCLLGVVTKE-- 80 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcCC--
Confidence 45788899999999999999987543 4689999987543 24577899999998 899999999998554
Q ss_pred CCcEEEEEeecCchhhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCC
Q 020826 91 KTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 151 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~ 151 (321)
...++++||+.+++|..++. .++...+..++.|++.||.|+|++|++|+||||+||+++.+
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 45679999999998877651 36778889999999999999999999999999999999977
Q ss_pred CCeEEEeeccceeecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHH
Q 020826 152 QRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLV 227 (321)
Q Consensus 152 ~~~v~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~ 227 (321)
+ .++|+|||++........ .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..|| .+....+...
T Consensus 161 ~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~-~~~~~~~~~~ 237 (283)
T cd05091 161 L-NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPY-CGYSNQDVIE 237 (283)
T ss_pred C-ceEecccccccccccchheeeccCccCCccccCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCCC-CCCCHHHHHH
Confidence 7 799999999875432221 123345678999999876 678999999999999999998 66666 3333322222
Q ss_pred HHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 228 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
.+..... ...+..+++.+.+++.+||+.+|++||+++++++.
T Consensus 238 ~i~~~~~------------------------------------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 238 MIRNRQV------------------------------------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred HHHcCCc------------------------------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 2211000 00122466789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=275.29 Aligned_cols=256 Identities=26% Similarity=0.412 Sum_probs=197.5
Q ss_pred ceEEeeeeeeecceEEEEEEEe---cCCceEEEEEecccc-------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPVK-------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~---~~~~~~~vK~~~~~~-------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
+|++.+.||+|++|.||++++. .+++.+++|+++... ...+..|+.++.++.+||+++++++.+.. ..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~--~~ 78 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT--DT 78 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec--CC
Confidence 4889999999999999999864 356889999986421 24567899999999779999999998854 45
Q ss_pred CcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 92 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
..++|+||+.+++|...+ ..+++..+..++.|++.+|.+||+.|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 79 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~ 157 (288)
T cd05583 79 KLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG-HVVLTDFGLSKEFLA 157 (288)
T ss_pred EEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEEECcccccccc
Confidence 667999999999887766 3478999999999999999999999999999999999999887 799999999865433
Q ss_pred CCc--cccccCCccccccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhh
Q 020826 169 GKE--YNVRVASRYFKGPELLVDLQ-DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245 (321)
Q Consensus 169 ~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (321)
... .....++..|+|||...+.. ..+.++|+||||+++++|++|..||..... ......+.+....
T Consensus 158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~-~~~~~~~~~~~~~---------- 226 (288)
T cd05583 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE-QNSQSEISRRILK---------- 226 (288)
T ss_pred ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcc-cchHHHHHHHHHc----------
Confidence 221 12235778899999986622 378899999999999999999999842211 1111111110000
Q ss_pred cccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC---HHHHhcCCCcccCCCc
Q 020826 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT---AKEAMAHPYFFPIRNA 314 (321)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps---~~ell~hp~~~~~~~~ 314 (321)
. ....+..+++.+.+++.+||+.||++||| +.++++||||+.+.-.
T Consensus 227 -------------~----------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~ 275 (288)
T cd05583 227 -------------S----------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD 275 (288)
T ss_pred -------------c----------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence 0 00112235678999999999999999998 5688999999997544
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-39 Score=271.12 Aligned_cols=236 Identities=22% Similarity=0.383 Sum_probs=183.7
Q ss_pred eeeeeecceEEEEEEEecCCceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeecC
Q 020826 27 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 102 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 102 (321)
+.||+|+||.||+|.+..+++.+++|.+... ....+.+|+++++.+ +||||+++++++.. ....++|+||+.+
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQ--KQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcC--CCCeEEEEeeccC
Confidence 3689999999999999889999999987543 235688999999999 89999999999855 4467799999999
Q ss_pred chhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCcc---ccc
Q 020826 103 TDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVR 175 (321)
Q Consensus 103 ~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~---~~~ 175 (321)
++|..++. .+++..+..++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||.+......... ...
T Consensus 78 ~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~ 156 (252)
T cd05084 78 GDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN-VLKISDFGMSREEEDGVYASTGGMK 156 (252)
T ss_pred CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCC-cEEECccccCcccccccccccCCCC
Confidence 99887762 378999999999999999999999999999999999999887 7999999998654322111 111
Q ss_pred cCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhH
Q 020826 176 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLA 254 (321)
Q Consensus 176 ~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (321)
..+..|+|||.+.+ ..++.++|+||||+++|++++ |..||. ..........+.. .
T Consensus 157 ~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~-~~~~~~~~~~~~~-~--------------------- 212 (252)
T cd05084 157 QIPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYA-NLSNQQTREAIEQ-G--------------------- 212 (252)
T ss_pred CCceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcc-ccCHHHHHHHHHc-C---------------------
Confidence 22346999999877 678999999999999999998 777763 2111111111100 0
Q ss_pred hhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 255 ALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
. ....+...+..+.+++.+||+.||++|||+.++++
T Consensus 213 ------~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 213 ------V--------RLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred ------C--------CCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 00111235678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=276.71 Aligned_cols=244 Identities=21% Similarity=0.337 Sum_probs=191.2
Q ss_pred ccCceEEeeeeeeecceEEEEEEEec-----CCceEEEEEecccc---hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~~vK~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
...+|.+.+.||+|+||.||+|.+.. ++..+++|.++... .+.+.+|+..++++ +||||+++++++.. .
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~ 79 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL-QHEHIVKFYGVCGD--G 79 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcC-CCCCcceEEEEEcc--C
Confidence 35679999999999999999998643 34568899886543 35688999999999 89999999999854 4
Q ss_pred CCcEEEEEeecCchhhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCC
Q 020826 91 KTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 151 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~ 151 (321)
...+++|||+.+++|.+++. .+++..+..++.|++.||+|||++|++|+||||+||+++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 56789999999999987762 26788999999999999999999999999999999999988
Q ss_pred CCeEEEeeccceeecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHH
Q 020826 152 QRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLV 227 (321)
Q Consensus 152 ~~~v~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~ 227 (321)
+ .++|+|||++........ .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||.... ..+...
T Consensus 160 ~-~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~-~~~~~~ 236 (291)
T cd05094 160 L-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQPWFQLS-NTEVIE 236 (291)
T ss_pred C-cEEECCCCcccccCCCceeecCCCCCcceeecChHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHH
Confidence 7 899999999875433221 123345678999999887 678899999999999999998 888874322 211111
Q ss_pred HHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 228 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
.+.. .. . .......+..+.+++.+||+.||++|||+.++++
T Consensus 237 ~~~~----~~-----------------------~---------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 237 CITQ----GR-----------------------V---------LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred HHhC----CC-----------------------C---------CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 1100 00 0 0001134578999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=272.78 Aligned_cols=242 Identities=18% Similarity=0.343 Sum_probs=188.8
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCc----eEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~----~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
.++|++.+.||+|+||+||+|.+..++. .||+|+++... ...+.+|+.++..+ +||||+++++++.. .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~---~ 81 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGV-GSPYVCRLLGICLT---S 81 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhc-CCCCCceEEEEEcC---C
Confidence 5789999999999999999999877765 48999886432 34577899999998 89999999998854 2
Q ss_pred CcEEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 92 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
..+++++++++++|..++. .+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++....
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~-~~kL~dfG~~~~~~ 160 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPN-HVKITDFGLARLLD 160 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC-cEEECCCCceeecc
Confidence 3569999999998877762 479999999999999999999999999999999999998777 79999999997664
Q ss_pred CCCcc---ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 168 PGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 168 ~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
..... ....++..|+|||...+ ..++.++|||||||++|++++ |..||. ... .............
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~-~~~-~~~~~~~~~~~~~-------- 229 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILH-RRFTHQSDVWSYGVTVWELMTFGAKPYD-GIP-AREIPDLLEKGER-------- 229 (279)
T ss_pred cccceeecCCCccchhhCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCC-CCC-HHHHHHHHHCCCc--------
Confidence 32221 11234567999999877 678999999999999999998 777772 221 1111111110000
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
...+...++++.+++.+||+.||++|||+.+++.
T Consensus 230 ---------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 230 ---------------------------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred ---------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0011235678999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=271.38 Aligned_cols=243 Identities=18% Similarity=0.319 Sum_probs=191.1
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc--chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
..+|++.+.||+|++|.||++.+. ++..+++|.+... ....+.+|+++++.+ +||||+++++++.. ....++++
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~lv~ 78 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKL-SHPNLVQLYGVCTK--QRPIFIVT 78 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEEEEEEEEcC--CCceEEEE
Confidence 457899999999999999999884 5678999998643 345678899999999 89999999998854 44678999
Q ss_pred EeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCcc-
Q 020826 98 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY- 172 (321)
Q Consensus 98 e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~- 172 (321)
|++++++|.+++. .+++..+..++.|++.||++||++|++|+||+|+||+++.++ .++|+|||.+.........
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDN-VVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCC-cEEECCcccceecccccccc
Confidence 9999999887762 478899999999999999999999999999999999999887 8999999998755322211
Q ss_pred -ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 173 -NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 173 -~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
....++..|+|||.+.+ ..++.++|+||||+++|++++ |..||. ..+..+....+....
T Consensus 158 ~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~~~~~~~~~~~~----------------- 218 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDY-SRFSSKSDVWSFGVLMWEVFSEGKMPYE-RFSNSEVVESVSAGY----------------- 218 (256)
T ss_pred cCCCCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHhccCCCCCC-CCCHHHHHHHHHcCC-----------------
Confidence 11123346999999887 678899999999999999998 777773 222222222111100
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
....+...++++.+++.+||+.+|++|||+.++++.
T Consensus 219 -------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 219 -------------------RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred -------------------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 011122356799999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=284.14 Aligned_cols=247 Identities=19% Similarity=0.331 Sum_probs=189.2
Q ss_pred cCceEEeeeeeeecceEEEEEEEe-----cCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
.++|++.+.||+|+||+||+|.+. .+++.||+|.++... ...+.+|+.++.++.+||||+++++++....
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~- 84 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG- 84 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC-
Confidence 568999999999999999999853 356789999987532 2457789999999978999999999875433
Q ss_pred CCcEEEEEeecCchhhhhcC------------------------------------------------------------
Q 020826 91 KTPSLIFEHVNNTDFKVLYP------------------------------------------------------------ 110 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~~------------------------------------------------------------ 110 (321)
...++++||+.+++|.+++.
T Consensus 85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (343)
T cd05103 85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 164 (343)
T ss_pred CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence 45679999999999876652
Q ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc---cccccC
Q 020826 111 ----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVA 177 (321)
Q Consensus 111 ----------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~---~~~~~~ 177 (321)
.++...+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++........ .....+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCC-cEEEEecccccccccCcchhhcCCCCC
Confidence 246667788999999999999999999999999999999877 899999999875432211 112234
Q ss_pred CccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhh
Q 020826 178 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAAL 256 (321)
Q Consensus 178 ~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (321)
+..|+|||.+.+ ..++.++|+||||+++|++++ |..||............+..
T Consensus 244 ~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~------------------------- 297 (343)
T cd05103 244 PLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE------------------------- 297 (343)
T ss_pred CcceECcHHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhc-------------------------
Confidence 567999999877 678999999999999999997 88787322211111111000
Q ss_pred hcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 257 VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
.. ....+...++++.+++.+||+.||++|||+.++++|
T Consensus 298 ---~~--------~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 298 ---GT--------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred ---cC--------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 00 001112345789999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=276.21 Aligned_cols=261 Identities=22% Similarity=0.346 Sum_probs=195.0
Q ss_pred cCceEEeeeeeeecceEEEEEEE----ecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVH----CTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~----~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
...|++++.||+|+||.||+++. ..++..+++|.++... ...+.+|+.+++.+ +|||++++.+++.+....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCCC
Confidence 45689999999999999999974 3467899999987432 35688999999999 999999999998766556
Q ss_pred CcEEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 92 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
..++++||+++++|..++. .+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++....
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~-~~~l~dfg~~~~~~ 160 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH-QVKIGDFGLTKAIE 160 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCC-CEEECCCccccccc
Confidence 7789999999999988762 478899999999999999999999999999999999999887 79999999987654
Q ss_pred CCCc----cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 168 PGKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
.... .....++..|+|||...+ ..++.++||||||+++|++++++.|....... . .+..+........
T Consensus 161 ~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~ellt~~~~~~~~~~~---~---~~~~~~~~~~~~~- 232 (284)
T cd05079 161 TDKEYYTVKDDLDSPVFWYAPECLIQ-SKFYIASDVWSFGVTLYELLTYCDSESSPMTL---F---LKMIGPTHGQMTV- 232 (284)
T ss_pred cCccceeecCCCCCCccccCHHHhcc-CCCCccccchhhhhhhhhhhcCCCCCccccch---h---hhhcccccccccH-
Confidence 3222 122345567999999877 67889999999999999999987665321111 0 0111100000000
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
............ ......+++++.+|+.+||+.||++|||+++++++
T Consensus 233 -------~~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 233 -------TRLVRVLEEGKR--------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred -------HHHHHHHHcCcc--------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 000000000000 11122467899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=273.55 Aligned_cols=242 Identities=17% Similarity=0.354 Sum_probs=186.0
Q ss_pred EEeeeeeeecceEEEEEEEecCCc--eEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeecc----CCCC
Q 020826 24 EVVRKVGRGKYSEVFEGVHCTDNE--KCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----QSKT 92 (321)
Q Consensus 24 ~~~~~lg~g~~g~v~~~~~~~~~~--~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~----~~~~ 92 (321)
.+.+.||+|+||.||+|.+..++. .+++|.++.. ....+..|+.+++.+ +||||+++++++... ....
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEF-DHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEccCCcccCCCC
Confidence 467889999999999999876665 6899987642 235577899999999 899999999976432 1235
Q ss_pred cEEEEEeecCchhhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccce
Q 020826 93 PSLIFEHVNNTDFKVLY---------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~ 163 (321)
.++++||+.+++|..++ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~ 159 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENM-NVCVADFGLS 159 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCC-CEEECCCCcc
Confidence 68999999999887654 2378889999999999999999999999999999999999877 7999999998
Q ss_pred eecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhh
Q 020826 164 EFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELN 239 (321)
Q Consensus 164 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (321)
........ .....++..|++||...+ ..++.++|+||||+++|++++ |..|| .+.........+.. .
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~-~~~~~~~~~~~~~~----~--- 230 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPY-PGVENSEIYDYLRQ----G--- 230 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCC-CCCCHHHHHHHHHc----C---
Confidence 76543221 122345567999999987 678999999999999999999 67776 33332222221110 0
Q ss_pred HHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 240 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
.. ......+++.+.+++.+||+.||++|||+.+++++
T Consensus 231 ---------------------~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 231 ---------------------NR--------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred ---------------------CC--------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00 00112355789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=275.06 Aligned_cols=251 Identities=19% Similarity=0.337 Sum_probs=192.5
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCC----------------ceEEEEEecccc----hHHHHHHHHHHHhhcCCCCe
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDN----------------EKCIIKILKPVK----KKKIKREIKILQNLCGGPNI 78 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~----------------~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i 78 (321)
...+|++.+.||+|+||.||+|.+...+ ..+++|.+.... ...+.+|+.+++.+ +|||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i 81 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRL-SDPNI 81 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhc-CCCCE
Confidence 3568999999999999999999876543 457999987542 35678899999999 89999
Q ss_pred eeeeeeeeccCCCCcEEEEEeecCchhhhhcC--------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCC
Q 020826 79 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP--------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPH 144 (321)
Q Consensus 79 ~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--------------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~ 144 (321)
+++++++.+. ...++++|++.+++|..++. .+++..++.++.|++.||+|||++|++|+||||+
T Consensus 82 ~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~ 159 (296)
T cd05051 82 ARLLGVCTVD--PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR 159 (296)
T ss_pred eEEEEEEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence 9999998553 56789999999998877762 4788899999999999999999999999999999
Q ss_pred CeEEcCCCCeEEEeeccceeecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh--CCCCCccC
Q 020826 145 NVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF--RKEPFFYG 219 (321)
Q Consensus 145 nili~~~~~~v~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~--g~~p~~~~ 219 (321)
||+++.++ .++|+|||++........ .....++..|+|||.+.+ ..++.++|||||||++|++++ +..||. .
T Consensus 160 Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~~~~~~~p~~-~ 236 (296)
T cd05051 160 NCLVGKNY-TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVWAFGVTLWEILTLCREQPYE-H 236 (296)
T ss_pred ceeecCCC-ceEEccccceeecccCcceeecCcCCCCceecCHHHhhc-CCCCccchhhhhHHHHHHHHhcCCCCCCC-C
Confidence 99999887 899999999876533221 123345668999999877 678999999999999999998 566663 2
Q ss_pred CCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCH
Q 020826 220 HDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA 299 (321)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~ 299 (321)
......+........... .......+..+++++.+++.+||+.||++|||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~ 287 (296)
T cd05051 237 LTDQQVIENAGHFFRDDG-----------------------------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTF 287 (296)
T ss_pred cChHHHHHHHHhcccccc-----------------------------ccccCCCccCCCHHHHHHHHHHhccChhcCCCH
Confidence 222222222211110000 000001122356789999999999999999999
Q ss_pred HHHhc
Q 020826 300 KEAMA 304 (321)
Q Consensus 300 ~ell~ 304 (321)
.|+++
T Consensus 288 ~el~~ 292 (296)
T cd05051 288 REIHL 292 (296)
T ss_pred HHHHH
Confidence 99964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=278.15 Aligned_cols=252 Identities=26% Similarity=0.413 Sum_probs=196.8
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
....|+..+.||+|++|+||+|++..++..+++|.+... ....+.+|+.+++.+ +|+|++++.+++.+. ..
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~ 89 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLRE--HT 89 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCcccEEEEEEcC--Ce
Confidence 456688889999999999999999889999999988632 123567899999999 899999999998654 45
Q ss_pred cEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 93 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
.++|+||+.+..+.... ..+++..+..++.|++.||.|||+++++|+||+|+||+++.++ .++|+|||++....+.
T Consensus 90 ~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~ 168 (308)
T cd06634 90 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAPA 168 (308)
T ss_pred eEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC-cEEECCcccceeecCc
Confidence 67999999864433322 3488999999999999999999999999999999999999887 8999999998765432
Q ss_pred CccccccCCccccccccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 170 KEYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 170 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
....++..|+|||.+.+ ...++.++|||||||++|++++|..||.... .......+.....
T Consensus 169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~-~~~~~~~~~~~~~------------- 231 (308)
T cd06634 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNES------------- 231 (308)
T ss_pred ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc-HHHHHHHHhhcCC-------------
Confidence 23457788999999752 2457889999999999999999999984321 1111111110000
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCC
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~ 313 (321)
+ ......++..+.++|++||+.+|++||+++++++|||+....-
T Consensus 232 ----------------~------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~~ 275 (308)
T cd06634 232 ----------------P------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275 (308)
T ss_pred ----------------C------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccCC
Confidence 0 0001135568999999999999999999999999999988644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=287.04 Aligned_cols=250 Identities=22% Similarity=0.380 Sum_probs=195.2
Q ss_pred eeeeeecccCceEEeeeeeeecceEEEEEEEecCCc---e-EEEEEeccc------chHHHHHHHHHHHhhcCCCCeeee
Q 020826 12 CVWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNE---K-CIIKILKPV------KKKKIKREIKILQNLCGGPNIVKL 81 (321)
Q Consensus 12 ~~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~---~-~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~ 81 (321)
+.|++...+- .+.++||+|+||.||+|+.+..+. . ||+|..+.. ....+.+|..+|+++ +||||+++
T Consensus 150 ~~Wel~H~~v--~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l-~H~NVVr~ 226 (474)
T KOG0194|consen 150 QKWELSHSDI--ELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQL-NHPNVVRF 226 (474)
T ss_pred cccEEeccCc--cccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhC-CCCCEEEE
Confidence 4788886644 445999999999999998865422 3 899988742 245688999999999 99999999
Q ss_pred eeeeeccCCCCcEEEEEeecCchhhhhcCC----CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEE
Q 020826 82 LDIVRDQQSKTPSLIFEHVNNTDFKVLYPT----LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRL 157 (321)
Q Consensus 82 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~----~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l 157 (321)
||+..+... +++|||.|.||+|.+++++ ++..+...++.+.+.||+|||+++++||||..+|+|++.++ .+||
T Consensus 227 yGVa~~~~P--l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~-~vKI 303 (474)
T KOG0194|consen 227 YGVAVLEEP--LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKG-VVKI 303 (474)
T ss_pred EEEEcCCCc--cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCC-eEEe
Confidence 999976554 5699999999999999954 78999999999999999999999999999999999999877 7899
Q ss_pred eeccceeecCCCCccc-cccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCC
Q 020826 158 IDWGLAEFYHPGKEYN-VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGT 235 (321)
Q Consensus 158 ~dfg~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 235 (321)
+|||++.......... ...-...|+|||.+.. ..+++++||||||+++||+++ |..|| ++....+....+....-.
T Consensus 304 SDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~-~~~s~kTDV~sfGV~~~Eif~~g~~Py-~g~~~~~v~~kI~~~~~r 381 (474)
T KOG0194|consen 304 SDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNT-GIFSFKTDVWSFGVLLWEIFENGAEPY-PGMKNYEVKAKIVKNGYR 381 (474)
T ss_pred CccccccCCcceeeccccccCcceecChhhhcc-CccccccchhheeeeEEeeeccCCCCC-CCCCHHHHHHHHHhcCcc
Confidence 9999987543111111 2234567999999988 699999999999999999998 77777 444443333332110000
Q ss_pred hhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 236 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
...+...++++..++.+|+..||++|||+.++.+
T Consensus 382 -----------------------------------~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 382 -----------------------------------MPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred -----------------------------------CCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 0011134468999999999999999999987653
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=269.22 Aligned_cols=243 Identities=19% Similarity=0.334 Sum_probs=193.3
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc--chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
..++|++.+.||+|++|+||+|.+. ++..+++|.+... ..+.+.+|+..++.+ +|||++++++++.. ....+++
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v 79 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKL-RHDKLVQLYAVCSE--EEPIYIV 79 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhC-CCCCEeeeeeeeec--CCceEEE
Confidence 4679999999999999999999974 5578999998753 346788999999999 89999999999854 3456899
Q ss_pred EEeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc
Q 020826 97 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 171 (321)
Q Consensus 97 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~ 171 (321)
+|++.+++|.+++. .++...+..++.|++.|+.|||++|++|+||+|+||+++.++ .++|+|||.+........
T Consensus 80 ~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 80 TEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENL-VCKIADFGLARLIEDDEY 158 (261)
T ss_pred EeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCC-CEEECccccceeccchhh
Confidence 99999999987763 478899999999999999999999999999999999999887 899999999876543211
Q ss_pred c--ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 172 Y--NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 172 ~--~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
. .....+..|+|||.+.+ ...+.++|+||||++++++++ |+.||. +.........+.....
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~-~~~~~~~~~~~~~~~~-------------- 222 (261)
T cd05034 159 TAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYP-GMTNREVLEQVERGYR-------------- 222 (261)
T ss_pred hhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHcCCC--------------
Confidence 1 11223457999999987 678999999999999999998 888873 3333333332211000
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
...+...++++.+++.+||+.||++|||++++++
T Consensus 223 ----------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 223 ----------------------MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 0011224578999999999999999999998873
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-39 Score=275.18 Aligned_cols=250 Identities=18% Similarity=0.341 Sum_probs=189.0
Q ss_pred cCceEEeeeeeeecceEEEEEEEecC--------------CceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeee
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTD--------------NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKL 81 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~--------------~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~ 81 (321)
.++|++.+.||+|+||.||++.+..+ ...+++|.++... ...+.+|++++.++ +|||++++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~i~~~ 82 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRL-KNPNIIRL 82 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCcCeE
Confidence 56899999999999999999987543 2358999987532 34578899999999 89999999
Q ss_pred eeeeeccCCCCcEEEEEeecCchhhhhcC---------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCe
Q 020826 82 LDIVRDQQSKTPSLIFEHVNNTDFKVLYP---------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNV 146 (321)
Q Consensus 82 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---------------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~ni 146 (321)
++++.. ....+++|||+.+++|..++. .++...+..++.|++.||+|||++|++|+||||+||
T Consensus 83 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 83 LGVCVS--DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred EEEEcC--CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 999854 456679999999999877652 257788899999999999999999999999999999
Q ss_pred EEcCCCCeEEEeeccceeecCCCCcc---ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh--CCCCCccCCC
Q 020826 147 MIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF--RKEPFFYGHD 221 (321)
Q Consensus 147 li~~~~~~v~l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~--g~~p~~~~~~ 221 (321)
+++.++ .++|+|||++......... ....++..|+|||...+ ..++.++|+||||+++++|++ +..||. ...
T Consensus 161 ll~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~~l~el~~~~~~~p~~-~~~ 237 (295)
T cd05097 161 LVGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEMFTLCKEQPYS-LLS 237 (295)
T ss_pred EEcCCC-cEEecccccccccccCcceeccCcCcCceeecChhhhcc-CCcCchhhHHHHHHHHHHHHHcCCCCCCc-ccC
Confidence 999777 7999999998754322211 22234567999999877 678999999999999999998 555663 222
Q ss_pred ChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHH
Q 020826 222 NYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE 301 (321)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~e 301 (321)
.........+...... .......+...++.+.+++.+||+.||++|||+++
T Consensus 238 ~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~ 288 (295)
T cd05097 238 DEQVIENTGEFFRNQG-----------------------------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNK 288 (295)
T ss_pred hHHHHHHHHHhhhhcc-----------------------------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHH
Confidence 2222222111110000 00001112235678999999999999999999999
Q ss_pred Hhc
Q 020826 302 AMA 304 (321)
Q Consensus 302 ll~ 304 (321)
+++
T Consensus 289 i~~ 291 (295)
T cd05097 289 IHH 291 (295)
T ss_pred HHH
Confidence 864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=275.72 Aligned_cols=241 Identities=18% Similarity=0.337 Sum_probs=186.9
Q ss_pred ceEEeeeeeeecceEEEEEEEecC-----CceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTD-----NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~-----~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
+|++.+.||+|+||+||+|.+... ...+++|.+.... ...+.+|+.++..+ +||||+++++.+... ..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV-NHPHVIKLYGACSQD--GP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhC-CCCCEeeEEEEEecC--CC
Confidence 478899999999999999987532 2568888876432 24678899999999 899999999988543 45
Q ss_pred cEEEEEeecCchhhhhcC---------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCC
Q 020826 93 PSLIFEHVNNTDFKVLYP---------------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHN 145 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~~---------------------------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~n 145 (321)
.++++||+.+++|..++. .++...+..++.|++.||+|||+.|++|+||+|+|
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~n 157 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARN 157 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhhe
Confidence 679999999999877642 36788889999999999999999999999999999
Q ss_pred eEEcCCCCeEEEeeccceeecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCC
Q 020826 146 VMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHD 221 (321)
Q Consensus 146 ili~~~~~~v~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~ 221 (321)
|+++.++ .++|+|||++........ .....++..|+|||...+ ..++.++||||||+++++|++ |..||. +..
T Consensus 158 ill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~-~~~ 234 (290)
T cd05045 158 VLVAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPYP-GIA 234 (290)
T ss_pred EEEcCCC-cEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHHHHHHHHHHHHhcCCCCCC-CCC
Confidence 9999777 899999999875432222 122334567999999876 678999999999999999998 887872 322
Q ss_pred ChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHH
Q 020826 222 NYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE 301 (321)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~e 301 (321)
. ..+...... .. ....+..++.++.+++.+||+.||++||++.+
T Consensus 235 ~-~~~~~~~~~---------------------------~~--------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~ 278 (290)
T cd05045 235 P-ERLFNLLKT---------------------------GY--------RMERPENCSEEMYNLMLTCWKQEPDKRPTFAD 278 (290)
T ss_pred H-HHHHHHHhC---------------------------CC--------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence 2 211111110 00 00112245679999999999999999999999
Q ss_pred Hhc
Q 020826 302 AMA 304 (321)
Q Consensus 302 ll~ 304 (321)
+++
T Consensus 279 i~~ 281 (290)
T cd05045 279 ISK 281 (290)
T ss_pred HHH
Confidence 874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=270.05 Aligned_cols=240 Identities=17% Similarity=0.334 Sum_probs=189.4
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 98 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 98 (321)
.++|++.+.||+|++|.||++.. .+..+++|.++... .+.+.+|+.+++.+ +|++++++++++... ....++++|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~-~~~~~lv~e 80 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEE-KGGLYIVTE 80 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhC-CCCCeeeEEEEEEcC-CCceEEEEE
Confidence 45899999999999999999976 57789999987543 35688999999999 899999999976433 345689999
Q ss_pred eecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCccc
Q 020826 99 HVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 173 (321)
Q Consensus 99 ~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~~ 173 (321)
|+.+++|..++. .+++..+..++.|++.||++||++|++|+||||+||+++.++ .++|+|||++....... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~--~ 157 (256)
T cd05082 81 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQ--D 157 (256)
T ss_pred CCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCC-cEEecCCccceeccccC--C
Confidence 999999887763 277889999999999999999999999999999999999888 89999999987543222 2
Q ss_pred cccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChh
Q 020826 174 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 252 (321)
Q Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (321)
....+..|+|||++.+ ..++.++|||||||++|+|++ |..||. ..........+.+ .
T Consensus 158 ~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~-~~~~~~~~~~~~~----~---------------- 215 (256)
T cd05082 158 TGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYP-RIPLKDVVPRVEK----G---------------- 215 (256)
T ss_pred CCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHhc----C----------------
Confidence 2334557999999876 678899999999999999997 888873 2221111111100 0
Q ss_pred hHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 253 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
. .......+++.+.+++.+||+.||++|||+.++++
T Consensus 216 ----------~------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 216 ----------Y------KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred ----------C------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0 00111245678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=284.04 Aligned_cols=296 Identities=26% Similarity=0.400 Sum_probs=223.1
Q ss_pred EEEEeeeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccch--HHHHHHHHHHHhhcC-----CCCeee
Q 020826 8 VIYWCVWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLCG-----GPNIVK 80 (321)
Q Consensus 8 ~~~~~~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~E~~~l~~l~~-----h~~i~~ 80 (321)
..|+.+.+++-...+|.+....|+|-|++|.+|.+...+..||||+++..+. +.=..|+++|++|.. .-|++.
T Consensus 419 EGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclr 498 (752)
T KOG0670|consen 419 EGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLR 498 (752)
T ss_pred cceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHH
Confidence 4688999999999999999999999999999999999999999999987653 556789999999942 247888
Q ss_pred eeeeeeccCCCCcEEEEEeecCchhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeE
Q 020826 81 LLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL 155 (321)
Q Consensus 81 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v 155 (321)
++..|. ...++|+|+|.+..+.-.-+. -.+....++.++.|+..||..|-..||+|.||||+|||++.+...+
T Consensus 499 l~r~F~--hknHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iL 576 (752)
T KOG0670|consen 499 LFRHFK--HKNHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNIL 576 (752)
T ss_pred HHHHhh--hcceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCccee
Confidence 888884 456788999988765433222 2488889999999999999999999999999999999999877689
Q ss_pred EEeeccceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCC
Q 020826 156 RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 235 (321)
Q Consensus 156 ~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (321)
||||||.|.....+.. ++..-+.-|+|||+++| ..|++..|+||.||+|||+.||+..| ++..+-.++.-....-|.
T Consensus 577 KLCDfGSA~~~~enei-tPYLVSRFYRaPEIiLG-~~yd~~iD~WSvgctLYElYtGkIlF-pG~TNN~MLrl~me~KGk 653 (752)
T KOG0670|consen 577 KLCDFGSASFASENEI-TPYLVSRFYRAPEIILG-LPYDYPIDTWSVGCTLYELYTGKILF-PGRTNNQMLRLFMELKGK 653 (752)
T ss_pred eeccCccccccccccc-cHHHHHHhccCcceeec-CcccCCccceeeceeeEEeeccceec-CCCCcHHHHHHHHHhcCC
Confidence 9999999976654433 44556677999999999 89999999999999999999999887 666666665554444333
Q ss_pred hhhhHHhhhhcccCChhhHhhhc-----------cc------CCCCCccccccccc-cC-------CcchHHHHHHHhhc
Q 020826 236 DELNAYLNKYHIELDPHLAALVG-----------RH------SRKPWSKFITVENQ-HL-------AVPEAVDFLDKLLR 290 (321)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~-----------~~------~~~~~~~~~~~~~~-~~-------~s~~~~~ll~~~l~ 290 (321)
- ++-+-+.+...+..|..... .. ..+|...+...... .. +-.++++||.+||.
T Consensus 654 ~--p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~ 731 (752)
T KOG0670|consen 654 F--PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI 731 (752)
T ss_pred C--cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence 2 22222222222222221110 00 11221111111110 11 12469999999999
Q ss_pred cCCCCCcCHHHHhcCCCccc
Q 020826 291 YDHQERPTAKEAMAHPYFFP 310 (321)
Q Consensus 291 ~dp~~Rps~~ell~hp~~~~ 310 (321)
.||++|.|+.++|+||||..
T Consensus 732 LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 732 LDPEKRITVNQALKHPFITE 751 (752)
T ss_pred cChhhcCCHHHHhcCCcccC
Confidence 99999999999999999974
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=269.46 Aligned_cols=237 Identities=30% Similarity=0.497 Sum_probs=193.0
Q ss_pred eeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeecC
Q 020826 29 VGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 102 (321)
Q Consensus 29 lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 102 (321)
||.|++|.||++.+..+++.+++|.++... ...+..|+.+++.+ +|||++++++.+.+ ....++++|++.+
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v~e~~~~ 77 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRI-NHPFIVKLHYAFQT--EEKLYLVLEYAPG 77 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHc-CCCcHHHHHHHeec--CCeeEEEEecCCC
Confidence 689999999999998889999999986532 24678899999999 89999999998844 5567899999998
Q ss_pred chhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC-CccccccCC
Q 020826 103 TDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNVRVAS 178 (321)
Q Consensus 103 ~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~-~~~~~~~~~ 178 (321)
++|.+++. .+++..+..++.|++.||.+||+.+++|+||+|+||+++.++ .++|+|||.+...... .......++
T Consensus 78 ~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05123 78 GELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADG-HIKLTDFGLAKELSSEGSRTNTFCGT 156 (250)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCC-cEEEeecCcceecccCCCcccCCcCC
Confidence 88877763 479999999999999999999999999999999999999887 8999999998765433 223445677
Q ss_pred ccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhc
Q 020826 179 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVG 258 (321)
Q Consensus 179 ~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (321)
..|+|||...+ ...+.++|+||||+++|++++|..||... +.......+.. .
T Consensus 157 ~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~-~~~~~~~~~~~--~------------------------ 208 (250)
T cd05123 157 PEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAE-DRKEIYEKILK--D------------------------ 208 (250)
T ss_pred ccccChHHhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHhc--C------------------------
Confidence 88999999877 66889999999999999999999998422 22111111110 0
Q ss_pred ccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCH---HHHhcCCCc
Q 020826 259 RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA---KEAMAHPYF 308 (321)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~---~ell~hp~~ 308 (321)
....+..+++.+.+++++||..||++|||+ +++++||||
T Consensus 209 -----------~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 209 -----------PLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred -----------CCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 011122345789999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=273.16 Aligned_cols=236 Identities=19% Similarity=0.311 Sum_probs=181.8
Q ss_pred eeeeecceEEEEEEEecCCc--eEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeec
Q 020826 28 KVGRGKYSEVFEGVHCTDNE--KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVN 101 (321)
Q Consensus 28 ~lg~g~~g~v~~~~~~~~~~--~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 101 (321)
.||+|+||.||+|.+..++. .+++|.++.. ....+..|+.++.++.+||||+++++++.. ....+++||++.
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~--~~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--RGYLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec--CCCceEEEEeCC
Confidence 58999999999999977765 4688887642 234677899999999889999999999854 445789999999
Q ss_pred CchhhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccc
Q 020826 102 NTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 162 (321)
Q Consensus 102 ~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~ 162 (321)
+++|..++. .++...+..++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||+
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~-~~kl~dfgl 158 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADFGL 158 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCC-eEEECCCCC
Confidence 999877762 267889999999999999999999999999999999999887 899999998
Q ss_pred eeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHH
Q 020826 163 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAY 241 (321)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (321)
+..............+..|+|||++.. ..++.++|+||||+++++|++ |..||. +.+.......+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~-~~~~~~~~~~~~~---------- 226 (270)
T cd05047 159 SRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYC-GMTCAELYEKLPQ---------- 226 (270)
T ss_pred ccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCcc-ccCHHHHHHHHhC----------
Confidence 853221111122223456999999876 678999999999999999997 888883 2221111111100
Q ss_pred hhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 242 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
. ........++.++.+++.+||+.||.+|||+.++++
T Consensus 227 -----------------~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 227 -----------------G---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred -----------------C---------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 0 000111235578999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=272.69 Aligned_cols=239 Identities=24% Similarity=0.438 Sum_probs=182.8
Q ss_pred EEeeeeeeecceEEEEEEEe----cCCceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 24 EVVRKVGRGKYSEVFEGVHC----TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 24 ~~~~~lg~g~~g~v~~~~~~----~~~~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
.+.+.||.|.||.||+|... ..+..|+||.++.. ....+.+|++.+.++ +||||+++++++... ...++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~g~~~~~--~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKL-RHPNIVKLYGFCIEN--EPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTH-SBTTBE-EEEEEESS--SSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccc-ccccccccccccccc--ccccc
Confidence 56788999999999999997 34568999999643 246788999999999 999999999999743 34679
Q ss_pred EEEeecCchhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 96 IFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 96 v~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
|+||+.+++|.+++ ..++...+..++.||+.||+|||+++++|++|++.||+++.++ .+||+|||++.......
T Consensus 79 v~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~-~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 79 VMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNG-QVKLSDFGLSRPISEKS 157 (259)
T ss_dssp EEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTT-EEEEESTTTGEETTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccc
Confidence 99999999988766 2588999999999999999999999999999999999999888 99999999998763222
Q ss_pred cc---ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhc
Q 020826 171 EY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246 (321)
Q Consensus 171 ~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (321)
.. ........|+|||.+.. ..++.++||||||+++||+++ |..|| .+.........+.+. .
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~-~~~~~ksDVysfG~~l~ei~~~~~~p~-~~~~~~~~~~~~~~~-~------------ 222 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKD-GEYTKKSDVYSFGMLLYEILTLGKFPF-SDYDNEEIIEKLKQG-Q------------ 222 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHH-SEESHHHHHHHHHHHHHHHHTTSSGTT-TTSCHHHHHHHHHTT-E------------
T ss_pred cccccccccccccccccccccc-ccccccccccccccccccccccccccc-ccccccccccccccc-c------------
Confidence 21 22345567999999987 668999999999999999999 56776 333333333322110 0
Q ss_pred ccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
....+..++..+.+++.+||..||++|||+.++++
T Consensus 223 -----------------------~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 223 -----------------------RLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp -----------------------ETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred -----------------------cceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 01112246678999999999999999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=272.87 Aligned_cols=248 Identities=19% Similarity=0.349 Sum_probs=193.5
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEec----CCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeec
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHCT----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRD 87 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~~----~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (321)
|....++|++.+.||+|+||.||+|.+.. ++..+++|.+.... ...+.+|+.+++.+ +|||++++++++..
T Consensus 1 ~~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~ 79 (280)
T cd05043 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL-SHQNILPILHVCIE 79 (280)
T ss_pred CccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEec
Confidence 34567899999999999999999999865 25789999886432 35578899999999 99999999998754
Q ss_pred cCCCCcEEEEEeecCchhhhhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEE
Q 020826 88 QQSKTPSLIFEHVNNTDFKVLYP-----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLR 156 (321)
Q Consensus 88 ~~~~~~~lv~e~~~~~~l~~~~~-----------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~ 156 (321)
. ....+++++++.+++|..++. .+++..+..++.|++.||+|||+++++|+||+|+||+++.++ .++
T Consensus 80 ~-~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~-~~k 157 (280)
T cd05043 80 D-GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL-QVK 157 (280)
T ss_pred C-CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC-cEE
Confidence 3 355689999999999877762 378889999999999999999999999999999999999777 899
Q ss_pred EeeccceeecCCCCcc---ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHH
Q 020826 157 LIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKV 232 (321)
Q Consensus 157 l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 232 (321)
|+|||+++...+.... ....++..|+|||.+.+ ..++.++|||||||++|++++ |..||.. ....+....+..
T Consensus 158 l~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~- 234 (280)
T cd05043 158 ITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQTPYVE-IDPFEMAAYLKD- 234 (280)
T ss_pred ECCCCCcccccCCceEEeCCCCCcchhccCHHHHhc-CCCCchhhHHHhHHHHHHHhcCCCCCcCc-CCHHHHHHHHHc-
Confidence 9999998755332211 12334567999999977 678999999999999999998 8888832 221111111100
Q ss_pred hCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 233 LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
. . .......+++++.+++.+||+.||++|||+.++++
T Consensus 235 ---~------------------------~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 235 ---G------------------------Y--------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred ---C------------------------C--------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 0 00111235678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=268.70 Aligned_cols=241 Identities=16% Similarity=0.310 Sum_probs=189.7
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc--hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
.++|++.+.||+|+||.||++.+ ..+..+++|.++... ...+.+|+.+++.+ +|+|++++++.+.+ ...++++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~---~~~~~v~ 79 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVTK---EPIYIIT 79 (260)
T ss_pred ccceeEEeEecCccceEEEEEEe-cCCccEEEEecCCChhHHHHHHHHHHHHHhc-CCCCcceEEEEEcC---CCeEEEE
Confidence 67999999999999999999986 456679999887543 35688899999999 89999999998854 4568999
Q ss_pred EeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc-
Q 020826 98 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE- 171 (321)
Q Consensus 98 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~- 171 (321)
||+++++|.+++. .++...+..++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYT 158 (260)
T ss_pred EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC-cEEECCCcceeeccCCCcc
Confidence 9999999887763 267788899999999999999999999999999999999887 899999999876543221
Q ss_pred -cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 172 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
.....++..|+|||.+.. ..++.++|+||||+++|++++ |..||. +.+.......+....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~-~~~~~~~~~~~~~~~---------------- 220 (260)
T cd05073 159 AREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYP-GMSNPEVIRALERGY---------------- 220 (260)
T ss_pred cccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCC-CCCHHHHHHHHhCCC----------------
Confidence 112234566999999976 678999999999999999998 887773 322222221111000
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
........+.++.+++.+||+.||++||++.++++
T Consensus 221 --------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 221 --------------------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred --------------------CCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 00111235578999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-39 Score=276.89 Aligned_cols=254 Identities=25% Similarity=0.401 Sum_probs=198.2
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
.....|+..+.||+|+||.||++++..++..+++|.+.... ...+..|+.+++.+ +|||++++++++.+. .
T Consensus 22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~ 98 (317)
T cd06635 22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRI-KHPNSIEYKGCYLRE--H 98 (317)
T ss_pred CchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhC-CCCCEEEEEEEEeeC--C
Confidence 33455889999999999999999998899999999986321 24577899999999 899999999998654 4
Q ss_pred CcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 92 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
..++++||+.+..+.... .++++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 99 ~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~-~~kl~dfg~~~~~~~ 177 (317)
T cd06635 99 TAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG-QVKLADFGSASIASP 177 (317)
T ss_pred eEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCC-CEEEecCCCccccCC
Confidence 567999999875443332 4588999999999999999999999999999999999999877 899999998865432
Q ss_pred CCccccccCCccccccccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhc
Q 020826 169 GKEYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246 (321)
Q Consensus 169 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (321)
.....++..|+|||.+.. ...++.++|+|||||++|+|++|+.||... ........+......
T Consensus 178 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~-~~~~~~~~~~~~~~~----------- 242 (317)
T cd06635 178 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM-NAMSALYHIAQNESP----------- 242 (317)
T ss_pred ---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc-cHHHHHHHHHhccCC-----------
Confidence 233467788999999742 256888999999999999999999998532 211112111110000
Q ss_pred ccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
.......++.+.+++.+||+.+|++|||+.++++|+|+......
T Consensus 243 ------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 286 (317)
T cd06635 243 ------------------------TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPE 286 (317)
T ss_pred ------------------------CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcc
Confidence 00111345689999999999999999999999999999765443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=271.59 Aligned_cols=244 Identities=24% Similarity=0.436 Sum_probs=192.1
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc--------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
+|.+.+.||+|+||+||++.+..++..+++|+++.. ....+..|+.+++.+ +|||++++++.+.+. ...
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~ 77 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKL-DHPAIVKFHASFLER--DAF 77 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhC-CCCcHHHHHHHHhcC--Cce
Confidence 689999999999999999999877777777776531 223466788999999 899999999988544 456
Q ss_pred EEEEEeecCchhhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeec
Q 020826 94 SLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 166 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~ 166 (321)
++++||+.+++|...+ ..+++..+..++.|++.||.+||+.|++|+||+|+||+++. + .++|+|||.+...
T Consensus 78 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~-~~~l~d~g~~~~~ 155 (260)
T cd08222 78 CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-N-LLKIGDFGVSRLL 155 (260)
T ss_pred EEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-C-CEeecccCceeec
Confidence 7999999999987654 34889999999999999999999999999999999999974 4 5999999998765
Q ss_pred CCCCc-cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhh
Q 020826 167 HPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245 (321)
Q Consensus 167 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (321)
..... .....++..|+|||...+ ..++.++|+||||++++++++|..||. ..........+. ... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~-~~~~~~~~~~~~---~~~-~------- 222 (260)
T cd08222 156 MGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFE-GQNFLSVVLRIV---EGP-T------- 222 (260)
T ss_pred CCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CccHHHHHHHHH---cCC-C-------
Confidence 43322 233457788999999876 678889999999999999999999983 222211111110 000 0
Q ss_pred cccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
...+..+++++.++|.+||+.||++||++.++++||||
T Consensus 223 -------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 223 -------------------------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred -------------------------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 00112355789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=267.42 Aligned_cols=239 Identities=19% Similarity=0.343 Sum_probs=191.8
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc--hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
.++|++.+.||.|++|.||+|.. .+..+++|.++... .+.+.+|+.+++.+ +|+|++++++++.+ ....++++
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v~ 79 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTL-RHPNLVQLLGVVLQ--GNPLYIVT 79 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhc-CCcceeeeEEEEcC--CCCeEEEE
Confidence 56899999999999999999986 47889999987653 35788899999999 89999999999865 45667999
Q ss_pred EeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCcc
Q 020826 98 EHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 172 (321)
Q Consensus 98 e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~ 172 (321)
|++++++|..++. .+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||.+.......
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~-~~~l~d~g~~~~~~~~~-- 156 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDL-VAKVSDFGLAKEASQGQ-- 156 (256)
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCC-CEEEccccccccccccc--
Confidence 9999999888763 488999999999999999999999999999999999999887 89999999987653221
Q ss_pred ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCCh
Q 020826 173 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251 (321)
Q Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (321)
.....+..|+|||.+.. ..++.++|+||||++++++++ |..||... ....+..... ..
T Consensus 157 ~~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~--~~~~~~~~~~---~~--------------- 215 (256)
T cd05039 157 DSGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRI--PLKDVVPHVE---KG--------------- 215 (256)
T ss_pred ccCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCC--CHHHHHHHHh---cC---------------
Confidence 22334557999999876 678899999999999999997 88887322 1111111100 00
Q ss_pred hhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 252 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
.. ...+..+++++.++|.+||..+|++|||+.++++
T Consensus 216 -----------~~------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 216 -----------YR------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred -----------CC------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 00 0112245679999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=273.81 Aligned_cols=244 Identities=18% Similarity=0.314 Sum_probs=190.0
Q ss_pred ccCceEEeeeeeeecceEEEEEEEe-----cCCceEEEEEecccc---hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~~~vK~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
...+|.+.++||+|+||.||++... .++..+++|.+.... ...+.+|++.+..+ +|+||+++++++.+.
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-- 79 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVL-QHQHIVRFYGVCTEG-- 79 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcC-CCCCCceEEEEEecC--
Confidence 3568899999999999999999753 345688899876433 35688999999999 999999999988553
Q ss_pred CCcEEEEEeecCchhhhhcC------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCC
Q 020826 91 KTPSLIFEHVNNTDFKVLYP------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ 152 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~~------------------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~ 152 (321)
...++++||+.+++|..++. .+++..+..++.|++.|++|||+.|++|+||||+||+++.++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 45689999999999877762 267888999999999999999999999999999999999777
Q ss_pred CeEEEeeccceeecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHH
Q 020826 153 RKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVK 228 (321)
Q Consensus 153 ~~v~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~ 228 (321)
.++|+|||++........ .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.. ....+....
T Consensus 160 -~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~~~~~~~ 236 (280)
T cd05092 160 -VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQPWYQ-LSNTEAIEC 236 (280)
T ss_pred -CEEECCCCceeEcCCCceeecCCCccccccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCcc-CCHHHHHHH
Confidence 899999999875533221 122234567999999887 678999999999999999998 7877732 222222111
Q ss_pred HHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 229 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
+.... ....+..+++.+.+++.+||+.||++||++.++++
T Consensus 237 ~~~~~------------------------------------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 237 ITQGR------------------------------------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHcCc------------------------------------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 11000 00111246678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=268.80 Aligned_cols=237 Identities=23% Similarity=0.408 Sum_probs=190.8
Q ss_pred eeeeeecceEEEEEEEecC---CceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEe
Q 020826 27 RKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 99 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~~---~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 99 (321)
+.||+|+||.||+|.+... +..+++|.++... ...+.+|+..+..+ +|+|++++++++.+ ....++++||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~--~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVVRLLGVCTE--EEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhc-CCCChheeeeeecC--CCceEEEEEe
Confidence 3689999999999999765 8899999987543 35788999999999 69999999999865 5667899999
Q ss_pred ecCchhhhhc------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 100 VNNTDFKVLY------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 100 ~~~~~l~~~~------------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
+.+++|..++ ..+++..++.++.|++.||++||++|++|+||+|+||+++.++ .++|+|||.+....
T Consensus 78 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~-~~~l~dfg~~~~~~ 156 (262)
T cd00192 78 MEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL-VVKISDFGLSRDVY 156 (262)
T ss_pred ccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCC-cEEEcccccccccc
Confidence 9999987776 3378999999999999999999999999999999999999887 89999999997665
Q ss_pred CCC---ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 168 PGK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 168 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
... ......++..|+|||.+.. ..++.++||||||+++|++++ |..||. ..........+.. .
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~~~~~~~~~~----~------- 223 (262)
T cd00192 157 DDDYYRKKTGGKLPIRWMAPESLKD-GIFTSKSDVWSFGVLLWEIFTLGATPYP-GLSNEEVLEYLRK----G------- 223 (262)
T ss_pred cccccccccCCCcCccccCHHHhcc-CCcchhhccHHHHHHHHHHHhcCCCCCC-CCCHHHHHHHHHc----C-------
Confidence 432 1233456778999999887 578999999999999999999 577773 3222222221111 0
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
.....+..+|+++.+++.+||+.||++|||+.+++++
T Consensus 224 -------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 224 -------------------------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred -------------------------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 0111223456899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=270.62 Aligned_cols=242 Identities=17% Similarity=0.317 Sum_probs=186.7
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCc----eEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~----~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
.++|++.+.||+|+||+||+|.+..++. .+++|.+.... ...+..|+..+..+ .||||+++++++.+ .
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l-~h~~iv~~~~~~~~---~ 81 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSL-DHAYIVRLLGICPG---A 81 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcC-CCCCcceEEEEECC---C
Confidence 4689999999999999999999876665 47778775332 23456677778888 89999999998743 3
Q ss_pred CcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 92 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
..++++|++.+++|.+++ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||.+....
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~-~~kl~Dfg~~~~~~ 160 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDS-IVQIADFGVADLLY 160 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC-cEEEcCCccceecc
Confidence 457899999999988777 2478999999999999999999999999999999999999877 89999999997654
Q ss_pred CCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 168 PGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 168 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
+... .....++..|+|||.+.+ ..++.++||||||+++|++++ |..||. +... .....+......
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~-~~~~-~~~~~~~~~~~~-------- 229 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYA-GMRP-HEVPDLLEKGER-------- 229 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCC-CCCH-HHHHHHHHCCCc--------
Confidence 3321 223345667999999977 678999999999999999998 888873 2221 111111110000
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
...+...+.++.+++.+|+..||++|||+.|+++
T Consensus 230 ---------------------------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 230 ---------------------------LAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred ---------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0011124467899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=268.87 Aligned_cols=234 Identities=20% Similarity=0.359 Sum_probs=183.0
Q ss_pred eeeeecceEEEEEEE--ecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEee
Q 020826 28 KVGRGKYSEVFEGVH--CTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 100 (321)
Q Consensus 28 ~lg~g~~g~v~~~~~--~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 100 (321)
.||+|+||.||+|.+ ..++..+++|+++... ...+..|+.+++.+ +||||+++++++.+ ...++++|++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---~~~~lv~e~~ 77 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQL-DNPYIVRMIGICEA---ESWMLVMELA 77 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhC-CCCCcceEEEEEcC---CCcEEEEecC
Confidence 589999999999965 3567899999986432 34678899999999 89999999998743 3457999999
Q ss_pred cCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCcc----c
Q 020826 101 NNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----N 173 (321)
Q Consensus 101 ~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~----~ 173 (321)
++++|..++ ..+++..+..++.|++.||++||++|++|+||||.||+++.++ .++|+|||++......... .
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05116 78 ELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH-YAKISDFGLSKALGADENYYKAKT 156 (257)
T ss_pred CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC-eEEECCCccccccCCCCCeeeecC
Confidence 999988776 3589999999999999999999999999999999999999877 8999999998765433221 1
Q ss_pred cccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChh
Q 020826 174 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 252 (321)
Q Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (321)
...++..|+|||.+.. ..++.++|+|||||++|++++ |..||. .....+....+.+. .
T Consensus 157 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~-~~~~~~~~~~i~~~-~------------------ 215 (257)
T cd05116 157 HGKWPVKWYAPECMNY-YKFSSKSDVWSFGVLMWEAFSYGQKPYK-GMKGNEVTQMIESG-E------------------ 215 (257)
T ss_pred CCCCCccccCHhHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHCC-C------------------
Confidence 1223467999999876 678899999999999999998 888873 22222222221110 0
Q ss_pred hHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 253 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
....+..+++++.++|++||+.||++|||++++..
T Consensus 216 -----------------~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 216 -----------------RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred -----------------CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 00112246689999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=269.60 Aligned_cols=243 Identities=18% Similarity=0.322 Sum_probs=190.6
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCc---eEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNE---KCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~---~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
..+|++.+.||+|+||.||+|.+..++. .+++|.++... ...+..|+.+++.+ +||||+++++++.. ...
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~ 79 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTK--SKP 79 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec--CCc
Confidence 4689999999999999999999865443 78999886432 34678899999999 89999999999854 456
Q ss_pred cEEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 93 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
.++++|++++++|..++. .++...+..++.|++.||++||+.|++|+||||+||+++.++ .++|+|||++.....
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~-~~~l~dfg~~~~~~~ 158 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNL-VCKVSDFGLSRVLED 158 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCC-eEEeCCCCccccccc
Confidence 789999999999887763 478889999999999999999999999999999999999877 899999999876543
Q ss_pred CCcc----ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 169 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 169 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
.... .....+..|+|||.+.+ ..++.++|+||||+++|++++ |..||.. ....+....+.+...
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~ell~~g~~p~~~-~~~~~~~~~~~~~~~--------- 227 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWE-MSNQDVIKAIEEGYR--------- 227 (267)
T ss_pred ccceeeecCCCccceeecCHhHhcc-CccCchhhhHHHHHHHHHHhcCCCCCccc-CCHHHHHHHHhCCCc---------
Confidence 2211 11122457999999987 678999999999999999886 9988842 222222222111000
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
......+++.+.+++.+||+.+|++|||+.++++
T Consensus 228 ---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 228 ---------------------------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred ---------------------------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 0011235678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=276.29 Aligned_cols=244 Identities=19% Similarity=0.317 Sum_probs=188.6
Q ss_pred cCceEEeeeeeeecceEEEEEEEec-------CCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeecc
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCT-------DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 88 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~-------~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (321)
.++|.+.+.||+|+||.||+|.+.. ....+++|.++... ...+..|+.+++.+.+||||+++++++.+.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 4699999999999999999998642 24468999887432 245778999999986799999999998543
Q ss_pred CCCCcEEEEEeecCchhhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEc
Q 020826 89 QSKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 149 (321)
Q Consensus 89 ~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~ 149 (321)
...++++||+.+++|..++. .++...+..++.|++.||.|||++|++|+||||+||+++
T Consensus 91 --~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 91 --GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT 168 (314)
T ss_pred --CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence 45689999999999877762 267788899999999999999999999999999999999
Q ss_pred CCCCeEEEeeccceeecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHH
Q 020826 150 HEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQ 225 (321)
Q Consensus 150 ~~~~~v~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~ 225 (321)
.++ .++|+|||.+........ .....++..|+|||.+.+ ..++.++|+||||+++|++++ |..||. +.+..+.
T Consensus 169 ~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el~~~g~~p~~-~~~~~~~ 245 (314)
T cd05099 169 EDN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEIFTLGGSPYP-GIPVEEL 245 (314)
T ss_pred CCC-cEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHHHhCCCCCCC-CCCHHHH
Confidence 887 899999999875532211 111223356999999877 678999999999999999999 777773 3322222
Q ss_pred HHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 226 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
...+.. . .. ...+..++.++.+++.+||+.||++|||+.++++
T Consensus 246 ~~~~~~----~--------------------------~~------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 246 FKLLRE----G--------------------------HR------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred HHHHHc----C--------------------------CC------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 221110 0 00 0011235578999999999999999999998885
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=267.63 Aligned_cols=226 Identities=21% Similarity=0.319 Sum_probs=179.7
Q ss_pred ecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeecCchhhhhc--
Q 020826 32 GKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-- 109 (321)
Q Consensus 32 g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-- 109 (321)
|.+|+||++++..+++.+++|.++... ....|...+... .|||++++++++.+ ....+++|||+.+++|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--~~~~~~~~~~~~-~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--EYSRERLTIIPH-CVPNMVCLHKYIVS--EDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--hhhhHHHHHHhc-CCCceeehhhheec--CCeEEEEEecCCCCCHHHHHHH
Confidence 889999999999999999999987543 234444444444 69999999999855 45678999999999987766
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCccccccCCcccccccccc
Q 020826 110 -PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 188 (321)
Q Consensus 110 -~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~ 188 (321)
..+++..+..++.|++.||+|||+.|++|+||||+||+++.++ .++++|||.+...... .....++..|+|||...
T Consensus 79 ~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~ 155 (237)
T cd05576 79 FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRG-HIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGG 155 (237)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC-CEEEecccchhccccc--cccCCcCccccCCcccC
Confidence 3589999999999999999999999999999999999999888 7999999987554322 22334566799999987
Q ss_pred CCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccc
Q 020826 189 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKF 268 (321)
Q Consensus 189 ~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (321)
+ ..++.++|+||+|+++|++++|..|+...... . ...
T Consensus 156 ~-~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---------------~---------------------------~~~ 192 (237)
T cd05576 156 I-SEETEACDWWSLGAILFELLTGKTLVECHPSG---------------I---------------------------NTH 192 (237)
T ss_pred C-CCCCchhhHHHHHHHHHHHHHCcchhhcCchh---------------c---------------------------ccc
Confidence 6 67889999999999999999999776211100 0 000
Q ss_pred cccccccCCcchHHHHHHHhhccCCCCCcCH-----HHHhcCCCc
Q 020826 269 ITVENQHLAVPEAVDFLDKLLRYDHQERPTA-----KEAMAHPYF 308 (321)
Q Consensus 269 ~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~-----~ell~hp~~ 308 (321)
.....+..+++.+.++|.+||+.||++|+|+ +++++||||
T Consensus 193 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 193 TTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred cccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 0011223466789999999999999999986 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=273.38 Aligned_cols=250 Identities=18% Similarity=0.340 Sum_probs=187.6
Q ss_pred cCceEEeeeeeeecceEEEEEEEec----------------CCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCee
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCT----------------DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIV 79 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~----------------~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~ 79 (321)
.++|++.+.||+|+||+||++.+.. ++..+++|+++... ...+.+|+.+++.+ +||||+
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~ 82 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRL-KDPNII 82 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcc
Confidence 4679999999999999999986532 34468999987532 35678999999999 899999
Q ss_pred eeeeeeeccCCCCcEEEEEeecCchhhhhcCC--------------CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCC
Q 020826 80 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT--------------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHN 145 (321)
Q Consensus 80 ~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--------------~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~n 145 (321)
++++++.+. ...++++|++.+++|..++.. +++..+..++.|++.||+|||+.|++|+||||+|
T Consensus 83 ~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N 160 (296)
T cd05095 83 RLLAVCITS--DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN 160 (296)
T ss_pred eEEEEEecC--CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence 999998654 456799999999998777632 5567899999999999999999999999999999
Q ss_pred eEEcCCCCeEEEeeccceeecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh--CCCCCccCC
Q 020826 146 VMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF--RKEPFFYGH 220 (321)
Q Consensus 146 ili~~~~~~v~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~--g~~p~~~~~ 220 (321)
|+++.++ .++|+|||++........ ......+..|++||...+ ..++.++|+|||||++|+|++ |..||. ..
T Consensus 161 ili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~DiwSlG~~l~el~~~~~~~p~~-~~ 237 (296)
T cd05095 161 CLVGKNY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL-GKFTTASDVWAFGVTLWEILTLCKEQPYS-QL 237 (296)
T ss_pred EEEcCCC-CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhc-CCccchhhhhHHHHHHHHHHHhCCCCCcc-cc
Confidence 9999777 899999999875533221 112233567999998876 678999999999999999998 667773 22
Q ss_pred CChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHH
Q 020826 221 DNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 300 (321)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ 300 (321)
+..+............ .. ......+..+++.+.+++.+||+.||++|||+.
T Consensus 238 ~~~~~~~~~~~~~~~~---------------------~~--------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ 288 (296)
T cd05095 238 SDEQVIENTGEFFRDQ---------------------GR--------QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQ 288 (296)
T ss_pred ChHHHHHHHHHHHhhc---------------------cc--------cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHH
Confidence 2222211110000000 00 000111223567899999999999999999999
Q ss_pred HHhc
Q 020826 301 EAMA 304 (321)
Q Consensus 301 ell~ 304 (321)
++++
T Consensus 289 ~i~~ 292 (296)
T cd05095 289 EIHA 292 (296)
T ss_pred HHHH
Confidence 9864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=269.02 Aligned_cols=243 Identities=17% Similarity=0.316 Sum_probs=189.9
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCc---eEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNE---KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~---~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
..+|++.+.||+|+||.||+|.+..++. .|++|.++.. ....+..|+.+++.+ +||||+++.+++.+ ...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~ni~~~~~~~~~--~~~ 79 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNIIHLEGVVTK--SRP 79 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCcCcceEEEEECC--CCc
Confidence 3568999999999999999999876654 5999998643 235688899999999 89999999999854 455
Q ss_pred cEEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 93 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
.++++|++.+++|..++. .++...+..++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~-~~kl~dfg~~~~~~~ 158 (269)
T cd05065 80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLED 158 (269)
T ss_pred eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCC-cEEECCCcccccccc
Confidence 679999999999887763 378899999999999999999999999999999999999777 899999999865433
Q ss_pred CCcc---cccc---CCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHH
Q 020826 169 GKEY---NVRV---ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAY 241 (321)
Q Consensus 169 ~~~~---~~~~---~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (321)
.... .... .+..|+|||.+.+ ..++.++|||||||++|++++ |..||.. .+.......+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~-~~~~~~~~~i~~~~-------- 228 (269)
T cd05065 159 DTSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWD-MSNQDVINAIEQDY-------- 228 (269)
T ss_pred CccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCC-CCHHHHHHHHHcCC--------
Confidence 2211 1111 1346999999876 678999999999999999886 8888843 22222222211100
Q ss_pred hhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 242 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
....+..+++.+.+++.+||+.+|.+||++.++++
T Consensus 229 ----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 229 ----------------------------RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred ----------------------------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00111235678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=268.48 Aligned_cols=243 Identities=23% Similarity=0.421 Sum_probs=190.7
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecC---CceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~---~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
..++|.+.+.||+|++|.||+|.+... ...+++|...... ...+.+|+.+++.+ +|||++++++++.+ .
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~-~h~~i~~~~~~~~~---~ 79 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF-DHPHIVKLIGVITE---N 79 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCchhceeEEEcC---C
Confidence 456899999999999999999987544 3478999876432 34688899999999 89999999998854 2
Q ss_pred CcEEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 92 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
..++++|++.+++|..++. .+++..+..++.|++.||+|||+.|++|+||+|+||+++.++ .++|+|||++....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~ 158 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD-CVKLGDFGLSRYLE 158 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCC-CeEEccCceeeecc
Confidence 3579999999999988773 378999999999999999999999999999999999999877 89999999987654
Q ss_pred CCCccc--cccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhh
Q 020826 168 PGKEYN--VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244 (321)
Q Consensus 168 ~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (321)
...... ...++..|+|||.+.. ..++.++||||||++++++++ |..||. +....+....+...
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~-~~~~~~~~~~~~~~------------ 224 (270)
T cd05056 159 DESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQ-GVKNNDVIGRIENG------------ 224 (270)
T ss_pred cccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHHcC------------
Confidence 332211 1223457999999876 678999999999999999986 888883 32222222221100
Q ss_pred hcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
. ....+..+++++.+++.+|+..+|++|||+.+++.
T Consensus 225 ------------------~------~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 225 ------------------E------RLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred ------------------C------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 00112245679999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=267.31 Aligned_cols=244 Identities=18% Similarity=0.337 Sum_probs=190.8
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCc---eEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNE---KCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~---~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
..++|+..+.||+|++|.||+|++..++. .+++|.++... ...+..|+.++..+ +|||++++.+++.+ ..
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~ 79 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQF-SHHNIIRLEGVVTK--FK 79 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCCCeeEEEEEEcc--CC
Confidence 35689999999999999999999876554 68999886432 34578899999999 89999999999854 44
Q ss_pred CcEEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 92 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
..+++||++++++|..++. .+++..+..++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||++....
T Consensus 80 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~ 158 (268)
T cd05063 80 PAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNL-ECKVSDFGLSRVLE 158 (268)
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCC-cEEECCCccceecc
Confidence 5679999999999987762 478899999999999999999999999999999999999877 89999999987654
Q ss_pred CCCcc--c--cccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHh
Q 020826 168 PGKEY--N--VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242 (321)
Q Consensus 168 ~~~~~--~--~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (321)
..... . ....+..|+|||.+.+ ..++.++|+|||||++|++++ |..||... ...+....+....
T Consensus 159 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~il~ell~~g~~p~~~~-~~~~~~~~i~~~~--------- 227 (268)
T cd05063 159 DDPEGTYTTSGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSFGERPYWDM-SNHEVMKAINDGF--------- 227 (268)
T ss_pred cccccceeccCCCcCceecCHHHhhc-CCcChHhHHHHHHHHHHHHHhCCCCCCCcC-CHHHHHHHHhcCC---------
Confidence 32211 1 1122346999999877 678999999999999999997 89898432 2222222211100
Q ss_pred hhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
. ......++.++.+++.+||+.+|++||++.++++
T Consensus 228 -------------------~--------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 228 -------------------R--------LPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred -------------------C--------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0 0011135578999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=274.62 Aligned_cols=297 Identities=29% Similarity=0.488 Sum_probs=236.4
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEec---CCceEEEEEeccc-chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHCT---DNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~~---~~~~~~vK~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
++...+.|..+.+||+|.|++||++.+.. ....||+|.+... ...++..|++.|..+.++.||+++.+.+.. ..
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rn--nd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRN--ND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhcc--CC
Confidence 44556789999999999999999999877 6789999998754 468899999999999999999999999954 44
Q ss_pred CcEEEEEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeec-----
Q 020826 92 TPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY----- 166 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~----- 166 (321)
..++|+||++...+.++...++..++..++..++.||+++|++||+||||||.|++.+.....-.|.|||++...
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred eeEEEecccCccCHHHHHhcCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence 556999999999999999999999999999999999999999999999999999999977667899999998611
Q ss_pred ------------CC--CC---------------c-----------cccccCCccccccccccCCCCCCCcchHHHHHHHH
Q 020826 167 ------------HP--GK---------------E-----------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMF 206 (321)
Q Consensus 167 ------------~~--~~---------------~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l 206 (321)
.+ +. . .-...||++|+|||++......+++.||||.|+++
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL 268 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence 00 00 0 01246899999999999888899999999999999
Q ss_pred HHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc--cCC----hhhHhhhcccC------CCCCcc--ccccc
Q 020826 207 AGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI--ELD----PHLAALVGRHS------RKPWSK--FITVE 272 (321)
Q Consensus 207 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~----~~~~~~~~~~~------~~~~~~--~~~~~ 272 (321)
..++++..||+...++...+.++...+|...+.+..-..+. ... +-......... ...... .....
T Consensus 269 Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~ 348 (418)
T KOG1167|consen 269 LSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREI 348 (418)
T ss_pred ehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecc
Confidence 99999999999999999999999999998877765544443 111 00111111000 001011 11122
Q ss_pred cccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 273 NQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 273 ~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
..+..+..+.+|+.+||..||.+|.||+++|+||||....+.
T Consensus 349 ~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~~ 390 (418)
T KOG1167|consen 349 GSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADRT 390 (418)
T ss_pred ccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhhh
Confidence 223345589999999999999999999999999999976443
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=264.90 Aligned_cols=243 Identities=17% Similarity=0.357 Sum_probs=191.3
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc--chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
..+|++.+.||+|++|.||++.+. ++..+++|.++.. ....+.+|+++++.+ +||+++++++++.. ....++++
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~--~~~~~~v~ 78 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKL-SHPKLVQLYGVCTE--RSPICLVF 78 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhC-CCCCeeeEEEEEcc--CCceEEEE
Confidence 468999999999999999999884 4678999988743 245788999999999 89999999999854 34568999
Q ss_pred EeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc--
Q 020826 98 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-- 171 (321)
Q Consensus 98 e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~-- 171 (321)
|++.+++|.+++. .+++..+..++.|++.++++||+.|++|+||+|.||+++.++ .++|+|||.+........
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ-VVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCC-eEEECCCcceeecccCcccc
Confidence 9999999887762 378899999999999999999999999999999999999777 899999999875532211
Q ss_pred cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 172 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
.....++..|+|||.+.+ ..++.++|+||||+++|++++ |..||. ..........+.+.
T Consensus 158 ~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~-~~~~~~~~~~~~~~------------------ 217 (256)
T cd05112 158 STGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYE-NRSNSEVVETINAG------------------ 217 (256)
T ss_pred cCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCC-cCCHHHHHHHHhCC------------------
Confidence 112234567999999877 678899999999999999998 888873 22222222221100
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
. ....+...++++.+++.+||+.+|++|||+.+++++
T Consensus 218 ---------~---------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 218 ---------F---------RLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred ---------C---------CCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 0 000112245789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=291.79 Aligned_cols=276 Identities=21% Similarity=0.274 Sum_probs=179.0
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecC----CceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeeee----ccCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTD----NEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVR----DQQS 90 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~----~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~----~~~~ 90 (321)
..++|++.+.||+|+||+||+|++..+ +..+|+|.++.........+. .++.. .+.++..+...+. ....
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e-~l~~~-~~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE-RVRRA-CPNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHH-HHHhh-chhhHHHHHHhhhcccccccC
Confidence 567999999999999999999999888 899999987643322211111 11221 2222222222111 1334
Q ss_pred CCcEEEEEeecCchhhhhcCC-----------------------CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeE
Q 020826 91 KTPSLIFEHVNNTDFKVLYPT-----------------------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVM 147 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~~~-----------------------~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nil 147 (321)
...++++||+++++|.+++.. .....+..++.|++.||+|||++||+|+||||+||+
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NIL 287 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNII 287 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEE
Confidence 567899999999988776632 112346689999999999999999999999999999
Q ss_pred EcCCCCeEEEeeccceeecCCCC--ccccccCCccccccccccCCC---------------------CCCCcchHHHHHH
Q 020826 148 IDHEQRKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLVDLQ---------------------DYDYSLDLWSLGC 204 (321)
Q Consensus 148 i~~~~~~v~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~DvwslG~ 204 (321)
++.+...+||+|||+++...... ......+++.|+|||.+.... .++.++|||||||
T Consensus 288 l~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv 367 (566)
T PLN03225 288 FSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL 367 (566)
T ss_pred EeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence 98654489999999997543222 223457888999999653211 2334569999999
Q ss_pred HHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHH
Q 020826 205 MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDF 284 (321)
Q Consensus 205 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 284 (321)
++|+|+++..+. .+....+..+....+.+ ...+... .... ...............+...++|
T Consensus 368 iL~el~~~~~~~---~~~~~~~~~~l~~~~~~-~~~~~~~------------~~~~--~~~~~~~~~~~~d~~~~~~~dL 429 (566)
T PLN03225 368 IFLQMAFPNLRS---DSNLIQFNRQLKRNDYD-LVAWRKL------------VEPR--ASPDLRRGFEVLDLDGGAGWEL 429 (566)
T ss_pred HHHHHHhCcCCC---chHHHHHHHHHHhcCCc-HHHHHHh------------hccc--cchhhhhhhhhccccchHHHHH
Confidence 999999866543 22223333332222221 1111110 0000 0000000001111223467899
Q ss_pred HHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 285 LDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 285 l~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
|++||+.||++|||++++|+||||++....
T Consensus 430 i~~mL~~dP~kR~ta~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 430 LKSMMRFKGRQRISAKAALAHPYFDREGLL 459 (566)
T ss_pred HHHHccCCcccCCCHHHHhCCcCcCCCCcc
Confidence 999999999999999999999999986543
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=273.43 Aligned_cols=247 Identities=18% Similarity=0.299 Sum_probs=190.9
Q ss_pred cccCceEEeeeeeeecceEEEEEEEec-------CCceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeee
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCT-------DNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVR 86 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~-------~~~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (321)
...++|.+.+.||+|+||.||+|++.. ++..+++|.++.. ....+.+|+.+++.+.+||||+++++.+.
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 91 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT 91 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence 457899999999999999999997532 3347999988643 23568899999999878999999999986
Q ss_pred ccCCCCcEEEEEeecCchhhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeE
Q 020826 87 DQQSKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVM 147 (321)
Q Consensus 87 ~~~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nil 147 (321)
.. ...++++||+.+++|..++. .++...+..++.|++.||.|||++|++|+||||+||+
T Consensus 92 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 169 (304)
T cd05101 92 QD--GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL 169 (304)
T ss_pred cC--CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence 54 45679999999999877762 2566778899999999999999999999999999999
Q ss_pred EcCCCCeEEEeeccceeecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCCh
Q 020826 148 IDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNY 223 (321)
Q Consensus 148 i~~~~~~v~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~ 223 (321)
++.++ .++|+|||.+........ .....++..|+|||++.+ ..++.++||||||+++|++++ |..|| .+.+..
T Consensus 170 i~~~~-~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~-~~~~~~ 246 (304)
T cd05101 170 VTENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPY-PGIPVE 246 (304)
T ss_pred EcCCC-cEEECCCccceecccccccccccCCCCCceeeCchhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCc-ccCCHH
Confidence 99877 899999999876543221 122234567999999977 678999999999999999998 66666 233222
Q ss_pred HHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHh
Q 020826 224 DQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 303 (321)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell 303 (321)
+....+.. . . . ...+..++.++.+++.+||+.+|++|||+.+++
T Consensus 247 ~~~~~~~~----~-----------------------~---~------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l 290 (304)
T cd05101 247 ELFKLLKE----G-----------------------H---R------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLV 290 (304)
T ss_pred HHHHHHHc----C-----------------------C---c------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHH
Confidence 22221100 0 0 0 001124567899999999999999999999998
Q ss_pred cC
Q 020826 304 AH 305 (321)
Q Consensus 304 ~h 305 (321)
+.
T Consensus 291 ~~ 292 (304)
T cd05101 291 ED 292 (304)
T ss_pred HH
Confidence 64
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=281.15 Aligned_cols=251 Identities=22% Similarity=0.327 Sum_probs=192.4
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEec-----CCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeee
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLD 83 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (321)
.|.|+ .++|.+.+.||+|+||.||+|++.. ++..||+|+++... ...+.+|+.++..+..||||+++++
T Consensus 31 ~~~~~--~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~ 108 (401)
T cd05107 31 AWEMP--RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLG 108 (401)
T ss_pred cceec--HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEE
Confidence 56666 4589999999999999999998643 44689999997432 2357789999999955999999999
Q ss_pred eeeccCCCCcEEEEEeecCchhhhhcC-----------------------------------------------------
Q 020826 84 IVRDQQSKTPSLIFEHVNNTDFKVLYP----------------------------------------------------- 110 (321)
Q Consensus 84 ~~~~~~~~~~~lv~e~~~~~~l~~~~~----------------------------------------------------- 110 (321)
.+... ...++|+||+.+++|.+++.
T Consensus 109 ~~~~~--~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 186 (401)
T cd05107 109 ACTKG--GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDES 186 (401)
T ss_pred EEccC--CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccc
Confidence 98654 45789999999998876652
Q ss_pred ------------------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCC
Q 020826 111 ------------------------------------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVK 142 (321)
Q Consensus 111 ------------------------------------------------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlk 142 (321)
.++...+..++.|++.||+|||+.+++|+|||
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlk 266 (401)
T cd05107 187 ADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLA 266 (401)
T ss_pred cCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCC
Confidence 14555678899999999999999999999999
Q ss_pred CCCeEEcCCCCeEEEeeccceeecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCcc
Q 020826 143 PHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFY 218 (321)
Q Consensus 143 p~nili~~~~~~v~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~ 218 (321)
|+||+++.++ .++|+|||++........ .....++..|+|||.+.+ ..++.++|+||||++++++++ |..||.
T Consensus 267 p~NiLl~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslGvil~e~l~~g~~P~~- 343 (401)
T cd05107 267 ARNVLICEGK-LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN-NLYTTLSDVWSFGILLWEIFTLGGTPYP- 343 (401)
T ss_pred cceEEEeCCC-EEEEEecCcceecccccccccCCCcCCCCceeChHHhcC-CCCCcHhHHHHHHHHHHHHHHcCCCCCC-
Confidence 9999999777 899999999876432221 122345678999999987 678999999999999999998 787873
Q ss_pred CCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC
Q 020826 219 GHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT 298 (321)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps 298 (321)
.....+........ . .....+..+++++.+++.+||+.+|++||+
T Consensus 344 ~~~~~~~~~~~~~~---~--------------------------------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs 388 (401)
T cd05107 344 ELPMNEQFYNAIKR---G--------------------------------YRMAKPAHASDEIYEIMQKCWEEKFEIRPD 388 (401)
T ss_pred CCCchHHHHHHHHc---C--------------------------------CCCCCCCCCCHHHHHHHHHHcCCChhHCcC
Confidence 22222222111110 0 000112235679999999999999999999
Q ss_pred HHHHhcC
Q 020826 299 AKEAMAH 305 (321)
Q Consensus 299 ~~ell~h 305 (321)
++++++.
T Consensus 389 ~~ell~~ 395 (401)
T cd05107 389 FSQLVHL 395 (401)
T ss_pred HHHHHHH
Confidence 9999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=271.53 Aligned_cols=244 Identities=18% Similarity=0.309 Sum_probs=190.1
Q ss_pred ccCceEEeeeeeeecceEEEEEEEec-----CCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 89 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (321)
..++|++.+.||+|+||.||+|.+.. ++..+++|.++... ...+.+|+..+..+ .|||++++++++.+
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l-~h~~iv~~~~~~~~-- 79 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DHPNIVKLLGVCAV-- 79 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhc-CCCchheEEEEEcC--
Confidence 45789999999999999999998753 56789999986432 35578899999999 89999999998854
Q ss_pred CCCcEEEEEeecCchhhhhcC-------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCC
Q 020826 90 SKTPSLIFEHVNNTDFKVLYP-------------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPH 144 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~~-------------------------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~ 144 (321)
....++++||+.+++|..++. .+++..+..++.|++.||++||++|++|+||+|.
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ 159 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR 159 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence 345689999999999877763 2567788999999999999999999999999999
Q ss_pred CeEEcCCCCeEEEeeccceeecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCC
Q 020826 145 NVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGH 220 (321)
Q Consensus 145 nili~~~~~~v~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~ 220 (321)
||+++.++ .++|+|||++........ ......+..|+|||...+ ..++.++|||||||++|+|++ |..||...
T Consensus 160 nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~~~~~p~~~~- 236 (288)
T cd05050 160 NCLVGENM-VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGMQPYYGM- 236 (288)
T ss_pred heEecCCC-ceEECccccceecccCccccccCCCccChhhcCHHHHhc-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC-
Confidence 99999887 899999999875432211 122234556999999877 678999999999999999997 77787422
Q ss_pred CChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHH
Q 020826 221 DNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 300 (321)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ 300 (321)
...+....+.. .. ....+..+++++.+++.+||+.||++|||+.
T Consensus 237 ~~~~~~~~~~~----~~--------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~ 280 (288)
T cd05050 237 AHEEVIYYVRD----GN--------------------------------VLSCPDNCPLELYNLMRLCWSKLPSDRPSFA 280 (288)
T ss_pred CHHHHHHHHhc----CC--------------------------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHH
Confidence 22111111100 00 0001123567899999999999999999999
Q ss_pred HHhc
Q 020826 301 EAMA 304 (321)
Q Consensus 301 ell~ 304 (321)
|+++
T Consensus 281 el~~ 284 (288)
T cd05050 281 SINR 284 (288)
T ss_pred HHHH
Confidence 9874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=265.13 Aligned_cols=234 Identities=18% Similarity=0.343 Sum_probs=181.2
Q ss_pred eeeeecceEEEEEEEe--cCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeec
Q 020826 28 KVGRGKYSEVFEGVHC--TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVN 101 (321)
Q Consensus 28 ~lg~g~~g~v~~~~~~--~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 101 (321)
.||+|+||.||+|.+. .++..+++|+++... ...+.+|+.+++++ +||||+++++++.. ...++|+||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~ii~~~~~~~~---~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQL-DNPYIVRMIGVCEA---EALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhc-CCCCeEEEEEEEcC---CCeEEEEEeCC
Confidence 3899999999999875 345579999986543 24578999999999 99999999998742 35689999999
Q ss_pred CchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCcc----c
Q 020826 102 NTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----N 173 (321)
Q Consensus 102 ~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~----~ 173 (321)
+++|.+++. .+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++......... .
T Consensus 78 ~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~ 156 (257)
T cd05115 78 GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH-YAKISDFGLSKALGADDSYYKARS 156 (257)
T ss_pred CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCC-cEEeccCCccccccCCccceeccC
Confidence 999887762 489999999999999999999999999999999999999877 8999999998754322211 1
Q ss_pred cccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChh
Q 020826 174 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 252 (321)
Q Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (321)
...++..|+|||.+.. ..++.++||||||+++|++++ |..||. +.........+.+. .
T Consensus 157 ~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~-~~~~~~~~~~~~~~-~------------------ 215 (257)
T cd05115 157 AGKWPLKWYAPECINF-RKFSSRSDVWSYGITMWEAFSYGQKPYK-KMKGPEVMSFIEQG-K------------------ 215 (257)
T ss_pred CCCCCcccCCHHHHcc-CCCCchhhHHHHHHHHHHHhcCCCCCcC-cCCHHHHHHHHHCC-C------------------
Confidence 1122457999999876 678899999999999999996 888873 22221111111100 0
Q ss_pred hHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 253 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
....+..+++++.+++.+||..||++||++.++.+
T Consensus 216 -----------------~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 216 -----------------RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred -----------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00112245679999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=264.95 Aligned_cols=235 Identities=19% Similarity=0.334 Sum_probs=183.7
Q ss_pred eeeeeecceEEEEEEEecCC---ceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEe
Q 020826 27 RKVGRGKYSEVFEGVHCTDN---EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 99 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~~~---~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 99 (321)
++||+|+||.||+|++..++ ..+++|.++... ...+..|+.+++.+ .|||++++++++.. ...++++|+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQL-DHPCIVRLIGVCKG---EPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhc-CCCCeeeEEEEEcC---CceEEEEEe
Confidence 46899999999999876554 789999987543 34678899999999 89999999998743 345899999
Q ss_pred ecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCccc---
Q 020826 100 VNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN--- 173 (321)
Q Consensus 100 ~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~~--- 173 (321)
+.+++|.+++. .+++..+..++.|++.||++||..|++|+||||+||+++.++ .++|+|||.+..........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~-~~kl~df~~~~~~~~~~~~~~~~ 155 (257)
T cd05060 77 APLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRH-QAKISDFGMSRALGAGSDYYRAT 155 (257)
T ss_pred CCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCC-cEEeccccccceeecCCcccccc
Confidence 99999887773 488999999999999999999999999999999999999887 89999999987654332211
Q ss_pred -cccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCCh
Q 020826 174 -VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251 (321)
Q Consensus 174 -~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (321)
...++..|+|||.+.+ ..++.++|+||||+++|++++ |..||.. .+..+....+.. ..
T Consensus 156 ~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~-~~~~~~~~~~~~-~~----------------- 215 (257)
T cd05060 156 TAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGE-MKGAEVIAMLES-GE----------------- 215 (257)
T ss_pred cCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCccc-CCHHHHHHHHHc-CC-----------------
Confidence 1122356999999876 678999999999999999998 8888732 222111111110 00
Q ss_pred hhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 252 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
....+..+++.+.+++.+||..||++|||+.++++
T Consensus 216 ------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 216 ------------------RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred ------------------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 01112245678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=271.46 Aligned_cols=260 Identities=20% Similarity=0.356 Sum_probs=196.1
Q ss_pred cCceEEeeeeeeecceEEEEEEEec----CCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCT----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~----~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
.++|++.+.||+|+||.||+|.... ++..+++|+++... ...+.+|+..++.+ .||||+++++++......
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l-~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTL-DHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhC-CCCChheEEeeeecCCCC
Confidence 4678899999999999999998643 47899999987543 34688999999999 899999999998766667
Q ss_pred CcEEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 92 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
+.++++||+.+++|..++. .+++..+..++.|++.||++||++|++|+||+|+||+++.++ .++|+|||.+....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~ 160 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED-LVKISDFGLAKVLP 160 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC-CEEEcccccccccc
Confidence 7889999999999988873 388999999999999999999999999999999999999887 89999999987664
Q ss_pred CCCcc----ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 168 PGKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 168 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
..... ....++..|++||...+ ..++.++|+||||+++++|++|..|+......... ..+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~------~~~~~~~----- 228 (284)
T cd05038 161 EDKDYYYVKEPGESPIFWYAPECLRT-SKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR------MIGIAQG----- 228 (284)
T ss_pred cCCcceeccCCCCCcccccCcHHHcc-CCCCcccchHHHhhhhheeeccCCCcccccchhcc------ccccccc-----
Confidence 22221 12234456999999877 67889999999999999999999987432211100 0000000
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
................. ..+..+++++.+++.+||+.||++|||+.|+++
T Consensus 229 ---~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 229 ---QMIVTRLLELLKEGERL--------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred ---cccHHHHHHHHHcCCcC--------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00000011111111110 111235578999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=277.40 Aligned_cols=251 Identities=19% Similarity=0.312 Sum_probs=192.4
Q ss_pred eeeeeecccCceEEeeeeeeecceEEEEEEEecC-------CceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeee
Q 020826 12 CVWFINREQDDYEVVRKVGRGKYSEVFEGVHCTD-------NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVK 80 (321)
Q Consensus 12 ~~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~-------~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~ 80 (321)
+.|.+. ..+|++.+.||+|+||.||+|.+... +..+++|.++... ...+.+|+.+++++.+||||++
T Consensus 5 ~~~~~~--~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~ 82 (334)
T cd05100 5 PKWELS--RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIIN 82 (334)
T ss_pred cccccC--HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeee
Confidence 345555 45899999999999999999986432 2368999886432 3567889999999978999999
Q ss_pred eeeeeeccCCCCcEEEEEeecCchhhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecC
Q 020826 81 LLDIVRDQQSKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDV 141 (321)
Q Consensus 81 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dl 141 (321)
+++.+.+ ....++++||+++++|..++. .++...+..++.|++.||+|||++|++|+||
T Consensus 83 ~~~~~~~--~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dl 160 (334)
T cd05100 83 LLGACTQ--DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDL 160 (334)
T ss_pred eeEEEcc--CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeecccc
Confidence 9999854 345679999999999887752 2566788899999999999999999999999
Q ss_pred CCCCeEEcCCCCeEEEeeccceeecCCCCcc---ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCc
Q 020826 142 KPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFF 217 (321)
Q Consensus 142 kp~nili~~~~~~v~l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~ 217 (321)
||+||+++.++ .++|+|||++......... ....++..|+|||++.+ ..++.++||||||+++|+|++ |..||.
T Consensus 161 kp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~ 238 (334)
T cd05100 161 AARNVLVTEDN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEIFTLGGSPYP 238 (334)
T ss_pred ccceEEEcCCC-cEEECCcccceecccccccccccCCCcCceEcCHHHhcc-CCcCchhhhHHHHHHHHHHHhcCCCCCC
Confidence 99999999887 8999999998765432211 11223456999999987 778899999999999999998 777763
Q ss_pred cCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc
Q 020826 218 YGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP 297 (321)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp 297 (321)
+.+..+....+... . ....+...+.++.+++.+||+.+|++||
T Consensus 239 -~~~~~~~~~~~~~~---------------------------~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rp 281 (334)
T cd05100 239 -GIPVEELFKLLKEG---------------------------H---------RMDKPANCTHELYMIMRECWHAVPSQRP 281 (334)
T ss_pred -CCCHHHHHHHHHcC---------------------------C---------CCCCCCCCCHHHHHHHHHHcccChhhCc
Confidence 33222222111100 0 0011223557899999999999999999
Q ss_pred CHHHHhcC
Q 020826 298 TAKEAMAH 305 (321)
Q Consensus 298 s~~ell~h 305 (321)
|+.|++++
T Consensus 282 s~~ell~~ 289 (334)
T cd05100 282 TFKQLVED 289 (334)
T ss_pred CHHHHHHH
Confidence 99999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-40 Score=289.82 Aligned_cols=206 Identities=25% Similarity=0.438 Sum_probs=179.8
Q ss_pred eeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccC
Q 020826 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 89 (321)
Q Consensus 14 ~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (321)
..=...+.-+...+.||+|+||.||+|+++.+|+.||||.++.. ..+..-+|++++++| +|||||+..++-....
T Consensus 6 ~l~~~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKL-nh~NIVk~f~iee~~~ 84 (732)
T KOG4250|consen 6 VLTSGENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKL-NHPNIVKLFDIEETKF 84 (732)
T ss_pred ccccCCCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHc-CchhhhhhcccCCccc
Confidence 33344455666778899999999999999999999999998753 456788999999999 7999999999875555
Q ss_pred ----CCCcEEEEEeecCchhhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCC--CC-eEE
Q 020826 90 ----SKTPSLIFEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QR-KLR 156 (321)
Q Consensus 90 ----~~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~--~~-~v~ 156 (321)
.....++||||.+|+|...+. .+++.++..++..+..||.|||++||+||||||.||++..+ |. .-|
T Consensus 85 ~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyK 164 (732)
T KOG4250|consen 85 LGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYK 164 (732)
T ss_pred cCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEe
Confidence 567889999999999988884 49999999999999999999999999999999999999533 22 469
Q ss_pred EeeccceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCC
Q 020826 157 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH 220 (321)
Q Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~ 220 (321)
|+|||.|+....+.......||..|++||.+...+.++..+|.|||||++|++.||..||-+-.
T Consensus 165 LtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 165 LTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred eecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 9999999999888888899999999999999744789999999999999999999999996543
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=298.48 Aligned_cols=246 Identities=20% Similarity=0.385 Sum_probs=201.8
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCC-----ceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeecc
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDN-----EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 88 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~-----~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (321)
......++.+.||+|+||.||.|...... ..|++|.+++. +...+.+|..+|..+ +||||+++++++.+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f-~HpNiv~liGv~l~- 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKF-DHPNIVSLIGVCLD- 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcC-CCcceeeEEEeecC-
Confidence 45678889999999999999999876533 24899998754 346789999999999 99999999999976
Q ss_pred CCCCcEEEEEeecCchhhhhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEe
Q 020826 89 QSKTPSLIFEHVNNTDFKVLYP----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI 158 (321)
Q Consensus 89 ~~~~~~lv~e~~~~~~l~~~~~----------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~ 158 (321)
....+|++|||.+|+|..+++ .++..+...++.+|+.|+.||++++++||||.+.|++++... .|||+
T Consensus 767 -~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r-~VKIa 844 (1025)
T KOG1095|consen 767 -SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERR-VVKIA 844 (1025)
T ss_pred -CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccC-cEEEc
Confidence 445679999999999988883 278999999999999999999999999999999999999886 89999
Q ss_pred eccceeecCCCCccccc---cCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCC
Q 020826 159 DWGLAEFYHPGKEYNVR---VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 235 (321)
Q Consensus 159 dfg~~~~~~~~~~~~~~---~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (321)
|||+++.......+... .-...|||||.+.. +.++.++||||||+++||++|...+.+++.++.+.+.......
T Consensus 845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-- 921 (1025)
T KOG1095|consen 845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-- 921 (1025)
T ss_pred ccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC--
Confidence 99999844322222111 22346999999998 8999999999999999999986555557777766666433211
Q ss_pred hhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 236 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
.+..+..+++.+.++|..||+.+|++||++..+++
T Consensus 922 ----------------------------------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 922 ----------------------------------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred ----------------------------------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 23345568889999999999999999999999887
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=266.00 Aligned_cols=240 Identities=23% Similarity=0.401 Sum_probs=190.9
Q ss_pred eEEeeeeeeecceEEEEEEEecCC----ceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 23 YEVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 23 y~~~~~lg~g~~g~v~~~~~~~~~----~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
+++.+.||.|+||.||++.+...+ ..+++|.++... .+.+..|+..++.+ +|+|++++++.+.+. ...+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKL-DHPNIVKLLGVCTEE--EPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhc-CCCchheEEEEEcCC--CeeE
Confidence 356788999999999999997766 889999987543 45788999999999 999999999998654 4567
Q ss_pred EEEEeecCchhhhhcC---C--CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 95 LIFEHVNNTDFKVLYP---T--LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 95 lv~e~~~~~~l~~~~~---~--~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
+++|++.+++|..++. . +++..+..++.|++.||++||+.|++|+||+|+||+++.++ .++|+|||++......
T Consensus 78 ~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 78 IVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENL-VVKISDFGLSRDLYDD 156 (258)
T ss_pred EEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCC-eEEEcccCCceecccc
Confidence 9999999999877763 2 89999999999999999999999999999999999999887 8999999998766543
Q ss_pred Ccccc--ccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhc
Q 020826 170 KEYNV--RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246 (321)
Q Consensus 170 ~~~~~--~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (321)
..... ..++..|+|||...+ ..++.++|+||||+++++|++ |..|| ...+.......+....
T Consensus 157 ~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~-~~~~~~~~~~~~~~~~------------- 221 (258)
T smart00219 157 DYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPY-PGMSNEEVLEYLKKGY------------- 221 (258)
T ss_pred cccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHhcCC-------------
Confidence 22221 235678999999866 788999999999999999998 66665 3322222222211100
Q ss_pred ccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
........+.++.+++.+||..||++|||+.++++
T Consensus 222 -----------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 222 -----------------------RLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred -----------------------CCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 00111225678999999999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=266.42 Aligned_cols=234 Identities=18% Similarity=0.271 Sum_probs=177.1
Q ss_pred eeeeeecceEEEEEEEecC------------CceEEEEEecccch---HHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 27 RKVGRGKYSEVFEGVHCTD------------NEKCIIKILKPVKK---KKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~~------------~~~~~vK~~~~~~~---~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
+.||+|+||.||+|+...+ ...+++|++..... ..+.+|+.++..+ +||||+++++++... .
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l-~hp~iv~~~~~~~~~--~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQV-SHKHIVLLYGVCVRD--V 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC--C
Confidence 3689999999999985322 23688998765433 3567788889988 999999999998643 4
Q ss_pred CcEEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCC------eEEEeecc
Q 020826 92 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR------KLRLIDWG 161 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~------~v~l~dfg 161 (321)
..++++||+++++|..++. .+++..+..++.||+.||+|||++|++|+||||+||+++.++. .++++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 5679999999998876663 4889999999999999999999999999999999999976542 38999999
Q ss_pred ceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHH-hCCCCCccCCCChHHHHHHHHHhCChhhhH
Q 020826 162 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI-FRKEPFFYGHDNYDQLVKIAKVLGTDELNA 240 (321)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (321)
.+..... .....++..|+|||.+.....++.++|||||||++|+|+ +|..|+. .....+ ...... ..
T Consensus 158 ~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~-~~~~~~-~~~~~~---~~---- 225 (262)
T cd05077 158 IPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLK-DKTLAE-KERFYE---GQ---- 225 (262)
T ss_pred CCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC-CcchhH-HHHHHh---cC----
Confidence 8865432 123456778999999875467899999999999999998 4776662 221111 000000 00
Q ss_pred HhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 241 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
. ......++++.+++.+||+.||++||++.+++++
T Consensus 226 --------------------~----------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 226 --------------------C----------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred --------------------c----------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 0 0001123578999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=265.40 Aligned_cols=237 Identities=16% Similarity=0.310 Sum_probs=187.9
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEe
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 99 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 99 (321)
.+|++.+.||+|+||.||++.. +++.+++|.++.. ....+.+|+.+++.+ +|||++++++++... ..++++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~-~~~~i~~~~~~~~~~---~~~~v~e~ 79 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKL-HHKNLVRLLGVILHN---GLYIVMEL 79 (254)
T ss_pred HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhC-CCCCcCeEEEEEcCC---CcEEEEEC
Confidence 6799999999999999999874 7788999998754 345688999999999 899999999988543 35799999
Q ss_pred ecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCcccc
Q 020826 100 VNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV 174 (321)
Q Consensus 100 ~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~~~ 174 (321)
+.+++|..++. .++...+..++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||++...... ...
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~-~~kl~Dfg~~~~~~~~--~~~ 156 (254)
T cd05083 80 MSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG-VAKVSDFGLARVGSMG--VDN 156 (254)
T ss_pred CCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-cEEECCCccceecccc--CCC
Confidence 99999877763 378888999999999999999999999999999999999887 8999999998754322 122
Q ss_pred ccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhh
Q 020826 175 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 253 (321)
Q Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (321)
...+..|+|||.+.+ ..++.++|+||||+++|+|++ |..||. ..+..+....+.+
T Consensus 157 ~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~-~~~~~~~~~~~~~---------------------- 212 (254)
T cd05083 157 SKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYP-KMSLKEVKECVEK---------------------- 212 (254)
T ss_pred CCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCc-cCCHHHHHHHHhC----------------------
Confidence 334567999999876 678999999999999999997 887773 2222111111100
Q ss_pred HhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 254 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
.. .......+++++.+++++||+.+|++|||+++++.
T Consensus 213 ------~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 213 ------GY--------RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred ------CC--------CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00 00011245678999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=269.40 Aligned_cols=235 Identities=15% Similarity=0.261 Sum_probs=180.6
Q ss_pred eeeeeecceEEEEEEEecCCc-------eEEEEEecccch---HHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 27 RKVGRGKYSEVFEGVHCTDNE-------KCIIKILKPVKK---KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~~~~-------~~~vK~~~~~~~---~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
+.||+|+||+||+|.+...+. .+++|.+..... ..+..|..+++.+ .|||++++++++... ...++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~-~h~~iv~~~~~~~~~--~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQL-SHKHLVLNYGVCVCG--DESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhC-CCCChhheeeEEEeC--CCcEEE
Confidence 368999999999999865443 488888764332 4567888999998 899999999998654 456799
Q ss_pred EEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCC-------eEEEeeccceee
Q 020826 97 FEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR-------KLRLIDWGLAEF 165 (321)
Q Consensus 97 ~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~-------~v~l~dfg~~~~ 165 (321)
|||+.+++|..++. .+++..+..++.||+.||+|||++|++|+||||+||+++.++. .++++|||.+..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 99999999988773 3788899999999999999999999999999999999987653 279999998865
Q ss_pred cCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhh
Q 020826 166 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245 (321)
Q Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (321)
..+. ....++..|+|||.+.+...++.++|+||||+++|++++|..+++...+........ .
T Consensus 158 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~-~-------------- 219 (258)
T cd05078 158 VLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY-E-------------- 219 (258)
T ss_pred cCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH-H--------------
Confidence 4322 234567789999999875568899999999999999999965543332221111100 0
Q ss_pred cccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
.. ...+...++++.+++.+||+.||++|||++++++.
T Consensus 220 -------------~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 220 -------------DR----------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred -------------cc----------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 00 00111234679999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=296.08 Aligned_cols=141 Identities=28% Similarity=0.508 Sum_probs=125.6
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
.++|++.+.||+|+||+||+|.+..+++.||+|+++... ...+..|+.++..+ +||||+++++.+.. ..+.
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~--~~~~ 79 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALS-KSPFIVHLYYSLQS--ANNV 79 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhc-CCCCcCeEEEEEEE--CCEE
Confidence 578999999999999999999998899999999987432 25678899999988 99999999988854 4567
Q ss_pred EEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecccee
Q 020826 94 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 164 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~ 164 (321)
++||||+.+++|..++ ..+++..++.++.||+.||.|||.+||+|+||||+||+++.++ .++|+|||++.
T Consensus 80 ~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g-~vkL~DFGls~ 152 (669)
T cd05610 80 YLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG-HIKLTDFGLSK 152 (669)
T ss_pred EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCC-CEEEEeCCCCc
Confidence 8999999999988776 3578999999999999999999999999999999999999887 89999999874
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=266.18 Aligned_cols=243 Identities=20% Similarity=0.340 Sum_probs=190.2
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCc----eEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~----~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
...+|++.+.||+|+||+||+|.++.++. .+++|.+.... ...+.+|+..++.+ +|||++++++++..
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--- 80 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASV-DHPHVVRLLGICLS--- 80 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEEec---
Confidence 35789999999999999999999876654 58899876543 34677899999999 89999999998864
Q ss_pred CCcEEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeec
Q 020826 91 KTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 166 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~ 166 (321)
...++++|++.+++|.+++. .+++..+..++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||.+...
T Consensus 81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~-~~kL~dfg~~~~~ 159 (279)
T cd05057 81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLL 159 (279)
T ss_pred CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCC-eEEECCCcccccc
Confidence 46789999999999887763 488999999999999999999999999999999999999777 8999999998765
Q ss_pred CCCCcccc---ccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHh
Q 020826 167 HPGKEYNV---RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242 (321)
Q Consensus 167 ~~~~~~~~---~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (321)
........ ..++..|+|||.... ..++.++|+||||++++++++ |..||. +....+....+.. ..
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~-~~~~~~~~~~~~~-~~-------- 228 (279)
T cd05057 160 DVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYE-GIPAVEIPDLLEK-GE-------- 228 (279)
T ss_pred cCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCC-CCCHHHHHHHHhC-CC--------
Confidence 43322111 223457999999876 678899999999999999998 888873 2221111111110 00
Q ss_pred hhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
....+...+.++.+++.+||..||++|||+.++++
T Consensus 229 ---------------------------~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 229 ---------------------------RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred ---------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00111234568999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=309.78 Aligned_cols=255 Identities=23% Similarity=0.382 Sum_probs=209.6
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
...-+++-...||.|.||.||.|.+..+|+..|+|-++-.. .+.+.+|..++..+ +|||+|+++++-.+.+..+
T Consensus 1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~l-nHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGL-NHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhc-cCccccccCceeecHHHHH
Confidence 34456777788999999999999999999999999876322 24578999999999 9999999999887665555
Q ss_pred cEEEEEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 93 PSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
|.||||.+|+|.++.. -.++.....+..|++.|++|||+.|||||||||.||+++.+| .+|++|||.+....++
T Consensus 1311 --IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g-~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1311 --IFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG-LIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred --HHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCC-cEEeecccceeEecCc
Confidence 9999999999988884 367777888999999999999999999999999999999988 8999999999776544
Q ss_pred C-----ccccccCCccccccccccCCC--CCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHh
Q 020826 170 K-----EYNVRVASRYFKGPELLVDLQ--DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242 (321)
Q Consensus 170 ~-----~~~~~~~~~~y~aPE~~~~~~--~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (321)
. ......||+.|||||++.+.. .-..+.|||||||++.||+||+.||..-.+++.++.. +.....++++.
T Consensus 1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~-V~~gh~Pq~P~-- 1464 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYH-VAAGHKPQIPE-- 1464 (1509)
T ss_pred hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhH-HhccCCCCCch--
Confidence 3 234567999999999997643 3457899999999999999999999544444444443 33333333322
Q ss_pred hhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
.+|++.++||..||..||++|.++.|++.|-|-+.-.
T Consensus 1465 ---------------------------------~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1465 ---------------------------------RLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred ---------------------------------hhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccc
Confidence 3678999999999999999999999999999877543
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=263.66 Aligned_cols=236 Identities=20% Similarity=0.316 Sum_probs=185.2
Q ss_pred eeeeeecceEEEEEEEec-CCc--eEEEEEecccch----HHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEe
Q 020826 27 RKVGRGKYSEVFEGVHCT-DNE--KCIIKILKPVKK----KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 99 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~-~~~--~~~vK~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 99 (321)
+.||+|++|+||+|.+.. ++. .+++|.++.... +.+.+|+..+.++ +||||+++++.+.+ ...++++|+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~---~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSL-DHENLIRLYGVVLT---HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhc-CCCCccceeEEEcC---CeEEEEEEe
Confidence 368999999999999865 333 689999876433 4678899999999 89999999999865 567899999
Q ss_pred ecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc---
Q 020826 100 VNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--- 171 (321)
Q Consensus 100 ~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~--- 171 (321)
+.+++|...+. .+++..++.++.|++.||++||++|++|+||+|+||+++.++ .++|+|||++........
T Consensus 77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 77 APLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDD-KVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred cCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCC-EEEecccccccccccccccee
Confidence 99999877662 478899999999999999999999999999999999999887 899999999876543221
Q ss_pred -cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 172 -YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 172 -~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
.....++..|+|||.+.+ ..++.++|||||||++++|++ |..||. .....+....+... .
T Consensus 156 ~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~-~~~~~~~~~~~~~~-~--------------- 217 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWA-GLSGSQILKKIDKE-G--------------- 217 (257)
T ss_pred cccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHhc-C---------------
Confidence 122345678999999876 678999999999999999998 998873 22222222221110 0
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
.....+...++.+.+++.+||+.+|++|||+.++++
T Consensus 218 -------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 218 -------------------ERLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred -------------------CcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 000011235578999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=301.74 Aligned_cols=256 Identities=26% Similarity=0.435 Sum_probs=196.0
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeecc----
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ---- 88 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~---- 88 (321)
.+--.+|+.+..||+||||.||+++++-+|..||||.+... ....+.+|+..+.+| +|||||+++..+...
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArL-nHpNVVRYysAWVEs~~~~ 553 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARL-NHPNVVRYYSAWVESTAEL 553 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhc-CCcceeeeehhhhccCCcc
Confidence 44566889999999999999999999999999999998643 235688999999999 999999998411000
Q ss_pred --------------------------------------------------------------------------------
Q 020826 89 -------------------------------------------------------------------------------- 88 (321)
Q Consensus 89 -------------------------------------------------------------------------------- 88 (321)
T Consensus 554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t 633 (1351)
T KOG1035|consen 554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT 633 (1351)
T ss_pred ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence
Q ss_pred --------------------------C-------CCCcEEEEEeecCchhhhhcCC--C--CHHHHHHHHHHHHHHHHHH
Q 020826 89 --------------------------Q-------SKTPSLIFEHVNNTDFKVLYPT--L--SDYDVRYYIYELLKALDYC 131 (321)
Q Consensus 89 --------------------------~-------~~~~~lv~e~~~~~~l~~~~~~--~--~~~~~~~i~~qi~~~l~~l 131 (321)
+ ..++||-||||...++.+++.. + ....+|+++.+|++||.|+
T Consensus 634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence 0 0246788999999888888843 4 3678999999999999999
Q ss_pred HHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC-------------------CCCccccccCCccccccccccCCC-
Q 020826 132 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-------------------PGKEYNVRVASRYFKGPELLVDLQ- 191 (321)
Q Consensus 132 h~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~-------------------~~~~~~~~~~~~~y~aPE~~~~~~- 191 (321)
|++|++||||||.|||++.++ .|||+|||+++... +....+..+||..|.|||++.+..
T Consensus 714 H~~giIHRDLKP~NIFLd~~~-~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 714 HDQGIIHRDLKPRNIFLDSRN-SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred HhCceeeccCCcceeEEcCCC-CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 999999999999999999887 89999999997611 011345678999999999998755
Q ss_pred -CCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccc
Q 020826 192 -DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 270 (321)
Q Consensus 192 -~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
.|+.+.|+||||++++||+ .||....+-...+..+ ....++.. ..+
T Consensus 793 ~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~L----R~g~iP~~------------------------~~f-- 839 (1351)
T KOG1035|consen 793 NKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTNL----RKGSIPEP------------------------ADF-- 839 (1351)
T ss_pred ccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhc----ccCCCCCC------------------------ccc--
Confidence 5999999999999999998 4663222222222222 12211110 000
Q ss_pred cccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCccc
Q 020826 271 VENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 310 (321)
Q Consensus 271 ~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~ 310 (321)
.. .--+.-..+|+.||+.||++||||.|+|++.||-.
T Consensus 840 --~~-~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp 876 (1351)
T KOG1035|consen 840 --FD-PEHPEEASLIRWLLSHDPSKRPTATELLNSELLPP 876 (1351)
T ss_pred --cc-ccchHHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence 00 01146789999999999999999999999999984
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=265.99 Aligned_cols=245 Identities=18% Similarity=0.354 Sum_probs=190.7
Q ss_pred cCceEEeeeeeeecceEEEEEEEec-----CCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
.++|++...||+|+||+||+|+.+. +.+.+++|.+.... ...+.+|+.+++++ +|||++++++++.+ .
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~ 80 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL-SHKNVVRLLGLCRE--A 80 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhc-CCcceeeeEEEECC--C
Confidence 4789999999999999999999754 34679999886433 34688999999999 89999999999854 3
Q ss_pred CCcEEEEEeecCchhhhhcC------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEe
Q 020826 91 KTPSLIFEHVNNTDFKVLYP------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI 158 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~~------------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~ 158 (321)
...++++|++.+++|.+++. .+++..+..++.|++.||+|||+.|++|+||||+||+++.++ .++++
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~-~~~l~ 159 (275)
T cd05046 81 EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQR-EVKVS 159 (275)
T ss_pred CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCC-cEEEc
Confidence 45689999999999987762 478999999999999999999999999999999999999887 89999
Q ss_pred eccceeecCCC--CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCC
Q 020826 159 DWGLAEFYHPG--KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGT 235 (321)
Q Consensus 159 dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 235 (321)
|||++...... .......++..|+|||.+.+ ...+.++||||||++++++++ |..||. +.........+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~~~~~~p~~-~~~~~~~~~~~~~---- 233 (275)
T cd05046 160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQE-DDFSTKSDVWSFGVLMWEVFTQGELPFY-GLSDEEVLNRLQA---- 233 (275)
T ss_pred ccccccccCcccccccCCceeEEeecChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCcc-ccchHHHHHHHHc----
Confidence 99988643221 12233345667999999876 678899999999999999998 667773 2222111111100
Q ss_pred hhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 236 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
. ... ......+++.+.+++.+||+.||++|||+.++++.
T Consensus 234 ~-------------------------~~~------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 234 G-------------------------KLE------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred C-------------------------CcC------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 0 000 00112456789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=261.34 Aligned_cols=235 Identities=22% Similarity=0.382 Sum_probs=183.7
Q ss_pred eeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeecC
Q 020826 27 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 102 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 102 (321)
+.||.|++|.||++.+.. ++.+++|.++... ...+..|+++++.+ +||||+++++++.+. ...++++|++.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l-~~~~i~~~~~~~~~~--~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQY-DHPNIVKLIGVCVQK--QPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCeEEEEEEEecC--CCeEEEEEcCCC
Confidence 368999999999999876 9999999886532 34688899999999 899999999998544 466799999999
Q ss_pred chhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCcc---ccc
Q 020826 103 TDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVR 175 (321)
Q Consensus 103 ~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~---~~~ 175 (321)
++|..++ ..++...+..++.+++.+|++||+++++|+||+|+||+++.++ .++|+|||.+......... ...
T Consensus 77 ~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 77 GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENN-VLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC-cEEEeeccccccccCCcceeccccC
Confidence 9987776 2378888999999999999999999999999999999999887 8999999998754321111 112
Q ss_pred cCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhH
Q 020826 176 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLA 254 (321)
Q Consensus 176 ~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (321)
..+..|+|||.+.+ ..++.++|+||||+++|++++ |..||. +.........+...
T Consensus 156 ~~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~-~~~~~~~~~~~~~~---------------------- 211 (251)
T cd05041 156 QIPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYP-GMSNQQTRERIESG---------------------- 211 (251)
T ss_pred cceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCc-cCCHHHHHHHHhcC----------------------
Confidence 23456999999876 678999999999999999999 676662 22221111111000
Q ss_pred hhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 255 ALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
. ....+..++.++.+++.+||+.+|.+|||+.|+++
T Consensus 212 ------~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 212 ------Y--------RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred ------C--------CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 0 00112235678999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=260.75 Aligned_cols=234 Identities=22% Similarity=0.372 Sum_probs=182.8
Q ss_pred eeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeecCc
Q 020826 28 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT 103 (321)
Q Consensus 28 ~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~ 103 (321)
.||+|+||.||+|.. .++..+++|.++... ...+.+|+++++.+ +|||++++++++... ...++++||+.++
T Consensus 2 ~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~~lv~e~~~~~ 77 (250)
T cd05085 2 LLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQY-DHPNIVKLIGVCTQR--QPIYIVMELVPGG 77 (250)
T ss_pred ccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhC-CCCCcCeEEEEEecC--CccEEEEECCCCC
Confidence 689999999999986 568899999986543 23577899999999 899999999998554 4567999999999
Q ss_pred hhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCcc--ccccC
Q 020826 104 DFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY--NVRVA 177 (321)
Q Consensus 104 ~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~--~~~~~ 177 (321)
+|..++. .+++..+..++.|++.+|.++|++|++|+||+|+||+++.++ .++|+|||++......... ....+
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~ 156 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENN-VLKISDFGMSRQEDDGIYSSSGLKQI 156 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCC-eEEECCCccceeccccccccCCCCCC
Confidence 9887763 378899999999999999999999999999999999999877 8999999998654322111 11233
Q ss_pred CccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhh
Q 020826 178 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAAL 256 (321)
Q Consensus 178 ~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (321)
+..|+|||++.+ ..++.++|+||||+++|++++ |..||. +.........+... .
T Consensus 157 ~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~-~~~~~~~~~~~~~~---~-------------------- 211 (250)
T cd05085 157 PIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYP-GMTNQQAREQVEKG---Y-------------------- 211 (250)
T ss_pred cccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCC-CCCHHHHHHHHHcC---C--------------------
Confidence 456999999876 678999999999999999998 888873 22221111111000 0
Q ss_pred hcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 257 VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
....+..++..+.+++.+||+.+|++|||+.++++
T Consensus 212 -------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 212 -------------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred -------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 00112235678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-38 Score=263.68 Aligned_cols=238 Identities=20% Similarity=0.358 Sum_probs=180.9
Q ss_pred eeeeeecceEEEEEEEec---CCceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEe
Q 020826 27 RKVGRGKYSEVFEGVHCT---DNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 99 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~---~~~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 99 (321)
+.||+|+||+||+|.+.. .+..+++|.+... ....+.+|+.+++.+ +|||++++++++...+ ...++++||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~-~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDF-SHPNVLSLLGICLPSE-GSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccC-CCCCcceEEEEeecCC-CCcEEEEec
Confidence 368999999999998753 3457999987532 234677899999998 9999999999765333 346799999
Q ss_pred ecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-----
Q 020826 100 VNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK----- 170 (321)
Q Consensus 100 ~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~----- 170 (321)
+.+++|..++. ..+...+..++.|++.||+|||+.+++|+||+|+||+++.++ .++|+|||++.......
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~ 157 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESF-TVKVADFGLARDIYDKEYYSVH 157 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC-cEEECCccccccccCCcceeec
Confidence 99999988863 356777888999999999999999999999999999999887 89999999986543211
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
......++..|+|||.+.+ ..++.++|||||||++|+|++|+.|++...+.......+.. .
T Consensus 158 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~---~--------------- 218 (262)
T cd05058 158 NHTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ---G--------------- 218 (262)
T ss_pred ccccCcCCccccChhHhcc-CccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc---C---------------
Confidence 1112334567999999876 67899999999999999999976665444332222111100 0
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
. ....+..+++.+.+++.+||+.+|++||++.++++
T Consensus 219 ------------~------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 219 ------------R------RLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred ------------C------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 00011235578999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=264.89 Aligned_cols=244 Identities=20% Similarity=0.425 Sum_probs=190.7
Q ss_pred ceEEeeeeeeecceEEEEEEEec-CCceEEEEEecccc-------------hHHHHHHHHHHHhhcCCCCeeeeeeeeec
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCT-DNEKCIIKILKPVK-------------KKKIKREIKILQNLCGGPNIVKLLDIVRD 87 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~-~~~~~~vK~~~~~~-------------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (321)
.|++.+.||+|+||.||+|.+.. +++.+++|.+.... ...+..|+.++....+|||++++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47888999999999999999977 67889999875321 13356788877764489999999999854
Q ss_pred cCCCCcEEEEEeecCchhhhhc-------CCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCeEEcCCCCeEEEee
Q 020826 88 QQSKTPSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLID 159 (321)
Q Consensus 88 ~~~~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lh~-~~i~H~dlkp~nili~~~~~~v~l~d 159 (321)
....++++||+.+++|..++ ..+++..++.++.|++.||.+||+ .|++|+||+|.||+++.++ .++|+|
T Consensus 81 --~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~-~~~l~d 157 (269)
T cd08528 81 --NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-KVTITD 157 (269)
T ss_pred --CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC-cEEEec
Confidence 45678999999998887654 248889999999999999999996 6899999999999999887 899999
Q ss_pred ccceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhh
Q 020826 160 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN 239 (321)
Q Consensus 160 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (321)
||.+.............++..|+|||.+.+ ..++.++|+||||+++|++++|+.||... ........+.....
T Consensus 158 fg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~-~~~~~~~~~~~~~~----- 230 (269)
T cd08528 158 FGLAKQKQPESKLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYST-NMLSLATKIVEAVY----- 230 (269)
T ss_pred ccceeecccccccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCccccc-CHHHHHHHHhhccC-----
Confidence 999977654444445667888999999987 67899999999999999999999998322 11111111111000
Q ss_pred HHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 240 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
.+ ......++++.+++++||+.||++|||+.|+.++
T Consensus 231 -----------------------~~-------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 231 -----------------------EP-------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred -----------------------Cc-------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 00 0011355789999999999999999999998754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=265.44 Aligned_cols=259 Identities=18% Similarity=0.227 Sum_probs=181.5
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEecC---CceEEEEEecccchH--------------HHHHHHHHHHhhcCC
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVKKK--------------KIKREIKILQNLCGG 75 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~---~~~~~vK~~~~~~~~--------------~~~~E~~~l~~l~~h 75 (321)
...+.....+|++.+.||+|+||+||+|.+..+ +..+++|+....... ....+...+..+ .|
T Consensus 4 ~~~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~-~h 82 (294)
T PHA02882 4 IPLIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNI-DH 82 (294)
T ss_pred eeeeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccC-CC
Confidence 345566778999999999999999999998777 667777764322110 011122233444 79
Q ss_pred CCeeeeeeeeeccCC--CCcEEEEEeecCch--hhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCC
Q 020826 76 PNIVKLLDIVRDQQS--KTPSLIFEHVNNTD--FKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 151 (321)
Q Consensus 76 ~~i~~~~~~~~~~~~--~~~~lv~e~~~~~~--l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~ 151 (321)
++++++++....... .+.+++++.+.... +.......++..+..++.|++.||+|||+++++||||||+||+++.+
T Consensus 83 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 83 LGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGN 162 (294)
T ss_pred CCCCcEEEeeeEecCCceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 999999986643322 23456777664432 22223346788899999999999999999999999999999999987
Q ss_pred CCeEEEeeccceeecCCCC--------ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCCh
Q 020826 152 QRKLRLIDWGLAEFYHPGK--------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY 223 (321)
Q Consensus 152 ~~~v~l~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~ 223 (321)
+ .++|+|||+++...... ......+|+.|+|||+..+ ..++.++|||||||++++|++|..||.......
T Consensus 163 ~-~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~ 240 (294)
T PHA02882 163 N-RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG 240 (294)
T ss_pred C-cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence 7 89999999987653221 1123468999999999987 778999999999999999999999995332322
Q ss_pred HHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHh
Q 020826 224 DQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 303 (321)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell 303 (321)
.......... .... .. . .......++++.++++.|+..+|++||+.++++
T Consensus 241 ~~~~~~~~~~----~~~~----------------~~----~------~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~ 290 (294)
T PHA02882 241 NLIHAAKCDF----IKRL----------------HE----G------KIKIKNANKFIYDFIECVTKLSYEEKPDYDALI 290 (294)
T ss_pred HHHHHhHHHH----HHHh----------------hh----h------hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHH
Confidence 2221111000 0000 00 0 000112457899999999999999999999987
Q ss_pred c
Q 020826 304 A 304 (321)
Q Consensus 304 ~ 304 (321)
+
T Consensus 291 ~ 291 (294)
T PHA02882 291 K 291 (294)
T ss_pred H
Confidence 4
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=267.98 Aligned_cols=243 Identities=18% Similarity=0.328 Sum_probs=188.5
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCc----eEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~----~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
.++|+..+.||+|+||.||+|.+..++. .+++|.+.... ...+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l-~h~niv~~~~~~~~~--- 81 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASM-DHPHLVRLLGVCLSP--- 81 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcCC---
Confidence 5688999999999999999999877775 46888876432 23567899999999 999999999988543
Q ss_pred CcEEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 92 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
..++++++++++++.+++. .+++..+..++.|++.||+|||++|++|+||||+||+++.++ .+||+|||++....
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~-~~kL~Dfg~~~~~~ 160 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPN-HVKITDFGLARLLE 160 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCC-ceEEcccccccccc
Confidence 3468999999998877763 478889999999999999999999999999999999998777 79999999997654
Q ss_pred CCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 168 PGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 168 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
.... .....++..|+|||.+.+ ..++.++||||||+++|++++ |+.||. +. .......+....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~-~~-~~~~~~~~~~~~---------- 227 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYD-GI-PTREIPDLLEKG---------- 227 (303)
T ss_pred CcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCC-CC-CHHHHHHHHHCC----------
Confidence 3221 122334567999999876 778999999999999999997 888873 22 111111111100
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
.. .......+..+.+++.+|+..+|++||+++++++.
T Consensus 228 -----------------~~--------~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 228 -----------------ER--------LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred -----------------CC--------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 00 00112345689999999999999999999998874
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=264.55 Aligned_cols=233 Identities=15% Similarity=0.229 Sum_probs=176.3
Q ss_pred eeeeecceEEEEEEEecC------------------------CceEEEEEecccch---HHHHHHHHHHHhhcCCCCeee
Q 020826 28 KVGRGKYSEVFEGVHCTD------------------------NEKCIIKILKPVKK---KKIKREIKILQNLCGGPNIVK 80 (321)
Q Consensus 28 ~lg~g~~g~v~~~~~~~~------------------------~~~~~vK~~~~~~~---~~~~~E~~~l~~l~~h~~i~~ 80 (321)
.||+|+||.||+|....+ ...+++|++..... ..+.+|+.+++.+ +||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l-~h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQV-SHIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcC-CCCCeee
Confidence 589999999999975322 23588898865332 3567788888888 8999999
Q ss_pred eeeeeeccCCCCcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCC----
Q 020826 81 LLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ---- 152 (321)
Q Consensus 81 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~---- 152 (321)
+++++.+. ...++||||+++++|..++ ..+++..+..++.|++.||+|||++|++|+||||+||+++..+
T Consensus 81 ~~~~~~~~--~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 81 VHGVCVRG--SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred EEEEEEeC--CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 99998654 4567999999999987776 2478999999999999999999999999999999999997543
Q ss_pred --CeEEEeeccceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHH-hCCCCCccCCCChHHHHHH
Q 020826 153 --RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI-FRKEPFFYGHDNYDQLVKI 229 (321)
Q Consensus 153 --~~v~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~-~g~~p~~~~~~~~~~~~~~ 229 (321)
..++++|||.+...... ....++..|+|||.+.+...++.++|+||||+++|+++ +|..||... ...+.....
T Consensus 159 ~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~-~~~~~~~~~ 234 (274)
T cd05076 159 TSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER-TPSEKERFY 234 (274)
T ss_pred ccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCcccc-ChHHHHHHH
Confidence 14899999987543221 22356778999999876567899999999999999985 688777322 211111100
Q ss_pred HHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 230 AKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
.. .. ..+...++++.++|.+||+.+|++|||+.+++++
T Consensus 235 ~~----------------------------~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 235 EK----------------------------KH----------RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred Hh----------------------------cc----------CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 00 00 0001133579999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=262.15 Aligned_cols=240 Identities=17% Similarity=0.225 Sum_probs=177.0
Q ss_pred eeeeecceEEEEEEEec--CCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeec
Q 020826 28 KVGRGKYSEVFEGVHCT--DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVN 101 (321)
Q Consensus 28 ~lg~g~~g~v~~~~~~~--~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 101 (321)
.||+|+||.||+|.... ++..+++|.++... ...+.+|+.+++.+ +||||+++++.+.+. ...+++|||+.
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~lv~e~~~ 78 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSL-QHSNLLQCLGQCTEV--TPYLLVMEFCP 78 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcCC--CCcEEEEECCC
Confidence 58999999999998643 45679999886532 24577899999999 899999999988543 45679999999
Q ss_pred CchhhhhcC--------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc--
Q 020826 102 NTDFKVLYP--------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-- 171 (321)
Q Consensus 102 ~~~l~~~~~--------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~-- 171 (321)
+++|..++. ..+...+..++.|++.||+|||+.|++|+||||+||+++.++ .++|+|||.+........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~-~~kL~dfg~~~~~~~~~~~~ 157 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKEDYYV 157 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC-cEEECCccccccccCcceee
Confidence 999987763 245667788999999999999999999999999999999877 899999999864332211
Q ss_pred -cccccCCccccccccccCC------CCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 172 -YNVRVASRYFKGPELLVDL------QDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 172 -~~~~~~~~~y~aPE~~~~~------~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
.....++..|+|||++.+. ..++.++|+||||+++|++++ |..||.. ....+...........
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~-~~~~~~~~~~~~~~~~-------- 228 (269)
T cd05087 158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRH-LSDEQVLTYTVREQQL-------- 228 (269)
T ss_pred cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCC-CChHHHHHHHhhcccC--------
Confidence 1223456779999998542 135789999999999999996 9888832 2222211111000000
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
..+ ........++.+.+++++|+ .+|++|||++|++.
T Consensus 229 ------------------~~~-----~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 229 ------------------KLP-----KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ------------------CCC-----CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 000 00011134568899999998 68999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=262.43 Aligned_cols=240 Identities=18% Similarity=0.269 Sum_probs=176.4
Q ss_pred eeeeecceEEEEEEEec--CCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeec
Q 020826 28 KVGRGKYSEVFEGVHCT--DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVN 101 (321)
Q Consensus 28 ~lg~g~~g~v~~~~~~~--~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 101 (321)
.||+|+||+||+|.... ....+++|.+.... ...+.+|+..++.+ +||||+++++.+.+ ....+++|||+.
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~nii~~~~~~~~--~~~~~lv~e~~~ 78 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYREL-NHPNVLQCLGQCIE--SIPYLLVLEFCP 78 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhC-CCCCcceEEEEECC--CCceEEEEEeCC
Confidence 58999999999997543 34578888775432 24567899999998 89999999998854 345679999999
Q ss_pred CchhhhhcCC--------CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc--
Q 020826 102 NTDFKVLYPT--------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-- 171 (321)
Q Consensus 102 ~~~l~~~~~~--------~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~-- 171 (321)
+++|..++.. .++..+..++.||+.||+|||++|++|+||||+||+++.++ .++|+|||++........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~ 157 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADL-SVKIGDYGLALEQYPEDYYI 157 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCC-cEEEeccccccccccchhee
Confidence 9999887632 35677889999999999999999999999999999999887 899999999864322211
Q ss_pred -cccccCCccccccccccC------CCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 172 -YNVRVASRYFKGPELLVD------LQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 172 -~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
.....++..|+|||+... ...++.++|||||||++|+|++ |..|| ....+.+.+..+.......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~-~~~~~~~~~~~~~~~~~~~------- 229 (269)
T cd05042 158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPY-PDLSDEQVLKQVVREQDIK------- 229 (269)
T ss_pred ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCC-CcCCHHHHHHHHhhccCcc-------
Confidence 122334567999998743 2456889999999999999999 56666 3333333222221111000
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
......+..+++.+.+++..|+ .||++|||++++++
T Consensus 230 ------------------------~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 230 ------------------------LPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred ------------------------CCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 0000112245678889999998 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=261.07 Aligned_cols=232 Identities=17% Similarity=0.262 Sum_probs=179.6
Q ss_pred eeeeeecceEEEEEEEecCC----------ceEEEEEecccc--hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 27 RKVGRGKYSEVFEGVHCTDN----------EKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~~~----------~~~~vK~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
+.||+|+||.||+|.+..++ ..+++|.+.... ...+.+|+.+++.+ +|||++++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~---~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQL-SHKHLVKLYGVCVR---DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcC-CCcchhheeeEEec---CCcE
Confidence 36899999999999997766 357888876543 46788899999999 89999999998865 3457
Q ss_pred EEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCC------eEEEeecccee
Q 020826 95 LIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR------KLRLIDWGLAE 164 (321)
Q Consensus 95 lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~------~v~l~dfg~~~ 164 (321)
+++||+.+++|..++. .++...+..++.|++.||+|||++|++|+||||+||+++.++. .++|+|||++.
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 9999999999987773 4788999999999999999999999999999999999986652 59999999987
Q ss_pred ecCCCCccccccCCccccccccccCC-CCCCCcchHHHHHHHHHHHHhC-CCCCccCCCChHHHHHHHHHhCChhhhHHh
Q 020826 165 FYHPGKEYNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFR-KEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242 (321)
Q Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (321)
.... .....++..|+|||++.+. ..++.++|+||||++++++++| ..||. ............ ..
T Consensus 157 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~-~~~~~~~~~~~~---~~------- 222 (259)
T cd05037 157 TVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLS-TLSSSEKERFYQ---DQ------- 222 (259)
T ss_pred cccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcc-cCCchhHHHHHh---cC-------
Confidence 6432 2234456679999998773 3788999999999999999995 55552 221111111000 00
Q ss_pred hhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
.. .+...+.++.+++.+||+.+|++|||+.++++
T Consensus 223 ------------------~~----------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 223 ------------------HR----------LPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred ------------------CC----------CCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00 00011158999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-39 Score=256.25 Aligned_cols=286 Identities=28% Similarity=0.504 Sum_probs=222.1
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecc-----cchHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC-
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT- 92 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~-----~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~- 92 (321)
.+.+.+..+.||.|+||.||.+.|..+|+.|++|.+.. ...+++.+|+.++..+ +|.|++..+++.+-.+..+
T Consensus 51 qq~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfF-kHdNVLSaLDILQPph~dfF 129 (449)
T KOG0664|consen 51 QQQDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSF-RHDNVLSLLDILQPANPSFF 129 (449)
T ss_pred ccccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhh-ccccHHHHHHhcCCCCchHH
Confidence 45567777899999999999999999999999998753 3457889999999999 9999999998875443322
Q ss_pred --cEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 93 --PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 93 --~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
++.++|.+..+ |...+ +.++...++-++.||++||+|||+.||.||||||.|.+++++. .+||+|||+++...
T Consensus 130 qEiYV~TELmQSD-LHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNC-vLKICDFGLARvee 207 (449)
T KOG0664|consen 130 QELYVLTELMQSD-LHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNC-ILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHHHHHHhh-hhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCc-eEEecccccccccc
Confidence 34566666543 33333 3488889999999999999999999999999999999999888 89999999998775
Q ss_pred CCCc--cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhh
Q 020826 168 PGKE--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245 (321)
Q Consensus 168 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (321)
.... .+..+-|.+|+|||++.+...|+.+.||||.||++.|++..+..| ...+..++++.+.+.+|.+.+......
T Consensus 208 ~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILF-QAq~PiqQL~lItdLLGTPs~EaMr~A- 285 (449)
T KOG0664|consen 208 QRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILF-QAAGPIEQLQMIIDLLGTPSQEAMKYA- 285 (449)
T ss_pred hhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhh-hccChHHHHHHHHHHhCCCcHHHHHHH-
Confidence 4433 234467889999999999889999999999999999999777665 788889999999999999877654322
Q ss_pred cccCChhhHhhhcccCCCCC-ccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 246 HIELDPHLAALVGRHSRKPW-SKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
...-..-......+.+. ...-++..+..-..+...++.++|.+||.+|.+.++++.|++.....
T Consensus 286 ---CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 286 ---CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred ---hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 11111112222222232 22223333334445788999999999999999999999999987653
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=262.90 Aligned_cols=236 Identities=21% Similarity=0.346 Sum_probs=182.1
Q ss_pred eeeeecceEEEEEEEecCC------ceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 28 KVGRGKYSEVFEGVHCTDN------EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 28 ~lg~g~~g~v~~~~~~~~~------~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
.||+|+||.||+|+++... ..+++|.+... ....+.+|+.+++.+ +||||+++++++.+ ....++++
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~~v~ 78 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNF-NHPNIVKLLGVCLL--NEPQYIIM 78 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhc-CCCCeeeEeeeecC--CCCeEEEE
Confidence 5899999999999886433 67899987543 345678899999999 99999999999854 34578999
Q ss_pred EeecCchhhhhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCC----CeEEEeeccce
Q 020826 98 EHVNNTDFKVLYP----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ----RKLRLIDWGLA 163 (321)
Q Consensus 98 e~~~~~~l~~~~~----------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~----~~v~l~dfg~~ 163 (321)
|++++++|..++. .+++..+..++.|++.||+|||+++++|+||+|+||+++.++ ..++++|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999877662 267788999999999999999999999999999999998654 26999999998
Q ss_pred eecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhh
Q 020826 164 EFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELN 239 (321)
Q Consensus 164 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (321)
........ ......+..|+|||.+.+ ..++.++||||||+++|+|++ |..||. .....+....+.. .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~g~~p~~-~~~~~~~~~~~~~----~--- 229 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYP-ALNNQEVLQHVTA----G--- 229 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHcCCCCCc-ccCHHHHHHHHhc----C---
Confidence 65432221 122344567999999987 678999999999999999998 888873 2222222211100 0
Q ss_pred HHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 240 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
........+|+.+.+++.+||+.+|++||+++++++
T Consensus 230 -----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 230 -----------------------------GRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred -----------------------------CccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 000111235678999999999999999999999874
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=257.52 Aligned_cols=241 Identities=16% Similarity=0.228 Sum_probs=175.3
Q ss_pred eeeeecceEEEEEEEecCC--ceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeec
Q 020826 28 KVGRGKYSEVFEGVHCTDN--EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVN 101 (321)
Q Consensus 28 ~lg~g~~g~v~~~~~~~~~--~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 101 (321)
.||+|+||+||++....++ ..+++|.++.. ....+.+|+..+..+ +|||++++++.+.+ ....+++|||+.
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~h~~iv~~~~~~~~--~~~~~lv~e~~~ 78 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRIL-QHPNILQCLGQCVE--AIPYLLVFEYCE 78 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhcc-CCcchhheEEEecC--CCccEEEEecCC
Confidence 5899999999999764332 35667776543 235688899999998 99999999999864 456689999999
Q ss_pred CchhhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC---c
Q 020826 102 NTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK---E 171 (321)
Q Consensus 102 ~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~---~ 171 (321)
+++|..++. ..+...+..++.||+.||+|||+++++|+||||+||+++.++ .++|+|||++....... .
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCc-cEEecccccccccCcchhhhc
Confidence 999987663 256667889999999999999999999999999999999887 79999999875422111 1
Q ss_pred cccccCCccccccccccCC------CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhh
Q 020826 172 YNVRVASRYFKGPELLVDL------QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~------~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (321)
.....++..|+|||+.... ...+.++||||||+++|+|+++..+.+...+..+....+.......
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~--------- 228 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK--------- 228 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc---------
Confidence 1234567789999987431 2457899999999999999976443333333333333221100000
Q ss_pred cccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
..........++.+.++++.|+ .+|++|||++++++
T Consensus 229 ----------------------~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 229 ----------------------LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred ----------------------cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 0000011135578999999999 68999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=263.08 Aligned_cols=251 Identities=25% Similarity=0.371 Sum_probs=208.1
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
..+|.++.+||+|+||+|.+|..+++.+.+|||+++++. ..-...|-.+|....+-|.+++++..|+. ...+
T Consensus 348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT--mDRL 425 (683)
T KOG0696|consen 348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT--MDRL 425 (683)
T ss_pred ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh--hhhe
Confidence 457888999999999999999999999999999998642 22234566666666577899999999954 4456
Q ss_pred EEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC-CC
Q 020826 94 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PG 169 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~-~~ 169 (321)
++||||++||+|...+ .++.+..+.-++.+|+-||=+||++||++||||.+||+++.+| .+||+|||+++... ..
T Consensus 426 yFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eG-HiKi~DFGmcKEni~~~ 504 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIFDG 504 (683)
T ss_pred eeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCC-ceEeeecccccccccCC
Confidence 7999999999997766 5699999999999999999999999999999999999999999 89999999997543 33
Q ss_pred CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 170 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
..+.+.+||+.|+|||++.- .+|+.+.|-||+|++||||+.|+.|| .+.+..+....|.+..
T Consensus 505 ~TTkTFCGTPdYiAPEIi~Y-qPYgksvDWWa~GVLLyEmlaGQpPF-dGeDE~elF~aI~ehn---------------- 566 (683)
T KOG0696|consen 505 VTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQPPF-DGEDEDELFQAIMEHN---------------- 566 (683)
T ss_pred cceeeecCCCcccccceEEe-cccccchhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHHcc----------------
Confidence 45567899999999999987 89999999999999999999999998 4555555555543311
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCH-----HHHhcCCCcccCC
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA-----KEAMAHPYFFPIR 312 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~-----~ell~hp~~~~~~ 312 (321)
...++.+|.+..++++..|..+|.+|... .++-.||||+.++
T Consensus 567 ---------------------vsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iD 613 (683)
T KOG0696|consen 567 ---------------------VSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRID 613 (683)
T ss_pred ---------------------CcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhcc
Confidence 11233577899999999999999999643 5899999999875
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=268.44 Aligned_cols=260 Identities=24% Similarity=0.444 Sum_probs=206.6
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----------hHHHHHHHHHHHhhcCCCCeeeeeeeeec
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----------KKKIKREIKILQNLCGGPNIVKLLDIVRD 87 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (321)
..+++|-+++.||+|||+.||+|.|......||+|+-.... .+..-+|..+.+.| +||.||++|+++.-
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeL-DHpRIVKlYDyfsl 538 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKEL-DHPRIVKLYDYFSL 538 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhcc-Ccceeeeeeeeeee
Confidence 45789999999999999999999998888999999853211 23466899999999 99999999999964
Q ss_pred cCCCCcEEEEEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCC--CeeecCCCCCeEEcCCC--CeEEEeec
Q 020826 88 QQSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQ--RKLRLIDW 160 (321)
Q Consensus 88 ~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~--i~H~dlkp~nili~~~~--~~v~l~df 160 (321)
.+ ..+|-|.|||+|++|+.+++ .+++.+++.|+.||+.||.||.+.. |+|-||||.||++-.+. +.+||+||
T Consensus 539 Dt-dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 539 DT-DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cc-ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 43 44589999999999999884 4899999999999999999999874 99999999999996332 27999999
Q ss_pred cceeecCCCCc--------cccccCCccccccccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHH
Q 020826 161 GLAEFYHPGKE--------YNVRVASRYFKGPELLVDL---QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 229 (321)
Q Consensus 161 g~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 229 (321)
|+++....... +....||.+|++||.+.-+ ...+.+.||||+|+++|.++.|+.||..+.+..+++++-
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN 697 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN 697 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence 99987643211 2334689999999998542 457889999999999999999999995554444444331
Q ss_pred HHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcc
Q 020826 230 AKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF 309 (321)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~ 309 (321)
..+. .........+.+|++..+||++||++.-+.|....++..||||.
T Consensus 698 -TIlk-------------------------------AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyll 745 (775)
T KOG1151|consen 698 -TILK-------------------------------ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLL 745 (775)
T ss_pred -chhc-------------------------------ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcccc
Confidence 0000 00011222346788999999999999999999999999999998
Q ss_pred cC
Q 020826 310 PI 311 (321)
Q Consensus 310 ~~ 311 (321)
.-
T Consensus 746 Ph 747 (775)
T KOG1151|consen 746 PH 747 (775)
T ss_pred ch
Confidence 63
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-38 Score=272.52 Aligned_cols=243 Identities=20% Similarity=0.379 Sum_probs=195.2
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecC--C--ceEEEEEecc----cchHHHHHHHHHHHhhcCCCCeeeeeeeeeccC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTD--N--EKCIIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 89 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~--~--~~~~vK~~~~----~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (321)
...+...+.+.||.|-||.||+|....- | -.||||+-+. ++...+..|..+|+++ +||||+++++++.+.
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnf-dHphIikLIGv~~e~- 463 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNF-DHPHIIKLIGVCVEQ- 463 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhC-CCcchhheeeeeecc-
Confidence 3344566778899999999999987432 2 3688998775 3457799999999999 999999999999653
Q ss_pred CCCcEEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 90 SKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
-.+||||.++.|.|+.+++ .++......++.||+.||+|||+.++|||||...||++.+.. .|||+|||+++.
T Consensus 464 --P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~-CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 464 --PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQ-CVKLADFGLSRY 540 (974)
T ss_pred --ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcc-eeeecccchhhh
Confidence 3579999999999988884 488889999999999999999999999999999999999877 899999999987
Q ss_pred cCCCCccccccC--CccccccccccCCCCCCCcchHHHHHHHHHHHH-hCCCCCccCCCChHHHHHHHHHhCChhhhHHh
Q 020826 166 YHPGKEYNVRVA--SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI-FRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242 (321)
Q Consensus 166 ~~~~~~~~~~~~--~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (321)
.....-+....+ ..-|+|||.+.- ..++.+||||.||+++||++ .|..||..-.+. +..
T Consensus 541 ~ed~~yYkaS~~kLPIKWmaPESINf-RrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs-DVI---------------- 602 (974)
T KOG4257|consen 541 LEDDAYYKASRGKLPIKWMAPESINF-RRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS-DVI---------------- 602 (974)
T ss_pred ccccchhhccccccceeecCccccch-hcccchhhHHHHHHHHHHHHHhcCCcccccccc-ceE----------------
Confidence 765544443333 234999999876 88999999999999999987 588898422211 110
Q ss_pred hhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHh
Q 020826 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 303 (321)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell 303 (321)
......+....++.+++.+..|+.+||+++|.+||++.|+.
T Consensus 603 --------------------~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 603 --------------------GHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred --------------------EEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 01112234556778999999999999999999999987654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=253.44 Aligned_cols=285 Identities=27% Similarity=0.465 Sum_probs=219.4
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC---
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS--- 90 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~--- 90 (321)
...+|.-+..+|.|.- .|-.+.|.-.+..|++|..... ..++..+|...+..+ +|+|+++++.++.-...
T Consensus 15 v~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v-~~~nii~l~n~ftP~~~l~~ 92 (369)
T KOG0665|consen 15 VPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCV-NHKNIISLLNVFTPQKTLEE 92 (369)
T ss_pred eeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhh-cccceeeeeeccCccccHHH
Confidence 3467888888999988 8888889889999999976432 346688999999999 99999999998853221
Q ss_pred -CCcEEEEEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 91 -KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 91 -~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
...++|||++..+.-....-.++...+.+++.|++.|+++||+.||+||||||+||++..+. .+||.|||++......
T Consensus 93 ~~e~y~v~e~m~~nl~~vi~~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~-~lKi~dfg~ar~e~~~ 171 (369)
T KOG0665|consen 93 FQEVYLVMELMDANLCQVILMELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDC-TLKILDFGLARTEDTD 171 (369)
T ss_pred HHhHHHHHHhhhhHHHHHHHHhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchh-heeeccchhhcccCcc
Confidence 23569999998766555556789999999999999999999999999999999999999888 8999999999876655
Q ss_pred CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc-
Q 020826 170 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE- 248 (321)
Q Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 248 (321)
...+..+.+..|+|||+..+ ..+....||||+||++.||++|+..| ++.+..++...+.+.+|.+.......-....
T Consensus 172 ~~mtpyVvtRyyrapevil~-~~~ke~vdiwSvGci~gEli~~~Vlf-~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r 249 (369)
T KOG0665|consen 172 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELILGTVLF-PGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVR 249 (369)
T ss_pred cccCchhheeeccCchheec-cCCcccchhhhhhhHHHHHhhceEEe-cCchHHHHHHHHHHHhcCCCHHHHHHhhHHHH
Confidence 45567788999999999999 55999999999999999999999877 6888888888888888887654322211000
Q ss_pred ----CChhhHhhhcccCCCCCcccccccccc-CCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcc
Q 020826 249 ----LDPHLAALVGRHSRKPWSKFITVENQH-LAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF 309 (321)
Q Consensus 249 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~ 309 (321)
..+.... ..-...-+...+....+.. .=+..+++++.+||..||++|.|++++|+|||++
T Consensus 250 ~yv~~~~~y~~-~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 250 NYVENRPQYQA-ISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHhhcChHhhc-cchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence 1111111 1111112222222211111 2224699999999999999999999999999998
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=260.46 Aligned_cols=243 Identities=18% Similarity=0.349 Sum_probs=184.6
Q ss_pred eEEeeeeeeecceEEEEEEEec---CCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC----
Q 020826 23 YEVVRKVGRGKYSEVFEGVHCT---DNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---- 90 (321)
Q Consensus 23 y~~~~~lg~g~~g~v~~~~~~~---~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~---- 90 (321)
|.+.+.||+|+||.||+|.+.. ++..+++|++.... .+.+.+|+..++.+ +|||++++++++.....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEF-DHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcC-CCCCcceEEEEEccCCCCCcc
Confidence 5678899999999999998643 56899999986532 34577899999999 89999999998754322
Q ss_pred CCcEEEEEeecCchhhhhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecc
Q 020826 91 KTPSLIFEHVNNTDFKVLYP---------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 161 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~~---------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg 161 (321)
...+++++|+.++++..++. .++...+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~-~~kl~dfg 158 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM-TVCVADFG 158 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCC-CEEECccc
Confidence 23468889999998865541 368888999999999999999999999999999999999777 79999999
Q ss_pred ceeecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChh
Q 020826 162 LAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDE 237 (321)
Q Consensus 162 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (321)
++........ .....++..|++||...+ ..++.++|||||||++|++++ |..|| .+.+.......+.. ..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~-~~~~~~~~~~~~~~---~~- 232 (273)
T cd05074 159 LSKKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPY-AGVENSEIYNYLIK---GN- 232 (273)
T ss_pred ccccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCC-CCCCHHHHHHHHHc---CC-
Confidence 9876533221 122234567999999876 678899999999999999999 67666 33222111111110 00
Q ss_pred hhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 238 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
....+...++.+.+++.+||+.+|++|||+.+++++
T Consensus 233 --------------------------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 233 --------------------------------RLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred --------------------------------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000112355789999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=271.59 Aligned_cols=259 Identities=25% Similarity=0.436 Sum_probs=208.7
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
.-|..++.||-|+||.|.+++...+...||.|.+++.+ ....+.|.++|... +.+.||++|-.|+| ...+|
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEA-Dn~WVVrLyySFQD--kdnLY 705 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEA-DNEWVVRLYYSFQD--KDNLY 705 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhc-CCcceEEEEEEecc--CCceE
Confidence 35778889999999999999998999999999987543 35578899999987 89999999999965 45677
Q ss_pred EEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC----
Q 020826 95 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH---- 167 (321)
Q Consensus 95 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~---- 167 (321)
+||+|.+||++..++ .-|.+..++.++.++..|+++.|.+|++||||||+|||||.+| .+||+|||+++-+.
T Consensus 706 FVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdG-HIKLTDFGLCTGfRWTHd 784 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWTHD 784 (1034)
T ss_pred EEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCC-ceeeeeccccccceeccc
Confidence 999999999876555 4489999999999999999999999999999999999999999 89999999985431
Q ss_pred -----CCCcc----------------------------------ccccCCccccccccccCCCCCCCcchHHHHHHHHHH
Q 020826 168 -----PGKEY----------------------------------NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAG 208 (321)
Q Consensus 168 -----~~~~~----------------------------------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~ 208 (321)
.+... -..+||+.|.|||++.. ..++..+|.||.|++||+
T Consensus 785 skYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r-~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 785 SKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR-TGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred cccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc-cCccccchhhHhhHHHHH
Confidence 01000 01368999999999987 789999999999999999
Q ss_pred HHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHh
Q 020826 209 MIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKL 288 (321)
Q Consensus 209 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~ 288 (321)
|+.|+.||-.+.....+ .....|..++.+..-..+|+++.++|.++
T Consensus 864 m~~g~~pf~~~tp~~tq----------------------------------~kv~nw~~~l~~~~~~~ls~e~~~li~kL 909 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQ----------------------------------YKVINWRNFLHIPYQGNLSKEALDLIQKL 909 (1034)
T ss_pred HhhCCCCccCCCCCcce----------------------------------eeeeehhhccccccccccCHHHHHHHHHH
Confidence 99999999543332111 11233444555555567889999999986
Q ss_pred hccCCCCCc---CHHHHhcCCCcccCCCcccccc
Q 020826 289 LRYDHQERP---TAKEAMAHPYFFPIRNAESSRS 319 (321)
Q Consensus 289 l~~dp~~Rp---s~~ell~hp~~~~~~~~~~~~~ 319 (321)
+ .+++.|. .++++-+||||++++-.+.++-
T Consensus 910 c-~sad~RLGkng~d~vKaHpfFkgIDfsslRkq 942 (1034)
T KOG0608|consen 910 C-CSADSRLGKNGADQVKAHPFFKGIDFSSLRKQ 942 (1034)
T ss_pred h-cChhhhhcccchhhhhcCccccccchHhhhhc
Confidence 5 5777885 4778999999999987775543
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=276.32 Aligned_cols=260 Identities=24% Similarity=0.454 Sum_probs=213.1
Q ss_pred eeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc--hHHHHHHHHHHHhhcCCCCeeeeeeeeec---cC
Q 020826 15 FINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRD---QQ 89 (321)
Q Consensus 15 ~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~---~~ 89 (321)
.++-..+.|++.+.||.|.+|.||+++.+.+++..|+|+...+. ...++.|.++++.+..|||++.+++++.. ..
T Consensus 13 ~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 13 SLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred hCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 34455788999999999999999999999999999999987654 46788899999999999999999998853 34
Q ss_pred CCCcEEEEEeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecccee
Q 020826 90 SKTPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 164 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~ 164 (321)
+..++||||+|++|+.-++.+ ++.+..+.+|+..++.|+.+||.+.++|+|||-.||++..++ .|||+|||.+.
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~-~VKLvDFGvSa 171 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENA-EVKLVDFGVSA 171 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccC-cEEEeeeeeee
Confidence 567899999999999877774 488999999999999999999999999999999999999998 89999999975
Q ss_pred ecC-CCCccccccCCccccccccccCCC----CCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhh
Q 020826 165 FYH-PGKEYNVRVASRYFKGPELLVDLQ----DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN 239 (321)
Q Consensus 165 ~~~-~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (321)
-.. ......+..||+.|+|||++.... .++.++|+||||++..||.-|..|+. +......+..+
T Consensus 172 QldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~-DmHPmraLF~I---------- 240 (953)
T KOG0587|consen 172 QLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLC-DMHPMRALFLI---------- 240 (953)
T ss_pred eeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCcc-CcchhhhhccC----------
Confidence 442 334456788999999999996543 46789999999999999999998884 33222222211
Q ss_pred HHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCccc
Q 020826 240 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 310 (321)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~ 310 (321)
.+.| ..++..++..+.++.++|..||..|-++||+..++|.|||+..
T Consensus 241 ---------------------pRNP---PPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 241 ---------------------PRNP---PPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITE 287 (953)
T ss_pred ---------------------CCCC---CccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcccc
Confidence 1111 1122233456679999999999999999999999999999984
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=251.50 Aligned_cols=253 Identities=25% Similarity=0.466 Sum_probs=210.8
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
-.+|.++++||+|+|++|..++.+++.+.||+|++++. +-+..+.|-.++....+||.+|-++..|+. ...+
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt--esrl 326 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT--ESRL 326 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc--cceE
Confidence 46899999999999999999999999999999998753 235578888899988899999999999954 4567
Q ss_pred EEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeec-CCC
Q 020826 94 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HPG 169 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~-~~~ 169 (321)
++|.||.+|++|...+ ++++++.++-+...|+.||.|||++||+++|||.+|++++..| .+||+|+|+++.. .++
T Consensus 327 ffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeg-hikltdygmcke~l~~g 405 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGLGPG 405 (593)
T ss_pred EEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCC-ceeecccchhhcCCCCC
Confidence 7999999999986665 5699999999999999999999999999999999999999999 8999999999754 466
Q ss_pred CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCcc-CCCC-----hHHHHHHHHHhCChhhhHHhh
Q 020826 170 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY-GHDN-----YDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~-~~~~-----~~~~~~~~~~~~~~~~~~~~~ 243 (321)
+.+++.+||+.|.|||++.+ ..|....|-|+||++++||+.|+.||.- +.++ .+.+.++
T Consensus 406 d~tstfcgtpnyiapeilrg-eeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv-------------- 470 (593)
T KOG0695|consen 406 DTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV-------------- 470 (593)
T ss_pred cccccccCCCcccchhhhcc-cccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH--------------
Confidence 77788999999999999998 8999999999999999999999999942 1111 1112111
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc------CHHHHhcCCCcccCC
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP------TAKEAMAHPYFFPIR 312 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp------s~~ell~hp~~~~~~ 312 (321)
+... ++.++..+|.....+++..|+.||.+|. ...++-.|+||+.++
T Consensus 471 ------------ilek----------qiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~id 523 (593)
T KOG0695|consen 471 ------------ILEK----------QIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSID 523 (593)
T ss_pred ------------Hhhh----------cccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCC
Confidence 1111 1223344667888999999999999996 367999999998653
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=270.77 Aligned_cols=247 Identities=19% Similarity=0.397 Sum_probs=199.1
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc--chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
.|.+++. +..+.++||-|.||.||.|.+++-.-.||||.++.+ ....|..|..+|+.+ +|||+|+++++|..+..
T Consensus 261 kWEmeRt--dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKei-kHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 261 KWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred hhhccch--heeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhh-cCccHHHHhhhhccCCC
Confidence 5777644 788999999999999999999988889999999865 467899999999999 99999999999976554
Q ss_pred CCcEEEEEeecCchhhhhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 91 KTPSLIFEHVNNTDFKVLYPT-----LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
+|||+|||..|+|.++++. ++.....+++.||..||+||..++++||||...|+|+..+. .||++|||+++.
T Consensus 338 --FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnh-iVKvADFGLsRl 414 (1157)
T KOG4278|consen 338 --FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-IVKVADFGLSRL 414 (1157)
T ss_pred --eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccc-eEEeeccchhhh
Confidence 4599999999998888854 55566789999999999999999999999999999999887 899999999986
Q ss_pred cCCCCccccccC---CccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHh
Q 020826 166 YHPGKEYNVRVA---SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242 (321)
Q Consensus 166 ~~~~~~~~~~~~---~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (321)
.. .+.++...| ..-|.|||.+.- ..++.++|||+||++|||+.|...-.+++-+-. ++..+.+ ..
T Consensus 415 Mt-gDTYTAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlS-qVY~LLE---kg------ 482 (1157)
T KOG4278|consen 415 MT-GDTYTAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYGLLE---KG------ 482 (1157)
T ss_pred hc-CCceecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHH-HHHHHHh---cc------
Confidence 54 444444443 345999999976 789999999999999999997544333444322 2222111 00
Q ss_pred hhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHh
Q 020826 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 303 (321)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell 303 (321)
.....+..+++.+.+|++.||+++|++||+++|+-
T Consensus 483 --------------------------yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 483 --------------------------YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred --------------------------ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 11223446889999999999999999999998763
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=271.20 Aligned_cols=253 Identities=25% Similarity=0.431 Sum_probs=215.7
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
.-.+++++..||-|+||.|=++..+.....+|+|++++. ....+..|-.+|... .+|.|+++|..|.+ ..+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~-~s~fIvrLYrTfrd--~ky 494 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMEC-RSDFIVRLYRTFRD--SKY 494 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhc-CchHHHHHHHHhcc--chh
Confidence 345678888999999999999988666666888888642 234577899999998 79999999999955 567
Q ss_pred cEEEEEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 93 PSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
.|++||.|-||.+...++ .|....++-++.-+++|++|||.+||++|||||+|.+++.+| .+||.|||+++....+
T Consensus 495 vYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~G-y~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 495 VYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRG-YLKLVDFGFAKKIGSG 573 (732)
T ss_pred hhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCC-ceEEeehhhHHHhccC
Confidence 779999999999988874 599999999999999999999999999999999999999999 8999999999999989
Q ss_pred CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 170 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
..+.+.+||+.|.|||+++. ..-+.+.|.||||+++||+++|..|| .+.+.......|.+.+..-.+
T Consensus 574 ~KTwTFcGTpEYVAPEIILn-KGHD~avDyWaLGIli~ELL~G~pPF-s~~dpmktYn~ILkGid~i~~----------- 640 (732)
T KOG0614|consen 574 RKTWTFCGTPEYVAPEIILN-KGHDRAVDYWALGILIYELLTGSPPF-SGVDPMKTYNLILKGIDKIEF----------- 640 (732)
T ss_pred CceeeecCCcccccchhhhc-cCcchhhHHHHHHHHHHHHHcCCCCC-CCCchHHHHHHHHhhhhhhhc-----------
Confidence 99999999999999999998 77889999999999999999999988 455555555555553333332
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC-----HHHHhcCCCcccCC
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPIR 312 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps-----~~ell~hp~~~~~~ 312 (321)
+..++....+|++++...+|.+|.. +.++-+|.||.+.+
T Consensus 641 ------------------------Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfd 684 (732)
T KOG0614|consen 641 ------------------------PRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFD 684 (732)
T ss_pred ------------------------ccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCC
Confidence 3345568999999999999999975 88999999999754
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=266.25 Aligned_cols=266 Identities=18% Similarity=0.308 Sum_probs=179.0
Q ss_pred cccCceEEeeeeeeecceEEEEEEEe----------------cCCceEEEEEecccch-----------------HHHHH
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHC----------------TDNEKCIIKILKPVKK-----------------KKIKR 64 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~----------------~~~~~~~vK~~~~~~~-----------------~~~~~ 64 (321)
...++|++.++||+|+||+||+|.+. ..+..||||.++.... .....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 35779999999999999999999752 2346799999864321 11234
Q ss_pred HHHHHHhhcCCCC-----eeeeeeeeecc------CCCCcEEEEEeecCchhhhhcC-----------------------
Q 020826 65 EIKILQNLCGGPN-----IVKLLDIVRDQ------QSKTPSLIFEHVNNTDFKVLYP----------------------- 110 (321)
Q Consensus 65 E~~~l~~l~~h~~-----i~~~~~~~~~~------~~~~~~lv~e~~~~~~l~~~~~----------------------- 110 (321)
|+.++.++ +|.+ ++++++++... .....++|+||+.+++|.+++.
T Consensus 222 E~~~l~~l-~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~ 300 (507)
T PLN03224 222 EAYMCAKI-KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDN 300 (507)
T ss_pred HHHHHHHh-hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhh
Confidence 66667777 3433 45666666432 1235689999999998876652
Q ss_pred ----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCcccc--ccCCcccccc
Q 020826 111 ----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV--RVASRYFKGP 184 (321)
Q Consensus 111 ----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~~~--~~~~~~y~aP 184 (321)
.+++..++.++.|++.+|.|||+.+++|+||||+||+++.++ .++|+|||++........... ...++.|+||
T Consensus 301 ~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP 379 (507)
T PLN03224 301 MPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP 379 (507)
T ss_pred cccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCC-cEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence 124556888999999999999999999999999999999887 899999999865433322222 2347889999
Q ss_pred ccccCCCC---------------------CCCcchHHHHHHHHHHHHhCCC-CCccCCCChHHHHHHHHHhCChhhhHHh
Q 020826 185 ELLVDLQD---------------------YDYSLDLWSLGCMFAGMIFRKE-PFFYGHDNYDQLVKIAKVLGTDELNAYL 242 (321)
Q Consensus 185 E~~~~~~~---------------------~~~~~DvwslG~~l~~l~~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (321)
|.+..... .....|+||+||++++|++|.. |+. +...... ..+... .....+.
T Consensus 380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~-~~~~f~~---~~~~~~-~~~~~~r 454 (507)
T PLN03224 380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA-NIRLFNT---ELRQYD-NDLNRWR 454 (507)
T ss_pred hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc-chhhhhh---HHhhcc-chHHHHH
Confidence 99854211 1124799999999999999876 442 1111000 000000 0000000
Q ss_pred hhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCC---CCCcCHHHHhcCCCccc
Q 020826 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDH---QERPTAKEAMAHPYFFP 310 (321)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp---~~Rps~~ell~hp~~~~ 310 (321)
. ...... ........+++.++|+.+||..+| .+|+|++|+|+||||..
T Consensus 455 ---------------~-~~~~~~----~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 455 ---------------M-YKGQKY----DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred ---------------h-hcccCC----CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 0 000000 011123467899999999999866 68999999999999964
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=247.81 Aligned_cols=237 Identities=34% Similarity=0.585 Sum_probs=191.6
Q ss_pred cceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeecCchhhhh
Q 020826 33 KYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL 108 (321)
Q Consensus 33 ~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~ 108 (321)
+||.||+|.+..+++.+++|++.... ...+.+|+..++++ +|++++++++.+... ...++++|++.+++|..+
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~--~~~~l~~e~~~~~~L~~~ 77 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKL-KHPNIVRLYDVFEDE--DKLYLVMEYCDGGDLFDL 77 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhC-CCCcHHHHHhheeeC--CEEEEEEeCCCCCCHHHH
Confidence 58999999998889999999987543 46788999999999 999999999988543 566799999999898877
Q ss_pred cCC---CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCccccccCCccccccc
Q 020826 109 YPT---LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 185 (321)
Q Consensus 109 ~~~---~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE 185 (321)
+.. ++...+..++.+++.++.+||+.+++|+||+|.||+++.++ .++++|||.+.............++..|++||
T Consensus 78 ~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE 156 (244)
T smart00220 78 LKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDG-HVKLADFGLARQLDPGGLLTTFVGTPEYMAPE 156 (244)
T ss_pred HHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC-cEEEccccceeeeccccccccccCCcCCCCHH
Confidence 643 78899999999999999999999999999999999999887 89999999998776554455667788899999
Q ss_pred cccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCC
Q 020826 186 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPW 265 (321)
Q Consensus 186 ~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (321)
...+ ..++.++|+||||++++++++|..||............+ . .... ..
T Consensus 157 ~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~-~---~~~~------------------------~~- 206 (244)
T smart00220 157 VLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKI-G---KPKP------------------------PF- 206 (244)
T ss_pred HHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH-h---ccCC------------------------CC-
Confidence 9976 678889999999999999999999984322221111111 1 0000 00
Q ss_pred ccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 266 SKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 266 ~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
......++.++.+++.+||..+|++||++.++++||||
T Consensus 207 -----~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 207 -----PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred -----ccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 00000145689999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=268.10 Aligned_cols=251 Identities=18% Similarity=0.298 Sum_probs=202.7
Q ss_pred eeeecccCceEEeeeeeeecceEEEEEEEec-CC--ceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeee
Q 020826 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCT-DN--EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVR 86 (321)
Q Consensus 14 ~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~-~~--~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (321)
++|+ .++..+.++||+|+||.|++|.|+. .| ..||||.++.+. .+.|.+|+.+|.+| +|||++++|++..
T Consensus 105 clIp--ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L-~H~hliRLyGvVl 181 (1039)
T KOG0199|consen 105 CLIP--EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKL-QHPHLIRLYGVVL 181 (1039)
T ss_pred eecc--HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhc-cCcceeEEeeeec
Confidence 4555 5578888999999999999999864 23 478999998654 46799999999999 9999999999986
Q ss_pred ccCCCCcEEEEEeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecc
Q 020826 87 DQQSKTPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 161 (321)
Q Consensus 87 ~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg 161 (321)
+ .-..+|+|.+.+|+|.+.+. .|.......++.||+.||.||..+++|||||...|+++-... .|||+|||
T Consensus 182 ~---qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllaspr-tVKI~DFG 257 (1039)
T KOG0199|consen 182 D---QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPR-TVKICDFG 257 (1039)
T ss_pred c---chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccc-eeeeeccc
Confidence 5 33569999999999877664 378888899999999999999999999999999999998766 89999999
Q ss_pred ceeecCCCCcccc----ccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChh
Q 020826 162 LAEFYHPGKEYNV----RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 237 (321)
Q Consensus 162 ~~~~~~~~~~~~~----~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (321)
+.+.+..+..... ..-...|.|||.+.. ..++.+||||++|+++|||+++..-.+.+-....+++.+-
T Consensus 258 LmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh-~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD------- 329 (1039)
T KOG0199|consen 258 LMRALGENEDMYVMAPQRKVPFAWCAPESLRH-RKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID------- 329 (1039)
T ss_pred ceeccCCCCcceEecCCCcCcccccCHhHhcc-ccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-------
Confidence 9988765544322 122345999999987 8999999999999999999985443335666555555432
Q ss_pred hhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 238 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
.-+.+..++.+|.++.++++.||..+|++|||+..|.+.-+.
T Consensus 330 -----------------------------~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l 371 (1039)
T KOG0199|consen 330 -----------------------------AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL 371 (1039)
T ss_pred -----------------------------ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence 113344556788999999999999999999999987644333
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=261.10 Aligned_cols=251 Identities=19% Similarity=0.332 Sum_probs=198.4
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
...+...+.++||+|.||.|-++.- ..+.+||+|.++++. +..+.+|+.+|.+| +||||+.+.++|... .-+
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqL-khPNIveLvGVC~~D--ePi 610 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRL-KHPNIVELLGVCVQD--DPL 610 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhcc-CCCCeeEEEeeeecC--Cch
Confidence 3356788999999999999999987 457999999998654 46789999999999 999999999999654 445
Q ss_pred EEEEEeecCchhhhhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 94 SLIFEHVNNTDFKVLYPT-----LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~~~-----~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
++++||+..|+|.+++.. ..-....+|+.||+.||+||.+.++|||||.+.|++++.+. ++||+|||+++.+..
T Consensus 611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~-~iKiadfgmsR~lys 689 (807)
T KOG1094|consen 611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEF-TIKIADFGMSRNLYS 689 (807)
T ss_pred HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcc-cEEecCccccccccc
Confidence 699999999999888832 24455678999999999999999999999999999999988 899999999987655
Q ss_pred CCccc---cccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh--CCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 169 GKEYN---VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF--RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 169 ~~~~~---~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
+..+. ..+-..+|+|||.+.- +.++++||+|+||+++||+++ ...||. .-.+..........+..+....
T Consensus 690 g~yy~vqgr~vlpiRwmawEsill-gkFttaSDvWafgvTlwE~~~~C~e~Py~-~lt~e~vven~~~~~~~~~~~~--- 764 (807)
T KOG1094|consen 690 GDYYRVQGRAVLPIRWMAWESILL-GKFTTASDVWAFGVTLWEVFMLCREQPYS-QLTDEQVVENAGEFFRDQGRQV--- 764 (807)
T ss_pred CCceeeecceeeeeeehhHHHHHh-ccccchhhhhhhHHHHHHHHHHHhhCchh-hhhHHHHHHhhhhhcCCCCcce---
Confidence 44432 2244568999999987 799999999999999999864 566772 2233333333333222222111
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
-...+..++..+.++|.+||..|-++|||++++-.
T Consensus 765 --------------------------~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 765 --------------------------VLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred --------------------------eccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 12234457788999999999999999999999854
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=272.08 Aligned_cols=245 Identities=18% Similarity=0.338 Sum_probs=204.8
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCC---ceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDN---EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~---~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
+.....|.++||.|.||.|++|+.+..+ ..||||.++.- .+..|..|..+|-++ +||||+++.++... ..
T Consensus 627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQF-dHPNIIrLEGVVTk--s~ 703 (996)
T KOG0196|consen 627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQF-DHPNIIRLEGVVTK--SK 703 (996)
T ss_pred ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccC-CCCcEEEEEEEEec--Cc
Confidence 3556788999999999999999987655 47999999853 346789999999999 99999999999944 55
Q ss_pred CcEEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 92 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
-.+||+|||+.++|+.+++ .|...++..|++.|+.||+||-++|+|||||.+.|||++.+- .+|++|||+++...
T Consensus 704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnL-vCKVsDFGLSRvle 782 (996)
T KOG0196|consen 704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVLE 782 (996)
T ss_pred eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccce-EEEeccccceeecc
Confidence 6789999999999998884 488899999999999999999999999999999999999877 89999999999875
Q ss_pred CCCc--cccccC--CccccccccccCCCCCCCcchHHHHHHHHHHHH-hCCCCCccCCCChHHHHHHHHHhCChhhhHHh
Q 020826 168 PGKE--YNVRVA--SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI-FRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242 (321)
Q Consensus 168 ~~~~--~~~~~~--~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~-~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (321)
.... +++..| ..+|.|||++.- ..++.+|||||+|+++||.+ .|.-||+ +.++.+.+..+.+...-+
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~-RKFTsASDVWSyGIVmWEVmSyGERPYW-dmSNQdVIkaIe~gyRLP------ 854 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYW-DMSNQDVIKAIEQGYRLP------ 854 (996)
T ss_pred cCCCccccccCCccceeecChhHhhh-cccCchhhccccceEEEEecccCCCccc-ccchHHHHHHHHhccCCC------
Confidence 4432 222222 357999999987 89999999999999999977 5888885 666667777665544333
Q ss_pred hhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
.+..++..+.+|+..||+.|-.+||.+.+++++
T Consensus 855 ------------------------------pPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 855 ------------------------------PPMDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred ------------------------------CCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 233578899999999999999999999988764
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=247.05 Aligned_cols=259 Identities=21% Similarity=0.345 Sum_probs=200.3
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
...++.+-++.||.|+||+|++-.++..|+..|||.++... .+++..|.+...+-.+.||||++++..-.+.. .
T Consensus 61 F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd--c 138 (361)
T KOG1006|consen 61 FTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD--C 138 (361)
T ss_pred cccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc--e
Confidence 34567777889999999999999999999999999997532 35677888777776689999999997754443 3
Q ss_pred EEEEEeecCchhhhhc--------CCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCCeEEcCCCCeEEEeecccee
Q 020826 94 SLIFEHVNNTDFKVLY--------PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 164 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~~lh~~-~i~H~dlkp~nili~~~~~~v~l~dfg~~~ 164 (321)
++.||.|.-. +..+. ..+++..+-.+......||.||-+. +|+|||+||+||+++..| .|||+|||++-
T Consensus 139 WiCMELMd~S-lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G-~vKLCDFGIcG 216 (361)
T KOG1006|consen 139 WICMELMDIS-LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG-DVKLCDFGICG 216 (361)
T ss_pred eeeHHHHhhh-HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC-CEeeecccchH
Confidence 6888888643 22222 3588888888888889999999864 799999999999999998 89999999986
Q ss_pred ecCCCCccccccCCccccccccccCCCC-CCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 165 FYHPGKEYNVRVASRYFKGPELLVDLQD-YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
.+..+...+...|...|+|||.+..... ++.+|||||||++++|+.||..|+..=.+..+++..++. ....
T Consensus 217 qLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~---gdpp----- 288 (361)
T KOG1006|consen 217 QLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVI---GDPP----- 288 (361)
T ss_pred hHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHc---CCCC-----
Confidence 6655555566788889999999976544 899999999999999999999998432333333333221 1110
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
....-......|..+..+|.-||..|-+.||.-.+++++||++.-
T Consensus 289 -----------------------~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 289 -----------------------ILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY 333 (361)
T ss_pred -----------------------eecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence 000011112366789999999999999999999999999999853
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=288.03 Aligned_cols=254 Identities=21% Similarity=0.282 Sum_probs=185.7
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeec
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVN 101 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~ 101 (321)
.+.....||+|+||.||+|++..++..||+|.++.... ....|++.++++ +||||+++++++.+. ...++||||++
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~l~~l-~HpnIv~~~~~~~~~--~~~~lv~Ey~~ 766 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-IPSSEIADMGKL-QHPNIVKLIGLCRSE--KGAYLIHEYIE 766 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-ccHHHHHHHhhC-CCCCcceEEEEEEcC--CCCEEEEeCCC
Confidence 45667789999999999999988999999999864332 234678899999 999999999999654 45679999999
Q ss_pred CchhhhhcCCCCHHHHHHHHHHHHHHHHHHH---HCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCccccccCC
Q 020826 102 NTDFKVLYPTLSDYDVRYYIYELLKALDYCH---SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 178 (321)
Q Consensus 102 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh---~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~~~~~~~ 178 (321)
+++|.+++..+++..+..++.|++.||+||| +.+++||||||+||+++.++ ..++. ++...... ......++
T Consensus 767 ~g~L~~~l~~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~-~~~~~-~~~~~~~~---~~~~~~~t 841 (968)
T PLN00113 767 GKNLSEVLRNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKD-EPHLR-LSLPGLLC---TDTKCFIS 841 (968)
T ss_pred CCcHHHHHhcCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCC-ceEEE-eccccccc---cCCCcccc
Confidence 9999999999999999999999999999999 66999999999999999776 55554 55433221 11233678
Q ss_pred ccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhc
Q 020826 179 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVG 258 (321)
Q Consensus 179 ~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (321)
..|+|||++.+ ..++.++|||||||++|||++|+.||.................-.. .....+.+
T Consensus 842 ~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~ 906 (968)
T PLN00113 842 SAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSD--------------CHLDMWID 906 (968)
T ss_pred ccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCc--------------cchhheeC
Confidence 89999999887 7899999999999999999999999843322211111111100000 00000000
Q ss_pred ccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 259 RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
........ .......++.+++.+||+.||++|||++|+++.
T Consensus 907 ~~~~~~~~------~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 907 PSIRGDVS------VNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred ccccCCCC------ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 00000000 000111367899999999999999999999865
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=265.09 Aligned_cols=243 Identities=26% Similarity=0.403 Sum_probs=184.4
Q ss_pred Eeeeeeeecce-EEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeecCc
Q 020826 25 VVRKVGRGKYS-EVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT 103 (321)
Q Consensus 25 ~~~~lg~g~~g-~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~ 103 (321)
-.+.+|.|+.| .||+|.. .++.||||.+-....+.+.+|++.++.-..||||+++++.- .+..+.||..|.|...
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E--~d~qF~YIalELC~~s 588 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE--QDRQFLYIALELCACS 588 (903)
T ss_pred cHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec--cCCceEEEEehHhhhh
Confidence 34568899987 5799987 77899999988777888999999999888899999998865 4566778999998754
Q ss_pred hhhhhcCC-------CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcC---CC-CeEEEeeccceeecCCCCc-
Q 020826 104 DFKVLYPT-------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH---EQ-RKLRLIDWGLAEFYHPGKE- 171 (321)
Q Consensus 104 ~l~~~~~~-------~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~---~~-~~v~l~dfg~~~~~~~~~~- 171 (321)
|.+++.. ......+.++.|++.||++||+.+|+||||||+||+|+. ++ ..++|+|||+++.+..+..
T Consensus 589 -L~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS 667 (903)
T KOG1027|consen 589 -LQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS 667 (903)
T ss_pred -HHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch
Confidence 3333321 122456788999999999999999999999999999986 23 3789999999998865543
Q ss_pred ---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhC-CCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 172 ---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFR-KEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 172 ---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
.....||.+|+|||.+.+ ..-+.+.|||||||++|+.++| .+||. .+ .++...|.. +..
T Consensus 668 ~~r~s~~sGt~GW~APE~L~~-~~~~~avDiFslGCvfyYvltgG~HpFG--d~-~~R~~NIl~--~~~----------- 730 (903)
T KOG1027|consen 668 FSRLSGGSGTSGWQAPEQLRE-DRKTQAVDIFSLGCVFYYVLTGGSHPFG--DS-LERQANILT--GNY----------- 730 (903)
T ss_pred hhcccCCCCcccccCHHHHhc-cccCcccchhhcCceEEEEecCCccCCC--ch-HHhhhhhhc--Ccc-----------
Confidence 234568899999999987 5567799999999999999987 77882 21 122111111 000
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCccc
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 310 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~ 310 (321)
....+..... .+..+||.+|++++|..||+|.++|.||||=.
T Consensus 731 -------------------~L~~L~~~~d--~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 731 -------------------TLVHLEPLPD--CEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred -------------------ceeeeccCch--HHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 0000000000 17899999999999999999999999999954
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=245.05 Aligned_cols=279 Identities=19% Similarity=0.250 Sum_probs=201.6
Q ss_pred EEeeeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhh-cCCCCeeeeeeeeecc
Q 020826 10 YWCVWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNL-CGGPNIVKLLDIVRDQ 88 (321)
Q Consensus 10 ~~~~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l-~~h~~i~~~~~~~~~~ 88 (321)
.+++.+.+ ....++.+.+|+|.||.||+|.. +++.||||++...++..+..|-+++... .+|+||+++++.-...
T Consensus 201 ~~sspl~~--l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~ 276 (534)
T KOG3653|consen 201 APSSPLLE--LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRG 276 (534)
T ss_pred CCCccccc--CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccC
Confidence 34455555 55678889999999999999987 5699999999999999999998888864 2799999999865322
Q ss_pred C--CCCcEEEEEeecCchhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHC---------CCeeecCCCCCeEEcCCCCeE
Q 020826 89 Q--SKTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQ---------GIMHRDVKPHNVMIDHEQRKL 155 (321)
Q Consensus 89 ~--~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lh~~---------~i~H~dlkp~nili~~~~~~v 155 (321)
. ...++||+++...|+|.+++. ..++....+++..+++||+|||+. .|+|||||..|||+..+. +.
T Consensus 277 t~~~~eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl-Tc 355 (534)
T KOG3653|consen 277 TADRMEYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL-TC 355 (534)
T ss_pred CccccceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC-cE
Confidence 2 346789999999999999985 489999999999999999999975 499999999999999888 89
Q ss_pred EEeeccceeecCCCCc---cccccCCccccccccccCCCCCC-----CcchHHHHHHHHHHHHhCCCCCccCCCChHHHH
Q 020826 156 RLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYD-----YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 227 (321)
Q Consensus 156 ~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~-----~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~ 227 (321)
.|+|||++-.+.+... .-..+||.+|||||++.+.-++. .+.||||+|+++||++++...++++... +...
T Consensus 356 cIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp-~Yql 434 (534)
T KOG3653|consen 356 CIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVP-EYQL 434 (534)
T ss_pred EeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCC-cccC
Confidence 9999999988765433 33478999999999997754444 4689999999999999987766432221 1111
Q ss_pred HHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHH------H
Q 020826 228 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK------E 301 (321)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~------e 301 (321)
-....+|....- ...+..+.....+| .....+... .-..-+.+.+..||+.||+.|.|+. .
T Consensus 435 pfe~evG~hPt~-----------e~mq~~VV~kK~RP-~~p~~W~~h-~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~ 501 (534)
T KOG3653|consen 435 PFEAEVGNHPTL-----------EEMQELVVRKKQRP-KIPDAWRKH-AGMAVLCETIEECWDHDAEARLTAGCVEERMA 501 (534)
T ss_pred chhHHhcCCCCH-----------HHHHHHHHhhccCC-CChhhhhcC-ccHHHHHHHHHHHcCCchhhhhhhHHHHHHHH
Confidence 111112211100 01111111111111 111111111 1114689999999999999999985 3
Q ss_pred HhcCCC
Q 020826 302 AMAHPY 307 (321)
Q Consensus 302 ll~hp~ 307 (321)
-+.|.|
T Consensus 502 ~l~~~~ 507 (534)
T KOG3653|consen 502 ELMMLW 507 (534)
T ss_pred HHhccC
Confidence 455555
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=258.08 Aligned_cols=252 Identities=23% Similarity=0.376 Sum_probs=195.1
Q ss_pred eeeeeecccCceEEeeeeeeecceEEEEEEEec-------CCceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeee
Q 020826 12 CVWFINREQDDYEVVRKVGRGKYSEVFEGVHCT-------DNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVK 80 (321)
Q Consensus 12 ~~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~-------~~~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~ 80 (321)
+.|++++.+. .+.+.||+|.||.|++|.... ....||||.++.. +.+.+..|+++|+.+..|||++.
T Consensus 289 ~~~e~~~~~l--~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~ 366 (609)
T KOG0200|consen 289 PKWEIPRENL--KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVN 366 (609)
T ss_pred Cceeechhhc--cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhh
Confidence 4688887655 555699999999999997542 1457899998743 35678999999999999999999
Q ss_pred eeeeeeccCCCCcEEEEEeecCchhhhhc--CC-----------------CCHHHHHHHHHHHHHHHHHHHHCCCeeecC
Q 020826 81 LLDIVRDQQSKTPSLIFEHVNNTDFKVLY--PT-----------------LSDYDVRYYIYELLKALDYCHSQGIMHRDV 141 (321)
Q Consensus 81 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~--~~-----------------~~~~~~~~i~~qi~~~l~~lh~~~i~H~dl 141 (321)
+++.+.. ....+++.||+..|+|..++ .+ ++......++.||+.|++||++..++||||
T Consensus 367 llG~~t~--~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDL 444 (609)
T KOG0200|consen 367 LLGACTQ--DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDL 444 (609)
T ss_pred heeeecc--CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhh
Confidence 9999965 55678999999999887666 23 778889999999999999999999999999
Q ss_pred CCCCeEEcCCCCeEEEeeccceeecCCCCccccc--c--CCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCc
Q 020826 142 KPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR--V--ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 217 (321)
Q Consensus 142 kp~nili~~~~~~v~l~dfg~~~~~~~~~~~~~~--~--~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~ 217 (321)
.+.||++..+. .+||+|||+++.......+... . -...|+|||.+.. ..++.+|||||+|+++||+++.+.+.+
T Consensus 445 AaRNVLi~~~~-~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PY 522 (609)
T KOG0200|consen 445 AARNVLITKNK-VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPY 522 (609)
T ss_pred hhhhEEecCCC-EEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCC
Confidence 99999999776 8999999999865444333222 1 1234999999988 899999999999999999998544443
Q ss_pred cCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc
Q 020826 218 YGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP 297 (321)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp 297 (321)
++-.....+.+..+.. .....+..+++++.++++.||+.+|++||
T Consensus 523 p~~~~~~~l~~~l~~G-----------------------------------~r~~~P~~c~~eiY~iM~~CW~~~p~~RP 567 (609)
T KOG0200|consen 523 PGIPPTEELLEFLKEG-----------------------------------NRMEQPEHCSDEIYDLMKSCWNADPEDRP 567 (609)
T ss_pred CCCCcHHHHHHHHhcC-----------------------------------CCCCCCCCCCHHHHHHHHHHhCCCcccCC
Confidence 4432122222211110 11222345678999999999999999999
Q ss_pred CHHHHhc
Q 020826 298 TAKEAMA 304 (321)
Q Consensus 298 s~~ell~ 304 (321)
++.++..
T Consensus 568 ~F~~~~~ 574 (609)
T KOG0200|consen 568 TFSECVE 574 (609)
T ss_pred CHHHHHH
Confidence 9987653
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-34 Score=216.84 Aligned_cols=224 Identities=20% Similarity=0.372 Sum_probs=184.5
Q ss_pred EEEEeeeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeee
Q 020826 8 VIYWCVWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLD 83 (321)
Q Consensus 8 ~~~~~~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (321)
.+|.+.--++...++...+..||+|++|.|=+.++..+|...|+|.++.. ..+++..|+++..+...+|++|++++
T Consensus 33 ~i~I~~~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyG 112 (282)
T KOG0984|consen 33 LIYIGDRNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYG 112 (282)
T ss_pred eEEEecCccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeeh
Confidence 44555444666778888889999999999999999999999999998643 34567788988888778999999999
Q ss_pred eeeccCCCCcEEEEEeecCchhhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCCeEEcCCCCeE
Q 020826 84 IVRDQQSKTPSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKL 155 (321)
Q Consensus 84 ~~~~~~~~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lh~~-~i~H~dlkp~nili~~~~~~v 155 (321)
...++.+ .++.||.|... +..+. ..+++..+-+|+..+..||.|||++ .++|||+||.|||++.+| .|
T Consensus 113 a~~regd--vwIcME~M~tS-ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G-qV 188 (282)
T KOG0984|consen 113 ALFREGD--VWICMELMDTS-LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG-QV 188 (282)
T ss_pred hhhcccc--EEEeHHHhhhh-HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC-cE
Confidence 7755444 45888888754 32222 3489999999999999999999986 799999999999999999 89
Q ss_pred EEeeccceeecCCCCccccccCCccccccccccCC---CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHH
Q 020826 156 RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL---QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 232 (321)
Q Consensus 156 ~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 232 (321)
|+||||++-.+.++-..+...|...|+|||.+... ..|+.+|||||||+++.||.+++.||......++++.++++.
T Consensus 189 KiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 189 KICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred EEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 99999999777655555667788899999998542 368899999999999999999999998888888998887764
Q ss_pred hCC
Q 020826 233 LGT 235 (321)
Q Consensus 233 ~~~ 235 (321)
..+
T Consensus 269 p~P 271 (282)
T KOG0984|consen 269 PSP 271 (282)
T ss_pred CCC
Confidence 433
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=234.94 Aligned_cols=255 Identities=17% Similarity=0.225 Sum_probs=190.0
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHh-hcCCCCeeeeeeeeeccC--CCCcEE
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQN-LCGGPNIVKLLDIVRDQQ--SKTPSL 95 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~-l~~h~~i~~~~~~~~~~~--~~~~~l 95 (321)
...+..+.+.||+|.||.||+|.+ .|+.||||++...+...+.+|.++++. +.+|+||+.+++.-...+ -..++|
T Consensus 209 iarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 209 IARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred hhheeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 456789999999999999999998 789999999998888899999999886 349999999998532222 235789
Q ss_pred EEEeecCchhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHC--------CCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 96 IFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQ--------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 96 v~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lh~~--------~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
|++|-+.|+|.+++. .++.....+++..++.||++||.. .|+|||||..||++..++ .+.|+|+|++-.
T Consensus 287 vTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~-~C~IADLGLAv~ 365 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVR 365 (513)
T ss_pred eeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCC-cEEEeeceeeEE
Confidence 999999999999995 488999999999999999999964 499999999999999998 899999999976
Q ss_pred cCCCC-----ccccccCCccccccccccCCCCC-----CCcchHHHHHHHHHHHHhC----------CCCCccCCCChHH
Q 020826 166 YHPGK-----EYNVRVASRYFKGPELLVDLQDY-----DYSLDLWSLGCMFAGMIFR----------KEPFFYGHDNYDQ 225 (321)
Q Consensus 166 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~-----~~~~DvwslG~~l~~l~~g----------~~p~~~~~~~~~~ 225 (321)
..... ..+..+||.+|||||++...-+. -..+||||||+++||+.-. ..||+.--+....
T Consensus 366 h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs 445 (513)
T KOG2052|consen 366 HDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPS 445 (513)
T ss_pred ecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCC
Confidence 65432 24678999999999999653221 1468999999999998753 3344322222222
Q ss_pred HHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHH
Q 020826 226 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 302 (321)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~el 302 (321)
.+++.+..-. ++.+......+..++.+ ..+..+++.||..||.-|.||-.+
T Consensus 446 ~eeMrkVVCv-------------------------~~~RP~ipnrW~s~~~l-~~m~klMkeCW~~Np~aRltALri 496 (513)
T KOG2052|consen 446 FEEMRKVVCV-------------------------QKLRPNIPNRWKSDPAL-RVMAKLMKECWYANPAARLTALRI 496 (513)
T ss_pred HHHHhcceee-------------------------cccCCCCCcccccCHHH-HHHHHHHHHhhcCCchhhhHHHHH
Confidence 2222221111 11122222222221111 357788999999999999987543
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-33 Score=248.64 Aligned_cols=244 Identities=18% Similarity=0.313 Sum_probs=193.3
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCc----eEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 89 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~----~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (321)
......+..++||+|+||+||+|.+...++ +|++|++... ....+.+|..+|.++ +|||++++++++..+.
T Consensus 693 ~kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masl-dHpnl~RLLgvc~~s~ 771 (1177)
T KOG1025|consen 693 LKETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASL-DHPNLLRLLGVCMLST 771 (1177)
T ss_pred chhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcC-CCchHHHHhhhcccch
Confidence 344556677889999999999999876654 6788887532 346788999999999 9999999999986543
Q ss_pred CCCcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 90 SKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
+.||++|+++|.|.++. .++.......++.||+.||.|||+++++||||.+.|||+..-+ .||++|||+++.
T Consensus 772 ---~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~-hvkitdfgla~l 847 (1177)
T KOG1025|consen 772 ---LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPN-HVKITDFGLAKL 847 (1177)
T ss_pred ---HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCC-eEEEEecchhhc
Confidence 67999999999987777 4588889999999999999999999999999999999999777 899999999988
Q ss_pred cCCCCccc-ccc--CCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHH
Q 020826 166 YHPGKEYN-VRV--ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAY 241 (321)
Q Consensus 166 ~~~~~~~~-~~~--~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (321)
..+..... ... ...-|+|-|.+.. ..++.++||||+|+++||++| |..|+. +.+..++-..+ ..
T Consensus 848 l~~d~~ey~~~~gK~pikwmale~i~~-~~~thqSDVWsfGVtiWElmTFGa~Py~-gi~~~eI~dll----e~------ 915 (1177)
T KOG1025|consen 848 LAPDEKEYSAPGGKVPIKWMALESIRI-RKYTHQSDVWSFGVTIWELMTFGAKPYD-GIPAEEIPDLL----EK------ 915 (1177)
T ss_pred cCcccccccccccccCcHHHHHHHhhc-cCCCchhhhhhhhhhHHHHHhcCCCccC-CCCHHHhhHHH----hc------
Confidence 76554322 222 2345899998887 789999999999999999987 777873 33322222111 11
Q ss_pred hhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 242 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
.+.+..+..++-++..++.+||..|+..||+++++..
T Consensus 916 --------------------------geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 916 --------------------------GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred --------------------------cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 1123344557779999999999999999999988753
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=240.93 Aligned_cols=193 Identities=27% Similarity=0.515 Sum_probs=168.1
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----------hHHHHHHHHHHHhhc--CCCCeeeeeeeeec
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLC--GGPNIVKLLDIVRD 87 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----------~~~~~~E~~~l~~l~--~h~~i~~~~~~~~~ 87 (321)
.+|..++.+|+|+||.|+.|.++.+...|++|.+.+.. ...+..|+++|..|. .|+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 47999999999999999999999999999999986532 123678999999993 39999999999955
Q ss_pred cCCCCcEEEEEeec-Cchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccce
Q 020826 88 QQSKTPSLIFEHVN-NTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163 (321)
Q Consensus 88 ~~~~~~~lv~e~~~-~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~ 163 (321)
+.+++|+||.-+ +.+|.+++ +.+++.+++.|++||..|+++||+.||+|||||-+|+.++.+| -+||+|||.+
T Consensus 641 --dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g-~~klidfgsa 717 (772)
T KOG1152|consen 641 --DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNG-FVKLIDFGSA 717 (772)
T ss_pred --CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCC-eEEEeeccch
Confidence 566779999754 45666665 6799999999999999999999999999999999999999999 8999999998
Q ss_pred eecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCc
Q 020826 164 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 217 (321)
Q Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~ 217 (321)
.... +.......||..|.|||++.+..+....-|||+||+++|-++....||+
T Consensus 718 a~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 718 AYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred hhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 6543 4556778999999999999997777889999999999999999999985
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-33 Score=248.11 Aligned_cols=257 Identities=25% Similarity=0.437 Sum_probs=205.9
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc---chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
...++|+.+..+|+|++|.||+++++.+++..|+|+++.. +.+.++.|+-+++.. +||||+.+++.+. ...-++
T Consensus 12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc-~h~nivay~gsyl--r~dklw 88 (829)
T KOG0576|consen 12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDC-RHPNIVAYFGSYL--RRDKLW 88 (829)
T ss_pred CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecC-CCcChHHHHhhhh--hhcCcE
Confidence 3578999999999999999999999999999999998753 456788999999987 9999999999773 345578
Q ss_pred EEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC-C
Q 020826 95 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K 170 (321)
Q Consensus 95 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~-~ 170 (321)
+.||||++++|.+.. ..+++.++.++++..+.|++|||++|=+|||||--||+++..| .||+.|||.+...... .
T Consensus 89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~g-DvklaDfgvsaqitati~ 167 (829)
T KOG0576|consen 89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEG-DVKLADFGVSAQITATIA 167 (829)
T ss_pred EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccC-ceeecccCchhhhhhhhh
Confidence 999999999998777 5699999999999999999999999999999999999999888 7999999987544322 2
Q ss_pred ccccccCCcccccccccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 171 EYNVRVASRYFKGPELLV--DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
......||++|+|||+.. ..+.++..+|+|++|....|+-.-..|.+ +-.....+..+.+ .+.
T Consensus 168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplf-dlhpmr~l~LmTk-S~~------------- 232 (829)
T KOG0576|consen 168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLF-DLHPMRALFLMTK-SGF------------- 232 (829)
T ss_pred hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCccc-ccchHHHHHHhhc-cCC-------------
Confidence 234568999999999962 12578899999999999999877666653 2222222221111 000
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
+ ..+...+...++.+.+|++.+|..+|.+|||++.+|.|||..+-
T Consensus 233 --------------q----pp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 233 --------------Q----PPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred --------------C----CCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 0 01222334566789999999999999999999999999998764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-30 Score=212.01 Aligned_cols=205 Identities=34% Similarity=0.614 Sum_probs=178.4
Q ss_pred eeeecceEEEEEEEecCCceEEEEEecccch----HHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeecCch
Q 020826 29 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD 104 (321)
Q Consensus 29 lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~ 104 (321)
||+|.+|.||++....+++.+++|++..... ..+.+|+..++.+ .|++++++++++... ...++++|++.+.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~--~~~~~~~e~~~~~~ 77 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKL-NHPNIVKLYGVFEDE--NHLYLVMEYCEGGS 77 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhc-CCCCeeeEeeeeecC--CeEEEEEecCCCCc
Confidence 6899999999999977899999999987654 6799999999999 889999999998543 56679999999999
Q ss_pred hhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcC-CCCeEEEeeccceeecCCCC-ccccccCC
Q 020826 105 FKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH-EQRKLRLIDWGLAEFYHPGK-EYNVRVAS 178 (321)
Q Consensus 105 l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~-~~~~v~l~dfg~~~~~~~~~-~~~~~~~~ 178 (321)
|..++. .++...+..++.+++.++.+||+.|++|+||+|.||+++. ++ .++|+|||.+....... ......+.
T Consensus 78 l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~ 156 (215)
T cd00180 78 LKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNG-KVKLADFGLSKLLTSDKSLLKTIVGT 156 (215)
T ss_pred HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCC-cEEEecCCceEEccCCcchhhcccCC
Confidence 888874 4789999999999999999999999999999999999998 56 89999999997664332 12335567
Q ss_pred ccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhc
Q 020826 179 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVG 258 (321)
Q Consensus 179 ~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (321)
..|.+||........+.++|+|++|++++++
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------- 187 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------- 187 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------------
Confidence 7899999987733788999999999999998
Q ss_pred ccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCC
Q 020826 259 RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 306 (321)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp 306 (321)
+.+.+++.+|++.||++||++.++++|+
T Consensus 188 --------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 1678999999999999999999999885
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.7e-33 Score=218.91 Aligned_cols=259 Identities=19% Similarity=0.279 Sum_probs=193.9
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc--hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
...+.|.+.+.+|+|.||.+-++.++.+...+++|.+.... .+.+.+|...--.|..|.||+.-|++.-.. ..++++
T Consensus 21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt-~d~YvF 99 (378)
T KOG1345|consen 21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQT-SDAYVF 99 (378)
T ss_pred chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhc-CceEEE
Confidence 35688999999999999999999999999999999987653 367888887777777899999988854333 346689
Q ss_pred EEEeecCchhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEc-CCCCeEEEeeccceeecCCCCcc
Q 020826 96 IFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID-HEQRKLRLIDWGLAEFYHPGKEY 172 (321)
Q Consensus 96 v~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~-~~~~~v~l~dfg~~~~~~~~~~~ 172 (321)
++|+++.|+|..-.. .+.+...+.++.|++.|+.|+|++++||||||.+|||+. .+...|||+|||.+.... ..-
T Consensus 100 ~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g--~tV 177 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG--TTV 177 (378)
T ss_pred eeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC--cee
Confidence 999999999988884 589999999999999999999999999999999999994 455589999999986532 122
Q ss_pred ccccCCccccccccccCC----CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 173 NVRVASRYFKGPELLVDL----QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 173 ~~~~~~~~y~aPE~~~~~----~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
.....+..|.+||..... -...+.+|+|.||+++|.++||..||...........+..+..+
T Consensus 178 ~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~-------------- 243 (378)
T KOG1345|consen 178 KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLK-------------- 243 (378)
T ss_pred hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhc--------------
Confidence 223345568899987432 23678899999999999999999999422221111111111111
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCC---cCHHHHhcCCCcc
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER---PTAKEAMAHPYFF 309 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~R---ps~~ell~hp~~~ 309 (321)
+........+ ..+|+.+..+.++-|..+|++| -++.......|..
T Consensus 244 ----------rk~~~~P~~F------~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 244 ----------RKNPALPKKF------NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE 291 (378)
T ss_pred ----------ccCccCchhh------cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence 1111111111 2467889999999999999999 5566555555554
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-29 Score=206.51 Aligned_cols=192 Identities=33% Similarity=0.623 Sum_probs=165.2
Q ss_pred eEEeeeeeeecceEEEEEEEecCCceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEE
Q 020826 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 98 (321)
Q Consensus 23 y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 98 (321)
|.+.+.||+|++|+||++....+++.+++|.+... ..+.+.+|++.++.+ +|++++++++.+... ...++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~-~~~~i~~~~~~~~~~--~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKL-KHPNIVKLYGVFEDP--EPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCChhhheeeeecC--CceEEEEe
Confidence 56788999999999999999888999999999765 356788999999999 899999999988543 45679999
Q ss_pred eecCchhhhhcC---C-CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC--cc
Q 020826 99 HVNNTDFKVLYP---T-LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--EY 172 (321)
Q Consensus 99 ~~~~~~l~~~~~---~-~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~--~~ 172 (321)
++.+++|..++. . +++..+..++.+++.++.+||+.+++|+||+|.||+++.++ .++|+|||.+....... ..
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~-~~~l~d~g~~~~~~~~~~~~~ 156 (225)
T smart00221 78 YCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDG-LVKLADFGLARFIHRDLAALL 156 (225)
T ss_pred ccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeeCceeeEecCcccccc
Confidence 999988887773 2 78899999999999999999999999999999999999876 89999999988765442 33
Q ss_pred ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCcc
Q 020826 173 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY 218 (321)
Q Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~ 218 (321)
....++..|++||.+.+...++.++|+|+||++++++++|+.||..
T Consensus 157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 4456777899999984336778899999999999999999999943
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=213.07 Aligned_cols=248 Identities=17% Similarity=0.315 Sum_probs=190.8
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEecC-----CceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeee
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTD-----NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVR 86 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~-----~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (321)
+.....+++..-.+.+|.||.||+|.+... .+.+.+|.++... ...+..|.-.+..+ .|||+..+.++..
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~-sH~nll~V~~V~i 357 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGA-SHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcC-cCCCccceeEEEe
Confidence 334466788888999999999999976533 2456677765432 34567777777777 7999999999876
Q ss_pred ccCCCCcEEEEEeecCchhhhhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeE
Q 020826 87 DQQSKTPSLIFEHVNNTDFKVLYP-----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL 155 (321)
Q Consensus 87 ~~~~~~~~lv~e~~~~~~l~~~~~-----------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v 155 (321)
. +...++.++.+.+.++|+.++. .++-.+...++.|++.|++|||..|++|.||.+.|.+++..- .|
T Consensus 358 e-~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~L-qV 435 (563)
T KOG1024|consen 358 E-DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQL-QV 435 (563)
T ss_pred e-ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhhe-eE
Confidence 4 3566789999999999988773 366777889999999999999999999999999999999664 89
Q ss_pred EEeeccceeecCCCCcc---ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHH
Q 020826 156 RLIDWGLAEFYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAK 231 (321)
Q Consensus 156 ~l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 231 (321)
||+|-.+++..-+.+-. ...--...|++||.+.. ..++.++|+||||+++|||+| |+.|+ ..-+.++.-..+.+
T Consensus 436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n-~~yssasDvWsfGVllWELmtlg~~Py-aeIDPfEm~~ylkd 513 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQN-SHYSSASDVWSFGVLLWELMTLGKLPY-AEIDPFEMEHYLKD 513 (563)
T ss_pred EeccchhccccCcccccccCCCCCCcccccCHHHHhh-hhhcchhhhHHHHHHHHHHHhcCCCCc-cccCHHHHHHHHhc
Confidence 99999999766544321 11122345999999988 899999999999999999997 67776 34444444333322
Q ss_pred HhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 232 VLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
.. .+..+-++++++..++..||+.+|++||+.+++..
T Consensus 514 Gy------------------------------------RlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 514 GY------------------------------------RLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred cc------------------------------------eecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 11 12233468899999999999999999999998864
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.8e-30 Score=244.83 Aligned_cols=195 Identities=13% Similarity=0.175 Sum_probs=133.8
Q ss_pred CCeeeeeeeee----c-cCCCCcEEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCe
Q 020826 76 PNIVKLLDIVR----D-QQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNV 146 (321)
Q Consensus 76 ~~i~~~~~~~~----~-~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~ni 146 (321)
+||+.+++.+. + .....++.++|++. ++|..++. .+++..++.++.||+.||+|||++||+||||||+||
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni 111 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF 111 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence 45555555541 1 11234567788775 46766662 389999999999999999999999999999999999
Q ss_pred EEcCCC------------------CeEEEeeccceeecCCCC-----------------ccccccCCccccccccccCCC
Q 020826 147 MIDHEQ------------------RKLRLIDWGLAEFYHPGK-----------------EYNVRVASRYFKGPELLVDLQ 191 (321)
Q Consensus 147 li~~~~------------------~~v~l~dfg~~~~~~~~~-----------------~~~~~~~~~~y~aPE~~~~~~ 191 (321)
+++..+ ..+|++|||++....... ......+|+.|+|||++.+ .
T Consensus 112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~ 190 (793)
T PLN00181 112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNG-S 190 (793)
T ss_pred EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhcc-C
Confidence 996433 145666777664321000 0011357888999999987 6
Q ss_pred CCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCcccccc
Q 020826 192 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 271 (321)
Q Consensus 192 ~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (321)
.++.++|||||||++|||++|..|+... ......+....-.+. .
T Consensus 191 ~~~~~sDVwSlGviL~ELl~~~~~~~~~---~~~~~~~~~~~~~~~-----------------------------~---- 234 (793)
T PLN00181 191 SSNCASDVYRLGVLLFELFCPVSSREEK---SRTMSSLRHRVLPPQ-----------------------------I---- 234 (793)
T ss_pred CCCchhhhhhHHHHHHHHhhCCCchhhH---HHHHHHHHHhhcChh-----------------------------h----
Confidence 7899999999999999999987765211 111111110000000 0
Q ss_pred ccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 272 ENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 272 ~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
..-.+...+++.+||+.||.+|||+.|+++||||...
T Consensus 235 ---~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 235 ---LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred ---hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhhh
Confidence 0012456789999999999999999999999999864
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.2e-28 Score=192.22 Aligned_cols=156 Identities=22% Similarity=0.280 Sum_probs=117.9
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCccccccCCccccccccccCC
Q 020826 111 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 190 (321)
Q Consensus 111 ~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~ 190 (321)
.+++..++.++.|++.||.|||+++ ||+||+++.++ .+++ ||++...... ...+++.|+|||++.+
T Consensus 13 ~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~-~~~~--fG~~~~~~~~----~~~g~~~y~aPE~~~~- 78 (176)
T smart00750 13 PLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDG-LLKL--DGSVAFKTPE----QSRVDPYFMAPEVIQG- 78 (176)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCcc-ceee--ccceEeeccc----cCCCcccccChHHhcC-
Confidence 4899999999999999999999998 99999999887 7888 9998765432 2367899999999987
Q ss_pred CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccc
Q 020826 191 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 270 (321)
Q Consensus 191 ~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
..++.++|||||||++|+|++|..||.........+..+........... .
T Consensus 79 ~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------------------~-------- 129 (176)
T smart00750 79 QSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRD---------------------R-------- 129 (176)
T ss_pred CCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccc---------------------c--------
Confidence 78899999999999999999999998533332222222222111110000 0
Q ss_pred cccccCCcc--hHHHHHHHhhccCCCCCcCHHHHhcCCCccc
Q 020826 271 VENQHLAVP--EAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 310 (321)
Q Consensus 271 ~~~~~~~s~--~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~ 310 (321)
.....+++ ++.+++.+||+.||.+|||+.++++|+|+..
T Consensus 130 -~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 130 -SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred -ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 00001222 6999999999999999999999999999864
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-27 Score=218.30 Aligned_cols=256 Identities=23% Similarity=0.322 Sum_probs=186.6
Q ss_pred EEeeeeeeecceEEEEEEEecCCceEEEEEec----ccc-h----HHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 24 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVK-K----KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 24 ~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~----~~~-~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
.....+|.|++|.|+.+......+....|.++ +.. . ..+..|.-+-..| .|||++..+..+.+.....
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l-~h~~~~e~l~~~~~~~~~~-- 397 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSL-SHPNIIETLDIVQEIDGIL-- 397 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccc-cCCchhhhHHHHhhcccch--
Confidence 45677999999988888876666656555543 111 1 1144555556666 8999988777765443333
Q ss_pred EEEEeecCchhhhhc-C--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc
Q 020826 95 LIFEHVNNTDFKVLY-P--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 171 (321)
Q Consensus 95 lv~e~~~~~~l~~~~-~--~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~ 171 (321)
-.||||++ +|..++ . .+...++..++.|++.|++|+|+.|+.|+|+|++|+++..++ .+||+|||.+........
T Consensus 398 ~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g-~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 398 QSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENG-ILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCC-ceEEeecCcceeeccCcc
Confidence 33999999 776665 3 589999999999999999999999999999999999999998 899999999877653333
Q ss_pred -----cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhc
Q 020826 172 -----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246 (321)
Q Consensus 172 -----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (321)
.....|+..|.|||++.+........||||.|+++..|.+|+.||-.......+....
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~----------------- 538 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN----------------- 538 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh-----------------
Confidence 2445788899999999985556677999999999999999999994332221111000
Q ss_pred ccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCC
Q 020826 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~ 313 (321)
....+..........-..++...+.+|.+||++||.+|.|+++|++.+||+.++.
T Consensus 539 ------------~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 539 ------------NYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred ------------ccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 0000000111111111235678999999999999999999999999999998754
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.2e-25 Score=190.29 Aligned_cols=164 Identities=18% Similarity=0.236 Sum_probs=128.1
Q ss_pred eeeecccCceEEeeeeeeecceEEEEEEEec-CCceEEEEEeccc--------chHHHHHHHHHHHhhcCCCCeee-eee
Q 020826 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCT-DNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVK-LLD 83 (321)
Q Consensus 14 ~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~-~~~~~~vK~~~~~--------~~~~~~~E~~~l~~l~~h~~i~~-~~~ 83 (321)
-.+....++|++.+.||+|+||+||+|.+.. +++.+|+|.+... ....+.+|+.+++.+ +|++++. +++
T Consensus 11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L-~h~~iv~~l~~ 89 (365)
T PRK09188 11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTV-RGIGVVPQLLA 89 (365)
T ss_pred cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhc-cCCCCCcEEEE
Confidence 3456678899999999999999999999876 6777899986422 234588999999999 8888874 543
Q ss_pred eeeccCCCCcEEEEEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecC-CCCCeEEcCCCCeEEEeeccc
Q 020826 84 IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDV-KPHNVMIDHEQRKLRLIDWGL 162 (321)
Q Consensus 84 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dl-kp~nili~~~~~~v~l~dfg~ 162 (321)
. ...++||||+.|++|.... ... ...++.|++.+|.|||++||+|||| ||+||+++.++ .++|+|||+
T Consensus 90 ~------~~~~LVmE~~~G~~L~~~~-~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~-~ikLiDFGl 158 (365)
T PRK09188 90 T------GKDGLVRGWTEGVPLHLAR-PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG-EAAVIDFQL 158 (365)
T ss_pred c------CCcEEEEEccCCCCHHHhC-ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC-CEEEEECcc
Confidence 2 2357999999999887432 211 2467899999999999999999999 99999998777 799999999
Q ss_pred eeecCCCCc---------cccccCCccccccccccC
Q 020826 163 AEFYHPGKE---------YNVRVASRYFKGPELLVD 189 (321)
Q Consensus 163 ~~~~~~~~~---------~~~~~~~~~y~aPE~~~~ 189 (321)
+........ .....++..|.|||.+..
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 986643321 123456677899998854
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.1e-24 Score=185.01 Aligned_cols=193 Identities=24% Similarity=0.326 Sum_probs=156.8
Q ss_pred ceEEeeeeeeecceEEEEEEEecCC-ceEEEEEecccch---HHHHHHHHHHHhhc---CCCCeeeeeeeeeccCCCCcE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDN-EKCIIKILKPVKK---KKIKREIKILQNLC---GGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~-~~~~vK~~~~~~~---~~~~~E~~~l~~l~---~h~~i~~~~~~~~~~~~~~~~ 94 (321)
+|.+.+.||+|+||.||.|.+..++ ..+|+|+...... ..+..|..++..+. ..+++..+++... ....+.+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~-~~~~~~~ 97 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR-STEDFNF 97 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc-CCCceeE
Confidence 8999999999999999999987664 6788998765422 26889999999985 2468899998874 3345667
Q ss_pred EEEEeecCchhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCC----CeEEEeecccee-
Q 020826 95 LIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ----RKLRLIDWGLAE- 164 (321)
Q Consensus 95 lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~----~~v~l~dfg~~~- 164 (321)
+||+.++.+. .++. +.++...+..++.|++.+|+++|+.|++||||||.|+++.... ..+.|.|||+++
T Consensus 98 iVM~l~G~sL-~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~ 176 (322)
T KOG1164|consen 98 IVMSLLGPSL-EDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR 176 (322)
T ss_pred EEEeccCccH-HHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence 8887776543 3333 4699999999999999999999999999999999999998653 479999999998
Q ss_pred -ecCCCC--------c-cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCc
Q 020826 165 -FYHPGK--------E-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 217 (321)
Q Consensus 165 -~~~~~~--------~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~ 217 (321)
...... . .....||..|.++.+..+ ...+.+.|+||++.++.+++.|..||.
T Consensus 177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~-~e~~r~DDles~~Y~l~el~~g~LPW~ 238 (322)
T KOG1164|consen 177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLG-IEQGRRDDLESLFYMLLELLKGSLPWE 238 (322)
T ss_pred ccccCCCCcccccCCCCccCCCCccccccHHHhCC-CccCCchhhhhHHHHHHHHhcCCCCCc
Confidence 321111 0 123459999999999988 788999999999999999999999984
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=5.1e-24 Score=166.81 Aligned_cols=194 Identities=22% Similarity=0.367 Sum_probs=161.4
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 98 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 98 (321)
..+|.++++||+|+||.+|.|.....|+.||||+-+... ..++..|..+.+.|+....|+.+..+. .+..+-.+||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~--~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYG--TEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhc--cccccceeeee
Confidence 578999999999999999999999999999999976543 357889999999997778888888887 44566679998
Q ss_pred eecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCC--CCeEEEeeccceeecCCCCc-
Q 020826 99 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAEFYHPGKE- 171 (321)
Q Consensus 99 ~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~--~~~v~l~dfg~~~~~~~~~~- 171 (321)
.++.. |+++. +.++...+.-++-|++.-++|+|.++++||||||+|++..-+ ...+.++|||+++.+.....
T Consensus 92 LLGPs-LEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~ 170 (341)
T KOG1163|consen 92 LLGPS-LEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTR 170 (341)
T ss_pred ccCcc-HHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcccccc
Confidence 87643 43333 569999999999999999999999999999999999999633 33789999999987643322
Q ss_pred -------cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCc
Q 020826 172 -------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 217 (321)
Q Consensus 172 -------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~ 217 (321)
.....||..|++-.+..+ ..-+.+.|+-|+|.++.++.-|..||.
T Consensus 171 ~HIpyre~r~ltGTaRYASinAh~g-~eqSRRDDmeSvgYvLmYfnrG~LPWQ 222 (341)
T KOG1163|consen 171 QHIPYREDRNLTGTARYASINAHLG-IEQSRRDDMESVGYVLMYFNRGSLPWQ 222 (341)
T ss_pred ccCccccCCccceeeeehhhhhhhh-hhhhhhhhhhhhcceeeeeecCCCccc
Confidence 234568889999888776 667889999999999999999999983
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-22 Score=174.60 Aligned_cols=256 Identities=32% Similarity=0.513 Sum_probs=194.1
Q ss_pred eEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCC-CeeeeeeeeeccCCCCcEE
Q 020826 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGP-NIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 23 y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~-~i~~~~~~~~~~~~~~~~l 95 (321)
|.+...||.|+|+.||.+.+. ..+++|.+.... ...+.+|...+..+ .|+ +++++.+.+... ...++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~-~~~~~i~~~~~~~~~~--~~~~~ 75 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASL-NHPPNIVKLYDFFQDE--GSLYL 75 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHc-cCCcceeeEEEEEecC--CEEEE
Confidence 788899999999999999986 788899886432 45578899999999 555 899999998433 33679
Q ss_pred EEEeecCchhhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 96 IFEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 96 v~e~~~~~~l~~~~~------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
+++++.++.+..+.. .+....+..++.|++.++.++|+.+++|+|+||+||+++..+..++++|||.+......
T Consensus 76 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~ 155 (384)
T COG0515 76 VMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP 155 (384)
T ss_pred EEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence 999999998886663 68899999999999999999999999999999999999977646999999998755433
Q ss_pred C-------ccccccCCccccccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCccCCCC--hHHHHHHHHHhCCh-h
Q 020826 170 K-------EYNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN--YDQLVKIAKVLGTD-E 237 (321)
Q Consensus 170 ~-------~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~-~ 237 (321)
. ......++..|++||...+. ...+...|+|++|++++++++|..||...... .............. .
T Consensus 156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (384)
T COG0515 156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSL 235 (384)
T ss_pred CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccc
Confidence 2 23566889999999999873 47889999999999999999999996433321 22222221211111 0
Q ss_pred hhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 238 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
.. ....... ......+.+++..++..+|..|.+..+...+++.....
T Consensus 236 ~~------------------------~~~~~~~----~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~~ 282 (384)
T COG0515 236 AS------------------------PLSPSNP----ELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLK 282 (384)
T ss_pred cc------------------------ccCcccc----chhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCcc
Confidence 00 0000000 11124789999999999999999999999887766543
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.5e-23 Score=173.76 Aligned_cols=235 Identities=19% Similarity=0.262 Sum_probs=141.6
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcC---------CCCeee
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCG---------GPNIVK 80 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~---------h~~i~~ 80 (321)
.+.....+...+.||.|+++.||.+++..+++.+++|++.... .+.+++|.-....+.. |-.++.
T Consensus 7 ~~~~~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~ 86 (288)
T PF14531_consen 7 LGQRPRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLV 86 (288)
T ss_dssp SS--EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B--
T ss_pred CCCCceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEe
Confidence 3445567788899999999999999999999999999975322 2344444433333211 222333
Q ss_pred eeeeeeccC------------CC---CcEEEEEeecCchhhhhc------CC----CCHHHHHHHHHHHHHHHHHHHHCC
Q 020826 81 LLDIVRDQQ------------SK---TPSLIFEHVNNTDFKVLY------PT----LSDYDVRYYIYELLKALDYCHSQG 135 (321)
Q Consensus 81 ~~~~~~~~~------------~~---~~~lv~e~~~~~~l~~~~------~~----~~~~~~~~i~~qi~~~l~~lh~~~ 135 (321)
.++....++ .. ..+++|+.+.+. |..+. .. +.......+..|++..+++||..|
T Consensus 87 P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~d-L~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G 165 (288)
T PF14531_consen 87 PLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRAQGD-LQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG 165 (288)
T ss_dssp -SEEEEETTS-SEEEECETTEEEEEESEEEEEE--SEE-HHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred eeEEEEEcCCCcceecCCCCccceeehhhhccchhhhc-HHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc
Confidence 333222111 11 235677766543 33332 11 122233456689999999999999
Q ss_pred CeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCccccccCCccccccccccCC-------CCCCCcchHHHHHHHHHH
Q 020826 136 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL-------QDYDYSLDLWSLGCMFAG 208 (321)
Q Consensus 136 i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~DvwslG~~l~~ 208 (321)
++|+||+|+|++++.+| .+.|+||+.......... ....+..|.+||..... ..++.+.|.|+||+++|.
T Consensus 166 lVHgdi~~~nfll~~~G-~v~Lg~F~~~~r~g~~~~--~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~ 242 (288)
T PF14531_consen 166 LVHGDIKPENFLLDQDG-GVFLGDFSSLVRAGTRYR--CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYS 242 (288)
T ss_dssp EEEST-SGGGEEE-TTS--EEE--GGGEEETTEEEE--GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHH
T ss_pred eEecccceeeEEEcCCC-CEEEcChHHHeecCceee--ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHH
Confidence 99999999999999998 899999998765432222 14455678999987442 246889999999999999
Q ss_pred HHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHh
Q 020826 209 MIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKL 288 (321)
Q Consensus 209 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~ 288 (321)
++++..||.-.... . .... .+ .... .+|+.++.||+.+
T Consensus 243 lWC~~lPf~~~~~~--~---------~~~~----------------------------~f--~~C~-~~Pe~v~~LI~~l 280 (288)
T PF14531_consen 243 LWCGRLPFGLSSPE--A---------DPEW----------------------------DF--SRCR-DMPEPVQFLIRGL 280 (288)
T ss_dssp HHHSS-STCCCGGG--S---------TSGG----------------------------GG--TTSS----HHHHHHHHHH
T ss_pred HHHccCCCCCCCcc--c---------cccc----------------------------cc--hhcC-CcCHHHHHHHHHH
Confidence 99999999311110 0 0000 00 1112 4667899999999
Q ss_pred hccCCCCC
Q 020826 289 LRYDHQER 296 (321)
Q Consensus 289 l~~dp~~R 296 (321)
|+.||++|
T Consensus 281 L~~~~~~R 288 (288)
T PF14531_consen 281 LQRNPEDR 288 (288)
T ss_dssp T-SSGGGS
T ss_pred ccCCcccC
Confidence 99999988
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-23 Score=167.32 Aligned_cols=171 Identities=14% Similarity=0.176 Sum_probs=130.4
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc---hH---H------HHHHHHHHHhhcCCCCeeeeeeee
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KK---K------IKREIKILQNLCGGPNIVKLLDIV 85 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~---~~---~------~~~E~~~l~~l~~h~~i~~~~~~~ 85 (321)
..+.+|++++.+|.|+||.||++.+ ++..+++|++++.. .. . +++|+..+.++ .||+|....+++
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL-~~~GI~~~~d~~ 104 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRV-RSEGLASLNDFY 104 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHH-HHCCCCcceEee
Confidence 3478999999999999999999655 46689999997432 11 1 57888899999 999999999886
Q ss_pred eccC------CCCcEEEEEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEee
Q 020826 86 RDQQ------SKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLID 159 (321)
Q Consensus 86 ~~~~------~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~d 159 (321)
.... ....+++|||++|.+|.+.. .+++ ....+++.++..+|+.|++|+|++|.||+++.++ ++|+|
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g--i~liD 177 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELNDMP-EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG--LRIID 177 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHHHhh-hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC--EEEEE
Confidence 5432 23468999999999998773 2333 3456999999999999999999999999998776 99999
Q ss_pred ccceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHH
Q 020826 160 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI 210 (321)
Q Consensus 160 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~ 210 (321)
||........... ..+... ..+..++|+||||+++..+.
T Consensus 178 fg~~~~~~e~~a~-----------d~~vle-r~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQRKAK-----------DRIDLE-RHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccchhhH-----------HHHHHH-hHhcccccccceeEeehHHH
Confidence 9987644211111 112333 45667999999999876543
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-22 Score=164.20 Aligned_cols=218 Identities=21% Similarity=0.333 Sum_probs=174.0
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEec-ccchHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 98 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 98 (321)
.-.|++.++||+|.||.++.|++.-+++.||||.-. +.+.-++..|...++.|...+.|+.++-+. +...+-.+|+|
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG--qeG~~NiLVid 104 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG--QEGKYNILVID 104 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec--cccchhhhhhh
Confidence 557999999999999999999999999999999864 345578899999999998899999999877 55667778998
Q ss_pred eecCc--hhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCC----CCeEEEeeccceeecCCCCc
Q 020826 99 HVNNT--DFKVLY-PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----QRKLRLIDWGLAEFYHPGKE 171 (321)
Q Consensus 99 ~~~~~--~l~~~~-~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~----~~~v~l~dfg~~~~~~~~~~ 171 (321)
.++-. +|.++- +.|+...+.-++.|++.-++++|++++++|||||+|+||..- ...+.++|||+++.+.....
T Consensus 105 LLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T 184 (449)
T KOG1165|consen 105 LLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT 184 (449)
T ss_pred hhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence 87643 344444 569999999999999999999999999999999999999532 23789999999987754332
Q ss_pred --------cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCcc--CCCChHHHHHHHHHhCChhhhH
Q 020826 172 --------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY--GHDNYDQLVKIAKVLGTDELNA 240 (321)
Q Consensus 172 --------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~--~~~~~~~~~~~~~~~~~~~~~~ 240 (321)
.....||.+||+=...++ ..-+.+.|+-|||=++.+.+-|.+||-. ...+.+.-+.|.+.-....+..
T Consensus 185 kqHIPYrE~KSLsGTARYMSINTHlG-rEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~ 262 (449)
T KOG1165|consen 185 KQHIPYREHKSLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEV 262 (449)
T ss_pred cccCccccccccccceeeeEeecccc-chhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHH
Confidence 234578999999998888 7889999999999999999999999932 2233344444443333333333
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-24 Score=198.49 Aligned_cols=244 Identities=19% Similarity=0.356 Sum_probs=167.0
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHH-HhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKIL-QNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l-~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
.+|...+.||++.|=+|.+|++ ..|. +++|++-+.. ...+.+++.-. ..+.++||++.+..+... ....++
T Consensus 23 ~e~~~~~~LGstRFlKv~r~k~-~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t--~kAAyl 98 (1431)
T KOG1240|consen 23 VECHYVENLGSTRFLKVARAKD-REGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVT--DKAAYL 98 (1431)
T ss_pred cceeeecccCchhhhhhhhccC-CCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHh--hHHHHH
Confidence 3788899999999999999998 4454 8899974332 23333333222 233489999999887533 344457
Q ss_pred EEEeecCchhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC-C---C
Q 020826 96 IFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-P---G 169 (321)
Q Consensus 96 v~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~-~---~ 169 (321)
|-+|...+..+.+- +.+...+.+.|+.|++.||..+|..||+|||||.+||++..-+ -+.|+||...+... + +
T Consensus 99 vRqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWN-W~~LtDFAsFKPtYLPeDNP 177 (1431)
T KOG1240|consen 99 VRQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWN-WLYLTDFASFKPTYLPEDNP 177 (1431)
T ss_pred HHHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeec-hhhhhcccccCCccCCCCCc
Confidence 77777655433332 3478889999999999999999999999999999999999777 69999999775432 1 1
Q ss_pred Ccc----ccccCCccccccccccCCC---------C-CCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCC
Q 020826 170 KEY----NVRVASRYFKGPELLVDLQ---------D-YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 235 (321)
Q Consensus 170 ~~~----~~~~~~~~y~aPE~~~~~~---------~-~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (321)
... .+..-..+|.|||.+.... . .+++.||||+||+++|+++.+.|.|. ..++-...... .
T Consensus 178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~----LSQL~aYr~~~-~ 252 (1431)
T KOG1240|consen 178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT----LSQLLAYRSGN-A 252 (1431)
T ss_pred ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc----HHHHHhHhccC-c
Confidence 111 2223344699999986522 1 56899999999999999986555431 11111111000 1
Q ss_pred hhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 236 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
..... ..+.+ -++.++++|..|++.||++|.||++.|+-
T Consensus 253 ~~~e~--------------------------~Le~I-----ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 253 DDPEQ--------------------------LLEKI-----EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred cCHHH--------------------------HHHhC-----cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 10000 01111 12479999999999999999999999975
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2e-24 Score=190.33 Aligned_cols=234 Identities=26% Similarity=0.372 Sum_probs=185.4
Q ss_pred eeeecceEEEEEEEe---cCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEee
Q 020826 29 VGRGKYSEVFEGVHC---TDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV 100 (321)
Q Consensus 29 lg~g~~g~v~~~~~~---~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~ 100 (321)
+|+|++|.|++++.. ..+..+++|++++.. +.....|..++....+||.++++...++.+...+ ++.++.
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~--l~ld~~ 79 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLY--LILDFL 79 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchh--Hhhhhc
Confidence 689999999987543 346678888876421 2245567788888867999999999986655544 999999
Q ss_pred cCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCccccccC
Q 020826 101 NNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA 177 (321)
Q Consensus 101 ~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~~~~~~ 177 (321)
.++.+..... .+.+.....+...++.+++++|+.+++|+|+|++||+++.+| .+++.|||.++..-.... .+|
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~G-hi~~tdfglske~v~~~~---~cg 155 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEG-HIKLTDFGLSKEAVKEKI---ACG 155 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccC-ccccCCchhhhHhHhhhh---ccc
Confidence 9988766653 377888888999999999999999999999999999999999 899999999976543322 288
Q ss_pred CccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHH-HhCChhhhHHhhhhcccCChhhHhh
Q 020826 178 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK-VLGTDELNAYLNKYHIELDPHLAAL 256 (321)
Q Consensus 178 ~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (321)
|..|+|||+..+ ...+.|-||+|++.+++++|..||.. +....|.+ .++
T Consensus 156 t~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~-----~~~~~Il~~~~~---------------------- 205 (612)
T KOG0603|consen 156 TYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG-----DTMKRILKAELE---------------------- 205 (612)
T ss_pred chhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch-----HHHHHHhhhccC----------------------
Confidence 999999999973 45789999999999999999999943 33333322 111
Q ss_pred hcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC-----HHHHhcCCCcccCCCc
Q 020826 257 VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPIRNA 314 (321)
Q Consensus 257 ~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps-----~~ell~hp~~~~~~~~ 314 (321)
.+..++..+++++..++..+|..|.- +.|+.+|+||+.++-.
T Consensus 206 ----------------~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 206 ----------------MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred ----------------CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 22245578999999999999999974 4799999999987655
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-22 Score=158.03 Aligned_cols=184 Identities=17% Similarity=0.140 Sum_probs=139.4
Q ss_pred EEeeeeeeecceEEEEEEEecCCceEEEEEecccch-------HHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 24 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-------KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 24 ~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~-------~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
.+...|++|+||+|+.+.. .+.+++.+.+..... ..+.+|+++|++|.+++++++++++. ..+++
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------~~~lv 76 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD------GRHLD 76 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc------CEEEE
Confidence 3567899999999997664 677888777654332 25789999999997778899998862 23699
Q ss_pred EEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecC-CCCCeEEcCCCCeEEEeeccceeecCCCCcc---
Q 020826 97 FEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDV-KPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY--- 172 (321)
Q Consensus 97 ~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dl-kp~nili~~~~~~v~l~dfg~~~~~~~~~~~--- 172 (321)
|+|+.|.+|...... ....++.|++.+|+++|++|++|+|| ||+||+++.++ .++|+|||++.........
T Consensus 77 meyI~G~~L~~~~~~----~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g-~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 77 RSYLAGAAMYQRPPR----GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDG-SPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred EeeecCccHHhhhhh----hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCC-CEEEEECCCceecCCcchHHHH
Confidence 999999988654322 12357889999999999999999999 79999999777 7999999999865543321
Q ss_pred -----------ccccCCccccccccccCCCCCC-CcchHHHHHHHHHHHHhCCCCCccCC
Q 020826 173 -----------NVRVASRYFKGPELLVDLQDYD-YSLDLWSLGCMFAGMIFRKEPFFYGH 220 (321)
Q Consensus 173 -----------~~~~~~~~y~aPE~~~~~~~~~-~~~DvwslG~~l~~l~~g~~p~~~~~ 220 (321)
.....++.+++|+...-....+ .+.+-++.|+.+|.++|++.+.+.+.
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0123466677777654333444 56778889999999999999886543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.9e-23 Score=191.68 Aligned_cols=204 Identities=20% Similarity=0.356 Sum_probs=167.1
Q ss_pred EEEEeeeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhc--CCCCeeeeeeee
Q 020826 8 VIYWCVWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLC--GGPNIVKLLDIV 85 (321)
Q Consensus 8 ~~~~~~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~--~h~~i~~~~~~~ 85 (321)
...-+.+.+.-.++.|.|.+.+|+|+||+||.|...+ ++.+|+|+-++.....+.-=.+++.+|. --+-|..+....
T Consensus 685 ~~l~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~ 763 (974)
T KOG1166|consen 685 PKLNPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAH 763 (974)
T ss_pred cccCccceeeecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHH
Confidence 3344677888889999999999999999999999955 9999999999888777776667777772 113344444444
Q ss_pred eccCCCCcEEEEEeecCchhhhhcCC---CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEc------CCCCeEE
Q 020826 86 RDQQSKTPSLIFEHVNNTDFKVLYPT---LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID------HEQRKLR 156 (321)
Q Consensus 86 ~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~------~~~~~v~ 156 (321)
.-.+.. ++|++|.+.|+|.+++.. +++..+..+..|++..++.||.++|+||||||+|.++. .+...++
T Consensus 764 ~~~~~S--~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 764 VFQNAS--VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred ccCCcc--eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceE
Confidence 334444 499999999999888853 88999999999999999999999999999999999993 3334689
Q ss_pred Eeecccee---ecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCC
Q 020826 157 LIDWGLAE---FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEP 215 (321)
Q Consensus 157 l~dfg~~~---~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p 215 (321)
|+|||.+. .+.++.......+|..+-.+|...| ..|+++.|.|.|+.+++-|+.|+..
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~g-rpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREG-RPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcC-CCCchhhhhHHHHHHHHHHHHHHHH
Confidence 99999874 3455556677788999999999988 8999999999999999999999753
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-22 Score=159.01 Aligned_cols=133 Identities=20% Similarity=0.262 Sum_probs=103.4
Q ss_pred eeeeeeecceEEEEEEEecCCceEEEEEecccch-----------------------------HHHHHHHHHHHhhcCCC
Q 020826 26 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-----------------------------KKIKREIKILQNLCGGP 76 (321)
Q Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~-----------------------------~~~~~E~~~l~~l~~h~ 76 (321)
.+.||+|++|.||+|.+. +|+.||+|+++.... .....|...+.++ .++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL-VTA 79 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH-HHC
Confidence 467999999999999996 899999999875421 1123488999998 566
Q ss_pred CeeeeeeeeeccCCCCcEEEEEeecCchhhhh-c--CCCCHHHHHHHHHHHHHHHHHH-HHCCCeeecCCCCCeEEcCCC
Q 020826 77 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-Y--PTLSDYDVRYYIYELLKALDYC-HSQGIMHRDVKPHNVMIDHEQ 152 (321)
Q Consensus 77 ~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~-~--~~~~~~~~~~i~~qi~~~l~~l-h~~~i~H~dlkp~nili~~~~ 152 (321)
++.....+.. .. .++||||++++++... . ..++...+..++.|++.+|.++ |+.|++|+||||+||+++ ++
T Consensus 80 ~v~~p~~~~~--~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~ 154 (190)
T cd05147 80 GIPCPEPILL--KS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DG 154 (190)
T ss_pred CCCCCcEEEe--cC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CC
Confidence 5533222211 11 2699999998766433 2 4688899999999999999999 799999999999999998 45
Q ss_pred CeEEEeeccceeec
Q 020826 153 RKLRLIDWGLAEFY 166 (321)
Q Consensus 153 ~~v~l~dfg~~~~~ 166 (321)
.++|+|||++...
T Consensus 155 -~v~LiDFG~a~~~ 167 (190)
T cd05147 155 -KLYIIDVSQSVEH 167 (190)
T ss_pred -cEEEEEccccccC
Confidence 7999999998753
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.4e-21 Score=154.09 Aligned_cols=134 Identities=17% Similarity=0.214 Sum_probs=105.4
Q ss_pred eeeeeeecceEEEEEEEecCCceEEEEEecccch-----------------------------HHHHHHHHHHHhhcCCC
Q 020826 26 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-----------------------------KKIKREIKILQNLCGGP 76 (321)
Q Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~-----------------------------~~~~~E~~~l~~l~~h~ 76 (321)
.+.||+|++|+||+|.+. +|+.||+|+++.... .....|...+.++ .++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~ 79 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRL-YEA 79 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHH-HhC
Confidence 567999999999999986 899999999875321 1235788889888 677
Q ss_pred CeeeeeeeeeccCCCCcEEEEEeecCchhhhh-c--CCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCeEEcCCC
Q 020826 77 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-Y--PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQ 152 (321)
Q Consensus 77 ~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~-~--~~~~~~~~~~i~~qi~~~l~~lh~-~~i~H~dlkp~nili~~~~ 152 (321)
++.....+... ..++||||++++++... . ..++...+..++.|++.++.++|. .|++|+||||+||+++ ++
T Consensus 80 ~i~~p~~~~~~----~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 80 GVPVPEPILLK----KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCCCceEEEec----CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC
Confidence 76443333221 13699999998754222 2 347788899999999999999999 9999999999999998 55
Q ss_pred CeEEEeeccceeecC
Q 020826 153 RKLRLIDWGLAEFYH 167 (321)
Q Consensus 153 ~~v~l~dfg~~~~~~ 167 (321)
.++|+|||++....
T Consensus 155 -~~~liDFG~a~~~~ 168 (190)
T cd05145 155 -KPYIIDVSQAVELD 168 (190)
T ss_pred -CEEEEEcccceecC
Confidence 79999999997643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4e-22 Score=159.03 Aligned_cols=236 Identities=17% Similarity=0.226 Sum_probs=174.3
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
-.+..++-+|.+...|..|+|+++ |..+++|+++.. ....+..|.-.++.+ .||||+.+++.+.. ...+.
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrif-shpnilpvlgacns--ppnlv 263 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIF-SHPNILPVLGACNS--PPNLV 263 (448)
T ss_pred hhhhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeee-cCCchhhhhhhccC--CCCce
Confidence 345566778899999999999994 455666766532 345688899999988 99999999999944 46778
Q ss_pred EEEEeecCchhhhhcCC-----CCHHHHHHHHHHHHHHHHHHHHCC--CeeecCCCCCeEEcCCCCeEEE--eeccceee
Q 020826 95 LIFEHVNNTDFKVLYPT-----LSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRL--IDWGLAEF 165 (321)
Q Consensus 95 lv~e~~~~~~l~~~~~~-----~~~~~~~~i~~qi~~~l~~lh~~~--i~H~dlkp~nili~~~~~~v~l--~dfg~~~~ 165 (321)
++..|++.++|...+.. .+..++.+++.++++|++|||+.. |.---|+...+++|.+- +.+| +|-.++.
T Consensus 264 ~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-tarismad~kfsf- 341 (448)
T KOG0195|consen 264 IISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-TARISMADTKFSF- 341 (448)
T ss_pred EeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-hhheecccceeee-
Confidence 99999999999888853 678889999999999999999875 33446888899998664 4443 3433221
Q ss_pred cCCCCccccccCCccccccccccCCCC--CCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 166 YHPGKEYNVRVASRYFKGPELLVDLQD--YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
........+.|++||.+..... .-.++|+|||++++||+.|...||. +-++.+.-..+.
T Consensus 342 -----qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfa-dlspmecgmkia------------- 402 (448)
T KOG0195|consen 342 -----QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFA-DLSPMECGMKIA------------- 402 (448)
T ss_pred -----eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccc-cCCchhhhhhhh-------------
Confidence 1233456788999999966322 2357999999999999999999993 333322211111
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHh
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 303 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell 303 (321)
-+-+...++..+|+....|+.-|+..||.+||.++.++
T Consensus 403 ----------------------leglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 403 ----------------------LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred ----------------------hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 11123344556778999999999999999999987654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-21 Score=181.41 Aligned_cols=230 Identities=24% Similarity=0.355 Sum_probs=162.5
Q ss_pred eeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 14 ~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
|.-.....+|..++.+..|++|-||.++++.+.+.+|+|.-+ ...+.+- ++... ..|.+|
T Consensus 76 s~~~p~e~df~~IklisngAygavylvrh~~trqrfa~kiNk---q~lilRn--ilt~a-~npfvv-------------- 135 (1205)
T KOG0606|consen 76 SRRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINK---QNLILRN--ILTFA-GNPFVV-------------- 135 (1205)
T ss_pred cccCCCccccceeEeeccCCCCceeeeeccccccchhhcccc---cchhhhc--ccccc-CCccee--------------
Confidence 344566789999999999999999999999899999985422 1111111 12111 333333
Q ss_pred EEEEEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc--
Q 020826 94 SLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-- 171 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~-- 171 (321)
....++...++.++... +.+++|+|.-||+|+|+||+|.+|..-| .+|++|||+++.......
T Consensus 136 ------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mG-hiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 ------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMG-HIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred ------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecc-cccccchhhhhhhhhhccch
Confidence 11112222223344333 6789999999999999999999999888 899999999865421111
Q ss_pred --------------cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChh
Q 020826 172 --------------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 237 (321)
Q Consensus 172 --------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (321)
....+||+.|.|||+..- ..|....|.|+||+++|+.+-|+.||+.+. ..+.+..++....
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr-qgygkpvdwwamGiIlyeFLVgcvpffGdt-peelfg~visd~i--- 275 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR-QGYGKPVDWWAMGIILYEFLVGCVPFFGDT-PEELFGQVISDDI--- 275 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhh-hccCCCccHHHHHHHHHHHheeeeeccCCC-HHHHHhhhhhhhc---
Confidence 012379999999999987 789999999999999999999999996433 2333332221111
Q ss_pred hhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCC---cCHHHHhcCCCcccCCCc
Q 020826 238 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER---PTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~R---ps~~ell~hp~~~~~~~~ 314 (321)
+-.+.+..++++++++|.++|+.+|..| +.+-++.+|+||+.++-.
T Consensus 276 -------------------------------~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 276 -------------------------------EWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred -------------------------------cccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 1111233466899999999999999999 457799999999988654
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=156.99 Aligned_cols=205 Identities=19% Similarity=0.252 Sum_probs=138.9
Q ss_pred cCCCCeeeeeeeeeccC-------------------------CCCcEEEEEeecCchhhhhc--CCCCHHHHHHHHHHHH
Q 020826 73 CGGPNIVKLLDIVRDQQ-------------------------SKTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELL 125 (321)
Q Consensus 73 ~~h~~i~~~~~~~~~~~-------------------------~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~ 125 (321)
..||||+.+.+.|.++- ...+++||..+.. +|.+++ +..+.....-++.|++
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlL 351 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLL 351 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHH
Confidence 47999999999775532 2345666655543 455454 3467777888999999
Q ss_pred HHHHHHHHCCCeeecCCCCCeEEcCCC---CeEEEeeccceeecCC-------CCccccccCCccccccccccCCCC---
Q 020826 126 KALDYCHSQGIMHRDVKPHNVMIDHEQ---RKLRLIDWGLAEFYHP-------GKEYNVRVASRYFKGPELLVDLQD--- 192 (321)
Q Consensus 126 ~~l~~lh~~~i~H~dlkp~nili~~~~---~~v~l~dfg~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~~~~--- 192 (321)
+|+.|||++|++|+|+|.+||++.-++ ..+.++|||++-.... ........|....+|||+......
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 999999999999999999999995332 3678999998743221 112233456667899999855222
Q ss_pred --CCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccc
Q 020826 193 --YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 270 (321)
Q Consensus 193 --~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
.-.++|.|+.|.+.||+++...||+....-.. ... .+.+...
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L---------~~r---------------------------~Yqe~qL 475 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL---------DTR---------------------------TYQESQL 475 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchhee---------chh---------------------------hhhhhhC
Confidence 12589999999999999999999964211000 000 0011111
Q ss_pred cccccCCcchHHHHHHHhhccCCCCCcCHH---HHhc------CCCcccCCCc
Q 020826 271 VENQHLAVPEAVDFLDKLLRYDHQERPTAK---EAMA------HPYFFPIRNA 314 (321)
Q Consensus 271 ~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~---ell~------hp~~~~~~~~ 314 (321)
-..++.+++.+++++..+|+.||++|+|+. .+++ |.|+++..+.
T Consensus 476 Palp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~LsLw~~~~~vka~~~~ 528 (598)
T KOG4158|consen 476 PALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLNLSLWRMGEDVKAMMEK 528 (598)
T ss_pred CCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHHHHHhcCchHHHHhccc
Confidence 223345778999999999999999999854 4443 4555554443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=146.10 Aligned_cols=134 Identities=19% Similarity=0.241 Sum_probs=102.7
Q ss_pred EeeeeeeecceEEEEEEEecCCceEEEEEeccc---chHHHHHHHHHHHhhc----CCCCeeeeeeeeeccCC-CC-cEE
Q 020826 25 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLC----GGPNIVKLLDIVRDQQS-KT-PSL 95 (321)
Q Consensus 25 ~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~---~~~~~~~E~~~l~~l~----~h~~i~~~~~~~~~~~~-~~-~~l 95 (321)
-...||+|++|.||. +..++.. +||++... ..+.+.+|+.+++.+. .||||+++++++..... .. ..+
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 356799999999995 6556655 68987654 4567899999999994 47999999999976532 22 337
Q ss_pred EEEe--ecCchhhhhcCC--CCHHHHHHHHHHHHHHH-HHHHHCCCeeecCCCCCeEEcCC---CCeEEEeeccce
Q 020826 96 IFEH--VNNTDFKVLYPT--LSDYDVRYYIYELLKAL-DYCHSQGIMHRDVKPHNVMIDHE---QRKLRLIDWGLA 163 (321)
Q Consensus 96 v~e~--~~~~~l~~~~~~--~~~~~~~~i~~qi~~~l-~~lh~~~i~H~dlkp~nili~~~---~~~v~l~dfg~~ 163 (321)
|+|| +.+++|.+++.. +++. ..++.|++.++ +|||+++|+|+||||+||+++.. ...++|+|++.+
T Consensus 83 I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 8999 447899888853 4444 45678888777 99999999999999999999742 227999994433
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.7e-19 Score=147.36 Aligned_cols=138 Identities=15% Similarity=0.190 Sum_probs=108.6
Q ss_pred cCceEEeeeeeeecceEEEEEE-EecCCceEEEEEecccch---------------------------HHHHHHHHHHHh
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGV-HCTDNEKCIIKILKPVKK---------------------------KKIKREIKILQN 71 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~-~~~~~~~~~vK~~~~~~~---------------------------~~~~~E~~~l~~ 71 (321)
..-|++.+.||+|++|.||+|. +..+|+.||+|+++.... ..+..|...+.+
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3458889999999999999999 667899999999874320 225689999999
Q ss_pred hcC-CCCeeeeeeeeeccCCCCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CeeecCCCCCe
Q 020826 72 LCG-GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQG-IMHRDVKPHNV 146 (321)
Q Consensus 72 l~~-h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~-i~H~dlkp~ni 146 (321)
+.. ...++++++.. ..++|||++++.++.... ..+....+..++.|++.++.+||+.| ++|+||||+||
T Consensus 107 L~~~~i~~p~~~~~~------~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NI 180 (237)
T smart00090 107 LYEAGVPVPKPIAWR------RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNI 180 (237)
T ss_pred HHhcCCCCCeeeEec------CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhE
Confidence 832 23345555431 136999999998875543 23555667899999999999999999 99999999999
Q ss_pred EEcCCCCeEEEeeccceee
Q 020826 147 MIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 147 li~~~~~~v~l~dfg~~~~ 165 (321)
+++ ++ .++|+|||.+..
T Consensus 181 li~-~~-~i~LiDFg~a~~ 197 (237)
T smart00090 181 LVH-DG-KVVIIDVSQSVE 197 (237)
T ss_pred EEE-CC-CEEEEEChhhhc
Confidence 998 55 799999998864
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.9e-20 Score=161.20 Aligned_cols=175 Identities=22% Similarity=0.369 Sum_probs=133.3
Q ss_pred CCcEEEEEeecCchhhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecccee
Q 020826 91 KTPSLIFEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 164 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~ 164 (321)
.+++|.|++|...+|.+++. ..+......++.|++.|++| +|.+|+|+||.||++..++ .++|.|||+.+
T Consensus 329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~-q~kIgDFgl~t 404 (516)
T KOG1033|consen 329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD-QLKIGDFGLVT 404 (516)
T ss_pred cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch-hhhhhhhhhee
Confidence 46889999999999999984 26677788999999999999 9999999999999998777 89999999987
Q ss_pred ecCCCC-------ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChh
Q 020826 165 FYHPGK-------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 237 (321)
Q Consensus 165 ~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (321)
...... ..+...+|.+|++||.+.+ ..++.++||||||++++|+++ +|.........+..+....-++.
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g-~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~d~r~g~ip~~ 480 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRG-QQYSEKVDIYALGLILAELLI---QFSTQFERIATLTDIRDGIIPPE 480 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhh-hhhhhhcchhhHHHHHHHHHH---HhccHHHHHHhhhhhhcCCCChH
Confidence 654433 4566789999999999998 899999999999999999986 23111111111111111000000
Q ss_pred hhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcc
Q 020826 238 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF 309 (321)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~ 309 (321)
.+. =-|+-..|+++||...|++||++.+.-.|+|.+
T Consensus 481 --~~~----------------------------------d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 481 --FLQ----------------------------------DYPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred --Hhh----------------------------------cCcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 000 004677999999999999999999888888764
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=4.5e-18 Score=138.65 Aligned_cols=131 Identities=24% Similarity=0.365 Sum_probs=106.6
Q ss_pred eeeeeecceEEEEEEEecCCceEEEEEecccc-----------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 27 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
+.||+|++|.||+|.+ ++..+++|+..... ...+.+|+..+..+ .+++++....++.+.. ..++
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~--~~~l 76 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRA-RKAGVNVPAVYFVDPE--NFII 76 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHH-HHCCCCCCeEEEEeCC--CCEE
Confidence 5689999999999987 67789999865321 13467899999998 7777766555554333 4569
Q ss_pred EEEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 96 IFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 96 v~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
+|||++|.+|.+.+..... ....++.+++.+|.++|+.|++|+|++|.||+++ ++ .++++|||.+..
T Consensus 77 v~e~~~G~~L~~~~~~~~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~-~~~liDf~~a~~ 143 (211)
T PRK14879 77 VMEYIEGEPLKDLINSNGM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GG-KIYLIDFGLAEF 143 (211)
T ss_pred EEEEeCCcCHHHHHHhccH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CC-CEEEEECCcccC
Confidence 9999999999888765444 7889999999999999999999999999999998 55 799999998864
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.9e-18 Score=152.51 Aligned_cols=203 Identities=20% Similarity=0.292 Sum_probs=146.8
Q ss_pred HhhcCCCCeeeeeeeeeccCCCCcEEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCC-eeecCCCC
Q 020826 70 QNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGI-MHRDVKPH 144 (321)
Q Consensus 70 ~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i-~H~dlkp~ 144 (321)
+.+ .|.|+.++++.+.+. ...+.|.++|..++|.+.+. .++......++++|+.||+|+|..-+ .|+.++..
T Consensus 2 ~~l-~h~n~~~f~g~~~~~--~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~ 78 (484)
T KOG1023|consen 2 RQL-DHDNLNKFIGASVDG--PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS 78 (484)
T ss_pred ccc-chhhhhhheeeEecC--CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence 445 799999999999776 56679999999999988884 37777888899999999999998765 99999999
Q ss_pred CeEEcCCCCeEEEeeccceeecCCC---CccccccCCccccccccccCCC---C---CCCcchHHHHHHHHHHHHhCCCC
Q 020826 145 NVMIDHEQRKLRLIDWGLAEFYHPG---KEYNVRVASRYFKGPELLVDLQ---D---YDYSLDLWSLGCMFAGMIFRKEP 215 (321)
Q Consensus 145 nili~~~~~~v~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~---~---~~~~~DvwslG~~l~~l~~g~~p 215 (321)
|.+++..- .+||+|||+....... ...........|.|||.+.+.. . .+.+.|+||+|++++|+++...|
T Consensus 79 nClvd~~w-~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 79 NCLVDSRW-VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred cceeeeeE-EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99999777 8999999998765321 1112222345699999997631 1 46779999999999999999999
Q ss_pred CccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCC
Q 020826 216 FFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE 295 (321)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~ 295 (321)
|......... .++...+.... .....|..... ..+.+++..+++.||..+|++
T Consensus 158 ~~~~~~~~~~-~eii~~~~~~~---------------------~~~~rP~i~~~-----~e~~~~l~~l~~~cw~e~P~~ 210 (484)
T KOG1023|consen 158 FDLRNLVEDP-DEIILRVKKGG---------------------SNPFRPSIELL-----NELPPELLLLVARCWEEIPEK 210 (484)
T ss_pred cccccccCCh-HHHHHHHHhcC---------------------CCCcCcchhhh-----hhcchHHHHHHHHhcccChhh
Confidence 9765444433 22111100000 00000000000 023457999999999999999
Q ss_pred CcCHHHHh
Q 020826 296 RPTAKEAM 303 (321)
Q Consensus 296 Rps~~ell 303 (321)
||+++.+-
T Consensus 211 rPs~~~i~ 218 (484)
T KOG1023|consen 211 RPSIEQIR 218 (484)
T ss_pred CccHHHHH
Confidence 99998664
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=9.5e-18 Score=135.22 Aligned_cols=134 Identities=19% Similarity=0.327 Sum_probs=105.5
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-------------------------hHHHHHHHHHHHhhcCC
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-------------------------KKKIKREIKILQNLCGG 75 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-------------------------~~~~~~E~~~l~~l~~h 75 (321)
..|.+.+.||+|+||.||++.. .+++.++||+++... ......|...+..+ .+
T Consensus 15 ~~~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~ 92 (198)
T cd05144 15 VVESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKAL-YE 92 (198)
T ss_pred chhhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHH-HH
Confidence 3588889999999999999987 479999999865321 11256788888888 55
Q ss_pred C--CeeeeeeeeeccCCCCcEEEEEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCC
Q 020826 76 P--NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 153 (321)
Q Consensus 76 ~--~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~ 153 (321)
+ .++..++. ...+++|||+.+.++...... .....++.+++.++.++|+.|++|+||+|.||+++.++
T Consensus 93 ~~i~v~~~~~~------~~~~lv~e~~~g~~L~~~~~~---~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~- 162 (198)
T cd05144 93 EGFPVPKPIDW------NRHAVVMEYIDGVELYRVRVL---EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE- 162 (198)
T ss_pred cCCCCCceeec------CCceEEEEEeCCcchhhcccc---ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC-
Confidence 5 44444432 223799999999988765432 44567889999999999999999999999999999877
Q ss_pred eEEEeeccceeec
Q 020826 154 KLRLIDWGLAEFY 166 (321)
Q Consensus 154 ~v~l~dfg~~~~~ 166 (321)
.++|+|||.+...
T Consensus 163 ~~~liDfg~~~~~ 175 (198)
T cd05144 163 KIYIIDWPQMVST 175 (198)
T ss_pred cEEEEECCccccC
Confidence 8999999998544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.7e-17 Score=131.39 Aligned_cols=127 Identities=20% Similarity=0.372 Sum_probs=97.4
Q ss_pred eeeeecceEEEEEEEecCCceEEEEEecccc-----------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 28 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 28 ~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
.||+|++|+||+|.. ++..+++|...... ...+.+|+.++..+ .++++.....+..+.. ..+++
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~~--~~~lv 75 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRA-RKAGVNTPVVYDVDPD--NKTIV 75 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHH-HHCCCCCCEEEEEECC--CCEEE
Confidence 379999999999985 66789999854311 24467899999998 5554433332332232 34699
Q ss_pred EEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 97 FEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 97 ~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
||+++|.++......... .++.+++.+|.++|+.|++|+|++|.||+++ ++ .++++|||.+..
T Consensus 76 ~e~~~g~~l~~~~~~~~~----~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~-~~~liDfg~a~~ 138 (199)
T TIGR03724 76 MEYIEGKPLKDVIEEGND----ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DD-KLYLIDFGLGKY 138 (199)
T ss_pred EEEECCccHHHHHhhcHH----HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CC-cEEEEECCCCcC
Confidence 999999998877543221 7899999999999999999999999999998 55 799999998865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.71 E-value=8.9e-17 Score=148.43 Aligned_cols=132 Identities=18% Similarity=0.324 Sum_probs=102.9
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEe--ccc---------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL--KPV---------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~--~~~---------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
.|...+.||+|+||+||++.+... .+++|+. +.. ....+.+|+.+++.+ +|++++....+..+.
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~p~~~~~~~-- 408 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEA-RRAGVPTPVIYDVDP-- 408 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhh-cccCCCeeEEEEEeC--
Confidence 346678999999999999987433 3333332 110 124577899999999 888887766655443
Q ss_pred CCcEEEEEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 91 KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
...+++|||+++++|.+++. ....++.+++.+|.+||+.|++||||||+||+++ ++ .++|+|||++..
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~-----~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl~-~~-~~~liDFGla~~ 476 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE-----GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIVR-DD-RLYLIDFGLGKY 476 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH-----HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEEE-CC-cEEEEeCccccc
Confidence 33569999999999987764 4577899999999999999999999999999994 55 799999999865
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.2e-18 Score=160.57 Aligned_cols=257 Identities=21% Similarity=0.337 Sum_probs=193.5
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecC-CceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTD-NEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~-~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
....|.+.+.||+|.++.|-......+ ...++.|.+.... ...+..|..+-..+.+|+|++.+++...+ ..+
T Consensus 18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~--~~~ 95 (601)
T KOG0590|consen 18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS--PRS 95 (601)
T ss_pred ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC--Ccc
Confidence 367889999999999999998877443 3456666654322 23455677777777559999999998844 455
Q ss_pred cEEEEEeecCchhhhhc-C----CCCHHHHHHHHHHHHHHHHHHH-HCCCeeecCCCCCeEEcCCCCeEEEeeccceeec
Q 020826 93 PSLIFEHVNNTDFKVLY-P----TLSDYDVRYYIYELLKALDYCH-SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 166 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~-~----~~~~~~~~~i~~qi~~~l~~lh-~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~ 166 (321)
.++.+++..++++..-+ . ..+...+..++.|+..++.|+| ..++.|+|++|+|.+++..+...++.|||+++.+
T Consensus 96 ~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 96 YLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccc
Confidence 66999998888876666 2 4677788899999999999999 9999999999999999877646899999999877
Q ss_pred CC-CCc---cccccC-CccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHH
Q 020826 167 HP-GKE---YNVRVA-SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY 241 (321)
Q Consensus 167 ~~-~~~---~~~~~~-~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (321)
.. ... ....+| +..|.|||...+.....+..|+||.|+++..+++|..|+.........
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~---------------- 239 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR---------------- 239 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc----------------
Confidence 55 222 344567 899999999988557788999999999999999999998422211100
Q ss_pred hhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCccc
Q 020826 242 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 310 (321)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~ 310 (321)
+..+.... .......-..++....+++.+++..+|+.|.+.+++-.+||+..
T Consensus 240 -----------~~~~~~~~------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 240 -----------YSSWKSNK------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred -----------ceeecccc------cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 00000000 00011111245578999999999999999999999999999998
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=3.4e-16 Score=125.06 Aligned_cols=132 Identities=20% Similarity=0.303 Sum_probs=95.0
Q ss_pred eeeeeeecceEEEEEEEecCCceEEEEEecccchH-----H----------------------HHHHHHHHHhhcCC-CC
Q 020826 26 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK-----K----------------------IKREIKILQNLCGG-PN 77 (321)
Q Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~-----~----------------------~~~E~~~l~~l~~h-~~ 77 (321)
.+.||+|+||+||+|.+. +++.|++|+++..... . ...|...+..+..+ ..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999985 7899999998753211 0 13455555555222 23
Q ss_pred eeeeeeeeeccCCCCcEEEEEeecCchhh-hhcCCCCH-HHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCeEEcCCCCe
Q 020826 78 IVKLLDIVRDQQSKTPSLIFEHVNNTDFK-VLYPTLSD-YDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRK 154 (321)
Q Consensus 78 i~~~~~~~~~~~~~~~~lv~e~~~~~~l~-~~~~~~~~-~~~~~i~~qi~~~l~~lh~-~~i~H~dlkp~nili~~~~~~ 154 (321)
+++.++.. ..++++||++++.+. ..+..... ..+..++.+++.++.++|. .|++|+||+|+||+++ ++ .
T Consensus 81 ~~~~~~~~------~~~lv~e~~~g~~~~~~~l~~~~~~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~-~ 152 (187)
T cd05119 81 VPKPIDLN------RHVLVMEFIGGDGIPAPRLKDVRLLEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG-K 152 (187)
T ss_pred CCceEecC------CCEEEEEEeCCCCccChhhhhhhhcccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC-c
Confidence 44444431 247999999984322 11111122 6778999999999999999 9999999999999999 65 7
Q ss_pred EEEeeccceeec
Q 020826 155 LRLIDWGLAEFY 166 (321)
Q Consensus 155 v~l~dfg~~~~~ 166 (321)
++++|||.+...
T Consensus 153 ~~liDfg~a~~~ 164 (187)
T cd05119 153 VYIIDVPQAVEI 164 (187)
T ss_pred EEEEECcccccc
Confidence 999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.68 E-value=7.7e-16 Score=127.09 Aligned_cols=131 Identities=18% Similarity=0.321 Sum_probs=99.3
Q ss_pred eeee-eecceEEEEEEEecCCceEEEEEecc----------------cchHHHHHHHHHHHhhcCCCC--eeeeeeeeec
Q 020826 27 RKVG-RGKYSEVFEGVHCTDNEKCIIKILKP----------------VKKKKIKREIKILQNLCGGPN--IVKLLDIVRD 87 (321)
Q Consensus 27 ~~lg-~g~~g~v~~~~~~~~~~~~~vK~~~~----------------~~~~~~~~E~~~l~~l~~h~~--i~~~~~~~~~ 87 (321)
..|| .|+.|+||.+.. .+..++||.+.. .....+.+|+.++..| .+++ ++..+++...
T Consensus 37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L-~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQL-YEAGLPVPRPIAARVV 113 (239)
T ss_pred ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHH-HhCCCCCceeEeeeee
Confidence 4577 899999999876 477888887742 1124577899999999 6666 4666665433
Q ss_pred cCCC--CcEEEEEeecC-chhhhhcCC--CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccc
Q 020826 88 QQSK--TPSLIFEHVNN-TDFKVLYPT--LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 162 (321)
Q Consensus 88 ~~~~--~~~lv~e~~~~-~~l~~~~~~--~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~ 162 (321)
.... ..++|+|++++ .+|..++.. +++. .+.+++.+|.+||++||+|+||||.||+++.++ .++|+|||.
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~-~v~LIDfg~ 188 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEAPLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDG-KFWLIDFDR 188 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcCCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC-CEEEEECCC
Confidence 2222 23599999997 678777643 3333 367899999999999999999999999999877 799999998
Q ss_pred eee
Q 020826 163 AEF 165 (321)
Q Consensus 163 ~~~ 165 (321)
+..
T Consensus 189 ~~~ 191 (239)
T PRK01723 189 GEL 191 (239)
T ss_pred ccc
Confidence 865
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.8e-15 Score=116.38 Aligned_cols=132 Identities=22% Similarity=0.315 Sum_probs=108.8
Q ss_pred EeeeeeeecceEEEEEEEecCCceEEEEEecccc-hHHHHHHHHHHHhhcCC-CCeeeeeeeeeccCCCCcEEEEEeecC
Q 020826 25 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-KKKIKREIKILQNLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNN 102 (321)
Q Consensus 25 ~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~E~~~l~~l~~h-~~i~~~~~~~~~~~~~~~~lv~e~~~~ 102 (321)
+++.||+|.++.||++... +..+++|..+... ...+..|...++.+.++ .++++++...... ...++++||+.+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESD--GWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--CccEEEEEecCC
Confidence 4577999999999999973 3789999986544 35788999999999544 6888888877543 456899999998
Q ss_pred chhhhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 103 TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 103 ~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~---~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
..+..+ +......++.+++.+++.+|.. +++|+|++|.||+++..+ .+++.|||.+..
T Consensus 78 ~~~~~~----~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~-~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV----SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK-ILGIIDWEYAGY 138 (155)
T ss_pred eecccC----CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc-EEEEEecccccC
Confidence 877655 5566678899999999999985 699999999999999766 899999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.61 E-value=6.8e-16 Score=136.62 Aligned_cols=255 Identities=20% Similarity=0.198 Sum_probs=193.9
Q ss_pred eeeeecccCceEEeeeeee--ecceEEEEEEE--ecCCceEEEEEecc-----cchHHHHHHHHHHHhhcCCCCeeeeee
Q 020826 13 VWFINREQDDYEVVRKVGR--GKYSEVFEGVH--CTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLD 83 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~--g~~g~v~~~~~--~~~~~~~~vK~~~~-----~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (321)
......+...+.+...+|. |.+|.+|.+.. ..++..+++|.-+. .....-.+|+...+++..|++.++.+.
T Consensus 106 S~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~ 185 (524)
T KOG0601|consen 106 SPFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSP 185 (524)
T ss_pred CCccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCc
Confidence 4456677788889999999 99999999988 77888999997331 223445678888888878999999888
Q ss_pred eeeccCCCCcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHH----HHHHHHHCCCeeecCCCCCeEEcCCCCeE
Q 020826 84 IVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLK----ALDYCHSQGIMHRDVKPHNVMIDHEQRKL 155 (321)
Q Consensus 84 ~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~----~l~~lh~~~i~H~dlkp~nili~~~~~~v 155 (321)
.+.. ....++-+|.|+. ++..+. ..++...++..+.+... ||..+|..+++|.|++|.||+...+....
T Consensus 186 ~~e~--~~~lfiqtE~~~~-sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~ 262 (524)
T KOG0601|consen 186 AWEG--SGILFIQTELCGE-SLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSC 262 (524)
T ss_pred cccc--CCcceeeeccccc-hhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccccee
Confidence 8744 4556688899884 443333 33889999999999999 99999999999999999999999884589
Q ss_pred EEeeccceeecCCCCc-cc-----cccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCC-hHHHHH
Q 020826 156 RLIDWGLAEFYHPGKE-YN-----VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN-YDQLVK 228 (321)
Q Consensus 156 ~l~dfg~~~~~~~~~~-~~-----~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~-~~~~~~ 228 (321)
+++|||+.....+..- .. ...+...|++||+..+ -++...|++++|.++.+..++..+...+... +.++..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 9999999877654432 11 1257778999999875 6788999999999999999888776444221 111000
Q ss_pred HHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 229 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
.. .+.+.-...+.++...+..|++.+|-.|++++.+++|++.
T Consensus 341 ---------------------------------~~-----ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i 382 (524)
T KOG0601|consen 341 ---------------------------------GY-----IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVI 382 (524)
T ss_pred ---------------------------------cc-----CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccc
Confidence 00 1111111244567779999999999999999999999998
Q ss_pred cc
Q 020826 309 FP 310 (321)
Q Consensus 309 ~~ 310 (321)
..
T Consensus 383 ~s 384 (524)
T KOG0601|consen 383 HS 384 (524)
T ss_pred cc
Confidence 74
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.1e-14 Score=118.18 Aligned_cols=199 Identities=20% Similarity=0.225 Sum_probs=138.3
Q ss_pred CCCCeeeeeeeeeccCC---CCcEEEEEeecCchhhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC--CeeecC
Q 020826 74 GGPNIVKLLDIVRDQQS---KTPSLIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQG--IMHRDV 141 (321)
Q Consensus 74 ~h~~i~~~~~~~~~~~~---~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lh~~~--i~H~dl 141 (321)
-|.||++++.++.+... ....+++||+..+++..+++ .+....-.+++.||+.||.|||+.. ++|+++
T Consensus 125 vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiihgnl 204 (458)
T KOG1266|consen 125 VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNL 204 (458)
T ss_pred HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCc
Confidence 68899999999975432 34678999999999988874 3677778899999999999999985 999999
Q ss_pred CCCCeEEcCCCCeEEEeeccceeecCCC-----CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 020826 142 KPHNVMIDHEQRKLRLIDWGLAEFYHPG-----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 216 (321)
Q Consensus 142 kp~nili~~~~~~v~l~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~ 216 (321)
..+.|++..++ .+|+..-........- .......+-++|.+||.=.- ..-+.++|||++|....+|..+..--
T Consensus 205 Tc~tifiq~ng-LIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlemailEiq~ 282 (458)
T KOG1266|consen 205 TCDTIFIQHNG-LIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMAILEIQS 282 (458)
T ss_pred chhheeecCCc-eEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc-cccccchhhhhhhHHHHHHHHheecc
Confidence 99999999777 6776543322111100 01122345567889997554 56778999999999999998876543
Q ss_pred ccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCC
Q 020826 217 FYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER 296 (321)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~R 296 (321)
..+.+..+.-..+..... ..++ +--++++++|++-.|..|
T Consensus 283 tnseS~~~~ee~ia~~i~-----------------------------------~len-----~lqr~~i~kcl~~eP~~r 322 (458)
T KOG1266|consen 283 TNSESKVEVEENIANVII-----------------------------------GLEN-----GLQRGSITKCLEGEPNGR 322 (458)
T ss_pred CCCcceeehhhhhhhhee-----------------------------------eccC-----ccccCcCcccccCCCCCC
Confidence 222211111111110000 0000 123578999999999999
Q ss_pred cCHHHHhcCCCcccCCCc
Q 020826 297 PTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 297 ps~~ell~hp~~~~~~~~ 314 (321)
|++.+++.||.+-.+...
T Consensus 323 p~ar~llfHpllfeVhsl 340 (458)
T KOG1266|consen 323 PDARLLLFHPLLFEVHSL 340 (458)
T ss_pred cchhhhhcCceeeecchH
Confidence 999999999998776443
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.7e-13 Score=120.81 Aligned_cols=168 Identities=21% Similarity=0.367 Sum_probs=125.5
Q ss_pred EE-EEEEecCCceEEEEEecccch---HHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeecCchhhhhcCCC
Q 020826 37 VF-EGVHCTDNEKCIIKILKPVKK---KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTL 112 (321)
Q Consensus 37 v~-~~~~~~~~~~~~vK~~~~~~~---~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~ 112 (321)
+| .|..+.++.++.|.+.+.... ....+-+..++.+ +||+|+++++.++.. ..+++|+|.+.- |..++..+
T Consensus 27 ~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtl-RHP~Il~yL~t~e~~--~~~ylvTErV~P--l~~~lk~l 101 (690)
T KOG1243|consen 27 LWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTL-RHPNILSYLDTTEEE--GTLYLVTERVRP--LETVLKEL 101 (690)
T ss_pred cccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhc-cCchhhhhhhhhccc--CceEEEeecccc--HHHHHHHh
Confidence 45 466667888999988876544 5567778889998 999999999988544 466799998753 44444555
Q ss_pred CHHHHHHHHHHHHHHHHHHH-HCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc-cccccCCccccccccccCC
Q 020826 113 SDYDVRYYIYELLKALDYCH-SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDL 190 (321)
Q Consensus 113 ~~~~~~~i~~qi~~~l~~lh-~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~ 190 (321)
....+...+.||+.||.+|| +.+++|++|....|+++..| ..+|++|..+........ ......-..|..|+....
T Consensus 102 ~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G-eWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~- 179 (690)
T KOG1243|consen 102 GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG-EWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDP- 179 (690)
T ss_pred HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC-cEEEeeeEEEeccccCCcccccchhhhcccChhhcCc-
Confidence 68888899999999999998 67899999999999999998 899999998865432221 011111223566665433
Q ss_pred CCCCCcchHHHHHHHHHHHHhCC
Q 020826 191 QDYDYSLDLWSLGCMFAGMIFRK 213 (321)
Q Consensus 191 ~~~~~~~DvwslG~~l~~l~~g~ 213 (321)
.. ...|.|.|||++++++.|.
T Consensus 180 s~--~s~D~~~Lg~li~el~ng~ 200 (690)
T KOG1243|consen 180 SE--WSIDSWGLGCLIEELFNGS 200 (690)
T ss_pred cc--cchhhhhHHHHHHHHhCcc
Confidence 12 4579999999999999983
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.49 E-value=3.1e-13 Score=121.13 Aligned_cols=136 Identities=18% Similarity=0.330 Sum_probs=91.8
Q ss_pred eeeeeecceEEEEEEEecCCceEEEEEecccchHHHH-------------------------------------------
Q 020826 27 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK------------------------------------------- 63 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~------------------------------------------- 63 (321)
+.||+|++|.||+|+. .+|+.||||+.++...+.+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 4699999999999987 57899999998765332222
Q ss_pred HHHHHHHhhc----CCCCeeeeeeeeeccCCCCcEEEEEeecCchhhhhcCC--CCHHHHHHHHHHHHH-HHHHHHHCCC
Q 020826 64 REIKILQNLC----GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLK-ALDYCHSQGI 136 (321)
Q Consensus 64 ~E~~~l~~l~----~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~i~~qi~~-~l~~lh~~~i 136 (321)
+|...+.++. +++++ .+-.++.+- ....+++|||+.|.++.+.... ... ....++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~-~~~~vLvmE~i~G~~L~~~~~~~~~~~-~~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGV-YVPEVYWDR-TSERVLTMEWIDGIPLSDIAALDEAGL-DRKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCE-EeCCEehhh-cCCceEEEEeECCcccccHHHHHhcCC-CHHHHHHHHHHHHHHHHHhCCc
Confidence 2333333331 23332 222222211 1234799999999988765421 111 23345555555 4788999999
Q ss_pred eeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 137 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 137 ~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
+|+|++|.||+++.++ .++++|||++....
T Consensus 279 ~H~D~hPgNilv~~~g-~i~liDfG~~~~l~ 308 (437)
T TIGR01982 279 FHADLHPGNIFVLKDG-KIIALDFGIVGRLS 308 (437)
T ss_pred eeCCCCcccEEECCCC-cEEEEeCCCeeECC
Confidence 9999999999998887 89999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.48 E-value=4e-13 Score=105.52 Aligned_cols=126 Identities=21% Similarity=0.252 Sum_probs=96.2
Q ss_pred eeeeeeecceEEEEEEEecCCceEEEEEecccc--hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeecCc
Q 020826 26 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT 103 (321)
Q Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~ 103 (321)
++.++.|.++.||++.. .+..+++|...... ......|..+++.+.+...+++++... .. ..++|||+++|.
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~--~~~lv~e~i~G~ 76 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--PE--TGVLITEFIEGS 76 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--CC--CCeEEEEecCCC
Confidence 45688999999999886 47789999976543 345788999999885444455666554 22 236999999998
Q ss_pred hhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCC-----eeecCCCCCeEEcCCCCeEEEeecccee
Q 020826 104 DFKVLYPTLSDYDVRYYIYELLKALDYCHSQGI-----MHRDVKPHNVMIDHEQRKLRLIDWGLAE 164 (321)
Q Consensus 104 ~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i-----~H~dlkp~nili~~~~~~v~l~dfg~~~ 164 (321)
++... . ......+.+++.+|+.||..++ +|+|++|.||+++ ++ .++++||+.+.
T Consensus 77 ~l~~~--~---~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~-~~~liDf~~a~ 135 (170)
T cd05151 77 ELLTE--D---FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG-RLWLIDWEYAG 135 (170)
T ss_pred ccccc--c---ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC-eEEEEeccccc
Confidence 77643 1 1123456789999999999985 9999999999998 55 69999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.46 E-value=1.9e-12 Score=102.37 Aligned_cols=133 Identities=17% Similarity=0.243 Sum_probs=97.5
Q ss_pred eeeeeeecceEEEEEEEec------CCceEEEEEeccc-------------------------chHH----HHHHHHHHH
Q 020826 26 VRKVGRGKYSEVFEGVHCT------DNEKCIIKILKPV-------------------------KKKK----IKREIKILQ 70 (321)
Q Consensus 26 ~~~lg~g~~g~v~~~~~~~------~~~~~~vK~~~~~-------------------------~~~~----~~~E~~~l~ 70 (321)
...||.|.-+.||.|.... .+..+|||+.+.. ..+. .++|...|.
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4578999999999998643 3579999997410 0112 348999999
Q ss_pred hhcCC-CCeeeeeeeeeccCCCCcEEEEEeecCchhh-hhcC--CCCHHHHHHHHHHHHHHHHHH-HHCCCeeecCCCCC
Q 020826 71 NLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-VLYP--TLSDYDVRYYIYELLKALDYC-HSQGIMHRDVKPHN 145 (321)
Q Consensus 71 ~l~~h-~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~-~~~~--~~~~~~~~~i~~qi~~~l~~l-h~~~i~H~dlkp~n 145 (321)
++... -++++.+++. .-++|||+++++.+. ..+. .++...+..+..+++.+|..+ |+.|++||||++.|
T Consensus 82 rl~~~Gv~vP~pi~~~------~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 82 RMQKAGIPCPEVVVLK------KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHHcCCCCCeEEEec------CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 88433 5677777652 135999999875331 1111 345556778889999999988 89999999999999
Q ss_pred eEEcCCCCeEEEeeccceeec
Q 020826 146 VMIDHEQRKLRLIDWGLAEFY 166 (321)
Q Consensus 146 ili~~~~~~v~l~dfg~~~~~ 166 (321)
|+++. + .+.|+|||-+...
T Consensus 156 IL~~~-~-~v~iIDF~qav~~ 174 (197)
T cd05146 156 MLWHD-G-KVWFIDVSQSVEP 174 (197)
T ss_pred EEEEC-C-cEEEEECCCceeC
Confidence 99974 4 6999999987644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=1.9e-13 Score=121.26 Aligned_cols=252 Identities=18% Similarity=0.112 Sum_probs=177.6
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEe-cCCceEEEEEecccch-----HHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHC-TDNEKCIIKILKPVKK-----KKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~~vK~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
.....+|..+..||.|.|+.|+.+... .++..|++|-+...-. -.-..|+.+...+..|.+++.....+.....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 344678899999999999999998754 5677888887653221 2234677777777778888887776643333
Q ss_pred CCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 91 KTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
.++--|+|.+++..... ..+.+...+++..|++.++.++|++.++|.|++|.||++..++...++.|||+.+...
T Consensus 341 --~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 341 --GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred --ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 34888999888765554 3488889999999999999999999999999999999998764478899999886421
Q ss_pred CCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 168 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
-........+..|...|++.....+..+.|++|||+.+.+..++...- ........+..
T Consensus 419 -~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls-~~~~~~~~i~~------------------- 477 (524)
T KOG0601|consen 419 -FSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS-ESGVQSLTIRS------------------- 477 (524)
T ss_pred -eecccccccccccccchhhccccccccccccccccccccccccCcccC-cccccceeeec-------------------
Confidence 111111222333423555555577888999999999999999887433 11111000000
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
.........+.+++.+.+.++..++..||++.++..|+=|....
T Consensus 478 ---------------------~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~~ 521 (524)
T KOG0601|consen 478 ---------------------GDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRDS 521 (524)
T ss_pred ---------------------ccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhhc
Confidence 00111112235788999999999999999999999998776553
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.34 E-value=7.4e-11 Score=103.28 Aligned_cols=209 Identities=15% Similarity=0.218 Sum_probs=149.0
Q ss_pred cceEEEEEEEecCCceEEEEEeccc---chHHHHHHHHHHHhhcCCCCeeeeeeeeec--cCCCCcEEEEEeecCc-hhh
Q 020826 33 KYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRD--QQSKTPSLIFEHVNNT-DFK 106 (321)
Q Consensus 33 ~~g~v~~~~~~~~~~~~~vK~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~~~lv~e~~~~~-~l~ 106 (321)
-..+.|++....+|..|++|.++.+ .....-.-+++++++ .|+|++++.+++.. -.+..+++|++|.++. +|.
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl-~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~ 366 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKL-CHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLY 366 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHh-ccCceeehhhhhhhhccCcceEEEEEecCCCCchHH
Confidence 3458999999999999999999432 223344567889999 89999999998862 1345678999998765 343
Q ss_pred hhc------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 107 VLY------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 107 ~~~------------------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
+.. .+.++..+|.++.|+..||.++|+.|++.+-|.|.+|+++.+. +++|+.-|+.....+
T Consensus 367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~-RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKM-RIRISGCGIMDVLQE 445 (655)
T ss_pred HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcc-eEEEecccceeeecC
Confidence 332 1367889999999999999999999999999999999998776 788887777665433
Q ss_pred CCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHH-HHHHHHHhCChhhhHHhhhhcc
Q 020826 169 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ-LVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
... |.+.+ -.+-|.=.||.+++.|.||..-=......... +..+.
T Consensus 446 d~~-------------~~le~----~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~----------------- 491 (655)
T KOG3741|consen 446 DPT-------------EPLES----QQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT----------------- 491 (655)
T ss_pred CCC-------------cchhH----HhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-----------------
Confidence 220 11111 13568899999999999997542222222111 11111
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
...|.++++++..+...++.+ -++.+++.|
T Consensus 492 ---------------------------~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 492 ---------------------------TTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred ---------------------------hhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 124567888888888888876 677777654
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.33 E-value=7.9e-12 Score=113.56 Aligned_cols=142 Identities=12% Similarity=0.225 Sum_probs=87.5
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHH-------------------------------------H--
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-------------------------------------I-- 62 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~-------------------------------------~-- 62 (321)
+|+. ..||+|++|+||+|+.+.+|+.||||++++...+. +
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4555 67999999999999997779999999997542211 1
Q ss_pred ----HHHHHHHHhhc---CCCCeeeeeeeeeccCCCCcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHH
Q 020826 63 ----KREIKILQNLC---GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYC 131 (321)
Q Consensus 63 ----~~E~~~l~~l~---~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~l 131 (321)
.+|...+.++. .+...+.+=.++.+- ....+++|||+.|+.+.+.. ...+........ +-.-+..+
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~-st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~--v~~~~~Qi 276 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDY-CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERG--VEVFFTQV 276 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeeccc-CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHH--HHHHHHHH
Confidence 22332333331 122222222222211 22346999999999886532 122222211111 11123344
Q ss_pred HHCCCeeecCCCCCeEEcCCC---CeEEEeeccceeecC
Q 020826 132 HSQGIMHRDVKPHNVMIDHEQ---RKLRLIDWGLAEFYH 167 (321)
Q Consensus 132 h~~~i~H~dlkp~nili~~~~---~~v~l~dfg~~~~~~ 167 (321)
...|++|+|++|.||+++.++ ..+++.|||++....
T Consensus 277 f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 277 FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 569999999999999998765 379999999987664
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.4e-10 Score=99.34 Aligned_cols=190 Identities=16% Similarity=0.207 Sum_probs=132.5
Q ss_pred EEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeee-----eccCCCCcEEEEE
Q 020826 24 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIV-----RDQQSKTPSLIFE 98 (321)
Q Consensus 24 ~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~-----~~~~~~~~~lv~e 98 (321)
...+.||+|+-+.+|..-. -...+.|++.........+-+..|.....||-+..-+.+- -......+.++|.
T Consensus 14 ~~gr~LgqGgea~ly~l~e---~~d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGE---VRDQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CCCccccCCccceeeecch---hhchhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 3456799999999996532 2335677776555444445555555554555443311110 0112233567777
Q ss_pred eecCch-hhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 99 HVNNTD-FKVLY---------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 99 ~~~~~~-l~~~~---------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
...+.. ...+. +.+.+..+.+.+..++.+.+.||..|.+-||++++|++++.++ .|.|.|-..-....+
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~-~V~LVdsDsfqi~~n 169 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDS-KVVLVDSDSFQINAN 169 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCc-eEEEEcccceeeccC
Confidence 766542 22222 3477888999999999999999999999999999999999887 899998776665555
Q ss_pred CCccccccCCccccccccccC----CCCCCCcchHHHHHHHHHHHHhC-CCCCc
Q 020826 169 GKEYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFR-KEPFF 217 (321)
Q Consensus 169 ~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~l~~g-~~p~~ 217 (321)
+..+.-.+|...|++||...- ...-+...|.|.||+++++++.| ++||.
T Consensus 170 g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPys 223 (637)
T COG4248 170 GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYS 223 (637)
T ss_pred CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCC
Confidence 555566778899999998641 13456789999999999999887 88883
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.31 E-value=4.5e-11 Score=91.53 Aligned_cols=126 Identities=19% Similarity=0.336 Sum_probs=91.3
Q ss_pred eeeeecceEEEEEEEecCCceEEEEEecc-c----------chHHHHHHHHHHHhhcC-CCCeeeeeeeeeccCCCCcEE
Q 020826 28 KVGRGKYSEVFEGVHCTDNEKCIIKILKP-V----------KKKKIKREIKILQNLCG-GPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 28 ~lg~g~~g~v~~~~~~~~~~~~~vK~~~~-~----------~~~~~~~E~~~l~~l~~-h~~i~~~~~~~~~~~~~~~~l 95 (321)
.+++|+-+.+|.+.+ -|..+++|.--+ . ...+..+|..++.++.. --+.+.++++- +... .|
T Consensus 3 ~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD--~~~~--~I 76 (204)
T COG3642 3 LIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD--PDNG--LI 76 (204)
T ss_pred hhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc--CCCC--EE
Confidence 467899999999865 344577776321 1 12446678888887732 22445555543 4443 49
Q ss_pred EEEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 96 IFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 96 v~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
+|||.+|..+.+.+..-. ..++..+-..+.-||..||+||||+++||+++.+ .+.++|||++..
T Consensus 77 ~me~I~G~~lkd~l~~~~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~--~i~~IDfGLg~~ 140 (204)
T COG3642 77 VMEYIEGELLKDALEEAR----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGG--RIYFIDFGLGEF 140 (204)
T ss_pred EEEEeCChhHHHHHHhcc----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCC--cEEEEECCcccc
Confidence 999999999987775542 4556677777888999999999999999999855 499999999864
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.29 E-value=9.3e-11 Score=89.50 Aligned_cols=136 Identities=20% Similarity=0.294 Sum_probs=95.0
Q ss_pred EeeeeeeecceEEEEEEEecCCceEEEEEecc-----------cchHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 25 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----------VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 25 ~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~-----------~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
.+..+.+|+-+.|+++.+ .|+.++||.-.. -.+.+..+|+..+.++. --.|.--.-++.|....
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~-~~GI~~P~l~~~D~~~~-- 85 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR-ALGIPAPRLIFIDTYGG-- 85 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH-HhCCCCceEEEEecCCC--
Confidence 566788999999999987 788888886321 12355678888888762 22222211223333333
Q ss_pred EEEEEeecCc-hhhhhc----CC-CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeE--EEeeccceee
Q 020826 94 SLIFEHVNNT-DFKVLY----PT-LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL--RLIDWGLAEF 165 (321)
Q Consensus 94 ~lv~e~~~~~-~l~~~~----~~-~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v--~l~dfg~~~~ 165 (321)
+|+||+..|. ++.+++ .. ........++.+|-+.+.-||.++++||||+++||++..++..+ .++|||++..
T Consensus 86 ~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 86 QIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred eEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 4999999883 444444 22 22333367888999999999999999999999999998776544 8999999865
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.29 E-value=1.5e-12 Score=117.35 Aligned_cols=155 Identities=17% Similarity=0.240 Sum_probs=111.9
Q ss_pred HHHHHHHHHHH-CCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCcccc----------ccCCccccccccccCCC
Q 020826 123 ELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV----------RVASRYFKGPELLVDLQ 191 (321)
Q Consensus 123 qi~~~l~~lh~-~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~~~----------~~~~~~y~aPE~~~~~~ 191 (321)
+++.|+.++|. .++||++|.|++|+++.++ .+||+.|+++.....+..+.. ......|.|||++.+ .
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~-~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~ 184 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANG-DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-T 184 (700)
T ss_pred cccchhhhhccCcceeecccchhheeeccCc-ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-c
Confidence 34489999996 4899999999999999888 799999999865544222211 123446999999988 7
Q ss_pred CCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCcccccc
Q 020826 192 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITV 271 (321)
Q Consensus 192 ~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (321)
..+.++|++|+|+++|-+..|+.+..........-..-.. ...- ...
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~-------------------------~~~~--------~~~ 231 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN-------------------------LLNA--------GAF 231 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc-------------------------cccc--------ccc
Confidence 8899999999999999998666565433322111110000 0000 001
Q ss_pred ccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 272 ENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 272 ~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
.....+++++++=|.+++..++..||++.+++..|||.+..
T Consensus 232 ~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~~ 272 (700)
T KOG2137|consen 232 GYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDPG 272 (700)
T ss_pred cccccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCch
Confidence 11145778999999999999999999999999999999854
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.27 E-value=1.1e-12 Score=122.77 Aligned_cols=257 Identities=22% Similarity=0.303 Sum_probs=174.8
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
..+.+.+.+-+.+|.++.++.+.-...+...+.|+.... .......+-.+.... .+|.++....-+ .....
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~--~~rsP 878 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSF--PCRSP 878 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCC--CCCCC
Confidence 466788888899999999999887777765555554321 122223333332222 345544433332 22234
Q ss_pred cEEEEEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC--
Q 020826 93 PSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-- 167 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~-- 167 (321)
..++++++++++|...+. ..+...++.....+..++++||...+.|+|++|.|.+...++ ..+++||+......
T Consensus 879 ~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~g-h~~l~~~~t~~~vg~~ 957 (1205)
T KOG0606|consen 879 LPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDG-HRPLTDFGTLSKVGLI 957 (1205)
T ss_pred cchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccC-CcccCccccccccccc
Confidence 569999999988766653 356667778888889999999999999999999999998888 68899987321110
Q ss_pred ----CC----C--------------c--------cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCc
Q 020826 168 ----PG----K--------------E--------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFF 217 (321)
Q Consensus 168 ----~~----~--------------~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~ 217 (321)
.. . . .....+|+.|.+||...+ ..-...+|.|+.|+++++.++|..||.
T Consensus 958 ~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg-~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen 958 PPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLG-RRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred cCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccc-ccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence 00 0 0 012357889999999998 667788999999999999999998883
Q ss_pred cCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc
Q 020826 218 YGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP 297 (321)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp 297 (321)
..........+.. . ..++... ....+++.++++...+..+|.+|.
T Consensus 1037 -a~tpq~~f~ni~~---------------------------~--~~~~p~g-----~~~~s~~aq~~~~~ll~~~~~qr~ 1081 (1205)
T KOG0606|consen 1037 -AETPQQIFENILN---------------------------R--DIPWPEG-----PEEGSYEAQDLINRLLTEEPTQRL 1081 (1205)
T ss_pred -Ccchhhhhhcccc---------------------------C--CCCCCCC-----ccccChhhhhhhhhhhccCchhcc
Confidence 2222122211110 0 1111111 123567899999999999999998
Q ss_pred CHH---HHhcCCCcccCCCcc
Q 020826 298 TAK---EAMAHPYFFPIRNAE 315 (321)
Q Consensus 298 s~~---ell~hp~~~~~~~~~ 315 (321)
.+. ++-.||||+.++-.+
T Consensus 1082 ~a~~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1082 GAKGAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred CcccccccccCCccCCCCccc
Confidence 887 999999999876543
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.19 E-value=4.6e-10 Score=88.57 Aligned_cols=122 Identities=24% Similarity=0.377 Sum_probs=82.4
Q ss_pred EEEEEEEecCCceEEEEEeccc-----------------------------chHHHHHHHHHHHhhcCC-CCeeeeeeee
Q 020826 36 EVFEGVHCTDNEKCIIKILKPV-----------------------------KKKKIKREIKILQNLCGG-PNIVKLLDIV 85 (321)
Q Consensus 36 ~v~~~~~~~~~~~~~vK~~~~~-----------------------------~~~~~~~E~~~l~~l~~h-~~i~~~~~~~ 85 (321)
.||.|.. .++..+|+|+.+.. .....++|...|.++... -++++.+++.
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3788887 67889999986411 012367899999999443 2677887664
Q ss_pred eccCCCCcEEEEEeec--CchhhhhcCC-CCHHHHHHHHHHHHHHHHH-HHHCCCeeecCCCCCeEEcCCCCeEEEeecc
Q 020826 86 RDQQSKTPSLIFEHVN--NTDFKVLYPT-LSDYDVRYYIYELLKALDY-CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 161 (321)
Q Consensus 86 ~~~~~~~~~lv~e~~~--~~~l~~~~~~-~~~~~~~~i~~qi~~~l~~-lh~~~i~H~dlkp~nili~~~~~~v~l~dfg 161 (321)
. -++||||++ |..+..+... ++......++.+++..+.. +|..|++|||+++.||+++.+ .+.++|||
T Consensus 80 --~----~~ivME~I~~~G~~~~~l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~--~~~iIDf~ 151 (188)
T PF01163_consen 80 --R----NVIVMEYIGEDGVPLPRLKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG--KVYIIDFG 151 (188)
T ss_dssp --T----TEEEEE--EETTEEGGCHHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT--CEEE--GT
T ss_pred --C----CEEEEEecCCCccchhhHHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc--eEEEEecC
Confidence 1 259999999 7666554432 3356677788888885554 679999999999999999865 69999999
Q ss_pred ceeec
Q 020826 162 LAEFY 166 (321)
Q Consensus 162 ~~~~~ 166 (321)
-+...
T Consensus 152 qav~~ 156 (188)
T PF01163_consen 152 QAVDS 156 (188)
T ss_dssp TEEET
T ss_pred cceec
Confidence 88654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.19 E-value=5.5e-10 Score=91.60 Aligned_cols=138 Identities=25% Similarity=0.428 Sum_probs=103.2
Q ss_pred eeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcC-CCCeeeeeeeeeccC-CCCcEEEEEee
Q 020826 27 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCG-GPNIVKLLDIVRDQQ-SKTPSLIFEHV 100 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~-h~~i~~~~~~~~~~~-~~~~~lv~e~~ 100 (321)
+.|+.|..+.+|++.. .+|..+++|...... ...+..|..+++.+.. +.++++++.+..... ....++++|++
T Consensus 4 ~~l~~G~~n~~~~v~~-~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTA-GGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEe-cCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 5688999999999987 346889999976532 4578999999999843 234677777654321 12457999999
Q ss_pred cCchhhhhc--CCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------------
Q 020826 101 NNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHS--------------------------------------------- 133 (321)
Q Consensus 101 ~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lh~--------------------------------------------- 133 (321)
.|.++.... ..++......++.+++.+|..||+
T Consensus 83 ~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (223)
T cd05154 83 DGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLR 162 (223)
T ss_pred CCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHH
Confidence 999887665 356777777777788877777773
Q ss_pred -----------CCCeeecCCCCCeEEcCC-CCeEEEeeccceee
Q 020826 134 -----------QGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEF 165 (321)
Q Consensus 134 -----------~~i~H~dlkp~nili~~~-~~~v~l~dfg~~~~ 165 (321)
..++|+|+.|.||+++.+ +..+.|+||+.+..
T Consensus 163 ~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 163 WLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 236999999999999873 32689999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.2e-08 Score=85.39 Aligned_cols=128 Identities=18% Similarity=0.188 Sum_probs=88.7
Q ss_pred EEEEEEEecCCceEEEEEecccc--------------hHHHHHHHHHHHhhcC-CCCeeeeeeeeeccC---CCCcEEEE
Q 020826 36 EVFEGVHCTDNEKCIIKILKPVK--------------KKKIKREIKILQNLCG-GPNIVKLLDIVRDQQ---SKTPSLIF 97 (321)
Q Consensus 36 ~v~~~~~~~~~~~~~vK~~~~~~--------------~~~~~~E~~~l~~l~~-h~~i~~~~~~~~~~~---~~~~~lv~ 97 (321)
.|.++.. +|+.+.||...... ...+.+|...+.++.. .-..++.+.+..... ....++|+
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 3555543 56788888664322 1137788888888731 112233333433211 23457999
Q ss_pred EeecCc-hhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcC------CCCeEEEeeccceee
Q 020826 98 EHVNNT-DFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH------EQRKLRLIDWGLAEF 165 (321)
Q Consensus 98 e~~~~~-~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~------~~~~v~l~dfg~~~~ 165 (321)
|++++. ++.++.. ..+......++.+++..+.-||+.|++|+|+++.||+++. ++..+.++||+.+..
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~ 194 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI 194 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence 999986 6776653 3456677889999999999999999999999999999975 234799999998753
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.03 E-value=3e-09 Score=86.56 Aligned_cols=131 Identities=22% Similarity=0.379 Sum_probs=99.7
Q ss_pred eEEeeeeeeecceEEEEEEEecCCceEEEEEecc-------c------------------chHHHHHHHHHHHhhcCC-C
Q 020826 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-------V------------------KKKKIKREIKILQNLCGG-P 76 (321)
Q Consensus 23 y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~-------~------------------~~~~~~~E~~~l~~l~~h-~ 76 (321)
+.+...||-|.-+.||.|.+ ..|.++++|.=+. . .+...++|.++|++|... -
T Consensus 93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 34567899999999999998 5889999997320 0 123367899999999433 3
Q ss_pred CeeeeeeeeeccCCCCcEEEEEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEE
Q 020826 77 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLR 156 (321)
Q Consensus 77 ~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~ 156 (321)
.+++-+++-. -.+|||+..|..|.... ++...+..++..|++-+.-+-..|++|||+++-||+++.+| .+.
T Consensus 172 ~VP~P~~~nR------HaVvMe~ieG~eL~~~r--~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg-~~~ 242 (304)
T COG0478 172 KVPKPIAWNR------HAVVMEYIEGVELYRLR--LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDG-DIV 242 (304)
T ss_pred CCCCcccccc------ceeeeehcccceeeccc--CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCC-CEE
Confidence 6777766532 25999999997665443 24666667777788777777799999999999999999988 799
Q ss_pred Eeeccce
Q 020826 157 LIDWGLA 163 (321)
Q Consensus 157 l~dfg~~ 163 (321)
++||-=+
T Consensus 243 vIDwPQ~ 249 (304)
T COG0478 243 VIDWPQA 249 (304)
T ss_pred EEeCccc
Confidence 9999543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.96 E-value=2.6e-08 Score=79.16 Aligned_cols=133 Identities=18% Similarity=0.188 Sum_probs=95.8
Q ss_pred eeecceEEEEEEEecCCceEEEEEec---------ccchHHHHHHHHHHHhhcC-CCCeeeeeee--eeccCCCCcEEEE
Q 020826 30 GRGKYSEVFEGVHCTDNEKCIIKILK---------PVKKKKIKREIKILQNLCG-GPNIVKLLDI--VRDQQSKTPSLIF 97 (321)
Q Consensus 30 g~g~~g~v~~~~~~~~~~~~~vK~~~---------~~~~~~~~~E~~~l~~l~~-h~~i~~~~~~--~~~~~~~~~~lv~ 97 (321)
|.||.+.|++... .|+.+-+|.-. +.....+.+|...+++|.. .-.+++.... .........+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 5689999998765 34467788754 3456789999999998842 1224444421 1122233467999
Q ss_pred EeecCc-hhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCC-eEEEeecccee
Q 020826 98 EHVNNT-DFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAE 164 (321)
Q Consensus 98 e~~~~~-~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~-~v~l~dfg~~~ 164 (321)
|.+++. +|..++ .+.+......++.+++.+++-||+.|+.|+|+.+.||+++.++. .+.++||.-+.
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 987754 676654 23466777899999999999999999999999999999986652 39999998664
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.83 E-value=1.6e-07 Score=75.00 Aligned_cols=138 Identities=16% Similarity=0.245 Sum_probs=89.7
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchH------------HHHHHHHHHHhhc--CCCCeeeeee
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK------------KIKREIKILQNLC--GGPNIVKLLD 83 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~------------~~~~E~~~l~~l~--~h~~i~~~~~ 83 (321)
..+.+|.+.+.+.......|.+.. -++..+++|..+...+. ...+++..+..+. +......++.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 346788999999888877777665 47789999997653321 1223333333331 2222222222
Q ss_pred eeec---cCCCCcEEEEEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeec
Q 020826 84 IVRD---QQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW 160 (321)
Q Consensus 84 ~~~~---~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~df 160 (321)
+... .-....++++||+.|..+.+... +++ .+...+.+++..+|+.|+.|||++|.|++++.+ .+++.|+
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~-i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~--~i~iID~ 178 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED-IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN--GIRIIDT 178 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh-cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC--cEEEEEC
Confidence 2211 11233468999999987765432 222 244567788999999999999999999999855 4999999
Q ss_pred ccee
Q 020826 161 GLAE 164 (321)
Q Consensus 161 g~~~ 164 (321)
+...
T Consensus 179 ~~k~ 182 (229)
T PF06176_consen 179 QGKR 182 (229)
T ss_pred cccc
Confidence 8654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.2e-07 Score=76.52 Aligned_cols=132 Identities=15% Similarity=0.248 Sum_probs=93.7
Q ss_pred EeeeeeeecceEEEEEEEecCCceEEEEEecccc----------------------h-----HHHHHHHHHHHhhc-CCC
Q 020826 25 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----------------------K-----KKIKREIKILQNLC-GGP 76 (321)
Q Consensus 25 ~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----------------------~-----~~~~~E~~~l~~l~-~h~ 76 (321)
+...|++|.-+.||+|.. .++..+|+|+++... . ....+|..-|.++. .+-
T Consensus 52 ~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGV 130 (268)
T COG1718 52 LVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGV 130 (268)
T ss_pred eEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCC
Confidence 344688899999999986 678999999985321 0 11346777777763 234
Q ss_pred CeeeeeeeeeccCCCCcEEEEEeecCchhh-hhcC--CCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCeEEcCCC
Q 020826 77 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-VLYP--TLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQ 152 (321)
Q Consensus 77 ~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~-~~~~--~~~~~~~~~i~~qi~~~l~~lh~-~~i~H~dlkp~nili~~~~ 152 (321)
.+++-+.+.. -.|+||+++..... -.+. ++...++..+..+++..+.-|-. .++||+||+.-||++. ++
T Consensus 131 rvP~Pi~~~~------nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 131 RVPEPIAFRN------NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DG 203 (268)
T ss_pred CCCCceeecC------CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CC
Confidence 5566666542 25999999876211 1111 12333678888899999888887 8999999999999999 55
Q ss_pred CeEEEeeccceee
Q 020826 153 RKLRLIDWGLAEF 165 (321)
Q Consensus 153 ~~v~l~dfg~~~~ 165 (321)
.+.++|+|=+..
T Consensus 204 -~p~iID~~QaV~ 215 (268)
T COG1718 204 -EPYIIDVSQAVT 215 (268)
T ss_pred -eEEEEECccccc
Confidence 799999996653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.75 E-value=2e-07 Score=75.37 Aligned_cols=108 Identities=25% Similarity=0.369 Sum_probs=80.4
Q ss_pred hHHHHHHHHHHHhhcC-CCCeeeeeeeeeccC--CCCcEEEEEeecCc-hhhhhcCC---CCHHHHHHHHHHHHHHHHHH
Q 020826 59 KKKIKREIKILQNLCG-GPNIVKLLDIVRDQQ--SKTPSLIFEHVNNT-DFKVLYPT---LSDYDVRYYIYELLKALDYC 131 (321)
Q Consensus 59 ~~~~~~E~~~l~~l~~-h~~i~~~~~~~~~~~--~~~~~lv~e~~~~~-~l~~~~~~---~~~~~~~~i~~qi~~~l~~l 131 (321)
.....+|...+..|.. .=..++.+++..... ....++++|++++. +|.++... .+......++.+++..++-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 4567788888777732 223444555443322 13347999999875 68777754 66777889999999999999
Q ss_pred HHCCCeeecCCCCCeEEcCCC--CeEEEeeccceeec
Q 020826 132 HSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEFY 166 (321)
Q Consensus 132 h~~~i~H~dlkp~nili~~~~--~~v~l~dfg~~~~~ 166 (321)
|++|++|+|+++.||+++.++ ..+.++||+-+...
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999999999999998664 36899999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.59 E-value=7.3e-07 Score=81.00 Aligned_cols=133 Identities=16% Similarity=0.330 Sum_probs=87.9
Q ss_pred eeeeeecceEEEEEEEecCCceEEEEEecccchHHH-------------------------------------------H
Q 020826 27 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI-------------------------------------------K 63 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~-------------------------------------------~ 63 (321)
.-++.++.|.||+|+. .+|+.||||+.++.-.+.+ .
T Consensus 131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 4588999999999998 4599999999875433222 2
Q ss_pred HHHHHHHhhc----CCCC--eeeeeeeeeccCCCCcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHH
Q 020826 64 REIKILQNLC----GGPN--IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHS 133 (321)
Q Consensus 64 ~E~~~l~~l~----~h~~--i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~ 133 (321)
+|..-+.++. +.|+ |++++.-+ . ..-+++|||+.|..+.+.. ...+...+...+.++. +..+-.
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~--t--~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~ 283 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEY--T--TRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLR 283 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhc--c--CCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHh
Confidence 3333333331 2232 33443322 2 2236999999998776663 3355444433333322 344445
Q ss_pred CCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 134 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 134 ~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
.|++|+|..|.||+++.++ .+.+.|||+.....
T Consensus 284 dgffHaDpHpGNi~v~~~g-~i~~lDfGi~g~l~ 316 (517)
T COG0661 284 DGFFHADPHPGNILVRSDG-RIVLLDFGIVGRLD 316 (517)
T ss_pred cCccccCCCccceEEecCC-cEEEEcCcceecCC
Confidence 8999999999999999998 89999999986554
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.54 E-value=7.2e-07 Score=68.25 Aligned_cols=140 Identities=19% Similarity=0.301 Sum_probs=98.1
Q ss_pred eeeeecccCce--EEeeeeeeecceEEEEEEEecCCceEEEEEeccc-chHHHHHHHHHHHhhcCCCCeeeeeeeeeccC
Q 020826 13 VWFINREQDDY--EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 89 (321)
Q Consensus 13 ~~~i~~~~~~y--~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (321)
.|.++.....| +..+.|++|+.|.||++.+ .+..+++|+-+.+ .+..++.|.+++..+...---++++.+..+
T Consensus 12 ~~i~~~~~~~~~~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~-- 87 (201)
T COG2112 12 IEILNVEEGKYELRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGED-- 87 (201)
T ss_pred eeeeeeeccchhhhhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechh--
Confidence 44444444444 4566799999999999998 4558888887654 467899999999998555555667766532
Q ss_pred CCCcEEEEEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCC-CCCeEEcCCCCeEEEeeccceee
Q 020826 90 SKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVK-PHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlk-p~nili~~~~~~v~l~dfg~~~~ 165 (321)
++.|||..|..|...-...... -...+++..--|-..||-|+.|+ |...++-.++ .+.|+||..++.
T Consensus 88 ----~i~me~i~G~~L~~~~~~~~rk----~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~-~~~iIDFd~At~ 155 (201)
T COG2112 88 ----FIRMEYIDGRPLGKLEIGGDRK----HLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDR-DVYIIDFDSATF 155 (201)
T ss_pred ----hhhhhhhcCcchhhhhhcccHH----HHHHHHHHHHHHHHhccchhhhcCCceeEEecCC-cEEEEEccchhh
Confidence 2669999998776655443333 34456666566777899999985 4545554455 699999998863
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.53 E-value=3.9e-06 Score=69.25 Aligned_cols=80 Identities=16% Similarity=0.328 Sum_probs=57.3
Q ss_pred eeeeeeecceEEEEEEEecCCceEEEEEeccc-chHHHHHHHHHHHhhcCC-CCeeeeeeeeec-cCCCCcEEEEEeecC
Q 020826 26 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGG-PNIVKLLDIVRD-QQSKTPSLIFEHVNN 102 (321)
Q Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-~~~~~~~E~~~l~~l~~h-~~i~~~~~~~~~-~~~~~~~lv~e~~~~ 102 (321)
++.++.|..+.||++...+ ..+++|..... ....+..|..+++.+..+ ..+++++..... ......+++++++.|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g 79 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG 79 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence 4678999999999998733 59999998765 456788999999888544 236667664322 223346899999999
Q ss_pred chhhh
Q 020826 103 TDFKV 107 (321)
Q Consensus 103 ~~l~~ 107 (321)
..+..
T Consensus 80 ~~~~~ 84 (239)
T PF01636_consen 80 RPLDD 84 (239)
T ss_dssp EEHHH
T ss_pred ccccc
Confidence 87766
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.49 E-value=3e-06 Score=69.44 Aligned_cols=71 Identities=24% Similarity=0.353 Sum_probs=51.2
Q ss_pred eeeeeecceEEEEEEEecCCceEEEEEecccc-hHHHHHHHHHHHhhcCC-CCeeeeeeeeeccCCCCcEEEEEeecCc
Q 020826 27 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-KKKIKREIKILQNLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNT 103 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~E~~~l~~l~~h-~~i~~~~~~~~~~~~~~~~lv~e~~~~~ 103 (321)
..||+|..+.||+. .+..+++|..+... .....+|.+++..+... -.+++.+.+..+.+. ..++|+++.|.
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~--~glv~e~i~G~ 79 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGR--LGLIYELIVGK 79 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCe--eeeeeeecCCc
Confidence 46899999999983 24568899877533 45689999999998433 235777777644333 45899999986
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.45 E-value=3.8e-06 Score=69.94 Aligned_cols=75 Identities=20% Similarity=0.206 Sum_probs=54.7
Q ss_pred eeeecc-eEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeecCchhhh
Q 020826 29 VGRGKY-SEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKV 107 (321)
Q Consensus 29 lg~g~~-g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~ 107 (321)
|..|.+ +.||+... .+..+++|.........+.+|+.+++.+..+-.+++++.+.... ...++||++++|.++..
T Consensus 6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDD--GRAWLLTSAVPGVPAAA 81 (244)
T ss_pred cCCCCCcCeEEEEcC--CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecC--CccEEEEEeeCCccHhH
Confidence 455655 78899865 34688899876554556889999999986666677888776443 34679999999887653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.2e-06 Score=84.45 Aligned_cols=199 Identities=19% Similarity=0.236 Sum_probs=132.5
Q ss_pred HHHHHHHHHhhcCCCCeeeeeeeeeccCCCC--cEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCC
Q 020826 62 IKREIKILQNLCGGPNIVKLLDIVRDQQSKT--PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGI 136 (321)
Q Consensus 62 ~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~--~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i 136 (321)
.+.|+..+..+ .|+|++.++.+........ ..+..+++...++...+ ...+...++.+..+.+.||+++|+...
T Consensus 229 ~E~e~~~l~k~-~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l 307 (1351)
T KOG1035|consen 229 TEIELESLSKI-AHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSL 307 (1351)
T ss_pred HHHHHHHHHhh-ccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhcc
Confidence 45567777777 8999999888764332222 12344667666655444 458888999999999999999999966
Q ss_pred eeecCCCC---CeEEcCCCCeEEEe--eccceeecCCCCccccccCCccccccccccCCCCC--CCcchHHHHHHHHHHH
Q 020826 137 MHRDVKPH---NVMIDHEQRKLRLI--DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY--DYSLDLWSLGCMFAGM 209 (321)
Q Consensus 137 ~H~dlkp~---nili~~~~~~v~l~--dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~--~~~~DvwslG~~l~~l 209 (321)
.|.-+... +.-.+.++ .+.++ ||+.+.................+-++|.... ... ....|+|.+|.....+
T Consensus 308 ~~v~L~~s~~~~~~~~~e~-~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~-~~~~~~r~~dL~~lgll~~~~ 385 (1351)
T KOG1035|consen 308 EHVVLSASSSKESTVDGEG-VVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKE-NTAKKSRLTDLWCLGLLLLQL 385 (1351)
T ss_pred ceeEEecccccccccCccc-eeecchhhhcccccCCCcccchhhcCcccccccccccc-ccchhhhhhHHHHHHHHHhhh
Confidence 66555544 33334344 45555 8888776655544444455556777777754 333 3447999999999999
Q ss_pred HhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhh
Q 020826 210 IFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLL 289 (321)
Q Consensus 210 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l 289 (321)
..|..+-.... .... ++.. ....+..+.+.+|+
T Consensus 386 ~~~~~i~~~~~----~~~~---------------------------------------~l~~----~~~~~~~d~~~~~~ 418 (1351)
T KOG1035|consen 386 SQGEDISEKSA----VPVS---------------------------------------LLDV----LSTSELLDALPKCL 418 (1351)
T ss_pred hhcCccccccc----chhh---------------------------------------hhcc----ccchhhhhhhhhhc
Confidence 88765531000 0000 0000 01125778999999
Q ss_pred ccCCCCCcCHHHHhcCCCccc
Q 020826 290 RYDHQERPTAKEAMAHPYFFP 310 (321)
Q Consensus 290 ~~dp~~Rps~~ell~hp~~~~ 310 (321)
.-++++|+++.+++.|+|.+.
T Consensus 419 ~~~~~~Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 419 DEDSEERLSALELLTHPFLRF 439 (1351)
T ss_pred chhhhhccchhhhhhchhccc
Confidence 999999999999999999875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.35 E-value=9.5e-08 Score=86.27 Aligned_cols=245 Identities=15% Similarity=0.106 Sum_probs=161.8
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEE
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 98 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 98 (321)
...-+...+.+++++++++++.+...+...+ .+.+... -...-++++|.++ +||| ..+++.-..+...+.++.++
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--l~~rl~~eLLdK~-n~P~-~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--LSRRLAIELLDKV-NNPN-PVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--hhhHHHHHHHHHc-cCCC-CcccccccCCcccccchhhh
Confidence 3444566677889999999998876555444 6665433 3445678889998 8999 33333333455677889999
Q ss_pred eecCc-hhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCccc
Q 020826 99 HVNNT-DFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 173 (321)
Q Consensus 99 ~~~~~-~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~~ 173 (321)
++.++ +-...+. .+.+.+...+...-+.+++++|+.-=+|+| ||+... + .++..||+....+.......
T Consensus 315 i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~-~~~~~~~~v~~~L~~~~~~~ 388 (829)
T KOG0576|consen 315 ICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-E-EVKLLDFAVPPQLTRTMKPR 388 (829)
T ss_pred hhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-c-ccccccccCCcccCcccccc
Confidence 99877 2222221 244455566677778899999988667877 777764 3 58999999887776555567
Q ss_pred cccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhh
Q 020826 174 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 253 (321)
Q Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (321)
...+++.++|||+... ..+....|+|++|.-..++.-|..|-. . ....+.. .+.
T Consensus 389 t~~~~~~~~~pev~~~-~~~~~~p~~~~~~~~~~~~ap~~pPr~-~--P~~~~~~----~g~------------------ 442 (829)
T KOG0576|consen 389 TAIGTPEPLAPEVIQE-NTIDGCPDSGSLAVSAIQMAPGLPPRS-S--PPAVLPM----IGN------------------ 442 (829)
T ss_pred cCCCCCCCCCchhhcc-cccccCCCccCCCcchhhcCCCCCCCC-C--CccccCC----CCC------------------
Confidence 7789999999998877 678889999999987666666655431 1 0000000 000
Q ss_pred HhhhcccCCCCCccccccccccCCcchH-HHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 254 AALVGRHSRKPWSKFITVENQHLAVPEA-VDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~-~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
.+....+... ...++.. .++...|+.--|..|+.+.+++-|.+|++-
T Consensus 443 ---------~p~s~~L~~~--~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngC 490 (829)
T KOG0576|consen 443 ---------GPNSPMLTDK--SAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGC 490 (829)
T ss_pred ---------CCCccccchh--hhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence 0000000000 0111122 247888999999999999999999999863
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.33 E-value=5.6e-06 Score=75.15 Aligned_cols=134 Identities=19% Similarity=0.271 Sum_probs=87.1
Q ss_pred eeeeeecceEEEEEEEecCCceEEEEEecccchH----------------------------------HHHHHHHHHHhh
Q 020826 27 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK----------------------------------KIKREIKILQNL 72 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~----------------------------------~~~~E~~~l~~l 72 (321)
+.|+..+.|.|++|+.+ +|+.||||+.++.-.+ .+..|++..+.-
T Consensus 167 ~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 45889999999999985 5999999997653221 122333322211
Q ss_pred c---------CCCC------eeeeeeeeeccCCCCcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHH
Q 020826 73 C---------GGPN------IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHS 133 (321)
Q Consensus 73 ~---------~h~~------i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~ 133 (321)
+ .|-+ |++++..+ ....+|+|||+.|..+.+.. .+++...+..-+.+.. ++.+-.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~----st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~--~~qIf~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL----STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAY--LEQIFK 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc----CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHH--HHHHHh
Confidence 0 2233 55555443 22346999999998664443 3466665544444432 234445
Q ss_pred CCCeeecCCCCCeEEcC---CCCeEEEeeccceeecC
Q 020826 134 QGIMHRDVKPHNVMIDH---EQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 134 ~~i~H~dlkp~nili~~---~~~~v~l~dfg~~~~~~ 167 (321)
.|++|+|-.|.||++.+ .+..+.+.|||+.....
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 78999999999999984 34489999999987554
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.28 E-value=2.3e-05 Score=76.55 Aligned_cols=80 Identities=19% Similarity=0.290 Sum_probs=56.4
Q ss_pred eeeeeeecceEEEEEEEecCC--ceEEEEEeccc----chHHHHHHHHHHHhhcCCCC--eeeeeeeeeccC-CCCcEEE
Q 020826 26 VRKVGRGKYSEVFEGVHCTDN--EKCIIKILKPV----KKKKIKREIKILQNLCGGPN--IVKLLDIVRDQQ-SKTPSLI 96 (321)
Q Consensus 26 ~~~lg~g~~g~v~~~~~~~~~--~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~--i~~~~~~~~~~~-~~~~~lv 96 (321)
+..++.|.++.+|+.....++ ..+++|..... ....+.+|..+++.+..|++ +++++.++.+.. ....++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 567899999999998764332 46778875432 23568899999999954554 478887775532 2346799
Q ss_pred EEeecCchh
Q 020826 97 FEHVNNTDF 105 (321)
Q Consensus 97 ~e~~~~~~l 105 (321)
||++.|..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999988753
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.26 E-value=4.3e-05 Score=60.54 Aligned_cols=126 Identities=23% Similarity=0.304 Sum_probs=89.7
Q ss_pred cCceEEeeeeeeecc-eEEEEEEEecCCceEEEEEecc---c---------------------chHHHHHHHHHHHhhcC
Q 020826 20 QDDYEVVRKVGRGKY-SEVFEGVHCTDNEKCIIKILKP---V---------------------KKKKIKREIKILQNLCG 74 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~-g~v~~~~~~~~~~~~~vK~~~~---~---------------------~~~~~~~E~~~l~~l~~ 74 (321)
..+++.++.||.|.- |.||+++. +|..+|+|+++. . ...-+..|..+.-+|+.
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke 113 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKE 113 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHh
Confidence 479999999999999 99999987 777999999421 0 01235678888887742
Q ss_pred --CCCe--eeeeeeeecc----------------CCCCcEEEEEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHC
Q 020826 75 --GPNI--VKLLDIVRDQ----------------QSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 134 (321)
Q Consensus 75 --h~~i--~~~~~~~~~~----------------~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~ 134 (321)
+..+ ++++++..-. ......||-|+..... .+. ..-+.+|++-+..+|+.
T Consensus 114 ~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------~~~----~~~~~~~~~dl~~~~k~ 183 (207)
T PF13095_consen 114 AGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------PLQ----IRDIPQMLRDLKILHKL 183 (207)
T ss_pred ccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------ccc----hhHHHHHHHHHHHHHHC
Confidence 3344 8999987322 1112346777665433 122 33456778888999999
Q ss_pred CCeeecCCCCCeEEcCCCCeEEEeeccce
Q 020826 135 GIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163 (321)
Q Consensus 135 ~i~H~dlkp~nili~~~~~~v~l~dfg~~ 163 (321)
||+-+|+++.|.. +| +|+|||.+
T Consensus 184 gI~~~Dv~~~ny~---~G---~lvDfs~~ 206 (207)
T PF13095_consen 184 GIVPRDVKPRNYR---GG---KLVDFSSS 206 (207)
T ss_pred CeeeccCcccccc---CC---EEEecccC
Confidence 9999999999985 44 78999854
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.7e-05 Score=65.71 Aligned_cols=75 Identities=11% Similarity=0.161 Sum_probs=48.2
Q ss_pred eeeeeecce-EEEEEEEecCCceEEEEEeccc-chHHHHHHHHHHHhhcCC--CCeeeeeeeeeccCC-CCcEEEEEeec
Q 020826 27 RKVGRGKYS-EVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGG--PNIVKLLDIVRDQQS-KTPSLIFEHVN 101 (321)
Q Consensus 27 ~~lg~g~~g-~v~~~~~~~~~~~~~vK~~~~~-~~~~~~~E~~~l~~l~~h--~~i~~~~~~~~~~~~-~~~~lv~e~~~ 101 (321)
+.++.|+.. .||+. +..+++|..+.. ....+.+|..++..+..+ -.++++++.....+. ...+++|+++.
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 456777776 58875 235788886653 345789999999988533 245555554432222 24578999999
Q ss_pred Cchhh
Q 020826 102 NTDFK 106 (321)
Q Consensus 102 ~~~l~ 106 (321)
|.++.
T Consensus 78 G~~l~ 82 (235)
T cd05155 78 GETAT 82 (235)
T ss_pred CCCCC
Confidence 87653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.19 E-value=6.6e-05 Score=59.89 Aligned_cols=125 Identities=20% Similarity=0.406 Sum_probs=87.5
Q ss_pred eeeeeeecceEEEEEEEecCCceEEEEEecccc-------------------hHHHHHHHHHHHhhc-----CCCCeeee
Q 020826 26 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-------------------KKKIKREIKILQNLC-----GGPNIVKL 81 (321)
Q Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-------------------~~~~~~E~~~l~~l~-----~h~~i~~~ 81 (321)
...||+|+.-.||.- ......+||+.++.. .+...+|+.....+. .+.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H---P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH---PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC---CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 346899999999963 355677899987766 566788888887773 26789999
Q ss_pred eeeeeccCCCCcEEEEEeecCc------hhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCC-
Q 020826 82 LDIVRDQQSKTPSLIFEHVNNT------DFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ- 152 (321)
Q Consensus 82 ~~~~~~~~~~~~~lv~e~~~~~------~l~~~~~--~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~- 152 (321)
+++.+ .+..+.+|+|..... +|.+++. .++. .. ...+-+-..+|-+.+|+.+|++|.||++...+
T Consensus 83 ~G~ve--T~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~~---~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 83 YGFVE--TNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-EL---RQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred eEEEe--cCCceEEEEEEEECCCCCcCccHHHHHHcCCccH-HH---HHHHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 99984 445567888876432 4666663 2444 33 33334456688899999999999999996433
Q ss_pred -C-eEEEee
Q 020826 153 -R-KLRLID 159 (321)
Q Consensus 153 -~-~v~l~d 159 (321)
. .+.|+|
T Consensus 157 ~~~~lvlID 165 (199)
T PF10707_consen 157 GEFRLVLID 165 (199)
T ss_pred CceEEEEEe
Confidence 2 455555
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.0003 Score=58.14 Aligned_cols=74 Identities=14% Similarity=0.253 Sum_probs=49.6
Q ss_pred eeeeeeecceEEEEEEEec-CCceEEEEEecccch--HHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeecC
Q 020826 26 VRKVGRGKYSEVFEGVHCT-DNEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 102 (321)
Q Consensus 26 ~~~lg~g~~g~v~~~~~~~-~~~~~~vK~~~~~~~--~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 102 (321)
++.|..|-...+|++.... .++.+++|+...... -...+|..+++.+..+.-.++++.... . .+++||+.|
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~----~~l~e~i~G 76 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQ--N----GLIYEFIPG 76 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeC--C----cEEEEeeCC
Confidence 3457778888999987532 357899998764322 233578888888855555566665432 1 389999988
Q ss_pred chh
Q 020826 103 TDF 105 (321)
Q Consensus 103 ~~l 105 (321)
.++
T Consensus 77 ~~l 79 (235)
T cd05157 77 RTL 79 (235)
T ss_pred CcC
Confidence 765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.88 E-value=0.0001 Score=58.51 Aligned_cols=95 Identities=22% Similarity=0.187 Sum_probs=76.4
Q ss_pred HHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeecCchhh-------hhcCCCCHHHHHHHHHHHHHHHHHHHH--
Q 020826 63 KREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-------VLYPTLSDYDVRYYIYELLKALDYCHS-- 133 (321)
Q Consensus 63 ~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~-------~~~~~~~~~~~~~i~~qi~~~l~~lh~-- 133 (321)
..|.-+++.+...+++++++|.+- . +++.|+.+.+.+. .+ -..++....+++.+++..+++++.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~--~~v~E~~~~~~~~~~~~~l~~~-~~~~w~~R~~iA~~lL~~l~~l~~~~ 79 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----R--FYVVEYVGAGSLYGIYRPLSQF-LQSPWEQRAKIALQLLELLEELDHGP 79 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----C--EEEEEeecCccccccccccccc-cccCHHHHHHHHHHHHHHHHHHhcCC
Confidence 357778888866679999999982 2 4899999976543 22 246888899999999999999997
Q ss_pred -CCCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 134 -QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 134 -~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
..+.-.|++|+|+.++.++ .++++|.+.+..
T Consensus 80 ~~~~~lcDv~~~nfgv~~~~-~lk~iDld~v~~ 111 (188)
T PF12260_consen 80 LGFFYLCDVSPDNFGVNDDG-RLKLIDLDDVFV 111 (188)
T ss_pred CCcEEEeecchHHeEEeCCC-cEEEEechhcch
Confidence 3467789999999999877 799999987643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.87 E-value=0.00017 Score=60.43 Aligned_cols=127 Identities=22% Similarity=0.256 Sum_probs=76.7
Q ss_pred eeeecceEEEEEEEecCCceEEEEEecccchH---HHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeecCchh
Q 020826 29 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK---KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 105 (321)
Q Consensus 29 lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~---~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l 105 (321)
+..|-.+.+|+.. .++..+++|........ ...+|..+++.+..+.-.++++... . .++|++|+.|..+
T Consensus 4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~----~~~v~e~i~G~~~ 75 (256)
T TIGR02721 4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E----HWLLVEWLEGEVI 75 (256)
T ss_pred CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C----CEEEEEeccCccc
Confidence 4567778899876 45678889986543222 3578999999885443345555443 2 2589999988765
Q ss_pred hhh-------c----------CC-------CCHH-HHHHHHHHH---------HHHHHHHHHC--------CCeeecCCC
Q 020826 106 KVL-------Y----------PT-------LSDY-DVRYYIYEL---------LKALDYCHSQ--------GIMHRDVKP 143 (321)
Q Consensus 106 ~~~-------~----------~~-------~~~~-~~~~i~~qi---------~~~l~~lh~~--------~i~H~dlkp 143 (321)
... . .. ++.. .+..+..++ ...+..+-.. .++|+|+.|
T Consensus 76 ~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~ 155 (256)
T TIGR02721 76 TLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHA 155 (256)
T ss_pred ccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCc
Confidence 321 0 00 1111 111211111 1112222221 489999999
Q ss_pred CCeEEcCCCCeEEEeeccceee
Q 020826 144 HNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 144 ~nili~~~~~~v~l~dfg~~~~ 165 (321)
.||+++.++ +.++||..+..
T Consensus 156 ~Nil~~~~~--~~lIDwE~a~~ 175 (256)
T TIGR02721 156 YNLVVTPQG--LKLIDWEYASD 175 (256)
T ss_pred CcEEEeCCC--CEEEeccccCc
Confidence 999998765 78999998754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00034 Score=60.20 Aligned_cols=134 Identities=20% Similarity=0.280 Sum_probs=90.6
Q ss_pred eEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-------------------------h----HHHHHHHHHHHhhc
Q 020826 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-------------------------K----KKIKREIKILQNLC 73 (321)
Q Consensus 23 y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-------------------------~----~~~~~E~~~l~~l~ 73 (321)
-.+.+.|..|.-+.||.|.. .+|..+|||+++..- + -..+.|..-|.++
T Consensus 146 ~~inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl- 223 (520)
T KOG2270|consen 146 VEINGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRL- 223 (520)
T ss_pred eecccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHH-
Confidence 35677899999999999987 677889999974210 1 1245677777777
Q ss_pred CCCCeeeeeeeeeccCCCCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHH-HCCCeeecCCCCCeEEc
Q 020826 74 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCH-SQGIMHRDVKPHNVMID 149 (321)
Q Consensus 74 ~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh-~~~i~H~dlkp~nili~ 149 (321)
....|+----+.. ..-+|||++++......-. ..++...+..+-.|++.-+.-|- .+++||.||+--|+++.
T Consensus 224 ~~aGIP~PePIlL----k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 224 NNAGIPCPEPILL----KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH 299 (520)
T ss_pred HhcCCCCCCceee----ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE
Confidence 3322222111111 1235999999865543222 23666677777777777776654 57999999999999997
Q ss_pred CCCCeEEEeecccee
Q 020826 150 HEQRKLRLIDWGLAE 164 (321)
Q Consensus 150 ~~~~~v~l~dfg~~~ 164 (321)
+| .++++|.+=+-
T Consensus 300 -dG-~lyiIDVSQSV 312 (520)
T KOG2270|consen 300 -DG-KLYIIDVSQSV 312 (520)
T ss_pred -CC-EEEEEEccccc
Confidence 55 79999987553
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00044 Score=59.32 Aligned_cols=137 Identities=14% Similarity=0.200 Sum_probs=83.2
Q ss_pred eeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCC-Ceeeeeeeeec----cCCCCcEEEEEee
Q 020826 26 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGP-NIVKLLDIVRD----QQSKTPSLIFEHV 100 (321)
Q Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~-~i~~~~~~~~~----~~~~~~~lv~e~~ 100 (321)
.+.+..|....+|+... ++..+++|+........+..|+.++..|.++- .+++++....+ ......+.+++++
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i 96 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL 96 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence 55677787789998764 34578999987655667888999888884331 34555442110 1122457899999
Q ss_pred cCchhhhhc------------------CCCCH--------HHHH------------HHHHHHHHHHHHHHH-------CC
Q 020826 101 NNTDFKVLY------------------PTLSD--------YDVR------------YYIYELLKALDYCHS-------QG 135 (321)
Q Consensus 101 ~~~~l~~~~------------------~~~~~--------~~~~------------~i~~qi~~~l~~lh~-------~~ 135 (321)
+|..+.... ..+.. .... .....+..++.++.+ .+
T Consensus 97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~ 176 (296)
T cd05153 97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG 176 (296)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence 886543200 01100 0000 011112233444443 36
Q ss_pred CeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 136 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 136 i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
++|+|+.|.|++++.++ .+.|.||+.+..
T Consensus 177 l~HgD~~~~Nil~~~~~-~~~iIDfe~a~~ 205 (296)
T cd05153 177 VIHADLFRDNVLFDGDE-LSGVIDFYFACT 205 (296)
T ss_pred CCccCcCcccEEEeCCc-eEEEeehhhhcC
Confidence 99999999999999765 568999998754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00073 Score=58.14 Aligned_cols=73 Identities=16% Similarity=0.193 Sum_probs=48.3
Q ss_pred eeeeeecceEEEEEEEec------CCceEEEEEecccc--hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEE
Q 020826 27 RKVGRGKYSEVFEGVHCT------DNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 98 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~------~~~~~~vK~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 98 (321)
+.+..|-...+|++.... .++.+++|+..... .....+|..++..+..+.-.++++..+. + .+|++
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~----~~v~e 77 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFP--N----GRIEE 77 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeC--C----Cchhh
Confidence 445566667888887532 25789999976542 2456788888888855444556666552 1 26788
Q ss_pred eecCchh
Q 020826 99 HVNNTDF 105 (321)
Q Consensus 99 ~~~~~~l 105 (321)
++.|..+
T Consensus 78 ~i~G~~l 84 (302)
T cd05156 78 FIPSRTL 84 (302)
T ss_pred eeCCCcC
Confidence 8877654
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.60 E-value=0.001 Score=57.77 Aligned_cols=137 Identities=12% Similarity=0.200 Sum_probs=77.1
Q ss_pred eeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCC-CCeeeeeeeeec----cCCCCcEEEEEee
Q 020826 26 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGG-PNIVKLLDIVRD----QQSKTPSLIFEHV 100 (321)
Q Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h-~~i~~~~~~~~~----~~~~~~~lv~e~~ 100 (321)
.+.++.|...++|+... . +..+++|+++......+..|...++.|..+ -.+++.+....+ ......+++++++
T Consensus 27 ~~~l~~G~~n~~y~v~t-~-~g~~vLK~~~~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l 104 (319)
T PRK05231 27 LKGIAEGIENSNFFLTT-T-QGEYVLTLFERLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFL 104 (319)
T ss_pred cchhccccccceEEEEe-C-CCcEEEEEeccCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEec
Confidence 44567777789999875 2 336889988643456667777777777322 124444431100 1123357899998
Q ss_pred cCchhhh-----h------c-------CCCC----------H-HHH-HH-----------HHHH-HHHHHHHHH------
Q 020826 101 NNTDFKV-----L------Y-------PTLS----------D-YDV-RY-----------YIYE-LLKALDYCH------ 132 (321)
Q Consensus 101 ~~~~l~~-----~------~-------~~~~----------~-~~~-~~-----------i~~q-i~~~l~~lh------ 132 (321)
+|..+.. . + ..++ . ... .. .+.+ +...++.+.
T Consensus 105 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 184 (319)
T PRK05231 105 EGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPA 184 (319)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccccc
Confidence 8864311 0 0 1110 0 000 00 1111 111122222
Q ss_pred -HCCCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 133 -SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 133 -~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
..+++|+|+.|.||+++.+. ...++||+.+..
T Consensus 185 lp~~liHgD~~~~Nil~~~~~-~~~iIDf~~~~~ 217 (319)
T PRK05231 185 LPRGVIHADLFRDNVLFEGDR-LSGFIDFYFACN 217 (319)
T ss_pred CCcccCCCCCCCCcEEEECCc-eEEEEecccccC
Confidence 23799999999999998554 558999998854
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.0011 Score=58.74 Aligned_cols=74 Identities=16% Similarity=0.255 Sum_probs=52.7
Q ss_pred eeeeeeecceEEEEEEEecCCceEEEEEecc----------cchHHHHHHHHHHHhhcCC--CCeeeeeeeeeccCCCCc
Q 020826 26 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKP----------VKKKKIKREIKILQNLCGG--PNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~----------~~~~~~~~E~~~l~~l~~h--~~i~~~~~~~~~~~~~~~ 93 (321)
.+.||.|.+..||++.+..+++.++||.-.+ ....+...|.+.|+.+... .++++++.+- . ...
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D--~--~~~ 106 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD--E--ELA 106 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC--C--CCC
Confidence 4578999999999999854446899997431 1335567788888886433 4678888774 2 234
Q ss_pred EEEEEeecCc
Q 020826 94 SLIFEHVNNT 103 (321)
Q Consensus 94 ~lv~e~~~~~ 103 (321)
++|||++++.
T Consensus 107 ~lVME~L~~~ 116 (401)
T PRK09550 107 VTVMEDLSDH 116 (401)
T ss_pred EEEEecCCCc
Confidence 6999998753
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00013 Score=61.61 Aligned_cols=131 Identities=19% Similarity=0.315 Sum_probs=92.2
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEecc-------c--c----------------hHHHHHHHHHHHhhcCCC
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-------V--K----------------KKKIKREIKILQNLCGGP 76 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~-------~--~----------------~~~~~~E~~~l~~l~~h~ 76 (321)
=+.+.+.||-|.-+.||.+.+ ..|+..++|.=+. . . +-...+|...|+.|..|.
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 456778899999999999988 6788888886210 0 0 011457888888885443
Q ss_pred -CeeeeeeeeeccCCCCcEEEEEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeE
Q 020826 77 -NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL 155 (321)
Q Consensus 77 -~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v 155 (321)
.+++.+++.. .++|||...|-.+.....-.+... +...++.-+--|..+|++|||.+-=||++..++ .+
T Consensus 172 fpVPkpiD~~R------H~Vvmelv~g~Pl~~v~~v~d~~~---ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~-~i 241 (465)
T KOG2268|consen 172 FPVPKPIDHNR------HCVVMELVDGYPLRQVRHVEDPPT---LYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD-KI 241 (465)
T ss_pred CCCCCcccccc------eeeHHHhhcccceeeeeecCChHH---HHHHHHHHHHHHHHcCceecccchheeEEecCC-CE
Confidence 3555555432 268999888877665543333333 334444556678889999999999999999776 79
Q ss_pred EEeeccce
Q 020826 156 RLIDWGLA 163 (321)
Q Consensus 156 ~l~dfg~~ 163 (321)
+++||-=.
T Consensus 242 ~vIDFPQm 249 (465)
T KOG2268|consen 242 VVIDFPQM 249 (465)
T ss_pred EEeechHh
Confidence 99999743
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0017 Score=55.99 Aligned_cols=140 Identities=17% Similarity=0.239 Sum_probs=81.6
Q ss_pred eEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-chHHHHHHHHHHHhhcCC-CCeeeeeeeeec----cCCCCcEEE
Q 020826 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGG-PNIVKLLDIVRD----QQSKTPSLI 96 (321)
Q Consensus 23 y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-~~~~~~~E~~~l~~l~~h-~~i~~~~~~~~~----~~~~~~~lv 96 (321)
...+..++.|....+|++.. ++..+++|+.+.. ....+..|.+++..|.++ -.+++++....+ ......+++
T Consensus 24 ~~~i~~~~~G~~n~~y~v~t--~~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l 101 (307)
T TIGR00938 24 LLSLKGIAEGVENSNYLLTT--DVGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACL 101 (307)
T ss_pred ceeccccCCccccceEEEEe--CCCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEE
Confidence 33455677777789998764 3346888987653 245667788888887322 124454442110 112345789
Q ss_pred EEeecCchhhhh-----c-------------CCCCH-------HHHHH----------------HHHHHHHHHHHHHH--
Q 020826 97 FEHVNNTDFKVL-----Y-------------PTLSD-------YDVRY----------------YIYELLKALDYCHS-- 133 (321)
Q Consensus 97 ~e~~~~~~l~~~-----~-------------~~~~~-------~~~~~----------------i~~qi~~~l~~lh~-- 133 (321)
++|++|..+... . ..++. ...+. ....+...++++..
T Consensus 102 ~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~ 181 (307)
T TIGR00938 102 VEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFW 181 (307)
T ss_pred EEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhh
Confidence 999887543210 0 11100 00000 01112234444432
Q ss_pred -----CCCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 134 -----QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 134 -----~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
.+++|+|+.+.|++++.++ .+.++||+.+..
T Consensus 182 ~~~~~~~l~HgD~~~~Nvl~~~~~-~~~vIDfd~~~~ 217 (307)
T TIGR00938 182 PRDLPRGVIHADLFPDNVLFDGDS-VKGVIDFYFACT 217 (307)
T ss_pred hhcCCCccCCCCCCcCcEEEECCc-eEEEeecccccC
Confidence 5799999999999998776 678999998754
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0016 Score=55.79 Aligned_cols=109 Identities=9% Similarity=0.103 Sum_probs=79.5
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-chHHHHHHHHHHHhhcCC--CCeeeeeeeeeccC-CCCcEEEE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGG--PNIVKLLDIVRDQQ-SKTPSLIF 97 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-~~~~~~~E~~~l~~l~~h--~~i~~~~~~~~~~~-~~~~~lv~ 97 (321)
...-.+.||.|..+.||+... .+..+++|..+.. ....+..|...++.|.++ -.++++++++.+.. ....++||
T Consensus 15 ~~~~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 15 KLSRVECISEQPYAALWALYD--SQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hhheeeecCCccceeEEEEEc--CCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 444566799999999999864 3335778886552 456899999999999654 47889998775432 23467999
Q ss_pred EeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHC
Q 020826 98 EHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 134 (321)
Q Consensus 98 e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~ 134 (321)
|++.+.++.+. .........+..+++.+|+.||+.
T Consensus 93 E~i~G~~~~~~--~~~~~~~~~l~~~l~~~La~LH~~ 127 (297)
T PRK10593 93 ERLRGVSVEAP--ARTPERWEQLKDQIVEGLLAWHRI 127 (297)
T ss_pred eccCCEecCCC--CCCHHHHHHHHHHHHHHHHHHhCC
Confidence 99999887662 233444566777888999999985
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0041 Score=52.67 Aligned_cols=31 Identities=35% Similarity=0.705 Sum_probs=25.5
Q ss_pred CCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 135 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 135 ~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
.++|+|++|.||+++.++...-|.||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 3899999999999986453567999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0092 Score=51.20 Aligned_cols=143 Identities=19% Similarity=0.300 Sum_probs=83.5
Q ss_pred eEEeeeeeeecceEEEEEEEecCCceEEEEEecc-----cchHHHHHHHHHHHhhcC-CCCeeeeeeeeeccCCCCcEEE
Q 020826 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCG-GPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 23 y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~-----~~~~~~~~E~~~l~~l~~-h~~i~~~~~~~~~~~~~~~~lv 96 (321)
..+.+.+..|....+|...+ +++.+++. ..+ .......+|..+++.+.. .-.+...++++.+.....++.|
T Consensus 27 ~~~v~~~~~G~sn~t~~~~~--~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v 103 (321)
T COG3173 27 LLIVEEISGGWSNDTFRLGD--TGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV 103 (321)
T ss_pred CceeeeccCCcccceEEEec--CCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence 34444454455556666554 37788888 221 123556788888888743 3345556666643333467899
Q ss_pred EEeecCchhhhhcCCCCHH-----------------------------------HHHHHHHH--------------HHHH
Q 020826 97 FEHVNNTDFKVLYPTLSDY-----------------------------------DVRYYIYE--------------LLKA 127 (321)
Q Consensus 97 ~e~~~~~~l~~~~~~~~~~-----------------------------------~~~~i~~q--------------i~~~ 127 (321)
|+++.|............. ++.....+ ....
T Consensus 104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~ 183 (321)
T COG3173 104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL 183 (321)
T ss_pred EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence 9999984322222111000 11111111 1122
Q ss_pred HHHHHHC--------CCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 128 LDYCHSQ--------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 128 l~~lh~~--------~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
..+++.+ .++|||+.+.|++++.++ -+-+.||+.+....+.
T Consensus 184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~-~~gVlDwe~~~lGDP~ 232 (321)
T COG3173 184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGR-PTGVLDWELATLGDPL 232 (321)
T ss_pred HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCC-eeEEEeccccccCCcH
Confidence 3444433 379999999999999888 5899999999765443
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.011 Score=51.93 Aligned_cols=137 Identities=19% Similarity=0.248 Sum_probs=80.7
Q ss_pred ceEEeeeeeeecceEEEEEEEec----CCceEEEEEecccchH--HHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCT----DNEKCIIKILKPVKKK--KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~----~~~~~~vK~~~~~~~~--~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
...+ ..+..|-...+|++.... +++.+++|+....... ....|..+++.+..+.--+++++.+ .+. .
T Consensus 38 ~~~i-~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~--~~g----~ 110 (344)
T PLN02236 38 ALQV-IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRF--PNG----R 110 (344)
T ss_pred cEEE-EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEE--CCc----e
Confidence 4443 355567778999987532 2468999987653221 2367888988886555556677665 222 5
Q ss_pred EEEeecCchhhhh--c------------------C-C----CC-HHHHHHHHHHH-----------------HHHHHHH-
Q 020826 96 IFEHVNNTDFKVL--Y------------------P-T----LS-DYDVRYYIYEL-----------------LKALDYC- 131 (321)
Q Consensus 96 v~e~~~~~~l~~~--~------------------~-~----~~-~~~~~~i~~qi-----------------~~~l~~l- 131 (321)
+.+|+.+.++... . . + .. ...+..+..++ ...+..|
T Consensus 111 v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~ 190 (344)
T PLN02236 111 VEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLE 190 (344)
T ss_pred EEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHH
Confidence 7888877665311 0 0 0 00 11222222111 1111111
Q ss_pred ---H----HCCCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 132 ---H----SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 132 ---h----~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
. ...++|+|+++.||+++.++..+.++||..+..
T Consensus 191 ~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 191 KELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred HHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 1 125899999999999986444799999998754
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.16 E-value=0.0023 Score=57.54 Aligned_cols=175 Identities=21% Similarity=0.219 Sum_probs=100.6
Q ss_pred hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCee
Q 020826 59 KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMH 138 (321)
Q Consensus 59 ~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H 138 (321)
...+.-..++++.+ .|+|+...+++..... ....+|+|+++...-.-..... .. +.. + + .+|+.|
T Consensus 26 s~~ilgr~~~lktl-~~~~l~~yl~~~r~~~-~r~IVV~e~~~~Sled~~~~~~-l~-~~s----~---~----~~~~~~ 90 (725)
T KOG1093|consen 26 SIQILGRFQYLKSL-QHDNLCQYLDFSRGKH-ERVIVVMEHYTMSLEDILKTGN-LK-DES----L---L----AHGVLH 90 (725)
T ss_pred HHHHhhhhHHHHhh-cCccceeeEeeecCcc-ceEEEEehhhccchHHHHHhcc-cc-hhh----h---c----ccccce
Confidence 45566777888888 8999999998875443 3367899998864433222221 11 000 0 0 112211
Q ss_pred ecCCCCCeEEcCCCCeEEEeeccceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCcc
Q 020826 139 RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY 218 (321)
Q Consensus 139 ~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~ 218 (321)
.| ..+.+| .+.+. | | ....+++||||+|.++.++.-|...+ .
T Consensus 91 -----~~--------~~~~td-~~~t~---------------~--~------~~~~pKsdVwsl~~i~~el~L~~~l~-~ 132 (725)
T KOG1093|consen 91 -----LN--------IIYITD-HFLTK---------------Y--P------SPIGPKSDVWSLGFIILELYLGISLE-A 132 (725)
T ss_pred -----eh--------hhhccc-ccccc---------------C--C------CCCCcchhhhhHHHHHHHHHHhhHHH-H
Confidence 12 223333 00100 0 0 11114999999999999999887665 3
Q ss_pred CCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC
Q 020826 219 GHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT 298 (321)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps 298 (321)
.-.+.+++..+.+..-.+.......... ...-.++..+..++.+|+-..|..||.
T Consensus 133 ~~~~s~~l~~i~k~~~~d~~~~~~a~e~-------------------------~~~~~~d~~~~~~~~~c~~~~~~ir~l 187 (725)
T KOG1093|consen 133 ELTESEYLEILLKYYTDDQELLSTAMEH-------------------------LIQLLADKKRLPLLKKCLWLEPIIRPL 187 (725)
T ss_pred HHHHHHHHHHHHHhccCchhHHHHHHHH-------------------------HHHHhhhHhHHHHhccCCccccccccc
Confidence 4444445544443332222111110000 001124457889999999999999999
Q ss_pred HHHHhcCCCcccC
Q 020826 299 AKEAMAHPYFFPI 311 (321)
Q Consensus 299 ~~ell~hp~~~~~ 311 (321)
..++.+++-|..+
T Consensus 188 ~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 188 PMELSKRCSFTEV 200 (725)
T ss_pred hhHHhcCccHHHH
Confidence 9999999998765
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0082 Score=52.35 Aligned_cols=79 Identities=16% Similarity=0.291 Sum_probs=48.2
Q ss_pred cCceEEeeeeeeecceEEEEEEEecC---CceEEEEEecccch--HHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~---~~~~~vK~~~~~~~--~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
.+..++.. |..|-...+|++...+. +..+++|+...... -.-.+|..+++.+..+.--+++++++ .+.
T Consensus 14 ~~~i~i~~-l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~--~~G---- 86 (330)
T PLN02421 14 DSDFSVER-ISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVF--GNG---- 86 (330)
T ss_pred cCceEEEE-eCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEe--CCc----
Confidence 34555444 44566678898865332 34899998765322 12367888888885544445666655 221
Q ss_pred EEEEeecCchh
Q 020826 95 LIFEHVNNTDF 105 (321)
Q Consensus 95 lv~e~~~~~~l 105 (321)
++.+|+.+.++
T Consensus 87 ~i~~fi~g~~l 97 (330)
T PLN02421 87 MIQSFINARTL 97 (330)
T ss_pred EeehhhcCCCC
Confidence 57788776654
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.98 E-value=0.0087 Score=51.81 Aligned_cols=130 Identities=24% Similarity=0.282 Sum_probs=79.5
Q ss_pred cceEEEEEEEecCCceEEEEEeccc-chHHHHHHHHHHHhhcCCCC-----eeeeeeeeeccCC--CCcEEEEEeecCch
Q 020826 33 KYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPN-----IVKLLDIVRDQQS--KTPSLIFEHVNNTD 104 (321)
Q Consensus 33 ~~g~v~~~~~~~~~~~~~vK~~~~~-~~~~~~~E~~~l~~l~~h~~-----i~~~~~~~~~~~~--~~~~lv~e~~~~~~ 104 (321)
.-..+|+... .+| .+++|+.++. ....+..|+..++.|..+.- ++..-+-....-. ....-+++|++|..
T Consensus 37 ~eN~~f~~~~-~~g-~~iLki~~~~~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~~ 114 (331)
T COG2334 37 EENSNFRVQT-EDG-RYILKIYRPGWTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGRP 114 (331)
T ss_pred ccCceEEEEe-cCC-CeEEEEecCCCCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCcC
Confidence 4567888776 333 3499999886 67788999999999854321 2222221111112 36678899999887
Q ss_pred hhh-hc------------------CCCC-----------HH----H---------HHHHHHHHHHHHHHHHHC-------
Q 020826 105 FKV-LY------------------PTLS-----------DY----D---------VRYYIYELLKALDYCHSQ------- 134 (321)
Q Consensus 105 l~~-~~------------------~~~~-----------~~----~---------~~~i~~qi~~~l~~lh~~------- 134 (321)
+.. .. +.++ +. . ......++...+..+.+.
T Consensus 115 ~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp~ 194 (331)
T COG2334 115 LERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLPA 194 (331)
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCCc
Confidence 762 11 1111 10 0 011233344445555433
Q ss_pred C---CeeecCCCCCeEEcCCCCeEEEeecccee
Q 020826 135 G---IMHRDVKPHNVMIDHEQRKLRLIDWGLAE 164 (321)
Q Consensus 135 ~---i~H~dlkp~nili~~~~~~v~l~dfg~~~ 164 (321)
+ ++|+|+.|.||+++.+...+.+.||+.+.
T Consensus 195 ~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 195 LGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred ccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 3 89999999999999776347899999775
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.00029 Score=70.60 Aligned_cols=150 Identities=11% Similarity=-0.041 Sum_probs=105.0
Q ss_pred HHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeecCchhhhhc-C------CCCHHHHHHHHHHHHHHHHHHHHC-C
Q 020826 64 REIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-P------TLSDYDVRYYIYELLKALDYCHSQ-G 135 (321)
Q Consensus 64 ~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~------~~~~~~~~~i~~qi~~~l~~lh~~-~ 135 (321)
.|.+.++.. .|+++.....-.........+..++++.+|.+...+ + .+.+.-+.....+......-+|.. +
T Consensus 1278 ~e~de~~~~-~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tn 1356 (2724)
T KOG1826|consen 1278 SERDELREA-KHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTN 1356 (2724)
T ss_pred hhhhhhhhh-hceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhccc
Confidence 344444455 788888777766555555566889999888876666 2 133333333334435556666644 2
Q ss_pred ----CeeecCCCCCeEEcCCCCeEEEeeccceeecCC-CCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHH
Q 020826 136 ----IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI 210 (321)
Q Consensus 136 ----i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~ 210 (321)
-+|.++++.|.++..+. +++++++|+.+...+ ........+++.|++|+.... -.++.++|+|..|+.+|...
T Consensus 1357 lg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~-ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1357 LGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNE-IKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred CCccchhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHHHH-HhhhhHHHHHHHHHHHHHHh
Confidence 68899999999999777 899999999984332 223344567778889998766 67787899999999999887
Q ss_pred hCCCCC
Q 020826 211 FRKEPF 216 (321)
Q Consensus 211 ~g~~p~ 216 (321)
.|..+|
T Consensus 1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred cccHHH
Confidence 776665
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.94 E-value=0.011 Score=51.51 Aligned_cols=71 Identities=17% Similarity=0.281 Sum_probs=47.1
Q ss_pred eeeeecceEEEEEEEecCCceEEEEEecc----------cchHHHHHHHHHHHhhcCC-C-CeeeeeeeeeccCCCCcEE
Q 020826 28 KVGRGKYSEVFEGVHCTDNEKCIIKILKP----------VKKKKIKREIKILQNLCGG-P-NIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 28 ~lg~g~~g~v~~~~~~~~~~~~~vK~~~~----------~~~~~~~~E~~~l~~l~~h-~-~i~~~~~~~~~~~~~~~~l 95 (321)
.+|.|....||++.+..+++.++||.-.+ -...+...|...|+..... | .+++++.+- + ....+
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D--~--e~~~~ 77 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFD--T--EMAVT 77 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEc--c--cccee
Confidence 47999999999999754446899997431 1234556788888776432 3 566777653 2 23358
Q ss_pred EEEeecC
Q 020826 96 IFEHVNN 102 (321)
Q Consensus 96 v~e~~~~ 102 (321)
+||+++.
T Consensus 78 vMEdL~~ 84 (370)
T TIGR01767 78 VMEDLSH 84 (370)
T ss_pred hHhhCcc
Confidence 9998854
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.0095 Score=48.33 Aligned_cols=54 Identities=15% Similarity=0.121 Sum_probs=34.6
Q ss_pred CceEEEEEeccc--chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeecCchh
Q 020826 46 NEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF 105 (321)
Q Consensus 46 ~~~~~vK~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l 105 (321)
++.|++++.... ..-....|..+++.+..+..-+++++.+.+ ..+.+|+.+.++
T Consensus 2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~------g~v~e~i~g~~l 57 (211)
T PF01633_consen 2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFEN------GRVEEFIEGRTL 57 (211)
T ss_dssp TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT------EEEEE--SSEE-
T ss_pred CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCC------CcEEEEeccccc
Confidence 467888887655 234567788888888666666778877632 267788877654
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.023 Score=50.19 Aligned_cols=73 Identities=19% Similarity=0.254 Sum_probs=49.0
Q ss_pred eeeeeeecceEEEEEEEecCCceEEEEEecc---------cchHHHHHHHHHHHhhcC-CC-CeeeeeeeeeccCCCCcE
Q 020826 26 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---------VKKKKIKREIKILQNLCG-GP-NIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~---------~~~~~~~~E~~~l~~l~~-h~-~i~~~~~~~~~~~~~~~~ 94 (321)
...||.|...-||++.+...+..++||.-.+ -..++...|.+.|+.+.. .| ++++++.+- + ....
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D--~--e~~~ 109 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD--S--VMNC 109 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC--c--HHhh
Confidence 5678999999999999843456799986421 123566778888887643 23 577777653 2 2234
Q ss_pred EEEEeecC
Q 020826 95 LIFEHVNN 102 (321)
Q Consensus 95 lv~e~~~~ 102 (321)
+|||+++.
T Consensus 110 ~vMEdL~~ 117 (409)
T PRK12396 110 CVMEDLSD 117 (409)
T ss_pred HHHHhCcc
Confidence 78887753
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.39 E-value=0.044 Score=47.31 Aligned_cols=30 Identities=17% Similarity=0.303 Sum_probs=26.7
Q ss_pred CCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 135 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 135 ~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
+++|+|+.+.|++++.++ .+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~-~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETR-GGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCC-CEEEEEhhhccc
Confidence 699999999999998777 689999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.30 E-value=0.016 Score=50.98 Aligned_cols=125 Identities=20% Similarity=0.211 Sum_probs=73.5
Q ss_pred eeeeecceEEEEEEEe---------------cCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeee-------
Q 020826 28 KVGRGKYSEVFEGVHC---------------TDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIV------- 85 (321)
Q Consensus 28 ~lg~g~~g~v~~~~~~---------------~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~------- 85 (321)
.||.|+-+.||+|..+ .+.+.+|+|+.++...+.+...+.++.....-+|+++-..+.
T Consensus 196 PIGsG~IAQVY~atl~~a~lekd~~~~~~~~~~tq~~AiKv~Hp~V~~~ir~Dl~Il~f~Akl~~~vP~l~wL~l~~~vk 275 (565)
T KOG1236|consen 196 PIGSGCIAQVYRATLKTAYLEKDSGKEYVQKLGTQSCAIKVLHPNVEKQIRLDLGILGFGAKLINNVPDLSWLSLPLEVK 275 (565)
T ss_pred ccccchhhhhhhhhhhHHHhhcccchhhhcCCccceeeeeccCccHHHHHHHHHHHHhhhhhhhhhcCccccccCcchHH
Confidence 4899999999998532 123578999998877777666666655443222222221111
Q ss_pred --------------------------ec------c-----CCCCcEEEEEeecCchhhhhcCC--CCHHHHHHHHHHHHH
Q 020826 86 --------------------------RD------Q-----QSKTPSLIFEHVNNTDFKVLYPT--LSDYDVRYYIYELLK 126 (321)
Q Consensus 86 --------------------------~~------~-----~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~i~~qi~~ 126 (321)
.. + -.....++=+|..|.+...++.. .+++...+++.-...
T Consensus 276 qF~v~ln~QvdL~~EA~hL~rF~~NF~~s~~V~fP~P~~~~~~~~vl~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~~ 355 (565)
T KOG1236|consen 276 QFSVGLNAQVDLRQEALHLPRFTNNFSGSKKVLFPKPIAPLHTDLVLVETYERGLSVLRFVKWKSQPEALVKKVAKLGVN 355 (565)
T ss_pred HHHHHHHhhcchhhhhhhhHHHHHhcccceeecCCcccccccccceeeeeccccccHHhhhhcccChHHHHHHHHHHHHH
Confidence 00 0 00112244445666666666643 455455555555455
Q ss_pred HH-HHHHHCCCeeecCCCCCeEEcCCC
Q 020826 127 AL-DYCHSQGIMHRDVKPHNVMIDHEQ 152 (321)
Q Consensus 127 ~l-~~lh~~~i~H~dlkp~nili~~~~ 152 (321)
|+ ..+--.+++|.|+.|.||++..+.
T Consensus 356 AllkMl~vDNFvHaDlHPGNVlirf~~ 382 (565)
T KOG1236|consen 356 ALLKMLIVDNFVHADLHPGNVLIRFNK 382 (565)
T ss_pred HHHHHHHhhcceecccCCCcEEEEecC
Confidence 43 344557899999999999996443
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.24 E-value=0.09 Score=46.75 Aligned_cols=78 Identities=17% Similarity=0.153 Sum_probs=48.0
Q ss_pred ceEEeeeeeeecceEEEEEEEecC-Cce-----EEEEEecccc--hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTD-NEK-----CIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~-~~~-----~~vK~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
..++ ..|..|-...+|++..... +.. |.++...... .-.-.+|..+++.+..+..-+++++.+.+
T Consensus 52 ~i~i-~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~------ 124 (383)
T PTZ00384 52 FIEI-KKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD------ 124 (383)
T ss_pred cEEE-EEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC------
Confidence 3443 3555677789999875332 122 3444322111 11236789999999666677788887732
Q ss_pred EEEEEeecCchhh
Q 020826 94 SLIFEHVNNTDFK 106 (321)
Q Consensus 94 ~lv~e~~~~~~l~ 106 (321)
+++.||+.|.++.
T Consensus 125 g~l~efIeGr~l~ 137 (383)
T PTZ00384 125 FTIQEWVEGNTMG 137 (383)
T ss_pred EEEEEEeccccCC
Confidence 4999999887653
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=95.98 E-value=0.15 Score=51.46 Aligned_cols=137 Identities=18% Similarity=0.275 Sum_probs=77.3
Q ss_pred eeeeeecceEEEEEEEecCCceEEEEEecccc-hHHHHHHHHHHHhhcCC-C--Ceeeeeee--------eec-cCCCCc
Q 020826 27 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-KKKIKREIKILQNLCGG-P--NIVKLLDI--------VRD-QQSKTP 93 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~E~~~l~~l~~h-~--~i~~~~~~--------~~~-~~~~~~ 93 (321)
..|+ |..-.+|+... .++..+++|+.+... ......|...+..|..+ + .+++.+.. ..+ ......
T Consensus 31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~ 108 (1013)
T PRK06148 31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSEPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL 108 (1013)
T ss_pred eecC-CcCCceEEEEe-CCCCeEEEEEcCCccchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence 3453 34577888764 567789999998543 34556677777766432 2 23343321 111 122245
Q ss_pred EEEEEeecCchhhhhc---------------------CCC---------CH-----------------HHHHHHHHHHHH
Q 020826 94 SLIFEHVNNTDFKVLY---------------------PTL---------SD-----------------YDVRYYIYELLK 126 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~---------------------~~~---------~~-----------------~~~~~i~~qi~~ 126 (321)
+.+++|.+|..+.... ..+ .+ ...+.++.+++.
T Consensus 109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~ 188 (1013)
T PRK06148 109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA 188 (1013)
T ss_pred EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence 6789999987665411 000 00 011122223333
Q ss_pred HHHH-----HH--HCCCeeecCCCCCeEEcCCC--CeEEEeeccceee
Q 020826 127 ALDY-----CH--SQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEF 165 (321)
Q Consensus 127 ~l~~-----lh--~~~i~H~dlkp~nili~~~~--~~v~l~dfg~~~~ 165 (321)
.... +. ..+++|+|+.+.||+++.++ ...-|+|||.+..
T Consensus 189 ~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 189 RFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred HHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 2221 11 14699999999999998764 2455999998754
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.91 E-value=0.22 Score=45.21 Aligned_cols=78 Identities=15% Similarity=0.181 Sum_probs=48.9
Q ss_pred CceEEeeeeeeecceEEEEEEEecC--------CceEEEEEecccchH--HHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTD--------NEKCIIKILKPVKKK--KIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~--------~~~~~vK~~~~~~~~--~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
++. -+..|..|-...+|++..... ++.|++++....... .-..|..+++.+..+.--+++++.+. +
T Consensus 106 ~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~--g- 181 (442)
T PTZ00296 106 DDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS--G- 181 (442)
T ss_pred ccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC--C-
Confidence 445 455676777778898875321 467999987643322 24568888888754444455666552 1
Q ss_pred CCcEEEEEeecCchh
Q 020826 91 KTPSLIFEHVNNTDF 105 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l 105 (321)
+.+.+|+.|.++
T Consensus 182 ---g~I~efi~g~~l 193 (442)
T PTZ00296 182 ---GRIEEWLYGDPL 193 (442)
T ss_pred ---CEEEEeeCCccC
Confidence 367888887643
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.81 E-value=0.28 Score=43.74 Aligned_cols=72 Identities=17% Similarity=0.224 Sum_probs=49.8
Q ss_pred EeeeeeeecceEEEEEEEecCCceEEEEEecc----------cchHHHHHHHHHHHhhcC--CCCeeeeeeeeeccCCCC
Q 020826 25 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP----------VKKKKIKREIKILQNLCG--GPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 25 ~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~----------~~~~~~~~E~~~l~~l~~--h~~i~~~~~~~~~~~~~~ 92 (321)
..+.||.|....||+..+ .+..++||.-.+ ....+...|...|+.+.+ ..++++++.+..+ .
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded----~ 109 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT----M 109 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC----C
Confidence 366789999999999886 345688997541 123445566777776632 2478889888742 2
Q ss_pred cEEEEEeecC
Q 020826 93 PSLIFEHVNN 102 (321)
Q Consensus 93 ~~lv~e~~~~ 102 (321)
.+++||++.+
T Consensus 110 ~vlvME~L~~ 119 (418)
T PLN02756 110 ALIGMRYLEP 119 (418)
T ss_pred CEEEEeecCC
Confidence 3589999976
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.72 E-value=0.22 Score=43.32 Aligned_cols=71 Identities=14% Similarity=0.198 Sum_probs=42.0
Q ss_pred ecceEEEEEEEecCCceEEEEEeccc--chHHHHHHHHHHHhhcCCC-Ceeeee---e-eeeccCCCCcEEEEEeecCch
Q 020826 32 GKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGP-NIVKLL---D-IVRDQQSKTPSLIFEHVNNTD 104 (321)
Q Consensus 32 g~~g~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~E~~~l~~l~~h~-~i~~~~---~-~~~~~~~~~~~lv~e~~~~~~ 104 (321)
+.-..||+... .++..+++|+.++. ....+..|...+..|..+. .++... + ... ......+.++++++|..
T Consensus 36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~-~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 36 SYENRVYQFGD-EDGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLH-EHQGFRFALFPRRGGRA 113 (325)
T ss_pred cccceEEEEec-CCCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEE-EECCEEEEEEeeeCCCC
Confidence 34457888765 45678999998754 3566788998888884321 112211 1 001 11234567888887753
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.54 E-value=0.089 Score=42.51 Aligned_cols=86 Identities=21% Similarity=0.250 Sum_probs=57.1
Q ss_pred HHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHC--CCe
Q 020826 60 KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ--GIM 137 (321)
Q Consensus 60 ~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~--~i~ 137 (321)
..+..+..++.++ -.|+++. +.+.....++.|.|... ..... .++..=+.+|.-.|+. +..
T Consensus 103 ~~y~nky~v~Arm---hGilrL~----NDn~~~yGvIlE~Cy~~---------~i~~~-N~i~agi~~L~~fH~~~~~~l 165 (308)
T PF07387_consen 103 ALYFNKYRVFARM---HGILRLK----NDNNYKYGVILERCYKI---------KINFS-NFITAGIKDLMDFHSENQHCL 165 (308)
T ss_pred hhhhhhhhHHHHh---hheeEee----cCCCceeEEEEeeccCc---------ccchh-HHHHHhHHHHHHhhccCCCee
Confidence 4567777777776 3566665 23445567889998732 11111 1111114557778843 699
Q ss_pred eecCCCCCeEEcCCCCeEEEeeccce
Q 020826 138 HRDVKPHNVMIDHEQRKLRLIDWGLA 163 (321)
Q Consensus 138 H~dlkp~nili~~~~~~v~l~dfg~~ 163 (321)
|||..|+||+-|+.| .+||.|-+..
T Consensus 166 HGD~np~NiM~D~~G-~lKlVDP~~L 190 (308)
T PF07387_consen 166 HGDCNPDNIMCDKFG-YLKLVDPVCL 190 (308)
T ss_pred cCCCChhheeecCCC-CEEecChhhh
Confidence 999999999999999 8999997754
|
The function of this family is unknown. |
| >PF03109 ABC1: ABC1 family; InterPro: IPR004147 This entry includes ABC1 from yeast [] and AarF from Escherichia coli [] | Back alignment and domain information |
|---|
Probab=94.97 E-value=0.013 Score=42.65 Aligned_cols=45 Identities=20% Similarity=0.426 Sum_probs=39.6
Q ss_pred eeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhh
Q 020826 27 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNL 72 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l 72 (321)
.-|+.|+.|.||+|+. .+|+.||||+.++.-...+...+.+++.+
T Consensus 17 ~PlasASiaQVh~a~l-~~g~~VaVKV~rP~i~~~i~~Dl~~l~~~ 61 (119)
T PF03109_consen 17 EPLASASIAQVHRARL-KDGEEVAVKVQRPGIEEQIEADLRILRRL 61 (119)
T ss_pred chhhheehhhheeeee-cccchhhhhhcchHHHHHHHHHHHHHHHH
Confidence 4689999999999998 45999999999998888888888888776
|
These proteins have a nuclear or mitochondrial subcellular location in eukaryotes. The exact molecular functions of these proteins is not clear, however yeast ABC1 suppresses a cytochrome b mRNA translation defect and is essential for the electron transfer in the bc 1 complex [] and E. coli AarF is required for ubiquinone production []. It has been suggested that members of the ABC1 family are novel chaperonins []. These proteins are unrelated to the ABC transporter proteins. |
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.85 E-value=0.27 Score=49.50 Aligned_cols=76 Identities=8% Similarity=0.137 Sum_probs=43.6
Q ss_pred eeeeeecceEEEEEEEecCCceEEEEEeccc-chHHHHHHHHHHHhhcCC---CCeeeeeee--------eeccCCCCcE
Q 020826 27 RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGG---PNIVKLLDI--------VRDQQSKTPS 94 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-~~~~~~~E~~~l~~l~~h---~~i~~~~~~--------~~~~~~~~~~ 94 (321)
..|+. ..-.+|+.... +..+++|+.+.. ....+..|...+..|... -.+++.+.. .......+.+
T Consensus 37 ~~L~s-~~d~nf~v~t~--~~~yVLKi~~~~~~~~~l~~e~~~l~hL~~~~~glpvp~pi~t~~G~~~~~~~~~g~~~~v 113 (972)
T PRK06149 37 TELGS-QQDRNFRVDSD--GGRFVLKICHAAYAAVELEAQHAALRHLAEREPALRVPVVIPALDGEELLTLDVRGQGLRV 113 (972)
T ss_pred EecCC-cCcceEEEEec--CCcEEEEeCCccCChHHHHHHHHHHHHHHhhCCCCCCceeeECCCCCeEEEEecCCceEEE
Confidence 34543 33467877642 347888998743 445677788888877433 233344331 1112234456
Q ss_pred EEEEeecCchh
Q 020826 95 LIFEHVNNTDF 105 (321)
Q Consensus 95 lv~e~~~~~~l 105 (321)
.+++|++|..+
T Consensus 114 rL~~~l~G~~~ 124 (972)
T PRK06149 114 RLLDYLPGQPL 124 (972)
T ss_pred EEEEecCCccc
Confidence 78889888654
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=94.59 E-value=0.41 Score=40.78 Aligned_cols=96 Identities=18% Similarity=0.166 Sum_probs=59.9
Q ss_pred eEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhc--CCCCeeeeeeeeeccCCCCcEEEEEee
Q 020826 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLC--GGPNIVKLLDIVRDQQSKTPSLIFEHV 100 (321)
Q Consensus 23 y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~--~h~~i~~~~~~~~~~~~~~~~lv~e~~ 100 (321)
.+-.+.++.|....+|+.. .++..+.||+-.......+..|.+-|+.|. ..-.+++++.+....+. .++++|+.
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~--~fLlle~l 94 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDD--AFLLLEFL 94 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSC--CEEEEE--
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCC--ceEEEEee
Confidence 4556678889999999977 678899999987666778999999999983 34467888887754433 36999999
Q ss_pred cCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHH
Q 020826 101 NNTDFKVLYPTLSDYDVRYYIYELLKALDYCHS 133 (321)
Q Consensus 101 ~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~ 133 (321)
+.+. .+.. -...+...|+.||+
T Consensus 95 ~~~~-------~~~~----~~~~lg~~LA~LH~ 116 (288)
T PF03881_consen 95 EMGS-------PSPP----DWEELGRQLAALHQ 116 (288)
T ss_dssp -------------CC----HHHHHHHHHHHHHH
T ss_pred cCCC-------CCch----hHHHHHHHHHHHhh
Confidence 8651 1111 12455667788998
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 321 | ||||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-145 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-145 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-144 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-144 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-144 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 1e-143 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 1e-143 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 1e-142 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-142 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-142 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-124 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-124 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 1e-123 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 1e-123 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 1e-123 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-123 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 1e-123 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 1e-123 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 1e-123 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 1e-123 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 1e-123 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 1e-123 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 1e-123 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-123 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-123 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 1e-122 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-122 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-34 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-33 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-33 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 7e-33 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 9e-31 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-30 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-30 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-30 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-30 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-30 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 6e-30 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-30 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-29 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-29 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-29 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-29 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-29 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-29 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-29 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-29 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-29 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-29 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-29 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-29 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-29 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-29 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-29 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-29 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-29 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-29 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-29 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-29 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 3e-29 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 3e-29 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-29 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-29 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 4e-29 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-29 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-29 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-29 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-29 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-29 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-29 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-29 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-29 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-29 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 6e-29 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-29 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 6e-29 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 6e-29 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 6e-29 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 6e-29 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-29 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-29 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 7e-29 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-29 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 7e-29 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-29 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-29 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-29 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-29 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 8e-29 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 8e-29 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 8e-29 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-29 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-29 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-28 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-28 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-28 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-28 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 4e-28 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-28 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 6e-28 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-27 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-27 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-27 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 5e-27 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 9e-27 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 2e-26 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 2e-26 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-26 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-26 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-26 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-26 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-26 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-26 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-26 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-26 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-26 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-26 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-26 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-26 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-26 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-26 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-26 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-26 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-26 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-26 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-26 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-26 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 4e-26 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 4e-26 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 4e-26 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-26 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-26 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-26 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-26 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-26 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-26 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-26 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-26 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-26 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-26 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-26 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-26 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-26 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-26 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-26 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-26 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-26 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 6e-26 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-26 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 6e-26 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 6e-26 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 7e-26 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 7e-26 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-26 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-26 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 7e-26 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 7e-26 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 7e-26 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 7e-26 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 7e-26 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 7e-26 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-26 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 7e-26 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 7e-26 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 7e-26 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-26 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 7e-26 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-26 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 8e-26 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 8e-26 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-26 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 8e-26 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-26 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 8e-26 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-26 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 9e-26 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 9e-26 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-25 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-25 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-25 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-25 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 2e-25 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-25 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-25 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-25 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 4e-25 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-25 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 6e-25 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-24 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-23 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-23 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 2e-23 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-23 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-23 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 6e-23 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 7e-23 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 6e-22 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 1e-21 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-21 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-21 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-21 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-21 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 3e-21 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-21 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-21 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-21 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 3e-21 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-21 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-21 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-21 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-21 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 4e-21 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-21 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-21 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-21 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-21 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 4e-21 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-21 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-21 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-21 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-21 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 6e-21 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 6e-21 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 6e-21 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 6e-21 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-21 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 7e-21 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 7e-21 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 7e-21 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 7e-21 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-21 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 7e-21 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-21 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 7e-21 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-21 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-20 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 1e-20 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 2e-20 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 5e-20 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-20 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-19 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-18 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-17 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 4e-17 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 4e-15 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 4e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-15 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 6e-15 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 6e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 7e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 7e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 7e-15 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 8e-15 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-14 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 4e-14 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 5e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-14 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 6e-14 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 7e-14 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 1e-13 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 2e-13 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 2e-13 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 2e-13 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-13 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-13 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 4e-13 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 4e-13 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 4e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-13 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 4e-13 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-13 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-13 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-13 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-13 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-13 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-13 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-13 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 9e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 9e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-12 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-12 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-12 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-12 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-12 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-12 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-12 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-12 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-12 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-12 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-12 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-12 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 3e-12 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 4e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-12 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 4e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 5e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 5e-12 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 5e-12 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 5e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 5e-12 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-12 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-12 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 7e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-12 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 7e-12 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-12 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 7e-12 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 7e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 7e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-12 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 8e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-12 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-12 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 8e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 9e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 9e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-11 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-11 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-11 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-11 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-11 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-11 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-11 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-11 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-11 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-11 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-11 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-11 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-11 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-11 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 2e-11 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-11 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-11 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 2e-11 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-11 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-11 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 3e-11 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-11 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-11 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 4e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-11 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-11 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 7e-11 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-11 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-11 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 1e-10 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-10 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-10 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-10 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-10 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-10 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-10 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-10 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-10 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 2e-10 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-10 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-10 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 2e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 3e-10 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-10 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 4e-10 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 4e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 4e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-10 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 5e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-10 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-10 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-10 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 5e-10 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-10 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 6e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-10 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 7e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 7e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 7e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 7e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 7e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 7e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 7e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-10 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 7e-10 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-10 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 8e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 8e-10 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 8e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 8e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 8e-10 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-10 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-10 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-10 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 9e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-09 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-09 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-09 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 1e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 1e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-09 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-09 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-09 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 3e-09 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-09 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 4e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-09 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-09 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 5e-09 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-09 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-09 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 5e-09 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 5e-09 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 5e-09 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-09 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 5e-09 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-09 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-09 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 5e-09 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 5e-09 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-09 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 5e-09 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-09 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 5e-09 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-09 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 6e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 6e-09 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-09 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-09 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 6e-09 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 7e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 7e-09 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 7e-09 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 8e-09 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-09 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-08 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-08 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-08 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-08 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-08 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 1e-08 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-08 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-08 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-08 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-08 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-08 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-08 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-08 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-08 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-08 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-08 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-08 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-08 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-08 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-08 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 3e-08 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 3e-08 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 4e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 4e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-08 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 4e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 4e-08 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-08 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-08 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-08 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 5e-08 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-08 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 5e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 6e-08 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 6e-08 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 7e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 7e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 7e-08 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 9e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 9e-08 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 9e-08 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-07 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 1e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-07 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-07 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-07 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-07 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 1e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 1e-07 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-07 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-07 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-07 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-07 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-07 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-07 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-07 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-07 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-07 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-07 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-07 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-07 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-07 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-07 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-07 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-07 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-07 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-07 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 2e-07 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-07 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-07 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-07 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 2e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 3e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 6e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-07 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 6e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 6e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 6e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-06 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-06 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-06 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-06 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-06 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-06 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-06 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 2e-06 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-06 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 3e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 3e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-06 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 3e-06 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-06 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 4e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 6e-06 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 7e-06 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-05 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-05 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-05 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 1e-05 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-05 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-05 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-05 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-05 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 2e-05 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-05 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 2e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-05 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-05 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-05 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-05 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 3e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 3e-05 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-05 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-05 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-05 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 4e-05 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-05 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-05 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 4e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-05 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 7e-05 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 7e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 8e-05 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 8e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 8e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 8e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 8e-05 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 8e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 8e-05 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 9e-05 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 9e-05 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-05 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 9e-05 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-05 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-04 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-04 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-04 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-04 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-04 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-04 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-04 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-04 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-04 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-04 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-04 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 1e-04 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 1e-04 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-04 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 2e-04 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-04 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-04 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-04 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 2e-04 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-04 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-04 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-04 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-04 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 3e-04 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-04 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-04 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 4e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-04 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 7e-04 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-04 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 8e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 8e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 9e-04 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 9e-04 |
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 512 bits (1320), Expect = 0.0
Identities = 224/297 (75%), Positives = 261/297 (87%)
Query: 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNI 78
QDDY++VRK+GRGKYSEVFE ++ T+NEK ++KILKPVKKKKIKREIKIL+NL GGPNI
Sbjct: 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNI 93
Query: 79 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMH 138
+ L DIV+D S+TP+L+FEHVNNTDFK LY TL+DYD+R+Y+YE+LKALDYCHS GIMH
Sbjct: 94 ITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMH 153
Query: 139 RDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLD 198
RDVKPHNVMIDHE RKLRLIDWGLAEFYHPG+EYNVRVASRYFKGPELLVD Q YDYSLD
Sbjct: 154 RDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLD 213
Query: 199 LWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVG 258
+WSLGCM A MIFRKEPFF+GHDNYDQLV+IAKVLGT++L Y++KY+IELDP ++G
Sbjct: 214 MWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILG 273
Query: 259 RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315
RHSRK W +F+ ENQHL PEA+DFLDKLLRYDHQ R TA+EAM HPYF+ + +
Sbjct: 274 RHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKDQ 330
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 9e-73
Identities = 97/311 (31%), Positives = 152/311 (48%), Gaps = 28/311 (9%)
Query: 17 NREQDD-YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGG 75
+R Q+ Y + +G G + V++ C E IK + K+ K RE++I++ L
Sbjct: 49 DRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN-RELQIMRKL-DH 106
Query: 76 PNIVKLLDIVRDQQSKTPS----LIFEHVNNTDFKVLYP------TLSDYDVRYYIYELL 125
NIV+L K L+ ++V T ++V TL V+ Y+Y+L
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166
Query: 126 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 185
++L Y HS GI HRD+KP N+++D + L+L D+G A+ G+ + SRY++ PE
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPE 226
Query: 186 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYL 242
L+ DY S+D+WS GC+ A ++ + P F G DQLV+I KVLGT +++
Sbjct: 227 LIFGATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMN 285
Query: 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 302
Y P + PW+K + PEA+ +LL Y R T EA
Sbjct: 286 PNYTEFKFPQI-------KAHPWTKVF----RPRTPPEAIALCSRLLEYTPTARLTPLEA 334
Query: 303 MAHPYFFPIRN 313
AH +F +R+
Sbjct: 335 CAHSFFDELRD 345
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 3e-71
Identities = 95/311 (30%), Positives = 155/311 (49%), Gaps = 28/311 (9%)
Query: 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPN 77
+ + Y + +G G + VF+ +E I K+L+ K+ RE++I++ + PN
Sbjct: 37 QREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD--KRFKNRELQIMRIV-KHPN 93
Query: 78 IVKLLDIVRDQQSKTPS----LIFEHVNNTDFKVL--YP----TLSDYDVRYYIYELLKA 127
+V L K L+ E+V T ++ Y T+ ++ Y+Y+LL++
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRS 153
Query: 128 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 187
L Y HS GI HRD+KP N+++D L+LID+G A+ G+ + SRY++ PEL+
Sbjct: 154 LAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELI 213
Query: 188 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYLNK 244
+Y ++D+WS GC+ A ++ + P F G DQLV+I KVLGT +++
Sbjct: 214 FGATNYTTNIDIWSTGCVMAELMQGQ-PLFPGESGIDQLVEIIKVLGTPSREQIKTMNPN 272
Query: 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304
Y P + P+SK P+A+D + +LL Y R TA EA+
Sbjct: 273 YMEHKFPQI-------RPHPFSKVFRPR----TPPDAIDLISRLLEYTPSARLTAIEALC 321
Query: 305 HPYFFPIRNAE 315
HP+F +R E
Sbjct: 322 HPFFDELRTGE 332
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 3e-70
Identities = 84/317 (26%), Positives = 146/317 (46%), Gaps = 28/317 (8%)
Query: 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK--ILKPVKKKKIKREIKILQNLCG 74
+E D ++V R G+G + V G + IK I P + + + ++ L L
Sbjct: 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-H 77
Query: 75 GPNIVKLLDIVRDQQSKTPS-----LIFEHVNNTDFKVL--YP----TLSDYDVRYYIYE 123
PNIV+L + ++ E+V +T + Y ++ ++++
Sbjct: 78 HPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQ 137
Query: 124 LLKALDYCH--SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYF 181
L++++ H S + HRD+KPHNV+++ L+L D+G A+ P + + SRY+
Sbjct: 138 LIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYY 197
Query: 182 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DEL 238
+ PEL+ Q Y ++D+WS+GC+FA M+ + P F G ++ QL +I +VLG + L
Sbjct: 198 RAPELIFGNQHYTTAVDIWSVGCIFAEMMLGE-PIFRGDNSAGQLHEIVRVLGCPSREVL 256
Query: 239 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT 298
+ + PWS + + EA D L LL+Y +ER
Sbjct: 257 RKLNPSHTDVDLYNS-------KGIPWSNVFSDHSLK-DAKEAYDLLSALLQYLPEERMK 308
Query: 299 AKEAMAHPYFFPIRNAE 315
EA+ HPYF + +
Sbjct: 309 PYEALCHPYFDELHDPA 325
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 2e-66
Identities = 93/338 (27%), Positives = 156/338 (46%), Gaps = 59/338 (17%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLL 82
Y + + +G G + V E ++ +K + + K RE+ I++ L NI+KL+
Sbjct: 9 YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN-RELDIMKVLDH-VNIIKLV 66
Query: 83 DIVRDQQSKTPS------------------------------------LIFEHVNNTDFK 106
D + P +I E+V +T K
Sbjct: 67 DYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHK 126
Query: 107 VLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW 160
VL ++ + YIY+L +A+ + HS GI HRD+KP N++++ + L+L D+
Sbjct: 127 VLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDF 186
Query: 161 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGH 220
G A+ P + + SR+++ PEL++ +Y S+DLWS+GC+F +I K P F G
Sbjct: 187 GSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK-PLFSGE 245
Query: 221 DNYDQLVKIAKVLGT---DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLA 277
+ DQLV+I +++GT +++ Y P L K W K +
Sbjct: 246 TSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTL-------KAKDWRKIL----PEGT 294
Query: 278 VPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315
A+D L+++LRY+ R EAMAHP+F +RN+
Sbjct: 295 PSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSY 332
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 202 bits (516), Expect = 2e-63
Identities = 89/313 (28%), Positives = 146/313 (46%), Gaps = 38/313 (12%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIK 67
+ YE + K+G G Y VF+ + + IK K REI+
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK--------KFLESEDDPVIKKIALREIR 54
Query: 68 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPT-LSDYDVRYYIYEL 124
+L+ L PN+V LL++ R ++ L+FE+ ++T L Y + ++ V+ ++
Sbjct: 55 MLKQLKH-PNLVNLLEVFRRKRRLH--LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQT 111
Query: 125 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKG 183
L+A+++CH +HRDVKP N++I ++L D+G A P Y+ VA+R+++
Sbjct: 112 LQAVNFCHKHNCIHRDVKPENILITKHSV-IKLCDFGFARLLTGPSDYYDDEVATRWYRS 170
Query: 184 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243
PELLV Y +D+W++GC+FA ++ P + G + DQL I K LG L
Sbjct: 171 PELLVGDTQYGPPVDVWAIGCVFAELL-SGVPLWPGKSDVDQLYLIRKTLGD------LI 223
Query: 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAV-PEAVDFLDKLLRYDHQERPTAKEA 302
H ++ G +E + + A+ L L D ER T ++
Sbjct: 224 PRHQQVFSTNQYFSG-VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQL 282
Query: 303 MAHPYFFPIRNAE 315
+ HPYF IR E
Sbjct: 283 LHHPYFENIREIE 295
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 2e-62
Identities = 85/305 (27%), Positives = 140/305 (45%), Gaps = 30/305 (9%)
Query: 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-IK----REIKILQNL 72
+ + YE + VG G Y V + + IK K +K REIK+L+ L
Sbjct: 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81
Query: 73 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPT-LSDYDVRYYIYELLKALD 129
N+V LL++ + ++ L+FE V++T L +P L V+ Y+++++ +
Sbjct: 82 RH-ENLVNLLEVCKKKKRWY--LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIG 138
Query: 130 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLV 188
+CHS I+HRD+KP N+++ ++L D+G A PG+ Y+ VA+R+++ PELLV
Sbjct: 139 FCHSHNIIHRDIKPENILVSQSGV-VKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLV 197
Query: 189 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT-DELN----AYLN 243
Y ++D+W++GC+ M F EP F G + DQL I LG +
Sbjct: 198 GDVKYGKAVDVWAIGCLVTEM-FMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP 256
Query: 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 303
+ P R+P + +D K L D +RP E +
Sbjct: 257 VFAGVRLPE------IKEREPLERRYP-----KLSEVVIDLAKKCLHIDPDKRPFCAELL 305
Query: 304 AHPYF 308
H +F
Sbjct: 306 HHDFF 310
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 1e-61
Identities = 90/308 (29%), Positives = 150/308 (48%), Gaps = 43/308 (13%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIK 67
YE + K+G G Y VF+ + +E V K+++ REI
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEI--------VALKRVRLDDDDEGVPSSALREIC 53
Query: 68 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYE 123
+L+ L NIV+L D++ + T L+FE + D K L V+ ++++
Sbjct: 54 LLKELKH-KNIVRLHDVLHSDKKLT--LVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQ 109
Query: 124 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFK 182
LLK L +CHS+ ++HRD+KP N++I+ L+L ++GLA + P + Y+ V + +++
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRNGE-LKLANFGLARAFGIPVRCYSAEVVTLWYR 168
Query: 183 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT-DELNAY 241
P++L + Y S+D+WS GC+FA + P F G+D DQL +I ++LGT E
Sbjct: 169 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE---- 224
Query: 242 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQ-HLAVPEAVDFLDKLLRYDHQERPTAK 300
E P + L + ++ N D L LL+ + +R +A+
Sbjct: 225 ------EQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAE 278
Query: 301 EAMAHPYF 308
EA+ HPYF
Sbjct: 279 EALQHPYF 286
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 4e-61
Identities = 81/318 (25%), Positives = 145/318 (45%), Gaps = 39/318 (12%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKREIKILQNLCGGPNIV 79
Y ++ +G G VF V +++ IK + P K REIKI++ L NIV
Sbjct: 13 YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-DHDNIV 71
Query: 80 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP-------------TLSDYDVRYYIYELLK 126
K+ +I+ S+ + ++ L + R ++Y+LL+
Sbjct: 72 KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLLR 131
Query: 127 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----VASRYFK 182
L Y HS ++HRD+KP N+ I+ E L++ D+GLA P + + +++++
Sbjct: 132 GLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYR 191
Query: 183 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELN 239
P LL+ +Y ++D+W+ GC+FA M+ K F G +Q+ I + + ++
Sbjct: 192 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK-TLFAGAHELEQMQLILESIPVVHEEDRQ 250
Query: 240 AYLNKY--HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP 297
L+ +I D KP ++ + + EAVDFL+++L + +R
Sbjct: 251 ELLSVIPVYIRNDMT-------EPHKPLTQLLPGIS-----REAVDFLEQILTFSPMDRL 298
Query: 298 TAKEAMAHPYFFPIRNAE 315
TA+EA++HPY
Sbjct: 299 TAEEALSHPYMSIYSFPM 316
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 5e-61
Identities = 90/311 (28%), Positives = 152/311 (48%), Gaps = 51/311 (16%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------REIK 67
+ Y + K+G G Y V++ + + KKI+ REI
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYG---------ETFALKKIRLEKEDEGIPSTTIREIS 52
Query: 68 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYE 123
IL+ L NIVKL D++ ++ L+FEH++ D K L L + ++ +
Sbjct: 53 ILKELKH-SNIVKLYDVIHTKKRLV--LVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 124 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFK 182
LL + YCH + ++HRD+KP N++I+ E L++ D+GLA + P ++Y + + +++
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLLINREGE-LKIADFGLARAFGIPVRKYTHEIVTLWYR 167
Query: 183 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT-DELN-- 239
P++L+ + Y ++D+WS+GC+FA M+ P F G DQL++I ++LGT + N
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMV-NGTPLFPGVSEADQLMRIFRILGTPNSKNWP 226
Query: 240 --AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP 297
L KY + PW F+ +D L K+L+ D +R
Sbjct: 227 NVTELPKYDPNFT--------VYEPLPWESFLKG-----LDESGIDLLSKMLKLDPNQRI 273
Query: 298 TAKEAMAHPYF 308
TAK+A+ H YF
Sbjct: 274 TAKQALEHAYF 284
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 8e-61
Identities = 81/325 (24%), Positives = 139/325 (42%), Gaps = 64/325 (19%)
Query: 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------- 63
YE V ++G G Y V++ V K ++
Sbjct: 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHF--------VALKSVRVPNGGGGGGGLPIS 57
Query: 64 --REIKILQNLCGG--PNIVKLLDIVRDQQSKTPS---LIFEHVNNTDFKVL-----YPT 111
RE+ +L+ L PN+V+L+D+ ++ L+FEHV+ D + P
Sbjct: 58 TVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPG 116
Query: 112 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 171
L ++ + + L+ LD+ H+ I+HRD+KP N+++ ++L D+GLA Y
Sbjct: 117 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT-VKLADFGLARIYSYQMA 175
Query: 172 YNVRVASRYFKGPELLVDLQD-YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 230
V + +++ PE+L LQ Y +D+WS+GC+FA M FR++P F G+ DQL KI
Sbjct: 176 LTPVVVTLWYRAPEVL--LQSTYATPVDMWSVGCIFAEM-FRRKPLFCGNSEADQLGKIF 232
Query: 231 KVLGT-DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAV------PEAVD 283
++G E + P +L P F + +
Sbjct: 233 DLIGLPPE----------DDWPRDVSL-------PRGAFPPRGPRPVQSVVPEMEESGAQ 275
Query: 284 FLDKLLRYDHQERPTAKEAMAHPYF 308
L ++L ++ +R +A A+ H Y
Sbjct: 276 LLLEMLTFNPHKRISAFRALQHSYL 300
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 8e-61
Identities = 84/321 (26%), Positives = 147/321 (45%), Gaps = 59/321 (18%)
Query: 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------R 64
D Y + K+G G Y EV++ + NE V K+I+ R
Sbjct: 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNET--------VAIKRIRLEHEEEGVPGTAIR 82
Query: 65 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYI 121
E+ +L+ L NI++L ++ LIFE+ D K P +S ++ ++
Sbjct: 83 EVSLLKELQH-RNIIELKSVIHHNHRLH--LIFEYAE-NDLKKYMDKNPDVSMRVIKSFL 138
Query: 122 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK----LRLIDWGLAEFYH-PGKEYNVRV 176
Y+L+ +++CHS+ +HRD+KP N+++ L++ D+GLA + P +++ +
Sbjct: 139 YQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEI 198
Query: 177 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT- 235
+ +++ PE+L+ + Y S+D+WS+ C++A M+ K P F G DQL KI +VLG
Sbjct: 199 ITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML-MKTPLFPGDSEIDQLFKIFEVLGLP 257
Query: 236 --------DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDK 287
L + + + K + + L E +D L
Sbjct: 258 DDTTWPGVTALPDWKQSFP------------KFRGKTLKRVLG----ALLDDEGLDLLTA 301
Query: 288 LLRYDHQERPTAKEAMAHPYF 308
+L D +R +AK A+ HPYF
Sbjct: 302 MLEMDPVKRISAKNALEHPYF 322
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 1e-60
Identities = 92/322 (28%), Positives = 151/322 (46%), Gaps = 60/322 (18%)
Query: 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------R 64
R YE V ++G G Y +VF+ + + V K+++ R
Sbjct: 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRF-------VALKRVRVQTGEEGMPLSTIR 60
Query: 65 EIKILQNLCGG--PNIVKLLDIVRDQQSKTPS---LIFEHVNNTDFKVL-----YPTLSD 114
E+ +L++L PN+V+L D+ ++ + L+FEHV+ D P +
Sbjct: 61 EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPT 119
Query: 115 YDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV 174
++ +++LL+ LD+ HS ++HRD+KP N+++ + ++L D+GLA Y
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQ-IKLADFGLARIYSFQMALTS 178
Query: 175 RVASRYFKGPELLVDLQD-YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL 233
V + +++ PE+L LQ Y +DLWS+GC+FA M FR++P F G + DQL KI V+
Sbjct: 179 VVVTLWYRAPEVL--LQSSYATPVDLWSVGCIFAEM-FRRKPLFRGSSDVDQLGKILDVI 235
Query: 234 GT-DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAV------PEAVDFLD 286
G E E P AL P F + Q + D L
Sbjct: 236 GLPGE----------EDWPRDVAL-------PRQAFHSKSAQPIEKFVTDIDELGKDLLL 278
Query: 287 KLLRYDHQERPTAKEAMAHPYF 308
K L ++ +R +A A++HPYF
Sbjct: 279 KCLTFNPAKRISAYSALSHPYF 300
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 2e-60
Identities = 85/315 (26%), Positives = 155/315 (49%), Gaps = 49/315 (15%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK------------REIKI 68
++ + K+G G Y+ V++G++ T V K++K REI +
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVY--------VALKEVKLDSEEGTPSTAIREISL 56
Query: 69 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---------YPTLSDYDVRY 119
++ L NIV+L D++ + T L+FE ++ D K L V+Y
Sbjct: 57 MKELKH-ENIVRLYDVIHTENKLT--LVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKY 112
Query: 120 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVAS 178
+ ++LL+ L +CH I+HRD+KP N++I+ + L+L D+GLA + P ++ V +
Sbjct: 113 FQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQ-LKLGDFGLARAFGIPVNTFSSEVVT 171
Query: 179 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT-DE 237
+++ P++L+ + Y S+D+WS GC+ A MI +P F G ++ +QL I ++GT +E
Sbjct: 172 LWYRAPDVLMGSRTYSTSIDIWSCGCILAEMI-TGKPLFPGTNDEEQLKLIFDIMGTPNE 230
Query: 238 LN----AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDH 293
L KY+ + + + + + + +DFL LL+ +
Sbjct: 231 SLWPSVTKLPKYNPNI--------QQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNP 282
Query: 294 QERPTAKEAMAHPYF 308
R +AK+A+ HP+F
Sbjct: 283 DMRLSAKQALHHPWF 297
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 7e-60
Identities = 96/317 (30%), Positives = 156/317 (49%), Gaps = 50/317 (15%)
Query: 15 FINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK----------- 63
+ + Y+ + KVG G Y V++ + V K+I+
Sbjct: 15 YFQGLMEKYQKLEKVGEGTYGVVYKAKDSQG---------RIVALKRIRLDAEDEGIPST 65
Query: 64 --REIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDV 117
REI +L+ L PNIV L+D++ ++ T L+FE + D K + L D +
Sbjct: 66 AIREISLLKELHH-PNIVSLIDVIHSERCLT--LVFEFME-KDLKKVLDENKTGLQDSQI 121
Query: 118 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRV 176
+ Y+Y+LL+ + +CH I+HRD+KP N++I+ + L+L D+GLA + P + Y V
Sbjct: 122 KIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGA-LKLADFGLARAFGIPVRSYTHEV 180
Query: 177 ASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT- 235
+ +++ P++L+ + Y S+D+WS+GC+FA MI K P F G + DQL KI +LGT
Sbjct: 181 VTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK-PLFPGVTDDDQLPKIFSILGTP 239
Query: 236 DELN----AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRY 291
+ L + +KPWS I E +D L +L +
Sbjct: 240 NPREWPQVQELPLWKQRTFQ-------VFEKKPWSSIIPG-----FCQEGIDLLSNMLCF 287
Query: 292 DHQERPTAKEAMAHPYF 308
D +R +A++AM HPYF
Sbjct: 288 DPNKRISARDAMNHPYF 304
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 3e-59
Identities = 85/310 (27%), Positives = 153/310 (49%), Gaps = 48/310 (15%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK------------REIKI 68
+ Y + K+G G Y+ V++G + V K+I+ RE+ +
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNL--------VALKEIRLEHEEGAPCTAIREVSL 53
Query: 69 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYEL 124
L++L NIV L DI+ ++S T L+FE+++ D K ++ ++V+ ++++L
Sbjct: 54 LKDLKH-ANIVTLHDIIHTEKSLT--LVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQL 109
Query: 125 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKG 183
L+ L YCH Q ++HRD+KP N++I+ L+L D+GLA P K Y+ V + +++
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGE-LKLADFGLARAKSIPTKTYDNEVVTLWYRP 168
Query: 184 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT-DELN--- 239
P++L+ DY +D+W +GC+F M + P F G +QL I ++LGT E
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGR-PLFPGSTVEEQLHFIFRILGTPTEETWPG 227
Query: 240 -AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT 298
++ P ++ + + D L KLL+++ + R +
Sbjct: 228 ILSNEEFKTYNYP-------KYRAEALLSHAP-----RLDSDGADLLTKLLQFEGRNRIS 275
Query: 299 AKEAMAHPYF 308
A++AM HP+F
Sbjct: 276 AEDAMKHPFF 285
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 192 bits (490), Expect = 4e-59
Identities = 88/308 (28%), Positives = 152/308 (49%), Gaps = 30/308 (9%)
Query: 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK--------REIK 67
+ YE + +G G+++ V++ N+ IK +K + + K REIK
Sbjct: 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIK 64
Query: 68 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYE 123
+LQ L PNI+ LLD + + + L+F+ + TD +V+ L+ ++ Y+
Sbjct: 65 LLQELSH-PNIIGLLDAFGHKSNIS--LVFDFME-TDLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 124 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFK 182
L+ L+Y H I+HRD+KP+N+++D L+L D+GLA F P + Y +V +R+++
Sbjct: 121 TLQGLEYLHQHWILHRDLKPNNLLLDENGV-LKLADFGLAKSFGSPNRAYTHQVVTRWYR 179
Query: 183 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT-DELNAY 241
PELL + Y +D+W++GC+ A ++ R PF G + DQL +I + LGT E
Sbjct: 180 APELLFGARMYGVGVDMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFETLGTPTE---- 234
Query: 242 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE 301
E P + +L + K + A + +D + L ++ R TA +
Sbjct: 235 ------EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQ 288
Query: 302 AMAHPYFF 309
A+ YF
Sbjct: 289 ALKMKYFS 296
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 5e-59
Identities = 89/308 (28%), Positives = 157/308 (50%), Gaps = 28/308 (9%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK----KKIKREIKILQNLCGG 75
Y VG G Y V + EK IK + +P + K+ RE+ +L+++
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQH- 82
Query: 76 PNIVKLLDIVRDQQSKTPS----LIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYC 131
N++ LLD+ S L+ + K++ S+ ++Y +Y++LK L Y
Sbjct: 83 ENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYI 142
Query: 132 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDL 190
HS G++HRD+KP N+ ++ E +L+++D+GLA Y V +R+++ PE+++
Sbjct: 143 HSAGVVHRDLKPGNLAVN-EDCELKILDFGLARHADAEMTGY---VVTRWYRAPEVILSW 198
Query: 191 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYLNKYHI 247
Y+ ++D+WS+GC+ A M+ K F G D DQL +I KV G + + +K
Sbjct: 199 MHYNQTVDIWSVGCIMAEMLTGK-TLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 257
Query: 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 307
++ +L + RK +++ + P+A D L+K+L D +R TA +A+ HP+
Sbjct: 258 S---YIQSL-PQTPRKDFTQLFPRAS-----PQAADLLEKMLELDVDKRLTAAQALTHPF 308
Query: 308 FFPIRNAE 315
F P R+ E
Sbjct: 309 FEPFRDPE 316
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-58
Identities = 89/309 (28%), Positives = 161/309 (52%), Gaps = 29/309 (9%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK----KKIKREIKILQNLCGG 75
Y ++ VG G Y V V K IK + +P + K+ RE+++L+++
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH- 83
Query: 76 PNIVKLLDIVRDQQSKTPS----LIFEHVNNTDFKVLYP-TLSDYDVRYYIYELLKALDY 130
N++ LLD+ ++ L+ + K++ L + +++ +Y++LK L Y
Sbjct: 84 ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 143
Query: 131 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVD 189
H+ GI+HRD+KP N+ ++ E +L+++D+GLA Y V +R+++ PE++++
Sbjct: 144 IHAAGIIHRDLKPGNLAVN-EDCELKILDFGLARQADSEMTGY---VVTRWYRAPEVILN 199
Query: 190 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYLNKYH 246
Y ++D+WS+GC+ A MI K F G D+ DQL +I KV GT + + +
Sbjct: 200 WMRYTQTVDIWSVGCIMAEMITGK-TLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEA 258
Query: 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 306
++ L +K ++ +T + P AV+ L+K+L D ++R TA EA+AHP
Sbjct: 259 KN---YMKGL-PELEKKDFASILTNAS-----PLAVNLLEKMLVLDAEQRVTAGEALAHP 309
Query: 307 YFFPIRNAE 315
YF + + E
Sbjct: 310 YFESLHDTE 318
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 8e-58
Identities = 83/310 (26%), Positives = 158/310 (50%), Gaps = 31/310 (10%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-----KPVKKKKIKREIKILQNLCGG 75
+ Y+ + VG G Y V + +K L + K+ RE+++L+++
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH- 87
Query: 76 PNIVKLLDIVRDQQSKTPS----LIFEHVNNTDF-KVLYP-TLSDYDVRYYIYELLKALD 129
N++ LLD+ +S L+ + D ++ L+D V++ IY++L+ L
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQILRGLK 146
Query: 130 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLV 188
Y HS I+HRD+KP N+ ++ E +L+++D+GLA Y VA+R+++ PE+++
Sbjct: 147 YIHSADIIHRDLKPSNLAVN-EDCELKILDFGLARHTADEMTGY---VATRWYRAPEIML 202
Query: 189 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYLNKY 245
+ Y+ ++D+WS+GC+ A ++ + F G D+ DQL I +++GT + L ++
Sbjct: 203 NWMHYNQTVDIWSVGCIMAELLTGR-TLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261
Query: 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305
++ +L + + ++ N P AVD L+K+L D +R TA +A+AH
Sbjct: 262 ARN---YIQSL-TQMPKMNFANVFIGAN-----PLAVDLLEKMLVLDSDKRITAAQALAH 312
Query: 306 PYFFPIRNAE 315
YF + +
Sbjct: 313 AYFAQYHDPD 322
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 1e-57
Identities = 80/319 (25%), Positives = 148/319 (46%), Gaps = 37/319 (11%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK-------------KKIKREI 66
Y V R + G Y V GV ++ IK + V K++ REI
Sbjct: 22 SPYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 67 KILQNLCGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTDF-KVLY---PTLSDYDVRY 119
++L + PNI+ L DI + L+ E + TD +V++ +S ++Y
Sbjct: 81 RLLNHF-HHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQY 138
Query: 120 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR 179
++Y +L L H G++HRD+ P N+++ + + + D+ LA V R
Sbjct: 139 FMYHILLGLHVLHEAGVVHRDLHPGNILLA-DNNDITICDFNLAREDTADANKTHYVTHR 197
Query: 180 YFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---D 236
+++ PEL++ + + +D+WS GC+ A M RK F G Y+QL KI +V+GT +
Sbjct: 198 WYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK-ALFRGSTFYNQLNKIVEVVGTPKIE 256
Query: 237 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER 296
++ + + + +L + + W+ + + P A+D + K+L ++ Q R
Sbjct: 257 DVVMFSSPSARD---YLRNSLSNVPARAWTAVVPTAD-----PVALDLIAKMLEFNPQRR 308
Query: 297 PTAKEAMAHPYFFPIRNAE 315
+ ++A+ HPYF + +
Sbjct: 309 ISTEQALRHPYFESLFDPL 327
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 1e-57
Identities = 90/319 (28%), Positives = 154/319 (48%), Gaps = 37/319 (11%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKILQNLCGGP 76
D+++ +G G Y V H E IK ++P K + REIKIL++
Sbjct: 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-KHE 69
Query: 77 NIVKLLDIVRDQQSKTPS---LIFEHVNNTDF-KVLYP-TLSDYDVRYYIYELLKALDYC 131
NI+ + +I R + + +I E + TD +V+ LSD ++Y+IY+ L+A+
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVL 128
Query: 132 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR-----------VASRY 180
H ++HRD+KP N++I+ L++ D+GLA N VA+R+
Sbjct: 129 HGSNVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRW 187
Query: 181 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT----D 236
++ PE+++ Y ++D+WS GC+ A + R+ P F G D QL+ I ++GT +
Sbjct: 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR-PIFPGRDYRHQLLLIFGIIGTPHSDN 246
Query: 237 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER 296
+L + E ++ +L + P K N P+ +D L ++L +D +R
Sbjct: 247 DLRCIESPRARE---YIKSL-PMYPAAPLEKMFPRVN-----PKGIDLLQRMLVFDPAKR 297
Query: 297 PTAKEAMAHPYFFPIRNAE 315
TAKEA+ HPY +
Sbjct: 298 ITAKEALEHPYLQTYHDPN 316
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 3e-57
Identities = 83/334 (24%), Positives = 158/334 (47%), Gaps = 42/334 (12%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK----KKIKREIKILQNLCGG 75
YE+V+K+G+G Y V++ + E +K I + ++ REI IL L G
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGH 68
Query: 76 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDF-KVLY-PTLSDYDVRYYIYELLKALDYCHS 133
NIV LL+++R + L+F+++ TD V+ L +Y +Y+L+K + Y HS
Sbjct: 69 ENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHS 127
Query: 134 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR------------------ 175
G++HRD+KP N++++ + +++ D+GL+ + +
Sbjct: 128 GGLLHRDMKPSNILLN-AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 176 ----VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 231
VA+R+++ PE+L+ Y +D+WSLGC+ ++ K P F G +QL +I
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK-PIFPGSSTMNQLERIIG 245
Query: 232 VLGT---DELNAYLNKYHIEL-------DPHLAALVGRHSRKPWSKFITVENQHLAVPEA 281
V+ +++ + + + + + K + + + + EA
Sbjct: 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEA 305
Query: 282 VDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315
+D LDKLL+++ +R +A +A+ HP+ N
Sbjct: 306 LDLLDKLLQFNPNKRISANDALKHPFVSIFHNPN 339
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 188 bits (479), Expect = 3e-57
Identities = 86/311 (27%), Positives = 159/311 (51%), Gaps = 29/311 (9%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKILQNLCGGP 76
Y + +G G Y V + + IK + P + ++ REIKIL
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHE 85
Query: 77 NIVKLLDIVRDQQSKTPS---LIFEHVNNTDF-KVLY-PTLSDYDVRYYIYELLKALDYC 131
NI+ + DI+R + ++ + + TD K+L LS+ + Y++Y++L+ L Y
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 132 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGPELL 187
HS ++HRD+KP N++++ L++ D+GLA P ++ VA+R+++ PE++
Sbjct: 145 HSANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 203
Query: 188 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT---DELNAYLNK 244
++ + Y S+D+WS+GC+ A M+ + P F G DQL I +LG+ ++LN +N
Sbjct: 204 LNSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262
Query: 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304
+L +L ++ PW++ + +A+D LDK+L ++ +R ++A+A
Sbjct: 263 KARN---YLLSL-PHKNKVPWNRLFPNAD-----SKALDLLDKMLTFNPHKRIEVEQALA 313
Query: 305 HPYFFPIRNAE 315
HPY +
Sbjct: 314 HPYLEQYYDPS 324
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 5e-57
Identities = 88/328 (26%), Positives = 138/328 (42%), Gaps = 63/328 (19%)
Query: 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK-------------R 64
E YE + K+G+G + EVF+ H +K V KK+ R
Sbjct: 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQK--------VALKKVLMENEKEGFPITALR 65
Query: 65 EIKILQNLCGGPNIVKLLDIVRDQQSKTPS------LIFEHVNNTDFKVL----YPTLSD 114
EIKILQ L N+V L++I R + S L+F+ D L +
Sbjct: 66 EIKILQLL-KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVLVKFTL 123
Query: 115 YDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-----PG 169
+++ + LL L Y H I+HRD+K NV+I + L+L D+GLA +
Sbjct: 124 SEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQP 182
Query: 170 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 229
Y RV + +++ PELL+ +DY +DLW GC+ A M + + P G+ QL I
Sbjct: 183 NRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM-WTRSPIMQGNTEQHQLALI 241
Query: 230 AKVLGT---------DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPE 280
+++ G+ D L + K ++ P
Sbjct: 242 SQLCGSITPEVWPNVDNY------------ELYEKL--ELVKGQKRKVKDRLKAYVRDPY 287
Query: 281 AVDFLDKLLRYDHQERPTAKEAMAHPYF 308
A+D +DKLL D +R + +A+ H +F
Sbjct: 288 ALDLIDKLLVLDPAQRIDSDDALNHDFF 315
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 1e-54
Identities = 78/319 (24%), Positives = 145/319 (45%), Gaps = 38/319 (11%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK----KKIKREIKILQNLCGG 75
Y+ ++ +G G V + IK + +P + K+ RE+ +++ +
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NH 120
Query: 76 PNIVKLLDIVRDQQSKTPS----LIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYC 131
NI+ LL++ Q++ L+ E ++ +V+ L + Y +Y++L + +
Sbjct: 121 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 180
Query: 132 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLV 188
HS GI+HRD+KP N+++ L+++D+GLA Y V +RY++ PE+++
Sbjct: 181 HSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPY---VVTRYYRAPEVIL 236
Query: 189 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT--DELNAYLN--- 243
Y ++D+WS+GC+ M+ K F G D DQ K+ + LGT E L
Sbjct: 237 G-MGYKENVDIWSVGCIMGEMVRHK-ILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294
Query: 244 KYHIELDPHLAALVGRHSRKPWSKF-------ITVENQHLAVPEAVDFLDKLLRYDHQER 296
+ ++E P ++ + K E+ L +A D L K+L D +R
Sbjct: 295 RNYVENRPK-------YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 347
Query: 297 PTAKEAMAHPYFFPIRNAE 315
+ +A+ HPY +
Sbjct: 348 ISVDDALQHPYINVWYDPA 366
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 4e-54
Identities = 76/313 (24%), Positives = 141/313 (45%), Gaps = 26/313 (8%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK----KKIKREIKILQNLCGG 75
Y+ ++ +G G V IK + +P + K+ RE+ +++ +
Sbjct: 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NH 83
Query: 76 PNIVKLLDIVRDQQSKTPS----LIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYC 131
NI+ LL++ Q+S ++ E ++ +V+ L + Y +Y++L + +
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 143
Query: 132 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 191
HS GI+HRD+KP N+++ L+++D+GLA V +RY++ PE+++
Sbjct: 144 HSAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-M 201
Query: 192 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT--DELNAYLNKYHIEL 249
Y ++D+WS+GC+ MI F G D+ DQ K+ + LGT E L
Sbjct: 202 GYKENVDIWSVGCIMGEMIKGG-VLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT- 259
Query: 250 DPHLAALVGRHSRKPWSKF-------ITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 302
++ +++ + K E+ L +A D L K+L D +R + EA
Sbjct: 260 --YVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 316
Query: 303 MAHPYFFPIRNAE 315
+ HPY +
Sbjct: 317 LQHPYINVWYDPS 329
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 6e-52
Identities = 88/367 (23%), Positives = 157/367 (42%), Gaps = 84/367 (22%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK----KKIKREIKILQNLCGG 75
D YE+ +G G Y V E + IK IL+ + K+I REI IL L
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-NH 111
Query: 76 PNIVKLLDIVRDQQSKTPS---LIFEHVNNTDF-KVLY--PTLSDYDVRYYIYELLKALD 129
++VK+LDIV + + ++ E + +DF K+ L++ ++ +Y LL +
Sbjct: 112 DHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVK 170
Query: 130 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR-------------- 175
Y HS GI+HRD+KP N +++ + +++ D+GLA + N +
Sbjct: 171 YVHSAGILHRDLKPANCLVN-QDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVT 229
Query: 176 --------------VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI----------F 211
V +R+++ PEL++ ++Y ++D+WS+GC+FA ++
Sbjct: 230 FPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA 289
Query: 212 RKEPFFYGHD--------------------NYDQLVKIAKVLGT---DELNAYLNKYHIE 248
+ P F G N DQL I +LGT +++ A +
Sbjct: 290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKR 349
Query: 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
+ ++ + +A+ L ++L ++ +R T E +AHP+F
Sbjct: 350 YIRIF----PKREGTDLAERFPASS-----ADAIHLLKRMLVFNPNKRITINECLAHPFF 400
Query: 309 FPIRNAE 315
+R AE
Sbjct: 401 KEVRIAE 407
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 1e-51
Identities = 80/334 (23%), Positives = 146/334 (43%), Gaps = 56/334 (16%)
Query: 18 REQDDYEVVR-KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK---------REIK 67
R +D +E KVGRG Y V++ + + K+I+ REI
Sbjct: 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYAL------KQIEGTGISMSACREIA 70
Query: 68 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE-----------HVNNTDFKVLYPTLSDYD 116
+L+ L PN++ L + + L+F+ + L
Sbjct: 71 LLRELKH-PNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGM 129
Query: 117 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK---LRLIDWGLA-EFYHPGKEY 172
V+ +Y++L + Y H+ ++HRD+KP N+++ E + +++ D G A F P K
Sbjct: 130 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 189
Query: 173 ---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD-------- 221
+ V + +++ PELL+ + Y ++D+W++GC+FA ++ EP F+
Sbjct: 190 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL-TSEPIFHCRQEDIKTSNP 248
Query: 222 -NYDQLVKIAKVLGT--DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAV 278
++DQL +I V+G D+ + K P + L+ R ++ ++
Sbjct: 249 YHHDQLDRIFNVMGFPADKDWEDIKKM-----PEHSTLMKDFRRNTYTNCSLIKYMEKHK 303
Query: 279 P----EAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
+A L KLL D +R T+++AM PYF
Sbjct: 304 VKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 337
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 171 bits (434), Expect = 4e-50
Identities = 78/359 (21%), Positives = 150/359 (41%), Gaps = 76/359 (21%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKK----KKIKREIKILQNLCGG 75
D+Y + +GRG Y V+ + IK + + + K+I REI IL L
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KS 84
Query: 76 PNIVKLLDIVRDQQSKTPS---LIFEHVNNTDF-KVLYP--TLSDYDVRYYIYELLKALD 129
I++L D++ ++ E + +D K+ L++ ++ +Y LL +
Sbjct: 85 DYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGEN 143
Query: 130 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR-------------- 175
+ H GI+HRD+KP N +++ + +++ D+GLA + K+ N+
Sbjct: 144 FIHESGIIHRDLKPANCLLN-QDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202
Query: 176 ---------VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI----------FRKEPF 216
V +R+++ PEL++ ++Y S+D+WS GC+FA ++ + P
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPL 262
Query: 217 FYG-----------------HDNYDQLVKIAKVLGT---DELNAYLNKYHIELDPHLAAL 256
F G N DQL I ++GT D+L I+ ++
Sbjct: 263 FPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIK---YIKLF 319
Query: 257 VGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315
+ + ++ L+ +L+++ +R T +A+ HPY +R +
Sbjct: 320 -PHRKPINLKQKY-----PSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK 372
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 6e-49
Identities = 66/308 (21%), Positives = 113/308 (36%), Gaps = 61/308 (19%)
Query: 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCGG- 75
Y +++++G G S+VF+ ++ + IK + EI L L
Sbjct: 29 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 87
Query: 76 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYDVRYYIYELLKALDYCHS 133
I++L D + ++ E N L ++ ++ + Y +L+A+ H
Sbjct: 88 DKIIRLYDYEIT--DQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 134 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVDL 190
GI+H D+KP N +I L+LID+G+A P V+ V + + PE + D+
Sbjct: 146 HGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 191 ----------QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 240
D+WSLGC+ M + K PF + +L I
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID--------- 254
Query: 241 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 300
+ IE + D L L+ D ++R +
Sbjct: 255 --PNHEIEFPDIPE------------------------KDLQDVLKCCLKRDPKQRISIP 288
Query: 301 EAMAHPYF 308
E +AHPY
Sbjct: 289 ELLAHPYV 296
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-48
Identities = 67/308 (21%), Positives = 112/308 (36%), Gaps = 61/308 (19%)
Query: 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCGG- 75
Y +++++G G S+VF+ ++ + IK + EI L L
Sbjct: 10 IYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 76 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYDVRYYIYELLKALDYCHS 133
I++L D Q ++ E N L ++ ++ + Y +L+A+ H
Sbjct: 69 DKIIRLYDYEITDQ--YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 134 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGPELLVD- 189
GI+H D+KP N +I L+LID+G+A P V+ V + + PE + D
Sbjct: 127 HGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 190 ---------LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 240
D+WSLGC+ M + K PF + +L I
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID--------- 235
Query: 241 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 300
+ IE + D L L+ D ++R +
Sbjct: 236 --PNHEIEFPDIPE------------------------KDLQDVLKCCLKRDPKQRISIP 269
Query: 301 EAMAHPYF 308
E +AHPY
Sbjct: 270 ELLAHPYV 277
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 7e-48
Identities = 68/315 (21%), Positives = 115/315 (36%), Gaps = 61/315 (19%)
Query: 15 FINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKIL 69
I+ + Y +++++G G S+VF+ ++ + IK + EI L
Sbjct: 50 CISVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYL 108
Query: 70 QNLCG-GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYDVRYYIYELLK 126
L I++L D Q ++ E N L ++ ++ + Y +L+
Sbjct: 109 NKLQQHSDKIIRLYDYEITDQ--YIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLE 166
Query: 127 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKG 183
A+ H GI+H D+KP N +I L+LID+G+A P V+ V + +
Sbjct: 167 AVHTIHQHGIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224
Query: 184 PELLVD----------LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL 233
PE + D D+WSLGC+ M + K PF + +L I
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID-- 282
Query: 234 GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDH 293
+ IE + D L L+ D
Sbjct: 283 ---------PNHEIEFPDIPE------------------------KDLQDVLKCCLKRDP 309
Query: 294 QERPTAKEAMAHPYF 308
++R + E +AHPY
Sbjct: 310 KQRISIPELLAHPYV 324
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 1e-45
Identities = 70/299 (23%), Positives = 132/299 (44%), Gaps = 49/299 (16%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCG 74
+ Y+ V+K+G G Y EV + + IKI + K+ E+ +L+ L
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-D 94
Query: 75 GPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYC 131
PNI+KL D D+++ L+ E D + ++ D I ++L + Y
Sbjct: 95 HPNIMKLYDFFEDKRNY--YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYL 152
Query: 132 HSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 189
H I+HRD+KP N++++ + ++++D+GL+ + K+ R+ + Y+ PE+L
Sbjct: 153 HKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-- 210
Query: 190 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249
+ YD D+WS+G + ++ P F G + + L K+ K
Sbjct: 211 RKKYDEKCDVWSIGVILFILLAGYPP-FGGQTDQEILRKV-------------EKGKYTF 256
Query: 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
D W ++ A D + ++L++D Q R +A++A+ HP+
Sbjct: 257 D-----------SPEWKN-VS--------EGAKDLIKQMLQFDSQRRISAQQALEHPWI 295
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 6e-45
Identities = 71/300 (23%), Positives = 129/300 (43%), Gaps = 50/300 (16%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLC 73
D Y+ R +G+G + EV ++C +K++ K+ + RE+++L+ L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL- 83
Query: 74 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDY 130
PNI+KL + D+ L+ E D + S+ D I ++L + Y
Sbjct: 84 DHPNIMKLYEFFEDKGYF--YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITY 141
Query: 131 CHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 188
H I+HRD+KP N++++ + +R+ID+GL+ + K+ ++ + Y+ PE+L
Sbjct: 142 MHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL- 200
Query: 189 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248
YD D+WS G + ++ P F G + YD L K+ K
Sbjct: 201 -HGTYDEKCDVWSTGVILYILLSGCPP-FNGANEYDILKKV-------------EKGKYT 245
Query: 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
+ W K ++ A D + K+L Y R +A++A+ H +
Sbjct: 246 FE-----------LPQWKK-VS--------ESAKDLIRKMLTYVPSMRISARDALDHEWI 285
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-44
Identities = 69/332 (20%), Positives = 128/332 (38%), Gaps = 71/332 (21%)
Query: 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKKIKREIKILQNLCG 74
R D+E + +G+G + +V + + D+ IK ++ K I E+ +L +L
Sbjct: 2 LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-N 60
Query: 75 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-Y---PTLSDY-----------DVRY 119
+V+ ++++ + +T F + Y TL D +
Sbjct: 61 HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120
Query: 120 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR 179
++L+AL Y HSQGI+HRD+KP N+ ID E R +++ D+GLA+ H + +
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 180 YFKG---------------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD 224
E+L Y+ +D++SLG +F MI+ PF G + +
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN 236
Query: 225 QLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDF 284
L K+ IE P +
Sbjct: 237 ILKKL-------------RSVSIEFPPDF-----------DDNKM---------KVEKKI 263
Query: 285 LDKLLRYDHQERPTAKEAMAHPYFFPIRNAES 316
+ L+ +D +RP A+ + + P+++ +
Sbjct: 264 IRLLIDHDPNKRPGARTLLNSG-WLPVKHQDE 294
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 1e-44
Identities = 60/304 (19%), Positives = 119/304 (39%), Gaps = 52/304 (17%)
Query: 19 EQDDYEVVRKVGRGKYSE-VFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPN 77
+ + +G G V+ G+ DN +K + P RE+++L+ PN
Sbjct: 22 GKISFCPKDVLGHGAEGTIVYRGMF--DNRDVAVKRILPECFSFADREVQLLRESDEHPN 79
Query: 78 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQ 134
+++ +D+Q + + E T + + + + + L + HS
Sbjct: 80 VIRYFCTEKDRQFQ--YIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL 137
Query: 135 GIMHRDVKPHNVMIDHE----QRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGPEL 186
I+HRD+KPHN++I + K + D+GL + G+ R + + PE+
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 187 LVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244
L + ++ Y++D++S GC+F +I F + + + N L
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG--KSLQR-----------QANILLGA 244
Query: 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304
++ P A + ++K++ D Q+RP+AK +
Sbjct: 245 CSLD------------CLHPEKHED---------VIARELIEKMIAMDPQKRPSAKHVLK 283
Query: 305 HPYF 308
HP+F
Sbjct: 284 HPFF 287
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 156 bits (397), Expect = 3e-44
Identities = 70/306 (22%), Positives = 128/306 (41%), Gaps = 63/306 (20%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCG 74
+ Y +V +G+G + EV + ++ +K+ K I RE+++L+ L
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-D 79
Query: 75 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKAL 128
PNI+KL +I+ D S ++ E + L+ S++D I ++ +
Sbjct: 80 HPNIMKLFEILEDSSSF--YIVGELYTGGE---LFDEIIKRKRFSEHDAARIIKQVFSGI 134
Query: 129 DYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 186
Y H I+HRD+KP N++++ + +++ID+GL+ + + R+ + Y+ PE+
Sbjct: 135 TYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEV 194
Query: 187 LVDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242
L YD D+WS G + +G P FYG + YD L ++
Sbjct: 195 L--RGTYDEKCDVWSAGVILYILLSG-----TPPFYGKNEYDILKRV------------- 234
Query: 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 302
D W I+ +A D + K+L + R TA +
Sbjct: 235 ETGKYAFD-----------LPQWRT-IS--------DDAKDLIRKMLTFHPSLRITATQC 274
Query: 303 MAHPYF 308
+ HP+
Sbjct: 275 LEHPWI 280
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 4e-44
Identities = 58/310 (18%), Positives = 109/310 (35%), Gaps = 34/310 (10%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK----IKREIKILQNLCGGP 76
+ + +G+G + VF G H + IK+ + + RE ++L+ L
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-K 67
Query: 77 NIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL-----YPTLSDYDVRYYIYELLKALDY 130
NIVKL I + ++ LI E + VL L + + + +++ +++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 131 CHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 187
GI+HR++KP N+M + Q +L D+G A +++ + + P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 188 -------VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 240
+ Y ++DLWS+G F PF + K++ A
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247
Query: 241 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQ--HLAVPEAVDFLDKLLRYDHQERPT 298
E P WS + V L +L D ++
Sbjct: 248 ISGVQKAENGP-----------IDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296
Query: 299 AKEAMAHPYF 308
+ A
Sbjct: 297 FDQFFAETSD 306
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 5e-44
Identities = 64/306 (20%), Positives = 121/306 (39%), Gaps = 61/306 (19%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGG 75
D + RK+G G + +V + + +IK + V ++I+ EI++L++L
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DH 79
Query: 76 PNIVKLLDIVRDQQSKTPSLIFEHVNN-------TDFKVLYPTLSDYDVRYYIYELLKAL 128
PNI+K+ ++ D + ++ E + LS+ V + +++ AL
Sbjct: 80 PNIIKIFEVFEDYHNM--YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137
Query: 129 DYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 186
Y HSQ ++H+D+KP N++ +++ID+GLAE + + + + PE+
Sbjct: 138 AYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV 197
Query: 187 LVDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242
+D + D+WS G + G F G + K
Sbjct: 198 F--KRDVTFKCDIWSAGVVMYFLLTGC-----LPFTGTSLEEVQQKATYK---------- 240
Query: 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 302
+T P+AVD L ++L D + RP+A +
Sbjct: 241 ---EPNYAVE-----------CRP--LT--------PQAVDLLKQMLTKDPERRPSAAQV 276
Query: 303 MAHPYF 308
+ H +F
Sbjct: 277 LHHEWF 282
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 6e-44
Identities = 62/299 (20%), Positives = 103/299 (34%), Gaps = 52/299 (17%)
Query: 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNL 72
Q ++ + ++G G Y EVF+ D +K P + + E+ + +
Sbjct: 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKV 113
Query: 73 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALD 129
P V+L ++ L E + + +L + V Y+ + L AL
Sbjct: 114 GQHPCCVRLEQ--AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALA 171
Query: 130 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 189
+ HSQG++H DVKP N+ + R +L D+GL V+ + PELL
Sbjct: 172 HLHSQGLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG 230
Query: 190 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249
Y + D++SLG + E G + + QL + E
Sbjct: 231 --SYGTAADVFSLGLTILEVACNMELPHGG-EGWQQLRQ--------------GYLPPEF 273
Query: 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
S E L +L D + R TA+ +A P
Sbjct: 274 TAG------------LS------------SELRSVLVMMLEPDPKLRATAEALLALPVL 308
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 7e-44
Identities = 66/308 (21%), Positives = 121/308 (39%), Gaps = 67/308 (21%)
Query: 21 DDYEVVRKV-GRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIV 79
DDY+V +V G G +V + + EK +K+L+ K +RE+++ P+IV
Sbjct: 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIV 118
Query: 80 KLLDIVRDQQSKTPS--LIFEHVN------------NTDFKVLYPTLSDYDVRYYIYELL 125
+++D+ + + ++ E ++ + F ++ + + +
Sbjct: 119 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-------TEREASEIMKSIG 171
Query: 126 KALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKG 183
+A+ Y HS I HRDVKP N++ ++ L+L D+G A+ + Y+
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 231
Query: 184 PELLVDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKI-AKVLGTDEL 238
PE+L + YD S D+WSLG + G P FY + + ++
Sbjct: 232 PEVL-GPEKYDKSCDMWSLGVIMYILLCGY-----PPFYSNHGLAISPGMKTRIR----- 280
Query: 239 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT 298
E WS+ ++ E + LL+ + +R T
Sbjct: 281 -----MGQYEFP-----------NPEWSE-VS--------EEVKMLIRNLLKTEPTQRMT 315
Query: 299 AKEAMAHP 306
E M HP
Sbjct: 316 ITEFMNHP 323
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 1e-43
Identities = 70/320 (21%), Positives = 136/320 (42%), Gaps = 64/320 (20%)
Query: 14 WFINREQ----DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-------------- 55
++ +++ + Y VRK+G G Y EV + + IK++K
Sbjct: 25 MYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNK 84
Query: 56 --PVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYP 110
++I EI +L++L PNI+KL D+ D++ L+ E + +
Sbjct: 85 NIEKFHEEIYNEISLLKSL-DHPNIIKLFDVFEDKKYF--YLVTEFYEGGELFEQIINRH 141
Query: 111 TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHP 168
+ D + ++L + Y H I+HRD+KP N++++ + ++++D+GL+ F+
Sbjct: 142 KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK 201
Query: 169 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 228
+ R+ + Y+ PE+L + Y+ D+WS G + ++ P F G ++ D + K
Sbjct: 202 DYKLRDRLGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPP-FGGQNDQDIIKK 258
Query: 229 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKL 288
+ K D W I+ EA + + +
Sbjct: 259 V-------------EKGKYYFD-----------FNDWKN-IS--------DEAKELIKLM 285
Query: 289 LRYDHQERPTAKEAMAHPYF 308
L YD+ +R TA+EA+ +
Sbjct: 286 LTYDYNKRCTAEEALNSRWI 305
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-43
Identities = 68/301 (22%), Positives = 120/301 (39%), Gaps = 52/301 (17%)
Query: 20 QDDYEVVRKV-GRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNI 78
DDY++ ++V G G +V E H +KC +K+L K ++E+ GGP+I
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLY--DSPKARQEVDHHWQASGGPHI 84
Query: 79 VKLLDIVRDQQSKTPS--LIFEHVNNTD-----FKVLYPTLSDYDVRYYIYELLKALDYC 131
V +LD+ + +I E + + + ++ + + ++ A+ +
Sbjct: 85 VCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFL 144
Query: 132 HSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 189
HS I HRDVKP N++ +++ L+L D+G A+ + Y+ PE+L
Sbjct: 145 HSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYVAPEVL-G 202
Query: 190 LQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245
+ YD S D+WSLG + G P FY + + + +
Sbjct: 203 PEKYDKSCDMWSLGVIMYILLCGF-----PPFYSNTGQAISPGMKRRIR---------LG 248
Query: 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305
WS+ ++ +A + LL+ D ER T + M H
Sbjct: 249 QYGFP-----------NPEWSE-VS--------EDAKQLIRLLLKTDPTERLTITQFMNH 288
Query: 306 P 306
P
Sbjct: 289 P 289
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 8e-43
Identities = 53/321 (16%), Positives = 111/321 (34%), Gaps = 67/321 (20%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIV 79
++ + +G G V +K + EIK+L PN++
Sbjct: 14 KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVI 72
Query: 80 KLLDIVRDQQSKTPSLIFEH---------VNNTDFKVLYPTLSDYDVRYYIYELLKALDY 130
+ + + E + +Y+ + ++ + +
Sbjct: 73 RYYCSETTDRFL--YIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130
Query: 131 CHSQGIMHRDVKPHNVMID------------HEQRKLRLIDWGLAEFYHPGKEY-----N 173
HS I+HRD+KP N+++ E ++ + D+GL + G+ N
Sbjct: 131 LHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN 190
Query: 174 VRVASRYFKGPELLVDLQD------YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 227
+ ++ PELL + + S+D++S+GC+F ++ + + F D Y +
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG--DKYSRES 248
Query: 228 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDK 287
I + + ++ I EA D + +
Sbjct: 249 NIIR-----------GIFSLDEMK----------CLHDRSLI---------AEATDLISQ 278
Query: 288 LLRYDHQERPTAKEAMAHPYF 308
++ +D +RPTA + + HP F
Sbjct: 279 MIDHDPLKRPTAMKVLRHPLF 299
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 8e-43
Identities = 64/303 (21%), Positives = 123/303 (40%), Gaps = 63/303 (20%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL--KPVKKKKIKREIKILQNLCGGPN 77
+ Y + +GRG++ V V + + + K + K + +K+EI IL N
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRN 62
Query: 78 IVKLLDIVRDQQSKTPSLI---------FEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 128
I+ L + + +I FE +N + F+ L++ ++ Y++++ +AL
Sbjct: 63 ILHLHESFESMEELV--MIFEFISGLDIFERINTSAFE-----LNEREIVSYVHQVCEAL 115
Query: 129 DYCHSQGIMHRDVKPHNVM-IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 187
+ HS I H D++P N++ +++I++G A PG + + + + PE+
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVH 175
Query: 188 VDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243
+ D+WSLG + +G+ F N + I
Sbjct: 176 -QHDVVSTATDMWSLGTLVYVLLSGI-----NPFLAETNQQIIENIMNA----------- 218
Query: 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 303
D + + + I+ EA+DF+D+LL + + R TA EA+
Sbjct: 219 --EYTFD-----------EEAFKE-IS--------IEAMDFVDRLLVKERKSRMTASEAL 256
Query: 304 AHP 306
HP
Sbjct: 257 QHP 259
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-42
Identities = 64/304 (21%), Positives = 113/304 (37%), Gaps = 64/304 (21%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKC---IIKILKPVKKKKIKREIKILQNLCGGP 76
D Y++ ++G G + V + K+ +++EI+ + L P
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHP 214
Query: 77 NIVKLLDIVRDQQSKTPSLI---------FEHVNNTDFKVLYPTLSDYDVRYYIYELLKA 127
+V L D D +I FE V + K +S+ + Y+ ++ K
Sbjct: 215 TLVNLHDAFEDDNEMV--MIYEFMSGGELFEKVADEHNK-----MSEDEAVEYMRQVCKG 267
Query: 128 LDYCHSQGIMHRDVKPHNVMI-DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 186
L + H +H D+KP N+M +L+LID+GL P + V + F PE+
Sbjct: 268 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEV 327
Query: 187 LVDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242
+ + Y D+WS+G + +G+ F G ++ + L +
Sbjct: 328 A-EGKPVGYYTDMWSVGVLSYILLSGL-----SPFGGENDDETLRNVKSC---------- 371
Query: 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 302
+D +S I+ + DF+ KLL D R T +A
Sbjct: 372 ---DWNMD-----------DSAFSG-IS--------EDGKDFIRKLLLADPNTRMTIHQA 408
Query: 303 MAHP 306
+ HP
Sbjct: 409 LEHP 412
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 3e-42
Identities = 56/321 (17%), Positives = 109/321 (33%), Gaps = 67/321 (20%)
Query: 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPN 77
R D++ + +G G + +VF+ H D + +IK +K +K +RE+K L L N
Sbjct: 8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVK-YNNEKAEREVKALAKLDH-VN 65
Query: 78 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY--------------------PTLSDYDV 117
IV + + K L+ L
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKT-KCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124
Query: 118 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA 177
++ K +DY HS+ +++RD+KP N+ + + ++++ D+GL +
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK-QVKIGDFGLVTSLKNDGKRTRSKG 183
Query: 178 SRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 237
+ + PE + QDY +DL++LG + A ++ + F + L
Sbjct: 184 TLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRD--------- 233
Query: 238 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP 297
+ + + L KLL ++RP
Sbjct: 234 ---------GIISDI------------FD------------KKEKTLLQKLLSKKPEDRP 260
Query: 298 TAKEAMAHPYFFPIRNAESSR 318
E + + ++ R
Sbjct: 261 NTSEILRTLTVWKKSPEKNER 281
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-42
Identities = 68/301 (22%), Positives = 117/301 (38%), Gaps = 55/301 (18%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKREIKILQNLCGGP 76
Y + +GRG + EV V + K + + K+EI+I+++L P
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHP 66
Query: 77 NIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCHS 133
NI++L + D L+ E + V + D + ++L A+ YCH
Sbjct: 67 NIIRLYETFEDNTDI--YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK 124
Query: 134 QGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 191
+ HRD+KP N + L+LID+GLA + PGK +V + Y+ P++L
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL--EG 182
Query: 192 DYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247
Y D WS G + G P F + + ++KI +
Sbjct: 183 LYGPECDEWSAGVMMYVLLCGY-----PPFSAPTDSEVMLKIREG-------------TF 224
Query: 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 307
K W ++ P+A + +LL ++R T+ +A+ H +
Sbjct: 225 TFP-----------EKDWLN-VS--------PQAESLIRRLLTKSPKQRITSLQALEHEW 264
Query: 308 F 308
F
Sbjct: 265 F 265
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 3e-42
Identities = 70/304 (23%), Positives = 127/304 (41%), Gaps = 64/304 (21%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKC---IIKILKPVKKKKIKREIKILQNLCGGP 76
D Y+++ ++G G + V V I P+ K +K EI I+ L P
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH-P 108
Query: 77 NIVKLLDIVRDQQSKTPSLI---------FEHVNNTDFKVLYPTLSDYDVRYYIYELLKA 127
++ L D D+ LI F+ + D+K +S+ +V Y+ + +
Sbjct: 109 KLINLHDAFEDKYEMV--LILEFLSGGELFDRIAAEDYK-----MSEAEVINYMRQACEG 161
Query: 128 LDYCHSQGIMHRDVKPHNVMI-DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 186
L + H I+H D+KP N+M + +++ID+GLA +P + V A+ F PE+
Sbjct: 162 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEI 221
Query: 187 LVDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242
+ D + + D+W++G + +G+ F G D+ + L + +
Sbjct: 222 V-DREPVGFYTDMWAIGVLGYVLLSGL-----SPFAGEDDLETLQNVKRC---------- 265
Query: 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 302
E D +S ++ PEA DF+ LL+ + ++R T +A
Sbjct: 266 ---DWEFDE-----------DAFSS-VS--------PEAKDFIKNLLQKEPRKRLTVHDA 302
Query: 303 MAHP 306
+ HP
Sbjct: 303 LEHP 306
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-41
Identities = 77/345 (22%), Positives = 149/345 (43%), Gaps = 61/345 (17%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLC-----GG 75
YEV++ +G+G + +V + ++ +K+++ K+ ++ EI+IL++L
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158
Query: 76 PNIVKLLD---------IVRDQQSKTPSL---IFEHVNNTDFKVLYPTLSDYDVRYYIYE 123
N++ +L+ + L ++E + F+ L VR + +
Sbjct: 159 MNVIHMLENFTFRNHICMT------FELLSMNLYELIKKNKFQGFSLPL----VRKFAHS 208
Query: 124 LLKALDYCHSQGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGKEYNVRVASRYFK 182
+L+ LD H I+H D+KP N+++ + R +++ID+G + + H + Y + SR+++
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEH-QRVYTY-IQSRFYR 266
Query: 183 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG-------- 234
PE+++ Y +D+WSLGC+ A + P G D DQL + ++LG
Sbjct: 267 APEVILGA-RYGMPIDMWSLGCILAEL-LTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324
Query: 235 ---------TDELNAYLNKYHIELDPHLAALVGRHSRK-----PWSKFITVENQHLAVPE 280
+ + D + GR R P S+ + P
Sbjct: 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPL 384
Query: 281 AVDFLDKLLRYDHQERPTAKEAMAHPYF-----FPIRNAESSRSR 320
+DFL + L +D R T +A+ HP+ P ++S R
Sbjct: 385 FLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEKTSVKR 429
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-41
Identities = 70/306 (22%), Positives = 133/306 (43%), Gaps = 61/306 (19%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK---------PVKKKKIKREIKILQ 70
+D Y++ ++G G+++ V + + + K +K V +++I+RE+ IL+
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 71 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKA 127
+ N++ L D+ ++ LI E V+ DF +LS+ + +I ++L
Sbjct: 71 QV-LHHNVITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 128 LDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 184
++Y H++ I H D+KP N+M+ + ++LID+GLA G E+ + F P
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
Query: 185 ELLVDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 240
E++ + + D+WS+G + +G F G + L I V
Sbjct: 188 EIV-NYEPLGLEADMWSIGVITYILLSGA-----SPFLGDTKQETLANITSV-------- 233
Query: 241 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 300
+ D + +S + A DF+ KLL + ++R T +
Sbjct: 234 -----SYDFDE-----------EFFSH-TS--------ELAKDFIRKLLVKETRKRLTIQ 268
Query: 301 EAMAHP 306
EA+ HP
Sbjct: 269 EALRHP 274
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-41
Identities = 58/304 (19%), Positives = 125/304 (41%), Gaps = 58/304 (19%)
Query: 20 QDDYEVVRKV-GRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLC 73
+ Y + K GRGK++ V + + + ++ K + +I EI +L+
Sbjct: 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAK 86
Query: 74 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-F----KVLYPTLSDYDVRYYIYELLKAL 128
P ++ L ++ + LI E+ + F L +S+ DV I ++L+ +
Sbjct: 87 SCPRVINLHEVYENTSEII--LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGV 144
Query: 129 DYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 186
Y H I+H D+KP N+++ + ++++D+G++ E + + + PE+
Sbjct: 145 YYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEI 204
Query: 187 LVDLQDYDYSLDLWSLG----CMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242
L + + D+W++G + F G DN + + I++V
Sbjct: 205 L-NYDPITTATDMWNIGIIAYMLLTHT-----SPFVGEDNQETYLNISQV---------- 248
Query: 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 302
+++ + +S ++ A DF+ LL + ++RPTA+
Sbjct: 249 ---NVDYS-----------EETFSS-VS--------QLATDFIQSLLVKNPEKRPTAEIC 285
Query: 303 MAHP 306
++H
Sbjct: 286 LSHS 289
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 4e-41
Identities = 70/301 (23%), Positives = 126/301 (41%), Gaps = 57/301 (18%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCG 74
+ Y +V +G+G + EV + ++ +K+ K I RE+++L+ L
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-D 79
Query: 75 GPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYC 131
PNI+KL +I+ D S ++ E D + S++D I ++ + Y
Sbjct: 80 HPNIMKLFEILEDSSSF--YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYM 137
Query: 132 HSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 189
H I+HRD+KP N++++ + +++ID+GL+ + + R+ + Y+ PE+L
Sbjct: 138 HKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-- 195
Query: 190 LQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245
YD D+WS G + +G P FYG + YD L ++
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGT-----PPFYGKNEYDILKRVETG------------- 237
Query: 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305
D W I+ +A D + K+L + R TA + + H
Sbjct: 238 KYAFDL-----------PQWRT-IS--------DDAKDLIRKMLTFHPSLRITATQCLEH 277
Query: 306 P 306
P
Sbjct: 278 P 278
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 7e-41
Identities = 58/307 (18%), Positives = 107/307 (34%), Gaps = 34/307 (11%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGP 76
+ + +G+G + VF G H + IK+ + RE ++L+ L
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNH-K 67
Query: 77 NIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL-----YPTLSDYDVRYYIYELLKALDY 130
NIVKL I + ++ LI E + VL L + + + +++ +++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 131 CHSQGIMHRDVKPHNVMIDH---EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 187
GI+HR++KP N+M Q +L D+G A +++ + + P++
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMY 187
Query: 188 -------VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 240
+ Y ++DLWS+G F PF + K++ A
Sbjct: 188 ERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247
Query: 241 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQ--HLAVPEAVDFLDKLLRYDHQERPT 298
E P WS + V L +L D ++
Sbjct: 248 ISGVQKAENGP-----------IDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296
Query: 299 AKEAMAH 305
+ A
Sbjct: 297 FDQFFAE 303
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 9e-41
Identities = 68/313 (21%), Positives = 123/313 (39%), Gaps = 65/313 (20%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------------PVKKKKIKREIK 67
++YE +GRG S V +H ++ +KI+ ++ +E+
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 68 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYEL 124
IL+ + G PNI++L D L+F+ + D+ TLS+ + R + L
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFF--FLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 133
Query: 125 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 184
L+ + H I+HRD+KP N+++D + ++L D+G + PG++ + + P
Sbjct: 134 LEVICALHKLNIVHRDLKPENILLD-DDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAP 192
Query: 185 ELL-----VDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 235
E++ + Y +D+WS G + AG P F+ L I
Sbjct: 193 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS-----PPFWHRKQMLMLRMIMSG--- 244
Query: 236 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE 295
+ + W + D + + L Q+
Sbjct: 245 ----------NYQFGS-----------PEWDD-YS--------DTVKDLVSRFLVVQPQK 274
Query: 296 RPTAKEAMAHPYF 308
R TA+EA+AHP+F
Sbjct: 275 RYTAEEALAHPFF 287
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-40
Identities = 49/346 (14%), Positives = 92/346 (26%), Gaps = 73/346 (21%)
Query: 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL------KPVKKKKIKREIKIL 69
+++ + ++V + G S VF E +K+ + +++
Sbjct: 57 LSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAA 116
Query: 70 QNL-----------------------CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT--- 103
L P +L D L+ +
Sbjct: 117 ARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLEL 176
Query: 104 ------DFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRL 157
V + +L++ S+G++H P N+ I + R L L
Sbjct: 177 LFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGR-LML 235
Query: 158 IDWGLAEFYHPGKEYNVRVASRYFKGPELL-VDLQDYDYSLDLWSLGCMFAGMIFRKEPF 216
D + G + E L + ++L+ W LG + PF
Sbjct: 236 GDVSAL--WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293
Query: 217 FYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHL 276
K + R F +
Sbjct: 294 GLVTPGIKGSWKRPSL--------------------------RVPGTDSLAFGSCTP--- 324
Query: 277 AVPEAV-DFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSRSRS 321
+P+ V + + L +D + R EAM P F ++N SS +
Sbjct: 325 -LPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEISSSLST 369
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 2e-40
Identities = 72/306 (23%), Positives = 135/306 (44%), Gaps = 61/306 (19%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK---------PVKKKKIKREIKILQ 70
+D Y++ ++G G+++ V + + + K +K V +++I+RE+ IL+
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 71 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKA 127
+ PNI+ L D+ ++ LI E V+ DF +LS+ + +I ++L
Sbjct: 71 QV-LHPNIITLHDVYENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSFIKQILDG 127
Query: 128 LDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 184
++Y H++ I H D+KP N+M+ + ++LID+GLA G E+ + F P
Sbjct: 128 VNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAP 187
Query: 185 ELLVDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 240
E++ + + D+WS+G + +G F G + L I V
Sbjct: 188 EIV-NYEPLGLEADMWSIGVITYILLSGA-----SPFLGDTKQETLANITAV-------- 233
Query: 241 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 300
+ D + +S+ + A DF+ KLL + ++R T +
Sbjct: 234 -----SYDFDE-----------EFFSQ-TS--------ELAKDFIRKLLVKETRKRLTIQ 268
Query: 301 EAMAHP 306
EA+ HP
Sbjct: 269 EALRHP 274
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 3e-40
Identities = 64/345 (18%), Positives = 121/345 (35%), Gaps = 89/345 (25%)
Query: 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLC 73
R D+E ++ +GRG + VFE + D+ IK ++ + ++K+ RE+K L L
Sbjct: 2 RYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE 61
Query: 74 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY--------PTLSDY---------- 115
P IV+ + ++ + + ++ LY L D+
Sbjct: 62 H-PGIVRYFNAWLEKNTTE-----KLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEER 115
Query: 116 ---DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-------EF 165
+ ++ +A+++ HS+G+MHRD+KP N+ + +++ D+GL E
Sbjct: 116 ERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEE 174
Query: 166 YHPGKEYNVRVASRYFKG------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYG 219
G PE + Y + +D++SLG + +++ PF
Sbjct: 175 QTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFSTQ 230
Query: 220 HDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVP 279
+ L + + K+ P
Sbjct: 231 MERVRTLTDVRN--------------------------LKFPPLFTQKY----------P 254
Query: 280 EAVDFLDKLLRYDHQERPTAKEAMAHPYF----FPIRNAESSRSR 320
+ +L ERP A + + F FP + RSR
Sbjct: 255 CEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTVLRQRSR 299
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-40
Identities = 72/334 (21%), Positives = 144/334 (43%), Gaps = 57/334 (17%)
Query: 23 YEVVRKVGRGKYSEVFEGV-HCTDNEKCIIKILKPVKK--KKIKREIKILQNLC-----G 74
YE+V +G G + +V E + H +KI+K V + + + EI++L++L
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNS 75
Query: 75 GPNIVKLLD---------IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELL 125
V++L+ IV + S ++ + F +R Y++
Sbjct: 76 TFRCVQMLEWFEHHGHICIVFELLG--LST-YDFIKENGFL----PFRLDHIRKMAYQIC 128
Query: 126 KALDYCHSQGIMHRDVKPHNVMIDHEQR------------------KLRLIDWGLAEFYH 167
K++++ HS + H D+KP N++ ++++D+G A +
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD 188
Query: 168 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 227
+ V++R+++ PE+++ L + D+WS+GC+ + F HD+ + L
Sbjct: 189 E-HHSTL-VSTRHYRAPEVILALG-WSQPCDVWSIGCILIEY-YLGFTVFPTHDSKEHLA 244
Query: 228 KIAKVLGT--DEL--NAYLNKYHIE--LDPHLAALVGRHSR---KPWSKFITVENQHLAV 278
+ ++LG + KY LD + GR+ KP +F+ ++
Sbjct: 245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEH-- 302
Query: 279 PEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312
D + K+L YD +R T +EA+ HP+F ++
Sbjct: 303 ERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK 336
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 4e-40
Identities = 71/303 (23%), Positives = 124/303 (40%), Gaps = 53/303 (17%)
Query: 20 QDDYEV---VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGP 76
Y++ + +G G +S + VH N+ +KI+ + ++EI L+ G P
Sbjct: 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHP 66
Query: 77 NIVKLLDIVRDQQSKTPSLIFEHVNNTD-F-----KVLYPTLSDYDVRYYIYELLKALDY 130
NIVKL ++ DQ L+ E +N + F K + S+ + Y + +L+ A+ +
Sbjct: 67 NIVKLHEVFHDQLHT--FLVMELLNGGELFERIKKKKHF---SETEASYIMRKLVSAVSH 121
Query: 131 CHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHP-GKEYNVRVASRYFKGPELL 187
H G++HRD+KP N++ E ++++ID+G A P + + ++ PELL
Sbjct: 122 MHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL 181
Query: 188 VDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243
+ YD S DLWSLG M +G F HD +++ +
Sbjct: 182 -NQNGYDESCDLWSLGVILYTMLSGQ-----VPFQSHDRSLTCTSAVEIM------KKIK 229
Query: 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 303
K + + W ++ EA D + LL D +R
Sbjct: 230 KGDFSFEG-----------EAWKN-VS--------QEAKDLIQGLLTVDPNKRLKMSGLR 269
Query: 304 AHP 306
+
Sbjct: 270 YNE 272
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 5e-40
Identities = 72/301 (23%), Positives = 132/301 (43%), Gaps = 56/301 (18%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCG 74
D+Y+V ++G+G +S V VH T + KI L +K++RE +I + L
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 75 GPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYC 131
PNIV+L D ++++ L+F+ V + V S+ D + I ++L+++ YC
Sbjct: 88 -PNIVRLHDSIQEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 144
Query: 132 HSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 189
HS GI+HR++KP N+++ + ++L D+GLA + + ++ + + PE+L
Sbjct: 145 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL-K 203
Query: 190 LQDYDYSLDLWSLGCMF----AGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245
Y +D+W+ G + G P F+ D + +I
Sbjct: 204 KDPYSKPVDIWACGVILYILLVGY-----PPFWDEDQHRLYAQIKAG------------- 245
Query: 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305
+ W +T PEA +D +L + ++R TA +A+
Sbjct: 246 AYDYP-----------SPEWDT-VT--------PEAKSLIDSMLTVNPKKRITADQALKV 285
Query: 306 P 306
P
Sbjct: 286 P 286
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-40
Identities = 69/306 (22%), Positives = 133/306 (43%), Gaps = 61/306 (19%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK---------PVKKKKIKREIKILQ 70
+D YE+ ++G G+++ V + ++ K +K V +++I+RE+ IL+
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 71 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKA 127
+ PNI+ L DI ++ LI E V+ DF +L++ + ++ ++L
Sbjct: 64 EI-RHPNIITLHDIFENKTDVV--LILELVSGGELFDFLAEKESLTEDEATQFLKQILDG 120
Query: 128 LDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 184
+ Y HS+ I H D+KP N+M+ + +++LID+G+A G E+ + F P
Sbjct: 121 VHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 180
Query: 185 ELLVDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 240
E++ + + D+WS+G + +G F G + L I+ V
Sbjct: 181 EIV-NYEPLGLEADMWSIGVITYILLSGA-----SPFLGETKQETLTNISAV-------- 226
Query: 241 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 300
+ + D + +S + A DF+ +LL D + R T
Sbjct: 227 -----NYDFD-----------EEYFSN-TS--------ELAKDFIRRLLVKDPKRRMTIA 261
Query: 301 EAMAHP 306
+++ H
Sbjct: 262 QSLEHS 267
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 6e-40
Identities = 66/345 (19%), Positives = 122/345 (35%), Gaps = 91/345 (26%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--------PVKKKKIKREIKILQN 71
Q Y + +G+G Y V + IKI+ P ++IK E+++++
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 72 LCGGPNIVKLLDIVRDQQS----------------------------------------- 90
L PNI +L ++ D+Q
Sbjct: 85 LHH-PNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 91 KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 150
+ + + L + + + ++ AL Y H+QGI HRD+KP N +
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFST 203
Query: 151 -EQRKLRLIDWGLAEFYHPGKE-----YNVRVASRYFKGPELL-VDLQDYDYSLDLWSLG 203
+ +++L+D+GL++ ++ + + YF PE+L + Y D WS G
Sbjct: 204 NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAG 263
Query: 204 CMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRK 263
+ ++ P F G ++ D + ++ K E
Sbjct: 264 VLLHLLLMGAVP-FPGVNDADTISQVLN-----------KKLCFE-------------NP 298
Query: 264 PWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
++ ++ P A D L LL + ER A A+ HP+
Sbjct: 299 NYNV-LS--------PLARDLLSNLLNRNVDERFDAMRALQHPWI 334
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 9e-40
Identities = 80/347 (23%), Positives = 152/347 (43%), Gaps = 61/347 (17%)
Query: 23 YEVVRKVGRGKYSEVFEGV-HCTDNEKCIIKILKPVKK--KKIKREIKILQNLC-----G 74
YE+V +G G + +V E + H + +KI++ V K + + EI +L+ +
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKEN 80
Query: 75 GPNIVKLLD---------IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELL 125
V + D I + + FE + +F+ VR+ Y+L
Sbjct: 81 KFLCVLMSDWFNFHGHMCIAFELLG--KNT-FEFLKENNFQ----PYPLPHVRHMAYQLC 133
Query: 126 KALDYCHSQGIMHRDVKPHNVMIDHEQRK------------------LRLIDWGLAEFYH 167
AL + H + H D+KP N++ + + + +R+ D+G A F H
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH 193
Query: 168 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 227
+ VA+R+++ PE++++L + D+WS+GC+ +R F H+N + LV
Sbjct: 194 E-HHTTI-VATRHYRPPEVILELG-WAQPCDVWSIGCILFEY-YRGFTLFQTHENREHLV 249
Query: 228 KIAKVLGT--DEL--NAYLNKYHIE--LDPHLAALVGRHSR---KPWSKFITVENQHLAV 278
+ K+LG + KY + L + GR+ + KP ++ ++
Sbjct: 250 MMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEH-- 307
Query: 279 PEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI----RNAESSRSRS 321
+ D + ++L +D +R T EA+ HP+F + R+ +SR+ S
Sbjct: 308 VQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHTSRNPS 354
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-39
Identities = 65/306 (21%), Positives = 132/306 (43%), Gaps = 61/306 (19%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK---------PVKKKKIKREIKILQ 70
D Y+ ++G G+++ V + + + K +K V ++ I+RE+ IL+
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 71 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKA 127
+ PN++ L ++ ++ LI E V DF +L++ + ++ ++L
Sbjct: 70 EI-QHPNVITLHEVYENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEFLKQILNG 126
Query: 128 LDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 184
+ Y HS I H D+KP N+M+ + + ++++ID+GLA G E+ + F P
Sbjct: 127 VYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAP 186
Query: 185 ELLVDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 240
E++ + + D+WS+G + +G F G + L ++ V
Sbjct: 187 EIV-NYEPLGLEADMWSIGVITYILLSGA-----SPFLGDTKQETLANVSAV-------- 232
Query: 241 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 300
+ E + + +S + A DF+ +LL D ++R T +
Sbjct: 233 -----NYEFE-----------DEYFSN-TS--------ALAKDFIRRLLVKDPKKRMTIQ 267
Query: 301 EAMAHP 306
+++ HP
Sbjct: 268 DSLQHP 273
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-39
Identities = 72/301 (23%), Positives = 132/301 (43%), Gaps = 56/301 (18%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCG 74
D+Y+V ++G+G +S V VH T + KI L +K++RE +I + L
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 75 GPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYC 131
PNIV+L D ++++ L+F+ V + V S+ D + I ++L+++ YC
Sbjct: 65 -PNIVRLHDSIQEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121
Query: 132 HSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 189
HS GI+HR++KP N+++ + ++L D+GLA + + ++ + + PE+L
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVL-K 180
Query: 190 LQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245
Y +D+W+ G + G P F+ D + +I
Sbjct: 181 KDPYSKPVDIWACGVILYILLVGY-----PPFWDEDQHRLYAQIKAG------------- 222
Query: 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305
+ W +T PEA +D +L + ++R TA +A+
Sbjct: 223 AYDYPS-----------PEWDT-VT--------PEAKSLIDSMLTVNPKKRITADQALKV 262
Query: 306 P 306
P
Sbjct: 263 P 263
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 2e-39
Identities = 72/309 (23%), Positives = 127/309 (41%), Gaps = 65/309 (21%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--------PVKKKKIKREIKILQN 71
+D YE+ +G+G +S V ++ ++ +KI+ + + +KRE I
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 72 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN-------TDFKVLYPTLSDYDVRYYIYEL 124
L P+IV+LL+ ++FE ++ S+ +Y+ ++
Sbjct: 83 L-KHPHIVELLETYSSDGML--YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI 139
Query: 125 LKALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYF 181
L+AL YCH I+HRDVKPH V++ ++L +G+A + G RV + +F
Sbjct: 140 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 199
Query: 182 KGPELLVDLQDYDYSLDLWSLG----CMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 237
PE++ + Y +D+W G + +G FYG +
Sbjct: 200 MAPEVV-KREPYGKPVDVWGCGVILFILLSGC-----LPFYGTK--------------ER 239
Query: 238 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP 297
L + K +++P + WS I+ A D + ++L D ER
Sbjct: 240 LFEGIIKGKYKMNP-----------RQWSH-IS--------ESAKDLVRRMLMLDPAERI 279
Query: 298 TAKEAMAHP 306
T EA+ HP
Sbjct: 280 TVYEALNHP 288
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 3e-39
Identities = 69/311 (22%), Positives = 124/311 (39%), Gaps = 64/311 (20%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK-----------KIKREIKIL 69
Y+ +GRG S V VH + +KI++ ++ +RE IL
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 70 QNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLK 126
+ + G P+I+ L+D L+F+ + D+ LS+ + R + LL+
Sbjct: 154 RQVAGHPHIITLIDSYESSSFM--FLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLE 211
Query: 127 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 186
A+ + H+ I+HRD+KP N+++D + ++RL D+G + PG++ + + PE+
Sbjct: 212 AVSFLHANNIVHRDLKPENILLD-DNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEI 270
Query: 187 L-----VDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 237
L Y +DLW+ G + AG P F+ L I +
Sbjct: 271 LKCSMDETHPGYGKEVDLWACGVILFTLLAGS-----PPFWHRRQILMLRMIMEG----- 320
Query: 238 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP 297
+ W + D + +LL+ D + R
Sbjct: 321 --------QYQFS-----------SPEWDD-RS--------STVKDLISRLLQVDPEARL 352
Query: 298 TAKEAMAHPYF 308
TA++A+ HP+F
Sbjct: 353 TAEQALQHPFF 363
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 3e-39
Identities = 71/299 (23%), Positives = 118/299 (39%), Gaps = 55/299 (18%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK-ILKPVKKKKIKREIKILQNLCGGPNI 78
D +EV ++GRG S V+ + +K + K V KK ++ EI +L L PNI
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSH-PNI 110
Query: 79 VKLLDIVRDQQSKTPSLIFEHVNNT-----DFKVLYPTLSDYDVRYYIYELLKALDYCHS 133
+KL +I SL+ E V T D V S+ D + ++L+A+ Y H
Sbjct: 111 IKLKEIFETPTEI--SLVLELV--TGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHE 166
Query: 134 QGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 191
GI+HRD+KP N++ L++ D+GL++ + + PE+L
Sbjct: 167 NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRG-C 225
Query: 192 DYDYSLDLWSLGCMF----AGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247
Y +D+WS+G + G FY + ++L
Sbjct: 226 AYGPEVDMWSVGIITYILLCGF-----EPFYDERGDQFM--FRRIL----------NCEY 268
Query: 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 306
W + ++ A D + KL+ D ++R T +A+ HP
Sbjct: 269 YFIS-----------PWWDE-VS--------LNAKDLVRKLIVLDPKKRLTTFQALQHP 307
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 3e-39
Identities = 76/333 (22%), Positives = 132/333 (39%), Gaps = 63/333 (18%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLC------- 73
Y +VRK+G G +S V+ +N +KI++ K + + EIK+LQ +
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80
Query: 74 ---GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD------FKVLYPTLSDY--------- 115
G +I+KLLD F H F+VL L
Sbjct: 81 DSMGANHILKLLDH------------FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI 128
Query: 116 ---DVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQR-----KLRLIDWGLAEFY 166
V+ +LL LDY H + GI+H D+KP NV+++ ++++ D G A +Y
Sbjct: 129 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 188
Query: 167 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD----- 221
+ Y + +R ++ PE+L+ + D+WS C+ +I F +
Sbjct: 189 D--EHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGD-FLFEPDEGHSYT 244
Query: 222 -NYDQLVKIAKVLG--TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAV 278
+ D + +I ++LG L + + + + E +
Sbjct: 245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK 304
Query: 279 PEA---VDFLDKLLRYDHQERPTAKEAMAHPYF 308
EA DFL +L+ D ++R A + HP+
Sbjct: 305 DEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 337
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-39
Identities = 69/297 (23%), Positives = 116/297 (39%), Gaps = 50/297 (16%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVK 80
D YEV +G G YS +H N + +KI+ K+ EI+IL PNI+
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID-KSKRDPTEEIEILLRYGQHPNIIT 80
Query: 81 LLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIM 137
L D+ D + ++ E + D + S+ + ++ + K ++Y H+QG++
Sbjct: 81 LKDVYDDGKYV--YVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVV 138
Query: 138 HRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDY 193
HRD+KP N++ +R+ D+G A+ + F PE+L + Q Y
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL-ERQGY 197
Query: 194 DYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249
D + D+WSLG M G F + +A++ L
Sbjct: 198 DAACDIWSLGVLLYTMLTGY-----TPFANGPDDTPEEILARIG----------SGKFSL 242
Query: 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 306
W+ ++ A D + K+L D +R TA + HP
Sbjct: 243 S-----------GGYWNS-VS--------DTAKDLVSKMLHVDPHQRLTAALVLRHP 279
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 7e-39
Identities = 66/304 (21%), Positives = 119/304 (39%), Gaps = 32/304 (10%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKKKKIKREIKILQNLCGGP 76
+E+ ++G G + V +H E K + L P +++ EI+I++ L P
Sbjct: 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHP 72
Query: 77 NIVKLLDIVRDQQSKTPS----LIFEHVNNTD-FKVL-----YPTLSDYDVRYYIYELLK 126
N+V ++ Q P+ L E+ D K L L + +R + ++
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 127 ALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 184
AL Y H I+HRD+KP N+++ ++ ++ID G A+ G+ V + + P
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 192
Query: 185 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244
ELL + + Y ++D WS G + I P F + Q + +
Sbjct: 193 ELL-EQKKYTVTVDYWSFGTLAFECITGFRP-FLPNWQPVQWHGKVREKSNE-------- 242
Query: 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304
HI + L V S P ++ +L +L + ++R T +
Sbjct: 243 -HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLER----WLQCMLMWHQRQRGTDPQNPN 297
Query: 305 HPYF 308
F
Sbjct: 298 VGCF 301
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-38
Identities = 67/311 (21%), Positives = 124/311 (39%), Gaps = 63/311 (20%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-----------KPVKKKKIKREIKI 68
+D+Y + + +G G EV +K I+I+ + ++ EI+I
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 69 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELL 125
L+ L P I+K+ + ++ ++ E + D V L + + Y Y++L
Sbjct: 194 LKKL-NHPCIIKIKNFF---DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 249
Query: 126 KALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 183
A+ Y H GI+HRD+KP NV++ E +++ D+G ++ + +
Sbjct: 250 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 309
Query: 184 PELLVDLQD--YDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 237
PE+LV + Y+ ++D WSLG +G PF +I
Sbjct: 310 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGY----PPFSEHRTQVSLKDQITSG----- 360
Query: 238 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP 297
P + W++ ++ +A+D + KLL D + R
Sbjct: 361 --------KYNFIP-----------EVWAE-VS--------EKALDLVKKLLVVDPKARF 392
Query: 298 TAKEAMAHPYF 308
T +EA+ HP+
Sbjct: 393 TTEEALRHPWL 403
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 2e-38
Identities = 62/306 (20%), Positives = 129/306 (42%), Gaps = 66/306 (21%)
Query: 20 QDDYEVVRK--VGRGKYSEVFEGVHCTDNEKC---IIKILKPVKKKKIKREIKILQNLCG 74
Y V + +G G++ +V + K IIK K+++K EI ++ L
Sbjct: 86 NSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-D 144
Query: 75 GPNIVKLLDIVRDQQSKTPSLI---------FEHVNNTDFKVLYPTLSDYDVRYYIYELL 125
N+++L D + L+ F+ + + + L++ D ++ ++
Sbjct: 145 HANLIQLYDAFESKNDIV--LVMEYVDGGELFDRIIDESYN-----LTELDTILFMKQIC 197
Query: 126 KALDYCHSQGIMHRDVKPHNVM-IDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 184
+ + + H I+H D+KP N++ ++ + +++++ID+GLA Y P ++ V + F P
Sbjct: 198 EGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAP 257
Query: 185 ELLVDLQDYDYSLDLWSLG----CMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 240
E++ + + D+WS+G + +G+ F G ++ + L I
Sbjct: 258 EVV-NYDFVSFPTDMWSVGVIAYMLLSGL-----SPFLGDNDAETLNNILAC-------- 303
Query: 241 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 300
+L+ + + I+ EA +F+ KLL + R +A
Sbjct: 304 -----RWDLED-----------EEFQD-IS--------EEAKEFISKLLIKEKSWRISAS 338
Query: 301 EAMAHP 306
EA+ HP
Sbjct: 339 EALKHP 344
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-38
Identities = 62/317 (19%), Positives = 130/317 (41%), Gaps = 60/317 (18%)
Query: 20 QDDYEVVRKV-GRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKREIKILQNLCGG 75
+D Y++ V G G ++ V ++ +++ +KI+ + ++ RE+++L G
Sbjct: 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 76 PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-F-----KVLYPTLSDYDVRYYIYELLKALD 129
N+++L++ ++ L+FE + + + ++ + + ++ ALD
Sbjct: 71 RNVLELIEFFEEEDRF--YLVFEKMRGGSILSHIHKRRHF---NELEASVVVQDVASALD 125
Query: 130 YCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGKEYNV--------RVASR 179
+ H++GI HRD+KP N++ +H + +++ D+ L + + S
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 180 YFKGPELL----VDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAK 231
+ PE++ + YD DLWSLG + +G P F G D +
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY-----PPFVGRCGSDCGWDRGE 240
Query: 232 VLGTDELNAYLN--KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLL 289
+ + + + E K W+ I+ A D + KLL
Sbjct: 241 ACPACQNMLFESIQEGKYEFP-----------DKDWAH-IS--------CAAKDLISKLL 280
Query: 290 RYDHQERPTAKEAMAHP 306
D ++R +A + + HP
Sbjct: 281 VRDAKQRLSAAQVLQHP 297
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 3e-38
Identities = 73/332 (21%), Positives = 141/332 (42%), Gaps = 57/332 (17%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLC-----GG 75
YE+ +G+G + +V + + E IKI+K K + + E+++L+ +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMK 115
Query: 76 PNIVKLLD---------IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLK 126
IV L +V + S +L ++ + NT+F+ +S R + ++
Sbjct: 116 YYIVHLKRHFMFRNHLCLVFEMLS--YNL-YDLLRNTNFR----GVSLNLTRKFAQQMCT 168
Query: 127 ALDYCHSQ--GIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKG 183
AL + + I+H D+KP N+++ + +R ++++D+G + + + SR+++
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLG--QRIYQYIQSRFYRS 226
Query: 184 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG--TDEL--N 239
PE+L+ + YD ++D+WSLGC+ M EP F G + DQ+ KI +VLG +
Sbjct: 227 PEVLLGM-PYDLAIDMWSLGCILVEM-HTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQ 284
Query: 240 AYLNKYHIELDPHLAALV-------GRHSRKPWSKFITVENQHLAVPEA----------- 281
A + E P + + K + P
Sbjct: 285 APKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVA 344
Query: 282 -----VDFLDKLLRYDHQERPTAKEAMAHPYF 308
D + ++L YD + R A+ H +F
Sbjct: 345 DYLKFKDLILRMLDYDPKTRIQPYYALQHSFF 376
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 6e-38
Identities = 73/336 (21%), Positives = 142/336 (42%), Gaps = 63/336 (18%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNL----CGGP 76
+ V+RK+G G + V H + + +K+++ +KK + K E IL+ +
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNN 96
Query: 77 NIVKLLD---------IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKA 127
NIVK ++ + PSL +E + ++ + ++ Y E+LKA
Sbjct: 97 NIVKYHGKFMYYDHMCLIFEPLG--PSL-YEIITRNNYNGFHIED----IKLYCIEILKA 149
Query: 128 LDYCHSQGIMHRDVKPHNVMIDHEQRK------------------------LRLIDWGLA 163
L+Y + H D+KP N+++D + ++LID+G A
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA 209
Query: 164 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY 223
F ++ + +R ++ PE++++L +D S D+WS GC+ A + + F H++
Sbjct: 210 TFKSD-YHGSI-INTRQYRAPEVILNLG-WDVSSDMWSFGCVLAEL-YTGSLLFRTHEHM 265
Query: 224 DQLVKIAKVLGT-----------DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVE 272
+ L + ++ + Y+NK ++L A +S K K + +
Sbjct: 266 EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENA-SSINSIKHVKKCLPLY 324
Query: 273 NQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
+ DFL +L+ D RP+ E + H +
Sbjct: 325 KI-IKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 8e-38
Identities = 68/301 (22%), Positives = 118/301 (39%), Gaps = 59/301 (19%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKREIKILQNLCGGP 76
+ + + +G G +SEVF + +K + + ++ EI +L+ +
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH-E 66
Query: 77 NIVKLLDIVRDQQSKTPSLIFEHVNNT-----DFKVLYPTLSDYDVRYYIYELLKALDYC 131
NIV L DI L+ + V + D + ++ D I ++L A+ Y
Sbjct: 67 NIVTLEDIYESTTHY--YLVMQLV--SGGELFDRILERGVYTEKDASLVIQQVLSAVKYL 122
Query: 132 HSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 189
H GI+HRD+KP N++ E K+ + D+GL++ G + + + PE+L
Sbjct: 123 HENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI-MSTACGTPGYVAPEVLAQ 181
Query: 190 LQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245
+ Y ++D WS+G + G P FY KI +
Sbjct: 182 -KPYSKAVDCWSIGVITYILLCGY-----PPFYEETESKLFEKIKEG------------- 222
Query: 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305
+ E + W I+ A DF+ LL D ER T ++A++H
Sbjct: 223 YYEFES-----------PFWDD-IS--------ESAKDFICHLLEKDPNERYTCEKALSH 262
Query: 306 P 306
P
Sbjct: 263 P 263
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 8e-38
Identities = 63/308 (20%), Positives = 113/308 (36%), Gaps = 88/308 (28%)
Query: 21 DDYEVVRKV-GRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIV 79
DDY+V +V G G +V + + EK +K+L+ K +RE+++ P+IV
Sbjct: 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIV 74
Query: 80 KLLDIVRDQQSKTPS--LIFEHV------------NNTDFKVLYPTLSDYDVRYYIYELL 125
+++D+ + + ++ E + + F ++ + + +
Sbjct: 75 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAF-------TEREASEIMKSIG 127
Query: 126 KALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPGKEYNVRVASRYFKG 183
+A+ Y HS I HRDVKP N++ ++ L+L D+G A
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA-------------------- 167
Query: 184 PELLVDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKI-AKVLGTDEL 238
E + YD S D+WSLG + G P FY + + ++
Sbjct: 168 KETT--GEKYDKSCDMWSLGVIMYILLCGY-----PPFYSNHGLAISPGMKTRIR----- 215
Query: 239 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT 298
E WS+ ++ E + LL+ + +R T
Sbjct: 216 -----MGQYEFP-----------NPEWSE-VS--------EEVKMLIRNLLKTEPTQRMT 250
Query: 299 AKEAMAHP 306
E M HP
Sbjct: 251 ITEFMNHP 258
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-37
Identities = 70/311 (22%), Positives = 125/311 (40%), Gaps = 63/311 (20%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKI 68
+D+Y + + +G G EV +K IKI+ K ++ EI+I
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 69 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELL 125
L+ L P I+K+ + ++ ++ E + D V L + + Y Y++L
Sbjct: 69 LKKL-NHPCIIKIKNFF---DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124
Query: 126 KALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 183
A+ Y H GI+HRD+KP NV++ E +++ D+G ++ + +
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 184
Query: 184 PELLVDLQD--YDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 237
PE+LV + Y+ ++D WSLG +G PF +I G
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGY----PPFSEHRTQVSLKDQITS--G--- 235
Query: 238 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP 297
P + W++ ++ +A+D + KLL D + R
Sbjct: 236 --------KYNFIP-----------EVWAE-VS--------EKALDLVKKLLVVDPKARF 267
Query: 298 TAKEAMAHPYF 308
T +EA+ HP+
Sbjct: 268 TTEEALRHPWL 278
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-37
Identities = 54/326 (16%), Positives = 102/326 (31%), Gaps = 75/326 (23%)
Query: 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNL 72
R ++ + K+G G++ VF+ V D IK K V ++ RE+ L
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 73 CGGPNIVKLLDIVRDQQSKTPSLIF-EHVNN-------TDFKVLYPTLSDYDVRYYIYEL 124
++V+ + LI E+ N ++ + + +++ + ++
Sbjct: 68 GQHSHVVRYFSAWAEDDH---MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQV 124
Query: 125 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY------------ 172
+ L Y HS ++H D+KP N+ I + G + + K
Sbjct: 125 GRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 173 ---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 229
V F E+L + + D+++L + N DQ +I
Sbjct: 185 SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR----NGDQWHEI 240
Query: 230 AKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKP--WSKFITVENQHLAVPEAVDFLDK 287
+ GR R P S E + L
Sbjct: 241 RQ--------------------------GRLPRIPQVLS------------QEFTELLKV 262
Query: 288 LLRYDHQERPTAKEAMAHPYFFPIRN 313
++ D + RP+A + H
Sbjct: 263 MIHPDPERRPSAMALVKHSVLLSASR 288
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 3e-37
Identities = 63/306 (20%), Positives = 118/306 (38%), Gaps = 58/306 (18%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCGG 75
+DYEV+ +G G Y + +D + + K + +K+ + E+ +L+ L
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-H 64
Query: 76 PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-------FKVLYPTLSDYDVRYYIYELLKAL 128
PNIV+ D + D+ + T ++ E+ D L + V + +L AL
Sbjct: 65 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 129 DYCHSQG-----IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFK 182
CH + ++HRD+KP NV +D +Q ++L D+GLA + + V + Y+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGLARILNHDTSFAKTFVGTPYYM 183
Query: 183 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242
PE + Y+ D+WSLGC+ + PF + +L
Sbjct: 184 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFT--AFSQKELAG-------------- 226
Query: 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 302
+ + + E + + ++L RP+ +E
Sbjct: 227 -------------KIREGKFRRIPYRYS--------DELNEIITRMLNLKDYHRPSVEEI 265
Query: 303 MAHPYF 308
+ +P
Sbjct: 266 LENPLI 271
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-37
Identities = 70/301 (23%), Positives = 128/301 (42%), Gaps = 57/301 (18%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCGG 75
++Y++ ++G+G +S V V ++ I L +K++RE +I + L
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KH 69
Query: 76 PNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 132
PNIV+L D + ++ LIF+ V + V S+ D + I ++L+A+ +CH
Sbjct: 70 PNIVRLHDSISEEGHH--YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 127
Query: 133 SQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVD 189
G++HR++KP N+++ + ++L D+GLA + + + + PE+L
Sbjct: 128 QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL-R 186
Query: 190 LQDYDYSLDLWSLGCMF----AGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245
Y +DLW+ G + G P F+ D + +I
Sbjct: 187 KDPYGKPVDLWACGVILYILLVGY-----PPFWDEDQHRLYQQIKAG------------- 228
Query: 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305
+ W +T PEA D ++K+L + +R TA EA+ H
Sbjct: 229 AYDFP-----------SPEWDT-VT--------PEAKDLINKMLTINPSKRITAAEALKH 268
Query: 306 P 306
P
Sbjct: 269 P 269
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-36
Identities = 54/310 (17%), Positives = 112/310 (36%), Gaps = 63/310 (20%)
Query: 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKREIKILQNLCGGPNI 78
Y ++K+G G +S V D +K + + +++ +RE + + PNI
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHPNI 88
Query: 79 VKLLDIVRDQQSKTPS--LIFEHVNNTD-------FKVLYPTLSDYDVRYYIYELLKALD 129
++L+ ++ L+ K L++ + + + + + L+
Sbjct: 89 LRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLE 148
Query: 130 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR---------- 179
H++G HRD+KP N+++ ++ + L+D G E + + +
Sbjct: 149 AIHAKGYAHRDLKPTNILLG-DEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 180 YFKGPELLVDLQDY---DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD 236
++ PE L +Q + D D+WSLGC+ M+F + P+ D + +
Sbjct: 208 SYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ----- 261
Query: 237 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER 296
N+ I P HS L+ ++ D +R
Sbjct: 262 ------NQLSIPQSPR-------HS-----------------SALWQLLNSMMTVDPHQR 291
Query: 297 PTAKEAMAHP 306
P ++
Sbjct: 292 PHIPLLLSQL 301
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 8e-36
Identities = 61/313 (19%), Positives = 103/313 (32%), Gaps = 51/313 (16%)
Query: 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGP 76
E +VGRG + EV +C +K ++ + E+ L P
Sbjct: 54 REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--LEVFRVEELVACAGLSS-P 110
Query: 77 NIVKLLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHS 133
IV L VR+ ++ E + L + YY+ + L+ L+Y H+
Sbjct: 111 RIVPLYGAVREGP--WVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHT 168
Query: 134 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PELL 187
+ I+H DVK NV++ + + L D+G A P + Y G PE +
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE-V 227
Query: 188 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247
V + D +D+WS CM M+ P+ Y + + I
Sbjct: 228 VMGKPCDAKVDIWSSCCMMLHMLNGCHPWT----QYFRG----PLC-----------LKI 268
Query: 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 307
+P E P + + LR + R +A E
Sbjct: 269 ASEPP----------------PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKV- 311
Query: 308 FFPIRNAESSRSR 320
++ +S
Sbjct: 312 GKALQEVGGLKSP 324
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-35
Identities = 52/299 (17%), Positives = 119/299 (39%), Gaps = 53/299 (17%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCGG 75
+ Y ++K+G G + + D + +IK + ++++ +RE+ +L N+
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH- 82
Query: 76 PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL----YPTLSDYDVRYYIYELLKALDY 130
PNIV+ + + S ++ ++ D FK + + + + ++ AL +
Sbjct: 83 PNIVQYRESFEENGSL--YIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKH 140
Query: 131 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPELLVD 189
H + I+HRD+K N+ + + ++L D+G+A + E + + Y+ PE+ +
Sbjct: 141 VHDRKILHRDIKSQNIFLTKDG-TVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN 199
Query: 190 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249
+ Y+ D+W+LGC+ + K F + ++KI
Sbjct: 200 -KPYNNKSDIWALGCVLYELCTLKHA-FEAGSMKNLVLKIIS------------------ 239
Query: 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
G P S + + + +L + + ++RP+ + +
Sbjct: 240 --------GSF--PPVSLHYS--------YDLRSLVSQLFKRNPRDRPSVNSILEKGFI 280
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-35
Identities = 63/306 (20%), Positives = 115/306 (37%), Gaps = 69/306 (22%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---------KPVKKKKIKREIKILQN 71
Y+V +G G + V+ G+ +DN IK + + ++ E+ +L+
Sbjct: 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 102
Query: 72 LC-GGPNIVKLLDIVRDQQSKTPS---LIFEHVNNT----DFKVLYPTLSDYDVRYYIYE 123
+ G +++LLD + P LI E DF L + R + ++
Sbjct: 103 VSSGFSGVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 157
Query: 124 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 183
+L+A+ +CH+ G++HRD+K N++ID + +L+LID+G Y +R +
Sbjct: 158 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSP 216
Query: 184 PELLVDLQDYD-YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242
PE + Y S +WSLG + M+ PF + +I +
Sbjct: 217 PEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPF-------EHDEEIIR----------- 257
Query: 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 302
+ ++ E + L +RPT +E
Sbjct: 258 GQVFFR--QRVS------------------------SECQHLIRWCLALRPSDRPTFEEI 291
Query: 303 MAHPYF 308
HP+
Sbjct: 292 QNHPWM 297
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-35
Identities = 66/307 (21%), Positives = 126/307 (41%), Gaps = 73/307 (23%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK--------KIKREIKILQNL 72
+D+E+ R +G+GK+ V+ +K+L K + +++RE++I +L
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLF--KAQLEKAGVEHQLRREVEIQSHL 66
Query: 73 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPT--LSDYDVRYYIYELLKALD 129
PNI++L D + LI E+ ++ L + YI EL AL
Sbjct: 67 RH-PNILRLYGYFHD--ATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALS 123
Query: 130 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--------EYNVRVASRYF 181
YCHS+ ++HRD+KP N+++ +L++ D+G + + +Y +
Sbjct: 124 YCHSKRVIHRDIKPENLLLGS-AGELKIADFGWSVHAPSSRRTDLCGTLDY---LP---- 175
Query: 182 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY 241
PE++ + +D +DLWSLG + + K P F + + +I++V
Sbjct: 176 --PEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISRV--------- 222
Query: 242 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE 301
+ A D + +LL+++ +RP +E
Sbjct: 223 ----EFTFPDFVT------------------------EGARDLISRLLKHNPSQRPMLRE 254
Query: 302 AMAHPYF 308
+ HP+
Sbjct: 255 VLEHPWI 261
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-34
Identities = 66/311 (21%), Positives = 124/311 (39%), Gaps = 73/311 (23%)
Query: 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL------KPVKKKKIKREIKILQN 71
R + Y R +G+G +++ FE E KI+ KP +++K+ EI I ++
Sbjct: 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRS 97
Query: 72 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKAL 128
L ++V D + ++ E + L++ + RYY+ +++
Sbjct: 98 LAH-QHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 154
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE----------YNVRVAS 178
Y H ++HRD+K N+ ++ E ++++ D+GLA E Y +A
Sbjct: 155 QYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNY---IA- 209
Query: 179 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL-VKIAKVLGTDE 237
PE+L + + + +D+WS+GC+ ++ K PF + ++I K
Sbjct: 210 -----PEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFE--TSCLKETYLRIKK------ 255
Query: 238 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP 297
N+Y I H+ P A + K+L+ D RP
Sbjct: 256 -----NEYSI--PKHIN------------------------PVAASLIQKMLQTDPTARP 284
Query: 298 TAKEAMAHPYF 308
T E + +F
Sbjct: 285 TINELLNDEFF 295
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-34
Identities = 66/311 (21%), Positives = 124/311 (39%), Gaps = 73/311 (23%)
Query: 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL------KPVKKKKIKREIKILQN 71
R + Y R +G+G +++ FE E KI+ KP +++K+ EI I ++
Sbjct: 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRS 71
Query: 72 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKAL 128
L ++V D + ++ E + L++ + RYY+ +++
Sbjct: 72 LAH-QHVVGFHGFFED--NDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGC 128
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE----------YNVRVAS 178
Y H ++HRD+K N+ ++ E ++++ D+GLA E Y +A
Sbjct: 129 QYLHRNRVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNY---IA- 183
Query: 179 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL-VKIAKVLGTDE 237
PE+L + + + +D+WS+GC+ ++ K PF + ++I K
Sbjct: 184 -----PEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFE--TSCLKETYLRIKK------ 229
Query: 238 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP 297
N+Y I H+ P A + K+L+ D RP
Sbjct: 230 -----NEYSI--PKHIN------------------------PVAASLIQKMLQTDPTARP 258
Query: 298 TAKEAMAHPYF 308
T E + +F
Sbjct: 259 TINELLNDEFF 269
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 4e-34
Identities = 64/302 (21%), Positives = 116/302 (38%), Gaps = 55/302 (18%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIK------ILKPVKKKKIKREIKILQNLCG 74
++ + +K+GRG++SEV+ D +K ++ + +EI +L+ L
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 75 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-------FKVLYPTLSDYDVRYYIYELLKA 127
PN++K + +++ E + D FK + + V Y +L A
Sbjct: 92 -PNVIKYYASFIEDN--ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148
Query: 128 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPEL 186
L++ HS+ +MHRD+KP NV I ++L D GL F+ + V + Y+ PE
Sbjct: 149 LEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPER 207
Query: 187 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV-KIAKVLGTDELNAYLNKY 245
+ + Y++ D+WSLGC+ M + PF+ N L KI +
Sbjct: 208 IHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQ-------------- 252
Query: 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305
+ P + E ++ + D ++RP
Sbjct: 253 ------------CDYPPLPSDHY---------SEELRQLVNMCINPDPEKRPDVTYVYDV 291
Query: 306 PY 307
Sbjct: 292 AK 293
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 124 bits (315), Expect = 4e-34
Identities = 64/309 (20%), Positives = 127/309 (41%), Gaps = 74/309 (23%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL------KPVKKKKIKREIKILQNLCG 74
+D++V +G+G ++ V+ + IK++ K ++++ E+KI L
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 75 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYP---TLSDYDVRYYIYELLKALDY 130
P+I++L + D S L+ E +N + + L S+ + R+++++++ + Y
Sbjct: 71 -PSILELYNYFED--SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLY 127
Query: 131 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE----------YNVRVASRY 180
HS GI+HRD+ N+++ +++ D+GLA E Y ++
Sbjct: 128 LHSHGILHRDLTLSNLLLT-RNMNIKIADFGLATQLKMPHEKHYTLCGTPNY---IS--- 180
Query: 181 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV-KIAKVLGTDELN 239
PE+ + D+WSLGCMF ++ + PF D + K+
Sbjct: 181 ---PEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFD--TDTVKNTLNKVVL-------- 226
Query: 240 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA 299
Y + P F++ EA D + +LLR + +R +
Sbjct: 227 ---ADYEM---P---------------SFLS--------IEAKDLIHQLLRRNPADRLSL 257
Query: 300 KEAMAHPYF 308
+ HP+
Sbjct: 258 SSVLDHPFM 266
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-33
Identities = 63/312 (20%), Positives = 115/312 (36%), Gaps = 79/312 (25%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---------KPVKKKKIKREIKILQN 71
+Y + +G+G + VF G TD + IK++ E+ +L
Sbjct: 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 72 LCGG---PNIVKLLDIVRDQQSKTPS---LIFEHVNNT----DFKVLYPTLSDYDVRYYI 121
+ G P +++LLD +T L+ E D+ L + R +
Sbjct: 91 VGAGGGHPGVIRLLDWF-----ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF 145
Query: 122 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYF 181
+++ A+ +CHS+G++HRD+K N++ID + +LID+G H Y +R +
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP-YTDFDGTRVY 204
Query: 182 KGPELLVDLQDYD-YSLDLWSLG----CMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD 236
PE + Y +WSLG M G I PF + ++++
Sbjct: 205 SPPEWISR-HQYHALPATVWSLGILLYDMVCGDI----PF----ERDQEILE-------- 247
Query: 237 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER 296
+ H P H++ P+ + + L R
Sbjct: 248 ------AELHF---PA----------------------HVS-PDCCALIRRCLAPKPSSR 275
Query: 297 PTAKEAMAHPYF 308
P+ +E + P+
Sbjct: 276 PSLEEILLDPWM 287
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 8e-33
Identities = 65/306 (21%), Positives = 127/306 (41%), Gaps = 71/306 (23%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCG 74
DD+++ R +G+GK+ V+ + +K+L + + +++REI+I +L
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 75 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL--YPTLSDYDVRYYIYELLKALDYC 131
PNI+++ + D K L+ E + +K L + + ++ EL AL YC
Sbjct: 74 -PNILRMYNYFHD--RKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYC 130
Query: 132 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK---------EYNVRVASRYFK 182
H + ++HRD+KP N+++ + + +L++ D+G + + P +Y +
Sbjct: 131 HERKVIHRDIKPENLLMGY-KGELKIADFGWS-VHAPSLRRRTMCGTLDY---LP----- 180
Query: 183 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242
PE++ + +D +DLW G + + P F + + +I V
Sbjct: 181 -PEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPP-FDSPSHTETHRRIVNV---------- 227
Query: 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 302
++ P L+ + D + KLLRY +R K
Sbjct: 228 ---DLKFPPFLS------------------------DGSKDLISKLLRYHPPQRLPLKGV 260
Query: 303 MAHPYF 308
M HP+
Sbjct: 261 MEHPWV 266
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-32
Identities = 57/294 (19%), Positives = 112/294 (38%), Gaps = 51/294 (17%)
Query: 28 KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQNLCGGPNIVKLL 82
++GRG + V++G+ + L+ K K K E ++L+ L PNIV+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PNIVRFY 91
Query: 83 DIVRDQQSKTPSLIF--EHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYCHSQG-- 135
D ++ E + + + + + +R + ++LK L + H++
Sbjct: 92 DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP 151
Query: 136 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 195
I+HRD+K N+ I +++ D GLA V + + F PE+ + YD
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-IGTPEFMAPEMY--EEKYDE 208
Query: 196 SLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA 255
S+D+++ G M + P + N Q+ +
Sbjct: 209 SVDVYAFGMCMLEMATSEYP-YSECQNAAQIYRRVT------------------------ 243
Query: 256 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF 309
S +A+PE + ++ +R + ER + K+ + H +F
Sbjct: 244 ----------SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-32
Identities = 63/316 (19%), Positives = 113/316 (35%), Gaps = 74/316 (23%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKREIKILQNLCGGPNIV 79
V R + G ++ V+E + +K L + K + I +E+ ++ L G PNIV
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89
Query: 80 KLLD--IVRDQQSKTPSLIF----EHVNNTDFKVLYPT-----LSDYDVRYYIYELLKAL 128
+ + ++S T F E + L LS V Y+ +A+
Sbjct: 90 QFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149
Query: 129 DYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR------- 179
+ H Q I+HRD+K N+++ Q ++L D+G A +Y+ R
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLS-NQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEI 208
Query: 180 ------YFKGPELLVDL---QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 230
++ PE ++DL D+W+LGC+ + FR+ PF
Sbjct: 209 TRNTTPMYRTPE-IIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF-------------- 253
Query: 231 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLR 290
E L + G++S P + +L+
Sbjct: 254 -----------------EDGAKLRIVNGKYSIPPHDTQ---------YTVFHSLIRAMLQ 287
Query: 291 YDHQERPTAKEAMAHP 306
+ +ER + E +
Sbjct: 288 VNPEERLSIAEVVHQL 303
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-32
Identities = 64/306 (20%), Positives = 118/306 (38%), Gaps = 71/306 (23%)
Query: 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----------PVKKKKIKREIKILQ 70
Y + +G G + V+ V N++ ++K +K K K+ EI IL
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 71 NLCGGPNIVKLLDIVRDQQSKTPSLIF----EHVNNT---DFKVLYPTLSDYDVRYYIYE 123
+ NI+K+LDI + +H + F +P L + Y +
Sbjct: 85 RVEH-ANIIKVLDIF-----ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 124 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 183
L+ A+ Y + I+HRD+K N++I E ++LID+G A + GK + + +
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVIA-EDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCA 197
Query: 184 PELLVDLQDYD-YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242
PE+L+ Y L++WSLG ++F + PF ++ V+
Sbjct: 198 PEVLMG-NPYRGPELEMWSLGVTLYTLVFEENPF----CELEETVE-------------- 238
Query: 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 302
H P+ ++ E + + LL+ + R T ++
Sbjct: 239 AAIHP---PY----------------------LVS-KELMSLVSGLLQPVPERRTTLEKL 272
Query: 303 MAHPYF 308
+ P+
Sbjct: 273 VTDPWV 278
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 122 bits (306), Expect = 4e-32
Identities = 46/357 (12%), Positives = 94/357 (26%), Gaps = 101/357 (28%)
Query: 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK------KKIKREIKIL 69
+ +G+ E E + + ++ K++K E+ L
Sbjct: 68 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRL 127
Query: 70 QNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV------------ 117
+ L G N + +R P + + + D V
Sbjct: 128 RLLRGIKNQKQAKVHLRFI---FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQS 184
Query: 118 ------------------------RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 153
++++ L H G++H ++P ++++D
Sbjct: 185 NLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG 244
Query: 154 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD----------YDYSLDLWSLG 203
+ L + V SR F+ PEL +S D W+LG
Sbjct: 245 -VFLTGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALG 300
Query: 204 CMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRK 263
+ + P T + +++ ++
Sbjct: 301 LVIYWIWCADLPI------------------TKDAALGGSEWIFRSCKNI---------- 332
Query: 264 PWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSRSR 320
P L+ LRY ++R +AM P + +R S+
Sbjct: 333 P--------------QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALP 375
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 7e-32
Identities = 63/323 (19%), Positives = 123/323 (38%), Gaps = 62/323 (19%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--------------------PVKKK 60
+DY ++R + +GK++++ DN+ +K + K
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYD 88
Query: 61 KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL----------Y 109
K E++I+ ++ + I+ + +I+E++ N K
Sbjct: 89 DFKNELQIITDIKN-EYCLTCEGIITN--YDEVYIIYEYMENDSILKFDEYFFVLDKNYT 145
Query: 110 PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168
+ ++ I +L + Y H++ I HRDVKP N+++D + +++L D+G +E Y
Sbjct: 146 CFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMD-KNGRVKLSDFGESE-YMV 203
Query: 169 GKEYNVRVASRYFKGPELLVDLQDYD-YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 227
K+ + F PE + Y+ +D+WSLG M + PF + +L
Sbjct: 204 DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF-SLKISLVELF 262
Query: 228 -KIAKVLGTDELNAYLNKYHI-ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFL 285
I H + + F++ E +DFL
Sbjct: 263 NNIRTK-----------NIEYPLDRNHFLYPLTNKKSTCSNNFLS--------NEDIDFL 303
Query: 286 DKLLRYDHQERPTAKEAMAHPYF 308
LR + ER T+++A+ H +
Sbjct: 304 KLFLRKNPAERITSEDALKHEWL 326
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 61/312 (19%), Positives = 115/312 (36%), Gaps = 67/312 (21%)
Query: 29 VGRGKYSEVFEGVHCTDNEKCIIKILKPVKK---KKIKREIKILQNLCGGPNIVKLLDIV 85
+G+G Y V+ G ++ + IK + + + EI + ++L NIV+ L
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKH-KNIVQYLGSF 88
Query: 86 RDQQSKTPSLIFEHVNN----TDFKVLYPTLSDYD--VRYYIYELLKALDYCHSQGIMHR 139
+ + E V + + L D + + +Y ++L+ L Y H I+HR
Sbjct: 89 SENG--FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHR 146
Query: 140 DVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PE-LLVDLQD 192
D+K NV+I+ L++ D+G + + + + F G PE + +
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTS-----KRLAGINPCTETFTGTLQYMAPEIIDKGPRG 201
Query: 193 YDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248
Y + D+WSLGC M G K PF+ + + K+ K H E
Sbjct: 202 YGKAADIWSLGCTIIEMATG----KPPFYELGEPQAAMFKVGM-----------FKVHPE 246
Query: 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
+ ++ EA F+ K D +R A + + +
Sbjct: 247 IPESMS------------------------AEAKAFILKCFEPDPDKRACANDLLVDEFL 282
Query: 309 FPIRNAESSRSR 320
+ ++ +
Sbjct: 283 KVSSKKKKTQPK 294
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-31
Identities = 38/239 (15%), Positives = 84/239 (35%), Gaps = 31/239 (12%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDN-----EKCIIKILKPVKKKKIKREIKILQNLCGG 75
V +G G +++V+E N +K ++K+ KP + ++++ L
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPS 124
Query: 76 --PNIVKLLDIVRDQQSKTPSLIFEHVN--------NTDFKVLYPTLSDYDVRYYIYELL 125
+K Q L+ E + N + V + +L
Sbjct: 125 MQHMFMKFYSAHLFQNGS--VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 126 KALDYCHSQGIMHRDVKPHNVMIDH----------EQRKLRLIDWGLA---EFYHPGKEY 172
++ H I+H D+KP N ++ + L LID G + + + G +
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242
Query: 173 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 231
+ + F+ E+L + + ++Y +D + + M+F + + +
Sbjct: 243 TAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFR 300
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-31
Identities = 67/299 (22%), Positives = 134/299 (44%), Gaps = 58/299 (19%)
Query: 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI-----LKPVKKKKIKREIKILQNLCGGP 76
+Y +++ +G+G +++V H + IKI L P +K+ RE++I++ L P
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNH-P 74
Query: 77 NIVKLLDIVRDQQSKTPS---LIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDY 130
NIVKL +++ +T LI E+ + D+ V + + + + R +++ A+ Y
Sbjct: 75 NIVKLFEVI-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQY 129
Query: 131 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 190
CH + I+HRD+K N+++D +++ D+G + + G + + + + PEL
Sbjct: 130 CHQKRIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQG- 187
Query: 191 QDYD-YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249
+ YD +D+WSLG + ++ PF N +L + +VL KY I
Sbjct: 188 KKYDGPEVDVWSLGVILYTLVSGSLPF--DGQNLKELRE--RVLR--------GKYRI-- 233
Query: 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
P +++ + + L + L + +R T ++ M +
Sbjct: 234 -PF----------------------YMS-TDCENLLKRFLVLNPIKRGTLEQIMKDRWI 268
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 66/301 (21%), Positives = 121/301 (40%), Gaps = 55/301 (18%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-------PVKKKKIKREIKILQNLCGG 75
Y + +G G Y +V E + + +KILK P + +K+EI++L+ L
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH- 65
Query: 76 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDF----KVLYPTLSDYDVRYYIYELLKALDYC 131
N+++L+D++ +++ + ++ E+ V Y +L+ L+Y
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYL 125
Query: 132 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELLV 188
HSQGI+H+D+KP N+++ L++ G+AE HP + S F+ PE+
Sbjct: 126 HSQGIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184
Query: 189 DLQDYD-YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247
L + + +D+WS G + PF DN +L + + Y I
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGLYPFE--GDNIYKLFE--NIGKGS--------YAI 232
Query: 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 307
P P D L +L Y+ +R + ++ H +
Sbjct: 233 ---P---------------GDCG--------PPLSDLLKGMLEYEPAKRFSIRQIRQHSW 266
Query: 308 F 308
F
Sbjct: 267 F 267
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-28
Identities = 59/369 (15%), Positives = 120/369 (32%), Gaps = 120/369 (32%)
Query: 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL----KPVKKKKIKREIKILQNLC 73
R D+E ++ +GRG + VFE + D+ IK + + + ++K+ RE+K L L
Sbjct: 3 RYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL- 61
Query: 74 GGPNIVKLLD----------------------------------------IVRDQQSKTP 93
P IV+ + I R T
Sbjct: 62 EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTK 121
Query: 94 SLIFEHVNNTDFKVLY--------PTLSDY-------------DVRYYIYELLKALDYCH 132
+ + + ++ LY L D+ + ++ +A+++ H
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH 181
Query: 133 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG--------- 183
S+G+MHRD+KP N+ + +++ D+GL +E +
Sbjct: 182 SKGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK 240
Query: 184 ----PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN 239
PE + +Y + +D++SLG + +++ F + + +
Sbjct: 241 LYMSPEQIHG-NNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRN-------- 288
Query: 240 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA 299
+ K+ P+ + +L ERP A
Sbjct: 289 ------------------LKFPLLFTQKY----------PQEHMMVQDMLSPSPTERPEA 320
Query: 300 KEAMAHPYF 308
+ + + F
Sbjct: 321 TDIIENAIF 329
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 109 bits (276), Expect = 2e-28
Identities = 62/306 (20%), Positives = 119/306 (38%), Gaps = 65/306 (21%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKILQNLCGGP 76
+D+++V+ +G G Y EV V+ E +KI+ + + IK+EI I + L
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-E 65
Query: 77 NIVKLLDIVRDQQSKTPSLIF---EHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDY 130
N+VK + ++ + E+ + D + + D + + ++L+ + Y
Sbjct: 66 NVVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 131 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELL 187
H GI HRD+KP N+++D E+ L++ D+GLA + + + + PELL
Sbjct: 121 LHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 188 VDLQDYD-YSLDLWSLG----CMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242
+++ +D+WS G M AG + P+ D+ + +
Sbjct: 180 KR-REFHAEPVDVWSCGIVLTAMLAGEL----PWDQPSDSCQEYSDWKE----------- 223
Query: 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 302
+ PW K + L K+L + R T +
Sbjct: 224 ---------------KKTYLNPWKKI---------DSAPLALLHKILVENPSARITIPDI 259
Query: 303 MAHPYF 308
++
Sbjct: 260 KKDRWY 265
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-28
Identities = 65/303 (21%), Positives = 118/303 (38%), Gaps = 49/303 (16%)
Query: 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL--KPVKKKKIKREIKILQNLC 73
I + D Y+ V+ +G G + E +K + + ++REI ++L
Sbjct: 15 IMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLR 74
Query: 74 GGPNIVKLLDIVRDQQSKTPSLIF---EHVNNT---DFKVLYPTLSDYDVRYYIYELLKA 127
PNIV+ +++ TP+ + E+ + + S+ + R++ +LL
Sbjct: 75 H-PNIVRFKEVI-----LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSG 128
Query: 128 LDYCHSQGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 186
+ YCHS I HRD+K N ++D +L++ D+G ++ + V + + PE+
Sbjct: 129 VSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 188
Query: 187 LVDLQDYD-YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245
L+ Q+YD D+WS G M+ PF + D I ++L Y
Sbjct: 189 LLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK--------Y 239
Query: 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305
I P I+ PE + ++ D R + E H
Sbjct: 240 SI----------------PDDIRIS--------PECCHLISRIFVADPATRISIPEIKTH 275
Query: 306 PYF 308
+F
Sbjct: 276 SWF 278
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-28
Identities = 73/326 (22%), Positives = 128/326 (39%), Gaps = 76/326 (23%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI--LKPVKKKKIKREIKILQNLCGGPN 77
+E+V VG G Y +V++G H + IK+ + ++++IK+EI +L+ N
Sbjct: 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82
Query: 78 IVKLLDIVRDQQSKTPS----LIFEH---------VNNTDFKVLYPTLSDYDVRYYIYEL 124
I + L+ E + NT TL + + Y E+
Sbjct: 83 IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGN----TLKEEWIAYICREI 138
Query: 125 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKG 183
L+ L + H ++HRD+K NV++ E +++L+D+G+ A+ N + + Y+
Sbjct: 139 LRGLSHLHQHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 197
Query: 184 PELLVDLQD----YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN 239
PE++ ++ YD+ DLWSLG M P H + L
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH--------PMRAL------ 243
Query: 240 AYLNKYHI------ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDH 293
+ I L K WSK + F++ L +H
Sbjct: 244 -----FLIPRNPAPRLKS-----------KKWSK------------KFQSFIESCLVKNH 275
Query: 294 QERPTAKEAMAHPYFFPIRNAESSRS 319
+RP ++ M HP+ IR+ + R
Sbjct: 276 SQRPATEQLMKHPF---IRDQPNERQ 298
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-28
Identities = 67/322 (20%), Positives = 129/322 (40%), Gaps = 76/322 (23%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKK------------------- 60
Y + ++G+G Y V + DN +K+L K +++
Sbjct: 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 61 -------KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPT- 111
++ +EI IL+ PN+VKL++++ D ++FE VN +V
Sbjct: 75 QPRGPIEQVYQEIAILK-KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKP 133
Query: 112 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 171
LS+ R+Y +L+K ++Y H Q I+HRD+KP N+++ E +++ D+G++ +
Sbjct: 134 LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVG-EDGHIKIADFGVSNEFKGSDA 192
Query: 172 Y-NVRVASRYFKGPELLVDL-QDYD-YSLDLWSLGC-MFAGMIFRKEPFFYGHDNYDQL- 226
+ V + F PE L + + + +LD+W++G ++ +F + PF + L
Sbjct: 193 LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC-FVFGQCPFM--DERIMCLH 249
Query: 227 VKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLD 286
KI P +A + D +
Sbjct: 250 SKIKS-----------QALEFPDQPDIA------------------------EDLKDLIT 274
Query: 287 KLLRYDHQERPTAKEAMAHPYF 308
++L + + R E HP+
Sbjct: 275 RMLDKNPESRIVVPEIKLHPWV 296
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-27
Identities = 62/306 (20%), Positives = 119/306 (38%), Gaps = 65/306 (21%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKILQNLCGGP 76
+D+++V+ +G G Y EV V+ E +KI+ + + IK+EI I + L
Sbjct: 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH-E 65
Query: 77 NIVKLLDIVRDQQSKTPSLIF---EHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDY 130
N+VK + ++ + E+ + D + + D + + ++L+ + Y
Sbjct: 66 NVVKFYGHR-----REGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVY 120
Query: 131 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV---RVASRYFKGPELL 187
H GI HRD+KP N+++D E+ L++ D+GLA + + + + PELL
Sbjct: 121 LHGIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 188 VDLQDYD-YSLDLWSLG----CMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242
+++ +D+WS G M AG + P+ D+ + +
Sbjct: 180 KR-REFHAEPVDVWSCGIVLTAMLAGEL----PWDQPSDSCQEYSDWKE----------- 223
Query: 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 302
+ PW K + L K+L + R T +
Sbjct: 224 ---------------KKTYLNPWKKI---------DSAPLALLHKILVENPSARITIPDI 259
Query: 303 MAHPYF 308
++
Sbjct: 260 KKDRWY 265
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 3e-27
Identities = 43/357 (12%), Positives = 94/357 (26%), Gaps = 100/357 (28%)
Query: 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK------KKIKREIKIL 69
+ +G+ E E + + ++ K++K E+ L
Sbjct: 73 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRL 132
Query: 70 QNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDV------------ 117
+ L G N + +R P + + + D V
Sbjct: 133 RLLRGIKNQKQAKVHLRFI---FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQS 189
Query: 118 ------------------------RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 153
++++ L H G++H ++P ++++D
Sbjct: 190 NLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG 249
Query: 154 KLRLIDWGLAEFYHPGKEYNVRVASRY----FKGPELLVDLQD----YDYSLDLWSLGCM 205
+ L + G + + +L Q ++ D W+LG
Sbjct: 250 -VFLTGFEHLV--RDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA 306
Query: 206 FAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPW 265
+ P TD+ +++ +
Sbjct: 307 IYWIWCADLPN------------------TDDAALGGSEWIFRSCKN------------- 335
Query: 266 SKFITVENQHLAVPEAV-DFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSRSRS 321
+P+ V L+ LRY ++R +AM P + +R S+
Sbjct: 336 ------------IPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALPL 380
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-27
Identities = 71/299 (23%), Positives = 125/299 (41%), Gaps = 59/299 (19%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGP 76
Y + +G G + +V G H K +KIL K KIKREI+ L+ P
Sbjct: 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH-P 71
Query: 77 NIVKLLDIVRDQQSKTPSLIF---EHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDY 130
+I+KL ++ TP+ F E+V+ D+ + + + + R ++L A+DY
Sbjct: 72 HIIKLYQVI-----STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDY 126
Query: 131 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 190
CH ++HRD+KP NV++D ++ D+GL+ G+ S + PE++
Sbjct: 127 CHRHMVVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG- 184
Query: 191 QDYD-YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249
+ Y +D+WS G + ++ PF ++ L K K+ G ++I
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPF--DDEHVPTLFK--KIRGGV--------FYI-- 230
Query: 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
P +++ L +L+ D +R T K+ H +F
Sbjct: 231 -P---------------EYLN--------RSVATLLMHMLQVDPLKRATIKDIREHEWF 265
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 69/335 (20%), Positives = 122/335 (36%), Gaps = 84/335 (25%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGG 75
+DDYE+ +G G + V EK IK + ++ +EI+ + C
Sbjct: 14 RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMS-QCHH 72
Query: 76 PNIVK----------------------LLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLS 113
PNIV +LDI++ +K L
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHK-------------SGVLD 119
Query: 114 DYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 173
+ + + E+L+ L+Y H G +HRDVK N+++ E +++ D+G++ F G +
Sbjct: 120 ESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDIT 178
Query: 174 VRVASRYFKG------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 227
+ F G PE++ ++ YD+ D+WS G + P+ Y +
Sbjct: 179 RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH----KYPPM- 233
Query: 228 KIAKVLGTDELNAYLNKYHI--ELDPHL-AALVGRHSRKPWSKFITVENQHLAVPEAVDF 284
KVL P L + + K + K
Sbjct: 234 ---KVL-----------MLTLQNDPPSLETGVQDKEMLKKYGK------------SFRKM 267
Query: 285 LDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSRS 319
+ L+ D ++RPTA E + H +F + A++
Sbjct: 268 ISLCLQKDPEKRPTAAELLRHKFF---QKAKNKEF 299
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 1e-26
Identities = 49/193 (25%), Positives = 94/193 (48%), Gaps = 20/193 (10%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL------KPVKKKKIKREIKILQNLCGGP 76
Y + +G G + +V H +K +K + K +++REI L+ L P
Sbjct: 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRH-P 69
Query: 77 NIVKLLDIVRDQQSKTPSLIF---EHVNNT--DFKVLYPTLSDYDVRYYIYELLKALDYC 131
+I+KL D++ TP+ I E+ D+ V +++ + R + +++ A++YC
Sbjct: 70 HIIKLYDVI-----TTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYC 124
Query: 132 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 191
H I+HRD+KP N+++D + +++ D+GL+ G S + PE++ +
Sbjct: 125 HRHKIVHRDLKPENLLLD-DNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVING-K 182
Query: 192 DYD-YSLDLWSLG 203
Y +D+WS G
Sbjct: 183 LYAGPEVDVWSCG 195
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 63/311 (20%), Positives = 130/311 (41%), Gaps = 59/311 (18%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-KKIKREIKILQNLCGGPNI 78
++ ++V+ K+G G Y V++ +H + IK + ++I +EI I+Q C P++
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQ-CDSPHV 86
Query: 79 VKLLD-IVRDQQSKTPSL--IFEHVNN---TD-FKVLYPTLSDYDVRYYIYELLKALDYC 131
VK ++ L + E+ +D ++ TL++ ++ + LK L+Y
Sbjct: 87 VKYYGSYFKNTD-----LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYL 141
Query: 132 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDL 190
H +HRD+K N++++ + +L D+G+ + + N + + ++ PE++ +
Sbjct: 142 HFMRKIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQE- 199
Query: 191 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250
Y+ D+WSLG M K P+ H + + + I +
Sbjct: 200 IGYNCVADIWSLGITAIEMAEGKPPYADIH--------PMRAI-----------FMIPTN 240
Query: 251 --PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
P + WS DF+ + L ++R TA + + HP+
Sbjct: 241 PPPTF------RKPELWS------------DNFTDFVKQCLVKSPEQRATATQLLQHPF- 281
Query: 309 FPIRNAESSRS 319
+R+A+
Sbjct: 282 --VRSAKGVSI 290
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-26
Identities = 73/299 (24%), Positives = 123/299 (41%), Gaps = 59/299 (19%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGP 76
Y + +G G + +V G H K +KIL K KI+REI+ L+ P
Sbjct: 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRH-P 76
Query: 77 NIVKLLDIVRDQQSKTPSLIF---EHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDY 130
+I+KL ++ TPS IF E+V+ D+ L + + R ++L +DY
Sbjct: 77 HIIKLYQVI-----STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDY 131
Query: 131 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 190
CH ++HRD+KP NV++D ++ D+GL+ G+ S + PE++
Sbjct: 132 CHRHMVVHRDLKPENVLLD-AHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG- 189
Query: 191 QDYD-YSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249
+ Y +D+WS G + ++ PF D+ L K K+ ++
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGTLPF--DDDHVPTLFK--KICD--------GIFYT-- 235
Query: 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
P +L P + L +L+ D +R T K+ H +F
Sbjct: 236 -PQ----------------------YLN-PSVISLLKHMLQVDPMKRATIKDIREHEWF 270
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 9e-26
Identities = 60/339 (17%), Positives = 113/339 (33%), Gaps = 55/339 (16%)
Query: 19 EQDDYEVVRKVGRG--KYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQN 71
E YE++ +G+G V + E ++ + ++ E+ + +
Sbjct: 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSK- 81
Query: 72 LCGGPNIVKLLD-IVRDQQ-----------SKTPSLIFEHVNNTDFKVLYPTLSDYDVRY 119
L PNIV + D + S LI H + +++ + Y
Sbjct: 82 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAK-DLICTHFMDG--------MNELAIAY 132
Query: 120 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE--FYHPGKEYNVRVA 177
+ +LKALDY H G +HR VK +++I K+ L H ++ V
Sbjct: 133 ILQGVLKALDYIHHMGYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDF 191
Query: 178 SRYFKG------PELLV-DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD---QLV 227
+Y PE+L +LQ YD D++S+G + PF + L+
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK----DMPATQMLL 247
Query: 228 KIAK----VLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAV- 282
+ L + + + ++
Sbjct: 248 EKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFS 307
Query: 283 ----DFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESS 317
F+++ L+ + RP+A + H +F I+ S
Sbjct: 308 PHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRASE 346
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 2e-25
Identities = 71/311 (22%), Positives = 131/311 (42%), Gaps = 59/311 (18%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKREIKILQNLCGGP 76
+ Y K+G+G V+ + ++ I+ + + KK+ I EI +++ P
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE-NKNP 77
Query: 77 NIVKLLD--IVRDQQSKTPSL--IFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALD 129
NIV LD +V D+ L + E++ TD V + + + E L+AL+
Sbjct: 78 NIVNYLDSYLVGDE------LWVVMEYLAGGSLTDV-VTETCMDEGQIAAVCRECLQALE 130
Query: 130 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV 188
+ HS ++HRD+K N+++ ++L D+G A+ + + V + Y+ PE +V
Sbjct: 131 FLHSNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPE-VV 188
Query: 189 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248
+ Y +D+WSLG M MI + P+ + + L Y I
Sbjct: 189 TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--------LRAL-----------YLIA 229
Query: 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
+ P ++N DFL++ L D ++R +AKE + H +
Sbjct: 230 TNG-----------TP-----ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQF- 272
Query: 309 FPIRNAESSRS 319
++ A+ S
Sbjct: 273 --LKIAKPLSS 281
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 64/311 (20%), Positives = 127/311 (40%), Gaps = 59/311 (18%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL---KPVKKKKIKREIKILQNLCGGP 76
+ + K+G G V + +K++ K +++ + E+ I+++
Sbjct: 44 RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRD-YQHF 102
Query: 77 NIVKLLD--IVRDQQSKTPSL--IFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALD 129
N+V++ +V ++ L + E + TD V L++ + +L+AL
Sbjct: 103 NVVEMYKSYLVGEE------LWVLMEFLQGGALTDI-VSQVRLNEEQIATVCEAVLQALA 155
Query: 130 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLV 188
Y H+QG++HRD+K ++++ +++L D+G A+ + V + Y+ PE++
Sbjct: 156 YLHAQGVIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS 214
Query: 189 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248
Y +D+WSLG M M+ + P+F + + +
Sbjct: 215 R-SLYATEVDIWSLGIMVIEMVDGEPPYFSDS--------PVQAM-----------KRLR 254
Query: 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
P P ++N H P DFL+++L D QER TA+E + HP+
Sbjct: 255 DSP-----------PP-----KLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPF- 297
Query: 309 FPIRNAESSRS 319
+
Sbjct: 298 --LLQTGLPEC 306
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-25
Identities = 56/328 (17%), Positives = 113/328 (34%), Gaps = 88/328 (26%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL----KPVKKKKIKREIKILQNLCGGP 76
+D E + ++G G +V++ +K + + K+I ++ ++ P
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 77 NIVK---------------------LLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY 115
IV+ + + + I E +
Sbjct: 85 YIVQCFGTFITNTDVFIAMELMGTCAEKLKK----RMQGPIPERI--------------- 125
Query: 116 DVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV 174
+ ++KAL Y + G++HRDVKP N+++D + +++L D+G++ K +
Sbjct: 126 -LGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDE-RGQIKLCDFGISGRLVDDKAKDR 183
Query: 175 RVASRYFKGPE----LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 230
+ PE DYD D+WSLG + + P+ +++ L K+
Sbjct: 184 SAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVL 243
Query: 231 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLR 290
+ E P L +S + F+ L
Sbjct: 244 Q----------------EEPPLLP------GHMGFS------------GDFQSFVKDCLT 269
Query: 291 YDHQERPTAKEAMAHPYFFPIRNAESSR 318
DH++RP + + H + I+ E+
Sbjct: 270 KDHRKRPKYNKLLEHSF---IKRYETLE 294
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 4e-25
Identities = 73/311 (23%), Positives = 133/311 (42%), Gaps = 59/311 (18%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGG 75
++ + + K+G+G + EVF+G+ + IKI+ + + I++EI +L C
Sbjct: 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ-CDS 79
Query: 76 PNIVKLLD-IVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYELLKALDYC 131
P + K ++D + +I E++ D + L + + + E+LK LDY
Sbjct: 80 PYVTKYYGSYLKDTKL---WIIMEYLGGGSALDL-LEPGPLDETQIATILREILKGLDYL 135
Query: 132 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDL 190
HS+ +HRD+K NV++ E +++L D+G+ + + N V + ++ PE++
Sbjct: 136 HSEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ- 193
Query: 191 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250
YD D+WSLG + + P + KVL + I +
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPPHS----ELHPM----KVL-----------FLIPKN 234
Query: 251 --PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
P L +SK +F++ L + RPTAKE + H
Sbjct: 235 NPPTL--------EGNYSK------------PLKEFVEACLNKEPSFRPTAKELLKHK-- 272
Query: 309 FPIRNAESSRS 319
F +RNA+ +
Sbjct: 273 FILRNAKKTSY 283
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 5e-25
Identities = 69/315 (21%), Positives = 132/315 (41%), Gaps = 60/315 (19%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGP 76
+ +E+V ++G G + +V++ + K+++ + + EI+IL C P
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILAT-CDHP 76
Query: 77 NIVKLLD-IVRDQQSKTPSLIFEHVNN---TD-FKVLYPTLSDYDVRYYIYELLKALDYC 131
IVKLL D + ++ E L L++ ++ ++L+AL++
Sbjct: 77 YIVKLLGAYYHDGKL---WIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFL 133
Query: 132 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL-AEFYHPGKEYNVRVASRYFKGPELLVDL 190
HS+ I+HRD+K NV++ + +RL D+G+ A+ ++ + + + Y+ PE+++
Sbjct: 134 HSKRIIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCE 192
Query: 191 Q----DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246
YDY D+WSLG M + P + +VL
Sbjct: 193 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN--------PMRVL-----------LK 233
Query: 247 IELD--PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304
I P L + WS E DFL L + + RP+A + +
Sbjct: 234 IAKSDPPTLL------TPSKWS------------VEFRDFLKIALDKNPETRPSAAQLLE 275
Query: 305 HPYFFPIRNAESSRS 319
HP+ + + S+++
Sbjct: 276 HPF---VSSITSNKA 287
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 6e-25
Identities = 67/314 (21%), Positives = 124/314 (39%), Gaps = 63/314 (20%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK------IKREIKILQNLC 73
+ + +R++G G + V+ ++E IK + K+ I +E++ LQ
Sbjct: 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQK-L 111
Query: 74 GGPNIVKLLD-IVRDQQSKTPSLIFEHVN---NTDFKVLYPTLSDYDVRYYIYELLKALD 129
PN ++ +R+ L+ E+ + +V L + ++ + L+ L
Sbjct: 112 RHPNTIQYRGCYLREHT---AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLA 168
Query: 130 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 189
Y HS ++HRDVK N+++ E ++L D+G A P + V + Y+ PE+++
Sbjct: 169 YLHSHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPANSF---VGTPYWMAPEVILA 224
Query: 190 LQD--YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247
+ + YD +D+WSLG + RK P F + L YHI
Sbjct: 225 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMN--------AMSAL-----------YHI 265
Query: 248 ELD--PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305
+ P L WS +F+D L+ Q+RPT++ + H
Sbjct: 266 AQNESPAL-------QSGHWS------------EYFRNFVDSCLQKIPQDRPTSEVLLKH 306
Query: 306 PYFFPIRNAESSRS 319
+ +
Sbjct: 307 RF---VLRERPPTV 317
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-25
Identities = 66/326 (20%), Positives = 115/326 (35%), Gaps = 68/326 (20%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKI----LKPVKKKKIKREIKILQNLCGGP 76
DD+E + ++G G VF+ H K+ +KP + +I RE+++L C P
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE-CNSP 91
Query: 77 NIVK----------------------LLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSD 114
IV L ++ K I E +
Sbjct: 92 YIVGFYGAFYSDGEISICMEHMDGGSLDQVL-----KKAGRIPEQI-------------- 132
Query: 115 YDVRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--- 170
+ ++K L Y + IMHRDVKP N++++ + +++L D+G++ G+
Sbjct: 133 --LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNS-RGEIKLCDFGVS-----GQLID 184
Query: 171 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 229
N V +R + PE L Y D+WS+G M + P D + +
Sbjct: 185 SMANSFVGTRSYMSPERL-QGTHYSVQSDIWSMGLSLVEMAVGRYPIP-PPDAKELELMF 242
Query: 230 AKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAV-------PEAV 282
+ D + + R + + N+ E
Sbjct: 243 GCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 302
Query: 283 DFLDKLLRYDHQERPTAKEAMAHPYF 308
DF++K L + ER K+ M H +
Sbjct: 303 DFVNKCLIKNPAERADLKQLMVHAFI 328
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-24
Identities = 76/374 (20%), Positives = 134/374 (35%), Gaps = 105/374 (28%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLC------- 73
Y V+RK+G G +S V+ + +K++K + + EI++L+++
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98
Query: 74 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD------FKVLYPTLSDY------------ 115
+V+LLD F+ F+VL L +
Sbjct: 99 NREMVVQLLD------------DFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLP 146
Query: 116 DVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMI-------------------------- 148
V+ I ++L+ LDY H++ I+H D+KP N+++
Sbjct: 147 CVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPS 206
Query: 149 ----------------------DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPEL 186
+ E+ K+++ D G A K + + +R ++ E+
Sbjct: 207 GSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA--CWVHKHFTEDIQTRQYRSLEV 264
Query: 187 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY------DQLVKIAKVLGT--DEL 238
L+ Y+ D+WS CM + + F H D + I ++LG +L
Sbjct: 265 LIGS-GYNTPADIWSTACMAFE-LATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKL 322
Query: 239 NAYLNKYHIELDPHLAALVGRHSRKPWSKF-ITVENQHLAVPEA---VDFLDKLLRYDHQ 294
L KPW F + VE + EA DFL +L +
Sbjct: 323 IVAGKYSKEFFTKK-GDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPE 381
Query: 295 ERPTAKEAMAHPYF 308
+R TA E + HP+
Sbjct: 382 KRATAAECLRHPWL 395
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 8e-24
Identities = 61/323 (18%), Positives = 116/323 (35%), Gaps = 90/323 (27%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL----KPVKKKKIKREIKILQNLCGGP 76
+D + + ++GRG Y V + VH + +K + ++K++ ++ ++ P
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81
Query: 77 NIVK---------------------LLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDY 115
IV+ + S +I E +
Sbjct: 82 YIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEI--------------- 126
Query: 116 DVRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV 174
+ +KAL++ I+HRD+KP N+++D ++L D+G++ +
Sbjct: 127 -LGKITLATVKALNHLKENLKIIHRDIKPSNILLDR-SGNIKLCDFGIS------GQLVD 178
Query: 175 RVASRYFKG------PELL---VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 225
+A G PE + Q YD D+WSLG + + P+ + +DQ
Sbjct: 179 SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ 238
Query: 226 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFL 285
L ++ K P L+ R +S P ++F+
Sbjct: 239 LTQVVK----------------GDPPQLSNSEERE----FS------------PSFINFV 266
Query: 286 DKLLRYDHQERPTAKEAMAHPYF 308
+ L D +RP KE + HP+
Sbjct: 267 NLCLTKDESKRPKYKELLKHPFI 289
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 5e-23
Identities = 75/316 (23%), Positives = 129/316 (40%), Gaps = 75/316 (23%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKI---KREIKILQNLCG 74
+D++ + +G G +S V + + IKIL+ +K+ K+ RE ++ L
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-D 88
Query: 75 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYP--TLSDYDVRYYIYELLKALDYC 131
P VKL +D + + N + K + + + R+Y E++ AL+Y
Sbjct: 89 HPFFVKLYFTFQDDEKLY--FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 146
Query: 132 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------PE 185
H +GI+HRD+KP N++++ + +++ D+G A+ + R S F G PE
Sbjct: 147 HGKGIIHRDLKPENILLNEDMH-IQITDFGTAK-VLSPESKQARANS--FVGTAQYVSPE 202
Query: 186 LLVDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY 241
LL + + S DLW+LGC + AG+ P F + Y KI K
Sbjct: 203 LLTE-KSACKSSDLWALGCIIYQLVAGL-----PPFRAGNEYLIFQKIIK---------- 246
Query: 242 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT--- 298
+Y + + P+A D ++KLL D +R
Sbjct: 247 -LEYD------------------FPEKFF--------PKARDLVEKLLVLDATKRLGCEE 279
Query: 299 ---AKEAMAHPYFFPI 311
AHP+F +
Sbjct: 280 MEGYGPLKAHPFFESV 295
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 8e-23
Identities = 65/313 (20%), Positives = 118/313 (37%), Gaps = 67/313 (21%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR---------EIKILQN 71
+ + R +G+G + EV + K L+ KK+IK+ E +IL+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLE---KKRIKKRKGEAMALNEKQILE- 239
Query: 72 LCGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-----FKVLYPTLSDYDVRYYIYE 123
+V L +T L+ +N D + + + +Y E
Sbjct: 240 KVNSRFVVSLA-----YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE 294
Query: 124 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 183
+ L+ H + I++RD+KP N+++D +R+ D GLA G+ RV + +
Sbjct: 295 ICCGLEDLHRERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMA 353
Query: 184 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243
PE++ + + Y +S D W+LGC+ MI + P F + ++ +++
Sbjct: 354 PEVVKN-ERYTFSPDWWALGCLLYEMIAGQSP-FQQRKKKIKREEVERLVKEVPE----- 406
Query: 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER-----PT 298
+Y P+A +LL D ER +
Sbjct: 407 EYSERFS----------------------------PQARSLCSQLLCKDPAERLGCRGGS 438
Query: 299 AKEAMAHPYFFPI 311
A+E HP F +
Sbjct: 439 AREVKEHPLFKKL 451
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 4e-22
Identities = 73/313 (23%), Positives = 119/313 (38%), Gaps = 67/313 (21%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR---------EIKILQ- 70
+D+ V R +GRG + EV+ + +K L KK+IK E +L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLD---KKRIKMKQGETLALNERIMLSL 245
Query: 71 -NLCGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYE 123
+ P IV + TP I + +N D L S+ D+R+Y E
Sbjct: 246 VSTGDCPFIVCM-----SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE 300
Query: 124 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG 183
++ L++ H++ +++RD+KP N+++D +R+ D GLA K+ + V + +
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILLDEHGH-VRISDLGLAC-DFSKKKPHASVGTHGYMA 358
Query: 184 PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243
PE+L YD S D +SLGCM ++ P F H D+ L
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP-FRQHKTKDKHEIDRMTL---------- 407
Query: 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER-----PT 298
+ PE L+ LL+ D R
Sbjct: 408 ----------------TMAVELPDSFS--------PELRSLLEGLLQRDVNRRLGCLGRG 443
Query: 299 AKEAMAHPYFFPI 311
A+E P+F +
Sbjct: 444 AQEVKESPFFRSL 456
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 93.4 bits (232), Expect = 3e-21
Identities = 43/203 (21%), Positives = 80/203 (39%), Gaps = 17/203 (8%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCT-DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPN 77
YEV + G ++ + + ++K L + E + L + P+
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPS 140
Query: 78 IVKLLDIVRDQQSKTPSLIF---EHVNNTDFK-VLYPTLSDYDVRYYIYELLKALDYCHS 133
IV++ + V + + E+V K L + Y+ E+L AL Y HS
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHS 200
Query: 134 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 193
G+++ D+KP N+M+ EQ K LID G + + F+ PE++
Sbjct: 201 IGLVYNDLKPENIMLTEEQLK--LIDLGAV---SRINSFGYLYGTPGFQAPEIVRTGPT- 254
Query: 194 DYSLDLWSLGCMFAGMIFRKEPF 216
+ D++++G A +
Sbjct: 255 VAT-DIYTVGRTLAALTLDLPTR 276
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 4e-21
Identities = 71/321 (22%), Positives = 120/321 (37%), Gaps = 80/321 (24%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR---------EIKILQN 71
D + R +GRG + EVF + K L KK++K+ E KIL
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLN---KKRLKKRKGYQGAMVEKKILA- 240
Query: 72 LCGGPNIVKL-------------LDIVR--DQQSKTPSLIFEHVNNTDFKVLYPTLSDYD 116
IV L + I+ D I H+ N D P +
Sbjct: 241 KVHSRFIVSLAYAFETKTDLCLVMTIMNGGD--------IRYHIYNVDED--NPGFQEPR 290
Query: 117 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVR 175
+Y +++ L++ H + I++RD+KP NV++D + +R+ D GLA E +
Sbjct: 291 AIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGY 349
Query: 176 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 235
+ F PELL+ ++YD+S+D ++LG MI + P F + ++ + +
Sbjct: 350 AGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGP-FRARGEKVENKELKQRVLE 407
Query: 236 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE 295
+ Y + P + DF + LL+ D ++
Sbjct: 408 QAV-----TYPDKFS----------------------------PASKDFCEALLQKDPEK 434
Query: 296 R-----PTAKEAMAHPYFFPI 311
R + HP F I
Sbjct: 435 RLGFRDGSCDGLRTHPLFRDI 455
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 9e-21
Identities = 66/326 (20%), Positives = 118/326 (36%), Gaps = 83/326 (25%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKKKKIKREIKILQNLCGGP 76
DD E + ++GRG Y V + H + K I + ++K++ ++ I P
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 77 NIVKL--------------------LDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYD 116
V LD Q I E +
Sbjct: 67 FTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDI---------------- 110
Query: 117 VRYYIYELLKALDYCHSQG-IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR 175
+ ++KAL++ HS+ ++HRDVKP NV+I+ ++++ D+G++ + ++
Sbjct: 111 LGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINA-LGQVKMCDFGISGYLVDDVAKDID 169
Query: 176 VASRYFKGPE---LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 232
+ + PE ++ + Y D+WSLG + + P+ + QL ++ +
Sbjct: 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE- 228
Query: 233 LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYD 292
E P L +S E VDF + L+ +
Sbjct: 229 ---------------EPSPQL-------PADKFS------------AEFVDFTSQCLKKN 254
Query: 293 HQERPTAKEAMAHPYFFPIRNAESSR 318
+ERPT E M HP+ ES
Sbjct: 255 SKERPTYPELMQHPF---FTLHESKG 277
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-18
Identities = 57/313 (18%), Positives = 111/313 (35%), Gaps = 71/313 (22%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKK----IKREIKILQNLCG 74
D +E++R +G+G + +V + +K + ++ + +E++I+Q L
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-E 73
Query: 75 GPNIVKLLDIVRDQQS-KTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLKA 127
P +V L S + ++ + + D L + V+ +I EL+ A
Sbjct: 74 HPFLVNL------WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA 127
Query: 128 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 183
LDY +Q I+HRD+KP N+++D E + + D+ +A G
Sbjct: 128 LDYLQNQRIIHRDMKPDNILLD-EHGHVHITDFNIA------AMLPRETQITTMAGTKPY 180
Query: 184 --PELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN 239
PE+ Y +++D WSLG ++ + P ++ + +
Sbjct: 181 MAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP-YHIRSSTSSKEIVHTFE------ 233
Query: 240 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER-PT 298
+ + + E V L KLL + +R
Sbjct: 234 --------------------TTVVTYPSAWS--------QEMVSLLKKLLEPNPDQRFSQ 265
Query: 299 AKEAMAHPYFFPI 311
+ PY I
Sbjct: 266 LSDVQNFPYMNDI 278
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 1e-17
Identities = 70/324 (21%), Positives = 120/324 (37%), Gaps = 83/324 (25%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNL 72
DD+E+++ +GRG +SEV + +KI+ K +KR E +L N
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMN--KWDMLKRGEVSCFREERDVLVN- 117
Query: 73 CGGPNIVKLLDIVRDQQS-KTPS---LIFEHVNNTD-FKVLY---PTLSDYDVRYYIYEL 124
I +L + + + L+ E+ D +L + R+Y+ E+
Sbjct: 118 GDRRWITQL------HFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEI 171
Query: 125 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV--RVASRYFK 182
+ A+D H G +HRD+KP N+++D +RL D+G + V S
Sbjct: 172 VMAIDSVHRLGYVHRDIKPDNILLDRCG-HIRLADFGSC------LKLRADGTVRSLVAV 224
Query: 183 G------PELL------VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIA 230
G PE+L Y D W+LG M + + PF+ D+ +
Sbjct: 225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY--ADSTAET--YG 280
Query: 231 KVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLR 290
K++ + + L + EA DF+ +LL
Sbjct: 281 KIV-HYKEHLSLPLVDEGVP----------------------------EEARDFIQRLLC 311
Query: 291 YDHQER---PTAKEAMAHPYFFPI 311
+ R A + HP+FF +
Sbjct: 312 -PPETRLGRGGAGDFRTHPFFFGL 334
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 1e-17
Identities = 74/321 (23%), Positives = 126/321 (39%), Gaps = 88/321 (27%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNL 72
D+ ++ +G+G + +V H + +K+L+ KK +K+ E +L
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQ--KKAILKKKEEKHIMSERNVLLKN 95
Query: 73 CGGPNIVKLLDIVRDQQS-KTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELL 125
P +V L S +T + +++N + F L + R+Y E+
Sbjct: 96 VKHPFLVGL------HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIA 149
Query: 126 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK---------EYNVR 175
AL Y HS I++RD+KP N+++D + + L D+GL E EY
Sbjct: 150 SALGYLHSLNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEY--- 205
Query: 176 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 235
+A PE+L Q YD ++D W LG + M++ P FY + T
Sbjct: 206 LA------PEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPP-FYSRN-------------T 244
Query: 236 DEL-NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQ 294
E+ + LNK ++L P++ A L+ LL+ D
Sbjct: 245 AEMYDNILNK-PLQLKPNIT------------------------NSARHLLEGLLQKDRT 279
Query: 295 ER----PTAKEAMAHPYFFPI 311
+R E +H +F I
Sbjct: 280 KRLGAKDDFMEIKSHVFFSLI 300
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-17
Identities = 64/322 (19%), Positives = 122/322 (37%), Gaps = 81/322 (25%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNL 72
+D+E+++ +GRG + EV ++ +KIL K + +KR E +L N
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILN--KWEMLKRAETACFREERDVLVN- 130
Query: 73 CGGPNIVKLLDIVRDQQS-KTPS---LIFEHVNNTD-FKVLY---PTLSDYDVRYYIYEL 124
I L + + + L+ ++ D +L L + R+Y+ E+
Sbjct: 131 GDSKWITTL------HYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEM 184
Query: 125 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--YNVRVASRYFK 182
+ A+D H +HRD+KP N+++D +RL D+G + + V S
Sbjct: 185 VIAIDSVHQLHYVHRDIKPDNILMDMNG-HIRLADFGSC------LKLMEDGTVQSSVAV 237
Query: 183 G------PELLVDLQD----YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 232
G PE+L ++ Y D WSLG M++ + PF+ ++ + K+
Sbjct: 238 GTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY--AESLVET--YGKI 293
Query: 233 LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYD 292
+ +K + + + A D + +L+
Sbjct: 294 MN--------HKERFQFPTQVTDV---------------------SENAKDLIRRLIC-S 323
Query: 293 HQER---PTAKEAMAHPYFFPI 311
+ R ++ HP+F I
Sbjct: 324 REHRLGQNGIEDFKKHPFFSGI 345
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-17
Identities = 45/230 (19%), Positives = 90/230 (39%), Gaps = 35/230 (15%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQ 70
+ +G+G + + + H E ++K L ++ +E+K+++
Sbjct: 5 RIFRPSDLIHG--EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMR 62
Query: 71 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLK-ALD 129
L PN++K + ++ + K + I E++ L + D +Y + + A D
Sbjct: 63 CLEH-PNVLKFIGVLY--KDKRLNFITEYIKGGT---LRGIIKSMDSQYPWSQRVSFAKD 116
Query: 130 ------YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF---------YHPGKEYNV 174
Y HS I+HRD+ HN ++ E + + + D+GLA +
Sbjct: 117 IASGMAYLHSMNIIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPD 175
Query: 175 RVASRYFKG------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY 218
R G PE++ + YD +D++S G + +I R
Sbjct: 176 RKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 2e-17
Identities = 71/319 (22%), Positives = 126/319 (39%), Gaps = 73/319 (22%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKK----IKREIKILQNLCG 74
D++++R +GRG Y++V + +K++K V + ++ E + +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 75 GPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLKAL 128
P +V L +T S + E+VN D + L + R+Y E+ AL
Sbjct: 69 HPFLVGLH-----SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLAL 123
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK---------EYNVRVAS 178
+Y H +GI++RD+K NV++D E ++L D+G+ E PG Y +A
Sbjct: 124 NYLHERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNY---IA- 178
Query: 179 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 238
PE+L +DY +S+D W+LG + M+ + PF + + D L
Sbjct: 179 -----PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN-----TEDYL 227
Query: 239 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER-- 296
+ + I + L+ +A L L D +ER
Sbjct: 228 FQVILEKQIRIPRSLS------------------------VKAASVLKSFLNKDPKERLG 263
Query: 297 ----PTAKEAMAHPYFFPI 311
+ HP+F +
Sbjct: 264 CHPQTGFADIQGHPFFRNV 282
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 66/314 (21%), Positives = 119/314 (37%), Gaps = 77/314 (24%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKK----IKREIKILQNLCG 74
D ++ ++ +G G + V H +KIL V K K E +ILQ
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VN 99
Query: 75 GPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLKAL 128
P +VKL + K S ++ E+V + F L S+ R+Y +++
Sbjct: 100 FPFLVKL-----EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG----- 183
+Y HS +++RD+KP N++ID + +++ D+G A K R + G
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGY-IQVTDFGFA------KRVKGRTWT--LCGTPEAL 205
Query: 184 -PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242
PE+++ + Y+ ++D W+LG + M PFF D Q+ + K++
Sbjct: 206 APEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF--ADQPIQIYE--KIV--------- 251
Query: 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER-----P 297
+ + + + D L LL+ D +R
Sbjct: 252 -----------------SGKVRFPSHFS--------SDLKDLLRNLLQVDLTKRFGNLKN 286
Query: 298 TAKEAMAHPYFFPI 311
+ H +F
Sbjct: 287 GVNDIKNHKWFATT 300
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 6e-17
Identities = 38/150 (25%), Positives = 68/150 (45%), Gaps = 13/150 (8%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLCGGP 76
Y++V K+G G S V+ N K IK + K+ +RE+ L
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQ 71
Query: 77 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHS 133
NIV ++D+ + L+ E++ + LS + ++L + + H
Sbjct: 72 NIVSMIDVDEEDD--CYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 134 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163
I+HRD+KP N++ID + L++ D+G+A
Sbjct: 130 MRIVHRDIKPQNILIDSNKT-LKIFDFGIA 158
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 7e-17
Identities = 39/156 (25%), Positives = 71/156 (45%), Gaps = 18/156 (11%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-PVKKKKIKREIKILQNLCGGPNIVKL 81
+ V +K+G G + E+ G + NE IK+ + ++ E + + L G I ++
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70
Query: 82 LDIVRDQQSKT-------PSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 134
+ PSL E + F + T S V +L+ ++Y HS+
Sbjct: 71 YYFGPCGKYNAMVLELLGPSL--EDL----FDLCDRTFSLKTVLMIAIQLISRMEYVHSK 124
Query: 135 GIMHRDVKPHNVMI----DHEQRKLRLIDWGLAEFY 166
+++RDVKP N +I + Q+ + +ID+ LA+ Y
Sbjct: 125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 7e-17
Identities = 74/319 (23%), Positives = 129/319 (40%), Gaps = 84/319 (26%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNL 72
+D++ ++ +G+G + +V +KIL+ K+ I + E ++LQN
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILR--KEVIIAKDEVAHTVTESRVLQN- 61
Query: 73 CGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLK 126
P + L +T + E+ N + F L ++ R+Y E++
Sbjct: 62 TRHPFLTALK-----YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVS 116
Query: 127 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKG 183
AL+Y HS+ +++RD+K N+M+D + +++ D+GL KE + + F G
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKD-GHIKITDFGLC------KEGISDGATMKT--FCG 167
Query: 184 ------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 237
PE+L D DY ++D W LG + M+ + P FY D+ I +E
Sbjct: 168 TPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLP-FYNQDHERLFELILM----EE 221
Query: 238 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER- 296
+ ++ L PEA L LL+ D ++R
Sbjct: 222 I-----RFPRTLS----------------------------PEAKSLLAGLLKKDPKQRL 248
Query: 297 ----PTAKEAMAHPYFFPI 311
AKE M H +F I
Sbjct: 249 GGGPSDAKEVMEHRFFLSI 267
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 8e-17
Identities = 72/320 (22%), Positives = 119/320 (37%), Gaps = 81/320 (25%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKR---EIKILQNLCG 74
+DYEVV+ +GRG + EV H + + +K+L +K+ E I+
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF-AN 127
Query: 75 GPNIVKLLDIVRDQQS-KTPS---LIFEHVNNTDFKVLYPTLSDYD-----VRYYIYELL 125
P +V+L + + ++ E++ D L +S+YD R+Y E++
Sbjct: 128 SPWVVQL------FYAFQDDRYLYMVMEYMPGGD---LVNLMSNYDVPEKWARFYTAEVV 178
Query: 126 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV--RVASRYFKG 183
ALD HS G +HRDVKP N+++D L+L D+G + N V G
Sbjct: 179 LALDAIHSMGFIHRDVKPDNMLLDK-SGHLKLADFGTC------MKMNKEGMVRCDTAVG 231
Query: 184 ------PELLVD---LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 234
PE+L Y D WS+G M+ PF+ D+ +K++
Sbjct: 232 TPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY--ADSLVGT--YSKIM- 286
Query: 235 TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQ 294
+ N D ++ EA + + L D +
Sbjct: 287 -----NHKNSLTFPDDNDIS------------------------KEAKNLICAFLT-DRE 316
Query: 295 ER---PTAKEAMAHPYFFPI 311
R +E H +F
Sbjct: 317 VRLGRNGVEEIKRHLFFKND 336
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 1e-16
Identities = 70/319 (21%), Positives = 126/319 (39%), Gaps = 73/319 (22%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKK----IKREIKILQNLCG 74
D++++R +GRG Y++V + ++++K V + ++ E + +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 75 GPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLKAL 128
P +V L +T S + E+VN D + L + R+Y E+ AL
Sbjct: 112 HPFLVGLH-----SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLAL 166
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK---------EYNVRVAS 178
+Y H +GI++RD+K NV++D E ++L D+G+ E PG Y +A
Sbjct: 167 NYLHERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNY---IA- 221
Query: 179 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 238
PE+L +DY +S+D W+LG + M+ + PF + + D L
Sbjct: 222 -----PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN-----TEDYL 270
Query: 239 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER-- 296
+ + I + L+ +A L L D +ER
Sbjct: 271 FQVILEKQIRIPRSLS------------------------VKAASVLKSFLNKDPKERLG 306
Query: 297 ----PTAKEAMAHPYFFPI 311
+ HP+F +
Sbjct: 307 CHPQTGFADIQGHPFFRNV 325
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 1e-16
Identities = 63/321 (19%), Positives = 114/321 (35%), Gaps = 87/321 (27%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI---------KREIKILQN 71
D+ + +G+G + +V +E +KILK K + E ++L
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK---KDVVIQDDDVECTMVEKRVLAL 76
Query: 72 LCGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLYPT--LSDYDVRYYIYELL 125
P + +L +T + E+VN D + + +Y E+
Sbjct: 77 PGKPPFLTQLH-----SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIA 131
Query: 126 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK---------EYNVR 175
L + S+GI++RD+K NVM+D E +++ D+G+ E G +Y
Sbjct: 132 IGLFFLQSKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDY--- 187
Query: 176 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 235
+A PE++ Q Y S+D W+ G + M+ + P F G D + I +
Sbjct: 188 IA------PEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAP-FEGEDEDELFQSIME---- 235
Query: 236 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE 295
+ + K ++ EAV L+ +
Sbjct: 236 HNV-------------------------AYPKSMS--------KEAVAICKGLMTKHPGK 262
Query: 296 R----PT-AKEAMAHPYFFPI 311
R P ++ H +F I
Sbjct: 263 RLGCGPEGERDIKEHAFFRYI 283
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-16
Identities = 68/326 (20%), Positives = 115/326 (35%), Gaps = 96/326 (29%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKI---------KREIKILQN 71
D++E +R +G+G + +V + +K+LK K I E +IL
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLK---KDVILQDDDVECTMTEKRILSL 79
Query: 72 LCGGPNIVKLLDIVRDQQSK----TPS---LIFEHVNNTD-FKVLYPT--LSDYDVRYYI 121
P + +L TP + E VN D + + + R+Y
Sbjct: 80 ARNHPFLTQL---------FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYA 130
Query: 122 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK---------E 171
E++ AL + H +GI++RD+K NV++DHE +L D+G+ E G +
Sbjct: 131 AEIISALMFLHDKGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPD 189
Query: 172 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAK 231
Y +A PE+L + Y ++D W++G + M+ P F + D I
Sbjct: 190 Y---IA------PEILQE-MLYGPAVDWWAMGVLLYEMLCGHAP-FEAENEDDLFEAILN 238
Query: 232 VLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRY 291
DE+ Y L +A L +
Sbjct: 239 ----DEV-----VYPTWLH----------------------------EDATGILKSFMTK 261
Query: 292 DHQER------PTAKEAMAHPYFFPI 311
+ R + HP+F I
Sbjct: 262 NPTMRLGSLTQGGEHAILRHPFFKEI 287
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-16
Identities = 39/154 (25%), Positives = 69/154 (44%), Gaps = 16/154 (10%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKL 81
Y + RK+G G + +++ G E+ IK+ K ++ E KI + + GG I +
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70
Query: 82 LDIVRDQQSKT-------PSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 134
+ PSL E + F S V +++ ++Y HS+
Sbjct: 71 RWCGAEGDYNVMVMELLGPSL--EDL----FNFCSRKFSLKTVLLLADQMISRIEYIHSK 124
Query: 135 GIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFY 166
+HRDVKP N ++ ++ + +ID+GLA+ Y
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 78.9 bits (194), Expect = 2e-16
Identities = 64/319 (20%), Positives = 112/319 (35%), Gaps = 83/319 (26%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNL 72
D+ + +G+G + +V +E +KILK K I+ E ++L
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILK--KDVVIQDDDVECTMVEKRVLALP 398
Query: 73 CGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLYPT--LSDYDVRYYIYELLK 126
P + +L +T + E+VN D + + +Y E+
Sbjct: 399 GKPPFLTQLH-----SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI 453
Query: 127 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKG 183
L + S+GI++RD+K NVM+D E +++ D+G+ KE V + F G
Sbjct: 454 GLFFLQSKGIIYRDLKLDNVMLDSEGH-IKIADFGMC------KENIWDGVTTKT--FCG 504
Query: 184 ------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 237
PE++ Q Y S+D W+ G + M+ + P F G D + I +
Sbjct: 505 TPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAP-FEGEDEDELFQSIME----HN 558
Query: 238 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER- 296
+ Y + EAV L+ +R
Sbjct: 559 V-----AYPKSMS----------------------------KEAVAICKGLMTKHPGKRL 585
Query: 297 ----PTAKEAMAHPYFFPI 311
++ H +F I
Sbjct: 586 GCGPEGERDIKEHAFFRYI 604
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-16
Identities = 33/156 (21%), Positives = 67/156 (42%), Gaps = 18/156 (11%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKL 81
Y+V R++G G + +FEG + +N++ IK +++ E + + L G I +
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71
Query: 82 LDIVRDQQSKT-------PSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 134
++ PSL E + + S V ++L + H +
Sbjct: 72 YYFGQEGLHNVLVIDLLGPSL--EDL----LDLCGRKFSVKTVAMAAKQMLARVQSIHEK 125
Query: 135 GIMHRDVKPHNVMI----DHEQRKLRLIDWGLAEFY 166
+++RD+KP N +I + ++D+G+ +FY
Sbjct: 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-16
Identities = 47/208 (22%), Positives = 87/208 (41%), Gaps = 22/208 (10%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKI---LQNLC 73
Y + R VGRG +V+E +K++ PV + +++RE + LQ
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQE-- 93
Query: 74 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDY 130
P++V + D + + +N D + L+ + ++ ALD
Sbjct: 94 --PHVVPIHD--FGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDA 149
Query: 131 CHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK--EYNVRVASRYFKGPELLV 188
H+ G HRDVKP N+++ + L+D+G+A K + V + Y+ PE
Sbjct: 150 AHAAGATHRDVKPENILVSADDF-AYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFS 208
Query: 189 DLQDYDYSLDLWSLGCMFAGMIFRKEPF 216
+ Y D+++L C+ + P+
Sbjct: 209 E-SHATYRADIYALTCVLYECLTGSPPY 235
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 77.3 bits (191), Expect = 3e-16
Identities = 71/328 (21%), Positives = 137/328 (41%), Gaps = 90/328 (27%)
Query: 21 DDYEVVRKVGRGKYSEVF--EGVHCTDNEK-CIIKILKP---VKKKK----IKREIKILQ 70
+++E+++ +G G Y +VF + D K +K+LK V+K K + E ++L+
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 71 NLCGGPNIVKLLDIVRDQQS-KTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYE 123
++ P +V L + +T + LI +++N + F L ++++V+ Y+ E
Sbjct: 114 HIRQSPFLVTL------HYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE 167
Query: 124 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE----YNVRVASR 179
++ AL++ H GI++RD+K N+++D + L D+GL+ KE R
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLS------KEFVADETERAYD- 219
Query: 180 YFKG------PELLVDL-QDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQLVK 228
F G P+++ +D ++D WSLG + G F + +
Sbjct: 220 -FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA-----SPFTVDGEKNSQAE 273
Query: 229 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKL 288
I++ + E P+ + ++ A D + +L
Sbjct: 274 ISRRILKSEP-------------------------PYPQEMS--------ALAKDLIQRL 300
Query: 289 LRYDHQER----PT-AKEAMAHPYFFPI 311
L D ++R P A E H +F I
Sbjct: 301 LMKDPKKRLGCGPRDADEIKEHLFFQKI 328
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 76.8 bits (190), Expect = 3e-16
Identities = 59/314 (18%), Positives = 120/314 (38%), Gaps = 77/314 (24%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKK----IKREIKILQNLCG 74
D++++R +G G + V + +K+LK V + K E +L +
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-T 64
Query: 75 GPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLKAL 128
P I+++ + +I +++ + F +L + ++Y E+ AL
Sbjct: 65 HPFIIRMWG-----TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLAL 119
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG----- 183
+Y HS+ I++RD+KP N+++D +++ D+G A K + G
Sbjct: 120 EYLHSKDIIYRDLKPENILLDKNGH-IKITDFGFA------KYVPDVTYT--LCGTPDYI 170
Query: 184 -PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242
PE++ + Y+ S+D WS G + M+ PF+ N + + K+L
Sbjct: 171 APEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFY--DSNTMKTYE--KIL--------- 216
Query: 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER-----P 297
++ + F + D L +L+ D +R
Sbjct: 217 -----------------NAELRFPPFFN--------EDVKDLLSRLITRDLSQRLGNLQN 251
Query: 298 TAKEAMAHPYFFPI 311
++ HP+F +
Sbjct: 252 GTEDVKNHPWFKEV 265
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-16
Identities = 46/215 (21%), Positives = 84/215 (39%), Gaps = 38/215 (17%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIV 79
+ EV VGRG + V + + IK ++ +K E++ L + PNIV
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVNH-PNIV 64
Query: 80 KLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY-----PTLSDYDVRYYIYELLKALDYCHS 133
KL L+ E+ + VL+ P + + + + + Y HS
Sbjct: 65 KLYGACL----NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120
Query: 134 ---QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------- 183
+ ++HRD+KP N+++ L++ D+G A +
Sbjct: 121 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----------CDIQTHMTNNKGSAAW 169
Query: 184 --PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 216
PE+ +Y D++S G + +I R++PF
Sbjct: 170 MAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPF 203
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 6e-16
Identities = 63/314 (20%), Positives = 118/314 (37%), Gaps = 77/314 (24%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKK----IKREIKILQNLCG 74
+D+ + + +G+G + +VF N+ IK LK V E ++L
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 75 GPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLYP--TLSDYDVRYYIYELLKAL 128
P + + +T + E++N D + +Y E++ L
Sbjct: 77 HPFLTHMF-----CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGL 131
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK---------EYNVRVAS 178
+ HS+GI++RD+K N+++D + +++ D+G+ E +Y +A
Sbjct: 132 QFLHSKGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDY---IA- 186
Query: 179 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 238
PE+L+ Q Y++S+D WS G + M+ + P F+G D + I D
Sbjct: 187 -----PEILLG-QKYNHSVDWWSFGVLLYEMLIGQSP-FHGQDEEELFHSIRM----DNP 235
Query: 239 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT 298
+ +++ EA D L KL + ++R
Sbjct: 236 -------------------------FYPRWLE--------KEAKDLLVKLFVREPEKRLG 262
Query: 299 AKEA-MAHPYFFPI 311
+ HP F I
Sbjct: 263 VRGDIRQHPLFREI 276
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 9e-16
Identities = 29/169 (17%), Positives = 60/169 (35%), Gaps = 21/169 (12%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKKIKREIKILQNLCGGPNIVK 80
+ + +K+G G + ++ EK ++K + + E+K Q + I K
Sbjct: 39 WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKK 98
Query: 81 LLDIVRDQQSKTPSLIF---EHVNNTDFKV-----LYPTLSDY----------DVRYYIY 122
++ + P ++ L L V
Sbjct: 99 WIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGI 158
Query: 123 ELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGK 170
+L L+Y H +H D+K N+++ ++ ++ L D+GL+ Y P
Sbjct: 159 RMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNG 207
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-15
Identities = 50/237 (21%), Positives = 90/237 (37%), Gaps = 54/237 (22%)
Query: 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----------KKKKI 62
+ + + E +++G+G + V +G D IK L K ++
Sbjct: 13 LPTLADN--EIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEF 70
Query: 63 KREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIY 122
+RE+ I+ NL PNIVKL ++ + P ++ E V D LY L D
Sbjct: 71 QREVFIMSNLN-HPNIVKLYGLMHNP----PRMVMEFVPCGD---LYHRLLDKAHPIKWS 122
Query: 123 ELLK-ALD------YCHSQG--IMHRDVKPHNVMIDHEQRK----LRLIDWGLAEFYHPG 169
L+ LD Y +Q I+HRD++ N+ + ++ D+GL+
Sbjct: 123 VKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS------ 176
Query: 170 KEYNVRVASRYFKG---------PELLVDLQD-YDYSLDLWSLGCMFAGMIFRKEPF 216
+ + G PE + ++ Y D +S + ++ + PF
Sbjct: 177 -----QQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPF 228
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 40/154 (25%), Positives = 71/154 (46%), Gaps = 16/154 (10%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIVKL 81
+ + RK+G G + E++ G + NE+ IK+ K ++ E KI + L GG I +
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68
Query: 82 LDIVRDQQSKT-------PSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ 134
+ PSL E + F LS V +++ +++ HS+
Sbjct: 69 RWFGVEGDYNVLVMDLLGPSL--EDL----FNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
Query: 135 GIMHRDVKPHNVMI--DHEQRKLRLIDWGLAEFY 166
+HRD+KP N ++ ++ +ID+GLA+ Y
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 1e-15
Identities = 74/312 (23%), Positives = 125/312 (40%), Gaps = 69/312 (22%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNL 72
+++E ++ +G+G + +V +KILK K+ + + E ++LQN
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILK--KEVIVAKDEVAHTLTENRVLQN- 204
Query: 73 CGGPNIVKLLDIVRDQQSKTPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLK 126
P + L +T + E+ N + F L S+ R+Y E++
Sbjct: 205 SRHPFLTALK-----YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS 259
Query: 127 ALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGP 184
ALDY HS+ +++RD+K N+M+D + +++ D+GL E G + + P
Sbjct: 260 ALDYLHSEKNVVYRDLKLENLMLDKD-GHIKITDFGLCKEGIKDGATMKTFCGTPEYLAP 318
Query: 185 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244
E+L D DY ++D W LG + M+ + P FY D ++L +
Sbjct: 319 EVLED-NDYGRAVDWWGLGVVMYEMMCGRLP-FYNQD-------------HEKLFELILM 363
Query: 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER-----PTA 299
I L PEA L LL+ D ++R A
Sbjct: 364 EEIRFPRTLG------------------------PEAKSLLSGLLKKDPKQRLGGGSEDA 399
Query: 300 KEAMAHPYFFPI 311
KE M H +F I
Sbjct: 400 KEIMQHRFFAGI 411
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 74.1 bits (183), Expect = 3e-15
Identities = 77/324 (23%), Positives = 127/324 (39%), Gaps = 92/324 (28%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKR--------EIKILQNL 72
+E+++ +G+G + +VF + ++ + +K +KK +K E IL
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE- 82
Query: 73 CGGPNIVKLLDIVRDQQSK----TPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYYIY 122
P IVKL T LI + + D F L ++ DV++Y+
Sbjct: 83 VNHPFIVKL---------HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLA 133
Query: 123 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK---------EY 172
EL ALD+ HS GI++RD+KP N+++D E ++L D+GL+ E K EY
Sbjct: 134 ELALALDHLHSLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEY 192
Query: 173 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 232
+A PE++ + + S D WS G + M+ P F G D + + I K
Sbjct: 193 ---MA------PEVVNR-RGHTQSADWWSFGVLMFEMLTGTLP-FQGKDRKETMTMILK- 240
Query: 233 LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYD 292
+L +F++ PEA L L + +
Sbjct: 241 ---AKL-------------------------GMPQFLS--------PEAQSLLRMLFKRN 264
Query: 293 HQER-----PTAKEAMAHPYFFPI 311
R +E H +F I
Sbjct: 265 PANRLGAGPDGVEEIKRHSFFSTI 288
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 73.8 bits (182), Expect = 3e-15
Identities = 39/152 (25%), Positives = 69/152 (45%), Gaps = 13/152 (8%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLCGGP 76
YE+ +G G SEV D+ +K+L+ P + +RE + L P
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHP 72
Query: 77 NIVKLLDI--VRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYC 131
IV + D P ++ E+V+ + + ++ I + +AL++
Sbjct: 73 AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 132 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163
H GI+HRDVKP N+MI ++++D+G+A
Sbjct: 133 HQNGIIHRDVKPANIMISATNA-VKVMDFGIA 163
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 4e-15
Identities = 84/330 (25%), Positives = 130/330 (39%), Gaps = 102/330 (30%)
Query: 21 DDYEVVRKVGRGKYSEVF---EGVHCTDNEKCIIKILKP---VKKKK----IKREIKILQ 70
+ +E++R +G+G Y +VF + + +K+LK V+ K K E IL+
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 71 NLCGGPNIVKLLDIVRDQQSK----TPS---LIFEHVNNTD-FKVLY--PTLSDYDVRYY 120
P IV L T LI E+++ + F L + +Y
Sbjct: 77 E-VKHPFIVDL---------IYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY 126
Query: 121 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGK--------- 170
+ E+ AL + H +GI++RD+KP N+M++H+ ++L D+GL E H G
Sbjct: 127 LAEISMALGHLHQKGIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTI 185
Query: 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGC----MFAGMIFRKEPFFYGHDNYDQL 226
EY +A PE+L+ ++ ++D WSLG M G P F G + +
Sbjct: 186 EY---MA------PEILMR-SGHNRAVDWWSLGALMYDMLTG-----APPFTGENRKKTI 230
Query: 227 VKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLD 286
KI K +L L EA D L
Sbjct: 231 DKILK----CKL-----NLPPYLT----------------------------QEARDLLK 253
Query: 287 KLLRYDHQER----PT-AKEAMAHPYFFPI 311
KLL+ + R P A E AHP+F I
Sbjct: 254 KLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-14
Identities = 22/190 (11%), Positives = 53/190 (27%), Gaps = 38/190 (20%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------VKKKKIKREIKILQNLCGGP 76
Y ++ G + ++ + + + + + P ++ L + P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKP 91
Query: 77 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-VLYPTLSDYDVRYYIYELLKALDYCHSQG 135
+ ++LD+V + ++ E + + V + S + L A D H G
Sbjct: 92 GVARVLDVVHTRA--GGLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAG 149
Query: 136 IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 195
+ P V + + V +A +
Sbjct: 150 VALSIDHPSRVRVSIDGD--------------------VVLAYPATMPDA--------NP 181
Query: 196 SLDLWSLGCM 205
D+ +G
Sbjct: 182 QDDIRGIGAS 191
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 71.1 bits (173), Expect = 4e-14
Identities = 50/340 (14%), Positives = 96/340 (28%), Gaps = 75/340 (22%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-----------KPVKKKKIKREIKIL 69
+ + K+G G + EVF+ + D+ IKI+ ++I EI I
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 70 QNLCG--------GPNIVKLLDIVRDQQSKTPSLI------------------------- 96
+ L + L + Q S P L+
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 97 -----FEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDH 150
FE ++ S + +++L +L + HRD+ NV++
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK- 196
Query: 151 EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMI 210
+ Y + S L V + DY S +F +
Sbjct: 197 -------------KTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDV- 242
Query: 211 FRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGR-HSRKPWSKFI 269
E F G D I +++ + N + + L L + + +
Sbjct: 243 SMDEDLFTGD--GDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKC 300
Query: 270 TVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF 309
+ +F +L + +A + + F
Sbjct: 301 NTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLF 335
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 2e-13
Identities = 42/209 (20%), Positives = 75/209 (35%), Gaps = 34/209 (16%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKI 68
I+ + + K+ E+++G ++K+LK K + E
Sbjct: 5 SGIDFK--QLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPR 60
Query: 69 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN-TDFKVLYPTLSDYDVRYYIYELLK- 126
L+ PN++ +L + + P+LI + + + VL + + +K
Sbjct: 61 LRIFSH-PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVL---HEGTNFVVDQSQAVKF 116
Query: 127 ALD------YCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVR-V 176
ALD + H+ I + +VMID E R+ + F PG+ Y V
Sbjct: 117 ALDMARGMAFLHTLEPLIPRHALNSRSVMID-EDMTARISMADVKFSFQSPGRMYAPAWV 175
Query: 177 ASRYFKGPELLVDLQDYDYSL--DLWSLG 203
A PE L + D+WS
Sbjct: 176 A------PEALQKKPEDTNRRSADMWSFA 198
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-13
Identities = 30/173 (17%), Positives = 65/173 (37%), Gaps = 26/173 (15%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVKKKKIKREIKILQNLCGGPN 77
++V +G+G + ++ + + C++K+ +P + E+K Q
Sbjct: 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKV-EPSDNGPLFTELKFYQRAAKPEQ 95
Query: 78 IVKLLDIVRDQQSKTPSLIF---EHVNNTDFKVLY-----PTLSDY-----------DVR 118
I K + + + P N ++ + L V
Sbjct: 96 IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVL 155
Query: 119 YYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGK 170
+L L+Y H +H D+K N++++++ ++ L+D+GLA Y P
Sbjct: 156 QLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 1e-12
Identities = 47/231 (20%), Positives = 89/231 (38%), Gaps = 43/231 (18%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKI 68
W I E E+ +G+G++ +V+ G + I+++ + K KRE+
Sbjct: 28 WDIPFE--QLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMA 82
Query: 69 LQNLCGGPNIVKLLDIVRDQQSKTPSL--IFEHVNNTDFKVLYPTLSDYDVRYYIYELLK 126
+ N+V + P L I LY + D + + + +
Sbjct: 83 YRQTRH-ENVVLFMGAC----MSPPHLAIITSLCKGRT---LYSVVRDAKIVLDVNKTRQ 134
Query: 127 -ALD------YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR 179
A + Y H++GI+H+D+K NV D+ K+ + D+GL + R
Sbjct: 135 IAQEIVKGMGYLHAKGILHKDLKSKNVFYDN--GKVVITDFGLFSISGVLQAGRREDKLR 192
Query: 180 YFKG------PELL--------VDLQDYDYSLDLWSLGCMFAGMIFRKEPF 216
G PE++ D + D+++LG ++ + R+ PF
Sbjct: 193 IQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF 243
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 3e-12
Identities = 46/234 (19%), Positives = 97/234 (41%), Gaps = 37/234 (15%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKI 68
W I V +++G G + V++G D +K+L P + + K E+ +
Sbjct: 19 WEIPDG--QITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGV 73
Query: 69 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLK-A 127
L+ NI+ + Q +++ + + LY L + ++ + +L+ A
Sbjct: 74 LRKTRH-VNILLFMGYSTAPQ---LAIVTQWCEGSS---LYHHLHASETKFEMKKLIDIA 126
Query: 128 LD------YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYF 181
Y H++ I+HRD+K +N+ + E +++ D+GLA +
Sbjct: 127 RQTARGMDYLHAKSIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQL--- 182
Query: 182 KG------PELLVDLQDYDYSL--DLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 227
G PE++ YS D+++ G + ++ + P+ +N DQ++
Sbjct: 183 SGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQII 235
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 4e-12
Identities = 47/212 (22%), Positives = 87/212 (41%), Gaps = 39/212 (18%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKI 68
I D + K+G G + V +KIL + RE+ I
Sbjct: 32 MDIPWC--DLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAI 87
Query: 69 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYI--YELLK 126
++ L PNIV + V S++ E+++ LY L R + L
Sbjct: 88 MKRLRH-PNIVLFMGAVTQPP--NLSIVTEYLSRGS---LYRLLHKSGAREQLDERRRLS 141
Query: 127 -ALD------YCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA 177
A D Y H++ I+HR++K N+++D ++ +++ D+GL+ + + ++
Sbjct: 142 MAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRL-----KASTFLS 195
Query: 178 SRYFKG------PELLVDLQDYDYSLDLWSLG 203
S+ G PE+L D + + D++S G
Sbjct: 196 SKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFG 226
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 62.4 bits (152), Expect = 3e-11
Identities = 47/207 (22%), Positives = 85/207 (41%), Gaps = 28/207 (13%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQ-NLCGGPNIV 79
++V+++G+G+Y EV+ G EK +K+ ++ RE +I Q L NI+
Sbjct: 37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENIL 94
Query: 80 KLL--DIVRDQQSKTPSLIFE-HVNNTDFKVLYPTLSDYDVRYYI-YELLKALDYCHSQ- 134
+ DI LI + H N + + L T D + Y + L + H++
Sbjct: 95 GFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 135 -------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 183
I HRD+K N+++ + + D GLA + V + G
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVKFISDTN-EVDIPPNTRVGTKRY 212
Query: 184 --PELL---VDLQDYDYSL--DLWSLG 203
PE+L ++ + + D++S G
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFG 239
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 4e-11
Identities = 37/207 (17%), Positives = 82/207 (39%), Gaps = 28/207 (13%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQ-NLCGGPNIV 79
+ +G+G++ EV+ G E+ +KI +++ RE +I Q + NI+
Sbjct: 42 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVMLRHENIL 99
Query: 80 KLLDIVRDQQSKTP--SLIFE-HVNNTDFKVLYPTLSDYDVRYYI-YELLKALDYCHSQ- 134
+ L+ + H + + F L + + L + H +
Sbjct: 100 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 159
Query: 135 -------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG---- 183
I HRD+K N+++ + + D GLA + + + +A + G
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDT-IDIAPNHRVGTKRY 217
Query: 184 --PELL---VDLQDYDYSL--DLWSLG 203
PE+L ++++ ++ D++++G
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMG 244
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 4e-11
Identities = 47/204 (23%), Positives = 79/204 (38%), Gaps = 28/204 (13%)
Query: 24 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQ-NLCGGPNIVKLL 82
++ VG+G+Y EV+ G E +KI +K RE ++ + NI+ +
Sbjct: 11 TLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 83 --DIVRDQQSKTPSLIFE-HVNNTDFKVLYPTLSDYDVRYYI-YELLKALDYCHSQ---- 134
D+ S LI H + + L T D I + L + H +
Sbjct: 69 ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 135 ----GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG------P 184
I HRD+K N+++ + + + D GLA + + V + G P
Sbjct: 129 QGKPAIAHRDLKSKNILVK-KNGQCCIADLGLAVMHSQSTNQ-LDVGNNPRVGTKRYMAP 186
Query: 185 ELL-----VDLQDYDYSLDLWSLG 203
E+L VD D +D+W+ G
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFG 210
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 5e-11
Identities = 41/229 (17%), Positives = 89/229 (38%), Gaps = 40/229 (17%)
Query: 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-------KKKIKRE 65
+ I+ + + +G G + +V+ ++ +K + + +++E
Sbjct: 1 LLEIDFA--ELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQE 56
Query: 66 IKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYPTLSDYDVRYYI-YE 123
K+ L PNI+ L + + L+ E +VL D+ +
Sbjct: 57 AKLFAMLKH-PNIIALRGVCLKEP--NLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQ 113
Query: 124 LLKALDYCHSQG---IMHRDVKPHNVMIDHEQRK-------LRLIDWGLAEFYHPGKEYN 173
+ + ++Y H + I+HRD+K N++I + L++ D+GLA +H + +
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS 173
Query: 174 VRVASRYFKG------PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 216
G PE++ + D+WS G + ++ + PF
Sbjct: 174 -------AAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPF 214
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 29/175 (16%), Positives = 58/175 (33%), Gaps = 28/175 (16%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCT--------DNEKCIIKILKPVKKKKIKREIKILQNLCG 74
+++ R ++E + +K +K+ K ++ E Q
Sbjct: 44 WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDA--KDGRLFNEQNFFQRAAK 101
Query: 75 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKV-----LYPTLSDY------------DV 117
+ K + P+ + V+ ++ L +L V
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKHVLSERSV 161
Query: 118 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGKE 171
LL AL++ H +H +V N+ +D E Q ++ L +G A Y P +
Sbjct: 162 LQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGK 216
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 4e-10
Identities = 40/217 (18%), Positives = 81/217 (37%), Gaps = 41/217 (18%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKI-----LQNLCGG 75
D+ +++ +GRG+Y V++G D +K+ ++ E I +++
Sbjct: 13 DNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEH---- 66
Query: 76 PNIVKLL--DIVRDQQSKTP-SLIFE-HVNNTDFKVLYPTLSDYDVRYYI-YELLKALDY 130
NI + + D + L+ E + N + K L SD+ + + + + L Y
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAY 126
Query: 131 CHSQ---------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYF 181
H++ I HRD+ NV++ + D+GL+ +
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVK-NDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 182 KG---------PELL------VDLQDYDYSLDLWSLG 203
PE+L D + +D+++LG
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALG 222
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 7e-10
Identities = 42/160 (26%), Positives = 73/160 (45%), Gaps = 18/160 (11%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP----VKKKKIKREIKIL 69
W +N E D + ++GRG + EVF G DN +K + K K +E +IL
Sbjct: 109 WVLNHE--DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARIL 166
Query: 70 QNLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDFKVLY-----PTLSDYDVRYYIYE 123
+ PNIV+L+ + +Q P I E V DF + L + + +
Sbjct: 167 KQYS-HPNIVRLIGVCTQKQ---PIYIVMELVQGGDFLT-FLRTEGARLRVKTLLQMVGD 221
Query: 124 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163
++Y S+ +HRD+ N ++ E+ L++ D+G++
Sbjct: 222 AAAGMEYLESKCCIHRDLAARNCLVT-EKNVLKISDFGMS 260
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 8e-09
Identities = 48/230 (20%), Positives = 100/230 (43%), Gaps = 22/230 (9%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQN 71
W + R D + K+G G+Y EV+EGV + +K LK ++ ++ +E +++
Sbjct: 215 WEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 272
Query: 72 LCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNN---TDF--KVLYPTLSDYDVRYYIYELL 125
+ PN+V+LL + + P I E + D+ + +S + Y ++
Sbjct: 273 IK-HPNLVQLLGVCTREP---PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 328
Query: 126 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FK 182
A++Y + +HR++ N ++ E +++ D+GL+ G Y +++ +
Sbjct: 329 SAMEYLEKKNFIHRNLAARNCLVG-ENHLVKVADFGLSRLMT-GDTYTAHAGAKFPIKWT 386
Query: 183 GPELLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKIAK 231
PE L + D+W+ G ++ + P + G D + K
Sbjct: 387 APESLAY-NKFSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELLEK 434
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 41/172 (23%), Positives = 76/172 (44%), Gaps = 18/172 (10%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI----IKILKP----VKKKKIKRE 65
+ + +R +G G + +V + + + +K LKP +K+E
Sbjct: 16 THFEKR--FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKE 73
Query: 66 IKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYY 120
I+IL+NL NIVK I + LI E + + K Y ++ Y
Sbjct: 74 IEILRNLYH-ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE-YLPKNKNKINLKQQLKY 131
Query: 121 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 172
++ K +DY S+ +HRD+ NV+++ + ++++ D+GL + KEY
Sbjct: 132 AVQICKGMDYLGSRQYVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDKEY 182
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 54.7 bits (132), Expect = 1e-08
Identities = 44/227 (19%), Positives = 83/227 (36%), Gaps = 29/227 (12%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK--KIKREIKILQNLCGGPNI 78
+++ RG++ V++ NE +KI K+ + + E+ L + NI
Sbjct: 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKH-ENI 80
Query: 79 VKLL--DIVRDQQSKTPSLIFE-HVNNTDFKVLYPTLSDYDVRYYI-YELLKALDYCHSQ 134
++ + + LI H + L + ++ +I + + L Y H
Sbjct: 81 LQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHED 140
Query: 135 ----------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS----RY 180
I HRD+K NV++ + D+GLA + GK RY
Sbjct: 141 IPGLKDGHKPAISHRDIKSKNVLLK-NNLTACIADFGLALKFEAGKSAGDTHGQVGTRRY 199
Query: 181 FKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY 223
PE+L +D +D++++G + + R D Y
Sbjct: 200 M-APEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 1e-08
Identities = 36/173 (20%), Positives = 77/173 (44%), Gaps = 14/173 (8%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILKPV----KKKKIKREI 66
I E+ R +G+G + V+ G + + I IK L + + + RE
Sbjct: 14 VLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREG 73
Query: 67 KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK----VLYPTLSDYDVRYYIY 122
+++ L PN++ L+ I+ + P ++ ++ + D + D+ +
Sbjct: 74 LLMRGLN-HPNVLALIGIMLPPEG-LPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL 131
Query: 123 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR 175
++ + ++Y Q +HRD+ N M+D E +++ D+GLA + Y+V+
Sbjct: 132 QVARGMEYLAEQKFVHRDLAARNCMLD-ESFTVKVADFGLARDILDREYYSVQ 183
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 2e-08
Identities = 46/204 (22%), Positives = 89/204 (43%), Gaps = 19/204 (9%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGV--HCTDNEKCI--IKILK----PVKKKKIKRE 65
++ + +R +G G + +V D + +K LK P + K+E
Sbjct: 26 TVFHKR--YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQE 83
Query: 66 IKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK--VLYPTLSDYDVRYYIYE 123
I IL+ L +I+K D + + L+ E+V + + ++ + + +
Sbjct: 84 IDILRTLYH-EHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQ 142
Query: 124 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRY-F 181
+ + + Y H+Q +HRD+ NV++D R +++ D+GLA + Y VR
Sbjct: 143 ICEGMAYLHAQHYIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPV 201
Query: 182 K--GPELLVDLQDYDYSLDLWSLG 203
PE L + + + Y+ D+WS G
Sbjct: 202 FWYAPECLKEYK-FYYASDVWSFG 224
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 2e-08
Identities = 46/230 (20%), Positives = 97/230 (42%), Gaps = 26/230 (11%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILKPV----KKKKIKREI 66
I +GRG + V+ G ++ K I +K L + + + E
Sbjct: 18 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEG 77
Query: 67 KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYI 121
I+++ PN++ LL I + +P ++ ++ + D + + + D+ +
Sbjct: 78 IIMKDFS-HPNVLSLLGICLRSEG-SPLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFG 134
Query: 122 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA------EFYHPGKEYNVR 175
++ K + Y S+ +HRD+ N M+D E+ +++ D+GLA E+Y + +
Sbjct: 135 LQVAKGMKYLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKTGAK 193
Query: 176 VASRYFKGPELLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYD 224
+ ++ E L Q + D+WS G ++ M P + + +D
Sbjct: 194 LPVKWM-ALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPP-YPDVNTFD 240
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 3e-08
Identities = 48/239 (20%), Positives = 101/239 (42%), Gaps = 26/239 (10%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI----IKILK---PVKKKKIKREI 66
+ + ++G+G + V + + +K L+ P +++ +REI
Sbjct: 18 TIFEER--HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREI 75
Query: 67 KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN---TDF-KVLYPTLSDYDVRYYIY 122
+IL+ L IVK + ++ L+ E++ + DF + L + Y
Sbjct: 76 QILKAL-HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSS 134
Query: 123 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-YNVRVASRY- 180
++ K ++Y S+ +HRD+ N++++ + +++ D+GLA+ K+ Y VR +
Sbjct: 135 QICKGMEYLGSRRCVHRDLAARNILVE-SEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 181 FK--GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 237
PE L D + D+WS G + E F Y + + +++G +
Sbjct: 194 IFWYAPESLSDNI-FSRQSDVWSFG------VVLYELFTYCDKSCSPSAEFLRMMGCER 245
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 3e-08
Identities = 44/162 (27%), Positives = 76/162 (46%), Gaps = 20/162 (12%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP----VKKKKIKREI 66
+ I RE D + R +G G + EV+EGV+ + I +K K K+K E
Sbjct: 7 YGIARE--DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEA 64
Query: 67 KILQNLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDF----KVLYPTLSDYDVRYYI 121
I++NL P+IVKL+ I+ + P+ I E + + +L + Y
Sbjct: 65 VIMKNLD-HPHIVKLIGII----EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS 119
Query: 122 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163
++ KA+ Y S +HRD+ N+++ ++L D+GL+
Sbjct: 120 LQICKAMAYLESINCVHRDIAVRNILVA-SPECVKLGDFGLS 160
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 53.2 bits (128), Expect = 3e-08
Identities = 44/232 (18%), Positives = 93/232 (40%), Gaps = 30/232 (12%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILKPV----KKKKIKREI 66
I +GRG + V+ G ++ K I +K L + + + E
Sbjct: 82 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEG 141
Query: 67 KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYI 121
I+++ PN++ LL I + P ++ ++ + D + + + D+ +
Sbjct: 142 IIMKDFS-HPNVLSLLGICLRSEGS-PLVVLPYMKHGDLRN-FIRNETHNPTVKDLIGFG 198
Query: 122 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYF 181
++ K + + S+ +HRD+ N M+D E+ +++ D+GLA + + +V +
Sbjct: 199 LQVAKGMKFLASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKT--- 254
Query: 182 KG--------PELLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYD 224
E L Q + D+WS G ++ M P + + +D
Sbjct: 255 GAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPP-YPDVNTFD 304
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 53.3 bits (128), Expect = 4e-08
Identities = 47/230 (20%), Positives = 95/230 (41%), Gaps = 24/230 (10%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQN 71
W I R + + K+G+G + EV+ G + IK LKP + + +E ++++
Sbjct: 262 WEIPR--ESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKK 318
Query: 72 LCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDF-----KVLYPTLSDYDVRYYIYELL 125
L +V+L +V S+ P I E+++ L + ++
Sbjct: 319 LR-HEKLVQLYAVV----SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 373
Query: 126 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FK 182
+ Y +HRD++ N+++ E ++ D+GLA EY R +++ +
Sbjct: 374 SGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWT 431
Query: 183 GPELLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKIAK 231
PE + + D+WS G + + P + G N + L ++ +
Sbjct: 432 APEAALY-GRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVER 479
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 4e-08
Identities = 40/162 (24%), Positives = 76/162 (46%), Gaps = 20/162 (12%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP----VKKKKIKREI 66
+ I RE E+ R +G G++ +V +G++ + + IK K ++K +E
Sbjct: 10 YEIQRE--RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 67
Query: 67 KILQNLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDF----KVLYPTLSDYDVRYYI 121
++ P+IVKL+ ++ ++ P I E + +V +L + Y
Sbjct: 68 LTMRQFD-HPHIVKLIGVI----TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 122
Query: 122 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163
Y+L AL Y S+ +HRD+ NV++ ++L D+GL+
Sbjct: 123 YQLSTALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGLS 163
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 8e-08
Identities = 39/164 (23%), Positives = 76/164 (46%), Gaps = 22/164 (13%)
Query: 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP----VKKKKIKRE 65
+ I RE E+ R +G G++ +V +G++ + + IK K ++K +E
Sbjct: 384 DYEIQRE--RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQE 441
Query: 66 IKILQNLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDFKVLY-----PTLSDYDVRY 119
++ P+IVKL+ ++ ++ P I E + + + +L +
Sbjct: 442 ALTMRQFDH-PHIVKLIGVI----TENPVWIIMELCTLGELRS-FLQVRKFSLDLASLIL 495
Query: 120 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163
Y Y+L AL Y S+ +HRD+ NV++ ++L D+GL+
Sbjct: 496 YAYQLSTALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGLS 538
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 52.5 bits (126), Expect = 8e-08
Identities = 47/230 (20%), Positives = 95/230 (41%), Gaps = 24/230 (10%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQN 71
W I R + + K+G+G + EV+ G + IK LKP + + +E ++++
Sbjct: 179 WEIPR--ESLRLEVKLGQGCFGEVWMGT-WNGTTRVAIKTLKPGTMSPEAFLQEAQVMKK 235
Query: 72 LCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDF-----KVLYPTLSDYDVRYYIYELL 125
L +V+L +V S+ P I E+++ L + ++
Sbjct: 236 LR-HEKLVQLYAVV----SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 290
Query: 126 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY---FK 182
+ Y +HRD++ N+++ E ++ D+GLA EY R +++ +
Sbjct: 291 SGMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWT 348
Query: 183 GPELLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKIAK 231
PE + + D+WS G + + P + G N + L ++ +
Sbjct: 349 APEAALY-GRFTIKSDVWSFGILLTELTTKGRVP-YPGMVNREVLDQVER 396
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 2e-07
Identities = 39/175 (22%), Positives = 79/175 (45%), Gaps = 18/175 (10%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQN 71
W + R D + K+G G+Y EV+EGV + +K LK ++ ++ +E +++
Sbjct: 8 WEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 65
Query: 72 LCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDFKVLY------PTLSDYDVRYYIYEL 124
+ PN+V+LL + + P I E + + Y +S + Y ++
Sbjct: 66 IK-HPNLVQLLGVCTREP---PFYIITEFMTYGNLLD-YLRECNRQEVSAVVLLYMATQI 120
Query: 125 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR 179
A++Y + +HRD+ N ++ E +++ D+GL+ G Y ++
Sbjct: 121 SSAMEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRLMT-GDTYTAHAGAK 173
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 42/237 (17%), Positives = 100/237 (42%), Gaps = 28/237 (11%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI----IKILKPVKKKKIK---REI 66
+ ++++G+G + V + + +K L+ ++ ++ REI
Sbjct: 36 TQFEER--HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREI 93
Query: 67 KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN---TDF-KVLYPTLSDYDVRYYIY 122
+IL++L NIVK + + LI E++ D+ + + + Y
Sbjct: 94 EILKSLQH-DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 152
Query: 123 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRY- 180
++ K ++Y ++ +HRD+ N++++ + ++++ D+GL + Y V+
Sbjct: 153 QICKGMEYLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEYYKVKEPGESP 211
Query: 181 FK--GPELLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 234
PE L + + + + D+WS G ++ E F Y + + +++G
Sbjct: 212 IFWYAPESLTESK-FSVASDVWSFGVVLY-------ELFTYIEKSKSPPAEFMRMIG 260
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 5e-07
Identities = 34/187 (18%), Positives = 76/187 (40%), Gaps = 25/187 (13%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP-----VKKKKIKRE 65
I +Q + + R +G+G++ V E ++ + +K+LK ++ RE
Sbjct: 18 VLIPEQQ--FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 66 IKILQNLCGGPNIVKLLDIVRDQQSKTPS----LIFEHVNNTDFK---------VLYPTL 112
++ P++ KL+ + ++K +I + + D L
Sbjct: 76 AACMKEFD-HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNL 134
Query: 113 SDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 172
+ ++ ++ ++Y S+ +HRD+ N M+ E + + D+GL+ + G Y
Sbjct: 135 PLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA-EDMTVCVADFGLSRKIYSGDYY 193
Query: 173 NVRVASR 179
AS+
Sbjct: 194 RQGCASK 200
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 6e-07
Identities = 28/158 (17%), Positives = 67/158 (42%), Gaps = 17/158 (10%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQN 71
+ RE + +++++G G++ V G +K++K + + + +E + +
Sbjct: 3 MELKRE--EITLLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEFFQEAQTMMK 59
Query: 72 LCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDFKVLY-----PTLSDYDVRYYIYELL 125
L P +VK + + P I E+++N Y L + Y++
Sbjct: 60 LS-HPKLVKFYGVCSKEY---PIYIVTEYISNGCLLN-YLRSHGKGLEPSQLLEMCYDVC 114
Query: 126 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163
+ + + S +HRD+ N ++D +++ D+G+
Sbjct: 115 EGMAFLESHQFIHRDLAARNCLVD-RDLCVKVSDFGMT 151
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 6e-07
Identities = 34/243 (13%), Positives = 81/243 (33%), Gaps = 41/243 (16%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGV-------HCTDNEKCIIKILKPV---KKKKIK 63
I E D +G+G ++++F+GV + ++K+L +
Sbjct: 3 HKIRNE--DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFF 60
Query: 64 REIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDFKVLY-----PTLSDYDV 117
++ L ++V + +++ E V Y ++
Sbjct: 61 EAASMMSKLS-HKHLVLNYGVCVCGD---ENILVQEFVKFGSLD-TYLKKNKNCINILWK 115
Query: 118 RYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI-------DWGLAEFYHPGK 170
+L A+ + ++H +V N+++ E+ + D G++ P
Sbjct: 116 LEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD 175
Query: 171 EYNVRV---ASRYFKGPELLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQL 226
R+ PE + + ++ + + D WS G ++ +P D+ +L
Sbjct: 176 ILQERIPWVP------PECIENPKNLNLATDKWSFGTTLWEICSGGDKP-LSALDSQRKL 228
Query: 227 VKI 229
Sbjct: 229 QFY 231
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 7e-07
Identities = 42/237 (17%), Positives = 99/237 (41%), Gaps = 28/237 (11%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGV----HCTDNEKCIIKILKPVKKKKIK---REI 66
+ ++++G+G + V E +K L+ ++ ++ REI
Sbjct: 5 TQFEER--HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREI 62
Query: 67 KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN---TDF-KVLYPTLSDYDVRYYIY 122
+IL++L NIVK + + LI E++ D+ + + + Y
Sbjct: 63 EILKSLQH-DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTS 121
Query: 123 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRY- 180
++ K ++Y ++ +HRD+ N++++ + ++++ D+GL + + V+
Sbjct: 122 QICKGMEYLGTKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEFFKVKEPGESP 180
Query: 181 FK--GPELLVDLQDYDYSLDLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 234
PE L + + + + D+WS G ++ E F Y + + +++G
Sbjct: 181 IFWYAPESLTESK-FSVASDVWSFGVVLY-------ELFTYIEKSKSPPAEFMRMIG 229
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 8e-07
Identities = 32/157 (20%), Positives = 73/157 (46%), Gaps = 15/157 (9%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQN 71
W I+ + D ++++G G++ V G IK++K + + + E K++ N
Sbjct: 19 WEIDPK--DLTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMN 75
Query: 72 LCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDF----KVLYPTLSDYDVRYYIYELLK 126
L +V+L + Q+ P I E++ N + + + ++ +
Sbjct: 76 LS-HEKLVQLYGVCTKQR---PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 131
Query: 127 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163
A++Y S+ +HRD+ N +++ +Q +++ D+GL+
Sbjct: 132 AMEYLESKQFLHRDLAARNCLVN-DQGVVKVSDFGLS 167
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 1e-06
Identities = 33/172 (19%), Positives = 69/172 (40%), Gaps = 28/172 (16%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGV-----HCTDNEKCIIKILKP----VKKKKIKR 64
W + RE+ + R++G+G + V+EGV + IK + ++ +
Sbjct: 20 WEVAREK--ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77
Query: 65 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK-------------VLYPT 111
E +++ ++V+LL +V Q +I E + D K +
Sbjct: 78 EASVMKEF-NCHHVVRLLGVVSQGQP--TLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 134
Query: 112 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163
S + E+ + Y ++ +HRD+ N M+ E +++ D+G+
Sbjct: 135 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA-EDFTVKIGDFGMT 185
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 1e-06
Identities = 37/213 (17%), Positives = 87/213 (40%), Gaps = 28/213 (13%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP-----VKKKKIKRE 65
I+R + + +G G++ V EG ++ + +K +K + ++ E
Sbjct: 29 VVIDRNL--LILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86
Query: 66 IKILQNLCGGPNIVKLLDIVRDQQSK---TPSLIFEHVNNTDFK---------VLYPTLS 113
+++ PN+++LL + + S+ P +I + D +
Sbjct: 87 AACMKDFS-HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP 145
Query: 114 DYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYN 173
+ ++ ++ ++Y ++ +HRD+ N M+ + + + D+GL++ + G Y
Sbjct: 146 LQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR-DDMTVCVADFGLSKKIYSGDYYR 204
Query: 174 VRVASRY-FK--GPELLVDLQDYDYSLDLWSLG 203
++ K E L D + Y D+W+ G
Sbjct: 205 QGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFG 236
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 1e-06
Identities = 31/170 (18%), Positives = 77/170 (45%), Gaps = 19/170 (11%)
Query: 15 FINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI----IKILK----PVKKKKIKREI 66
+ +++ ++ +G G + V++G+ + EK IK L+ P K+I E
Sbjct: 11 ILKET--EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 68
Query: 67 KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN---TDF-KVLYPTLSDYDVRYYIY 122
++ ++ P++ +LL I LI + + D+ + + + +
Sbjct: 69 YVMASVD-NPHVCRLLGICLTST---VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 123 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 172
++ K ++Y + ++HRD+ NV++ + +++ D+GLA+ ++
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKE 173
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 2e-06
Identities = 33/167 (19%), Positives = 69/167 (41%), Gaps = 19/167 (11%)
Query: 9 IYWCVWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP----VKKKK 61
++ ++ + + + VG G++ EV G ++K I IK LK +++
Sbjct: 35 VHEFAKELDAT--NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD 92
Query: 62 IKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDF----KVLYPTLSDYD 116
E I+ PNI++L +V + P +I E++ N + +
Sbjct: 93 FLGEASIMGQFD-HPNIIRLEGVVTKSK---PVMIVTEYMENGSLDSFLRKHDAQFTVIQ 148
Query: 117 VRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163
+ + + + Y G +HRD+ N++I+ ++ D+GL
Sbjct: 149 LVGMLRGIASGMKYLSDMGYVHRDLAARNILIN-SNLVCKVSDFGLG 194
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 30/164 (18%), Positives = 66/164 (40%), Gaps = 20/164 (12%)
Query: 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI----IKILKP----VKKKKIKR 64
I+ + +G G++ EV++G+ T + K IK LK ++
Sbjct: 38 TTEIHPS--CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG 95
Query: 65 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDF----KVLYPTLSDYDVRY 119
E I+ NI++L ++ + P +I E++ N + S +
Sbjct: 96 EAGIMGQFS-HHNIIRLEGVISKYK---PMMIITEYMENGALDKFLREKDGEFSVLQLVG 151
Query: 120 YIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163
+ + + Y + +HRD+ N++++ ++ D+GL+
Sbjct: 152 MLRGIAAGMKYLANMNYVHRDLAARNILVN-SNLVCKVSDFGLS 194
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 2e-06
Identities = 31/163 (19%), Positives = 63/163 (38%), Gaps = 19/163 (11%)
Query: 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP----VKKKKIKRE 65
I + + +G G EV G ++ + IK LK +++ E
Sbjct: 43 TREIEAS--RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSE 100
Query: 66 IKILQNLCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDF----KVLYPTLSDYDVRYY 120
I+ PNI++L +V + ++I E++ N + + +
Sbjct: 101 ASIMGQFD-HPNIIRLEGVVTRGR---LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGM 156
Query: 121 IYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163
+ + + Y G +HRD+ NV++D ++ D+GL+
Sbjct: 157 LRGVGAGMRYLSDLGYVHRDLAARNVLVD-SNLVCKVSDFGLS 198
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 2e-06
Identities = 48/241 (19%), Positives = 91/241 (37%), Gaps = 37/241 (15%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILKP------VKKKKIKR 64
I + D ++ K+G G + V G + K + +K LKP R
Sbjct: 13 CLIGEK--DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR 70
Query: 65 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYEL 124
E+ + +L N+++L +V K ++ E L L + + + L
Sbjct: 71 EVNAMHSLD-HRNLIRLYGVVLTPPMK---MVTELAPLGS---LLDRLRKHQGHFLLGTL 123
Query: 125 L-------KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRV 176
+ + Y S+ +HRD+ N+++ + +++ D+GL Y ++
Sbjct: 124 SRYAVQVAEGMGYLESKRFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQE 182
Query: 177 ASRY-FK--GPELLVDLQDYDYSL--DLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKIA 230
+ F PE L +S D W G ++ + +EP + G + L KI
Sbjct: 183 HRKVPFAWCAPESLKTRT---FSHASDTWMFGVTLWEMFTYGQEP-WIGLNGSQILHKID 238
Query: 231 K 231
K
Sbjct: 239 K 239
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 2e-06
Identities = 26/157 (16%), Positives = 68/157 (43%), Gaps = 15/157 (9%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQN 71
W I+ + V+++G G++ V G + +K IK ++ + ++ E +++
Sbjct: 3 WVIDPS--ELTFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMK 59
Query: 72 LCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDF----KVLYPTLSDYDVRYYIYELLK 126
L P +V+L + +Q P + E + + + + + ++ +
Sbjct: 60 LS-HPKLVQLYGVCLEQA---PICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 115
Query: 127 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163
+ Y ++HRD+ N ++ E + +++ D+G+
Sbjct: 116 GMAYLEEACVIHRDLAARNCLVG-ENQVIKVSDFGMT 151
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 36/174 (20%), Positives = 74/174 (42%), Gaps = 18/174 (10%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQN 71
W I RE ++ +K+G G++ EV+ + K +K +KP + + E +++
Sbjct: 183 WEIPRE--SLKLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLAEANVMKT 239
Query: 72 LCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNN---TDF--KVLYPTLSDYDVRYYIYELL 125
L +VKL +V +K P I E + DF + + ++
Sbjct: 240 LQ-HDKLVKLHAVV----TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIA 294
Query: 126 KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR 179
+ + + + +HRD++ N+++ ++ D+GLA EY R ++
Sbjct: 295 EGMAFIEQRNYIHRDLRAANILVS-ASLVCKIADFGLARVIE-DNEYTAREGAK 346
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 4e-06
Identities = 31/159 (19%), Positives = 71/159 (44%), Gaps = 19/159 (11%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQN 71
W + RE ++V ++G G++ EV+ G + K +K LK + E +++
Sbjct: 8 WEVPRE--TLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQ 64
Query: 72 LCGGPNIVKLLDIVRDQQSKTPSLI-FEHVNNTDFKVLY------PTLSDYDVRYYIYEL 124
L +V+L +V ++ P I E++ N + L+ + ++
Sbjct: 65 LQ-HQRLVRLYAVV----TQEPIYIITEYMENGSLVD-FLKTPSGIKLTINKLLDMAAQI 118
Query: 125 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163
+ + + + +HRD++ N+++ + ++ D+GLA
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVS-DTLSCKIADFGLA 156
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 5e-06
Identities = 40/236 (16%), Positives = 93/236 (39%), Gaps = 29/236 (12%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI----IKILK----PVKKKKIKRE 65
+ ++ +G G + V +GV + E IK+++ + +
Sbjct: 8 RIFKET--ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDH 65
Query: 66 IKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN---TDF-KVLYPTLSDYDVRYYI 121
+ + +L +IV+LL + L+ +++ D + L + +
Sbjct: 66 MLAIGSLD-HAHIVRLLGLCPGSS---LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG 121
Query: 122 YELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY- 180
++ K + Y G++HR++ NV++ ++++ D+G+A+ P + + ++
Sbjct: 122 VQIAKGMYYLEEHGMVHRNLAARNVLLK-SPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180
Query: 181 FK--GPELLVDLQDYDYSL--DLWSLG-CMFAGMIFRKEPFFYGHDNYDQLVKIAK 231
K E + Y+ D+WS G ++ M F EP+ G + + K
Sbjct: 181 IKWMALE---SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYA-GLRLAEVPDLLEK 232
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 5e-06
Identities = 44/221 (19%), Positives = 91/221 (41%), Gaps = 36/221 (16%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEG-----VHCTDNEKCIIKILKP----VKKKKIKR 64
W R++ ++ + +GRG + +V E +K+LK + + +
Sbjct: 22 WEFPRDR--LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 79
Query: 65 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK------------------ 106
E+KIL ++ N+V LL + +I E +
Sbjct: 80 ELKILIHIGHHLNVVNLLGAC-TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 138
Query: 107 -VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165
+ L+ + Y +++ K +++ S+ +HRD+ N+++ E+ +++ D+GLA
Sbjct: 139 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARD 197
Query: 166 YHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDLWSLG 203
+ +Y + +R K PE + D + Y D+WS G
Sbjct: 198 IYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFG 237
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 6e-06
Identities = 32/170 (18%), Positives = 79/170 (46%), Gaps = 19/170 (11%)
Query: 15 FINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI----IKILK----PVKKKKIKREI 66
+ +++ ++ +G G + V++G+ + EK IK L+ P K+I E
Sbjct: 11 ILKET--EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEA 68
Query: 67 KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN---TDF-KVLYPTLSDYDVRYYIY 122
++ ++ P++ +LL I + T LI + + D+ + + + +
Sbjct: 69 YVMASVD-NPHVCRLLGIC---LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 124
Query: 123 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 172
++ K ++Y + ++HRD+ NV++ + +++ D+GLA+ ++
Sbjct: 125 QIAKGMNYLEDRRLVHRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEKE 173
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 8e-06
Identities = 30/159 (18%), Positives = 72/159 (45%), Gaps = 19/159 (11%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNL 72
W +N + + ++++ +G+G++ +V G + K +K +K + E ++ L
Sbjct: 16 WALNMK--ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL 71
Query: 73 CGGPNIVKLLDIVRDQQSKTPSL--IFEHVNNTDFKVLY------PTLSDYDVRYYIYEL 124
N+V+LL ++ +++ L + E++ Y L + + ++
Sbjct: 72 R-HSNLVQLLGVIVEEK---GGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDV 126
Query: 125 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163
+A++Y +HRD+ NV++ E ++ D+GL
Sbjct: 127 CEAMEYLEGNNFVHRDLAARNVLVS-EDNVAKVSDFGLT 164
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 1e-05
Identities = 33/164 (20%), Positives = 70/164 (42%), Gaps = 24/164 (14%)
Query: 14 WFINREQDDYEVVR-KVGRGKYSEVFEGVHCTDNEKCI--IKILKP----VKKKKIKREI 66
F+ R+ + + ++G G + V +GV+ ++ IK+LK +++ RE
Sbjct: 4 LFLKRD--NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 61
Query: 67 KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELL- 125
+I+ L P IV+L+ + Q++ L+ E L+ L + +
Sbjct: 62 QIMHQLD-NPYIVRLIGVC---QAEALMLVMEMAGGGP---LHKFLVGKREEIPVSNVAE 114
Query: 126 ------KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163
+ Y + +HRD+ NV++ + ++ D+GL+
Sbjct: 115 LLHQVSMGMKYLEEKNFVHRDLAARNVLLV-NRHYAKISDFGLS 157
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 44.9 bits (107), Expect = 1e-05
Identities = 47/221 (21%), Positives = 83/221 (37%), Gaps = 35/221 (15%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEG-----VHCTDNEKCIIKILKP----VKKKKIKR 64
W R + +G G + +V E + +K+LKP +++ +
Sbjct: 18 WEFPRN--RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 75
Query: 65 EIKILQNLCGGPNIVKLLDIVRDQQ-------------------SKTPSLIFEHVNNTDF 105
E+K+L L NIV LL K S I +
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 106 KVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165
+ L D+ + Y++ K + + S+ +HRD+ N+++ R ++ D+GLA
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT-HGRITKICDFGLARD 194
Query: 166 YHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDLWSLG 203
Y V+ +R K PE + + Y + D+WS G
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYG 234
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 34/196 (17%), Positives = 72/196 (36%), Gaps = 35/196 (17%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGV-------HCTDNEKCIIKILKP----VKKKKI 62
W R+ + + +G G + +V + +K+LK +
Sbjct: 30 WEFPRD--KLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 87
Query: 63 KREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK---------------- 106
E+++++ + NI+ LL +I E+ + + +
Sbjct: 88 VSEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYD 145
Query: 107 ---VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163
V ++ D+ Y+L + ++Y SQ +HRD+ NV++ E +++ D+GLA
Sbjct: 146 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLA 204
Query: 164 EFYHPGKEYNVRVASR 179
+ Y R
Sbjct: 205 RDINNIDYYKKTTNGR 220
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 2e-05
Identities = 31/175 (17%), Positives = 62/175 (35%), Gaps = 30/175 (17%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI--IKILKP----VKKKKIKREIK 67
++ D + +G G + +V + D + IK +K + E++
Sbjct: 20 PVLDWN--DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE 77
Query: 68 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK------------VLYPTLSDY 115
+L L PNI+ LL + L E+ + + + +
Sbjct: 78 VLCKLGHHPNIINLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANST 135
Query: 116 DVRYYIYELLK-ALD------YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163
+LL A D Y + +HRD+ N+++ E ++ D+GL+
Sbjct: 136 ASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG-ENYVAKIADFGLS 189
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 33/169 (19%), Positives = 75/169 (44%), Gaps = 16/169 (9%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNE--KCIIKILK-----PVKKKKIKREI 66
+++R+ E +++G G + V +G + +KILK P K ++ E
Sbjct: 11 VYLDRKLLTLED-KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEA 69
Query: 67 KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN---TDFKVLYPTLSDYDVRYYIYE 123
++Q L P IV+++ I ++++ L+ E + + D ++ +++
Sbjct: 70 NVMQQLD-NPYIVRMIGIC---EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 125
Query: 124 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 172
+ + Y +HRD+ NV++ Q ++ D+GL++ + Y
Sbjct: 126 VSMGMKYLEESNFVHRDLAARNVLLV-TQHYAKISDFGLSKALRADENY 173
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 45.2 bits (106), Expect = 2e-05
Identities = 53/354 (14%), Positives = 98/354 (27%), Gaps = 117/354 (33%)
Query: 9 IYWCVWFINREQDD--YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL------------ 54
W + +Q++ + V +V R Y + + + ++ +
Sbjct: 64 TLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDN 123
Query: 55 KPVKKKKIKREIKI------LQNLCGGPNIV--------K--L-LDIVRDQQSKTPSLIF 97
+ K + R L L N++ K + LD+ +
Sbjct: 124 QVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLS---------Y 174
Query: 98 EHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRL 157
+ DFK+ + L + + + E+L+ L +++ DH
Sbjct: 175 KVQCKMDFKIFWLNLKNCNSPETVLEMLQKL--------LYQIDPNWTSRSDHSSNIKLR 226
Query: 158 IDWGLAEFYHPGKEYNVRVASRYFKGPE----LLV--DLQDYDYSLDLWSLGCMFAGMIF 211
I AE R K LLV ++Q+ + + ++L C
Sbjct: 227 IHSIQAEL------------RRLLKSKPYENCLLVLLNVQNAK-AWNAFNLSC------- 266
Query: 212 RKEPFFYGHDNYDQLVKIAKVLGT-------DELNAYLNKYHIELDPHLAALVGRHSRKP 264
K+L T D L+A HI LD H L +
Sbjct: 267 -------------------KILLTTRFKQVTDFLSA-ATTTHISLDHHSMTLTPDEVKSL 306
Query: 265 WSKFITVENQHLAVPEAV---------------DFLDKLLRYDHQERPTAKEAM 303
K++ Q L E + D L + H +
Sbjct: 307 LLKYLDCRPQDLP-REVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTII 359
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.8 bits (105), Expect = 3e-05
Identities = 38/301 (12%), Positives = 77/301 (25%), Gaps = 90/301 (29%)
Query: 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGG 75
Q Y+ + V + + F+ D K I+ K EI ++
Sbjct: 11 TGEHQYQYKDILSVFEDAFVDNFDCKDVQDMPKSILS----------KEEID---HIIMS 57
Query: 76 PNIV----KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLS----DYDVRYYIYELLKA 127
+ V +L + +Q + E V ++K L + + +Y
Sbjct: 58 KDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYI---- 113
Query: 128 LDYCHSQGIMHRDV---KPHNVMIDHEQRKLR-----------LIDWGLAEFYHPGKEYN 173
+ ++ D +NV KLR ++ G+ GK
Sbjct: 114 --EQRDR--LYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGS---GK--T 164
Query: 174 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL 233
Y + C IF + +
Sbjct: 165 WVALDV----------CLSYK-------VQCKMDFKIF--------------WLNLKNCN 193
Query: 234 GTDELNAYLNKYHIELDPHLAALVGR--------HSRKPWSKFITVENQHLAVPEAVDFL 285
+ + L K ++DP+ + HS + + + + + L
Sbjct: 194 SPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY---ENCLLVL 250
Query: 286 D 286
Sbjct: 251 L 251
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 5e-05
Identities = 45/322 (13%), Positives = 96/322 (29%), Gaps = 65/322 (20%)
Query: 22 DYEVVRKVGRGKYSEVF-----EGVHCTDNEKCIIKILKPVKKKKIKREIK----ILQNL 72
+V + + + + + + ++K L + + + RE+ ++
Sbjct: 274 FKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLD-CRPQDLPREVLTTNPRRLSI 332
Query: 73 CG-----GPNIVK-LLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLS----DYDVRYYIY 122
G + D+ + + +++ ++ LS + +
Sbjct: 333 IAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILL 392
Query: 123 ELL----------KALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG--K 170
L+ ++ H ++ + K + I +L++ H
Sbjct: 393 SLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL-HRSIVD 451
Query: 171 EYNVRVASRYFKGPELLVDLQD-YDYS-----LDLWSLGCMFAGMIFRKEPFFYGHDNYD 224
YN+ + F +L+ D Y YS L +FR F ++
Sbjct: 452 HYNIP---KTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMT--LFRMV-FL----DFR 501
Query: 225 QL-VKI-----AKVLGTDELNAY--LNKY--HI-ELDPHLAALVGRHSRKPWSKFITVEN 273
L KI A LN L Y +I + DP LV F+
Sbjct: 502 FLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLV-----NAILDFLPKIE 556
Query: 274 QHLAVPEAVDFLDKLLRYDHQE 295
++L + D L L + +
Sbjct: 557 ENLICSKYTDLLRIALMAEDEA 578
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 30/168 (17%), Positives = 75/168 (44%), Gaps = 19/168 (11%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNL 72
W +N + + ++++ +G+G++ +V G + K +K +K + E ++ L
Sbjct: 188 WALNMK--ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL 243
Query: 73 CGGPNIVKLLDIVRDQQSKTPSL--IFEHVNNTDFKVLY------PTLSDYDVRYYIYEL 124
N+V+LL ++ +++ L + E++ Y L + + ++
Sbjct: 244 R-HSNLVQLLGVIVEEK---GGLYIVTEYMAKGSLVD-YLRSRGRSVLGGDCLLKFSLDV 298
Query: 125 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 172
+A++Y +HRD+ NV++ E ++ D+GL + ++
Sbjct: 299 CEAMEYLEGNNFVHRDLAARNVLVS-EDNVAKVSDFGLTKEASSTQDT 345
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* Length = 540 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 4e-05
Identities = 15/82 (18%), Positives = 33/82 (40%), Gaps = 8/82 (9%)
Query: 84 IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKP 143
+ D ++ ++N K + D Y++ + + H ++H D+
Sbjct: 405 YIFDVDLDNKRIMMSYINGKLAKDVIEDNLDI-----AYKIGEIVGKLHKNDVIHNDLTT 459
Query: 144 HNVMIDHEQRKLRLIDWGLAEF 165
N + D + L +ID+GL +
Sbjct: 460 SNFIFD---KDLYIIDFGLGKI 478
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 5e-05
Identities = 31/160 (19%), Positives = 71/160 (44%), Gaps = 16/160 (10%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI--IKILK----PVKKKKIKREIK 67
F+ R+ + ++G G + V +GV+ ++ IK+LK +++ RE +
Sbjct: 330 LFLKRD-NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 388
Query: 68 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF----KVLYPTLSDYDVRYYIYE 123
I+ L P IV+L+ + Q++ L+ E + +V +++
Sbjct: 389 IMHQLD-NPYIVRLIGVC---QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 444
Query: 124 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163
+ + Y + +HR++ NV++ + ++ D+GL+
Sbjct: 445 VSMGMKYLEEKNFVHRNLAARNVLLV-NRHYAKISDFGLS 483
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 6e-05
Identities = 32/180 (17%), Positives = 69/180 (38%), Gaps = 35/180 (19%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGV-------HCTDNEKCIIKILKP----VKKKKI 62
W R+ + + +G G + +V + +K+LK +
Sbjct: 76 WEFPRD--KLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL 133
Query: 63 KREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK---------------- 106
E+++++ + NI+ LL +I E+ + + +
Sbjct: 134 VSEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLRARRPPGMEYSYD 191
Query: 107 ---VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163
V ++ D+ Y+L + ++Y SQ +HRD+ NV++ E +++ D+GLA
Sbjct: 192 INRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT-ENNVMKIADFGLA 250
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 6e-05
Identities = 30/178 (16%), Positives = 66/178 (37%), Gaps = 32/178 (17%)
Query: 12 CVWFINREQDDYEVVRKVGRGKYSEVFEG-----VHCTDNEKCIIKILKPVKKKKIK--- 63
CV I R + ++G G + +VF + D +K LK + +
Sbjct: 34 CVHHIKRRD--IVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQ 91
Query: 64 REIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK----------------- 106
RE ++L L +IV+ + + + ++FE++ + D
Sbjct: 92 REAELLTMLQ-HQHIVRFFGVCT--EGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGE 148
Query: 107 -VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163
V L + ++ + Y +HRD+ N ++ + +++ D+G++
Sbjct: 149 DVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG-QGLVVKIGDFGMS 205
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 9e-05
Identities = 32/180 (17%), Positives = 69/180 (38%), Gaps = 35/180 (19%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGV-------HCTDNEKCIIKILKP----VKKKKI 62
W + R+ + + +G G + +V K +K+LK +
Sbjct: 64 WELPRD--RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL 121
Query: 63 KREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK---------------- 106
E+++++ + NI+ LL +I E+ + + +
Sbjct: 122 ISEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYN 179
Query: 107 ---VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163
LS D+ Y++ + ++Y S+ +HRD+ NV++ E +++ D+GLA
Sbjct: 180 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT-EDNVMKIADFGLA 238
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 41.9 bits (99), Expect = 2e-04
Identities = 51/220 (23%), Positives = 85/220 (38%), Gaps = 37/220 (16%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEG-----VHCTDNEKCIIKILKP----VKKKKIKR 64
W R + + +G G + +V E K +K+LK +K+ +
Sbjct: 41 WEFPRNN--LQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMS 98
Query: 65 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSL-IFEHVNNTDFK----------------- 106
E+KI+ +L NIV LL P L I E+ D
Sbjct: 99 ELKIMSHLGQHENIVNLLGACTHGG---PVLVITEYCCYGDLLNFLRRKSRVLETDPAFA 155
Query: 107 VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 166
+ T S D+ ++ ++ + + + S+ +HRDV NV++ ++ D+GLA
Sbjct: 156 IANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDI 214
Query: 167 HPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDLWSLG 203
Y V+ +R K PE + D Y D+WS G
Sbjct: 215 MNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYG 253
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 30/172 (17%), Positives = 64/172 (37%), Gaps = 26/172 (15%)
Query: 13 VWFINREQDDYEVVRKVGRGKYSEVFEG-----VHCTDNEKCIIKILKPV----KKKKIK 63
+ + R+ + ++R +G G + EV+EG + + +K L V +
Sbjct: 65 LKEVPRK--NITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 122
Query: 64 REIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK----------VLYPTLS 113
E I+ NIV+ + + ++ E + D K +L+
Sbjct: 123 MEALIISKFN-HQNIVRCIGVSLQSLP--RFILLELMAGGDLKSFLRETRPRPSQPSSLA 179
Query: 114 DYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLA 163
D+ + ++ Y +HRD+ N ++ R ++ D+G+A
Sbjct: 180 MLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 2e-04
Identities = 35/179 (19%), Positives = 65/179 (36%), Gaps = 33/179 (18%)
Query: 12 CVWFINREQDDYEVVRKVGRGKYSEVFEG-----VHCTDNEKCIIKILKPVKKKKIK--- 63
V I R + R++G G + +VF D +K LK K
Sbjct: 8 HVQHIKRRD--IVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQ 65
Query: 64 REIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK----------------- 106
RE ++L NL +IVK + D ++FE++ + D
Sbjct: 66 REAELLTNLQ-HEHIVKFYGVCGDGDP--LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQ 122
Query: 107 --VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163
L + + ++ + Y SQ +HRD+ N ++ +++ D+G++
Sbjct: 123 PRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG-ANLLVKIGDFGMS 180
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 2e-04
Identities = 30/172 (17%), Positives = 63/172 (36%), Gaps = 26/172 (15%)
Query: 13 VWFINREQDDYEVVRKVGRGKYSEVFEGV-----HCTDNEKCIIKILKPV----KKKKIK 63
+ + R + ++R +G G + EV+EG + + +K L V +
Sbjct: 24 LKEVPR--KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFL 81
Query: 64 REIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK----------VLYPTLS 113
E I+ NIV+ + + ++ E + D K +L+
Sbjct: 82 MEALIISKFN-HQNIVRCIGVSLQSLP--RFILMELMAGGDLKSFLRETRPRPSQPSSLA 138
Query: 114 DYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLA 163
D+ + ++ Y +HRD+ N ++ R ++ D+G+A
Sbjct: 139 MLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 9e-04
Identities = 49/228 (21%), Positives = 82/228 (35%), Gaps = 44/228 (19%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEG-----VHCTDNEKCIIKILKP----VKKKKIKR 64
W RE + E + +G G + +V + + +K+LK +++ +
Sbjct: 40 WEFPRE--NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMS 97
Query: 65 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK----------VLYPTLSD 114
E+K++ L NIV LL LIFE+ D +
Sbjct: 98 ELKMMTQLGSHENIVNLLGACTLSGP--IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYE 155
Query: 115 YDVRYYIYELLKAL----------------DYCHSQGIMHRDVKPHNVMIDHEQRKLRLI 158
R E L L ++ + +HRD+ NV++ + +++
Sbjct: 156 NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT-HGKVVKIC 214
Query: 159 DWGLAEFYHPGKEYNVRVASRY-FK--GPELLVDLQDYDYSLDLWSLG 203
D+GLA Y VR +R K PE L + Y D+WS G
Sbjct: 215 DFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYG 261
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 321 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.93 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.91 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.87 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.75 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.47 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.24 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.15 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.98 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.81 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.79 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.57 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.48 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.47 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.24 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.93 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.93 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.91 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.88 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.71 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.67 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.67 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.64 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.56 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.43 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.36 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.3 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.23 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.87 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.61 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.43 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.72 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 88.46 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 82.41 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 81.62 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-62 Score=418.63 Aligned_cols=254 Identities=22% Similarity=0.402 Sum_probs=215.7
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc---chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
..|+++++||+|+||+||+|+++.+|+.||||+++.. ....+.+|+.+++.+ +||||+++++++.+. ..+++||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~--~~~~ivm 150 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVG--DELWVVM 150 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHC-CCTTBCCEEEEEEET--TEEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC--CEEEEEE
Confidence 5699999999999999999999999999999998643 346688999999999 999999999999654 4678999
Q ss_pred EeecCchhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC-Ccccc
Q 020826 98 EHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNV 174 (321)
Q Consensus 98 e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~-~~~~~ 174 (321)
|||.+++|.+++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..... .....
T Consensus 151 Ey~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~~ 229 (346)
T 4fih_A 151 EFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKS 229 (346)
T ss_dssp CCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSSSCCBCC
T ss_pred eCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCC-CEEEecCcCceecCCCCCcccc
Confidence 999999998877 5699999999999999999999999999999999999999888 8999999999876543 33456
Q ss_pred ccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhH
Q 020826 175 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLA 254 (321)
Q Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (321)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+......
T Consensus 230 ~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~-~~~~~~~~~~i~~~~~~------------------- 288 (346)
T 4fih_A 230 LVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYF-NEPPLKAMKMIRDNLPP------------------- 288 (346)
T ss_dssp CCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHSSCC-------------------
T ss_pred cccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCC-CcCHHHHHHHHHcCCCC-------------------
Confidence 789999999999987 789999999999999999999999994 33333444333221100
Q ss_pred hhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 255 ALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
.......+|+++.+||.+||+.||++|||++|+|+||||++...+
T Consensus 289 ---------------~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p 333 (346)
T 4fih_A 289 ---------------RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 333 (346)
T ss_dssp ---------------CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred ---------------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence 011123477899999999999999999999999999999986544
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-62 Score=413.72 Aligned_cols=254 Identities=27% Similarity=0.473 Sum_probs=215.4
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
..++|++++.||+|+||+||+|+++.+++.||+|++++. ....+.+|+.+++.+ +||||+++++++++ ...
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~--~~~ 106 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQD--DEK 106 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEe--CCE
Confidence 356899999999999999999999999999999999643 235688999999999 89999999999965 456
Q ss_pred cEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 93 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
+++|||||.||+|.+++ +.+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||+++.....
T Consensus 107 ~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g-~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 107 LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPE 185 (311)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECCTT
T ss_pred EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCC-CEEEEEcCCceecCCC
Confidence 78999999999998877 5699999999999999999999999999999999999999888 8999999999876433
Q ss_pred C---ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhc
Q 020826 170 K---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246 (321)
Q Consensus 170 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (321)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+....+... .
T Consensus 186 ~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~-~~~~~~~~~~i~~~--~----------- 250 (311)
T 4aw0_A 186 SKQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFR-AGNEGLIFAKIIKL--E----------- 250 (311)
T ss_dssp TTCCCBCCCCSCGGGCCHHHHHH-SCBCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHT--C-----------
T ss_pred CCcccccCcccCcccCCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHcC--C-----------
Confidence 2 3455689999999999987 788999999999999999999999994 33333333333220 0
Q ss_pred ccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHH------HhcCCCcccCCCcc
Q 020826 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE------AMAHPYFFPIRNAE 315 (321)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~e------ll~hp~~~~~~~~~ 315 (321)
...+..+|+++++||++||+.||++|||++| +++||||++++-..
T Consensus 251 ------------------------~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~ 301 (311)
T 4aw0_A 251 ------------------------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 301 (311)
T ss_dssp ------------------------CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred ------------------------CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHH
Confidence 0112347789999999999999999999988 58999999886443
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-61 Score=405.50 Aligned_cols=248 Identities=24% Similarity=0.472 Sum_probs=193.1
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
-++|++.+.||+|+||+||+|+++.+++.||+|++++. ....+.+|+.+++.+ +||||+++++++.+ ...+
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~--~~~~ 88 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL-RHPHIIKLYDVIKS--KDEI 88 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEE--CCEE
Confidence 36899999999999999999999999999999998643 235688999999999 89999999999965 4567
Q ss_pred EEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 94 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
++||||++| +|.+++ .++++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||+++......
T Consensus 89 ~ivmEy~~g-~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~~~~~~ 166 (275)
T 3hyh_A 89 IMVIEYAGN-ELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHL-NVKIADFGLSNIMTDGN 166 (275)
T ss_dssp EEEEECCCE-EHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTC-CEEECCSSCC-------
T ss_pred EEEEeCCCC-CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCC-CEEEeecCCCeecCCCC
Confidence 899999964 554444 4699999999999999999999999999999999999999888 89999999998766555
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
.....+||+.|+|||++.+...++.++|||||||++|+|++|+.||. +.+.......+... .
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~-~~~~~~~~~~i~~~--~--------------- 228 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFD-DESIPVLFKNISNG--V--------------- 228 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHT--C---------------
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHcC--C---------------
Confidence 55667899999999999884556789999999999999999999993 33322222222110 0
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCccc
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 310 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~ 310 (321)
...+..+|+++.+||++||+.||++|||++|+++||||+.
T Consensus 229 --------------------~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 229 --------------------YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp --------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred --------------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 0112347789999999999999999999999999999974
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-60 Score=419.27 Aligned_cols=254 Identities=22% Similarity=0.402 Sum_probs=216.1
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc---chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
+.|+++++||+|+||+||+|+++.+|+.||||+++.. ....+.+|+.+|+.+ +||||+++++++.+. ..+++||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIV~l~~~~~~~--~~~~iVm 227 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDY-QHENVVEMYNSYLVG--DELWVVM 227 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHC-CCTTBCCEEEEEEET--TEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCCCceEEEEEEC--CEEEEEE
Confidence 5799999999999999999999999999999998643 346789999999999 999999999999654 4678999
Q ss_pred EeecCchhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC-Ccccc
Q 020826 98 EHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYNV 174 (321)
Q Consensus 98 e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~-~~~~~ 174 (321)
|||.||+|.+++ ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++..... .....
T Consensus 228 Ey~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g-~vKl~DFGla~~~~~~~~~~~~ 306 (423)
T 4fie_A 228 EFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEVPRRKS 306 (423)
T ss_dssp ECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTC-CEEECCCTTCEECCSSCCCBCC
T ss_pred eCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC-CEEEecCccceECCCCCccccc
Confidence 999999998877 5699999999999999999999999999999999999999888 8999999999876433 34456
Q ss_pred ccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhH
Q 020826 175 RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLA 254 (321)
Q Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (321)
.+||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+......
T Consensus 307 ~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~-~~~~~~~~~~i~~~~~~------------------- 365 (423)
T 4fie_A 307 LVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYF-NEPPLKAMKMIRDNLPP------------------- 365 (423)
T ss_dssp CEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHSCCC-------------------
T ss_pred cccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCC-CcCHHHHHHHHHcCCCC-------------------
Confidence 789999999999987 789999999999999999999999984 33333333333221100
Q ss_pred hhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 255 ALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
.......+|+++.+||.+||+.||++|||++|+|+||||++...+
T Consensus 366 ---------------~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~p 410 (423)
T 4fie_A 366 ---------------RLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP 410 (423)
T ss_dssp ---------------CCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred ---------------CCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCCC
Confidence 011223578899999999999999999999999999999986544
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-60 Score=417.28 Aligned_cols=295 Identities=27% Similarity=0.440 Sum_probs=230.6
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEe---cCCceEEEEEeccc-chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~---~~~~~~~vK~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
++...++|++.+.||+|+||+||+|+++ .+++.||+|.+.+. ....+.+|+.+++.+.+||||+++++++.+ ..
T Consensus 16 ~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~--~~ 93 (361)
T 4f9c_A 16 VPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRK--ND 93 (361)
T ss_dssp SGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE--TT
T ss_pred cCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEE--CC
Confidence 3456789999999999999999999885 35789999988654 446788999999998789999999999965 45
Q ss_pred CcEEEEEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-
Q 020826 92 TPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 170 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~- 170 (321)
++++||||+.+++|.++++.+++.+++.++.|++.||+|||++||+||||||+||+++.+...+||+|||+|+......
T Consensus 94 ~~~lvmE~~~g~~L~~~~~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~ 173 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI 173 (361)
T ss_dssp EEEEEEECCCCCCHHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred EEEEEEeCCCcccHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence 6789999999999999999999999999999999999999999999999999999998774489999999997653221
Q ss_pred ----------------------------ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCC
Q 020826 171 ----------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN 222 (321)
Q Consensus 171 ----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~ 222 (321)
.....+||+.|+|||++.+...++.++||||+||++|+|++|+.||+.+.++
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~ 253 (361)
T 4f9c_A 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDD 253 (361)
T ss_dssp GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCH
Confidence 1233579999999999987567899999999999999999999999999999
Q ss_pred hHHHHHHHHHhCChhhhHHhhhhcccCC-------hhhHhhhc----ccCC------CCCccccccccccCCcchHHHHH
Q 020826 223 YDQLVKIAKVLGTDELNAYLNKYHIELD-------PHLAALVG----RHSR------KPWSKFITVENQHLAVPEAVDFL 285 (321)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~----~~~~------~~~~~~~~~~~~~~~s~~~~~ll 285 (321)
.+++..+...+|.+.............. ........ .... ..............+|+++.+||
T Consensus 254 ~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl 333 (361)
T 4f9c_A 254 LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLL 333 (361)
T ss_dssp HHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHH
T ss_pred HHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHH
Confidence 9999999988887655443322211100 00000000 0000 00001111222345788999999
Q ss_pred HHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 286 DKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 286 ~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
++||++||++|+|++|+|+||||++++
T Consensus 334 ~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 334 DKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp HHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred HHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 999999999999999999999999874
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-60 Score=401.52 Aligned_cols=251 Identities=22% Similarity=0.399 Sum_probs=205.2
Q ss_pred cCce-EEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeecc--CCC
Q 020826 20 QDDY-EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSK 91 (321)
Q Consensus 20 ~~~y-~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~~ 91 (321)
..+| ++.++||+|+||+||+|.+..++..||+|.+... ....+.+|+.++++| +||||+++++++.+. ...
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~ 102 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEEETTEE
T ss_pred CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEeeccCCCc
Confidence 3455 7888899999999999999999999999998643 235688999999999 999999999998653 234
Q ss_pred CcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CeeecCCCCCeEEcC-CCCeEEEeeccceee
Q 020826 92 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDH-EQRKLRLIDWGLAEF 165 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~--i~H~dlkp~nili~~-~~~~v~l~dfg~~~~ 165 (321)
.+++|||||.+++|.+++ ..+++..+..++.||+.||+|||++| |+||||||+|||++. ++ .+||+|||+|+.
T Consensus 103 ~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g-~vKl~DFGla~~ 181 (290)
T 3fpq_A 103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG-SVKIGDLGLATL 181 (290)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTS-CEEECCTTGGGG
T ss_pred EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCC-CEEEEeCcCCEe
Confidence 578999999999998887 46999999999999999999999999 999999999999985 55 899999999975
Q ss_pred cCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhh
Q 020826 166 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245 (321)
Q Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (321)
.. .......+||+.|+|||++.+ .++.++|||||||++|+|+||+.||.. ..+...+.........
T Consensus 182 ~~-~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~-~~~~~~~~~~i~~~~~---------- 247 (290)
T 3fpq_A 182 KR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSE-CQNAAQIYRRVTSGVK---------- 247 (290)
T ss_dssp CC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTT-CSSHHHHHHHHTTTCC----------
T ss_pred CC-CCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCC-CCcHHHHHHHHHcCCC----------
Confidence 43 334456789999999999865 589999999999999999999999943 3333322221110000
Q ss_pred cccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCccc
Q 020826 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 310 (321)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~ 310 (321)
....+..+++++.+||.+||+.||++|||++|+|+||||++
T Consensus 248 ------------------------~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 248 ------------------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp ------------------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred ------------------------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 00112246689999999999999999999999999999986
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-61 Score=416.55 Aligned_cols=250 Identities=18% Similarity=0.369 Sum_probs=205.2
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
-++|++++.||+|+||+||+|+++.+++.||||+++.. ....+.+|+.++++| +||||+++++++.+ ...++
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~--~~~~y 99 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM-KHPNIVQYRESFEE--NGSLY 99 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHC-CCCCCCcEEEEEEE--CCEEE
Confidence 47999999999999999999999999999999998643 245688999999999 89999999999965 45678
Q ss_pred EEEEeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 95 LIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 95 lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
+|||||.|++|.+++. .+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++.....
T Consensus 100 iVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~~ 178 (350)
T 4b9d_A 100 IVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-TVQLGDFGIARVLNST 178 (350)
T ss_dssp EEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTC-CEEECSTTEESCCCHH
T ss_pred EEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC-CEEEcccccceeecCC
Confidence 9999999999988772 378999999999999999999999999999999999999888 8999999999865432
Q ss_pred C-ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 170 K-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 170 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
. .....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+....-.
T Consensus 179 ~~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~-~~~~~~~~~~i~~~~~~------------- 243 (350)
T 4b9d_A 179 VELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFE-AGSMKNLVLKIISGSFP------------- 243 (350)
T ss_dssp HHHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHTCCC-------------
T ss_pred cccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCC-CcCHHHHHHHHHcCCCC-------------
Confidence 2 2244679999999999987 789999999999999999999999994 33333333333221000
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
..+..+|+++.+||.+||+.||++|||++|+|+||||++-
T Consensus 244 -----------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 244 -----------------------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp -----------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred -----------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 0123477899999999999999999999999999999753
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-60 Score=403.81 Aligned_cols=250 Identities=27% Similarity=0.447 Sum_probs=204.0
Q ss_pred cCceEEeeeeeeecceEEEEEEEe---cCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~---~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
.++|++++.||+|+||+||+|++. .+++.||+|++++. ....+.+|+.+++++ +||||+++++++.+. .
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~--~ 99 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV-NHPFIVKLHYAFQTE--G 99 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCC-CCTTEECEEEEEEET--T
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHC-CCCCCCeEEEEEEEC--C
Confidence 468999999999999999999884 35789999998643 234688899999999 999999999999654 5
Q ss_pred CcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 92 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
.+++|||||.|++|.+++ ..+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||+++....
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESID 178 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTS-CEEEESSEEEEC---
T ss_pred EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCC-CEEecccccceeccC
Confidence 678999999999998877 4699999999999999999999999999999999999999888 899999999986543
Q ss_pred C-CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 169 G-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 169 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
. ......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+.+..+.+. .
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~PF~-~~~~~~~~~~i~~~--~------------ 242 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQ-GKDRKETMTMILKA--K------------ 242 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHC--C------------
T ss_pred CCccccccccCcccCCHHHhcc-CCCCCCCcccchHHHHHHHHhCCCCCC-CcCHHHHHHHHHcC--C------------
Confidence 2 33456789999999999987 789999999999999999999999993 43333333333220 0
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC-----HHHHhcCCCcccCC
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPIR 312 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps-----~~ell~hp~~~~~~ 312 (321)
...+..+|+++.+||++||+.||++||| ++|+++||||+.++
T Consensus 243 -----------------------~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id 289 (304)
T 3ubd_A 243 -----------------------LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID 289 (304)
T ss_dssp -----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred -----------------------CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence 0112347789999999999999999998 57999999999875
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-60 Score=404.78 Aligned_cols=258 Identities=23% Similarity=0.322 Sum_probs=211.3
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEE
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 98 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 98 (321)
..+.|++.++||+|+||+||+|+++.+++.||||+++... ...+|+.+++.+ +||||+++++++.+ ...+++|||
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~--~~~~E~~il~~l-~HpnIV~l~~~~~~--~~~~~ivmE 130 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV--FRVEELVACAGL-SSPRIVPLYGAVRE--GPWVNIFME 130 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT--CCTHHHHTTTTC-CCTTBCCEEEEEEE--TTEEEEEEC
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH--hHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEEEEEe
Confidence 4567999999999999999999999999999999997542 235799999999 99999999999965 456789999
Q ss_pred eecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc----
Q 020826 99 HVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---- 171 (321)
Q Consensus 99 ~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~---- 171 (321)
||.|++|.+++ ..+++..+..++.||+.||+|||++||+||||||+|||++.++..+||+|||+++.......
T Consensus 131 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~ 210 (336)
T 4g3f_A 131 LLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 210 (336)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---------
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce
Confidence 99999998887 46999999999999999999999999999999999999998875699999999987643321
Q ss_pred --cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 172 --YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
....+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.. .+.......+... ...
T Consensus 211 ~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~-~~~~~~~~~i~~~--~~~------------ 274 (336)
T 4g3f_A 211 LTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQ-YFRGPLCLKIASE--PPP------------ 274 (336)
T ss_dssp ---CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTT-TCCSCCHHHHHHS--CCG------------
T ss_pred ecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCC-CCHHHHHHHHHcC--CCC------------
Confidence 123579999999999988 7899999999999999999999999943 2222222222210 000
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHH-------------hcCCCcccCCCccc
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA-------------MAHPYFFPIRNAES 316 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~el-------------l~hp~~~~~~~~~~ 316 (321)
....+..+|+++.+||.+||+.||++|||++|+ ++|||+++..++..
T Consensus 275 --------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~Pr~ 334 (336)
T 4g3f_A 275 --------------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEPRG 334 (336)
T ss_dssp --------------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCCCC
T ss_pred --------------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCCCC
Confidence 011233578899999999999999999999997 68999999877765
Q ss_pred c
Q 020826 317 S 317 (321)
Q Consensus 317 ~ 317 (321)
+
T Consensus 335 n 335 (336)
T 4g3f_A 335 N 335 (336)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-59 Score=410.05 Aligned_cols=285 Identities=28% Similarity=0.517 Sum_probs=223.9
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeecc----CC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----QS 90 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~----~~ 90 (321)
.++|++++.||+|+||+||+|+++.+|+.||||+++.. ....+.+|+.+|+.+ +||||+++++++... ..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF-KHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSSCTTTC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhc-CCCCcceEeeeeecccccccC
Confidence 46899999999999999999999999999999999643 235678999999999 899999999988643 23
Q ss_pred CCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 91 KTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
..+++|||||+|+ |..++ ..+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||+++...
T Consensus 132 ~~~~ivmE~~~g~-L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~-~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 132 KSVYVVLDLMESD-LHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENC-ELKIGDFGMARGLC 209 (398)
T ss_dssp CCEEEEEECCSEE-HHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC-CEEECCCTTCBCC-
T ss_pred CEEEEEEeCCCCC-HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCC-CEEEeecceeeecc
Confidence 5678999999765 55544 4599999999999999999999999999999999999999888 89999999997653
Q ss_pred CC-----CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHh
Q 020826 168 PG-----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242 (321)
Q Consensus 168 ~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (321)
.. ......+||+.|+|||++.+...++.++||||+||++|+|++|+.|| .+.+..+++..+....+.+....+.
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF-~g~~~~~~l~~I~~~~g~p~~~~~~ 288 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLF-PGKNYVHQLQLIMMVLGTPSPAVIQ 288 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSS-CCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCC-CCCCHHHHHHHHHHhcCCCChHHhh
Confidence 22 22345689999999999988667899999999999999999999888 6777788888888888876543321
Q ss_pred hhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
.... .................+. .....+|+++.+||++||+.||++|||++|+|+||||++...+
T Consensus 289 ~~~~----~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p 354 (398)
T 4b99_A 289 AVGA----ERVRAYIQSLPPRQPVPWE--TVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDP 354 (398)
T ss_dssp ---------CHHHHHHSSCCCCCCCHH--HHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCG
T ss_pred hhhh----hhhhhhhhcCCCcCCCCHH--HhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCC
Confidence 1110 0011111111111111111 1122467899999999999999999999999999999987543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-58 Score=393.52 Aligned_cols=254 Identities=21% Similarity=0.380 Sum_probs=192.8
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC-----
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS----- 90 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~----- 90 (321)
.++|++++.||+|+||+||+|+++.+++.||||+++... ...+.+|+.+++++ +||||+++++++.+.+.
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l-~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEEC------
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEecCcccccc
Confidence 357999999999999999999999999999999986432 35678999999999 89999999999865443
Q ss_pred -----CCcEEEEEeecCchhhhhcCC------CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEee
Q 020826 91 -----KTPSLIFEHVNNTDFKVLYPT------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLID 159 (321)
Q Consensus 91 -----~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~d 159 (321)
.+++++||||.+++|.+++.. .+...++.++.||+.||+|||++||+||||||+||+++.++ .+||+|
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~-~vKl~D 161 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGD 161 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCC-cEEEcc
Confidence 246899999999999888732 34556889999999999999999999999999999999888 899999
Q ss_pred ccceeecCCCCc-------------cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHH
Q 020826 160 WGLAEFYHPGKE-------------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL 226 (321)
Q Consensus 160 fg~~~~~~~~~~-------------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~ 226 (321)
||+++....... ....+||+.|+|||++.+ ..++.++|||||||++|+|++ ||.. ..+..
T Consensus 162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyell~---Pf~~---~~~~~ 234 (299)
T 4g31_A 162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY---PFST---QMERV 234 (299)
T ss_dssp CCCC--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHS---CCSS---HHHHH
T ss_pred CccceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHHHHHHHcc---CCCC---ccHHH
Confidence 999976543221 133579999999999987 789999999999999999995 7731 11222
Q ss_pred HHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCC
Q 020826 227 VKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 306 (321)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp 306 (321)
..+.........+. ....++++.+||++||+.||++|||++|+++||
T Consensus 235 ~~~~~~~~~~~p~~---------------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~ 281 (299)
T 4g31_A 235 RTLTDVRNLKFPPL---------------------------------FTQKYPCEYVMVQDMLSPSPMERPEAINIIENA 281 (299)
T ss_dssp HHHHHHHTTCCCHH---------------------------------HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSG
T ss_pred HHHHHHhcCCCCCC---------------------------------CcccCHHHHHHHHHHcCCChhHCcCHHHHhcCH
Confidence 22211111110000 011346788999999999999999999999999
Q ss_pred CcccCCCcc
Q 020826 307 YFFPIRNAE 315 (321)
Q Consensus 307 ~~~~~~~~~ 315 (321)
||++++.+.
T Consensus 282 ~~~~~~~p~ 290 (299)
T 4g31_A 282 VFEDLDFPG 290 (299)
T ss_dssp GGCCC----
T ss_pred hhCCCCCCC
Confidence 999987654
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-55 Score=383.48 Aligned_cols=295 Identities=76% Similarity=1.303 Sum_probs=269.0
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEE
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 98 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 98 (321)
..++|++.+.||+|+||+||+|++..+++.||+|+++....+.+.+|+.+++.+.+||||+++++++.+......+++||
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e 113 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 113 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence 46899999999999999999999999999999999998888999999999999966999999999998766778899999
Q ss_pred eecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCccccccCC
Q 020826 99 HVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 178 (321)
Q Consensus 99 ~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~~~~~~~ 178 (321)
++.+++|..+...+++..++.++.|++.||+|||++|++|+||||+||+++.++..++|+|||++.............++
T Consensus 114 ~~~~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 193 (330)
T 3nsz_A 114 HVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS 193 (330)
T ss_dssp CCCCCCHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSC
T ss_pred ccCchhHHHHHHhCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCcccccccc
Confidence 99999999999999999999999999999999999999999999999999977768999999999887666666677899
Q ss_pred ccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhc
Q 020826 179 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVG 258 (321)
Q Consensus 179 ~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (321)
..|+|||++.+...++.++|||||||++|+|++|..||+.+......+..+...++.+..............+.+.....
T Consensus 194 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 273 (330)
T 3nsz_A 194 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILG 273 (330)
T ss_dssp GGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHC
T ss_pred ccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhh
Confidence 99999999987567899999999999999999999999888888999999999999998888888888888888888887
Q ss_pred ccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCC
Q 020826 259 RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~ 313 (321)
......+...........+++++.+||++||+.||++|||++|+|+||||+++..
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~ 328 (330)
T 3nsz_A 274 RHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 328 (330)
T ss_dssp CCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC-
T ss_pred hccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhcc
Confidence 7777777776666666678999999999999999999999999999999998854
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-56 Score=375.99 Aligned_cols=248 Identities=17% Similarity=0.338 Sum_probs=195.4
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeec
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRD 87 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (321)
.|+|+. +++++.++||+|+||+||+|++. ..||||+++.. ..+.+.+|+.++.++ +||||+++++++.+
T Consensus 30 ~Wei~~--~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~ 103 (307)
T 3omv_A 30 YWEIEA--SEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKT-RHVNILLFMGYMTK 103 (307)
T ss_dssp CCBCCT--TSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS
T ss_pred CcEEcH--HHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEC
Confidence 477764 68999999999999999999863 35899998642 235688999999999 99999999998753
Q ss_pred cCCCCcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccce
Q 020826 88 QQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163 (321)
Q Consensus 88 ~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~ 163 (321)
..+++|||||.+++|.+++ ..+++..+..++.||+.||+|||+++|+||||||+|||++.++ .+||+|||+|
T Consensus 104 ---~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~-~~Ki~DFGla 179 (307)
T 3omv_A 104 ---DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGL-TVKIGDFGLA 179 (307)
T ss_dssp ---SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTE-EEEECCCSSC
T ss_pred ---CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCC-cEEEeeccCc
Confidence 2468999999999998876 3589999999999999999999999999999999999999888 8999999999
Q ss_pred eecCCC---CccccccCCccccccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHH-hCChh
Q 020826 164 EFYHPG---KEYNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV-LGTDE 237 (321)
Q Consensus 164 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~ 237 (321)
+..... .......||+.|+|||++.+. ..++.++|||||||++|||+||+.||. +.++...+..+... ...+.
T Consensus 180 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~-~~~~~~~~~~~~~~~~~~p~ 258 (307)
T 3omv_A 180 TVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYS-HINNRDQIIFMVGRGYASPD 258 (307)
T ss_dssp BC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT-TCCCHHHHHHHHHTTCCCCC
T ss_pred eecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCC-CCChHHHHHHHHhcCCCCCC
Confidence 765322 223456899999999998642 358999999999999999999999984 33333333322221 00000
Q ss_pred hhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHh
Q 020826 238 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 303 (321)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell 303 (321)
....+..+|+++.+|+.+||+.||++|||+.|++
T Consensus 259 --------------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~ 292 (307)
T 3omv_A 259 --------------------------------LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQIL 292 (307)
T ss_dssp --------------------------------STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHH
T ss_pred --------------------------------cccccccchHHHHHHHHHHcCCCHhHCcCHHHHH
Confidence 0112235778999999999999999999998764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-56 Score=378.53 Aligned_cols=248 Identities=19% Similarity=0.321 Sum_probs=200.8
Q ss_pred cCceEEeeeeeeecceEEEEEEEe-----cCCceEEEEEecccc---hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~~~vK~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
.++|.+.+.||+|+||+||+|++. .++..||||+++... .+.+.+|+.++.++ +||||+++++++.+ ..
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~--~~ 88 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL-QHEHIVKFYGVCVE--GD 88 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--SS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhC-CCCCCccEEEEEee--CC
Confidence 468999999999999999999874 357789999997543 45688999999999 99999999999965 44
Q ss_pred CcEEEEEeecCchhhhhc----------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeE
Q 020826 92 TPSLIFEHVNNTDFKVLY----------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL 155 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~----------------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v 155 (321)
.+++|||||.+|+|.+++ ..+++..+..++.||+.||+|||+++|+||||||+||+++.++ .+
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~-~~ 167 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL-LV 167 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC-cE
Confidence 567999999999998877 2489999999999999999999999999999999999999888 89
Q ss_pred EEeeccceeecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHH
Q 020826 156 RLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAK 231 (321)
Q Consensus 156 ~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 231 (321)
||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||+| |+.||. +.+..+....+.+
T Consensus 168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~-~~~~~~~~~~i~~ 245 (299)
T 4asz_A 168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFTYGKQPWY-QLSNNEVIECITQ 245 (299)
T ss_dssp EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTT-TSCHHHHHHHHHH
T ss_pred EECCcccceecCCCCceeecCceecChhhcCHHHHcC-CCCCchhhHHHHHHHHHHHHcCCCCCCC-CCCHHHHHHHHHc
Confidence 9999999976543322 223468899999999987 789999999999999999998 898983 3333333333222
Q ss_pred HhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 232 VLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
... ...+..+|+++.+|+.+||+.||++|||++++ |+|++++
T Consensus 246 ~~~------------------------------------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~ 287 (299)
T 4asz_A 246 GRV------------------------------------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNL 287 (299)
T ss_dssp TCC------------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHH
T ss_pred CCC------------------------------------CCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHH
Confidence 000 11223577899999999999999999999999 4577654
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-55 Score=403.04 Aligned_cols=256 Identities=23% Similarity=0.408 Sum_probs=216.1
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc---chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
++|++.+.||+|+||+||+|+++.+|+.||+|+++.. ....+.+|+.+|+.| +||||+++++++.+ ...++++|
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~--~~~~~iv~ 233 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFED--DNEMVMIY 233 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEC--SSEEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhC-CCCCCCeEEEEEEE--CCEEEEEE
Confidence 6899999999999999999999999999999998653 345688999999999 99999999999965 45678999
Q ss_pred EeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCC-CCeEEEeeccceeecCCCCcc
Q 020826 98 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGKEY 172 (321)
Q Consensus 98 e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~-~~~v~l~dfg~~~~~~~~~~~ 172 (321)
|||.|++|.+++ ..+++..++.++.||+.||+|||++||+||||||+||+++.+ ...+||+|||+++...+....
T Consensus 234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~ 313 (573)
T 3uto_A 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313 (573)
T ss_dssp ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEE
T ss_pred eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCce
Confidence 999999987766 248999999999999999999999999999999999999854 237999999999988776666
Q ss_pred ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChh
Q 020826 173 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 252 (321)
Q Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (321)
...+||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+.......
T Consensus 314 ~~~~GT~~y~APEv~~~-~~y~~~~DiWSlGvilyeml~G~~Pf~-~~~~~~~~~~i~~~~~~~---------------- 375 (573)
T 3uto_A 314 KVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFG-GENDDETLRNVKSCDWNM---------------- 375 (573)
T ss_dssp EEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSC-CSSHHHHHHHHHTTCCCC----------------
T ss_pred eeeEECccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCC-CcCHHHHHHHHHhCCCCC----------------
Confidence 77889999999999988 788999999999999999999999983 444444443332210000
Q ss_pred hHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 253 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
.......+|+++.+||++||+.||++|||++|+|+||||+....+
T Consensus 376 -----------------~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~ 420 (573)
T 3uto_A 376 -----------------DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 420 (573)
T ss_dssp -----------------CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred -----------------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence 001122477899999999999999999999999999999986554
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-55 Score=399.84 Aligned_cols=255 Identities=25% Similarity=0.410 Sum_probs=207.9
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHH---HHHHhhcCCCCeeeeeeeeec
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREI---KILQNLCGGPNIVKLLDIVRD 87 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~---~~l~~l~~h~~i~~~~~~~~~ 87 (321)
+..-++|++++.||+|+||+||+|+++.+|+.||+|++++.. .....+|. .++..+ +||||+++++++++
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~-~HP~IV~l~~~f~~ 263 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHT 263 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEEC
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhC-CCCCEeEEEEEEEE
Confidence 445689999999999999999999999999999999996432 23344554 444445 89999999999965
Q ss_pred cCCCCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecccee
Q 020826 88 QQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 164 (321)
Q Consensus 88 ~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~ 164 (321)
. ..+++|||||.||+|..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.+| .+||+|||+|+
T Consensus 264 ~--~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G-~vKL~DFGlA~ 340 (689)
T 3v5w_A 264 P--DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLAC 340 (689)
T ss_dssp S--SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred C--CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCC-CEEecccceee
Confidence 4 5678999999999998877 5699999999999999999999999999999999999999888 89999999998
Q ss_pred ecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCC-ChHHHHHHHHHhCChhhhHHhh
Q 020826 165 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD-NYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
..... .....+||+.|+|||++.....++.++|+|||||++|+|++|..||..... +...+......
T Consensus 341 ~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~----------- 408 (689)
T 3v5w_A 341 DFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT----------- 408 (689)
T ss_dssp ECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHH-----------
T ss_pred ecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcC-----------
Confidence 76543 335578999999999997546799999999999999999999999953222 11111110000
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC-----HHHHhcCCCcccCC
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPIR 312 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps-----~~ell~hp~~~~~~ 312 (321)
.....+..+|+++.+||.+||+.||++|++ ++|+++||||++++
T Consensus 409 -------------------------~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~id 457 (689)
T 3v5w_A 409 -------------------------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457 (689)
T ss_dssp -------------------------CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCC
T ss_pred -------------------------CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCC
Confidence 001123357889999999999999999998 79999999999874
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-54 Score=373.71 Aligned_cols=244 Identities=18% Similarity=0.314 Sum_probs=194.5
Q ss_pred cCceEEeeeeeeecceEEEEEEEe-----cCCceEEEEEecccc---hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~~~vK~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
.++|.+.++||+|+||+||+|++. .++..||||+++... .+.+.+|+.++.++ +||||+++++++.+ ..
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l-~HpnIV~l~g~~~~--~~ 116 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML-QHQHIVRFFGVCTE--GR 116 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--SS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CC
Confidence 468999999999999999999864 357899999997543 45688999999999 99999999999965 44
Q ss_pred CcEEEEEeecCchhhhhc------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCC
Q 020826 92 TPSLIFEHVNNTDFKVLY------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 153 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~------------------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~ 153 (321)
.+++|||||.+|+|.+++ .++++..+..++.||+.||+|||+++|+||||||+||+++.++
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~- 195 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL- 195 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT-
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC-
Confidence 578999999999998875 2488999999999999999999999999999999999999888
Q ss_pred eEEEeeccceeecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHH
Q 020826 154 KLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKI 229 (321)
Q Consensus 154 ~v~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~ 229 (321)
.+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||+| |+.||. +.+..+.+..+
T Consensus 196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~-~~~~~~~~~~i 273 (329)
T 4aoj_A 196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEIFTYGKQPWY-QLSNTEAIDCI 273 (329)
T ss_dssp EEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTC-SSCHHHHHHHH
T ss_pred cEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHHHcCCCCCCC-CCCHHHHHHHH
Confidence 999999999976543322 234578999999999987 789999999999999999999 899984 33333333332
Q ss_pred HHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 230 AKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
.+.. ....+..+|+++.+|+.+||+.||++|||++|++++
T Consensus 274 ~~g~------------------------------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 274 TQGR------------------------------------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHTC------------------------------------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HcCC------------------------------------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 2210 011233577899999999999999999999999764
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-54 Score=369.70 Aligned_cols=244 Identities=18% Similarity=0.314 Sum_probs=199.2
Q ss_pred cCceEEeeeeeeecceEEEEEEEe-----cCCceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
..++++.++||+|+||+||+|+.. .+++.||||+++.. ..+.+.+|+.++.++ +||||+++++++.+ .
T Consensus 25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l-~HpNIV~l~g~~~~--~ 101 (308)
T 4gt4_A 25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARL-QHPNVVCLLGVVTK--D 101 (308)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHC-CCTTBCCEEEEECS--S
T ss_pred HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhC-CCCCCCCcceEEEE--C
Confidence 568899999999999999999863 35678999998643 246799999999999 99999999999965 3
Q ss_pred CCcEEEEEeecCchhhhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCC
Q 020826 91 KTPSLIFEHVNNTDFKVLY-------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE 151 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~ 151 (321)
..+++|||||.+|+|.+++ ..+++..+..++.||+.||+|||+++|+||||||+||+++.+
T Consensus 102 ~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~ 181 (308)
T 4gt4_A 102 QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK 181 (308)
T ss_dssp SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCC
Confidence 4567999999999998876 238899999999999999999999999999999999999988
Q ss_pred CCeEEEeeccceeecCCCC---ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHH
Q 020826 152 QRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLV 227 (321)
Q Consensus 152 ~~~v~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~ 227 (321)
+ .+||+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||+| |..|| .+.+..+...
T Consensus 182 ~-~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~~s~ksDVwSfGvvl~El~t~g~~Pf-~~~~~~~~~~ 258 (308)
T 4gt4_A 182 L-NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPY-CGYSNQDVVE 258 (308)
T ss_dssp G-CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTT-TTCCHHHHHH
T ss_pred C-CEEECCcccceeccCCCceeEecccccCCcccCHHHHhC-CCCCccchhhhHHHHHHHHHhCCCCCC-CCCCHHHHHH
Confidence 8 89999999997653222 2344578999999999987 789999999999999999998 78887 3443333332
Q ss_pred HHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 228 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
.+... . ....+..+|+++.+|+.+||+.||++|||++|++++
T Consensus 259 ~i~~~----------------------------~--------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 259 MIRNR----------------------------Q--------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHTT----------------------------C--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcC----------------------------C--------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 22110 0 011233577899999999999999999999999875
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-54 Score=374.87 Aligned_cols=252 Identities=19% Similarity=0.327 Sum_probs=204.4
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEecCC-----ceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeee
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDN-----EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLD 83 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~-----~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (321)
.|+|++ ++|++.+.||+|+||+||+|.+..++ +.||||.++... ...+.+|+.++.++.+||||+++++
T Consensus 58 ~wEi~~--~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g 135 (353)
T 4ase_A 58 KWEFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 135 (353)
T ss_dssp HHBCCG--GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccEecH--HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEE
Confidence 477774 69999999999999999999987643 579999987532 3568899999999966799999999
Q ss_pred eeeccCCCCcEEEEEeecCchhhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCC
Q 020826 84 IVRDQQSKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPH 144 (321)
Q Consensus 84 ~~~~~~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~ 144 (321)
++.+.. ..+++|||||.+|+|.+++. .+++..+..++.||+.||+|||+++|+||||||+
T Consensus 136 ~~~~~~-~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~ 214 (353)
T 4ase_A 136 ACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 214 (353)
T ss_dssp EECCTT-SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEecC-CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc
Confidence 885432 34679999999999988762 2788999999999999999999999999999999
Q ss_pred CeEEcCCCCeEEEeeccceeecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCC
Q 020826 145 NVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGH 220 (321)
Q Consensus 145 nili~~~~~~v~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~ 220 (321)
||+++.++ .+||+|||+++....... .....+|+.|+|||++.+ ..++.++|||||||++|||+| |..||....
T Consensus 215 NILl~~~~-~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~-~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 215 NILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GEEECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ceeeCCCC-CEEECcchhhhhcccCCCceeeccccccccccCHHHHhc-CCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 99999888 899999999986643332 234568899999999987 789999999999999999998 898984333
Q ss_pred CChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHH
Q 020826 221 DNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 300 (321)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ 300 (321)
........+... . ....+..+|+++.+++.+||+.||++|||++
T Consensus 293 ~~~~~~~~i~~g-~-----------------------------------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~ 336 (353)
T 4ase_A 293 IDEEFCRRLKEG-T-----------------------------------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 336 (353)
T ss_dssp CSHHHHHHHHHT-C-----------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred HHHHHHHHHHcC-C-----------------------------------CCCCCccCCHHHHHHHHHHcCcChhHCcCHH
Confidence 332222222110 0 0112234678999999999999999999999
Q ss_pred HHhcC
Q 020826 301 EAMAH 305 (321)
Q Consensus 301 ell~h 305 (321)
|+++|
T Consensus 337 eil~~ 341 (353)
T 4ase_A 337 ELVEH 341 (353)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 99988
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=355.89 Aligned_cols=297 Identities=30% Similarity=0.537 Sum_probs=221.8
Q ss_pred ccEEEEEEeeeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCe
Q 020826 4 GHVMVIYWCVWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNI 78 (321)
Q Consensus 4 ~~~~~~~~~~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i 78 (321)
.|.-..+-++.......++|++.+.||+|+||+||+|++ .+++.||+|+++... ...+.+|+.+++.+ +||||
T Consensus 4 ~~~~~~~~~~~~~q~l~~~y~~~~~lG~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i 81 (311)
T 3niz_A 4 HHHHSSGRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKEL-HHPNI 81 (311)
T ss_dssp -----------CEECSSCEEEEEEEEEECSSCEEEEEEE-TTSCEEEEEEEC------CHHHHHHHHHHHHHHC-CCTTB
T ss_pred cccccccccceeecchHhhhHhhhhccCCCCeEEEEEEE-CCCCEEEEEEEecccccchhhHHHHHHHHHHHHc-CCCCE
Confidence 333445566778888999999999999999999999998 468999999986432 35678999999999 89999
Q ss_pred eeeeeeeeccCCCCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeE
Q 020826 79 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL 155 (321)
Q Consensus 79 ~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v 155 (321)
+++++++.+ ....++||||+.++.+..+. ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .+
T Consensus 82 v~~~~~~~~--~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~-~~ 158 (311)
T 3niz_A 82 VSLIDVIHS--ERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG-AL 158 (311)
T ss_dssp CCEEEEECC--SSCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CE
T ss_pred eeeeeEEcc--CCEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCC-CE
Confidence 999999954 45678999999975544443 3489999999999999999999999999999999999999888 89
Q ss_pred EEeeccceeecCCC-CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhC
Q 020826 156 RLIDWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 234 (321)
Q Consensus 156 ~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 234 (321)
||+|||++...... .......+|+.|+|||++.+...++.++|||||||++|+|++|..|| .+....+.+..+...++
T Consensus 159 kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~i~~~~~ 237 (311)
T 3niz_A 159 KLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLF-PGVTDDDQLPKIFSILG 237 (311)
T ss_dssp EECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSTTTHHHHHHHHHC
T ss_pred EEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHHC
Confidence 99999999876432 33445678999999999977567899999999999999999999888 45556666777777666
Q ss_pred ChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCC
Q 020826 235 TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~ 313 (321)
.+....+..... ...+... ................+++++.+||++||+.||++|||++|+++||||++++.
T Consensus 238 ~~~~~~~~~~~~------~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 309 (311)
T 3niz_A 238 TPNPREWPQVQE------LPLWKQR-TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309 (311)
T ss_dssp CCCTTTSGGGTT------SHHHHSC-CCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred CCChHHhhhhhc------cchhhhc-ccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence 654433221100 0000000 00000000111122346789999999999999999999999999999998864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=352.82 Aligned_cols=280 Identities=30% Similarity=0.530 Sum_probs=224.6
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
++|++.+.||+|+||+||+|++..+++.||+|+++... ...+.+|+.+++++ +||||+++++++.+ ....++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~l 78 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHS--DKKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEEE--TTEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcC-CCCCEeeEEeEEEe--CCEEEE
Confidence 58999999999999999999999999999999986432 35678999999999 89999999999965 456789
Q ss_pred EEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC-Cc
Q 020826 96 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KE 171 (321)
Q Consensus 96 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~-~~ 171 (321)
||||+.++.+..+. ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++...... ..
T Consensus 79 v~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~ 157 (292)
T 3o0g_A 79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-ELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCSCCSC
T ss_pred EEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeecccceecCCcccc
Confidence 99999987765554 4699999999999999999999999999999999999999888 8999999999876432 33
Q ss_pred cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCCh
Q 020826 172 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (321)
.....+|..|+|||++.+...++.++|||||||++|+|++|..||+.+.+....+..+....+.+....+..........
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T 3o0g_A 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccc
Confidence 45567899999999998755689999999999999999999999988888888888887777765443322211100000
Q ss_pred hhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 252 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
.....+ ...........+++++.+||++||+.||++|||++|+++||||++..
T Consensus 238 -------~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 238 -------PYPMYP-ATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp -------CCCCCC-TTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred -------cccccc-CCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 000000 00111122235778999999999999999999999999999999864
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=357.67 Aligned_cols=255 Identities=22% Similarity=0.443 Sum_probs=213.1
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
....++|++.+.||+|+||+||+|++..+++.||+|++... ....+.+|+.+++.+ +||||+++++++.. ..
T Consensus 11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~--~~ 87 (328)
T 3fe3_A 11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKIL-NHPNIVKLFEVIET--EK 87 (328)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SS
T ss_pred CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEE--CC
Confidence 34467899999999999999999999999999999998643 234578999999999 89999999999954 45
Q ss_pred CcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 92 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
..++||||+.+++|.+++ ..+++..++.++.|++.||+|||++|++||||||+||+++.++ .+||+|||++.....
T Consensus 88 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~ 166 (328)
T 3fe3_A 88 TLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADM-NIKIADFGFSNEFTV 166 (328)
T ss_dssp EEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSTTCCGGGSS
T ss_pred EEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCC-CEEEeeccCceecCC
Confidence 678999999999987776 5799999999999999999999999999999999999999888 899999999987665
Q ss_pred CCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 169 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
........+|+.|+|||++.+....+.++|||||||++|+|++|..||. +.+.......+.. +.
T Consensus 167 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~-~~~~~~~~~~i~~--~~------------- 230 (328)
T 3fe3_A 167 GGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFD-GQNLKELRERVLR--GK------------- 230 (328)
T ss_dssp SCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHH--CC-------------
T ss_pred CCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCC-CCCHHHHHHHHHh--CC-------------
Confidence 6566677899999999999884445689999999999999999999983 3322222222211 00
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCC
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~ 313 (321)
...+..+|+++.+||++||+.||++|||++|+++||||+....
T Consensus 231 ----------------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 231 ----------------------YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE 273 (328)
T ss_dssp ----------------------CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence 0112246789999999999999999999999999999997543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-51 Score=373.00 Aligned_cols=286 Identities=26% Similarity=0.465 Sum_probs=223.1
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC---
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS--- 90 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~--- 90 (321)
..++|++++.||+|+||+||+|.+..+++.||+|++... ....+.+|+.+++.+ +||||+++++++.....
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhC-CCCCCCcEEEEEccCCcccc
Confidence 357899999999999999999999999999999998643 245678999999999 99999999999865432
Q ss_pred -CCcEEEEEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 91 -KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 91 -~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
...++||||+.++.+......+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||++......
T Consensus 139 ~~~~~lv~E~~~~~l~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~ 217 (464)
T 3ttj_A 139 FQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTS 217 (464)
T ss_dssp CCEEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCCC-----C
T ss_pred CCeEEEEEeCCCCCHHHHHhhcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCC-CEEEEEEEeeeecCCC
Confidence 35689999999988777777899999999999999999999999999999999999999888 8999999999876655
Q ss_pred CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 170 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.|| .+.+..+++..+.+.++.+....+.. .
T Consensus 218 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell~g~~pF-~g~~~~~~~~~i~~~lg~p~~~~~~~-----~ 290 (464)
T 3ttj_A 218 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTPCPEFMKK-----L 290 (464)
T ss_dssp CCC----CCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCSCCHHHHTT-----S
T ss_pred cccCCCcccccccCHHHHcC-CCCCHHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCCHHHHHH-----c
Confidence 55566789999999999988 68999999999999999999999888 67777888888888888765433211 1
Q ss_pred ChhhHhhhcccCCCCCccccccc----------cccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCC
Q 020826 250 DPHLAALVGRHSRKPWSKFITVE----------NQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~ 313 (321)
..................+.... .....++++.+||++||++||++|||++|+|+||||+.+..
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 364 (464)
T 3ttj_A 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 364 (464)
T ss_dssp CHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred chhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence 12222222111111111110000 00112567999999999999999999999999999997644
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=365.42 Aligned_cols=293 Identities=27% Similarity=0.521 Sum_probs=217.5
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
..++|++.+.||+|+||+||+|.+..+++.||+|++... ......+|+.+++.+.+||||+++++++...+....
T Consensus 7 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 7 VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred ccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 357899999999999999999999999999999998532 235677899999999669999999999987666678
Q ss_pred EEEEEeecCchhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC--
Q 020826 94 SLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-- 169 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~-- 169 (321)
++||||+.+ +|..++ ..+++..+..++.|++.||+|||++||+||||||+||+++.++ .+||+|||++......
T Consensus 87 ~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 87 YLVFDYMET-DLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAEC-HVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp EEEEECCSE-EHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEESSSCCC
T ss_pred EEEecccCc-CHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCC-CEEecCCccccccccccc
Confidence 999999996 555444 4689999999999999999999999999999999999999888 8999999999765321
Q ss_pred --------------------CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHH
Q 020826 170 --------------------KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKI 229 (321)
Q Consensus 170 --------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~ 229 (321)
.......+|+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+...++..+
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~i 243 (388)
T 3oz6_A 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIF-PGSSTMNQLERI 243 (388)
T ss_dssp CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHH
T ss_pred ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHH
Confidence 11233578999999999987567899999999999999999999887 577777888888
Q ss_pred HHHhCChhhhHHhhhhcccCChhhHhhhcccC--CCCCccc--------cccccccCCcchHHHHHHHhhccCCCCCcCH
Q 020826 230 AKVLGTDELNAYLNKYHIELDPHLAALVGRHS--RKPWSKF--------ITVENQHLAVPEAVDFLDKLLRYDHQERPTA 299 (321)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~--------~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~ 299 (321)
...++.+......................... ....... ........+++++.+||++||+.||++|||+
T Consensus 244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~ 323 (388)
T 3oz6_A 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA 323 (388)
T ss_dssp HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence 88887765543322111100000011000000 0000000 0111223567899999999999999999999
Q ss_pred HHHhcCCCcccCCCc
Q 020826 300 KEAMAHPYFFPIRNA 314 (321)
Q Consensus 300 ~ell~hp~~~~~~~~ 314 (321)
+|+|+||||+....+
T Consensus 324 ~e~l~Hp~~~~~~~~ 338 (388)
T 3oz6_A 324 NDALKHPFVSIFHNP 338 (388)
T ss_dssp HHHTTSTTTTTTCCG
T ss_pred HHHhCCHHHHHhcCC
Confidence 999999999886544
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-51 Score=358.75 Aligned_cols=259 Identities=27% Similarity=0.459 Sum_probs=215.5
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc---------hHHHHHHHHHHHhhcCCCCeeeeeeeee
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQNLCGGPNIVKLLDIVR 86 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~---------~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (321)
-....++|++.+.||+|+||+||+|+++.+++.||+|+++... ...+.+|+.+++.+ +||||+++++++.
T Consensus 7 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~ 85 (361)
T 2yab_A 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV-LHPNIITLHDVYE 85 (361)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEE
T ss_pred CCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhC-CCcCCCcEEEEEE
Confidence 3456788999999999999999999999999999999987532 35689999999999 8999999999995
Q ss_pred ccCCCCcEEEEEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCC---eEEEeec
Q 020826 87 DQQSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR---KLRLIDW 160 (321)
Q Consensus 87 ~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~---~v~l~df 160 (321)
+ ....++||||+.+++|.+++. .+++..+..++.||+.||.|||++|++|+||||+||+++.++. .++|+||
T Consensus 86 ~--~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DF 163 (361)
T 2yab_A 86 N--RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (361)
T ss_dssp C--SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred e--CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEec
Confidence 5 456789999999999988773 4899999999999999999999999999999999999986653 6999999
Q ss_pred cceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhH
Q 020826 161 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 240 (321)
Q Consensus 161 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (321)
|++.............||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+........
T Consensus 164 G~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~-~~~~~~~~~~i~~~~~~~~--- 238 (361)
T 2yab_A 164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITAVSYDFD--- 238 (361)
T ss_dssp SSCEECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSC-CSSHHHHHHHHHTTCCCCC---
T ss_pred CCceEcCCCCccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhcCCCCC---
Confidence 99988766555566789999999999987 688999999999999999999999984 3333333333221100000
Q ss_pred HhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 241 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
......+|+++.+||++||+.||++|||++|+++||||+..+
T Consensus 239 ------------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 239 ------------------------------EEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp ------------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred ------------------------------chhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence 000124678999999999999999999999999999999764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-51 Score=347.89 Aligned_cols=260 Identities=23% Similarity=0.417 Sum_probs=215.4
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc---chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
++...++|++.+.||+|+||+||+|.+..+++.||+|++... ....+.+|+.+++.+ +||||+++++++.+. ..
T Consensus 15 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~ 91 (297)
T 3fxz_A 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVG--DE 91 (297)
T ss_dssp SSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--TE
T ss_pred cCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcC-CCCCCCeEeEEEEEC--CE
Confidence 445678999999999999999999999999999999998643 346688999999999 999999999998654 45
Q ss_pred cEEEEEeecCchhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 93 PSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
.++||||+.+++|.+++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++.......
T Consensus 92 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 92 LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp EEEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSTT
T ss_pred EEEEEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCC-CEEEeeCCCceecCCcc
Confidence 68999999999998877 4589999999999999999999999999999999999999888 89999999987665332
Q ss_pred -ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 171 -EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+.......+..... .
T Consensus 171 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~-~~~~~~~~~~~~~~~~-~------------- 234 (297)
T 3fxz_A 171 SKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYL-NENPLRALYLIATNGT-P------------- 234 (297)
T ss_dssp CCBCCCCSCGGGCCHHHHHC-SCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHHCS-C-------------
T ss_pred cccCCccCCcCccChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCC-C-------------
Confidence 3345679999999999987 788999999999999999999999984 2222222222211100 0
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
....+..+++.+.+||.+||+.||++|||++|+++||||+.....+
T Consensus 235 --------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~ 280 (297)
T 3fxz_A 235 --------------------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLS 280 (297)
T ss_dssp --------------------CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCGG
T ss_pred --------------------CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCccc
Confidence 0111234678899999999999999999999999999999876554
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-51 Score=351.48 Aligned_cols=288 Identities=27% Similarity=0.534 Sum_probs=206.7
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
..++|++++.||+|+||+||+|.+..+++.||+|+++... ...+.+|+.+++.+ +||||+++++++.+ ....+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~~ 79 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-KHENIVRLYDVIHT--ENKLT 79 (317)
T ss_dssp ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTC-CBTTBCCEEEEECC--TTEEE
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhc-CCCCcceEEEEEEE--CCeEE
Confidence 3578999999999999999999999999999999986432 35688999999999 89999999999954 45678
Q ss_pred EEEEeecCchhhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 95 LIFEHVNNTDFKVLY---------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 95 lv~e~~~~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
+||||+.+ +|..++ ..+++..++.++.||+.||+|||++|++|+||||+||+++.++ .+||+|||++..
T Consensus 80 lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~ 157 (317)
T 2pmi_A 80 LVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRG-QLKLGDFGLARA 157 (317)
T ss_dssp EEEECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCSSCEE
T ss_pred EEEEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCC-CEEECcCcccee
Confidence 99999996 554444 2489999999999999999999999999999999999999888 899999999987
Q ss_pred cCCC-CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhh
Q 020826 166 YHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244 (321)
Q Consensus 166 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (321)
.... .......+|+.|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+.+..+.+..+.+....+...
T Consensus 158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (317)
T 2pmi_A 158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLF-PGTNDEEQLKLIFDIMGTPNESLWPSV 236 (317)
T ss_dssp TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCTTTCGGG
T ss_pred cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCChhHhhhh
Confidence 6432 23345678999999999987567899999999999999999999888 455566667777666665433222111
Q ss_pred hcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
.... .+.......................+++++.+||++||+.||++|||++|+++||||++...+.
T Consensus 237 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 304 (317)
T 2pmi_A 237 TKLP---KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHA 304 (317)
T ss_dssp GGCT---TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC--
T ss_pred hhhh---hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchh
Confidence 0000 0000000000011111112223345778999999999999999999999999999999875553
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-51 Score=356.61 Aligned_cols=251 Identities=23% Similarity=0.391 Sum_probs=206.3
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
.++|++.+.||+|+||+||+|+++.+++.||+|+++.. ....+..|..++..+.+||||+++++++.+ ....
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~~ 99 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT--PDRL 99 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe--CCEE
Confidence 57899999999999999999999999999999999753 234577899999988789999999999965 4467
Q ss_pred EEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC-C
Q 020826 94 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-G 169 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~-~ 169 (321)
++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||+++.... .
T Consensus 100 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g-~ikL~DFG~a~~~~~~~ 178 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGICNG 178 (353)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCC--
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCC-CEEEccccceeecccCC
Confidence 8999999999988776 5699999999999999999999999999999999999999888 899999999975432 2
Q ss_pred CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 170 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
......+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||. +.+..+....+...
T Consensus 179 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~-~~~~~~~~~~i~~~----------------- 239 (353)
T 3txo_A 179 VTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFE-AENEDDLFEAILND----------------- 239 (353)
T ss_dssp -------CCGGGCCHHHHHH-HHCTTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHC-----------------
T ss_pred ccccccCCCcCeEChhhcCC-CCcCCccCCCcchHHHHHHHhCCCCCC-CCCHHHHHHHHHcC-----------------
Confidence 33455679999999999987 678999999999999999999999984 33333333333220
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCH------HHHhcCCCcccCC
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA------KEAMAHPYFFPIR 312 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~------~ell~hp~~~~~~ 312 (321)
....+..+++++.+||++||+.||++||++ +++++||||+.++
T Consensus 240 --------------------~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~ 288 (353)
T 3txo_A 240 --------------------EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID 288 (353)
T ss_dssp --------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred --------------------CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence 001122466899999999999999999998 8999999999864
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=349.53 Aligned_cols=250 Identities=25% Similarity=0.451 Sum_probs=209.6
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
.++|++++.||+|+||+||+|+++.+++.||+|++++. ....+.+|+.+++.+ +||||+++++++.+. ...
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~l~~~~~~~--~~~ 80 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQTH--DRL 80 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEECS--SEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhC-CCCcCcceEEEEEeC--CEE
Confidence 57999999999999999999999999999999999643 235678899999999 899999999999654 467
Q ss_pred EEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC-CC
Q 020826 94 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PG 169 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~-~~ 169 (321)
++||||+.+++|..++ ..+++..++.++.||+.||+|||++|++||||||+||+++.++ .+||+|||++.... ..
T Consensus 81 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~ 159 (337)
T 1o6l_A 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCCTT
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCC-CEEEeeccchhhcccCC
Confidence 8999999999987776 4689999999999999999999999999999999999999888 89999999997643 23
Q ss_pred CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 170 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
.......||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.. .+.......+.. +.
T Consensus 160 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~-~~~~~~~~~i~~--~~-------------- 221 (337)
T 1o6l_A 160 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELILM--EE-------------- 221 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHH--CC--------------
T ss_pred CcccccccChhhCChhhhcC-CCCCchhhcccchhHHHHHhcCCCCCCC-CCHHHHHHHHHc--CC--------------
Confidence 34456679999999999987 7889999999999999999999999842 222222222211 00
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc-----CHHHHhcCCCcccCC
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIR 312 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp-----s~~ell~hp~~~~~~ 312 (321)
...+..+|+++.+||++||+.||++|| +++|+++||||+.++
T Consensus 222 ---------------------~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~ 268 (337)
T 1o6l_A 222 ---------------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp ---------------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred ---------------------CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence 011224678999999999999999999 999999999998764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=347.56 Aligned_cols=283 Identities=25% Similarity=0.480 Sum_probs=215.7
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc--------hHHHHHHHHHHHhhc--CCCCeeeeeeeee
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--------KKKIKREIKILQNLC--GGPNIVKLLDIVR 86 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~--------~~~~~~E~~~l~~l~--~h~~i~~~~~~~~ 86 (321)
....++|++.+.||+|+||+||+|++..+++.||+|+++... .....+|+.+++.+. +||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 345789999999999999999999999999999999986432 346778888888774 4999999999986
Q ss_pred ccCCC---CcEEEEEeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEe
Q 020826 87 DQQSK---TPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI 158 (321)
Q Consensus 87 ~~~~~---~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~ 158 (321)
..... ..++++|++.+ +|..++. .+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+
T Consensus 85 ~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~-~~kl~ 162 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-TVKLA 162 (308)
T ss_dssp ECCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTS-CEEEC
T ss_pred ccCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CEEEe
Confidence 54322 46899999986 6555542 289999999999999999999999999999999999999888 89999
Q ss_pred eccceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhh
Q 020826 159 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 238 (321)
Q Consensus 159 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (321)
|||++.............+|+.|+|||++.+ ..++.++|||||||++|+|++|..|| .+.+....+..+.+..+....
T Consensus 163 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~ 240 (308)
T 3g33_A 163 DFGLARIYSYQMALTPVVVTLWYRAPEVLLQ-STYATPVDMWSVGCIFAEMFRRKPLF-CGNSEADQLGKIFDLIGLPPE 240 (308)
T ss_dssp SCSCTTTSTTCCCSGGGGCCCSSCCHHHHHT-SCCCSTHHHHHHHHHHHHTTTSSCSC-CCSSHHHHHHHHHHHHCCCCT
T ss_pred eCccccccCCCcccCCccccccccCchHHcC-CCCCchHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCh
Confidence 9999987665555566789999999999987 67899999999999999999999888 455666677777776665543
Q ss_pred hHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCC
Q 020826 239 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~ 313 (321)
..+........ ....+............+++++.+||.+||+.||++|||++|+|+||||++...
T Consensus 241 ~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~~ 305 (308)
T 3g33_A 241 DDWPRDVSLPR----------GAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDEG 305 (308)
T ss_dssp TTSCSSCSSCG----------GGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-----
T ss_pred hhccchhhccc----------cccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCCC
Confidence 32221110000 000000000011122357789999999999999999999999999999998654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=355.35 Aligned_cols=254 Identities=24% Similarity=0.444 Sum_probs=210.1
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
..++|++++.||+|+||+||+|+++.+++.||+|++++.. ...+..|..++.++.+||||+++++++.+ ...
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~--~~~ 127 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESR 127 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC--SSE
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE--CCE
Confidence 3578999999999999999999999999999999997532 24478899999988789999999999965 456
Q ss_pred cEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeec-CC
Q 020826 93 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY-HP 168 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~-~~ 168 (321)
.++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||+++.. ..
T Consensus 128 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g-~ikL~DFGla~~~~~~ 206 (396)
T 4dc2_A 128 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRP 206 (396)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCT
T ss_pred EEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCC-CEEEeecceeeecccC
Confidence 78999999999987766 5699999999999999999999999999999999999999888 8999999999763 33
Q ss_pred CCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCC-------hHHHHHHHHHhCChhhhHH
Q 020826 169 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN-------YDQLVKIAKVLGTDELNAY 241 (321)
Q Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~-------~~~~~~~~~~~~~~~~~~~ 241 (321)
.......+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||...... ...+.....
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l~~-~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~---------- 275 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL---------- 275 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHH----------
T ss_pred CCccccccCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHh----------
Confidence 344566789999999999987 78899999999999999999999999422111 011111000
Q ss_pred hhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCH------HHHhcCCCcccCC
Q 020826 242 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA------KEAMAHPYFFPIR 312 (321)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~------~ell~hp~~~~~~ 312 (321)
.. ....+..+|+++.+||++||+.||++||++ +|+++||||++++
T Consensus 276 ----------------~~----------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~ 326 (396)
T 4dc2_A 276 ----------------EK----------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 326 (396)
T ss_dssp ----------------HC----------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred ----------------cc----------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence 00 011223467899999999999999999985 7999999999864
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-50 Score=347.93 Aligned_cols=256 Identities=23% Similarity=0.363 Sum_probs=208.0
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
...++|++.+.||+|+||+||+|++..+++.||+|++.... ...+.+|+.+++.+ +||||+++++++.+ ....
T Consensus 4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--~~~~ 80 (323)
T 3tki_A 4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRRE--GNIQ 80 (323)
T ss_dssp TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEE
T ss_pred cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhC-CCCCCCeEEEEEec--CCeE
Confidence 35689999999999999999999999899999999986432 35688999999999 89999999999854 4566
Q ss_pred EEEEEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 94 SLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
++||||+.+++|.+++. .+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~ 159 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNN 159 (323)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECEETT
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCC-CEEEEEeeccceeccCC
Confidence 79999999999988874 489999999999999999999999999999999999999888 89999999997653222
Q ss_pred ---ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 171 ---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 171 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
......||+.|+|||++.+....+.++|||||||++|+|++|..||................ .
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~---~----------- 225 (323)
T 3tki_A 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK---K----------- 225 (323)
T ss_dssp EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT---C-----------
T ss_pred cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc---c-----------
Confidence 23456789999999999874445789999999999999999999995433322221111100 0
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
. .......+++++.+||++||+.||++|||++|+++||||++..
T Consensus 226 -------------~--------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 226 -------------T--------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp -------------T--------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred -------------c--------cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 0 0000124668999999999999999999999999999998753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=350.72 Aligned_cols=255 Identities=25% Similarity=0.424 Sum_probs=213.4
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc--chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
..++|++.+.||+|+||+||+|.+..+++.+|+|.++.. ....+.+|+.+++.+ +||||+++++++.+. ...++|
T Consensus 3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~--~~~~lv 79 (321)
T 1tki_A 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFESM--EELVMI 79 (321)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEET--TEEEEE
T ss_pred hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhC-CCCCCCeEeEEEecC--CEEEEE
Confidence 468999999999999999999999999999999998754 345678999999999 899999999999654 467899
Q ss_pred EEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcC--CCCeEEEeeccceeecCCCC
Q 020826 97 FEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 97 ~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~--~~~~v~l~dfg~~~~~~~~~ 170 (321)
|||+.+++|.+++. .+++..++.++.|++.||+|||++|++|+||||+||+++. ++ .++|+|||++.......
T Consensus 80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~-~~kl~Dfg~a~~~~~~~ 158 (321)
T 1tki_A 80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSS-TIKIIEFGQARQLKPGD 158 (321)
T ss_dssp ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCC-CEEECCCTTCEECCTTC
T ss_pred EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCC-CEEEEECCCCeECCCCC
Confidence 99999999887773 4899999999999999999999999999999999999986 45 89999999998876666
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.........+.........
T Consensus 159 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~~~------------ 224 (321)
T 1tki_A 159 NFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFL-AETNQQIIENIMNAEYTFDE------------ 224 (321)
T ss_dssp EEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHHTCCCCCH------------
T ss_pred ccccccCChhhcCcHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCc-CCCHHHHHHHHHcCCCCCCh------------
Confidence 6666789999999999987 678999999999999999999999984 33333333333221111000
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
.....+|+++.+||++||+.||++|||+.|+++||||++..
T Consensus 225 ---------------------~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 225 ---------------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp ---------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred ---------------------hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 00124678999999999999999999999999999998753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-50 Score=341.31 Aligned_cols=276 Identities=30% Similarity=0.581 Sum_probs=209.7
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
++|++.+.||+|+||+||+|++ .+++.+|+|.++... ...+.+|+.+++.+ +||||+++++++.+. ...++
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~--~~~~l 77 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTK--KRLVL 77 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECS--SCEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhc-CCCCEeeeeeEEccC--CeEEE
Confidence 5899999999999999999998 778999999986432 35678999999999 899999999999653 46789
Q ss_pred EEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC-C
Q 020826 96 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K 170 (321)
Q Consensus 96 v~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~-~ 170 (321)
|||++.+ +|..++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .+||+|||++...... .
T Consensus 78 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~ 155 (288)
T 1ob3_A 78 VFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVR 155 (288)
T ss_dssp EEECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCTTHHHHHCC---
T ss_pred EEEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEEeECccccccCcccc
Confidence 9999997 444443 4589999999999999999999999999999999999999888 8999999998755322 2
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
......+|+.|+|||++.+...++.++|||||||++|+|++|..|| .+.+....+..+...++......+........
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 233 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF-PGVSEADQLMRIFRILGTPNSKNWPNVTELPK- 233 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT-
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHHCCCChhhchhhhcccc-
Confidence 3344578999999999977567899999999999999999999888 45555566666666665543322211100000
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
+.. ................+++++.+||++||+.||++|||++|+++||||++.
T Consensus 234 --~~~-----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 234 --YDP-----NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp --CCT-----TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred --ccc-----ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 000 000000000111223577899999999999999999999999999999875
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-51 Score=349.77 Aligned_cols=265 Identities=18% Similarity=0.196 Sum_probs=189.0
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHH--HHhhcCCCCeeeeeeeeeccCC--CCcEEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKI--LQNLCGGPNIVKLLDIVRDQQS--KTPSLI 96 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~--l~~l~~h~~i~~~~~~~~~~~~--~~~~lv 96 (321)
.+|.+.+.||+|+||+||+|++ +|+.||||+++.........|.++ +.++ +||||+++++++.+.+. ..+++|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l-~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcC-CCCCCCcEEEEEEecCCCceEEEEE
Confidence 5799999999999999999987 688999999987766655555544 4566 89999999999876543 346899
Q ss_pred EEeecCchhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHC--------CCeeecCCCCCeEEcCCCCeEEEeeccceeec
Q 020826 97 FEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQ--------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 166 (321)
Q Consensus 97 ~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lh~~--------~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~ 166 (321)
||||++++|.+++ .++++..+.+++.|++.||+|||++ +|+||||||+|||++.++ .+||+|||+++..
T Consensus 80 ~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~-~~Ki~DFGla~~~ 158 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRH 158 (303)
T ss_dssp EECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCCTTCEEE
T ss_pred ecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC-CEEEEeCCCCccc
Confidence 9999999998887 4689999999999999999999987 899999999999999888 8999999999766
Q ss_pred CCCCc-----cccccCCccccccccccCCC-----CCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCCh
Q 020826 167 HPGKE-----YNVRVASRYFKGPELLVDLQ-----DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD 236 (321)
Q Consensus 167 ~~~~~-----~~~~~~~~~y~aPE~~~~~~-----~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (321)
..... .....||+.|+|||++.+.. .++.++|||||||++|||+||..|+............. .....
T Consensus 159 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~--~~~~~ 236 (303)
T 3hmm_A 159 DSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL--VPSDP 236 (303)
T ss_dssp ETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT--SCSSC
T ss_pred cCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhc--ccccc
Confidence 43322 22357999999999997532 35679999999999999999987663221110000000 00000
Q ss_pred hhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 237 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
.. .............+.. . ........++.+.+|+.+||+.||++|||+.|+++.
T Consensus 237 ~~------------~~~~~~~~~~~~rp~~-p-~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 237 SV------------EEMRKVVCEQKLRPNI-P-NRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CH------------HHHHHHHTTSCCCCCC-C-GGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hH------------HHHHHHHhcccCCCCC-C-ccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 00 0000000000000000 0 000011123468899999999999999999999864
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=360.70 Aligned_cols=287 Identities=27% Similarity=0.534 Sum_probs=220.3
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC---
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS--- 90 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~--- 90 (321)
..++|++.+.||+|+||+||+|++..+++.||||+++.. ..+.+.+|+.+++.+ +||||+++++++.....
T Consensus 24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL-KSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTC
T ss_pred ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHc-CCCCcceEEEEEecCCCCcC
Confidence 467999999999999999999999999999999998643 235688999999999 89999999999865432
Q ss_pred CCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 91 KTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
...++|||++++ +|..++ ..+++..++.++.||+.||+|||++|++||||||+||+++.++ .+||+|||++....
T Consensus 103 ~~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 103 DELYIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDC-SVKVCDFGLARTIN 180 (432)
T ss_dssp CCEEEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEEC-
T ss_pred CeEEEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCC-CEEEccCCCccccc
Confidence 457899999886 565555 3489999999999999999999999999999999999999888 89999999998764
Q ss_pred CCC-----------------------ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhC----------CC
Q 020826 168 PGK-----------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFR----------KE 214 (321)
Q Consensus 168 ~~~-----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g----------~~ 214 (321)
... ......+|+.|+|||++.....++.++|||||||++|+|++| +.
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~ 260 (432)
T 3n9x_A 181 SEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260 (432)
T ss_dssp ------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCC
T ss_pred ccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccccc
Confidence 322 124567899999999976557899999999999999999974 45
Q ss_pred CCccCCC-----------------ChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCC
Q 020826 215 PFFYGHD-----------------NYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLA 277 (321)
Q Consensus 215 p~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 277 (321)
|++++.+ ...++..+...++.+........ .................... ......+
T Consensus 261 p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 334 (432)
T 3n9x_A 261 PLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNI----NKPEVIKYIKLFPHRKPINL--KQKYPSI 334 (432)
T ss_dssp CSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTC----CCHHHHHHHHTSCCCCCCCH--HHHSTTS
T ss_pred ccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhc----cCHHHHHHHHhCCCCCCCCH--HHHCCCC
Confidence 5555543 24567777777777655433221 11222222221111111111 1111347
Q ss_pred cchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 278 VPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 278 s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
++++.+||++||+.||++|||++|+|+||||+++..+
T Consensus 335 s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 335 SDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKK 371 (432)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence 8899999999999999999999999999999998554
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-50 Score=347.00 Aligned_cols=259 Identities=24% Similarity=0.433 Sum_probs=214.2
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc---------chHHHHHHHHHHHhhcCCCCeeeeeeeeec
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---------KKKKIKREIKILQNLCGGPNIVKLLDIVRD 87 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~---------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (321)
....++|++.+.||+|+||+||+|.+..+++.||+|+++.. ....+.+|+.+++.+ +||||+++++++.+
T Consensus 7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 85 (326)
T 2y0a_A 7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYEN 85 (326)
T ss_dssp SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC
T ss_pred CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEe
Confidence 44567899999999999999999999999999999998643 246689999999999 89999999999965
Q ss_pred cCCCCcEEEEEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCC---eEEEeecc
Q 020826 88 QQSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR---KLRLIDWG 161 (321)
Q Consensus 88 ~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~---~v~l~dfg 161 (321)
....++||||+.+++|.+++. .+++..++.++.|++.||.|||++|++|+||||+||+++.++. .++|+|||
T Consensus 86 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg 163 (326)
T 2y0a_A 86 --KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFG 163 (326)
T ss_dssp --SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred --CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence 456789999999999988774 4899999999999999999999999999999999999986652 69999999
Q ss_pred ceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHH
Q 020826 162 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY 241 (321)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (321)
++.............+|+.|+|||++.+ ..++.++|||||||++|+|++|..||. +....+.+..+........
T Consensus 164 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~~~~~~~~~~---- 237 (326)
T 2y0a_A 164 LAHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAVNYEFE---- 237 (326)
T ss_dssp TCEECCTTSCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSC-CSSHHHHHHHHHHTCCCCC----
T ss_pred CCeECCCCCccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCC-CCCHHHHHHHHHhcCCCcC----
Confidence 9988765555566789999999999977 688999999999999999999999984 3333333333222110000
Q ss_pred hhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCC
Q 020826 242 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~ 313 (321)
......+|+.+.+||++||+.||++|||++|+++||||++...
T Consensus 238 -----------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 280 (326)
T 2y0a_A 238 -----------------------------DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 280 (326)
T ss_dssp -----------------------------HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSH
T ss_pred -----------------------------ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcc
Confidence 0011235678999999999999999999999999999997643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=342.89 Aligned_cols=285 Identities=30% Similarity=0.486 Sum_probs=213.2
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
.++|++.+.||+|+||+||+|.+..+++.||+|++.... ...+.+|+.+++.+ +||||+++++++.+ ....+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~ 78 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL-KHPNLVNLLEVFRR--KRRLH 78 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--TTEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhC-CCCCccchhheeec--CCeEE
Confidence 368999999999999999999999999999999886432 35577899999999 89999999999965 45567
Q ss_pred EEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC-C
Q 020826 95 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K 170 (321)
Q Consensus 95 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~-~ 170 (321)
+||||+.++++..+. ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++...... .
T Consensus 79 lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~ 157 (311)
T 4agu_A 79 LVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHS-VIKLCDFGFARLLTGPSD 157 (311)
T ss_dssp EEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECC----
T ss_pred EEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCC-CEEEeeCCCchhccCccc
Confidence 999999999987765 4599999999999999999999999999999999999999888 8999999999876532 2
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
......++..|+|||++.+...++.++||||||+++|+|++|..|| .+....+....+.+.++........... ..
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 233 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLW-PGKSDVDQLYLIRKTLGDLIPRHQQVFS---TN 233 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCHHHHHHHH---TC
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhcccccccccccc---cc
Confidence 3345678999999999987567899999999999999999999888 4555556666665555543221111000 00
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
.... ......+............+++++.+||++||+.||++|||++|+++||||+++....
T Consensus 234 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 234 QYFS---GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIE 295 (311)
T ss_dssp GGGT---TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC---
T ss_pred cccc---cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCHH
Confidence 0000 0000000000001111135778899999999999999999999999999999986654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=349.35 Aligned_cols=256 Identities=23% Similarity=0.389 Sum_probs=210.9
Q ss_pred eeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeecc
Q 020826 15 FINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 88 (321)
Q Consensus 15 ~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (321)
.+....++|++.+.||+|+||+||+|+++.+++.||+|+++.. ....+..|..++..+.+||||+++++++.+
T Consensus 11 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~- 89 (345)
T 1xjd_A 11 QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT- 89 (345)
T ss_dssp -----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-
T ss_pred cCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe-
Confidence 3455678999999999999999999999999999999999753 235577899999887689999999999965
Q ss_pred CCCCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 89 QSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 89 ~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
....++||||+.+++|..++ ..+++..++.++.||+.||+|||++|++||||||+||+++.++ .++|+|||+++.
T Consensus 90 -~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~vkL~DFG~a~~ 167 (345)
T 1xjd_A 90 -KENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-HIKIADFGMCKE 167 (345)
T ss_dssp -SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBC
T ss_pred -CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCC-CEEEeEChhhhh
Confidence 44678999999999998777 4699999999999999999999999999999999999999888 899999999975
Q ss_pred cCC-CCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhh
Q 020826 166 YHP-GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244 (321)
Q Consensus 166 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (321)
... ........||+.|+|||++.+ ..++.++|+|||||++|+|++|..||. +.+..+....+... .
T Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~-~~~~~~~~~~i~~~--~--------- 234 (345)
T 1xjd_A 168 NMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFH-GQDEEELFHSIRMD--N--------- 234 (345)
T ss_dssp CCCTTCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHC--C---------
T ss_pred cccCCCcccCCCCCcccCChhhhcC-CCCCChhhhHHHHHHHHHHhcCCCCCC-CCCHHHHHHHHHhC--C---------
Confidence 432 233456689999999999987 678999999999999999999999984 33322222222110 0
Q ss_pred hcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHH-HHhcCCCcccCC
Q 020826 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK-EAMAHPYFFPIR 312 (321)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~-ell~hp~~~~~~ 312 (321)
...+..+|+++.+||++||+.||++||++. ++++||||+.++
T Consensus 235 --------------------------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~ 277 (345)
T 1xjd_A 235 --------------------------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 277 (345)
T ss_dssp --------------------------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred --------------------------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCC
Confidence 001224678999999999999999999998 999999999874
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=353.99 Aligned_cols=263 Identities=22% Similarity=0.378 Sum_probs=200.9
Q ss_pred eeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc--hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 14 ~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
.-+....++|++.+.||+|+||+||++++..+++.||+|++.... ...+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 13 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~ 89 (361)
T 3uc3_A 13 MPIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSL-RHPNIVRFKEVILT--PT 89 (361)
T ss_dssp CCCCCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SS
T ss_pred ccCCCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhC-CCCCCCcEEEEEee--CC
Confidence 345566789999999999999999999999999999999987543 46788999999999 89999999999965 44
Q ss_pred CcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCC-eEEEeeccceeecC
Q 020826 92 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYH 167 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~-~v~l~dfg~~~~~~ 167 (321)
..++||||+.+++|..++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.++. .+||+|||++....
T Consensus 90 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~ 169 (361)
T 3uc3_A 90 HLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169 (361)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred EEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence 578999999999987776 56999999999999999999999999999999999999986652 49999999987554
Q ss_pred CCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 168 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
.........+|+.|+|||++.+....+.++|||||||++|+|++|+.||............+.......
T Consensus 170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~----------- 238 (361)
T 3uc3_A 170 LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK----------- 238 (361)
T ss_dssp -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTC-----------
T ss_pred ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCC-----------
Confidence 444445667999999999998733334559999999999999999999953322211111111111100
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
. .......+|+++.+||++||+.||++|||++|+++||||.+.
T Consensus 239 -------------~--------~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 239 -------------Y--------SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp -------------C--------CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred -------------C--------CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 0 011112467899999999999999999999999999999654
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-50 Score=341.61 Aligned_cols=253 Identities=25% Similarity=0.472 Sum_probs=204.8
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----------------------------hHHHHHHHHHHH
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------------------------KKKIKREIKILQ 70 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----------------------------~~~~~~E~~~l~ 70 (321)
.++|++.+.||+|+||+||+|++..+++.||+|+++... ...+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 468999999999999999999999999999999986432 245789999999
Q ss_pred hhcCCCCeeeeeeeeeccCCCCcEEEEEeecCchhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEE
Q 020826 71 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 148 (321)
Q Consensus 71 ~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili 148 (321)
.+ +||||+++++++.+......++||||+.+++|..+.. .+++..++.++.|++.||+|||++|++|+||||+||++
T Consensus 92 ~l-~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 170 (298)
T 2zv2_A 92 KL-DHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV 170 (298)
T ss_dssp TC-CCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred hC-CCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 99 8999999999998766677899999999999887763 58999999999999999999999999999999999999
Q ss_pred cCCCCeEEEeeccceeecCCCC-ccccccCCccccccccccCCCC--CCCcchHHHHHHHHHHHHhCCCCCccCCCChHH
Q 020826 149 DHEQRKLRLIDWGLAEFYHPGK-EYNVRVASRYFKGPELLVDLQD--YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 225 (321)
Q Consensus 149 ~~~~~~v~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~--~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~ 225 (321)
+.++ .++|+|||++....... ......+|+.|+|||++.+... .+.++|||||||++|+|++|..||.. ......
T Consensus 171 ~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~-~~~~~~ 248 (298)
T 2zv2_A 171 GEDG-HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIMCL 248 (298)
T ss_dssp CTTS-CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHH
T ss_pred CCCC-CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCC-ccHHHH
Confidence 9888 89999999998765332 2345678999999999976332 47789999999999999999999842 211111
Q ss_pred HHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 226 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
...+.. ... .......+++++.++|.+||+.||++|||++|+++|
T Consensus 249 ~~~~~~---------------------------~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h 293 (298)
T 2zv2_A 249 HSKIKS---------------------------QAL--------EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH 293 (298)
T ss_dssp HHHHHH---------------------------CCC--------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred HHHHhc---------------------------ccC--------CCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence 111100 000 001122467899999999999999999999999999
Q ss_pred CCccc
Q 020826 306 PYFFP 310 (321)
Q Consensus 306 p~~~~ 310 (321)
|||++
T Consensus 294 p~~~~ 298 (298)
T 2zv2_A 294 PWVTR 298 (298)
T ss_dssp HHHHC
T ss_pred ccccC
Confidence 99964
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=349.67 Aligned_cols=282 Identities=27% Similarity=0.548 Sum_probs=213.5
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchH----HHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK----KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~----~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
++|++.+.||+|+||+||+|++..+++.||+|+++..... .+.+|+.+++.+ +||||+++++++.+ ....++|
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv 78 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL-KHANIVTLHDIIHT--EKSLTLV 78 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCC-CCTTBCCEEEEEEC--SSCEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhc-CCCCCCeeeeEEee--CCEEEEE
Confidence 5899999999999999999999989999999998754322 345799999999 89999999999965 4556799
Q ss_pred EEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC-Ccc
Q 020826 97 FEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEY 172 (321)
Q Consensus 97 ~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~-~~~ 172 (321)
|||+.++....+. ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++...... ...
T Consensus 79 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~~~ 157 (324)
T 3mtl_A 79 FEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERG-ELKLADFGLARAKSIPTKTY 157 (324)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTC-CEEECSSSEEECC-------
T ss_pred ecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCC-CEEEccCcccccccCCcccc
Confidence 9999964433322 3489999999999999999999999999999999999999888 8999999999765422 233
Q ss_pred ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChh
Q 020826 173 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 252 (321)
Q Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (321)
....+|..|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+.+..+...++.+....+..... ...
T Consensus 158 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~---~~~ 233 (324)
T 3mtl_A 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF-PGSTVEEQLHFIFRILGTPTEETWPGILS---NEE 233 (324)
T ss_dssp -----CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTTSTTGGG---CHH
T ss_pred ccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCChHhchhhhc---chh
Confidence 44578999999999987567899999999999999999999888 56666677777777777654433221110 000
Q ss_pred hHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 253 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
+... ................+++++.+||++||+.||++|||++|+++||||+++.+.
T Consensus 234 ~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 234 FKTY----NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp HHHT----CCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred hccc----ccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 0000 000111111122234577899999999999999999999999999999988654
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=360.36 Aligned_cols=286 Identities=30% Similarity=0.555 Sum_probs=204.6
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccC---CC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---SK 91 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~---~~ 91 (321)
.++|++.+.||+|+||+||+|++..+++.||||++... ..+.+.+|+.+++.+ +||||+++++++.... ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL-NHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhC-CCCCCCceEEEEecCCcccCc
Confidence 47899999999999999999999999999999998642 235688999999999 8999999999985432 24
Q ss_pred CcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 92 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
..++|||++++ +|..++ ..+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||++.....
T Consensus 131 ~~~lv~e~~~~-~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~-~~kl~DFGla~~~~~ 208 (458)
T 3rp9_A 131 ELYVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC-SVKVCDFGLARTVDY 208 (458)
T ss_dssp CEEEEECCCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC-CEEECCCTTCBCTTS
T ss_pred eEEEEEecccc-chhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCC-CEeecccccchhccC
Confidence 67899999875 444444 3489999999999999999999999999999999999999888 899999999976532
Q ss_pred CC----------------------------ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhC--------
Q 020826 169 GK----------------------------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFR-------- 212 (321)
Q Consensus 169 ~~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g-------- 212 (321)
.. .....++|+.|+|||++.....++.++|||||||++|+|++|
T Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~ 288 (458)
T 3rp9_A 209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288 (458)
T ss_dssp CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSG
T ss_pred ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcccccccc
Confidence 21 123456799999999876547799999999999999999984
Q ss_pred --CCCCccCCC--------------------ChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccc
Q 020826 213 --KEPFFYGHD--------------------NYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFIT 270 (321)
Q Consensus 213 --~~p~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
+.|++++.+ ...++..+...++.+........ ...................+
T Consensus 289 ~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~~-- 362 (458)
T 3rp9_A 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEAL----EKEDAKRYIRIFPKREGTDL-- 362 (458)
T ss_dssp GGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTS----SCHHHHHHHTTSCCCCCCCG--
T ss_pred ccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhc----CCHHHHHHHHhcCCCCCCCH--
Confidence 334444433 24566666777776554332211 11111111111111111111
Q ss_pred cccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 271 VENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 271 ~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
.......++++.+||++||+.||++|||++|+|+||||+++..+
T Consensus 363 ~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~ 406 (458)
T 3rp9_A 363 AERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA 406 (458)
T ss_dssp GGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCG
T ss_pred HHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCC
Confidence 11223467899999999999999999999999999999998554
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=348.90 Aligned_cols=251 Identities=22% Similarity=0.413 Sum_probs=206.8
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
...++|++.+.||+|+||+||+|.+..+++.||+|++... ....+.+|+.+++.+ +||||+++++++.+. .
T Consensus 6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~--~ 82 (336)
T 3h4j_B 6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-RHPHIIKLYDVITTP--T 82 (336)
T ss_dssp SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTC-CCTTBCCEEEEEECS--S
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhC-CCCCCCeEEEEEEeC--C
Confidence 4457899999999999999999999999999999998643 235688999999999 899999999999654 4
Q ss_pred CcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 92 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
..++||||+++ ++.+++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .+||+|||++.....
T Consensus 83 ~~~lv~E~~~g-~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kl~DFG~s~~~~~ 160 (336)
T 3h4j_B 83 DIVMVIEYAGG-ELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNL-NVKIADFGLSNIMTD 160 (336)
T ss_dssp EEEEEECCCCE-EHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTC-CEEECCSSCTBTTTT
T ss_pred EEEEEEECCCC-cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCC-CEEEEEeccceeccC
Confidence 56799999954 444443 5699999999999999999999999999999999999999888 899999999987665
Q ss_pred CCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 169 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
........||+.|+|||++.+....++++|||||||++|+|++|..||...... .
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~-----------------~-------- 215 (336)
T 3h4j_B 161 GNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP-----------------N-------- 215 (336)
T ss_dssp SBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST-----------------T--------
T ss_pred CcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH-----------------H--------
Confidence 555667789999999999987444578999999999999999999999422110 0
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
...... ......+..+|+++.+||++||+.||++|||++|+++||||+..
T Consensus 216 -------~~~~i~------~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 216 -------LFKKVN------SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp -------CBCCCC------SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred -------HHHHHH------cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 000000 00111234577899999999999999999999999999999864
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=342.82 Aligned_cols=248 Identities=21% Similarity=0.433 Sum_probs=209.1
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
.++|++.+.||+|+||+||+|++..+++.||+|+++.. ....+.+|..++..+ +||||+++++++.+ ....
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~Iv~~~~~~~~--~~~~ 81 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQD--AQQI 81 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEEC--SSEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhC-CCCCCceEeEEEEe--CCEE
Confidence 57899999999999999999999999999999998753 235577899999998 99999999999965 4567
Q ss_pred EEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 94 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
++||||+.+++|..++ ..+++..++.++.||+.||+|||++|++|+||||+||+++.++ .+||+|||++.....
T Consensus 82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~Dfg~a~~~~~-- 158 (318)
T 1fot_A 82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG-HIKITDFGFAKYVPD-- 158 (318)
T ss_dssp EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS-CEEECCCSSCEECSS--
T ss_pred EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCC-CEEEeecCcceecCC--
Confidence 8999999999998777 4589999999999999999999999999999999999999888 899999999986542
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
......||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.. .+.......+... .
T Consensus 159 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~-~~~~~~~~~i~~~--~--------------- 219 (318)
T 1fot_A 159 VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYD-SNTMKTYEKILNA--E--------------- 219 (318)
T ss_dssp CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHC--C---------------
T ss_pred ccccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCC-CCHHHHHHHHHhC--C---------------
Confidence 2345679999999999987 7889999999999999999999999942 2222222222210 0
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc-----CHHHHhcCCCcccCC
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIR 312 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp-----s~~ell~hp~~~~~~ 312 (321)
...+..+++++.++|++||+.||++|| +++++++||||++++
T Consensus 220 --------------------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~ 266 (318)
T 1fot_A 220 --------------------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266 (318)
T ss_dssp --------------------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred --------------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence 011224668999999999999999999 999999999999764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-50 Score=354.84 Aligned_cols=285 Identities=30% Similarity=0.522 Sum_probs=222.3
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeeeecc--------
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ-------- 88 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-------- 88 (321)
....++|++.+.||+|+||+||+|.+..+++.||+|++..+ .....+|+.+++.+ +||||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~-~~~~~~E~~il~~l-~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-PRYKNRELDIMKVL-DHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECC-TTSCCHHHHHHTTC-CCTTBCCEEEEEEEC--------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecC-cchHHHHHHHHHHc-CCCCccchhheeeecCccccccc
Confidence 45678999999999999999999999999999999998643 23345899999999 999999999988542
Q ss_pred ----------------------------CCCCcEEEEEeecCch---hhhhc---CCCCHHHHHHHHHHHHHHHHHHHHC
Q 020826 89 ----------------------------QSKTPSLIFEHVNNTD---FKVLY---PTLSDYDVRYYIYELLKALDYCHSQ 134 (321)
Q Consensus 89 ----------------------------~~~~~~lv~e~~~~~~---l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~ 134 (321)
...+.++||||++++. +..+. ..+++..++.++.||+.||+|||++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 160 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL 160 (383)
T ss_dssp -----------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 2345789999999642 22222 4699999999999999999999999
Q ss_pred CCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCC
Q 020826 135 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKE 214 (321)
Q Consensus 135 ~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~ 214 (321)
|++|+||||+||+++..+..+||+|||++.............+|+.|+|||++.+...++.++||||+||++|+|++|..
T Consensus 161 gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 240 (383)
T 3eb0_A 161 GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240 (383)
T ss_dssp TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCC
Confidence 99999999999999854338999999999887666666667889999999998875668999999999999999999998
Q ss_pred CCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCC
Q 020826 215 PFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQ 294 (321)
Q Consensus 215 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~ 294 (321)
|| .+.+..+++..+.+.++.+.......... .+.... .. ...........+..+|+++.+||.+||+.||+
T Consensus 241 pf-~~~~~~~~~~~i~~~~g~p~~~~~~~~~~-----~~~~~~--~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 311 (383)
T 3eb0_A 241 LF-SGETSIDQLVRIIQIMGTPTKEQMIRMNP-----HYTEVR--FP-TLKAKDWRKILPEGTPSLAIDLLEQILRYEPD 311 (383)
T ss_dssp SS-CCSSHHHHHHHHHHHHCCCCHHHHHHHCT-----TC--CC--CC-CCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred CC-CCCChHHHHHHHHHHhCCCCHHHHHHhCc-----cccccc--CC-ccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence 88 56777788888888888776554433211 000000 00 00001111222345778899999999999999
Q ss_pred CCcCHHHHhcCCCcccCC
Q 020826 295 ERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 295 ~Rps~~ell~hp~~~~~~ 312 (321)
+|||+.|+++||||+.+.
T Consensus 312 ~R~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 312 LRINPYEAMAHPFFDHLR 329 (383)
T ss_dssp GSCCHHHHHTSGGGHHHH
T ss_pred hCCCHHHHhcCHHHHHHH
Confidence 999999999999998753
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=349.73 Aligned_cols=253 Identities=22% Similarity=0.438 Sum_probs=211.9
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
.++|++.+.||+|+||+||+|.+..+++.||+|+++.. ....+.+|+.+++.+ +||||+++++++.+. ...
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~~--~~~ 90 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGL-EHPFLVNLWYSFQDE--EDM 90 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECS--SEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeC--CEE
Confidence 57999999999999999999999999999999998643 235678999999999 999999999999654 456
Q ss_pred EEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 94 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
++|+||+.+++|..++ ..+++..++.++.||+.||+|||++||+|+||||+||+++.++ .++|+|||++.......
T Consensus 91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~ 169 (384)
T 4fr4_A 91 FMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHG-HVHITDFNIAAMLPRET 169 (384)
T ss_dssp EEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCTTC
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCC-CEEEeccceeeeccCCC
Confidence 7999999999998777 3589999999999999999999999999999999999999888 89999999998876666
Q ss_pred ccccccCCccccccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCccCCCCh-HHHHHHHHHhCChhhhHHhhhhcc
Q 020826 171 EYNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY-DQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
......||+.|+|||++.+. ..++.++|+|||||++|+|++|..||....... ..........
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-------------- 235 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT-------------- 235 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC--------------
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc--------------
Confidence 66778899999999998642 458899999999999999999999995332221 1111110000
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC-HHHHhcCCCcccCC
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-AKEAMAHPYFFPIR 312 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps-~~ell~hp~~~~~~ 312 (321)
....+..+|+++.+||++||+.||++||+ ++++++||||++++
T Consensus 236 ----------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~ 279 (384)
T 4fr4_A 236 ----------------------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279 (384)
T ss_dssp ----------------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCC
T ss_pred ----------------------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCC
Confidence 01112346789999999999999999998 99999999999864
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=349.92 Aligned_cols=284 Identities=31% Similarity=0.540 Sum_probs=217.2
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC---
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS--- 90 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~--- 90 (321)
..++|++.+.||+|+||+||+|.+..+++.||+|.+... ....+.+|+.+++.+ +||||+++++++.....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 23 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTTT
T ss_pred ecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCcCCCCceeeEecCCcccc
Confidence 357899999999999999999999999999999998542 235678999999999 89999999999865432
Q ss_pred -CCcEEEEEeecCchhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 91 -KTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 91 -~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
...++|||++ +++|..++ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .+||+|||++....
T Consensus 102 ~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 102 FTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQAD 179 (367)
T ss_dssp CCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECC
T ss_pred CceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCC-CEEEEeeecccccc
Confidence 3468999999 67777666 5699999999999999999999999999999999999999888 89999999998754
Q ss_pred CCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 168 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
. ......+|+.|+|||++.+...++.++|||||||++++|++|+.|| .+.+...++..+.+..+.+....... .
T Consensus 180 ~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~l~~i~~~~g~~~~~~~~~-~-- 253 (367)
T 1cm8_A 180 S--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF-KGSDHLDQLKEIMKVTGTPPAEFVQR-L-- 253 (367)
T ss_dssp S--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHT-C--
T ss_pred c--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCCHHHHHH-h--
Confidence 2 2345678999999999987567999999999999999999999888 56666778888888777654332211 0
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
...................+. ......++++.+||.+||+.||++|||++|+|+||||+....+
T Consensus 254 -~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~ 317 (367)
T 1cm8_A 254 -QSDEAKNYMKGLPELEKKDFA--SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 317 (367)
T ss_dssp -SCHHHHHHHHHSCCCCCCCGG--GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred -hhHHHHHHHHhCCCCCCCCHH--HHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence 011111111111111111111 1123567899999999999999999999999999999987544
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-50 Score=357.15 Aligned_cols=285 Identities=32% Similarity=0.535 Sum_probs=222.8
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeeeecc----CCCCcE
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----QSKTPS 94 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~----~~~~~~ 94 (321)
...+|++.+.||+|+||+||+|++..+++.||||.+... .....+|+++++.+ +||||+++++++... ...+++
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~E~~il~~l-~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-KRFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC-TTSCCHHHHHHHTC-CCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc-chhHHHHHHHHHHc-CCCCccceeeEEeccCCCCcceeEE
Confidence 345799999999999999999999989999999998653 23345799999999 899999999988532 233567
Q ss_pred EEEEeecCchhhhh------cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 95 LIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 95 lv~e~~~~~~l~~~------~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
+|+||+.++.+... ...+++..++.++.||+.||+|||++||+||||||+||+++.++..+||+|||+++....
T Consensus 130 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~ 209 (420)
T 1j1b_A 130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR 209 (420)
T ss_dssp EEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhccc
Confidence 99999998644322 246999999999999999999999999999999999999997655899999999987655
Q ss_pred CCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 169 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
........+|+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+++..+.+.++.+....+.......
T Consensus 210 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf-~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~ 288 (420)
T 1j1b_A 210 GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF-PGDSGVDQLVEIIKVLGTPTREQIREMNPNY 288 (420)
T ss_dssp TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCSCCHHHHHHHCSCC
T ss_pred CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence 555556678999999999977557999999999999999999999888 5666677888888888876554433211000
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
....+ ......++ .......+++++.+||++||+.||++|||+.|+++||||+.+..+
T Consensus 289 ~~~~~----p~~~~~~~----~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 346 (420)
T 1j1b_A 289 TEFKF----PQIKAHPW----TKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 346 (420)
T ss_dssp CCCCC----CCCCCCCH----HHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred hhhcc----CccCCCCH----HHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccc
Confidence 00000 00000000 011123467899999999999999999999999999999887543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=346.71 Aligned_cols=252 Identities=23% Similarity=0.354 Sum_probs=209.8
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
..++|++.+.||+|+||+||+|+++.+++.||+|+++.. ....+..|..++..+.+||+|+++++++.+ ...
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~ 95 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDR 95 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC--SSE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc--CCE
Confidence 457999999999999999999999889999999998753 235577899999887789999999999965 456
Q ss_pred cEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC-C
Q 020826 93 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-P 168 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~-~ 168 (321)
.++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+||+++.++ .++|+|||++.... .
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCT
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCC-cEEEEeCCcccccccC
Confidence 78999999999998776 4699999999999999999999999999999999999999888 89999999997543 2
Q ss_pred CCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 169 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
.......+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||. +.+..+....+... .
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~-~~~~~~~~~~i~~~--~------------- 237 (353)
T 2i0e_A 175 GVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFE-GEDEDELFQSIMEH--N------------- 237 (353)
T ss_dssp TCCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHC--C-------------
T ss_pred CcccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCC-CCCHHHHHHHHHhC--C-------------
Confidence 333455689999999999987 778999999999999999999999984 33332333322210 0
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc-----CHHHHhcCCCcccCC
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIR 312 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp-----s~~ell~hp~~~~~~ 312 (321)
...+..+|+++.+||++||+.||++|| +++++++||||+.++
T Consensus 238 ----------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~ 284 (353)
T 2i0e_A 238 ----------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 284 (353)
T ss_dssp ----------------------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence 011224678999999999999999999 579999999999764
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=350.83 Aligned_cols=288 Identities=30% Similarity=0.519 Sum_probs=224.5
Q ss_pred eeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeeeeccC----C
Q 020826 15 FINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----S 90 (321)
Q Consensus 15 ~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~----~ 90 (321)
.......+|++.+.||+|+||+||+|++..+++ +|+|.+... .....+|+.+++.+ +||||+++++++.... .
T Consensus 34 ~~~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~-~~~~~~E~~il~~l-~h~niv~l~~~~~~~~~~~~~ 110 (394)
T 4e7w_A 34 TGEQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQD-KRFKNRELQIMRIV-KHPNVVDLKAFFYSNGDKKDE 110 (394)
T ss_dssp SCCEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECC-TTSCCHHHHHHHTC-CCTTBCCEEEEEEEESSSSSC
T ss_pred CCCcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecC-cchHHHHHHHHHhC-CCCCcceEEEEEEecCCCCCc
Confidence 344456789999999999999999999966665 777776432 23345799999999 8999999999986433 2
Q ss_pred CCcEEEEEeecCchhhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEc-CCCCeEEEeeccce
Q 020826 91 KTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID-HEQRKLRLIDWGLA 163 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~-~~~~~v~l~dfg~~ 163 (321)
.+.++||||+.++.+.... ..+++..++.++.||+.||+|||++|++||||||+||+++ .++ .+||+|||++
T Consensus 111 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~-~~kL~DFG~a 189 (394)
T 4e7w_A 111 VFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG-VLKLIDFGSA 189 (394)
T ss_dssp EEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTT-EEEECCCTTC
T ss_pred eEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCC-cEEEeeCCCc
Confidence 3477999999988654433 5699999999999999999999999999999999999999 455 8999999999
Q ss_pred eecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 164 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
.............+|+.|+|||++.+...++.++|||||||++|+|++|+.|| .+.+..+++..+.+.++.+.......
T Consensus 190 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~l~~i~~~~g~p~~~~~~~ 268 (394)
T 4e7w_A 190 KILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF-PGESGIDQLVEIIKVLGTPSREQIKT 268 (394)
T ss_dssp EECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence 88765655566788999999999977567999999999999999999999888 56677788888888888776554332
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
... .+.. ...... ............+++++.+||.+||+.||++|||+.|+++||||+++....
T Consensus 269 ~~~-----~~~~--~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~ 332 (394)
T 4e7w_A 269 MNP-----NYME--HKFPQI-RPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGE 332 (394)
T ss_dssp HCG-----GGSS--SCCCCC-CCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSSC
T ss_pred hCh-----hhhh--hccccc-cCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcccc
Confidence 211 0000 000000 011111112334778999999999999999999999999999999875543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=350.89 Aligned_cols=259 Identities=24% Similarity=0.440 Sum_probs=213.4
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc---chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
....++|++.+.||+|+||+||+|.+..+++.+|+|++... ....+.+|+.+++.+ +||||+++++++.+ ....
T Consensus 47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~--~~~~ 123 (387)
T 1kob_A 47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFED--KYEM 123 (387)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEEC--SSEE
T ss_pred CccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhC-CCcCCCeEEEEEEe--CCEE
Confidence 34457899999999999999999999999999999998754 345688999999999 89999999999965 4567
Q ss_pred EEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCC-CCeEEEeeccceeecCC
Q 020826 94 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~-~~~v~l~dfg~~~~~~~ 168 (321)
++||||+.+++|.+++. .+++..++.++.||+.||+|||++|++|+||||+||+++.+ ...++|+|||++.....
T Consensus 124 ~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~ 203 (387)
T 1kob_A 124 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203 (387)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred EEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence 89999999999988773 48999999999999999999999999999999999999743 23799999999988765
Q ss_pred CCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 169 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
........+|+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+....+..+......
T Consensus 204 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~-~~~~~~~~~~i~~~~~~------------- 268 (387)
T 1kob_A 204 DEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFA-GEDDLETLQNVKRCDWE------------- 268 (387)
T ss_dssp TSCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSC-CSSHHHHHHHHHHCCCC-------------
T ss_pred CcceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCCC-------------
Confidence 555566689999999999987 778999999999999999999999984 33332333222110000
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCC
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~ 313 (321)
. .......+|+++.+||++||+.||++|||++|+++||||+....
T Consensus 269 --------------~------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 269 --------------F------DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp --------------C------CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred --------------C------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 0 00111246789999999999999999999999999999997543
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=349.42 Aligned_cols=255 Identities=27% Similarity=0.463 Sum_probs=209.6
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
..++|++.+.||+|+||+||+|.+..+++.||+|+++.. ....+.+|+.+++.+ +||||+++++++.+ ....
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~--~~~~ 103 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQE--ESFH 103 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEe--CCEE
Confidence 457899999999999999999999999999999998643 235688999999999 89999999999965 4566
Q ss_pred EEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCC--CeEEEeeccceeecCC
Q 020826 94 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEFYHP 168 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~--~~v~l~dfg~~~~~~~ 168 (321)
++||||+.+++|.+.+ ..+++..+..++.||+.||+|||++|++|+||||+||+++.++ ..+||+|||++.....
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 104 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp EEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 7999999999987666 3489999999999999999999999999999999999998643 2699999999987665
Q ss_pred CCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 169 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
........+|+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+.......+.......
T Consensus 184 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~-~~~~~~~~~~i~~~~~~~------------ 249 (362)
T 2bdw_A 184 SEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFW-DEDQHRLYAQIKAGAYDY------------ 249 (362)
T ss_dssp CCSCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCCCC------------
T ss_pred CcccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhCCCCC------------
Confidence 555556789999999999987 688999999999999999999999984 333222222222110000
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
+. .....+++++.+||.+||+.||++|||++++++||||+..
T Consensus 250 ---------------~~------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 250 ---------------PS------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp ---------------CT------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred ---------------Cc------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 00 0012367899999999999999999999999999999753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=343.85 Aligned_cols=261 Identities=24% Similarity=0.423 Sum_probs=208.5
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
..++|++.+.||+|+||+||+|+++.+++.||+|+++... ...+.+|..++..+.+||||+++++++.+ ...
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~--~~~ 84 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT--ESR 84 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe--CCE
Confidence 3578999999999999999999999999999999997532 24577899999988789999999999965 456
Q ss_pred cEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC-C
Q 020826 93 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-P 168 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~-~ 168 (321)
.++||||+.+++|..++ ..+++..++.++.||+.||+|||++|++||||||+||+++.++ .+||+|||++.... .
T Consensus 85 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~DFG~a~~~~~~ 163 (345)
T 3a8x_A 85 LFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRP 163 (345)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCGGGCBCSCCT
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC-CEEEEeccccccccCC
Confidence 78999999999987776 4699999999999999999999999999999999999999888 89999999997533 2
Q ss_pred CCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 169 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
........||+.|+|||++.+ ..++.++|+|||||++|+|++|..||............ . ..
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~------~---~~-------- 225 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN------T---ED-------- 225 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------------C---HH--------
T ss_pred CCcccccCCCccccCccccCC-CCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccc------c---HH--------
Confidence 334456689999999999987 68899999999999999999999999432111000000 0 00
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCH------HHHhcCCCcccCC
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA------KEAMAHPYFFPIR 312 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~------~ell~hp~~~~~~ 312 (321)
.......... ...+..+|+++.+||++||+.||++||++ +++++||||++++
T Consensus 226 --~~~~~i~~~~----------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~ 283 (345)
T 3a8x_A 226 --YLFQVILEKQ----------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD 283 (345)
T ss_dssp --HHHHHHHHCC----------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCC
T ss_pred --HHHHHHHcCC----------CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCC
Confidence 0000000000 11123467899999999999999999995 8999999999764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-49 Score=335.21 Aligned_cols=262 Identities=27% Similarity=0.466 Sum_probs=214.8
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
...++|++.+.||+|+||+||+|.+..+++.|++|++.... ...+.+|+.+++++ +||||+++++++.+ ...
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~ 79 (284)
T 3kk8_A 3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL-QHPNIVRLHDSIQE--ESF 79 (284)
T ss_dssp TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SSE
T ss_pred hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHc-CCCCcCeEEEEEEc--CCE
Confidence 45789999999999999999999999999999999986432 35678999999999 89999999999854 455
Q ss_pred cEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCC--CeEEEeeccceeecC
Q 020826 93 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEFYH 167 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~--~~v~l~dfg~~~~~~ 167 (321)
.++++|++.+++|...+ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ ..++|+|||++....
T Consensus 80 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 159 (284)
T 3kk8_A 80 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN 159 (284)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcc
Confidence 67999999999886655 4599999999999999999999999999999999999998654 249999999998776
Q ss_pred CCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 168 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
.........+++.|+|||++.+ ..++.++||||||+++|+|++|..||. +.........+.......
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~-~~~~~~~~~~~~~~~~~~----------- 226 (284)
T 3kk8_A 160 DSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFW-DEDQHRLYAQIKAGAYDY----------- 226 (284)
T ss_dssp SSCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCCCC-----------
T ss_pred cCccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCC-CCchhHHHHHHHhccccC-----------
Confidence 5555566789999999999987 678999999999999999999999984 222222222221110000
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcccc
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESS 317 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~~~ 317 (321)
+ ......+++++.++|.+||+.||++|||++|+++||||++.....+.
T Consensus 227 ----------------~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~~~ 274 (284)
T 3kk8_A 227 ----------------P------SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASA 274 (284)
T ss_dssp ----------------C------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGGGS
T ss_pred ----------------C------chhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHHhH
Confidence 0 00112466899999999999999999999999999999988766553
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=347.27 Aligned_cols=254 Identities=26% Similarity=0.407 Sum_probs=207.1
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc--------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
..++|++.+.||+|+||+||+|.+..+++.||+|+++.. ....+.+|+.+++.+ +||||+++++++.+ .
T Consensus 22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--~ 98 (351)
T 3c0i_A 22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML-KHPHIVELLETYSS--D 98 (351)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--T
T ss_pred cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--C
Confidence 357899999999999999999999999999999998632 246789999999999 89999999999965 4
Q ss_pred CCcEEEEEeecCchhhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCC--CeEEEeecc
Q 020826 91 KTPSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWG 161 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~--~~v~l~dfg 161 (321)
...++||||+.+++|...+ ..+++..++.++.||+.||+|||++|++|+||||+||+++.++ ..++|+|||
T Consensus 99 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg 178 (351)
T 3c0i_A 99 GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFG 178 (351)
T ss_dssp TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCT
T ss_pred CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCc
Confidence 5678999999999886554 1389999999999999999999999999999999999998654 249999999
Q ss_pred ceeecCCCCc-cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhH
Q 020826 162 LAEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 240 (321)
Q Consensus 162 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (321)
++........ .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||... .......+........
T Consensus 179 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~~i~~~~~~~~--- 252 (351)
T 3c0i_A 179 VAIQLGESGLVAGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGT--KERLFEGIIKGKYKMN--- 252 (351)
T ss_dssp TCEECCTTSCBCCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCSS--HHHHHHHHHHTCCCCC---
T ss_pred ceeEecCCCeeecCCcCCcCccCHHHHcC-CCCCchHhhHHHHHHHHHHHHCCCCCCCc--HHHHHHHHHcCCCCCC---
Confidence 9987654332 345679999999999987 67899999999999999999999999432 2222222211000000
Q ss_pred HhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 241 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
......+|+++.+||++||+.||++|||+.|+++||||+..
T Consensus 253 ------------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 253 ------------------------------PRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp ------------------------------HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred ------------------------------ccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 00012467899999999999999999999999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=355.98 Aligned_cols=257 Identities=26% Similarity=0.438 Sum_probs=208.3
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
....++|++.+.||+|+||+||+|.+..+++.+|+|++.... ...+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~--~~ 83 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL-KHPNIVRLHDSISE--EG 83 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHC-CBTTBCCEEEEEEC--SS
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCcCCCeEEEEEEE--CC
Confidence 455789999999999999999999999999999999986432 35688999999999 99999999999954 45
Q ss_pred CcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCC--CCeEEEeeccceeec
Q 020826 92 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAEFY 166 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~--~~~v~l~dfg~~~~~ 166 (321)
..++||||+.+++|.+.+ ..+++..+..++.||+.||+|||++||+|+||||+||+++.+ +..+||+|||++...
T Consensus 84 ~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~ 163 (444)
T 3soa_A 84 HHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV 163 (444)
T ss_dssp EEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCC
T ss_pred EEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEe
Confidence 667999999999987666 569999999999999999999999999999999999999842 237999999999765
Q ss_pred CCCC-ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhh
Q 020826 167 HPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245 (321)
Q Consensus 167 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (321)
.... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+....+.......
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~-~~~~~~~~~~i~~~~~~~--------- 232 (444)
T 3soa_A 164 EGEQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFW-DEDQHRLYQQIKAGAYDF--------- 232 (444)
T ss_dssp CTTCCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHTCCCC---------
T ss_pred cCCCceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCC-CccHHHHHHHHHhCCCCC---------
Confidence 4332 2345679999999999987 688999999999999999999999984 333333333322211000
Q ss_pred cccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
+ ......+|+++.+||.+||+.||++|||++|+|+||||+..
T Consensus 233 ------------------~------~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 233 ------------------P------SPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp ------------------C------TTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred ------------------C------ccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 0 00112467899999999999999999999999999999754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=349.88 Aligned_cols=287 Identities=27% Similarity=0.472 Sum_probs=210.1
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC---
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS--- 90 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~--- 90 (321)
..++|++.+.||+|+||+||+|.+..+++.||+|++... ....+.+|+.+++.+ +||||+++++++.....
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhc-CCCCccceEEeecccccccc
Confidence 357999999999999999999999999999999998642 235678999999999 89999999999865432
Q ss_pred -CCcEEEEEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 91 -KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 91 -~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
...++|||++.++.+......+++..+..++.|++.||+|||++|++|+||||+||+++.++ .+||+|||++......
T Consensus 102 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~~~~~~ 180 (371)
T 2xrw_A 102 FQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTS 180 (371)
T ss_dssp CCEEEEEEECCSEEHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCCCC-------
T ss_pred ccceEEEEEcCCCCHHHHHhhccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC-CEEEEEeecccccccc
Confidence 35789999999876666667799999999999999999999999999999999999999888 8999999999876544
Q ss_pred CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 170 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|..|| .+.+....+..+.+.++.+..... . ..
T Consensus 181 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~-~----~~ 253 (371)
T 2xrw_A 181 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLF-PGTDHIDQWNKVIEQLGTPCPEFM-K----KL 253 (371)
T ss_dssp ---------CTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHC-CCCCCHHHH-T----TS
T ss_pred cccCCceecCCccCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHH-H----Hh
Confidence 44455678999999999987 67899999999999999999999998 455555666666655554432211 1 11
Q ss_pred ChhhHhhhcccCCCCCcccccc----------ccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 250 DPHLAALVGRHSRKPWSKFITV----------ENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
.+................+... ......++++.+||++||+.||++|||++|+++||||+....+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~ 328 (371)
T 2xrw_A 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDP 328 (371)
T ss_dssp CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCCH
T ss_pred hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcCc
Confidence 1111111111111110000000 0001125689999999999999999999999999999976443
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-49 Score=351.11 Aligned_cols=292 Identities=19% Similarity=0.225 Sum_probs=207.8
Q ss_pred ecccCceEEeeeeeee--cceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccC
Q 020826 17 NREQDDYEVVRKVGRG--KYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 89 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g--~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (321)
....++|++.+.||+| +||+||+|++..+++.||+|+++... ...+.+|+.+++.+ +||||+++++++.+.
T Consensus 21 ~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~- 98 (389)
T 3gni_B 21 LPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF-NHPNIVPYRATFIAD- 98 (389)
T ss_dssp CCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEET-
T ss_pred cCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhC-CCCCCCcEeEEEEEC-
Confidence 3457899999999999 99999999999999999999987432 35678899999999 899999999999654
Q ss_pred CCCcEEEEEeecCchhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecccee
Q 020826 90 SKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 164 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~ 164 (321)
...++||||+.+++|.+++ ..+++..++.++.||+.||+|||++||+|+||||+||+++.++ .++|+|||.+.
T Consensus 99 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~-~~kl~dfg~~~ 176 (389)
T 3gni_B 99 -NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG-KVYLSGLRSNL 176 (389)
T ss_dssp -TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCGGGCE
T ss_pred -CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEcccccce
Confidence 4678999999999988776 4589999999999999999999999999999999999999888 89999999875
Q ss_pred ecCCC--------CccccccCCccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCC
Q 020826 165 FYHPG--------KEYNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 235 (321)
Q Consensus 165 ~~~~~--------~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (321)
..... .......+|..|+|||++.+. ..++.++|||||||++|+|++|..||... +.......+......
T Consensus 177 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~-~~~~~~~~~~~~~~~ 255 (389)
T 3gni_B 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM-PATQMLLEKLNGTVP 255 (389)
T ss_dssp ECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTC-CSTTHHHHC------
T ss_pred eeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCC-CHHHHHHHHhcCCCC
Confidence 43211 112334788899999999763 46889999999999999999999998533 333332221110000
Q ss_pred h-----hhhH---HhhhhcccCChhhHhhhc-ccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCC
Q 020826 236 D-----ELNA---YLNKYHIELDPHLAALVG-RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 306 (321)
Q Consensus 236 ~-----~~~~---~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp 306 (321)
. .... .................. ..................+++++.+||++||+.||++|||++|+|+||
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp 335 (389)
T 3gni_B 256 CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 335 (389)
T ss_dssp --------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSG
T ss_pred ccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCH
Confidence 0 0000 000000000000000000 000001111111223345788999999999999999999999999999
Q ss_pred CcccCCC
Q 020826 307 YFFPIRN 313 (321)
Q Consensus 307 ~~~~~~~ 313 (321)
||+++..
T Consensus 336 ~f~~~~~ 342 (389)
T 3gni_B 336 FFKQIKR 342 (389)
T ss_dssp GGGGC--
T ss_pred HHHHHhh
Confidence 9998754
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=345.64 Aligned_cols=286 Identities=28% Similarity=0.525 Sum_probs=211.5
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
.....++|++.+.||+|+||+||+|++..+++.||+|+++... ...+.+|+.+++.+ +||||+++++++.+ .
T Consensus 29 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~ 105 (329)
T 3gbz_A 29 SATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL-QHRNIIELKSVIHH--N 105 (329)
T ss_dssp ---CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGC-CCTTBCCEEEEEEE--T
T ss_pred cccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHc-CCCCcceEEEEEec--C
Confidence 3455679999999999999999999999999999999986433 23467899999999 89999999999965 4
Q ss_pred CCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCC----CeEEEeeccce
Q 020826 91 KTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ----RKLRLIDWGLA 163 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~----~~v~l~dfg~~ 163 (321)
...++||||+.+ +|..++ ..+++..++.++.||+.||+|||++|++|+||||+||+++.++ ..++|+|||++
T Consensus 106 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a 184 (329)
T 3gbz_A 106 HRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA 184 (329)
T ss_dssp TEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred CEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence 567799999996 555554 4599999999999999999999999999999999999995332 26999999998
Q ss_pred eecCCC-CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHh
Q 020826 164 EFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242 (321)
Q Consensus 164 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (321)
...... .......+|..|+|||++.+...++.++|||||||++|+|++|..|| .+......+..+....+.+....+.
T Consensus 185 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (329)
T 3gbz_A 185 RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLF-PGDSEIDQLFKIFEVLGLPDDTTWP 263 (329)
T ss_dssp HHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred cccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCc-CCCCHHHHHHHHHHHhCCCchhhhh
Confidence 765422 23345577999999999987566899999999999999999999888 4555666667776666654433221
Q ss_pred hhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCC
Q 020826 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~ 313 (321)
....... +.... ...............+++++.+||++||+.||++|||++|+++||||++.+-
T Consensus 264 ~~~~~~~------~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 264 GVTALPD------WKQSF-PKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp TGGGSTT------CCTTC-CCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred hhhhhhh------hhhhh-hhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 1100000 00000 0000111111122346789999999999999999999999999999998764
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-50 Score=355.23 Aligned_cols=258 Identities=25% Similarity=0.396 Sum_probs=211.4
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
....++|++.+.||+|+||+||+|+++.+++.||+|++++. ....+.+|+.++..+ +||||+++++++.+ .
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~--~ 141 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFA-NSPWVVQLFYAFQD--D 141 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHC-CCTTBCCEEEEEEC--S
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEE--C
Confidence 34567999999999999999999999999999999998652 234578999999999 99999999999965 4
Q ss_pred CCcEEEEEeecCchhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 91 KTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
...++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||++.....
T Consensus 142 ~~~~lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g-~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 142 RYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMNK 220 (410)
T ss_dssp SEEEEEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCT
T ss_pred CEEEEEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCC-CEEEeccceeEeecc
Confidence 5678999999999998777 4689999999999999999999999999999999999999888 899999999987654
Q ss_pred CCc--cccccCCccccccccccCCCC---CCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 169 GKE--YNVRVASRYFKGPELLVDLQD---YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 169 ~~~--~~~~~~~~~y~aPE~~~~~~~---~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
... ....+||+.|+|||++.+... ++.++|+|||||++|+|++|..||. +.+.......+......
T Consensus 221 ~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~-~~~~~~~~~~i~~~~~~-------- 291 (410)
T 3v8s_A 221 EGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY-ADSLVGTYSKIMNHKNS-------- 291 (410)
T ss_dssp TSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHTHHHH--------
T ss_pred CCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCC-CCChhhHHHHHHhcccc--------
Confidence 332 345689999999999976321 7789999999999999999999994 33333333332210000
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCC--CcCHHHHhcCCCcccCC
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE--RPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~--Rps~~ell~hp~~~~~~ 312 (321)
........+|+++.+||++||+.+|.+ ||+++|+++||||+.++
T Consensus 292 -------------------------~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~ 337 (410)
T 3v8s_A 292 -------------------------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQ 337 (410)
T ss_dssp -------------------------CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSS
T ss_pred -------------------------ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCC
Confidence 000111246789999999999999988 99999999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=347.40 Aligned_cols=259 Identities=26% Similarity=0.378 Sum_probs=196.2
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
...++|++.+.||+|+||+||+|++..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+ ....++|
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~~~~~lv 126 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRL-SHPNIIKLKEIFET--PTEISLV 126 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHC-CCTTBCCEEEEEEC--SSEEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhC-CCCCCcceeeeEec--CCeEEEE
Confidence 3457799999999999999999999889999999999764 345678899999999 89999999999965 4457799
Q ss_pred EEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcC---CCCeEEEeeccceeecCCCC
Q 020826 97 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH---EQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 97 ~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~---~~~~v~l~dfg~~~~~~~~~ 170 (321)
|||+.+++|.+++. .+++..++.++.|++.||+|||++|++|+||||+||+++. ++ .++|+|||++.......
T Consensus 127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~-~~kl~Dfg~a~~~~~~~ 205 (349)
T 2w4o_A 127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDA-PLKIADFGLSKIVEHQV 205 (349)
T ss_dssp ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTC-CEEECCCC---------
T ss_pred EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCC-CEEEccCccccccCccc
Confidence 99999999877763 4899999999999999999999999999999999999975 45 89999999998665444
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||............+......
T Consensus 206 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~--------------- 269 (349)
T 2w4o_A 206 LMKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY--------------- 269 (349)
T ss_dssp -------CGGGSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCC---------------
T ss_pred ccccccCCCCccCHHHhcC-CCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCc---------------
Confidence 4455678999999999987 678999999999999999999999995433332222222110000
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
. .......+++++.+||++||+.||++|||+.|+++||||++....
T Consensus 270 ------------~------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 315 (349)
T 2w4o_A 270 ------------F------ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAAN 315 (349)
T ss_dssp ------------C------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCC
T ss_pred ------------c------CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccc
Confidence 0 000112467899999999999999999999999999999986543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-49 Score=335.76 Aligned_cols=253 Identities=25% Similarity=0.456 Sum_probs=200.8
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
...++|++.+.||+|+||+||+|.+..++..+++|++.... ...+.+|+.+++.+ +||||+++++++.+ ....
T Consensus 19 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~~~ 95 (285)
T 3is5_A 19 TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL-DHPNIIKIFEVFED--YHNM 95 (285)
T ss_dssp CHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEE
T ss_pred ChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhC-CCchHHhHHHheec--CCeE
Confidence 56689999999999999999999999999999999986542 46789999999999 89999999999954 4557
Q ss_pred EEEEEeecCchhhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcC---CCCeEEEeeccce
Q 020826 94 SLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH---EQRKLRLIDWGLA 163 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~---~~~~v~l~dfg~~ 163 (321)
++|+||+.+++|.+.+ ..+++..++.++.|++.||+|||++|++|+||||+||+++. ++ .++|+|||++
T Consensus 96 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~-~~kl~Dfg~a 174 (285)
T 3is5_A 96 YIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHS-PIKIIDFGLA 174 (285)
T ss_dssp EEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTC-CEEECCCCCC
T ss_pred EEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCC-CEEEEeeecc
Confidence 8999999999887666 56999999999999999999999999999999999999953 34 7999999999
Q ss_pred eecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 164 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
.............+++.|+|||++. ..++.++||||||+++|+|++|..||. +............ ....
T Consensus 175 ~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~-~~~~~~~~~~~~~-~~~~------- 243 (285)
T 3is5_A 175 ELFKSDEHSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFT-GTSLEEVQQKATY-KEPN------- 243 (285)
T ss_dssp CC----------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHH-CCCC-------
T ss_pred eecCCcccCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCC-CCCHHHHHhhhcc-CCcc-------
Confidence 7765555556677899999999985 468899999999999999999999984 2222111111100 0000
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
.......+++++.+||++||+.||++|||++|+++||||++.
T Consensus 244 --------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~a 285 (285)
T 3is5_A 244 --------------------------YAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQA 285 (285)
T ss_dssp --------------------------CCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC-
T ss_pred --------------------------cccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhcC
Confidence 000111356899999999999999999999999999999863
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=343.26 Aligned_cols=250 Identities=23% Similarity=0.387 Sum_probs=210.2
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
...++|++.+.||+|+||+||+|++..+++.||+|+++.. ....+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 38 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~~ 114 (350)
T 1rdq_E 38 AQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKD--NS 114 (350)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SS
T ss_pred CCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEEc--CC
Confidence 3457999999999999999999999999999999998643 235678899999999 99999999999965 45
Q ss_pred CcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 92 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
..++||||+.+++|..++ ..+++..++.++.||+.||+|||++|++||||||+||+++.++ .++|+|||++.....
T Consensus 115 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-YIQVTDFGFAKRVKG 193 (350)
T ss_dssp EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECSS
T ss_pred EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCC-CEEEcccccceeccC
Confidence 678999999999987776 4699999999999999999999999999999999999999888 899999999987643
Q ss_pred CCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 169 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
. .....||+.|+|||++.+ ..++.++|+|||||++|+|++|..||. +.+.......+... .
T Consensus 194 ~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~-~~~~~~~~~~i~~~--~------------- 254 (350)
T 1rdq_E 194 R--TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF-ADQPIQIYEKIVSG--K------------- 254 (350)
T ss_dssp C--BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHC--C-------------
T ss_pred C--cccccCCccccCHHHhcC-CCCCCcCCEecccHhHhHHhhCCCCCC-CCCHHHHHHHHHcC--C-------------
Confidence 2 345678999999999987 678999999999999999999999984 32222222222210 0
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC-----HHHHhcCCCcccCC
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPIR 312 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps-----~~ell~hp~~~~~~ 312 (321)
...+..+++++.++|++||+.||++||+ ++++++||||+.++
T Consensus 255 ----------------------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~ 301 (350)
T 1rdq_E 255 ----------------------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp ----------------------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred ----------------------CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCC
Confidence 0112246789999999999999999998 99999999999754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=344.18 Aligned_cols=284 Identities=29% Similarity=0.535 Sum_probs=208.4
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeecc----CC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----QS 90 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~----~~ 90 (321)
.++|++.+.||+|+||+||+|.+..+++.||+|++... ....+.+|+.+++.+ +||||+++++++... ..
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEecCCccccC
Confidence 37899999999999999999999999999999998642 235678999999999 899999999998643 22
Q ss_pred CCcEEEEEeecCchhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 91 KTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
...++++|++ +++|..++ ..+++..++.++.||+.||+|||++|++|+||||+||+++.++ .+||+|||++.....
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kL~DFG~a~~~~~ 184 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTAD 184 (367)
T ss_dssp CCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECC---------
T ss_pred CeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCC-CEEEeeccccccccc
Confidence 4568999998 56776666 4599999999999999999999999999999999999999888 899999999976432
Q ss_pred CCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 169 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
......+|..|+|||++.+...++.++|||||||++|+|++|+.|| .+.+...++..+.+.++.+....... .
T Consensus 185 --~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~l~~i~~~~g~p~~~~~~~----~ 257 (367)
T 2fst_X 185 --EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAELLKK----I 257 (367)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCHHHHTT----C
T ss_pred --cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHH----h
Confidence 2345678999999999987567899999999999999999999888 56667778888888877764332211 1
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
...............+...+.. .....++++.+||++||+.||++|||++|+|+||||++...+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~~ 322 (367)
T 2fst_X 258 SSESARNYIQSLTQMPKMNFAN--VFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 322 (367)
T ss_dssp CCHHHHHHHHTSCCCCCCCHHH--HTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred hhHHHHHHHhccCCCCCCCHHH--HCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCCC
Confidence 1111111111111111111111 1124678999999999999999999999999999999876553
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=344.23 Aligned_cols=285 Identities=28% Similarity=0.508 Sum_probs=223.2
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccC---CCC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---SKT 92 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~---~~~ 92 (321)
.++|++.+.||+|+||+||+|.+..++..||+|++.... ...+.+|+.+++.+ +||||+++++++.... ...
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhc-CCCCCccceeEEecCCccccce
Confidence 479999999999999999999999999999999987432 35678999999999 8999999999986433 245
Q ss_pred cEEEEEeecCchhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 93 PSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
.++++|++.+ +|..++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++.......
T Consensus 105 ~~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~ 182 (364)
T 3qyz_A 105 VYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDH 182 (364)
T ss_dssp EEEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCGGG
T ss_pred EEEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCC-CEEEEeCcceEecCCCC
Confidence 7899999996 555444 4699999999999999999999999999999999999999888 89999999998664332
Q ss_pred c----cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhc
Q 020826 171 E----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246 (321)
Q Consensus 171 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (321)
. .....+|+.|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+.+..+...++.+........
T Consensus 183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~-- 259 (364)
T 3qyz_A 183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF-PGKHYLDQLNHILGILGSPSQEDLNCI-- 259 (364)
T ss_dssp CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSS-CCSSGGGHHHHHHHHHCSCCHHHHHTC--
T ss_pred CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCC-CCCChHHHHHHHHHHhCCCCHHHHHHh--
Confidence 2 234578999999999876567899999999999999999999888 566677778888777777654433211
Q ss_pred ccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
................... .......+++++.+||++||+.||++|||++|+++||||++...+
T Consensus 260 --~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~ 323 (364)
T 3qyz_A 260 --INLKARNYLLSLPHKNKVP--WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 323 (364)
T ss_dssp --CCHHHHHHHHTSCCCCCCC--HHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred --hhhhHHHHHHhcCCccCCC--HHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCc
Confidence 1111111111111111000 011123467899999999999999999999999999999987544
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=343.54 Aligned_cols=263 Identities=26% Similarity=0.415 Sum_probs=191.9
Q ss_pred cCceEEe---eeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 20 QDDYEVV---RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 20 ~~~y~~~---~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
.++|++. +.||+|+||+||+|.+..+++.||+|++.........+|+.+++.+.+||||+++++++.+ ....++|
T Consensus 7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~--~~~~~lv 84 (325)
T 3kn6_A 7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHD--QLHTFLV 84 (325)
T ss_dssp HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--SSEEEEE
T ss_pred hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEc--CCEEEEE
Confidence 4577776 7799999999999999999999999999887778899999999999669999999999965 4566799
Q ss_pred EEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCC--eEEEeeccceeecCCC-C
Q 020826 97 FEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAEFYHPG-K 170 (321)
Q Consensus 97 ~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~--~v~l~dfg~~~~~~~~-~ 170 (321)
|||+.+++|.+++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.++. .++|+|||++...... .
T Consensus 85 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~ 164 (325)
T 3kn6_A 85 MELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ 164 (325)
T ss_dssp ECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---
T ss_pred EEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC
Confidence 9999999987776 45899999999999999999999999999999999999976542 6999999999865433 2
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCCh--HHHHHHHHHhCChhhhHHhhhhccc
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY--DQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||....... .....+........
T Consensus 165 ~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~----------- 232 (325)
T 3kn6_A 165 PLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD----------- 232 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC-----------
T ss_pred cccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC-----------
Confidence 3345678999999999987 788999999999999999999999994322110 00001101000000
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
... .......+|+++.+||++||+.||++|||++|+++||||++....
T Consensus 233 ------------~~~------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~~ 280 (325)
T 3kn6_A 233 ------------FSF------EGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQL 280 (325)
T ss_dssp ------------CCC------CSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCCC
T ss_pred ------------CCC------CcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCccC
Confidence 000 000112467899999999999999999999999999999976443
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=346.05 Aligned_cols=291 Identities=29% Similarity=0.465 Sum_probs=219.2
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccC---
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ--- 89 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~--- 89 (321)
...++|++.+.||+|+||+||+|++..+++.||+|++.... ...+.+|+.+++.+ +||||+++++++....
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 92 (351)
T 3mi9_A 14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPY 92 (351)
T ss_dssp CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEEC----
T ss_pred ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhc-cCCCcccHhheeecccccc
Confidence 34689999999999999999999999999999999985432 34678999999999 8999999999987543
Q ss_pred ---CCCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccce
Q 020826 90 ---SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163 (321)
Q Consensus 90 ---~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~ 163 (321)
....++||||+.++.+..+. ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++
T Consensus 93 ~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a 171 (351)
T 3mi9_A 93 NRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLA 171 (351)
T ss_dssp ----CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred ccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC-CEEEccchhc
Confidence 34578999999976554444 4699999999999999999999999999999999999999888 8999999999
Q ss_pred eecCCC-----CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhh
Q 020826 164 EFYHPG-----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 238 (321)
Q Consensus 164 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (321)
...... .......+|+.|+|||++.+...++.++|||||||++|+|++|..|| .+......+..+....+....
T Consensus 172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM-QGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCT
T ss_pred ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCh
Confidence 765422 22344578999999999987567899999999999999999999887 455556666666665555433
Q ss_pred hHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCccc
Q 020826 239 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAES 316 (321)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~~ 316 (321)
..+........ ... ..... ...............++++.+||++||+.||++|||++|+++||||+....++.
T Consensus 251 ~~~~~~~~~~~---~~~-~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~ 323 (351)
T 3mi9_A 251 EVWPNVDNYEL---YEK-LELVK-GQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSD 323 (351)
T ss_dssp TTSTTGGGCGG---GTS-SCCCS-SCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCC
T ss_pred hhccccccchh---hcc-ccccc-ccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCccc
Confidence 22111100000 000 00000 000000000001113578999999999999999999999999999998766543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=340.28 Aligned_cols=261 Identities=26% Similarity=0.446 Sum_probs=215.0
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc---------chHHHHHHHHHHHhhcCCCCeeeeeeeee
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---------KKKKIKREIKILQNLCGGPNIVKLLDIVR 86 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~---------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (321)
.....++|++.+.||+|+||+||+|++..+++.+|+|+++.. ....+.+|+.+++.+ +||||+++++++.
T Consensus 7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 85 (321)
T 2a2a_A 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV-LHHNVITLHDVYE 85 (321)
T ss_dssp CSCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEE
T ss_pred chhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhC-CCCCcceEEEEEe
Confidence 345678899999999999999999999999999999998643 245689999999999 8999999999985
Q ss_pred ccCCCCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCC---eEEEeec
Q 020826 87 DQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR---KLRLIDW 160 (321)
Q Consensus 87 ~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~---~v~l~df 160 (321)
+ ....++|+|++.+++|.+++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.++. .++|+||
T Consensus 86 ~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Df 163 (321)
T 2a2a_A 86 N--RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163 (321)
T ss_dssp C--SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCC
T ss_pred c--CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccC
Confidence 5 45678999999999998877 34889999999999999999999999999999999999987663 6999999
Q ss_pred cceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhH
Q 020826 161 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 240 (321)
Q Consensus 161 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (321)
|++.............+|+.|+|||++.+ ..++.++|||||||++|+|++|..||. +....+.+..+........
T Consensus 164 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~-~~~~~~~~~~i~~~~~~~~--- 238 (321)
T 2a2a_A 164 GLAHEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANITSVSYDFD--- 238 (321)
T ss_dssp TTCEECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSC-CSSHHHHHHHHHTTCCCCC---
T ss_pred ccceecCccccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhcccccC---
Confidence 99987765555566679999999999987 788999999999999999999999984 3332233322211100000
Q ss_pred HhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 241 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
......+++.+.++|++||+.||++|||++|+++||||+.+...
T Consensus 239 ------------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~~ 282 (321)
T 2a2a_A 239 ------------------------------EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQ 282 (321)
T ss_dssp ------------------------------HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSHH
T ss_pred ------------------------------hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCcc
Confidence 00112466789999999999999999999999999999987543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=341.78 Aligned_cols=259 Identities=23% Similarity=0.393 Sum_probs=208.9
Q ss_pred ecccCceEEe-eeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 17 NREQDDYEVV-RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 17 ~~~~~~y~~~-~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
....++|.+. +.||+|+||+||+|.+..+++.||+|+++.. ....+.+|+.+++.+.+||||+++++++.+ .
T Consensus 24 ~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~--~ 101 (327)
T 3lm5_A 24 ENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN--T 101 (327)
T ss_dssp HHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--S
T ss_pred HhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe--C
Confidence 3457789988 8899999999999999999999999998743 246788999999999778999999999954 4
Q ss_pred CCcEEEEEeecCchhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcC---CCCeEEEeeccc
Q 020826 91 KTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH---EQRKLRLIDWGL 162 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~---~~~~v~l~dfg~ 162 (321)
...++||||+.+++|..++ ..+++..++.++.|++.||+|||++|++|+||||+||+++. ++ .++|+|||+
T Consensus 102 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~-~~kL~Dfg~ 180 (327)
T 3lm5_A 102 SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLG-DIKIVDFGM 180 (327)
T ss_dssp SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBC-CEEECCGGG
T ss_pred CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCC-cEEEeeCcc
Confidence 5578999999999998876 34899999999999999999999999999999999999986 45 799999999
Q ss_pred eeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHh
Q 020826 163 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242 (321)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (321)
+.............+|+.|+|||++.+ ..++.++||||||+++|+|++|..||. +.+..+....+........
T Consensus 181 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~~----- 253 (327)
T 3lm5_A 181 SRKIGHACELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFV-GEDNQETYLNISQVNVDYS----- 253 (327)
T ss_dssp CEEC---------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCCCCC-----
T ss_pred ccccCCccccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCchHHHHHHHhcccccC-----
Confidence 987765555556789999999999987 788999999999999999999999983 3333333332222111100
Q ss_pred hhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCC
Q 020826 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~ 313 (321)
......+++.+.++|++||+.||++|||++++++||||++++.
T Consensus 254 ----------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 254 ----------------------------EETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp ----------------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred ----------------------------chhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence 0111246688999999999999999999999999999998744
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-49 Score=332.72 Aligned_cols=257 Identities=26% Similarity=0.437 Sum_probs=212.6
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc---chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
..++|++.+.||+|+||+||+|.+..++..+++|.+... ....+.+|+.+++.+ +||||+++++++.+ ....++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 83 (277)
T 3f3z_A 7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL-DHPNIIRLYETFED--NTDIYL 83 (277)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSEEEE
T ss_pred hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhC-CCCCEeeEEEEEec--CCeEEE
Confidence 467899999999999999999999999999999998653 356788999999999 99999999999954 455789
Q ss_pred EEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEE---cCCCCeEEEeeccceeecCCC
Q 020826 96 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 96 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili---~~~~~~v~l~dfg~~~~~~~~ 169 (321)
||||+.+++|.+++ ..+++..++.++.|++.||+|||++|++|+||||+||++ +.++ .++|+|||++......
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~-~~~l~Dfg~~~~~~~~ 162 (277)
T 3f3z_A 84 VMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDS-PLKLIDFGLAARFKPG 162 (277)
T ss_dssp EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTC-CEEECCCTTCEECCTT
T ss_pred EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCC-cEEEEecccceeccCc
Confidence 99999999887665 568999999999999999999999999999999999999 5555 8999999999887666
Q ss_pred CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 170 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
.......+|+.|+|||++.+ .++.++||||||+++|+|++|..||. .....+....+..........
T Consensus 163 ~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~~~~---------- 229 (277)
T 3f3z_A 163 KMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFS-APTDSEVMLKIREGTFTFPEK---------- 229 (277)
T ss_dssp SCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCCCCCCHH----------
T ss_pred cchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhCCCCCCch----------
Confidence 66667789999999999865 48999999999999999999999984 333333333222211110000
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
....+++++.++|++||+.||++|||+.++++||||++....+
T Consensus 230 -----------------------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~ 272 (277)
T 3f3z_A 230 -----------------------DWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS 272 (277)
T ss_dssp -----------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCCS
T ss_pred -----------------------hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccccc
Confidence 0113568999999999999999999999999999999865444
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=347.44 Aligned_cols=291 Identities=27% Similarity=0.470 Sum_probs=217.6
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc--------------hHHHHHHHHHHHhhcCCCCeeee
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--------------KKKIKREIKILQNLCGGPNIVKL 81 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~--------------~~~~~~E~~~l~~l~~h~~i~~~ 81 (321)
+....++|++.+.||+|+||+||+|.+. ++..||+|.+.... ...+.+|+.+++.+ +||||+++
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~ 94 (362)
T 3pg1_A 17 LHAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHF-HHPNILGL 94 (362)
T ss_dssp HHHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHC-CCTTBCCC
T ss_pred HHHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhC-CCcCccce
Confidence 4566889999999999999999999984 58999999985421 26688999999999 89999999
Q ss_pred eeeeec---cCCCCcEEEEEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeE
Q 020826 82 LDIVRD---QQSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL 155 (321)
Q Consensus 82 ~~~~~~---~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v 155 (321)
++++.. ......++|||++.++.+..+.. .+++..++.++.|++.||.|||++|++|+||||+||+++.++ .+
T Consensus 95 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~-~~ 173 (362)
T 3pg1_A 95 RDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN-DI 173 (362)
T ss_dssp SEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CE
T ss_pred eeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCC-CE
Confidence 998854 23346789999999765554443 489999999999999999999999999999999999999888 89
Q ss_pred EEeeccceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCC
Q 020826 156 RLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 235 (321)
Q Consensus 156 ~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (321)
+|+|||++.............+++.|+|||++.+...++.++|||||||++|+|++|..|| .+......+..+....+.
T Consensus 174 kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~ 252 (362)
T 3pg1_A 174 TICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALF-RGSTFYNQLNKIVEVVGT 252 (362)
T ss_dssp EECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCC
T ss_pred EEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCC
Confidence 9999999976555555566678999999999987567899999999999999999999998 455666777777777776
Q ss_pred hhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 236 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
+........ ..+............. ............++.+.+||.+||+.||++|||++|+++||||+.+..+.
T Consensus 253 ~~~~~~~~~----~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 327 (362)
T 3pg1_A 253 PKIEDVVMF----SSPSARDYLRNSLSNV-PARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPL 327 (362)
T ss_dssp CCHHHHHHT----SCHHHHHHTTTCCCCC-CCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCGG
T ss_pred CChHHhhhc----cchhhhHHHHhhcccC-ChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCcc
Confidence 655443221 1111111111111111 00111122234678899999999999999999999999999999886553
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-49 Score=356.01 Aligned_cols=254 Identities=24% Similarity=0.419 Sum_probs=213.3
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccC
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 89 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (321)
.....++|++.+.||+|+||+||+|++..+++.||+|+++... ...+.+|+.+++.+ +||||+++++++.+.
T Consensus 11 ~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~l~~~~~~~- 88 (476)
T 2y94_A 11 GRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-RHPHIIKLYQVISTP- 88 (476)
T ss_dssp SCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTC-CCTTBCCEEEEEECS-
T ss_pred CCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC-
Confidence 3445679999999999999999999999899999999996432 35688999999999 899999999999654
Q ss_pred CCCcEEEEEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeec
Q 020826 90 SKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 166 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~ 166 (321)
...++||||+.+++|.+++. .+++..++.++.||+.||+|||++|++|+||||+||+++.++ .+||+|||++...
T Consensus 89 -~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~-~vkL~DFG~a~~~ 166 (476)
T 2y94_A 89 -SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMM 166 (476)
T ss_dssp -SEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTC-CEEECCCSSCEEC
T ss_pred -CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCC-CeEEEeccchhhc
Confidence 45789999999999988874 489999999999999999999999999999999999999888 8999999999887
Q ss_pred CCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhc
Q 020826 167 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246 (321)
Q Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (321)
..........||+.|+|||++.+....+.++|||||||++|+|++|..||. +.+.......+....
T Consensus 167 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~-~~~~~~~~~~i~~~~------------- 232 (476)
T 2y94_A 167 SDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFD-DDHVPTLFKKICDGI------------- 232 (476)
T ss_dssp CTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSC-CSSSHHHHHHHHTTC-------------
T ss_pred cccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCC-CCCHHHHHHHHhcCC-------------
Confidence 655555667899999999999874445789999999999999999999984 333322222221100
Q ss_pred ccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
...+..+++++.+||++||+.||++|||++|+++||||++.
T Consensus 233 ------------------------~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 233 ------------------------FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp ------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred ------------------------cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 01122467899999999999999999999999999999864
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=341.66 Aligned_cols=284 Identities=27% Similarity=0.514 Sum_probs=212.1
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc--------hHHHHHHHHHHHhhcCCCCeeeeeeeeec
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--------KKKIKREIKILQNLCGGPNIVKLLDIVRD 87 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~--------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (321)
+....++|++.+.||+|+||+||+|++..+++.||+|+++... ...+.+|+.+++.+ +||||+++++++.+
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 83 (346)
T 1ua2_A 5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGH 83 (346)
T ss_dssp --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECC
T ss_pred hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhC-CCCCCCeEEEEEee
Confidence 3456789999999999999999999998899999999986422 23577999999999 89999999999954
Q ss_pred cCCCCcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccce
Q 020826 88 QQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163 (321)
Q Consensus 88 ~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~ 163 (321)
....++|+|++.++ +...+ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++
T Consensus 84 --~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a 159 (346)
T 1ua2_A 84 --KSNISLVFDFMETD-LEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG-VLKLADFGLA 159 (346)
T ss_dssp --TTCCEEEEECCSEE-HHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCCGGG
T ss_pred --CCceEEEEEcCCCC-HHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCC-CEEEEecccc
Confidence 45567999999974 44443 2488999999999999999999999999999999999999888 8999999999
Q ss_pred eecCC-CCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHh
Q 020826 164 EFYHP-GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242 (321)
Q Consensus 164 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (321)
..... ........+|+.|+|||++.+...++.++|||||||++|+|++|..|| .+.+....+..+....+.+....+.
T Consensus 160 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~-~~~~~~~~~~~i~~~~~~~~~~~~~ 238 (346)
T 1ua2_A 160 KSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL-PGDSDLDQLTRIFETLGTPTEEQWP 238 (346)
T ss_dssp STTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred eeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCC-CCCCHHHHHHHHHHHcCCCChhhhh
Confidence 76532 233455678999999999976566899999999999999999998666 5666666777776666654433221
Q ss_pred hhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
...... ...................+++++.+||++||+.||++|||++|+++||||+....+
T Consensus 239 ~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~ 301 (346)
T 1ua2_A 239 DMCSLP---------DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 301 (346)
T ss_dssp STTSST---------TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred hhccCc---------ccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence 110000 000000000000001123467899999999999999999999999999999976544
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=355.38 Aligned_cols=259 Identities=24% Similarity=0.381 Sum_probs=210.7
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
....++|++.+.||+|+||+||+|+++.+++.||+|++++.. ...+.+|..++..+ +||||+++++++.+ .
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~--~ 146 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-DSKWITTLHYAFQD--D 146 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHS-CTTTBCCEEEEEEC--S
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEee--C
Confidence 345689999999999999999999999999999999997532 23488999999998 99999999999965 4
Q ss_pred CCcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeec
Q 020826 91 KTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 166 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~ 166 (321)
...++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||++...
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g-~vkL~DFGla~~~ 225 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG-HIRLADFGSCLKL 225 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCC-CEEEcchhhhhhc
Confidence 5678999999999988776 3589999999999999999999999999999999999999888 8999999999776
Q ss_pred CCCCc--cccccCCcccccccccc----CCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhH
Q 020826 167 HPGKE--YNVRVASRYFKGPELLV----DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 240 (321)
Q Consensus 167 ~~~~~--~~~~~~~~~y~aPE~~~----~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (321)
..... ....+||+.|+|||++. +...++.++|||||||++|+|++|+.||. +.+..+....+.......
T Consensus 226 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~-~~~~~~~~~~i~~~~~~~---- 300 (437)
T 4aw2_A 226 MEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFY-AESLVETYGKIMNHKERF---- 300 (437)
T ss_dssp CTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHTHHHHC----
T ss_pred ccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCC-CCChhHHHHhhhhccccc----
Confidence 54333 23457999999999986 23568999999999999999999999994 333333333332100000
Q ss_pred HhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCC--CcCHHHHhcCCCcccCC
Q 020826 241 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE--RPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~--Rps~~ell~hp~~~~~~ 312 (321)
..+ .....+|+++.+||++||+.+|++ |++++|+++||||++++
T Consensus 301 ---------------------~~p-------~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~ 346 (437)
T 4aw2_A 301 ---------------------QFP-------TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID 346 (437)
T ss_dssp ---------------------CCC-------SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred ---------------------cCC-------cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence 000 001246789999999999999888 99999999999999875
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=338.35 Aligned_cols=246 Identities=23% Similarity=0.272 Sum_probs=195.3
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
.++|++.++||+|+||+||+|++..+++.||||++.... ......|+..+..+.+||||+++++++.+ ....+
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~--~~~~~ 133 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE--GGILY 133 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE--TTEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe--CCEEE
Confidence 478999999999999999999998899999999986422 23445666666666689999999999954 45678
Q ss_pred EEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 95 LIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 95 lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
+|||++++. |..++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .+||+|||++.......
T Consensus 134 lv~e~~~~~-L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kl~DFG~a~~~~~~~ 211 (311)
T 3p1a_A 134 LQTELCGPS-LQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG-RCKLGDFGLLVELGTAG 211 (311)
T ss_dssp EEEECCCCB-HHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGG-CEEECCCTTCEECC---
T ss_pred EEEeccCCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC-CEEEccceeeeecccCC
Confidence 999999654 43333 4599999999999999999999999999999999999999888 89999999998776555
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
......||+.|+|||++.+ .++.++|||||||++|+|++|..|++.. .....+.....
T Consensus 212 ~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~----~~~~~~~~~~~---------------- 269 (311)
T 3p1a_A 212 AGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGG----EGWQQLRQGYL---------------- 269 (311)
T ss_dssp ---CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSH----HHHHHHTTTCC----------------
T ss_pred CCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCc----cHHHHHhccCC----------------
Confidence 5566679999999999875 6899999999999999999998776321 11111100000
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCccc
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 310 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~ 310 (321)
.......+++++.++|.+||+.||++|||++|+++||||++
T Consensus 270 -------------------~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 270 -------------------PPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp -------------------CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred -------------------CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 00112246789999999999999999999999999999986
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=337.73 Aligned_cols=251 Identities=28% Similarity=0.466 Sum_probs=200.1
Q ss_pred ccCceEEeeeeeeecceEEEEEEEe---cCCceEEEEEeccc-------chHHHHHHHHHHHhhcCCCCeeeeeeeeecc
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 88 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~---~~~~~~~vK~~~~~-------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (321)
..++|++.+.||+|+||+||+|++. .+++.+|+|+++.. ....+.+|+.+++.+ +||||+++++++.+
T Consensus 15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~- 92 (327)
T 3a62_A 15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV-KHPFIVDLIYAFQT- 92 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHC-CCTTBCCEEEEEEC-
T ss_pred CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhC-CCCCccceeEEEEc-
Confidence 4679999999999999999999985 57899999998753 234577899999999 89999999999965
Q ss_pred CCCCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 89 QSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 89 ~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
....++||||+.+++|..++ ..+++..++.++.||+.||+|||++|++|+||||+||+++.++ .+||+|||++..
T Consensus 93 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~~~~ 170 (327)
T 3a62_A 93 -GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG-HVKLTDFGLCKE 170 (327)
T ss_dssp -SSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTS-CEEECCCSCC--
T ss_pred -CCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCC-cEEEEeCCcccc
Confidence 45678999999999987776 4589999999999999999999999999999999999999888 899999999875
Q ss_pred cCC-CCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhh
Q 020826 166 YHP-GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244 (321)
Q Consensus 166 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (321)
... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+.......+....
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~-~~~~~~~~~~i~~~~----------- 237 (327)
T 3a62_A 171 SIHDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFT-GENRKKTIDKILKCK----------- 237 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHTC-----------
T ss_pred cccCCccccccCCCcCccCHhhCcC-CCCCCcccchhHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhCC-----------
Confidence 432 223345678999999999987 678999999999999999999999984 333222222222100
Q ss_pred hcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc-----CHHHHhcCCCcccCC
Q 020826 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIR 312 (321)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp-----s~~ell~hp~~~~~~ 312 (321)
...+..+++++.++|++||+.||++|| +++|+++||||+.++
T Consensus 238 --------------------------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~ 284 (327)
T 3a62_A 238 --------------------------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284 (327)
T ss_dssp --------------------------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred --------------------------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence 011224678999999999999999999 899999999999764
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=332.21 Aligned_cols=265 Identities=25% Similarity=0.394 Sum_probs=212.5
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------------hHHHHHHHHHHHhhcCCCCeeeeee
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------------KKKIKREIKILQNLCGGPNIVKLLD 83 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------------~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (321)
.....++|++.+.||+|+||.||+|.+..+++.||+|+++... ...+.+|+.+++++.+||||+++++
T Consensus 12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (298)
T 1phk_A 12 THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 91 (298)
T ss_dssp ---CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred CcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence 4556789999999999999999999999999999999986432 3457789999999966999999999
Q ss_pred eeeccCCCCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeec
Q 020826 84 IVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW 160 (321)
Q Consensus 84 ~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~df 160 (321)
++.+ ....++|+|++.+++|.+++ ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .++|+||
T Consensus 92 ~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~df 168 (298)
T 1phk_A 92 TYET--NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM-NIKLTDF 168 (298)
T ss_dssp EEEC--SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCC
T ss_pred eecc--CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCC-cEEEecc
Confidence 9854 45678999999999988776 4689999999999999999999999999999999999999888 8999999
Q ss_pred cceeecCCCCccccccCCcccccccccc-----CCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCC
Q 020826 161 GLAEFYHPGKEYNVRVASRYFKGPELLV-----DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 235 (321)
Q Consensus 161 g~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (321)
|++.............++..|+|||++. ....++.++||||||+++|+|++|..||.. .........+......
T Consensus 169 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~~~~ 247 (298)
T 1phk_A 169 GFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH-RKQMLMLRMIMSGNYQ 247 (298)
T ss_dssp TTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCC
T ss_pred cchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC-ccHHHHHHHHhcCCcc
Confidence 9998776555556677899999999985 225678999999999999999999999842 2222222222110000
Q ss_pred hhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 236 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
. + ......+++++.++|.+||+.||++|||++|+++||||++....+
T Consensus 248 ~---------------------------~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~ 294 (298)
T 1phk_A 248 F---------------------------G------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEE 294 (298)
T ss_dssp C---------------------------C------TTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC---
T ss_pred c---------------------------C------cccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccchh
Confidence 0 0 001124667899999999999999999999999999999987766
Q ss_pred cc
Q 020826 316 SS 317 (321)
Q Consensus 316 ~~ 317 (321)
.+
T Consensus 295 ~~ 296 (298)
T 1phk_A 295 VR 296 (298)
T ss_dssp --
T ss_pred hc
Confidence 43
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=357.59 Aligned_cols=260 Identities=27% Similarity=0.484 Sum_probs=213.5
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----------------hHHHHHHHHHHHhhcCCCCee
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----------------KKKIKREIKILQNLCGGPNIV 79 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----------------~~~~~~E~~~l~~l~~h~~i~ 79 (321)
.+...++|++++.||+|+||+||+|.+..+++.+|+|+++... ...+.+|+.+++.+ +||||+
T Consensus 31 ~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv 109 (504)
T 3q5i_A 31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL-DHPNII 109 (504)
T ss_dssp CSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC-CCTTBC
T ss_pred CCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC-CCCCCC
Confidence 3456789999999999999999999999999999999986432 35678999999999 899999
Q ss_pred eeeeeeeccCCCCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCC--e
Q 020826 80 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR--K 154 (321)
Q Consensus 80 ~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~--~ 154 (321)
++++++.+ ....++||||+.+++|...+ ..+++..+..++.||+.||+|||++|++|+||||+||+++.++. .
T Consensus 110 ~~~~~~~~--~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 110 KLFDVFED--KKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp CEEEEEEC--SSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSS
T ss_pred eEEEEEEc--CCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCcc
Confidence 99999954 45678999999999887666 56999999999999999999999999999999999999987653 5
Q ss_pred EEEeeccceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhC
Q 020826 155 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 234 (321)
Q Consensus 155 v~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 234 (321)
++|+|||++.............+|+.|+|||++.+ .++.++|||||||++|+|++|..||. +.+..+.+..+.....
T Consensus 188 ~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~ 264 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFG-GQNDQDIIKKVEKGKY 264 (504)
T ss_dssp EEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCCC
T ss_pred EEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHcCCC
Confidence 99999999988766666667789999999999864 68999999999999999999999983 3433334433322111
Q ss_pred ChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 235 TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
..... ....+|+++.+||++||+.||++|||++|+|+||||++....
T Consensus 265 ~~~~~---------------------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~ 311 (504)
T 3q5i_A 265 YFDFN---------------------------------DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN 311 (504)
T ss_dssp CCCHH---------------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCC
T ss_pred CCCcc---------------------------------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhc
Confidence 11000 012467899999999999999999999999999999986544
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-49 Score=350.90 Aligned_cols=295 Identities=24% Similarity=0.469 Sum_probs=209.4
Q ss_pred cccCceEEee-eeeeecceEEEEEEEe--cCCceEEEEEecccc-hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 18 REQDDYEVVR-KVGRGKYSEVFEGVHC--TDNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 18 ~~~~~y~~~~-~lg~g~~g~v~~~~~~--~~~~~~~vK~~~~~~-~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
+..+.|++.+ +||+|+||+||+|++. .+++.||+|++.... ...+.+|+.+++.+ +||||+++++++........
T Consensus 17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLREL-KHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHC-CCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhc-CCCCeeeEeeEEecCCCCeE
Confidence 4456788744 7999999999999975 468899999997543 45788999999999 89999999999977667788
Q ss_pred EEEEEeecCchhhhhc-----------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEE----cCCCCeEEEe
Q 020826 94 SLIFEHVNNTDFKVLY-----------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHEQRKLRLI 158 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~-----------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili----~~~~~~v~l~ 158 (321)
++||||+.++.+..+. ..+++..++.++.||+.||+|||++||+|+||||+||++ +.++ .+||+
T Consensus 96 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~-~~kl~ 174 (405)
T 3rgf_A 96 WLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG-RVKIA 174 (405)
T ss_dssp EEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTT-CEEEC
T ss_pred EEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCC-cEEEE
Confidence 9999999875443332 138999999999999999999999999999999999999 4455 89999
Q ss_pred eccceeecCCC----CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCC--------ChHHH
Q 020826 159 DWGLAEFYHPG----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--------NYDQL 226 (321)
Q Consensus 159 dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~--------~~~~~ 226 (321)
|||++...... .......+|+.|+|||++.+...++.++|||||||++|+|++|..||..... ...++
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l 254 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL 254 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence 99999765432 2234567899999999998756689999999999999999999999954332 24677
Q ss_pred HHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCcccc-ccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 227 VKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFI-TVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
..+...++.+....+............................ ........++++.+||++||+.||++|||++|+|+|
T Consensus 255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h 334 (405)
T 3rgf_A 255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD 334 (405)
T ss_dssp HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 7788877776554433222111111111111100000000000 011112346789999999999999999999999999
Q ss_pred CCcccCCCc
Q 020826 306 PYFFPIRNA 314 (321)
Q Consensus 306 p~~~~~~~~ 314 (321)
|||+....+
T Consensus 335 p~f~~~~~~ 343 (405)
T 3rgf_A 335 PYFLEDPLP 343 (405)
T ss_dssp GGGTSSSCC
T ss_pred hhhccCCCC
Confidence 999986544
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=341.64 Aligned_cols=254 Identities=26% Similarity=0.450 Sum_probs=209.4
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----------hHHHHHHHHHHHhhcCCCCeeeeeeeeecc
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 88 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (321)
.++|++.+.||+|+||.||+|++..+|+.||||+++... ...+.+|+.+++.+.+||||+++++++..
T Consensus 93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~- 171 (365)
T 2y7j_A 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYES- 171 (365)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEB-
T ss_pred hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEee-
Confidence 468999999999999999999998899999999986532 34578899999998789999999999855
Q ss_pred CCCCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 89 QSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 89 ~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
....++||||+.+++|.+++ ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++ .++|+|||++..
T Consensus 172 -~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~-~ikl~DfG~~~~ 249 (365)
T 2y7j_A 172 -SSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM-QIRLSDFGFSCH 249 (365)
T ss_dssp -SSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEE
T ss_pred -CCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEEEecCcccc
Confidence 45678999999999988776 4699999999999999999999999999999999999999888 899999999987
Q ss_pred cCCCCccccccCCccccccccccCC-----CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhH
Q 020826 166 YHPGKEYNVRVASRYFKGPELLVDL-----QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 240 (321)
Q Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (321)
...........+|+.|+|||++.+. ..++.++|||||||++|+|++|..||.. ......+..+.........
T Consensus 250 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~-- 326 (365)
T 2y7j_A 250 LEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH-RRQILMLRMIMEGQYQFSS-- 326 (365)
T ss_dssp CCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHTCCCCCH--
T ss_pred cCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCC-CCHHHHHHHHHhCCCCCCC--
Confidence 7666556667899999999998631 3578899999999999999999999843 2222222222111000000
Q ss_pred HhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCccc
Q 020826 241 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 310 (321)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~ 310 (321)
.....+++++.++|++||+.||++|||++++++||||++
T Consensus 327 -------------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 327 -------------------------------PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp -------------------------------HHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred -------------------------------cccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 001235678999999999999999999999999999974
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=343.02 Aligned_cols=283 Identities=23% Similarity=0.386 Sum_probs=211.5
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc--chHHHHHHHHHHHhhc----CCCCeeeeeeeeeccCCC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLC----GGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~E~~~l~~l~----~h~~i~~~~~~~~~~~~~ 91 (321)
...++|++.+.||+|+||+||+|++..+++.||+|+++.. .......|+.+++.+. .||||+++++++... .
T Consensus 32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~--~ 109 (360)
T 3llt_A 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY--D 109 (360)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET--T
T ss_pred EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC--C
Confidence 3467999999999999999999999999999999999743 3456788999999984 499999999998654 4
Q ss_pred CcEEEEEeecCchhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcC----------------
Q 020826 92 TPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH---------------- 150 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~---------------- 150 (321)
..++|||++ +++|.+++ ..+++..++.++.||+.||+|||++|++|+||||+||+++.
T Consensus 110 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~ 188 (360)
T 3llt_A 110 HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188 (360)
T ss_dssp EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTC
T ss_pred eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccc
Confidence 678999999 67776665 24899999999999999999999999999999999999974
Q ss_pred ---------CCCeEEEeeccceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCC
Q 020826 151 ---------EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 221 (321)
Q Consensus 151 ---------~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~ 221 (321)
++ .++|+|||++..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+
T Consensus 189 ~~~~~~~~~~~-~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~-~~~ 263 (360)
T 3llt_A 189 KKIQIYRTKST-GIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILN-LGWDVSSDMWSFGCVLAELYTGSLLFR-THE 263 (360)
T ss_dssp CEEEEEEESCC-CEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSCC-CSS
T ss_pred ccccccccCCC-CEEEEeccCceecCC--CCcCccCcccccCcHHHcC-CCCCCccchHHHHHHHHHHHHCCCCCC-CCc
Confidence 44 799999999986542 2345678999999999987 789999999999999999999999983 455
Q ss_pred ChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCcc--cc--------ccccccCCcchHHHHHHHhhcc
Q 020826 222 NYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSK--FI--------TVENQHLAVPEAVDFLDKLLRY 291 (321)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~--------~~~~~~~~s~~~~~ll~~~l~~ 291 (321)
..+.+..+....+..................... .......+... .. ........++.+.+||++||+.
T Consensus 264 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 342 (360)
T 3llt_A 264 HMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNK-DELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQI 342 (360)
T ss_dssp HHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEET-TTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCS
T ss_pred HHHHHHHHHHhcCCCCHHHHhhhhhccCccccCc-ccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcC
Confidence 5566666655555433222211110000000000 00000000000 00 0000112346788999999999
Q ss_pred CCCCCcCHHHHhcCCCcc
Q 020826 292 DHQERPTAKEAMAHPYFF 309 (321)
Q Consensus 292 dp~~Rps~~ell~hp~~~ 309 (321)
||++|||++|+|+||||+
T Consensus 343 dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 343 DPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp SGGGSCCHHHHTTSGGGC
T ss_pred ChhhCCCHHHHhcCcccC
Confidence 999999999999999996
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-48 Score=347.04 Aligned_cols=289 Identities=24% Similarity=0.429 Sum_probs=215.0
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc--hHHHHHHHHHHHhhc-----CCCCeeeeeeeeeccCCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLC-----GGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~E~~~l~~l~-----~h~~i~~~~~~~~~~~~~ 91 (321)
...+|++.+.||+|+||+||+|.+..+++.||+|+++... ...+.+|+.+++.+. +|+||+++++++.. ..
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~--~~ 172 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF--RN 172 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE--TT
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc--CC
Confidence 4568999999999999999999999999999999997653 356778998888873 57799999999865 35
Q ss_pred CcEEEEEeecCchhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCC-eEEEeeccceee
Q 020826 92 TPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEF 165 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~-~v~l~dfg~~~~ 165 (321)
..++++|++.++ |.+++ ..+++..++.++.||+.||+|||++||+|+||||+||+++.++. .+||+|||++..
T Consensus 173 ~~~lv~e~~~~~-L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~ 251 (429)
T 3kvw_A 173 HICMTFELLSMN-LYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251 (429)
T ss_dssp EEEEEECCCCCB-HHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred eEEEEEeccCCC-HHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence 678999999864 44333 34899999999999999999999999999999999999998772 299999999976
Q ss_pred cCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhh
Q 020826 166 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245 (321)
Q Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (321)
... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..|| .+.+..+.+..+.+.++.+.........
T Consensus 252 ~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltG~~pf-~~~~~~~~l~~i~~~~~~p~~~~~~~~~ 327 (429)
T 3kvw_A 252 EHQ--RVYTYIQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLL-PGEDEGDQLACMIELLGMPSQKLLDASK 327 (429)
T ss_dssp TTC--CCCSSCSCGGGCCHHHHHT-BCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHTBT
T ss_pred cCC--cccccCCCCCccChHHHhC-CCCCchHHHHhHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHcCCCCHHHHHhhh
Confidence 532 3345678999999999987 67899999999999999999999887 5667777888887777765443221110
Q ss_pred cc------cCChhhHhhh----------------cccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHh
Q 020826 246 HI------ELDPHLAALV----------------GRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 303 (321)
Q Consensus 246 ~~------~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell 303 (321)
.. ...+...... ......+.............++++.+||++||++||++|||++|+|
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L 407 (429)
T 3kvw_A 328 RAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQAL 407 (429)
T ss_dssp THHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred hhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHh
Confidence 00 0000000000 0000000011111111223467899999999999999999999999
Q ss_pred cCCCcccCCCc
Q 020826 304 AHPYFFPIRNA 314 (321)
Q Consensus 304 ~hp~~~~~~~~ 314 (321)
+||||++....
T Consensus 408 ~Hpw~~~~~~~ 418 (429)
T 3kvw_A 408 RHPWLRRRLPK 418 (429)
T ss_dssp TSTTTC-----
T ss_pred CChhhccCCCC
Confidence 99999986443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-49 Score=348.89 Aligned_cols=258 Identities=24% Similarity=0.404 Sum_probs=201.4
Q ss_pred cccCceEEe-eeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeeeec--cCCCCcE
Q 020826 18 REQDDYEVV-RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRD--QQSKTPS 94 (321)
Q Consensus 18 ~~~~~y~~~-~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~~~ 94 (321)
...++|.+. +.||+|+||+||+|.+..+++.||+|+++. ...+.+|+.++.++.+||||+++++++.. ....+++
T Consensus 58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~--~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc--chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 345678887 689999999999999999999999999864 45678899998777699999999998854 2245678
Q ss_pred EEEEeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcC---CCCeEEEeeccceeec
Q 020826 95 LIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH---EQRKLRLIDWGLAEFY 166 (321)
Q Consensus 95 lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~---~~~~v~l~dfg~~~~~ 166 (321)
+||||+.+++|.+++. .+++..++.++.||+.||.|||++||+|+||||+||+++. ++ .+||+|||++...
T Consensus 136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~-~~kl~DFG~a~~~ 214 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAKET 214 (400)
T ss_dssp EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTC-CEEECCCTTCEEC
T ss_pred EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCc-cEEEEeccccccc
Confidence 9999999999987773 3899999999999999999999999999999999999987 44 7999999999876
Q ss_pred CCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCCh---HHHHHHHHHhCChhhhHHhh
Q 020826 167 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY---DQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~ 243 (321)
..........+|+.|+|||++.+ ..++.++|||||||++|+|++|..||....... .....+..
T Consensus 215 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~------------ 281 (400)
T 1nxk_A 215 TSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM------------ 281 (400)
T ss_dssp C-----------CTTCCGGGSCC-CCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHH------------
T ss_pred CCCCccccCCCCCCccCHhhcCC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHc------------
Confidence 65555566788999999999977 789999999999999999999999995433211 01111100
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
.....+ ......+|+++.+||++||+.||++|||++|+++||||.+..
T Consensus 282 ---------------~~~~~~------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 282 ---------------GQYEFP------NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp ---------------TCCCCC------TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred ---------------CcccCC------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 000000 001124678999999999999999999999999999998653
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-49 Score=344.25 Aligned_cols=259 Identities=27% Similarity=0.442 Sum_probs=207.7
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
...++|++.+.||+|+||+||+|.++.+++.||+|+++... ....+|++++.++.+||||+++++++.+ ....++||
T Consensus 19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~-~~~~~E~~~l~~~~~hp~iv~~~~~~~~--~~~~~lv~ 95 (342)
T 2qr7_A 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK-RDPTEEIEILLRYGQHPNIITLKDVYDD--GKYVYVVT 95 (342)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTT-CCCHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEEEE
T ss_pred CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEccc-CChHHHHHHHHHhcCCCCcCeEEEEEEc--CCEEEEEE
Confidence 34678999999999999999999999999999999997543 3456789999988789999999999955 45678999
Q ss_pred EeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCC---CeEEEeeccceeecCCC-C
Q 020826 98 EHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ---RKLRLIDWGLAEFYHPG-K 170 (321)
Q Consensus 98 e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~---~~v~l~dfg~~~~~~~~-~ 170 (321)
||+.+++|.+.+ ..+++..+..++.||+.||+|||++|++|+||||+||++..++ ..+||+|||++...... .
T Consensus 96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~ 175 (342)
T 2qr7_A 96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175 (342)
T ss_dssp CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence 999999887766 3589999999999999999999999999999999999985432 14999999999876433 2
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCC-Ch-HHHHHHHHHhCChhhhHHhhhhccc
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD-NY-DQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||..... .. +....+... ...
T Consensus 176 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~-~~~------------ 241 (342)
T 2qr7_A 176 LLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG-KFS------------ 241 (342)
T ss_dssp CBCCSSCCSSCCCHHHHHH-HHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHC-CCC------------
T ss_pred ceeccCCCccccCHHHhcC-CCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccC-Ccc------------
Confidence 3445678999999999976 5688999999999999999999999954321 11 122221110 000
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCC
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~ 313 (321)
........+|+++.+||++||+.||++|||+.++++||||.++..
T Consensus 242 --------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~~ 286 (342)
T 2qr7_A 242 --------------------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ 286 (342)
T ss_dssp --------------------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGGG
T ss_pred --------------------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCccc
Confidence 000011246789999999999999999999999999999987643
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=342.44 Aligned_cols=285 Identities=31% Similarity=0.554 Sum_probs=218.1
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC---
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK--- 91 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~--- 91 (321)
.++|++.+.||+|+||+||+|.+..+++.||+|+++... ...+.+|+.+++.+ +||||+++++++......
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhc-CCCCchhhhhheeccCCcccc
Confidence 468999999999999999999999999999999987532 35678999999999 899999999998654432
Q ss_pred -CcEEEEEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 92 -TPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 92 -~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
..++++|++.+.........+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++.....
T Consensus 120 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~~~~-- 196 (371)
T 4exu_A 120 YDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLARHADA-- 196 (371)
T ss_dssp CCCEEEEECCCEEHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECSTTCC-------
T ss_pred eeEEEEEccccccHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCC-CEEEEecCccccccc--
Confidence 2489999999644444445699999999999999999999999999999999999999888 899999999975432
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
......+|+.|+|||++.+...++.++|||||||++|+|++|..|| .+.+..+.+..+.+..+.+........ ..
T Consensus 197 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~----~~ 271 (371)
T 4exu_A 197 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF-KGKDYLDQLTQILKVTGVPGTEFVQKL----ND 271 (371)
T ss_dssp ---CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCHHHHTTC----SC
T ss_pred CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCcHHHHHHh----hh
Confidence 2345678999999999987568899999999999999999999998 455566677777776666543221110 01
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
.............+...+. .....+++++.+||++||+.||++|||++|+++||||+....+.
T Consensus 272 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 334 (371)
T 4exu_A 272 KAAKSYIQSLPQTPRKDFT--QLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPE 334 (371)
T ss_dssp HHHHHHHHHSCCCCCCCHH--HHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred hhhhhhhhccCCCcchhHH--HhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCcc
Confidence 1111111111111111111 11234678999999999999999999999999999999875543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=356.54 Aligned_cols=260 Identities=25% Similarity=0.500 Sum_probs=212.2
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecc-----cchHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~-----~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
+...++|++.+.||+|+||+||+|++..+++.||+|++.. .....+.+|+.+++++ +||||+++++++.+ ..
T Consensus 18 g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~ 94 (486)
T 3mwu_A 18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILED--SS 94 (486)
T ss_dssp CHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SS
T ss_pred CChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhC-CCCCcCeEEEEEEc--CC
Confidence 3467899999999999999999999998999999999853 2346788999999999 99999999999965 45
Q ss_pred CcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCC--CeEEEeeccceeec
Q 020826 92 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEFY 166 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~--~~v~l~dfg~~~~~ 166 (321)
..++|+|++.+++|...+ ..+++..++.++.||+.||.|||++||+|+||||+||+++..+ ..+||+|||++...
T Consensus 95 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 678999999999887665 5699999999999999999999999999999999999996432 27999999999766
Q ss_pred CCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhc
Q 020826 167 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246 (321)
Q Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (321)
..........+|+.|+|||++.+ .++.++|||||||++|+|++|..||. +.+..+.+..+.........
T Consensus 175 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~~~-------- 243 (486)
T 3mwu_A 175 QQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFY-GKNEYDILKRVETGKYAFDL-------- 243 (486)
T ss_dssp CCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCCCSCS--------
T ss_pred CCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCCCCCC--------
Confidence 65555566789999999999875 58999999999999999999999984 34433444333221111100
Q ss_pred ccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
.....+|+++.+||++||+.||++|||+.++|+||||++.....
T Consensus 244 -------------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~ 287 (486)
T 3mwu_A 244 -------------------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSET 287 (486)
T ss_dssp -------------------------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCC
T ss_pred -------------------------cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcccC
Confidence 01124678999999999999999999999999999999875543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=327.92 Aligned_cols=259 Identities=22% Similarity=0.361 Sum_probs=209.0
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
..++|++.+.||+|+||+||+|.+..+++.|++|+++... ...+.+|+.+++.+ +||||+++++++.+ ....+
T Consensus 5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~ 81 (276)
T 2yex_A 5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRRE--GNIQY 81 (276)
T ss_dssp HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTC-CCTTBCCEEEEEEE--TTEEE
T ss_pred eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhc-CCCCceeeeeEEEc--CCEEE
Confidence 4578999999999999999999998899999999986432 36688999999999 89999999999865 45567
Q ss_pred EEEEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-
Q 020826 95 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 170 (321)
Q Consensus 95 lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~- 170 (321)
+++|++.+++|.+++. .+++..++.++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||.+.......
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 82 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNR 160 (276)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECEETTE
T ss_pred EEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCC-CEEEeeCCCccccCCCcc
Confidence 9999999999988874 489999999999999999999999999999999999999888 89999999987653221
Q ss_pred --ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 171 --EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
......++..|+|||.+.+....+.++||||||+++|+|++|..||................
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------------- 224 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK---------------- 224 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT----------------
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc----------------
Confidence 23445688999999999874445789999999999999999999995433322222211100
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCccc
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAES 316 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~~ 316 (321)
.. .......+++++.++|++||+.||++|||++|+++||||++......
T Consensus 225 -----------~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~ 273 (276)
T 2yex_A 225 -----------KT--------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGA 273 (276)
T ss_dssp -----------CT--------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC---
T ss_pred -----------cc--------ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhhccC
Confidence 00 00011246689999999999999999999999999999998755443
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=339.18 Aligned_cols=251 Identities=21% Similarity=0.373 Sum_probs=199.6
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC----
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---- 90 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~---- 90 (321)
..++|++.+.||+|+||+||+|++..+++.||+|+++.. ..+.+.+|+.+++++ +||||+++++++.+...
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKL-EHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSC-CCTTBCCEEEEEEECCSCHHH
T ss_pred hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEeccchhh
Confidence 457899999999999999999999889999999998632 346788999999999 89999999998854332
Q ss_pred ---------------------------------------------------CCcEEEEEeecCchhhhhcCC------CC
Q 020826 91 ---------------------------------------------------KTPSLIFEHVNNTDFKVLYPT------LS 113 (321)
Q Consensus 91 ---------------------------------------------------~~~~lv~e~~~~~~l~~~~~~------~~ 113 (321)
.+.+++|||+.+++|.+++.. .+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 237899999999999887732 45
Q ss_pred HHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-------------ccccccCCcc
Q 020826 114 DYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-------------EYNVRVASRY 180 (321)
Q Consensus 114 ~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~-------------~~~~~~~~~~ 180 (321)
...++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++....... ......+|+.
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 241 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCC-CEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence 566899999999999999999999999999999999888 89999999998765432 2233568999
Q ss_pred ccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhccc
Q 020826 181 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRH 260 (321)
Q Consensus 181 y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (321)
|+|||++.+ ..++.++|||||||++|+|++|..|+. ............. .+.
T Consensus 242 y~aPE~~~~-~~~~~~~Di~slG~il~el~~~~~~~~------~~~~~~~~~~~~~-~~~-------------------- 293 (332)
T 3qd2_B 242 YMSPEQIHG-NNYSHKVDIFSLGLILFELLYSFSTQM------ERVRIITDVRNLK-FPL-------------------- 293 (332)
T ss_dssp GSCHHHHHC-CCCCTHHHHHHHHHHHHHHHSCCCCHH------HHHHHHHHHHTTC-CCH--------------------
T ss_pred ccChHHhcC-CCCcchhhHHHHHHHHHHHHHcCCChh------HHHHHHHHhhccC-CCc--------------------
Confidence 999999987 688999999999999999999876541 1111111100000 000
Q ss_pred CCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 261 SRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 261 ~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
.....++++.++|.+||+.||++|||++|+++||||+++
T Consensus 294 ------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 294 ------------LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp ------------HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred ------------ccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence 001234678999999999999999999999999999874
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=334.25 Aligned_cols=254 Identities=22% Similarity=0.412 Sum_probs=209.8
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc---chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 98 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 98 (321)
.|+..+.||+|+||+||+|++..+++.||||+++.. ....+.+|+.+++.+ +||||+++++++... ...++|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDY-QHFNVVEMYKSYLVG--EELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTC-CCTTBCCEEEEEEET--TEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhC-CCCCcceEEEEEEEC--CEEEEEEe
Confidence 488889999999999999999889999999998643 345688999999999 899999999998654 45679999
Q ss_pred eecCchhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-ccccc
Q 020826 99 HVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-EYNVR 175 (321)
Q Consensus 99 ~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~-~~~~~ 175 (321)
|+.+++|.+++. .+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++....... .....
T Consensus 123 ~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~~~~~~ 201 (321)
T 2c30_A 123 FLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSL 201 (321)
T ss_dssp CCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSSSCCBCCC
T ss_pred cCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-cEEEeeeeeeeecccCccccccc
Confidence 999999988875 589999999999999999999999999999999999999888 89999999987664332 23456
Q ss_pred cCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHh
Q 020826 176 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAA 255 (321)
Q Consensus 176 ~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (321)
.+|+.|+|||++.+ ..++.++||||||+++|+|++|..||.. .........+.... .+
T Consensus 202 ~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~-~~~~~~~~~~~~~~-~~------------------- 259 (321)
T 2c30_A 202 VGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFS-DSPVQAMKRLRDSP-PP------------------- 259 (321)
T ss_dssp CSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSS-CC-------------------
T ss_pred cCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhcCC-CC-------------------
Confidence 78999999999987 7889999999999999999999999843 22222222211100 00
Q ss_pred hhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 256 LVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
.......+++++.++|.+||+.||++|||++|+++||||++...++
T Consensus 260 --------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 305 (321)
T 2c30_A 260 --------------KLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPE 305 (321)
T ss_dssp --------------CCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCCGG
T ss_pred --------------CcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCCCcc
Confidence 0011224668899999999999999999999999999999876554
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=349.55 Aligned_cols=256 Identities=25% Similarity=0.412 Sum_probs=198.7
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----------hHHHHHHHHHHHhhcCCCCeeeeeeeeec
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRD 87 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (321)
..++|++.+.||+|+||+||+|.+..+++.||+|++.... ...+.+|+.+++++ +||||+++++++..
T Consensus 133 ~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~ 211 (419)
T 3i6u_A 133 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDA 211 (419)
T ss_dssp HHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHC-CCTTBCCCCEEEES
T ss_pred hhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhC-CCCCEeeEEEEEec
Confidence 3578999999999999999999999999999999986432 12478999999999 99999999999854
Q ss_pred cCCCCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCC--CeEEEeeccc
Q 020826 88 QQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGL 162 (321)
Q Consensus 88 ~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~--~~v~l~dfg~ 162 (321)
. ..++||||+.+++|.+++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ ..+||+|||+
T Consensus 212 ~---~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~ 288 (419)
T 3i6u_A 212 E---DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 288 (419)
T ss_dssp S---EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred C---ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccc
Confidence 3 357999999999998776 3589999999999999999999999999999999999997544 2599999999
Q ss_pred eeecCCCCccccccCCccccccccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhH
Q 020826 163 AEFYHPGKEYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 240 (321)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (321)
+.............||+.|+|||++.+ ...++.++|||||||++|+|++|..||............+.. ......+
T Consensus 289 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~-~~~~~~~- 366 (419)
T 3i6u_A 289 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITS-GKYNFIP- 366 (419)
T ss_dssp TTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHT-TCCCCCH-
T ss_pred ceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhc-CCCCCCc-
Confidence 987655544556789999999999853 356788999999999999999999999533222222221111 0000000
Q ss_pred HhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 241 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
.....+++++.+||++||+.||++|||++|+++||||++.
T Consensus 367 -------------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 367 -------------------------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp -------------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred -------------------------------hhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 0112367899999999999999999999999999999864
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=342.85 Aligned_cols=293 Identities=28% Similarity=0.477 Sum_probs=213.4
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc--hHHHHHHHHHHHhhcCCCCeeeeeeeeeccC----
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ---- 89 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~---- 89 (321)
.....++|++.+.||+|+||+||+|++..+++.||+|++.... .....+++..+..+ +||||+++++++....
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l-~h~niv~~~~~~~~~~~~~~ 96 (360)
T 3e3p_A 18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-HHPNIVQLQSYFYTLGERDR 96 (360)
T ss_dssp HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHH-CCTTBCCEEEEEEEECSSCT
T ss_pred chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhc-CCCCcccHHHhhhccccccc
Confidence 3455679999999999999999999999999999999886432 34566777788888 8999999999985432
Q ss_pred -CCCcEEEEEeecCchhhhhc------CCCCHHHHHHHHHHHHHHHHHHH--HCCCeeecCCCCCeEEcC-CCCeEEEee
Q 020826 90 -SKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCH--SQGIMHRDVKPHNVMIDH-EQRKLRLID 159 (321)
Q Consensus 90 -~~~~~lv~e~~~~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lh--~~~i~H~dlkp~nili~~-~~~~v~l~d 159 (321)
..+.++||||+.++.+.... ..+++..++.++.|++.||.||| ++|++|+||||+||+++. ++ .++|+|
T Consensus 97 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~-~~kl~D 175 (360)
T 3e3p_A 97 RDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADG-TLKLCD 175 (360)
T ss_dssp TCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTT-EEEECC
T ss_pred cceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCC-cEEEee
Confidence 23478999999987543322 35889999999999999999999 999999999999999997 55 899999
Q ss_pred ccceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhh
Q 020826 160 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN 239 (321)
Q Consensus 160 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (321)
||++.............+|+.|+|||++.+...++.++|||||||++|+|++|..|| .+.+....+..+...++.+...
T Consensus 176 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~ 254 (360)
T 3e3p_A 176 FGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF-RGDNSAGQLHEIVRVLGCPSRE 254 (360)
T ss_dssp CTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHH
T ss_pred CCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCc-CCCChHHHHHHHHHHcCCCCHH
Confidence 999987765555566778999999999977566899999999999999999999888 4555666777777777665443
Q ss_pred HHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCccc
Q 020826 240 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAES 316 (321)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~~ 316 (321)
.+............. .....++... ........++++.+||.+||+.||++|||+.|+++||||+++..+..
T Consensus 255 ~~~~~~~~~~~~~~~----~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~ 326 (360)
T 3e3p_A 255 VLRKLNPSHTDVDLY----NSKGIPWSNV-FSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPAT 326 (360)
T ss_dssp HHHHHCTTCCCGGGG----CCCCCCHHHH-TTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTTC
T ss_pred HHHhcccchhhcccc----ccccCCcccc-cchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCccc
Confidence 322211111100000 0000000000 01112235678999999999999999999999999999999866543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-49 Score=354.38 Aligned_cols=251 Identities=26% Similarity=0.433 Sum_probs=200.9
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
..++|++.+.||+|+||+||+|++..+++.||+|+++.. ....+.+|+.+++.+ +||||+++++++.+. ..
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~l~~~~~~~--~~ 222 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS-RHPFLTALKYSFQTH--DR 222 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCC-SCTTSCCEEEEEEET--TE
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhC-CCCeEeeEEEEEeeC--CE
Confidence 357899999999999999999999999999999998743 224567888888888 899999999999654 45
Q ss_pred cEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 93 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~-~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
.++||||+.+++|..++ ..+++..+..++.||+.||+|||+ +||+|+||||+||+++.++ .+||+|||++.....
T Consensus 223 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS-CEEECCCCCCCTTCC
T ss_pred EEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC-CEEEccCCCceeccC
Confidence 78999999999987776 568999999999999999999998 9999999999999999888 899999999875332
Q ss_pred -CCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 169 -GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 169 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
........||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+.......+.. .
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~Pf~-~~~~~~~~~~i~~-~-------------- 364 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY-NQDHEKLFELILM-E-------------- 364 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHT-SCCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHH-C--------------
T ss_pred CCcccccccCCccccCHhhcCC-CCCCCccchhhhHHHHHHHhhCCCCCC-CCCHHHHHHHHHh-C--------------
Confidence 233455689999999999987 789999999999999999999999994 2222222222211 0
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc-----CHHHHhcCCCcccCC
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIR 312 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp-----s~~ell~hp~~~~~~ 312 (321)
....+..+++++.+||.+||+.||++|| |++|+++||||++++
T Consensus 365 ----------------------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~ 412 (446)
T 4ejn_A 365 ----------------------EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIV 412 (446)
T ss_dssp ----------------------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred ----------------------CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCC
Confidence 0011224678999999999999999999 999999999999864
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=343.16 Aligned_cols=245 Identities=25% Similarity=0.445 Sum_probs=206.7
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----------hHHHHHHHHHHHhhcCCCCeeeeeeeeec
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRD 87 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (321)
..++|++.+.||+|+||+||+|++..+++.||+|+++... ...+.+|+.+++.+ +||||+++++++.+
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~Iv~~~~~~~~ 100 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRV-EHANIIKVLDIFEN 100 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTC-CCTTBCCEEEEEEC
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEee
Confidence 4578999999999999999999999999999999987532 23577899999999 89999999999954
Q ss_pred cCCCCcEEEEEeecCc-hhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccce
Q 020826 88 QQSKTPSLIFEHVNNT-DFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163 (321)
Q Consensus 88 ~~~~~~~lv~e~~~~~-~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~ 163 (321)
....++|+|++.++ +|..++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++
T Consensus 101 --~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~a 177 (335)
T 3dls_A 101 --QGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF-TIKLIDFGSA 177 (335)
T ss_dssp --SSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTC
T ss_pred --CCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCC-cEEEeecccc
Confidence 45677999998766 777666 3589999999999999999999999999999999999999887 8999999999
Q ss_pred eecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 164 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
.............+|+.|+|||++.+....+.++|||||||++|+|++|..||.....
T Consensus 178 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---------------------- 235 (335)
T 3dls_A 178 AYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE---------------------- 235 (335)
T ss_dssp EECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG----------------------
T ss_pred eECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH----------------------
Confidence 8876665556678999999999998744448899999999999999999999831000
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
... .....+..+++++.+||.+||+.||++|||++++++||||++.
T Consensus 236 ------------~~~----------~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 236 ------------TVE----------AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp ------------GTT----------TCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred ------------HHh----------hccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 000 0011122467899999999999999999999999999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=357.34 Aligned_cols=254 Identities=24% Similarity=0.404 Sum_probs=212.6
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
...++|++.+.||+|+||.||+|++..+++.||+|++... ....+.+|+.++..+ +||||+++++++.+ ..
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~--~~ 257 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKV-NSRFVVSLAYAYET--KD 257 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SS
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHc-CCCCEeeEEEEEee--CC
Confidence 4567899999999999999999999999999999998643 234578899999999 89999999999965 45
Q ss_pred CcEEEEEeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeec
Q 020826 92 TPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 166 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~ 166 (321)
..++||||+.+++|..++. .+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||++...
T Consensus 258 ~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g-~vKL~DFGla~~~ 336 (576)
T 2acx_A 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG-HIRISDLGLAVHV 336 (576)
T ss_dssp EEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEEC
T ss_pred EEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCC-CeEEEecccceec
Confidence 6789999999999977662 389999999999999999999999999999999999999888 8999999999887
Q ss_pred CCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCC--hHHHHHHHHHhCChhhhHHhhh
Q 020826 167 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN--YDQLVKIAKVLGTDELNAYLNK 244 (321)
Q Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 244 (321)
..........||+.|+|||++.+ ..++.++|+|||||++|+|++|..||...... ...+........
T Consensus 337 ~~~~~~~~~~GT~~Y~APEvl~~-~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~---------- 405 (576)
T 2acx_A 337 PEGQTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP---------- 405 (576)
T ss_dssp CTTCCEECCCSCGGGCCHHHHTT-CEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCC----------
T ss_pred ccCccccccCCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhccc----------
Confidence 65555566789999999999987 67899999999999999999999999543221 111221111000
Q ss_pred hcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc-----CHHHHhcCCCcccCC
Q 020826 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIR 312 (321)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp-----s~~ell~hp~~~~~~ 312 (321)
...+..+|+++.+||++||+.||++|| +++|+++||||++++
T Consensus 406 --------------------------~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~ 452 (576)
T 2acx_A 406 --------------------------EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452 (576)
T ss_dssp --------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred --------------------------ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence 011234678999999999999999999 899999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-49 Score=348.50 Aligned_cols=259 Identities=26% Similarity=0.401 Sum_probs=209.5
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
...++|++.+.||+|+||+||+|+++.+++.||+|++++.. ...+.+|..++..+ +||||+++++++.+ ..
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~-~hp~Iv~l~~~~~~--~~ 134 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNG-DRRWITQLHFAFQD--EN 134 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHS-CTTTBCCEEEEEEC--SS
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhc-CCCCeeeEEEEEee--CC
Confidence 34689999999999999999999999999999999997432 24478899999998 99999999999965 45
Q ss_pred CcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 92 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
..++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||++....
T Consensus 135 ~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g-~vkL~DFGla~~~~ 213 (412)
T 2vd5_A 135 YLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG-HIRLADFGSCLKLR 213 (412)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECC
T ss_pred EEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCC-CEEEeechhheecc
Confidence 678999999999988776 3699999999999999999999999999999999999999888 89999999998765
Q ss_pred CCCc--cccccCCccccccccccC------CCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhh
Q 020826 168 PGKE--YNVRVASRYFKGPELLVD------LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN 239 (321)
Q Consensus 168 ~~~~--~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (321)
.... ....+||+.|+|||++.. ...++.++|+|||||++|+|++|+.||. +.+..+....+........
T Consensus 214 ~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~-~~~~~~~~~~i~~~~~~~~-- 290 (412)
T 2vd5_A 214 ADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFY-ADSTAETYGKIVHYKEHLS-- 290 (412)
T ss_dssp TTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHTHHHHCC--
T ss_pred CCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCC-CCCHHHHHHHHHhcccCcC--
Confidence 4433 234579999999999873 2468899999999999999999999994 3333333333221000000
Q ss_pred HHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCC---cCHHHHhcCCCcccCCCc
Q 020826 240 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER---PTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~R---ps~~ell~hp~~~~~~~~ 314 (321)
.+ .....+|+++++||++||+ +|++| |+++|+++||||+.++-.
T Consensus 291 -----------------------~p-------~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~ 337 (412)
T 2vd5_A 291 -----------------------LP-------LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWD 337 (412)
T ss_dssp -----------------------CC-----------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCST
T ss_pred -----------------------CC-------ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 00 0012477899999999999 99998 599999999999986543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=330.64 Aligned_cols=254 Identities=24% Similarity=0.457 Sum_probs=206.8
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
...++|++.+.||+|+||+||+|.+..++..+|+|++.... ...+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~ 82 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHD--AT 82 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SS
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcC-CCCCCcchhheEec--CC
Confidence 34679999999999999999999999999999999986432 35688899999999 89999999999955 45
Q ss_pred CcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 92 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
..+++|||+.+++|...+ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++.....
T Consensus 83 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~-~~~l~Dfg~~~~~~~ 161 (279)
T 3fdn_A 83 RVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPS 161 (279)
T ss_dssp EEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTS-CEEECSCCEESCC--
T ss_pred EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCC-CEEEEeccccccCCc
Confidence 577999999999887766 5689999999999999999999999999999999999999888 899999998865432
Q ss_pred CCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 169 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
. ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||. ..+.......+.. ..
T Consensus 162 ~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~-~~-------------- 223 (279)
T 3fdn_A 162 S-RRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISR-VE-------------- 223 (279)
T ss_dssp -------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHH-TC--------------
T ss_pred c-cccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCC-CCcHHHHHHHHHh-CC--------------
Confidence 2 2344578999999999987 788999999999999999999999983 2222222222211 00
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
...+..+++++.+||.+||+.||++|||++|+++||||+...+..
T Consensus 224 ----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~ 268 (279)
T 3fdn_A 224 ----------------------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKP 268 (279)
T ss_dssp ----------------------CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSSC
T ss_pred ----------------------CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCccCc
Confidence 011223567899999999999999999999999999999876554
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-49 Score=345.94 Aligned_cols=253 Identities=25% Similarity=0.421 Sum_probs=203.2
Q ss_pred CceEE--eeeeeeecceEEEEEEEecCCceEEEEEeccc---chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 21 DDYEV--VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 21 ~~y~~--~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
..|.+ .+.||+|+||+||+|.+..+++.||+|+++.. ....+.+|+.+++++ +||||+++++++.+ ....++
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~--~~~~~l 163 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL-DHANLIQLYDAFES--KNDIVL 163 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhC-CCCCCCeEEEEEEE--CCEEEE
Confidence 44555 67899999999999999999999999999764 346688999999999 89999999999965 345789
Q ss_pred EEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEc--CCCCeEEEeeccceeecCCC
Q 020826 96 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID--HEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 96 v~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~--~~~~~v~l~dfg~~~~~~~~ 169 (321)
||||+.+++|.+++ ..+++..+..++.||+.||+|||+.|++|+||||+||++. .++ .++|+|||++......
T Consensus 164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~-~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPR 242 (373)
T ss_dssp EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTT-EEEECCCSSCEECCTT
T ss_pred EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCC-cEEEEeCCCceecCCc
Confidence 99999999886655 2489999999999999999999999999999999999994 344 8999999999887666
Q ss_pred CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 170 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
.......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+.......
T Consensus 243 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~-~~~~~~~~~~i~~~~~~~------------- 307 (373)
T 2x4f_A 243 EKLKVNFGTPEFLAPEVVNY-DFVSFPTDMWSVGVIAYMLLSGLSPFL-GDNDAETLNNILACRWDL------------- 307 (373)
T ss_dssp CBCCCCCSSCTTCCHHHHTT-CBCCHHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHHTCCCS-------------
T ss_pred cccccccCCCcEeChhhccC-CCCCcHHhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhccCCC-------------
Confidence 55566779999999999976 678999999999999999999999984 333333333332211000
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
+ ......+++++.+||.+||+.||++|||++|+++||||++..
T Consensus 308 --------------~------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 308 --------------E------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK 350 (373)
T ss_dssp --------------C------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred --------------C------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence 0 001124678999999999999999999999999999999763
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=355.98 Aligned_cols=253 Identities=27% Similarity=0.499 Sum_probs=206.6
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
.++|++++.||+|+||+||+|++..++..+|+|+++.. ....+.+|+.+++.+ +||||+++++++.+ ....+
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~~~~ 112 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL-DHPNIMKLYDFFED--KRNYY 112 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhC-CCCCCCeEEEEEEe--CCEEE
Confidence 45799999999999999999999999999999998643 346688999999999 89999999999965 45678
Q ss_pred EEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCC--CeEEEeeccceeecCCC
Q 020826 95 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 95 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~--~~v~l~dfg~~~~~~~~ 169 (321)
+||||+.+++|.+.+ ..+++..++.++.||+.||+|||++|++|+||||+||+++..+ ..+||+|||++......
T Consensus 113 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~ 192 (494)
T 3lij_A 113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192 (494)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence 999999999886665 5699999999999999999999999999999999999997543 25999999999887666
Q ss_pred CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 170 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
.......+|+.|+|||++.+ .++.++|||||||++|+|++|..||. +.+..+.+..+.........
T Consensus 193 ~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~~~----------- 258 (494)
T 3lij_A 193 KKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFG-GQTDQEILRKVEKGKYTFDS----------- 258 (494)
T ss_dssp BCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCCCCCS-----------
T ss_pred ccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCCCCCc-----------
Confidence 56666789999999999864 68999999999999999999999983 33333333333221111000
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
.....+|+++.+||++||+.||++|||+.|+|+||||++.
T Consensus 259 ----------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 259 ----------------------PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp ----------------------GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred ----------------------hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 0112467899999999999999999999999999999874
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-49 Score=338.72 Aligned_cols=277 Identities=19% Similarity=0.299 Sum_probs=212.2
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
....++|++.+.||+|+||+||+|.+..+++.||+|+++... ...+.+|+.+++.+ +||||+++++++.+.....
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCC
T ss_pred cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCcceEEEEeecCCCce
Confidence 355789999999999999999999999999999999987532 35678999999999 8999999999998777667
Q ss_pred cEEEEEeecCchhhhhcCC------CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEE----cCCCCeEEEeeccc
Q 020826 93 PSLIFEHVNNTDFKVLYPT------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHEQRKLRLIDWGL 162 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~~~------~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili----~~~~~~v~l~dfg~ 162 (321)
.++||||+.+++|..++.. +++..++.++.|++.||+|||++|++|+||||+||++ +.++ .+||+|||+
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~-~~kL~Dfg~ 162 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFGA 162 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCE-EEEECCCTT
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCc-eEEEccCCC
Confidence 8999999999999887732 8999999999999999999999999999999999998 5555 799999999
Q ss_pred eeecCCCCccccccCCccccccccccC-------CCCCCCcchHHHHHHHHHHHHhCCCCCccCCCC---hHHHHHHHHH
Q 020826 163 AEFYHPGKEYNVRVASRYFKGPELLVD-------LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN---YDQLVKIAKV 232 (321)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~---~~~~~~~~~~ 232 (321)
+.............+|..|+|||++.. ...++.++|||||||++|+|++|..||...... .+.+..+...
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 242 (319)
T 4euu_A 163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (319)
T ss_dssp CEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred ceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence 988766666566789999999999862 267889999999999999999999999543322 2233333222
Q ss_pred hCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCC
Q 020826 233 LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 307 (321)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~ 307 (321)
............ .... ..-....+ ........+++.+.++|++||+.||++|||++|+++||=
T Consensus 243 ~p~~~~~~~~~~----~~~~----~~~~~~~~----~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 243 KPSGAISGVQKA----ENGP----IDWSGDMP----VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305 (319)
T ss_dssp CCTTCCEEEECS----TTCC----EEEESSCC----TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred CCcccchhhhcc----cCCc----cccCccCC----cccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence 111110000000 0000 00000000 000112235568999999999999999999999999973
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=337.05 Aligned_cols=286 Identities=28% Similarity=0.464 Sum_probs=215.1
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
--...++|++.+.||+|+||+||+|++..+++.||+|++.... ...+.+|+.+++.+ +||||+++++++.+ .
T Consensus 20 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~ 96 (331)
T 4aaa_A 20 YFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL-RHENLVNLLEVCKK--K 96 (331)
T ss_dssp CCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEE--T
T ss_pred hhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhC-CCCCEeeEEEEeec--C
Confidence 3345789999999999999999999999999999999985432 34567899999999 89999999999965 4
Q ss_pred CCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 91 KTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
...++||||+.++++..+. ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++....
T Consensus 97 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~ 175 (331)
T 4aaa_A 97 KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG-VVKLCDFGFARTLA 175 (331)
T ss_dssp TEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCTTC----
T ss_pred CEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCC-cEEEEeCCCceeec
Confidence 5668999999999988764 5699999999999999999999999999999999999999888 89999999997654
Q ss_pred C-CCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhc
Q 020826 168 P-GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246 (321)
Q Consensus 168 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (321)
. ........++..|+|||++.+...++.++|||||||++|+|++|..|| .+.+....+..+....+............
T Consensus 176 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (331)
T 4aaa_A 176 APGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF-PGDSDIDQLYHIMMCLGNLIPRHQELFNK 254 (331)
T ss_dssp --------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCHHHHHHHHH
T ss_pred CCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCChhhhhHhhh
Confidence 3 223345678999999999987557899999999999999999999888 45555556666555555432211100000
Q ss_pred ccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
.+..... .................+++++.+||.+||+.||++|||++|+|+||||+...
T Consensus 255 ---~~~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 314 (331)
T 4aaa_A 255 ---NPVFAGV---RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG 314 (331)
T ss_dssp ---CGGGTTC---CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred ---ccccccc---cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCC
Confidence 0000000 00000000001111235778999999999999999999999999999998753
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-49 Score=358.42 Aligned_cols=256 Identities=27% Similarity=0.487 Sum_probs=212.7
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
...++|++.+.||+|+||+||+|++..+++.||+|++... ....+.+|+.+++++ +||||+++++++.+ ..
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--~~ 99 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL-DHPNIMKLYEFFED--KG 99 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SS
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhC-CCCCCCcEEEEEEe--CC
Confidence 3467899999999999999999999999999999998532 356789999999999 89999999999965 45
Q ss_pred CcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEc---CCCCeEEEeeccceee
Q 020826 92 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID---HEQRKLRLIDWGLAEF 165 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~---~~~~~v~l~dfg~~~~ 165 (321)
..++|+|++.+++|.+.+ ..+++..++.++.||+.||+|||++|++|+||||+||+++ .++ .++|+|||++..
T Consensus 100 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~-~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 100 YFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDA-NIRIIDFGLSTH 178 (484)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTC-CEEECCTTHHHH
T ss_pred EEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCC-cEEEEeeeeeEE
Confidence 678999999999987666 4599999999999999999999999999999999999995 344 799999999987
Q ss_pred cCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhh
Q 020826 166 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245 (321)
Q Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (321)
...........+|+.|+|||++.+ .++.++|||||||++|+|++|..||. +.+..+.+..+........
T Consensus 179 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~~i~~~~~~~~-------- 247 (484)
T 3nyv_A 179 FEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFN-GANEYDILKKVEKGKYTFE-------- 247 (484)
T ss_dssp BCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCCCCCC--------
T ss_pred cccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCC-CCCHHHHHHHHHcCCCCCC--------
Confidence 765555566789999999999875 68999999999999999999999983 4444344433322111100
Q ss_pred cccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCC
Q 020826 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~ 313 (321)
......+|+++.+||++||+.||++|||++|+|+||||+....
T Consensus 248 -------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 248 -------------------------LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp -------------------------SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred -------------------------CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 0111246789999999999999999999999999999997644
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-48 Score=339.96 Aligned_cols=261 Identities=25% Similarity=0.439 Sum_probs=207.0
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc--------chHHHHHHHHHHHhhcCCCCeeeeeeeeecc
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 88 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (321)
....++|++.+.||+|+||+||+|.+..+++.+|+|+++.. ....+.+|+.+++.+ +||||+++++++.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~- 99 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL-HHPNIARLYEVYED- 99 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHC-CCTTBCCEEEEEEC-
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhC-CCCCcceeehhhcc-
Confidence 34467899999999999999999999999999999998643 235688999999999 89999999999955
Q ss_pred CCCCcEEEEEeecCchhhhhcC-------------------------------------------CCCHHHHHHHHHHHH
Q 020826 89 QSKTPSLIFEHVNNTDFKVLYP-------------------------------------------TLSDYDVRYYIYELL 125 (321)
Q Consensus 89 ~~~~~~lv~e~~~~~~l~~~~~-------------------------------------------~~~~~~~~~i~~qi~ 125 (321)
....++||||+.+++|.+++. .+++..++.++.|++
T Consensus 100 -~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 178 (345)
T 3hko_A 100 -EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178 (345)
T ss_dssp -SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred -CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence 456789999999999987773 135677889999999
Q ss_pred HHHHHHHHCCCeeecCCCCCeEEcCCCC-eEEEeeccceeecCCCC-----ccccccCCccccccccccCC-CCCCCcch
Q 020826 126 KALDYCHSQGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGK-----EYNVRVASRYFKGPELLVDL-QDYDYSLD 198 (321)
Q Consensus 126 ~~l~~lh~~~i~H~dlkp~nili~~~~~-~v~l~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~-~~~~~~~D 198 (321)
.||+|||++|++|+||||+||+++.++. .++|+|||++....... ......+|+.|+|||++.+. ..++.++|
T Consensus 179 ~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D 258 (345)
T 3hko_A 179 SALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258 (345)
T ss_dssp HHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred HHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence 9999999999999999999999986542 69999999998653211 13456789999999998642 56889999
Q ss_pred HHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCc
Q 020826 199 LWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAV 278 (321)
Q Consensus 199 vwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 278 (321)
||||||++|+|++|..||. +....+....+........ ......++
T Consensus 259 iwslG~il~el~~g~~pf~-~~~~~~~~~~~~~~~~~~~---------------------------------~~~~~~~~ 304 (345)
T 3hko_A 259 AWSAGVLLHLLLMGAVPFP-GVNDADTISQVLNKKLCFE---------------------------------NPNYNVLS 304 (345)
T ss_dssp HHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCCCCTT---------------------------------SGGGGGSC
T ss_pred HHHHHHHHHHHHHCCCCCC-CCChHHHHHHHHhcccccC---------------------------------CcccccCC
Confidence 9999999999999999983 3333333333222111000 00112366
Q ss_pred chHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 279 PEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 279 ~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
+++.+||.+||+.||++|||+.++++||||++....
T Consensus 305 ~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~~ 340 (345)
T 3hko_A 305 PLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDK 340 (345)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSSC
T ss_pred HHHHHHHHHHcCCChhHCCCHHHHhcChhhccChHh
Confidence 899999999999999999999999999999987543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=342.01 Aligned_cols=251 Identities=24% Similarity=0.426 Sum_probs=201.0
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHH-HhhcCCCCeeeeeeeeeccCCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKIL-QNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l-~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
..++|++++.||+|+||+||+|+++.+++.||+|++++.. ...+..|..++ +.+ +||||+++++++.+ ..
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~-~hp~Iv~l~~~~~~--~~ 112 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNV-KHPFLVGLHFSFQT--AD 112 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCC-CCTTBCCEEEEEEC--SS
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhC-CCCCCCCEEEEEEe--CC
Confidence 4578999999999999999999999999999999997542 23345566653 445 89999999999965 45
Q ss_pred CcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC-
Q 020826 92 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH- 167 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~- 167 (321)
..++||||+.+++|..++ ..+++..++.++.||+.||+|||++|++||||||+||+++.++ .+||+|||+++...
T Consensus 113 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~ikL~DFG~a~~~~~ 191 (373)
T 2r5t_A 113 KLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIE 191 (373)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCBCGGGBC
T ss_pred EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC-CEEEeeCcccccccc
Confidence 678999999999987776 4589999999999999999999999999999999999999888 89999999987532
Q ss_pred CCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 168 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
........+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||. +.+..+....+...
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~-~~~~~~~~~~i~~~--------------- 254 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFY-SRNTAEMYDNILNK--------------- 254 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTC-CSBHHHHHHHHHHS---------------
T ss_pred CCCccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHHhc---------------
Confidence 2334456789999999999987 788999999999999999999999984 23222222222110
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCH----HHHhcCCCcccCC
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA----KEAMAHPYFFPIR 312 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~----~ell~hp~~~~~~ 312 (321)
....+..+++++.+||++||+.||++||++ +++++||||+.++
T Consensus 255 ----------------------~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~ 301 (373)
T 2r5t_A 255 ----------------------PLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN 301 (373)
T ss_dssp ----------------------CCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred ----------------------ccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence 001123467899999999999999999987 6999999999764
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=334.94 Aligned_cols=280 Identities=21% Similarity=0.355 Sum_probs=203.4
Q ss_pred eeeecccCceEEe-eeeeeecceEEEEEEEecCCceEEEEEeccc---chHHHHHHHHHHHhhcCCCCeeeeeeeeeccC
Q 020826 14 WFINREQDDYEVV-RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 89 (321)
Q Consensus 14 ~~i~~~~~~y~~~-~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (321)
.+..+..++|++. +.||+|+||+||+|++..+++.||+|+++.. ....+.+|+.++.++.+||||+++++++.+.
T Consensus 5 ~~~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~- 83 (316)
T 2ac3_A 5 SFSGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE- 83 (316)
T ss_dssp SSCCCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-
T ss_pred ccCcccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-
Confidence 3456778899996 7899999999999999899999999998653 3467889999999976899999999999654
Q ss_pred CCCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCC--eEEEeecccee
Q 020826 90 SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGLAE 164 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~--~v~l~dfg~~~ 164 (321)
...++||||+.+++|.+++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.++. .++|+|||++.
T Consensus 84 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~ 162 (316)
T 2ac3_A 84 -DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGS 162 (316)
T ss_dssp -TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred -CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence 4678999999999988777 46999999999999999999999999999999999999987652 39999999986
Q ss_pred ecCCCC--------ccccccCCccccccccccCC----CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHH
Q 020826 165 FYHPGK--------EYNVRVASRYFKGPELLVDL----QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 232 (321)
Q Consensus 165 ~~~~~~--------~~~~~~~~~~y~aPE~~~~~----~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 232 (321)
...... ......+|..|+|||++.+. ..++.++|||||||++|+|++|..||............ ..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~-~~- 240 (316)
T 2ac3_A 163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR-GE- 240 (316)
T ss_dssp -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC------
T ss_pred ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc-cc-
Confidence 543211 12234589999999998641 34788999999999999999999999543221100000 00
Q ss_pred hCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 233 LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
....... .............+ ......+++++.+||++||+.||++|||++|+++||||++..
T Consensus 241 -~~~~~~~----------~~~~~i~~~~~~~~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 241 -ACPACQN----------MLFESIQEGKYEFP------DKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp -CCHHHHH----------HHHHHHHHCCCCCC------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred -cchhHHH----------HHHHHHhccCcccC------chhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 0000000 00000000000000 001124678999999999999999999999999999999875
Q ss_pred Cc
Q 020826 313 NA 314 (321)
Q Consensus 313 ~~ 314 (321)
..
T Consensus 304 ~~ 305 (316)
T 2ac3_A 304 PE 305 (316)
T ss_dssp --
T ss_pred Cc
Confidence 44
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-48 Score=326.78 Aligned_cols=256 Identities=23% Similarity=0.451 Sum_probs=187.6
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccC
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 89 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (321)
++...++|++.+.||+|+||+||+|++..+++.|++|++.... ...+.+|+.+++.+ +||||+++++++.+
T Consensus 6 ~g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-- 82 (278)
T 3cok_A 6 IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQL-KHPSILELYNYFED-- 82 (278)
T ss_dssp HCSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTB-CCTTBCCEEEEEEC--
T ss_pred cccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhC-CCCCeEeEEEEEcc--
Confidence 4556688999999999999999999998899999999986432 35688999999999 89999999999965
Q ss_pred CCCcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 90 SKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
....++++|++.+++|..++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++..
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~ 161 (278)
T 3cok_A 83 SNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM-NIKIADFGLATQ 161 (278)
T ss_dssp SSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred CCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEEEeecceee
Confidence 45678999999999987776 3489999999999999999999999999999999999999888 899999999976
Q ss_pred cCCC-CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhh
Q 020826 166 YHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244 (321)
Q Consensus 166 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (321)
.... .......+++.|+|||.+.+ ..++.++||||||+++|+|++|..||...... ..+..+
T Consensus 162 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~--------------- 224 (278)
T 3cok_A 162 LKMPHEKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVK-NTLNKV--------------- 224 (278)
T ss_dssp CC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------C---------------
T ss_pred ccCCCCcceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHH-HHHHHH---------------
Confidence 5432 22334568899999999987 67899999999999999999999998432211 111000
Q ss_pred hcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
.. .....+..+++++.++|.+||+.||++|||++++++||||.+....
T Consensus 225 ----------------~~------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 272 (278)
T 3cok_A 225 ----------------VL------ADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSST 272 (278)
T ss_dssp ----------------CS------SCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC-----
T ss_pred ----------------hh------cccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCCCc
Confidence 00 0011223467899999999999999999999999999999976543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=335.36 Aligned_cols=284 Identities=31% Similarity=0.568 Sum_probs=216.1
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC----
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS---- 90 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~---- 90 (321)
.++|.+.+.||+|+||+||+|.+..+++.||+|++.... ...+.+|+.+++.+ +||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM-QHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCCcccHhheEecccccccc
Confidence 478999999999999999999999999999999986432 35678999999999 89999999999865432
Q ss_pred CCcEEEEEeecCchhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 91 KTPSLIFEHVNNTDFKVLY-PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
...+++||++.+ +|..++ ..+++..+..++.||+.||+|||++|++|+||||+||+++.++ .++|+|||++.....
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~- 178 (353)
T 3coi_A 102 YDFYLVMPFMQT-DLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLARHADA- 178 (353)
T ss_dssp CCCEEEEECCSE-EGGGTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTC-CEEECSTTCTTC----
T ss_pred eeEEEEeccccC-CHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCC-cEEEeecccccCCCC-
Confidence 235899999985 555554 4699999999999999999999999999999999999999888 899999999875432
Q ss_pred CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 170 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
......+|+.|+|||++.+...++.++|||||||++|+|++|..|| .+.+....+..+.+..+.+....... ..
T Consensus 179 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~----~~ 252 (353)
T 3coi_A 179 -EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLF-KGKDYLDQLTQILKVTGVPGTEFVQK----LN 252 (353)
T ss_dssp ------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSS-BSSCHHHHHHHHHHHHCBCCHHHHTT----CS
T ss_pred -CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHHHHH----Hh
Confidence 2344578999999999877567899999999999999999999998 45555566666666666543222111 00
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
..............+...+. .....+++++.+||.+||+.||++|||++++++||||+....+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~ 316 (353)
T 3coi_A 253 DKAAKSYIQSLPQTPRKDFT--QLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPE 316 (353)
T ss_dssp CHHHHHHHHTSCBCSSCCTT--TTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred hHHHHHHHHhCcCCCCccHH--HhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCcc
Confidence 11111111111111111111 11235678999999999999999999999999999999876543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=327.57 Aligned_cols=259 Identities=21% Similarity=0.370 Sum_probs=208.7
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeec
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRD 87 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (321)
..-+......|++.+.||+|+||+||+|.+..++..|++|.+... ....+.+|+.+++.+ +||||+++++++.+
T Consensus 18 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~ 96 (290)
T 1t4h_A 18 AVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWES 96 (290)
T ss_dssp CCEECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEE
T ss_pred hhhcccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhC-CCCCeeeeeeeecc
Confidence 445566778899999999999999999999999999999998643 235688999999999 89999999998864
Q ss_pred c--CCCCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CeeecCCCCCeEEc-CCCCeEEEee
Q 020826 88 Q--QSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMID-HEQRKLRLID 159 (321)
Q Consensus 88 ~--~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~--i~H~dlkp~nili~-~~~~~v~l~d 159 (321)
. .....++||||+.+++|..++ ..+++..++.++.|++.||+|||+.| ++|+||||+||+++ .++ .++|+|
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~-~~kl~D 175 (290)
T 1t4h_A 97 TVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTG-SVKIGD 175 (290)
T ss_dssp ESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTS-CEEECC
T ss_pred ccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCC-CEEEee
Confidence 3 345678999999999998877 46999999999999999999999999 99999999999998 455 899999
Q ss_pred ccceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhh
Q 020826 160 WGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN 239 (321)
Q Consensus 160 fg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (321)
||++..... .......+++.|+|||++.+ .++.++||||||+++|+|++|..||............+......
T Consensus 176 fg~~~~~~~-~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---- 248 (290)
T 1t4h_A 176 LGLATLKRA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP---- 248 (290)
T ss_dssp TTGGGGCCT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC----
T ss_pred CCCcccccc-cccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc----
Confidence 999865432 23345678999999998864 58999999999999999999999984333222222111110000
Q ss_pred HHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 240 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
...+...++++.++|.+||+.||++|||++++++||||++.
T Consensus 249 -------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 249 -------------------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp -------------------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred -------------------------------cccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 01122355789999999999999999999999999999864
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-48 Score=337.25 Aligned_cols=291 Identities=28% Similarity=0.521 Sum_probs=220.0
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeecc---
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQ--- 88 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--- 88 (321)
+....++|++.+.||+|+||+||+|.+..+++.||+|+++... ...+.+|+.+++.+ +||||+++++++...
T Consensus 6 ~~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~ 84 (353)
T 2b9h_A 6 VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF-KHENIITIFNIQRPDSFE 84 (353)
T ss_dssp CCCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHC-CCTTBCCEEEECCCSCST
T ss_pred ccccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhC-cCCCcCCeeeeecccccC
Confidence 4456789999999999999999999998899999999986433 34567899999999 899999999987543
Q ss_pred CCCCcEEEEEeecCchhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeec
Q 020826 89 QSKTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 166 (321)
Q Consensus 89 ~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~ 166 (321)
.....++++|++.+ +|..++ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++...
T Consensus 85 ~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~ 162 (353)
T 2b9h_A 85 NFNEVYIIQELMQT-DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC-DLKVCDFGLARII 162 (353)
T ss_dssp TCCCEEEEECCCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred ccceEEEEEeccCc-cHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCC-cEEEEeccccccc
Confidence 23567899999985 565554 4699999999999999999999999999999999999999888 8999999999765
Q ss_pred CCCCc-----------cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCC
Q 020826 167 HPGKE-----------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 235 (321)
Q Consensus 167 ~~~~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (321)
..... .....+|..|+|||++.+...++.++|||||||++|+|++|..|| .+.+....+..+....+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~~~~~~~~ 241 (353)
T 2b9h_A 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF-PGRDYRHQLLLIFGIIGT 241 (353)
T ss_dssp C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCC
T ss_pred ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCC
Confidence 42211 123467899999999876577899999999999999999999888 455555566666665555
Q ss_pred hhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 236 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
+....... .................+..... .....+++++.+||++||+.||++|||++|+++||||+....++
T Consensus 242 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 316 (353)
T 2b9h_A 242 PHSDNDLR---CIESPRAREYIKSLPMYPAAPLE--KMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN 316 (353)
T ss_dssp CCSTTTTT---TCCCHHHHHHHHTSCCCCCCCHH--HHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred Cchhcccc---ccccchhhHHhhcccCCCCcchh--hhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcc
Confidence 43221111 01111111111111111111111 11235778999999999999999999999999999999876553
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=329.58 Aligned_cols=258 Identities=26% Similarity=0.459 Sum_probs=207.3
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc---------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~---------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
.++|++.+.||+|+||+||+|++..+++.+++|+++.. ....+.+|+.+++.+ +||||+++++++.+ .
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~ 80 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI-RHPNIITLHDIFEN--K 80 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--S
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhC-CCCCeeehhheecC--C
Confidence 46899999999999999999999889999999998643 246789999999999 89999999999965 4
Q ss_pred CCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCC---eEEEeecccee
Q 020826 91 KTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR---KLRLIDWGLAE 164 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~---~v~l~dfg~~~ 164 (321)
...++++|++.+++|.+++ ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++. .++|+|||++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~ 160 (283)
T 3bhy_A 81 TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH 160 (283)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCE
T ss_pred CeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccce
Confidence 4568999999999998876 46999999999999999999999999999999999999986542 69999999998
Q ss_pred ecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhh
Q 020826 165 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244 (321)
Q Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (321)
............+++.|+|||++.+ ..++.++||||||+++|+|++|..||. +.........+.......
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~-------- 230 (283)
T 3bhy_A 161 KIEAGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GETKQETLTNISAVNYDF-------- 230 (283)
T ss_dssp ECC--------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHTTCCCC--------
T ss_pred eccCCCcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCC-CcchHHHHHHhHhcccCC--------
Confidence 7665555556678999999999987 678999999999999999999999984 222222222221100000
Q ss_pred hcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
.......+++.+.++|++||+.||++|||++++++||||+++....
T Consensus 231 -------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 231 -------------------------DEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp -------------------------CHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred -------------------------cchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence 0001123567899999999999999999999999999999874443
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=330.62 Aligned_cols=284 Identities=29% Similarity=0.533 Sum_probs=219.0
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEe-cCCceEEEEEecccc-----hHHHHHHHHHHHhhc--CCCCeeeeeeeeec-
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHC-TDNEKCIIKILKPVK-----KKKIKREIKILQNLC--GGPNIVKLLDIVRD- 87 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~-~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~--~h~~i~~~~~~~~~- 87 (321)
....++|++.+.||+|+||+||+|.+. .+++.||+|+++... ...+.+|+.+++.+. +||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 455789999999999999999999995 678899999986432 235778888888774 79999999998852
Q ss_pred --cCCCCcEEEEEeecCchhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeec
Q 020826 88 --QQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW 160 (321)
Q Consensus 88 --~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~df 160 (321)
......++++|++.+ +|..++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+||
T Consensus 87 ~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~-~~kl~Df 164 (326)
T 1blx_A 87 RTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADF 164 (326)
T ss_dssp ECSSEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECSC
T ss_pred ccCCCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCC-CEEEecC
Confidence 134567899999995 665554 2389999999999999999999999999999999999999888 8999999
Q ss_pred cceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhH
Q 020826 161 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 240 (321)
Q Consensus 161 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (321)
|++.............++..|+|||++.+ ..++.++|||||||++|+|++|..|| .+......+..+....+.+....
T Consensus 165 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~ 242 (326)
T 1blx_A 165 GLARIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLF-RGSSDVDQLGKILDVIGLPGEED 242 (326)
T ss_dssp CSCCCCCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCGGG
T ss_pred cccccccCCCCccccccccceeCHHHHhc-CCCCcchhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHHHHcCCCCccc
Confidence 99976554444455678999999999987 67899999999999999999999888 45555566666666665543332
Q ss_pred HhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 241 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
+....... .......... ........+++++.+||.+||+.||++|||++|+++||||+++...
T Consensus 243 ~~~~~~~~-----~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 243 WPRDVALP-----RQAFHSKSAQ-----PIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 306 (326)
T ss_dssp SCTTCSSC-----GGGSCCCCCC-----CGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred Cccccccc-----hhhhcccCcc-----hhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence 22110000 0000000000 0112234577899999999999999999999999999999987654
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-48 Score=332.78 Aligned_cols=256 Identities=25% Similarity=0.418 Sum_probs=205.2
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----------hHHHHHHHHHHHhhcCCCCeeeeeeeeec
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRD 87 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (321)
..++|++.+.||+|+||+||+|.+..+++.||+|++.... ...+.+|+.+++.+ +||||+++++++..
T Consensus 8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~ 86 (322)
T 2ycf_A 8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL-NHPCIIKIKNFFDA 86 (322)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHC-CCTTBCCEEEEEES
T ss_pred hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhC-CCCCCceEeeEEcC
Confidence 4578999999999999999999999999999999986432 23478999999999 99999999999864
Q ss_pred cCCCCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCC--eEEEeeccc
Q 020826 88 QQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLIDWGL 162 (321)
Q Consensus 88 ~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~--~v~l~dfg~ 162 (321)
.. .++|+||+.+++|.+++ ..+++..++.++.||+.||+|||++|++|+||||+||+++.++. .++|+|||+
T Consensus 87 ~~---~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~ 163 (322)
T 2ycf_A 87 ED---YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH 163 (322)
T ss_dssp SS---EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTT
T ss_pred Cc---eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcc
Confidence 32 68999999999887766 35899999999999999999999999999999999999986552 499999999
Q ss_pred eeecCCCCccccccCCcccccccccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhH
Q 020826 163 AEFYHPGKEYNVRVASRYFKGPELLV--DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 240 (321)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (321)
+.............++..|+|||++. +...++.++|||||||++|+|++|..||............+... .....+
T Consensus 164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~- 241 (322)
T 2ycf_A 164 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG-KYNFIP- 241 (322)
T ss_dssp CEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHT-CCCCCH-
T ss_pred ceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhC-ccccCc-
Confidence 98765444344567899999999974 23578899999999999999999999995433322222221110 000000
Q ss_pred HhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 241 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
.....+++++.++|++||+.||++|||++++++||||++.
T Consensus 242 -------------------------------~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 242 -------------------------------EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp -------------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred -------------------------------hhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 0012366799999999999999999999999999999864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=361.15 Aligned_cols=252 Identities=23% Similarity=0.355 Sum_probs=211.6
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
..++|++++.||+|+||+||+|++..+++.||+|+++.. ....+..|..++..+.+||+|+++++++.+ ...
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~--~~~ 416 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT--MDR 416 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC--SSE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe--CCE
Confidence 356899999999999999999999999999999998743 235577899999888789999999999954 456
Q ss_pred cEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC-C
Q 020826 93 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-P 168 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~-~ 168 (321)
+++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||+++... .
T Consensus 417 ~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g-~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 417 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIWD 495 (674)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSS-CEEECCCTTCEECCCT
T ss_pred EEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCC-cEEEeecceeeccccC
Confidence 78999999999998777 4699999999999999999999999999999999999999888 89999999998643 3
Q ss_pred CCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 169 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
........||+.|+|||++.+ ..++.++|+|||||++|+|++|..||. +.+..+....+...
T Consensus 496 ~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~-~~~~~~~~~~i~~~---------------- 557 (674)
T 3pfq_A 496 GVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFE-GEDEDELFQSIMEH---------------- 557 (674)
T ss_dssp TCCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHSS----------------
T ss_pred CcccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCC-CCCHHHHHHHHHhC----------------
Confidence 334456789999999999987 788999999999999999999999984 33333333322110
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCH-----HHHhcCCCcccCC
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA-----KEAMAHPYFFPIR 312 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~-----~ell~hp~~~~~~ 312 (321)
....+..+|+++.+||++||+.||++||++ +|+++||||+.++
T Consensus 558 ---------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~ 605 (674)
T 3pfq_A 558 ---------------------NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 605 (674)
T ss_dssp ---------------------CCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCC
T ss_pred ---------------------CCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCC
Confidence 011123577899999999999999999997 9999999999864
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=350.35 Aligned_cols=253 Identities=26% Similarity=0.410 Sum_probs=209.6
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
...++|++.+.||+|+||+||+|+++.+++.||+|+++... ...+.+|+.++..+ +||||+++++++.+ ..
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l-~hp~Iv~l~~~~~~--~~ 258 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKV-HSRFIVSLAYAFET--KT 258 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--SS
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhc-CCCCEeeEEEEEee--CC
Confidence 34589999999999999999999999999999999996432 34578899999999 99999999999865 45
Q ss_pred CcEEEEEeecCchhhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecccee
Q 020826 92 TPSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 164 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~ 164 (321)
.+++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||++.
T Consensus 259 ~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g-~vkL~DFGla~ 337 (543)
T 3c4z_A 259 DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG-NVRISDLGLAV 337 (543)
T ss_dssp EEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCE
T ss_pred EEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCC-CEEEeecceee
Confidence 678999999999987665 2489999999999999999999999999999999999999888 89999999998
Q ss_pred ecCCCCc-cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCC--hHHH-HHHHHHhCChhhhH
Q 020826 165 FYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN--YDQL-VKIAKVLGTDELNA 240 (321)
Q Consensus 165 ~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~--~~~~-~~~~~~~~~~~~~~ 240 (321)
....... .....||+.|+|||++.+ ..++.++|+|||||++|+|++|..||...... ...+ ..+..
T Consensus 338 ~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~--------- 407 (543)
T 3c4z_A 338 ELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLE--------- 407 (543)
T ss_dssp ECCTTCCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH---------
T ss_pred eccCCCcccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhh---------
Confidence 7654433 334589999999999987 78999999999999999999999999543221 1111 11110
Q ss_pred HhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC-----HHHHhcCCCcccCC
Q 020826 241 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPIR 312 (321)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps-----~~ell~hp~~~~~~ 312 (321)
. ....+..+|+++.+||++||+.||++||+ ++++++||||+.++
T Consensus 408 ------------------~----------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~ 456 (543)
T 3c4z_A 408 ------------------Q----------AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456 (543)
T ss_dssp ------------------C----------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred ------------------c----------ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCC
Confidence 0 00112346789999999999999999995 58999999999864
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=324.75 Aligned_cols=252 Identities=25% Similarity=0.396 Sum_probs=199.2
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
...++|++.+.||+|+||+||+|.+..+++.|++|+++... ...+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~ 84 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-RHPHIIKLYQVIST--PT 84 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SS
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcC-CCCCEeEEEEEEec--CC
Confidence 34579999999999999999999998899999999986432 34688999999999 89999999999855 45
Q ss_pred CcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 92 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
..++++|++.+++|.+++ ..+++..+..++.|++.||++||++|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSD 163 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTS-CEEECCCCGGGCCCC
T ss_pred eEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCC-CEEEeecccccccCC
Confidence 678999999999988776 4689999999999999999999999999999999999999888 899999999977654
Q ss_pred CCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 169 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
........+++.|+|||.+.+....+.++||||||+++++|++|..||.. .........+... .
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~~--~------------- 227 (276)
T 2h6d_A 164 GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGG--V------------- 227 (276)
T ss_dssp -------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCC-SSHHHHHHHHHHC--C-------------
T ss_pred CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCC-CcHHHHHHHhhcC--c-------------
Confidence 44445567889999999998744446899999999999999999999832 2221111111110 0
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
...+..+++++.++|.+||+.||++|||++++++||||++.
T Consensus 228 ----------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 228 ----------------------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp ----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred ----------------------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 00122356789999999999999999999999999999875
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-48 Score=328.45 Aligned_cols=255 Identities=23% Similarity=0.408 Sum_probs=189.0
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccch----HHHHHHHHH-HHhhcCCCCeeeeeeeeeccCCC
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKI-LQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~----~~~~~E~~~-l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
....++|++.+.||+|+||+||+|.+..+++.||+|+++.... .....|... ++.+ +||||+++++++.+ ..
T Consensus 3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~~--~~ 79 (290)
T 3fme_A 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV-DCPFTVTFYGALFR--EG 79 (290)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SS
T ss_pred cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhC-CCCeEEEEeeeeec--cC
Confidence 4457899999999999999999999999999999999875421 223334433 5555 89999999999965 44
Q ss_pred CcEEEEEeecCchhhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCCeEEcCCCCeEEEeeccce
Q 020826 92 TPSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lh~~-~i~H~dlkp~nili~~~~~~v~l~dfg~~ 163 (321)
..++|||+++++ +..++ ..+++..++.++.|++.||+|||++ |++|+||||+||+++.++ .++|+|||++
T Consensus 80 ~~~lv~e~~~~~-l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~ 157 (290)
T 3fme_A 80 DVWICMELMDTS-LDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG-QVKMCDFGIS 157 (290)
T ss_dssp SEEEEEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC-CEEBCCC---
T ss_pred CEEEEEehhccc-hHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeecCCc
Confidence 567999999864 43332 4699999999999999999999998 999999999999999888 8999999999
Q ss_pred eecCCCCccccccCCcccccccccc---CCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhH
Q 020826 164 EFYHPGKEYNVRVASRYFKGPELLV---DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 240 (321)
Q Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (321)
.............+|+.|+|||++. ....++.++|||||||++|+|++|..||.........+..........
T Consensus 158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---- 233 (290)
T 3fme_A 158 GYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ---- 233 (290)
T ss_dssp ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC----
T ss_pred ccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC----
Confidence 8765555555567899999999972 336788999999999999999999999953333333332221110000
Q ss_pred HhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 241 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
.....+++++.++|.+||+.||++|||++|+++||||+..
T Consensus 234 -------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 234 -------------------------------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp -------------------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred -------------------------------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 0112466899999999999999999999999999999865
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=325.44 Aligned_cols=256 Identities=23% Similarity=0.413 Sum_probs=211.8
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
+...++|++.+.||+|+||+||+|.+..+++.+++|++... ....+.+|+.+++.+ +||||+++++++.+ .
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~ 87 (294)
T 2rku_A 11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFED--N 87 (294)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--S
T ss_pred CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhC-CCCCEeeeeeeecc--C
Confidence 46778999999999999999999999989999999998643 245678899999999 99999999999955 4
Q ss_pred CCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 91 KTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
...++++|++.+++|.+++ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++....
T Consensus 88 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~ 166 (294)
T 2rku_A 88 DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVE 166 (294)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECC
T ss_pred CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCC-CEEEEeccCceecc
Confidence 5678999999999987776 4689999999999999999999999999999999999999888 89999999998764
Q ss_pred CC-CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhc
Q 020826 168 PG-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246 (321)
Q Consensus 168 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (321)
.. .......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.. ....+....+..
T Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~-~~~~~~~~~~~~--------------- 229 (294)
T 2rku_A 167 YDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKK--------------- 229 (294)
T ss_dssp STTCCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHT---------------
T ss_pred cCccccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHhh---------------
Confidence 32 23344578899999999987 6789999999999999999999999832 221111111100
Q ss_pred ccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
. ....+..+++++.++|++||+.||++|||++++++||||+....+.
T Consensus 230 ------------~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~ 276 (294)
T 2rku_A 230 ------------N----------EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 276 (294)
T ss_dssp ------------T----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred ------------c----------cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence 0 0011224667899999999999999999999999999999875543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=330.92 Aligned_cols=255 Identities=23% Similarity=0.411 Sum_probs=211.4
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
....++|++.+.||+|+||+||++.+..+++.+++|++... ....+.+|+.+++.+ +||||+++++++.+ .
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~ 113 (335)
T 2owb_A 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSL-AHQHVVGFHGFFED--N 113 (335)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--S
T ss_pred cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEec--C
Confidence 45678999999999999999999999999999999998643 245678899999999 99999999999965 4
Q ss_pred CCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 91 KTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
...+++|||+.+++|.+++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++....
T Consensus 114 ~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~ 192 (335)
T 2owb_A 114 DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVE 192 (335)
T ss_dssp SEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECC
T ss_pred CeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCC-CEEEeeccCceecc
Confidence 5678999999999987776 4699999999999999999999999999999999999999888 89999999998764
Q ss_pred CC-CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhc
Q 020826 168 PG-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246 (321)
Q Consensus 168 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (321)
.. .......++..|+|||++.+ ..++.++||||||+++|+|++|..||.. ....+....+...
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~~-------------- 256 (335)
T 2owb_A 193 YDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFET-SCLKETYLRIKKN-------------- 256 (335)
T ss_dssp STTCCBCCCCSCCSSCCHHHHHT-SCBCTHHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHHT--------------
T ss_pred cCcccccccCCCccccCHHHhcc-CCCCchhhHHHHHHHHHHHHHCcCCCCC-CCHHHHHHHHhcC--------------
Confidence 22 23345678999999999987 6789999999999999999999999832 2222221111110
Q ss_pred ccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
....+..+++++.++|++||+.||++|||++|+++||||.....+
T Consensus 257 -----------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~ 301 (335)
T 2owb_A 257 -----------------------EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 301 (335)
T ss_dssp -----------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred -----------------------CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCcc
Confidence 001122466789999999999999999999999999999976443
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=342.83 Aligned_cols=298 Identities=24% Similarity=0.374 Sum_probs=219.5
Q ss_pred EEeeeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc--hHHHHHHHHHHHhhc-------CCCCeee
Q 020826 10 YWCVWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLC-------GGPNIVK 80 (321)
Q Consensus 10 ~~~~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~E~~~l~~l~-------~h~~i~~ 80 (321)
|.+........++|++.+.||+|+||+||+|++..+++.||+|+++... ...+.+|+.+++.+. +|+||++
T Consensus 26 ~~~~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 26 YHLVKIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp CCSSCTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred ceEEehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 3444445556789999999999999999999999999999999997543 466889999999984 2788999
Q ss_pred eeeeeecc--CCCCcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCCeEEcCCC-
Q 020826 81 LLDIVRDQ--QSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQ- 152 (321)
Q Consensus 81 ~~~~~~~~--~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~-~i~H~dlkp~nili~~~~- 152 (321)
+++++... .....++|||+++++++..+. ..+++..++.++.||+.||+|||++ |++|+||||+||+++.++
T Consensus 106 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~ 185 (397)
T 1wak_A 106 LLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQ 185 (397)
T ss_dssp EEEEEEEEETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHH
T ss_pred eecceeecCCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccch
Confidence 99988632 345678999999877776555 3489999999999999999999998 999999999999998664
Q ss_pred -----------------------------------------------CeEEEeeccceeecCCCCccccccCCccccccc
Q 020826 153 -----------------------------------------------RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 185 (321)
Q Consensus 153 -----------------------------------------------~~v~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE 185 (321)
..++|+|||++..... ......+|..|+|||
T Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~--~~~~~~gt~~y~aPE 263 (397)
T 1wak_A 186 YIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--HFTEDIQTRQYRSLE 263 (397)
T ss_dssp HHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB--CSCSCCSCGGGCCHH
T ss_pred hhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc--cCccCCCCCcccCCh
Confidence 2699999999987643 234567899999999
Q ss_pred cccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCC-----ChHHHHHHHHHhCChhhhHHhhhhcccCCh-hhHhhhcc
Q 020826 186 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD-----NYDQLVKIAKVLGTDELNAYLNKYHIELDP-HLAALVGR 259 (321)
Q Consensus 186 ~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 259 (321)
++.+ ..++.++|||||||++|+|++|..||..... ....+..+.+.++................. ........
T Consensus 264 ~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 342 (397)
T 1wak_A 264 VLIG-SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHI 342 (397)
T ss_dssp HHHT-SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSC
T ss_pred hhcC-CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccc
Confidence 9987 6789999999999999999999999954332 234555566666654332221110000000 00000000
Q ss_pred cCCCCCcccc----ccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCccc
Q 020826 260 HSRKPWSKFI----TVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 310 (321)
Q Consensus 260 ~~~~~~~~~~----~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~ 310 (321)
....++.... ........++++.+||.+||+.||++|||++|+|+||||++
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 343 TKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp CCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0001111000 01112234567999999999999999999999999999974
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=323.65 Aligned_cols=251 Identities=23% Similarity=0.433 Sum_probs=208.2
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
..++|++.+.||+|+||+||+|.+..++..+++|++.... ...+.+|+.+++.+ +||||+++++++.+ ...
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~ 88 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHL-RHPNILRMYNYFHD--RKR 88 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSE
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcC-CCCCEeeEEEEEEc--CCE
Confidence 4579999999999999999999998899999999986432 35688999999999 89999999999965 456
Q ss_pred cEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 93 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
.++++|++.+++|.+++ ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++ .++|+|||++......
T Consensus 89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~~~~ 167 (284)
T 2vgo_A 89 IYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKG-ELKIADFGWSVHAPSL 167 (284)
T ss_dssp EEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTC-CEEECCCTTCEECSSS
T ss_pred EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCC-CEEEecccccccCccc
Confidence 78999999999887776 4689999999999999999999999999999999999999888 8999999998765432
Q ss_pred CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 170 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
......++..|+|||++.+ ..++.++||||||+++|+|++|..||.. .........+..
T Consensus 168 -~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~~~~------------------ 226 (284)
T 2vgo_A 168 -RRRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDS-PSHTETHRRIVN------------------ 226 (284)
T ss_dssp -CBCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCC-SSHHHHHHHHHT------------------
T ss_pred -ccccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCC-CCHhHHHHHHhc------------------
Confidence 2345678999999999987 6789999999999999999999999832 222221111110
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCC
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~ 313 (321)
. ....+..+++++.++|.+||+.||++|||++++++||||+....
T Consensus 227 ---------~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 227 ---------V----------DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp ---------T----------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred ---------c----------ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 0 00112246789999999999999999999999999999997543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-47 Score=326.85 Aligned_cols=256 Identities=24% Similarity=0.382 Sum_probs=207.1
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc---chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
...++|++.+.||+|+||+||+|++..+++.||+|+++.. ....+.+|+.+++.+ +||||+++++++.+ ....+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~~~ 82 (304)
T 2jam_A 6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI-KHENIVTLEDIYES--TTHYY 82 (304)
T ss_dssp CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHC-CCTTBCCEEEEEEC--SSEEE
T ss_pred chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhC-CCCCeeehhhhccc--CCEEE
Confidence 3467899999999999999999999889999999998754 235688999999999 89999999999855 45678
Q ss_pred EEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEE---cCCCCeEEEeeccceeecCC
Q 020826 95 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 95 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili---~~~~~~v~l~dfg~~~~~~~ 168 (321)
+++|++.+++|.+++ ..+++..+..++.|++.||.|||++|++|+||||+||++ +.++ .++|+|||++.....
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~-~~kl~Dfg~~~~~~~ 161 (304)
T 2jam_A 83 LVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENS-KIMITDFGLSKMEQN 161 (304)
T ss_dssp EEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTC-CEEBCSCSTTCCCCC
T ss_pred EEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCC-CEEEccCCcceecCC
Confidence 999999999887765 468999999999999999999999999999999999999 5555 899999999875432
Q ss_pred CCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 169 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.. .........+.......
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~-~~~~~~~~~i~~~~~~~------------ 226 (304)
T 2jam_A 162 -GIMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYE-ETESKLFEKIKEGYYEF------------ 226 (304)
T ss_dssp -BTTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHCCCCC------------
T ss_pred -CccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCC-CCHHHHHHHHHcCCCCC------------
Confidence 22344568999999999987 7889999999999999999999999842 22222222221100000
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCC
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~ 313 (321)
.......+++++.++|.+||+.||++|||++++++||||++...
T Consensus 227 ---------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (304)
T 2jam_A 227 ---------------------ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTA 270 (304)
T ss_dssp ---------------------CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCS
T ss_pred ---------------------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCc
Confidence 00111246789999999999999999999999999999987643
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=329.06 Aligned_cols=288 Identities=27% Similarity=0.467 Sum_probs=210.0
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc---hHHHHHHHHHHHhhcCCCCeeeeeeeeecc------
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQ------ 88 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~------ 88 (321)
...++|++.+.||+|+||+||+|.+..+++.||+|++.... ...+.+|+.+++.+ +||||+++++++...
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~~~~~~~ 86 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL-DHDNIVKVFEILGPSGSQLTD 86 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECTTSCBCCC
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhc-CCCCeeEEEEecccccccccc
Confidence 44689999999999999999999998899999999987543 35678999999999 899999999987432
Q ss_pred ------CCCCcEEEEEeecCchhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeec
Q 020826 89 ------QSKTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW 160 (321)
Q Consensus 89 ------~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~df 160 (321)
.....++++||+.+ +|..++. .+++..++.++.|++.||+|||++|++|+||||+||+++.++..++|+||
T Consensus 87 ~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Df 165 (320)
T 2i6l_A 87 DVGSLTELNSVYIVQEYMET-DLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDF 165 (320)
T ss_dssp ----CCSCSEEEEEEECCSE-EHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCC
T ss_pred ccccccccCceeEEeeccCC-CHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccC
Confidence 23467899999985 6766663 48999999999999999999999999999999999999855558999999
Q ss_pred cceeecCCC----CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCCh
Q 020826 161 GLAEFYHPG----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD 236 (321)
Q Consensus 161 g~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (321)
|++...... .......++..|+|||.+.+...++.++|||||||++|+|++|+.||. +.........+.......
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~-~~~~~~~~~~~~~~~~~~ 244 (320)
T 2i6l_A 166 GLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFA-GAHELEQMQLILESIPVV 244 (320)
T ss_dssp TTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHHSCCC
T ss_pred ccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCC-CCCHHHHHHHHHHhcCCC
Confidence 999765322 122345678899999998765678999999999999999999999984 444445555555544432
Q ss_pred hhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 237 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
.......... ......... ...+.... ......+++++.+||++||+.||++|||++|+++||||+....+.
T Consensus 245 ~~~~~~~~~~-~~~~~~~~~----~~~~~~~~--~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 245 HEEDRQELLS-VIPVYIRND----MTEPHKPL--TQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp CHHHHHHHHT-TSCHHHHHH----TTSCCCCH--HHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC--
T ss_pred chhhhhhhhh-cCccccccc----ccCCCCCh--hHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCcc
Confidence 2211111000 000000000 00000000 111234778999999999999999999999999999999876654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=333.67 Aligned_cols=282 Identities=24% Similarity=0.408 Sum_probs=210.0
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc--hHHHHHHHHHHHhhcCCCC-----eeeeeeeeeccC
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPN-----IVKLLDIVRDQQ 89 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~E~~~l~~l~~h~~-----i~~~~~~~~~~~ 89 (321)
....++|++.+.||+|+||+||+|.+..+++.||+|+++... ...+..|+.+++.+..|++ ++++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~- 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR- 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET-
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC-
Confidence 344679999999999999999999999899999999997543 3567788999888855664 89999988653
Q ss_pred CCCcEEEEEeecCchhhhhc-----CCCCHHHHHHHHHHHHHHHHHHH--HCCCeeecCCCCCeEEcC--CCCeEEEeec
Q 020826 90 SKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCH--SQGIMHRDVKPHNVMIDH--EQRKLRLIDW 160 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh--~~~i~H~dlkp~nili~~--~~~~v~l~df 160 (321)
...++|||++.+ +|.+++ ..+++..++.++.|++.||.||| +.||+|+||||+||+++. ++ .+||+||
T Consensus 129 -~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~-~~kL~DF 205 (382)
T 2vx3_A 129 -NHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS-AIKIVDF 205 (382)
T ss_dssp -TEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC-CEEECCC
T ss_pred -CceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC-cEEEEec
Confidence 567899999986 554444 34899999999999999999999 579999999999999953 44 7999999
Q ss_pred cceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhH
Q 020826 161 GLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 240 (321)
Q Consensus 161 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (321)
|++..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..|| .+.+..+.+..+.+..+.+....
T Consensus 206 G~a~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~pf-~~~~~~~~~~~i~~~~~~~~~~~ 281 (382)
T 2vx3_A 206 GSSCQLGQ--RIYQYIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLF-SGANEVDQMNKIVEVLGIPPAHI 281 (382)
T ss_dssp TTCEETTC--CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCSCCHHH
T ss_pred cCceeccc--ccccccCCccccChHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHHHhCCCCHHH
Confidence 99987643 2345678999999999987 67999999999999999999999888 45566677777777666543322
Q ss_pred HhhhhcccCChhhHhhhcccCCC----------------C-Ccccccc----------------ccccCCcchHHHHHHH
Q 020826 241 YLNKYHIELDPHLAALVGRHSRK----------------P-WSKFITV----------------ENQHLAVPEAVDFLDK 287 (321)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~----------------~-~~~~~~~----------------~~~~~~s~~~~~ll~~ 287 (321)
.... +............ + ....... ......++++.+||++
T Consensus 282 ~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 355 (382)
T 2vx3_A 282 LDQA------PKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILR 355 (382)
T ss_dssp HTTC------TTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHH
T ss_pred HHhh------HHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHH
Confidence 1100 0000000000000 0 0000000 0000011378999999
Q ss_pred hhccCCCCCcCHHHHhcCCCcccCC
Q 020826 288 LLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 288 ~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
||++||++|||++|+|+||||++..
T Consensus 356 mL~~dP~~Rpta~e~L~hp~f~~~~ 380 (382)
T 2vx3_A 356 MLDYDPKTRIQPYYALQHSFFKKTA 380 (382)
T ss_dssp HTCSCTTTSCCHHHHTTSGGGCC--
T ss_pred hcCCChhhCCCHHHHhcCcccccCC
Confidence 9999999999999999999999864
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-47 Score=328.83 Aligned_cols=264 Identities=23% Similarity=0.408 Sum_probs=207.5
Q ss_pred eeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc--chHHHHHHHHHHHhhcCCCCeeeeeeeeeccC--
Q 020826 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ-- 89 (321)
Q Consensus 14 ~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-- 89 (321)
-.+....++|++.+.||+|+||+||+|++..+++.||+|++... ....+.+|+.+++++.+||||+++++++....
T Consensus 17 ~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 17 SALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred hhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 34556688999999999999999999999889999999998643 45778999999999978999999999987643
Q ss_pred --CCCcEEEEEeecCchhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccc
Q 020826 90 --SKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 162 (321)
Q Consensus 90 --~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~ 162 (321)
....++||||+.+++|.+++ ..+++..++.++.||+.||+|||++|++|+||||+||+++.++ .++|+|||+
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~ 175 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA-EVKLVDFGV 175 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC-CEEECCCTT
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCC-CEEEeeCcC
Confidence 45678999999999988776 3589999999999999999999999999999999999999887 899999999
Q ss_pred eeecCCC-CccccccCCccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChh
Q 020826 163 AEFYHPG-KEYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 237 (321)
Q Consensus 163 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (321)
+...... .......++..|+|||++.. ...++.++|||||||++|+|++|..||. +.........+.... .
T Consensus 176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~~-~-- 251 (326)
T 2x7f_A 176 SAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC-DMHPMRALFLIPRNP-A-- 251 (326)
T ss_dssp TC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHSC-C--
T ss_pred ceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCC-CCcHHHHHHHhhcCc-c--
Confidence 8765322 22344578999999999862 2568899999999999999999999983 222222222111100 0
Q ss_pred hhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 238 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
.......+++.+.++|++||+.||++|||++++++||||++....
T Consensus 252 --------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~ 296 (326)
T 2x7f_A 252 --------------------------------PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNE 296 (326)
T ss_dssp --------------------------------CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTTH
T ss_pred --------------------------------ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCccc
Confidence 000122467899999999999999999999999999999987543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=322.85 Aligned_cols=249 Identities=18% Similarity=0.241 Sum_probs=200.6
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
...++|++.+.||+|+||+||+|.+..+++.||+|+++.. ....+.+|+..+..+.+||||+++++++.+. ..
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~--~~ 85 (289)
T 1x8b_A 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED--DH 85 (289)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET--TE
T ss_pred cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC--Ce
Confidence 4567999999999999999999999889999999998743 3456788999999887899999999999653 46
Q ss_pred cEEEEEeecCchhhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCC-------------
Q 020826 93 PSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ------------- 152 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~------------- 152 (321)
.++|+||+.+++|.+++ ..+++..++.++.||+.||+|||++|++|+||||+||+++.++
T Consensus 86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~ 165 (289)
T 1x8b_A 86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD 165 (289)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence 78999999999998777 4489999999999999999999999999999999999998432
Q ss_pred -----CeEEEeeccceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHH
Q 020826 153 -----RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 227 (321)
Q Consensus 153 -----~~v~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~ 227 (321)
..++|+|||.+...... ....++..|+|||++.+...++.++|||||||++|+|++|..++. .. ....
T Consensus 166 ~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~-~~---~~~~ 238 (289)
T 1x8b_A 166 WASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPR-NG---DQWH 238 (289)
T ss_dssp ----CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCS-SS---HHHH
T ss_pred ccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCc-ch---hHHH
Confidence 26899999999876433 334689999999999874567789999999999999999886652 11 1111
Q ss_pred HHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCC
Q 020826 228 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 307 (321)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~ 307 (321)
.+.. .. ....+..+++++.++|.+||+.||++|||++++++|||
T Consensus 239 ~~~~---------------------------~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 282 (289)
T 1x8b_A 239 EIRQ---------------------------GR---------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSV 282 (289)
T ss_dssp HHHT---------------------------TC---------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTT
T ss_pred HHHc---------------------------CC---------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChH
Confidence 1100 00 00112346789999999999999999999999999999
Q ss_pred cccC
Q 020826 308 FFPI 311 (321)
Q Consensus 308 ~~~~ 311 (321)
|++.
T Consensus 283 ~~~~ 286 (289)
T 1x8b_A 283 LLSA 286 (289)
T ss_dssp C---
T ss_pred hhhh
Confidence 9975
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=324.92 Aligned_cols=258 Identities=24% Similarity=0.500 Sum_probs=209.6
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
...++|++.+.||+|+||+||+|++..+++.|++|++... ....+.+|+.+++++ +||||+++++++.+ ...
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~ 95 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL-DHPNIMKLFEILED--SSS 95 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC--SSE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhc-cCCCccEEEEEEeC--CCe
Confidence 4457999999999999999999999889999999998643 346788999999999 99999999999865 456
Q ss_pred cEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCC--CeEEEeeccceeecC
Q 020826 93 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLAEFYH 167 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~--~~v~l~dfg~~~~~~ 167 (321)
.++++|++.+++|.+.+ ..+++..++.++.|++.||++||++|++|+||+|+||+++.++ ..++|+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 67999999998886665 5699999999999999999999999999999999999997543 269999999987665
Q ss_pred CCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 168 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
.........++..|+|||.+.+ .++.++||||||+++|+|++|..||. +.+.......+.......
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~-~~~~~~~~~~~~~~~~~~----------- 241 (287)
T 2wei_A 176 QNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFY-GKNEYDILKRVETGKYAF----------- 241 (287)
T ss_dssp CCSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCCCCC-----------
T ss_pred CCCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCC-CCCHHHHHHHHHcCCCCC-----------
Confidence 4444455568889999999875 48899999999999999999999984 332222222221100000
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
.......+|+++.++|++||+.||++|||++|+++||||++....
T Consensus 242 ----------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 286 (287)
T 2wei_A 242 ----------------------DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE 286 (287)
T ss_dssp ----------------------CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCCC
T ss_pred ----------------------CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccccC
Confidence 001112467899999999999999999999999999999987553
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=331.40 Aligned_cols=253 Identities=25% Similarity=0.406 Sum_probs=204.1
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
..++|++.+.||+|+||+||+|++..+++.||+|++.... ...+.+|+.+++.+ +||||+++++++.+. ..
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~--~~ 128 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLRE--HT 128 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--TE
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEEC--Ce
Confidence 4467999999999999999999998999999999986432 24578999999999 899999999998654 46
Q ss_pred cEEEEEeecCchhhhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 93 PSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
.++||||+.++.+..+ ...+++..+..++.|++.||+|||++|++|+||||+||+++.++ .+||+|||++.....
T Consensus 129 ~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~- 206 (348)
T 1u5q_A 129 AWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAP- 206 (348)
T ss_dssp EEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-EEEECCCTTCBSSSS-
T ss_pred EEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEeeccCceecCC-
Confidence 6799999986544333 25699999999999999999999999999999999999999888 899999999876532
Q ss_pred CccccccCCccccccccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 170 KEYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 170 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
.....+|+.|+|||++.+ ...++.++|||||||++|+|++|..||.. .+....+..+.....
T Consensus 207 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~-~~~~~~~~~~~~~~~------------- 270 (348)
T 1u5q_A 207 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN-MNAMSALYHIAQNES------------- 270 (348)
T ss_dssp --BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHSCC-------------
T ss_pred --CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHHhcCC-------------
Confidence 234578999999999852 35788999999999999999999999843 222222222211000
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
+ ......+++.+.+||.+||+.||++|||++++++||||.....+
T Consensus 271 ----------------~------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~ 315 (348)
T 1u5q_A 271 ----------------P------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPP 315 (348)
T ss_dssp ----------------C------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCT
T ss_pred ----------------C------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCCc
Confidence 0 00112456789999999999999999999999999999875443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=331.89 Aligned_cols=255 Identities=25% Similarity=0.444 Sum_probs=196.7
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCC-CCeeeeeeeeeccC
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGG-PNIVKLLDIVRDQQ 89 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h-~~i~~~~~~~~~~~ 89 (321)
|....++|++.+.||+|+||+||++.+ .+++.||+|+++... ...+.+|+.++..+.+| |||+++++++.+
T Consensus 4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-- 80 (343)
T 3dbq_A 4 ISVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-- 80 (343)
T ss_dssp EESSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--
T ss_pred eeeecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee--
Confidence 556788999999999999999999998 568899999986432 25678999999999432 999999999854
Q ss_pred CCCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeec
Q 020826 90 SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 166 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~ 166 (321)
....++||| +.+++|.+++ ..+++..+..++.|++.||+|||++|++|+||||+||+++ ++ .+||+|||++...
T Consensus 81 ~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~-~~kl~DFG~a~~~ 157 (343)
T 3dbq_A 81 DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG-MLKLIDFGIANQM 157 (343)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TT-EEEECCCSSSCCC
T ss_pred CCEEEEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CC-cEEEeeccccccc
Confidence 456789999 5566776665 4689999999999999999999999999999999999997 55 7999999999765
Q ss_pred CCCCc---cccccCCccccccccccC----------CCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHh
Q 020826 167 HPGKE---YNVRVASRYFKGPELLVD----------LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL 233 (321)
Q Consensus 167 ~~~~~---~~~~~~~~~y~aPE~~~~----------~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 233 (321)
..... .....||+.|+|||++.+ ...++.++|||||||++|+|++|..||.........+..+ .
T Consensus 158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~---~ 234 (343)
T 3dbq_A 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---I 234 (343)
T ss_dssp ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH---H
T ss_pred CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHH---h
Confidence 43322 235579999999999853 2467889999999999999999999994322221111111 1
Q ss_pred CChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 234 GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
... . ....+...++++.+||.+||+.||++|||+.|+++||||+..
T Consensus 235 ~~~------------------------~--------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 280 (343)
T 3dbq_A 235 DPN------------------------H--------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ 280 (343)
T ss_dssp CTT------------------------S--------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred cCC------------------------c--------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence 100 0 011122345689999999999999999999999999999854
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=324.51 Aligned_cols=262 Identities=22% Similarity=0.390 Sum_probs=205.5
Q ss_pred eeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 14 ~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
.+.....++|++.+.||+|+||+||+|.+..+++.||+|.++.. ....+.+|+.+++.+ +||||+++++++.+ ...
T Consensus 22 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~--~~~ 98 (314)
T 3com_A 22 SLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQC-DSPHVVKYYGSYFK--NTD 98 (314)
T ss_dssp --------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTC-CCTTBCCEEEEEEE--TTE
T ss_pred hhhhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhC-CCCCCccEEEEEEe--CCE
Confidence 34456678999999999999999999999889999999998754 346789999999999 99999999999865 345
Q ss_pred cEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 93 PSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
.++++||+.+++|.+++ ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 99 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~ 177 (314)
T 3com_A 99 LWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEG-HAKLADFGVAGQLTD 177 (314)
T ss_dssp EEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECBT
T ss_pred EEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCC-CEEEeecccchhhhh
Confidence 67999999999988776 4699999999999999999999999999999999999999888 899999999976543
Q ss_pred CC-ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 169 GK-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 169 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
.. ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.. .........+... ..
T Consensus 178 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~-~~~~~~~~~~~~~-~~------------ 242 (314)
T 3com_A 178 TMAKRNTVIGTPFWMAPEVIQE-IGYNCVADIWSLGITAIEMAEGKPPYAD-IHPMRAIFMIPTN-PP------------ 242 (314)
T ss_dssp TBSCBCCCCSCGGGCCHHHHSS-SCBCTTHHHHHHHHHHHHHHHSSCTTTT-SCHHHHHHHHHHS-CC------------
T ss_pred hccccCccCCCCCccChhhcCC-CCCCccccHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHhcC-CC------------
Confidence 32 2344578899999999987 6789999999999999999999999842 2221111111100 00
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
.....+..+++++.++|.+||+.||++|||+.++++||||+.....+
T Consensus 243 ---------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~~ 289 (314)
T 3com_A 243 ---------------------PTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVS 289 (314)
T ss_dssp ---------------------CCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCGG
T ss_pred ---------------------cccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcch
Confidence 00011223567899999999999999999999999999999876543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=336.89 Aligned_cols=256 Identities=25% Similarity=0.442 Sum_probs=198.5
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcC-CCCeeeeeeeeeccC
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCG-GPNIVKLLDIVRDQQ 89 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~-h~~i~~~~~~~~~~~ 89 (321)
+.....+|++.+.||+|+||+||+|.+. +++.||+|++.... ...+.+|+.+++.+.+ ||||+++++++...
T Consensus 51 ~~~~~~~y~~~~~LG~G~fg~Vy~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~- 128 (390)
T 2zmd_A 51 ISVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD- 128 (390)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-
T ss_pred ccccCCceEEEEEEccCCCeEEEEEEcC-CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecC-
Confidence 4445678999999999999999999985 48899999986432 3568899999999953 69999999998654
Q ss_pred CCCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeec
Q 020826 90 SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 166 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~ 166 (321)
...++||| +.+++|..++ ..+++..+..++.||+.||+|||++||+||||||+||+++ ++ .+||+|||++...
T Consensus 129 -~~~~lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~-~~kl~DFG~a~~~ 204 (390)
T 2zmd_A 129 -QYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG-MLKLIDFGIANQM 204 (390)
T ss_dssp -SEEEEEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SS-CEEECCCSSSCCC
T ss_pred -CEEEEEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CC-eEEEEecCccccc
Confidence 45789999 5667776665 4588999999999999999999999999999999999996 45 7999999999765
Q ss_pred CCCCc---cccccCCccccccccccCC----------CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHh
Q 020826 167 HPGKE---YNVRVASRYFKGPELLVDL----------QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL 233 (321)
Q Consensus 167 ~~~~~---~~~~~~~~~y~aPE~~~~~----------~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 233 (321)
..... .....||+.|+|||++.+. ..++.++|||||||++|+|++|..||.........+..+.
T Consensus 205 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~--- 281 (390)
T 2zmd_A 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII--- 281 (390)
T ss_dssp ---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHH---
T ss_pred cCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHh---
Confidence 43321 2456799999999998641 3688999999999999999999999943222222222111
Q ss_pred CChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 234 GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
... . ....+...++++.+||++||+.||++|||+.|+++||||+...
T Consensus 282 ~~~------------------------~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 282 DPN------------------------H--------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp CTT------------------------S--------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred Ccc------------------------c--------cCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 100 0 0011123456899999999999999999999999999998654
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-47 Score=332.96 Aligned_cols=256 Identities=22% Similarity=0.394 Sum_probs=204.5
Q ss_pred cCceEEeeeeeeecceEEEEEEEe---cCCceEEEEEeccc-------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 89 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~---~~~~~~~vK~~~~~-------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (321)
.++|++.+.||+|+||+||+|++. .+++.||+|+++.. ....+.+|+.++..+.+||||+++++++.+.
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~- 131 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE- 131 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC-
Confidence 379999999999999999999984 47899999998643 2356778999999997899999999998653
Q ss_pred CCCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeec
Q 020826 90 SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 166 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~ 166 (321)
...++||||+.+++|..++ ..+++..++.++.||+.||+|||++|++|+||||+||+++.++ .+||+|||++...
T Consensus 132 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 132 -TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEF 209 (355)
T ss_dssp -TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEESCSSEEEEC
T ss_pred -ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-cEEEeeCCCCeec
Confidence 4567999999999988776 4699999999999999999999999999999999999999888 8999999999865
Q ss_pred CCCC--ccccccCCccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 167 HPGK--EYNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 167 ~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
.... ......+|+.|+|||++.+. ..++.++|||||||++|+|++|..||......... ..+....
T Consensus 210 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~~---------- 278 (355)
T 1vzo_A 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-AEISRRI---------- 278 (355)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-HHHHHHH----------
T ss_pred ccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH-HHHHHHH----------
Confidence 4222 22345789999999999752 35789999999999999999999999533221111 1111000
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc-----CHHHHhcCCCcccCC
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIR 312 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp-----s~~ell~hp~~~~~~ 312 (321)
... ....+..+++.+.+||++||+.||++|| |++|+++||||++++
T Consensus 279 -------------~~~----------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~ 329 (355)
T 1vzo_A 279 -------------LKS----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329 (355)
T ss_dssp -------------HHC----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred -------------hcc----------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence 000 0011224667899999999999999999 999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=322.54 Aligned_cols=256 Identities=25% Similarity=0.424 Sum_probs=207.9
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
+...++|++.+.||+|+||+||+|.+..+++.+++|.+... ....+.+|+.+++.+ +||||+++++++.+....
T Consensus 2 p~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~ 80 (279)
T 2w5a_A 2 PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNT 80 (279)
T ss_dssp -CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEEGGGT
T ss_pred CCchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhc-CCCCCCeEEEEEecCCCc
Confidence 45678999999999999999999999989999999998643 245688999999999 899999999988766666
Q ss_pred CcEEEEEeecCchhhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC-----CeeecCCCCCeEEcCCCCeEEEee
Q 020826 92 TPSLIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQG-----IMHRDVKPHNVMIDHEQRKLRLID 159 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lh~~~-----i~H~dlkp~nili~~~~~~v~l~d 159 (321)
..+++|||+.+++|.+++. .+++..++.++.|++.||+|||+.| ++|+||||+||+++.++ .++|+|
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~-~~kl~d 159 (279)
T 2w5a_A 81 TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGD 159 (279)
T ss_dssp EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSS-CEEECC
T ss_pred eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCC-CEEEec
Confidence 7889999999999887773 3899999999999999999999999 99999999999999888 899999
Q ss_pred ccceeecCCCCc-cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhh
Q 020826 160 WGLAEFYHPGKE-YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 238 (321)
Q Consensus 160 fg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (321)
||++........ .....++..|+|||.+.+ ..++.++||||||+++|+|++|..||. ..+.......+... ..
T Consensus 160 fg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~i~~~-~~--- 233 (279)
T 2w5a_A 160 FGLARILNHDTSFAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFT-AFSQKELAGKIREG-KF--- 233 (279)
T ss_dssp CCHHHHC---CHHHHHHHSCCTTCCHHHHHC-C-CCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHT-CC---
T ss_pred CchheeeccccccccccCCCccccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCc-ccCHHHHHHHHhhc-cc---
Confidence 999876543222 234568899999999987 678999999999999999999999984 22222222221110 00
Q ss_pred hHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 239 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
...+..+++++.++|.+||+.||++|||++|+++|+|+.+-+
T Consensus 234 --------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 234 --------------------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp --------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred --------------------------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 011224668999999999999999999999999999998754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=323.91 Aligned_cols=262 Identities=25% Similarity=0.394 Sum_probs=206.6
Q ss_pred eeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc---chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 15 FINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 15 ~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
......++|++.+.||+|+||+||+|.+..+++.+++|++... ....+.+|+.++..+ +||||+++++++.+. .
T Consensus 13 ~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~ 89 (302)
T 2j7t_A 13 RDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATC-DHPYIVKLLGAYYHD--G 89 (302)
T ss_dssp SSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHC-CCTTBCCEEEEEECC---
T ss_pred cccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcC-CCCCEeeeeeeeeeC--C
Confidence 3345678999999999999999999999889999999998643 346788999999999 899999999998653 4
Q ss_pred CcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 92 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
..++|+|++.+++|..++ ..+++..++.++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++....
T Consensus 90 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~ 168 (302)
T 2j7t_A 90 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNL 168 (302)
T ss_dssp CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTS-CEEECCCHHHHHHH
T ss_pred eEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCC-CEEEEECCCCcccc
Confidence 678999999999987765 4599999999999999999999999999999999999999888 89999999874321
Q ss_pred C-CCccccccCCcccccccccc----CCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHh
Q 020826 168 P-GKEYNVRVASRYFKGPELLV----DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242 (321)
Q Consensus 168 ~-~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (321)
. ........++..|+|||++. ....++.++||||||+++|+|++|..||. ..+.......+..... +
T Consensus 169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~~~-~------ 240 (302)
T 2j7t_A 169 KTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH-ELNPMRVLLKIAKSDP-P------ 240 (302)
T ss_dssp HHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHSCC-C------
T ss_pred ccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCc-cCCHHHHHHHHhccCC-c------
Confidence 1 11123456889999999984 23678899999999999999999999983 2222222222111000 0
Q ss_pred hhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
....+..+++++.++|.+||+.||++|||++++++||||+.+....
T Consensus 241 ---------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~ 286 (302)
T 2j7t_A 241 ---------------------------TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNK 286 (302)
T ss_dssp ---------------------------CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCCH
T ss_pred ---------------------------ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccch
Confidence 0111234667899999999999999999999999999999886543
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=323.62 Aligned_cols=256 Identities=25% Similarity=0.409 Sum_probs=203.8
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
..++|++.+.||+|+||.||+|.+..++..+++|+++.. ....+.+|+.+++.+ +||||+++++++.+....
T Consensus 3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-RHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECC---
T ss_pred cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhc-CCCCeeEEEEEEEcCCCC
Confidence 357899999999999999999999999999999998743 235688999999999 899999999998766666
Q ss_pred CcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 92 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
..++||||+.++....+. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++ .++|+|||++....
T Consensus 82 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~-~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 82 KMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGG-TLKISALGVAEALH 160 (305)
T ss_dssp CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECC
T ss_pred eEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCC-cEEeeccccccccC
Confidence 788999999988332222 3589999999999999999999999999999999999999888 89999999998764
Q ss_pred CC---CccccccCCccccccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 168 PG---KEYNVRVASRYFKGPELLVDLQ-DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 168 ~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
.. .......++..|+|||++.+.. ..+.++||||||+++|+|++|..||. +.+.......+...
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~i~~~----------- 228 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFE-GDNIYKLFENIGKG----------- 228 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHC-----------
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCC-CchHHHHHHHHhcC-----------
Confidence 32 2224456899999999987622 24779999999999999999999984 22222222221110
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
....+..+++++.++|++||+.||++|||++|+++||||++...+
T Consensus 229 --------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 229 --------------------------SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273 (305)
T ss_dssp --------------------------CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred --------------------------CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence 001122466899999999999999999999999999999976443
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=330.39 Aligned_cols=257 Identities=21% Similarity=0.316 Sum_probs=202.8
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
...++|++.+.||+|+||+||+|++..+++.||+|+++... ...+.+|+.++..+ +||||+++++++......
T Consensus 9 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~ 87 (311)
T 3ork_A 9 HLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPA 87 (311)
T ss_dssp EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCC-CCTTBCCEEEEEEEEETT
T ss_pred eecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcC-CCCCcceEEEeeeccCCC
Confidence 45789999999999999999999999999999999997532 24578899999999 899999999998655433
Q ss_pred --CcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeec
Q 020826 92 --TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 166 (321)
Q Consensus 92 --~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~ 166 (321)
..++||||+.+++|.+++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++...
T Consensus 88 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~~ 166 (311)
T 3ork_A 88 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN-AVKVMDFGIARAI 166 (311)
T ss_dssp EEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTS-CEEECCCSCC---
T ss_pred CcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCC-CEEEeeccCcccc
Confidence 447999999999998876 4699999999999999999999999999999999999999888 8999999999765
Q ss_pred CCCC----ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHh
Q 020826 167 HPGK----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242 (321)
Q Consensus 167 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (321)
.... ......+|+.|+|||++.+ ..++.++||||||+++|+|++|..||. +..................
T Consensus 167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~-~~~~~~~~~~~~~~~~~~~----- 239 (311)
T 3ork_A 167 ADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFT-GDSPVSVAYQHVREDPIPP----- 239 (311)
T ss_dssp ---------------CCTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHCCCCCH-----
T ss_pred cccccccccccccCcCcccCCHHHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCC-CCChHHHHHHHhcCCCCCc-----
Confidence 4322 1233468999999999987 688999999999999999999999983 3322222222211110000
Q ss_pred hhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
......+|+++.++|.+||+.||++||++.+++.|+|++..
T Consensus 240 ----------------------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 240 ----------------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp ----------------------------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred ----------------------------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 00112467899999999999999999999999999999854
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-48 Score=339.83 Aligned_cols=266 Identities=17% Similarity=0.185 Sum_probs=192.3
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhc-CCCCeeeee-------
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLC-GGPNIVKLL------- 82 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~-~h~~i~~~~------- 82 (321)
.....+|++.+.||+|+||+||+|.+..+++.||+|+++... ...+.+|+.+++.|. +||||++++
T Consensus 58 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~ 137 (371)
T 3q60_A 58 SQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPS 137 (371)
T ss_dssp TCCEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCC
T ss_pred CCCceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeee
Confidence 344567999999999999999999999899999999997633 345778877777774 599988755
Q ss_pred eeeeccCC---------------CCcEEEEEeecCchhhhhcC----CCCHHHH------HHHHHHHHHHHHHHHHCCCe
Q 020826 83 DIVRDQQS---------------KTPSLIFEHVNNTDFKVLYP----TLSDYDV------RYYIYELLKALDYCHSQGIM 137 (321)
Q Consensus 83 ~~~~~~~~---------------~~~~lv~e~~~~~~l~~~~~----~~~~~~~------~~i~~qi~~~l~~lh~~~i~ 137 (321)
+++..... ...++||||+. ++|.+++. .+..... ..++.||+.||+|||++||+
T Consensus 138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~iv 216 (371)
T 3q60_A 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLV 216 (371)
T ss_dssp EEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCc
Confidence 33332221 23689999999 78777763 3555555 67789999999999999999
Q ss_pred eecCCCCCeEEcCCCCeEEEeeccceeecCCCCccccccCCccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCC
Q 020826 138 HRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPF 216 (321)
Q Consensus 138 H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~ 216 (321)
|+||||+||+++.++ .+||+|||++..... ......+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||
T Consensus 217 HrDikp~NIll~~~~-~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf 293 (371)
T 3q60_A 217 HGHFTPDNLFIMPDG-RLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF 293 (371)
T ss_dssp ETTCSGGGEEECTTS-CEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred cCcCCHHHEEECCCC-CEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence 999999999999888 899999999986542 22245667999999999642 46899999999999999999999999
Q ss_pred ccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCC
Q 020826 217 FYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER 296 (321)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~R 296 (321)
......... ......................+++++.+||.+||+.||++|
T Consensus 294 ~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 344 (371)
T 3q60_A 294 GLVTPGIKG-----------------------------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRR 344 (371)
T ss_dssp TBCCTTCTT-----------------------------CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTC
T ss_pred CCcCccccc-----------------------------chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhC
Confidence 533211000 000000000000011111223578899999999999999999
Q ss_pred cCHHHHhcCCCcccCCCcc
Q 020826 297 PTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 297 ps~~ell~hp~~~~~~~~~ 315 (321)
||++++++||||+++....
T Consensus 345 pt~~e~l~hp~f~~~~~~~ 363 (371)
T 3q60_A 345 LLPLEAMETPEFLQLQNEI 363 (371)
T ss_dssp CCHHHHTTSHHHHHHHHHH
T ss_pred CCHHHHhcCHHHHHHHHHH
Confidence 9999999999999875543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=330.34 Aligned_cols=271 Identities=22% Similarity=0.375 Sum_probs=210.1
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccch--------------------HHHHHHHHHHHhhcCCCCe
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--------------------KKIKREIKILQNLCGGPNI 78 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~--------------------~~~~~E~~~l~~l~~h~~i 78 (321)
..++|++.+.||+|+||+||+|.+ +++.||+|++..... ..+.+|+.++..+ +||||
T Consensus 29 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i 105 (348)
T 2pml_X 29 YINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI-KNEYC 105 (348)
T ss_dssp EETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTC-CCTTB
T ss_pred ccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhC-CCCCc
Confidence 357999999999999999999998 899999999864321 7789999999999 89999
Q ss_pred eeeeeeeeccCCCCcEEEEEeecCchhhhh------c-----CCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCe
Q 020826 79 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVL------Y-----PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNV 146 (321)
Q Consensus 79 ~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~------~-----~~~~~~~~~~i~~qi~~~l~~lh~-~~i~H~dlkp~ni 146 (321)
+++++++.+. ...++||||+.+++|.++ + ..+++..++.++.|++.||.|||+ +|++|+||+|+||
T Consensus 106 ~~~~~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 106 LTCEGIITNY--DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183 (348)
T ss_dssp CCCSEEEESS--SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred ceEEEEEeeC--CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence 9999999654 467899999999999887 3 358999999999999999999999 9999999999999
Q ss_pred EEcCCCCeEEEeeccceeecCCCCccccccCCccccccccccCCCCCCC-cchHHHHHHHHHHHHhCCCCCccCCCChHH
Q 020826 147 MIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY-SLDLWSLGCMFAGMIFRKEPFFYGHDNYDQ 225 (321)
Q Consensus 147 li~~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~DvwslG~~l~~l~~g~~p~~~~~~~~~~ 225 (321)
+++.++ .++|+|||++...... ......++..|+|||++.+...++. ++|||||||++|+|++|..||.........
T Consensus 184 l~~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 261 (348)
T 2pml_X 184 LMDKNG-RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL 261 (348)
T ss_dssp EECTTS-CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred EEcCCC-cEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence 999888 8999999999875433 3455678999999999987435655 999999999999999999999544433333
Q ss_pred HHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 226 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
...+... ....+.... ....+............+++++.+||.+||+.||++|||++|+++|
T Consensus 262 ~~~i~~~--~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h 323 (348)
T 2pml_X 262 FNNIRTK--NIEYPLDRN----------------HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH 323 (348)
T ss_dssp HHHHTSC--CCCCCCSSS----------------SSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred HHHHhcc--CcCCccchh----------------hhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 3332111 000000000 0000000000011124577899999999999999999999999999
Q ss_pred CCcccCCCc
Q 020826 306 PYFFPIRNA 314 (321)
Q Consensus 306 p~~~~~~~~ 314 (321)
|||++....
T Consensus 324 p~f~~~~~~ 332 (348)
T 2pml_X 324 EWLADTNIE 332 (348)
T ss_dssp GGGTTCCHH
T ss_pred ccccCCCHH
Confidence 999987543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=322.13 Aligned_cols=256 Identities=24% Similarity=0.402 Sum_probs=210.9
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
...+.|++.+.||+|+||+||+|.+..+++.||+|+++.. ....+.+|+.+++.+ +||||+++++++.+. ...
T Consensus 19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~ 95 (303)
T 3a7i_A 19 DPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC-DSPYVTKYYGSYLKD--TKL 95 (303)
T ss_dssp CGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--TEE
T ss_pred ChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecC--CeE
Confidence 4467899999999999999999999889999999998643 346788999999999 999999999998653 457
Q ss_pred EEEEEeecCchhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-
Q 020826 94 SLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 170 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~- 170 (321)
++||||+.+++|.+++. .+++..+..++.|++.||.+||++|++|+||+|+||+++.++ .++|+|||++.......
T Consensus 96 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~~~~~~ 174 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQI 174 (303)
T ss_dssp EEEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECBTTBC
T ss_pred EEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCC-CEEEeecccceecCcccc
Confidence 89999999999988874 489999999999999999999999999999999999999888 89999999997764332
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
......++..|+|||++.+ ..++.++||||||+++|+|++|..||. ..........+... .
T Consensus 175 ~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~-~~~~~~~~~~~~~~-~---------------- 235 (303)
T 3a7i_A 175 KRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHS-ELHPMKVLFLIPKN-N---------------- 235 (303)
T ss_dssp CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHS-C----------------
T ss_pred ccCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCC-CcCHHHHHHHhhcC-C----------------
Confidence 2345578899999999987 678899999999999999999999983 22222111111100 0
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
.......+++++.++|.+||+.||++|||++++++||||......+
T Consensus 236 -------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~ 281 (303)
T 3a7i_A 236 -------------------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKT 281 (303)
T ss_dssp -------------------CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCCCG
T ss_pred -------------------CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCCcc
Confidence 0011224667899999999999999999999999999998765443
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=344.43 Aligned_cols=253 Identities=17% Similarity=0.218 Sum_probs=197.0
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhc--CCCCeeeee------
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLC--GGPNIVKLL------ 82 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~--~h~~i~~~~------ 82 (321)
....++|++.+.||+|+||+||+|++..+++.||||+++.. ..+.+.+|+.+++.+. +||||++++
T Consensus 69 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~ 148 (377)
T 3byv_A 69 GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFP 148 (377)
T ss_dssp SCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCC
T ss_pred CCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhh
Confidence 34468999999999999999999999889999999998632 2366889996555553 799999998
Q ss_pred -eeeeccCC---------------CCcEEEEEeecCchhhhhcC---CCCH-------HHHHHHHHHHHHHHHHHHHCCC
Q 020826 83 -DIVRDQQS---------------KTPSLIFEHVNNTDFKVLYP---TLSD-------YDVRYYIYELLKALDYCHSQGI 136 (321)
Q Consensus 83 -~~~~~~~~---------------~~~~lv~e~~~~~~l~~~~~---~~~~-------~~~~~i~~qi~~~l~~lh~~~i 136 (321)
+++.+.+. ...+++|||++ ++|.+++. .+++ ..+..++.||+.||+|||++||
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 227 (377)
T 3byv_A 149 FDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGL 227 (377)
T ss_dssp SEEEECTTSCSEEEC------CEEESEEEEEECCS-EEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhhhhccCCccccccccCCCceEEEEEEEEEeccC-CCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence 55543321 13679999995 67777663 3444 7788899999999999999999
Q ss_pred eeecCCCCCeEEcCCCCeEEEeeccceeecCCCCccccccCCccccccccccCC----------CCCCCcchHHHHHHHH
Q 020826 137 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL----------QDYDYSLDLWSLGCMF 206 (321)
Q Consensus 137 ~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------~~~~~~~DvwslG~~l 206 (321)
+|+||||+||+++.++ .+||+|||++.... .......| +.|+|||++.+. ..++.++|||||||++
T Consensus 228 vHrDikp~NIll~~~~-~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il 303 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRG-GVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVI 303 (377)
T ss_dssp ECSCCCGGGEEECTTC-CEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHH
T ss_pred ecCCCCHHHEEEcCCC-CEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHH
Confidence 9999999999999888 89999999998643 23344566 899999999873 1789999999999999
Q ss_pred HHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHH
Q 020826 207 AGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLD 286 (321)
Q Consensus 207 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~ 286 (321)
|+|++|..||...... . .... .......+++++.+||.
T Consensus 304 ~elltg~~Pf~~~~~~-~------------~~~~-----------------------------~~~~~~~~~~~~~~li~ 341 (377)
T 3byv_A 304 YWIWCADLPITKDAAL-G------------GSEW-----------------------------IFRSCKNIPQPVRALLE 341 (377)
T ss_dssp HHHHHSSCCC-------C------------CSGG-----------------------------GGSSCCCCCHHHHHHHH
T ss_pred HHHHHCCCCCcccccc-c------------chhh-----------------------------hhhhccCCCHHHHHHHH
Confidence 9999999998321110 0 0000 00011356789999999
Q ss_pred HhhccCCCCCcCHHHHhcCCCcccCCCccc
Q 020826 287 KLLRYDHQERPTAKEAMAHPYFFPIRNAES 316 (321)
Q Consensus 287 ~~l~~dp~~Rps~~ell~hp~~~~~~~~~~ 316 (321)
+||+.||++|||+.++++||||+++....+
T Consensus 342 ~~L~~dp~~Rpt~~e~l~hp~f~~~~~~~~ 371 (377)
T 3byv_A 342 GFLRYPKEDRLLPLQAMETPEYEQLRTELS 371 (377)
T ss_dssp HHTCSSGGGCCCHHHHHTSHHHHHHHHHHH
T ss_pred HHcCCCchhCCCHHHHhhChHHHHHHHHHH
Confidence 999999999999999999999998765543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=329.73 Aligned_cols=266 Identities=22% Similarity=0.368 Sum_probs=186.3
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
...++|++.+.||+|+||+||+|.+..+++.||+|.+... ....+.+|+.++..+ +||||+++++++... ...
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~--~~~ 88 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQC-HHPNIVSYYTSFVVK--DEL 88 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCC-CCTTBCCEEEEEESS--SCE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhc-CCCCEeeEEEEEeec--CCc
Confidence 3467999999999999999999999889999999998643 235577899999998 899999999999654 356
Q ss_pred EEEEEeecCchhhhhcC-----------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccc
Q 020826 94 SLIFEHVNNTDFKVLYP-----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 162 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~~-----------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~ 162 (321)
++|+||+.+++|.+++. .+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||+
T Consensus 89 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~ 167 (303)
T 2vwi_A 89 WLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG-SVQIADFGV 167 (303)
T ss_dssp EEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC-CEEECCCHH
T ss_pred EEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCC-CEEEEeccc
Confidence 79999999998877652 389999999999999999999999999999999999999888 899999999
Q ss_pred eeecCCCC------ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCCh
Q 020826 163 AEFYHPGK------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD 236 (321)
Q Consensus 163 ~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (321)
+....... ......+++.|+|||++.+...++.++||||||+++|+|++|..||... ........... ..
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-~~~~~~~~~~~---~~ 243 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY-PPMKVLMLTLQ---ND 243 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTS-CGGGHHHHHHT---SS
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccC-chhhHHHHHhc---cC
Confidence 86543221 1234568899999999875456889999999999999999999998432 22222111100 00
Q ss_pred hhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 237 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
................+++++.++|.+||+.||++|||++++++||||++....+
T Consensus 244 ------------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~ 298 (303)
T 2vwi_A 244 ------------------------PPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNKE 298 (303)
T ss_dssp ------------------------CCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-------
T ss_pred ------------------------CCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCCCc
Confidence 0000000011112235678999999999999999999999999999999886654
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=329.66 Aligned_cols=291 Identities=25% Similarity=0.431 Sum_probs=213.4
Q ss_pred eeeecccCceEEeeeeeeecceEEEEEEEecCC-ceEEEEEeccc--chHHHHHHHHHHHhhcCCCC------eeeeeee
Q 020826 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDN-EKCIIKILKPV--KKKKIKREIKILQNLCGGPN------IVKLLDI 84 (321)
Q Consensus 14 ~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~-~~~~vK~~~~~--~~~~~~~E~~~l~~l~~h~~------i~~~~~~ 84 (321)
.......++|++.+.||+|+||+||+|.+..++ ..||+|+++.. ....+.+|+.+++.+ .|++ ++.++++
T Consensus 12 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~~~~~~~~~~~~~~~~~ 90 (355)
T 2eu9_A 12 RIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKI-KEKDKENKFLCVLMSDW 90 (355)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHH-HHHCTTSCSCBCCEEEE
T ss_pred ccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHH-hhcCCCCceeEEEeeee
Confidence 334456789999999999999999999997766 68999999753 345678899999988 4443 8888888
Q ss_pred eeccCCCCcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEE------------
Q 020826 85 VRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI------------ 148 (321)
Q Consensus 85 ~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili------------ 148 (321)
+.. ....++|||+++++++..+. ..+++..++.++.||+.||+|||++|++|+||||+||++
T Consensus 91 ~~~--~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 91 FNF--HGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp EEE--TTEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred eee--CCeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccc
Confidence 854 34678999999777665544 358999999999999999999999999999999999999
Q ss_pred -------cCCCCeEEEeeccceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCC
Q 020826 149 -------DHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 221 (321)
Q Consensus 149 -------~~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~ 221 (321)
+.++ .++|+|||++..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||. +..
T Consensus 169 ~~~~~~~~~~~-~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~-~~~ 243 (355)
T 2eu9_A 169 KSCEEKSVKNT-SIRVADFGSATFDHE--HHTTIVATRHYRPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQ-THE 243 (355)
T ss_dssp -CCCEEEESCC-CEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCC-CSS
T ss_pred ccccccccCCC-cEEEeecCccccccc--cccCCcCCCcccCCeeeec-CCCCCccchHHHHHHHHHHHhCCCCCC-CCC
Confidence 4445 799999999986432 2345678999999999987 788999999999999999999999983 445
Q ss_pred ChHHHHHHHHHhCChhhhHHhhhhcc--------cCChh--hHhhhcccCCCCCccccccccccCCcchHHHHHHHhhcc
Q 020826 222 NYDQLVKIAKVLGTDELNAYLNKYHI--------ELDPH--LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRY 291 (321)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~ 291 (321)
....+..+.+..+............. ..... ....... ...+... ........++++.+||++||+.
T Consensus 244 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKE-NCKPLKS--YMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHH-HCCCGGG--GCSCCSHHHHHHHHHHHHHTCS
T ss_pred HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccc-cCCcccc--cccccchhHHHHHHHHHHHhcC
Confidence 55555555555554322211110000 00000 0000000 0000000 0111122346899999999999
Q ss_pred CCCCCcCHHHHhcCCCcccCCCcc
Q 020826 292 DHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 292 dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
||++|||++|+++||||+++....
T Consensus 321 dP~~Rpt~~e~l~hp~f~~~~~~~ 344 (355)
T 2eu9_A 321 DPAQRITLAEALLHPFFAGLTPEE 344 (355)
T ss_dssp STTTSCCHHHHTTSGGGGGCCHHH
T ss_pred ChhhCcCHHHHhcChhhcCCChhh
Confidence 999999999999999999986543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=336.49 Aligned_cols=285 Identities=21% Similarity=0.313 Sum_probs=208.2
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
....++|++.+.||+|+||+||+|.+..++..+|+|+++.. ....+.+|+.+++.+ +||||+++++++.+ ...
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~--~~~ 105 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYS--DGE 105 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEE--TTE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHC-CCCCEEEEeEEEEE--CCE
Confidence 44578999999999999999999999989999999998754 235688999999999 89999999999865 345
Q ss_pred cEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 93 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~-~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
.++||||+.+++|.+++ ..+++..+..++.|++.||+|||+. |++|+||||+||+++.++ .++|+|||++.....
T Consensus 106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~ 184 (360)
T 3eqc_A 106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLID 184 (360)
T ss_dssp EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHHHHH
T ss_pred EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC-CEEEEECCCCccccc
Confidence 78999999999998877 4699999999999999999999996 999999999999999888 899999999864421
Q ss_pred CCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhc--
Q 020826 169 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH-- 246 (321)
Q Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 246 (321)
. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.... ...+....................
T Consensus 185 ~-~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (360)
T 3eqc_A 185 S-MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPD--AKELELMFGCQVEGDAAETPPRPRTP 260 (360)
T ss_dssp H-C----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCC--HHHHHHHHC-----------------
T ss_pred c-cccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHhcccccccCCCCCCCcccC
Confidence 1 2234578999999999987 788999999999999999999999994322 222221111000000000000000
Q ss_pred --------ccCC--hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCC
Q 020826 247 --------IELD--PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 247 --------~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~ 313 (321)
.... ............... .......+++++.+||++||+.||++|||++|+++||||++...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 333 (360)
T 3eqc_A 261 GRPLNKFGMDSRPPMAIFELLDYIVNEPP----PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 333 (360)
T ss_dssp -------------CCCHHHHHHHHHHSCC----CCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred CCcccccccCCCCcccchhhhhHHhccCC----CCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence 0000 000000000000000 00112246789999999999999999999999999999997643
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=326.79 Aligned_cols=285 Identities=23% Similarity=0.449 Sum_probs=209.3
Q ss_pred cccCceEEeeeeeeecceEEEEEEE-ecCCceEEEEEecccc--hHHHHHHHHHHHhhc-----CCCCeeeeeeeeeccC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVH-CTDNEKCIIKILKPVK--KKKIKREIKILQNLC-----GGPNIVKLLDIVRDQQ 89 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~-~~~~~~~~vK~~~~~~--~~~~~~E~~~l~~l~-----~h~~i~~~~~~~~~~~ 89 (321)
...++|++.+.||+|+||+||+|.+ ..+++.||+|+++... ...+.+|+.+++.+. .+++++++++++.+.
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~- 89 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH- 89 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET-
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC-
Confidence 4467999999999999999999998 5578999999997543 356888999998882 234599999998653
Q ss_pred CCCcEEEEEeecCchhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCC-------------
Q 020826 90 SKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE------------- 151 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~------------- 151 (321)
...++|||++ +++|.+++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.+
T Consensus 90 -~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~ 167 (339)
T 1z57_A 90 -GHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD 167 (339)
T ss_dssp -TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred -CcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence 4678999999 55555444 248899999999999999999999999999999999999863
Q ss_pred -----CCeEEEeeccceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHH
Q 020826 152 -----QRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL 226 (321)
Q Consensus 152 -----~~~v~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~ 226 (321)
...++|+|||++..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..|| ...+..+..
T Consensus 168 ~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf-~~~~~~~~~ 243 (339)
T 1z57_A 168 ERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIEYYLGFTVF-PTHDSKEHL 243 (339)
T ss_dssp EEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTT-SCCCTHHHHHHHHHHHHHHHHSSCSC-CCSCHHHHH
T ss_pred cccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhC-CCCCcchhhHHHHHHHHHHHhCCCCC-CCCChHHHH
Confidence 22699999999986542 2345678999999999987 78899999999999999999999998 445555555
Q ss_pred HHHHHHhCChhhhHHhhhhcc--------cCC--hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCC
Q 020826 227 VKIAKVLGTDELNAYLNKYHI--------ELD--PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER 296 (321)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~--------~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~R 296 (321)
..+....+............. ... ......... ...+... ........++++.+||++||+.||++|
T Consensus 244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~~l~~li~~~L~~dP~~R 320 (339)
T 1z57_A 244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSR-ACKPLKE--FMLSQDVEHERLFDLIQKMLEYDPAKR 320 (339)
T ss_dssp HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHH-HCCCGGG--GCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhh-cCcchhh--hcccchhhHHHHHHHHHHHhCcCcccc
Confidence 555555554322111110000 000 000000000 0000000 011122345689999999999999999
Q ss_pred cCHHHHhcCCCcccCC
Q 020826 297 PTAKEAMAHPYFFPIR 312 (321)
Q Consensus 297 ps~~ell~hp~~~~~~ 312 (321)
||++|+++||||+.+.
T Consensus 321 pt~~ell~hp~f~~~~ 336 (339)
T 1z57_A 321 ITLREALKHPFFDLLK 336 (339)
T ss_dssp CCHHHHTTSGGGGGGG
T ss_pred cCHHHHhcCHHHHHHh
Confidence 9999999999999874
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=319.52 Aligned_cols=260 Identities=21% Similarity=0.358 Sum_probs=198.4
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc---hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEE
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 98 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 98 (321)
+|.....||+|+||+||+|.+..++..|++|.++... ...+.+|+.+++.+ +||||+++++++.+ ....++++|
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--~~~~~lv~e 99 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL-KHKNIVQYLGSFSE--NGFIKIFME 99 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTC-CCTTBCCEEEEEEE--TTEEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhC-CCCCEeeEeeEEEe--CCcEEEEEE
Confidence 3444458999999999999999999999999987543 45688999999999 89999999999965 346679999
Q ss_pred eecCchhhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-c
Q 020826 99 HVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 171 (321)
Q Consensus 99 ~~~~~~l~~~~~------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~-~ 171 (321)
++.+++|..++. .+++..++.++.|++.||+|||++|++|+||+|+||+++..+..++|+|||++....... .
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~ 179 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence 999999887762 356888999999999999999999999999999999998733389999999997654322 2
Q ss_pred cccccCCccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 172 YNVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
.....++..|+|||++.+. ..++.++||||||+++|+|++|..||............... ..
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~---------------- 242 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM-FK---------------- 242 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHH-HC----------------
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcc-cc----------------
Confidence 3445788999999998652 23789999999999999999999998532222111111000 00
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcccccc
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAESSRS 319 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~~~~~ 319 (321)
. ....+..+++++.++|.+||+.||++|||++++++||||+.........+
T Consensus 243 --------~----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~p 293 (295)
T 2clq_A 243 --------V----------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQP 293 (295)
T ss_dssp --------C----------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC---------
T ss_pred --------c----------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhccccCCCCC
Confidence 0 00112346789999999999999999999999999999998765554443
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=330.25 Aligned_cols=300 Identities=25% Similarity=0.407 Sum_probs=214.2
Q ss_pred EEeeeeeec-ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc--hHHHHHHHHHHHhhc----------CCC
Q 020826 10 YWCVWFINR-EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLC----------GGP 76 (321)
Q Consensus 10 ~~~~~~i~~-~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~E~~~l~~l~----------~h~ 76 (321)
|.++..... ..++|++.+.||+|+||+||+|++..+++.||+|+++... ...+.+|+.+++++. .||
T Consensus 7 ~~p~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~ 86 (373)
T 1q8y_A 7 YHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 86 (373)
T ss_dssp CCCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHT
T ss_pred ceeeecCCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccc
Confidence 444433333 3579999999999999999999999999999999997543 456788999999883 279
Q ss_pred CeeeeeeeeeccC--CCCcEEEEEeecCchhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCCeEE
Q 020826 77 NIVKLLDIVRDQQ--SKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMI 148 (321)
Q Consensus 77 ~i~~~~~~~~~~~--~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~-~i~H~dlkp~nili 148 (321)
||+++++++.... ....++++|++ +++|..++ ..+++..+..++.||+.||+|||++ |++|+||||+||++
T Consensus 87 ~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll 165 (373)
T 1q8y_A 87 HILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLM 165 (373)
T ss_dssp TBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEE
T ss_pred hHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEE
Confidence 9999999986542 33678999999 66666554 3489999999999999999999998 99999999999999
Q ss_pred cCCC-----CeEEEeeccceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCC--
Q 020826 149 DHEQ-----RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD-- 221 (321)
Q Consensus 149 ~~~~-----~~v~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~-- 221 (321)
+.++ ..++|+|||++..... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus 166 ~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 242 (373)
T 1q8y_A 166 EIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHS 242 (373)
T ss_dssp EEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred eccCCCcCcceEEEcccccccccCC--CCCCCCCCccccCcHHHhC-CCCCchHhHHHHHHHHHHHHhCCCCCCCCcccc
Confidence 5322 2799999999986542 2344578999999999987 6789999999999999999999999954321
Q ss_pred ---ChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCC-CCc--cc--cccccccCCcchHHHHHHHhhccCC
Q 020826 222 ---NYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRK-PWS--KF--ITVENQHLAVPEAVDFLDKLLRYDH 293 (321)
Q Consensus 222 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~--~~--~~~~~~~~~s~~~~~ll~~~l~~dp 293 (321)
....+..+...++............................. .+. .. .....+..+++++.+||++||+.||
T Consensus 243 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP 322 (373)
T 1q8y_A 243 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 322 (373)
T ss_dssp --CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSST
T ss_pred cCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCc
Confidence 234455555555543322111100000000000000000000 000 00 0011222355789999999999999
Q ss_pred CCCcCHHHHhcCCCcccCCC
Q 020826 294 QERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 294 ~~Rps~~ell~hp~~~~~~~ 313 (321)
++|||++|+++||||++...
T Consensus 323 ~~Rpt~~ell~hp~f~~~~~ 342 (373)
T 1q8y_A 323 RKRADAGGLVNHPWLKDTLG 342 (373)
T ss_dssp TTCBCHHHHHTCGGGTTCTT
T ss_pred cccCCHHHHhhChhhhcccC
Confidence 99999999999999998644
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=320.38 Aligned_cols=254 Identities=19% Similarity=0.331 Sum_probs=194.8
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
+....++|++.+.||+|+||+||+|++ ++..||+|++.... ...+.+|+.+++++ +||||+++++++.+ .
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--~ 106 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRL-RHPNIVLFMGAVTQ--P 106 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--T
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEE--C
Confidence 344477999999999999999999986 68889999986432 34678999999999 89999999999954 4
Q ss_pred CCcEEEEEeecCchhhhhcCC------CCHHHHHHHHHHHHHHHHHHHHCC--CeeecCCCCCeEEcCCCCeEEEeeccc
Q 020826 91 KTPSLIFEHVNNTDFKVLYPT------LSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGL 162 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~i~~qi~~~l~~lh~~~--i~H~dlkp~nili~~~~~~v~l~dfg~ 162 (321)
...++||||+.+++|.+++.. +++..++.++.|++.||+|||++| ++|+||||+||+++.++ .++|+|||+
T Consensus 107 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~ 185 (309)
T 3p86_A 107 PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKY-TVKVCDFGL 185 (309)
T ss_dssp TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTC-CEEECCCC-
T ss_pred CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCC-cEEECCCCC
Confidence 456799999999999887732 889999999999999999999999 99999999999999888 899999999
Q ss_pred eeecCCCC-ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHH
Q 020826 163 AEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY 241 (321)
Q Consensus 163 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (321)
+....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+.......+.....
T Consensus 186 a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~Pf~-~~~~~~~~~~~~~~~~------- 256 (309)
T 3p86_A 186 SRLKASTFLSSKSAAGTPEWMAPEVLRD-EPSNEKSDVYSFGVILWELATLQQPWG-NLNPAQVVAAVGFKCK------- 256 (309)
T ss_dssp ----------------CCTTSCHHHHTT-CCCCTTHHHHHHHHHHHHHHHCCCTTT-TSCHHHHHHHHHHSCC-------
T ss_pred CccccccccccccCCCCccccChhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhcCC-------
Confidence 87543322 2345678999999999987 678999999999999999999999983 2222222221111000
Q ss_pred hhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc--CCCcccCC
Q 020826 242 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA--HPYFFPIR 312 (321)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~--hp~~~~~~ 312 (321)
....+..+++++.++|++||+.||++|||++++++ .++++...
T Consensus 257 ----------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~ 301 (309)
T 3p86_A 257 ----------------------------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV 301 (309)
T ss_dssp ----------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred ----------------------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence 01122356789999999999999999999999987 56666543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=318.85 Aligned_cols=259 Identities=20% Similarity=0.306 Sum_probs=201.3
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
....++|++.+.||+|+||+||+|.+..++..+|+|++... ....+.+|+.++..+ +||||+++++++.+ .
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~--~ 83 (294)
T 4eqm_A 7 KIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQL-SHQNIVSMIDVDEE--D 83 (294)
T ss_dssp SCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CBTTBCCEEEEEEC--S
T ss_pred hHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcC-CCCCCceEEEeeee--C
Confidence 34578999999999999999999999999999999998532 235678999999999 89999999999854 4
Q ss_pred CCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 91 KTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
...++||||+.+++|.+++ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++....
T Consensus 84 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 84 DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNK-TLKIFDFGIAKALS 162 (294)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCSSSTTC-
T ss_pred CeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEEeCCCccccc
Confidence 5678999999999998876 4699999999999999999999999999999999999999888 89999999987553
Q ss_pred CCC--ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhh
Q 020826 168 PGK--EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245 (321)
Q Consensus 168 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (321)
... ......+|+.|+|||.+.+ ..++.++||||||+++|+|++|..||.. .............. .+.
T Consensus 163 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~g~~pf~~-~~~~~~~~~~~~~~-~~~-------- 231 (294)
T 4eqm_A 163 ETSLTQTNHVLGTVQYFSPEQAKG-EATDECTDIYSIGIVLYEMLVGEPPFNG-ETAVSIAIKHIQDS-VPN-------- 231 (294)
T ss_dssp ------------CCSSCCHHHHHT-CCCCTTHHHHHHHHHHHHHHHSSCSSCS-SCHHHHHHHHHSSC-CCC--------
T ss_pred cccccccCccccCccccCHhHhcC-CCCCchHhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHHhhcc-CCC--------
Confidence 322 2234568999999999987 7789999999999999999999999842 22211111111000 000
Q ss_pred cccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCC
Q 020826 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~ 313 (321)
........+++.+.++|.+||+.||++||+..+.+.+.|..-+.+
T Consensus 232 -----------------------~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~ 276 (294)
T 4eqm_A 232 -----------------------VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE 276 (294)
T ss_dssp -----------------------HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred -----------------------cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence 001122346789999999999999999997666777766655433
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=325.53 Aligned_cols=256 Identities=24% Similarity=0.402 Sum_probs=206.1
Q ss_pred eeeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc---------hHHHHHHHHHHHhhc-CCCCeeee
Q 020826 12 CVWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQNLC-GGPNIVKL 81 (321)
Q Consensus 12 ~~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~---------~~~~~~E~~~l~~l~-~h~~i~~~ 81 (321)
+........++|++.+.||+|+||+||+|++..+++.||+|+++... ...+.+|+.+++.+. .||||+++
T Consensus 34 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~ 113 (320)
T 3a99_A 34 PGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 113 (320)
T ss_dssp ------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCE
T ss_pred cccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEE
Confidence 45566778899999999999999999999999999999999987542 245678999999995 37999999
Q ss_pred eeeeeccCCCCcEEEEEeecC-chhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEE
Q 020826 82 LDIVRDQQSKTPSLIFEHVNN-TDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRL 157 (321)
Q Consensus 82 ~~~~~~~~~~~~~lv~e~~~~-~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l 157 (321)
++++.+. ...++++|++.+ ++|.+++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.+...++|
T Consensus 114 ~~~~~~~--~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL 191 (320)
T 3a99_A 114 LDWFERP--DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKL 191 (320)
T ss_dssp EEEEECS--SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEE
T ss_pred EEEEecC--CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEE
Confidence 9999654 456799999976 7777665 468999999999999999999999999999999999999844338999
Q ss_pred eeccceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChh
Q 020826 158 IDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 237 (321)
Q Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (321)
+|||++...... ......+|..|+|||++.+....+.++|||||||++|+|++|..||... . .+..
T Consensus 192 ~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~----~---~~~~------ 257 (320)
T 3a99_A 192 IDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----E---EIIR------ 257 (320)
T ss_dssp CCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----H---HHHH------
T ss_pred eeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh----h---hhhc------
Confidence 999999876532 3344578999999999977444578899999999999999999998311 0 0000
Q ss_pred hhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 238 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
. .......+++++.++|++||+.||++|||++++++||||++...+
T Consensus 258 ---------------------~----------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~ 303 (320)
T 3a99_A 258 ---------------------G----------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 303 (320)
T ss_dssp ---------------------C----------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred ---------------------c----------cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCc
Confidence 0 001123467899999999999999999999999999999988654
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=320.13 Aligned_cols=257 Identities=23% Similarity=0.396 Sum_probs=198.2
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc--hHHHHHHHHHHHhhcCCCCeeeeeeeeeccC-------
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ------- 89 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~------- 89 (321)
..++|++.+.||+|+||+||+|++..+++.||+|.++... ...+.+|+.+++.+ +||||+++++++.+..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASL-NHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEECCCCCC---
T ss_pred ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhc-CchHHHHHHHHHHhhcchhhhhc
Confidence 4578999999999999999999998899999999986543 35688999999999 8999999999876432
Q ss_pred ----CCCcEEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecc
Q 020826 90 ----SKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 161 (321)
Q Consensus 90 ----~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg 161 (321)
....++++||+.+++|.+++. .+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~-~~kl~dfg 161 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR-NVKIGDFG 161 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCC-CEEEeeCc
Confidence 345789999999999988773 377889999999999999999999999999999999999888 89999999
Q ss_pred ceeecCCC---------------CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHH
Q 020826 162 LAEFYHPG---------------KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL 226 (321)
Q Consensus 162 ~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~ 226 (321)
++...... .......++..|+|||++.+...++.++|||||||++|+|++ ||....+.....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~ 238 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNIL 238 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHH
Confidence 98754321 122345688899999999875578999999999999999997 553221111111
Q ss_pred HHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCC
Q 020826 227 VKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 306 (321)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp 306 (321)
..+.. .....+ .......++.+.++|++||+.||++|||++++++||
T Consensus 239 ~~~~~---------------------------~~~~~~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~ 285 (303)
T 1zy4_A 239 KKLRS---------------------------VSIEFP------PDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSG 285 (303)
T ss_dssp HHHHS---------------------------TTCCCC------TTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSS
T ss_pred Hhccc---------------------------cccccC------ccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCC
Confidence 11100 000000 011223456799999999999999999999999999
Q ss_pred CcccCCC
Q 020826 307 YFFPIRN 313 (321)
Q Consensus 307 ~~~~~~~ 313 (321)
||+....
T Consensus 286 ~~~~~~~ 292 (303)
T 1zy4_A 286 WLPVKHQ 292 (303)
T ss_dssp CSCCCCH
T ss_pred CcCCCCh
Confidence 9987543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=317.95 Aligned_cols=249 Identities=18% Similarity=0.310 Sum_probs=200.9
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc---chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
.++|++.+.||+|+||+||+|.+..+++.+|+|.+... ....+.+|+.+++.+ +||||+++++++.+. ...++|
T Consensus 9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~--~~~~lv 85 (310)
T 3s95_A 9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL-EHPNVLKFIGVLYKD--KRLNFI 85 (310)
T ss_dssp GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEET--TEEEEE
T ss_pred hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCcCcccEEEEEecC--CeeEEE
Confidence 67999999999999999999999999999999988643 345688999999999 899999999999653 557799
Q ss_pred EEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCcc
Q 020826 97 FEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 172 (321)
Q Consensus 97 ~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~ 172 (321)
|||+.+++|.+++ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++.........
T Consensus 86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~ 164 (310)
T 3s95_A 86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENK-NVVVADFGLARLMVDEKTQ 164 (310)
T ss_dssp EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTS-CEEECCCTTCEECC-----
T ss_pred EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCC-CEEEeecccceeccccccc
Confidence 9999999998776 4589999999999999999999999999999999999999888 8999999999765432221
Q ss_pred ---------------ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChh
Q 020826 173 ---------------NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 237 (321)
Q Consensus 173 ---------------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (321)
....||+.|+|||++.+ ..++.++||||||+++|+|++|..|+........... .
T Consensus 165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~--------~- 234 (310)
T 3s95_A 165 PEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG--------L- 234 (310)
T ss_dssp ---------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSS--------B-
T ss_pred ccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHh--------h-
Confidence 14568999999999987 7889999999999999999999988742221100000 0
Q ss_pred hhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCccc
Q 020826 238 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 310 (321)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~ 310 (321)
.. ........+..+++++.+++.+||+.||++|||++++++ ++++
T Consensus 235 --------------~~------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~ 279 (310)
T 3s95_A 235 --------------NV------------RGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLET 279 (310)
T ss_dssp --------------CH------------HHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred --------------hh------------hccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHH
Confidence 00 000011122356789999999999999999999999986 4444
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=324.72 Aligned_cols=265 Identities=24% Similarity=0.395 Sum_probs=184.3
Q ss_pred eeeecccCceEEee-eeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeeeecc--CC
Q 020826 14 WFINREQDDYEVVR-KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QS 90 (321)
Q Consensus 14 ~~i~~~~~~y~~~~-~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~ 90 (321)
..-....++|++.+ .||+|+||+||+|.+..+++.||+|++... ....+|+..+.+..+||||+++++++... ..
T Consensus 21 ~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 21 PKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS--PKARQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp CBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred CCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc--HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 33345678999966 599999999999999999999999998753 33445555544444999999999998642 23
Q ss_pred CCcEEEEEeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCC--CeEEEeeccce
Q 020826 91 KTPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRLIDWGLA 163 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~--~~v~l~dfg~~ 163 (321)
...++||||+.+++|..++. .+++..++.++.|++.||.|||++|++|+||||+||+++.++ ..++|+|||++
T Consensus 99 ~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 99 RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred ceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 45789999999999887772 489999999999999999999999999999999999997543 25999999999
Q ss_pred eecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 164 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
...... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..||....... ............
T Consensus 179 ~~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~------- 248 (336)
T 3fhr_A 179 KETTQN-ALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQA-ISPGMKRRIRLG------- 248 (336)
T ss_dssp EEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------------
T ss_pred eecccc-ccccCCCCcCccChhhhCC-CCCCchhhHHHHHHHHHHHHHCCCCCCCccchh-hhhhHHHhhhcc-------
Confidence 765432 3345678999999999876 678899999999999999999999984322211 000000000000
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
... ........+++++.+||++||+.||++|||++|+++||||++..
T Consensus 249 ----------------~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 249 ----------------QYG------FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp ------------------C------CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred ----------------ccc------cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 000 00011124678999999999999999999999999999999753
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=332.90 Aligned_cols=274 Identities=19% Similarity=0.310 Sum_probs=207.9
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
...+++|++.+.||+|+||+||+|++..+++.||+|+++.. ....+.+|+.+++.+ +||||+++++++.+.....
T Consensus 5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-NHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHC-CCTTBCCEEEEEECTTTCC
T ss_pred CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhc-CCCCCCeEEEeeccCCCCe
Confidence 35578999999999999999999999999999999999753 235678999999999 8999999999998776667
Q ss_pred cEEEEEeecCchhhhhcCC------CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEE----cCCCCeEEEeeccc
Q 020826 93 PSLIFEHVNNTDFKVLYPT------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI----DHEQRKLRLIDWGL 162 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~~~------~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili----~~~~~~v~l~dfg~ 162 (321)
.++||||+.+++|..++.. +++..++.++.|++.||+|||++|++|+||||+||++ +.++ .+||+|||+
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~-~~kL~DFG~ 162 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQS-VYKLTDFGA 162 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCE-EEEECCGGG
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCce-eEEEecCCC
Confidence 8999999999999888853 8999999999999999999999999999999999998 5555 799999999
Q ss_pred eeecCCCCccccccCCccccccccccCC-------CCCCCcchHHHHHHHHHHHHhCCCCCccCCC---ChHHHHHHHHH
Q 020826 163 AEFYHPGKEYNVRVASRYFKGPELLVDL-------QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD---NYDQLVKIAKV 232 (321)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~---~~~~~~~~~~~ 232 (321)
+.............+|..|+|||++.+. ..++.++|||||||++|+|++|..||..... ..+.+..+...
T Consensus 163 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 242 (396)
T 4eut_A 163 ARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG 242 (396)
T ss_dssp CEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred ceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence 9887655555667799999999998641 3567899999999999999999999954322 22333333221
Q ss_pred hCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 233 LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
........... .....+ .+ ....+ ........+++.+.++|++||+.||++|||++++++
T Consensus 243 ~p~~~~~~~~~----~~~~~~-~~---~~~~~----~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 243 KPSGAISGVQK----AENGPI-DW---SGDMP----VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp CCTTCCEEEEC----STTCCE-EE---ESSCC----TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred CCcccchhhee----ccCCCc-cc---CccCC----cccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 11111000000 000000 00 00000 000111234567999999999999999999998854
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=317.07 Aligned_cols=256 Identities=21% Similarity=0.342 Sum_probs=185.0
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccch----HHHHHH-HHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKRE-IKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~----~~~~~E-~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
....++|++.+.||+|+||+||+|.+..+++.||+|+++.... .....| ..+++.+ +||||+++++++.+. .
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~i~~~~~~~~~~--~ 97 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSH-DCPYIVQCFGTFITN--T 97 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTT-TCTTBCCEEEEEECS--S
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhc-CCCceeeEEEEEecC--C
Confidence 4456799999999999999999999988999999999875422 223333 3455555 899999999999654 4
Q ss_pred CcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCCeEEcCCCCeEEEeeccceeec
Q 020826 92 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 166 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~-~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~ 166 (321)
..++|||+++ +.+..+. ..+++..++.++.|++.||.|||++ |++|+||||+||+++.++ .++|+|||++...
T Consensus 98 ~~~lv~e~~~-~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~ 175 (318)
T 2dyl_A 98 DVFIAMELMG-TCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-QIKLCDFGISGRL 175 (318)
T ss_dssp EEEEEECCCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTS-CEEECCCTTC---
T ss_pred cEEEEEeccC-CcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCC-CEEEEECCCchhc
Confidence 6789999994 4443333 4699999999999999999999995 999999999999999888 8999999999766
Q ss_pred CCCCccccccCCccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHh
Q 020826 167 HPGKEYNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242 (321)
Q Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (321)
..........+++.|+|||++.+ ...++.++||||||+++|+|++|..||.........+..+......
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------- 248 (318)
T 2dyl_A 176 VDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPP------- 248 (318)
T ss_dssp -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCC-------
T ss_pred cCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCC-------
Confidence 54444455678999999999852 2568899999999999999999999985433333333332221000
Q ss_pred hhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
.......+++++.++|.+||+.||++|||++++++||||++.
T Consensus 249 ---------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 249 ---------------------------LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp ---------------------------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred ---------------------------CCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 011112467899999999999999999999999999999875
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=310.51 Aligned_cols=248 Identities=17% Similarity=0.365 Sum_probs=200.1
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc--chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
.|.|+ .++|++.+.||+|+||+||+|.+. ++..||+|+++.. ....+.+|+.+++++ +||||+++++++.+ .
T Consensus 4 ~~~i~--~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~ 77 (269)
T 4hcu_A 4 KWVID--PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLE--Q 77 (269)
T ss_dssp -CBCC--GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEECS--S
T ss_pred cEEeC--hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhC-CCCCEeeEEEEEec--C
Confidence 45555 569999999999999999999985 6778999998754 356789999999999 89999999999855 4
Q ss_pred CCcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeec
Q 020826 91 KTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 166 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~ 166 (321)
...+++|||+.+++|.+++ ..+++..++.++.|++.||++||++|++|+||||+||+++.++ .++|+|||++...
T Consensus 78 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~ 156 (269)
T 4hcu_A 78 APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFV 156 (269)
T ss_dssp SSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG-CEEECCTTGGGGB
T ss_pred CceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCC-CEEeccccccccc
Confidence 4578999999999988777 2389999999999999999999999999999999999999887 8999999998754
Q ss_pred CCCC--ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 167 HPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
.... ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||. +.........+....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~ll~~g~~p~~-~~~~~~~~~~~~~~~---------- 224 (269)
T 4hcu_A 157 LDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYE-NRSNSEVVEDISTGF---------- 224 (269)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHHHTTC----------
T ss_pred cccccccccCcccccccCCHHHhcC-CCCCchhhhHHHHHHHHHHhcCCCCCCC-CCCHHHHHHHHhcCc----------
Confidence 3221 1233455678999999987 678999999999999999999 888873 333322222221100
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
....+...++++.+++.+||+.||++|||++++++|
T Consensus 225 --------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 225 --------------------------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp --------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------------cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 011122356789999999999999999999999875
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=320.07 Aligned_cols=258 Identities=18% Similarity=0.336 Sum_probs=185.8
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCc---eEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNE---KCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 89 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~---~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (321)
...++|++.+.||+|+||+||+|.+..++. .||+|+++.. ....+.+|+.+++.+ +||||+++++++....
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 98 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF-DHPHVAKLVGVSLRSR 98 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTC-CCTTBCCCCEEEECC-
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHC-CCCceehhhceeeccc
Confidence 346799999999999999999999876664 8999998643 245688999999999 9999999999986544
Q ss_pred CC----CcEEEEEeecCchhhhhcC---------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEE
Q 020826 90 SK----TPSLIFEHVNNTDFKVLYP---------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLR 156 (321)
Q Consensus 90 ~~----~~~lv~e~~~~~~l~~~~~---------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~ 156 (321)
.. ..++++||+.+++|..++. .+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++
T Consensus 99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~-~~k 177 (323)
T 3qup_A 99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM-TVC 177 (323)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEE
T ss_pred cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC-CEE
Confidence 32 2379999999999887762 489999999999999999999999999999999999999887 899
Q ss_pred EeeccceeecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHH
Q 020826 157 LIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKV 232 (321)
Q Consensus 157 l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 232 (321)
|+|||++........ .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||. +....+....+...
T Consensus 178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~-~~~~~~~~~~~~~~ 255 (323)
T 3qup_A 178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLAD-NLYTVHSDVWAFGVTMWEIMTRGQTPYA-GIENAEIYNYLIGG 255 (323)
T ss_dssp ECCCCC-----------------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCGGGHHHHHHTT
T ss_pred EeeccccccccccccccccccccCcccccCchhhcC-CCCCCccchhhHHHHHHHHHhCCCCCcc-ccChHHHHHHHhcC
Confidence 999999976543322 223445678999999987 788999999999999999999 787773 33333332222110
Q ss_pred hCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC-------HHHHhcC
Q 020826 233 LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-------AKEAMAH 305 (321)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps-------~~ell~h 305 (321)
. ....+..+++++.++|.+||+.||++||| ++++++|
T Consensus 256 ~------------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~ 299 (323)
T 3qup_A 256 N------------------------------------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGH 299 (323)
T ss_dssp C------------------------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred C------------------------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence 0 01112346689999999999999999999 8899999
Q ss_pred CCcccCCCcc
Q 020826 306 PYFFPIRNAE 315 (321)
Q Consensus 306 p~~~~~~~~~ 315 (321)
||+......+
T Consensus 300 ~~~~~~~~~p 309 (323)
T 3qup_A 300 LSVLSTSQDP 309 (323)
T ss_dssp ----------
T ss_pred hhhcCCCCCC
Confidence 9999865443
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=323.85 Aligned_cols=252 Identities=19% Similarity=0.329 Sum_probs=201.0
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEE-----ecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeee
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVH-----CTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLD 83 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~-----~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (321)
.|.++ .++|++.+.||+|+||.||+|.+ ..+++.||+|+++... ...+.+|+.++.++.+||||+++++
T Consensus 16 ~~~~~--~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~ 93 (359)
T 3vhe_A 16 KWEFP--RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 93 (359)
T ss_dssp HHBCC--GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccc--ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeee
Confidence 44444 67999999999999999999994 4456899999997532 3458899999999988999999999
Q ss_pred eeeccCCCCcEEEEEeecCchhhhhcCC----------------------------------------------------
Q 020826 84 IVRDQQSKTPSLIFEHVNNTDFKVLYPT---------------------------------------------------- 111 (321)
Q Consensus 84 ~~~~~~~~~~~lv~e~~~~~~l~~~~~~---------------------------------------------------- 111 (321)
++.+.. ...+++|||+.+++|.+++..
T Consensus 94 ~~~~~~-~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 94 ACTKPG-GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EECSTT-SCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeecCC-CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 986543 446899999999998777621
Q ss_pred -----------------CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc---
Q 020826 112 -----------------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE--- 171 (321)
Q Consensus 112 -----------------~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~--- 171 (321)
+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++........
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~ 251 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVR 251 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTSCTTCEE
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCC-cEEEEeccceeeecccccchh
Confidence 78889999999999999999999999999999999999887 899999999976533222
Q ss_pred cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 172 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
.....+|..|+|||++.+ ..++.++|||||||++|+|++ |..||............+.. ...
T Consensus 252 ~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~~~--------------- 314 (359)
T 3vhe_A 252 KGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE-GTR--------------- 314 (359)
T ss_dssp C--CEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHH-TCC---------------
T ss_pred ccccCCCceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHc-CCC---------------
Confidence 234567788999999987 788999999999999999998 99888433333222222111 100
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
...+..+++++.+++.+||+.||++|||++|+++|
T Consensus 315 --------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 315 --------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp --------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 01122466899999999999999999999999976
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=321.47 Aligned_cols=246 Identities=18% Similarity=0.295 Sum_probs=197.8
Q ss_pred ccCceEEeeeeeeecceEEEEEEEec-------CCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeec
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCT-------DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRD 87 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~-------~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (321)
..++|++.+.||+|+||+||+|++.. ++..||+|+++... ...+.+|+.+++.+.+||||+++++++.+
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 35799999999999999999999753 34579999987542 35688999999999789999999999855
Q ss_pred cCCCCcEEEEEeecCchhhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEE
Q 020826 88 QQSKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 148 (321)
Q Consensus 88 ~~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili 148 (321)
...+++||||+.+++|.+++. .++...+..++.||+.||+|||++|++|+||||+||++
T Consensus 159 --~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 159 --DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 236 (370)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred --CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence 445779999999999987762 37888999999999999999999999999999999999
Q ss_pred cCCCCeEEEeeccceeecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChH
Q 020826 149 DHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYD 224 (321)
Q Consensus 149 ~~~~~~v~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~ 224 (321)
+.++ .+||+|||++........ .....+++.|+|||++.+ ..++.++|||||||++|+|++ |..||. +.+..+
T Consensus 237 ~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~p~~-~~~~~~ 313 (370)
T 2psq_A 237 TENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYP-GIPVEE 313 (370)
T ss_dssp CTTC-CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHTTSCCSST-TCCGGG
T ss_pred CCCC-CEEEccccCCcccCcccceecccCCCcccceECHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCCC-CCCHHH
Confidence 9888 899999999986643322 233456778999999987 789999999999999999999 888873 333222
Q ss_pred HHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 225 QLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
....+.... ....+..+++++.++|.+||+.||++|||+.|+++
T Consensus 314 ~~~~~~~~~------------------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~ 357 (370)
T 2psq_A 314 LFKLLKEGH------------------------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVE 357 (370)
T ss_dssp HHHHHHTTC------------------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHhcCC------------------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 222111100 01112346789999999999999999999999986
Q ss_pred C
Q 020826 305 H 305 (321)
Q Consensus 305 h 305 (321)
+
T Consensus 358 ~ 358 (370)
T 2psq_A 358 D 358 (370)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-46 Score=319.47 Aligned_cols=251 Identities=24% Similarity=0.427 Sum_probs=195.7
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc---------hHHHHHHHHHHHhhc---CCCCeeeeee
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQNLC---GGPNIVKLLD 83 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~---------~~~~~~E~~~l~~l~---~h~~i~~~~~ 83 (321)
.....++|++.+.||+|+||+||+|.+..+++.||+|+++... ...+.+|+.++.++. +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 4556789999999999999999999998899999999986532 233567999998885 7999999999
Q ss_pred eeeccCCCCcEEEEEe-ecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEc-CCCCeEEEe
Q 020826 84 IVRDQQSKTPSLIFEH-VNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID-HEQRKLRLI 158 (321)
Q Consensus 84 ~~~~~~~~~~~lv~e~-~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~-~~~~~v~l~ 158 (321)
++.+. ...++++|+ +.+++|.+++ ..+++..++.++.|++.||+|||++|++|+||||+||+++ .++ .++|+
T Consensus 106 ~~~~~--~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~-~~kl~ 182 (312)
T 2iwi_A 106 WFETQ--EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRG-CAKLI 182 (312)
T ss_dssp EC-------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTT-EEEEC
T ss_pred EEecC--CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCC-eEEEE
Confidence 98554 456799999 7888887776 4599999999999999999999999999999999999999 555 89999
Q ss_pred eccceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhh
Q 020826 159 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 238 (321)
Q Consensus 159 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (321)
|||++...... ......++..|+|||++.+....+.++||||||+++|+|++|..||... . .+..
T Consensus 183 dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~----~---~~~~------- 247 (312)
T 2iwi_A 183 DFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD----Q---EILE------- 247 (312)
T ss_dssp CCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----H---HHHH-------
T ss_pred EcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh----H---HHhh-------
Confidence 99999876533 3345668999999999877444456899999999999999999998311 0 0000
Q ss_pred hHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 239 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
. ....+..+++++.++|.+||+.||++|||++|+++||||+...+.
T Consensus 248 --------------------~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~ 293 (312)
T 2iwi_A 248 --------------------A----------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAED 293 (312)
T ss_dssp --------------------T----------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC----
T ss_pred --------------------h----------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhc
Confidence 0 001123467899999999999999999999999999999987554
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=312.52 Aligned_cols=263 Identities=19% Similarity=0.350 Sum_probs=198.8
Q ss_pred cccCceEEeeeeeeecceEEEEEE----EecCCceEEEEEecccch---HHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGV----HCTDNEKCIIKILKPVKK---KKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~----~~~~~~~~~vK~~~~~~~---~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
...++|++.+.||+|+||+||+|+ +..+++.||+|+++.... ..+.+|+.+++.+ +||||+++++++.....
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 85 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGR 85 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECHHHH
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecCCC
Confidence 457899999999999999999998 556889999999875443 5678999999999 89999999999876555
Q ss_pred CCcEEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeec
Q 020826 91 KTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 166 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~ 166 (321)
...++||||+.+++|.+++. .+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++...
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 86 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVL 164 (295)
T ss_dssp TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCCSCC--
T ss_pred CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCC-eEEEccCcccccc
Confidence 66789999999999988773 389999999999999999999999999999999999999888 8999999999765
Q ss_pred CCCCc----cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHh
Q 020826 167 HPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242 (321)
Q Consensus 167 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (321)
..... .....++..|+|||.+.+ ..++.++||||||+++|+|++|..|+... . . ......+........
T Consensus 165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~~~~~~--~-~---~~~~~~~~~~~~~~~ 237 (295)
T 3ugc_A 165 PQDKEFFKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSP--P-A---EFMRMIGNDKQGQMI 237 (295)
T ss_dssp -----------CTTCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTTCTTCSH--H-H---HHHHHHCTTCCTHHH
T ss_pred cCCcceeeeccCCCCccceeCcHHhcC-CCCChHHHHHHHHHHHHHHHhcccccCCC--h-H---HHHhhhcCccccchh
Confidence 43322 223346667999999987 68899999999999999999999887311 1 1 111111111100000
Q ss_pred hhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
. ........... ....+..+++++.++|++||+.||++|||++|+++
T Consensus 238 ~-------~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 238 V-------FHLIELLKNNG--------RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp H-------HHHHHHHHTTC--------CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred H-------HHHHHHHhccC--------cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0 00000000000 11123357789999999999999999999999875
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=318.13 Aligned_cols=262 Identities=21% Similarity=0.355 Sum_probs=181.1
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
.....++|++.+.||+|+||+||+|.+..+++.||+|+++... ...+..|+..+.+..+||||+++++++.+. .
T Consensus 17 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~--~ 94 (327)
T 3aln_A 17 WDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE--G 94 (327)
T ss_dssp ECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS--S
T ss_pred cccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC--C
Confidence 3445789999999999999999999998899999999987532 234556666444434899999999999654 4
Q ss_pred CcEEEEEeecCchhhhh-------cCCCCHHHHHHHHHHHHHHHHHHHHC-CCeeecCCCCCeEEcCCCCeEEEeeccce
Q 020826 92 TPSLIFEHVNNTDFKVL-------YPTLSDYDVRYYIYELLKALDYCHSQ-GIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~-------~~~~~~~~~~~i~~qi~~~l~~lh~~-~i~H~dlkp~nili~~~~~~v~l~dfg~~ 163 (321)
..++|||++.++....+ ...+++..+..++.|++.||.|||+. |++|+||||+||+++.++ .+||+|||++
T Consensus 95 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~ 173 (327)
T 3aln_A 95 DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG-NIKLCDFGIS 173 (327)
T ss_dssp EEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT-EEEECCCSSS
T ss_pred ceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC-CEEEccCCCc
Confidence 56799999997532222 24589999999999999999999999 999999999999999888 8999999999
Q ss_pred eecCCCCccccccCCcccccccccc---CCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhH
Q 020826 164 EFYHPGKEYNVRVASRYFKGPELLV---DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 240 (321)
Q Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (321)
.............++..|+|||++. ....++.++|||||||++|+|++|..||.........+..
T Consensus 174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~------------ 241 (327)
T 3aln_A 174 GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQ------------ 241 (327)
T ss_dssp CC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CC------------
T ss_pred eecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHH------------
Confidence 7665444444557899999999983 2256889999999999999999999998422211110000
Q ss_pred HhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 241 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
.....+ ..........+++++.+||++||+.||++|||+.++++||||....
T Consensus 242 ------------------~~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 242 ------------------VVKGDP--PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp ------------------CCCSCC--CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred ------------------HhcCCC--CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 000000 0000111234678999999999999999999999999999998653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=317.45 Aligned_cols=247 Identities=17% Similarity=0.303 Sum_probs=197.4
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEecCCc---eEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeecc
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNE---KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 88 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~---~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (321)
.....++|++.+.||+|+||+||+|.+..+++ .||+|+++.. ....+.+|+.+++.+ +||||+++++++.+.
T Consensus 44 ~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 44 REIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQF-DHPNIIRLEGVVTRG 122 (325)
T ss_dssp CBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECGG
T ss_pred cccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEeC
Confidence 34457899999999999999999999976554 4999998753 235688999999999 899999999999654
Q ss_pred CCCCcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecccee
Q 020826 89 QSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 164 (321)
Q Consensus 89 ~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~ 164 (321)
...++||||+.+++|..++ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++.
T Consensus 123 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~ 199 (325)
T 3kul_A 123 --RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL-VCKVSDFGLSR 199 (325)
T ss_dssp --GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCSSCE
T ss_pred --CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCC-CEEECCCCccc
Confidence 4567999999999998877 3589999999999999999999999999999999999999887 89999999998
Q ss_pred ecCCCCc----cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhh
Q 020826 165 FYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELN 239 (321)
Q Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (321)
....... .....+|..|+|||++.+ ..++.++|||||||++|+|++ |..||. +.........+....
T Consensus 200 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~-~~~~~~~~~~~~~~~------ 271 (325)
T 3kul_A 200 VLEDDPDAAYTTTGGKIPIRWTAPEAIAF-RTFSSASDVWSFGVVMWEVLAYGERPYW-NMTNRDVISSVEEGY------ 271 (325)
T ss_dssp ECC----CCEECC---CCGGGSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTT-TSCHHHHHHHHHTTC------
T ss_pred ccccCccceeeccCCCCcccccCHhHhcC-CCCCcHHHHHHHHHHHHHHHcCCCCCcc-cCCHHHHHHHHHcCC------
Confidence 7643322 122345667999999987 678999999999999999999 898883 333222222221100
Q ss_pred HHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 240 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
....+..+++++.++|.+||+.||++|||+.++++
T Consensus 272 ------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 272 ------------------------------RLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp ------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------------CCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 01112346789999999999999999999999885
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-45 Score=307.18 Aligned_cols=245 Identities=16% Similarity=0.297 Sum_probs=198.7
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc--chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
...++|++.+.||+|+||+||+|.+ .++..||+|+++.. ....+.+|+.+++++ +||||+++++++.+ ....++
T Consensus 5 l~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~l 80 (268)
T 3sxs_A 5 LKREEITLLKELGSGQFGVVKLGKW-KGQYDVAVKMIKEGSMSEDEFFQEAQTMMKL-SHPKLVKFYGVCSK--EYPIYI 80 (268)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECBTTBCHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSEEE
T ss_pred echhheeeeeeeccCCCceEEEEEe-cCceeEEEEEeccCCCcHHHHHHHHHHHHhC-CCCCEeeEEEEEcc--CCceEE
Confidence 4578999999999999999999987 46778999998754 356789999999999 89999999999854 456789
Q ss_pred EEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc
Q 020826 96 IFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 171 (321)
Q Consensus 96 v~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~ 171 (321)
|||++.+++|.+++. .+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~ 159 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDL-CVKVSDFGMTRYVLDDQY 159 (268)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTC-CEEECCTTCEEECCTTCE
T ss_pred EEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCC-CEEEccCccceecchhhh
Confidence 999999999887763 489999999999999999999999999999999999999888 899999999986644322
Q ss_pred --cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 172 --YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
.....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||. ..........+....
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~~~~~~~~~~~~--------------- 222 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHY-FKYSSKSDVWAFGILMWEVFSLGKMPYD-LYTNSEVVLKVSQGH--------------- 222 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHH-SEEETTHHHHHHHHHHHHHHTTTCCTTT-TSCHHHHHHHHHTTC---------------
T ss_pred hcccCCCcCcccCCHHHHhc-cCCchhhhhHHHHHHHHHHHcCCCCCcc-ccChHHHHHHHHcCC---------------
Confidence 123345667999999987 678899999999999999999 888883 322222222211100
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
....+...++++.+++.+||+.||++|||+++++++
T Consensus 223 ---------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 223 ---------------------RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp ---------------------CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 001122356789999999999999999999999976
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=310.70 Aligned_cols=252 Identities=16% Similarity=0.240 Sum_probs=201.6
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
...++|++.+.||+|+||+||+|.+..+++.||+|++... ....+.+|+.+++.+.+|++++++++++.+ ....+++
T Consensus 7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~lv 84 (298)
T 1csn_A 7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVLV 84 (298)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEEE
T ss_pred ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCC--CceeEEE
Confidence 3467899999999999999999999899999999998643 346789999999999889999999999854 4566799
Q ss_pred EEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCC----eEEEeeccceeecCC
Q 020826 97 FEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR----KLRLIDWGLAEFYHP 168 (321)
Q Consensus 97 ~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~----~v~l~dfg~~~~~~~ 168 (321)
+|++ +++|.+++. .+++..+..++.|++.||+|||++|++|+||||+||+++.++. .++|+|||++.....
T Consensus 85 ~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~ 163 (298)
T 1csn_A 85 IDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRD 163 (298)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBC
T ss_pred EEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccc
Confidence 9999 888877763 5999999999999999999999999999999999999986651 399999999987643
Q ss_pred CCc--------cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCC--hHHHHHHHHHhCChhh
Q 020826 169 GKE--------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN--YDQLVKIAKVLGTDEL 238 (321)
Q Consensus 169 ~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~ 238 (321)
... .....+|..|+|||++.+ ..++.++||||||+++|+|++|+.||...... ......+.........
T Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (298)
T 1csn_A 164 PVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPL 242 (298)
T ss_dssp TTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCH
T ss_pred ccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccH
Confidence 322 244568999999999987 67899999999999999999999999543221 1222222111100000
Q ss_pred hHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 239 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
.. ....+++++.+++.+||+.||++|||++++++.
T Consensus 243 ~~--------------------------------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 243 RE--------------------------------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HH--------------------------------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred HH--------------------------------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 00 011366899999999999999999999988753
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=315.15 Aligned_cols=259 Identities=25% Similarity=0.437 Sum_probs=196.1
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcC-CCCeeeeeeeeeccC
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCG-GPNIVKLLDIVRDQQ 89 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~-h~~i~~~~~~~~~~~ 89 (321)
+....++|++.+.||+|+||+||++.+ .+++.||+|++... ....+.+|+.++..+.+ ||||+++++++.+
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-- 99 (313)
T 3cek_A 23 MSVKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-- 99 (313)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEC-TTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC--
T ss_pred eeeccceEEEEEEecCCCCEEEEEEEc-CCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec--
Confidence 445578999999999999999999998 45889999998643 23567899999999954 6999999999855
Q ss_pred CCCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeec
Q 020826 90 SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 166 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~ 166 (321)
....+++|| +.+++|.+++ ..+++..++.++.|++.||.|||++|++|+||||+||+++ ++ .++|+|||++...
T Consensus 100 ~~~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~-~~kL~Dfg~~~~~ 176 (313)
T 3cek_A 100 DQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DG-MLKLIDFGIANQM 176 (313)
T ss_dssp SSEEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TT-EEEECCCSSSCC-
T ss_pred CCEEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CC-eEEEeeccccccc
Confidence 446789999 5666776665 4589999999999999999999999999999999999997 45 8999999998765
Q ss_pred CCCCc---cccccCCccccccccccCC----------CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHh
Q 020826 167 HPGKE---YNVRVASRYFKGPELLVDL----------QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL 233 (321)
Q Consensus 167 ~~~~~---~~~~~~~~~y~aPE~~~~~----------~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 233 (321)
..... .....+++.|+|||++.+. ..++.++||||||+++|+|++|..||.........+..+.
T Consensus 177 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~--- 253 (313)
T 3cek_A 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII--- 253 (313)
T ss_dssp -------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH---
T ss_pred cCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHH---
Confidence 43221 2345689999999998641 3678899999999999999999999843322221111110
Q ss_pred CChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCC
Q 020826 234 GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~ 313 (321)
... . ....+...++++.++|.+||+.||++|||++|+++||||+....
T Consensus 254 ~~~------------------------~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 301 (313)
T 3cek_A 254 DPN------------------------H--------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301 (313)
T ss_dssp CTT------------------------S--------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred hcc------------------------c--------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence 000 0 00111234578999999999999999999999999999998755
Q ss_pred cc
Q 020826 314 AE 315 (321)
Q Consensus 314 ~~ 315 (321)
+.
T Consensus 302 ~~ 303 (313)
T 3cek_A 302 PV 303 (313)
T ss_dssp --
T ss_pred ch
Confidence 54
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=324.20 Aligned_cols=251 Identities=16% Similarity=0.265 Sum_probs=198.9
Q ss_pred ccCceEEeeeeeeecceEEEEEEE-----ecCCceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVH-----CTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 89 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~-----~~~~~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (321)
..++|++.+.||+|+||+||+|++ ..++..||+|+++.. ....+.+|+.++..+ +||||+++++++.+
T Consensus 69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~-- 145 (367)
T 3l9p_A 69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQ-- 145 (367)
T ss_dssp CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--
T ss_pred CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhC-CCCCCCeEEEEEec--
Confidence 357899999999999999999994 456779999998643 234578899999999 99999999999855
Q ss_pred CCCcEEEEEeecCchhhhhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCC--CeEEE
Q 020826 90 SKTPSLIFEHVNNTDFKVLYP----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKLRL 157 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~~----------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~--~~v~l 157 (321)
....++||||+.+++|..++. .+++..++.++.||+.||+|||++|++||||||+||+++.++ ..+||
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence 445579999999999887772 388999999999999999999999999999999999998543 25999
Q ss_pred eeccceeecC---CCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHh
Q 020826 158 IDWGLAEFYH---PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVL 233 (321)
Q Consensus 158 ~dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~ 233 (321)
+|||++.... .........+|+.|+|||++.+ ..++.++|||||||++|+|++ |..||. +.+..+....+....
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DvwslG~il~ellt~g~~pf~-~~~~~~~~~~i~~~~ 303 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYP-SKSNQEVLEFVTSGG 303 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSST-TCCHHHHHHHHHTTC
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHcCC
Confidence 9999986432 1122334567889999999987 789999999999999999998 888873 333322222221100
Q ss_pred CChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCccc
Q 020826 234 GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 310 (321)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~ 310 (321)
. ...+..+++++.+||.+||+.||++|||++++++|.++-.
T Consensus 304 ~------------------------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 304 R------------------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp C------------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C------------------------------------CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 0 0112246678999999999999999999999999876653
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=306.87 Aligned_cols=247 Identities=18% Similarity=0.285 Sum_probs=197.7
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccch----------HHHHHHHHHHHhhcCCCCeeeeeeeee
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----------KKIKREIKILQNLCGGPNIVKLLDIVR 86 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~----------~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (321)
....++|++.+.||+|+||+||+|++..+++.||+|++..... ..+.+|+.+++.+ +||||+++++++.
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~ 93 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL-NHPNIVKLYGLMH 93 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTC-CCTTBCCEEEEET
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhC-CCCCchhhheeec
Confidence 4557899999999999999999999999999999999853221 5688999999999 8999999999985
Q ss_pred ccCCCCcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC--CeeecCCCCCeEEcCCCC----eEE
Q 020826 87 DQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQR----KLR 156 (321)
Q Consensus 87 ~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~--i~H~dlkp~nili~~~~~----~v~ 156 (321)
+. . +++|||+.+++|.+.+ ..+++..++.++.|++.||+|||++| ++|+||||+||+++.++. .++
T Consensus 94 ~~--~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~k 169 (287)
T 4f0f_A 94 NP--P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAK 169 (287)
T ss_dssp TT--T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred CC--C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEE
Confidence 43 2 5999999998886655 35899999999999999999999999 999999999999987662 299
Q ss_pred EeeccceeecCCCCccccccCCccccccccccC-CCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCC
Q 020826 157 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD-LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 235 (321)
Q Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (321)
|+|||++.... .......+++.|+|||++.+ ...++.++|||||||++|+|++|..||.................+.
T Consensus 170 l~Dfg~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 247 (287)
T 4f0f_A 170 VADFGLSQQSV--HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGL 247 (287)
T ss_dssp ECCCTTCBCCS--SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCC
T ss_pred eCCCCcccccc--ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCC
Confidence 99999987543 23445678999999999843 2457889999999999999999999995433332221211111000
Q ss_pred hhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 236 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
....+..+++++.++|.+||+.||++|||++++++
T Consensus 248 ----------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 248 ----------------------------------RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp ----------------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------------------CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00112346789999999999999999999999985
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-45 Score=306.55 Aligned_cols=247 Identities=17% Similarity=0.351 Sum_probs=190.1
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-------hHHHHHHHHHHHhhcCCCCeeeeeeeeecc
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-------KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 88 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (321)
++...++|++.+.||+|+||+||+|.+ +++.+|+|+++... ...+.+|+.+++.+ +||||+++++++.+
T Consensus 2 ~~~~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~- 77 (271)
T 3dtc_A 2 LEIDFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML-KHPNIIALRGVCLK- 77 (271)
T ss_dssp CBCCTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHC-CCTTBCCEEEEECC-
T ss_pred CccchhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhc-CCCCEeeEEEEEec-
Confidence 455678999999999999999999997 48899999986432 35678999999999 89999999999955
Q ss_pred CCCCcEEEEEeecCchhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---CeeecCCCCCeEEcCC-------CCeEE
Q 020826 89 QSKTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQG---IMHRDVKPHNVMIDHE-------QRKLR 156 (321)
Q Consensus 89 ~~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lh~~~---i~H~dlkp~nili~~~-------~~~v~ 156 (321)
....+++|||+.+++|..++ ..+++..++.++.|++.||+|||++| ++|+||||+||+++.. ...++
T Consensus 78 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~k 156 (271)
T 3dtc_A 78 -EPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILK 156 (271)
T ss_dssp -C--CEEEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEE
T ss_pred -CCceEEEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceE
Confidence 44567999999999998887 45899999999999999999999999 8999999999999852 23799
Q ss_pred EeeccceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCCh
Q 020826 157 LIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD 236 (321)
Q Consensus 157 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (321)
|+|||++....... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||. +.+..........
T Consensus 157 l~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~-~~~~~~~~~~~~~----- 228 (271)
T 3dtc_A 157 ITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRA-SMFSKGSDVWSYGVLLWELLTGEVPFR-GIDGLAVAYGVAM----- 228 (271)
T ss_dssp ECCCCC--------------CCGGGSCHHHHHH-CCCSHHHHHHHHHHHHHHHHHCCCTTT-TSCHHHHHHHHHT-----
T ss_pred EccCCccccccccc-ccCCCCccceeCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHhhhc-----
Confidence 99999997654332 234578999999999987 678999999999999999999999984 2222111111100
Q ss_pred hhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 237 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
.. .....+..+++++.+++.+||+.||++|||++|++++
T Consensus 229 ----------------------~~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 229 ----------------------NK--------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp ----------------------SC--------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------CC--------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 00 0011123467899999999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=310.70 Aligned_cols=244 Identities=14% Similarity=0.244 Sum_probs=198.3
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCC-------ceEEEEEecccc---hHHHHHHHHHHHhhcCCCCeeeeeeeee
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDN-------EKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVR 86 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~-------~~~~vK~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (321)
....++|++.+.||+|+||+||+|.+..++ ..+++|+++... ...+.+|+.+++.+ +||||+++++++.
T Consensus 4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~ 82 (289)
T 4fvq_A 4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL-SHKHLVLNYGVCV 82 (289)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTS-CCTTBCCEEEEEC
T ss_pred EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEE
Confidence 345789999999999999999999998777 469999986533 46688999999999 8999999999996
Q ss_pred ccCCCCcEEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCe--------
Q 020826 87 DQQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK-------- 154 (321)
Q Consensus 87 ~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~-------- 154 (321)
+. ...++||||+.+++|.+++. .+++..+..++.|++.||+|||++|++|+||||+||+++.++ .
T Consensus 83 ~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~~~~~~~~ 159 (289)
T 4fvq_A 83 CG--DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREE-DRKTGNPPF 159 (289)
T ss_dssp CT--TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECC-BGGGTBCCE
T ss_pred eC--CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCC-cccccccce
Confidence 53 45679999999999988773 389999999999999999999999999999999999998776 4
Q ss_pred EEEeeccceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhC
Q 020826 155 LRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLG 234 (321)
Q Consensus 155 v~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 234 (321)
++|+|||++.... ......++..|+|||++.+...++.++|||||||++|+|++|..|++..............
T Consensus 160 ~kl~Dfg~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~--- 233 (289)
T 4fvq_A 160 IKLSDPGISITVL---PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED--- 233 (289)
T ss_dssp EEECCCCSCTTTS---CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT---
T ss_pred eeeccCccccccc---CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc---
Confidence 9999999986432 2234457888999999987567899999999999999999977776544433222221110
Q ss_pred ChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 235 TDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
. ...+...++++.++|++||+.||++|||++++++|
T Consensus 234 ~-----------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 234 R-----------------------------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp T-----------------------------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred c-----------------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0 00112345789999999999999999999999976
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-45 Score=315.63 Aligned_cols=247 Identities=21% Similarity=0.301 Sum_probs=197.6
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 98 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 98 (321)
.++|++.+.||+|+||+||+|++..+++.||+|++... ....+.+|+.+++.+.+||||+++++++.+ ....++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~lv~e 85 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC--GKYNAMVLE 85 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEE--TTEEEEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEec--CCccEEEEE
Confidence 57899999999999999999999999999999998743 345689999999999889999999999865 456789999
Q ss_pred eecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCe-----EEEeeccceeecCCC
Q 020826 99 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRK-----LRLIDWGLAEFYHPG 169 (321)
Q Consensus 99 ~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~-----v~l~dfg~~~~~~~~ 169 (321)
++ +++|.+++ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ . ++|+|||++......
T Consensus 86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~-~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 86 LL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPG-NKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGG-GTCTTSEEECCCTTCEESBCT
T ss_pred eC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCC-CCCCceEEEEEcccceeeecC
Confidence 99 77777665 4699999999999999999999999999999999999998776 4 999999999875433
Q ss_pred Cc--------cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCC--hHHHHHHHHHhCChhhh
Q 020826 170 KE--------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN--YDQLVKIAKVLGTDELN 239 (321)
Q Consensus 170 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~ 239 (321)
.. .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .+....+..........
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 242 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIE 242 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred CCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHH
Confidence 22 245678999999999987 78899999999999999999999999533221 11122211100000000
Q ss_pred HHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 240 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
. ....+ +++.+++..||+.||.+||+++++.+
T Consensus 243 ~--------------------------------~~~~~-p~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 243 V--------------------------------LCENF-PEMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp H--------------------------------HTTTC-HHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred H--------------------------------HhccC-hHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 0 00123 38999999999999999999988876
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=319.91 Aligned_cols=272 Identities=18% Similarity=0.241 Sum_probs=198.8
Q ss_pred eeeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccch--HHHHHHHHHHHhhcCCCCeeeeeeeeeccC
Q 020826 12 CVWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQ 89 (321)
Q Consensus 12 ~~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (321)
+.++++ .++|++.+.||+|+||+||+|++ +++.||+|+++.... .....|+.++.++ +||||+++++++.+..
T Consensus 17 ~n~~~~--~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~~~ 91 (322)
T 3soc_A 17 ENLYFQ--SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGM-KHENILQFIGAEKRGT 91 (322)
T ss_dssp CCEEET--TEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEEC
T ss_pred cccccc--hhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCchHHHHHHHHHHHHhcC-CCCCchhhcceeccCC
Confidence 345555 67999999999999999999987 478999999976544 3455678888888 8999999999987654
Q ss_pred --CCCcEEEEEeecCchhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHC----------CCeeecCCCCCeEEcCCCCeE
Q 020826 90 --SKTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQ----------GIMHRDVKPHNVMIDHEQRKL 155 (321)
Q Consensus 90 --~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lh~~----------~i~H~dlkp~nili~~~~~~v 155 (321)
....++||||+.+++|.+++ ..+++..++.++.|++.||+|||+. |++|+||||+||+++.++ .+
T Consensus 92 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~-~~ 170 (322)
T 3soc_A 92 SVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL-TA 170 (322)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC-CE
T ss_pred CCCceEEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC-eE
Confidence 23468999999999998887 4599999999999999999999999 999999999999999887 89
Q ss_pred EEeeccceeecCCCCc---cccccCCccccccccccCC----CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHH
Q 020826 156 RLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDL----QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 228 (321)
Q Consensus 156 ~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~----~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~ 228 (321)
||+|||++........ .....+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||...........
T Consensus 171 kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~- 249 (322)
T 3soc_A 171 CIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF- 249 (322)
T ss_dssp EECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTT-
T ss_pred EEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccch-
Confidence 9999999976643322 2335789999999999763 2345688999999999999999999854322111000
Q ss_pred HHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 229 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
.......+.... ...........+. ..........++++.+||++||+.||++|||++|+++
T Consensus 250 ~~~~~~~~~~~~------------~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 250 EEEIGQHPSLED------------MQEVVVHKKKRPV--LRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HHHHCSSCCHHH------------HHHHHTTSCCCCC--CCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhhccCCchhh------------hhhhhhcccCCCC--ccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 000001111000 0011111111110 0000111123356999999999999999999999985
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-45 Score=313.39 Aligned_cols=259 Identities=21% Similarity=0.305 Sum_probs=198.5
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhh-cCCCCeeeeeeeeecc--CCCCc
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNL-CGGPNIVKLLDIVRDQ--QSKTP 93 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l-~~h~~i~~~~~~~~~~--~~~~~ 93 (321)
....++|++.+.||+|+||+||+|++ +++.||+|++.......+..|.+++... .+||||+++++++.+. .....
T Consensus 4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~ 81 (301)
T 3q4u_A 4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81 (301)
T ss_dssp CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence 34578999999999999999999987 7899999999887777788888888873 2899999999986543 23457
Q ss_pred EEEEEeecCchhhhhcC--CCCHHHHHHHHHHHHHHHHHHH--------HCCCeeecCCCCCeEEcCCCCeEEEeeccce
Q 020826 94 SLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCH--------SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lh--------~~~i~H~dlkp~nili~~~~~~v~l~dfg~~ 163 (321)
++||||+.+++|.+++. .+++..+..++.|++.||+||| +.|++|+||||+||+++.++ .+||+|||++
T Consensus 82 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~a 160 (301)
T 3q4u_A 82 WLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG-QCCIADLGLA 160 (301)
T ss_dssp EEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCCTTC
T ss_pred EEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC-CEEEeeCCCe
Confidence 89999999999988874 5899999999999999999999 99999999999999999888 8999999999
Q ss_pred eecCCCCc-----cccccCCccccccccccCCC-----CCCCcchHHHHHHHHHHHHhC----------CCCCccCCCCh
Q 020826 164 EFYHPGKE-----YNVRVASRYFKGPELLVDLQ-----DYDYSLDLWSLGCMFAGMIFR----------KEPFFYGHDNY 223 (321)
Q Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~-----~~~~~~DvwslG~~l~~l~~g----------~~p~~~~~~~~ 223 (321)
........ .....+|+.|+|||++.+.. .++.++|||||||++|+|++| ..||.......
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~ 240 (301)
T 3q4u_A 161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND 240 (301)
T ss_dssp EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence 76543322 12347899999999997732 344789999999999999999 77775432222
Q ss_pred HHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHh
Q 020826 224 DQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 303 (321)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell 303 (321)
.....+........ ..+. ..........++++.+++.+||+.||++|||+++++
T Consensus 241 ~~~~~~~~~~~~~~------------------------~~~~--~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~ 294 (301)
T 3q4u_A 241 PSFEDMRKVVCVDQ------------------------QRPN--IPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294 (301)
T ss_dssp CCHHHHHHHHTTSC------------------------CCCC--CCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred cchhhhhHHHhccC------------------------CCCC--CChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHH
Confidence 21222111111100 0000 000001112446899999999999999999999998
Q ss_pred c
Q 020826 304 A 304 (321)
Q Consensus 304 ~ 304 (321)
+
T Consensus 295 ~ 295 (301)
T 3q4u_A 295 K 295 (301)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-44 Score=317.99 Aligned_cols=245 Identities=19% Similarity=0.316 Sum_probs=198.3
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCC-------ceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeecc
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDN-------EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 88 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~-------~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (321)
.++|++.+.||+|+||+||+|++..++ ..||+|+++... ...+.+|+.+++.+.+||||+++++++.+
T Consensus 68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~- 146 (382)
T 3tt0_A 68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ- 146 (382)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc-
Confidence 579999999999999999999986433 579999987542 25678999999999889999999999955
Q ss_pred CCCCcEEEEEeecCchhhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEc
Q 020826 89 QSKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID 149 (321)
Q Consensus 89 ~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~ 149 (321)
....++||||+.+++|.+++. .+++..++.++.|++.||+|||++|++|+||||+||+++
T Consensus 147 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~ 225 (382)
T 3tt0_A 147 -DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 225 (382)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred -CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEc
Confidence 445679999999999987762 389999999999999999999999999999999999999
Q ss_pred CCCCeEEEeeccceeecCCCC---ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHH
Q 020826 150 HEQRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQ 225 (321)
Q Consensus 150 ~~~~~v~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~ 225 (321)
.++ .+||+|||++....... ......++..|+|||++.+ ..++.++|||||||++++|++ |..||. +.+..+.
T Consensus 226 ~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~ellt~g~~p~~-~~~~~~~ 302 (382)
T 3tt0_A 226 EDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYP-GVPVEEL 302 (382)
T ss_dssp TTC-CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCSST-TCCHHHH
T ss_pred CCC-cEEEcccCcccccccccccccccCCCCCcceeCHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCC-CCCHHHH
Confidence 888 89999999997654332 2233456778999999987 789999999999999999999 888873 3322222
Q ss_pred HHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 226 LVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
...+.... ....+..+++++.++|++||+.||++|||++|++++
T Consensus 303 ~~~~~~~~------------------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 303 FKLLKEGH------------------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHTTC------------------------------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCC------------------------------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 22111100 011123467899999999999999999999999976
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=313.45 Aligned_cols=249 Identities=22% Similarity=0.347 Sum_probs=207.0
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeeeec---------
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRD--------- 87 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--------- 87 (321)
.....+|++.+.||+|+||.||+|.+..+++.|++|.++... ..+.+|+.+++.+ +||||+++++++..
T Consensus 7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~l~~l-~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 7 KRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-EKAEREVKALAKL-DHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-GGGHHHHHHHHHC-CCTTBCCEEEEEEEEEEC-----
T ss_pred chhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-HHHHHHHHHHHhC-CCCCEEEEeeeEeccccCccccc
Confidence 445678999999999999999999998899999999987543 5678999999999 89999999998754
Q ss_pred -----cCCCCcEEEEEeecCchhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEE
Q 020826 88 -----QQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRL 157 (321)
Q Consensus 88 -----~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l 157 (321)
......+++|||+.+++|.+++ ..+++..++.++.|++.||.|||++|++|+||||+||+++.++ .++|
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl 163 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK-QVKI 163 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC-CEEE
Confidence 1233468999999999998776 3589999999999999999999999999999999999999888 8999
Q ss_pred eeccceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChh
Q 020826 158 IDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 237 (321)
Q Consensus 158 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (321)
+|||++.............+++.|+|||.+.+ ..++.++||||||+++|+|++|..|+.... .....+
T Consensus 164 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~-------- 231 (284)
T 2a19_B 164 GDFGLVTSLKNDGKRTRSKGTLRYMSPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFETS---KFFTDL-------- 231 (284)
T ss_dssp CCCTTCEESSCCSCCCCCCSCCTTSCHHHHHC-SCCCTHHHHHHHHHHHHHHHSCCSSHHHHH---HHHHHH--------
T ss_pred CcchhheeccccccccccCCcccccChhhhcc-CCCcchhhhHHHHHHHHHHHhcCCcchhHH---HHHHHh--------
Confidence 99999987765555556678999999999987 778999999999999999999998873110 000000
Q ss_pred hhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 238 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
.. ......+++++.++|.+||+.||++|||+.|+++|.+.-+.
T Consensus 232 -------------------~~------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~ 274 (284)
T 2a19_B 232 -------------------RD------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK 274 (284)
T ss_dssp -------------------HT------------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred -------------------hc------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence 00 00112356789999999999999999999999999876554
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-45 Score=310.41 Aligned_cols=250 Identities=20% Similarity=0.340 Sum_probs=198.9
Q ss_pred EeeeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc--chHHHHHHHHHHHhhcCCCCeeeeeeeeecc
Q 020826 11 WCVWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ 88 (321)
Q Consensus 11 ~~~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (321)
...|.+. .++|++.+.||+|+||+||++.+ .++..||+|+++.. ....+.+|+.++..+ +||||+++++++.+
T Consensus 16 ~~~~~~~--~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~- 90 (283)
T 3gen_A 16 YGSWEID--PKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTK- 90 (283)
T ss_dssp CCTTBCC--GGGEEEEEECC---CEEEEEEEE-TTTEEEEEEEECTTSBCHHHHHHHHHHHHTC-CCTTBCCEEEEECS-
T ss_pred CCCccCC--HHHHHhHhhcCCCCCceEEEEEE-cCCCeEEEEEecCCCCCHHHHHHHHHHHhcC-CCCCEeeEEEEEec-
Confidence 4566665 67999999999999999999987 46778999999754 456789999999999 89999999999954
Q ss_pred CCCCcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecccee
Q 020826 89 QSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 164 (321)
Q Consensus 89 ~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~ 164 (321)
....++||||+.+++|.+++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++.
T Consensus 91 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~ 168 (283)
T 3gen_A 91 -QRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSR 168 (283)
T ss_dssp -SSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTS-CEEECSTTGGG
T ss_pred -CCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCC-CEEEccccccc
Confidence 45678999999999988776 3599999999999999999999999999999999999999888 89999999987
Q ss_pred ecCCCC--ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHH
Q 020826 165 FYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAY 241 (321)
Q Consensus 165 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (321)
...... ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||. ..+.......+.....
T Consensus 169 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~l~~l~t~g~~p~~-~~~~~~~~~~~~~~~~------- 239 (283)
T 3gen_A 169 YVLDDEYTSSVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPYE-RFTNSETAEHIAQGLR------- 239 (283)
T ss_dssp GBCCHHHHSTTSTTSCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTTCCTTT-TSCHHHHHHHHHTTCC-------
T ss_pred cccccccccccCCccCcccCCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCcc-ccChhHHHHHHhcccC-------
Confidence 543221 1223345678999999987 678999999999999999998 888883 3332222222211100
Q ss_pred hhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 242 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
...+...++.+.++|.+||+.||++|||++++++|
T Consensus 240 -----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 240 -----------------------------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp -----------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -----------------------------CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 01122356789999999999999999999999875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=316.27 Aligned_cols=260 Identities=16% Similarity=0.233 Sum_probs=195.6
Q ss_pred eeeecccCceEEeeeeeeecceEEEEEEEecC-----CceEEEEEecccchHHHHHHHHHHHhhc--------------C
Q 020826 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTD-----NEKCIIKILKPVKKKKIKREIKILQNLC--------------G 74 (321)
Q Consensus 14 ~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~-----~~~~~vK~~~~~~~~~~~~E~~~l~~l~--------------~ 74 (321)
...+...++|++.+.||+|+||+||+|.+..+ ++.||+|++.... ..+.+|+.+++.+. +
T Consensus 28 ~i~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~~~~~~~~~~~~e~~~~~~l~ 106 (364)
T 3op5_A 28 IITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN-GPLFTELKFYQRAAKPEQIQKWIRTRKLK 106 (364)
T ss_dssp EEECTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC-HHHHHHHHHHHHHCCHHHHHHHHHHTTCS
T ss_pred EeeccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc-hhHHHHHHHHHhhhhhHHHHHHHHHhhcc
Confidence 33345677999999999999999999998664 5789999987543 23444444444432 5
Q ss_pred CCCeeeeeeeeeccCC--CCcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEE
Q 020826 75 GPNIVKLLDIVRDQQS--KTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI 148 (321)
Q Consensus 75 h~~i~~~~~~~~~~~~--~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili 148 (321)
||||+++++++..... .+.++||||+ +++|..++ ..+++..+..++.||+.||+|||++|++|+||||+||++
T Consensus 107 h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill 185 (364)
T 3op5_A 107 YLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLL 185 (364)
T ss_dssp CCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred CCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEE
Confidence 9999999999865432 5578999999 88887776 459999999999999999999999999999999999999
Q ss_pred c--CCCCeEEEeeccceeecCCCCc--------cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCcc
Q 020826 149 D--HEQRKLRLIDWGLAEFYHPGKE--------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY 218 (321)
Q Consensus 149 ~--~~~~~v~l~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~ 218 (321)
+ .++ .+||+|||++........ .....+|..|+|||++.+ ..++.++|||||||++|+|++|..||..
T Consensus 186 ~~~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~g~~Pf~~ 263 (364)
T 3op5_A 186 NYKNPD-QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG-VAPSRRGDLEILGYCMIQWLTGHLPWED 263 (364)
T ss_dssp ESSCTT-CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred ecCCCC-eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 8 666 899999999976543221 123458999999999987 6799999999999999999999999964
Q ss_pred CCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC
Q 020826 219 GHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT 298 (321)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps 298 (321)
............... ...+...... ......+++++.+++..||+.||++|||
T Consensus 264 ~~~~~~~~~~~~~~~-~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~cl~~~p~~RP~ 316 (364)
T 3op5_A 264 NLKDPKYVRDSKIRY-RENIASLMDK--------------------------CFPAANAPGEIAKYMETVKLLDYTEKPL 316 (364)
T ss_dssp GTTCHHHHHHHHHHH-HHCHHHHHHH--------------------------HSCTTCCCHHHHHHHHHHHTCCTTCCCC
T ss_pred cccCHHHHHHHHHHh-hhhHHHHHHH--------------------------hcccccCHHHHHHHHHHHhcCCCCCCCC
Confidence 343333222221111 0111111100 0011246689999999999999999999
Q ss_pred HHHHhc
Q 020826 299 AKEAMA 304 (321)
Q Consensus 299 ~~ell~ 304 (321)
++++++
T Consensus 317 ~~~l~~ 322 (364)
T 3op5_A 317 YENLRD 322 (364)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 998875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=322.16 Aligned_cols=248 Identities=22% Similarity=0.389 Sum_probs=198.5
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeecc
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 88 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (321)
.|.++ .++|++.+.||+|+||+||+|.+..+++.||+|+++... ...+.+|+.+++.+ +||||+++++++.+
T Consensus 108 ~~~~~--~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~- 183 (377)
T 3cbl_A 108 KWVLN--HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQY-SHPNIVRLIGVCTQ- 183 (377)
T ss_dssp TTBCC--GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTC-CCTTBCCEEEEECS-
T ss_pred ccEEc--hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEec-
Confidence 45555 569999999999999999999998899999999987542 24577899999999 89999999999954
Q ss_pred CCCCcEEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecccee
Q 020826 89 QSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 164 (321)
Q Consensus 89 ~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~ 164 (321)
....++||||+.+++|.+++. .+++..+..++.|++.||+|||++|++|+||||+||+++.++ .+||+|||++.
T Consensus 184 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~-~~kl~DfG~s~ 261 (377)
T 3cbl_A 184 -KQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN-VLKISDFGMSR 261 (377)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCGGGCE
T ss_pred -CCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCC-cEEECcCCCce
Confidence 345679999999999887763 489999999999999999999999999999999999999888 89999999997
Q ss_pred ecCCCCcc---ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhH
Q 020826 165 FYHPGKEY---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNA 240 (321)
Q Consensus 165 ~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (321)
........ ....++..|+|||++.+ ..++.++|||||||++|++++ |..||. +.........+.. .
T Consensus 262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~il~el~t~g~~p~~-~~~~~~~~~~~~~-~------- 331 (377)
T 3cbl_A 262 EEADGVYAASGGLRQVPVKWTAPEALNY-GRYSSESDVWSFGILLWETFSLGASPYP-NLSNQQTREFVEK-G------- 331 (377)
T ss_dssp ECTTSEEECCSSCCEEEGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCSST-TSCHHHHHHHHHT-T-------
T ss_pred ecCCCceeecCCCCCCCcCcCCHhHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHc-C-------
Confidence 64332111 11234567999999987 678999999999999999998 888873 3322222111110 0
Q ss_pred HhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 241 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
. ....+..+++++.++|.+||+.||++|||++++++
T Consensus 332 --------------------~--------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 332 --------------------G--------RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp --------------------C--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------C--------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 0 01112346689999999999999999999999874
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=326.88 Aligned_cols=253 Identities=22% Similarity=0.359 Sum_probs=189.6
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEe
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEH 99 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~ 99 (321)
..+|++.+.||+|+||+|+. ....+++.||||++.........+|+.+++.+.+||||+++++++.+ ....++|||+
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~--~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKD--RQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEE--TTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEec--CCEEEEEEEC
Confidence 56899999999999999763 34468899999999876666788999999998789999999999854 4566899999
Q ss_pred ecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCC----CeEEEeeccceeecCCCC-
Q 020826 100 VNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ----RKLRLIDWGLAEFYHPGK- 170 (321)
Q Consensus 100 ~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~----~~v~l~dfg~~~~~~~~~- 170 (321)
+.+ +|.+++. ...+..+..++.||+.||+|||++||+||||||+||+++.++ ..++|+|||++.......
T Consensus 100 ~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~ 178 (432)
T 3p23_A 100 CAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH 178 (432)
T ss_dssp CSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred CCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence 986 6655552 355667789999999999999999999999999999995322 257899999997664332
Q ss_pred ---ccccccCCccccccccccC--CCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhh
Q 020826 171 ---EYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244 (321)
Q Consensus 171 ---~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (321)
......||+.|+|||++.+ ...++.++|||||||++|+|++ |..||. .. .......+. +.....
T Consensus 179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~-~~-~~~~~~~~~---~~~~~~----- 248 (432)
T 3p23_A 179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFG-KS-LQRQANILL---GACSLD----- 248 (432)
T ss_dssp -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTB-ST-TTHHHHHHT---TCCCCT-----
T ss_pred ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcc-hh-hHHHHHHHh---ccCCcc-----
Confidence 2344578999999999974 2567889999999999999999 887773 22 111111110 000000
Q ss_pred hcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
........++.+.+||.+||+.||++|||++++++||||..+
T Consensus 249 -------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 249 -------------------------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp -------------------------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred -------------------------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 000011233568999999999999999999999999999764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=315.55 Aligned_cols=247 Identities=20% Similarity=0.322 Sum_probs=198.0
Q ss_pred cCceEEeeeeeeecceEEEEEEEe-----cCCceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
.++|++.+.||+|+||+||+|.+. .++..||+|+++.. ....+.+|+.++.++.+||||+++++++.+ .
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--~ 121 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL--S 121 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--S
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee--C
Confidence 579999999999999999999973 35568999998743 246688999999999789999999999965 4
Q ss_pred CCcEEEEEeecCchhhhhcCC--------------------------CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCC
Q 020826 91 KTPSLIFEHVNNTDFKVLYPT--------------------------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPH 144 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~~~--------------------------~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~ 144 (321)
...++||||+.+++|.+++.. +++..++.++.||+.||+|||++|++|+||||+
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~ 201 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence 456799999999998877621 688899999999999999999999999999999
Q ss_pred CeEEcCCCCeEEEeeccceeecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCC
Q 020826 145 NVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGH 220 (321)
Q Consensus 145 nili~~~~~~v~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~ 220 (321)
||+++.++ .++|+|||++........ .....+|..|+|||.+.+ ..++.++|||||||++|+|++ |..||....
T Consensus 202 NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 279 (344)
T 1rjb_A 202 NVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 279 (344)
T ss_dssp GEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred hEEEcCCC-cEEeCCCccCcccccCccceeccCccCccCccCHHHhcc-CCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence 99999888 899999999976543322 223456778999999987 688999999999999999998 888884333
Q ss_pred CChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHH
Q 020826 221 DNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK 300 (321)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ 300 (321)
.. ........... ....+..+++++.++|.+||+.||++|||+.
T Consensus 280 ~~-~~~~~~~~~~~-----------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ 323 (344)
T 1rjb_A 280 VD-ANFYKLIQNGF-----------------------------------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFP 323 (344)
T ss_dssp CS-HHHHHHHHTTC-----------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred cH-HHHHHHHhcCC-----------------------------------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHH
Confidence 22 22222111000 0111224568999999999999999999999
Q ss_pred HHhcCC
Q 020826 301 EAMAHP 306 (321)
Q Consensus 301 ell~hp 306 (321)
++++|-
T Consensus 324 ~l~~~l 329 (344)
T 1rjb_A 324 NLTSFL 329 (344)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999864
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=311.23 Aligned_cols=251 Identities=21% Similarity=0.319 Sum_probs=200.8
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEE-----ecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeee
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVH-----CTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLD 83 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~-----~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (321)
.|.++ .++|++.+.||+|+||+||+|.+ ..+++.||+|.++... ...+.+|+.++.++.+||||+++++
T Consensus 17 ~~~~~--~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 94 (313)
T 1t46_A 17 KWEFP--RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLG 94 (313)
T ss_dssp GGBCC--GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccC--hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence 44443 57999999999999999999986 3467899999997542 3668899999999988999999999
Q ss_pred eeeccCCCCcEEEEEeecCchhhhhcC---------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCC
Q 020826 84 IVRDQQSKTPSLIFEHVNNTDFKVLYP---------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVK 142 (321)
Q Consensus 84 ~~~~~~~~~~~lv~e~~~~~~l~~~~~---------------------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlk 142 (321)
++.+. ...+++||++.+++|.+++. .+++..++.++.|++.||+|||++|++|+|||
T Consensus 95 ~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk 172 (313)
T 1t46_A 95 ACTIG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA 172 (313)
T ss_dssp EECSS--SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEecC--CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCc
Confidence 99554 45679999999999887762 38899999999999999999999999999999
Q ss_pred CCCeEEcCCCCeEEEeeccceeecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCcc
Q 020826 143 PHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFY 218 (321)
Q Consensus 143 p~nili~~~~~~v~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~ 218 (321)
|+||+++.++ .++|+|||++........ .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||..
T Consensus 173 p~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~ 250 (313)
T 1t46_A 173 ARNILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPG 250 (313)
T ss_dssp GGGEEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred cceEEEcCCC-CEEEccccccccccccccceeccCCCCcceeeChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 9999999887 899999999976643332 123346678999999987 789999999999999999999 8888843
Q ss_pred CCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC
Q 020826 219 GHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT 298 (321)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps 298 (321)
.... ............ ...+..+++++.++|.+||+.||++|||
T Consensus 251 ~~~~-~~~~~~~~~~~~-----------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps 294 (313)
T 1t46_A 251 MPVD-SKFYKMIKEGFR-----------------------------------MLSPEHAPAEMYDIMKTCWDADPLKRPT 294 (313)
T ss_dssp CCSS-HHHHHHHHHTCC-----------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred ccch-hHHHHHhccCCC-----------------------------------CCCcccCCHHHHHHHHHHcCCCchhCcC
Confidence 3322 222222111000 0112246679999999999999999999
Q ss_pred HHHHhcC
Q 020826 299 AKEAMAH 305 (321)
Q Consensus 299 ~~ell~h 305 (321)
++|++++
T Consensus 295 ~~ell~~ 301 (313)
T 1t46_A 295 FKQIVQL 301 (313)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-45 Score=326.32 Aligned_cols=257 Identities=21% Similarity=0.340 Sum_probs=191.4
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
....+.|.+.+.||+|+||+||.+ ...+++.||||.+.......+.+|+.+++.+.+||||+++++++.+ ....++|
T Consensus 11 ~~l~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~--~~~~~lv 87 (434)
T 2rio_A 11 QSLKNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETT--DRFLYIA 87 (434)
T ss_dssp CSCSSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEEC--SSEEEEE
T ss_pred hhhhheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEec--CCeEEEE
Confidence 345667788899999999999875 4468999999999877777889999999987689999999999854 4567899
Q ss_pred EEeecCchhhhhcCC----------CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCC------------CCe
Q 020826 97 FEHVNNTDFKVLYPT----------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE------------QRK 154 (321)
Q Consensus 97 ~e~~~~~~l~~~~~~----------~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~------------~~~ 154 (321)
+|++++ +|.+++.. .++..++.++.||+.||+|||++|++|+||||+||+++.+ ...
T Consensus 88 ~E~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 88 LELCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp ECCCSE-EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EecCCC-CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 999975 77776632 1333467899999999999999999999999999999753 237
Q ss_pred EEEeeccceeecCCCCc-----cccccCCccccccccccC------CCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCC
Q 020826 155 LRLIDWGLAEFYHPGKE-----YNVRVASRYFKGPELLVD------LQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDN 222 (321)
Q Consensus 155 v~l~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~------~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~ 222 (321)
++|+|||++........ .....||+.|+|||++.+ ...++.++|||||||++|+|++ |..||......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~ 246 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSR 246 (434)
T ss_dssp EEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTH
T ss_pred EEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhh
Confidence 99999999987654322 234578999999999865 2468899999999999999999 88888322211
Q ss_pred hHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHH
Q 020826 223 YDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 302 (321)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~el 302 (321)
. ..+...... .... .......+++++.++|.+||+.||++|||+.++
T Consensus 247 -~--~~i~~~~~~--------------------------~~~~----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ei 293 (434)
T 2rio_A 247 -E--SNIIRGIFS--------------------------LDEM----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293 (434)
T ss_dssp -H--HHHHHTCCC--------------------------CCCC----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred -H--HHHhcCCCC--------------------------cccc----cccccccchHHHHHHHHHHhhCChhhCCCHHHH
Confidence 1 111110000 0000 000112345789999999999999999999999
Q ss_pred hcCCCccc
Q 020826 303 MAHPYFFP 310 (321)
Q Consensus 303 l~hp~~~~ 310 (321)
++||||..
T Consensus 294 l~hp~f~~ 301 (434)
T 2rio_A 294 LRHPLFWP 301 (434)
T ss_dssp HTSGGGSC
T ss_pred HhCCccCC
Confidence 99999964
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=306.05 Aligned_cols=249 Identities=22% Similarity=0.384 Sum_probs=188.7
Q ss_pred eeeeeecccCceEEeeeeeeecceEEEEEEEecC---CceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeee
Q 020826 12 CVWFINREQDDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDI 84 (321)
Q Consensus 12 ~~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~---~~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (321)
..|.+ ..++|++.+.||+|+||+||+|.+..+ +..+++|.++.. ....+.+|+.+++.+ +||||++++++
T Consensus 8 ~~~~~--~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~ 84 (281)
T 1mp8_A 8 RDYEI--QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGV 84 (281)
T ss_dssp -CCBC--CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEE
T ss_pred cceEE--ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCccceEEEE
Confidence 34444 477999999999999999999998654 457999998643 235678999999999 89999999999
Q ss_pred eeccCCCCcEEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeec
Q 020826 85 VRDQQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW 160 (321)
Q Consensus 85 ~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~df 160 (321)
+.+ ...++||||+.+++|.+++. .+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+||
T Consensus 85 ~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Df 160 (281)
T 1mp8_A 85 ITE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDF 160 (281)
T ss_dssp ECS---SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECC-
T ss_pred Ecc---CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCC-CEEECcc
Confidence 843 34679999999999887763 589999999999999999999999999999999999999887 8999999
Q ss_pred cceeecCCCCc--cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChh
Q 020826 161 GLAEFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDE 237 (321)
Q Consensus 161 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (321)
|++........ .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||. +....+....+....
T Consensus 161 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~pf~-~~~~~~~~~~i~~~~---- 234 (281)
T 1mp8_A 161 GLSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQ-GVKNNDVIGRIENGE---- 234 (281)
T ss_dssp ------------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTTT-TCCGGGHHHHHHTTC----
T ss_pred ccccccCcccccccccCCCcccccChhhccc-CCCCCccCchHHHHHHHHHHhcCCCCCC-cCCHHHHHHHHHcCC----
Confidence 99976543322 223345678999999987 688999999999999999997 888873 333322222221100
Q ss_pred hhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 238 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
....+..+++++.++|.+||+.||++|||+.+++++
T Consensus 235 --------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 235 --------------------------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp --------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 001123467899999999999999999999999863
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-44 Score=305.92 Aligned_cols=253 Identities=19% Similarity=0.308 Sum_probs=204.8
Q ss_pred eeeeeecccCceEEeeeeeeecceEEEEEEEecCCc---eEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeee
Q 020826 12 CVWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNE---KCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDI 84 (321)
Q Consensus 12 ~~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~---~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (321)
..++++.....|++.+.||+|+||+||+|.+..++. .+++|.++... ...+.+|+.+++.+ +||||++++++
T Consensus 12 ~~~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~ 90 (298)
T 3pls_A 12 KDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL-NHPNVLALIGI 90 (298)
T ss_dssp GGGBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEE
T ss_pred hheEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhC-CCCCeeeEEEE
Confidence 356788888899999999999999999999765554 79999987532 35678999999999 89999999999
Q ss_pred eeccCCCCcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeec
Q 020826 85 VRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW 160 (321)
Q Consensus 85 ~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~df 160 (321)
+.+.+ ...++++|++.+++|..++ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+||
T Consensus 91 ~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~-~~kl~Df 168 (298)
T 3pls_A 91 MLPPE-GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF-TVKVADF 168 (298)
T ss_dssp ECCSS-SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECCT
T ss_pred EecCC-CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-cEEeCcC
Confidence 86543 3347999999999988776 3488999999999999999999999999999999999999888 8999999
Q ss_pred cceeecCCC-----CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCC
Q 020826 161 GLAEFYHPG-----KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 235 (321)
Q Consensus 161 g~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (321)
|++...... .......++..|+|||.+.+ ..++.++||||||+++|+|++|..|++...+.......+.....
T Consensus 169 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~- 246 (298)
T 3pls_A 169 GLARDILDREYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR- 246 (298)
T ss_dssp TSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC-
T ss_pred CCcccccCCcccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC-
Confidence 999754322 12234456788999999987 78899999999999999999988887655554443333221110
Q ss_pred hhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 236 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
...+..+++++.+++++||+.||++|||++++++
T Consensus 247 -----------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 247 -----------------------------------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp -----------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------------------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 0112246678999999999999999999999875
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=311.47 Aligned_cols=247 Identities=16% Similarity=0.297 Sum_probs=198.0
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEe-----cCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeec
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRD 87 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (321)
....++|++.+.||+|+||.||+|.+. .++..||+|+++... ...+.+|+.+++.+ +||||+++++++.+
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-NHPHVIKLYGACSQ 97 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhC-CCCceeeEEEEEec
Confidence 334689999999999999999999984 345789999987532 35678999999999 89999999999855
Q ss_pred cCCCCcEEEEEeecCchhhhhcC---------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeec
Q 020826 88 QQSKTPSLIFEHVNNTDFKVLYP---------------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRD 140 (321)
Q Consensus 88 ~~~~~~~lv~e~~~~~~l~~~~~---------------------------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~d 140 (321)
....++++||+.+++|.+++. .+++..++.++.|++.||+|||++|++|+|
T Consensus 98 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 175 (314)
T 2ivs_A 98 --DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175 (314)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred --CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 445679999999999887762 278889999999999999999999999999
Q ss_pred CCCCCeEEcCCCCeEEEeeccceeecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCC
Q 020826 141 VKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPF 216 (321)
Q Consensus 141 lkp~nili~~~~~~v~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~ 216 (321)
|||+||+++.++ .++|+|||++........ .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||
T Consensus 176 ikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~ 253 (314)
T 2ivs_A 176 LAARNILVAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVWSFGVLLWEIVTLGGNPY 253 (314)
T ss_dssp CSGGGEEEETTT-EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred cchheEEEcCCC-CEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999999999887 899999999986643322 223356678999999987 678999999999999999999 88888
Q ss_pred ccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCC
Q 020826 217 FYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER 296 (321)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~R 296 (321)
. +.........+.... ....+..+++++.++|.+||+.||++|
T Consensus 254 ~-~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~~li~~~l~~dp~~R 296 (314)
T 2ivs_A 254 P-GIPPERLFNLLKTGH------------------------------------RMERPDNCSEEMYRLMLQCWKQEPDKR 296 (314)
T ss_dssp T-TCCGGGHHHHHHTTC------------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred C-CCCHHHHHHHhhcCC------------------------------------cCCCCccCCHHHHHHHHHHccCChhhC
Confidence 3 222222221111100 011123467899999999999999999
Q ss_pred cCHHHHhcC
Q 020826 297 PTAKEAMAH 305 (321)
Q Consensus 297 ps~~ell~h 305 (321)
||+++++++
T Consensus 297 ps~~~l~~~ 305 (314)
T 2ivs_A 297 PVFADISKD 305 (314)
T ss_dssp CCHHHHHHH
T ss_pred cCHHHHHHH
Confidence 999999865
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=314.50 Aligned_cols=247 Identities=19% Similarity=0.321 Sum_probs=198.0
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEec-----CCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeec
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRD 87 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (321)
....++|++.+.||+|+||.||+|++.. +++.||+|+++... ...+.+|+.+++.+ +||||+++++++.+
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGVCAV 121 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEcc
Confidence 4457899999999999999999999973 45889999987542 35688999999999 89999999999955
Q ss_pred cCCCCcEEEEEeecCchhhhhc---------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeec
Q 020826 88 QQSKTPSLIFEHVNNTDFKVLY---------------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRD 140 (321)
Q Consensus 88 ~~~~~~~lv~e~~~~~~l~~~~---------------------------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~d 140 (321)
....++||||+.+++|.+++ ..+++..++.++.||+.||+|||++|++|+|
T Consensus 122 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 199 (343)
T 1luf_A 122 --GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199 (343)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred --CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 45678999999999987776 3588899999999999999999999999999
Q ss_pred CCCCCeEEcCCCCeEEEeeccceeecCCCC---ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCC
Q 020826 141 VKPHNVMIDHEQRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPF 216 (321)
Q Consensus 141 lkp~nili~~~~~~v~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~ 216 (321)
|||+||+++.++ .++|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..||
T Consensus 200 lkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~ 277 (343)
T 1luf_A 200 LATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPY 277 (343)
T ss_dssp CSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred CCcceEEECCCC-eEEEeecCCCcccccCccccccCCCcccceecChhhhcc-CCcCcccccHHHHHHHHHHHhcCCCcC
Confidence 999999999888 89999999986543221 2234457788999999987 678999999999999999999 88888
Q ss_pred ccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCC
Q 020826 217 FYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER 296 (321)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~R 296 (321)
. +....+....+... .. ...+..+++++.++|++||+.||++|
T Consensus 278 ~-~~~~~~~~~~~~~~----------------------------~~--------~~~~~~~~~~l~~li~~~l~~~p~~R 320 (343)
T 1luf_A 278 Y-GMAHEEVIYYVRDG----------------------------NI--------LACPENCPLELYNLMRLCWSKLPADR 320 (343)
T ss_dssp T-TSCHHHHHHHHHTT----------------------------CC--------CCCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred C-CCChHHHHHHHhCC----------------------------Cc--------CCCCCCCCHHHHHHHHHHcccCcccC
Confidence 4 22222222211110 00 01123467899999999999999999
Q ss_pred cCHHHHhcC
Q 020826 297 PTAKEAMAH 305 (321)
Q Consensus 297 ps~~ell~h 305 (321)
||+.+++++
T Consensus 321 ps~~~~~~~ 329 (343)
T 1luf_A 321 PSFCSIHRI 329 (343)
T ss_dssp CCHHHHHHH
T ss_pred CCHHHHHHH
Confidence 999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=312.84 Aligned_cols=245 Identities=18% Similarity=0.334 Sum_probs=191.7
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCce----EEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEK----CIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 89 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~----~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (321)
...++|++.+.||+|+||+||+|++..+++. +++|.++.. ....+.+|+.++..+ +||||+++++++.+..
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~ 90 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST 90 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHC-CBTTBCCEEEEEESSS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEeEEEEEEecCC
Confidence 3468999999999999999999998777664 577776532 346788999999999 8999999999986532
Q ss_pred CCCcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 90 SKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
.+++++++.+++|..++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .+||+|||++..
T Consensus 91 ---~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~ 166 (327)
T 3poz_A 91 ---VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKL 166 (327)
T ss_dssp ---EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCTTHHHH
T ss_pred ---eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCC-CEEEccCcceeE
Confidence 57999999999987766 3589999999999999999999999999999999999999888 899999999976
Q ss_pred cCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHH
Q 020826 166 YHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAY 241 (321)
Q Consensus 166 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (321)
...... .....+|..|+|||.+.+ ..++.++|||||||++|+|++ |..||. +.........+... .
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~-~~~~~~~~~~~~~~-~------- 236 (327)
T 3poz_A 167 LGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKG-E------- 236 (327)
T ss_dssp HTTTCC-------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCGGGHHHHHHTT-C-------
T ss_pred ccCCcccccccCCCccccccChHHhcc-CCCCchhhhhhhHHHHHHHHhcCCCCcc-CCCHHHHHHHHHcC-C-------
Confidence 543322 223345778999999987 789999999999999999999 898883 32222222111110 0
Q ss_pred hhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 242 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
....+..+++++.+++.+||+.||++|||+.+++++
T Consensus 237 ----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 237 ----------------------------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp ----------------------------CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred ----------------------------CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 001122456789999999999999999999999876
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=315.21 Aligned_cols=262 Identities=18% Similarity=0.296 Sum_probs=202.7
Q ss_pred ccCceEEeeeeeeecceEEEEEE----EecCCceEEEEEecccc---hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGV----HCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~----~~~~~~~~~vK~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
..++|++.+.||+|+||+||+|+ +..+++.||+|++.... ...+.+|+.+++.+ +||||+++++++......
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~~ 99 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKAL-HSDFIVKYRGVSYGPGRQ 99 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEECSSSC
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhc-CCCceeEEEEEEecCCCc
Confidence 36799999999999999999999 45678999999997543 34588999999999 999999999998766677
Q ss_pred CcEEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 92 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
..++||||+.+++|.+++. .+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++....
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 100 SLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA-HVKIADFGLAKLLP 178 (327)
T ss_dssp EEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCGGGCEECC
T ss_pred eEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCC-CEEEcccccceecc
Confidence 7889999999999887763 489999999999999999999999999999999999999888 89999999998765
Q ss_pred CCCc----cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 168 PGKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
.... .....++..|+|||++.+ ..++.++||||||+++|+|++|..||..... .................
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~--~~~~~~~~~~~~~~~~~--- 252 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSD-NIFSRQSDVWSFGVVLYELFTYCDKSCSPSA--EFLRMMGCERDVPALSR--- 252 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH--HHHHHCC----CCHHHH---
T ss_pred cCCccceeeccCCccccccCHHHhcc-CCCChHHhHHHHHHHHHHHHhCCCCCccccc--hhhhhcccccccccHHH---
Confidence 3332 233457778999999987 6789999999999999999999999842111 10000000000000000
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
......... ....+..+++++.++|++||+.||++|||+++++++
T Consensus 253 ---------~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 253 ---------LLELLEEGQ--------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp ---------HHHHHHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------HHHHhhccc--------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 000000000 111233577899999999999999999999999654
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=308.63 Aligned_cols=261 Identities=21% Similarity=0.341 Sum_probs=199.7
Q ss_pred ccCceEEeeeeeeecceEEEEEE----EecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGV----HCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~----~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
...+|++.+.||+|+||+||+|+ +..+++.||+|+++... ...+.+|+.+++.+ +||||+++++++.+...
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~~~ 97 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL-YHENIVKYKGICTEDGG 97 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTC-CCTTBCCEEEEEEC---
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhC-CCCCeeeeeeEEecCCC
Confidence 35679999999999999999999 56688999999987542 36788999999999 89999999999987666
Q ss_pred CCcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeec
Q 020826 91 KTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 166 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~ 166 (321)
...+++||++.+++|.+++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++...
T Consensus 98 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~ 176 (302)
T 4e5w_A 98 NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH-QVKIGDFGLTKAI 176 (302)
T ss_dssp CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEEC
T ss_pred ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCC-CEEECcccccccc
Confidence 7788999999999998776 4599999999999999999999999999999999999999888 8999999999876
Q ss_pred CCCCc----cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHh
Q 020826 167 HPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242 (321)
Q Consensus 167 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (321)
..... .....+|..|+|||++.+ ..++.++||||||+++|+|++|..|+... ........+........
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~------~~~~~~~~~~~~~~~~~ 249 (302)
T 4e5w_A 177 ETDKEYYTVKDDRDSPVFWYAPECLMQ-SKFYIASDVWSFGVTLHELLTYCDSDSSP------MALFLKMIGPTHGQMTV 249 (302)
T ss_dssp CTTCCEEECCCCTTCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSH------HHHHHHHHCSCCGGGHH
T ss_pred cCCCcceeccCCCCCCccccCCeeecC-CCCCcchhHHHHHHHHHHHHHccCCCcch------hhHHhhccCCcccccCH
Confidence 54432 234457778999999987 67889999999999999999999886211 11111111111000000
Q ss_pred hhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
........... ....+..+++++.++|.+||+.||++|||++++++
T Consensus 250 --------~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 250 --------TRLVNTLKEGK--------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp --------HHHHHHHHTTC--------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred --------HHHHHHHhccC--------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 00000000000 11122357789999999999999999999999875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=311.75 Aligned_cols=263 Identities=15% Similarity=0.166 Sum_probs=197.3
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEec---CCceEEEEEecccch--------------HHHHHHHHHHHhhcCC
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCT---DNEKCIIKILKPVKK--------------KKIKREIKILQNLCGG 75 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~---~~~~~~vK~~~~~~~--------------~~~~~E~~~l~~l~~h 75 (321)
........++|++.+.||+|+||+||+|.+.. ++..+|+|++..... ..+.+|+..+..+ +|
T Consensus 29 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l-~h 107 (345)
T 2v62_A 29 KVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQL-DY 107 (345)
T ss_dssp CEEECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTC-SC
T ss_pred CeeccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccc-cc
Confidence 44555677899999999999999999999977 788999999865321 2245677777887 89
Q ss_pred CCeeeeeeeeecc--CCCCcEEEEEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcC
Q 020826 76 PNIVKLLDIVRDQ--QSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 150 (321)
Q Consensus 76 ~~i~~~~~~~~~~--~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~ 150 (321)
|||+++++++... .....++|||++ +++|.+++. .+++..++.++.||+.||+|||++|++|+||||+||+++.
T Consensus 108 ~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 108 LGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGY 186 (345)
T ss_dssp CCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEES
T ss_pred cCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEcc
Confidence 9999999998652 255778999999 889988875 5899999999999999999999999999999999999986
Q ss_pred CC-CeEEEeeccceeecCCCC--------ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCC
Q 020826 151 EQ-RKLRLIDWGLAEFYHPGK--------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 221 (321)
Q Consensus 151 ~~-~~v~l~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~ 221 (321)
++ ..++|+|||++....... ......+|..|+|||++.+ ..++.++|||||||++|+|++|..||.....
T Consensus 187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~pf~~~~~ 265 (345)
T 2v62_A 187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG-VALSRRSDVEILGYCMLRWLCGKLPWEQNLK 265 (345)
T ss_dssp SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCTTGGGTT
T ss_pred CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence 54 279999999997653221 1134578999999999987 6789999999999999999999999954434
Q ss_pred ChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHH
Q 020826 222 NYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE 301 (321)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~e 301 (321)
............... .+.... .......+++++.++|.+||+.||++|||+++
T Consensus 266 ~~~~~~~~~~~~~~~-~~~~~~--------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ 318 (345)
T 2v62_A 266 DPVAVQTAKTNLLDE-LPQSVL--------------------------KWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQA 318 (345)
T ss_dssp CHHHHHHHHHHHHHT-TTHHHH--------------------------HHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHH
T ss_pred ccHHHHHHHHhhccc-ccHHHH--------------------------hhccccccHHHHHHHHHHHhhcCcccCCCHHH
Confidence 433333222111110 000000 00011246689999999999999999999998
Q ss_pred HhcC
Q 020826 302 AMAH 305 (321)
Q Consensus 302 ll~h 305 (321)
+++.
T Consensus 319 l~~~ 322 (345)
T 2v62_A 319 LKKI 322 (345)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 8753
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=317.26 Aligned_cols=283 Identities=18% Similarity=0.262 Sum_probs=201.3
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHh--hcCCCCeeeeeeeeec---cCCCC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQN--LCGGPNIVKLLDIVRD---QQSKT 92 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~--l~~h~~i~~~~~~~~~---~~~~~ 92 (321)
...++|++.+.||+|+||+||+|++ +++.||+|+++......+..|.+++.. + +||||+++++.+.. .....
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~-~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLM-EHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECTTSCEE
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhc-cCcchhhheecccccccCCCce
Confidence 3467999999999999999999976 789999999987777666666666543 5 89999999975532 23335
Q ss_pred cEEEEEeecCchhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---------CCeeecCCCCCeEEcCCCCeEEEeecc
Q 020826 93 PSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQ---------GIMHRDVKPHNVMIDHEQRKLRLIDWG 161 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lh~~---------~i~H~dlkp~nili~~~~~~v~l~dfg 161 (321)
.++||||+.+++|.+++ ...++..+..++.|++.||+|||+. |++|+||||+||+++.++ .+||+|||
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kL~DFG 165 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG-TCVISDFG 165 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS-CEEECCCT
T ss_pred EEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC-cEEEeecc
Confidence 68999999999998887 4578899999999999999999999 999999999999999888 89999999
Q ss_pred ceeecCCCC---------ccccccCCccccccccccCC------CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHH
Q 020826 162 LAEFYHPGK---------EYNVRVASRYFKGPELLVDL------QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQL 226 (321)
Q Consensus 162 ~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~------~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~ 226 (321)
++....... ......+|..|+|||++.+. ..++.++|||||||++|+|++|..||+.+.......
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 997654321 12244689999999998752 245578999999999999999998987655432211
Q ss_pred HHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHH----
Q 020826 227 VKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA---- 302 (321)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~el---- 302 (321)
..+....+...... .......... ..............+++++.+||.+||+.||++|||++|+
T Consensus 246 ~~~~~~~~~~~~~~-----------~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L 313 (336)
T 3g2f_A 246 MAFQTEVGNHPTFE-----------DMQVLVSREK-QRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERM 313 (336)
T ss_dssp CTTHHHHCSSCCHH-----------HHHHHHTTSC-CCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred HhhhcccCCCchHH-----------HHHhhhcccc-cCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHH
Confidence 11111111111000 0011111111 1111111111222345679999999999999999999999
Q ss_pred --hcCCCcccCCCccc
Q 020826 303 --MAHPYFFPIRNAES 316 (321)
Q Consensus 303 --l~hp~~~~~~~~~~ 316 (321)
+.++|-++......
T Consensus 314 ~~ll~~~~~~~~~~~~ 329 (336)
T 3g2f_A 314 AELMMIWERNKSVSPT 329 (336)
T ss_dssp HHHHHCCCC-------
T ss_pred HHHHHHHHhcccCCCc
Confidence 66788887655543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=340.19 Aligned_cols=282 Identities=20% Similarity=0.316 Sum_probs=204.3
Q ss_pred eeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeec---
Q 020826 15 FINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRD--- 87 (321)
Q Consensus 15 ~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--- 87 (321)
..+...++|++.+.||+|+||+||+|.+..+++.||+|+++.. ....+.+|+.+++.+ +||||+++++++.+
T Consensus 8 ~pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L-~HpnIV~l~~v~~~~~~ 86 (676)
T 3qa8_A 8 LPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKL-NHPNVVSAREVPDGLQK 86 (676)
T ss_dssp ---------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHC-CBTTBCCEEECCTTTCC
T ss_pred CCCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCceeeeeccccc
Confidence 3344458999999999999999999999889999999998653 245688899999999 89999999998754
Q ss_pred -cCCCCcEEEEEeecCchhhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCC--eEEEe
Q 020826 88 -QQSKTPSLIFEHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR--KLRLI 158 (321)
Q Consensus 88 -~~~~~~~lv~e~~~~~~l~~~~~------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~--~v~l~ 158 (321)
......++||||+.+++|..++. .+++..++.++.|++.||+|||+.|++|+||||+||+++.++. .++|+
T Consensus 87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~ 166 (676)
T 3qa8_A 87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKII 166 (676)
T ss_dssp CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEEC
T ss_pred ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEc
Confidence 22456689999999999987773 4889999999999999999999999999999999999986652 48999
Q ss_pred eccceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhh
Q 020826 159 DWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 238 (321)
Q Consensus 159 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (321)
|||++.............++..|+|||++.+ ..++.++|||||||++|+|++|..||....... ... ........
T Consensus 167 DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~-~~~---~~i~~~~~ 241 (676)
T 3qa8_A 167 DLGYAKELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPV-QWH---GKVREKSN 241 (676)
T ss_dssp SCCCCCBTTSCCCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHH-HSS---TTCC----
T ss_pred ccccccccccccccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCcccchh-hhh---hhhhcccc
Confidence 9999987765555566789999999999987 789999999999999999999999995332110 000 00000000
Q ss_pred hHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 239 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
.. ...... ....................+++.+.++|++||++||++|||++++++||||+.+.
T Consensus 242 ~~------~~~~~~----l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~ 305 (676)
T 3qa8_A 242 EH------IVVYDD----LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALD 305 (676)
T ss_dssp --------CCSCCC----CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHH
T ss_pred hh------hhhhhh----hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHH
Confidence 00 000000 00000000000001112223667899999999999999999999999999999763
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=305.70 Aligned_cols=253 Identities=19% Similarity=0.297 Sum_probs=200.8
Q ss_pred eeeeeecccCceEEeeeeeeecceEEEEEEEecC---CceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeee
Q 020826 12 CVWFINREQDDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDI 84 (321)
Q Consensus 12 ~~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~---~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (321)
..+.|+....+|++.+.||+|+||+||+|.+..+ ...+++|.++... ...+.+|+.+++++ +||||++++++
T Consensus 16 ~~~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~ 94 (298)
T 3f66_A 16 QHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGI 94 (298)
T ss_dssp GGGBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTC-CCTTBCCCCEE
T ss_pred hheecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhC-CCCCEeeeeeE
Confidence 3567888899999999999999999999997543 3468999887532 35678999999999 89999999998
Q ss_pred eeccCCCCcEEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeec
Q 020826 85 VRDQQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW 160 (321)
Q Consensus 85 ~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~df 160 (321)
+... ....+++||++.+++|.+++. .+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+||
T Consensus 95 ~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Df 172 (298)
T 3f66_A 95 CLRS-EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF-TVKVADF 172 (298)
T ss_dssp ECCS-SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECSC
T ss_pred EEcC-CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCC-CEEECcc
Confidence 6443 345679999999999988772 488999999999999999999999999999999999999887 8999999
Q ss_pred cceeecCCCC-----ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCC
Q 020826 161 GLAEFYHPGK-----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 235 (321)
Q Consensus 161 g~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (321)
|++....... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|..|++.+.........+.....
T Consensus 173 g~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~- 250 (298)
T 3f66_A 173 GLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR- 250 (298)
T ss_dssp GGGCCCSCGGGCBC-----CCBCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC-
T ss_pred cccccccccchhccccccCCCCCccccChHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC-
Confidence 9997654322 1233456778999999987 78899999999999999999977666555544433333211000
Q ss_pred hhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 236 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
...+..+++++.+++.+||+.||++|||+.++++
T Consensus 251 -----------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 251 -----------------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp -----------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -----------------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0112235678999999999999999999999885
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=312.04 Aligned_cols=244 Identities=18% Similarity=0.289 Sum_probs=193.6
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCce----EEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEK----CIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~----~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
..++|++.+.||+|+||+||+|.+..+++. +++|.+.... ...+.+|+.++..+ +||||+++++++.+
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~--- 86 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL-DHAHIVRLLGLCPG--- 86 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTC-CCTTBCCEEEEECB---
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcC-CCCCcCeEEEEEcC---
Confidence 467999999999999999999999888775 7777764322 24577899999999 89999999999853
Q ss_pred CCcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeec
Q 020826 91 KTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 166 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~ 166 (321)
...++|+||+.+++|..++ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++...
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a~~~ 165 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPS-QVQVADFGVADLL 165 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSS-CEEECSCSGGGGS
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCC-eEEECCCCccccc
Confidence 3467999999999987766 3589999999999999999999999999999999999999888 8999999999765
Q ss_pred CCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHh
Q 020826 167 HPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242 (321)
Q Consensus 167 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (321)
..... .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||.. .........+.. .
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~~~~~~~~~~~-~--------- 233 (325)
T 3kex_A 166 PPDDKQLLYSEAKTPIKWMALESIHF-GKYTHQSDVWSYGVTVWELMTFGAEPYAG-LRLAEVPDLLEK-G--------- 233 (325)
T ss_dssp CCCTTCCC-----CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTT-SCTTHHHHHHHT-T---------
T ss_pred CcccccccccCCCCcccccChHHhcc-CCCChhhHhHHhHHHHHHHHhCCCCCccc-cCHHHHHHHHHc-C---------
Confidence 43322 234456778999999987 679999999999999999999 9999842 222222211110 0
Q ss_pred hhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
.....+..+++++.+++.+||+.||++|||+.++++|
T Consensus 234 --------------------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 234 --------------------------ERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp --------------------------CBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred --------------------------CCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0011122356789999999999999999999999876
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=309.62 Aligned_cols=248 Identities=19% Similarity=0.325 Sum_probs=199.4
Q ss_pred ccCceEEeeeeeeecceEEEEEEEe-----cCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 89 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (321)
..++|++.+.||+|+||+||+|.+. .+++.||+|+++... ...+.+|+.++..+.+||||+++++++...
T Consensus 25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~- 103 (316)
T 2xir_A 25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 103 (316)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC-
Confidence 4679999999999999999999864 456899999987532 346789999999997899999999998654
Q ss_pred CCCcEEEEEeecCchhhhhcCC-------------------CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcC
Q 020826 90 SKTPSLIFEHVNNTDFKVLYPT-------------------LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 150 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~~~-------------------~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~ 150 (321)
....++++||+.+++|..++.. +++..++.++.|++.||.|||++|++|+||||+||+++.
T Consensus 104 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~ 183 (316)
T 2xir_A 104 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183 (316)
T ss_dssp TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECC
Confidence 3456899999999999877732 788899999999999999999999999999999999998
Q ss_pred CCCeEEEeeccceeecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHH
Q 020826 151 EQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQL 226 (321)
Q Consensus 151 ~~~~v~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~ 226 (321)
++ .++|+|||++........ .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||..........
T Consensus 184 ~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~ 261 (316)
T 2xir_A 184 KN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 261 (316)
T ss_dssp GG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHH
T ss_pred CC-CEEECCCccccccccCccceeccCCCcceeecCchhhcc-ccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHH
Confidence 87 899999999976543322 233456788999999987 788999999999999999998 888884333332222
Q ss_pred HHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 227 VKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
..+... .. ...+..+++++.++|.+||+.||++|||+.++++|
T Consensus 262 ~~~~~~-~~-----------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 262 RRLKEG-TR-----------------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHT-CC-----------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhccC-cc-----------------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 222110 00 01122356799999999999999999999999976
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=305.80 Aligned_cols=248 Identities=19% Similarity=0.355 Sum_probs=201.8
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc--hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
.|.+. .++|++.+.||+|+||+||+|.+..++..+++|.++... ...+.+|+.+++.+ +||||+++++++.+ .
T Consensus 7 ~~~~~--~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~ 81 (288)
T 3kfa_A 7 KWEME--RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTR--E 81 (288)
T ss_dssp TTBCC--GGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--S
T ss_pred ccccc--ccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcc--C
Confidence 45554 779999999999999999999999999999999987543 46688999999999 89999999999854 4
Q ss_pred CCcEEEEEeecCchhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 91 KTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
...++|+|++.+++|.+++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++..
T Consensus 82 ~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~ 160 (288)
T 3kfa_A 82 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRL 160 (288)
T ss_dssp SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGG-CEEECCCCGGGT
T ss_pred CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCC-CEEEccCcccee
Confidence 5568999999999988777 2389999999999999999999999999999999999999887 899999999876
Q ss_pred cCCCCc--cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHh
Q 020826 166 YHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242 (321)
Q Consensus 166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (321)
...... .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||. +.+.......+....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~~g~~p~~-~~~~~~~~~~~~~~~--------- 229 (288)
T 3kfa_A 161 MTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYP-GIDLSQVYELLEKDY--------- 229 (288)
T ss_dssp SCSSSSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSST-TCCGGGHHHHHHTTC---------
T ss_pred ccCCccccccCCccccCcCChhhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHhccC---------
Confidence 543322 233446678999999987 678999999999999999999 887773 333222222211100
Q ss_pred hhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
....+..+++++.+++++||+.||++|||++++++
T Consensus 230 ---------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 230 ---------------------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp ---------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------------CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 01112346789999999999999999999999975
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-44 Score=301.19 Aligned_cols=248 Identities=17% Similarity=0.356 Sum_probs=198.8
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc--chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
.|.|+ .++|++.+.||+|+||+||+|.+. ++..+++|.++.. ....+.+|+.+++.+ +||||+++++++.+.
T Consensus 2 ~~~i~--~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~~-- 75 (267)
T 3t9t_A 2 KWVID--PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQ-- 75 (267)
T ss_dssp -CBCC--GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTC-CCTTBCCEEEEECSS--
T ss_pred ceEEc--hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEccC--
Confidence 35554 579999999999999999999984 6788999999754 346789999999999 899999999998553
Q ss_pred CCcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeec
Q 020826 91 KTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 166 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~ 166 (321)
...++++|++.+++|.+++ ..+++..+..++.|++.||++||++|++|+||||+||+++.++ .++|+|||++...
T Consensus 76 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~ 154 (267)
T 3t9t_A 76 APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFV 154 (267)
T ss_dssp SSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGG-CEEECCTTGGGGB
T ss_pred CCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCC-CEEEccccccccc
Confidence 4567999999999988776 3489999999999999999999999999999999999999887 8999999998754
Q ss_pred CCCC--ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 167 HPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 167 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
.... ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||. +.........+....
T Consensus 155 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~~~~~~~i~~~~---------- 222 (267)
T 3t9t_A 155 LDDQYTSSTGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYE-NRSNSEVVEDISTGF---------- 222 (267)
T ss_dssp CCHHHHSTTSTTCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHHHTTC----------
T ss_pred ccccccccccccccccccChhhhcC-CCccchhchhhhHHHHHHHhccCCCCCC-CCCHHHHHHHHhcCC----------
Confidence 3221 1123456678999999987 678999999999999999999 788873 332222222211100
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
....+...++++.+++.+||+.||++|||+++++++
T Consensus 223 --------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 223 --------------------------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp --------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------------cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 001122356789999999999999999999999864
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=311.64 Aligned_cols=265 Identities=17% Similarity=0.238 Sum_probs=203.0
Q ss_pred eeeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc---hHHHHHHHHHHHhhcCCCCeeeeeeeeecc
Q 020826 12 CVWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 88 (321)
Q Consensus 12 ~~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (321)
+...+....++|++.+.||+|+||+||+|++ .+++.||+|.+.... ...+.+|+.+++.+ +||||+++++++.+
T Consensus 30 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~- 106 (321)
T 2qkw_B 30 PLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFC-RHPHLVSLIGFCDE- 106 (321)
T ss_dssp CCSCCCCCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSC-CCTTBCCEEEECCC-
T ss_pred cHHHHHHHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhC-CCCCEeeEEEEEcC-
Confidence 3445666779999999999999999999997 578999999986543 45688999999999 89999999999854
Q ss_pred CCCCcEEEEEeecCchhhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecc
Q 020826 89 QSKTPSLIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 161 (321)
Q Consensus 89 ~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg 161 (321)
....++|+||+.+++|.+++. .+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||
T Consensus 107 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg 184 (321)
T 2qkw_B 107 -RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENF-VPKITDFG 184 (321)
T ss_dssp -TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTC-CEEECCCT
T ss_pred -CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCC-CEEEeecc
Confidence 455679999999999988873 388999999999999999999999999999999999999888 89999999
Q ss_pred ceeecCCCC---ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChH--HHHHHHHHhCCh
Q 020826 162 LAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYD--QLVKIAKVLGTD 236 (321)
Q Consensus 162 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~--~~~~~~~~~~~~ 236 (321)
++....... ......+|..|+|||++.+ ..++.++|||||||++|+|++|+.||........ ............
T Consensus 185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIK-GRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263 (321)
T ss_dssp TCEECSSSSCCCCBCCCEEETTTCCHHHHHH-CBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT
T ss_pred cccccccccccccccccCCCccccCHHHhcC-CCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc
Confidence 997653222 2233457899999999987 6789999999999999999999999854322110 000000000000
Q ss_pred hhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 237 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
. .................++.+.+++.+||+.||++|||++|++++
T Consensus 264 ~-----------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 264 Q-----------------------LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp C-----------------------CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred c-----------------------HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 0 000000000011112345679999999999999999999999976
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=301.24 Aligned_cols=246 Identities=24% Similarity=0.397 Sum_probs=195.4
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecC---CceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccC
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 89 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~---~~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (321)
....++|++.+.||+|+||+||+|++..+ +..|++|.++.. ....+.+|+.+++.+ +||||+++++++.+.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~- 85 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL-DHPHIVKLIGIIEEE- 85 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHH-CCTTBCCEEEEECSS-
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhC-CCCCcceEEEEEcCC-
Confidence 44578999999999999999999997543 346999998754 346688999999999 899999999998542
Q ss_pred CCCcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 90 SKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
..++++|++.+++|.+++ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++..
T Consensus 86 --~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 86 --PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPE-CVKLGDFGLSRY 162 (281)
T ss_dssp --SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT-EEEECCCCGGGC
T ss_pred --CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCC-cEEeCccCCCcc
Confidence 347999999999988777 3489999999999999999999999999999999999999888 899999999876
Q ss_pred cCCCCc--cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHh
Q 020826 166 YHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242 (321)
Q Consensus 166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (321)
...... .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||... ........+.....
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~-~~~~~~~~~~~~~~-------- 232 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWL-ENKDVIGVLEKGDR-------- 232 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTS-CGGGHHHHHHHTCC--------
T ss_pred cccccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccC-ChHHHHHHHhcCCC--------
Confidence 543221 233456778999999976 688999999999999999998 99998432 22222222111000
Q ss_pred hhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
...+..+++.+.++|.+||+.||++|||+.|++++
T Consensus 233 ----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 233 ----------------------------LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp ----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------------CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 01122466889999999999999999999999864
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=300.55 Aligned_cols=247 Identities=17% Similarity=0.324 Sum_probs=200.1
Q ss_pred eeeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc--chHHHHHHHHHHHhhcCCCCeeeeeeeeeccC
Q 020826 12 CVWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 89 (321)
Q Consensus 12 ~~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (321)
..|.++ .++|++.+.||+|+||+||+|.+ .++..+++|.++.. ..+.+.+|+.+++.+ +||||+++++++.+
T Consensus 6 ~~~~v~--~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~-- 79 (279)
T 1qpc_A 6 DEWEVP--RETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ-- 79 (279)
T ss_dssp CTTBCC--GGGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS--
T ss_pred hhcccC--HHhhhheeeecCCCCeEEEEEEE-cCCcEEEEEEecCCcccHHHHHHHHHHHHhC-CCcCcceEEEEEcC--
Confidence 356665 57999999999999999999997 46778999998754 457789999999999 89999999999853
Q ss_pred CCCcEEEEEeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecccee
Q 020826 90 SKTPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 164 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~ 164 (321)
...++++|++.+++|.+++. .+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++.
T Consensus 80 -~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~ 157 (279)
T 1qpc_A 80 -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL-SCKIADFGLAR 157 (279)
T ss_dssp -SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred -CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCC-CEEECCCcccc
Confidence 23679999999999998885 589999999999999999999999999999999999999887 89999999998
Q ss_pred ecCCCCc--cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHH
Q 020826 165 FYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAY 241 (321)
Q Consensus 165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (321)
....... .....++..|+|||.+.+ ..++.++||||||+++++|++ |..||. +....+....+....
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~-~~~~~~~~~~~~~~~-------- 227 (279)
T 1qpc_A 158 LIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYP-GMTNPEVIQNLERGY-------- 227 (279)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSST-TCCHHHHHHHHHTTC--------
T ss_pred cccCcccccccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCc-ccCHHHHHHHHhccc--------
Confidence 7643322 123345678999999976 678899999999999999999 888873 333222222211100
Q ss_pred hhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 242 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
....+..+++++.+++.+||+.||++|||++++++
T Consensus 228 ----------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 228 ----------------------------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp ----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------------CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 00112346789999999999999999999999876
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=310.05 Aligned_cols=246 Identities=20% Similarity=0.287 Sum_probs=197.2
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCc-----eEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNE-----KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 89 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~-----~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (321)
..++|++.+.||+|+||+||+|.+..++. .+++|.++.. ....+.+|+.++..+.+||||+++++++.+
T Consensus 44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-- 121 (333)
T 2i1m_A 44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH-- 121 (333)
T ss_dssp CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec--
Confidence 36789999999999999999999876654 7999998754 345688999999999789999999999955
Q ss_pred CCCcEEEEEeecCchhhhhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCC
Q 020826 90 SKTPSLIFEHVNNTDFKVLYP-----------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ 152 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~~-----------------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~ 152 (321)
....++||||+.+++|.+++. .+++..++.++.|++.||+|||++|++|+||||+||+++.++
T Consensus 122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~ 201 (333)
T 2i1m_A 122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH 201 (333)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG
T ss_pred CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC
Confidence 445679999999999877652 478999999999999999999999999999999999999887
Q ss_pred CeEEEeeccceeecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHH
Q 020826 153 RKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVK 228 (321)
Q Consensus 153 ~~v~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~ 228 (321)
.++|+|||++........ .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||.. .........
T Consensus 202 -~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~t~g~~p~~~-~~~~~~~~~ 278 (333)
T 2i1m_A 202 -VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGLNPYPG-ILVNSKFYK 278 (333)
T ss_dssp -EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTT-CCSSHHHHH
T ss_pred -eEEECccccccccccccceeecCCCCCCccccCHHHhcc-CCCChHHHHHHHHHHHHHHHcCCCCCCcc-cchhHHHHH
Confidence 899999999976533222 223445678999999987 678999999999999999998 8878743 322222222
Q ss_pred HHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 229 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
+...... ...+...++++.++|.+||+.||++|||+.++++
T Consensus 279 ~~~~~~~-----------------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 279 LVKDGYQ-----------------------------------MAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHTCC-----------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhcCCC-----------------------------------CCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 2111000 0112235678999999999999999999999986
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=304.42 Aligned_cols=242 Identities=20% Similarity=0.292 Sum_probs=190.2
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
..++|++.+.||+|+||+||+|++ +++.|++|.+... ....+.+|+.+++++ +||||+++++++.+ ..++||
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~----~~~lv~ 78 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRV-NHPNIVKLYGACLN----PVCLVM 78 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHC-CCTTBCCEEEBCTT----TTEEEE
T ss_pred CHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcC-CCCCcCeEEEEEcC----CcEEEE
Confidence 467999999999999999999987 4788999998754 346788999999999 89999999998853 257999
Q ss_pred EeecCchhhhhcC------CCCHHHHHHHHHHHHHHHHHHHH---CCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 98 EHVNNTDFKVLYP------TLSDYDVRYYIYELLKALDYCHS---QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 98 e~~~~~~l~~~~~------~~~~~~~~~i~~qi~~~l~~lh~---~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
||+.+++|.+++. .++...+..++.|++.||+|||+ +|++|+||||+||+++.++..+||+|||++.....
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~ 158 (307)
T 2eva_A 79 EYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158 (307)
T ss_dssp ECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------
T ss_pred EcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccc
Confidence 9999999988773 36788999999999999999999 89999999999999998875689999999875432
Q ss_pred CCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 169 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
......+|..|+|||++.+ ..++.++||||||+++|+|++|+.||................
T Consensus 159 --~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---------------- 219 (307)
T 2eva_A 159 --HMTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN---------------- 219 (307)
T ss_dssp --------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT----------------
T ss_pred --ccccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc----------------
Confidence 2234568999999999987 788999999999999999999999985332222111110000
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
.. .......+++.+.+++.+||+.||++|||+++++++
T Consensus 220 -----------~~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 220 -----------GT--------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp -----------TC--------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------CC--------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 00 001122467899999999999999999999999873
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=301.62 Aligned_cols=249 Identities=18% Similarity=0.266 Sum_probs=194.1
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
..++|++.+.||+|+||+||+|++..+++.||+|++... ....+.+|+.+++.+ .|++++..+..+.. .....++++
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l-~~~~~i~~~~~~~~-~~~~~~lv~ 84 (296)
T 3uzp_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMM-QGGVGIPTIRWCGA-EGDYNVMVM 84 (296)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHH-TTSTTCCCEEEEEE-ETTEEEEEE
T ss_pred eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHh-hcCCCCCccccccC-CCCceEEEE
Confidence 468999999999999999999999999999999998654 346789999999999 56555544444432 345668999
Q ss_pred EeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEc---CCCCeEEEeeccceeecCCCC
Q 020826 98 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMID---HEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 98 e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~---~~~~~v~l~dfg~~~~~~~~~ 170 (321)
|++ +++|.+++ ..+++..++.++.|++.||+|||++|++|+||||+||+++ .++ .++|+|||++.......
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~-~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTT-CEEECCCTTCEECBCTT
T ss_pred Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCC-eEEEeeCCCcccccccc
Confidence 999 77777665 3599999999999999999999999999999999999994 555 89999999998765432
Q ss_pred c--------cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCC--ChHHHHHHHHHhCChhhhH
Q 020826 171 E--------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--NYDQLVKIAKVLGTDELNA 240 (321)
Q Consensus 171 ~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~ 240 (321)
. .....+|..|+|||++.+ ..++.++|||||||++|+|++|+.||..... .......+..........
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 240 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE- 240 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH-
T ss_pred cccccccccccccccccccCChhhhcC-CCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH-
Confidence 2 244578999999999987 6789999999999999999999999953221 112222221100000000
Q ss_pred HhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 241 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
.....+|+++.+++++||+.||++|||++++++
T Consensus 241 -------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 241 -------------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp -------------------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred -------------------------------HHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 011246689999999999999999999998875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-44 Score=303.73 Aligned_cols=250 Identities=17% Similarity=0.336 Sum_probs=187.7
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeec
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRD 87 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (321)
.+.|. .++|++.+.||+|+||+||+|++. ..+++|+++.. ....+.+|+.+++.+ +||||++++++..
T Consensus 18 ~~ei~--~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~- 90 (289)
T 3og7_A 18 DWEIP--DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYST- 90 (289)
T ss_dssp CCBCC--TTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEC-
T ss_pred CCccC--ccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhC-CCCcEEEEEeecc-
Confidence 44444 789999999999999999999863 35999998643 235688999999999 8999999999753
Q ss_pred cCCCCcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccce
Q 020826 88 QQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163 (321)
Q Consensus 88 ~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~ 163 (321)
....++++||+.+++|..++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++
T Consensus 91 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~ 167 (289)
T 3og7_A 91 --APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN-TVKIGDFGLA 167 (289)
T ss_dssp --SSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT-EEEECCCC--
T ss_pred --CCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC-CEEEccceec
Confidence 23467999999999987776 3489999999999999999999999999999999999999888 8999999998
Q ss_pred eecCC---CCccccccCCccccccccccC--CCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhh
Q 020826 164 EFYHP---GKEYNVRVASRYFKGPELLVD--LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 238 (321)
Q Consensus 164 ~~~~~---~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (321)
..... ........+|..|+|||++.. ...++.++||||||+++|+|++|..||... .....+...........
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~-~~~~~~~~~~~~~~~~~- 245 (289)
T 3og7_A 168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI-NNRDQIIEMVGRGSLSP- 245 (289)
T ss_dssp ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSC-CCHHHHHHHHHHTSCCC-
T ss_pred cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcccc-chHHHHHHHhcccccCc-
Confidence 75432 122334568999999999862 256788999999999999999999998433 33333332222111000
Q ss_pred hHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 239 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
. .......+++++.++|.+||+.||++|||++++++
T Consensus 246 -------------------------~-----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 246 -------------------------D-----LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp -------------------------C-----TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------------c-----hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 0 00112246789999999999999999999999985
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=309.35 Aligned_cols=250 Identities=18% Similarity=0.307 Sum_probs=198.6
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEe-------cCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeee
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHC-------TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKL 81 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~-------~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~ 81 (321)
.|.++ .++|++.+.||+|+||+||+|.+. .++..||+|+++... ...+.+|+.+++.+.+||||+++
T Consensus 29 ~~~~~--~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 106 (334)
T 2pvf_A 29 KWEFP--RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINL 106 (334)
T ss_dssp TTBCC--GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred cccCC--HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence 44444 679999999999999999999975 356789999987542 35678999999999889999999
Q ss_pred eeeeeccCCCCcEEEEEeecCchhhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCC
Q 020826 82 LDIVRDQQSKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVK 142 (321)
Q Consensus 82 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlk 142 (321)
++++.+ ....++|+||+.+++|.+++. .+++..++.++.|++.||+|||++|++|+|||
T Consensus 107 ~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlk 184 (334)
T 2pvf_A 107 LGACTQ--DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLA 184 (334)
T ss_dssp EEEECS--SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred EEEEcc--CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCc
Confidence 999855 446679999999999987762 27888999999999999999999999999999
Q ss_pred CCCeEEcCCCCeEEEeeccceeecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCcc
Q 020826 143 PHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFY 218 (321)
Q Consensus 143 p~nili~~~~~~v~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~ 218 (321)
|+||+++.++ .++|+|||++........ .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||.
T Consensus 185 p~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~- 261 (334)
T 2pvf_A 185 ARNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLMWEIFTLGGSPYP- 261 (334)
T ss_dssp GGGEEECTTC-CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSST-
T ss_pred cceEEEcCCC-CEEEccccccccccccccccccCCCCcccceeChHHhcC-CCcChHHHHHHHHHHHHHHHhCCCCCcC-
Confidence 9999999888 899999999987654322 223346678999999987 678999999999999999999 888873
Q ss_pred CCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC
Q 020826 219 GHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT 298 (321)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps 298 (321)
+.+..+....+.... ....+..+++++.++|++||+.||++|||
T Consensus 262 ~~~~~~~~~~~~~~~------------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps 305 (334)
T 2pvf_A 262 GIPVEELFKLLKEGH------------------------------------RMDKPANCTNELYMMMRDCWHAVPSQRPT 305 (334)
T ss_dssp TCCHHHHHHHHHHTC------------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred cCCHHHHHHHHhcCC------------------------------------CCCCCccCCHHHHHHHHHHccCChhhCcC
Confidence 332222222211100 00112246689999999999999999999
Q ss_pred HHHHhcC
Q 020826 299 AKEAMAH 305 (321)
Q Consensus 299 ~~ell~h 305 (321)
+.+++++
T Consensus 306 ~~ell~~ 312 (334)
T 2pvf_A 306 FKQLVED 312 (334)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999865
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=301.91 Aligned_cols=250 Identities=18% Similarity=0.270 Sum_probs=189.8
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
...++|++.+.||+|+||+||+|++..+++.||+|++... ....+.+|+.+++.+ .|++++..+..+.. .....+++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l-~~~~~i~~~~~~~~-~~~~~~lv 83 (296)
T 4hgt_A 6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMM-QGGVGIPTIRWCGA-EGDYNVMV 83 (296)
T ss_dssp -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHH-TTSTTCCCEEEEEE-ETTEEEEE
T ss_pred ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHh-cCCCCCCeeeeecC-CCCceEEE
Confidence 3468999999999999999999999999999999987543 345688999999999 55555555444432 34566899
Q ss_pred EEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEE---cCCCCeEEEeeccceeecCCC
Q 020826 97 FEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 97 ~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili---~~~~~~v~l~dfg~~~~~~~~ 169 (321)
||++ +++|.+++ ..+++..+..++.|++.||+|||++|++|+||||+||++ +.++ .++|+|||++......
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~-~~kL~Dfg~a~~~~~~ 161 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKYRDA 161 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTT-CEEECCCTTCEECBCT
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCC-eEEEecCccceeccCc
Confidence 9999 77776665 469999999999999999999999999999999999999 5666 8999999999876433
Q ss_pred Cc--------cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCC--hHHHHHHHHHhCChhhh
Q 020826 170 KE--------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN--YDQLVKIAKVLGTDELN 239 (321)
Q Consensus 170 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~ 239 (321)
.. .....+|..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... ......+..........
T Consensus 162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (296)
T 4hgt_A 162 RTHQHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 240 (296)
T ss_dssp TTCCBCCCCCSCCCCSCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred ccCccCCCCcccccCCCccccchHHhcC-CCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence 22 234578999999999987 67899999999999999999999999532221 11111111100000000
Q ss_pred HHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 240 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
.....+|+++.+++.+||+.||++|||++++++
T Consensus 241 --------------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 241 --------------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp --------------------------------HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred --------------------------------hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 001235689999999999999999999999876
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=306.81 Aligned_cols=248 Identities=24% Similarity=0.448 Sum_probs=189.1
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
...++|++.+.||+|+||+||+|.+..+++.||+|+++.. ....+.+|+.+++.+ +||||+++++++.+. .
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~~--~ 105 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL-NHPNVIKYYASFIED--N 105 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEET--T
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcC--C
Confidence 3457899999999999999999999889999999998642 235678999999999 899999999998653 4
Q ss_pred CcEEEEEeecCchhhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecccee
Q 020826 92 TPSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 164 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~ 164 (321)
..++++|++.+++|.+++ ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++.
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~-~~kl~Dfg~~~ 184 (310)
T 2wqm_A 106 ELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGR 184 (310)
T ss_dssp EEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCC----
T ss_pred cEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCC-CEEEEecccee
Confidence 667999999999987766 3489999999999999999999999999999999999999888 89999999987
Q ss_pred ecCCCC-ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 165 FYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 165 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
...... ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.........+..........
T Consensus 185 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------- 256 (310)
T 2wqm_A 185 FFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP------- 256 (310)
T ss_dssp --------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSC-------
T ss_pred eecCCCccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCC-------
Confidence 654322 2234568899999999987 7889999999999999999999999954333322222111100000
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
......+++++.++|.+||+.||++|||++++++
T Consensus 257 ---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 257 ---------------------------PLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp ---------------------------CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------------CCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0001246679999999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=313.26 Aligned_cols=247 Identities=19% Similarity=0.305 Sum_probs=196.6
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceE--EEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKC--IIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~--~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
...++|++.+.||+|+||.||+|++..++..+ ++|.++.. ....+.+|+.+++++.+||||+++++++.+. .
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--G 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--T
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC--C
Confidence 44579999999999999999999998888755 89988642 3356889999999997899999999999654 4
Q ss_pred CcEEEEEeecCchhhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCC
Q 020826 92 TPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ 152 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~ 152 (321)
..++|||++.+++|.+++. .+++..++.++.|++.||+|||++|++|+||||+||+++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 6789999999999877762 488999999999999999999999999999999999999887
Q ss_pred CeEEEeeccceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHH
Q 020826 153 RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAK 231 (321)
Q Consensus 153 ~~v~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 231 (321)
.++|+|||++.............++..|+|||++.+ ..++.++|||||||++|+|++ |..||. +.........+..
T Consensus 180 -~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~-~~~~~~~~~~~~~ 256 (327)
T 1fvr_A 180 -VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYC-GMTCAELYEKLPQ 256 (327)
T ss_dssp -CEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHGGG
T ss_pred -eEEEcccCcCccccccccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcCCCCCCC-CCcHHHHHHHhhc
Confidence 899999999875433333344556788999999977 678999999999999999998 998883 2222111111100
Q ss_pred HhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 232 VLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
. .....+..+++++.++|.+||+.||++|||+++++++
T Consensus 257 ---------------------------~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 257 ---------------------------G---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp ---------------------------T---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------------C---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 0 0011123467899999999999999999999999876
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=318.86 Aligned_cols=245 Identities=18% Similarity=0.347 Sum_probs=197.4
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
.|.|+ .++|++.+.||+|+||+||+|.+ +++.||||+++.. ....+.+|+.+++++ +||||+++++++.+.. .
T Consensus 187 ~~~i~--~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~-~ 260 (450)
T 1k9a_A 187 GWALN--MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEK-G 260 (450)
T ss_dssp TCBCC--GGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTC-CCTTBCCEEEEEECTT-S
T ss_pred ccccC--hHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhc-cCCCEEEEEEEEEcCC-C
Confidence 34454 56999999999999999999987 4779999999764 346789999999999 8999999999876543 3
Q ss_pred CcEEEEEeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeec
Q 020826 92 TPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 166 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~ 166 (321)
..++||||+.+++|.+++. .+++..+..++.||+.||+|||++|++|+||||+||+++.++ .+||+|||++...
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~ 339 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEA 339 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTS-CEEECCCTTCEEC
T ss_pred ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCC-CEEEeeCCCcccc
Confidence 5689999999999987773 278999999999999999999999999999999999999888 8999999999764
Q ss_pred CCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhh
Q 020826 167 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245 (321)
Q Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (321)
... .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||. +.+..+....+....
T Consensus 340 ~~~--~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~~-~~~~~~~~~~i~~~~------------ 403 (450)
T 1k9a_A 340 SST--QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYP-RIPLKDVVPRVEKGY------------ 403 (450)
T ss_dssp C--------CCCTTTSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTTCCSST-TSCTTTHHHHHHTTC------------
T ss_pred ccc--ccCCCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHcCC------------
Confidence 322 223356788999999987 789999999999999999998 998884 333222222211100
Q ss_pred cccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
....+..+++++.++|++||+.||++|||+.++++
T Consensus 404 ------------------------~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 404 ------------------------KMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp ------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------------------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 01123357789999999999999999999999874
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=303.18 Aligned_cols=250 Identities=19% Similarity=0.291 Sum_probs=188.9
Q ss_pred eeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeecc
Q 020826 15 FINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 88 (321)
Q Consensus 15 ~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (321)
..+...++|++.+.||+|+||+||+|.+..+++.|++|+++... ...+.+|+.+++.+ +||||+++++++.+
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~- 105 (309)
T 2h34_A 28 REGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRL-QEPHVVPIHDFGEI- 105 (309)
T ss_dssp ------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEE-
T ss_pred CCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhc-CCCCeeEEEEEEee-
Confidence 34555689999999999999999999998899999999987532 25678999999999 89999999999865
Q ss_pred CCCCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 89 QSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 89 ~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
....++++|++.+++|.+++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++..
T Consensus 106 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~-~~kl~Dfg~~~~ 183 (309)
T 2h34_A 106 -DGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADD-FAYLVDFGIASA 183 (309)
T ss_dssp -TTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSCCC---
T ss_pred -CCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCC-CEEEecCccCcc
Confidence 44677999999999998877 4599999999999999999999999999999999999999888 899999999876
Q ss_pred cCCCC--ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 166 YHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 166 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
..... ......++..|+|||++.+ ..++.++||||||+++|+|++|..||... ....+.........
T Consensus 184 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~--~~~~~~~~~~~~~~-------- 252 (309)
T 2h34_A 184 TTDEKLTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGD--QLSVMGAHINQAIP-------- 252 (309)
T ss_dssp -------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSC--HHHHHHHHHHSCCC--------
T ss_pred ccccccccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCc--hHHHHHHHhccCCC--------
Confidence 54322 2234568899999999987 78899999999999999999999998321 11111111110000
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc-CHHHHhc
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-TAKEAMA 304 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp-s~~ell~ 304 (321)
........+|+++.++|.+||+.||++|| |++++++
T Consensus 253 -------------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 253 -------------------------RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp -------------------------CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred -------------------------CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 00111235778999999999999999999 7777664
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-44 Score=300.95 Aligned_cols=243 Identities=16% Similarity=0.261 Sum_probs=195.7
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
...++|++.+.||+|+||+||+|++ +++.+|+|+++... ...+.+|+.+++.+ +||||+++++++.+.....
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~ 83 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF-SHPNVLPVLGACQSPPAPH 83 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCC-SCTTEECEEEEECTTTSSS
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCchhheEEEEccCCCCC
Confidence 3467999999999999999999998 48889999987432 35688999999999 8999999999997765577
Q ss_pred cEEEEEeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCC--CeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 93 PSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~--i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
.++++||+.+++|.+++. .+++..++.++.|++.||+|||++| ++|+||||+||+++.++ .++++|||+...
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~-~~~l~~~~~~~~ 162 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDM-TARISMADVKFS 162 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTS-CEEEEGGGSCCT
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCc-ceeEEeccceee
Confidence 889999999999988873 3899999999999999999999999 99999999999999887 799999888754
Q ss_pred cCCCCccccccCCccccccccccCCC--CCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 166 YHPGKEYNVRVASRYFKGPELLVDLQ--DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
. ......+|+.|+|||.+.+.. .++.++|||||||++|+|++|..||. +.........+......
T Consensus 163 ~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~-~~~~~~~~~~~~~~~~~-------- 229 (271)
T 3kmu_A 163 F----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFA-DLSNMEIGMKVALEGLR-------- 229 (271)
T ss_dssp T----SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTT-TSCHHHHHHHHHHSCCC--------
T ss_pred e----cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcc-ccChHHHHHHHHhcCCC--------
Confidence 2 223456789999999997622 22337999999999999999999983 22222222221110000
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
...+..+++++.++|.+||+.||++|||++++++
T Consensus 230 ---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 230 ---------------------------PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp ---------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0112346789999999999999999999999985
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-44 Score=307.00 Aligned_cols=249 Identities=17% Similarity=0.311 Sum_probs=189.7
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEec---CCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeecc
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCT---DNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 88 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~---~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (321)
....++|++.+.||+|+||+||+|.+.. ++..||+|.++... ...+.+|+.+++.+ +||||+++++++.+.
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF-SHPNVIRLLGVCIEM 108 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEC-
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcC-CCCCeeeeeEEEeec
Confidence 3456799999999999999999998865 45589999987432 35578999999999 899999999998754
Q ss_pred CCC---CcEEEEEeecCchhhhhc---------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEE
Q 020826 89 QSK---TPSLIFEHVNNTDFKVLY---------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLR 156 (321)
Q Consensus 89 ~~~---~~~lv~e~~~~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~ 156 (321)
... ..++++|++.+++|..++ ..+++..++.++.|++.||.|||++|++|+||||+||+++.++ .++
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~-~~k 187 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM-TVC 187 (313)
T ss_dssp ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS-CEE
T ss_pred cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-cEE
Confidence 432 458999999999988776 3589999999999999999999999999999999999999887 899
Q ss_pred EeeccceeecCCCC---ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHH
Q 020826 157 LIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKV 232 (321)
Q Consensus 157 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~ 232 (321)
|+|||++....... ......++..|+|||.+.+ ..++.++||||||+++|+|++ |..|| .+.........+...
T Consensus 188 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~-~~~~~~~~~~~~~~~ 265 (313)
T 3brb_A 188 VADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPY-PGVQNHEMYDYLLHG 265 (313)
T ss_dssp ECSCSCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCGGGHHHHHHTT
T ss_pred EeecCcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCC-ccCCHHHHHHHHHcC
Confidence 99999987654322 1233456778999999987 788999999999999999999 77776 333332222221110
Q ss_pred hCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 233 LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
. ....+..+++++.++|.+||+.||++|||+.+++++
T Consensus 266 ~------------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 266 H------------------------------------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp C------------------------------------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred C------------------------------------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 0 001123466899999999999999999999999864
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-44 Score=321.62 Aligned_cols=246 Identities=17% Similarity=0.321 Sum_probs=199.6
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc--chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
.|.|+ .++|++.+.||+|+||+||+|.+ .++..||||+++.. ....+.+|+.+++.+ +||||+++++++. .
T Consensus 182 ~~~i~--~~~~~~~~~lG~G~fg~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~l~~~~~---~ 254 (454)
T 1qcf_A 182 AWEIP--RESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGSMSVEAFLAEANVMKTL-QHDKLVKLHAVVT---K 254 (454)
T ss_dssp CSBCC--GGGEEEEEEEECCSSEEEEEEEE-TTTEEEEEEEECTTSBCHHHHHHHHHHHTTC-CCTTBCCEEEEEC---S
T ss_pred ceeec--hHHeEEEEEcccCCceEEEEEEE-CCccEEEEEEecCCCccHHHHHHHHHHHhhC-CCCCEeeEEEEEe---C
Confidence 45555 56999999999999999999998 45778999999754 457789999999999 8999999999985 2
Q ss_pred CCcEEEEEeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 91 KTPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
...++||||+.+++|.+++. .++...+..++.||+.||+|||++|++|+||||+||+++.++ .+||+|||++..
T Consensus 255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~~ 333 (454)
T 1qcf_A 255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLARV 333 (454)
T ss_dssp SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTC-CEEECSTTGGGG
T ss_pred CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCC-cEEEeeCCCceE
Confidence 35689999999999988874 588999999999999999999999999999999999999887 899999999976
Q ss_pred cCCCCc--cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHh
Q 020826 166 YHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242 (321)
Q Consensus 166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (321)
...... .....++..|+|||++.. ..++.++||||||+++|+|++ |..|| .+.+..+....+.....
T Consensus 334 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~-~~~~~~~~~~~i~~~~~-------- 403 (454)
T 1qcf_A 334 IEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPY-PGMSNPEVIRALERGYR-------- 403 (454)
T ss_dssp BCCHHHHTTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSS-TTCCHHHHHHHHHHTCC--------
T ss_pred cCCCceeccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCCC--------
Confidence 532211 122345678999999987 679999999999999999999 88888 33333333332221100
Q ss_pred hhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
...+..+++++.++|.+||+.||++|||++++++
T Consensus 404 ----------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 404 ----------------------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp ----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 1112346789999999999999999999998875
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=301.33 Aligned_cols=246 Identities=18% Similarity=0.332 Sum_probs=198.3
Q ss_pred cccCceEEee-eeeeecceEEEEEEEe--cCCceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 18 REQDDYEVVR-KVGRGKYSEVFEGVHC--TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 18 ~~~~~y~~~~-~lg~g~~g~v~~~~~~--~~~~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
...++|.+.+ .||+|+||+||+|.+. .++..||+|+++.. ....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--- 81 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA--- 81 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEES---
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhC-CCCCEeEEEEEecC---
Confidence 3467888888 9999999999999864 46778999999753 245688999999999 89999999999843
Q ss_pred CCcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeec
Q 020826 91 KTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 166 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~ 166 (321)
...++|+|++.+++|.+++ ..+++..++.++.|++.||.+||+.|++|+||||+||+++.++ .++|+|||++...
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLSKAL 160 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT-EEEECCCTTCEEC
T ss_pred CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCC-CEEECcccceeee
Confidence 3468999999999998877 3489999999999999999999999999999999999999887 8999999999876
Q ss_pred CCCCcc----ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHH
Q 020826 167 HPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAY 241 (321)
Q Consensus 167 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (321)
...... ....++..|+|||++.+ ..++.++||||||+++|+|++ |..||. +....+....+....
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~-~~~~~~~~~~i~~~~-------- 230 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYK-KMKGPEVMAFIEQGK-------- 230 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTT-TCCTHHHHHHHHTTC--------
T ss_pred ccCcceeeccccccccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCcc-cCCHHHHHHHHhcCC--------
Confidence 433221 22345788999999976 678999999999999999998 998883 333322222211100
Q ss_pred hhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCC
Q 020826 242 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 306 (321)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp 306 (321)
....+..+++++.++|.+||+.||++|||+.++++|.
T Consensus 231 ----------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 231 ----------------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp ----------------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred ----------------------------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 0111234678999999999999999999999999873
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=307.48 Aligned_cols=253 Identities=19% Similarity=0.336 Sum_probs=200.9
Q ss_pred cccCceEEeeeeeeecceEEEEEEEe-----cCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeecc
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 88 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (321)
...++|++.+.||+|+||+||+|.+. .++..|++|.++... ...+.+|+.+++.+ +||||+++++++.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~- 99 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLGVVSQ- 99 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEEEECS-
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhc-CCCCEeeeEEEEcc-
Confidence 34679999999999999999999886 357889999987432 34578999999999 89999999999854
Q ss_pred CCCCcEEEEEeecCchhhhhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeE
Q 020826 89 QSKTPSLIFEHVNNTDFKVLY-------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKL 155 (321)
Q Consensus 89 ~~~~~~lv~e~~~~~~l~~~~-------------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v 155 (321)
....++|||++.+++|.+++ ..+++..+..++.|++.||.|||++|++|+||||+||+++.++ .+
T Consensus 100 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~-~~ 177 (322)
T 1p4o_A 100 -GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-TV 177 (322)
T ss_dssp -SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC-CE
T ss_pred -CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC-eE
Confidence 44567999999999988776 2468899999999999999999999999999999999999887 89
Q ss_pred EEeeccceeecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHH
Q 020826 156 RLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAK 231 (321)
Q Consensus 156 ~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 231 (321)
+|+|||++........ .....+++.|+|||++.+ ..++.++||||||+++|+|++ |..||. +.........+..
T Consensus 178 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~-~~~~~~~~~~~~~ 255 (322)
T 1p4o_A 178 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQ-GLSNEQVLRFVME 255 (322)
T ss_dssp EECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTT-TSCHHHHHHHHHT
T ss_pred EECcCccccccccccccccccCCCCCCCccChhhhcc-CCCCchhhHHHHHHHHHHHHhcCCCccc-cCCHHHHHHHHHc
Confidence 9999999875432221 123345778999999987 678999999999999999999 777773 3322222221111
Q ss_pred HhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC------
Q 020826 232 VLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH------ 305 (321)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h------ 305 (321)
. . ....+..+++++.++|.+||+.||++|||+.|+++|
T Consensus 256 ~-~-----------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~ 299 (322)
T 1p4o_A 256 G-G-----------------------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 299 (322)
T ss_dssp T-C-----------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred C-C-----------------------------------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence 0 0 001123467889999999999999999999999987
Q ss_pred CCcccCC
Q 020826 306 PYFFPIR 312 (321)
Q Consensus 306 p~~~~~~ 312 (321)
++|+.+.
T Consensus 300 ~~~~~~~ 306 (322)
T 1p4o_A 300 PGFREVS 306 (322)
T ss_dssp TTHHHHC
T ss_pred cCCcccc
Confidence 7776543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=313.34 Aligned_cols=270 Identities=18% Similarity=0.216 Sum_probs=202.8
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccch----HHHHHHHHHHHhhcCCCCeeeeeeeeecc
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKILQNLCGGPNIVKLLDIVRDQ 88 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (321)
.-.+....++|++.+.||+|+||+||+|.+ .+++.||+|+++.... ..+.+|+.++..+ +||||+++++++.+.
T Consensus 22 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~ 99 (326)
T 3uim_A 22 LRELQVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMA-VHRNLLRLRGFCMTP 99 (326)
T ss_dssp THHHHTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTC-CCTTBCCCCEEECCS
T ss_pred HHHHHHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhc-cCCCccceEEEEecC
Confidence 344556688999999999999999999986 5789999999875432 3688999999999 899999999999654
Q ss_pred CCCCcEEEEEeecCchhhhhcC-------CCCHHHHHHHHHHHHHHHHHHHHC---CCeeecCCCCCeEEcCCCCeEEEe
Q 020826 89 QSKTPSLIFEHVNNTDFKVLYP-------TLSDYDVRYYIYELLKALDYCHSQ---GIMHRDVKPHNVMIDHEQRKLRLI 158 (321)
Q Consensus 89 ~~~~~~lv~e~~~~~~l~~~~~-------~~~~~~~~~i~~qi~~~l~~lh~~---~i~H~dlkp~nili~~~~~~v~l~ 158 (321)
...++|+||+.+++|..++. .+++..+..++.|++.||+|||++ |++|+||||+||+++.++ .++|+
T Consensus 100 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~-~~kl~ 176 (326)
T 3uim_A 100 --TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVG 176 (326)
T ss_dssp --SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC-CEEEC
T ss_pred --CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC-CEEec
Confidence 45679999999999887762 388999999999999999999999 999999999999999887 89999
Q ss_pred eccceeecCCCCc--cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCcc----CCCChHHHHHHHHH
Q 020826 159 DWGLAEFYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY----GHDNYDQLVKIAKV 232 (321)
Q Consensus 159 dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~----~~~~~~~~~~~~~~ 232 (321)
|||++........ .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||.. ..........+...
T Consensus 177 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 255 (326)
T 3uim_A 177 DFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST-GKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255 (326)
T ss_dssp CCSSCEECCSSSSCEECCCCSCGGGCCHHHHHH-SEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred cCccccccCcccccccccccCCcCccCHHHhcc-CCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence 9999987643322 334458999999999977 6789999999999999999999999831 00000000000000
Q ss_pred hCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 233 LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
..... .................++++.+++.+||+.||++|||++|+++|-.-...
T Consensus 256 ~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~ 311 (326)
T 3uim_A 256 LKEKK-----------------------LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL 311 (326)
T ss_dssp TSSCC-----------------------STTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred hhchh-----------------------hhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence 00000 000000000011112234679999999999999999999999998554433
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-44 Score=324.81 Aligned_cols=248 Identities=19% Similarity=0.355 Sum_probs=201.6
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc--chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
.|.+. .++|++.+.||+|+||+||+|.+..++..||+|.++.. ....+.+|+.+++++ +||||+++++++.+.
T Consensus 214 ~~~~~--~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~l~~~~~~~-- 288 (495)
T 1opk_A 214 KWEME--RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTRE-- 288 (495)
T ss_dssp CCBCC--GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSS--
T ss_pred ccccC--HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhc-CCCCEeeEEEEEecC--
Confidence 35554 56899999999999999999999888999999999754 457789999999999 899999999999553
Q ss_pred CCcEEEEEeecCchhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 91 KTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
...++||||+.+++|.+++ ..+++..+..++.||+.||+|||++|++|+||||+||+++.++ .+||+|||++..
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~ 367 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENH-LVKVADFGLSRL 367 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG-CEEECCTTCEEC
T ss_pred CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCC-cEEEeeccccee
Confidence 4567999999999988776 2488999999999999999999999999999999999999887 899999999986
Q ss_pred cCCCCc--cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHh
Q 020826 166 YHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242 (321)
Q Consensus 166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (321)
...... .....++..|+|||++.. ..++.++|||||||++|+|++ |..|| .+.+.......+...
T Consensus 368 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlG~~l~el~t~g~~p~-~~~~~~~~~~~~~~~---------- 435 (495)
T 1opk_A 368 MTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPY-PGIDLSQVYELLEKD---------- 435 (495)
T ss_dssp CTTCCEECCTTCCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCSS-TTCCGGGHHHHHHTT----------
T ss_pred ccCCceeecCCCcCCcceeCHhHHhc-CCCCcHHhHHhHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcC----------
Confidence 543221 122345668999999987 678999999999999999999 88777 333332222211110
Q ss_pred hhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
.....+..+++++.+||.+||+.||++|||+.++++
T Consensus 436 --------------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 436 --------------------------YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp --------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 001122356789999999999999999999999975
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=310.42 Aligned_cols=259 Identities=17% Similarity=0.207 Sum_probs=199.2
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEec--------CCceEEEEEecccchHHHHHHHHHHHhhcCCCCeee----
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCT--------DNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVK---- 80 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~--------~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~---- 80 (321)
....+...++|++.+.||+|+||+||+|++.. .++.||+|+++.. ..+.+|+.+++++ +||||++
T Consensus 34 ~~i~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--~~~~~E~~~l~~l-~h~niv~~~~~ 110 (352)
T 2jii_A 34 TVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--GRLFNEQNFFQRA-AKPLQVNKWKK 110 (352)
T ss_dssp CEEECTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--STHHHHHHHHHHH-CCHHHHHHHHH
T ss_pred ceeecccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--chHHHHHHHHHHh-cccchhhhhhh
Confidence 44455667899999999999999999999977 4889999998754 5788999999999 8998887
Q ss_pred -----------eeeeeeccCCCCcEEEEEeecCchhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCC
Q 020826 81 -----------LLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPH 144 (321)
Q Consensus 81 -----------~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~ 144 (321)
+++++.. .....++||||+ +++|.+++ ..+++..++.++.||+.||+|||++|++|+||||+
T Consensus 111 ~~~~~~~~i~~~~~~~~~-~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~ 188 (352)
T 2jii_A 111 LYSTPLLAIPTCMGFGVH-QDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAE 188 (352)
T ss_dssp HTTCTTCSCCCCCEEEEE-TTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGG
T ss_pred hccCCccCccchhhcccc-CCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHH
Confidence 4555543 245678999999 88888776 35899999999999999999999999999999999
Q ss_pred CeEEcCCC-CeEEEeeccceeecCCCC--------ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCC
Q 020826 145 NVMIDHEQ-RKLRLIDWGLAEFYHPGK--------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEP 215 (321)
Q Consensus 145 nili~~~~-~~v~l~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p 215 (321)
||+++.++ ..++|+|||++....... ......+|+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 189 NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p 267 (352)
T 2jii_A 189 NIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG-CGPSRRSDLQSLGYCMLKWLYGFLP 267 (352)
T ss_dssp GEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSCCT
T ss_pred HEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999765 269999999997653221 1133478999999999987 6889999999999999999999999
Q ss_pred CccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCC
Q 020826 216 FFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE 295 (321)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~ 295 (321)
|.................... +............+++++.++|.+||+.||++
T Consensus 268 f~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~ 320 (352)
T 2jii_A 268 WTNCLPNTEDIMKQKQKFVDK---------------------------PGPFVGPCGHWIRPSETLQKYLKVVMALTYEE 320 (352)
T ss_dssp TGGGTTCHHHHHHHHHHHHHS---------------------------CCCEECTTSCEECCCHHHHHHHHHHHTCCTTC
T ss_pred cccCCcCHHHHHHHHHhccCC---------------------------hhhhhhhccccCCCcHHHHHHHHHHHhCChhh
Confidence 965443433333222111000 00000001111245789999999999999999
Q ss_pred CcCHHHHhc
Q 020826 296 RPTAKEAMA 304 (321)
Q Consensus 296 Rps~~ell~ 304 (321)
|||++++++
T Consensus 321 Rps~~~l~~ 329 (352)
T 2jii_A 321 KPPYAMLRN 329 (352)
T ss_dssp CCCHHHHHH
T ss_pred CCCHHHHHH
Confidence 999999875
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=300.24 Aligned_cols=244 Identities=18% Similarity=0.310 Sum_probs=194.1
Q ss_pred cccCceEEee-eeeeecceEEEEEEE--ecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccC
Q 020826 18 REQDDYEVVR-KVGRGKYSEVFEGVH--CTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 89 (321)
Q Consensus 18 ~~~~~y~~~~-~lg~g~~g~v~~~~~--~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (321)
....+|++.+ .||+|+||+||+|.+ ..+++.|++|+++... ...+.+|+.+++.+ +||||+++++++.
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~--- 88 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICE--- 88 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEE---
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhC-CCCCEEEEEEEEC---
Confidence 3467999999 999999999999965 4567899999987532 45688999999999 8999999999983
Q ss_pred CCCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeec
Q 020826 90 SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 166 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~ 166 (321)
....++|+|++.+++|.+++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++...
T Consensus 89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 89 AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKAL 167 (291)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEEC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCC-cEEEccCCcceee
Confidence 23467999999999998877 4589999999999999999999999999999999999999888 8999999999876
Q ss_pred CCCCcc----ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHH
Q 020826 167 HPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAY 241 (321)
Q Consensus 167 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (321)
...... ....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||. +.........+.. ..
T Consensus 168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~~~~~~~~~~-~~------- 237 (291)
T 1xbb_A 168 RADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYR-GMKGSEVTAMLEK-GE------- 237 (291)
T ss_dssp CTTCSEEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSST-TCCHHHHHHHHHT-TC-------
T ss_pred ccCCCcccccccCCCCceeeChHHhcc-CCCChhhhHHHHHHHHHHHHhcCCCCCC-CCCHHHHHHHHHc-CC-------
Confidence 543321 22345678999999977 678899999999999999999 998883 2222222111110 00
Q ss_pred hhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 242 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
....+..+++++.++|.+||+.||++|||+.++++
T Consensus 238 ----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 238 ----------------------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp ----------------------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ----------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 00112346789999999999999999999999875
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=307.88 Aligned_cols=249 Identities=21% Similarity=0.343 Sum_probs=182.4
Q ss_pred eecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc---hHHHHHHHHHHHhhcCCCCeeeeeeeeec-----
Q 020826 16 INREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRD----- 87 (321)
Q Consensus 16 i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~----- 87 (321)
+.....+|++.+.||+|+||+||+|++..+++.||+|++.... ...+.+|+.+++++.+||||+++++++..
T Consensus 23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 4445679999999999999999999999999999999885443 35678999999999669999999998842
Q ss_pred -cCCCCcEEEEEeecCchhhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCC--CeeecCCCCCeEEcCCCCeEEEe
Q 020826 88 -QQSKTPSLIFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLI 158 (321)
Q Consensus 88 -~~~~~~~lv~e~~~~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lh~~~--i~H~dlkp~nili~~~~~~v~l~ 158 (321)
......++++|++.+ +|.+++ ..+++..++.++.||+.||+|||+.| ++|+||||+||+++.++ .++|+
T Consensus 103 ~~~~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~-~~kl~ 180 (337)
T 3ll6_A 103 DTGQAEFLLLTELCKG-QLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG-TIKLC 180 (337)
T ss_dssp TTSSEEEEEEEECCSE-EHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTS-CEEBC
T ss_pred ccCCceEEEEEEecCC-CHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCC-CEEEe
Confidence 223447899999985 444333 35999999999999999999999999 99999999999999888 89999
Q ss_pred eccceeecCCCCcc-------------ccccCCcccccccccc--CCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCCh
Q 020826 159 DWGLAEFYHPGKEY-------------NVRVASRYFKGPELLV--DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY 223 (321)
Q Consensus 159 dfg~~~~~~~~~~~-------------~~~~~~~~y~aPE~~~--~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~ 223 (321)
|||++......... ....+|+.|+|||++. ....++.++|||||||++|+|++|..||..... .
T Consensus 181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~-~ 259 (337)
T 3ll6_A 181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK-L 259 (337)
T ss_dssp CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH-H
Confidence 99999765432221 1345888999999983 225788999999999999999999999832111 0
Q ss_pred HHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHh
Q 020826 224 DQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 303 (321)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell 303 (321)
.... . . .........++.+.+||++||+.||++|||++|++
T Consensus 260 ~~~~---~----------------------------~--------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l 300 (337)
T 3ll6_A 260 RIVN---G----------------------------K--------YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVV 300 (337)
T ss_dssp ---------------------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHH
T ss_pred Hhhc---C----------------------------c--------ccCCcccccchHHHHHHHHHccCChhhCcCHHHHH
Confidence 0000 0 0 00111223557899999999999999999999999
Q ss_pred cCC
Q 020826 304 AHP 306 (321)
Q Consensus 304 ~hp 306 (321)
+|-
T Consensus 301 ~~l 303 (337)
T 3ll6_A 301 HQL 303 (337)
T ss_dssp HHH
T ss_pred HHH
Confidence 873
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=314.68 Aligned_cols=245 Identities=18% Similarity=0.327 Sum_probs=185.9
Q ss_pred cccCceEEeeeeeeecceEEEEEEEe---cCCceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~---~~~~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
....+|++.+.||+|+||+||+|++. .++..||+|.++.. ....+.+|+.++.++ +||||+++++++.+ .
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~--~ 118 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQF-DHPNIIRLEGVVTK--S 118 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECS--S
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEee--C
Confidence 34568999999999999999999986 45778999998743 235688999999999 89999999999954 4
Q ss_pred CCcEEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeec
Q 020826 91 KTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 166 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~ 166 (321)
...++||||+.+++|.+++. .+++..+..++.||+.||+|||++|++|+||||+||+++.++ .+||+|||++...
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL-VCKVSDFGLGRVL 197 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC------
T ss_pred CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCC-CEEECcCcccccc
Confidence 56679999999999988772 589999999999999999999999999999999999999888 8999999999765
Q ss_pred CCCCc----cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHH
Q 020826 167 HPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAY 241 (321)
Q Consensus 167 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (321)
..... .....++..|+|||++.+ ..++.++||||||+++|++++ |..||. +.........+....
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~SlG~il~ellt~g~~P~~-~~~~~~~~~~i~~~~-------- 267 (373)
T 2qol_A 198 EDDPEAAYTTRGGKIPIRWTSPEAIAY-RKFTSASDVWSYGIVLWEVMSYGERPYW-EMSNQDVIKAVDEGY-------- 267 (373)
T ss_dssp ----------------CTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTC-CTTT-TCCHHHHHHHHHTTE--------
T ss_pred ccCCccceeccCCCcCCCccChhhhcc-CCcCchhcHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHcCC--------
Confidence 43221 112234567999999987 789999999999999999998 998884 222222222111100
Q ss_pred hhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 242 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
....+..+++++.+++.+||+.||++|||+.++++
T Consensus 268 ----------------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 268 ----------------------------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp ----------------------------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ----------------------------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 01112246678999999999999999999998875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=307.06 Aligned_cols=245 Identities=18% Similarity=0.333 Sum_probs=190.8
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceE----EEEEecc----cchHHHHHHHHHHHhhcCCCCeeeeeeeeeccC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKC----IIKILKP----VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 89 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~----~vK~~~~----~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (321)
...++|++.+.||+|+||+||+|.+..+++.+ ++|.++. .....+.+|+.+++.+ +||||+++++++....
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~ 90 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTST 90 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTC-CBTTBCCCCEEEESSS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhC-CCCCeeEEEEEEecCC
Confidence 45789999999999999999999998887755 6666643 2356788999999999 8999999999986542
Q ss_pred CCCcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 90 SKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
.+++++++.+++|.+++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++..
T Consensus 91 ---~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kL~DfG~a~~ 166 (327)
T 3lzb_A 91 ---VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKL 166 (327)
T ss_dssp ---EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCTTC---
T ss_pred ---ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCC-CEEEccCcceeE
Confidence 57999999999887766 3589999999999999999999999999999999999999888 899999999976
Q ss_pred cCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHH
Q 020826 166 YHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAY 241 (321)
Q Consensus 166 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (321)
...... .....++..|+|||.+.+ ..++.++|||||||++|+|++ |..||. +.........+....
T Consensus 167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~~g~~p~~-~~~~~~~~~~~~~~~-------- 236 (327)
T 3lzb_A 167 LGAEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYD-GIPASEISSILEKGE-------- 236 (327)
T ss_dssp -------------CCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCGGGHHHHHHTTC--------
T ss_pred ccCccccccccCCCccccccCHHHHcC-CCCChHHHHHHHHHHHHHHHHCCCCCCC-CCCHHHHHHHHHcCC--------
Confidence 543222 223345678999999987 789999999999999999999 888883 332222222111100
Q ss_pred hhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 242 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
....+..+++++.++|++||+.||++|||+.|+++.
T Consensus 237 ----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 237 ----------------------------RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp ----------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 011122466789999999999999999999999863
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=301.34 Aligned_cols=242 Identities=24% Similarity=0.384 Sum_probs=188.5
Q ss_pred ecccCceEEe-eeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeeeec--cCCCCc
Q 020826 17 NREQDDYEVV-RKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRD--QQSKTP 93 (321)
Q Consensus 17 ~~~~~~y~~~-~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~~ 93 (321)
+...++|.+. +.||+|+||+||+|.+..+++.||+|+++. .....+|+.++.++.+||||+++++++.+ ......
T Consensus 13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 90 (299)
T 3m2w_A 13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 90 (299)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc--cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence 4456788888 779999999999999999999999999864 45678899998776699999999998864 234567
Q ss_pred EEEEEeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcC---CCCeEEEeeccceee
Q 020826 94 SLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH---EQRKLRLIDWGLAEF 165 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~---~~~~v~l~dfg~~~~ 165 (321)
++||||+.+++|..++. .+++..++.++.|++.||+|||++|++|+||||+||+++. ++ .++|+|||++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~-~~kl~Dfg~a~~ 169 (299)
T 3m2w_A 91 LIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA-ILKLTDFGFAKE 169 (299)
T ss_dssp EEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTC-CEEECCCTTCEE
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCC-cEEEeccccccc
Confidence 89999999999877762 4899999999999999999999999999999999999997 45 799999998864
Q ss_pred cCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhh
Q 020826 166 YHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245 (321)
Q Consensus 166 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (321)
.. + ..++.++|||||||++|+|++|..||...... .....+
T Consensus 170 ~~---------------------~-~~~~~~~DiwslG~il~el~tg~~pf~~~~~~-~~~~~~---------------- 210 (299)
T 3m2w_A 170 TT---------------------G-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL-AISPGM---------------- 210 (299)
T ss_dssp CT---------------------T-CGGGGHHHHHHHHHHHHHHHHSSCSCCC--------CCS----------------
T ss_pred cc---------------------c-ccCCchhhHHHHHHHHHHHHHCCCCCCCCcch-hhhHHH----------------
Confidence 32 1 35678999999999999999999998422211 000000
Q ss_pred cccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCC
Q 020826 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~ 313 (321)
........ ..........+++++.++|.+||+.||++|||++|+++||||++...
T Consensus 211 -----------~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 211 -----------KTRIRMGQ--YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp -----------CCSSCTTC--CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred -----------HHHHhhcc--ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 00000000 00000111346789999999999999999999999999999987643
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-44 Score=314.29 Aligned_cols=253 Identities=18% Similarity=0.297 Sum_probs=191.9
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEecCC---ceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeee
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDN---EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIV 85 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~---~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (321)
.+.|++...+|++.+.||+|+||+||+|.+..++ ..+++|.++.. ....+.+|+.+++++ +||||+++++++
T Consensus 81 ~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~ 159 (373)
T 3c1x_A 81 HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGIC 159 (373)
T ss_dssp TTBCCSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTC-CCTTBCCCCEEE
T ss_pred ccccChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCcceEEEEE
Confidence 3456777788999999999999999999986443 46899988642 246688999999999 899999999986
Q ss_pred eccCCCCcEEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecc
Q 020826 86 RDQQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 161 (321)
Q Consensus 86 ~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg 161 (321)
.... ...++||||+.+++|.+++. .+++..+..++.||+.||+|||++|++|+||||+||+++.++ .+||+|||
T Consensus 160 ~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kL~DFG 237 (373)
T 3c1x_A 160 LRSE-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-TVKVADFG 237 (373)
T ss_dssp CCCS-SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC-
T ss_pred EcCC-CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCC-CEEEeecc
Confidence 4432 45679999999999988873 478899999999999999999999999999999999999887 89999999
Q ss_pred ceeecCCCCc-----cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCCh
Q 020826 162 LAEFYHPGKE-----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD 236 (321)
Q Consensus 162 ~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (321)
++........ .....++..|+|||++.+ ..++.++|||||||++|+|++|+.|++.+.+..+....+....
T Consensus 238 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~--- 313 (373)
T 3c1x_A 238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--- 313 (373)
T ss_dssp --------------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC---
T ss_pred ccccccccccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC---
Confidence 9975532211 123456678999999987 7889999999999999999995555544444333322221100
Q ss_pred hhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 237 ELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
....+..+++++.+++.+||+.||++|||+++++++
T Consensus 314 ---------------------------------~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 314 ---------------------------------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp ---------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 001123467899999999999999999999999864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=305.53 Aligned_cols=260 Identities=20% Similarity=0.339 Sum_probs=198.0
Q ss_pred cCc-eEEeeeeeeecceEEEEEEE----ecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 20 QDD-YEVVRKVGRGKYSEVFEGVH----CTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 20 ~~~-y~~~~~lg~g~~g~v~~~~~----~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
..+ |++++.||+|+||+||++.. ..+++.||+|+++... ...+.+|+.+++.+ +||||+++++++.+...
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL-YHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEEETTT
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhC-CCcchhhEEEEEecCCC
Confidence 344 49999999999999987754 4578899999997543 35688999999999 89999999999987766
Q ss_pred CCcEEEEEeecCchhhhhcC--CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 91 KTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
...++||||+.+++|.+++. .+++..++.++.|++.||++||++|++|+||||+||+++.++ .++|+|||++.....
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a~~~~~ 186 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR-LVKIGDFGLAKAVPE 186 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCGGGCEECCT
T ss_pred ceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCC-CEEECCccccccccc
Confidence 77889999999999988874 489999999999999999999999999999999999999887 899999999987654
Q ss_pred CCc----cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhh
Q 020826 169 GKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244 (321)
Q Consensus 169 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (321)
... .....++..|+|||++.+ ..++.++||||||+++|+|++|..||..... .. .............
T Consensus 187 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~ll~g~~p~~~~~~---~~---~~~~~~~~~~~~~-- 257 (318)
T 3lxp_A 187 GHEYYRVREDGDSPVFWYAPECLKE-YKFYYASDVWSFGVTLYELLTHCDSSQSPPT---KF---LELIGIAQGQMTV-- 257 (318)
T ss_dssp TCSEEEC---CCCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH---HH---HHHHCSCCHHHHH--
T ss_pred cccccccccCCCCCceeeChHHhcC-CCCCcHHHHHHHHHHHHHHHhCCCcccccch---hh---hhhhcccccchhH--
Confidence 432 233456778999999987 6788999999999999999999999832110 00 0000000000000
Q ss_pred hcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
........... ....+..+++++.+||++||+.||++|||++|+++
T Consensus 258 ------~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 258 ------LRLTELLERGE--------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp ------HHHHHHHHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ------HHHHHHHhccc--------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 00001111110 11122356789999999999999999999999984
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-44 Score=308.53 Aligned_cols=252 Identities=19% Similarity=0.338 Sum_probs=196.0
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc---chHHHHHHHHHHHhhcCCCCeeeeeeeeecc--CCC
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSK 91 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~~ 91 (321)
....++|++.+.||+|+||+||+|.+..+++.||+|++... ....+.+|+.+++.+ +||||+++++++... ...
T Consensus 25 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~~~~ 103 (317)
T 2buj_A 25 IIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHPNILRLVAYCLRERGAKH 103 (317)
T ss_dssp EETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEEEETTEE
T ss_pred EECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhc-CCCCeeeEEEEEEeccCCCc
Confidence 34478999999999999999999999999999999988643 345688999999999 999999999988633 234
Q ss_pred CcEEEEEeecCchhhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecccee
Q 020826 92 TPSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 164 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~ 164 (321)
..++++||+.+++|.+++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++.
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~dfg~~~ 182 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG-QPVLMDLGSMN 182 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCSSCE
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC-CEEEEecCcch
Confidence 678999999999987665 3489999999999999999999999999999999999999888 89999999887
Q ss_pred ecCCCCc----------cccccCCccccccccccCCC--CCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHH
Q 020826 165 FYHPGKE----------YNVRVASRYFKGPELLVDLQ--DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV 232 (321)
Q Consensus 165 ~~~~~~~----------~~~~~~~~~y~aPE~~~~~~--~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 232 (321)
....... .....++..|+|||++.+.. .++.++||||||+++|+|++|..||.............
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~--- 259 (317)
T 2buj_A 183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA--- 259 (317)
T ss_dssp ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH---
T ss_pred hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH---
Confidence 5432111 12335688999999987522 26889999999999999999999983100000000000
Q ss_pred hCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 233 LGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
.... ........+++++.++|.+||+.||++|||+++++++
T Consensus 260 ------------------------~~~~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 260 ------------------------VQNQ--------LSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp ------------------------HHCC----------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ------------------------hhcc--------CCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 0000 0011123467899999999999999999999999986
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=306.89 Aligned_cols=259 Identities=19% Similarity=0.279 Sum_probs=194.1
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhh-cCCCCeeeeeeeeeccCC--CCc
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNL-CGGPNIVKLLDIVRDQQS--KTP 93 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l-~~h~~i~~~~~~~~~~~~--~~~ 93 (321)
....++|++.+.||+|+||+||+|++ +++.||+|++..........|.+++..+ .+||||+++++++.+... ...
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 110 (337)
T 3mdy_A 33 RTIAKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110 (337)
T ss_dssp TTHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred cccccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence 34457999999999999999999987 4899999999877777777777776654 289999999999865432 567
Q ss_pred EEEEEeecCchhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHC--------CCeeecCCCCCeEEcCCCCeEEEeeccce
Q 020826 94 SLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQ--------GIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lh~~--------~i~H~dlkp~nili~~~~~~v~l~dfg~~ 163 (321)
++||||+.+++|.+++ ..+++..++.++.|++.||+|||++ |++|+||||+||+++.++ .+||+|||++
T Consensus 111 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kl~Dfg~a 189 (337)
T 3mdy_A 111 YLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLA 189 (337)
T ss_dssp EEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCCTTC
T ss_pred EEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC-CEEEEeCCCc
Confidence 8999999999998887 4689999999999999999999999 999999999999999888 8999999999
Q ss_pred eecCCCCcc-----ccccCCccccccccccCCCCCCCc------chHHHHHHHHHHHHhC----------CCCCccCCCC
Q 020826 164 EFYHPGKEY-----NVRVASRYFKGPELLVDLQDYDYS------LDLWSLGCMFAGMIFR----------KEPFFYGHDN 222 (321)
Q Consensus 164 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~------~DvwslG~~l~~l~~g----------~~p~~~~~~~ 222 (321)
......... ....+|+.|+|||++.+ ...+.. +|||||||++|+|++| ..||......
T Consensus 190 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~ 268 (337)
T 3mdy_A 190 VKFISDTNEVDIPPNTRVGTKRYMPPEVLDE-SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPS 268 (337)
T ss_dssp EECC---------CCSSCSCGGGCCHHHHTT-CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCS
T ss_pred eeeccccccccCCCCCCccCcceeChhhccc-ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCC
Confidence 765433221 24578999999999977 444443 9999999999999999 5555322111
Q ss_pred hHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHH
Q 020826 223 YDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 302 (321)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~el 302 (321)
............. ....+ ..........+++++.+++.+||+.||++|||++++
T Consensus 269 ~~~~~~~~~~~~~------------------------~~~~~--~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~el 322 (337)
T 3mdy_A 269 DPSYEDMREIVCI------------------------KKLRP--SFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRV 322 (337)
T ss_dssp SCCHHHHHHHHTT------------------------SCCCC--CCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred CCchhhhHHHHhh------------------------hccCc--cccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHH
Confidence 1111111110000 00000 000001112355679999999999999999999999
Q ss_pred hcC
Q 020826 303 MAH 305 (321)
Q Consensus 303 l~h 305 (321)
++|
T Consensus 323 l~~ 325 (337)
T 3mdy_A 323 KKT 325 (337)
T ss_dssp HHH
T ss_pred HHH
Confidence 875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=304.57 Aligned_cols=247 Identities=16% Similarity=0.288 Sum_probs=191.2
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCC----ceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeecc
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQ 88 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~----~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (321)
+....+|++.+.||+|+||+||+|.+..++ ..||+|.++... ...+.+|+.+++.+ +||||+++++++.+
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~- 117 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISK- 117 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS-
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEec-
Confidence 345679999999999999999999986553 359999987532 34578999999999 89999999999854
Q ss_pred CCCCcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecccee
Q 020826 89 QSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 164 (321)
Q Consensus 89 ~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~ 164 (321)
....++|||++.+++|..++ ..+++..+..++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++.
T Consensus 118 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~~~ 195 (333)
T 1mqb_A 118 -YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL-VCKVSDFGLSR 195 (333)
T ss_dssp -SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCCC--
T ss_pred -CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCC-cEEECCCCcch
Confidence 45678999999999998776 3589999999999999999999999999999999999999887 89999999997
Q ss_pred ecCCCCc----cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhh
Q 020826 165 FYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELN 239 (321)
Q Consensus 165 ~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (321)
....... .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||. +....+....+....
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~pf~-~~~~~~~~~~~~~~~------ 267 (333)
T 1mqb_A 196 VLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYW-ELSNHEVMKAINDGF------ 267 (333)
T ss_dssp ---------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHHHTTC------
T ss_pred hhccccccccccCCCCccccccCchhccc-CCCCchhhhHHHHHHHHHHHcCCCCCcc-cCCHHHHHHHHHCCC------
Confidence 6543221 122345678999999987 788999999999999999998 998884 222222222211100
Q ss_pred HHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 240 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
....+..+++++.+++.+||+.||++|||+.+++++
T Consensus 268 ------------------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 268 ------------------------------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp ------------------------------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ------------------------------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 001122466899999999999999999999998865
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=307.29 Aligned_cols=253 Identities=16% Similarity=0.283 Sum_probs=195.7
Q ss_pred ecccCceEEeeeeeeecceEEEEEE-----EecCCceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeec
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGV-----HCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRD 87 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~-----~~~~~~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (321)
....++|++.+.||+|+||+||+|+ +..++..||+|.+... ....+.+|+.+++.+ +||||+++++++.+
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF-NHQNIVRCIGVSLQ 104 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhC-CCCCCCeEEEEEcC
Confidence 4457899999999999999999999 4567789999998643 235678899999999 99999999999865
Q ss_pred cCCCCcEEEEEeecCchhhhhcC----------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCC--CeE
Q 020826 88 QQSKTPSLIFEHVNNTDFKVLYP----------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ--RKL 155 (321)
Q Consensus 88 ~~~~~~~lv~e~~~~~~l~~~~~----------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~--~~v 155 (321)
. ...++||||+.+++|.+++. .+++..++.++.|++.||.|||++|++|+||||+||+++.++ ..+
T Consensus 105 ~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~ 182 (327)
T 2yfx_A 105 S--LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA 182 (327)
T ss_dssp S--SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred C--CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceE
Confidence 3 45679999999999887772 388899999999999999999999999999999999998432 269
Q ss_pred EEeeccceeecCCCC---ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHH
Q 020826 156 RLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAK 231 (321)
Q Consensus 156 ~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~ 231 (321)
+|+|||++....... ......++..|+|||++.+ ..++.++||||||+++|+|++ |..||. ..........+..
T Consensus 183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~-~~~~~~~~~~~~~ 260 (327)
T 2yfx_A 183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFME-GIFTSKTDTWSFGVLLWEIFSLGYMPYP-SKSNQEVLEFVTS 260 (327)
T ss_dssp EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSST-TCCHHHHHHHHHT
T ss_pred EECccccccccccccccccCCCcCCCcceeCHhHhcC-CCCCchhhHHHHHHHHHHHHcCCCCCCC-CcCHHHHHHHHhc
Confidence 999999986432221 2234457888999999987 678999999999999999998 888873 3322222221111
Q ss_pred HhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCccc
Q 020826 232 VLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 310 (321)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~ 310 (321)
. .. ...+..+++.+.++|.+||+.||++|||++++++|.|+-.
T Consensus 261 ~-~~-----------------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 261 G-GR-----------------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp T-CC-----------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred C-CC-----------------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 0 00 0112246689999999999999999999999999988653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=312.01 Aligned_cols=246 Identities=15% Similarity=0.211 Sum_probs=196.5
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEE-----EecCCceEEEEEecccchHHHHHHHHHHHhhcC--CCCeeeeeeee
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGV-----HCTDNEKCIIKILKPVKKKKIKREIKILQNLCG--GPNIVKLLDIV 85 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~-----~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~--h~~i~~~~~~~ 85 (321)
...+....++|++.+.||+|+||+||+|. +..+++.||+|+++......+..|..++..+.. |+|++++++++
T Consensus 57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 34556668899999999999999999994 667889999999998888889999999998832 89999999998
Q ss_pred eccCCCCcEEEEEeecCchhhhhc--------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcC-------
Q 020826 86 RDQQSKTPSLIFEHVNNTDFKVLY--------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH------- 150 (321)
Q Consensus 86 ~~~~~~~~~lv~e~~~~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~------- 150 (321)
... ...++||||+.+++|.+++ ..+++..++.++.||+.||+|||++||+||||||+||+++.
T Consensus 137 ~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~ 214 (365)
T 3e7e_A 137 LFQ--NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDD 214 (365)
T ss_dssp ECS--SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC--
T ss_pred ecC--CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccc
Confidence 654 4567999999999998776 24899999999999999999999999999999999999987
Q ss_pred ----CCCeEEEeeccceeecC---CCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCCh
Q 020826 151 ----EQRKLRLIDWGLAEFYH---PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNY 223 (321)
Q Consensus 151 ----~~~~v~l~dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~ 223 (321)
++ .+||+|||++.... .........||..|+|||++.+ ..++.++|||||||++|+|++|+.||.......
T Consensus 215 ~~~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~pf~~~~~~~ 292 (365)
T 3e7e_A 215 EDDLSA-GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE 292 (365)
T ss_dssp ----CT-TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred cccccC-CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC-CCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence 56 89999999997543 2333455679999999999987 679999999999999999999999985322110
Q ss_pred HHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHh
Q 020826 224 DQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 303 (321)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell 303 (321)
.. . .........++...+++..||+.+|.+|++..+.+
T Consensus 293 ~~------------~------------------------------~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l 330 (365)
T 3e7e_A 293 CK------------P------------------------------EGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLL 330 (365)
T ss_dssp EE------------E------------------------------CSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHH
T ss_pred ee------------e------------------------------chhccccCcHHHHHHHHHHHcCCCCCCcchHHHHH
Confidence 00 0 00000001345788999999999999996544444
Q ss_pred c
Q 020826 304 A 304 (321)
Q Consensus 304 ~ 304 (321)
.
T Consensus 331 ~ 331 (365)
T 3e7e_A 331 R 331 (365)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=318.46 Aligned_cols=253 Identities=19% Similarity=0.333 Sum_probs=198.9
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc--chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
.|.|+ .++|++.+.||+|+||+||+|.+. ++..||+|+++.. ....+.+|+.+++++ +||||+++++++.+
T Consensus 178 ~~~i~--~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~--- 250 (452)
T 1fmk_A 178 AWEIP--RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE--- 250 (452)
T ss_dssp CSBCC--GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---
T ss_pred ccccC--hhHceeeeeecCCCCeEEEEEEEC-CCceEEEEEeccCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEcC---
Confidence 45554 568999999999999999999985 4567999999754 346789999999999 89999999999854
Q ss_pred CCcEEEEEeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 91 KTPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
...++||||+.+++|.+++. .+++..+..++.|++.||+|||++|++|+||||+||+++.++ .+||+|||++..
T Consensus 251 ~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~ 329 (452)
T 1fmk_A 251 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARL 329 (452)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCTTC-
T ss_pred CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCC-CEEECCCcccee
Confidence 34689999999999988874 489999999999999999999999999999999999999877 899999999976
Q ss_pred cCCCCc--cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHh
Q 020826 166 YHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242 (321)
Q Consensus 166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (321)
...... .....++..|+|||++.+ ..++.++||||||+++|+|++ |..|| .+....+....+....
T Consensus 330 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwslG~~l~el~t~g~~P~-~~~~~~~~~~~i~~~~--------- 398 (452)
T 1fmk_A 330 IEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERGY--------- 398 (452)
T ss_dssp -------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSS-TTCCHHHHHHHHHTTC---------
T ss_pred cCCCceecccCCcccccccCHhHHhc-CCCCccccHHhHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCC---------
Confidence 542221 123345678999999987 689999999999999999999 88887 3333333322221100
Q ss_pred hhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC--CCcccC
Q 020826 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH--PYFFPI 311 (321)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h--p~~~~~ 311 (321)
....+..+++++.++|.+||+.||++|||++++++. .++...
T Consensus 399 ---------------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~ 442 (452)
T 1fmk_A 399 ---------------------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 442 (452)
T ss_dssp ---------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred ---------------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence 011123467899999999999999999999999873 666554
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=299.33 Aligned_cols=247 Identities=17% Similarity=0.334 Sum_probs=191.1
Q ss_pred EeeeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-chHHHHHHHHHHHhhcCCCCeeeeeeeeeccC
Q 020826 11 WCVWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 89 (321)
Q Consensus 11 ~~~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (321)
-..|.++ .++|++.+.||+|+||+||++.+ +++.+++|+++.. ..+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 13 ~~~~~~~--~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~- 86 (278)
T 1byg_A 13 RSGWALN--MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEE- 86 (278)
T ss_dssp --CCBCC--GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTC-CCTTBCCEEEEECCC-
T ss_pred hccccCC--hhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhC-CCCCEeeEEEEEEcC-
Confidence 3445554 67999999999999999999987 5889999998764 346788999999999 899999999987543
Q ss_pred CCCcEEEEEeecCchhhhhcCC-----CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecccee
Q 020826 90 SKTPSLIFEHVNNTDFKVLYPT-----LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 164 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~ 164 (321)
....++++|++.+++|.+++.. +++..+..++.|++.||++||++|++|+||||+||+++.++ .++|+|||++.
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~ 165 (278)
T 1byg_A 87 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTK 165 (278)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEECCCCC--
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCC-cEEEeeccccc
Confidence 2356899999999999887742 88999999999999999999999999999999999999888 89999999987
Q ss_pred ecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 165 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
..... .....++..|+|||.+.+ ..++.++||||||+++|+|++ |..||. ..+.......+...
T Consensus 166 ~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~-~~~~~~~~~~~~~~----------- 230 (278)
T 1byg_A 166 EASST--QDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYP-RIPLKDVVPRVEKG----------- 230 (278)
T ss_dssp ------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCT-TSCGGGHHHHHTTT-----------
T ss_pred ccccc--ccCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHhcC-----------
Confidence 54322 233456788999999987 788999999999999999998 888873 22222221111000
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
.....+..+++++.++|++||+.||++|||+.++++
T Consensus 231 -------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 231 -------------------------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp -------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -------------------------CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 001122346789999999999999999999999875
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=302.67 Aligned_cols=263 Identities=19% Similarity=0.350 Sum_probs=199.1
Q ss_pred cccCceEEeeeeeeecceEEEEEE----EecCCceEEEEEecccc---hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGV----HCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~----~~~~~~~~~vK~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
...++|++.+.||+|+||+||+|+ +..+++.||+|.++... ...+.+|+.+++.+ +||||+++++++.....
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~~iv~~~~~~~~~~~ 116 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL-QHDNIVKYKGVCYSAGR 116 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTC-CCTTBCCEEEEECC---
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEEecCC
Confidence 346679999999999999999998 45678999999987543 35688999999999 89999999999876665
Q ss_pred CCcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeec
Q 020826 91 KTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 166 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~ 166 (321)
...++|+|++.+++|.+++ ..+++..++.++.|++.||++||++|++|+||||+||+++.++ .++|+|||++...
T Consensus 117 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~-~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVL 195 (326)
T ss_dssp -CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTCEEC
T ss_pred CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCC-cEEEecCcchhhc
Confidence 6778999999999998776 3489999999999999999999999999999999999999888 8999999999876
Q ss_pred CCCCc----cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHh
Q 020826 167 HPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242 (321)
Q Consensus 167 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (321)
..... .....++..|+|||.+.+ ..++.++||||||+++|+|++|..|+... ........+........
T Consensus 196 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~tg~~~~~~~------~~~~~~~~~~~~~~~~~ 268 (326)
T 2w1i_A 196 PQDKEYYKVKEPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYIEKSKSP------PAEFMRMIGNDKQGQMI 268 (326)
T ss_dssp CSSCSEEECSSCCSCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHHTTCGGGSH------HHHHHHHHCTTCCTHHH
T ss_pred cccccccccccCCCCceeEECchhhcC-CCCCchhhHHHHHHHHHHHHhcCCCCCCC------HHHHHHhhccccchhhh
Confidence 54332 123346677999999987 67889999999999999999999887311 11111111111100000
Q ss_pred hhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
. ............ ...+..+++++.++|++||+.||++|||+.++++
T Consensus 269 ~-------~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 269 V-------FHLIELLKNNGR--------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp H-------HHHHHHHHTTCC--------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred H-------HHHHHHhhcCCC--------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 0 000011111000 1122357789999999999999999999999874
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=305.57 Aligned_cols=259 Identities=18% Similarity=0.245 Sum_probs=199.0
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhh-cCCCCeeeeeeeeeccCC--CCcE
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNL-CGGPNIVKLLDIVRDQQS--KTPS 94 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l-~~h~~i~~~~~~~~~~~~--~~~~ 94 (321)
...++|++.+.||+|+||+||+|++ +++.||+|+++......+.+|.+++..+ .+||||+++++++..... ...+
T Consensus 39 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~ 116 (342)
T 1b6c_B 39 TIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 116 (342)
T ss_dssp HHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEE
T ss_pred cccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeE
Confidence 3457999999999999999999987 5899999999887778888999999883 289999999999865542 3678
Q ss_pred EEEEeecCchhhhhc--CCCCHHHHHHHHHHHHHHHHHHH--------HCCCeeecCCCCCeEEcCCCCeEEEeecccee
Q 020826 95 LIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCH--------SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 164 (321)
Q Consensus 95 lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lh--------~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~ 164 (321)
+|+||+.+++|.+++ ..+++..++.++.|++.||+||| +.|++|+||||+||+++.++ .++|+|||++.
T Consensus 117 lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~ 195 (342)
T 1b6c_B 117 LVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAV 195 (342)
T ss_dssp EEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred EEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC-CEEEEECCCce
Confidence 999999999998887 45899999999999999999999 89999999999999999888 89999999997
Q ss_pred ecCCCCc-----cccccCCccccccccccCCCC-----CCCcchHHHHHHHHHHHHhC----------CCCCccCCCChH
Q 020826 165 FYHPGKE-----YNVRVASRYFKGPELLVDLQD-----YDYSLDLWSLGCMFAGMIFR----------KEPFFYGHDNYD 224 (321)
Q Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~-----~~~~~DvwslG~~l~~l~~g----------~~p~~~~~~~~~ 224 (321)
....... .....+|..|+|||++.+... ++.++|||||||++|+|++| ..||........
T Consensus 196 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~ 275 (342)
T 1b6c_B 196 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 275 (342)
T ss_dssp EEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred eccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcc
Confidence 6644332 244578999999999976322 23689999999999999999 677743322211
Q ss_pred HHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 225 QLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
....+.+....... ........ ....+++.+.+++.+||+.||++|||++++++
T Consensus 276 ~~~~~~~~~~~~~~----------------------~~~~~~~~----~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~ 329 (342)
T 1b6c_B 276 SVEEMRKVVCEQKL----------------------RPNIPNRW----QSCEALRVMAKIMRECWYANGAARLTALRIKK 329 (342)
T ss_dssp CHHHHHHHHTTSCC----------------------CCCCCGGG----GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cHHHHHHHHHHHHh----------------------CCCCcccc----cchhHHHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11111111100000 00000000 01123457999999999999999999999987
Q ss_pred C
Q 020826 305 H 305 (321)
Q Consensus 305 h 305 (321)
|
T Consensus 330 ~ 330 (342)
T 1b6c_B 330 T 330 (342)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=314.64 Aligned_cols=250 Identities=20% Similarity=0.292 Sum_probs=195.9
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
...++|++.+.||+|+||.||+|++..+++.||||+++.. ....+..|+.+++.+.+++++..+..+..+ ....++|
T Consensus 4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~--~~~~~lv 81 (483)
T 3sv0_A 4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVE--GDYNVLV 81 (483)
T ss_dssp EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEE--TTEEEEE
T ss_pred CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEee--CCEEEEE
Confidence 4568999999999999999999999999999999998643 345688999999999656777777666543 4566899
Q ss_pred EEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEE---cCCCCeEEEeeccceeecCCC
Q 020826 97 FEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMI---DHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 97 ~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili---~~~~~~v~l~dfg~~~~~~~~ 169 (321)
|||+ +++|.+++ ..+++..++.++.||+.||+|||++||+|+||||+||++ +.++ .+||+|||++......
T Consensus 82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~-~vkL~DFGla~~~~~~ 159 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAKKYRDT 159 (483)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTT-CEEECCCTTCEECBCT
T ss_pred EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCC-eEEEEeCCcceeccCC
Confidence 9999 77776665 469999999999999999999999999999999999999 4555 8999999999876543
Q ss_pred Cc--------cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCC--hHHHHHHHHHhCChhhh
Q 020826 170 KE--------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN--YDQLVKIAKVLGTDELN 239 (321)
Q Consensus 170 ~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~ 239 (321)
.. .....+|..|+|||++.+ ..++.++|||||||++|+|++|..||...... ......+..........
T Consensus 160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~ 238 (483)
T 3sv0_A 160 STHQHIPYRENKNLTGTARYASVNTHLG-IEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIE 238 (483)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHH
T ss_pred ccccccccccccccCCCccccCHHHhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHH
Confidence 22 125578999999999987 78899999999999999999999999533221 11112111110000000
Q ss_pred HHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 240 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
. ....+++++.++|.+||+.||++||++++|++
T Consensus 239 ~--------------------------------l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 239 A--------------------------------LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp H--------------------------------HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred H--------------------------------HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 0 01235679999999999999999999987764
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-43 Score=298.34 Aligned_cols=246 Identities=18% Similarity=0.293 Sum_probs=188.0
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEec-CCc--eEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeec
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCT-DNE--KCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRD 87 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~-~~~--~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (321)
....++|++.+.||+|+||+||+|++.. +++ .|++|+++.. ....+.+|+.+++.+ +||||+++++++.+
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~ 92 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGVVLT 92 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhC-CCCCcccEEEEEcc
Confidence 3347899999999999999999998754 333 6899998643 235688999999999 89999999999865
Q ss_pred cCCCCcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccce
Q 020826 88 QQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163 (321)
Q Consensus 88 ~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~ 163 (321)
.. .++++|++.+++|.+++ ..+++..+..++.|++.||.+||++|++|+||||+||+++.++ .++|+|||++
T Consensus 93 ~~---~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~ 168 (291)
T 1u46_A 93 PP---MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLM 168 (291)
T ss_dssp SS---CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTC
T ss_pred CC---ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCC-CEEEcccccc
Confidence 43 67999999999887776 3489999999999999999999999999999999999999888 8999999999
Q ss_pred eecCCCCc----cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhh
Q 020826 164 EFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDEL 238 (321)
Q Consensus 164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (321)
........ .....++..|+|||++.+ ..++.++||||||+++|+|++ |..||. +.+.......+...
T Consensus 169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~-~~~~~~~~~~~~~~------ 240 (291)
T 1u46_A 169 RALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWI-GLNGSQILHKIDKE------ 240 (291)
T ss_dssp EECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHHHTS------
T ss_pred ccccccccchhhhccCCCCceeeCchhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCcc-cCCHHHHHHHHHcc------
Confidence 87654332 123456778999999987 678899999999999999999 898883 22222222211110
Q ss_pred hHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 239 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
.. .......+++++.++|.+||+.||++|||+.++++
T Consensus 241 ---------------------~~--------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 241 ---------------------GE--------RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp ---------------------CC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---------------------CC--------CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 00 00112346789999999999999999999999987
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-43 Score=320.67 Aligned_cols=253 Identities=19% Similarity=0.337 Sum_probs=202.2
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc--chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
.|.|. .++|++.+.||+|+||+||+|.+. ++..||||+++.. ....+.+|+.+++.+ +||||+++++++.+
T Consensus 261 ~~~i~--~~~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l-~hpniv~~~~~~~~--- 333 (535)
T 2h8h_A 261 AWEIP--RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSE--- 333 (535)
T ss_dssp CSBCC--GGGEEEEEEEEECSSEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS---
T ss_pred ceecc--hhhhhhheecccCCCeEEEEEEEC-CCceEEEEEeCCCCCCHHHHHHHHHHHHhC-CCCCEeeEEEEEee---
Confidence 45555 568999999999999999999984 4567999999754 346789999999999 89999999999854
Q ss_pred CCcEEEEEeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 91 KTPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
...++||||+.+++|.+++. .+++..+..++.||+.||+|||++|++|+||||+||+++.++ .+||+|||++..
T Consensus 334 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~ 412 (535)
T 2h8h_A 334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARL 412 (535)
T ss_dssp SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCTTSTTT
T ss_pred ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCC-cEEEccccccee
Confidence 34689999999999988874 389999999999999999999999999999999999999877 899999999875
Q ss_pred cCCCC--ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHh
Q 020826 166 YHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242 (321)
Q Consensus 166 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (321)
..... ......++..|+|||++.. ..++.++|||||||++|+|++ |..|| .+....+.+..+....
T Consensus 413 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDvwSlGv~l~el~t~g~~P~-~~~~~~~~~~~i~~~~--------- 481 (535)
T 2h8h_A 413 IEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPY-PGMVNREVLDQVERGY--------- 481 (535)
T ss_dssp CCCHHHHTTCSTTSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTTCCSS-TTCCHHHHHHHHHTTC---------
T ss_pred cCCCceecccCCcCcccccCHHHhcc-CCCCchhhHHHHHHHHHHHHhCCCCCC-CCCCHHHHHHHHHcCC---------
Confidence 43211 1122345678999999987 689999999999999999999 88887 3333333322221100
Q ss_pred hhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC--CCcccC
Q 020826 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH--PYFFPI 311 (321)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h--p~~~~~ 311 (321)
....+..+++++.+||.+||+.||++|||++++++. .+|...
T Consensus 482 ---------------------------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~ 525 (535)
T 2h8h_A 482 ---------------------------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 525 (535)
T ss_dssp ---------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred ---------------------------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence 011123467889999999999999999999999874 555544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-43 Score=313.54 Aligned_cols=250 Identities=15% Similarity=0.200 Sum_probs=184.9
Q ss_pred eeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCC-CCeee-------
Q 020826 15 FINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGG-PNIVK------- 80 (321)
Q Consensus 15 ~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h-~~i~~------- 80 (321)
.+.....+|...+.||+|+||+||+|.+..+++.||||+++.. ..+.+.+|+.+++.+ .| ++...
T Consensus 72 ~~~~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l-~~~~~~~~~~~~~~~ 150 (413)
T 3dzo_A 72 ELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLL-RGIKNQKQAKVHLRF 150 (413)
T ss_dssp SSSSCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGS-TTCCSHHHHHHHTCB
T ss_pred cCCCCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhh-ccCCCHHHHHHhccc
Confidence 3445566799999999999999999999999999999998732 235688999999888 44 32211
Q ss_pred --------------eeeeeeccC---CCCcEEEEEeecCchhhhhc----------CCCCHHHHHHHHHHHHHHHHHHHH
Q 020826 81 --------------LLDIVRDQQ---SKTPSLIFEHVNNTDFKVLY----------PTLSDYDVRYYIYELLKALDYCHS 133 (321)
Q Consensus 81 --------------~~~~~~~~~---~~~~~lv~e~~~~~~l~~~~----------~~~~~~~~~~i~~qi~~~l~~lh~ 133 (321)
+..++.... ....+++++.+. ++|.+++ ..+++..+..++.|++.||+|||+
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 229 (413)
T 3dzo_A 151 IFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH 229 (413)
T ss_dssp CCCCEEEECCC---------------CCSEEEEEECCS-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred ccchhhcccCCCCccccccCCCccccccceEEEeehhc-CCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 111111111 223456666554 5555554 126777888999999999999999
Q ss_pred CCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCccccccCCcccccccccc---------CCCCCCCcchHHHHHH
Q 020826 134 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV---------DLQDYDYSLDLWSLGC 204 (321)
Q Consensus 134 ~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---------~~~~~~~~~DvwslG~ 204 (321)
+||+||||||+||+++.++ .+||+|||++...... .....| +.|+|||++. ....++.++|||||||
T Consensus 230 ~~iiHrDiKp~NILl~~~~-~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv 305 (413)
T 3dzo_A 230 YGLVHTYLRPVDIVLDQRG-GVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL 305 (413)
T ss_dssp TTEECSCCCGGGEEECTTC-CEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred CCcccCCcccceEEEecCC-eEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence 9999999999999999888 7999999998765422 344566 8999999993 2256788999999999
Q ss_pred HHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHH
Q 020826 205 MFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDF 284 (321)
Q Consensus 205 ~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 284 (321)
++|+|++|+.||...... .. .. . .......+|+++.+|
T Consensus 306 il~elltg~~Pf~~~~~~-~~------------~~---------------~--------------~~~~~~~~~~~~~~l 343 (413)
T 3dzo_A 306 AIYWIWCADLPNTDDAAL-GG------------SE---------------W--------------IFRSCKNIPQPVRAL 343 (413)
T ss_dssp HHHHHHHSSCCCCTTGGG-SC------------SG---------------G--------------GGSSCCCCCHHHHHH
T ss_pred HHHHHHHCCCCCCCcchh-hh------------HH---------------H--------------HHhhcccCCHHHHHH
Confidence 999999999998421100 00 00 0 000112467899999
Q ss_pred HHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 285 LDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 285 l~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
|.+||+.||++|||+.++++||||+++.
T Consensus 344 i~~~l~~dP~~Rpt~~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 344 LEGFLRYPKEDRLLPLQAMETPEYEQLR 371 (413)
T ss_dssp HHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHhCHHHHHHH
Confidence 9999999999999999999999999763
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=293.08 Aligned_cols=251 Identities=20% Similarity=0.296 Sum_probs=190.1
Q ss_pred EEeeeeeeecceEEEEEEEecCCceEEEEEeccc-------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 24 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 24 ~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
...+.||+|+||+||+|.+ +++.+++|.+... ....+.+|+.+++.+ +||||+++++++.+ ....+++
T Consensus 34 ~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~~i~~~~~~~~~--~~~~~lv 108 (307)
T 2nru_A 34 VGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKC-QHENLVELLGFSSD--GDDLCLV 108 (307)
T ss_dssp TTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHC-CCTTBCCEEEEECS--SSSCEEE
T ss_pred ccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhc-CCCCeEEEEEEEec--CCceEEE
Confidence 3348899999999999986 6889999998642 246688999999999 89999999999955 4456799
Q ss_pred EEeecCchhhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 97 FEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 97 ~e~~~~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
+|++.+++|.+++ ..+++..++.++.|++.||+|||++|++|+||||+||+++.++ .++|+|||++.......
T Consensus 109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~ 187 (307)
T 2nru_A 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF-TAKISDFGLARASEKFA 187 (307)
T ss_dssp EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECCSCS
T ss_pred EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC-cEEEeeccccccccccc
Confidence 9999999987766 2489999999999999999999999999999999999999887 89999999987654322
Q ss_pred c---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 171 E---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 171 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
. .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||...... ..+..+........
T Consensus 188 ~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~---------- 254 (307)
T 2nru_A 188 QTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLDIKEEIEDEE---------- 254 (307)
T ss_dssp SCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSS-SBTTHHHHHHHTTS----------
T ss_pred ccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcch-HHHHHHHHHhhhhh----------
Confidence 2 233468999999999865 4789999999999999999999998533221 11111111100000
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
........... .......++.+.+++.+||+.||++|||+++++++
T Consensus 255 ---~~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 255 ---KTIEDYIDKKM---------NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp ---CCHHHHSCSSC---------SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ---hhhhhhccccc---------cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 00000000000 00111234679999999999999999999999864
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=319.43 Aligned_cols=241 Identities=18% Similarity=0.337 Sum_probs=190.9
Q ss_pred cCceEEee-eeeeecceEEEEEEEec--CCceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 20 QDDYEVVR-KVGRGKYSEVFEGVHCT--DNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 20 ~~~y~~~~-~lg~g~~g~v~~~~~~~--~~~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
.+++.+.+ .||+|+||+||+|.+.. ++..||||+++.. ....+.+|+.+++.+ +||||+++++++.+ ..
T Consensus 334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~hpniv~l~~~~~~---~~ 409 (613)
T 2ozo_A 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQA---EA 409 (613)
T ss_dssp TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTC-CCTTBCCEEEEEES---SS
T ss_pred ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhC-CCCCEeeEEEEecc---CC
Confidence 44566666 89999999999998763 4567999999753 346789999999999 99999999999864 34
Q ss_pred cEEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 93 PSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
.++||||+.+++|..++. .+++..+..++.||+.||+|||++||+|+||||+||+++.++ .+||+|||++.....
T Consensus 410 ~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~-~vkL~DFGla~~~~~ 488 (613)
T 2ozo_A 410 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH-YAKISDFGLSKALGA 488 (613)
T ss_dssp EEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCSTTTTCC-
T ss_pred eEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCC-cEEEeeccCcccccC
Confidence 789999999999988763 489999999999999999999999999999999999999888 899999999976533
Q ss_pred CCcc----ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 169 GKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 169 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
.... ....++..|+|||++.+ ..++.++|||||||++|+|++ |..||. +....+....+....
T Consensus 489 ~~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~-~~~~~~~~~~i~~~~---------- 556 (613)
T 2ozo_A 489 DDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYK-KMKGPEVMAFIEQGK---------- 556 (613)
T ss_dssp -------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCSHHHHHHHHTTC----------
T ss_pred CCceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCC-CCCHHHHHHHHHcCC----------
Confidence 2211 12234578999999987 789999999999999999998 998883 334333333221100
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHh
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 303 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell 303 (321)
....+..+++++.++|.+||+.||++|||+++++
T Consensus 557 --------------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~ 590 (613)
T 2ozo_A 557 --------------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVE 590 (613)
T ss_dssp --------------------------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred --------------------------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 0112235778999999999999999999999874
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=320.53 Aligned_cols=240 Identities=18% Similarity=0.301 Sum_probs=189.1
Q ss_pred ceEEe-eeeeeecceEEEEEEEe--cCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 22 DYEVV-RKVGRGKYSEVFEGVHC--TDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 22 ~y~~~-~~lg~g~~g~v~~~~~~--~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
.+.+. +.||+|+||+||+|.+. .+++.||||+++... ...+.+|+.+++++ +||||+++++++.+. ..
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~l~~~~~~~---~~ 444 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEAE---SW 444 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHC-CCTTBCCEEEEEESS---SE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC---CE
Confidence 34443 47999999999999654 456889999997532 36789999999999 899999999998532 36
Q ss_pred EEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 94 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
++||||+.+++|..++ ..+++..+..++.||+.||+|||++||+|+||||+||+++.++ .+||+|||++.......
T Consensus 445 ~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~-~~kL~DFGla~~~~~~~ 523 (635)
T 4fl3_A 445 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADE 523 (635)
T ss_dssp EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCTTHHHHTTC--
T ss_pred EEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCC-CEEEEEcCCccccccCc
Confidence 7999999999998877 4589999999999999999999999999999999999999888 89999999997654332
Q ss_pred c----cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhh
Q 020826 171 E----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245 (321)
Q Consensus 171 ~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (321)
. .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||. +....+....+....
T Consensus 524 ~~~~~~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~-~~~~~~~~~~i~~~~------------ 589 (635)
T 4fl3_A 524 NYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYR-GMKGSEVTAMLEKGE------------ 589 (635)
T ss_dssp -----------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSST-TCCHHHHHHHHHTTC------------
T ss_pred cccccccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCC-CCCHHHHHHHHHcCC------------
Confidence 2 223345678999999987 789999999999999999998 998883 333322222221100
Q ss_pred cccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
....+..+++++.++|.+||+.||++|||++++++
T Consensus 590 ------------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 590 ------------------------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp ------------------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred ------------------------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 01112346789999999999999999999999874
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=299.97 Aligned_cols=249 Identities=18% Similarity=0.203 Sum_probs=185.6
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----------hHHHHHHHHHHHhhc--------CCCCe
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLC--------GGPNI 78 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----------~~~~~~E~~~l~~l~--------~h~~i 78 (321)
...++|++.+.||+|+||+||+|++ +++.||+|+++... ...+.+|+.+++.+. .||||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 3467899999999999999999998 78999999997542 267899999999985 47777
Q ss_pred eeeeeeee-----------------cc-----------CCCCcEEEEEeecCch-hhhhc-CCCCHHHHHHHHHHHHHHH
Q 020826 79 VKLLDIVR-----------------DQ-----------QSKTPSLIFEHVNNTD-FKVLY-PTLSDYDVRYYIYELLKAL 128 (321)
Q Consensus 79 ~~~~~~~~-----------------~~-----------~~~~~~lv~e~~~~~~-l~~~~-~~~~~~~~~~i~~qi~~~l 128 (321)
+++.+++. +. .....++||||+.+++ +..+. ..+++..++.++.||+.||
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASL 174 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 77666532 10 1467889999998885 44444 4589999999999999999
Q ss_pred HHHH-HCCCeeecCCCCCeEEcCCC-------------------CeEEEeeccceeecCCCCccccccCCcccccccccc
Q 020826 129 DYCH-SQGIMHRDVKPHNVMIDHEQ-------------------RKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 188 (321)
Q Consensus 129 ~~lh-~~~i~H~dlkp~nili~~~~-------------------~~v~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~ 188 (321)
+||| ++||+||||||+||+++.++ ..+||+|||+++.... ....||+.|+|||++.
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~----~~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD----GIVVFCDVSMDEDLFT 250 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET----TEEECCCCTTCSGGGC
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC----CcEEEeecccChhhhc
Confidence 9999 99999999999999998764 2799999999986543 2457899999999998
Q ss_pred CCCCCCCcchHHHHHHH-HHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCcc
Q 020826 189 DLQDYDYSLDLWSLGCM-FAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSK 267 (321)
Q Consensus 189 ~~~~~~~~~DvwslG~~-l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (321)
+ .. +.++||||||++ .+++++|..||............+...... .....
T Consensus 251 g-~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~-- 301 (336)
T 2vuw_A 251 G-DG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTF-------------------------KTKCN-- 301 (336)
T ss_dssp C-CS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCC-------------------------SSCCC--
T ss_pred C-CC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhcc-------------------------Ccccc--
Confidence 7 33 889999998776 777888888872100000000010000000 00000
Q ss_pred ccccccccCCcchHHHHHHHhhccCCCCCcCHHHHh-cCCCcc
Q 020826 268 FITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM-AHPYFF 309 (321)
Q Consensus 268 ~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell-~hp~~~ 309 (321)
......+|+++.+||++||+.| |++|+| +||||+
T Consensus 302 ---~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 302 ---TPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp ---SHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred ---hhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 0011236689999999999977 999999 999996
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-42 Score=295.54 Aligned_cols=242 Identities=21% Similarity=0.335 Sum_probs=188.8
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
..++|++.+.||+|+||+||+|.+.. .+++|+++.. ....+.+|+.+++.+ +||||+++++++.+. ...
T Consensus 31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l-~h~~iv~~~~~~~~~--~~~ 104 (319)
T 2y4i_B 31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQT-RHENVVLFMGACMSP--PHL 104 (319)
T ss_dssp CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTC-CCTTBCCCCEEEECS--SCE
T ss_pred CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcC-CCCCEeEEEEEEecC--Cce
Confidence 36799999999999999999998743 4999998643 235577899999999 899999999999654 456
Q ss_pred EEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC-
Q 020826 94 SLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP- 168 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~- 168 (321)
++++|++.+++|.+++. .+++..++.++.|++.||+|||++|++|+||||+||+++ ++ .++|+|||++.....
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~-~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NG-KVVITDFGLFSISGVL 182 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC----CCEECCCSCCC-----
T ss_pred EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CC-CEEEeecCCccccccc
Confidence 79999999999988884 489999999999999999999999999999999999998 55 799999998765421
Q ss_pred -----CCccccccCCccccccccccC--------CCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCC
Q 020826 169 -----GKEYNVRVASRYFKGPELLVD--------LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 235 (321)
Q Consensus 169 -----~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (321)
........++..|+|||++.+ ...++.++||||||+++|+|++|..||. +.........+....
T Consensus 183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~-~~~~~~~~~~~~~~~-- 259 (319)
T 2y4i_B 183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFK-TQPAEAIIWQMGTGM-- 259 (319)
T ss_dssp -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSS-SCCHHHHHHHHHTTC--
T ss_pred cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHhccCC--
Confidence 122234458889999999864 2357889999999999999999999983 222222222111100
Q ss_pred hhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 236 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
.+ ......+++++.+++.+||+.||++|||++++++
T Consensus 260 ---------------------------~~------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 260 ---------------------------KP------NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp ---------------------------CC------CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred ---------------------------CC------CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 00 0011236679999999999999999999999986
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-41 Score=314.05 Aligned_cols=243 Identities=22% Similarity=0.395 Sum_probs=193.1
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecC---CceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~---~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
..++|++.+.||+|+||+||+|.+..+ +..+++|.++... ...+.+|+.+++.+ +||||+++++++.+ .
T Consensus 388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~~~---~ 463 (656)
T 2j0j_A 388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVITE---N 463 (656)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEECS---S
T ss_pred ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEec---C
Confidence 457899999999999999999998654 4579999876432 35688999999999 99999999999843 3
Q ss_pred CcEEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 92 TPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
..++||||+.+++|.+++. .+++..+..++.|++.||+|||++|++||||||+||+++.++ .+||+|||++....
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~-~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYME 542 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCCCCCSCC
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCC-CEEEEecCCCeecC
Confidence 4689999999999988773 488999999999999999999999999999999999999888 89999999997654
Q ss_pred CCCc--cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhh
Q 020826 168 PGKE--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244 (321)
Q Consensus 168 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (321)
.... .....++..|+|||++.+ ..++.++|||||||++|+|++ |..||. +....+....+.....
T Consensus 543 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwSlG~il~ellt~g~~Pf~-~~~~~~~~~~i~~~~~---------- 610 (656)
T 2j0j_A 543 DSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQ-GVKNNDVIGRIENGER---------- 610 (656)
T ss_dssp C----------CCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHHHHTCC----------
T ss_pred CCcceeccCCCCCcceeCHHHhcC-CCCCchhhHHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHHcCCC----------
Confidence 3322 123345678999999987 688999999999999999997 887873 3333333322211000
Q ss_pred hcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
...+..+++++.++|.+||+.||++|||+.++++
T Consensus 611 --------------------------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 611 --------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp --------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred --------------------------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 0112346789999999999999999999999875
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=321.10 Aligned_cols=241 Identities=21% Similarity=0.274 Sum_probs=194.3
Q ss_pred cccCceEEeeeeeeecceEEEEEEEec-CCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC-
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCT-DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK- 91 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~-~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~- 91 (321)
...++|++.+.||+|+||+||+|.+.. +++.|+||++.... ...+.+|+.++..+ +||||+++++++......
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l-~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV-VHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGC-CCTTBCCEEEEEEEECTTS
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhc-CCCCcCeEeeeEeecCCCC
Confidence 345899999999999999999999976 78999999986432 34578899999999 899999999998765431
Q ss_pred --CcEEEEEeecCchhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 92 --TPSLIFEHVNNTDFKVLYP-TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 92 --~~~lv~e~~~~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
..++||||+.+++|...+. .+++..+..++.||+.||.|||++||+|+||||+||+++.+ .+||+|||++.....
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~--~~kl~DFG~a~~~~~ 233 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE--QLKLIDLGAVSRINS 233 (681)
T ss_dssp CEEEEEEEECCCCEECC----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS--CEEECCCTTCEETTC
T ss_pred CceeEEEEEeCCCCcHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC--cEEEEecccchhccc
Confidence 2589999999999987764 69999999999999999999999999999999999999864 699999999987643
Q ss_pred CCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 169 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
. ....||+.|+|||++.+ ..+.++|||||||++|+|++|..||...... ..
T Consensus 234 ~---~~~~gt~~y~aPE~~~~--~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------------~~---------- 284 (681)
T 2pzi_A 234 F---GYLYGTPGFQAPEIVRT--GPTVATDIYTVGRTLAALTLDLPTRNGRYVD--------------GL---------- 284 (681)
T ss_dssp C---SCCCCCTTTSCTTHHHH--CSCHHHHHHHHHHHHHHHHSCCCEETTEECS--------------SC----------
T ss_pred C---CccCCCccccCHHHHcC--CCCCceehhhhHHHHHHHHhCCCCCcccccc--------------cc----------
Confidence 3 45678999999999876 3488999999999999999998776311000 00
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCccc
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 310 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~ 310 (321)
+. .......++.+.++|.+||+.||++||+..+.+.|+|+.-
T Consensus 285 ---------------~~-----~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 285 ---------------PE-----DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp ---------------CT-----TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred ---------------cc-----cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 00 0000013468999999999999999999999999988763
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=279.05 Aligned_cols=224 Identities=12% Similarity=0.120 Sum_probs=176.3
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
..++|++.+.||+|+||+||+|.+..+++.||+|+++... ...+.+|+..+..+ +||||+++++++.+. ..
T Consensus 29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~hp~iv~~~~~~~~~--~~ 105 (286)
T 3uqc_A 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI-DKPGVARVLDVVHTR--AG 105 (286)
T ss_dssp TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEET--TE
T ss_pred ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcC-CCCCcceeeEEEEEC--Cc
Confidence 3478999999999999999999998889999999997542 25688999999999 999999999999654 45
Q ss_pred cEEEEEeecCchhhhhcCC-CCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc
Q 020826 93 PSLIFEHVNNTDFKVLYPT-LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 171 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~~~-~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~ 171 (321)
.++||||+.+++|.+++.. ....++..++.|++.||+|||++|++|+||||+||+++.++ .++|++++
T Consensus 106 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g-~~kl~~~~---------- 174 (286)
T 3uqc_A 106 GLVVAEWIRGGSLQEVADTSPSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDG-DVVLAYPA---------- 174 (286)
T ss_dssp EEEEEECCCEEEHHHHHTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTS-CEEECSCC----------
T ss_pred EEEEEEecCCCCHHHHHhcCCChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCC-CEEEEecc----------
Confidence 7899999999999888753 56677899999999999999999999999999999999888 78887443
Q ss_pred cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCCh
Q 020826 172 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (321)
|++ .++.++|||||||++|+|++|+.||...... ..+.
T Consensus 175 ---------~~~--------~~~~~~Di~slG~il~elltg~~Pf~~~~~~-~~~~------------------------ 212 (286)
T 3uqc_A 175 ---------TMP--------DANPQDDIRGIGASLYALLVNRWPLPEAGVR-SGLA------------------------ 212 (286)
T ss_dssp ---------CCT--------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBC-CCSE------------------------
T ss_pred ---------ccC--------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcc-hhhH------------------------
Confidence 222 3678999999999999999999999432211 0000
Q ss_pred hhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 252 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
...................+++++.++|.+||+.||++| |+.|+++.
T Consensus 213 ------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 213 ------PAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp ------ECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred ------HHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 000000000000011223577899999999999999999 99998863
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-33 Score=260.01 Aligned_cols=199 Identities=20% Similarity=0.153 Sum_probs=134.0
Q ss_pred eeeeecccCceEEe-eeeeeecceEEEEEEEecCCceEEEEEeccc-------------chHHHHHHHHHHHhhcCCCCe
Q 020826 13 VWFINREQDDYEVV-RKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-------------KKKKIKREIKILQNLCGGPNI 78 (321)
Q Consensus 13 ~~~i~~~~~~y~~~-~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-------------~~~~~~~E~~~l~~l~~h~~i 78 (321)
.|.++.....|.-- ...+.|+.|....++..-.|+.+++|++... ....+.+|+++|+++..|+||
T Consensus 225 ~~~~~~~~~~~~~w~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i 304 (569)
T 4azs_A 225 RVLINDFNQPFQHWQNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDA 304 (569)
T ss_dssp EEEETTEEEECSEEECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCC
T ss_pred cccccchhhhHHhhhhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCe
Confidence 45554443333222 2356777777777777778999999998642 124588999999999889999
Q ss_pred eeeeeeeeccCCCCcEEEEEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEe
Q 020826 79 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI 158 (321)
Q Consensus 79 ~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~ 158 (321)
+++++++++ ....||||||+.|++|.+++..........|+.||+.||+|+|++||+||||||+|||++.++ .+||+
T Consensus 305 ~~~~~~~ed--~~~~yLVMEyv~G~~L~d~i~~~~~l~~~~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg-~vKL~ 381 (569)
T 4azs_A 305 PAVLAHGEN--AQSGWLVMEKLPGRLLSDMLAAGEEIDREKILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQ-HARLI 381 (569)
T ss_dssp CCEEEEEEC--SSEEEEEEECCCSEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTS-CEEEC
T ss_pred eEEEEEEEE--CCEEEEEEecCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHCCceeccCchHhEEECCCC-CEEEe
Confidence 999999965 456779999999999999884422223346889999999999999999999999999999888 89999
Q ss_pred eccceeecCCC-CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 020826 159 DWGLAEFYHPG-KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 216 (321)
Q Consensus 159 dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~ 216 (321)
|||+++..... ......+||+.|+|||++.+ ....++|+||+|++++++.++..++
T Consensus 382 DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g--~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 382 DFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE--NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp CCTTEESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTHHHH
T ss_pred ecccCeeCCCCCccccCceechhhccHHHhCC--CCCCcccccccccchhhhccccchh
Confidence 99999865433 33455689999999999976 4667899999999988876655443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.5e-27 Score=214.26 Aligned_cols=180 Identities=17% Similarity=0.211 Sum_probs=136.7
Q ss_pred EEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 24 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 24 ~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
...+.||+|+||+||+|. ..+..+++|...... .+.+.+|+.+++++ +||||+++..+..+. ..
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~~~~~~--~~ 413 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALV-KDFGIPAPYIFDVDL--DN 413 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHG-GGGTCCCCCEEEEET--TT
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhc-CCCCcCceEEEEEeC--Cc
Confidence 345689999999999994 467888888753211 24478999999999 899999444443333 34
Q ss_pred cEEEEEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCcc
Q 020826 93 PSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY 172 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~ 172 (321)
.++||||+.+++|.+++.. +..++.|++.||+|||++||+|+||||+||+++. .+||+|||+++........
T Consensus 414 ~~lVmE~~~ggsL~~~l~~-----~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~---~~kL~DFGla~~~~~~~~~ 485 (540)
T 3en9_A 414 KRIMMSYINGKLAKDVIED-----NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK---DLYIIDFGLGKISNLDEDK 485 (540)
T ss_dssp TEEEEECCCSEEHHHHSTT-----CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS---SEEECCCTTCEECCCHHHH
T ss_pred cEEEEECCCCCCHHHHHHH-----HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC---eEEEEECccCEECCCcccc
Confidence 4799999999999999877 6789999999999999999999999999999987 6999999999876543221
Q ss_pred --------ccccCCccccccccccCC-CCCCCcchHHHHHHHHHHHHhCCCCC
Q 020826 173 --------NVRVASRYFKGPELLVDL-QDYDYSLDLWSLGCMFAGMIFRKEPF 216 (321)
Q Consensus 173 --------~~~~~~~~y~aPE~~~~~-~~~~~~~DvwslG~~l~~l~~g~~p~ 216 (321)
....||+.|+|||++... ..|+..+|+|+..+-..+-+.++.+|
T Consensus 486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 345789999999999651 24667789999988888877776655
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7e-24 Score=179.08 Aligned_cols=141 Identities=18% Similarity=0.240 Sum_probs=113.9
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc---------------------chHHHHHHHHHHHhhcCCCCeee
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---------------------KKKKIKREIKILQNLCGGPNIVK 80 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~---------------------~~~~~~~E~~~l~~l~~h~~i~~ 80 (321)
.|.+.+.||+|+||.||+|.+ .+++.||+|+++.. ....+.+|+.+++.+. | ++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~---~-~~ 165 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ---G-LA 165 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT---T-SS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc---C-CC
Confidence 344559999999999999999 88999999998632 2345789999999994 4 55
Q ss_pred eeeeeeccCCCCcEEEEEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeec
Q 020826 81 LLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW 160 (321)
Q Consensus 81 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~df 160 (321)
+.+++.. ...++||||+.+++|.. + ....+..++.|++.||.+||++|++|+||||+||+++ ++ .++|+||
T Consensus 166 v~~~~~~---~~~~lvmE~~~g~~L~~-l---~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~-~vkl~DF 236 (282)
T 1zar_A 166 VPKVYAW---EGNAVLMELIDAKELYR-V---RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EE-GIWIIDF 236 (282)
T ss_dssp SCCEEEE---ETTEEEEECCCCEEGGG-C---CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TT-EEEECCC
T ss_pred cCeEEec---cceEEEEEecCCCcHHH-c---chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CC-cEEEEEC
Confidence 5555432 23579999999999988 3 2244567999999999999999999999999999999 77 8999999
Q ss_pred cceeecCCCCccccccCCcccccccccc
Q 020826 161 GLAEFYHPGKEYNVRVASRYFKGPELLV 188 (321)
Q Consensus 161 g~~~~~~~~~~~~~~~~~~~y~aPE~~~ 188 (321)
|++... ..+.|||++.
T Consensus 237 G~a~~~------------~~~~a~e~l~ 252 (282)
T 1zar_A 237 PQSVEV------------GEEGWREILE 252 (282)
T ss_dssp TTCEET------------TSTTHHHHHH
T ss_pred CCCeEC------------CCCCHHHHHH
Confidence 998743 2457888874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.1e-21 Score=163.59 Aligned_cols=136 Identities=18% Similarity=0.190 Sum_probs=108.3
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCce--EEEEEecccc---------------------------hHHHHHHHHHHHh
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEK--CIIKILKPVK---------------------------KKKIKREIKILQN 71 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~--~~vK~~~~~~---------------------------~~~~~~E~~~l~~ 71 (321)
.-|++.+.||+|+||.||+|.+..+|+. ||||+++... ...+.+|+..+.+
T Consensus 47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 126 (258)
T 1zth_A 47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER 126 (258)
T ss_dssp SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence 4578999999999999999999778888 9999875421 1257889999999
Q ss_pred hcCCCC--eeeeeeeeeccCCCCcEEEEEeecC-c----hhhhhcCCCCHHHHHHHHHHHHHHHHHHH-HCCCeeecCCC
Q 020826 72 LCGGPN--IVKLLDIVRDQQSKTPSLIFEHVNN-T----DFKVLYPTLSDYDVRYYIYELLKALDYCH-SQGIMHRDVKP 143 (321)
Q Consensus 72 l~~h~~--i~~~~~~~~~~~~~~~~lv~e~~~~-~----~l~~~~~~~~~~~~~~i~~qi~~~l~~lh-~~~i~H~dlkp 143 (321)
+ .|++ ++.+++. ...++||||+++ + .|.......++..+..++.|++.+|.+|| +.|++|+||||
T Consensus 127 l-~~~~i~~p~~~~~------~~~~lVmE~~g~~g~~~~~L~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 127 A-KEAGVSVPQPYTY------MKNVLLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp H-HHTTCCCCCEEEE------ETTEEEEECCEETTEECCBHHHHGGGGGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred H-HhCCCCCCeEEEc------CCCEEEEEecCCCCCccccHHHHhhccChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 8 5554 3444432 134799999953 2 56655544456678899999999999999 99999999999
Q ss_pred CCeEEcCCCCeEEEeeccceeec
Q 020826 144 HNVMIDHEQRKLRLIDWGLAEFY 166 (321)
Q Consensus 144 ~nili~~~~~~v~l~dfg~~~~~ 166 (321)
+||+++. .++|+|||++...
T Consensus 200 ~NILl~~---~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID---KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS---SEEECCCTTCEET
T ss_pred HHEEEcC---cEEEEECcccccC
Confidence 9999986 5999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.75 E-value=5.9e-18 Score=146.82 Aligned_cols=134 Identities=16% Similarity=0.232 Sum_probs=99.6
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----------------h--------HHHHHHHHHHHhhcCC
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----------------K--------KKIKREIKILQNLCGG 75 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----------------~--------~~~~~E~~~l~~l~~h 75 (321)
.-|++.+.||.|++|.||+|.+ .+|+.||||+++... . -...+|...+.++ .+
T Consensus 95 ~iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL-~~ 172 (397)
T 4gyi_A 95 DVYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKAL-YE 172 (397)
T ss_dssp SCSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHH-HH
T ss_pred CEEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHH-Hh
Confidence 3499999999999999999998 579999999875311 0 0123566777776 33
Q ss_pred CCe--eeeeeeeeccCCCCcEEEEEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCC
Q 020826 76 PNI--VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 153 (321)
Q Consensus 76 ~~i--~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~ 153 (321)
..+ +..++.. ..++|||++.|.++..+.. ...+..++.|++.+|.+||++|++||||||.||+++.++.
T Consensus 173 ~gv~vp~p~~~~------~~~LVME~i~G~~L~~l~~---~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd 243 (397)
T 4gyi_A 173 EGFPVPEPIAQS------RHTIVMSLVDALPMRQVSS---VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKD 243 (397)
T ss_dssp TTCSCCCEEEEE------TTEEEEECCSCEEGGGCCC---CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEEC
T ss_pred cCCCCCeeeecc------CceEEEEecCCccHhhhcc---cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCC
Confidence 332 2333221 1269999999998876543 2345678899999999999999999999999999986652
Q ss_pred ---------eEEEeeccceee
Q 020826 154 ---------KLRLIDWGLAEF 165 (321)
Q Consensus 154 ---------~v~l~dfg~~~~ 165 (321)
.+.|+||+=+..
T Consensus 244 ~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 244 AEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SSCTTSEEEEEEECCCTTCEE
T ss_pred cccccccccceEEEEeCCccc
Confidence 388999996644
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.47 E-value=5.3e-13 Score=111.30 Aligned_cols=138 Identities=18% Similarity=0.238 Sum_probs=111.0
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecc---cchHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~---~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
..|++...++.|+.+.||++.. .+..+++|+... .....+.+|..+++.+..+..+++++++..+ ....++||
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~--~~~~~lv~ 89 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH--DGWSNLLM 89 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE--TTEEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec--CCceEEEE
Confidence 4688899999999999999874 468899999875 3445799999999999667788899988754 34567999
Q ss_pred EeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 020826 98 EHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHS-------------------------------------------- 133 (321)
Q Consensus 98 e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~-------------------------------------------- 133 (321)
|+++|.++...... ......++.+++.+|..||+
T Consensus 90 e~i~G~~l~~~~~~--~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (263)
T 3tm0_A 90 SEADGVLCSEEYED--EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP 167 (263)
T ss_dssp ECCSSEEHHHHCCT--TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred EecCCeehhhccCC--cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence 99999998876432 23345778899999999998
Q ss_pred ---------------CCCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 134 ---------------QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 134 ---------------~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
..++|+|++|.||+++.++ .+.|+||+.+..
T Consensus 168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~lIDwe~a~~ 213 (263)
T 3tm0_A 168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK-VSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE-EEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc-EEEEEEchhccc
Confidence 4489999999999998543 567999997753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.35 E-value=4.9e-12 Score=105.16 Aligned_cols=139 Identities=17% Similarity=0.150 Sum_probs=101.5
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCC-eeeeeeeeeccCCCCcEEE
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPN-IVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~-i~~~~~~~~~~~~~~~~lv 96 (321)
.....+.+....+.|..+.||++.. .++..+++|+........+..|..+++.+..+.- +++++++..+. ...+++
T Consensus 17 ~~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~--~~~~~v 93 (264)
T 1nd4_A 17 ERLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWLL 93 (264)
T ss_dssp TTTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEEE
T ss_pred HhcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCC--CCCEEE
Confidence 3345566655444566699999864 5677899999876555678899999999965532 66788876443 446799
Q ss_pred EEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCC-----------------------------------------
Q 020826 97 FEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQG----------------------------------------- 135 (321)
Q Consensus 97 ~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~----------------------------------------- 135 (321)
||+++|.++. ..... ...++.+++..|..||+..
T Consensus 94 ~e~i~G~~l~--~~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (264)
T 1nd4_A 94 LGEVPGQDLL--SSHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPA 168 (264)
T ss_dssp EECCSSEETT--TSCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHH
T ss_pred EEecCCcccC--cCcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHH
Confidence 9999999885 22222 2356677888888888643
Q ss_pred -----------------CeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 136 -----------------IMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 136 -----------------i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
++|+|++|.||+++.++ .+.|+||+.+..
T Consensus 169 ~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~liD~~~a~~ 214 (264)
T 1nd4_A 169 ELFARLKARMPDGEDLVVTHGDACLPNIMVENGR-FSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred HHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCc-EEEEEcchhccc
Confidence 99999999999998554 567999998754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.24 E-value=1e-10 Score=102.03 Aligned_cols=141 Identities=21% Similarity=0.352 Sum_probs=108.0
Q ss_pred EeeeeeeecceEEEEEEEecCCceEEEEEec--ccc----hHHHHHHHHHHHhhcC-CCCeeeeeeeeeccCC-CCcEEE
Q 020826 25 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVK----KKKIKREIKILQNLCG-GPNIVKLLDIVRDQQS-KTPSLI 96 (321)
Q Consensus 25 ~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~--~~~----~~~~~~E~~~l~~l~~-h~~i~~~~~~~~~~~~-~~~~lv 96 (321)
.++.++.|.++.||++.. .+..+++|... ... ...+.+|..+++.|.. +..+++++.++.+... ...++|
T Consensus 42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v 119 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI 119 (359)
T ss_dssp EEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence 466789999999999875 34678898876 322 3578899999999953 3568888888754422 346799
Q ss_pred EEeecCchhh-hhcCCCCHHHHHHHHHHHHHHHHHHHH------------------------------------------
Q 020826 97 FEHVNNTDFK-VLYPTLSDYDVRYYIYELLKALDYCHS------------------------------------------ 133 (321)
Q Consensus 97 ~e~~~~~~l~-~~~~~~~~~~~~~i~~qi~~~l~~lh~------------------------------------------ 133 (321)
||+++|..+. .....++......++.+++.+|+.||+
T Consensus 120 me~v~G~~l~~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (359)
T 3dxp_A 120 MEFVSGRVLWDQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDS 199 (359)
T ss_dssp EECCCCBCCCCTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHH
T ss_pred EEecCCeecCCCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHH
Confidence 9999998884 345668888889999999999999997
Q ss_pred ----------------CCCeeecCCCCCeEEcCCCC-eEEEeeccceeecC
Q 020826 134 ----------------QGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYH 167 (321)
Q Consensus 134 ----------------~~i~H~dlkp~nili~~~~~-~v~l~dfg~~~~~~ 167 (321)
..++|||++|.||+++.++. .+.|+||+.+....
T Consensus 200 ~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~ 250 (359)
T 3dxp_A 200 LMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH 250 (359)
T ss_dssp HHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred HHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence 35899999999999987652 46899999987643
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.15 E-value=1.2e-10 Score=99.15 Aligned_cols=186 Identities=17% Similarity=0.260 Sum_probs=123.7
Q ss_pred eeeeeeecceEEEEEEEecCCceEEEEEeccc-chHHHHHHHHHHHhhcCCCC--eeeeeeeeeccCC-CCcEEEEEeec
Q 020826 26 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPN--IVKLLDIVRDQQS-KTPSLIFEHVN 101 (321)
Q Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-~~~~~~~E~~~l~~l~~h~~--i~~~~~~~~~~~~-~~~~lv~e~~~ 101 (321)
++.++.|....||++. ..+++|+.... ....+.+|..+++.+..+.. +++++........ ...++||++++
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 3458999999999863 56899986644 34678899999998844332 4555554432221 24578999999
Q ss_pred Cchhhh-hcCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------------
Q 020826 102 NTDFKV-LYPTLSDYDVRYYIYELLKALDYCHS----------------------------------------------- 133 (321)
Q Consensus 102 ~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lh~----------------------------------------------- 133 (321)
|.++.. ....++..+...++.+++..++.||+
T Consensus 100 G~~l~~~~~~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 179 (304)
T 3sg8_A 100 GVPLTPLLLNNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRD 179 (304)
T ss_dssp CEECCHHHHHTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHH
T ss_pred CeECCccccccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHH
Confidence 998864 34567888888888999988888886
Q ss_pred -----------CCCeeecCCCCCeEEcCC-CCeEEEeeccceeecCCCCccccccCCccccccccc---c-CCCC-----
Q 020826 134 -----------QGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL---V-DLQD----- 192 (321)
Q Consensus 134 -----------~~i~H~dlkp~nili~~~-~~~v~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~---~-~~~~----- 192 (321)
..++|+|++|.||+++.+ +..+.++||+.+....+............-..|+.. . ..+.
T Consensus 180 ~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~ 259 (304)
T 3sg8_A 180 ILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPT 259 (304)
T ss_dssp HHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHH
T ss_pred HHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHH
Confidence 136999999999999974 436789999998765332221111110000112211 0 0000
Q ss_pred ----CCCcchHHHHHHHHHHHHhCCCCC
Q 020826 193 ----YDYSLDLWSLGCMFAGMIFRKEPF 216 (321)
Q Consensus 193 ----~~~~~DvwslG~~l~~l~~g~~p~ 216 (321)
.....+.|+++.+++.+.+|..+|
T Consensus 260 ~~~r~~~~~~~~~l~~~~~~~~~g~~~~ 287 (304)
T 3sg8_A 260 VLEKYRMKEKYWSFEKIIYGKEYGYMDW 287 (304)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence 112368999999999999998776
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.81 E-value=1.5e-07 Score=80.03 Aligned_cols=136 Identities=18% Similarity=0.260 Sum_probs=96.5
Q ss_pred eeeeeeecceEEEEEEEecCCceEEEEEeccc-chHHHHHHHHHHHhhcCC-C-CeeeeeeeeeccCCCCcEEEEEeecC
Q 020826 26 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGG-P-NIVKLLDIVRDQQSKTPSLIFEHVNN 102 (321)
Q Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-~~~~~~~E~~~l~~l~~h-~-~i~~~~~~~~~~~~~~~~lv~e~~~~ 102 (321)
+..++.|....||+. +..+++|+.+.. ....+.+|..+++.+..+ + .+++.+.+... .....+++|++++|
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~-~~g~~~~v~e~i~G 97 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKR-SDGNPFVGYRKVQG 97 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEEC-TTSCEEEEEECCCS
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeeccc-CCCceEEEEeccCC
Confidence 345788888899987 567889986432 346788999999999543 2 35666666542 23456799999999
Q ss_pred chhhh-hcCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------------
Q 020826 103 TDFKV-LYPTLSDYDVRYYIYELLKALDYCHSQ----------------------------------------------- 134 (321)
Q Consensus 103 ~~l~~-~~~~~~~~~~~~i~~qi~~~l~~lh~~----------------------------------------------- 134 (321)
..+.. ....++......++.++...|+.||+.
T Consensus 98 ~~l~~~~~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~ 177 (306)
T 3tdw_A 98 QILGEDGMAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQ 177 (306)
T ss_dssp EECHHHHHTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHH
T ss_pred eECchhhhhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHH
Confidence 98865 234456666666666666666666642
Q ss_pred -------------CCeeecCCCCCeEEcC---CCCeEEEeeccceeecC
Q 020826 135 -------------GIMHRDVKPHNVMIDH---EQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 135 -------------~i~H~dlkp~nili~~---~~~~v~l~dfg~~~~~~ 167 (321)
.++|+|++|.||+++. ++..+.|+||+.+....
T Consensus 178 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd 226 (306)
T 3tdw_A 178 SYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD 226 (306)
T ss_dssp HHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred HHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence 2489999999999987 35356899999887643
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.79 E-value=5.9e-08 Score=80.91 Aligned_cols=133 Identities=14% Similarity=0.106 Sum_probs=96.0
Q ss_pred eeeecce-EEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeecCchhhh
Q 020826 29 VGRGKYS-EVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKV 107 (321)
Q Consensus 29 lg~g~~g-~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~ 107 (321)
+..|..+ .||+.....++..+++|+-.......+..|...++.|..+-.+++++.+..+. ...++||++++|.++..
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~--~~~~lvme~l~G~~~~~ 109 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP--DDAWLLTTAIPGKTAFQ 109 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEEEECCCSEEHHH
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC--CeEEEEEEeeCCccccc
Confidence 4456555 68998877778889999987766778899999999996665688888887654 45679999999987655
Q ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHC-----------------------------------------------------
Q 020826 108 LYPTLSDYDVRYYIYELLKALDYCHSQ----------------------------------------------------- 134 (321)
Q Consensus 108 ~~~~~~~~~~~~i~~qi~~~l~~lh~~----------------------------------------------------- 134 (321)
..... ......+..++...|..||+.
T Consensus 110 ~~~~~-~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 188 (272)
T 4gkh_A 110 VLEEY-PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLP 188 (272)
T ss_dssp HHHHC-GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCC
T ss_pred cccCC-HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhccc
Confidence 43221 122234445555555555531
Q ss_pred -----CCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 135 -----GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 135 -----~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
.++|||+.+.||+++.++ .+-|+||+.+..
T Consensus 189 ~~~~~~l~HGDl~~~Nil~~~~~-~~~viDwe~a~~ 223 (272)
T 4gkh_A 189 FSPDSVVTHGDFSLDNLIFDEGK-LIGCIDVGRVGI 223 (272)
T ss_dssp CCCCEEEECSCCCTTSEEEETTE-EEEECCCTTCEE
T ss_pred ccCCcEEEcCCCCCCeEEEECCe-EEEEEECccccc
Confidence 168999999999998655 667999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.48 E-value=7e-07 Score=77.50 Aligned_cols=84 Identities=12% Similarity=0.098 Sum_probs=58.8
Q ss_pred eEEeeee-eeecceEEEEEEEe--c----CCceEEEEEecccc------hHHHHHHHHHHHhhcCC--CCeeeeeeeeec
Q 020826 23 YEVVRKV-GRGKYSEVFEGVHC--T----DNEKCIIKILKPVK------KKKIKREIKILQNLCGG--PNIVKLLDIVRD 87 (321)
Q Consensus 23 y~~~~~l-g~g~~g~v~~~~~~--~----~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h--~~i~~~~~~~~~ 87 (321)
....+.| +.|....+|+.... . ++..+++|...... ...+.+|..+++.|..+ -.+++++.+..+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 4455677 78888999988653 1 25688999876433 25688999999988554 357788877644
Q ss_pred cC-CCCcEEEEEeecCchhh
Q 020826 88 QQ-SKTPSLIFEHVNNTDFK 106 (321)
Q Consensus 88 ~~-~~~~~lv~e~~~~~~l~ 106 (321)
.. ....+++||+++|..+.
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp STTTSSCEEEEECCCCBCCC
T ss_pred CCccCCceEEEEecCCCChh
Confidence 32 13457999999987654
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.24 E-value=4.8e-06 Score=73.30 Aligned_cols=74 Identities=16% Similarity=0.220 Sum_probs=49.1
Q ss_pred eeeeeeecceEEEEEEEecCCceEEEEEeccc----------chHHHHHHHHHHHhhcCC-C-CeeeeeeeeeccCCCCc
Q 020826 26 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----------KKKKIKREIKILQNLCGG-P-NIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~----------~~~~~~~E~~~l~~l~~h-~-~i~~~~~~~~~~~~~~~ 93 (321)
.+.+|.|..+.||++....++..+++|...+. ....+..|..+++.+... | .+++++.+. .. ..
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~d--~~--~~ 110 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TE--MA 110 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TT--TT
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEEc--CC--cc
Confidence 55789999999999976556788999976432 124567899999887442 2 345566542 22 34
Q ss_pred EEEEEeecCc
Q 020826 94 SLIFEHVNNT 103 (321)
Q Consensus 94 ~lv~e~~~~~ 103 (321)
++|||++.+.
T Consensus 111 ~lvmE~l~g~ 120 (397)
T 2olc_A 111 VTVMEDLSHL 120 (397)
T ss_dssp EEEECCCTTS
T ss_pred EEEEEeCCCc
Confidence 6999999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.93 E-value=7.3e-05 Score=64.13 Aligned_cols=77 Identities=13% Similarity=0.174 Sum_probs=43.0
Q ss_pred eeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCC-CCeeeeeeeeec----cCCCCcEEEEEee
Q 020826 26 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGG-PNIVKLLDIVRD----QQSKTPSLIFEHV 100 (321)
Q Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h-~~i~~~~~~~~~----~~~~~~~lv~e~~ 100 (321)
+..|+.|..+.||++.. ++..+++|+... ....+..|..+++.|..+ -.+++++..... ......+++++++
T Consensus 37 ~~~l~gG~~n~~~~v~~--~~~~~vlk~~~~-~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i 113 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHT--DSGAVCLKRIHR-PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWI 113 (346)
T ss_dssp EEECC----CEEEEEEE--TTEEEEEEEECS-CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECC
T ss_pred eeeccccccCcEEEEEe--CCCCEEEEecCC-CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEee
Confidence 34566677889999875 234589999875 334556677777766321 134444431100 1123457999999
Q ss_pred cCchh
Q 020826 101 NNTDF 105 (321)
Q Consensus 101 ~~~~l 105 (321)
+|..+
T Consensus 114 ~G~~~ 118 (346)
T 2q83_A 114 EGRPF 118 (346)
T ss_dssp CCBCC
T ss_pred cCccC
Confidence 88643
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.93 E-value=9e-05 Score=62.74 Aligned_cols=78 Identities=18% Similarity=0.193 Sum_probs=60.1
Q ss_pred EEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCC--CCeeeeeeeeeccCCCCcEEEEEeec
Q 020826 24 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGG--PNIVKLLDIVRDQQSKTPSLIFEHVN 101 (321)
Q Consensus 24 ~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h--~~i~~~~~~~~~~~~~~~~lv~e~~~ 101 (321)
.-.+.|+.|....+|+... ++..+++|+........+..|...|+.|... ..+++++.+.... ...++|||+++
T Consensus 39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~--g~~~lvme~l~ 114 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ--GHSFLLLEALN 114 (312)
T ss_dssp CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS--SEEEEEEECCC
T ss_pred eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC--CceEEEEEecc
Confidence 3456789999999999874 5678899998766667789999999988543 5678888876443 45679999998
Q ss_pred Cchh
Q 020826 102 NTDF 105 (321)
Q Consensus 102 ~~~l 105 (321)
+..+
T Consensus 115 G~~~ 118 (312)
T 3jr1_A 115 KSKN 118 (312)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 7643
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.91 E-value=0.00016 Score=56.94 Aligned_cols=91 Identities=10% Similarity=-0.017 Sum_probs=58.8
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCccccccCCcccccccccc
Q 020826 110 PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 188 (321)
Q Consensus 110 ~~~~~~~~~~i~~qi~~~l~~lh~-~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~ 188 (321)
.++++.++|.++.|.+.+|.-+-. +.-...=+.|..|++..+| .|.+.+ ..+ ......+.|||...
T Consensus 44 ~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG-~V~f~~-~~s-----------~~~~~~~~~pe~~~ 110 (229)
T 2yle_A 44 QPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG-AVTLAP-AAD-----------DAGEPPPVAGKLGY 110 (229)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS-CEEECC-C-----------------------CCSS
T ss_pred CCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC-ceeccc-ccc-----------cccccCCCChhhcc
Confidence 689999999999999998877632 2212334457889998888 666553 111 01223456888763
Q ss_pred CCCCCCCcchHHHHHHHHHHHHhCCCC
Q 020826 189 DLQDYDYSLDLWSLGCMFAGMIFRKEP 215 (321)
Q Consensus 189 ~~~~~~~~~DvwslG~~l~~l~~g~~p 215 (321)
...+.+.-|+|||+++|..+--..|
T Consensus 111 --~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 111 --SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp --SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred --ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 3567888999999999999865555
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.88 E-value=0.00012 Score=61.78 Aligned_cols=70 Identities=9% Similarity=0.025 Sum_probs=46.5
Q ss_pred eeeeeeecceEEEEEEEecCCceEEEEEecccch--HHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEee-cC
Q 020826 26 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHV-NN 102 (321)
Q Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~--~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~-~~ 102 (321)
++.|+.|....+|++ ..+++|+...... -....|...++.+..+.-.++++... .... +++++++ ++
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~--~~v~e~i~~g 92 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATG--VMVTRYIAGA 92 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTC--CEEEECCTTC
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCC--EEEEeecCCC
Confidence 567889999999998 6788998765322 23467888888775443335666554 2222 4899999 76
Q ss_pred chh
Q 020826 103 TDF 105 (321)
Q Consensus 103 ~~l 105 (321)
.++
T Consensus 93 ~~l 95 (301)
T 3dxq_A 93 QTM 95 (301)
T ss_dssp EEC
T ss_pred ccC
Confidence 554
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.71 E-value=0.00017 Score=61.37 Aligned_cols=139 Identities=17% Similarity=0.173 Sum_probs=78.8
Q ss_pred EEeeeeeeecceEEEEEEEecCCceEEEEEeccc-chHHHHHHHHHHHhhcCCC-Ceeeeeeeeec----cCCCCcEEEE
Q 020826 24 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGP-NIVKLLDIVRD----QQSKTPSLIF 97 (321)
Q Consensus 24 ~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-~~~~~~~E~~~l~~l~~h~-~i~~~~~~~~~----~~~~~~~lv~ 97 (321)
.-.+.|+.|....+|++.. .+ ..+++|+.... ....+..|..+++.|..+. .+++++..... ......++++
T Consensus 25 ~~~~~i~~G~~n~~~~v~~-~~-g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~ 102 (322)
T 2ppq_A 25 TSYKGIAEGVENSNFLLHT-TK-DPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 102 (322)
T ss_dssp EEEEEECC---EEEEEEEE-SS-CCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred eEeeccCCCcccceEEEEe-CC-ccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence 3455677888899999875 23 37889998762 4556788998888885332 24444432100 0112357899
Q ss_pred EeecCchhhh------------------hcCCCCH-------HHHHH----------------HHHHHHHHHHHHHH---
Q 020826 98 EHVNNTDFKV------------------LYPTLSD-------YDVRY----------------YIYELLKALDYCHS--- 133 (321)
Q Consensus 98 e~~~~~~l~~------------------~~~~~~~-------~~~~~----------------i~~qi~~~l~~lh~--- 133 (321)
++++|..+.. ....++. ...+. +...+...++.+.+
T Consensus 103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~ 182 (322)
T 2ppq_A 103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 182 (322)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence 9998764321 0011100 00000 00113334455543
Q ss_pred ----CCCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 134 ----QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 134 ----~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
.+++|+|+.+.||+++.++ .+.++||+.+..
T Consensus 183 ~~~~~~liHgDl~~~Nil~~~~~-~~~lIDf~~a~~ 217 (322)
T 2ppq_A 183 KDLPAGVIHADLFQDNVFFLGDE-LSGLIDFYFACN 217 (322)
T ss_dssp CSSCEEEECSCCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred ccCCcccCCCCCCccCEEEeCCc-eEEEecchhccC
Confidence 3699999999999998654 558999998754
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00026 Score=62.83 Aligned_cols=74 Identities=14% Similarity=0.140 Sum_probs=52.0
Q ss_pred eeeeeeecceEEEEEEEec-------CCceEEEEEecccch-HHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 26 VRKVGRGKYSEVFEGVHCT-------DNEKCIIKILKPVKK-KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 26 ~~~lg~g~~g~v~~~~~~~-------~~~~~~vK~~~~~~~-~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
+..|+.|....+|++.... ++..+++|+...... ..+..|..+++.|..+.-.+++++.+. + .+++
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~----g~v~ 151 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFS--G----GRLE 151 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T----EEEE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C----CEEE
Confidence 4568888889999997642 257899999854223 566689999998865544567777652 2 3889
Q ss_pred EeecCchh
Q 020826 98 EHVNNTDF 105 (321)
Q Consensus 98 e~~~~~~l 105 (321)
+|++|.++
T Consensus 152 e~l~G~~l 159 (429)
T 1nw1_A 152 EYIPSRPL 159 (429)
T ss_dssp CCCCEEEC
T ss_pred EEeCCccc
Confidence 99887543
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00012 Score=64.79 Aligned_cols=78 Identities=13% Similarity=0.141 Sum_probs=45.9
Q ss_pred HCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCccccccC--CccccccccccCCCC--CCCcchHHHHHHHHHH
Q 020826 133 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVA--SRYFKGPELLVDLQD--YDYSLDLWSLGCMFAG 208 (321)
Q Consensus 133 ~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~~~~~~--~~~y~aPE~~~~~~~--~~~~~DvwslG~~l~~ 208 (321)
...++|||++|.||+++.++ +.++||+.+....+......... ...|.+|+....... .....++.++...+++
T Consensus 231 ~~~liHGDl~~~Nil~~~~~--~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS--TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC--EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC--CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 45699999999999998664 89999998876543222211111 123556655432111 1123444566666666
Q ss_pred HHhC
Q 020826 209 MIFR 212 (321)
Q Consensus 209 l~~g 212 (321)
.+++
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6654
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.64 E-value=0.00012 Score=62.62 Aligned_cols=136 Identities=14% Similarity=0.134 Sum_probs=72.1
Q ss_pred eeeeeecceE-EEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCC-CeeeeeeeeeccCCCCcEEEEEeecCch
Q 020826 27 RKVGRGKYSE-VFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGP-NIVKLLDIVRDQQSKTPSLIFEHVNNTD 104 (321)
Q Consensus 27 ~~lg~g~~g~-v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~-~i~~~~~~~~~~~~~~~~lv~e~~~~~~ 104 (321)
+.|+.|.... +|+... .++..+++|...+.....+..|+.+++.|..+. .+++++.+. .... ++++|++++..
T Consensus 24 ~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~d--~~~g--~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAEE--HARG--LLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEEC-TTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEEE--TTTT--EEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEc-CCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeeec--CCCC--EEEEeeCCCcc
Confidence 3465555444 667653 236677888655433256677888888875432 356666653 2222 58999987654
Q ss_pred hhhhc-----------------------------CCCCHHHHHH--------HH------------HHHHHHHHHHH---
Q 020826 105 FKVLY-----------------------------PTLSDYDVRY--------YI------------YELLKALDYCH--- 132 (321)
Q Consensus 105 l~~~~-----------------------------~~~~~~~~~~--------i~------------~qi~~~l~~lh--- 132 (321)
+...+ +.+....... +. ..+...+..+.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 42111 0111111000 00 01111222221
Q ss_pred ---HCCCeeecCCCCCeEEcCC---CCeEEEeeccceeecC
Q 020826 133 ---SQGIMHRDVKPHNVMIDHE---QRKLRLIDWGLAEFYH 167 (321)
Q Consensus 133 ---~~~i~H~dlkp~nili~~~---~~~v~l~dfg~~~~~~ 167 (321)
...++|||+.+.||+++.+ ...+.++||+.+....
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~ 219 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH 219 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence 2369999999999999864 1278999999887644
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.56 E-value=0.0012 Score=55.07 Aligned_cols=76 Identities=14% Similarity=0.132 Sum_probs=55.9
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc---hHHHHHHHHHHHhhcCC--CCeeeeeeeeeccCCCCcEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGG--PNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~---~~~~~~E~~~l~~l~~h--~~i~~~~~~~~~~~~~~~~l 95 (321)
.+..-++.+|.|..+.||+... .+|+.+++|+..... ...+..|...|+.|... -.+++++.+. . .++
T Consensus 15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~--~----~~l 87 (288)
T 3f7w_A 15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD--D----RTL 87 (288)
T ss_dssp CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE--T----TEE
T ss_pred CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc--C----ceE
Confidence 4566778899999999999986 678899999865432 34688999999998543 2456666543 1 258
Q ss_pred EEEeecCc
Q 020826 96 IFEHVNNT 103 (321)
Q Consensus 96 v~e~~~~~ 103 (321)
+||+..+.
T Consensus 88 v~e~l~~~ 95 (288)
T 3f7w_A 88 AMEWVDER 95 (288)
T ss_dssp EEECCCCC
T ss_pred EEEeeccc
Confidence 99988654
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.43 E-value=0.00096 Score=58.01 Aligned_cols=133 Identities=12% Similarity=0.176 Sum_probs=80.8
Q ss_pred eeeeeecceEEEEEEEec-------CCceEEEEEeccc--chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 27 RKVGRGKYSEVFEGVHCT-------DNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 27 ~~lg~g~~g~v~~~~~~~-------~~~~~~vK~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
+.|..|-...+|++.... ++..+++|+.... ......+|..+++.|..+.-.+++++.+.+ .+|+
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~------g~v~ 129 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE------GRLE 129 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT------EEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC------ccEE
Confidence 457778888999987632 3578999986432 345567899999988655555777776632 2999
Q ss_pred EeecCchhhhh--c-------------------CC----CC--HHHHHHHHHHHHH-------------------HHHHH
Q 020826 98 EHVNNTDFKVL--Y-------------------PT----LS--DYDVRYYIYELLK-------------------ALDYC 131 (321)
Q Consensus 98 e~~~~~~l~~~--~-------------------~~----~~--~~~~~~i~~qi~~-------------------~l~~l 131 (321)
|+++|.++... . .+ .. ...+.++..++.. .+..|
T Consensus 130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L 209 (379)
T 3feg_A 130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL 209 (379)
T ss_dssp ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence 99988654311 0 01 11 2334444433321 12222
Q ss_pred H----HC----CCeeecCCCCCeEEcCC---CCeEEEeeccceee
Q 020826 132 H----SQ----GIMHRDVKPHNVMIDHE---QRKLRLIDWGLAEF 165 (321)
Q Consensus 132 h----~~----~i~H~dlkp~nili~~~---~~~v~l~dfg~~~~ 165 (321)
. .. .++|+|+.+.||+++.+ ...+.++||..+..
T Consensus 210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 22 48999999999999876 12789999998864
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.36 E-value=0.0015 Score=58.37 Aligned_cols=75 Identities=16% Similarity=0.165 Sum_probs=50.2
Q ss_pred EeeeeeeecceEEEEEEEecCCceEEEEEecccchH--HHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeecC
Q 020826 25 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKK--KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNN 102 (321)
Q Consensus 25 ~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~--~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~ 102 (321)
-+..|+.|-...+|++.....+..+++|+....... ...+|..+++.|..+.-.+++++.+ .+ .++++|++|
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~----G~v~e~I~G 185 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF--TN----GRIEEFMDG 185 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT----EEEEECCCS
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC----eEEEEeeCC
Confidence 345688888899999886433578999987543221 2368999999996555456777766 22 369999987
Q ss_pred chh
Q 020826 103 TDF 105 (321)
Q Consensus 103 ~~l 105 (321)
.++
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 554
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.30 E-value=0.0013 Score=56.96 Aligned_cols=74 Identities=14% Similarity=0.148 Sum_probs=46.1
Q ss_pred eeeeeeecceEEEEEEEec--------CCceEEEEEecccchH--HHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 26 VRKVGRGKYSEVFEGVHCT--------DNEKCIIKILKPVKKK--KIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 26 ~~~lg~g~~g~v~~~~~~~--------~~~~~~vK~~~~~~~~--~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
...++.|....+|++.... .+..+++|+....... ....|..+++.+..+.-.++++... . -++
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~----~~~ 111 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N----GGR 111 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T----TEE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C----CcE
Confidence 4467788888999987643 1368899987643222 2478888888885443355666544 2 258
Q ss_pred EEEeecCchh
Q 020826 96 IFEHVNNTDF 105 (321)
Q Consensus 96 v~e~~~~~~l 105 (321)
++++++|..+
T Consensus 112 v~e~i~G~~l 121 (369)
T 3c5i_A 112 IEEWLYGDPL 121 (369)
T ss_dssp EEECCCSEEC
T ss_pred EEEEecCCcC
Confidence 9999987643
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.23 E-value=0.0017 Score=55.18 Aligned_cols=75 Identities=15% Similarity=0.249 Sum_probs=48.1
Q ss_pred eeeeecceEEEEEEEecCCceEEEEEeccc--chHHHHHHHHHHHhhcCCC-Ceeeeeeeeecc----CCCCcEEEEEee
Q 020826 28 KVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGP-NIVKLLDIVRDQ----QSKTPSLIFEHV 100 (321)
Q Consensus 28 ~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~E~~~l~~l~~h~-~i~~~~~~~~~~----~~~~~~lv~e~~ 100 (321)
.++ |....||++.. .+|+.+++|..++. ....+..|..+++.|..+. .+++++.. ... .....+++++++
T Consensus 33 ~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~-~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 33 PLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF-NGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB-TTBSCEEETTEEEEEEECC
T ss_pred eec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec-CCcEEEEECCEEEEEEEec
Confidence 455 77889998754 45668999998743 4567788999888884332 24445443 110 122446899999
Q ss_pred cCchh
Q 020826 101 NNTDF 105 (321)
Q Consensus 101 ~~~~l 105 (321)
+|..+
T Consensus 110 ~G~~~ 114 (328)
T 1zyl_A 110 GGRQF 114 (328)
T ss_dssp CCEEC
T ss_pred CCCCC
Confidence 87543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.61 E-value=0.013 Score=50.01 Aligned_cols=70 Identities=9% Similarity=0.115 Sum_probs=42.8
Q ss_pred eecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCC--CCeeeeeeeeec----cCCCCcEEEEEeecCch
Q 020826 31 RGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGG--PNIVKLLDIVRD----QQSKTPSLIFEHVNNTD 104 (321)
Q Consensus 31 ~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h--~~i~~~~~~~~~----~~~~~~~lv~e~~~~~~ 104 (321)
.|....||++.. .++ .+++|+.+... ...|...++.|..+ |++++.+..... ......+++++|++|..
T Consensus 33 ~g~~N~vy~v~~-~~g-~~vLK~~~~~~---~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~~ 107 (339)
T 3i1a_A 33 ADTNAFAYQADS-ESK-SYFIKLKYGYH---DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPN 107 (339)
T ss_dssp SCSSCEEEEEEC-SSC-EEEEEEEECSS---CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCCB
T ss_pred CccccceEEEEe-CCC-CEEEEEecCcc---chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCCc
Confidence 334678999875 344 89999876543 25677777777432 324555432111 11245679999998865
Q ss_pred h
Q 020826 105 F 105 (321)
Q Consensus 105 l 105 (321)
+
T Consensus 108 ~ 108 (339)
T 3i1a_A 108 G 108 (339)
T ss_dssp T
T ss_pred C
Confidence 4
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.43 E-value=0.013 Score=51.75 Aligned_cols=74 Identities=12% Similarity=0.157 Sum_probs=50.2
Q ss_pred eeeeeeecceEEEEEEEecC-------CceEEEEEecccch--HHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 26 VRKVGRGKYSEVFEGVHCTD-------NEKCIIKILKPVKK--KKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 26 ~~~lg~g~~g~v~~~~~~~~-------~~~~~vK~~~~~~~--~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
++.+..|-...+|++..... +..+++++...... -...+|..+++.|..+.-.+++++.+ . -+.|
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~----~~~I 148 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P----EGRI 148 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T----TEEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C----CCEE
Confidence 44577778889999886421 57899998654321 23468999998886555556677644 2 2589
Q ss_pred EEeecCchh
Q 020826 97 FEHVNNTDF 105 (321)
Q Consensus 97 ~e~~~~~~l 105 (321)
++|++|..+
T Consensus 149 ~efI~G~~l 157 (424)
T 3mes_A 149 EEFIDGEPL 157 (424)
T ss_dssp EECCCSEEC
T ss_pred EEEeCCccC
Confidence 999988654
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.72 E-value=0.074 Score=46.51 Aligned_cols=30 Identities=30% Similarity=0.596 Sum_probs=24.5
Q ss_pred CeeecCCCCCeEEcC-----CCCeEEEeeccceee
Q 020826 136 IMHRDVKPHNVMIDH-----EQRKLRLIDWGLAEF 165 (321)
Q Consensus 136 i~H~dlkp~nili~~-----~~~~v~l~dfg~~~~ 165 (321)
++|+|+.+.||++.. ++..+.++||..+..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 689999999999942 333799999998865
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=88.46 E-value=0.72 Score=36.19 Aligned_cols=122 Identities=10% Similarity=0.150 Sum_probs=76.7
Q ss_pred HHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEEeec-CchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCC
Q 020826 64 REIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVN-NTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVK 142 (321)
Q Consensus 64 ~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlk 142 (321)
.|+..+.. .+|+.+.. .+-.+. ....+.++.-. +.++.. ++.++....++++.+|+....+++. -.|--+.
T Consensus 35 ~el~LL~~--~~~~Fl~~-~I~e~e--D~v~~~y~~~~~~~~f~~-ik~~~~~eKlr~l~ni~~l~~~~~~--r~tf~L~ 106 (215)
T 4ann_A 35 HLMYLLEQ--HSPYFIDA-ELTELR--DSFQIHYDINDNHTPFDN-IKSFTKNEKLRYLLNIKNLEEVNRT--RYTFVLA 106 (215)
T ss_dssp GGGGGGGS--CCTTBCCE-EEEECS--SEEEEEECCCTTSEEGGG-GGGSCHHHHHHHHHHGGGGGGGGGS--SEECCCS
T ss_pred HHHHHHhc--cCCcccce-EEEEcc--cEEEEEEEcCcccCCHHH-HHhcCHHHHHHHHHHHHHHHHHhcC--ceEEEEe
Confidence 44555543 68888765 333222 23233333333 223444 6788999999999999887644433 4788999
Q ss_pred CCCeEEcCCCCeEEEeeccceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 020826 143 PHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 216 (321)
Q Consensus 143 p~nili~~~~~~v~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~ 216 (321)
|+|++++.++ .+++.-.|+-... +|. ..+...=.-.+=|++..+++++..|
T Consensus 107 P~NL~f~~~~-~p~i~~RGik~~l----------------~P~------~~~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 107 PDELFFTRDG-LPIAKTRGLQNVV----------------DPL------PVSEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp GGGEEECTTS-CEEESCCEETTTB----------------SCC------CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred cceEEEcCCC-CEEEEEccCccCC----------------CCC------CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 9999999888 7888877754321 111 1122222335778888899988887
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=82.41 E-value=16 Score=30.73 Aligned_cols=140 Identities=14% Similarity=0.192 Sum_probs=73.6
Q ss_pred ceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeee-----------------
Q 020826 22 DYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDI----------------- 84 (321)
Q Consensus 22 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~----------------- 84 (321)
+++.++..-.|.. .||.+.. ++..++||.........+-.++.....+ .-|+..-+.-.
T Consensus 70 ~v~~I~~s~~Gst-gvff~~t--d~~~~VVK~s~~l~~E~l~s~LA~~LGl-piP~~Riv~~~~~E~~e~~~~L~~~~~~ 145 (342)
T 1cja_A 70 QFKGIERSEKGTE-GLFFVET--ESGVFIVKRSTNIESETFCSLLCMRLGL-HAPKVRVVSSNSEEGTNMLECLAAIDKS 145 (342)
T ss_dssp GEEEEEECCSTTS-CEEEEEE--SSCEEEEECCTTHHHHHHHHHHHHHHTC-CCCCEEEEESSSHHHHHHHHHHHHHCSS
T ss_pred CeeEEEeccCCCC-CeEEEEe--CCCEEEEeCcHHHHHHHHHHHHHHHhCC-CCCCeeEEeeCcHHHHHHHHHHHHhhhh
Confidence 3777777766654 5555544 5778999965322222233333333333 44543222211
Q ss_pred ---eeccCCCCcEEEEEeecCchhhhhcCCC-CHHHHHHHHHHH--HHHHHHHHHCC--C---eeecCCCCCeEEcCCCC
Q 020826 85 ---VRDQQSKTPSLIFEHVNNTDFKVLYPTL-SDYDVRYYIYEL--LKALDYCHSQG--I---MHRDVKPHNVMIDHEQR 153 (321)
Q Consensus 85 ---~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~i~~qi--~~~l~~lh~~~--i---~H~dlkp~nili~~~~~ 153 (321)
..........++|+|..|..|....... .+........++ +-++..+..++ . -+..-.+.||+++.++.
T Consensus 146 ~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~~~~k~LG~Ii~FDi~InN~DR~Pl~W~n~GN~~NIL~~~~n~ 225 (342)
T 1cja_A 146 FRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKSTMQQLGSLMALDVIVNNSDRLPIAWTNEGNLDNIMLSERGA 225 (342)
T ss_dssp SCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHHHHHHHHHHHHHHHHTCCSSSCSSSCSCCCGGGEEEESBTT
T ss_pred hHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCHHHHHhhchhheehhhhcCCccCcccccCCCChhheEEeCCCC
Confidence 0111122345999999987766554321 111112223332 23455555543 1 11235789999987765
Q ss_pred eEEEeeccceee
Q 020826 154 KLRLIDWGLAEF 165 (321)
Q Consensus 154 ~v~l~dfg~~~~ 165 (321)
.+.++|-+.+..
T Consensus 226 ~~~~IDhn~af~ 237 (342)
T 1cja_A 226 TVVPIDSKIIPL 237 (342)
T ss_dssp CEEECSCCCCCC
T ss_pred eEEEEcCCcccc
Confidence 788999988854
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=81.62 E-value=1.3 Score=34.91 Aligned_cols=113 Identities=14% Similarity=0.158 Sum_probs=70.1
Q ss_pred CCCCeeeeeeeeeccCCCCcEEEEEeecCc-hhhhhcCCCCHHHHHHHHHHHHHHHH-HHHHCCCeeecCCCCCeEEcCC
Q 020826 74 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNT-DFKVLYPTLSDYDVRYYIYELLKALD-YCHSQGIMHRDVKPHNVMIDHE 151 (321)
Q Consensus 74 ~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-~l~~~~~~~~~~~~~~i~~qi~~~l~-~lh~~~i~H~dlkp~nili~~~ 151 (321)
.+|+...-+.. + ...+.+.++.-.+. ++. .++.++..+.++++.+|+.... ++ ..-.|--+.|+|++++.+
T Consensus 48 ~~~~f~~~I~~--~--eD~~~i~y~~~~~~~~f~-~i~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~ 120 (219)
T 4ano_A 48 VDPCIVRDIDV--S--EDEVKVVIKPPSSFLTFA-AIRKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA 120 (219)
T ss_dssp SCSSSEEEEEE--C--SSEEEEEEECCTTCEEHH-HHHTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred cCCCCCeEEEE--e--CCEEEEEEEcCcccCcHH-HHHhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence 67888433332 2 22323444443233 344 4477899999999998887544 33 445788999999999988
Q ss_pred CCeEEEeeccceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCC
Q 020826 152 QRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF 216 (321)
Q Consensus 152 ~~~v~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~ 216 (321)
+ .+++.-.|+-... +|. ..+..-=.-.+=|++..++.++..|
T Consensus 121 ~-~p~i~hRGi~~~l----------------pP~------e~~ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 121 L-EPFFLHVGVKESL----------------PPD------EWDDERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp C-CEEESCCEETTTB----------------SSC------SCCHHHHHHHHHHHHHHHTTCSSCH
T ss_pred C-cEEEEEcCCcccC----------------CCC------CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 8 7999888754321 221 1111112334677888888887776
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 321 | ||||
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-92 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 4e-61 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-57 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-54 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-53 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-52 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-52 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-52 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-52 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 6e-52 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-51 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-51 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-51 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-50 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-50 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 6e-50 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-49 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 5e-49 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-48 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-48 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-48 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-47 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-47 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-46 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-46 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 7e-44 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-43 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 4e-43 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-43 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-40 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-38 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-38 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-38 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-37 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-37 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-36 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 5e-36 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-35 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-35 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-35 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-34 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-34 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-33 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-33 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-33 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-32 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-32 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 3e-32 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-31 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-31 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-31 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-31 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-30 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-29 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-29 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-27 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-27 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-26 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-26 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 6e-18 |
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 275 bits (705), Expect = 2e-92
Identities = 224/295 (75%), Positives = 260/295 (88%)
Query: 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPN 77
QDDY++VRK+GRGKYSEVFE ++ T+NEK ++KILKPVKKKKIKREIKIL+NL GGPN
Sbjct: 32 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPN 91
Query: 78 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIM 137
I+ L DIV+D S+TP+L+FEHVNNTDFK LY TL+DYD+R+Y+YE+LKALDYCHS GIM
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIM 151
Query: 138 HRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSL 197
HRDVKPHNVMIDHE RKLRLIDWGLAEFYHPG+EYNVRVASRYFKGPELLVD Q YDYSL
Sbjct: 152 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSL 211
Query: 198 DLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALV 257
D+WSLGCM A MIFRKEPFF+GHDNYDQLV+IAKVLGT++L Y++KY+IELDP ++
Sbjct: 212 DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDIL 271
Query: 258 GRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312
GRHSRK W +F+ ENQHL PEA+DFLDKLLRYDHQ R TA+EAM HPYF+ +
Sbjct: 272 GRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (499), Expect = 4e-61
Identities = 92/305 (30%), Positives = 145/305 (47%), Gaps = 21/305 (6%)
Query: 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNI 78
++ Y + +G G + V++ C E IK + K+ RE++I++ L NI
Sbjct: 18 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-DKRFKNRELQIMRKL-DHCNI 75
Query: 79 VKLLDIVRDQQSKTPS----LIFEHVNNTDFKVL------YPTLSDYDVRYYIYELLKAL 128
V+L K L+ ++V T ++V TL V+ Y+Y+L ++L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLV 188
Y HS GI HRD+KP N+++D + L+L D+G A+ G+ + SRY++ PEL+
Sbjct: 136 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF 195
Query: 189 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248
DY S+D+WS GC+ A ++ + P F G DQLV+I KVLGT
Sbjct: 196 GATDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
+ + PW+K + PEA+ +LL Y R T EA AH +F
Sbjct: 255 TEFKFP----QIKAHPWTKVF----RPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306
Query: 309 FPIRN 313
+R+
Sbjct: 307 DELRD 311
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 5e-57
Identities = 62/302 (20%), Positives = 111/302 (36%), Gaps = 20/302 (6%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK----PVKKKKIKREIKILQNLCGGP 76
DD+E + ++G G VF+ H K++ P + +I RE+++L P
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS-P 64
Query: 77 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCHS 133
IV S+ EH++ + + + + ++K L Y
Sbjct: 65 YIVGFYGAFYSDGE--ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 134 Q-GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 192
+ IMHRDVKP N++++ ++L D+G++ N V +R + PE L
Sbjct: 123 KHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQG-TH 179
Query: 193 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT------DELNAYLNKYH 246
Y D+WS+G M + P +L+ +V G
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239
Query: 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 306
+D + ++ + E DF++K L + ER K+ M H
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299
Query: 307 YF 308
+
Sbjct: 300 FI 301
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 3e-54
Identities = 90/310 (29%), Positives = 146/310 (47%), Gaps = 27/310 (8%)
Query: 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQNL 72
E YE + K+G+G + EVF+ H +K +K + +K+ REIKILQ L
Sbjct: 7 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 66
Query: 73 CGGPNIVKLLDIVRDQQSK------TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYE 123
N+V L++I R + S + L+F+ + +L + +++ +
Sbjct: 67 -KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 125
Query: 124 LLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-----YNVRVAS 178
LL L Y H I+HRD+K NV+I + L+L D+GLA + K Y RV +
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVT 184
Query: 179 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 238
+++ PELL+ +DY +DLW GC+ A M R P G+ QL I+++ G+
Sbjct: 185 LWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS-PIMQGNTEQHQLALISQLCGSITP 243
Query: 239 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT 298
+ N + EL L + K ++ P A+D +DKLL D +R
Sbjct: 244 EVWPNVDNYELYEKL-----ELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID 298
Query: 299 AKEAMAHPYF 308
+ +A+ H +F
Sbjct: 299 SDDALNHDFF 308
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (449), Expect = 1e-53
Identities = 83/300 (27%), Positives = 155/300 (51%), Gaps = 21/300 (7%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK----KKIKREIKILQNLCGGP 76
Y + +G G Y V + + IK + P + ++ REIKIL
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRH-E 66
Query: 77 NIVKLLDIVRD---QQSKTPSLIFEHVNNTDFKVL-YPTLSDYDVRYYIYELLKALDYCH 132
NI+ + DI+R +Q K L+ + +K+L LS+ + Y++Y++L+ L Y H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 133 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV----RVASRYFKGPELLV 188
S ++HRD+KP N++++ L++ D+GLA P ++ VA+R+++ PE+++
Sbjct: 127 SANVLHRDLKPSNLLLNTTCD-LKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 189 DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248
+ + Y S+D+WS+GC+ A M+ + P F G DQL I +LG+ +++
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNR-PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244
Query: 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
+L + + ++ PW++ + +A+D LDK+L ++ +R ++A+AHPY
Sbjct: 245 ARNYLLS-LPHKNKVPWNRLFPNAD-----SKALDLLDKMLTFNPHKRIEVEQALAHPYL 298
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 173 bits (440), Expect = 3e-52
Identities = 65/296 (21%), Positives = 128/296 (43%), Gaps = 46/296 (15%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK---PVKKKKIKREIKILQNLCGGPN 77
D Y+++ ++G G + V V + K + P+ K +K EI I+ L P
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPK 87
Query: 78 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHS 133
++ L D D+ LI E ++ + +S+ +V Y+ + + L + H
Sbjct: 88 LINLHDAFEDKYE--MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE 145
Query: 134 QGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 192
I+H D+KP N+M + ++ +++ID+GLA +P + V A+ F PE++ D +
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-DREP 204
Query: 193 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 252
+ D+W++G + ++ P F G D+ + L + + + +
Sbjct: 205 VGFYTDMWAIGVLGYVLLSGLSP-FAGEDDLETLQNVKRCDWE---------FDEDAFSS 254
Query: 253 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
++ PEA DF+ LL+ + ++R T +A+ HP+
Sbjct: 255 VS------------------------PEAKDFIKNLLQKEPRKRLTVHDALEHPWL 286
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 4e-52
Identities = 86/313 (27%), Positives = 146/313 (46%), Gaps = 28/313 (8%)
Query: 18 REQDDYEVVRKVGRGKYSEVFEGVHC-TDNEKCIIKILKPVK-----KKKIKREIKILQN 71
R YE V ++G G Y +VF+ +K ++ RE+ +L++
Sbjct: 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63
Query: 72 LCGG--PNIVKLLDIVRDQQSKTPS---LIFEHVNNTDFKVLY----PTLSDYDVRYYIY 122
L PN+V+L D+ ++ + L+FEHV+ L P + ++ ++
Sbjct: 64 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123
Query: 123 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFK 182
+LL+ LD+ HS ++HRD+KP N+++ + +L D+GLA Y V + +++
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQI-KLADFGLARIYSFQMALTSVVVTLWYR 182
Query: 183 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242
PE+L+ Y +DLWS+GC+FA M RK P F G + DQL KI V+G +
Sbjct: 183 APEVLLQ-SSYATPVDLWSVGCIFAEMFRRK-PLFRGSSDVDQLGKILDVIGLPGEEDWP 240
Query: 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 302
+ S +P KF+T + D L K L ++ +R +A A
Sbjct: 241 RDVALPRQ-----AFHSKSAQPIEKFVTDID-----ELGKDLLLKCLTFNPAKRISAYSA 290
Query: 303 MAHPYFFPIRNAE 315
++HPYF + +
Sbjct: 291 LSHPYFQDLERCK 303
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 5e-52
Identities = 86/296 (29%), Positives = 155/296 (52%), Gaps = 19/296 (6%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQNLCGG 75
++++ V K+G G Y V++ + E +K ++ + + REI +L+ L
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH- 60
Query: 76 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDF--KVLYPTLSDYDVRYYIYELLKALDYCHS 133
PNIVKLLD++ + F H + F + ++ Y+++LL+ L +CHS
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 134 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQD 192
++HRD+KP N++I+ E ++L D+GLA + P + Y V + +++ PE+L+ +
Sbjct: 121 HRVLHRDLKPQNLLINTEGA-IKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 193 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 252
Y ++D+WSLGC+FA M+ R+ F G DQL +I + LGT + + + P
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRAL-FPGDSEIDQLFRIFRTLGTPDEVVWPGVTSM---PD 235
Query: 253 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
+ +R+ +SK + + + L ++L YD +R +AK A+AHP+F
Sbjct: 236 YKPSFPKWARQDFSKVVPPLD-----EDGRSLLSQMLHYDPNKRISAKAALAHPFF 286
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 5e-52
Identities = 82/297 (27%), Positives = 144/297 (48%), Gaps = 26/297 (8%)
Query: 24 EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK--------KKIKREIKILQNLCGG 75
E + +G G+++ V++ N+ IK +K + + REIK+LQ L
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH- 59
Query: 76 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCH 132
PNI+ LLD + SL+F+ + ++ L+ ++ Y+ L+ L+Y H
Sbjct: 60 PNIIGLLDAFGHK--SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 117
Query: 133 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 191
I+HRD+KP+N+++D E L+L D+GLA F P + Y +V +R+++ PELL +
Sbjct: 118 QHWILHRDLKPNNLLLD-ENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGAR 176
Query: 192 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251
Y +D+W++GC+ A ++ R PF G + DQL +I + LGT + + +
Sbjct: 177 MYGVGVDMWAVGCILAELLLRV-PFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235
Query: 252 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
+ G +S A + +D + L ++ R TA +A+ YF
Sbjct: 236 TFKSFPGIPLHHIFSA---------AGDDLLDLIQGLFLFNPCARITATQALKMKYF 283
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (437), Expect = 6e-52
Identities = 86/306 (28%), Positives = 159/306 (51%), Gaps = 21/306 (6%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCG 74
+ Y ++ VG G Y V V K IK L + K+ RE+++L+++
Sbjct: 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRH 76
Query: 75 GPNIVKLLDIVRDQQSKTPS----LIFEHVNNTDFKVL-YPTLSDYDVRYYIYELLKALD 129
N++ LLD+ ++ L+ + K++ + L + +++ +Y++LK L
Sbjct: 77 -ENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135
Query: 130 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 189
Y H+ GI+HRD+KP N+ ++ + +++D+GLA E V +R+++ PE++++
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCEL-KILDFGLA--RQADSEMTGYVVTRWYRAPEVILN 192
Query: 190 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249
Y ++D+WS+GC+ A MI K F G D+ DQL +I KV GT ++ + +
Sbjct: 193 WMRYTQTVDIWSVGCIMAEMITGKTLF-KGSDHLDQLKEIMKVTGTPPAE-FVQRLQSDE 250
Query: 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF 309
+ + +K ++ +T + P AV+ L+K+L D ++R TA EA+AHPYF
Sbjct: 251 AKNYMKGLPELEKKDFASILTNAS-----PLAVNLLEKMLVLDAEQRVTAGEALAHPYFE 305
Query: 310 PIRNAE 315
+ + E
Sbjct: 306 SLHDTE 311
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 170 bits (430), Expect = 1e-51
Identities = 87/297 (29%), Positives = 153/297 (51%), Gaps = 23/297 (7%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGG 75
+ Y + K+G G Y V++ + E +K ++ K REI IL+ L
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKH- 59
Query: 76 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCH 132
NIVKL D++ ++ L+FEH++ K+L L + ++ +LL + YCH
Sbjct: 60 SNIVKLYDVIHTKKRLV--LVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 133 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDLQ 191
+ ++HRD+KP N++I+ E L++ D+GLA + P ++Y + + +++ P++L+ +
Sbjct: 118 DRRVLHRDLKPQNLLINREGE-LKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 192 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251
Y ++D+WS+GC+FA M+ P F G DQL++I ++LGT + N + P
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGT-PLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL---P 232
Query: 252 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
+ PW F+ + +D L K+L+ D +R TAK+A+ H YF
Sbjct: 233 KYDPNFTVYEPLPWESFLKGLD-----ESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 3e-51
Identities = 84/297 (28%), Positives = 144/297 (48%), Gaps = 21/297 (7%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKK-----IKREIKILQNLCGG 75
YE + K+G G Y VF+ + +E +K ++ + REI +L+ L
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH- 60
Query: 76 PNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYCH 132
NIV+L D++ + T L+FE + F L V+ ++++LLK L +CH
Sbjct: 61 KNIVRLHDVLHSDKKLT--LVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 133 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQ 191
S+ ++HRD+KP N++I+ +L ++GLA F P + Y+ V + +++ P++L +
Sbjct: 119 SRNVLHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 192 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251
Y S+D+WS GC+FA + P F G+D DQL +I ++LGT + + +
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 252 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
S + D L LL+ + +R +A+EA+ HPYF
Sbjct: 238 PYPMYPATTSLVNVVPKLN--------ATGRDLLQNLLKCNPVQRISAEEALQHPYF 286
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 3e-51
Identities = 64/295 (21%), Positives = 124/295 (42%), Gaps = 45/295 (15%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 78
+ Y + +GRG++ V V + + + K +K + +K+EI IL NI
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNI 63
Query: 79 VKLLDIVRDQQSKTPSLIFEHVNNTD-FKVL---YPTLSDYDVRYYIYELLKALDYCHSQ 134
+ L + + +IFE ++ D F+ + L++ ++ Y++++ +AL + HS
Sbjct: 64 LHLHESFESMEE--LVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 135 GIMHRDVKPHNVMID-HEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 193
I H D++P N++ +++I++G A PG + + + + PE+
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH-DVV 180
Query: 194 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 253
+ D+WSLG + ++ P F N + I T + E +
Sbjct: 181 STATDMWSLGTLVYVLLSGINP-FLAETNQQIIENIMNAEYT---------FDEEAFKEI 230
Query: 254 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
+ EA+DF+D+LL + + R TA EA+ HP+
Sbjct: 231 S------------------------IEAMDFVDRLLVKERKSRMTASEALQHPWL 261
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 169 bits (428), Expect = 1e-50
Identities = 60/300 (20%), Positives = 114/300 (38%), Gaps = 46/300 (15%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPN 77
D Y++ ++G G + V K + K+ +++EI+ + L P
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH-PT 84
Query: 78 IVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL----YPTLSDYDVRYYIYELLKALDYCHS 133
+V L D D +I+E ++ + + +S+ + Y+ ++ K L + H
Sbjct: 85 LVNLHDAFEDDNE--MVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 134 QGIMHRDVKPHNVMIDHEQR-KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQD 192
+H D+KP N+M ++ +L+LID+GL P + V + F PE+ +
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG-KP 201
Query: 193 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 252
Y D+WS+G + ++ P F G ++ + L +
Sbjct: 202 VGYYTDMWSVGVLSYILLSGLSP-FGGENDDETLRNVKSCDWN---------MDDSAFSG 251
Query: 253 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312
++ + DF+ KLL D R T +A+ HP+ P
Sbjct: 252 IS------------------------EDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (421), Expect = 2e-50
Identities = 66/297 (22%), Positives = 124/297 (41%), Gaps = 53/297 (17%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCG 74
+D+E+ R +G+GK+ V+ +K+L + + +++RE++I +L
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 75 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYC 131
PNI++L D LI E+ + YI EL AL YC
Sbjct: 66 -PNILRLYGYFHDATR--VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC 122
Query: 132 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 191
HS+ ++HRD+KP N+++ L++ D+G + + P + + PE++ +
Sbjct: 123 HSKRVIHRDIKPENLLLGSAGE-LKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEG-R 179
Query: 192 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251
+D +DLWSLG + + K P F + + +I++V
Sbjct: 180 MHDEKVDLWSLGVLCYEFLVGKPP-FEANTYQETYKRISRV------------------- 219
Query: 252 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
+ F+T A D + +LL+++ +RP +E + HP+
Sbjct: 220 ----------EFTFPDFVT--------EGARDLISRLLKHNPSQRPMLREVLEHPWI 258
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 165 bits (418), Expect = 6e-50
Identities = 68/309 (22%), Positives = 125/309 (40%), Gaps = 57/309 (18%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------------KKKIKREIK 67
++YE +GRG S V +H ++ +KI+ ++ +E+
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 68 ILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY--PTLSDYDVRYYIYEL 124
IL+ + G PNI++L D L+F+ + + F L TLS+ + R + L
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTF--FFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRAL 119
Query: 125 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGP 184
L+ + H I+HRD+KP N+++D + ++L D+G + PG++ + + P
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPSYLAP 178
Query: 185 ELL-----VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN 239
E++ + Y +D+WS G + ++ P F+ L I
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP-FWHRKQMLMLRMI---------- 227
Query: 240 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA 299
+F + E + D + + L Q+R TA
Sbjct: 228 ----------------------MSGNYQFGSPEWDDYS-DTVKDLVSRFLVVQPQKRYTA 264
Query: 300 KEAMAHPYF 308
+EA+AHP+F
Sbjct: 265 EEALAHPFF 273
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 3e-49
Identities = 83/306 (27%), Positives = 153/306 (50%), Gaps = 21/306 (6%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCG 74
+ Y+ + VG G Y V + +K L + K+ RE+++L+++
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 75 GPNIVKLLDIVRDQQS---KTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALD 129
N++ LLD+ +S + H+ D + L+D V++ IY++L+ L
Sbjct: 77 -ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLK 135
Query: 130 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 189
Y HS I+HRD+KP N+ ++ + +++D+GLA H E VA+R+++ PE++++
Sbjct: 136 YIHSADIIHRDLKPSNLAVNEDCEL-KILDFGLA--RHTDDEMTGYVATRWYRAPEIMLN 192
Query: 190 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249
Y+ ++D+WS+GC+ A ++ + F G D+ DQL I +++GT L K E
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAE-LLKKISSES 250
Query: 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF 309
+ + + + ++ N P AVD L+K+L D +R TA +A+AH YF
Sbjct: 251 ARNYIQSLTQMPKMNFANVFIGAN-----PLAVDLLEKMLVLDSDKRITAAQALAHAYFA 305
Query: 310 PIRNAE 315
+ +
Sbjct: 306 QYHDPD 311
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (417), Expect = 5e-49
Identities = 65/298 (21%), Positives = 120/298 (40%), Gaps = 43/298 (14%)
Query: 21 DDYEVVRKV-GRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIV 79
DDY+V +V G G +V + + EK +K+L+ K +RE+++ P+IV
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ--DCPKARREVELHWRASQCPHIV 68
Query: 80 KLLDIVRDQQS--KTPSLIFEHVNNTDF-----KVLYPTLSDYDVRYYIYELLKALDYCH 132
+++D+ + + K ++ E ++ + ++ + + + +A+ Y H
Sbjct: 69 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128
Query: 133 SQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 190
S I HRDVKP N++ L+L D+G A+ + Y+ PE+L
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP- 187
Query: 191 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250
+ YD S D+WSLG + ++ PF Y + + +
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPF-YSNHGLAISPGMKTRI----------------- 229
Query: 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
R +F E ++ E + LL+ + +R T E M HP+
Sbjct: 230 -----------RMGQYEFPNPEWSEVS-EEVKMLIRNLLKTEPTQRMTITEFMNHPWI 275
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 1e-48
Identities = 61/301 (20%), Positives = 122/301 (40%), Gaps = 51/301 (16%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK---REIKILQNLCGGP 76
+D +E++ ++G G + +V++ + + K++ +++++ EI IL + P
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH-P 69
Query: 77 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCH 132
NIVKLLD + + ++ E + L++ ++ + L AL+Y H
Sbjct: 70 NIVKLLDAFYYENN--LWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH 127
Query: 133 SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLV--- 188
I+HRD+K N++ + ++L D+G++ + + + + + Y+ PE+++
Sbjct: 128 DNKIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 186
Query: 189 -DLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247
+ YDY D+WSLG M + P + + L+KIAK
Sbjct: 187 SKDRPYDYKADVWSLGITLIEMAEIEPP-HHELNPMRVLLKIAK---------------- 229
Query: 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 307
+ DFL K L + R T + + HP+
Sbjct: 230 ----------SEPPTLAQPSRWS--------SNFKDFLKKCLEKNVDARWTTSQLLQHPF 271
Query: 308 F 308
Sbjct: 272 V 272
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 2e-48
Identities = 60/295 (20%), Positives = 117/295 (39%), Gaps = 46/295 (15%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP---VKKKKIKREIKILQNLCGGP 76
+ Y K+G+G V+ + ++ I+ + KK+ I EI +++ P
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNP 77
Query: 77 NIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHSQ 134
NIV LD ++ E++ + + + + E L+AL++ HS
Sbjct: 78 NIVNYLDSYLVGDE--LWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 135 GIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDLQDY 193
++HRD+K N+++ + ++L D+G + + + V + Y+ PE++ + Y
Sbjct: 136 QVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAY 193
Query: 194 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 253
+D+WSLG M MI + P + + L IA ++ L
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP-YLNENPLRALYLIAT----------NGTPELQNPEKL 242
Query: 254 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
+ DFL++ L D ++R +AKE + H +
Sbjct: 243 S------------------------AIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 5e-48
Identities = 63/298 (21%), Positives = 116/298 (38%), Gaps = 49/298 (16%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGP 76
+D+++V+ +G G Y EV V+ E +KI+ + + IK+EI I + L
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHE 63
Query: 77 NIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLYP--TLSDYDVRYYIYELLKALDYCHS 133
N+VK R + L E+ + + F + P + + D + + ++L+ + Y H
Sbjct: 64 NVVKFYGHRR--EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 134 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDL 190
GI HRD+KP N+++D L++ D+GLA + N + + PELL
Sbjct: 122 IGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180
Query: 191 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250
+ + +D+WS G + M+ + + + Q K
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGE-LPWDQPSDSCQEYSDWK------------------- 220
Query: 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
+ PW K + L K+L + R T + ++
Sbjct: 221 ------EKKTYLNPWKKID---------SAPLALLHKILVENPSARITIPDIKKDRWY 263
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 159 bits (402), Expect = 4e-47
Identities = 64/299 (21%), Positives = 120/299 (40%), Gaps = 54/299 (18%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK------KKIKREIKILQNLCG 74
+ +R++G G + V+ ++E IK + K + I +E++ LQ L
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 75 GPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKALDYC 131
PN ++ + T L+ E+ + +V L + ++ + L+ L Y
Sbjct: 75 -PNTIQYRGCYLRE--HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL 131
Query: 132 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 191
HS ++HRDVK N+++ ++L D+G A P + V + Y+ PE+++ +
Sbjct: 132 HSHNMIHRDVKAGNILLSEPGL-VKLGDFGSASIMAPANSF---VGTPYWMAPEVILAMD 187
Query: 192 D--YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249
+ YD +D+WSLG + RK P F + L IA+ N+
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLF-NMNAMSALYHIAQ-----------NESPALQ 235
Query: 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
H + +F+D L+ Q+RPT++ + H +
Sbjct: 236 SGHWS------------------------EYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 7e-47
Identities = 75/302 (24%), Positives = 138/302 (45%), Gaps = 18/302 (5%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGG 75
Y+ ++ +G G V + IK L K+ RE+ +++ +
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH- 75
Query: 76 PNIVKLLDIVRDQQS----KTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYC 131
NI+ LL++ Q++ + L+ E ++ +V+ L + Y +Y++L + +
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHL 135
Query: 132 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQ 191
HS GI+HRD+KP N+++ + +++D+GLA V +RY++ PE+++
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG-M 193
Query: 192 DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTD-----ELNAYLNKYH 246
Y ++D+WS+GC+ M+ K F G D DQ K+ + LGT + + +
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHK-ILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252
Query: 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHP 306
+E P A L E+ L +A D L K+L D +R + +A+ HP
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312
Query: 307 YF 308
Y
Sbjct: 313 YI 314
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (397), Expect = 2e-46
Identities = 68/298 (22%), Positives = 124/298 (41%), Gaps = 47/298 (15%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP----VKKKKIKREIKILQNLCGG 75
+D Y+ +G G +SEV + IK + K+ ++ EI +L +
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KH 66
Query: 76 PNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY--PTLSDYDVRYYIYELLKALDYCH 132
PNIV L DI LI + V+ + F + ++ D I+++L A+ Y H
Sbjct: 67 PNIVALDDIYESGGH--LYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 133 SQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 190
GI+HRD+KP N++ E K+ + D+GL++ PG + + + PE+L
Sbjct: 125 DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ- 183
Query: 191 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250
+ Y ++D WS+G + ++ PF Y ++ +I K ++
Sbjct: 184 KPYSKAVDCWSIGVIAYILLCGYPPF-YDENDAKLFEQILKAEY---------EFDSPYW 233
Query: 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
++ A DF+ L+ D ++R T ++A+ HP+
Sbjct: 234 DDIS------------------------DSAKDFIRHLMEKDPEKRFTCEQALQHPWI 267
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 3e-46
Identities = 65/305 (21%), Positives = 118/305 (38%), Gaps = 58/305 (19%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKILQNLCGG 75
+DYEV+ +G G Y + +D + + K L +K+ + E+ +L+ L
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-H 62
Query: 76 PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKAL 128
PNIV+ D + D+ + T ++ E+ D + L + V + +L AL
Sbjct: 63 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122
Query: 129 DYCHSQG-----IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFK 182
CH + ++HRD+KP NV +D +Q ++L D+GLA + + V + Y+
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAKAFVGTPYYM 181
Query: 183 GPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242
PE + Y+ D+WSLGC+ + P F + KI
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPP-FTAFSQKELAGKI------------R 227
Query: 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA 302
+ + E + + ++L RP+ +E
Sbjct: 228 EGKFRRIPYRYS------------------------DELNEIITRMLNLKDYHRPSVEEI 263
Query: 303 MAHPY 307
+ +P
Sbjct: 264 LENPL 268
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 7e-44
Identities = 58/301 (19%), Positives = 115/301 (38%), Gaps = 57/301 (18%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQ 70
+ Y+V +G G + V+ G+ +DN IK ++ + ++ E+ +L+
Sbjct: 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLK 62
Query: 71 NLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL--YPTLSDYDVRYYIYELLKA 127
+ G +++LLD S L F + L + R + +++L+A
Sbjct: 63 KVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEA 122
Query: 128 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 187
+ +CH+ G++HRD+K N++ID + +L+LID+G Y +R + PE +
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWI 181
Query: 188 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247
+ + S +WSLG + M+ PF + + + + +
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE--------------------IIRGQV 221
Query: 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPY 307
++ E + L +RPT +E HP+
Sbjct: 222 FFRQRVS------------------------SECQHLIRWCLALRPSDRPTFEEIQNHPW 257
Query: 308 F 308
Sbjct: 258 M 258
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 3e-43
Identities = 70/309 (22%), Positives = 125/309 (40%), Gaps = 61/309 (19%)
Query: 18 REQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQN 71
+ +D++ + +G G +S V + + IKIL+ K + RE ++
Sbjct: 5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64
Query: 72 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD---FKVLYPTLSDYDVRYYIYELLKAL 128
L P VKL +D + + N + + + + R+Y E++ AL
Sbjct: 65 LDH-PFFVKLYFTFQDDEK--LYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 121
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGPE 185
+Y H +GI+HRD+KP N++++ + +++ D+G A+ P + N V + + PE
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180
Query: 186 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245
LL + + S DLW+LGC+ ++ P F + Y KI K+
Sbjct: 181 LLTE-KSACKSSDLWALGCIIYQLVAGLPP-FRAGNEYLIFQKIIKL------------- 225
Query: 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA--- 302
+ P+A D ++KLL D +R +E
Sbjct: 226 EYDFPEKFF------------------------PKARDLVEKLLVLDATKRLGCEEMEGY 261
Query: 303 ---MAHPYF 308
AHP+F
Sbjct: 262 GPLKAHPFF 270
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 4e-43
Identities = 56/298 (18%), Positives = 114/298 (38%), Gaps = 51/298 (17%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPN 77
+ ++GRG + V++G+ + L+ K +++ K E ++L+ L PN
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQH-PN 69
Query: 78 IVKLLDIVRD--QQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYCH 132
IV+ D + K L+ E + + K + + +R + ++LK L + H
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129
Query: 133 SQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDL 190
++ I+HRD+K N+ I +++ D GLA V + + F PE+
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAV-IGTPEFMAPEMY--E 186
Query: 191 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250
+ YD S+D+++ G M + P+ + ++ D
Sbjct: 187 EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-----------GVKPASFD 235
Query: 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308
+PE + ++ +R + ER + K+ + H +F
Sbjct: 236 KVA------------------------IPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 8e-43
Identities = 64/306 (20%), Positives = 132/306 (43%), Gaps = 53/306 (17%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQN 71
D Y+ ++G G+++ V + + + K +K + ++ I+RE+ IL+
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 72 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNT---DFKVLYPTLSDYDVRYYIYELLKAL 128
+ PN++ L ++ ++ LI E V DF +L++ + ++ ++L +
Sbjct: 70 IQH-PNVITLHEVYENKTD--VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGV 126
Query: 129 DYCHSQGIMHRDVKPHNVMIDHE---QRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 185
Y HS I H D+KP N+M+ + ++++ID+GLA G E+ + F PE
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 186 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245
++ + + D+WS+G + ++ PF G + L ++ V ++
Sbjct: 187 IV-NYEPLGLEADMWSIGVITYILLSGASPF-LGDTKQETLANVSAVNY---------EF 235
Query: 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305
E + + A DF+ +LL D ++R T ++++ H
Sbjct: 236 EDEYFSNTS------------------------ALAKDFIRRLLVKDPKKRMTIQDSLQH 271
Query: 306 PYFFPI 311
P+ P
Sbjct: 272 PWIKPK 277
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 6e-41
Identities = 59/299 (19%), Positives = 118/299 (39%), Gaps = 53/299 (17%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCG 74
+D+ + + +G+G + +VF N+ IK LK + E ++L
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 75 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALDYC 131
P + + + +++ + E++N D +Y E++ L +
Sbjct: 62 HPFLTHMFCTFQTKEN--LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFL 119
Query: 132 HSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEYNVRVASRYFKGPELLVDL 190
HS+GI++RD+K N+++D + ++ D+G+ E + N + + PE+L+
Sbjct: 120 HSKGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLG- 177
Query: 191 QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250
Q Y++S+D WS G + M+ + P F+G D + I
Sbjct: 178 QKYNHSVDWWSFGVLLYEMLIGQSP-FHGQDEEELFHSI--------------------- 215
Query: 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK-EAMAHPYF 308
R + +++ EA D L KL + ++R + + HP F
Sbjct: 216 --------RMDNPFYPRWLE--------KEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 258
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 143 bits (361), Expect = 2e-40
Identities = 70/307 (22%), Positives = 121/307 (39%), Gaps = 55/307 (17%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCG 74
+D+ V R +GRG + EV+ + +K L + + E +L +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 75 G--PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKALD 129
G P IV + S I + +N D + S+ D+R+Y E++ L+
Sbjct: 64 GDCPFIVCMSYAFHTPDK--LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLE 121
Query: 130 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 189
+ H++ +++RD+KP N+++D E +R+ D GLA + K + + + PE+L
Sbjct: 122 HMHNRFVVYRDLKPANILLD-EHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQK 179
Query: 190 LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249
YD S D +SLGCM ++ P F H D+ E++ +EL
Sbjct: 180 GVAYDSSADWFSLGCMLFKLLRGHSP-FRQHKTKDKH----------EIDRMTLTMAVEL 228
Query: 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMA 304
+ PE L+ LL+ D R A+E
Sbjct: 229 PDSFS------------------------PELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264
Query: 305 HPYFFPI 311
P+F +
Sbjct: 265 SPFFRSL 271
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 2e-38
Identities = 48/306 (15%), Positives = 111/306 (36%), Gaps = 56/306 (18%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-----PVKKKKIKREIKI 68
W I V +++G G + V++G + +K+L P + + K E+ +
Sbjct: 3 WEIPD--GQITVGQRIGSGSFGTVYKGKW---HGDVAVKMLNVTAPTPQQLQAFKNEVGV 57
Query: 69 LQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY---PTLSDYDVRYYIYEL 124
L+ NI+ + Q +++ + + + L+ + +
Sbjct: 58 LRKTRH-VNILLFMGYSTAPQ---LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT 113
Query: 125 LKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYF 181
+ +DY H++ I+HRD+K +N+ + + +++ D+GLA + S +
Sbjct: 114 AQGMDYLHAKSIIHRDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILW 172
Query: 182 KGPELLVDLQD--YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN 239
PE++ Y + D+++ G + ++ + P + +N DQ++ +
Sbjct: 173 MAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLP-YSNINNRDQIIFMVG-------- 223
Query: 240 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA 299
L P L+ + + + L+ ERP
Sbjct: 224 ------RGYLSPDLSKVRSNCP-----------------KAMKRLMAECLKKKRDERPLF 260
Query: 300 KEAMAH 305
+ +A
Sbjct: 261 PQILAS 266
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 137 bits (344), Expect = 3e-38
Identities = 73/328 (22%), Positives = 128/328 (39%), Gaps = 33/328 (10%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKKIKREIKILQNL-------- 72
Y +VRK+G G +S V+ +N +KI++ V + + EIK+LQ +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 73 --CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDF------KVLYPTLSDYDVRYYIYEL 124
G +I+KLLD + ++ + K + + V+ +L
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQL 134
Query: 125 LKALDYCH-SQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS---RY 180
L LDY H GI+H D+KP NV+++ LI +A+ + S R
Sbjct: 135 LLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTRE 194
Query: 181 FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPF-----FYGHDNYDQLVKIAKVLGT 235
++ PE+L+ + D+WS C+ +I F + D + +I ++LG
Sbjct: 195 YRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 253
Query: 236 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAV-----PEAVDFLDKLLR 290
N + + L+ S+ + V + E DFL +L+
Sbjct: 254 LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ 313
Query: 291 YDHQERPTAKEAMAHPYFFPIRNAESSR 318
D ++R A + HP+ E R
Sbjct: 314 LDPRKRADAGGLVNHPWLKDTLGMEEIR 341
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 133 bits (336), Expect = 8e-38
Identities = 54/301 (17%), Positives = 99/301 (32%), Gaps = 50/301 (16%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLC 73
D YE+ +G G SEV + +K+L+ P + +RE + L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL- 64
Query: 74 GGPNIVKLLDIVRDQ--QSKTPSLIFEHVNNTDFKVL---YPTLSDYDVRYYIYELLKAL 128
P IV + D + P ++ E+V+ + + ++ I + +AL
Sbjct: 65 NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQAL 124
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQR---KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 185
++ H GI+HRDVKP N+MI I +A+ + + + + + PE
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184
Query: 186 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245
D D++SLGC+ ++ + P F G + +
Sbjct: 185 QARG-DSVDARSDVYSLGCVLYEVLTGEPP-FTGDSPVSVAYQHVREDPIPPS------- 235
Query: 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305
L+ + + K L + + R M
Sbjct: 236 --ARHEGLS------------------------ADLDAVVLKALAKNPENRYQTAAEMRA 269
Query: 306 P 306
Sbjct: 270 D 270
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 3e-37
Identities = 55/330 (16%), Positives = 111/330 (33%), Gaps = 79/330 (23%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNE-----KCIIKILK----PVKKKKIKR 64
W R ++ E + +G G + +V ++ + +K+LK +++ +
Sbjct: 32 WEFPR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMS 89
Query: 65 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-------------------- 104
E+K++ L NIV LL S LIFE+ D
Sbjct: 90 ELKMMTQLGSHENIVNLLGACTL--SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYE 147
Query: 105 ------FKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLI 158
+ L+ D+ + Y++ K +++ + +HRD+ NV++ H + +++
Sbjct: 148 NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKV-VKIC 206
Query: 159 DWGLAEFYHPGKEYNVR---VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEP 215
D+GLA Y VR + PE L + Y D+WS G + +
Sbjct: 207 DFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVN 265
Query: 216 FFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQH 275
+ G K+ + N + ++ +
Sbjct: 266 PYPGIPVDANFYKLIQ-----------NGFKMDQPFYAT--------------------- 293
Query: 276 LAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305
E + +D ++RP+ +
Sbjct: 294 ---EEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 8e-37
Identities = 41/298 (13%), Positives = 104/298 (34%), Gaps = 52/298 (17%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK-PVKKKKIKREIKILQNL 72
W +N + ++++ +G+G++ +V G + K +K +K + E ++ L
Sbjct: 2 WALNM--KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL 57
Query: 73 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-----FKVLYPTLSDYDVRYYIYELLKA 127
N+V+LL ++ +++ ++ E++ L + + ++ +A
Sbjct: 58 RH-SNLVQLLGVIVEEKGG-LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 115
Query: 128 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 187
++Y +HRD+ NV++ + ++ D+GL + + + + PE L
Sbjct: 116 MEYLEGNNFVHRDLAARNVLVSEDNV-AKVSDFGLTKEASSTQ--DTGKLPVKWTAPEAL 172
Query: 188 VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247
+ + + D+WS G + + + D + ++ K Y +
Sbjct: 173 RE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK------------GYKM 219
Query: 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305
+ P + + D RP+ +
Sbjct: 220 DAPDGCP------------------------PAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 3e-36
Identities = 58/300 (19%), Positives = 106/300 (35%), Gaps = 52/300 (17%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCG 74
+D++ ++ +G+G + +V +KIL+ E ++LQN
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 75 GPNIVKLLDIVRDQQSK-TPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHS 133
P + L + ++ R+Y E++ AL+Y HS
Sbjct: 65 -PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 134 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 193
+ +++RD+K N+M+D + +++ D+GL + +++ DY
Sbjct: 124 RDVVYRDIKLENLMLD-KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182
Query: 194 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 253
++D W LG + M+ + P FY D+ I I L
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLP-FYNQDHERLFELI-------------LMEEIRFPRTL 228
Query: 254 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYF 308
+ PEA L LL+ D ++R AKE M H +F
Sbjct: 229 S------------------------PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (327), Expect = 5e-36
Identities = 55/307 (17%), Positives = 124/307 (40%), Gaps = 54/307 (17%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTD---NEKCIIKILKPVK-------KKKIKREIKILQ 70
+++E+++ +G G Y +VF + + +K+LK + + E ++L+
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 71 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYDVRYYIYELLKALD 129
++ P +V L + + L + + + ++++V+ Y+ E++ AL+
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALE 143
Query: 130 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPEL 186
+ H GI++RD+K N+++D + L D+GL++ + + Y+ Y +
Sbjct: 144 HLHKLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202
Query: 187 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246
+D ++D WSLG + ++ P F + +I++ + E
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASP-FTVDGEKNSQAEISRRILKSEP-------- 253
Query: 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKE 301
P+ + ++ A D + +LL D ++R A E
Sbjct: 254 -----------------PYPQEMS--------ALAKDLIQRLLMKDPKKRLGCGPRDADE 288
Query: 302 AMAHPYF 308
H +F
Sbjct: 289 IKEHLFF 295
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 2e-35
Identities = 52/306 (16%), Positives = 106/306 (34%), Gaps = 56/306 (18%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQN 71
W I RE + K+G+G + EV+ G + IK LKP + + +E ++++
Sbjct: 12 WEIPRE--SLRLEVKLGQGCFGEVWMGTW-NGTTRVAIKTLKPGTMSPEAFLQEAQVMKK 68
Query: 72 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLK 126
L +V+L +V ++ ++ E+++ L + ++
Sbjct: 69 LRH-EKLVQLYAVVSEEP---IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIAS 124
Query: 127 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY--NVRVASRYFKGP 184
+ Y +HRD++ N+++ E ++ D+GLA + + P
Sbjct: 125 GMAYVERMNYVHRDLRAANILVG-ENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAP 183
Query: 185 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244
E + + D+WS G + + + + G N + L ++
Sbjct: 184 EAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV------------ERG 230
Query: 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE--A 302
Y + P D + + R + +ERPT + A
Sbjct: 231 YRMPCPPECP------------------------ESLHDLMCQCWRKEPEERPTFEYLQA 266
Query: 303 MAHPYF 308
YF
Sbjct: 267 FLEDYF 272
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 128 bits (322), Expect = 2e-35
Identities = 55/300 (18%), Positives = 111/300 (37%), Gaps = 55/300 (18%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLCG 74
D++++R +G G + V + +K+LK + + E +L +
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-T 62
Query: 75 GPNIVKLLDIVRDQQSKTPSLIF-EHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHS 133
P I+++ +D Q + + E + ++Y E+ AL+Y HS
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 134 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 193
+ I++RD+KP N+++D + +++ D+G A++ + + PE++ + Y
Sbjct: 123 KDIIYRDLKPENILLD-KNGHIKITDFGFAKYVP--DVTYTLCGTPDYIAPEVVST-KPY 178
Query: 194 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 253
+ S+D WS G + M+ P FY + KI + P
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTP-FYDSNTMKTYEKILNA-------------ELRFPPFF 224
Query: 254 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER-----PTAKEAMAHPYF 308
+ D L +L+ D +R ++ HP+F
Sbjct: 225 N------------------------EDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 5e-35
Identities = 43/305 (14%), Positives = 106/305 (34%), Gaps = 54/305 (17%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQN 71
W + R + ++V ++G G++ EV+ G + + K +K LK + E +++
Sbjct: 8 WEVPR--ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQ 64
Query: 72 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLK 126
L +V+L +V + +I E++ N L+ + ++ +
Sbjct: 65 LQH-QRLVRLYAVVTQEP---IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 120
Query: 127 ALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKG-PE 185
+ + + +HRD++ N+++ + ++ D+GLA + A K
Sbjct: 121 GMAFIEERNYIHRDLRAANILV-SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAP 179
Query: 186 LLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKY 245
++ + D+WS G + ++ + G N + + + + Y
Sbjct: 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER------------GY 227
Query: 246 HIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE--AM 303
+ + E + + ++RPT ++
Sbjct: 228 RMVRPDNCP------------------------EELYQLMRLCWKERPEDRPTFDYLRSV 263
Query: 304 AHPYF 308
+F
Sbjct: 264 LEDFF 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 1e-34
Identities = 42/299 (14%), Positives = 92/299 (30%), Gaps = 56/299 (18%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILKPVK------KKKIKREIKILQN 71
D ++ K+G G + V G + K + +K LKP RE+ + +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 72 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKA 127
L N+++L +V K ++ E + Y ++ +
Sbjct: 68 LDH-RNLIRLYGVVLTPPMK---MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 128 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR---VASRYFKGP 184
+ Y S+ +HRD+ N+++ +++ D+GL ++ V +
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDL-VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 185 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244
+ + + ++ D W G M + + G + L KI K
Sbjct: 183 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK-----------EG 231
Query: 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 303
+ + + + + + ++RPT
Sbjct: 232 ERLPRPEDCP------------------------QDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 126 bits (316), Expect = 3e-34
Identities = 58/303 (19%), Positives = 112/303 (36%), Gaps = 55/303 (18%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIK------REIKILQNLCG 74
D ++ ++ +G G + V H +KIL K K+K E +ILQ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-N 99
Query: 75 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-YPTLSDYDVRYYIYELLKALDYCHS 133
P +VKL +D + + + + S+ R+Y +++ +Y HS
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 134 QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDY 193
+++RD+KP N++ID + +++ D+G A+ + PE+++ + Y
Sbjct: 160 LDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKG--RTWTLCGTPEALAPEIILS-KGY 215
Query: 194 DYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 253
+ ++D W+LG + M PFF D Q+ + + + H
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFF--ADQPIQIYE------------KIVSGKVRFPSHF 261
Query: 254 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQER-----PTAKEAMAHPYF 308
+ + D L LL+ D +R + H +F
Sbjct: 262 S------------------------SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297
Query: 309 FPI 311
Sbjct: 298 ATT 300
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 6e-34
Identities = 55/304 (18%), Positives = 108/304 (35%), Gaps = 55/304 (18%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-------KKIKREI 66
+ I R + E+ R +G G++ +V +G++ + + +K K +K +E
Sbjct: 2 YEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 59
Query: 67 KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIY 122
++ P+IVKL+ ++ + +I E + + +L + Y Y
Sbjct: 60 LTMRQF-DHPHIVKLIGVITENP---VWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 115
Query: 123 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV-RVASRYF 181
+L AL Y S+ +HRD+ NV++ ++L D+GL+ + Y +
Sbjct: 116 QLSTALAYLESKRFVHRDIAARNVLVS-SNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174
Query: 182 KGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY 241
++ + + + D+W G ++ F G N D + +I
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI------------ 222
Query: 242 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE 301
N + + P+ P + K YD RP E
Sbjct: 223 ENGERLPMPPNCP------------------------PTLYSLMTKCWAYDPSRRPRFTE 258
Query: 302 AMAH 305
A
Sbjct: 259 LKAQ 262
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 2e-33
Identities = 42/293 (14%), Positives = 100/293 (34%), Gaps = 50/293 (17%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 78
+ V+++G G++ V G + +K IK ++ + ++ E +++ L P +
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSH-PKL 62
Query: 79 VKLLDIVRDQQSKTPSLIFEHVNNTD----FKVLYPTLSDYDVRYYIYELLKALDYCHSQ 134
V+L + +Q L+FE + + + + + ++ + + Y
Sbjct: 63 VQLYGVCLEQAP--ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 135 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR--VASRYFKGPELLVDLQD 192
++HRD+ N ++ Q +++ D+G+ F + + + PE+
Sbjct: 121 CVIHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SR 178
Query: 193 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 252
Y D+WS G + + + + N + + I+
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST--------------------- 217
Query: 253 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305
G KP LA ++ + ++RP +
Sbjct: 218 -----GFRLYKP----------RLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 2e-33
Identities = 47/293 (16%), Positives = 106/293 (36%), Gaps = 50/293 (17%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP--VKKKKIKREIKILQNLCGGPNI 78
D ++++G G++ V G IK++K + + + E K++ NL +
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSH-EKL 61
Query: 79 VKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQ 134
V+L + Q + +I E++ N + ++ +A++Y S+
Sbjct: 62 VQLYGVCTKQ--RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 135 GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNV--RVASRYFKGPELLVDLQD 192
+HRD+ N +++ + +++ D+GL+ + + + + PE+L+
Sbjct: 120 QFLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SK 177
Query: 193 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 252
+ D+W+ G + + + + N + IA+
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ--------------------- 216
Query: 253 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305
G +P HLA + + ERPT K +++
Sbjct: 217 -----GLRLYRP----------HLASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 3e-33
Identities = 46/310 (14%), Positives = 98/310 (31%), Gaps = 65/310 (20%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK------PVKKKKIKREIKILQNLCG 74
+D + +G G + +V + D + I + + E+++L L
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 75 GPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-------------------FKVLYPTLSDY 115
PNI+ LL + L E+ + + TLS
Sbjct: 70 HPNIINLLGAC--EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 116 DVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR 175
+ ++ ++ + +DY + +HRD+ N+++ E ++ D+GL+ + +
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVG-ENYVAKIADFGLSRGQEVYVKKTMG 186
Query: 176 VASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 235
+ E L Y + D+WS G + ++ + G + K+
Sbjct: 187 RLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL------ 239
Query: 236 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQE 295
Y +E + E D + + R E
Sbjct: 240 ------PQGYRLEKPLNCD------------------------DEVYDLMRQCWREKPYE 269
Query: 296 RPTAKEAMAH 305
RP+ + +
Sbjct: 270 RPSFAQILVS 279
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 1e-32
Identities = 55/322 (17%), Positives = 102/322 (31%), Gaps = 72/322 (22%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEG-----VHCTDNEKCIIKILKPVK----KKKIKR 64
W R + + +G G + +V E + +K+LKP ++ +
Sbjct: 18 WEFPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 75
Query: 65 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-------------------- 104
E+K+L L NIV LL +I E+ D
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPA 133
Query: 105 -FKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163
+ L D+ + Y++ K + + S+ +HRD+ N+++ H + ++ D+GLA
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT-KICDFGLA 192
Query: 164 EFYHPGKEYNVRVASRYFKG--PELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 221
Y V+ +R + Y + D+WS G + + G
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252
Query: 222 NYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEA 281
+ K+ K + + H E
Sbjct: 253 VDSKFYKMIK-----------EGFRMLSPEHAP------------------------AEM 277
Query: 282 VDFLDKLLRYDHQERPTAKEAM 303
D + D +RPT K+ +
Sbjct: 278 YDIMKTCWDADPLKRPTFKQIV 299
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 120 bits (301), Expect = 1e-32
Identities = 46/297 (15%), Positives = 103/297 (34%), Gaps = 48/297 (16%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILK--PVKKKKIKREIKILQN 71
W + R D + K+G G+Y EV+EGV + +K LK ++ ++ +E +++
Sbjct: 12 WEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKE 69
Query: 72 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKA 127
+ PN+V+LL + + F L +S + Y ++ A
Sbjct: 70 IKH-PNLVQLLGVCTREPPFYIITEF-MTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 127
Query: 128 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-NVRVASRYFKGPEL 186
++Y + +HRD+ N ++ E +++ D+GL+ +
Sbjct: 128 MEYLEKKNFIHRDLAARNCLVG-ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186
Query: 187 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246
+ + D+W+ G + + + G D Q+ ++ + Y
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYELLE-----------KDYR 234
Query: 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 303
+E + + + +++ +RP+ E
Sbjct: 235 MERPEGCP------------------------EKVYELMRACWQWNPSDRPSFAEIH 267
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 119 bits (299), Expect = 3e-32
Identities = 47/305 (15%), Positives = 101/305 (33%), Gaps = 50/305 (16%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP-VKKKKIKREIKILQNLCGGPNIV 79
+ Y + RK+G G + +++ G E+ IK+ K ++ E KI + + GG I
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIP 66
Query: 80 KLLDIVRDQQSKTPSLIFEHVNNTD---FKVLYPTLSDYDVRYYIYELLKALDYCHSQGI 136
+ + ++ E + + F S V +++ ++Y HS+
Sbjct: 67 TIRWCGAEGDY--NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNF 124
Query: 137 MHRDVKPHNVMIDHEQRKLRL--IDWGLAEFYHPGKEYNVR--------VASRYFKGPEL 186
+HRDVKP N ++ ++ + ID+GLA+ Y + + + +
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184
Query: 187 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246
+ + DL SLG + P+ + Y
Sbjct: 185 HLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA-------------TKRQKYERISE 230
Query: 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA---KEAM 303
++ + L + E +L+ ++P ++
Sbjct: 231 KKMSTPIEVLCKGYP-----------------SEFATYLNFCRSLRFDDKPDYSYLRQLF 273
Query: 304 AHPYF 308
+ +
Sbjct: 274 RNLFH 278
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 1e-31
Identities = 50/312 (16%), Positives = 106/312 (33%), Gaps = 60/312 (19%)
Query: 14 WFINREQDDYEVV-RKVGRGKYSEVFEGVHCTDNEKCI--IKILKPVKKKK----IKREI 66
F+ R D+ + ++G G + V +GV+ ++ IK+LK +K + RE
Sbjct: 3 LFLKR--DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 67 KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTD-FKVLY---PTLSDYDVRYYIY 122
+I+ L P IV+L+ + + + L+ E K L + +V ++
Sbjct: 61 QIMHQL-DNPYIVRLIGVCQAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 116
Query: 123 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASR--- 179
++ + Y + +HRD+ NV++ + ++ D+GL++ Y ++
Sbjct: 117 QVSMGMKYLEEKNFVHRDLAARNVLLV-NRHYAKISDFGLSKALGADDSYYTARSAGKWP 175
Query: 180 YFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN 239
++ + + D+WS G + + + + + I
Sbjct: 176 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI---------- 225
Query: 240 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTA 299
+E P PE + Y ++RP
Sbjct: 226 --EQGKRMECPPECP------------------------PELYALMSDCWIYKWEDRPDF 259
Query: 300 KE---AMAHPYF 308
M Y+
Sbjct: 260 LTVEQRMRACYY 271
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (295), Expect = 2e-31
Identities = 44/301 (14%), Positives = 102/301 (33%), Gaps = 57/301 (18%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPVKKKK----IKREIKILQN 71
+ +++ ++ +G G + V++G+ + E IK L+ K I E ++ +
Sbjct: 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67
Query: 72 LCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKA 127
+ P++ +LL I T LI + + + + + ++ K
Sbjct: 68 VDN-PHVCRLLGICLT---STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123
Query: 128 LDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY---NVRVASRYFKGP 184
++Y + ++HRD+ NV++ Q +++ D+GLA+ ++ +
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 182
Query: 185 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244
E ++ + Y + D+WS G ++ + G + + K
Sbjct: 183 ESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK------------G 229
Query: 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304
+ P + + K D RP +E +
Sbjct: 230 ERLPQPPICT------------------------IDVYMIMVKCWMIDADSRPKFRELII 265
Query: 305 H 305
Sbjct: 266 E 266
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 117 bits (293), Expect = 2e-31
Identities = 39/231 (16%), Positives = 90/231 (38%), Gaps = 20/231 (8%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKIL-KPVKKKKIKREIKILQNLCGGPNIVKL 81
Y+V R++G G + +FEG + +N++ IK + +++ E + + L G I +
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 66
Query: 82 LDIVRDQQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMH 138
++ L+ + + + +L S V ++L + H + +++
Sbjct: 67 YYFGQEG--LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 124
Query: 139 RDVKPHNVMID----HEQRKLRLIDWGLAEFYHPG--------KEYNVRVASRYFKGPEL 186
RD+KP N +I + ++D+G+ +FY +E + +
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184
Query: 187 LVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 237
+ ++ DL +LG +F + + G K ++ +
Sbjct: 185 HLG-REQSRRDDLEALGHVFMYFLRGS-LPWQGLKAATNKQKYERIGEKKQ 233
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 116 bits (292), Expect = 3e-31
Identities = 41/301 (13%), Positives = 90/301 (29%), Gaps = 56/301 (18%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKK-------KKIKREIKILQNLC 73
++ + +G G++ EV G ++ I +K +K + E I+
Sbjct: 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85
Query: 74 GGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALD 129
PN++ L +V S +I E + N + + + + +
Sbjct: 86 H-PNVIHLEGVVTK--STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 142
Query: 130 YCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVD 189
Y +HRD+ N++++ ++ D+GL+ F ++ K P
Sbjct: 143 YLADMNYVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTA 201
Query: 190 -----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244
+ + + D+WS G + ++ E ++ N D + I
Sbjct: 202 PEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI------------EQD 249
Query: 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304
Y + + + D RP + +
Sbjct: 250 YRLPPPMDCP------------------------SALHQLMLDCWQKDRNHRPKFGQIVN 285
Query: 305 H 305
Sbjct: 286 T 286
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 1e-30
Identities = 47/303 (15%), Positives = 101/303 (33%), Gaps = 58/303 (19%)
Query: 27 RKVGRGKYSEVFEGVHC--TDNEKCIIKILK-----PVKKKKIKREIKILQNLCGGPNIV 79
+++G G + V +G + + +KILK P K ++ E ++Q L P IV
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDN-PYIV 71
Query: 80 KLLDIVRDQQSKTPSLIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGI 136
+++ I ++++ L+ E + D ++ ++++ + Y
Sbjct: 72 RMIGIC---EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 128
Query: 137 MHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVR----VASRYFKGPELLVDLQD 192
+HRD+ NV++ Q ++ D+GL++ + Y + PE +
Sbjct: 129 VHRDLAARNVLLV-TQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YK 186
Query: 193 YDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 252
+ D+WS G + + + G + + K +
Sbjct: 187 FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK------------GERMGCPAG 234
Query: 253 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE--AMAHPYFFP 310
E D ++ YD + RP Y++
Sbjct: 235 CP------------------------REMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270
Query: 311 IRN 313
+ N
Sbjct: 271 VVN 273
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 1e-29
Identities = 49/308 (15%), Positives = 107/308 (34%), Gaps = 56/308 (18%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCI---IKILKPVKK----KKIKREI 66
I +GRG + V+ G ++ K I +K L + + E
Sbjct: 20 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEG 79
Query: 67 KILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIY 122
I+++ PN++ LL I + P ++ ++ + D + + D+ +
Sbjct: 80 IIMKDFSH-PNVLSLLGICLRSEGS-PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL 137
Query: 123 ELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVASRY-- 180
++ K + + S+ +HRD+ N M+D + +++ D+GLA + + +V +
Sbjct: 138 QVAKGMKFLASKKFVHRDLAARNCMLDEKFT-VKVADFGLARDMYDKEFDSVHNKTGAKL 196
Query: 181 ---FKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 237
+ E L Q + D+WS G + ++ R P + + +D V +
Sbjct: 197 PVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-------- 247
Query: 238 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP 297
L + + + + K + RP
Sbjct: 248 ----LQGRRLLQPEYCP------------------------DPLYEVMLKCWHPKAEMRP 279
Query: 298 TAKEAMAH 305
+ E ++
Sbjct: 280 SFSELVSR 287
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 111 bits (279), Expect = 3e-29
Identities = 47/320 (14%), Positives = 96/320 (30%), Gaps = 78/320 (24%)
Query: 20 QDDYEVVRKVGRGKYSEVFEGVH-----CTDNEKCIIKILKPVK----KKKIKREIKILQ 70
+++ E VR +G G + VF+ +K+LK + +RE ++
Sbjct: 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA 71
Query: 71 NLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK------------------------ 106
PNIVKLL + + L+FE++ D
Sbjct: 72 EFDN-PNIVKLLGVCAVGKP--MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 128
Query: 107 ---VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163
P LS + ++ + Y + +HRD+ N ++ E +++ D+GL+
Sbjct: 129 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVG-ENMVVKIADFGLS 187
Query: 164 EFYHPGKEYNV--RVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 221
+ Y A P + Y D+W+ G + + +YG
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247
Query: 222 NYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEA 281
+ + + + + + + E
Sbjct: 248 HEEVIYYV------------RDGNILACPENC------------------------PLEL 271
Query: 282 VDFLDKLLRYDHQERPTAKE 301
+ + +RP+
Sbjct: 272 YNLMRLCWSKLPADRPSFCS 291
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 2e-27
Identities = 41/300 (13%), Positives = 98/300 (32%), Gaps = 57/300 (19%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEK----CIIKILKPV----KKKKIKREIKILQNL 72
+ +G G++ EV++G+ T + K IK LK ++ E I+
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 73 CGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKAL 128
NI++L ++ + +I E++ N S + + + +
Sbjct: 67 SH-HNIIRLEGVISKYKPMM--IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGM 123
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY----NVRVASRYFKGP 184
Y + +HRD+ N++++ ++ D+GL+ E + + P
Sbjct: 124 KYLANMNYVHRDLAARNILVN-SNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182
Query: 185 ELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244
E + + S D+WS G + ++ E ++ N++ + I +
Sbjct: 183 EAISYRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAI------------NDG 229
Query: 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304
+ + + + + + RP + ++
Sbjct: 230 FRLPTPMDC------------------------PSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 7e-27
Identities = 48/306 (15%), Positives = 100/306 (32%), Gaps = 42/306 (13%)
Query: 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQ-NLCGGPNIV 79
+ +G+G++ EV+ G E+ +KI +++ RE +I Q + NI+
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENIL 60
Query: 80 KLLDIVRDQQSKTPS--LIFEHVNNTD-FKVLY-PTLSDYDVRYYIYELLKALDYCHSQ- 134
+ L+ ++ + F L T++ + L + H +
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEI 120
Query: 135 -------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEY-----NVRVASRYFK 182
I HRD+K N+++ + D GLA + + N RV ++ +
Sbjct: 121 VGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 183 GPELL-----VDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDE 237
PE+L + + D++++G +F + R D + + E
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 238 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP 297
+ +V +P A+ + + + R
Sbjct: 240 --------------EMRKVVCEQKLRP--NIPNRWQSCEALRVMAKIMRECWYANGAARL 283
Query: 298 TAKEAM 303
TA
Sbjct: 284 TALRIK 289
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (260), Expect = 1e-26
Identities = 52/324 (16%), Positives = 107/324 (33%), Gaps = 73/324 (22%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNE-------KCIIKILKPVKKKK----I 62
W + R D + + +G G + +V ++ K +K+LK +K +
Sbjct: 8 WELPR--DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL 65
Query: 63 KREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-------------- 108
E+++++ + NI+ LL +I E+ + + +
Sbjct: 66 ISEMEMMKMIGKHKNIINLLGACTQDGP--LYVIVEYASKGNLREYLQARRPPGLEYSYN 123
Query: 109 -----YPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163
LS D+ Y++ + ++Y S+ +HRD+ NV++ + ++ D+GLA
Sbjct: 124 PSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVM-KIADFGLA 182
Query: 164 EFYHPGKEYNVRVASRYFKGPELLVDLQD--YDYSLDLWSLGCMFAGMIFRKEPFFYGHD 221
H Y R L D Y + D+WS G + + + G
Sbjct: 183 RDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242
Query: 222 NYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEA 281
++L K+ K + ++ + E
Sbjct: 243 V-EELFKLLK-----------EGHRMDKPSNCT------------------------NEL 266
Query: 282 VDFLDKLLRYDHQERPTAKEAMAH 305
+ +RPT K+ +
Sbjct: 267 YMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 104 bits (259), Expect = 1e-26
Identities = 50/324 (15%), Positives = 108/324 (33%), Gaps = 73/324 (22%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKP----VKKKKIKR 64
W R D ++ + +GRG + +V E +K+LK + + +
Sbjct: 8 WEFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS 65
Query: 65 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK------------------ 106
E+KIL ++ N+V LL +I E +
Sbjct: 66 ELKILIHIGHHLNVVNLLGACTKPGGP-LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPE 124
Query: 107 -VLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165
+ L+ + Y +++ K +++ S+ +HRD+ N+++ E+ +++ D+GLA
Sbjct: 125 DLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS-EKNVVKICDFGLARD 183
Query: 166 YHPGKEY----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 221
+ +Y + R+ ++ + + Y D+WS G + + + G
Sbjct: 184 IYKDPDYVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241
Query: 222 NYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEA 281
++ + K + + PE
Sbjct: 242 IDEEFCRRLK-----------EGTRMRAPDYTT------------------------PEM 266
Query: 282 VDFLDKLLRYDHQERPTAKEAMAH 305
+ + +RPT E + H
Sbjct: 267 YQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (257), Expect = 4e-26
Identities = 49/317 (15%), Positives = 105/317 (33%), Gaps = 68/317 (21%)
Query: 14 WFINREQDDYEVVRKVGRGKYSEVFEGVH-----CTDNEKCIIKILKPVK----KKKIKR 64
W + RE + R++G+G + V+EGV + IK + + +
Sbjct: 15 WEVARE--KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 72
Query: 65 EIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFEHVNNTDFKVL-------------YPT 111
E +++ ++V+LL +V Q + +I E + D K
Sbjct: 73 EASVMKEF-NCHHVVRLLGVV--SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129
Query: 112 LSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 171
S + E+ + Y ++ +HRD+ N M+ + +++ D+G+ +
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDY 188
Query: 172 Y---NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVK 228
Y + + PE L D + D+WS G + + E + G N L
Sbjct: 189 YRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF 247
Query: 229 IAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKL 288
+ + ++ + + +
Sbjct: 248 V------------MEGGLLDKPDNCP------------------------DMLFELMRMC 271
Query: 289 LRYDHQERPTAKEAMAH 305
+Y+ + RP+ E ++
Sbjct: 272 WQYNPKMRPSFLEIISS 288
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 78.3 bits (192), Expect = 6e-18
Identities = 32/203 (15%), Positives = 68/203 (33%), Gaps = 34/203 (16%)
Query: 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKP------------VKKKKIKREIKILQ 70
+ + +G GK S VF +C++K K + I
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 71 NLCGGPNIVKLLD--IVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKAL 128
+ KL + + + +++ E ++ + + + + +L+ +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRV----ENPDEVLDMILEEV 116
Query: 129 DYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA-EFYHPGKEY----NVRVASRYFKG 183
+ +GI+H D+ +NV++ E +ID+ + E G +VR YF
Sbjct: 117 AKFYHRGIVHGDLSQYNVLVSEEGIW--IIDFPQSVEVGEEGWREILERDVRNIITYFS- 173
Query: 184 PELLVDLQDYDYSLDLWSLGCMF 206
+ Y D+ S
Sbjct: 174 -------RTYRTEKDINSAIDRI 189
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 321 | |||
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.53 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.21 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.07 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.29 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.28 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.12 |
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2e-61 Score=417.13 Aligned_cols=294 Identities=76% Similarity=1.307 Sum_probs=261.7
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEE
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 98 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 98 (321)
..++|+++++||+|+||+||+|+++.+++.||+|+++....+.+.+|+++|+.+.+||||+++++++.......+++|||
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e 112 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE 112 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEe
Confidence 46789999999999999999999999999999999998888899999999999967999999999998777778899999
Q ss_pred eecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCccccccCC
Q 020826 99 HVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKEYNVRVAS 178 (321)
Q Consensus 99 ~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~~~~~~~~ 178 (321)
|+.+++|....+.+++..++.++.||+.||+|||++||+||||||+||+++.++..++|+|||++.............+|
T Consensus 113 ~~~~~~L~~~~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t 192 (328)
T d3bqca1 113 HVNNTDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS 192 (328)
T ss_dssp CCCSCBGGGTTTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSC
T ss_pred ecCCCcHHHHhcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCcccccccC
Confidence 99999999999999999999999999999999999999999999999999977657999999999887766666777899
Q ss_pred ccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhc
Q 020826 179 RYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVG 258 (321)
Q Consensus 179 ~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (321)
+.|+|||.+.+...++.++||||+||+++++++|+.||....+...+...+...++.+....+.........+.+.....
T Consensus 193 ~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~ 272 (328)
T d3bqca1 193 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILG 272 (328)
T ss_dssp GGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCC
T ss_pred ccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcc
Confidence 99999999987667899999999999999999999999888888888888888888877777777766666666666665
Q ss_pred ccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 259 RHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 259 ~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
..................+|+++.+||++||++||++|||++|+|+||||+.+.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 273 RHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp CCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred cccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 555555555555555567889999999999999999999999999999999874
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-61 Score=400.68 Aligned_cols=253 Identities=23% Similarity=0.371 Sum_probs=208.3
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
..++|++++.||+|+||+||+|+++.+++.||+|+++... .+.+.+|+.+++++ +||||+++++++.+. ...+
T Consensus 3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l-~HpnIv~~~~~~~~~--~~~~ 79 (271)
T d1nvra_ 3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-NHENVVKFYGHRREG--NIQY 79 (271)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTC-CCTTBCCEEEEEEET--TEEE
T ss_pred CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhC-CCCCEeeEeeeeccC--ceeE
Confidence 4678999999999999999999999999999999986432 35688999999999 999999999999654 5667
Q ss_pred EEEEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-
Q 020826 95 LIFEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 170 (321)
Q Consensus 95 lv~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~- 170 (321)
+||||+.+++|.+++. .+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||+++......
T Consensus 80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~-~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNR 158 (271)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECEETTE
T ss_pred EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCC-CEEEccchhheeeccCCc
Confidence 9999999999988873 489999999999999999999999999999999999999888 89999999998764322
Q ss_pred --ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 171 --EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 171 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
......||+.|+|||++.+...++.++|||||||++|+|++|..||....+........... ...
T Consensus 159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~-~~~------------ 225 (271)
T d1nvra_ 159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-KTY------------ 225 (271)
T ss_dssp ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTT-CTT------------
T ss_pred cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcC-CCC------------
Confidence 23456799999999999874445788999999999999999999995443332222221110 000
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCccc
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 310 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~ 310 (321)
......+|+++.+||++||+.||++|||++|+++||||++
T Consensus 226 ----------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 226 ----------------------LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp ----------------------STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred ----------------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 0011246789999999999999999999999999999985
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-60 Score=398.25 Aligned_cols=253 Identities=24% Similarity=0.426 Sum_probs=213.7
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc---chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
.++|++++.||+|+||+||+|+++.+|+.||+|+++.. ..+.+.+|+.+++.+ +||||+++++++.+. ...++|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~--~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN-KNPNIVNYLDSYLVG--DELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHC-CCTTBCCEEEEEEET--TEEEEE
T ss_pred ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhC-CCCCEeeEeEEEEEC--CEEEEE
Confidence 56899999999999999999999999999999998643 346789999999999 999999999999654 457799
Q ss_pred EEeecCchhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC-Cccc
Q 020826 97 FEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEYN 173 (321)
Q Consensus 97 ~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~-~~~~ 173 (321)
||||.+++|..+. ..+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||+++..... ....
T Consensus 96 mEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~-~vkl~DFG~a~~~~~~~~~~~ 174 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQSKRS 174 (293)
T ss_dssp EECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSTTCCBC
T ss_pred EEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCC-cEeeccchhheeecccccccc
Confidence 9999999998776 4699999999999999999999999999999999999999888 8999999999876533 3345
Q ss_pred cccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhh
Q 020826 174 VRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHL 253 (321)
Q Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (321)
...||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+....+..+......
T Consensus 175 ~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~-~~~~~~~~~~~~~~~~~------------------ 234 (293)
T d1yhwa1 175 TMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYL-NENPLRALYLIATNGTP------------------ 234 (293)
T ss_dssp CCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHHCSC------------------
T ss_pred ccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCC-CCCHHHHHHHHHhCCCC------------------
Confidence 6679999999999987 788999999999999999999999984 33333333333221100
Q ss_pred HhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 254 AALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
....+..+|+++++||.+||+.||++|||++|+|+||||+...
T Consensus 235 ----------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~ 277 (293)
T d1yhwa1 235 ----------------ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (293)
T ss_dssp ----------------CCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ----------------CCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCC
Confidence 0112235778999999999999999999999999999998543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-60 Score=393.71 Aligned_cols=248 Identities=25% Similarity=0.472 Sum_probs=209.9
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
-++|++.+.||+|+||+||+|+++.+++.||+|++.+. ....+.+|+.+++.+ +||||+++++++.+. ...
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~--~~~ 81 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL-RHPNILRLYGYFHDA--TRV 81 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTC-CCTTBCCEEEEEECS--SEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhc-CCCCCCeEEEEEEEC--CEE
Confidence 46899999999999999999999999999999998642 245688999999999 999999999999654 457
Q ss_pred EEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 94 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||++......
T Consensus 82 ~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~-~~kl~DFG~a~~~~~~- 159 (263)
T d2j4za1 82 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSS- 159 (263)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCSCSCCCCC-
T ss_pred EEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCC-CEeecccceeeecCCC-
Confidence 7999999999998776 5699999999999999999999999999999999999999888 8999999999765432
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+.+.
T Consensus 160 ~~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~G~~Pf~-~~~~~~~~~~i~~~------------------ 219 (263)
T d2j4za1 160 RRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFE-ANTYQETYKRISRV------------------ 219 (263)
T ss_dssp CCEETTEEGGGCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHTT------------------
T ss_pred cccccCCCCcccCHHHHcC-CCCCchhhhhhHhHHHHHHhcCCCCCC-CCCHHHHHHHHHcC------------------
Confidence 3455679999999999988 778999999999999999999999983 33332332222110
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
....+..+|+++.+||.+||+.||++|||++|+++||||+..
T Consensus 220 -------------------~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 220 -------------------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp -------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred -------------------CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCCc
Confidence 001123467899999999999999999999999999999754
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-59 Score=392.31 Aligned_cols=254 Identities=24% Similarity=0.400 Sum_probs=210.2
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc---chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~---~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
.+.|++++.||+|+||+||+|++..+++.||+|+++.. ..+.+.+|+++++++ +||||+++++++.+. ...++|
T Consensus 11 ~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~--~~~~lv 87 (288)
T d2jfla1 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASC-DHPNIVKLLDAFYYE--NNLWIL 87 (288)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHC-CCTTBCCEEEEEEET--TEEEEE
T ss_pred ccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhC-CCCCCCeEEEEEeeC--CeEEEE
Confidence 35799999999999999999999999999999998653 346788999999999 899999999999654 456799
Q ss_pred EEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC-Cc
Q 020826 97 FEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KE 171 (321)
Q Consensus 97 ~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~-~~ 171 (321)
||||.+++|..++ ..+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++...... ..
T Consensus 88 mEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~-~~Kl~DFG~a~~~~~~~~~ 166 (288)
T d2jfla1 88 IEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQR 166 (288)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECHHHHHH
T ss_pred EecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCC-CEEEEechhhhccCCCccc
Confidence 9999999987765 4599999999999999999999999999999999999999888 8999999999765322 22
Q ss_pred cccccCCccccccccccC----CCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 172 YNVRVASRYFKGPELLVD----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~----~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
.....||+.|+|||++.. ...++.++|||||||++|+|++|..||. +.+..+.+..+.....
T Consensus 167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~-~~~~~~~~~~i~~~~~------------- 232 (288)
T d2jfla1 167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHH-ELNPMRVLLKIAKSEP------------- 232 (288)
T ss_dssp HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTT-TSCGGGHHHHHHHSCC-------------
T ss_pred ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCC-CCCHHHHHHHHHcCCC-------------
Confidence 345679999999999843 2457899999999999999999999984 3344444433322100
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
.....+..+|+++.+||++||+.||++|||++|+++||||+...
T Consensus 233 ---------------------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~ 276 (288)
T d2jfla1 233 ---------------------PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDS 276 (288)
T ss_dssp ---------------------CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCC
T ss_pred ---------------------CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 01112235778999999999999999999999999999998643
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-58 Score=386.33 Aligned_cols=251 Identities=22% Similarity=0.402 Sum_probs=203.8
Q ss_pred cCce-EEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeecc--CCC
Q 020826 20 QDDY-EVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ--QSK 91 (321)
Q Consensus 20 ~~~y-~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--~~~ 91 (321)
+.+| ++.++||+|+||+||+|++..++..||+|.+... ....+.+|+++++++ +||||+++++++.+. ...
T Consensus 7 ~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~ 85 (270)
T d1t4ha_ 7 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL-QHPNIVRFYDSWESTVKGKK 85 (270)
T ss_dssp TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEEESSSCE
T ss_pred CCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhC-CCCCeeeEEEEEeeccccCC
Confidence 4455 7888999999999999999999999999998643 235688999999999 899999999998653 345
Q ss_pred CcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC--CeeecCCCCCeEEcCCCCeEEEeeccceeec
Q 020826 92 TPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQG--IMHRDVKPHNVMIDHEQRKLRLIDWGLAEFY 166 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~--i~H~dlkp~nili~~~~~~v~l~dfg~~~~~ 166 (321)
.+++||||+++++|..++ ..+++..++.++.||+.||+|||+++ |+||||||+||+++.+...+||+|||+++..
T Consensus 86 ~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~ 165 (270)
T d1t4ha_ 86 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 165 (270)
T ss_dssp EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence 678999999999998877 46999999999999999999999999 9999999999999753338999999999754
Q ss_pred CCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhc
Q 020826 167 HPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246 (321)
Q Consensus 167 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (321)
.. .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||....+.......+......
T Consensus 166 ~~-~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~----------- 231 (270)
T d1t4ha_ 166 RA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP----------- 231 (270)
T ss_dssp CT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-----------
T ss_pred cC-CccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCC-----------
Confidence 32 23345689999999999865 58999999999999999999999994333222222221110000
Q ss_pred ccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcc
Q 020826 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF 309 (321)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~ 309 (321)
...+...++++.+||.+||+.||++|||++|+|+||||+
T Consensus 232 ------------------------~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 232 ------------------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp ------------------------GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred ------------------------cccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 011224668999999999999999999999999999996
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-59 Score=388.09 Aligned_cols=249 Identities=26% Similarity=0.430 Sum_probs=197.2
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
.++|++++.||+|+||+||+|+++.+++.||+|.++... ...+.+|+.+++++ +||||+++++++.+.....++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL-KHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSC-CCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEeCCCCEEE
Confidence 478999999999999999999999999999999986432 35578999999999 999999999999776667778
Q ss_pred EEEEeecCchhhhhc-------CCCCHHHHHHHHHHHHHHHHHHHHCC-----CeeecCCCCCeEEcCCCCeEEEeeccc
Q 020826 95 LIFEHVNNTDFKVLY-------PTLSDYDVRYYIYELLKALDYCHSQG-----IMHRDVKPHNVMIDHEQRKLRLIDWGL 162 (321)
Q Consensus 95 lv~e~~~~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~lh~~~-----i~H~dlkp~nili~~~~~~v~l~dfg~ 162 (321)
+|||||++++|.+++ ..+++..++.++.||+.||+|||++| |+||||||+||+++.++ .+||+|||+
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~-~vkl~DFG~ 160 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGL 160 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS-CEEECCHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC-cEEEeeccc
Confidence 999999999998776 35999999999999999999999976 99999999999999888 899999999
Q ss_pred eeecCCCC-ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHH
Q 020826 163 AEFYHPGK-EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAY 241 (321)
Q Consensus 163 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (321)
++...... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+....+... ..
T Consensus 161 a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~-~~~~~~~~~~i~~~-~~------ 231 (269)
T d2java1 161 ARILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFT-AFSQKELAGKIREG-KF------ 231 (269)
T ss_dssp HHHC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHT-CC------
T ss_pred eeecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCC-CCCHHHHHHHHHcC-CC------
Confidence 97664332 2345679999999999987 788999999999999999999999983 33332222222110 00
Q ss_pred hhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCc
Q 020826 242 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYF 308 (321)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~ 308 (321)
...+..+|+++.+||++||+.||++|||++|+++|||+
T Consensus 232 -----------------------------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 232 -----------------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp -----------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred -----------------------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 01123477899999999999999999999999999995
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-58 Score=390.56 Aligned_cols=251 Identities=28% Similarity=0.491 Sum_probs=208.4
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
.++|++.+.||+|+||+||+|+++.+++.||||+++.. ....+.+|+.+++++ +||||+++++++.+. ...
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~~~~~~~--~~~ 83 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL-DHPFFVKLYFTFQDD--EKL 83 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHC-CSTTBCCEEEEEECS--SEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHc-CCCCeeEEEEEEEEC--CEE
Confidence 46899999999999999999999999999999998642 235688999999999 999999999999654 556
Q ss_pred EEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 94 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
++||||+.+++|.+++ +.+++..++.++.|++.||+|||++||+||||||+||+++.++ .+||+|||+++......
T Consensus 84 ~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~-~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 84 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPES 162 (288)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECC---
T ss_pred EEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCc-eEEecccccceecccCC
Confidence 8999999999987766 5699999999999999999999999999999999999999888 89999999998764322
Q ss_pred ---ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 171 ---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 171 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+.......+.+.
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~-~~~~~~~~~~i~~~--------------- 225 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFR-AGNEYLIFQKIIKL--------------- 225 (288)
T ss_dssp -------CCCCGGGCCHHHHHT-CCCCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHTT---------------
T ss_pred cccccccccCCccccCceeecc-CCCCcccceehhhHHHHHHhhCCCCCC-CcCHHHHHHHHHcC---------------
Confidence 2345679999999999987 788999999999999999999999984 33333332222110
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHH------HhcCCCcccCCC
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE------AMAHPYFFPIRN 313 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~e------ll~hp~~~~~~~ 313 (321)
....+..+|+++.+||++||+.||++|||++| +++||||+.++-
T Consensus 226 ----------------------~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w 275 (288)
T d1uu3a_ 226 ----------------------EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTW 275 (288)
T ss_dssp ----------------------CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCC
T ss_pred ----------------------CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCH
Confidence 00112347789999999999999999999988 589999998753
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-59 Score=403.11 Aligned_cols=286 Identities=22% Similarity=0.308 Sum_probs=212.6
Q ss_pred ecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 17 NREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 17 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
+...++|++++.||+|+||+||+|++..+++.||+|+++.. ....+.+|+.+++.+ +||||+++++++.+. ..
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~~--~~ 78 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC-NSPYIVGFYGAFYSD--GE 78 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGC-CCTTBCCEEEEEECS--SE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC--CE
Confidence 34578999999999999999999999999999999998643 245688999999999 899999999999654 45
Q ss_pred cEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 93 PSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~-~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
.++||||+.+++|..++ ..+++..++.++.|++.||.|||+ +||+||||||+||+++.++ .+||+|||+|.....
T Consensus 79 ~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 79 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLID 157 (322)
T ss_dssp EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHHHHH
T ss_pred EEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC-CEEEeeCCCccccCC
Confidence 78999999999998877 469999999999999999999997 5999999999999999888 899999999976532
Q ss_pred CCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhc--
Q 020826 169 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH-- 246 (321)
Q Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-- 246 (321)
. ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.................+............
T Consensus 158 ~-~~~~~~GT~~Y~APEvl~~-~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (322)
T d1s9ja_ 158 S-MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235 (322)
T ss_dssp H-TC---CCSSCCCCHHHHHC-SCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred C-ccccccCCccccCchHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence 2 2345689999999999998 78999999999999999999999999765544433332222222111000000000
Q ss_pred --cc------CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 247 --IE------LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 247 --~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
.. ................. .......+|+++.+||.+||+.||++|||++|+|+||||++.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 236 PLSSYGMDSRPPMAIFELLDYIVNEPP----PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp ----------CCCCHHHHHHHHHTSCC----CCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred cccccccccccchhHHHHHhhhhccCC----ccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 00 00000000000000000 0011123678999999999999999999999999999998754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-58 Score=389.33 Aligned_cols=259 Identities=24% Similarity=0.428 Sum_probs=214.1
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc---------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV---------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 89 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~---------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (321)
..++|++.+.||+|+||+||+|+++.+|+.||+|++++. ..+.+.+|+.+++++ +||||+++++++.+
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~-- 84 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI-QHPNVITLHEVYEN-- 84 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHC-CCTTBCCEEEEEEC--
T ss_pred cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--
Confidence 457899999999999999999999999999999998632 246689999999999 89999999999965
Q ss_pred CCCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCC---eEEEeeccce
Q 020826 90 SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR---KLRLIDWGLA 163 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~---~v~l~dfg~~ 163 (321)
....++|||||.+++|.+++ ..+++..++.++.|++.||+|||++|++||||||+||+++.++. .+|++|||++
T Consensus 85 ~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a 164 (293)
T d1jksa_ 85 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 164 (293)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhh
Confidence 45677999999999998776 46999999999999999999999999999999999999986653 5999999999
Q ss_pred eecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 164 EFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 164 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
.............+|+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+.......
T Consensus 165 ~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~-~~~~~~~~~~i~~~~~~~------- 235 (293)
T d1jksa_ 165 HKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFL-GDTKQETLANVSAVNYEF------- 235 (293)
T ss_dssp EECTTSCBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHTTCCCC-------
T ss_pred hhcCCCccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCC-CCCHHHHHHHHHhcCCCC-------
Confidence 88766666667789999999999987 788999999999999999999999984 333333333322110000
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
.......+|+++.+||++||+.||++|||++|+++||||++.+...
T Consensus 236 --------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~ 281 (293)
T d1jksa_ 236 --------------------------EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQ 281 (293)
T ss_dssp --------------------------CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-----
T ss_pred --------------------------CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChhH
Confidence 0011124678999999999999999999999999999999865543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.4e-58 Score=397.18 Aligned_cols=256 Identities=23% Similarity=0.412 Sum_probs=215.1
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc---hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
++|++.+.||+|+||+||+|+++.+|+.||+|++.... .+.+.+|+.+++++ +||||+++++++.+. ..+++||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~--~~~~ivm 102 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL-RHPTLVNLHDAFEDD--NEMVMIY 102 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHT-CCTTBCCEEEEEEET--TEEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhC-CCCCCCcEEEEEEEC--CEEEEEE
Confidence 58999999999999999999999999999999986543 45678999999999 899999999999654 5678999
Q ss_pred EeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCC-CCeEEEeeccceeecCCCCcc
Q 020826 98 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE-QRKLRLIDWGLAEFYHPGKEY 172 (321)
Q Consensus 98 e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~-~~~v~l~dfg~~~~~~~~~~~ 172 (321)
|||.+++|.+++ ..+++..++.++.||+.||+|||++|++||||||+||+++.+ +..+||+|||+++........
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 182 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 182 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE
T ss_pred EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccccc
Confidence 999999987766 248999999999999999999999999999999999999643 237999999999887766666
Q ss_pred ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChh
Q 020826 173 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 252 (321)
Q Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (321)
....||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+..+.+..+........
T Consensus 183 ~~~~gT~~Y~aPEv~~~-~~~~~~~DiwSlGvilyell~G~~Pf~-~~~~~~~~~~i~~~~~~~~--------------- 245 (350)
T d1koaa2 183 KVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFG-GENDDETLRNVKSCDWNMD--------------- 245 (350)
T ss_dssp EEECSCTTTCCHHHHHT-CCBCHHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCCCSC---------------
T ss_pred ceecCcccccCHHHHcC-CCCChhHhhhhhhHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCCCCC---------------
Confidence 77889999999999987 778999999999999999999999983 4444444444332111100
Q ss_pred hHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 253 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
......+|+++.+||++||+.||++|||++|+|+||||+....+
T Consensus 246 ------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 246 ------------------DSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 289 (350)
T ss_dssp ------------------CGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred ------------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence 01112467899999999999999999999999999999976543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-58 Score=394.11 Aligned_cols=254 Identities=25% Similarity=0.421 Sum_probs=195.1
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
..++|++.+.||+|+||+||+|+++.+++.||||++.... ...+.+|+.+++.+ +||||+++++++.+ ....+
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~l~~~~~~--~~~~~ 83 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI-KHPNIVALDDIYES--GGHLY 83 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTC-CCTTBCCEEEEEEC--SSEEE
T ss_pred CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEE
Confidence 3567999999999999999999999999999999987432 34577899999999 99999999999965 45678
Q ss_pred EEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcC---CCCeEEEeeccceeecCC
Q 020826 95 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH---EQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 95 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~---~~~~v~l~dfg~~~~~~~ 168 (321)
+|||||.+++|.+++ ..+++..+..++.||+.||+|||++|++||||||+||++.. ++ .+||+|||+++....
T Consensus 84 lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~-~vkl~DFG~a~~~~~ 162 (307)
T d1a06a_ 84 LIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDS-KIMISDFGLSKMEDP 162 (307)
T ss_dssp EEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTC-CEEECCC--------
T ss_pred EEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCc-eEEEeccceeEEccC
Confidence 999999999998776 35999999999999999999999999999999999999953 44 799999999987665
Q ss_pred CCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhccc
Q 020826 169 GKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIE 248 (321)
Q Consensus 169 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (321)
........||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.........+......
T Consensus 163 ~~~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~-~~~~~~~~~~i~~~~~~------------- 227 (307)
T d1a06a_ 163 GSVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFY-DENDAKLFEQILKAEYE------------- 227 (307)
T ss_dssp ----------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHTTCCC-------------
T ss_pred CCeeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCC-CCCHHHHHHHHhccCCC-------------
Confidence 555566789999999999987 788999999999999999999999984 33333332222210000
Q ss_pred CChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 249 LDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
........+|+++.+||.+||+.||++|||++|+++||||++.
T Consensus 228 --------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 228 --------------------FDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp --------------------CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred --------------------CCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 0011123577899999999999999999999999999999864
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=4.8e-58 Score=397.22 Aligned_cols=254 Identities=25% Similarity=0.444 Sum_probs=214.5
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc---hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
.++|++++.||+|+||+||+|++..+++.||+|+++... ...+.+|+.+++++ +||||+++++++.+ ...+++|
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~--~~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL-HHPKLINLHDAFED--KYEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTC-CSTTBCCEEEEEEC--SSEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhC-CCCCCCcEEEEEEE--CCEEEEE
Confidence 467999999999999999999999999999999987543 45678999999999 99999999999965 4567799
Q ss_pred EEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcC--CCCeEEEeeccceeecCCCC
Q 020826 97 FEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH--EQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 97 ~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~--~~~~v~l~dfg~~~~~~~~~ 170 (321)
||||.+++|.+.+. ++++.+++.++.||+.||+|||++||+||||||+||+++. ++ .+||+|||++.......
T Consensus 105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~-~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKAS-SVKIIDFGLATKLNPDE 183 (352)
T ss_dssp EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCC-CEEECCCTTCEECCTTS
T ss_pred EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCC-eEEEeecccceecCCCC
Confidence 99999999976652 4899999999999999999999999999999999999973 44 89999999999887766
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|..|| .+.+..+.+..+.......
T Consensus 184 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf-~~~~~~~~~~~i~~~~~~~-------------- 247 (352)
T d1koba_ 184 IVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPF-AGEDDLETLQNVKRCDWEF-------------- 247 (352)
T ss_dssp CEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSS-CCSSHHHHHHHHHHCCCCC--------------
T ss_pred ceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhCCCCC--------------
Confidence 6677889999999999987 78999999999999999999999998 3444444444332211100
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
.......+|+++.+||++||+.||++|||++|+|+||||++..
T Consensus 248 -------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 248 -------------------DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp -------------------CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred -------------------CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 0111234778999999999999999999999999999998653
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-57 Score=390.27 Aligned_cols=249 Identities=25% Similarity=0.453 Sum_probs=211.3
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
-++|++++.||+|+||+||+|+++.+++.||+|++++. ....+.+|+.+++.+ +||||+++++++.+ ...+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l-~hp~Iv~l~~~~~~--~~~~ 80 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT-RHPFLTALKYAFQT--HDRL 80 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CCTTBCCEEEEEEC--SSEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhC-CCCCEEEEEeeecc--cccc
Confidence 46899999999999999999999999999999998743 245678999999999 89999999999965 4567
Q ss_pred EEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC-C
Q 020826 94 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP-G 169 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~-~ 169 (321)
++||||+.+++|..++ ..+++..++.++.||+.||+|||++||+||||||+||+++.+| .+||+|||+++.... .
T Consensus 81 ~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g-~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 81 CFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDG 159 (337)
T ss_dssp EEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCCTT
T ss_pred ccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCC-CEEEeecccccccccCC
Confidence 8999999999997777 4699999999999999999999999999999999999999888 899999999986543 3
Q ss_pred CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 170 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
......+||+.|+|||++.+ ..++.++|+|||||++|+|++|+.||. +.+..+....+.. +
T Consensus 160 ~~~~~~~GT~~Y~aPE~~~~-~~y~~~~DiwSlGvilyeml~G~~pf~-~~~~~~~~~~i~~--~--------------- 220 (337)
T d1o6la_ 160 ATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFY-NQDHERLFELILM--E--------------- 220 (337)
T ss_dssp CCBCCCEECGGGCCGGGGSS-SCBCTTHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHH--C---------------
T ss_pred cccccceeCHHHhhhhhccC-CCCChhhcccchhhHHHHHHHCCCCCC-CcCHHHHHHHHhc--C---------------
Confidence 34456789999999999988 788999999999999999999999984 3332222222211 0
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC-----HHHHhcCCCcccC
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPI 311 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps-----~~ell~hp~~~~~ 311 (321)
....+..+|+++.+||++||+.||++|++ ++|+++||||+++
T Consensus 221 --------------------~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i 267 (337)
T d1o6la_ 221 --------------------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp --------------------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred --------------------CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence 01123357889999999999999999994 9999999999875
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-57 Score=387.79 Aligned_cols=277 Identities=27% Similarity=0.486 Sum_probs=218.7
Q ss_pred EeeeeeeecceEEEEEEEecCCceEEEEEecccc--------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 25 VVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 25 ~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~--------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
.++.||+|+||+||+|+++.+++.||||+++... ...+.+|+.+++.+ +||||+++++++.+. ...++|
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~~~~~--~~~~iv 78 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL-SHPNIIGLLDAFGHK--SNISLV 78 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHC-CCTTBCCEEEEECCT--TCCEEE
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhC-CCCCEeEEEeeeccC--Cceeeh
Confidence 4678999999999999999999999999986432 24578999999999 899999999999654 457799
Q ss_pred EEeecCchhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC-Ccc
Q 020826 97 FEHVNNTDFKVLYP---TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KEY 172 (321)
Q Consensus 97 ~e~~~~~~l~~~~~---~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~-~~~ 172 (321)
|||+.++++..+.. .+++..++.++.||+.||+|||++|++||||||+||+++.++ .+||+|||+++..... ...
T Consensus 79 mE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~-~~KL~DFG~a~~~~~~~~~~ 157 (299)
T d1ua2a_ 79 FDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG-VLKLADFGLAKSFGSPNRAY 157 (299)
T ss_dssp EECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCCGGGSTTTSCCCCC
T ss_pred hhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCC-ccccccCccccccCCCcccc
Confidence 99999998876663 489999999999999999999999999999999999999888 8999999999765433 233
Q ss_pred ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChh
Q 020826 173 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 252 (321)
Q Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (321)
....+|+.|+|||++.....++.++|||||||++|+|++|..|| .+.++.+++..+.+..+.+....+.........
T Consensus 158 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf-~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~-- 234 (299)
T d1ua2a_ 158 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL-PGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDY-- 234 (299)
T ss_dssp CCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTC--
T ss_pred cceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCC-CCCCHHHHHHHHHHhcCCCChhhccchhccchh--
Confidence 45679999999999977567899999999999999999998776 677777888888877776544332221111000
Q ss_pred hHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 253 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
.................+|+++.+||++||+.||++||||+|+|+||||+....+.
T Consensus 235 -------~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~ 290 (299)
T d1ua2a_ 235 -------VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT 290 (299)
T ss_dssp -------CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred -------hhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCC
Confidence 00000000111112235678999999999999999999999999999999876554
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.5e-57 Score=380.52 Aligned_cols=254 Identities=25% Similarity=0.414 Sum_probs=212.2
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------------hHHHHHHHHHHHhhcCCCCeeeeeeeeec
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------------KKKIKREIKILQNLCGGPNIVKLLDIVRD 87 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (321)
.++|++.+.||+|+||+||+|++..+++.||||+++... .+.+.+|+.+++++..||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 579999999999999999999999999999999986432 23577899999999669999999999965
Q ss_pred cCCCCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecccee
Q 020826 88 QQSKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 164 (321)
Q Consensus 88 ~~~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~ 164 (321)
....++||||+.+++|.+++ .++++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||+++
T Consensus 82 --~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~ 158 (277)
T d1phka_ 82 --NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSC 158 (277)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCE
T ss_pred --CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCC-CeEEccchhee
Confidence 45678999999999998777 5699999999999999999999999999999999999999888 89999999998
Q ss_pred ecCCCCccccccCCccccccccccC-----CCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhh
Q 020826 165 FYHPGKEYNVRVASRYFKGPELLVD-----LQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELN 239 (321)
Q Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 239 (321)
............||+.|+|||.+.+ ...++.++||||+||++|+|++|+.||. +.+.......+...-...
T Consensus 159 ~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~-~~~~~~~~~~i~~~~~~~--- 234 (277)
T d1phka_ 159 QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW-HRKQMLMLRMIMSGNYQF--- 234 (277)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHTCCCC---
T ss_pred EccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCC-CCCHHHHHHHHHhCCCCC---
Confidence 8766655666789999999999863 2346889999999999999999999994 333333333332210000
Q ss_pred HHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCccc
Q 020826 240 AYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 310 (321)
Q Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~ 310 (321)
.......+|+++++||++||+.||++|||++|+++||||++
T Consensus 235 ------------------------------~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 235 ------------------------------GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp ------------------------------CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred ------------------------------CCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 00112247889999999999999999999999999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.4e-57 Score=387.69 Aligned_cols=249 Identities=25% Similarity=0.411 Sum_probs=206.5
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
..|++++.||+|+||+||+|++..+++.||||+++... .+.+.+|+.+++++ +||||+++++++.+. ...+
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~--~~~~ 91 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKL-RHPNTIQYRGCYLRE--HTAW 91 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEEET--TEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHC-CCCCEeeEEEEEEEC--CEEE
Confidence 36999999999999999999999999999999986432 24578999999999 899999999999654 4578
Q ss_pred EEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc
Q 020826 95 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 171 (321)
Q Consensus 95 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~ 171 (321)
+|||||.++++..+. .++++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||++.....
T Consensus 92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~-~~Kl~DFG~a~~~~~--- 167 (309)
T d1u5ra_ 92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAP--- 167 (309)
T ss_dssp EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-EEEECCCTTCBSSSS---
T ss_pred EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCC-CEEEeecccccccCC---
Confidence 999999999886544 5699999999999999999999999999999999999999888 899999999976532
Q ss_pred cccccCCccccccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 172 YNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
.....||+.|+|||++.+. ..++.++|||||||++|+|++|..||. +.+....+..+......
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~-~~~~~~~~~~i~~~~~~-------------- 232 (309)
T d1u5ra_ 168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF-NMNAMSALYHIAQNESP-------------- 232 (309)
T ss_dssp BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTT-TSCHHHHHHHHHHSCCC--------------
T ss_pred CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCC-CCCHHHHHHHHHhCCCC--------------
Confidence 3456799999999998642 458899999999999999999999984 33333333332220000
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
......+|+++.+||.+||+.||++|||++|+|+||||.+-.
T Consensus 233 ---------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~ 274 (309)
T d1u5ra_ 233 ---------------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (309)
T ss_dssp ---------------------CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred ---------------------CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence 001224678999999999999999999999999999998643
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-56 Score=383.98 Aligned_cols=283 Identities=29% Similarity=0.520 Sum_probs=224.1
Q ss_pred cccCceEEeeeeeeecceEEEEEEEecC-CceEEEEEecccc-----hHHHHHHHHHHHhhc--CCCCeeeeeeeeecc-
Q 020826 18 REQDDYEVVRKVGRGKYSEVFEGVHCTD-NEKCIIKILKPVK-----KKKIKREIKILQNLC--GGPNIVKLLDIVRDQ- 88 (321)
Q Consensus 18 ~~~~~y~~~~~lg~g~~g~v~~~~~~~~-~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~--~h~~i~~~~~~~~~~- 88 (321)
+.+++|++++.||+|+||+||+|++..+ ++.||||+++... ...+.+|+.+++.|. +||||+++++++...
T Consensus 4 ~~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~ 83 (305)
T d1blxa_ 4 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 83 (305)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred CCcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence 4578999999999999999999999655 6679999986432 345778998888774 799999999988532
Q ss_pred --CCCCcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccc
Q 020826 89 --QSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 162 (321)
Q Consensus 89 --~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~ 162 (321)
.....++++|++.++.+.... ..+++..++.++.|++.||+|||++||+||||||+||+++.++ .+||+|||+
T Consensus 84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~-~~kl~dfg~ 162 (305)
T d1blxa_ 84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGL 162 (305)
T ss_dssp CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECSCCS
T ss_pred cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCC-Ceeecchhh
Confidence 234678999999998765433 4589999999999999999999999999999999999999888 899999999
Q ss_pred eeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHh
Q 020826 163 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242 (321)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (321)
+.............||+.|+|||++.+ ..++.++|||||||++|+|++|..|| .+.+..+.+..+....+.+....+.
T Consensus 163 ~~~~~~~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 163 ARIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLF-RGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp CCCCCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred hhhhcccccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCC-CCCCHHHHHHHHHHhhCCCchhccc
Confidence 887655555667889999999999987 78999999999999999999999998 4666677778887777765443322
Q ss_pred hhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCC
Q 020826 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRN 313 (321)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~ 313 (321)
....... ......... ........+|+++.+||++||+.||++|||++|+|+||||++++.
T Consensus 241 ~~~~~~~-----~~~~~~~~~-----~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 241 RDVALPR-----QAFHSKSAQ-----PIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp TTCSSCG-----GGSCCCCCC-----CGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred ccccchh-----hhhcccccc-----chhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 1110000 000000001 111223457789999999999999999999999999999999854
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.2e-57 Score=384.07 Aligned_cols=248 Identities=21% Similarity=0.437 Sum_probs=209.7
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
-++|++++.||+|+||+||+|+++.+|+.||+|+++.. ..+.+.+|+.+++.+ +||||+++++++.+ ....
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~~~~ 79 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIV-THPFIIRMWGTFQD--AQQI 79 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSC-CBTTBCCEEEEEEC--SSEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhc-cCcChhheeeeEee--CCee
Confidence 36899999999999999999999999999999998643 235688999999999 99999999999965 4567
Q ss_pred EEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 94 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
++||||+.++++..++ ..+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||+++....
T Consensus 80 ~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g-~vkL~DFG~a~~~~~-- 156 (316)
T d1fota_ 80 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG-HIKITDFGFAKYVPD-- 156 (316)
T ss_dssp EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS-CEEECCCSSCEECSS--
T ss_pred eeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCC-CEEEecCccceEecc--
Confidence 8999999999987766 4589999999999999999999999999999999999999888 899999999987643
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+..+....+... .
T Consensus 157 ~~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~-~~~~~~~~~~i~~~--~--------------- 217 (316)
T d1fota_ 157 VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFY-DSNTMKTYEKILNA--E--------------- 217 (316)
T ss_dssp CBCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHHC--C---------------
T ss_pred ccccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCC-CcCHHHHHHHHHcC--C---------------
Confidence 2345689999999999987 778999999999999999999999994 33333333322210 0
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc-----CHHHHhcCCCcccCC
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIR 312 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp-----s~~ell~hp~~~~~~ 312 (321)
...+..+|+++.++|++||+.||++|+ |++++++||||++++
T Consensus 218 --------------------~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~ 264 (316)
T d1fota_ 218 --------------------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 264 (316)
T ss_dssp --------------------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred --------------------CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCC
Confidence 011234678999999999999999996 999999999999863
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=381.87 Aligned_cols=281 Identities=30% Similarity=0.582 Sum_probs=221.2
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
++|++++.||+|+||+||+|++..+++.||+|+++... ...+.+|+.+++++ +||||+++++++.+. ...++
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~Hp~Iv~~~~~~~~~--~~~~i 78 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL-NHPNIVKLLDVIHTE--NKLYL 78 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTC-CCTTBCCEEEEEEET--TEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEEeccccccc--cceeE
Confidence 68999999999999999999999999999999986432 45688999999999 899999999999654 45679
Q ss_pred EEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC-C
Q 020826 96 IFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K 170 (321)
Q Consensus 96 v~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~-~ 170 (321)
||||+.++.+.... ..+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||+++..... .
T Consensus 79 v~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~-~~kl~DFG~a~~~~~~~~ 157 (298)
T d1gz8a_ 79 VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPVR 157 (298)
T ss_dssp EEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSTTHHHHHCCCSB
T ss_pred EEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccC-cceeccCCcceeccCCcc
Confidence 99999987654433 4599999999999999999999999999999999999999888 8999999999766433 3
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
......+|+.|+|||++.....++.++|||||||++|+|++|+.|| .+.+....+..+....+.+....+...
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~------ 230 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF-PGDSEIDQLFRIFRTLGTPDEVVWPGV------ 230 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTTSTTG------
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCC-CCCCHHHHHHHHHHhcCCCchhhcccc------
Confidence 4455689999999999877667789999999999999999999998 455556667766666555432221110
Q ss_pred hhhHhhhcccCC-CCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 251 PHLAALVGRHSR-KPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 251 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
......... ..............+|+++.+||++||+.||++|||++|+++||||+++..+.
T Consensus 231 ---~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p~ 293 (298)
T d1gz8a_ 231 ---TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293 (298)
T ss_dssp ---GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred ---ccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCCC
Confidence 010000000 00111111112235778999999999999999999999999999999987654
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-56 Score=388.10 Aligned_cols=284 Identities=31% Similarity=0.497 Sum_probs=227.5
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeeeec----cCCCCcEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRD----QQSKTPSL 95 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~----~~~~~~~l 95 (321)
..+|+.+++||+|+||+||+|++..+++.||||+++... ....+|+.+++++ +||||+++++++.. .+..++++
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l-~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKL-DHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS-SSCCHHHHHHHHC-CCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccc-hHHHHHHHHHHhc-CCCCCCcEEEEEEecCccCCceEEEE
Confidence 347999999999999999999999999999999997543 3446899999999 99999999998853 23456789
Q ss_pred EEEeecCchhhhhc------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC
Q 020826 96 IFEHVNNTDFKVLY------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 96 v~e~~~~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~ 169 (321)
||||++++++..+. ..+++..++.++.||+.||+|||++||+||||||+||+++.++..+||+|||++......
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~ 176 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 176 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTT
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCC
Confidence 99999988644332 359999999999999999999999999999999999999987668999999999887666
Q ss_pred CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 170 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
.......+++.|+|||.+.+...++.++||||+||++|+|++|..|| ...+..+++..+.+.++.+....+........
T Consensus 177 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf-~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~ 255 (350)
T d1q5ka_ 177 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF-PGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255 (350)
T ss_dssp SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHHHCC---
T ss_pred cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCC-CCCCHHHHHHHHHHHhCCChHHhhhhhccchh
Confidence 66667789999999999887578999999999999999999999888 56667778888888888765544433211111
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
... ................+|+++.+||++||+.||++|||++|+|+||||+++..+
T Consensus 256 ~~~--------~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 312 (350)
T d1q5ka_ 256 EFK--------FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 312 (350)
T ss_dssp CCC--------CCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred hcc--------ccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence 100 000011111112233578899999999999999999999999999999987554
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.3e-56 Score=385.68 Aligned_cols=248 Identities=23% Similarity=0.385 Sum_probs=210.2
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCc
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 93 (321)
-++|++++.||+|+||+||+|+++.+|+.||||+++.. ....+.+|+.+++.+ +||||+++++++.+ ....
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~--~~~~ 116 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAV-NFPFLVKLEFSFKD--NSNL 116 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTC-CCTTBCCEEEEEEC--SSEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHc-CCCcEeeccccccc--cccc
Confidence 37899999999999999999999999999999998643 235678999999999 99999999999965 4556
Q ss_pred EEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC
Q 020826 94 SLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~ 170 (321)
++|+|++.++++...+ ..+++..++.++.||+.||.|||++||+||||||+||+++.++ .+||+|||+++.....
T Consensus 117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g-~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-YIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECSSC-
T ss_pred ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCC-CEEeeeceeeeecccc-
Confidence 7999999999987776 5699999999999999999999999999999999999999888 8999999999876532
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||. +.+.......+....
T Consensus 195 -~~~~~Gt~~Y~APE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~-~~~~~~~~~~i~~~~----------------- 254 (350)
T d1rdqe_ 195 -TWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFF-ADQPIQIYEKIVSGK----------------- 254 (350)
T ss_dssp -BCCCEECGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHHCC-----------------
T ss_pred -cccccCccccCCHHHHcC-CCCCccccccchhHHHHHHHhCCCCCC-CcCHHHHHHHHhcCC-----------------
Confidence 345679999999999987 788999999999999999999999984 333333333322100
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc-----CHHHHhcCCCcccCC
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIR 312 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp-----s~~ell~hp~~~~~~ 312 (321)
...+..+|+++.+||++||+.||++|+ |++++++||||++++
T Consensus 255 --------------------~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~ 301 (350)
T d1rdqe_ 255 --------------------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp --------------------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred --------------------CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCC
Confidence 011234778999999999999999994 999999999999764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=383.92 Aligned_cols=254 Identities=25% Similarity=0.433 Sum_probs=212.8
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc--hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
-++|++++.||+|+||+||+|+++.+++.||+|+++... ...+.+|+.+++.+ +||||+++++++.+. ..+++||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l-~HpnIv~~~~~~~~~--~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RHRNILHLHESFESM--EELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHS-CCTTBCCEEEEEEET--TEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhC-CCCCCCeEEEEEEEC--CEEEEEE
Confidence 478999999999999999999999999999999997654 34578999999999 899999999999654 4678999
Q ss_pred EeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCC-CeEEEeeccceeecCCCCcc
Q 020826 98 EHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQ-RKLRLIDWGLAEFYHPGKEY 172 (321)
Q Consensus 98 e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~-~~v~l~dfg~~~~~~~~~~~ 172 (321)
|||.+++|.+++. .+++.+++.++.||+.||+|||++||+||||||+||+++.++ ..++|+|||++.........
T Consensus 81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~ 160 (321)
T d1tkia_ 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcc
Confidence 9999999988773 489999999999999999999999999999999999997542 37999999999887666666
Q ss_pred ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChh
Q 020826 173 NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPH 252 (321)
Q Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (321)
....+++.|+|||...+ ..++.++|||||||++|+|++|..||. +.+..+....+........
T Consensus 161 ~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~-~~~~~~~~~~i~~~~~~~~--------------- 223 (321)
T d1tkia_ 161 RLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFL-AETNQQIIENIMNAEYTFD--------------- 223 (321)
T ss_dssp EEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTC-CSSHHHHHHHHHHTCCCCC---------------
T ss_pred cccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCCCCC---------------
Confidence 67789999999999987 778999999999999999999999984 3333333333322111100
Q ss_pred hHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 253 LAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
......+|+++.+||++||+.||++|||++|+++||||++.
T Consensus 224 ------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 224 ------------------EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp ------------------HHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred ------------------hhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 00112467899999999999999999999999999999753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=6.6e-56 Score=385.74 Aligned_cols=253 Identities=26% Similarity=0.422 Sum_probs=204.8
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHH---HHHHhhcCCCCeeeeeeeeeccCC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREI---KILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~---~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
-++|++.+.||+|+||+||+|++..+|+.||+|++.+.. ...+.+|. .+++.+ +||||+++++++.+.
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~-~hpnIv~l~~~~~~~-- 79 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG-DCPFIVCMSYAFHTP-- 79 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSS-CCTTBCCEEEEEECS--
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcC-CCCcEEEEEEEEEEC--
Confidence 468999999999999999999999999999999986432 23344554 444444 799999999999654
Q ss_pred CCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 91 KTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
...++||||+.+++|..++ ..+++..++.++.||+.||+|||++|++||||||+||+++.++ .+||+|||+++...
T Consensus 80 ~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g-~iKl~DFGla~~~~ 158 (364)
T d1omwa3 80 DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFS 158 (364)
T ss_dssp SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSS-CEEECCCTTCEECS
T ss_pred CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCC-cEEEeeeceeeecC
Confidence 4577999999999998876 4589999999999999999999999999999999999999888 89999999998765
Q ss_pred CCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 168 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
.. ......||+.|+|||++.....++.++|||||||++|+|++|..||...... ... .+......
T Consensus 159 ~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~-~~~-~~~~~~~~------------ 223 (364)
T d1omwa3 159 KK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK-DKH-EIDRMTLT------------ 223 (364)
T ss_dssp SS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS-CHH-HHHHHSSS------------
T ss_pred CC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH-HHH-HHHHhccc------------
Confidence 43 3355689999999999976467899999999999999999999999533221 111 11110000
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC-----HHHHhcCCCcccCC
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT-----AKEAMAHPYFFPIR 312 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps-----~~ell~hp~~~~~~ 312 (321)
.....+..+|+++.+||.+||+.||++||| |+|+++||||++++
T Consensus 224 ---------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~ 272 (364)
T d1omwa3 224 ---------------------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272 (364)
T ss_dssp ---------------------CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred ---------------------CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence 001123357889999999999999999999 79999999999864
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-56 Score=379.58 Aligned_cols=250 Identities=24% Similarity=0.415 Sum_probs=208.1
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
++|++.+.||+|+||+||+|+++.+++.||||++++. ....+..|..++.+..+||||+++++++.+. ...+
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~--~~~y 79 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK--ENLF 79 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS--SEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC--Ccee
Confidence 6899999999999999999999999999999999643 2345667777766433999999999999654 5578
Q ss_pred EEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC-C
Q 020826 95 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-K 170 (321)
Q Consensus 95 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~-~ 170 (321)
+||||+.+++|..++ ..+++..++.++.||+.||+|||++|++||||||+||+++.++ .+||+|||+++..... .
T Consensus 80 ivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~-~~kl~DFG~a~~~~~~~~ 158 (320)
T d1xjda_ 80 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-HIKIADFGMCKENMLGDA 158 (320)
T ss_dssp EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTTC
T ss_pred EEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCC-ceeccccchhhhcccccc
Confidence 999999999998877 5699999999999999999999999999999999999999888 8999999999765433 3
Q ss_pred ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 171 EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||. +.+.......+.. +..
T Consensus 159 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~PF~-~~~~~~~~~~i~~--~~~-------------- 220 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFH-GQDEEELFHSIRM--DNP-------------- 220 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSC-CSSHHHHHHHHHH--CCC--------------
T ss_pred cccccCCCCCcCCHHHHcC-CCCCchhhhhhhhHHHHHHHhCCCCCC-CCCHHHHHHHHHc--CCC--------------
Confidence 3455689999999999988 789999999999999999999999993 3333333332211 000
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHH-HHhcCCCcccCC
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK-EAMAHPYFFPIR 312 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~-ell~hp~~~~~~ 312 (321)
..+..+|+++.+||++||+.||++|||+. ++++||||++++
T Consensus 221 ---------------------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~ 262 (320)
T d1xjda_ 221 ---------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREIN 262 (320)
T ss_dssp ---------------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred ---------------------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCC
Confidence 11234778999999999999999999996 899999998863
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-56 Score=385.52 Aligned_cols=260 Identities=23% Similarity=0.403 Sum_probs=209.0
Q ss_pred cCceEEee-eeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCCCCeeeeeeeeec--cCCCCcEEE
Q 020826 20 QDDYEVVR-KVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGGPNIVKLLDIVRD--QQSKTPSLI 96 (321)
Q Consensus 20 ~~~y~~~~-~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~--~~~~~~~lv 96 (321)
-++|++.+ .||+|+||+||+|++..+++.||||+++. ...+.+|+.++.++.+||||+++++++.+ ....++++|
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~--~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~iv 87 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIV 87 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC--cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEE
Confidence 46899886 59999999999999999999999999864 45678999998777689999999999865 234567899
Q ss_pred EEeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCC--CCeEEEeeccceeecCCC
Q 020826 97 FEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAEFYHPG 169 (321)
Q Consensus 97 ~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~--~~~v~l~dfg~~~~~~~~ 169 (321)
||||+|++|.+++. .+++.+++.++.||+.||+|||++||+||||||+||+++.+ ...+||+|||+++.....
T Consensus 88 mEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~ 167 (335)
T d2ozaa1 88 MECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 167 (335)
T ss_dssp EECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC
T ss_pred EECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCC
Confidence 99999999988762 48999999999999999999999999999999999999853 236999999999887766
Q ss_pred CccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccC
Q 020826 170 KEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIEL 249 (321)
Q Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (321)
.......||+.|+|||++.+ ..++.++|||||||++|+|+||+.||..... ......+.......
T Consensus 168 ~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~-~~~~~~~~~~i~~~------------- 232 (335)
T d2ozaa1 168 NSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-LAISPGMKTRIRMG------------- 232 (335)
T ss_dssp CCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTC-C--------CCCSC-------------
T ss_pred CccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCH-HHHHHHHHHHHhcC-------------
Confidence 66677889999999999987 7799999999999999999999999953322 11111111100000
Q ss_pred ChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 250 DPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
... ........+|+++.+||++||+.||++|||++|+++||||++..
T Consensus 233 --------------~~~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 233 --------------QYE--FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp --------------SSS--CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred --------------CCC--CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 000 00011124778999999999999999999999999999997643
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.3e-55 Score=371.91 Aligned_cols=276 Identities=30% Similarity=0.563 Sum_probs=216.8
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
++|++++.||+|+||+||+|++ .+++.||||+++... ...+.+|+.+++++ +||||+++++.+.+. ...++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~hpnIv~~~~~~~~~--~~~~i 77 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKEL-KHSNIVKLYDVIHTK--KRLVL 77 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGC-CCTTBCCEEEEEECS--SCEEE
T ss_pred CCceeccEEecCCCcEEEEEEe-CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhC-CCCcEEeeeeecccC--CceeE
Confidence 6899999999999999999998 478999999986532 35788999999999 899999999999654 45679
Q ss_pred EEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCC-Cc
Q 020826 96 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPG-KE 171 (321)
Q Consensus 96 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~-~~ 171 (321)
+++++.++++..+. ..+++..++.++.||+.||+|||++||+||||||+||+++.++ .+|++|||.+...... ..
T Consensus 78 ~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~-~~kl~DfG~a~~~~~~~~~ 156 (286)
T d1ob3a_ 78 VFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVRK 156 (286)
T ss_dssp EEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCTTHHHHHCC----
T ss_pred EEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCC-CEEecccccceecccCccc
Confidence 99999998876665 4599999999999999999999999999999999999999888 8999999998765432 23
Q ss_pred cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCCh
Q 020826 172 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (321)
.....+++.|+|||.+.+...++.++|||||||++|+|++|+.|| .+.+..+++..+....+.+....+.........
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~- 234 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF-PGVSEADQLMRIFRILGTPNSKNWPNVTELPKY- 234 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC-
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCC-CCCCHHHHHHHHHHhhCCCChhhccchhhhhhc-
Confidence 345568899999999987677899999999999999999999998 455566677777776666554433221111000
Q ss_pred hhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCccc
Q 020826 252 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFP 310 (321)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~ 310 (321)
..................+|+++.+||++||+.||++|||++|+++||||++
T Consensus 235 -------~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 235 -------DPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp -------CTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred -------ccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 0000001111112223457789999999999999999999999999999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-56 Score=372.57 Aligned_cols=250 Identities=24% Similarity=0.437 Sum_probs=205.9
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc---------hHHHHHHHHHHHhhc-CCCCeeeeeeeeecc
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------KKKIKREIKILQNLC-GGPNIVKLLDIVRDQ 88 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~---------~~~~~~E~~~l~~l~-~h~~i~~~~~~~~~~ 88 (321)
.+++|++.+.||+|+||+||+|++..+++.||||+++... ...+.+|+.+++++. .||||+++++++.+.
T Consensus 2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~ 81 (273)
T d1xwsa_ 2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP 81 (273)
T ss_dssp CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence 4679999999999999999999999999999999986432 234678999999984 389999999999654
Q ss_pred CCCCcEEEEEeecC-chhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecccee
Q 020826 89 QSKTPSLIFEHVNN-TDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 164 (321)
Q Consensus 89 ~~~~~~lv~e~~~~-~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~ 164 (321)
...++|||++.+ +++..++ ..+++..++.++.||+.||+|||++||+||||||+||+++.++..+||+|||++.
T Consensus 82 --~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~ 159 (273)
T d1xwsa_ 82 --DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 159 (273)
T ss_dssp --SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred --CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccce
Confidence 456799999975 4555544 5699999999999999999999999999999999999998665589999999998
Q ss_pred ecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhh
Q 020826 165 FYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244 (321)
Q Consensus 165 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (321)
.... .......||+.|+|||++.+...++.++|||||||++|+|++|..||... . .+..
T Consensus 160 ~~~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~----~---~i~~------------- 218 (273)
T d1xwsa_ 160 LLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD----E---EIIR------------- 218 (273)
T ss_dssp ECCS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH----H---HHHH-------------
T ss_pred eccc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc----h---HHhh-------------
Confidence 6543 33455689999999999987455677899999999999999999998321 0 0000
Q ss_pred hcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
. ....+..+|+++.+||++||+.||++|||++|+++||||+++..+.
T Consensus 219 --------------~----------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~p~ 265 (273)
T d1xwsa_ 219 --------------G----------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQ 265 (273)
T ss_dssp --------------C----------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCHH
T ss_pred --------------c----------ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCCCC
Confidence 0 0112235788999999999999999999999999999999876543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-55 Score=378.46 Aligned_cols=284 Identities=31% Similarity=0.545 Sum_probs=215.7
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC---
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS--- 90 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~--- 90 (321)
..++|++++.||+|+||+||+|.++.+++.||||+++... .+.+.+|+.+|+.+ +||||+++++++...+.
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM-RHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHC-CBTTBCCCSEEECSCSSTTT
T ss_pred cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhc-CCCCeeEEEEEeccCccccc
Confidence 4679999999999999999999999999999999987432 35678999999999 89999999999865432
Q ss_pred -CCcEEEEEeecCchhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 91 -KTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 91 -~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
..+++||||++ .++.... ..+++..++.++.||+.||+|||++||+||||||+||+++.++ .++++|||++....
T Consensus 95 ~~~~~lv~e~~~-~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~-~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 95 FTDFYLVMPFMG-TDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQAD 172 (346)
T ss_dssp CCCCEEEEECCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECC
T ss_pred cceEEEEEeccc-ccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccc-ccccccccceeccC
Confidence 35789999994 4555444 5799999999999999999999999999999999999999888 89999999998754
Q ss_pred CCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 168 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
.......+|+.|+|||++.+...++.++||||+||++|+|++|..|| .+.+....+..+....+.......... ..
T Consensus 173 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~ 248 (346)
T d1cm8a_ 173 --SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLF-KGSDHLDQLKEIMKVTGTPPAEFVQRL-QS 248 (346)
T ss_dssp --SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHHTC-SC
T ss_pred --CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCC-CCCChHHHHHHHHhccCCCcHHHHhhh-cc
Confidence 33456779999999999987667899999999999999999999988 455666666666666665543322111 11
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCc
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~ 314 (321)
.................. ......+|+++.+||++||+.||++|||++|+|+||||+.+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~-----~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 249 DEAKNYMKGLPELEKKDF-----ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310 (346)
T ss_dssp HHHHHHHHHSCCCCCCCG-----GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred hhhhhhhccCCcccccch-----HHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence 111111111111111111 11223577899999999999999999999999999999987543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-55 Score=381.86 Aligned_cols=283 Identities=26% Similarity=0.454 Sum_probs=213.6
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeecc----CCC
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQ----QSK 91 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~----~~~ 91 (321)
++|+++++||+|+||+||+|+++.+|+.||||+++.. ....+.+|+.+++++ +||||+++++++... ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l-~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV-NHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECSCCSTTTCC
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhc-CCCCeeEEEEEEecccccccCc
Confidence 6899999999999999999999999999999999743 234678999999999 899999999998644 336
Q ss_pred CcEEEEEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc
Q 020826 92 TPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 171 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~ 171 (321)
++++||||+.++++......+++..++.++.||+.||+|||++||+|+||||+||+++.++ .++++|||++........
T Consensus 96 ~~~iv~Ey~~~~l~~~~~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~-~~kl~df~~~~~~~~~~~ 174 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFM 174 (355)
T ss_dssp EEEEEEECCSEEHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCCC---------
T ss_pred eeEEEEeccchHHHHhhhcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccccccc-ceeeechhhhhccccccc
Confidence 7899999999999998889999999999999999999999999999999999999999888 799999999887766666
Q ss_pred cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCCh
Q 020826 172 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (321)
.....+|+.|+|||++.+ ..+++++||||+||++++|++|+.|| .+.+...+...+....+.+....+... ..
T Consensus 175 ~~~~~~t~~y~aPE~l~~-~~~~~~~DiwSlG~~l~ell~g~~pF-~~~~~~~~~~~i~~~~~~~~~~~~~~~-----~~ 247 (355)
T d2b1pa1 175 MTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILF-PGRDYIDQWNKVIEQLGTPCPEFMKKL-----QP 247 (355)
T ss_dssp ------CCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCSS-CCSSHHHHHHHHHHHHCCCCHHHHTTS-----CH
T ss_pred cccccccccccChhhhcC-CCCCCCcccccccchHHHHhhCCCCC-CCCCHHHHHHHHHHhccCCCHHHHHHh-----hh
Confidence 667789999999999988 78999999999999999999999887 566666667777666665433222111 11
Q ss_pred hhHhhhcccCCCCCcc----------ccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCC
Q 020826 252 HLAALVGRHSRKPWSK----------FITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIR 312 (321)
Q Consensus 252 ~~~~~~~~~~~~~~~~----------~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~ 312 (321)
................ ..........|+++++||++||+.||++||||+|+|+||||+...
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 1111111110000000 000111123567899999999999999999999999999999754
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-54 Score=366.71 Aligned_cols=279 Identities=30% Similarity=0.516 Sum_probs=224.5
Q ss_pred CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEE
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSL 95 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~l 95 (321)
++|++++.||+|+||+||+|++..+++.||||+++... ...+.+|+.+++.+ +||||+++++++.+. ...++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~--~~~~i 78 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL-KHKNIVRLHDVLHSD--KKLTL 78 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTC-CCTTBCCEEEEEECS--SEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhc-CcCCEEeeccccccc--cceeE
Confidence 58999999999999999999999999999999986432 36688999999999 999999999999654 45679
Q ss_pred EEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-c
Q 020826 96 IFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK-E 171 (321)
Q Consensus 96 v~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~-~ 171 (321)
+++++.++++..+. +.+++..++.++.|++.||+|||++||+||||||+||+++.++ .+||+|||.+....... .
T Consensus 79 v~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~-~~kl~DFG~a~~~~~~~~~ 157 (292)
T d1unla_ 79 VFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-ELKLANFGLARAFGIPVRC 157 (292)
T ss_dssp EEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSCCSC
T ss_pred EeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCC-ceeeeecchhhcccCCCcc
Confidence 99999999877665 4689999999999999999999999999999999999999888 89999999998765433 3
Q ss_pred cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCCh
Q 020826 172 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (321)
.....++..|+|||++.+...++.++|||||||++|+|++|+.||+.+.+..+.+..+....+......+.........
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 236 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY- 236 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC-
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccc-
Confidence 3445677889999998875678999999999999999999999998888877787777776666543332221111000
Q ss_pred hhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 252 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
..................+++++.+||++||+.||++||||+|+|+||||++.
T Consensus 237 -------~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 237 -------KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp -------CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred -------cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 00000111111222334577899999999999999999999999999999875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-54 Score=370.11 Aligned_cols=288 Identities=30% Similarity=0.463 Sum_probs=217.0
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccC-----
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ----- 89 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~----- 89 (321)
.++|++++.||+|+||+||+|+++.+++.||||++... ....+.+|+.+++.+ +|||++++++++....
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l-~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL-KHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHC-CCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHh-cCCCccceEeeeecccccccc
Confidence 58999999999999999999999999999999998543 235688999999999 8999999999885432
Q ss_pred -CCCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 90 -SKTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 90 -~~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
....+++||++.++++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++ .+||+|||++..
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~-~~kl~dfg~~~~ 166 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLARA 166 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEE
T ss_pred cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCC-cEEeeecceeee
Confidence 24578999999988876655 4589999999999999999999999999999999999999888 899999999976
Q ss_pred cCCCC-----ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhH
Q 020826 166 YHPGK-----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNA 240 (321)
Q Consensus 166 ~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (321)
..... ......+|+.|+|||++.+...+++++|||||||++|+|++|+.|| .+.++...+..+....+......
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf-~~~~~~~~~~~i~~~~~~~~~~~ 245 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM-QGNTEQHQLALISQLCGSITPEV 245 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCTTT
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCC-CCCCHHHHHHHHHHhcCCCChhh
Confidence 54322 2234578999999999987667899999999999999999999887 45666666676766666544322
Q ss_pred HhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 241 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
............. .... ...............++++++||.+||++||++|||++|+|+||||+...-++
T Consensus 246 ~~~~~~~~~~~~~----~~~~-~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~ 315 (318)
T d3blha1 246 WPNVDNYELYEKL----ELVK-GQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 315 (318)
T ss_dssp STTCCCC-----------CCS-SCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCC
T ss_pred ccccchhhhhhhh----cccc-cccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCCC
Confidence 1111110000000 0000 00000001111122457889999999999999999999999999999754443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-54 Score=371.39 Aligned_cols=287 Identities=28% Similarity=0.509 Sum_probs=215.9
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC--Cc
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK--TP 93 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~--~~ 93 (321)
+++|++++.||+|+||+||+|++..+++.||||+++... .+.+.+|+.+|+.+ +||||+++++++...... ..
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l-~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRF-RHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHC-CCTTBCCCCEEECCSSTTTCCC
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHc-CCCCCCcEEEEEeeccccccce
Confidence 457999999999999999999999999999999997543 34678999999999 999999999998654321 23
Q ss_pred EEEEEeecCchhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCC-
Q 020826 94 SLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK- 170 (321)
Q Consensus 94 ~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~- 170 (321)
+++++++.+++|.+++ ..+++..++.++.|++.||+|||++||+||||||+||+++.++ .+||+|||++.......
T Consensus 86 ~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~-~~kl~DfG~a~~~~~~~~ 164 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHD 164 (345)
T ss_dssp EEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCGGGC
T ss_pred EEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCC-CEEEcccCceeeccCCCc
Confidence 4556677788887776 5799999999999999999999999999999999999999888 89999999997654322
Q ss_pred ---ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 171 ---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 171 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
......+|+.|+|||++.....++.++||||+||++|+|++|..|| .+.+..............+........
T Consensus 165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 240 (345)
T d1pmea_ 165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIF-PGKHYLDQLNHILGILGSPSQEDLNCI--- 240 (345)
T ss_dssp BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCSCCHHHHHTC---
T ss_pred cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCC-CCCCHHHHHHHHhhhccCCChhhhhhh---
Confidence 2345678999999999866577899999999999999999999998 444555555555555554433222111
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
.................... ......+|+++.+||.+||+.||++|||++|+|+||||++...+.
T Consensus 241 -~~~~~~~~~~~~~~~~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~~ 305 (345)
T d1pmea_ 241 -INLKARNYLLSLPHKNKVPW--NRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 305 (345)
T ss_dssp -CCHHHHHHHHTSCCCCCCCH--HHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCGG
T ss_pred -hhhhhhcccccCCccCCCCH--HHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCCc
Confidence 00111111111111111111 111235678999999999999999999999999999999776553
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-54 Score=363.19 Aligned_cols=254 Identities=17% Similarity=0.316 Sum_probs=210.5
Q ss_pred eeeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc--chHHHHHHHHHHHhhcCCCCeeeeeeeeeccC
Q 020826 12 CVWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQ 89 (321)
Q Consensus 12 ~~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (321)
..|.|++ ++|++.+.||+|+||+||+|++ .++..||||+++.. ..+.+.+|+.++.++ +||||+++++++.+
T Consensus 6 ~~wei~~--~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~-- 79 (272)
T d1qpca_ 6 DEWEVPR--ETLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSPDAFLAEANLMKQL-QHQRLVRLYAVVTQ-- 79 (272)
T ss_dssp CTTBCCG--GGEEEEEEEEEETTEEEEEEEE-TTTEEEEEEEECTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS--
T ss_pred CCeecCH--HHeEEeEEEecCCCcEEEEEEE-CCCCEEEEEEEccCcCCHHHHHHHHHHHHhC-CCCCEeEEEeeecc--
Confidence 4677774 6999999999999999999998 46788999999753 356799999999999 99999999998753
Q ss_pred CCCcEEEEEeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecccee
Q 020826 90 SKTPSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAE 164 (321)
Q Consensus 90 ~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~ 164 (321)
...++||||+.+++|.+++. ++++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||+++
T Consensus 80 -~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~-~~Kl~DFGla~ 157 (272)
T d1qpca_ 80 -EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL-SCKIADFGLAR 157 (272)
T ss_dssp -SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred -CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeeccc-ceeeccccceE
Confidence 23579999999999987663 489999999999999999999999999999999999999888 89999999998
Q ss_pred ecCCCCc--cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHh
Q 020826 165 FYHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242 (321)
Q Consensus 165 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (321)
....... .....+|..|+|||++.+ ..++.++|||||||++|||+||+.|++...+..+....+....
T Consensus 158 ~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~--------- 227 (272)
T d1qpca_ 158 LIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY--------- 227 (272)
T ss_dssp ECSSSCEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC---------
T ss_pred EccCCccccccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC---------
Confidence 7654332 234567889999999987 6789999999999999999998888766555444433322110
Q ss_pred hhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc--CCCccc
Q 020826 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA--HPYFFP 310 (321)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~--hp~~~~ 310 (321)
....+..+|+++.+|+++||+.||++|||++++++ |+||..
T Consensus 228 ---------------------------~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 228 ---------------------------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp ---------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ---------------------------CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 01122356789999999999999999999999998 788864
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.7e-54 Score=365.57 Aligned_cols=254 Identities=19% Similarity=0.340 Sum_probs=208.7
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc--chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
.|+|+. ++|++.+.||+|+||+||+|++..+++.||||+++.+ ..+.+.+|+.+++++ +||||+++++++.+ .
T Consensus 11 ~wei~~--~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~--~ 85 (287)
T d1opja_ 11 KWEMER--TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-KHPNLVQLLGVCTR--E 85 (287)
T ss_dssp TTBCCG--GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHC-CCTTBCCEEEEECS--S
T ss_pred ccEecH--HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhC-CCCCEecCCccEee--C
Confidence 577774 6899999999999999999999999999999998754 356789999999999 89999999999965 4
Q ss_pred CCcEEEEEeecCchhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 91 KTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
...+++|||+.++++..++ ..+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||+++.
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~-~~Kl~DFG~a~~ 164 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRL 164 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCCTTT
T ss_pred CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCC-cEEEccccceee
Confidence 4567999999999987765 3589999999999999999999999999999999999999888 899999999976
Q ss_pred cCCCCc--cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 166 YHPGKE--YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
...... .....++..|+|||++.+ ..++.++|||||||++|+|++|+.||+.+.+.......+....
T Consensus 165 ~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~---------- 233 (287)
T d1opja_ 165 MTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---------- 233 (287)
T ss_dssp CCSSSSEEETTEEECGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC----------
T ss_pred cCCCCceeeccccccccccChHHHcC-CCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC----------
Confidence 543322 233457888999999987 7899999999999999999999888865554433322221100
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccC
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPI 311 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~ 311 (321)
....+..+|+++.+||.+||+.||++|||++|+++ +|+.+
T Consensus 234 --------------------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~ 273 (287)
T d1opja_ 234 --------------------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM 273 (287)
T ss_dssp --------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred --------------------------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence 01122357789999999999999999999999976 44444
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=356.43 Aligned_cols=244 Identities=16% Similarity=0.325 Sum_probs=193.9
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc--chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
.++|++.+.||+|+||+||+|++. +++.||||+++.. ..+.+.+|+.+++++ +||||+++++++.+. ...++||
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~--~~~~lv~ 79 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKL-SHPKLVQLYGVCLEQ--APICLVF 79 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSS--SSCEEEE
T ss_pred hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhc-CCCCcccccceeccC--CceEEEE
Confidence 468999999999999999999984 6778999998753 346789999999999 899999999999654 4567999
Q ss_pred EeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc--
Q 020826 98 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-- 171 (321)
Q Consensus 98 e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~-- 171 (321)
||+.+++|.+++ ..+++..+..++.||+.||+|||+++++||||||+||+++.++ .+||+|||+++.......
T Consensus 80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGG-CEEECSCC------------
T ss_pred EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCC-CeEecccchheeccCCCcee
Confidence 999999988765 3478999999999999999999999999999999999999888 899999999976543322
Q ss_pred cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCCh
Q 020826 172 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDP 251 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (321)
.....+|..|+|||++.+ ..++.++|||||||++|||+|++.|++...+..+....+.....
T Consensus 159 ~~~~~gt~~y~aPE~l~~-~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~----------------- 220 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSF-SRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR----------------- 220 (263)
T ss_dssp ------CTTSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC-----------------
T ss_pred ecceecCcccCChHHhcC-CCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC-----------------
Confidence 233568889999999987 78999999999999999999977777655554444443322111
Q ss_pred hhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 252 HLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
...+..+++++.+|+.+||+.||++|||++|+++|
T Consensus 221 -------------------~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 221 -------------------LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp -------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 11123466899999999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=369.26 Aligned_cols=289 Identities=28% Similarity=0.548 Sum_probs=220.2
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeec
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRD 87 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (321)
+|.| .++|++++.||+|+||+||+|++..+++.||||+++... .+.+.+|+.+++.+ +|||++++++++..
T Consensus 13 ~~~~---~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l-~h~~iv~~~~~~~~ 88 (348)
T d2gfsa1 13 IWEV---PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM-KHENVIGLLDVFTP 88 (348)
T ss_dssp EEEE---ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHC-CCTTBCCCSEEECS
T ss_pred cccC---CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhc-CCCCeeeEEEEEee
Confidence 5655 478999999999999999999999999999999987432 34678999999999 89999999998854
Q ss_pred cC---CCCcEEEEEeecCchhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccc
Q 020826 88 QQ---SKTPSLIFEHVNNTDFKVLY--PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 162 (321)
Q Consensus 88 ~~---~~~~~lv~e~~~~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~ 162 (321)
.. ....+++++++.+++|..++ +++++..++.++.||+.||+|||++||+||||||+||+++.++ .++++|||.
T Consensus 89 ~~~~~~~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~-~~kl~dfg~ 167 (348)
T d2gfsa1 89 ARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGL 167 (348)
T ss_dssp CSSTTTCCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCC--
T ss_pred ccccccCceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccc-cccccccch
Confidence 32 22345677888889998887 4699999999999999999999999999999999999999888 899999999
Q ss_pred eeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHh
Q 020826 163 AEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYL 242 (321)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (321)
+.... .......+++.|+|||...+...++.++|||||||++|+|++|..|| .+.+.......+....+........
T Consensus 168 a~~~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF-~~~~~~~~~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 168 ARHTD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF-PGTDHIDQLKLILRLVGTPGAELLK 244 (348)
T ss_dssp --CCT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSC-CCSSHHHHHHHHHHHHCCCCHHHHT
T ss_pred hcccC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCC-CCCCHHHHHHHHHHhcCCCChHHhh
Confidence 86543 33455678889999999887667899999999999999999999888 4556666666666665554332211
Q ss_pred hhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcccCCCcc
Q 020826 243 NKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFFPIRNAE 315 (321)
Q Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~~~~~~~ 315 (321)
. ................+...+. .....+|+++.+||++||+.||++|||++|+|+||||++...++
T Consensus 245 ~----~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~ 311 (348)
T d2gfsa1 245 K----ISSESARNYIQSLTQMPKMNFA--NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311 (348)
T ss_dssp T----CCCHHHHHHHTTSCCCCCCCHH--HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred h----ccchhhhhhhhhcccCCCcchh--hhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCc
Confidence 1 0111111111111111111111 11235778999999999999999999999999999999875543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-54 Score=360.33 Aligned_cols=250 Identities=17% Similarity=0.341 Sum_probs=196.9
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-----chHHHHHHHHHHHhhcCCCCeeeeeeeeec
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-----KKKKIKREIKILQNLCGGPNIVKLLDIVRD 87 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (321)
.|+|+ .++|++.+.||+|+||+||+|+.. ..||||+++.. ..+.+.+|+.++.++ +||||+++++++.+
T Consensus 2 dwei~--~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~~~~~~ 75 (276)
T d1uwha_ 2 DWEIP--DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKT-RHVNILLFMGYSTA 75 (276)
T ss_dssp CCBCC--TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTC-CCTTBCCEEEEECS
T ss_pred Ccccc--cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhC-CCCCEeeeeEEEec
Confidence 36666 568999999999999999999753 35999998632 236788999999999 99999999998743
Q ss_pred cCCCCcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccce
Q 020826 88 QQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163 (321)
Q Consensus 88 ~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~ 163 (321)
..+++||||+.+++|.+++ ..+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||++
T Consensus 76 ---~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~-~~Kl~DFGla 151 (276)
T d1uwha_ 76 ---PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL-TVKIGDFGLA 151 (276)
T ss_dssp ---SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTS-SEEECCCCCS
T ss_pred ---cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCC-CEEEccccce
Confidence 2468999999999998776 3489999999999999999999999999999999999999888 8999999999
Q ss_pred eecCCCC---ccccccCCccccccccccCC--CCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHH-hCChh
Q 020826 164 EFYHPGK---EYNVRVASRYFKGPELLVDL--QDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKV-LGTDE 237 (321)
Q Consensus 164 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~--~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~ 237 (321)
+...... ......||+.|+|||++.+. ..++.++|||||||++|||+||+.||. +.+....+...... ...+.
T Consensus 152 ~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~-~~~~~~~~~~~~~~~~~~p~ 230 (276)
T d1uwha_ 152 TVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLSPD 230 (276)
T ss_dssp CC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTT-TCCCHHHHHHHHHHTSCCCC
T ss_pred eeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCC-CCChHHHHHHHHhcCCCCCc
Confidence 7654222 23445789999999998642 357899999999999999999999984 33333333332221 11110
Q ss_pred hhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 238 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
. ......+|+++.+||.+||+.||++|||++|++++
T Consensus 231 ~--------------------------------~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 231 L--------------------------------SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp G--------------------------------GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred c--------------------------------hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0 11223467899999999999999999999999976
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-53 Score=363.94 Aligned_cols=251 Identities=21% Similarity=0.347 Sum_probs=202.3
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEecCCc-----eEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeee
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNE-----KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLD 83 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~-----~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (321)
.|.|++ ++|++.+.||+|+||+||+|++..+++ .||+|.+... ....+.+|+.++.++.+||||+++++
T Consensus 31 kwei~~--~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 31 KWEFPR--ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp GGBCCG--GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccCCH--HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence 355653 589999999999999999999876543 6899988543 23568899999999878999999999
Q ss_pred eeeccCCCCcEEEEEeecCchhhhhcC--------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCe
Q 020826 84 IVRDQQSKTPSLIFEHVNNTDFKVLYP--------------------------TLSDYDVRYYIYELLKALDYCHSQGIM 137 (321)
Q Consensus 84 ~~~~~~~~~~~lv~e~~~~~~l~~~~~--------------------------~~~~~~~~~i~~qi~~~l~~lh~~~i~ 137 (321)
++.+. ..+++|||||.+++|.+++. .+++..++.++.||+.||+|||++||+
T Consensus 109 ~~~~~--~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~Ii 186 (325)
T d1rjba_ 109 ACTLS--GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCV 186 (325)
T ss_dssp EECSS--SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred EEeeC--CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 99654 45679999999999987762 378889999999999999999999999
Q ss_pred eecCCCCCeEEcCCCCeEEEeeccceeecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CC
Q 020826 138 HRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RK 213 (321)
Q Consensus 138 H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~ 213 (321)
||||||+||+++.++ .+||+|||+++....... .....+|+.|+|||++.+ ..++.++|||||||++|||+| |.
T Consensus 187 HRDlKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwS~Gvil~emlt~g~ 264 (325)
T d1rjba_ 187 HRDLAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGV 264 (325)
T ss_dssp ETTCSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred eccCchhccccccCC-eEEEeeccccccccCCCceeeeccccCCCccCChHHHcC-CCCCcceeccchhHHHHHHHhCCC
Confidence 999999999999888 999999999976543332 234457899999999987 789999999999999999998 78
Q ss_pred CCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCC
Q 020826 214 EPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDH 293 (321)
Q Consensus 214 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp 293 (321)
.||. +.+....+..+..... ....+..+|+++.+||.+||+.||
T Consensus 265 ~Pf~-~~~~~~~~~~~~~~~~-----------------------------------~~~~p~~~~~~l~~li~~cl~~dP 308 (325)
T d1rjba_ 265 NPYP-GIPVDANFYKLIQNGF-----------------------------------KMDQPFYATEEIYIIMQSCWAFDS 308 (325)
T ss_dssp CSST-TCCCSHHHHHHHHTTC-----------------------------------CCCCCTTCCHHHHHHHHHHTCSSG
T ss_pred CCCC-CCCHHHHHHHHHhcCC-----------------------------------CCCCCCcCCHHHHHHHHHHcCCCh
Confidence 8873 4443333333322100 011233577899999999999999
Q ss_pred CCCcCHHHHhcC
Q 020826 294 QERPTAKEAMAH 305 (321)
Q Consensus 294 ~~Rps~~ell~h 305 (321)
++|||++||++|
T Consensus 309 ~~RPt~~ei~~~ 320 (325)
T d1rjba_ 309 RKRPSFPNLTSF 320 (325)
T ss_dssp GGSCCHHHHHHH
T ss_pred hHCcCHHHHHHH
Confidence 999999999876
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-53 Score=355.88 Aligned_cols=255 Identities=18% Similarity=0.321 Sum_probs=207.3
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc--hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
.|.|+ .++|++.+.||+|+||+||+|++. ++..||||+++... .+.+.+|+.+++++ +||||+++++++.+.
T Consensus 11 ~~~i~--~~~~~i~~~iG~G~fg~Vy~~~~~-~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l-~h~nIv~~~g~~~~~-- 84 (285)
T d1fmka3 11 AWEIP--RESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSPEAFLQEAQVMKKL-RHEKLVQLYAVVSEE-- 84 (285)
T ss_dssp CSBCC--GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEECCTTSSCHHHHHHHHHHHHHC-CCTTBCCEEEEECSS--
T ss_pred ceEcC--HHHEEEeeEEeeCCCeEEEEEEEC-CCCEEEEEEECcccCCHHHHHHHHHHHHhc-ccCCEeEEEEEEecC--
Confidence 57776 468999999999999999999985 44679999997543 46799999999999 999999999998532
Q ss_pred CCcEEEEEeecCchhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 91 KTPSLIFEHVNNTDFKVLY-----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
..++||||+.++++..++ ..+++..+..++.||+.||+|||++|++||||||+||+++.++ .+||+|||+++.
T Consensus 85 -~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~-~~kl~DfGla~~ 162 (285)
T d1fmka3 85 -PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARL 162 (285)
T ss_dssp -SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCTTC-
T ss_pred -CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCC-cEEEcccchhhh
Confidence 357999999999887666 3589999999999999999999999999999999999999887 899999999976
Q ss_pred cCCCC--ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 166 YHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 166 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
..... ......+|+.|+|||++.. ..++.++|||||||++|+|++|+.|++.+....+.+..+.....
T Consensus 163 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~--------- 232 (285)
T d1fmka3 163 IEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--------- 232 (285)
T ss_dssp -------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC---------
T ss_pred ccCCCceeeccccccccccChHHHhC-CCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC---------
Confidence 54332 2234568899999999987 78899999999999999999988888766665555544322111
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc--CCCcccCC
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA--HPYFFPIR 312 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~--hp~~~~~~ 312 (321)
...+..+|+++.++|.+||+.||++|||++++++ ++||....
T Consensus 233 ---------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 233 ---------------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp ---------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred ---------------------------CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 1122356789999999999999999999999988 89998764
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8.2e-53 Score=354.37 Aligned_cols=254 Identities=21% Similarity=0.313 Sum_probs=198.0
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc------hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC--
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK------KKKIKREIKILQNLCGGPNIVKLLDIVRDQQS-- 90 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~------~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~-- 90 (321)
..++|++.+.||+|+||+||+|++..+++.||+|+++... ...+.+|+.+++.+ +||||+++++++...+.
T Consensus 5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~-~hpniv~~~~~~~~~~~~~ 83 (277)
T d1o6ya_ 5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAAL-NHPAIVAVYDTGEAETPAG 83 (277)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEEEEECSSS
T ss_pred ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhc-CCCCCCcccceeeeccCCC
Confidence 3678999999999999999999999999999999996432 24578999999999 99999999999875543
Q ss_pred CCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 91 KTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
..+++||||+.+++|..++ ..+++.+++.++.||+.||+|||++|++||||||+||+++.++ .++++|||.+....
T Consensus 84 ~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~-~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 84 PLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN-AVKVMDFGIARAIA 162 (277)
T ss_dssp EEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTS-CEEECCCTTCEECC
T ss_pred ceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccc-cceeehhhhhhhhc
Confidence 3478999999999988666 4699999999999999999999999999999999999999888 89999999986553
Q ss_pred CCC----ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 168 PGK----EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 168 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
... ......||+.|+|||++.+ ..+++++|||||||++|+|+||..||. +.+..+.+..+.......
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~-~~~~~~~~~~~~~~~~~~------- 233 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFT-GDSPVSVAYQHVREDPIP------- 233 (277)
T ss_dssp ----------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCC-CSSHHHHHHHHHHCCCCC-------
T ss_pred cccccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCC-CcCHHHHHHHHHhcCCCC-------
Confidence 222 2344578999999999987 788999999999999999999999983 333333333322210000
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcCCCcc
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAHPYFF 309 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~hp~~~ 309 (321)
.......+|+++.++|++||+.||++||+..+.+.|+|.+
T Consensus 234 --------------------------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 234 --------------------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp --------------------------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred --------------------------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 0112235778999999999999999999544444566653
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-53 Score=353.95 Aligned_cols=251 Identities=19% Similarity=0.341 Sum_probs=201.9
Q ss_pred eeeecccCceEEeee-eeeecceEEEEEEEec--CCceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeee
Q 020826 14 WFINREQDDYEVVRK-VGRGKYSEVFEGVHCT--DNEKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVR 86 (321)
Q Consensus 14 ~~i~~~~~~y~~~~~-lg~g~~g~v~~~~~~~--~~~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (321)
++|+ .++|.+.+. ||+|+||+||+|.+.. ++..||||+++.. ..+.+.+|+.++.++ +||||+++++++.
T Consensus 3 l~l~--~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l-~HpnIv~l~g~~~ 79 (285)
T d1u59a_ 3 LFLK--RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL-DNPYIVRLIGVCQ 79 (285)
T ss_dssp CBCC--GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHC-CCTTBCCEEEEEE
T ss_pred eeec--ccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhC-CCCCEeeEeeeec
Confidence 3444 468888885 9999999999998754 3457999998743 235688999999999 8999999999985
Q ss_pred ccCCCCcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccc
Q 020826 87 DQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGL 162 (321)
Q Consensus 87 ~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~ 162 (321)
++ .+++||||+++++|..++ ..+++..+..++.||+.||+|||++|++||||||+||+++.++ .+||+|||+
T Consensus 80 ~~---~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~-~~Kl~DFGl 155 (285)
T d1u59a_ 80 AE---ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGL 155 (285)
T ss_dssp SS---SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT-EEEECCCTT
T ss_pred cC---eEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCC-ceeeccchh
Confidence 42 368999999999998875 3489999999999999999999999999999999999999888 899999999
Q ss_pred eeecCCCCc----cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChh
Q 020826 163 AEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDE 237 (321)
Q Consensus 163 ~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~ 237 (321)
++....... .....+|+.|+|||++.. ..++.++|||||||++|||+| |..||. +.+..+....+.+..
T Consensus 156 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~-~~~~~~~~~~i~~~~---- 229 (285)
T d1u59a_ 156 SKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYK-KMKGPEVMAFIEQGK---- 229 (285)
T ss_dssp CEECTTCSCEECCCCSSCCCGGGCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTT-TCCTHHHHHHHHTTC----
T ss_pred hhcccccccccccccccccCccccChHHHhC-CCCCccchhhcchHHHHHHHhCCCCCCC-CCCHHHHHHHHHcCC----
Confidence 987654332 223457889999999987 688999999999999999998 888883 333333333221100
Q ss_pred hhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHH---hcCCCcc
Q 020826 238 LNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA---MAHPYFF 309 (321)
Q Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~el---l~hp~~~ 309 (321)
....+..+|+++.+||.+||+.||++|||+.++ |+|+|+.
T Consensus 230 --------------------------------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 230 --------------------------------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp --------------------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred --------------------------------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 011233577899999999999999999999877 6788875
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=348.67 Aligned_cols=243 Identities=20% Similarity=0.328 Sum_probs=201.1
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc--chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
.++|++.+.||+|+||+||+|++ .++..||||+++.. ..+.+.+|+.++.++ +||||+++++++.+. ..+++||
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l-~HpnIv~~~g~~~~~--~~~~iv~ 78 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL-SHEKLVQLYGVCTKQ--RPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSCHHHHHHHHHHHHTC-CCTTBCCEEEEECCS--SSEEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCCHHHHHHHHHHHHhc-CCCceeeEEEEEeeC--CceEEEE
Confidence 47899999999999999999998 57889999999753 457799999999999 999999999999654 4567999
Q ss_pred EeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc--
Q 020826 98 EHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE-- 171 (321)
Q Consensus 98 e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~-- 171 (321)
||+.++++..+. ..+++..+.+++.|++.||+|||++||+||||||+||+++.++ .+||+|||+++.......
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~-~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTC-CEEECCCSSCCBCSSSSCCC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCC-cEEECcchhheeccCCCcee
Confidence 999999887774 4589999999999999999999999999999999999999887 899999999976543322
Q ss_pred cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCC
Q 020826 172 YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELD 250 (321)
Q Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (321)
.....+|..|+|||++.+ ..++.++|||||||++|||+| |+.|| .+.+..+....+.+..
T Consensus 158 ~~~~~~t~~y~aPE~~~~-~~~~~ksDiwS~G~~l~el~t~g~~Pf-~~~~~~~~~~~i~~~~----------------- 218 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMY-SKFSSKSDIWAFGVLMWEIYSLGKMPY-ERFTNSETAEHIAQGL----------------- 218 (258)
T ss_dssp CCCSCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTSCHHHHHHHHHTTC-----------------
T ss_pred ecccCCCCCcCCcHHhcC-CCCCcceeecccchhhHhHHhcCCCCC-CCCCHHHHHHHHHhCC-----------------
Confidence 234568889999999987 788999999999999999998 78777 3444333333222100
Q ss_pred hhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 251 PHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
....+..+++++.+||++||+.||++|||++++++|
T Consensus 219 -------------------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 219 -------------------RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp -------------------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -------------------CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 011223466799999999999999999999999987
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-52 Score=355.11 Aligned_cols=244 Identities=16% Similarity=0.294 Sum_probs=187.1
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCc---eEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNE---KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~---~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
.++|++.+.||+|+||+||+|+++.+++ .||||.+... ..+.+.+|+.+++++ +||||+++++++.+. ..
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~--~~ 101 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF-DHPNVIHLEGVVTKS--TP 101 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC-CCTTBCCEEEEECSS--SS
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCCccEEEEEeeC--CE
Confidence 5689999999999999999999876654 5888887643 235688999999999 999999999999554 45
Q ss_pred cEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCC
Q 020826 93 PSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHP 168 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~ 168 (321)
.++|||||.+++|..++ +.+++..+..++.||+.||+|||++|++||||||+||+++.++ .+||+|||+++....
T Consensus 102 ~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~-~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 102 VMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLED 180 (299)
T ss_dssp CEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC--------
T ss_pred EEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCC-cEEECCcccceEccC
Confidence 67999999999998765 3489999999999999999999999999999999999999888 899999999976543
Q ss_pred CCcc------ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHH
Q 020826 169 GKEY------NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAY 241 (321)
Q Consensus 169 ~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (321)
.... ....+|+.|+|||.+.+ ..++.++|||||||++|||+| |..||. +....+.+..+....
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~-~~~~~~~~~~i~~~~-------- 250 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYW-DMTNQDVINAIEQDY-------- 250 (299)
T ss_dssp ---------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTT-TCCHHHHHHHHHTTC--------
T ss_pred CCCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCC-CCCHHHHHHHHHcCC--------
Confidence 3221 12346888999999987 789999999999999999998 788873 333333332221100
Q ss_pred hhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 242 LNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
....+..+++++.+|+.+||+.||++|||++|++++
T Consensus 251 ----------------------------~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 251 ----------------------------RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp ----------------------------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred ----------------------------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 011123467899999999999999999999998865
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-52 Score=348.65 Aligned_cols=244 Identities=18% Similarity=0.330 Sum_probs=192.9
Q ss_pred eEEe-eeeeeecceEEEEEEEec--CCceEEEEEecccc-----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcE
Q 020826 23 YEVV-RKVGRGKYSEVFEGVHCT--DNEKCIIKILKPVK-----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPS 94 (321)
Q Consensus 23 y~~~-~~lg~g~~g~v~~~~~~~--~~~~~~vK~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~ 94 (321)
+.+. ++||+|+||+||+|.+.. +++.||||+++... .+.+.+|+.+++++ +||||+++++++.++ ..+
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~g~~~~~---~~~ 83 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL-DNPYIVRMIGICEAE---SWM 83 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTC-CCTTBCCEEEEEESS---SEE
T ss_pred CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhC-CCCCCceEEEEeccC---CEE
Confidence 4443 469999999999998754 45689999986432 35688999999999 999999999998542 357
Q ss_pred EEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecCCCCc
Q 020826 95 LIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGKE 171 (321)
Q Consensus 95 lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~~ 171 (321)
+||||+.+++|..++ ..+++..+..++.||+.||+|||++|++||||||+||+++.++ .+||+|||+++.......
T Consensus 84 lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~-~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 84 LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADEN 162 (277)
T ss_dssp EEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEECCTTCS
T ss_pred EEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccC-cccccchhhhhhcccccc
Confidence 999999999998776 4599999999999999999999999999999999999999888 899999999987654332
Q ss_pred c----ccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhc
Q 020826 172 Y----NVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYH 246 (321)
Q Consensus 172 ~----~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (321)
. ....+|+.|+|||++.+ ..++.++|||||||++|||++ |..||. +.+..+....+.+.
T Consensus 163 ~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gv~l~ellt~g~~Pf~-~~~~~~~~~~i~~~-------------- 226 (277)
T d1xbba_ 163 YYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYR-GMKGSEVTAMLEKG-------------- 226 (277)
T ss_dssp EEEC----CCCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTTCCSST-TCCHHHHHHHHHTT--------------
T ss_pred ccccccccCCCceecCchhhcC-CCCCchhhhccchhhhhHHhhCCCCCCC-CCCHHHHHHHHHcC--------------
Confidence 2 23468889999999987 678999999999999999998 788873 33332222222110
Q ss_pred ccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHH---hcCCCcc
Q 020826 247 IELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEA---MAHPYFF 309 (321)
Q Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~el---l~hp~~~ 309 (321)
.....+..+|+++.+||.+||+.||++|||++++ |+|+|++
T Consensus 227 ----------------------~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 227 ----------------------ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp ----------------------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred ----------------------CCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 0011223577899999999999999999999988 5666654
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=346.79 Aligned_cols=244 Identities=16% Similarity=0.280 Sum_probs=192.2
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCC----ceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDN----EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~----~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
.+.|++.+.||+|+||+||+|.+..++ ..||||.++... ...+.+|+.++.++ +||||+++++++.+ ..
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l-~H~nIv~~~g~~~~--~~ 82 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF-SHHNIIRLEGVISK--YK 82 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEEECS--SS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhc-CCCCEeeeeEEEec--CC
Confidence 457999999999999999999987654 469999986432 34578999999999 89999999999954 44
Q ss_pred CcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 92 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
..++++|++.++++.... ..+++..+..++.||+.||+|||+++|+||||||+||+++.++ .+||+|||+++...
T Consensus 83 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~-~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 83 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVLE 161 (283)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCCC-----
T ss_pred ceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCC-eEEEcccchhhccc
Confidence 567999999999876654 4689999999999999999999999999999999999999888 89999999997654
Q ss_pred CCCc----cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 168 PGKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
.... .....||..|+|||++.+ ..++.++|||||||++|||++++.|++...+..+.+..+....
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~---------- 230 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF---------- 230 (283)
T ss_dssp ------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC----------
T ss_pred CCCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC----------
Confidence 3322 223457889999999987 7899999999999999999998888765555444333322110
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
....+..+++++.+||.+||+.||++|||+.|+++
T Consensus 231 --------------------------~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 231 --------------------------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp --------------------------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred --------------------------CCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 01122346688999999999999999999999986
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-52 Score=354.77 Aligned_cols=256 Identities=21% Similarity=0.377 Sum_probs=205.3
Q ss_pred CceEEeeeeeeecceEEEEEEEe---cCCceEEEEEeccc-------chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCC
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHC---TDNEKCIIKILKPV-------KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQS 90 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~---~~~~~~~vK~~~~~-------~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (321)
++|++++.||+|+||+||+|++. .+|+.||||++++. ....+.+|+.+++++.+||||+++++++.+.
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~-- 101 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-- 101 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET--
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC--
Confidence 67999999999999999999874 36889999998642 2356889999999996669999999999654
Q ss_pred CCcEEEEEeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 91 KTPSLIFEHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 91 ~~~~lv~e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
...++++||+.+++|..++ ..+++..++.++.||+.||+|+|++|++||||||+||+++.++ .++|+|||++....
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~-~vkL~DFG~a~~~~ 180 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEFV 180 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEESCSSEEEECC
T ss_pred CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCC-CEEEeeccchhhhc
Confidence 4677999999999998777 4688999999999999999999999999999999999999888 89999999997654
Q ss_pred CC--CccccccCCccccccccccCCC-CCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhh
Q 020826 168 PG--KEYNVRVASRYFKGPELLVDLQ-DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244 (321)
Q Consensus 168 ~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (321)
.. .......+++.|+|||.+.+.. .++.++|||||||++|+|++|..||.... .......+.....
T Consensus 181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~-~~~~~~~i~~~~~---------- 249 (322)
T d1vzoa_ 181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG-EKNSQAEISRRIL---------- 249 (322)
T ss_dssp GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT-SCCCHHHHHHHHH----------
T ss_pred ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHHhcc----------
Confidence 32 2234567899999999997633 57889999999999999999999985332 2222222111000
Q ss_pred hcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCc-----CHHHHhcCCCcccCCC
Q 020826 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERP-----TAKEAMAHPYFFPIRN 313 (321)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rp-----s~~ell~hp~~~~~~~ 313 (321)
.. ....+..+|+++.+||++||++||++|| |++|+++||||++++.
T Consensus 250 -------------~~----------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~ 300 (322)
T d1vzoa_ 250 -------------KS----------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINW 300 (322)
T ss_dssp -------------HC----------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCH
T ss_pred -------------cC----------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCH
Confidence 00 0011234678999999999999999999 5899999999998753
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=351.34 Aligned_cols=253 Identities=20% Similarity=0.324 Sum_probs=195.7
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEecC-----CceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeee
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCTD-----NEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLD 83 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~-----~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (321)
.|.|++ ++|++.+.||+|+||+||+|.+... ++.||+|+++... ...+.+|...+.++.+|+||+.+++
T Consensus 7 ~wei~~--~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~ 84 (299)
T d1ywna1 7 KWEFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG 84 (299)
T ss_dssp HHBCCG--GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccH--HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence 566774 6899999999999999999998653 3679999987432 3457788888888878999999999
Q ss_pred eeeccCCCCcEEEEEeecCchhhhhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCC
Q 020826 84 IVRDQQSKTPSLIFEHVNNTDFKVLYP-------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPH 144 (321)
Q Consensus 84 ~~~~~~~~~~~lv~e~~~~~~l~~~~~-------------------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~ 144 (321)
++... ....+++||||.+++|.+++. .+++..+..++.||+.||+|||++||+||||||+
T Consensus 85 ~~~~~-~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~ 163 (299)
T d1ywna1 85 ACTKP-GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 163 (299)
T ss_dssp EECST-TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeccC-CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcc
Confidence 87543 345689999999999987762 3788999999999999999999999999999999
Q ss_pred CeEEcCCCCeEEEeeccceeecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCC
Q 020826 145 NVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD 221 (321)
Q Consensus 145 nili~~~~~~v~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~ 221 (321)
||+++.++ .+||+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..|++.+..
T Consensus 164 NILl~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 164 NILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp GEEECGGG-CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ceeECCCC-cEEEccCcchhhccccccccccCceeeCccccchhHhhc-CCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 99999888 899999999976543322 234578999999999987 7899999999999999999998665545544
Q ss_pred ChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHH
Q 020826 222 NYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKE 301 (321)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~e 301 (321)
....+......... ...+..+|+++.++|.+||+.||++|||++|
T Consensus 242 ~~~~~~~~~~~~~~-----------------------------------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~e 286 (299)
T d1ywna1 242 IDEEFCRRLKEGTR-----------------------------------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSE 286 (299)
T ss_dssp CSHHHHHHHHHTCC-----------------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred HHHHHHHHHhcCCC-----------------------------------CCCCccCCHHHHHHHHHHcCCChhHCcCHHH
Confidence 43333332221111 1122346789999999999999999999999
Q ss_pred HhcC
Q 020826 302 AMAH 305 (321)
Q Consensus 302 ll~h 305 (321)
+++|
T Consensus 287 il~~ 290 (299)
T d1ywna1 287 LVEH 290 (299)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 9987
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-51 Score=345.31 Aligned_cols=248 Identities=23% Similarity=0.395 Sum_probs=190.8
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEecCC---ceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeee
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDN---EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIV 85 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~---~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (321)
.|+|++ ++|++.+.||+|+||+||+|++..++ ..||+|.++.. ....+.+|+.+++++ +||||+++++++
T Consensus 1 ~~ei~~--~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~~~~ 77 (273)
T d1mp8a_ 1 DYEIQR--ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF-DHPHIVKLIGVI 77 (273)
T ss_dssp CCBCCG--GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTC-CCTTBCCEEEEE
T ss_pred CCCcCH--HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEE
Confidence 367775 58999999999999999999986543 46888888643 235688999999999 999999999998
Q ss_pred eccCCCCcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecc
Q 020826 86 RDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 161 (321)
Q Consensus 86 ~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg 161 (321)
.+ ...++||||+.++++..++ ..+++..+..++.||+.||+|||++|++||||||+||+++.++ .+||+|||
T Consensus 78 ~~---~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~-~~Kl~DfG 153 (273)
T d1mp8a_ 78 TE---NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFG 153 (273)
T ss_dssp CS---SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECC--
T ss_pred ec---CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCC-cEEEccch
Confidence 53 3468999999999887654 3589999999999999999999999999999999999999888 89999999
Q ss_pred ceeecCCCC--ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhh
Q 020826 162 LAEFYHPGK--EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDEL 238 (321)
Q Consensus 162 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (321)
+++...... ......+|+.|+|||++.+ ..++.++|||||||++|||++ |..|| .+.+..+....+....
T Consensus 154 ~a~~~~~~~~~~~~~~~gt~~y~apE~l~~-~~~~~~~DiwSlGvil~e~lt~g~~P~-~~~~~~~~~~~i~~~~----- 226 (273)
T d1mp8a_ 154 LSRYMEDSTYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMHGVKPF-QGVKNNDVIGRIENGE----- 226 (273)
T ss_dssp -----------------CCGGGCCHHHHHH-CCCSHHHHHHHHHHHHHHHHTTSCCTT-TTCCGGGHHHHHHTTC-----
T ss_pred hheeccCCcceeccceecCcccchhhHhcc-CCCCCccccccchHHHHHHHhcCCCCC-CCCCHHHHHHHHHcCC-----
Confidence 997654322 2334567889999999987 789999999999999999998 66666 4444433333322100
Q ss_pred hHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 239 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
....+..+|+++.+||.+||+.||++|||++|+++|
T Consensus 227 -------------------------------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 227 -------------------------------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp -------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -------------------------------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 011233577899999999999999999999999976
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=347.45 Aligned_cols=243 Identities=18% Similarity=0.336 Sum_probs=192.3
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCc----eEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCC
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNE----KCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSK 91 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~----~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~ 91 (321)
.++|++++.||+|+||+||+|.+..+++ +||+|.++.. ..+.+.+|+.+++++ +||||+++++++.+.
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~l~g~~~~~--- 83 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV-DNPHVCRLLGICLTS--- 83 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHC-CCTTBCCEEEEEESS---
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEecC---
Confidence 3579999999999999999999987765 5888887643 245789999999999 899999999998653
Q ss_pred CcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 92 TPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 92 ~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
..+++++++.+++|...+ ..+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+|||+++...
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~-~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLG 162 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCCSHHHHTT
T ss_pred CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCC-CeEeeccccceecc
Confidence 346888998888775544 4589999999999999999999999999999999999999888 89999999998664
Q ss_pred CCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCChhhhHHhh
Q 020826 168 PGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGTDELNAYLN 243 (321)
Q Consensus 168 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (321)
.... .....||..|+|||++.+ ..++.++|||||||++|||+| |..|| .+.+..+....+.+..
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~-~~~~~~sDvwS~Gvil~el~t~g~~p~-~~~~~~~~~~~i~~~~---------- 230 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPY-DGIPASEISSILEKGE---------- 230 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTT-TTSCGGGHHHHHHHTC----------
T ss_pred cccccccccccccCccccChHHHhc-CCCChhhhhhhHHHHHHHHHHCCCCCC-CCCCHHHHHHHHHcCC----------
Confidence 3322 233467899999999987 789999999999999999999 55555 4444333333222110
Q ss_pred hhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 244 KYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
....+..+++++.+|+.+||+.||++|||+.|+++|
T Consensus 231 --------------------------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 231 --------------------------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp --------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --------------------------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 011223467899999999999999999999999988
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-51 Score=339.52 Aligned_cols=246 Identities=16% Similarity=0.322 Sum_probs=193.0
Q ss_pred eeeecccCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc-hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK-KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 14 ~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
|.|. -++|++.+.||+|+||+||+|++ +++.||||+++.+. .+.+.+|+.+++++ +||||+++++++.+.. ..
T Consensus 2 w~i~--~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~~~-~~ 75 (262)
T d1byga_ 2 WALN--MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQL-RHSNLVQLLGVIVEEK-GG 75 (262)
T ss_dssp CBCC--GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTC-CCTTBCCEEEEECCC---C
T ss_pred CccC--HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhC-CCCCEeeEEEEEEecC-Cc
Confidence 6666 45899999999999999999998 57789999997654 46789999999999 8999999999885433 33
Q ss_pred cEEEEEeecCchhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccceeecC
Q 020826 93 PSLIFEHVNNTDFKVLYP-----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEFYH 167 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~~-----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~~~ 167 (321)
+++||||+.+++|.+++. .+++..+..++.||+.||.|||+.+++||||||+||+++.++ .++++|||+++...
T Consensus 76 ~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~-~~kl~dfg~s~~~~ 154 (262)
T d1byga_ 76 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEAS 154 (262)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEECCCCC-----
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCC-CEeecccccceecC
Confidence 589999999999988863 389999999999999999999999999999999999999888 89999999997653
Q ss_pred CCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhhhcc
Q 020826 168 PGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHI 247 (321)
Q Consensus 168 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (321)
. ......++..|+|||++.+ ..++.++|||||||++|||+|++.|++...+.......+...
T Consensus 155 ~--~~~~~~~~~~y~aPE~l~~-~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~--------------- 216 (262)
T d1byga_ 155 S--TQDTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG--------------- 216 (262)
T ss_dssp ---------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT---------------
T ss_pred C--CCccccccccCCChHHHhC-CCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC---------------
Confidence 2 2334567889999999987 689999999999999999998444443444333333322110
Q ss_pred cCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 248 ELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
.....+..+++++.+||++||+.||++|||+.+++++
T Consensus 217 ---------------------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 217 ---------------------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp ---------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---------------------CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0011233567899999999999999999999999874
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-51 Score=349.00 Aligned_cols=247 Identities=19% Similarity=0.291 Sum_probs=200.4
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCce--EEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEK--CIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~--~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
..++|++.+.||+|+||+||+|+++.++.. ||||.++.. ..+.+.+|+.++.++.+||||+++++++.+. ..
T Consensus 8 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--~~ 85 (309)
T d1fvra_ 8 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR--GY 85 (309)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET--TE
T ss_pred CHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC--Ce
Confidence 357999999999999999999999888764 667776532 3356899999999986799999999999654 45
Q ss_pred cEEEEEeecCchhhhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCC
Q 020826 93 PSLIFEHVNNTDFKVLY-------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQR 153 (321)
Q Consensus 93 ~~lv~e~~~~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~ 153 (321)
+++||||+.+++|.+++ ..+++..+..++.||+.||.|||+++++||||||+||+++.++
T Consensus 86 ~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~- 164 (309)
T d1fvra_ 86 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY- 164 (309)
T ss_dssp EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG-
T ss_pred eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC-
Confidence 67999999999998876 3489999999999999999999999999999999999999888
Q ss_pred eEEEeeccceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHh
Q 020826 154 KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVL 233 (321)
Q Consensus 154 ~v~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 233 (321)
.+||+|||+++............+|..|+|||.+.+ ..++.++|||||||++|+|++|..|++.+.+..+....+.+.
T Consensus 165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~- 242 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG- 242 (309)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT-
T ss_pred ceEEccccccccccccccccceecCCcccchHHhcc-CCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc-
Confidence 899999999976654444455678899999999987 788999999999999999999887665555443333222110
Q ss_pred CChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 234 GTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
.....+..+++++.+||.+||+.||++|||++|+++|
T Consensus 243 -----------------------------------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 243 -----------------------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp -----------------------------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -----------------------------------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 0011223477899999999999999999999999987
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-50 Score=340.66 Aligned_cols=252 Identities=21% Similarity=0.317 Sum_probs=207.3
Q ss_pred eeeeeecccCceEEeeeeeeecceEEEEEEEe-----cCCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeee
Q 020826 12 CVWFINREQDDYEVVRKVGRGKYSEVFEGVHC-----TDNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLL 82 (321)
Q Consensus 12 ~~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~-----~~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~ 82 (321)
..|.|++ ++|++.+.||+|+||.||+|++. .+++.||||+++... ...+.+|+.++..+.+||||++++
T Consensus 16 ~~~~~~~--~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~ 93 (311)
T d1t46a_ 16 HKWEFPR--NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLL 93 (311)
T ss_dssp GGGBCCG--GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred ccccCCH--HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence 4577775 69999999999999999999874 345689999997532 346789999999997899999999
Q ss_pred eeeeccCCCCcEEEEEeecCchhhhhcC---------------------CCCHHHHHHHHHHHHHHHHHHHHCCCeeecC
Q 020826 83 DIVRDQQSKTPSLIFEHVNNTDFKVLYP---------------------TLSDYDVRYYIYELLKALDYCHSQGIMHRDV 141 (321)
Q Consensus 83 ~~~~~~~~~~~~lv~e~~~~~~l~~~~~---------------------~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dl 141 (321)
+++.+. ...+++||||.+++|..++. .+++..+..++.||+.||+|||++|++||||
T Consensus 94 g~~~~~--~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDL 171 (311)
T d1t46a_ 94 GACTIG--GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDL 171 (311)
T ss_dssp EEECSS--SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred EEEeeC--CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccc
Confidence 999554 45679999999999877762 4888999999999999999999999999999
Q ss_pred CCCCeEEcCCCCeEEEeeccceeecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCcc
Q 020826 142 KPHNVMIDHEQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY 218 (321)
Q Consensus 142 kp~nili~~~~~~v~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~ 218 (321)
||+||+++.++ .++++|||.++....... .....+|+.|+|||++.+ ..++.++|||||||++|+|+|++.|++.
T Consensus 172 Kp~NIl~~~~~-~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~ellt~g~p~~~ 249 (311)
T d1t46a_ 172 AARNILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYP 249 (311)
T ss_dssp SGGGEEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred ccccccccccC-cccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHHHHHhCCCCCCC
Confidence 99999999888 899999999987653322 234578899999999987 7899999999999999999997778776
Q ss_pred CCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC
Q 020826 219 GHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT 298 (321)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps 298 (321)
+.+..+.+..+...... ...+..+|+++.+||.+||+.||++|||
T Consensus 250 ~~~~~~~~~~~i~~~~~-----------------------------------~~~~~~~~~~l~~Li~~cl~~dP~~RPs 294 (311)
T d1t46a_ 250 GMPVDSKFYKMIKEGFR-----------------------------------MLSPEHAPAEMYDIMKTCWDADPLKRPT 294 (311)
T ss_dssp TCCSSHHHHHHHHHTCC-----------------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCHHHHHHHHHhcCCC-----------------------------------CCCcccccHHHHHHHHHHcCCChhHCcC
Confidence 66665555544331111 1122346789999999999999999999
Q ss_pred HHHHhc
Q 020826 299 AKEAMA 304 (321)
Q Consensus 299 ~~ell~ 304 (321)
++++++
T Consensus 295 ~~~il~ 300 (311)
T d1t46a_ 295 FKQIVQ 300 (311)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999985
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-50 Score=344.01 Aligned_cols=248 Identities=18% Similarity=0.279 Sum_probs=200.7
Q ss_pred eeeecccCceEEeeeeeeecceEEEEEEEec-----CCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeeee
Q 020826 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLDI 84 (321)
Q Consensus 14 ~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (321)
|+++ .++|++.+.||+|+||+||+|++.+ ++..||||+++... ...+.+|+.++..+ +||||++++++
T Consensus 8 ~e~p--~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~ 84 (301)
T d1lufa_ 8 LEYP--RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF-DNPNIVKLLGV 84 (301)
T ss_dssp TBCC--GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTC-CCTTBCCEEEE
T ss_pred ccCC--HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhc-CCCCcccceee
Confidence 4444 5689999999999999999999864 45789999987532 35689999999999 99999999999
Q ss_pred eeccCCCCcEEEEEeecCchhhhhcC---------------------------CCCHHHHHHHHHHHHHHHHHHHHCCCe
Q 020826 85 VRDQQSKTPSLIFEHVNNTDFKVLYP---------------------------TLSDYDVRYYIYELLKALDYCHSQGIM 137 (321)
Q Consensus 85 ~~~~~~~~~~lv~e~~~~~~l~~~~~---------------------------~~~~~~~~~i~~qi~~~l~~lh~~~i~ 137 (321)
+.. ....++++|++.+++|.+++. .+++..+..++.|++.||+|||+++++
T Consensus 85 ~~~--~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iv 162 (301)
T d1lufa_ 85 CAV--GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV 162 (301)
T ss_dssp ECS--SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred ecc--CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeE
Confidence 955 445679999999999887662 378889999999999999999999999
Q ss_pred eecCCCCCeEEcCCCCeEEEeeccceeecCCCC---ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCC
Q 020826 138 HRDVKPHNVMIDHEQRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKE 214 (321)
Q Consensus 138 H~dlkp~nili~~~~~~v~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~ 214 (321)
||||||+||+++.++ .+||+|||+++...... ......+++.|+|||.+.+ ..++.++|||||||++|||++|..
T Consensus 163 HrDlKp~NILld~~~-~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVwS~Gvvl~ell~~~~ 240 (301)
T d1lufa_ 163 HRDLATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGL 240 (301)
T ss_dssp CSCCSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTC
T ss_pred eeEEcccceEECCCC-cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhccchhhHHHHHccCC
Confidence 999999999999888 89999999987553222 2234567889999999987 789999999999999999999977
Q ss_pred CCccCCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCC
Q 020826 215 PFFYGHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQ 294 (321)
Q Consensus 215 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~ 294 (321)
|++.+.+..+....+.+... ...+..+++++.+||.+||+.||+
T Consensus 241 ~p~~~~~~~e~~~~v~~~~~------------------------------------~~~p~~~~~~~~~li~~cl~~~P~ 284 (301)
T d1lufa_ 241 QPYYGMAHEEVIYYVRDGNI------------------------------------LACPENCPLELYNLMRLCWSKLPA 284 (301)
T ss_dssp CTTTTSCHHHHHHHHHTTCC------------------------------------CCCCTTCCHHHHHHHHHHTCSSGG
T ss_pred CCCCCCCHHHHHHHHHcCCC------------------------------------CCCCccchHHHHHHHHHHcCCChh
Confidence 65555555544443321100 112235778999999999999999
Q ss_pred CCcCHHHHhc
Q 020826 295 ERPTAKEAMA 304 (321)
Q Consensus 295 ~Rps~~ell~ 304 (321)
+|||+.|+++
T Consensus 285 ~RPt~~ev~~ 294 (301)
T d1lufa_ 285 DRPSFCSIHR 294 (301)
T ss_dssp GSCCHHHHHH
T ss_pred HCcCHHHHHH
Confidence 9999999964
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-50 Score=337.18 Aligned_cols=246 Identities=19% Similarity=0.293 Sum_probs=190.1
Q ss_pred eeeecccCceEEeeeeeeecceEEEEEEEecC-C--ceEEEEEeccc------chHHHHHHHHHHHhhcCCCCeeeeeee
Q 020826 14 WFINREQDDYEVVRKVGRGKYSEVFEGVHCTD-N--EKCIIKILKPV------KKKKIKREIKILQNLCGGPNIVKLLDI 84 (321)
Q Consensus 14 ~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~-~--~~~~vK~~~~~------~~~~~~~E~~~l~~l~~h~~i~~~~~~ 84 (321)
.+|+ .++|++.+.||+|+||+||+|++..+ + ..||||++++. ..+.+.+|+.+++++ +||||++++++
T Consensus 3 ~~i~--~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~~~g~ 79 (273)
T d1u46a_ 3 CLIG--EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL-DHRNLIRLYGV 79 (273)
T ss_dssp EECC--GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHC-CCTTBCCEEEE
T ss_pred eEEc--hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhC-CCCCEEEEEEE
Confidence 4555 46899999999999999999987543 2 36899998643 235688999999999 99999999999
Q ss_pred eeccCCCCcEEEEEeecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeec
Q 020826 85 VRDQQSKTPSLIFEHVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDW 160 (321)
Q Consensus 85 ~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~df 160 (321)
+.+. ..++|+||+.++++.+.. ..+++..+..++.||+.||.|||++|++||||||+||+++.++ .+||+||
T Consensus 80 ~~~~---~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~-~vkl~Df 155 (273)
T d1u46a_ 80 VLTP---PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDF 155 (273)
T ss_dssp ECSS---SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCC
T ss_pred Eeec---chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcccccc-ceeeccc
Confidence 9542 457999999998876655 4599999999999999999999999999999999999999888 8999999
Q ss_pred cceeecCCCCc----cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHh-CCCCCccCCCChHHHHHHHHHhCC
Q 020826 161 GLAEFYHPGKE----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIF-RKEPFFYGHDNYDQLVKIAKVLGT 235 (321)
Q Consensus 161 g~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~-g~~p~~~~~~~~~~~~~~~~~~~~ 235 (321)
|+++....... .....++..|+|||++.+ ..++.++||||||+++|||+| |..|| .+.+..+....+.+..
T Consensus 156 Gl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf-~~~~~~~~~~~i~~~~-- 231 (273)
T d1u46a_ 156 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPW-IGLNGSQILHKIDKEG-- 231 (273)
T ss_dssp TTCEECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTT-TTCCHHHHHHHHHTSC--
T ss_pred hhhhhcccCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCC-CCcCHHHHHHHHHhCC--
Confidence 99987654432 123356778999999987 789999999999999999998 78887 4444444433332100
Q ss_pred hhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHh
Q 020826 236 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAM 303 (321)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell 303 (321)
.....+..+|+++.+||.+||+.||++|||++|++
T Consensus 232 ---------------------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~ 266 (273)
T d1u46a_ 232 ---------------------------------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266 (273)
T ss_dssp ---------------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ---------------------------------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 00112335778999999999999999999999986
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-50 Score=339.78 Aligned_cols=251 Identities=19% Similarity=0.299 Sum_probs=196.0
Q ss_pred eeeeeecccCceEEeeeeeeecceEEEEEEEecCC-------ceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeee
Q 020826 12 CVWFINREQDDYEVVRKVGRGKYSEVFEGVHCTDN-------EKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVK 80 (321)
Q Consensus 12 ~~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~-------~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~ 80 (321)
+.|.|+ .++|++.+.||+|+||.||+|++..++ ..||||+++... ...+.+|...+.++.+||||++
T Consensus 6 ~~~~i~--~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~ 83 (299)
T d1fgka_ 6 PRWELP--RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIIN 83 (299)
T ss_dssp TTTBCC--GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CcCccc--HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEe
Confidence 456666 459999999999999999999986554 379999987543 3557789999998878999999
Q ss_pred eeeeeeccCCCCcEEEEEeecCchhhhhc-------------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecC
Q 020826 81 LLDIVRDQQSKTPSLIFEHVNNTDFKVLY-------------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDV 141 (321)
Q Consensus 81 ~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-------------------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dl 141 (321)
+++++.+ ....++||||+.++++..++ ..+++..+..++.||+.||+|||+.+++||||
T Consensus 84 ~~~~~~~--~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDi 161 (299)
T d1fgka_ 84 LLGACTQ--DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDL 161 (299)
T ss_dssp EEEEECS--SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred ccccccc--CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeee
Confidence 9999965 45677999999999998877 24799999999999999999999999999999
Q ss_pred CCCCeEEcCCCCeEEEeeccceeecCCCC---ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCcc
Q 020826 142 KPHNVMIDHEQRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFY 218 (321)
Q Consensus 142 kp~nili~~~~~~v~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~ 218 (321)
||+||+++.++ .+||+|||++....... ......+++.|+|||.+.+ ..++.++||||||+++|+|++++.|++.
T Consensus 162 Kp~NiLl~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~ell~~g~~p~~ 239 (299)
T d1fgka_ 162 AARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYP 239 (299)
T ss_dssp SGGGEEECTTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred cccceeecCCC-CeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHhccCCCCCCC
Confidence 99999999888 89999999997654332 2344568889999999987 7899999999999999999985444434
Q ss_pred CCCChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcC
Q 020826 219 GHDNYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPT 298 (321)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps 298 (321)
+.+.......+.. .. ....+..+|+++.+||.+||+.||++|||
T Consensus 240 ~~~~~~~~~~i~~-~~-----------------------------------~~~~p~~~~~~l~~li~~cl~~dP~~Rps 283 (299)
T d1fgka_ 240 GVPVEELFKLLKE-GH-----------------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPT 283 (299)
T ss_dssp TCCHHHHHHHHHT-TC-----------------------------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCC
T ss_pred CCCHHHHHHHHHc-CC-----------------------------------CCCCCccchHHHHHHHHHHccCCHhHCcC
Confidence 4443322222111 00 01122357789999999999999999999
Q ss_pred HHHHhc
Q 020826 299 AKEAMA 304 (321)
Q Consensus 299 ~~ell~ 304 (321)
+.|+++
T Consensus 284 ~~eil~ 289 (299)
T d1fgka_ 284 FKQLVE 289 (299)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999986
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-50 Score=340.70 Aligned_cols=257 Identities=18% Similarity=0.318 Sum_probs=208.6
Q ss_pred eeeeecccCceEEeeeeeeecceEEEEEEEec-----CCceEEEEEecccc----hHHHHHHHHHHHhhcCCCCeeeeee
Q 020826 13 VWFINREQDDYEVVRKVGRGKYSEVFEGVHCT-----DNEKCIIKILKPVK----KKKIKREIKILQNLCGGPNIVKLLD 83 (321)
Q Consensus 13 ~~~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~-----~~~~~~vK~~~~~~----~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (321)
.|.|+ .++|++.+.||+|+||+||+|.+.. ++..||||+++... ...+.+|+.+++++ +||||+++++
T Consensus 14 ~~ei~--~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l-~h~nIv~~~~ 90 (308)
T d1p4oa_ 14 EWEVA--REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCHHVVRLLG 90 (308)
T ss_dssp TTBCC--GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGC-CCTTBCCEEE
T ss_pred ceeec--HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHc-CCCCEeeeee
Confidence 57777 4799999999999999999998853 35789999997532 24578999999999 8999999999
Q ss_pred eeeccCCCCcEEEEEeecCchhhhhc-------------CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcC
Q 020826 84 IVRDQQSKTPSLIFEHVNNTDFKVLY-------------PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDH 150 (321)
Q Consensus 84 ~~~~~~~~~~~lv~e~~~~~~l~~~~-------------~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~ 150 (321)
++.. ....++||||+.+++|..++ ..++...+..++.|++.||.|||+++++||||||+||+++.
T Consensus 91 ~~~~--~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~ 168 (308)
T d1p4oa_ 91 VVSQ--GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE 168 (308)
T ss_dssp EECS--SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECT
T ss_pred EEec--CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecC
Confidence 9954 34567999999999987766 23688899999999999999999999999999999999998
Q ss_pred CCCeEEEeeccceeecCCCCc---cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHH
Q 020826 151 EQRKLRLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLV 227 (321)
Q Consensus 151 ~~~~v~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~ 227 (321)
++ .+||+|||+++....... .....+|+.|+|||.+.+ ..++.++|||||||++|||+||..|++.+.+..+.+.
T Consensus 169 ~~-~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~-~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~ 246 (308)
T d1p4oa_ 169 DF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 246 (308)
T ss_dssp TC-CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHH
T ss_pred Cc-eEEEeecccceeccCCcceeeccceecccccCCHHHHcc-CCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 88 899999999975533222 233467899999999987 7889999999999999999999766655655544444
Q ss_pred HHHHHhCChhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc---
Q 020826 228 KIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA--- 304 (321)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~--- 304 (321)
.+.+.. ....+..+|+++.++|.+||+.||++|||++++++
T Consensus 247 ~i~~~~------------------------------------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~ 290 (308)
T d1p4oa_ 247 FVMEGG------------------------------------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK 290 (308)
T ss_dssp HHHTTC------------------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHG
T ss_pred HHHhCC------------------------------------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence 332100 01122346789999999999999999999999998
Q ss_pred ---CCCcccCC
Q 020826 305 ---HPYFFPIR 312 (321)
Q Consensus 305 ---hp~~~~~~ 312 (321)
+|+|+++.
T Consensus 291 ~~~~~~~~~~~ 301 (308)
T d1p4oa_ 291 EEMEPGFREVS 301 (308)
T ss_dssp GGSCTTHHHHC
T ss_pred HhcCCCCcCCC
Confidence 78887653
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.1e-49 Score=335.44 Aligned_cols=251 Identities=18% Similarity=0.308 Sum_probs=196.4
Q ss_pred eeecccCceEEeeeeeeecceEEEEEEEecCC---ceEEEEEeccc----chHHHHHHHHHHHhhcCCCCeeeeeeeeec
Q 020826 15 FINREQDDYEVVRKVGRGKYSEVFEGVHCTDN---EKCIIKILKPV----KKKKIKREIKILQNLCGGPNIVKLLDIVRD 87 (321)
Q Consensus 15 ~i~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~---~~~~vK~~~~~----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (321)
.++.....+.+.++||+|+||+||+|++..++ ..||||.++.. ..+.+.+|++++.++ +||||+++++++.+
T Consensus 21 ~~~~~~~~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l-~HpnIv~~~g~~~~ 99 (311)
T d1r0pa_ 21 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF-SHPNVLSLLGICLR 99 (311)
T ss_dssp BCCGGGEEEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTC-CCTTBCCCCEEEEE
T ss_pred EeChHHceeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC-CCCCEeEEeEEEEe
Confidence 44555555666788999999999999986543 36899998642 235689999999999 89999999998754
Q ss_pred cCCCCcEEEEEeecCchhhhhcC----CCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeeccce
Q 020826 88 QQSKTPSLIFEHVNNTDFKVLYP----TLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWGLA 163 (321)
Q Consensus 88 ~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg~~ 163 (321)
.. ...++|||||+++++.++.. .++...+..++.|++.||.|+|+.+++||||||+||+++.++ .+||+|||++
T Consensus 100 ~~-~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~-~~kL~DFG~~ 177 (311)
T d1r0pa_ 100 SE-GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLA 177 (311)
T ss_dssp TT-TEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECSSGGG
T ss_pred cC-CceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCC-CEEEecccch
Confidence 32 35689999999999987663 467888999999999999999999999999999999999877 8999999999
Q ss_pred eecCCCCc-----cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhh
Q 020826 164 EFYHPGKE-----YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDEL 238 (321)
Q Consensus 164 ~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (321)
+....... .....+|..|+|||.+.. ..++.++||||||+++|||++|+.||....+.......+...
T Consensus 178 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g------ 250 (311)
T d1r0pa_ 178 RDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG------ 250 (311)
T ss_dssp CCTTTTTCCCTTCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT------
T ss_pred hhccccccccceecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC------
Confidence 76543322 223467889999999987 789999999999999999999999986544332222221110
Q ss_pred hHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 239 NAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
. ....+..+++++.+||.+||+.||++|||+.|+++|
T Consensus 251 ----------------------~--------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 251 ----------------------R--------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp ----------------------C--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ----------------------C--------CCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 0 011223467899999999999999999999999988
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3e-49 Score=345.54 Aligned_cols=302 Identities=24% Similarity=0.365 Sum_probs=213.2
Q ss_pred EEeeeeeeccc-CceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc--hHHHHHHHHHHHhhc----------CCC
Q 020826 10 YWCVWFINREQ-DDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK--KKKIKREIKILQNLC----------GGP 76 (321)
Q Consensus 10 ~~~~~~i~~~~-~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~--~~~~~~E~~~l~~l~----------~h~ 76 (321)
|+|+..++... .+|+++++||+|+||+||+|+++.+|+.||||+++... .+...+|+.+++.+. .|+
T Consensus 1 ~~p~~~g~~~~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~ 80 (362)
T d1q8ya_ 1 YHPAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGAN 80 (362)
T ss_dssp CCCCCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHT
T ss_pred CCCCCCCCCccCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcC
Confidence 34555566544 57999999999999999999999999999999998653 356788999888873 368
Q ss_pred CeeeeeeeeeccCCCCcEEEEEeecCchh--hh----hcCCCCHHHHHHHHHHHHHHHHHHHH-CCCeeecCCCCCeEEc
Q 020826 77 NIVKLLDIVRDQQSKTPSLIFEHVNNTDF--KV----LYPTLSDYDVRYYIYELLKALDYCHS-QGIMHRDVKPHNVMID 149 (321)
Q Consensus 77 ~i~~~~~~~~~~~~~~~~lv~e~~~~~~l--~~----~~~~~~~~~~~~i~~qi~~~l~~lh~-~~i~H~dlkp~nili~ 149 (321)
||+++++++........+++++++..... .. ....+++..++.++.||+.||+|||+ .||+||||||+||+++
T Consensus 81 ~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~ 160 (362)
T d1q8ya_ 81 HILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 160 (362)
T ss_dssp TBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEE
T ss_pred ceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeee
Confidence 89999998876666666677776644432 11 11458999999999999999999998 8999999999999998
Q ss_pred CCCC-----eEEEeeccceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCC---
Q 020826 150 HEQR-----KLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHD--- 221 (321)
Q Consensus 150 ~~~~-----~v~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~--- 221 (321)
.++. .++++|||.+.... .......+|+.|+|||++.+ ..++.++|+||+||++++|++|+.||.....
T Consensus 161 ~~~~~~~~~~~kl~dfg~s~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~ 237 (362)
T d1q8ya_ 161 IVDSPENLIQIKIADLGNACWYD--EHYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELITGDFLFEPDEGHSY 237 (362)
T ss_dssp EEETTTTEEEEEECCCTTCEETT--BCCCSCCSCGGGCCHHHHHT-CCCCTHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred ccCcccccceeeEeecccccccc--cccccccccccccChhhccc-cCCCccccccchHHHHHHHHHCCCCCCCCccccc
Confidence 6542 48999999987654 33355679999999999987 7789999999999999999999999854322
Q ss_pred --ChHHHHHHHHHhCChhhhHHhhhhcccCChhhHhhhcccCC---CCCccc--cccccccCCcchHHHHHHHhhccCCC
Q 020826 222 --NYDQLVKIAKVLGTDELNAYLNKYHIELDPHLAALVGRHSR---KPWSKF--ITVENQHLAVPEAVDFLDKLLRYDHQ 294 (321)
Q Consensus 222 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~--~~~~~~~~~s~~~~~ll~~~l~~dp~ 294 (321)
....+......++............................ .+.... .........++++.+||.+||++||+
T Consensus 238 ~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~ 317 (362)
T d1q8ya_ 238 TKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPR 317 (362)
T ss_dssp -CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTT
T ss_pred cchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChh
Confidence 22344555555555332221111000000000000000000 000000 01111223567899999999999999
Q ss_pred CCcCHHHHhcCCCcccCCCc
Q 020826 295 ERPTAKEAMAHPYFFPIRNA 314 (321)
Q Consensus 295 ~Rps~~ell~hp~~~~~~~~ 314 (321)
+||||+|+|+||||+++...
T Consensus 318 ~Rpta~e~L~Hp~f~~~~~~ 337 (362)
T d1q8ya_ 318 KRADAGGLVNHPWLKDTLGM 337 (362)
T ss_dssp TCBCHHHHHTCGGGTTCTTC
T ss_pred HCcCHHHHhcCcccCCCCCc
Confidence 99999999999999976433
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-47 Score=325.63 Aligned_cols=259 Identities=17% Similarity=0.234 Sum_probs=195.2
Q ss_pred ccCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEE
Q 020826 19 EQDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIF 97 (321)
Q Consensus 19 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 97 (321)
.+++|++.+.||+|+||+||+|++..+++.||||++... ....+..|+++++.+.+|++|+.+..++.+ ....++||
T Consensus 5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~--~~~~~ivm 82 (299)
T d1ckia_ 5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE--GDYNVMVM 82 (299)
T ss_dssp ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEE--TTEEEEEE
T ss_pred ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEec--CCEEEEEE
Confidence 357899999999999999999999999999999998753 345688999999999545556666665543 34567999
Q ss_pred EeecCchhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCC--CCeEEEeeccceeecCCCCc-
Q 020826 98 EHVNNTDFKVLY---PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE--QRKLRLIDWGLAEFYHPGKE- 171 (321)
Q Consensus 98 e~~~~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~--~~~v~l~dfg~~~~~~~~~~- 171 (321)
|+++++.+.... ..+++..+..++.|++.||+|||++||+||||||+||+++.. +..++|+|||+++.......
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 83 ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred EEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 999877654443 469999999999999999999999999999999999998632 23799999999987643321
Q ss_pred -------cccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCChhhhHHhhh
Q 020826 172 -------YNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGTDELNAYLNK 244 (321)
Q Consensus 172 -------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (321)
.....||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... .....+.........
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~-~~~~~~~~~~~~~~~------ 234 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA-TKRQKYERISEKKMS------ 234 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHHTT-BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--------HHHHHHHHHH------
T ss_pred cceeccccCCcCCCccccCHHHHhC-CCCCChhhEEecCHHHHHHHhCCCcccccchH-HHHHHHHHhhcccCC------
Confidence 234579999999999987 77999999999999999999999999533222 111111110000000
Q ss_pred hcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHH---HHhcCCCccc
Q 020826 245 YHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAK---EAMAHPYFFP 310 (321)
Q Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~---ell~hp~~~~ 310 (321)
. ........+|+++.++|.+||+.||++||+++ ++|+|+|.+.
T Consensus 235 ------------------~-----~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 235 ------------------T-----PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp ------------------S-----CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred ------------------C-----ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 0 00001124678999999999999999999986 5678877654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-48 Score=327.60 Aligned_cols=266 Identities=18% Similarity=0.202 Sum_probs=190.9
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccchHHHHHHHHHHH--hhcCCCCeeeeeeeeeccCC--CCcEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQ--NLCGGPNIVKLLDIVRDQQS--KTPSL 95 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~--~l~~h~~i~~~~~~~~~~~~--~~~~l 95 (321)
.++|.+.+.||+|+||+||+|++ +|+.||||+++........+|.+++. .+ +||||+++++++.+.+. ...++
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~-~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVML-RHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTC-CCTTBCCEEEEEEEECSSSEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhC-CCCcCcceEEEEEeCCCcceEEEE
Confidence 36899999999999999999986 68899999998777666666665554 55 89999999999875543 35789
Q ss_pred EEEeecCchhhhhcC--CCCHHHHHHHHHHHHHHHHHHHH--------CCCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 96 IFEHVNNTDFKVLYP--TLSDYDVRYYIYELLKALDYCHS--------QGIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 96 v~e~~~~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~lh~--------~~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
||||+.+++|..++. ++++..+..++.|++.||+|+|+ +||+||||||+||+++.++ .+||+|||++..
T Consensus 79 v~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~-~~Kl~DFGl~~~ 157 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVR 157 (303)
T ss_dssp EEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCCTTCEE
T ss_pred EEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC-CeEEEecCcccc
Confidence 999999999988884 68999999999999999999996 5899999999999999888 899999999987
Q ss_pred cCCCCc-----cccccCCccccccccccCCC-----CCCCcchHHHHHHHHHHHHhCCCCCccCCCChHHHHHHHHHhCC
Q 020826 166 YHPGKE-----YNVRVASRYFKGPELLVDLQ-----DYDYSLDLWSLGCMFAGMIFRKEPFFYGHDNYDQLVKIAKVLGT 235 (321)
Q Consensus 166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~-----~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 235 (321)
...... .....||+.|+|||++.+.. .++.++|||||||++|||+||..|+............. ...
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~---~~~ 234 (303)
T d1vjya_ 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL---VPS 234 (303)
T ss_dssp EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT---SCS
T ss_pred ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhc---ccc
Confidence 644322 23457899999999987522 25678999999999999999987764322210000000 000
Q ss_pred hhhhHHhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhcC
Q 020826 236 DELNAYLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMAH 305 (321)
Q Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~h 305 (321)
.... .............+. . .........+..+.+|+.+||+.||++|||+.|++++
T Consensus 235 ~~~~-----------~~~~~~~~~~~~~p~-~-~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 235 DPSV-----------EEMRKVVCEQKLRPN-I-PNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SCCH-----------HHHHHHHTTSCCCCC-C-CGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred cchH-----------HHHHHHHhccccCCC-C-CcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 0000 000000000000000 0 0000011122468999999999999999999999763
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.8e-46 Score=317.55 Aligned_cols=249 Identities=17% Similarity=0.254 Sum_probs=194.8
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEeccc-chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLIFE 98 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 98 (321)
+++|++.+.||+|+||+||+|++..+++.||||+++.. ....+.+|+..+..+.+++|++.+++++.. ....++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~--~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE--GLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE--TTEEEEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeec--CCccEEEEE
Confidence 57999999999999999999999999999999998643 346688999999999777999999999854 456679999
Q ss_pred eecCchhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCC----CCeEEEeeccceeecCCCC
Q 020826 99 HVNNTDFKVLY----PTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHE----QRKLRLIDWGLAEFYHPGK 170 (321)
Q Consensus 99 ~~~~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~----~~~v~l~dfg~~~~~~~~~ 170 (321)
++++ +|..++ ..++...+..++.|++.||+|||++||+||||||+||+++.. ...++|+|||+++......
T Consensus 82 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~ 160 (293)
T d1csna_ 82 LLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160 (293)
T ss_dssp CCCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred ecCC-CHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence 9964 444443 469999999999999999999999999999999999999642 2379999999998764321
Q ss_pred --------ccccccCCccccccccccCCCCCCCcchHHHHHHHHHHHHhCCCCCccCCCC--hHHHHHHHHHhCChhhhH
Q 020826 171 --------EYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMFAGMIFRKEPFFYGHDN--YDQLVKIAKVLGTDELNA 240 (321)
Q Consensus 171 --------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~~~~~~~~ 240 (321)
......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... ......+...........
T Consensus 161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~ 239 (293)
T d1csna_ 161 TKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE 239 (293)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred cccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHH
Confidence 1234579999999999987 78999999999999999999999999532222 111222211100000000
Q ss_pred HhhhhcccCChhhHhhhcccCCCCCccccccccccCCcchHHHHHHHhhccCCCCCcCHHHHhc
Q 020826 241 YLNKYHIELDPHLAALVGRHSRKPWSKFITVENQHLAVPEAVDFLDKLLRYDHQERPTAKEAMA 304 (321)
Q Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ll~~~l~~dp~~Rps~~ell~ 304 (321)
....+|+++.+++..|+..+|++||+.+.+.+
T Consensus 240 --------------------------------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 240 --------------------------------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp --------------------------------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred --------------------------------hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 11246689999999999999999998776543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=2.1e-25 Score=175.89 Aligned_cols=167 Identities=17% Similarity=0.204 Sum_probs=120.7
Q ss_pred eEEeeeeeeecceEEEEEEEecCCceEEEEEecccc---------------------hHHHHHHHHHHHhhcCCCCeeee
Q 020826 23 YEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---------------------KKKIKREIKILQNLCGGPNIVKL 81 (321)
Q Consensus 23 y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~---------------------~~~~~~E~~~l~~l~~h~~i~~~ 81 (321)
+.+.+.||+|+||+||+|++ .+|+.||||+++... ......|...+.++ .+++++..
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l-~~~~v~~~ 79 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKL-QGLAVPKV 79 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHT-TTSSSCCE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHc-cCCCcceE
Confidence 35788999999999999998 578999999875311 12245678888888 78899888
Q ss_pred eeeeeccCCCCcEEEEEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeeecCCCCCeEEcCCCCeEEEeecc
Q 020826 82 LDIVRDQQSKTPSLIFEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHEQRKLRLIDWG 161 (321)
Q Consensus 82 ~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~~~i~H~dlkp~nili~~~~~~v~l~dfg 161 (321)
+++.. .+++||++++..+.. ++...+..++.|++.+|++||++|++|+||||+||+++.+ .++|+|||
T Consensus 80 ~~~~~------~~lvme~~~~~~~~~----l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~--~~~liDFG 147 (191)
T d1zara2 80 YAWEG------NAVLMELIDAKELYR----VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE--GIWIIDFP 147 (191)
T ss_dssp EEEET------TEEEEECCCCEEGGG----CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT--EEEECCCT
T ss_pred EEecC------CEEEEEeeccccccc----hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC--CEEEEECC
Confidence 76541 269999999877654 4556677899999999999999999999999999999854 58999999
Q ss_pred ceeecCCCCccccccCCccccccccccCCCCCCCcchHHHHHHHH
Q 020826 162 LAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDYSLDLWSLGCMF 206 (321)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~~l 206 (321)
.+.....+........+. ....+.+. ..++.++|+||+.--+
T Consensus 148 ~a~~~~~~~~~~~l~rd~-~~~~~~f~--r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 148 QSVEVGEEGWREILERDV-RNIITYFS--RTYRTEKDINSAIDRI 189 (191)
T ss_dssp TCEETTSTTHHHHHHHHH-HHHHHHHH--HHHCCCCCHHHHHHHH
T ss_pred CcccCCCCCcHHHHHHHH-HHHHHHHc--CCCCCcccHHHHHHHH
Confidence 987654222111000000 00012221 4577889999985443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.53 E-value=7.4e-07 Score=71.76 Aligned_cols=139 Identities=18% Similarity=0.231 Sum_probs=91.2
Q ss_pred cCceEEeeeeeeecceEEEEEEEecCCceEEEEEecccc---hHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCCcEEE
Q 020826 20 QDDYEVVRKVGRGKYSEVFEGVHCTDNEKCIIKILKPVK---KKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKTPSLI 96 (321)
Q Consensus 20 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~~---~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 96 (321)
.+.|+..+..+.++.+.||+.. .++..+++|...... ...+.+|...++.+..+-.+++++.+..+. ...++|
T Consensus 13 ~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~--~~~~lv 88 (263)
T d1j7la_ 13 IEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD--GWSNLL 88 (263)
T ss_dssp HTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET--TEEEEE
T ss_pred hhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecC--CceEEE
Confidence 4567766655445557899875 466778888876432 345788999999886665677888776443 456799
Q ss_pred EEeecCchhhhhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 020826 97 FEHVNNTDFKVLYPTLSDYDVRYYIYELLKALDYCHS------------------------------------------- 133 (321)
Q Consensus 97 ~e~~~~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lh~------------------------------------------- 133 (321)
|++.+|.++........ ....++.++...++.||+
T Consensus 89 ~~~l~G~~~~~~~~~~~--~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T d1j7la_ 89 MSEADGVLCSEEYEDEQ--SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp EECCSSEEHHHHTTTCS--CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSS
T ss_pred EEecccccccccccccc--cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchH
Confidence 99999987754432211 111223333333333332
Q ss_pred ----------C------CCeeecCCCCCeEEcCCCCeEEEeeccceee
Q 020826 134 ----------Q------GIMHRDVKPHNVMIDHEQRKLRLIDWGLAEF 165 (321)
Q Consensus 134 ----------~------~i~H~dlkp~nili~~~~~~v~l~dfg~~~~ 165 (321)
. .++|+|+.|.||+++.++ .+.|+||+.+..
T Consensus 167 ~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~-~~~lIDwe~a~~ 213 (263)
T d1j7la_ 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK-VSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTE-EEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCc-eEEEeechhccc
Confidence 1 268999999999998654 567999997754
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.21 E-value=7.8e-06 Score=65.18 Aligned_cols=76 Identities=17% Similarity=0.126 Sum_probs=54.5
Q ss_pred eeeecc-eEEEEEEEecCCceEEEEEecccchHHHHHHHHHHHhhcCC-CCeeeeeeeeeccCCCCcEEEEEeecCchhh
Q 020826 29 VGRGKY-SEVFEGVHCTDNEKCIIKILKPVKKKKIKREIKILQNLCGG-PNIVKLLDIVRDQQSKTPSLIFEHVNNTDFK 106 (321)
Q Consensus 29 lg~g~~-g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~E~~~l~~l~~h-~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~ 106 (321)
+..|.. +.||+... .++..+++|.........+..|...++.+..+ -.+++++.+..+. ...+++|++++|.++.
T Consensus 18 ~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~--~~~~~v~~~i~G~~~~ 94 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEA--GRDWLLLGEVPGQDLL 94 (255)
T ss_dssp CSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS--SCEEEEEECCSSEETT
T ss_pred cCCcccCCeEEEEEe-CCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccc--cceEEEEEeeeccccc
Confidence 445554 67898875 56677899998777777789999999888543 2367777766443 4567999999887654
Q ss_pred h
Q 020826 107 V 107 (321)
Q Consensus 107 ~ 107 (321)
.
T Consensus 95 ~ 95 (255)
T d1nd4a_ 95 S 95 (255)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.07 E-value=1.3e-05 Score=68.20 Aligned_cols=74 Identities=15% Similarity=0.181 Sum_probs=49.0
Q ss_pred eeeeeeecceEEEEEEEecCCceEEEEEeccc----------chHHHHHHHHHHHhhcCC--CCeeeeeeeeeccCCCCc
Q 020826 26 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV----------KKKKIKREIKILQNLCGG--PNIVKLLDIVRDQQSKTP 93 (321)
Q Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~----------~~~~~~~E~~~l~~l~~h--~~i~~~~~~~~~~~~~~~ 93 (321)
.+.+|.|....||++.+..+++.+++|.-.+. ...+...|...++.+..+ ..+++++.+. .. ..
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~--~~ 106 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TE--MA 106 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TT--TT
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CC--CC
Confidence 44689999999999988777889999964321 224567788888877543 3466666553 32 34
Q ss_pred EEEEEeecCc
Q 020826 94 SLIFEHVNNT 103 (321)
Q Consensus 94 ~lv~e~~~~~ 103 (321)
+++||++.+.
T Consensus 107 ~lvmE~L~~~ 116 (392)
T d2pula1 107 VTVMEDLSHL 116 (392)
T ss_dssp EEEECCCTTS
T ss_pred EEEEeccCCc
Confidence 6999998764
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.29 E-value=0.0004 Score=57.14 Aligned_cols=70 Identities=13% Similarity=0.183 Sum_probs=44.3
Q ss_pred ceEEEEEEEecCCceEEEEEeccc--chHHHHHHHHHHHhhcCCC-Ceeeeeeee---eccCCCCcEEEEEeecCch
Q 020826 34 YSEVFEGVHCTDNEKCIIKILKPV--KKKKIKREIKILQNLCGGP-NIVKLLDIV---RDQQSKTPSLIFEHVNNTD 104 (321)
Q Consensus 34 ~g~v~~~~~~~~~~~~~vK~~~~~--~~~~~~~E~~~l~~l~~h~-~i~~~~~~~---~~~~~~~~~lv~e~~~~~~ 104 (321)
-..||++.. .+|..+++|+.++. ....+..|...+..|..+. .++..+... ........+.++++..|..
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 468999876 67889999998764 4577889999998884321 122222110 0012334567888887653
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.28 E-value=0.00096 Score=56.39 Aligned_cols=78 Identities=13% Similarity=0.152 Sum_probs=54.4
Q ss_pred CceEEeeeeeeecceEEEEEEEec-------CCceEEEEEeccc-chHHHHHHHHHHHhhcCCCCeeeeeeeeeccCCCC
Q 020826 21 DDYEVVRKVGRGKYSEVFEGVHCT-------DNEKCIIKILKPV-KKKKIKREIKILQNLCGGPNIVKLLDIVRDQQSKT 92 (321)
Q Consensus 21 ~~y~~~~~lg~g~~g~v~~~~~~~-------~~~~~~vK~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 92 (321)
+++++ +.|+.|-.-.+|++.... ..+.+++++.... ..-...+|..+++.+..+.-.+++++++.+
T Consensus 43 ~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----- 116 (395)
T d1nw1a_ 43 EHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----- 116 (395)
T ss_dssp GGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT-----
T ss_pred cceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC-----
Confidence 44554 468888888999988643 2356778876532 234467899999988666666788887732
Q ss_pred cEEEEEeecCchh
Q 020826 93 PSLIFEHVNNTDF 105 (321)
Q Consensus 93 ~~lv~e~~~~~~l 105 (321)
.+|++|+.|..+
T Consensus 117 -g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 -GRLEEYIPSRPL 128 (395)
T ss_dssp -EEEECCCCEEEC
T ss_pred -ceEEEEeccccC
Confidence 489999887644
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.12 E-value=0.00066 Score=55.47 Aligned_cols=46 Identities=13% Similarity=0.214 Sum_probs=30.1
Q ss_pred eeeeeeecceEEEEEEEecCCceEEEEEeccc-chHHHHHHHHHHHhhc
Q 020826 26 VRKVGRGKYSEVFEGVHCTDNEKCIIKILKPV-KKKKIKREIKILQNLC 73 (321)
Q Consensus 26 ~~~lg~g~~g~v~~~~~~~~~~~~~vK~~~~~-~~~~~~~E~~~l~~l~ 73 (321)
.+.|..|--.+.|+... ++..+++|++... ....+..|+.++..|.
T Consensus 23 ~~~i~~G~~N~ny~v~t--~~g~yVLri~~~~~~~~~l~~~~~~l~~L~ 69 (316)
T d2ppqa1 23 YKGIAEGVENSNFLLHT--TKDPLILTLYEKRVEKNDLPFFLGLMQHLA 69 (316)
T ss_dssp EEEECC---EEEEEEEE--SSCCEEEEEECC---CCHHHHHHHHHHHHH
T ss_pred eecCCCCcccCeEEEEE--CCCcEEEEEcCCCCCHHHHHHHHHHHHhhh
Confidence 44456677788999875 3346899998754 4567788888888884
|